PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zlitni, S; Ferruccio, LF; Brown, ED				Zlitni, Soumaya; Ferruccio, Lauren F.; Brown, Eric D.			Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation	NATURE CHEMICAL BIOLOGY			English	Article							SIGNATURE-TAGGED MUTAGENESIS; ESCHERICHIA-COLI; D-ALANINE; VIRULENCE GENES; D-CYCLOSERINE; ACID; BIOSYNTHESIS; DISCOVERY; GROWTH; 6-DIAZO-5-OXO-L-NORLEUCINE	Characterizing new drugs and chemical probes of biological systems is hindered by difficulties in identifying the mechanism of action (MOA) of biologically active molecules. Here we present a metabolite suppression approach to explore the MOA of antibacterial compounds under nutrient restriction. We assembled an array of metabolites that can be screened for suppressors of inhibitory molecules. Further, we identified inhibitors of Escherichia coli growth under nutrient limitation and charted their interactions with our metabolite array. This strategy led to the discovery and characterization of three new antibacterial compounds, MAC168425, MAC173979 and MAC13772. We showed that MAC168425 interferes with glycine metabolism, MAC173979 is a time-dependent inhibitor of p-aminobenzoic acid biosynthesis and MAC13772 inhibits biotin biosynthesis. We conclude that metabolite suppression profiling is an effective approach to focus MOA studies on compounds impairing metabolic capabilities. Such bioactives can serve as chemical probes of bacterial physiology and as leads for antibacterial drug development.	[Zlitni, Soumaya; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Zlitni, Soumaya; Ferruccio, Lauren F.; Brown, Eric D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Ferruccio, Lauren F.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca			Canadian Institutes of Health Research [MOP-81330]; Canada Research Chair award; Vanier Canada Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Vanier Canada Graduate Scholarship	We thank B. Wanner of Purdue University and H. Mori of the Nara Institute for providing the Keio library clones used in these studies, F. Nizam for developing and assisting in using the in-house web-based unweighted pair group method with arithmetic mean (UPGMA)-based cluster analysis tool, M. Keramane for NMR characterization of analogs used in this study and A. Capretta for inspiring discussions. We also thank J. Blanchard and C. Murphy for technical support during the primary screen. This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP-81330) and by a Canada Research Chair award to E. D. B. S. Z. was supported by the Vanier Canada Graduate Scholarship.	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; [Anonymous], 2004, CLUSTER ANAL RES; Baba Tomoya, 2008, V416, P171, DOI 10.1007/978-1-59745-321-9_11; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Brown ED, 2013, CAN J MICROBIOL, V59, P153, DOI 10.1139/cjm-2013-0089; Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; CHAMBERLAIN LM, 1993, MICROB PATHOGENESIS, V15, P51, DOI 10.1006/mpat.1993.1056; COBB JR, 1977, J BACTERIOL, V131, P789, DOI 10.1128/JB.131.3.789-794.1977; Copeland RA, 2004, ENZYMES PRACTICAL IN; CRONAN JE, 2008, ESCHERICHIA COLI SAL; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; EIDINOFF ML, 1958, CANCER RES, V18, P105; FISCHER RS, 1986, J BACTERIOL, V168, P1147, DOI 10.1128/jb.168.3.1147-1154.1986; GENGHOF DS, 1948, ARCH BIOCHEM, V17, P413; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Green J. C., 1996, ESCHERICHIA COLI SAL, P665; HANDSCHUMACHER RE, 1960, J BIOL CHEM, V235, P2917; Haselbeck R, 2002, CURR PHARM DESIGN, V8, P1155, DOI 10.2174/1381612023394818; Ho JMW, 2011, CAN MED ASSOC J, V183, P1851, DOI 10.1503/cmaj.111152; Hoon S, 2008, NAT CHEM BIOL, V4, P632, DOI 10.1038/nchembio1008-632; Hua Q, 2004, APPL ENVIRON MICROB, V70, P2354, DOI 10.1128/AEM.70.4.2354-2366.2004; LEVENBERG B, 1957, J BIOL CHEM, V225, P163; Li XM, 2004, CHEM BIOL, V11, P1423, DOI 10.1016/j.chembiol.2004.08.014; Lightcap ES, 1996, J MED CHEM, V39, P686, DOI 10.1021/jm950437v; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; MORRIS JG, 1969, BIOCHEM J, V115, P603, DOI 10.1042/bj1150603; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; NEUHAUS FC, 1964, BIOCHEMISTRY-US, V3, P471, DOI 10.1021/bi00892a001; Park SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002264; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pittard J., 2008, ESCHERICHIA COLI SAL; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; RICHMOND MH, 1962, BACTERIOL REV, V26, P398, DOI 10.1128/MMBR.26.4.398-420.1962; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Sambrook J., 2001, MOL CLONING LAB MANU; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider G, 2001, FEBS LETT, V495, P7, DOI 10.1016/S0014-5793(01)02325-0; Shapiro S, 2013, J ANTIBIOT, V66, P371, DOI 10.1038/ja.2013.27; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Stauffer G.V., 2004, ESCHERICHIA COLI SAL; STOKSTAD ELR, 1987, J NUTR, V117, P1335, DOI 10.1093/jn/117.7.1335; STONER GL, 1975, J BIOL CHEM, V250, P4037; STROMINGER JL, 1960, J AM CHEM SOC, V82, P998, DOI 10.1021/ja01489a058; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Walsh C., 2003, ANTIBIOTICS ACTIONS; WALSH CT, 1987, BIOCHEMISTRY-US, V26, P4734, DOI 10.1021/bi00389a021; WARGEL RJ, 1970, J BACTERIOL, V103, P778, DOI 10.1128/JB.103.3.778-788.1970; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; ZAWADZKE LE, 1991, BIOCHEMISTRY-US, V30, P1673, DOI 10.1021/bi00220a033; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	57	78	80	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					796	+		10.1038/NCHEMBIO.1361	http://dx.doi.org/10.1038/NCHEMBIO.1361			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24121552	Green Accepted			2022-12-27	WOS:000327130000011
J	Schmeisser, K; Mansfeld, J; Kuhlow, D; Weimer, S; Priebe, S; Heiland, I; Birringer, M; Groth, M; Segref, A; Kanfi, Y; Price, NL; Schmeisser, S; Schuster, S; Pfeiffer, AFH; Guthke, R; Platzer, M; Hoppe, T; Cohen, HY; Zarse, K; Sinclair, DA; Ristow, M				Schmeisser, Kathrin; Mansfeld, Johannes; Kuhlow, Doreen; Weimer, Sandra; Priebe, Steffen; Heiland, Ines; Birringer, Marc; Groth, Marco; Segref, Alexandra; Kanfi, Yariv; Price, Nathan L.; Schmeisser, Sebastian; Schuster, Stefan; Pfeiffer, Andreas F. H.; Guthke, Reinhard; Platzer, Matthias; Hoppe, Thorsten; Cohen, Haim Y.; Zarse, Kim; Sinclair, David A.; Ristow, Michael			Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide	NATURE CHEMICAL BIOLOGY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; ALDEHYDE OXIDASE; COMPLEX-I; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; LONGEVITY; ELEGANS; STRESS; SIR2; GENE	Sirtuins, a family of histone deacetylases, have a fiercely debated role in regulating lifespan. In contrast with recent observations, here we find that overexpression of sir-2.1, the ortholog of mammalian SirT1, does extend Caenorhabditis elegans lifespan. Sirtuins mandatorily convert NAD(+) into nicotinamide (NAM). We here find that NAM and its metabolite, 1-methylnicotinamide (MNA), extend C. elegans lifespan, even in the absence of sir-2.1. We identify a previously unknown C. elegans nicotinamide-N-methyltransferase, encoded by a gene now named anmt-1, to generate MNA from NAM. Disruption and overexpression of anmt-1 have opposing effects on lifespan independent of sirtuins, with loss of anmt-1 fully inhibiting sir-2.1-mediated lifespan extension. MNA serves as a substrate for a newly identified aldehyde oxidase, GAD-3, to generate hydrogen peroxide, which acts as a mitohormetic reactive oxygen species signal to promote C. elegans longevity. Taken together, sirtuin-mediated lifespan extension depends on methylation of NAM, providing an unexpected mechanistic role for sirtuins beyond histone deacetylation.	[Schmeisser, Kathrin; Mansfeld, Johannes; Kuhlow, Doreen; Schmeisser, Sebastian; Zarse, Kim; Ristow, Michael] Univ Jena, Inst Nutr, Dept Human Nutr, Jena, Germany; [Mansfeld, Johannes; Weimer, Sandra; Zarse, Kim; Ristow, Michael] Swiss Fed Inst Technol, Energy Metab Lab, Zurich, Switzerland; [Mansfeld, Johannes] DFG Res Training Grp 1715 Mol Signatures Adapt St, Jena, Germany; [Kuhlow, Doreen; Weimer, Sandra; Pfeiffer, Andreas F. H.; Ristow, Michael] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Nuthetal, Germany; [Priebe, Steffen; Guthke, Reinhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Syst Biol & Bioinformat Grp, Jena, Germany; [Heiland, Ines; Schuster, Stefan] Univ Jena, Dept Bioinformat, Jena, Germany; [Birringer, Marc] Univ Appl Sci, Dept Nutr Food & Consumer Studies, Fulda, Germany; [Groth, Marco; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Segref, Alexandra; Hoppe, Thorsten] Univ Cologne, Inst Genet, Cologne, Germany; [Segref, Alexandra; Hoppe, Thorsten] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Kanfi, Yariv; Cohen, Haim Y.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Price, Nathan L.; Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Glenn Labs Biol Mech Aging, Boston, MA USA; [Schmeisser, Sebastian] Fritz Lipmann Inst, Leibniz Inst Age Res, Leibniz Grad Sch Aging, Jena, Germany	Friedrich Schiller University of Jena; Swiss Federal Institutes of Technology Domain; ETH Zurich; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Cologne; University of Cologne; Bar Ilan University; Harvard University; Harvard Medical School; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Schmeisser, K (corresponding author), Univ Jena, Inst Nutr, Dept Human Nutr, Jena, Germany.	mristow@mristow.org	Ristow, Michael/O-9858-2014; Zarse, Kim/D-2133-2016; Heiland, Ines/B-9212-2014; Kornweitz, Haya/L-6469-2018; Hoppe, Thorsten/AAC-7880-2020; Pfeiffer, Andreas F.H./AAJ-2311-2020	Ristow, Michael/0000-0003-2109-2453; Zarse, Kim/0000-0003-2542-6123; Heiland, Ines/0000-0002-9124-5112; Kornweitz, Haya/0000-0002-3562-0141; Pfeiffer, Andreas F.H./0000-0002-6887-0016; Hoppe, Thorsten/0000-0002-4734-9352; Segref, Alexandra/0000-0001-8095-4469; Cohen, Haim Y./0000-0002-6613-8710; Birringer, Marc/0000-0003-0343-4704; Price, Nathan/0000-0002-2821-9608; Sinclair, David/0000-0002-9936-436X	US National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; research program of the Jena Centre for Systems Biology of Ageing (JenAge); German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) [BMBF 0315581]; NIH; National Institute on Aging; United Mitochondrial Disease Foundation; Glenn Medical Foundation; NATIONAL INSTITUTE ON AGING [R37AG028730] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); research program of the Jena Centre for Systems Biology of Ageing (JenAge); German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); United Mitochondrial Disease Foundation; Glenn Medical Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Most of the C. elegans strains used in this work were provided by the Caenorhabditis Genetics Center (University of Minnesota), which is funded by the US National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440). The strains LG389 and LG390 were a kind gift of L. Guarente and M. Viswanathan (both from Massachusetts Institute of Technology). The excellent technical assistance of I. Heinze, B. Laube, A. Muller, S. Richter and W. Scheiding as well as the excellent secretarial assistance of M. Schalowski are gratefully acknowledged. The RNA sequencing data contained in this manuscript were funded by the research program of the Jena Centre for Systems Biology of Ageing (JenAge) funded by the German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung; support code BMBF 0315581). D.A.S. is supported by grants from the NIH and National Institute on Aging, the United Mitochondrial Disease Foundation and the Glenn Medical Foundation.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Banerjee KK, 2012, CELL REP, V2, P1485, DOI 10.1016/j.celrep.2012.11.013; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; CANTONI GL, 1951, J BIOL CHEM, V189, P203; Chlopicki S, 2012, PHARMACOL REP, V64, P369; CRAWFORD DL, 1982, ARCH MICROBIOL, V131, P351, DOI 10.1007/BF00411185; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; FUKUSHIMA T, 1995, J NEUROSCI RES, V42, P385, DOI 10.1002/jnr.490420313; Gebicki J., 2011, US Patent, Patent No. [7,935,717 B2 10, 7935717]; Gossmann TI, 2012, FEBS J, V279, P3355, DOI 10.1111/j.1742-4658.2012.08559.x; Hashimoto T, 2010, BIOGERONTOLOGY, V11, P31, DOI 10.1007/s10522-009-9225-3; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kundu TK, 2007, ARCH BIOCHEM BIOPHYS, V460, P113, DOI 10.1016/j.abb.2006.12.032; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Link CD, 2002, METHOD ENZYMOL, V353, P497; Maeda K, 2012, GENE, V505, P374, DOI 10.1016/j.gene.2012.06.010; Merksamer PI, 2013, AGING-US, V5, P144, DOI 10.18632/aging.100544; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Musfeld C, 2001, J PHARMACEUT BIOMED, V24, P391, DOI 10.1016/S0731-7085(00)00425-8; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Panoutsopoulos GI, 2004, ACTA BIOCHIM POL, V51, P943; Parsons RB, 2011, BIOCHEM J, V436, P145, DOI 10.1042/BJ20101685; Priebe S, 2011, FUNGAL GENET BIOL, V48, P353, DOI 10.1016/j.fgb.2010.11.001; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Rizki G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002235; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sawyer JM, 2011, GENETICS, V188, P549, DOI 10.1534/genetics.111.129486; Schmeisser S, 2013, MOL METAB, V2, P92, DOI 10.1016/j.molmet.2013.02.002; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Segref A, 2012, METHODS MOL BIOL, V832, P531, DOI 10.1007/978-1-61779-474-2_38; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; van der Horst A, 2007, MECH AGEING DEV, V128, P346, DOI 10.1016/j.mad.2007.01.004; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Webster BR, 2012, FREE RADICAL BIO MED, V52, P281, DOI 10.1016/j.freeradbiomed.2011.10.484; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	56	150	158	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					693	+		10.1038/NCHEMBIO.1352	http://dx.doi.org/10.1038/NCHEMBIO.1352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24077178	Green Accepted			2022-12-27	WOS:000325930500008
J	Schenone, M; Dancik, V; Wagner, BK; Clemons, PA				Schenone, Monica; Dancik, Vlado; Wagner, Bridget K.; Clemons, Paul A.			Target identification and mechanism of action in chemical biology and drug discovery	NATURE CHEMICAL BIOLOGY			English	Review							MAMMALIAN HISTONE DEACETYLASE; SMALL-MOLECULE PROBES; HIGH-THROUGHPUT; PROTEIN QUANTITATION; SELECTIVE ENRICHMENT; IN-VITRO; PROTEOMICS; EXPRESSION; GENETICS; PHARMACOLOGY	Target-identification and mechanism-of-action studies have important roles in small-molecule probe and drug discovery. Biological and technological advances have resulted in the increasing use of cell-based assays to discover new biologically active small molecules. Such studies allow small-molecule action to be tested in a more disease-relevant setting at the outset, but they require follow-up studies to determine the precise protein target or targets responsible for the observed phenotype. Target identification can be approached by direct biochemical methods, genetic interactions or computational inference. In many cases, however, combinations of approaches may be required to fully characterize on-target and off-target effects and to understand mechanisms of small-molecule action.	[Schenone, Monica] Broad Inst Harvard & MIT, Cambridge, MA USA; [Dancik, Vlado; Wagner, Bridget K.; Clemons, Paul A.] Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Clemons, PA (corresponding author), Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA USA.	pclemons@broadinstitute.org			US National Institutes of Health Genomics Based Drug Discovery [RL1HG004671]; US National Institutes of Health [RL1CA133834, RL1GM084437, UL1RR024924]; NATIONAL CANCER INSTITUTE [RL1CA133834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER	US National Institutes of Health Genomics Based Drug Discovery(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health Genomics Based Drug Discovery-Target ID Project grant RL1HG004671, which is administratively linked to the US National Institutes of Health grants RL1CA133834, RL1GM084437 and UL1RR024924.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Boran ADW, 2010, MT SINAI J MED, V77, P333, DOI 10.1002/msj.20191; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Brehmer D, 2004, MOL CELL PROTEOMICS, V3, P490, DOI 10.1074/mcp.M300139-MCP200; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carpenter AE, 2007, NAT CHEM BIOL, V3, P461, DOI 10.1038/nchembio.2007.15; Castoreno AB, 2010, NAT CHEM BIOL, V6, P457, DOI 10.1038/nchembio.363; Chan JNY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016642; Chen B, 2009, J CHEM INF MODEL, V49, P2044, DOI 10.1021/ci9001876; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Cheng TJ, 2011, J CHEM INF MODEL, V51, P2440, DOI 10.1021/ci200192v; Cisar JS, 2012, J AM CHEM SOC, V134, P10385, DOI 10.1021/ja304213w; Clemons PA, 2004, CURR OPIN CHEM BIOL, V8, P334, DOI 10.1016/j.cbpa.2004.04.002; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; CUATRECA.P, 1968, P NATL ACAD SCI USA, V61, P636, DOI 10.1073/pnas.61.2.636; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dixon SL, 1998, J CHEM INF COMP SCI, V38, P1192, DOI 10.1021/ci980105+; Ecker A, 2008, MOL MICROBIOL, V70, P209, DOI 10.1111/j.1365-2958.2008.06407.x; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fleischer TC, 2010, CHEM BIOL, V17, P659, DOI 10.1016/j.chembiol.2010.05.008; Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101; Fomina-Yadlin D, 2010, P NATL ACAD SCI USA, V107, P15099, DOI 10.1073/pnas.1010018107; Fonovic M, 2007, MOL CELL PROTEOMICS, V6, P1761, DOI 10.1074/mcp.M700124-MCP200; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Gregori-Puigjane E, 2012, P NATL ACAD SCI USA, V109, P11178, DOI 10.1073/pnas.1204524109; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Haupt VJ, 2011, BRIEF BIOINFORM, V12, P312, DOI 10.1093/bib/bbr011; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kauselmann G, 2012, CURR CANCER DRUG TAR, V12, P1; KAUVAR LM, 1995, CHEM BIOL, V2, P107, DOI 10.1016/1074-5521(95)90283-X; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khersonsky SM, 2003, J AM CHEM SOC, V125, P11804, DOI 10.1021/ja035334d; Kim YK, 2004, J AM CHEM SOC, V126, P14740, DOI 10.1021/ja048170p; Kim YK, 2007, MOL BIOSYST, V3, P392, DOI 10.1039/b702321a; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Koehn Frank E., 2008, V65; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Kuai LT, 2011, CHEM BIOL, V18, P891, DOI 10.1016/j.chembiol.2011.03.017; Lachance H, 2012, J MED CHEM, V55, P5989, DOI 10.1021/jm300288g; Laggner C, 2012, NAT CHEM BIOL, V8, P144, DOI 10.1038/nchembio.732; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Margolin AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007454; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; McNamara C, 2011, FUTURE MICROBIOL, V6, P693, DOI [10.2217/fmb.11.45, 10.2217/FMB.11.45]; Mei JP, 2013, BIOINFORMATICS, V29, P238, DOI 10.1093/bioinformatics/bts670; Mertins P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014423; Mitchison TJ, 1994, CHEM BIOL, V1, P3, DOI 10.1016/1074-5521(94)90034-5; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Nielsen TE, 2008, ANGEW CHEM INT EDIT, V47, P48, DOI 10.1002/anie.200703073; O'Connor CJ, 2012, CHEM SOC REV, V41, P4444, DOI 10.1039/c2cs35023h; Oda Y, 2003, ANAL CHEM, V75, P2159, DOI 10.1021/ac026196y; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Park J, 2012, ANGEW CHEM INT EDIT, V51, P5447, DOI 10.1002/anie.201200609; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Petrone FM, 2012, ACS CHEM BIOL, V7, P1399, DOI 10.1021/cb3001028; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Pierce SE, 2006, NAT METHODS, V3, P601, DOI 10.1038/NMETH905; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Roemer T, 2013, NAT CHEM BIOL, V9, P222, DOI [10.1038/NCHEMBIO.1205, 10.1038/nchembio.1205]; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saxena C, 2009, J PROTEOME RES, V8, P3951, DOI 10.1021/pr900277x; Schreiber SL, 1998, BIOORGAN MED CHEM, V6, P1127, DOI 10.1016/S0968-0896(98)00126-6; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Shiyama T, 2004, BIOORGAN MED CHEM, V12, P2831, DOI 10.1016/j.bmc.2004.03.052; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundberg SA, 2000, CURR OPIN BIOTECH, V11, P47, DOI 10.1016/S0958-1669(99)00051-8; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tanikawa T, 2009, J AM CHEM SOC, V131, P5075, DOI 10.1021/ja806583y; Tao SC, 2007, COMB CHEM HIGH T SCR, V10, P706, DOI 10.2174/138620707782507386; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Thompson A, 2006, ANAL CHEM, V78, P4235, DOI 10.1021/ac060310l; Tsou CC, 2009, NUCLEIC ACIDS RES, V37, pW661, DOI 10.1093/nar/gkp476; van der Veken P, 2005, CHEMBIOCHEM, V6, P2271, DOI 10.1002/cbic.200500209; Verhelst SHL, 2007, ANGEW CHEM INT EDIT, V46, P1284, DOI 10.1002/anie.200603811; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Wagner BK, 2009, CURR OPIN CHEM BIOL, V13, P539, DOI 10.1016/j.cbpa.2009.09.018; Wang GL, 2007, P NATL ACAD SCI USA, V104, P2068, DOI 10.1073/pnas.0610832104; Wang J, 2008, J BIOMOL SCREEN, V13, P29, DOI 10.1177/1087057107311223; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wen Q, 2012, CELL, V150, P575, DOI 10.1016/j.cell.2012.06.032; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9; Winter GE, 2012, NAT CHEM BIOL, V8, P905, DOI [10.1038/nchembio.1085, 10.1038/NCHEMBIO.1085]; Wissing J, 2004, MOL CELL PROTEOMICS, V3, P1181, DOI 10.1074/mcp.M400124-MCP200; Wolpaw AJ, 2011, P NATL ACAD SCI USA, V108, pE771, DOI 10.1073/pnas.1106149108; Wyatt PG, 2011, CURR TOP MED CHEM, V11, P1275; Xie L, 2011, CURR OPIN STRUC BIOL, V21, P189, DOI 10.1016/j.sbi.2011.01.004; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; YOSHIDA M, 1987, CANCER RES, V47, P3688; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zheng XFS, 2004, CHEM BIOL, V11, P609, DOI 10.1016/j.chembiol.2003.08.011	147	562	582	17	507	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					232	240		10.1038/NCHEMBIO.1199	http://dx.doi.org/10.1038/NCHEMBIO.1199			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23508189	Green Accepted			2022-12-27	WOS:000317025800011
J	Theofilopoulos, S; Wang, YQ; Kitambi, SS; Sacchetti, P; Sousa, KM; Bodin, K; Kirk, J; Salto, C; Gustafsson, M; Toledo, EM; Karu, K; Gustafsson, JA; Steffensen, KR; Ernfors, P; Sjovall, J; Griffiths, WJ; Arenas, E				Theofilopoulos, Spyridon; Wang, Yuqin; Kitambi, Satish Srinivas; Sacchetti, Paola; Sousa, Kyle M.; Bodin, Karl; Kirk, Jayne; Salto, Carmen; Gustafsson, Magnus; Toledo, Enrique M.; Karu, Kersti; Gustafsson, Jan-Ake; Steffensen, Knut R.; Ernfors, Patrik; Sjovall, Jan; Griffiths, William J.; Arenas, Ernest			Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATED NUCLEAR RECEPTORS; CENTRAL-NERVOUS-SYSTEM; BILE-ACIDS; LXR-ALPHA; CHOLESTEROL-METABOLISM; LIPID HOMEOSTASIS; STEM-CELLS; OXYSTEROLS; BETA; MICE	Liver X receptors (Lxr alpha and Lxr beta) are ligand-dependent nuclear receptors critical for ventral midbrain neurogenesis in vivo. However, no endogenous midbrain Lxr ligand has so far been identified. Here we used LC/MS and functional assays to identify cholic acid as a new Lxr ligand. Moreover, 24(S),25-epoxycholesterol (24,25-EC) was found to be the most potent and abundant Lxr ligand in the developing mouse midbrain. Both Lxr ligands promoted neural development in an Lxr-dependent manner in zebrafish in vivo. Notably, each ligand selectively regulated the development of distinct midbrain neuronal populations. Whereas cholic acid increased survival and neurogenesis of Brn3a-positive red nucleus neurons, 24,25-EC promoted dopaminergic neurogenesis. These results identify an entirely new class of highly selective and cell type-specific regulators of neurogenesis and neuronal survival. Moreover, 24,25-EC promoted dopaminergic differentiation of embryonic stem cells, suggesting that Lxr ligands may thus contribute to the development of cell replacement and regenerative therapies for Parkinson's disease.	[Theofilopoulos, Spyridon; Kitambi, Satish Srinivas; Sacchetti, Paola; Sousa, Kyle M.; Bodin, Karl; Salto, Carmen; Gustafsson, Magnus; Toledo, Enrique M.; Ernfors, Patrik; Sjovall, Jan; Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden; [Wang, Yuqin; Griffiths, William J.] Swansea Univ, Inst Mass Spectrometry, Coll Med, Swansea, W Glam, Wales; [Kirk, Jayne] Waters UK Ltd, Manchester, Lancs, England; [Karu, Kersti] Univ London, Sch Pharm, London WC1N 1AX, England; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Steffensen, Knut R.] Ctr Biosci, Dept Biosci & Nutr, Stockholm, Sweden	Karolinska Institutet; Swansea University; Waters UK; University of London; University College London; University of London School of Pharmacy; University of Houston System; University of Houston	Arenas, E (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden.	ernest.arenas@ki.se	Theofilopoulos, Spyridon/E-1508-2011; Theofilopoulos, Spyridon/B-2075-2015; Arenas, Ernest/AAO-5231-2020; Sacchetti, Paola/ABC-8884-2021; Toledo, Enrique/E-8860-2010; griffiths, william/N-4641-2016	Theofilopoulos, Spyridon/0000-0003-1986-0943; Arenas, Ernest/0000-0003-0197-6577; Sacchetti, Paola/0000-0002-6390-2744; Ernfors, Patrik/0000-0002-1140-3986; Steffensen, Knut/0000-0001-6093-2801; wang, yuqin/0000-0002-3063-3066; Toledo, Enrique/0000-0002-1460-4708; griffiths, william/0000-0002-4129-6616	Hjarnfonden; European Union; Swedish Foundation for Strategic Research; Karolinska Institutet; Karolinska Institutet (Thematic Center in Stem Cells and Regenerative Medicine); Swedish Research Council (DBRM) [2008:2811, 2011-3116, 3318]; UK Research Councils Biotechnology and Biological Sciences Research Council [BB/C515771/2, BB/C511356/1, BB/I001735/1, BB/H001018/1]; Swedish Medical Research Council; Onassis Foundation; BBSRC [BB/I001735/1, BB/H001018/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001018/1, BB/I001735/1, BB/C515771/2, BB/C511356/1] Funding Source: researchfish	Hjarnfonden; European Union(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Karolinska Institutet(Karolinska Institutet); Karolinska Institutet (Thematic Center in Stem Cells and Regenerative Medicine); Swedish Research Council (DBRM)(Swedish Research Council); UK Research Councils Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Onassis Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work in Karolinska was supported by Hjarnfonden, European Union (Strokemap and NeuroStemCell projects), Swedish Foundation for Strategic Research (SRL Program), Karolinska Institutet (Strategic Research Program and Thematic Center in Stem Cells and Regenerative Medicine) and the Swedish Research Council (DBRM, 2008:2811, 2011-3116 and 3318). The authors are grateful to L. Jansson-Sjostrand and J. Soderlund for technical assistance, A. Nanni for secretarial help and S. Yang for help with artwork. Work in Swansea was supported by funding from the UK Research Councils Biotechnology and Biological Sciences Research Council (BB/C515771/2, BB/C511356/1 and BB/I001735/1 to W.J.G. and BB/H001018/1 to Y.W.). S.T. was supported by the Swedish Medical Research Council and the Onassis Foundation.	Alberti S, 2000, GENE, V243, P93, DOI 10.1016/S0378-1119(99)00555-7; Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Berrodin TJ, 2010, MOL PHARMACOL, V78, P1046, DOI 10.1124/mol.110.065193; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; CLARE K, 1995, ATHEROSCLEROSIS, V118, P67, DOI 10.1016/0021-9150(95)05594-M; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; Goodwin BJ, 2008, CURR TOP MED CHEM, V8, P781, DOI 10.2174/156802608784535075; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kornyei Z, 2007, FASEB J, V21, P2496, DOI 10.1096/fj.06-7756com; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mano N, 2004, J LIPID RES, V45, P295, DOI 10.1194/jlr.M300369-JLR200; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Song C, 2000, ENDOCRINOLOGY, V141, P4180, DOI 10.1210/en.141.11.4180; Song C, 2000, STEROIDS, V65, P423, DOI 10.1016/S0039-128X(00)00127-6; Tint GS, 2006, J LIPID RES, V47, P1535, DOI 10.1194/jlr.M600141-JLR200; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Viennois E, 2011, EXPERT OPIN THER TAR, V15, P219, DOI 10.1517/14728222.2011.547853; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Wang YQ, 2009, MOL BIOSYST, V5, P529, DOI 10.1039/b819502a; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	49	91	94	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					126	133		10.1038/NCHEMBIO.1156	http://dx.doi.org/10.1038/NCHEMBIO.1156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23292650				2022-12-27	WOS:000314083200012
J	Baker, RP; Urban, S				Baker, Rosanna P.; Urban, Sinisa			Architectural and thermodynamic principles underlying intramembrane protease function	NATURE CHEMICAL BIOLOGY			English	Article							HELICAL MEMBRANE-PROTEINS; UNFOLDING FREE-ENERGY; TRANSMEMBRANE HELIX; ASPARTYL PROTEASES; RHOMBOID PROTEASE; GAMMA-SECRETASE; PROTEOLYSIS; STABILITY; ASSOCIATION; REVEALS	Intramembrane proteases hydrolyze peptide bonds within the membrane as a signaling paradigm universal to all life forms and with implications in disease. Deciphering the architectural strategies supporting intramembrane proteolysis is an essential but unattained goal. We integrated new, quantitative and high-throughput thermal light-scattering technology, reversible equilibrium unfolding and refolding and quantitative protease assays to interrogate rhomboid architecture with 151 purified variants. Rhomboid proteases maintain low intrinsic thermodynamic stability (Delta G = 2.1-4.5 kcal mol(-1)) resulting from a multitude of generally weak transmembrane packing interactions, making them highly responsive to their environment. Stability is consolidated by two buried glycines and several packing leucines, with a few multifaceted hydrogen bonds strategically deployed to two peripheral regions. Opposite these regions lie transmembrane segment 5 and connected loops that are notably exempt of structural responsibility, suggesting intramembrane proteolysis involves considerable but localized protein dynamics. Our analyses provide a comprehensive 'heat map' of the physiochemical anatomy underlying membrane-immersed enzyme function at, what is to our knowledge, unprecedented resolution.	[Baker, Rosanna P.; Urban, Sinisa] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21218 USA	Howard Hughes Medical Institute; Johns Hopkins University	Baker, RP (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21218 USA.	surban@jhmi.edu		Baker, Rosanna/0000-0002-9970-6278	Howard Hughes Medical Institute; David and Lucile Packard Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We are grateful to all members of the Urban lab and to D. Otzen for stimulating scientific discussions and to the Malaria Research Institute Biophysics Core for use of their CD spectropolarimeter. This work was supported by the Howard Hughes Medical Institute and the David and Lucile Packard Foundation.	Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Booth PJ, 2009, CURR OPIN STRUC BIOL, V19, P8, DOI 10.1016/j.sbi.2008.12.005; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; Curnow P, 2010, J MOL BIOL, V403, P630, DOI 10.1016/j.jmb.2010.09.003; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107; Fluhrer R, 2008, J BIOL CHEM, V283, P30121, DOI 10.1074/jbc.M806092200; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0; Joh NH, 2009, J AM CHEM SOC, V131, P10846, DOI 10.1021/ja904711k; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Senisterra GA, 2010, J BIOMOL SCREEN, V15, P314, DOI 10.1177/1087057109357117; Tastan O, 2009, BIOPHYS J, V96, P2299, DOI 10.1016/j.bpj.2008.12.3894; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2008, BIOL CHEM, V389, P1107, DOI 10.1515/BC.2008.122; Urban S, 2010, BIOCHEM J, V425, P501, DOI 10.1042/BJ20090861; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Veerappan A, 2011, BIOCHEMISTRY-US, V50, P10223, DOI 10.1021/bi201266m; Vinothkumar KR, 2011, J MOL BIOL, V407, P232, DOI 10.1016/j.jmb.2011.01.029; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yeh AP, 2006, ACTA CRYSTALLOGR D, V62, P451, DOI 10.1107/S0907444906005233; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	43	76	78	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					759	768		10.1038/NCHEMBIO.1021	http://dx.doi.org/10.1038/NCHEMBIO.1021			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22797666	Green Accepted			2022-12-27	WOS:000308077600007
J	Bianco, A; Townsley, FM; Greiss, S; Lang, K; Chin, JW				Bianco, Ambra; Townsley, Fiona M.; Greiss, Sebastian; Lang, Kathrin; Chin, Jason W.			Expanding the genetic code of Drosophila melanogaster	NATURE CHEMICAL BIOLOGY			English	Article							MAMMALIAN-CELLS; RECOMBINANT PROTEINS; AMINO-ACIDS; TRANSFORMATION; EXPRESSION	Genetic code expansion for unnatural amino acid mutagenesis has, until recently, been limited to cell culture. We demonstrate the site-specific incorporation of unnatural amino acids into proteins in Drosophila melanogaster at different developmental stages, in specific tissues and in a subset of cells within a tissue. This approach provides a foundation for probing and controlling processes in this established metazoan model organism with a new level of molecular precision.	[Bianco, Ambra; Townsley, Fiona M.; Greiss, Sebastian; Lang, Kathrin; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bianco, A (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	chin@mrc-lmb.cam.ac.uk	Greiss, Sebastian/B-2395-2015; Lang, Kathrin/AAD-2559-2020; Lang, Kathrin/M-6472-2015	Greiss, Sebastian/0000-0001-9130-0831; Lang, Kathrin/0000-0002-1318-6567	UK Medical Research Council (MRC) [U105181009, UD99999908]; Louis-Jeantet Foundation Young Investigator Career Award; MRC [MC_UP_A024_1008] Funding Source: UKRI; Medical Research Council [MC_UP_A024_1008] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Louis-Jeantet Foundation Young Investigator Career Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council (MRC) (grants U105181009 and UD99999908) and the Louis-Jeantet Foundation Young Investigator Career Award (both to J.W.C.). We are grateful to S. Bullock (MRC Laboratory of Molecular Biology) for providing initial plasmids and for extensive help and advice with this project; to S. Peak-Chew and M. Skehel in the MRC Laboratory of Molecular Biology Mass Spectrometry Facility for MS; S. Brunner for assistance with statistical analysis; and J. Schmitz and R. Pisa for experimental assistance.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; GARZA D, 1990, GENETICS, V126, P625; Gautier A, 2011, J AM CHEM SOC, V133, P2124, DOI 10.1021/ja1109979; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Isogai Y, 2007, EMBO J, V26, P76, DOI 10.1038/sj.emboj.7601448; Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250; LASKI FA, 1989, P NATL ACAD SCI USA, V86, P6696, DOI 10.1073/pnas.86.17.6696; Lemke EA, 2007, NAT CHEM BIOL, V3, P769, DOI 10.1038/nchembio.2007.44; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Mukai T, 2010, PROTEIN SCI, V19, P440, DOI 10.1002/pro.322; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Nguyen D.P., 2012, THESIS U CAMBRIDGE; Nguyen DP, 2009, J AM CHEM SOC, V131, P14194, DOI 10.1021/ja906603s; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Pignoni F, 1997, DEVELOPMENT, V124, P271; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Van Doren M, 1998, CURR BIOL, V8, P243; WASHBURN T, 1992, GENETICS, V130, P585	25	145	150	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					748	750		10.1038/NCHEMBIO.1043	http://dx.doi.org/10.1038/NCHEMBIO.1043			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22864544				2022-12-27	WOS:000308077600005
J	Fierz, B; Muir, TW				Fierz, Beat; Muir, Tom W.			Chromatin as an expansive canvas for chemical biology	NATURE CHEMICAL BIOLOGY			English	Review							HISTONE DEACETYLASE INHIBITORS; PLURIPOTENT STEM-CELLS; BINDING MODULES; PEPTIDE UBIQUITYLATION; PROTEIN INTERACTIONS; LYSINE METHYLATION; DNA INTERACTIONS; NUCLEOSOME CORE; H3 METHYLATION; SET DOMAIN	Chromatin is extensively chemically modified and thereby acts as a dynamic signaling platform controlling gene function. Chromatin regulation is integral to cell differentiation, lineage commitment and organism development, whereas chromatin dysregulation can lead to age-related and neurodegenerative disorders as well as cancer. Investigating chromatin biology presents a unique challenge, as the issue spans many disciplines, including cell and systems biology, biochemistry and molecular biophysics. In recent years, the application of chemical biology methods for investigating chromatin processes has gained considerable traction. Indeed, chemical biologists now have at their disposal powerful chemical tools that allow chromatin biology to be scrutinized at the level of the cell all the way down to the single chromatin fiber. Here we present recent examples of how this rapidly expanding palette of chemical tools is being used to paint a detailed picture of chromatin function in organism development and disease.	[Fierz, Beat; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University	Fierz, B (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	muir@princeton.edu	Fierz, Beat/H-3143-2012; Muir, Tom/AHD-0860-2022	Fierz, Beat/0000-0002-2991-3044; Muir, Tom/0000-0001-9635-0344	US National Institutes of Health; Swiss National Science Foundation [PA00P3-129130]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107047] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Some of the work discussed in this article was performed in the authors' group and was supported by the US National Institutes of Health and by the Swiss National Science Foundation, No. PA00P3-129130 (B. F.). We thank members of the Muir laboratory for critical reading of this article and apologize to the researchers whose work could not be cited because of space restraints.	[Anonymous], 2009, [No title captured], Patent No. [2009084693, WO2009084693]; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bieliauskas AV, 2008, CHEM SOC REV, V37, P1402, DOI 10.1039/b703830p; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Borah JC, 2011, CHEM BIOL, V18, P531, DOI 10.1016/j.chembiol.2010.12.021; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Chatterjee C, 2007, ANGEW CHEM INT EDIT, V46, P2814, DOI 10.1002/anie.200605155; Chatterjee C, 2010, J BIOL CHEM, V285, P11045, DOI 10.1074/jbc.R109.080291; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Garske AL, 2008, BIOCHEMISTRY-US, V47, P8094, DOI 10.1021/bi800766k; Garske AL, 2010, NAT CHEM BIOL, V6, P283, DOI [10.1038/NCHEMBIO.319, 10.1038/nchembio.319]; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kee JM, 2010, J AM CHEM SOC, V132, P14327, DOI 10.1021/ja104393t; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kumar KSA, 2009, ANGEW CHEM INT EDIT, V48, P8090, DOI 10.1002/anie.200902936; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li FP, 2011, ANGEW CHEM INT EDIT, V50, P9611, DOI 10.1002/anie.201103754; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Lin Q, 2001, J AM CHEM SOC, V123, P11608, DOI 10.1021/ja011423j; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Miyoshi S, 2009, International Patent, Patent No. [PCT/JP2008/073864, 2008073864]; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Moyle PM, 2010, J AM CHEM SOC, V132, P15878, DOI 10.1021/ja1064312; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Mund C, 2010, BIOESSAYS, V32, P949, DOI 10.1002/bies.201000061; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nikolov M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005371; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sachchidanand, 2006, CHEM BIOL, V13, P81, DOI 10.1016/j.chembiol.2005.10.014; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Sternson SM, 2001, ORG LETT, V3, P4239, DOI 10.1021/ol016915f; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Zeng L, 2005, J AM CHEM SOC, V127, P2376, DOI 10.1021/ja044885g; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200	101	95	97	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					417	427		10.1038/NCHEMBIO.938	http://dx.doi.org/10.1038/NCHEMBIO.938			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22510649	Green Accepted			2022-12-27	WOS:000302962500006
J	Miyamoto, T; DeRose, R; Suarez, A; Ueno, T; Chen, M; Sun, TP; Wolfgang, MJ; Mukherjee, C; Meyers, DJ; Inoue, T				Miyamoto, Takafumi; DeRose, Robert; Suarez, Allison; Ueno, Tasuku; Chen, Melinda; Sun, Tai-ping; Wolfgang, Michael J.; Mukherjee, Chandrani; Meyers, David J.; Inoue, Takanari			Rapid and orthogonal logic gating with a gibberellin-induced dimerization system	NATURE CHEMICAL BIOLOGY			English	Article							GENE-EXPRESSION; RECEPTOR GID1; CELLS; PROTEIN; LIGANDS; GATE; RECOGNITION; ACTIVATION; MECHANISM; CIRCUITS	Using a newly synthesized gibberellin analog containing an acetoxymethyl group (GA(3)-AM) and its binding proteins, we developed an efficient chemically inducible dimerization (CID) system that is completely orthogonal to existing rapamycin-mediated protein dimerization. Combining the two systems should allow applications that have been difficult or impossible with only one CID system. By using both chemical inputs (rapamycin and GA(3)-AM), we designed and synthesized Boolean logic gates in living mammalian cells. These gates produced output signals such as fluorescence and membrane ruffling on a timescale of seconds, substantially faster than earlier intracellular logic gates. The use of two orthogonal dimerization systems in the same cell also allows for finer modulation of protein perturbations than is possible with a single dimerizer.	[Miyamoto, Takafumi; DeRose, Robert; Suarez, Allison; Ueno, Tasuku; Chen, Melinda; Inoue, Takanari] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, Baltimore, MD 21218 USA; [Sun, Tai-ping] Duke Univ, Dept Biol, Durham, NC USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Mukherjee, Chandrani; Meyers, David J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Synthet Core Facil, Baltimore, MD 21205 USA	Johns Hopkins University; Duke University; Johns Hopkins University; Johns Hopkins University	Miyamoto, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, Baltimore, MD 21218 USA.	jctinoue@jhmi.edu	Miyamoto, Takafumi/T-6950-2019; Ueno, Tasuku/AAD-8371-2021	Ueno, Tasuku/0000-0001-6657-8209; Miyamoto, Takafumi/0000-0001-9363-2864	US National Institutes of Health (NIH) [GM092930, DK090868, NS072241]; US National Science Foundation [IOS-0641548, MCB-0923723]; National Center for Research Resources of the NIH; NIH Roadmap for Medical Research [UL1 RR 025005]; Japanese Society for the Promotion of Science; Provost's Undergraduate Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100051, R01GM092930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Provost's Undergraduate Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the US National Institutes of Health (NIH; GM092930 and DK090868 to T. I. and NS072241 to M.J.W), the US National Science Foundation (IOS-0641548 and MCB-0923723 to T. S.) and the National Center for Research Resources of the NIH and NIH Roadmap for Medical Research (UL1 RR 025005 to C. M. and D.J.M). T. U. is a recipient of a fellowship from the Japanese Society for the Promotion of Science. M. C. is a recipient of the Provost's Undergraduate Research Award.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Bronson JE, 2008, MOL BIOSYST, V4, P56, DOI 10.1039/b713852k; Czlapinski JL, 2008, J AM CHEM SOC, V130, P13186, DOI 10.1021/ja8037728; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Katz E, 2010, CHEM SOC REV, V39, P1835, DOI 10.1039/b806038j; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Liang FS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001449; Liberles SD, 1997, P NATL ACAD SCI USA, V94, P7825, DOI 10.1073/pnas.94.15.7825; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Qian L, 2011, J R SOC INTERFACE, V8, P1281, DOI 10.1098/rsif.2010.0729; Rackham O, 2005, J AM CHEM SOC, V127, P17584, DOI 10.1021/ja055338d; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Schreiber SL, 2007, CHEM BIOL SMALL MOL; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stojanovic MN, 2008, PROG NUCLEIC ACID RE, V82, P199, DOI 10.1016/S0079-6603(08)00006-8; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Swanson SJ, 1996, PLANT CELL, V8, P2211, DOI 10.1105/tpc.8.12.2211; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Ueno T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002033; Yoshida W, 2007, CHEM COMMUN, P195, DOI 10.1039/b613201d	41	124	130	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					465	470		10.1038/NCHEMBIO.922	http://dx.doi.org/10.1038/NCHEMBIO.922			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22446836	Green Accepted			2022-12-27	WOS:000302962500013
J	Carlsson, J; Coleman, RG; Setola, V; Irwin, JJ; Fan, H; Schlessinger, A; Sali, A; Roth, BL; Shoichet, BK				Carlsson, Jens; Coleman, Ryan G.; Setola, Vincent; Irwin, John J.; Fan, Hao; Schlessinger, Avner; Sali, Andrej; Roth, Bryan L.; Shoichet, Brian K.			Ligand discovery from a dopamine D-3 receptor homology model and crystal structure	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED-RECEPTOR; 2ND EXTRACELLULAR LOOP; DRUG DISCOVERY; BINDING-SITE; D3 RECEPTOR; DATABASE; AGONISTS; DOCKING; DESIGN; ANTAGONISTS	G protein-coupled receptors (GPCRs) are intensely studied as drug targets and for their role in signaling. With the determination of the first crystal structures, interest in structure-based ligand discovery increased. Unfortunately, for most GPCRs no experimental structures are available. The determination of the D-3 receptor structure and the challenge to the community to predict it enabled a fully prospective comparison of ligand discovery from a modeled structure versus that of the subsequently released crystal structure. Over 3.3 million molecules were docked against a homology model, and 26 of the highest ranking were tested for binding. Six had affinities ranging from 0.2 to 3.1 mu M. Subsequently, the crystal structure was released and the docking screen repeated. Of the 25 compounds selected, five had affinities ranging from 0.3 to 3.0 mu M. One of the new ligands from the homology model screen was optimized for affinity to 81 nM. The feasibility of docking screens against modeled GPCRs more generally is considered.	[Carlsson, Jens; Coleman, Ryan G.; Irwin, John J.; Fan, Hao; Schlessinger, Avner; Sali, Andrej; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Setola, Vincent; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Fan, Hao; Schlessinger, Avner; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Fan, Hao; Schlessinger, Avner; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	bryan_roth@med.unc.edu; shoichet@cgl.ucsf.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Setola, Vincent/0000-0002-9791-2270; Coleman, Ryan/0000-0003-4093-4281; Irwin, John/0000-0002-1195-6417; Carlsson, Jens/0000-0003-4623-2977	US National Institutes of Health [GM59957, GM71630, U54GM093342, GM71790, R01GM54762]; National Institutes of Mental Health; Knut and Alice Wallenberg Foundation; National Research Service [F32GM096544, F32GM088991]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096544, R01GM054762, F32GM088991, U54GM093342, P01GM071790, R01GM071630, R01GM059957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, R01DA027170] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Q. Yang and K. Sharp for help with 3K-ENM, M. Burlingame with help with compound LC/MS and G. Barnea (Brown University) for supplying beginning Tango constructs and a plasmid encoding the human V<INF>2</INF> Tango receptor. We thank OpenEye Scientific Software for the use of OEChem and Omega. Supported by US National Institutes of Health grants GM59957 and GM71630 (to B.K.S.), U54GM093342 (to A. Sali and B.K.S.), GM71790 and R01GM54762 (to A. Sali), the National Institutes of Mental Health Psychoactive Drug Screening Program (to B.L.R.), postdoctoral fellowships from the Knut and Alice Wallenberg Foundation (to J.C.) and National Research Service Award-Kirschstein fellowships F32GM096544 (to R.G.C.) and F32GM088991 (to A. Schlessinger).	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Becker OM, 2004, P NATL ACAD SCI USA, V101, P11304, DOI 10.1073/pnas.0401862101; Bissantz C, 2005, PROTEINS, V61, P938, DOI 10.1002/prot.20651; Bucci M, 2010, NAT CHEM BIOL, V6, P847, DOI 10.1038/nchembio.489; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; Cavasotto CN, 2008, J MED CHEM, V51, P581, DOI 10.1021/jm070759m; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; de Graaf C, 2008, PROTEINS, V71, P599, DOI 10.1002/prot.21724; de Graaf C, 2009, CURR PHARM DESIGN, V15, P4026, DOI 10.2174/138161209789824786; DONNELLY D, 1994, CURR OPIN STRUC BIOL, V4, P582, DOI 10.1016/S0959-440X(94)90221-6; Engel S, 2008, J AM CHEM SOC, V130, P5115, DOI 10.1021/ja077620l; Evers A, 2005, J MED CHEM, V48, P1088, DOI 10.1021/jm0491804; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Evers A, 2003, J MOL BIOL, V334, P327, DOI 10.1016/j.jmb.2003.09.032; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Gloriam DE, 2009, J MED CHEM, V52, P4429, DOI 10.1021/jm900319e; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jensen NH, 2008, NEUROPSYCHOPHARMACOL, V33, P2303, DOI 10.1038/sj.npp.1301646; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Katritch V, 2010, PROTEINS, V78, P197, DOI 10.1002/prot.22507; Kellenberger E, 2007, J MED CHEM, V50, P1294, DOI 10.1021/jm061389p; Kiss R, 2008, J MED CHEM, V51, P3145, DOI 10.1021/jm7014777; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kratochwil NA, 2005, J CHEM INF MODEL, V45, P1324, DOI 10.1021/ci050221u; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Kuhn B, 2010, J MED CHEM, V53, P2601, DOI 10.1021/jm100087s; Kurczab R, 2010, BIOORG MED CHEM LETT, V20, P2465, DOI 10.1016/j.bmcl.2010.03.012; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Newman AH, 2009, J MED CHEM, V52, P2559, DOI 10.1021/jm900095y; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Salo OMH, 2005, J MED CHEM, V48, P7166, DOI 10.1021/jm050565b; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Varady J, 2003, J MED CHEM, V46, P4377, DOI 10.1021/jm030085p; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yang QY, 2009, PROTEINS, V74, P682, DOI 10.1002/prot.22184	50	232	236	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					769	778		10.1038/nchembio.662	http://dx.doi.org/10.1038/nchembio.662			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21926995	Green Submitted, Green Accepted			2022-12-27	WOS:000296381600006
J	Duggan, KC; Hermanson, DJ; Musee, J; Prusakiewicz, JJ; Scheib, JL; Carter, BD; Banerjee, S; Oates, JA; Marnett, LJ				Duggan, Kelsey C.; Hermanson, Daniel J.; Musee, Joel; Prusakiewicz, Jeffery J.; Scheib, Jami L.; Carter, Bruce D.; Banerjee, Surajit; Oates, J. A.; Marnett, Lawrence J.			(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2	NATURE CHEMICAL BIOLOGY			English	Article							CYCLOOXYGENASE ACTIVE-SITE; ANTIINFLAMMATORY AGENTS; SYNAPTIC-TRANSMISSION; OXIDATIVE METABOLITE; ARACHIDONIC-ACID; GLYCEROL ESTER; 2-ARACHIDONOYLGLYCEROL; BINDING; RECEPTOR; SYSTEM	Cyclooxygenase-2 (COX-2) catalyzes the oxygenation of arachidonic acid and the endocannabinoids 2-arachidonoylglycerol and arachidonoylethanolamide. Evaluation of a series of COX-2 inhibitors revealed that many weak competitive inhibitors of arachidonic acid oxygenation are potent inhibitors of endocannabinoid oxygenation. (R) enantiomers of ibuprofen, naproxen and flurbiprofen, which are considered to be inactive as COX-2 inhibitors, are potent 'substrate-selective inhibitors' of endocannabinoid oxygenation. Crystal structures of the COX-2-(R)-naproxen and COX-2-(R)-flurbiprofen complexes verified this unexpected binding and defined the orientation of the (R) enantiomers relative to (S) enantiomers. (R)-Profens selectively inhibited endocannabinoid oxygenation by lipopolysaccharide-stimulated dorsal root ganglion (DRG) cells. Substrate-selective inhibition provides new tools for investigating the role of COX-2 in endocannabinoid oxygenation and a possible explanation for the ability of (R)-profens to maintain endocannabinoid tone in models of neuropathic pain.	[Duggan, Kelsey C.; Musee, Joel; Prusakiewicz, Jeffery J.; Scheib, Jami L.; Carter, Bruce D.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Hermanson, Daniel J.; Marnett, Lawrence J.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Banerjee, Surajit] Cornell Univ, NE Collaborat Access Team, Ithaca, NY USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Banerjee, Surajit] Argonne Natl Lab, Argonne, IL 60439 USA; [Oates, J. A.] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37212 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Oates, J. A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Cornell University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	larry.marnett@vanderbilt.edu		Banerjee, Surajit/0000-0002-9414-7163	A.B. Hancock Jr. Memorial Laboratory for Cancer Research and by research [CA89450, GM15431, NS064278]; US National Institutes of Health [DA022873, DA031572]; National Center for Research Resources at the US National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022873, F31DA031572] Funding Source: NIH RePORTER	A.B. Hancock Jr. Memorial Laboratory for Cancer Research and by research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the A.B. Hancock Jr. Memorial Laboratory for Cancer Research and by research (CA89450, GM15431, NS064278) and training grants (DA022873, DA031572) from the US National Institutes of Health. It is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the US National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. We are grateful to J. Harp for assistance with crystallography; K. Masuda, M. Brown, R. Stevens and B. Cravatt for a sample of FAAH; A. Brash for a sample of 15-lipoxygenase and J. Uddin for a sample of fluorocoxib A.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; BRUNE K, 1992, J CLIN PHARMACOL, V32, P944, DOI 10.1002/j.1552-4604.1992.tb04643.x; Chen JK, 2008, J BIOL CHEM, V283, P24514, DOI 10.1074/jbc.M709873200; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; Di Marzo V, 2005, HANDB EXP PHARMACOL, V168, P147; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Guay J, 2004, J BIOL CHEM, V279, P24866, DOI 10.1074/jbc.M403106200; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; JAMALI F, 1988, J PHARM SCI, V77, P666, DOI 10.1002/jps.2600770805; Kalgutkar AS, 1998, J MED CHEM, V41, P4800, DOI 10.1021/jm980303s; Kingsley PJ, 2007, METHOD ENZYMOL, V433, P91, DOI 10.1016/s0076-6879(07)33005-X; Kogan N M, 2006, J Endocrinol Invest, V29, P3; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Liang Y, 2008, BRIT J PHARMACOL, V154, P1079, DOI 10.1038/bjp.2008.142; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; LOTSCH J, 1995, BRIT J CLIN PHARMACO, V40, P339, DOI 10.1111/j.1365-2125.1995.tb04556.x; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Richie-Jannetta R, 2010, PROSTAG OTH LIPID M, V92, P19, DOI 10.1016/j.prostaglandins.2010.01.003; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; Rouzer CA, 2005, J BIOL CHEM, V280, P26690, DOI 10.1074/jbc.M501021200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Snider NT, 2010, PHARMACOL REV, V62, P136, DOI 10.1124/pr.109.001081; Uddin MJ, 2010, CANCER RES, V70, P3618, DOI 10.1158/0008-5472.CAN-09-2664; UEDA N, 1995, BBA-LIPID LIPID MET, V1254, P127, DOI 10.1016/0005-2760(94)00170-4; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Xie SQ, 2010, CHEM RES TOXICOL, V23, P1890, DOI 10.1021/tx1002194; Yang HW, 2008, CURR PHARM DESIGN, V14, P1443, DOI 10.2174/138161208784480144; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	48	129	134	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					803	809		10.1038/nchembio.663	http://dx.doi.org/10.1038/nchembio.663			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	22053353	Green Accepted			2022-12-27	WOS:000296381600010
J	Wang, H; Claveau, D; Vaillancourt, JP; Roemer, T; Meredith, TC				Wang, Hao; Claveau, David; Vaillancourt, John P.; Roemer, Terry; Meredith, Timothy C.			High-frequency transposition for determining antibacterial mode of action	NATURE CHEMICAL BIOLOGY			English	Article							STAPHYLOCOCCUS-AUREUS; DRUG DISCOVERY; QUINOLONE RESISTANCE; BACILLUS-SUBTILIS; ACID BIOSYNTHESIS; ESCHERICHIA-COLI; GENE-EXPRESSION; IN-VITRO; BAD BUGS; IDENTIFICATION	Connecting bacterial growth inhibitors to molecular targets at the whole-cell level is a major impediment to antibacterial development. Herein we report the design of a highly efficient and versatile bacteriophage-based mariner transposon delivery system in Staphylococcus aureus for determining inhibitor mode of action. Using bacteriophage-mediated delivery of concatameric minitransposon cassettes, we generated nonclonal transposant libraries with genome-wide insertion-site coverage in either laboratory or methicillin-resistant strain backgrounds and screened for drug resistance in situ on a single agar plate in one step. A gradient of gene-target expression levels, along with a correspondingly diverse assortment of drug-resistant phenotypes, was achieved by fitting the transposon cassette with a suite of outward-facing promoters. Using a panel of antibiotics, we demonstrate the ability to unveil not only an inhibitor's molecular target but also its route of cellular entry, efflux susceptibility and other off-target resistance mechanisms.	[Wang, Hao; Claveau, David; Vaillancourt, John P.; Roemer, Terry; Meredith, Timothy C.] Merck Frosst Ctr Therapeut Res, Div Infect Dis, Kirkland, PQ, Canada	Merck & Company	Meredith, TC (corresponding author), Novartis Inst Biomed Res, Infect Dis, Cambridge, MA USA.	terry_roemer@merck.com; tcmered@gmail.com	Meredith, Timothy/X-2713-2019	Meredith, Timothy/0000-0002-1901-6841				Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Anthony RM, 2005, J MICROBIOL METH, V60, P47, DOI 10.1016/j.mimet.2004.08.009; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Bockstael K, 2009, CENT EUR J MED, V4, P141, DOI 10.2478/s11536-008-0088-9; Bordi C, 2008, APPL ENVIRON MICROB, V74, P3419, DOI 10.1128/AEM.00476-08; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brandenberger M, 2000, BBA-GEN SUBJECTS, V1523, P135, DOI 10.1016/S0304-4165(00)00133-1; Breithaupt H, 1999, NAT BIOTECHNOL, V17, P1165, DOI 10.1038/70705; Brotz-Oesterhelt H, 2010, FUTURE MICROBIOL, V5, P1553, DOI 10.2217/FMB.10.119; CARLETON S, 1984, EMBO J, V3, P2407, DOI 10.1002/j.1460-2075.1984.tb02147.x; CASSELS R, 1995, J BACTERIOL, V177, P5161, DOI 10.1128/jb.177.17.5161-5165.1995; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; de Crecy-Lagard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-245; Donald RGK, 2009, CHEM BIOL, V16, P826, DOI 10.1016/j.chembiol.2009.07.004; Freiberg C, 2006, MOL CELL PROTEOMICS, V5, P2326, DOI 10.1074/mcp.M600127-MCP200; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Hurdle JG, 2004, J ANTIMICROB CHEMOTH, V54, P549, DOI 10.1093/jac/dkh352; Ince D, 2003, J BACTERIOL, V185, P6883, DOI 10.1128/JB.185.23.6883-6892.2003; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lange RP, 2007, CURR PHARM DESIGN, V13, P3140, DOI 10.2174/138161207782110408; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luong TT, 2002, J BACTERIOL, V184, P3623, DOI 10.1128/JB.184.13.3623-3629.2002; Meredith TC, 2008, J BACTERIOL, V190, P3046, DOI 10.1128/JB.01880-07; Miesel L, 2003, NAT REV GENET, V4, P442, DOI 10.1038/nrg1086; Mills SD, 2006, BIOCHEM PHARMACOL, V71, P1096, DOI 10.1016/j.bcp.2005.11.025; Ng EY, 1996, ANTIMICROB AGENTS CH, V40, P1881, DOI 10.1128/AAC.40.8.1881; NG EYW, 1994, ANTIMICROB AGENTS CH, V38, P1345, DOI 10.1128/AAC.38.6.1345; NOVICK RP, 1986, J MOL BIOL, V192, P209, DOI 10.1016/0022-2836(86)90360-8; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Payne David J, 2004, Methods Mol Biol, V266, P231; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Salipante SJ, 2003, ANTIMICROB AGENTS CH, V47, P3840, DOI 10.1128/AAC.47.12.3840-3845.2003; SAMMES PG, 1990, COMPREHENSIVE MED CH, P255; Saxild HH, 2001, J BACTERIOL, V183, P6175, DOI 10.1128/JB.183.21.6175-6183.2001; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; SWEDBERG G, 1979, J BACTERIOL, V137, P129, DOI 10.1128/JB.137.1.129-136.1979; Theuretzbacher U, 2009, INT J ANTIMICROB AG, V34, P15, DOI 10.1016/j.ijantimicag.2009.02.005; WERNER RG, 1976, EUR J BIOCHEM, V68, P1, DOI 10.1111/j.1432-1033.1976.tb10758.x; Wolz C, 2010, INT J MED MICROBIOL, V300, P142, DOI 10.1016/j.ijmm.2009.08.017; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Xia MM, 1999, PLASMID, V42, P144, DOI 10.1006/plas.1999.1422; YANSURA DG, 1984, P NATL ACAD SCI-BIOL, V81, P439, DOI 10.1073/pnas.81.2.439	50	39	43	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					720	729		10.1038/NCHEMBIO.643	http://dx.doi.org/10.1038/NCHEMBIO.643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21892185				2022-12-27	WOS:000295027100016
J	Zhang, M; Lin, SX; Song, XW; Liu, J; Fu, Y; Ge, X; Fu, XM; Chang, ZY; Chen, PR				Zhang, Meng; Lin, Shixian; Song, Xinwen; Liu, Jun; Fu, Ye; Ge, Xi; Fu, Xinmiao; Chang, Zengyi; Chen, Peng R.			A genetically incorporated crosslinker reveals chaperone cooperation in acid resistance	NATURE CHEMICAL BIOLOGY			English	Article							SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; ESCHERICHIA-COLI; MAMMALIAN-CELLS; TRANSFER-RNA; PERIPLASMIC PROTEIN; ENTERIC BACTERIA; CODE; HDEA; BINDING	Acid chaperones are essential factors in preserving the protein homeostasis for enteric pathogens to survive in the extremely acidic mammalian stomach (pH 1-3). The client proteins of these chaperones remain largely unknown, primarily because of the exceeding difficulty of determining protein-protein interactions under low-pH conditions. We developed a genetically encoded, highly efficient protein photocrosslinking probe, which enabled us to profile the in vivo substrates of a major acid-protection chaperone, HdeA, in Escherichia coli periplasm. Among the identified HdeA client proteins, the periplasmic chaperones DegP and SurA were initially found to be protected by HdeA at a low pH, but they subsequently facilitated the HdeA-mediated acid recovery of other client proteins. This unique, ATP-independent chaperone cooperation in the ATP-deprived E. coli periplasm may support the acid resistance of enteric bacteria. The crosslinker would be valuable in unveiling the physiological interaction partners of any given protein and thus their functions under normal and stress conditions.	[Zhang, Meng; Lin, Shixian; Liu, Jun; Chen, Peng R.] Peking Univ, Beijing Natl Lab Mol Sci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Zhang, Meng; Song, Xinwen; Ge, Xi; Fu, Xinmiao; Chang, Zengyi] Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci, Beijing 100871, Peoples R China; [Fu, Ye] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Fu, Xinmiao; Chang, Zengyi; Chen, Peng R.] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China; [Chen, Peng R.] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University; University of Chicago; Peking University	Chen, PR (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	changzy@pku.edu.cn; pengchen@pku.edu.cn	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904; Fu, Ye/0000-0003-4434-6014; Lin, Shixian/0000-0001-9718-9986; Fu, Ye/0000-0002-3807-9717	National Natural Science Foundation of China [91013005, 21001010, 30570355, 30670022]; National Key Basic Research Foundation of China [2010CB912300, 2006CB806508, 2006CB910300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China)	We thank the Nara Institute of Science and Technology (Ikoma, Nara, Japan) for E. coli strains BW25113 and JWK3478 and P. Schultz for the aminoacyl-tRNA synthetase and tRNA expression vectors. We are grateful to W. Hong, Y. Liu and C. Liu for valuable discussions. We would also like to thank T. Kellie of the Graduate University of the Chinese Academy of Sciences for his editorial assistance. This work was supported by research grants from the National Natural Science Foundation of China (91013005 and 21001010 to P. R. C., 30570355 and 30670022 to Z.C.) and the National Key Basic Research Foundation of China (2010CB912300 to P. R. C., 2006CB806508 and 2006CB910300 to Z.C.).	Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Fekner T, 2010, EUR J ORG CHEM, V2010, P4171, DOI 10.1002/ejoc.201000204; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Hancock SM, 2010, J AM CHEM SOC, V132, P14819, DOI 10.1021/ja104609m; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Huang Y, 2010, BIOORG MED CHEM LETT, V20, P878, DOI 10.1016/j.bmcl.2009.12.077; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Majmudar CY, 2009, J AM CHEM SOC, V131, P14240, DOI 10.1021/ja904378z; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Tanaka Y, 2008, J AM CHEM SOC, V130, P3278, DOI 10.1021/ja7109772; Tanaka Y, 2008, MOL BIOSYST, V4, P473, DOI 10.1039/b803218a; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tippmann EM, 2007, CHEMBIOCHEM, V8, P2210, DOI 10.1002/cbic.200700460; Vila-Perello M, 2007, J AM CHEM SOC, V129, P8068, DOI 10.1021/ja072013j; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wu YE, 2008, BIOCHEM J, V412, P389, DOI 10.1042/BJ20071682; Zhao BY, 2010, BIOCHEM CELL BIOL, V88, P301, DOI [10.1139/O09-182, 10.1139/o09-182]	30	181	193	8	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					671	677		10.1038/NCHEMBIO.644	http://dx.doi.org/10.1038/NCHEMBIO.644			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21892184				2022-12-27	WOS:000295027100010
J	Adibekian, A; Martin, BR; Wang, C; Hsu, KL; Bachovchin, DA; Niessen, S; Hoover, H; Cravatt, BF				Adibekian, Alexander; Martin, Brent R.; Wang, Chu; Hsu, Ku-Lung; Bachovchin, Daniel A.; Niessen, Sherry; Hoover, Heather; Cravatt, Benjamin F.			Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							ENZYME-ACTIVITY PROFILES; ACYLPEPTIDE HYDROLASE; FUNCTIONAL PROTEOMICS; CARCINOMA; BLOCKADE; POTENT; FAAH; TRANSPORT; PROTEINS; COVALENT	Serine hydrolases are a diverse enzyme class representing -1% of all human proteins. The biological functions of most serine hydrolases remain poorly characterized owing to a lack of selective inhibitors to probe their activity in living systems. Here we show that a substantial number of serine hydrolases can be irreversibly inactivated by 1,2,3-triazoleureas, which show negligible cross-reactivity with other protein classes. Rapid lead optimization by click chemistry-enabled synthesis and competitive activity-based profiling identified 1,2,3-triazole ureas that selectively inhibit enzymes from diverse branches of the serine hydrolase class, including peptidases (acyl-peptide hydrolase, or APEH), lipases (platelet-activating factor acetylhydrolase-2, or PAFAH2) and uncharacterized hydrolases (alpha,beta-hydrolase-11, or ABHD11), with exceptional potency in cells (sub-nanomolar) and mice (< 1 mg kg(-1)). We show that APEH inhibition leads to accumulation of N-acetylated proteins and promotes proliferation in T cells. These data indicate 1,2,3-triazole ureas are a pharmacologically privileged chemotype for serine hydrolase inhibition, combining broad activity across the serine hydrolase class with tunable selectivity for individual enzymes.	[Adibekian, Alexander; Martin, Brent R.; Wang, Chu; Hsu, Ku-Lung; Bachovchin, Daniel A.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Adibekian, Alexander; Martin, Brent R.; Wang, Chu; Hsu, Ku-Lung; Bachovchin, Daniel A.; Niessen, Sherry; Hoover, Heather; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Niessen, Sherry; Hoover, Heather] Scripps Res Inst, Ctr Physiol Prote, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Adibekian, A (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	wang, chu/GYJ-2191-2022; Hsu, Ku-Lung/J-2885-2014; Wang, Chu/C-4442-2015; Hsu, Ku-Lung/L-6256-2019; Wang, Chu/AAE-8759-2021; Martin, Brent/B-4370-2012; cisar, justin/C-4002-2012	Hsu, Ku-Lung/0000-0001-5620-3972; Wang, Chu/0000-0002-6925-1268; Hsu, Ku-Lung/0000-0001-5620-3972; Wang, Chu/0000-0002-6925-1268; Martin, Brent/0000-0002-7136-2397; 	US National Institutes of Health [DA028845, CA151460]; Deutscher Akademischer Austausch Dienst; US National Science Foundation; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [K99CA151460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025285, RC2DA028845] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); US National Science Foundation(National Science Foundation (NSF)); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Savas and D. McClatchy (The Scripps Research Institute) for generously providing <SUP>15</SUP>N-labeled mice and T. Ji for technical assistance. This work was supported by the US National Institutes of Health (DA028845, CA151460 (K99 award to B. R. M.)), the Deutscher Akademischer Austausch Dienst (postdoctoral fellowship to A. A.), the US National Science Foundation (predoctoral fellowship to D. A. B.) and the Skaggs Institute for Chemical Biology.	Alexander JP, 2006, J AM CHEM SOC, V128, P9699, DOI 10.1021/ja062999h; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Barglow KT, 2004, CHEM BIOL, V11, P1523, DOI 10.1016/j.chembiol.2004.08.023; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Blais DR, 2010, J BIOL CHEM, V285, P25602, DOI 10.1074/jbc.M110.135483; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Ebdrup S, 2004, J MED CHEM, V47, P400, DOI 10.1021/jm031004s; ERLANDSSON R, 1991, ONCOGENE, V6, P1293; Everley PA, 2007, MOL CELL PROTEOMICS, V6, P1771, DOI 10.1074/mcp.M700057-MCP200; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Henness S, 2006, DRUGS, V66, P1625, DOI 10.2165/00003495-200666120-00012; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Johnson DS, 2010, FUTURE MED CHEM, V2, P949, DOI 10.4155/FMC.10.21; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kaschani F, 2009, MOL CELL PROTEOMICS, V8, P1082, DOI 10.1074/mcp.M800494-MCP200; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Kluge AF, 2010, CURR OPIN CHEM BIOL, V14, P421, DOI 10.1016/j.cbpa.2010.03.035; Kodadek T, 2010, NAT CHEM BIOL, V6, P162, DOI 10.1038/nchembio.303; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lowe DB, 2004, BIOORG MED CHEM LETT, V14, P3155, DOI 10.1016/j.bmcl.2004.04.015; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mazzucchelli L, 2002, AM J PATHOL, V160, P7, DOI 10.1016/S0002-9440(10)64342-8; Moore SA, 2005, P NATL ACAD SCI USA, V102, P17852, DOI 10.1073/pnas.0507470102; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Okerberg ES, 2005, P NATL ACAD SCI USA, V102, P4996, DOI 10.1073/pnas.0501205102; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Orre LM, 2007, MOL CELL PROTEOMICS, V6, P2122, DOI 10.1074/mcp.M700202-MCP200; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Racchi M, 2004, PHARMACOL RES, V50, P441, DOI 10.1016/j.phrs.2003.12.027; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; SCALONI A, 1992, J LAB CLIN MED, V120, P546; Schubert C, 2009, CELL MOL LIFE SCI, V66, P1178, DOI 10.1007/s00018-008-8401-y; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Thornberry NA, 2007, CURR TOP MED CHEM, V7, P557, DOI 10.2174/156802607780091028; Timmer JC, 2007, BIOCHEM J, V407, P41, DOI 10.1042/BJ20070775; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j	50	164	169	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					469	478		10.1038/NCHEMBIO.579	http://dx.doi.org/10.1038/NCHEMBIO.579			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21572424	Green Accepted			2022-12-27	WOS:000292252100015
J	Yim, H; Haselbeck, R; Niu, W; Pujol-Baxley, C; Burgard, A; Boldt, J; Khandurina, J; Trawick, JD; Osterhout, RE; Stephen, R; Estadilla, J; Teisan, S; Schreyer, HB; Andrae, S; Yang, TH; Lee, SY; Burk, MJ; Van Dien, S				Yim, Harry; Haselbeck, Robert; Niu, Wei; Pujol-Baxley, Catherine; Burgard, Anthony; Boldt, Jeff; Khandurina, Julia; Trawick, John D.; Osterhout, Robin E.; Stephen, Rosary; Estadilla, Jazell; Teisan, Sy; Schreyer, H. Brett; Andrae, Stefan; Yang, Tae Hoon; Lee, Sang Yup; Burk, Mark J.; Van Dien, Stephen			Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol	NATURE CHEMICAL BIOLOGY			English	Article							PYRUVATE-DEHYDROGENASE; SUCCINIC ACID; CITRATE SYNTHASE; PATHWAY; GENE; K-12; NADH; 4-HYDROXYBUTYRATE; BIOSYNTHESIS; FERMENTATION	1,4-Butanediol (BDO) is an important commodity chemical used to manufacture over 2.5 million tons annually of valuable polymers, and it is currently produced exclusively through feedstocks derived from oil and natural gas. Herein we report what are to our knowledge the first direct biocatalytic routes to BDO from renewable carbohydrate feedstocks, leading to a strain of Escherichia coli capable of producing 18 gl-1 of this highly reduced, non-natural chemical. A pathway-identification algorithm elucidated multiple pathways for the biosynthesis of BDO from common metabolic intermediates. Guided by a genome-scale metabolic model, we engineered the E. coli host to enhance anaerobic operation of the oxidative tricarboxylic acid cycle, thereby generating reducing power to drive the BDO pathway. The organism produced BDO from glucose, xylose, sucrose and biomass-derived mixed sugar streams. This work demonstrates a systems-based metabolic engineering approach to strain design and development that can enable new bioprocesses for commodity chemicals that are not naturally produced by living cells.	[Yim, Harry; Haselbeck, Robert; Niu, Wei; Pujol-Baxley, Catherine; Burgard, Anthony; Boldt, Jeff; Khandurina, Julia; Trawick, John D.; Osterhout, Robin E.; Stephen, Rosary; Estadilla, Jazell; Teisan, Sy; Schreyer, H. Brett; Andrae, Stefan; Yang, Tae Hoon; Burk, Mark J.; Van Dien, Stephen] Genomat Inc, San Diego, CA USA; [Lee, Sang Yup] Korea Adv Inst Sci & Technol, Inst BioCentury, Ctr Syst & Synthet Biotechnol, Dept Chem & Biomol Engn,Program BK21, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Yim, H (corresponding author), Genomat Inc, San Diego, CA USA.	svandien@genomatica.com	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091; Niu, Wei/0000-0003-3826-1276				Altaras NE, 1999, APPL ENVIRON MICROB, V65, P1180; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burk M. J., 2010, World patent, Patent No. [2010030711, WO 2010030711 A3]; CAROLE TM, 2004, Appl BIOCH Biotechno, V113, P113; Cho A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-35; Donnelly MI, 1998, APPL BIOCHEM BIOTECH, V70-2, P187, DOI 10.1007/BF02920135; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Henry CS, 2010, BIOTECHNOL BIOENG, V106, P462, DOI 10.1002/bit.22673; Hong SH, 2001, BIOTECHNOL BIOENG, V74, P89, DOI 10.1002/bit.1098; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; JEWELL JB, 1986, CURR MICROBIOL, V13, P215, DOI 10.1007/BF01568949; Kim Y, 2008, J BACTERIOL, V190, P3851, DOI 10.1128/JB.00104-08; Kim Y, 2007, APPL ENVIRON MICROB, V73, P1766, DOI 10.1128/AEM.02456-06; KROSCHWITZ J, 1993, ENCY CHEM TECHNOLOGY; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Lee SJ, 2006, APPL ENVIRON MICROB, V72, P1939, DOI 10.1128/AEM.72.3.1939-1948.2006; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mahadevan R, 2005, BIOTECHNOL BIOPROC E, V10, P408; MAVROVOUNIOTIS ML, 1990, BIOTECHNOL BIOENG, V36, P1070, DOI 10.1002/bit.260361013; Menzel K, 1997, J BIOTECHNOL, V56, P135, DOI 10.1016/S0168-1656(97)00110-7; Moon TS, 2009, APPL ENVIRON MICROB, V75, P589, DOI 10.1128/AEM.00973-08; NAIR RV, 1994, J BACTERIOL, V176, P871, DOI 10.1128/jb.176.3.871-885.1994; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Orencio-Trejo M, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-8; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; PEREIRA DS, 1994, J BIOL CHEM, V269, P412; Qian ZG, 2009, BIOTECHNOL BIOENG, V104, P651, DOI 10.1002/bit.22502; Rathnasingh C, 2009, BIOTECHNOL BIOENG, V104, P729, DOI 10.1002/bit.22429; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Saito N, 2009, J BIOL CHEM, V284, P16442, DOI 10.1074/jbc.M109.002089; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHERF U, 1991, APPL ENVIRON MICROB, V57, P2699, DOI 10.1128/AEM.57.9.2699-2702.1991; Sivaraman K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1181; SNOEP JL, 1993, FEMS MICROBIOL LETT, V114, P279, DOI 10.1016/0378-1097(93)90284-9; SOHLING B, 1993, EUR J BIOCHEM, V212, P121, DOI 10.1111/j.1432-1033.1993.tb17641.x; Sohling B, 1996, J BACTERIOL, V178, P871; SPRENGER GA, 1988, J GEN MICROBIOL, V134, P1635; Stokell DJ, 2003, J BIOL CHEM, V278, P35435, DOI 10.1074/jbc.M302786200; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Toth J, 1999, APPL ENVIRON MICROB, V65, P4973; VALENTIN HE, 1995, EUR J BIOCHEM, V227, P43, DOI 10.1111/j.1432-1033.1995.tb20358.x; Webb E. C., 1992, ENZYME NOMENCLATURE	45	736	803	17	445	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					445	452		10.1038/NCHEMBIO.580	http://dx.doi.org/10.1038/NCHEMBIO.580			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21602812				2022-12-27	WOS:000292252100012
J	Daughdrill, GW				Daughdrill, Gary W.			PROTEIN DYNAMICS Bridging the gap	NATURE CHEMICAL BIOLOGY			English	News Item							INHIBITOR		[Daughdrill, Gary W.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Daughdrill, Gary W.] Univ S Florida, Ctr Drug Discovery & Innovat, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Daughdrill, GW (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	gdaughdrill@usf.edu						Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; TOMPA P, 2010, STRUCTURE FUNCTION I, V331; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; [No title captured], DOI DOI 10.1002/9783527619498.CH41	10	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					193	194		10.1038/nchembio.544	http://dx.doi.org/10.1038/nchembio.544			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21423160				2022-12-27	WOS:000288545000002
J	Nielsen, J				Nielsen, Jens			BIOFUELS Chimeric synthetic pathways	NATURE CHEMICAL BIOLOGY			English	News Item							SACCHAROMYCES-CEREVISIAE; BUTANOL		Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Chalmers University of Technology	Nielsen, J (corresponding author), Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Nielsen, Jens/Q-1347-2017	Nielsen, Jens/0000-0002-9955-6003				Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI 10.1038/NCHEMBIO.537; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Nielsen J, 2001, APPL MICROBIOL BIOT, V55, P263, DOI 10.1007/s002530000511; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Shen CR, 2008, METAB ENG, V10, P312, DOI 10.1016/j.ymben.2008.08.001; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104	10	8	8	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					195	196		10.1038/nchembio.548	http://dx.doi.org/10.1038/nchembio.548			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21423162				2022-12-27	WOS:000288545000004
J	Hoffstrom, BG; Kaplan, A; Letso, R; Schmid, RS; Turmel, GJ; Lo, DC; Stockwell, BR				Hoffstrom, Benjamin G.; Kaplan, Anna; Letso, Reka; Schmid, Ralf S.; Turmel, Gregory J.; Lo, Donald C.; Stockwell, Brent R.			Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins	NATURE CHEMICAL BIOLOGY			English	Article							OUTER-MEMBRANE PERMEABILIZATION; AMYOTROPHIC-LATERAL-SCLEROSIS; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; MOUSE MODEL; CYTOCHROME-C; TERMINAL ALKYNES; TRANSGENIC MICE; BCL-2 FAMILY; CELL-DEATH	A hallmark of many neurodegenerative diseases is accumulation of misfolded proteins within neurons, leading to cellular dysfunction and cell death. Although several mechanisms have been proposed to link protein misfolding to cellular toxicity, the connection remains enigmatic. Here, we report a cell death pathway involving protein disulfide isomerase (PDI), a protein chaperone that catalyzes isomerization, reduction and oxidation of disulfides. Through a small molecule screening approach, we discovered five structurally distinct compounds that prevent apoptosis induced by mutant huntingtin protein. Using modified Huisgen cycloaddition chemistry, we then identified PDI as the molecular target of these small molecules. Expression of polyglutamine-expanded huntingtin exon 1 in PC12 cells caused PDI to accumulate at mitochondrial-associated ER membranes and trigger apoptotic cell death via mitochondrial outer-membrane permeabilization. Inhibiting PDI in rat brain cells suppressed the toxicity of mutant huntingtin exon 1 and Ab peptides processed from the amyloid precursor protein. This pro-apoptotic function of PDI represents a new mechanism linking protein misfolding and apoptotic cell death.	[Hoffstrom, Benjamin G.; Kaplan, Anna; Letso, Reka; Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10032 USA; [Schmid, Ralf S.; Turmel, Gregory J.; Lo, Donald C.] Duke Univ, Med Ctr, Ctr Drug Discovery, Durham, NC USA; [Schmid, Ralf S.; Turmel, Gregory J.; Lo, Donald C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute; Duke University; Duke University; Columbia University	Hoffstrom, BG (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10032 USA.	bstockwell@columbia.edu	Schmid, Ralf/AAN-1011-2021; Stockwell, Brent R/AAE-7200-2019	Schmid, Ralf/0000-0002-1721-5775; Stockwell, Brent R/0000-0002-3532-3868	US National Institutes of Health [NIGMS 1RO1GM085081, NINDS R21NS048181]; Hereditary Disease Foundation; High Q Foundation; CHDI Foundation; Arnold and Mabel Beckman Foundation; Training Program in Molecular Biophysics [T32GM008281]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, R01GM085081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS048181] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; High Q Foundation; CHDI Foundation; Arnold and Mabel Beckman Foundation; Training Program in Molecular Biophysics; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Schweitzer (University of California-Los Angeles) for the transfected PC12 cell lines; C. Ross (Johns Hopkins University) for HTT DNAs upon which the constructs used here were based; I. Smukste for assistance with organic synthesis; A. Bauer for compound library assembly library; D. Dunn for additional brain-slice experiments; C. Thompson (University of Pennsylvania) for the Bax/Bak double-knockout MEF cells; L. Moore (Gage laboratory, Salk Institute) for tebufenozide; A. Speers, J. Alexander and B. Cravatt for reagents and advice on the cycloaddition reactions; E. Miller, E. Signer, A. Tobin, N. Wexler, C. Johnson, R. Pacifici and M. Finn for useful discussions; and E. Miller and S. Hoffschmidt for editorial comments on the manuscript. This research was supported by grants from the US National Institutes of Health (NIGMS 1RO1GM085081 to B.R.S. and NINDS R21NS048181 to D.C.L.), the Hereditary Disease Foundation (D.C.L., B.R.S.), the High Q Foundation (B.R.S.), CHDI Foundation (D.C.L., B.R.S.), the Arnold and Mabel Beckman Foundation (B.R.S.), the Training Program in Molecular Biophysics (T32GM008281 to A.K.) and a Burroughs Wellcome Fund Career Award at the Scientific Interface (B.R.S.). B.G.H. was supported in part by a postdoctoral fellowship from the High Q Foundation. B.R.S. is an Early Career Scientist of the Howard Hughes Medical Institute.	Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Bailey CDC, 2006, NEUROBIOL AGING, V27, P871, DOI 10.1016/j.neurobiolaging.2005.04.001; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Ciammola A, 2006, CELL DEATH DIFFER, V13, P2068, DOI 10.1038/sj.cdd.4401967; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hickey MA, 2003, PROG NEURO-PSYCHOPH, V27, P255, DOI 10.1016/S0278-5846(03)00021-6; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; HUISGEN R, 1984, 1 3 DIPOLAR CYCLOADD, P1; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Kiechle T, 2002, NEUROMOL MED, V1, P183; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Rigobello MP, 2001, BIOCHEM J, V356, P567, DOI 10.1042/0264-6021:3560567; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Tremblay ME, 2006, NEUROBIOL AGING, V27, P862, DOI 10.1016/j.neurobiolaging.2005.04.004; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Van Raamsdonk JM, 2005, J NEUROCHEM, V95, P210, DOI 10.1111/j.1471-4159.2005.03357.x; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Varma H, 2007, P NATL ACAD SCI USA, V104, P14525, DOI 10.1073/pnas.0704482104; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	50	220	231	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					900	906		10.1038/NCHEMBIO.467	http://dx.doi.org/10.1038/NCHEMBIO.467			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079601	Green Accepted			2022-12-27	WOS:000284214700019
J	Hilchie, AL; Wuerth, K; Hancock, REW				Hilchie, Ashley L.; Wuerth, Kelli; Hancock, Robert E. W.			Immune modulation by multifaceted cationic host defense (antimicrobial) peptides	NATURE CHEMICAL BIOLOGY			English	Article							PLASMACYTOID DENDRITIC CELLS; HUMAN MAST-CELLS; REGULATOR PEPTIDE; CATHELICIDIN LL-37; INNATE; RESPONSES; MACROPHAGES; LYMPHOCYTES; PROTECTION; IDR-1002	Cationic host defense (antimicrobial) peptides were originally studied for their direct antimicrobial activities. They have since been found to exhibit multifaceted immunomodulatory activities, including profound anti-infective and selective anti-inflammatory properties, as well as adjuvant and wound-healing activities in animal models. These biological properties suggest that host defense peptides, and synthetic derivatives thereof, possess clinical potential beyond the treatment of antibiotic-resistant infections. In this Review, we provide an overview of the biological activities of host defense and synthetic peptides, their mechanism(s) of action and new therapeutic applications and challenges that are associated with their clinical use.	[Hilchie, Ashley L.; Wuerth, Kelli; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Hancock, REW (corresponding author), Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada.	bob@hancocklab.com	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Wuerth, Kelli/0000-0001-5260-9166	Canadian Institutes for Health Research (CIHR); Cystic Fibrosis Canada Studentship	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada Studentship	We acknowledge current funding from the Canadian Institutes for Health Research (CIHR) for our own work on these peptides. A. L. H. has a postdoctoral fellowship from CIHR, K. W. holds a Cystic Fibrosis Canada Studentship and R. E. W. H. holds a Canada Research Chair.	Achtman AH, 2012, SCI TRANSL MED, V4; Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617; Alalwani SM, 2010, EUR J IMMUNOL, V40, P1118, DOI 10.1002/eji.200939275; Amatngalim GD, 2011, INFLAMMATION, V34, P412, DOI 10.1007/s10753-010-9248-6; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Barlow PG, 2006, J LEUKOCYTE BIOL, V80, P509, DOI 10.1189/jlb.1005560; Berkestedt I, 2008, BRIT J ANAESTH, V100, P803, DOI 10.1093/bja/aen074; Biragyn A, 2008, J LEUKOCYTE BIOL, V83, P998, DOI 10.1189/jlb.1007700; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bowler Philip G, 2003, Ostomy Wound Manage, V49, P44; Brikos Constantinos, 2008, V183, P21; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Brown THT, 2012, VACCINE, V30, P350, DOI 10.1016/j.vaccine.2011.10.086; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Fukumoto K, 2005, PEDIATR SURG INT, V21, P20, DOI 10.1007/s00383-004-1256-x; GANZ T, 1988, J CLIN INVEST, V82, P552, DOI 10.1172/JCI113631; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Garlapati S, 2012, VACCINE, V30, P5206, DOI 10.1016/j.vaccine.2012.06.011; Garlapati S, 2011, VACCINE, V29, P6540, DOI 10.1016/j.vaccine.2011.07.009; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Gibson AL, 2012, WOUND REPAIR REGEN, V20, P414, DOI 10.1111/j.1524-475X.2012.00786.x; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Gracia A, 2011, VACCINE, V29, P1595, DOI 10.1016/j.vaccine.2010.12.083; Grigat J, 2007, J IMMUNOL, V179, P3958, DOI 10.4049/jimmunol.179.6.3958; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hurtado P, 2010, J IMMUNOL, V184, P1425, DOI 10.4049/jimmunol.0902305; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Kindrachuk J, 2009, VACCINE, V27, P4662, DOI 10.1016/j.vaccine.2009.05.094; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lee PHA, 2004, WOUND REPAIR REGEN, V12, P351, DOI 10.1111/j.1067-1927.2004.012303.x; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Mader JS, 2006, AM J PATHOL, V169, P1753, DOI 10.2353/ajpath.2006.051229; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mader JS, 2011, EXP CELL RES, V317, P531, DOI 10.1016/j.yexcr.2010.11.015; Madera L, 2012, J INNATE IMMUN, V4, P553, DOI 10.1159/000338648; MattsbyBaltzer I, 1996, PEDIATR RES, V40, P257, DOI 10.1203/00006450-199608000-00011; Mayer ML, 2013, J IMMUNOL, V190, P1227, DOI 10.4049/jimmunol.1201404; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Mookherjee N, 2009, MOL BIOSYST, V5, P483, DOI 10.1039/b813787k; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Nijnik A, 2009, Emerg Health Threats J, V2, pe1, DOI 10.3134/ehtj.09.001; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Nijnik A, 2009, J IMMUNOL, V183, P5788, DOI 10.4049/jimmunol.0901491; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Niyonsaba F, 2013, J LEUKOCYTE BIOL, V94, P159, DOI 10.1189/jlb.1012497; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Otte JM, 2009, REGUL PEPTIDES, V156, P104, DOI 10.1016/j.regpep.2009.03.009; Pena OM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052449; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pistolic J, 2009, J INNATE IMMUN, V1, P254, DOI 10.1159/000171533; Polewicz M, 2013, VACCINE, V31, P3148, DOI 10.1016/j.vaccine.2013.05.008; Presicce P, 2009, J LEUKOCYTE BIOL, V86, P941, DOI 10.1189/jlb.0708412; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Ramos R, 2011, PEPTIDES, V32, P1469, DOI 10.1016/j.peptides.2011.06.005; Rivas-Santiago B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059119; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Schiemann F, 2009, J IMMUNOL, V183, P2223, DOI 10.4049/jimmunol.0803587; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Steinstraesser L, 2008, MOL MED, V14, P528, DOI 10.2119/2008-00002.Steinstraesser; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Tani K, 2000, INT IMMUNOL, V12, P691, DOI 10.1093/intimm/12.5.691; Tewary P, 2013, J IMMUNOL, V191, P865, DOI 10.4049/jimmunol.1201648; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; van der Does AM, 2010, J IMMUNOL, V185, P1442, DOI 10.4049/jimmunol.1000376; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Welling MM, 1998, J CLIN INVEST, V102, P1583, DOI 10.1172/JCI3664; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007; Wuerth K.C., 2013, ENCY LIFE SCI; Wuerth K, 2011, EUR J IMMUNOL, V41, P2817, DOI 10.1002/eji.201142055; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yu HB, 2009, J BIOL CHEM, V284, P36007, DOI 10.1074/jbc.C109.073627; Zhang LJ, 2009, CURR OPIN INVEST DR, V10, P164; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496	89	409	424	13	238	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					761	768		10.1038/NCHEMBIO.1393	http://dx.doi.org/10.1038/NCHEMBIO.1393			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24231617				2022-12-27	WOS:000327130000006
J	Lau, MWL; Ferre-D'Amare, AR				Lau, Matthew W. L.; Ferre-D'Amare, Adrian R.			An in vitro evolved glmS ribozyme has the wild-type fold but loses coenzyme dependence	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVE-SITE GUANINE; ACID-BASE CATALYSIS; STRUCTURAL BASIS; SELF-CLEAVAGE; RNA; RIBOSWITCH; BINDING; GLUCOSAMINE-6-PHOSPHATE; COFACTOR; REQUIREMENTS	Uniquely among known ribozymes, the glmS ribozyme-riboswitch requires a small-molecule coenzyme, glucosamine-6-phosphate (GlcN6P). Although consistent with its gene-regulatory function, the use of GlcN6P is unexpected because all of the other characterized self-cleaving ribozymes use RNA functional groups or divalent cations for catalysis. To determine what active site features make this ribozyme reliant on GlcN6P and to evaluate whether it might have evolved from a coenzyme-independent ancestor, we isolated a GlcN6P-independent variant through in vitro selection. Three active site mutations suffice to generate a highly reactive RNA that adopts the wild-type fold but uses divalent cations for catalysis and is insensitive to GlcN6P. Biochemical and crystallographic comparisons of wild-type and mutant ribozymes show that a handful of functional groups fine-tune the RNA to be either coenzyme or cation dependent. These results indicate that a few mutations can confer new biochemical activities on structured RNAs. Thus, families of structurally related ribozymes with divergent function may exist.	[Lau, Matthew W. L.; Ferre-D'Amare, Adrian R.] NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ferre-D'Amare, AR (corresponding author), NHLBI, Bldg 10, Bethesda, MD 20892 USA.	adrian.ferre@nih.gov			Croucher Foundation; US National Heart, Lung and Blood Institute-National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006102] Funding Source: NIH RePORTER	Croucher Foundation; US National Heart, Lung and Blood Institute-National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the staff at beamlines 5.0.1 and 5.0.2 of the Advanced Light Source and of 12-ID (BESSRC CAT) of the Advanced Photon Source for crystallographic and SAXS data collection support, respectively; X. Fang and Y.-X. Wang for access to SAXS beam-time; D.-Y. Lee and R. Levine for access to MS; J. Sellers for access to a rapid quench apparatus; N. Baird for performing analysis of SAXS data; K. Deigan, J. Posakony and J. Zhang for discussions; and an anonymous referee for motivating the phosphorothioate interference analysis of glmS<SUP>AAG</SUP> and glmS<SUP>UAG</SUP>. M. W. L. L. was a recipient of the Croucher Foundation Fellowship. This work was supported in part by the intramural program of the US National Heart, Lung and Blood Institute-National Institutes of Health.	Baird NJ, 2010, RNA, V16, P598, DOI 10.1261/rna.1852310; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Bevilacqua PC, 2003, BIOCHEMISTRY-US, V42, P2259, DOI 10.1021/bi027273m; Brooks KM, 2011, BIOCHEMISTRY-US, V50, P2424, DOI 10.1021/bi101842u; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Cochrane JC, 2009, BIOCHEMISTRY-US, V48, P3239, DOI 10.1021/bi802069p; Collins JA, 2007, GENE DEV, V21, P3356, DOI 10.1101/gad.1605307; COWAN JA, 1993, J INORG BIOCHEM, V49, P171, DOI 10.1016/0162-0134(93)80002-Q; Davis JH, 2011, BIOCHEMISTRY-US, V50, P7236, DOI 10.1021/bi200471c; de la Pena M, 2010, RNA, V16, P1943, DOI 10.1261/rna.2130310; Deigan KE, 2011, ACCOUNTS CHEM RES, V44, P1329, DOI 10.1021/ar200039b; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Draper DE, 2004, RNA, V10, P335, DOI 10.1261/rna.5205404; Emilsson GM, 2003, RNA, V9, P907, DOI 10.1261/rna.5680603; Ferre-D'Amare AR, 2011, PHILOS T R SOC B, V366, P2942, DOI 10.1098/rstb.2011.0131; Ferre-D'Amare AR, 2010, Q REV BIOPHYS, V43, P423, DOI 10.1017/S0033583510000144; Ferre-D'Amare AR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003574; Ferre-D'Amare AR, 2004, BIOPOLYMERS, V73, P71, DOI 10.1002/bip.10516; Gong B, 2011, J AM CHEM SOC, V133, P14188, DOI 10.1021/ja205185g; Hampel KJ, 2006, BIOCHEMISTRY-US, V45, P7861, DOI 10.1021/bi060337z; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; Jansen JA, 2006, NAT STRUCT MOL BIOL, V13, P517, DOI 10.1038/nsmb1094; Jayasena VK, 1997, P NATL ACAD SCI USA, V94, P10612, DOI 10.1073/pnas.94.20.10612; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kath-Schorr S, 2012, J AM CHEM SOC, V134, P16717, DOI 10.1021/ja3067429; Klawuhn K, 2010, CHEMBIOCHEM, V11, P2567, DOI 10.1002/cbic.201000544; Klein DJ, 2007, J AM CHEM SOC, V129, P14858, DOI 10.1021/ja0768441; Klein DJ, 2007, J MOL BIOL, V373, P178, DOI 10.1016/j.jmb.2007.07.062; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Klein Daniel J., 2009, V540, P129, DOI 10.1007/978-1-59745-558-9_10; Lazarev D, 2003, RNA, V9, P688, DOI 10.1261/rna.2600503; Link KH, 2006, NUCLEIC ACIDS RES, V34, P4968, DOI 10.1093/nar/gkl643; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; McCarthy TJ, 2005, CHEM BIOL, V12, P1221, DOI 10.1016/j.chembiol.2005.09.006; McCown PJ, 2011, RNA, V17, P728, DOI 10.1261/rna.2590811; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Pitt JN, 2009, J AM CHEM SOC, V131, P3532, DOI 10.1021/ja8067325; Posakony JJ, 2013, J ORG CHEM, V78, P4730, DOI 10.1021/jo400192e; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Roth A, 2006, RNA, V12, P607, DOI 10.1261/rna.2266506; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Ryder SP, 2000, METHOD ENZYMOL, V317, P92; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; SCHATZ D, 1991, P NATL ACAD SCI USA, V88, P6132, DOI 10.1073/pnas.88.14.6132; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; Soukup GA, 2006, NUCLEIC ACIDS RES, V34, P968, DOI 10.1093/nar/gkj497; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Tinsley RA, 2007, RNA, V13, P468, DOI 10.1261/rna.341807; Viladoms J, 2012, J AM CHEM SOC, V134, P19043, DOI 10.1021/ja307021f; Viladoms J, 2011, J AM CHEM SOC, V133, P18388, DOI 10.1021/ja207426j; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; WILLIAMS KP, 1995, EMBO J, V14, P4551, DOI 10.1002/j.1460-2075.1995.tb00134.x; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Xiao H, 2008, NATURE, V454, P358, DOI 10.1038/nature07033; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645	60	23	24	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					805	+		10.1038/NCHEMBIO.1360	http://dx.doi.org/10.1038/NCHEMBIO.1360			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24096303	Green Accepted			2022-12-27	WOS:000327130000012
J	Degiacomi, MT; Lacovache, I; Pernot, L; Chami, M; Kudryashev, M; Stahlberg, H; van der Goot, FG; Dal Peraro, M				Degiacomi, Matteo T.; Lacovache, Ioan; Pernot, Lucile; Chami, Mohamed; Kudryashev, Misha; Stahlberg, Henning; van der Goot, F. Gisou; Dal Peraro, Matteo			Molecular assembly of the aerolysin pore reveals a swirling membrane-insertion mechanism	NATURE CHEMICAL BIOLOGY			English	Article							GPI-ANCHORED PROTEINS; CRYSTAL-STRUCTURE; FORMING PROTEINS; TOXIN; CHANNEL; RECEPTOR; BINDING; HEPTAMERIZATION; IDENTIFICATION; TRANSMEMBRANE	Aerolysin is the founding member of a superfamily of (beta-pore-forming toxins whose pore structure is unknown. We have combined X-ray crystallography, cryo-EM, molecular dynamics and computational modeling to determine the structures of aerolysin mutants in their monomeric and heptameric forms, trapped at various stages of the pore formation process. A dynamic modeling approach based on swarm intelligence was applied, whereby the intrinsic flexibility of aerolysin extracted from new X-ray structures was used to fully exploit the cryo-EM spatial restraints. Using this integrated strategy, we obtained a radically new arrangement of the prepore conformation and a near-atomistic structure of the aerolysin pore, which is fully consistent with all of the biochemical data available so far. Upon transition from the prepore to pore, the aerolysin heptamer shows a unique concerted swirling movement, accompanied by a vertical collapse of the complex, ultimately leading to the insertion of a transmembrane beta-barrel.	[Degiacomi, Matteo T.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Lacovache, Ioan; Pernot, Lucile; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland; [Kudryashev, Misha; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, Basel, Switzerland; [Dal Peraro, Matteo] Swiss Inst Bioinformat, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Basel; Swiss Institute of Bioinformatics	Degiacomi, MT (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, Oxford, England.	gisou.vandergoot@epfl.ch; matteo.dalperaro@epfl.ch	Stahlberg, Henning/H-1868-2011; Degiacomi, Matteo/M-4342-2017; van der Goot, Gisou/B-2279-2012	Stahlberg, Henning/0000-0002-1185-4592; Degiacomi, Matteo/0000-0003-4672-471X; iacovache, ioan/0000-0001-8470-5056; van der Goot, Gisou/0000-0002-8522-274X; Kudryashev, Misha/0000-0003-3550-6274	Swiss National Science Foundation [200021_122120, 200020_138013]; Swiss Initiative for Systems Biology, SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Initiative for Systems Biology, SystemsX.ch	We thank F. David and S. Ho for technical assistance, G. Knot and D. Demurtas for help with EM, M. Grutter for testing of crystals, C. Schulze-Briese for assistance in collecting the data and M. Schiltz for support with X-ray crystallography. EM computation was performed at the Vital-IT (Swiss Institute of Bioinformatics). This work was supported by the Swiss National Science Foundation with grants to M.D.P. (200021_122120 and 200020_138013) and to F.G.v.d.G. and by the Swiss Initiative for Systems Biology, SystemsX.ch to EG.v.d.G. and H.S.	Abrami L, 2002, FEBS LETT, V512, P249, DOI 10.1016/S0014-5793(02)02274-3; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Akiba T, 2009, J MOL BIOL, V386, P121, DOI 10.1016/j.jmb.2008.12.002; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; De Colibus L, 2012, STRUCTURE, V20, P1498, DOI 10.1016/j.str.2012.06.011; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Degiacomi MT, 2013, STRUCTURE, V21, P1097, DOI 10.1016/j.str.2013.05.014; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Iacovache I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002135; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lesieur C, 1999, J BIOL CHEM, V274, P36722, DOI 10.1074/jbc.274.51.36722; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; Melton-Witt JA, 2006, BIOCHEMISTRY-US, V45, P14347, DOI 10.1021/bi061334p; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; TREUMANN A, 1995, J BIOL CHEM, V270, P6088, DOI 10.1074/jbc.270.11.6088; Tsitrin Y, 2002, NAT STRUCT BIOL, V9, P729, DOI 10.1038/nsb839; WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	32	148	155	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					623	629		10.1038/NCHEMBIO.1312	http://dx.doi.org/10.1038/NCHEMBIO.1312			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	23912165	Green Accepted			2022-12-27	WOS:000325041800009
J	Petrova, E; Rios-Esteves, J; Ouerfelli, O; Glickman, JF; Resh, MD				Petrova, Elissaveta; Rios-Esteves, Jessica; Ouerfelli, Ouathek; Glickman, J. Fraser; Resh, Marilyn D.			Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE; FATTY-ACIDS; PALMITOYLATION; ACTIVATION; PROTEINS; CELLS	Inhibition of Sonic hedgehog (Shh) signaling is of great clinical interest. Here we exploit Hedgehog acyltransferase (Hhat)-mediated Shh palmitoylation, a modification critical for Shh signaling, as a new target for Shh pathway inhibition. A target-oriented high-throughput screen was used to identify small-molecule inhibitors of Hhat. In cells, these Hhat inhibitors specifically block Shh palmitoylation and inhibit autocrine and paracrine Shh signaling.	[Petrova, Elissaveta; Rios-Esteves, Jessica; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Petrova, Elissaveta] Cornell Univ, Grad Program Pharmacol, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Rios-Esteves, Jessica; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10021 USA; [Ouerfelli, Ouathek] Mem Sloan Kettering Canc Ctr, Pharmacol Program, New York, NY 10021 USA; [Glickman, J. Fraser] Rockefeller Univ, High Throughput Screening Resource Ctr, New York, NY 10021 USA; [Resh, Marilyn D.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Cell Biol, New York, NY 10021 USA; [Resh, Marilyn D.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Biochem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	reshm@mskcc.org	Glickman, Joseph/H-3021-2013	Glickman, Joseph/0000-0002-6706-4039; Resh, Marilyn/0000-0001-6118-9466; Ouerfelli, Ouathek/0000-0002-7038-0219	US National Institutes of Health [GM57966, CA158474]; Cycle for Survival; Geoffrey Beene Cancer Research Foundation; Sarcoma Foundation of America; W.H. Goodwin and A. Goodwin; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center;  [NCI P30 CA008748-43]; NATIONAL CANCER INSTITUTE [R21CA158474, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966, F31GM100691] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cycle for Survival; Geoffrey Beene Cancer Research Foundation; Sarcoma Foundation of America; W.H. Goodwin and A. Goodwin; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Louft-Nisenbaum, K. Anderson, D. Tan, E. Legue and A. Joyner for helpful input. This work was supported by US National Institutes of Health grants GM57966 and CA158474, Cycle for Survival, the Geoffrey Beene Cancer Research Foundation, the Sarcoma Foundation of America, W.H. Goodwin and A. Goodwin and the Commonwealth Foundation for Cancer Research and the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center. The Organic Synthesis Core is partially supported by NCI P30 CA008748-43.	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Peukert S, 2010, CHEMMEDCHEM, V5, P500, DOI 10.1002/cmdc.201000011; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Stanton BZ, 2009, NAT CHEM BIOL, V5, P154, DOI 10.1038/nchembio.142; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393	23	115	120	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					247	249		10.1038/NCHEMBIO.1184	http://dx.doi.org/10.1038/NCHEMBIO.1184			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23416332	Green Accepted			2022-12-27	WOS:000317025800014
J	Huard, DJE; Kane, KM; Tezcan, FA				Huard, Dustin J. E.; Kane, Kathleen M.; Tezcan, F. Akif			Re-engineering protein interfaces yields copper-inducible ferritin cage assembly	NATURE CHEMICAL BIOLOGY			English	Article							DIMERIZATION IN-VIVO; SMALL MOLECULES; HORSE SPLEEN; SIGNAL-TRANSDUCTION; CHEMICAL INDUCER; IRON RELEASE; DESIGN; METAL; MECHANISM; APOFERRITIN	The ability to chemically control protein-protein interactions would allow the interrogation of dynamic cellular processes and lead to a better understanding and exploitation of self-assembling protein architectures. Here we introduce a new engineering strategy reverse metal-templated interface redesign (rMeTIR)-that transforms a natural protein-protein interface into one that only engages in selective response to a metal ion. We have applied rMeTIR to render the self-assembly of the cage-like protein ferritin controllable by divalent copper binding, which has allowed the study of the structure and stability of the isolated ferritin monomer, the demonstration of the primary role of conserved hydrogen-bonding interactions in providing geometric specificity for cage assembly and the uniform chemical modification of the cage interior under physiological conditions. Notably, copper acts as a structural template for ferritin assembly in a manner that is highly reminiscent of RNA sequences that template virus capsid formation.	[Huard, Dustin J. E.; Kane, Kathleen M.; Tezcan, F. Akif] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Tezcan, FA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	tezcan@ucsd.edu			US Department of Energy (Division of Materials Sciences, Office of Basic Energy Sciences) [DE-FG02-10ER46677]; Beckman Foundation; Sloan Foundation; National Science Foundation [CHE-0908115]	US Department of Energy (Division of Materials Sciences, Office of Basic Energy Sciences)(United States Department of Energy (DOE)); Beckman Foundation; Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported by the US Department of Energy (Division of Materials Sciences, Office of Basic Energy Sciences, Award DE-FG02-10ER46677 to F.A.T.). F.A.T. was additionally supported by the Beckman Foundation, the Sloan Foundation and the National Science Foundation (CHE-0908115). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, operated by Stanford University on behalf of the Department of Energy. We thank J. Brodin for experimental assistance with TEM measurements and J. Faraone Mennella for illustrations.	Abe S, 2009, J AM CHEM SOC, V131, P6958, DOI 10.1021/ja901234j; Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; BANCROFT J B, 1970, P99, DOI 10.1016/S0065-3527(08)60022-6; Brodin JD, 2010, J AM CHEM SOC, V132, P8610, DOI 10.1021/ja910844n; Butler P.J.G., 1979, INT REV BIOCHEM, V25, P205; Butts CA, 2008, BIOCHEMISTRY-US, V47, P12729, DOI 10.1021/bi8016735; Comellas-Aragones M, 2007, NAT NANOTECHNOL, V2, P635, DOI 10.1038/nnano.2007.299; Corson TW, 2008, ACS CHEM BIOL, V3, P677, DOI 10.1021/cb8001792; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Dalmau M, 2009, NANO LETT, V9, P160, DOI 10.1021/nl8027069; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Gendreizig S, 2003, J AM CHEM SOC, V125, P14970, DOI 10.1021/ja037883p; GERL M, 1988, BIOCHEMISTRY-US, V27, P4089, DOI 10.1021/bi00411a027; Guo ZH, 2000, SCIENCE, V288, P2042, DOI 10.1126/science.288.5473.2042; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hussey SL, 2003, J AM CHEM SOC, V125, P3692, DOI 10.1021/ja0293305; Johnson E, 2005, STRUCTURE, V13, P637, DOI 10.1016/j.str.2005.01.019; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Laganowsky A, 2011, PROTEIN SCI, V20, P1876, DOI 10.1002/pro.727; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Lin HN, 2000, J AM CHEM SOC, V122, P4247, DOI 10.1021/ja9941532; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Mines GA, 1996, CHEM BIOL, V3, P491, DOI 10.1016/S1074-5521(96)90097-6; Salgado EN, 2008, J AM CHEM SOC, V130, P6082, DOI 10.1021/ja8012177; Salgado EN, 2007, J AM CHEM SOC, V129, P13374, DOI 10.1021/ja075261o; Salgado EN, 2010, P NATL ACAD SCI USA, V107, P1827, DOI 10.1073/pnas.0906852107; Salgado EN, 2009, INORG CHEM, V48, P2726, DOI 10.1021/ic9001237; Santambrogio P, 1997, BIOCHEM J, V322, P461, DOI 10.1042/bj3220461; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; STEFANINI S, 1987, BIOCHEMISTRY-US, V26, P1831, DOI 10.1021/bi00381a007; Swift J, 2006, J AM CHEM SOC, V128, P6611, DOI 10.1021/ja057069x; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Treffry A, 1996, J BIOL INORG CHEM, V1, P49, DOI 10.1007/s007750050022; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690; Vriezema DM, 2005, CHEM REV, V105, P1445, DOI 10.1021/cr0300688; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; WEBB B, 1994, ARCH BIOCHEM BIOPHYS, V309, P178, DOI 10.1006/abbi.1994.1100; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Wong KKW, 1998, CHEM MATER, V10, P279, DOI 10.1021/cm970421o; YANG DW, 1995, BIOCHEM J, V307, P253, DOI 10.1042/bj3070253; Zhang Y, 2011, INT J MOL SCI, V12, P5406, DOI 10.3390/ijms12085406; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	50	139	142	0	159	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					169	176		10.1038/NCHEMBIO.1163	http://dx.doi.org/10.1038/NCHEMBIO.1163			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23340339				2022-12-27	WOS:000315132900012
J	Silvius, JR				Silvius, John R.			MEMBRANES First steps to rafts?	NATURE CHEMICAL BIOLOGY			English	News Item							CELL-MEMBRANES; LIPID RAFTS; ORGANIZATION; MOLECULES		McGill Univ, Dept Chem, Montreal, PQ, Canada	McGill University	Silvius, JR (corresponding author), McGill Univ, Dept Chem, Montreal, PQ, Canada.	john.silvius@mcgill.ca						Chen Y, 2009, J CELL SCI, V122, P3966, DOI 10.1242/jcs.049346; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]	9	4	4	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					743	744		10.1038/nchembio.1045	http://dx.doi.org/10.1038/nchembio.1045			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22907090				2022-12-27	WOS:000308077600003
J	Beisson, F; Ohlrogge, J				Beisson, Fred; Ohlrogge, John			PLANTS Knitting a polyester skin	NATURE CHEMICAL BIOLOGY			English	News Item							CUTIN; ACYLTRANSFERASE; BIOSYNTHESIS; EXPRESSION; SUBERIN		[Beisson, Fred] Aix Marseille Univ, Ctr Natl Rech Sci, Commissariat Energie Atom & Energies Alternat, Serv Biol Vegetale & Microbiol Environm,UMR 7265, Cadarache, France; [Ohlrogge, John] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Michigan State University	Beisson, F (corresponding author), Aix Marseille Univ, Ctr Natl Rech Sci, Commissariat Energie Atom & Energies Alternat, Serv Biol Vegetale & Microbiol Environm,UMR 7265, Cadarache, France.	frederic.beisson@cea.fr; ohlrogge@msu.edu	Beisson, Frederic/AAX-9165-2021	Beisson, Frederic/0000-0001-9995-7387				Heredia A, 2009, BIOINTERPHASES, V4, pP1, DOI 10.1116/1.3063816; Isaacson T, 2009, PLANT J, V60, P363, DOI 10.1111/j.1365-313X.2009.03969.x; Kannangara R, 2007, PLANT CELL, V19, P1278, DOI 10.1105/tpc.106.047076; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; Li YH, 2007, PLANT PHYSIOL, V144, P1267, DOI 10.1104/pp.107.099432; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Shi JX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001388; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; van der Walle GAM, 2001, ADV BIOCHEM ENG BIOT, V71, P263; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yeats TH, 2012, NAT CHEM BIOL, V8, P609, DOI [10.1038/NCHEMBIO.960, 10.1038/nchembio.960]	11	5	5	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					603	604		10.1038/nchembio.1004	http://dx.doi.org/10.1038/nchembio.1004			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22710305				2022-12-27	WOS:000305471400002
J	Irani, NG; Di Rubbo, S; Mylle, E; Van den Begin, J; Schneider-Pizon, J; Hnilikova, J; Sisa, M; Buyst, D; Vilarrasa-Blasi, J; Szatmari, AM; Van Damme, D; Mishev, K; Codreanu, MC; Kohout, L; Strnad, M; Cano-Delgado, AI; Friml, J; Madder, A; Russinova, E				Irani, Niloufer G.; Di Rubbo, Simone; Mylle, Evelien; Van den Begin, Jos; Schneider-Pizon, Joanna; Hnilikova, Jaroslava; Sisa, Miroslav; Buyst, Dieter; Vilarrasa-Blasi, Josep; Szatmari, Anna-Maria; Van Damme, Daniel; Mishev, Kiril; Codreanu, Mirela-Corina; Kohout, Ladislav; Strnad, Miroslav; Cano-Delgado, Ana I.; Friml, Jiri; Madder, Annemieke; Russinova, Eugenia			Fluorescent castasterone reveals BRI1 signaling from the plasma membrane	NATURE CHEMICAL BIOLOGY			English	Article							STEROID-BINDING PROTEIN-1; BRASSINOSTEROID RECEPTORS; DEPENDENT ENDOCYTOSIS; AUXIN TRANSPORT; ARABIDOPSIS; CLATHRIN; INHIBITION; TRANSDUCTION; GOLGI; PHOSPHORYLATION	Receptor-mediated endocytosis is an integral part of signal transduction as it mediates signal attenuation and provides spatial and temporal dimensions to signaling events. One of the best-studied leucine-rich repeat receptor-like kinases in plants, BRASSINOSTEROID INSENSITIVE 1 (BRI1), perceives its ligand, the brassinosteroid (BR) hormone, at the cell surface and is constitutively endocytosed. However, the importance of endocytosis for BR signaling remains unclear. Here we developed a bioactive, fluorescent BR analog, Alexa Fluor 647-castasterone (AFCS), and visualized the endocytosis of BRI1-AFCS complexes in living Arabidopsis thaliana cells. Impairment of endocytosis dependent on clathrin and the guanine nucleotide exchange factor for ARF GTPases (ARF-GEF) GNOM enhanced BR signaling by retaining active BRI1-ligand complexes at the plasma membrane. Increasing the trans-Golgi network/early endosome pool of BRI1-BR complexes did not affect BR signaling. Our findings provide what is to our knowledge the first visualization of receptor-ligand complexes in plants and reveal clathrin- and ARF-GEF-dependent endocytic regulation of BR signaling from the plasma membrane.	[Irani, Niloufer G.; Di Rubbo, Simone; Mylle, Evelien; Schneider-Pizon, Joanna; Szatmari, Anna-Maria; Van Damme, Daniel; Mishev, Kiril; Codreanu, Mirela-Corina; Friml, Jiri; Russinova, Eugenia] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Irani, Niloufer G.; Di Rubbo, Simone; Mylle, Evelien; Schneider-Pizon, Joanna; Szatmari, Anna-Maria; Van Damme, Daniel; Mishev, Kiril; Codreanu, Mirela-Corina; Friml, Jiri; Russinova, Eugenia] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Van den Begin, Jos; Buyst, Dieter; Madder, Annemieke] Univ Ghent, Lab Organ & Biomimet Chem, Dept Organ Chem, B-9000 Ghent, Belgium; [Hnilikova, Jaroslava; Kohout, Ladislav] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Sisa, Miroslav; Strnad, Miroslav] Palacky Univ, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Sisa, Miroslav; Strnad, Miroslav] Acad Sci Czech Republ, Inst Expt Bot, Olomouc, Czech Republic; [Vilarrasa-Blasi, Josep; Cano-Delgado, Ana I.] Ctr Res Agr Genom, Dept Mol Genet, Barcelona, Spain	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Irani, NG (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	jenny.russinova@psb.vib-ugent.be	Friml, Jiri/D-9511-2012; Buyst, Dieter/X-3309-2019; Mishev, Kiril/Q-2631-2017; Sisa, Miroslav/E-6803-2015; Strnad, Miroslav/H-1858-2014; van damme, daniel/ABA-1397-2020; van damme, daniel/F-6139-2014; Vilarrasa-Blasi, Josep/AAB-9586-2021	Friml, Jiri/0000-0002-8302-7596; Mishev, Kiril/0000-0001-5849-8786; Strnad, Miroslav/0000-0002-2806-794X; van damme, daniel/0000-0002-9385-4851; van damme, daniel/0000-0002-9385-4851; Vilarrasa-Blasi, Josep/0000-0003-4328-4798; Russinova, Eugenia/0000-0002-0569-1977; Madder, Annemieke/0000-0003-0179-7608; Irani, Niloufer/0000-0003-3252-4493	Research Foundation-Flanders; BRAVISSIMO Marie-Curie Initial Training Network; Agency for Innovation by Science and Technology; Ghent University; Free University of Brussels; University of Antwerp via the Flemish Government;  [1M06030];  [Z4 055 0506]	Research Foundation-Flanders(FWO); BRAVISSIMO Marie-Curie Initial Training Network; Agency for Innovation by Science and Technology; Ghent University(Ghent University); Free University of Brussels; University of Antwerp via the Flemish Government; ; 	We thank N. Geldner, Y. Yin, S. Clouse, Xiaofeng Wang, S. Huber and Xuelu Wang for sharing materials and protocols; S. Figaroli for technical assistance; M. De Cock for the help with manuscript preparation; and J. Martins for NMR and structure analysis. This work is supported by the Odysseus program of the Research Foundation-Flanders (to J.F.), the BRAVISSIMO Marie-Curie Initial Training Network (predoctoral fellowships to S.D.R. and J.S.-P.), the Research Foundation-Flanders (postdoctoral fellowship to D.V.D.), the Agency for Innovation by Science and Technology (postdoctoral fellowship to K.M.), the Research Foundation-Flanders (research grant to E.R.) and projects 1M06030 and Z4 055 0506 (to J.H., M.S. and L.K.). The 700-MHz equipment of the Interuniversitary NMR Facility used in this work was financed by Ghent University, the Free University of Brussels and the University of Antwerp via the 'Zware Apparatuur' Incentive of the Flemish Government.	Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Banbury AN, 2003, J BIOL CHEM, V278, P12022, DOI 10.1074/jbc.M211966200; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Irani NG, 2009, CURR OPIN PLANT BIOL, V12, P653, DOI 10.1016/j.pbi.2009.09.011; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Naramoto S, 2010, P NATL ACAD SCI USA, V107, P21890, DOI 10.1073/pnas.1016260107; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Song L, 2009, CELL RES, V19, P864, DOI 10.1038/cr.2009.66; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Van Damme D, 2011, P NATL ACAD SCI USA, V108, P615, DOI 10.1073/pnas.1017890108; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Viotti C, 2010, PLANT CELL, V22, P1344, DOI 10.1105/tpc.109.072637; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Yang XH, 2005, PLANT CELL, V17, P116, DOI 10.1105/tpc.104.028381; Yano K, 2004, PLANT CELL PHYSIOL, V45, P951, DOI 10.1093/pcp/pch105; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	49	150	156	2	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					583	589		10.1038/NCHEMBIO.958	http://dx.doi.org/10.1038/NCHEMBIO.958			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22561410				2022-12-27	WOS:000304256300015
J	Fluhe, E; Knappe, TA; Gattner, MJ; Schafer, A; Burghaus, O; Linne, U; Marahiel, MA				Fluehe, Eif; Knappe, Thomas A.; Gattner, Michael J.; Schaefer, Antje; Burghaus, Olaf; Linne, Uwe; Marahiel, Mohamed A.			The radical SAM enzyme AlbA catalyzes thioether bond formation in subtilosin A	NATURE CHEMICAL BIOLOGY			English	Article							IRON-SULFUR CLUSTER; CARBON CROSS-LINKS; S-ADENOSYLMETHIONINE; BACILLUS-SUBTILIS; BIOTIN SYNTHASE; 4FE-4S CLUSTERS; BACTERIOCIN SUBTILOSIN; ANTIMICROBIAL PEPTIDE; ESCHERICHIA-COLI; LIPOYL SYNTHASE	Subtilosin A is a 35-residue, ribosomally synthesized bacteriocin encoded by the sbo-alb operon of Bacillus subtilis. It is composed of a head-to-tail circular peptide backbone that is additionally restrained by three unusual thioether bonds between three cysteines and the alpha-carbon of one threonine and two phenylalanines, respectively. In this study, we demonstrate that these bonds are synthesized by the radical S-adenosylmethionine enzyme AlbA, which is encoded by the sbo-alb operon and comprises two [4Fe-4S] clusters. One [4Fe-4S] cluster is coordinated by the prototypical CXXXCXXC motif and is responsible for the observed S-adenosylmethionine cleavage reaction, whereas the second [4Fe-4S] cluster is required for the generation of all three thioether linkages. On the basis of the obtained results, we propose a new radical mechanism for thioether bond formation. In addition, we show that AlbA-directed substrate transformation is leader-peptide dependent, suggesting that thioether bond formation is the first step during subtilosin A maturation.	[Fluehe, Eif; Knappe, Thomas A.; Gattner, Michael J.; Schaefer, Antje; Burghaus, Olaf; Linne, Uwe; Marahiel, Mohamed A.] Univ Marburg, Dept Chem Biochem, Marburg, Germany	Philipps University Marburg	Fluhe, E (corresponding author), Univ Marburg, Dept Chem Biochem, Marburg, Germany.	marahiel@staff.uni-marburg.de			Deutsche Forschungsgemeinschaft; LOEWE Center for Synthetic Microbiology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Center for Synthetic Microbiology	We would like to thank N. Fritzler and J. Bamberger for practical realization of the HPLC-HRMS measurements. In addition, we would like to thank the whole Marahiel group for fruitful discussions. Furthermore, we gratefully acknowledge financial support from the Deutsche Forschungsgemeinschaft and from the LOEWE Center for Synthetic Microbiology.	Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; BABASAKI K, 1985, J BIOCHEM, V98, P585, DOI 10.1093/oxfordjournals.jbchem.a135315; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Cascales L, 2010, ORG BIOMOL CHEM, V8, P5035, DOI 10.1039/c0ob00139b; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; Fang QH, 2004, J BIOL CHEM, V279, P14570, DOI 10.1074/jbc.M313855200; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; Guianvarc'h D, 1997, BIOCHEM BIOPH RES CO, V236, P402, DOI 10.1006/bbrc.1997.6952; HAGEN KS, 1983, J AM CHEM SOC, V105, P3905, DOI 10.1021/ja00350a028; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Huang T, 2009, J BACTERIOL, V191, P5690, DOI 10.1128/JB.00541-09; Kawulka K, 2003, J AM CHEM SOC, V125, P4726, DOI 10.1021/ja029654t; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; Layer G, 2005, BIOL CHEM, V386, P971, DOI 10.1515/BC.2005.113; Lee H, 2009, FEMS MICROBIOL LETT, V299, P205, DOI 10.1111/j.1574-6968.2009.01749.x; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Maqueda M, 2008, FEMS MICROBIOL REV, V32, P2, DOI 10.1111/j.1574-6976.2007.00087.x; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; Murphy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020852; Nakano MM, 2000, J BACTERIOL, V182, P3274, DOI 10.1128/JB.182.11.3274-3277.2000; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Shelburne CE, 2007, J ANTIMICROB CHEMOTH, V59, P297, DOI 10.1093/jac/dkl495; Silkin L, 2008, BIOORG MED CHEM LETT, V18, P3103, DOI 10.1016/j.bmcl.2007.11.024; Sit CS, 2011, ANGEW CHEM INT EDIT, V50, P8718, DOI 10.1002/anie.201102527; Sit CS, 2011, J AM CHEM SOC, V133, P7680, DOI 10.1021/ja201802f; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sutyak K. E., 2008, INFECT DIS OBSTET GY; Ugulava NB, 2000, BIOCHEMISTRY-US, V39, P5206, DOI 10.1021/bi9926227; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8343, DOI 10.1021/bi0104625; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600; Yokoyama K, 2007, J AM CHEM SOC, V129, P15147, DOI 10.1021/ja072481t; Zheng GL, 1999, J BACTERIOL, V181, P7346, DOI 10.1128/JB.181.23.7346-7355.1999; Zheng GL, 2000, J BACTERIOL, V182, P3266, DOI 10.1128/JB.182.11.3266-3273.2000	50	135	135	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					350	357		10.1038/NCHEMBIO.798	http://dx.doi.org/10.1038/NCHEMBIO.798			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22366720				2022-12-27	WOS:000301890100009
J	Ashida, H; Ogawa, M; Kim, M; Mimuro, H; Sasakawa, C				Ashida, Hiroshi; Ogawa, Michinaga; Kim, Minsoo; Mimuro, Hitomi; Sasakawa, Chihiro			Bacteria and host interactions in the gut epithelial barrier	NATURE CHEMICAL BIOLOGY			English	Review							ENTEROPATHOGENIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; III EFFECTOR FAMILY; TIGHT JUNCTIONS; SECRETED PROTEASE; VIRULENCE FACTORS; INDUCED APOPTOSIS; MUCOSAL BARRIER; CELL-DEATH; MUCIN	The gut mucosa acts as a barrier against microbial invaders, whereas resident commensal and foreign invading bacteria interact intimately with the gut epithelium and influence the host cellular and immune systems. The epithelial barrier serves as an infectious foothold for many bacterial pathogens and as an entry port for pathogens to disseminate into deeper tissues. Enteric bacterial pathogens can efficiently infect the gut mucosa using highly sophisticated virulence mechanisms that allow bacteria to circumvent the defense barriers in the gut. We provide an overview of the components of the mucosal barrier and discuss the bacterial stratagems that circumvent these barriers with particular emphasis on the roles of bacterial effector proteins.	[Ashida, Hiroshi; Ogawa, Michinaga; Mimuro, Hitomi; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan; [Kim, Minsoo; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Int Res Ctr Infect Dis, Tokyo, Japan	University of Tokyo; University of Tokyo	Ashida, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan.	sasakawa@ims.u-tokyo.ac.jp		Ashida, Hiroshi/0000-0003-1408-6864; Kim, Minsoo/0000-0001-8536-8653	Japan Initiative for Global Research Network on Infectious Diseases from Ministry of Education, Culture, Sports, Science and Technology; Naito Foundation;  [23000012];  [20229006];  [23689027];  [23790471];  [23790472];  [23390102];  [23659220]	Japan Initiative for Global Research Network on Infectious Diseases from Ministry of Education, Culture, Sports, Science and Technology; Naito Foundation(Naito Memorial Foundation); ; ; ; ; ; ; 	This work was supported by Grant-in-Aid for Specially Promoted Research (23000012 to C. S.); a Grant-in-Aid for Scientific Research (S) (20229006 to C. S.); a Grant-in-Aid for Young Scientists (A) (23689027 to M. K.); a Grant-in-Aid for Young Scientists (B) (23790471 to M.O. and 23790472 to H. A.), a Grant-in-Aid for Scientific Research (B) (23390102 to H. M.); a Grant-in-Aid for Challenging Exploratory Research (23659220 to H. M.); and a grant from the Japan Initiative for Global Research Network on Infectious Diseases to C. S. from the Ministry of Education, Culture, Sports, Science and Technology. Part of this work was supported by grants from the Naito Foundation (to H.A.).	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Arbeloa A, 2008, CELL MICROBIOL, V10, P1429, DOI 10.1111/j.1462-5822.2008.01136.x; Arbeloa A, 2010, CELL MICROBIOL, V12, P654, DOI 10.1111/j.1462-5822.2009.01423.x; Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; ASHIDA H, J CELL BIOL IN PRESS; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Babbin BA, 2009, AM J PATHOL, V174, P1347, DOI 10.2353/ajpath.2009.080640; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Boyle EC, 2006, CELL MICROBIOL, V8, P1946, DOI 10.1111/j.1462-5822.2006.00762.x; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Casselli T, 2008, INFECT IMMUN, V76, P2202, DOI 10.1128/IAI.01704-07; Chang YJ, 2006, CELL MICROBIOL, V8, P1740, DOI 10.1111/j.1462-5822.2006.00743.x; Chowdhury Shankar R, 2007, BMC Genomics, V8, P215, DOI 10.1186/1471-2164-8-215; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Flynn AN, 2008, MICROB PATHOGENESIS, V45, P98, DOI 10.1016/j.micpath.2007.12.004; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Garner CD, 2009, INFECT IMMUN, V77, P2691, DOI 10.1128/IAI.01570-08; Graham WV, 2006, J BIOL CHEM, V281, P26205, DOI 10.1074/jbc.M602164200; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Keeney KM, 2011, CURR OPIN MICROBIOL, V14, P92, DOI 10.1016/j.mib.2010.12.012; Ki MR, 2008, AM J PHYSIOL-GASTR L, V294, pG635, DOI 10.1152/ajpgi.00281.2007; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Kum WWS, 2011, INFECT IMMUN, V79, P2554, DOI 10.1128/IAI.01235-10; Lapointe TK, 2010, CELL MICROBIOL, V12, P692, DOI 10.1111/j.1462-5822.2010.01429.x; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; MADARA JL, 1990, AM J PATHOL, V137, P1273; MANTLE M, 1993, INFECT IMMUN, V61, P4131, DOI 10.1128/IAI.61.10.4131-4138.1993; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Morikawa H, 2010, BIOCHEM BIOPH RES CO, V401, P268, DOI 10.1016/j.bbrc.2010.09.048; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Nougayrede JP, 2007, CELL MICROBIOL, V9, P680, DOI 10.1111/j.1462-5822.2006.00820.x; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Paesold G, 2002, CELL MICROBIOL, V4, P771, DOI 10.1046/j.1462-5822.2002.00233.x; Papini E, 1998, J CLIN INVEST, V102, P813, DOI 10.1172/JCI2764; Piguet PF, 1999, LAB INVEST, V79, P495; Pitsouli C, 2009, CELL HOST MICROBE, V6, P301, DOI 10.1016/j.chom.2009.10.001; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Schauser K, 2005, HISTOCHEM CELL BIOL, V124, P237, DOI 10.1007/s00418-005-0035-7; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; Silva AJ, 2003, MICROBIOL-SGM, V149, P1883, DOI 10.1099/mic.0.26086-0; Simovitch M, 2010, CELL MICROBIOL, V12, P489, DOI 10.1111/j.1462-5822.2009.01410.x; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Szabady RL, 2011, MICROBIOL-SGM, V157, P516, DOI 10.1099/mic.0.044529-0; Thanabalasuriar A, 2010, CELL MICROBIOL, V12, P31, DOI 10.1111/j.1462-5822.2009.01376.x; Tu QV, 2008, J MED MICROBIOL, V57, P795, DOI 10.1099/jmm.0.47752-0; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Watson AJM, 2009, ANN NY ACAD SCI, V1165, P135, DOI 10.1111/j.1749-6632.2009.04027.x; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wroblewski LE, 2009, GASTROENTEROLOGY, V136, P236, DOI 10.1053/j.gastro.2008.10.011; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	100	193	209	2	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					36	45		10.1038/nchembio.741	http://dx.doi.org/10.1038/nchembio.741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173358				2022-12-27	WOS:000298414100010
J	Ejim, L; Farha, MA; Falconer, SB; Wildenhain, J; Coombes, BK; Tyers, M; Brown, ED; Wright, GD				Ejim, Linda; Farha, Maya A.; Falconer, Shannon B.; Wildenhain, Jan; Coombes, Brian K.; Tyers, Mike; Brown, Eric D.; Wright, Gerard D.			Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; RESISTANCE; DISEASES; MICE	Combinations of antibiotics are commonly used in medicine to broaden antimicrobial spectrum and generate synergistic effects. Alternatively, combination of nonantibiotic drugs with antibiotics offers an opportunity to sample a previously untapped expanse of bioactive chemical space. We screened a collection of drugs to identify compounds that augment the activity of the antibiotic minocycline. Unexpected synergistic drug combinations exhibited in vitro and in vivo activity against bacterial pathogens, including multidrug-resistant isolates.	[Ejim, Linda; Farha, Maya A.; Falconer, Shannon B.; Coombes, Brian K.; Brown, Eric D.; Wright, Gerard D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Ejim, Linda; Farha, Maya A.; Falconer, Shannon B.; Coombes, Brian K.; Brown, Eric D.; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Wildenhain, Jan; Tyers, Mike] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	McMaster University; McMaster University; University of Edinburgh	Ejim, L (corresponding author), McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	ebrown@mcmaster.ca; wrightge@mcmaster.ca	Wildenhain, Jan/Q-6596-2019; Wright, G/ABB-7666-2021; Coombes, Brian K/A-1727-2009; Wildenhain, Jan/E-5597-2011; Tyers, Michael/ABE-3194-2021	Wildenhain, Jan/0000-0002-5461-3828; Wildenhain, Jan/0000-0002-5461-3828; Wright, Gerard/0000-0002-9129-7131; Coombes, Brian/0000-0001-9883-1010	Canada Research Chairs; Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research [MOP-81330, XNE-8705, FRN-79488]; European Research Council	Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Research Council(European Research Council (ERC)European Commission)	The authors thank the staff of the McMaster High Throughput Screening Laboratory for technical assistance. The work was supported by Canada Research Chairs to E.D.B., M.T., G.D.W., the Canadian Cystic Fibrosis Foundation, Canadian Institutes of Health Research operating grants to E.D.B. (MOP-81330), G.D.W. (XNE-8705, FRN-79488) and the European Research Council to M.T.	Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; CHOPRA I, 1989, FEMS MICROBIOL LETT, V60, P21, DOI 10.1016/0378-1097(89)90070-0; Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; HURWITZ A, 1994, LIFE SCI, V54, P1687, DOI 10.1016/0024-3205(94)00609-1; Kristiansen JE, 2007, J ANTIMICROB CHEMOTH, V59, P1271, DOI 10.1093/jac/dkm071; Kruszewska Hanna, 2004, Acta Pol Pharm, V61 Suppl, P18; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Lehtinen J, 2007, INT J ANTIMICROB AG, V30, P44, DOI 10.1016/j.ijantimicag.2007.02.019; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Mazumdar K, 2009, EUR J CLIN MICROBIOL, V28, P881, DOI 10.1007/s10096-009-0739-z; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; Sharom JR, 2004, CURR OPIN CHEM BIOL, V8, P81, DOI 10.1016/j.cbpa.2003.12.007; Stolk P, 2006, B WORLD HEALTH ORGAN, V84, P745, DOI 10.2471/BLT.06.031518; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; YAMAGUCHI A, 1991, ANTIMICROB AGENTS CH, V35, P53, DOI 10.1128/AAC.35.1.53	24	342	355	6	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					348	350		10.1038/NCHEMBIO.559	http://dx.doi.org/10.1038/NCHEMBIO.559			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21516114				2022-12-27	WOS:000290677900009
J	Barb, AW; Prestegard, JH				Barb, Adam W.; Prestegard, James H.			NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic	NATURE CHEMICAL BIOLOGY			English	Article							MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; FC-GAMMA RECEPTOR; ANTIINFLAMMATORY ACTIVITY; RHEUMATOID-ARTHRITIS; CRYSTAL-STRUCTURE; GLYCOSYLATION; OLIGOSACCHARIDE; SPECTROSCOPY; COMPLEX	The N-glycan at Asn297 of the immunoglobulin G Fc fragment modulates cellular responses of the adaptive immune system. However, the underlying mechanism remains undefined, as existing structural data suggest the glycan does not directly engage cell surface receptors. Here we characterize the dynamics of the glycan termini using solution NMR spectroscopy. Contrary to previous conclusions based on X-ray crystallography and limited NMR data, our spin relaxation studies indicate that the termini of both glycan branches are highly dynamic and experience considerable motion in addition to tumbling of the Fc molecule. Relaxation dispersion and temperature-dependent chemical shift perturbations demonstrate exchange of the alpha 1-6Man-linked branch between a protein-bound and a previously unobserved unbound state, suggesting the glycan samples conformational states that can be accessed by glycan-modifying enzymes and possibly glycan recognition domains. These findings suggest a role for Fc-glycan dynamics in Fc-receptor interactions and enzymatic glycan remodeling.	[Barb, Adam W.; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Barb, AW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	jpresteg@ccrc.uga.edu		Barb, Adam/0000-0003-3290-8649	US National Institutes of Health [R01GM033225, P41RR005351]; Kirschstein National Research Service [F32AR058084]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR058084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM033225] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Yang and M. Bar-Peled for the galactokinase, Y. Liu for discussions of dynamics and pulse sequences and E. Brady for preparing the UDP-<SUP>13</SUP>C-galactose, all of the University of Georgia. This research was funded by grants from the US National Institutes of Health (R01GM033225 and P41RR005351). A. W. B. was supported by a Kirschstein National Research Service Award fellowship (F32AR058084).	Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barb AW, 2010, METHOD ENZYMOL, V478, P365, DOI 10.1016/S0076-6879(10)78018-6; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; BOCK K, 1984, ADV CARBOHYD CHEM BI, V42, P193, DOI 10.1016/S0065-2318(08)60125-0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Goronzy JJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2758; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; HIROTSU K, 1974, B CHEM SOC JPN, V47, P1872, DOI 10.1246/bcsj.47.1872; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kobata A, 2008, BBA-GEN SUBJECTS, V1780, P472, DOI 10.1016/j.bbagen.2007.06.012; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lund J, 1996, J IMMUNOL, V157, P4963; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Raju TS, 2001, BIOCHEMISTRY-US, V40, P8868, DOI 10.1021/bi010475i; Roitt I., 2001, IMMUNOLOGY, V6th; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; Voynov V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008425; WIERUSZESKI JM, 1989, GLYCOCONJUGATE J, V6, P183, DOI 10.1007/BF01050647; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Yamaguchi Y, 1998, J BIOMOL NMR, V12, P385, DOI 10.1023/A:1008392229694	38	133	144	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					147	153		10.1038/NCHEMBIO.511	http://dx.doi.org/10.1038/NCHEMBIO.511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21258329	Green Accepted			2022-12-27	WOS:000287307600007
J	Zhang, Q; Li, YX; Chen, DD; Yu, Y; Duan, LA; Shen, B; Liu, W				Zhang, Qi; Li, Yuxue; Chen, Dandan; Yu, Yi; Duan, Lian; Shen, Ben; Liu, Wen			Radical-mediated enzymatic carbon chain fragmentation-recombination	NATURE CHEMICAL BIOLOGY			English	Article							PEPTIDE ANTIBIOTIC NOSIHEPTIDE; STREPTOMYCES-ACTUOSUS; SAM SUPERFAMILY; POSTTRANSLATIONAL MODIFICATIONS; THIOPEPTIDE ANTIBIOTICS; ESCHERICHIA-COLI; GLUTAMATE MUTASE; BIOSYNTHESIS; THIOSTREPTON; IDENTIFICATION	The radical S-adenosylmethionine (S-AdoMet) superfamily contains thousands of proteins that catalyze highly diverse conversions, most of which are poorly understood, owing to a lack of information regarding chemical products and radical-dependent transformations. We here report that NosL, involved in forming the indole side ring of the thiopeptide nosiheptide (NOS), is a radical S-AdoMet 3-methyl-2-indolic acid (MIA) synthase. NosL catalyzed an unprecedented carbon chain reconstitution of L-tryptophan to give MIA, showing removal of the C alpha-N unit and shift of the carboxylate to the indole ring. Dissection of the enzymatic process upon the identification of products and a putative glycyl intermediate uncovered a radical-mediated, unusual fragmentation-recombination reaction. This finding unveiled a key step in radical S-AdoMet enzyme-catalyzed structural rearrangements during complex biotransformations. Additionally, NosL tolerated fluorinated L-tryptophan as the substrate, allowing for production of a regiospecifically halogenated thiopeptide that has not been found among the more than 80 members of the naturally occurring thiopeptide family.	[Zhang, Qi; Chen, Dandan; Yu, Yi; Duan, Lian; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Li, Yuxue] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Organometall Chem, Shanghai 200032, Peoples R China; [Shen, Ben] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53706 USA	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of Wisconsin System; University of Wisconsin Madison	Zhang, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	wliu@mail.sioc.ac.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Duan, Lian/0000-0002-8266-717X	US National Institutes of Health [CA094426]; Chinese National Natural Science Foundation [20832009, 30525001, 90713012, 20921091]; Chinese Ministry of Science and Technology [2009ZX09501-008]; Chinese National Basic Research Program ("973 program)" [2010CB833200]; Chinese Academy of Sciences [KJCX2-YW-H08, KSCX2-YW-G-06]; Science and Technology Commission of Shanghai Municipality of China [09QH1402700]; NATIONAL CANCER INSTITUTE [R01CA094426] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Basic Research Program ("973 program)"(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality of China(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. G. Floss (University of Washington) for providing S. actuosus ATCC25421 and for his pioneering work on NOS biosynthesis and Y. Zhang and W. Tong, (High Magnetic Field Laboratory, Chinese Academy of Sciences) for assistance with EPR analysis. This work was supported in part by grants from US National Institutes of Health (CA094426 to B. S.), Chinese National Natural Science Foundation (20832009, 30525001, 90713012 and 20921091), Chinese Ministry of Science and Technology (2009ZX09501-008), Chinese National Basic Research Program ("973 program," 2010CB833200), Chinese Academy of Sciences (KJCX2-YW-H08 and KSCX2-YW-G-06) and Science and Technology Commission of Shanghai Municipality (09QH1402700) of China (all to W.L).	Acker MG, 2009, J AM CHEM SOC, V131, P17563, DOI 10.1021/ja908777t; Arndt HD, 2009, ANGEW CHEM INT EDIT, V48, P6770, DOI 10.1002/anie.200901808; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Bonifacic M, 1998, J AM CHEM SOC, V120, P9930, DOI 10.1021/ja9815428; Bowers AA, 2010, J AM CHEM SOC, V132, P7519, DOI 10.1021/ja102339q; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chih HW, 2000, J AM CHEM SOC, V122, P10732, DOI 10.1021/ja002488+; Chih HW, 1999, BIOCHEMISTRY-US, V38, P13684, DOI 10.1021/bi991064t; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; HOUCK DR, 1988, J AM CHEM SOC, V110, P5800, DOI 10.1021/ja00225a035; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; MOCEK U, 1993, J AM CHEM SOC, V115, P7992, DOI 10.1021/ja00071a009; MOCEK U, 1993, J AM CHEM SOC, V115, P7557, DOI 10.1021/ja00070a001; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Nicolaou KC, 2009, ANGEW CHEM INT EDIT, V48, P660, DOI 10.1002/anie.200801695; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Priestley ND, 1996, BIOORGAN MED CHEM, V4, P1135, DOI 10.1016/0968-0896(96)00126-5; SMITH TM, 1993, J CHEM SOC CHEM COMM, P1612, DOI 10.1039/c39930001612; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Wang J, 2010, APPL ENVIRON MICROB, V76, P2335, DOI 10.1128/AEM.01790-09; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x	31	108	114	3	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					154	160		10.1038/NCHEMBIO.512	http://dx.doi.org/10.1038/NCHEMBIO.512			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21240261	Green Accepted			2022-12-27	WOS:000287307600008
J	Kim, W; Bird, GH; Neff, T; Guo, GJ; Kerenyi, MA; Walensky, LD; Orkin, SH				Kim, Woojin; Bird, Gregory H.; Neff, Tobias; Guo, Guoji; Kerenyi, Marc A.; Walensky, Loren D.; Orkin, Stuart H.			Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer	NATURE CHEMICAL BIOLOGY			English	Article							GROUP PROTEIN EZH2; HISTONE METHYLTRANSFERASE ACTIVITY; LYSINE 27; POLYCOMB; METHYLATION; H3; EXPRESSION; CARCINOMA; LYMPHOMA; ENHANCER	Enhancer of zeste homolog 2 (EZH2) is the histone lysine N-methyltransferase component of the Polycomb repressive complex 2 (PRC2), which, in conjunction with embryonic ectoderm development (EED) and suppressor of zeste 12 homolog, regulates cell lineage determination and homeostasis. Enzymatic hyperactivity has been linked to aberrant repression of tumor suppressor genes in diverse cancers. Here, we report the development of stabilized alpha-helix of EZH2 (SAH-EZH2) peptides that selectively inhibit H3 Lys27 trimethylation by dose-responsively disrupting the EZH2-EED complex and reducing EZH2 protein levels, a mechanism distinct from that reported for small-molecule EZH2 inhibitors targeting the enzyme catalytic domain. MLL-AF9 leukemia cells, which are dependent on PRC2, undergo growth arrest and monocyte-macrophage differentiation upon treatment with SAH-EZH2, consistent with observed changes in expression of PRC2-regulated, lineage-specific marker genes. Thus, by dissociating the EZH2-EED complex, we pharmacologically modulate an epigenetic 'writer' and suppress PRC2-dependent cancer cell growth.	[Kim, Woojin; Guo, Guoji; Kerenyi, Marc A.; Walensky, Loren D.; Orkin, Stuart H.] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA; [Kim, Woojin; Bird, Gregory H.; Guo, Guoji; Kerenyi, Marc A.; Walensky, Loren D.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA USA; [Kim, Woojin; Bird, Gregory H.; Guo, Guoji; Kerenyi, Marc A.; Walensky, Loren D.; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bird, Gregory H.; Walensky, Loren D.] Dana Farber Canc Inst, Linde Program Canc Chem Biol, Boston, MA 02115 USA; [Neff, Tobias] Univ Colorado, Aurora, CO USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA.	loren_walensky@dfci.harvard.edu; stuart_orkin@dfci.harvard.edu		Neff, Tobias/0000-0002-0188-8393; Guo, Guoji/0000-0002-1716-4621	US National Institutes of Health [U01CA105423, 5R01GM090299]; Leukemia and Lymphoma Society Specialized Center of Research project grant; NATIONAL CANCER INSTITUTE [U01CA105423, K08CA154777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090299] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Specialized Center of Research project grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Smith for graphics assistance. This work was supported by US National Institutes of Health grant U01CA105423 to S.H.O. and 5R01GM090299 and a Leukemia and Lymphoma Society Specialized Center of Research project grant to L.D.W. S.H.O. is an Investigator of the Howard Hughes Medical Institute.	Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; BORCHARDT RT, 1984, J BIOL CHEM, V259, P4353; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chiang PK, 1998, PHARMACOL THERAPEUT, V77, P115, DOI 10.1016/S0163-7258(97)00089-2; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; do O PP, 2002, BLOOD, V99, P3939, DOI 10.1182/blood.V99.11.3939; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; He LR, 2010, INT J CANCER, V127, P138, DOI 10.1002/ijc.25031; Hinz S, 2008, J CANCER RES CLIN, V134, P331, DOI 10.1007/s00432-007-0288-8; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kong DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033729; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Momparler RL, 2012, LEUKEMIA RES, V36, P1049, DOI 10.1016/j.leukres.2012.03.001; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Sasaki M, 2008, J PATHOL, V215, P175, DOI 10.1002/path.2345; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi J, 2012, ONCOGENE, DOI [10.1038/onc.2012.110, DOI 10.1038/0NC.2012.110]; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Toren A, 2005, STEM CELLS, V23, P1142, DOI 10.1634/stemcells.2004-0317; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang CX, 2012, CANCER RES, V72, P315, DOI 10.1158/0008-5472.CAN-11-0961; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016	51	252	264	2	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					643	650		10.1038/NCHEMBIO.1331	http://dx.doi.org/10.1038/NCHEMBIO.1331			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	23974116	Green Accepted, Green Submitted			2022-12-27	WOS:000325041800012
J	Kee, JM; Oslund, RC; Perlman, DH; Muir, TW				Kee, Jung-Min; Oslund, Rob C.; Perlman, David H.; Muir, Tom W.			A pan-specific antibody for direct detection of protein histidine phosphorylation	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; ENZYME-I; PHOSPHOHISTIDINE; KINASES; PHOSPHOENOLPYRUVATE; REGULATOR; RESIDUES; CANCER; CELLS	Despite its importance in central metabolism and bacterial cell signaling, protein histidine phosphorylation has remained elusive with respect to its extent and functional roles in biological systems because of the lack of adequate research tools. We report the development of the first pan-phosphohistidine (pHis) antibody using a stable pHis mimetic as the hapten. This antibody was successfully used in ELISA, western blotting, dot blot assays and immunoprecipitation and in detection and identification of histidine-phosphorylated proteins from native cell lysates when coupled with MS analysis. We also observed that the amount of protein pHis in Escherichia coli lysates depends on carbon source and nitrogen availability in the growth medium. In particular, we found that the amount of pHis on phosphoenolpyruvate synthase (PpsA) is sensitive to nitrogen availability in vivo and that a-ketoglutarate inhibits phosphotransfer from phosphorylated PpsA to pyruvate. We expect this antibody to open opportunities for investigating other pHis proteins and their functions.	[Kee, Jung-Min; Oslund, Rob C.; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Perlman, David H.; Muir, Tom W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Perlman, David H.] Princeton Univ, Princeton Collaborat Prote & Mass Spectrometry Co, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Muir, TW (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	muir@princeton.edu	Kee, Jung-Min/H-4798-2016; Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344	US National Institutes of Health [5R01GM095880]; Damon Runyon Cancer Research Foundation [DRG-2005-09]; National Institutes of Health Research Service Award [1F32CA167901]; NATIONAL CANCER INSTITUTE [F32CA167901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; National Institutes of Health Research Service Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge S. Darst and M. Bick (The Rockefeller University) for providing KinB and J. Rabinowitz and M. Reaves (Princeton University) for providing NCM 3722 cells. We thank J. Rabinowitz, M. Reaves and B. Wang for stimulating discussions and S. Kyin and H. Shwe for their assistance in MS. This work was funded by the US National Institutes of Health (5R01GM095880). J.-M.K. and R.C.O. were supported by a postdoctoral fellowship from the Damon Runyon Cancer Research Foundation (DRG-2005-09) and a National Institutes of Health Research Service Award (1F32CA167901), respectively.	Attwood PV, 2007, AMINO ACIDS, V32, P145, DOI 10.1007/s00726-006-0443-6; Attwood PV, 2011, AMINO ACIDS, V40, P1035, DOI 10.1007/s00726-010-0738-5; BOYER PD, 1962, J BIOL CHEM, V237, P3306; Carlson HK, 2010, ANAL BIOCHEM, V397, P139, DOI 10.1016/j.ab.2009.10.009; CHULAVATNATOL M, 1973, J BIOL CHEM, V248, P2712; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/NCHEMBIO.685, 10.1038/nchembio.685]; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; FRACKELTON AR, 1983, MOL CELL BIOL, V3, P1343, DOI 10.1128/MCB.3.8.1343; FRACKELTON AR, 1991, METHOD ENZYMOL, V201, P79; Grimsrud PA, 2010, ACS CHEM BIOL, V5, P105, DOI 10.1021/cb900277e; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kee JM, 2012, ACS CHEM BIOL, V7, P44, DOI 10.1021/cb200445w; Kee JM, 2010, J AM CHEM SOC, V132, P14327, DOI 10.1021/ja104393t; Klumpp S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe13; Lasker M, 1999, PROTEIN SCI, V8, P2177, DOI 10.1110/ps.8.10.2177; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; McAllister TE, 2011, CHEM COMMUN, V47, P1297, DOI 10.1039/c0cc04238b; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Mukai S, 2012, AMINO ACIDS, V43, P857, DOI 10.1007/s00726-011-1145-2; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PATNAIK R, 1994, APPL ENVIRON MICROB, V60, P3903, DOI 10.1128/AEM.60.11.3903-3908.1994; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schenkels C, 1999, BIOORG MED CHEM LETT, V9, P1443, DOI 10.1016/S0960-894X(99)00209-7; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Venditti V, 2013, ACS CHEM BIOL, V8, P1232, DOI 10.1021/cb400027q; WALSH CT, 2006, POSTTRANSLATIONAL MO, pCH2; WAYGOOD EB, 1980, CAN J BIOCHEM CELL B, V58, P40, DOI 10.1139/o80-006; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60	30	108	112	0	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					416	U28		10.1038/NCHEMBIO.1259	http://dx.doi.org/10.1038/NCHEMBIO.1259			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23708076	Green Accepted			2022-12-27	WOS:000320449700005
J	Larkin, A; Chang, MM; Whitworth, GE; Imperiali, B				Larkin, Angelyn; Chang, Michelle M.; Whitworth, Garrett E.; Imperiali, Barbara			Biochemical evidence for an alternate pathway in N-linked glycoprotein biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							COMPLEX POLYSACCHARIDE BIOSYNTHESIS; S-LAYER GLYCOPROTEIN; PROTEIN GLYCOSYLATION; METHANOCOCCUS-VOLTAE; IDENTIFICATION; GLYCAN; SUGAR; PURIFICATION; TRANSFERASE; ATTACHMENT	Asparagine-linked glycosylation is a complex protein modification conserved among all three domains of life. Herein we report the in vitro analysis of N-linked glycosylation from the methanogenic archaeon Methanococcus voltae. Using a suite of synthetic and semisynthetic substrates, we show that AglK initiates N-linked glycosylation in M. voltae through the formation of a-linked dolichyl monophosphate N-acetylglucosamine, which contrasts with the polyprenyl diphosphate intermediates that feature in both eukaryotes and bacteria. Notably, AglK has high sequence homology to dolichyl phosphate beta-glucosyltransferases, including Alg5 in eukaryotes, suggesting a common evolutionary origin. The combined action of the first two enzymes, AglK and AglC, afforded an alpha-linked dolichyl monophosphate glycan that serves as a competent substrate for the archaeal oligosaccharyl transferase AglB. These studies provide what is to our knowledge the first biochemical evidence revealing that, despite the apparent similarity of the overall pathways, there are actually two general strategies to achieve N-linked glycoproteins across the domains of life.	[Larkin, Angelyn; Chang, Michelle M.; Whitworth, Garrett E.; Imperiali, Barbara] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chang, Michelle M.; Whitworth, Garrett E.; Imperiali, Barbara] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Larkin, A (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	imper@mit.edu		Imperiali, Barbara/0000-0002-5749-7869	US National Institutes of Health [GM039334]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039334, R01GM039334] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the US National Institutes of Health (GM039334 to B.I.) The authors are grateful to M. Jaffee for help with initial expression studies, J. Simpson (Department of Chemistry Instrumentation Facility, Massachusetts Institute of Technology) for assistance with NMR acquisition, W. Whitman (University of Georgia) for the gift of both M. voltae genomic DNA and M. maripaludis cell pellets and E. Swiezewska (Polish Academy of Sciences) for providing a sample of racemic short dolichols for preliminary studies.	Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; BEHRENS NH, 1970, P NATL ACAD SCI USA, V66, P153, DOI 10.1073/pnas.66.1.153; Branch CL, 1999, SYNTHETIC COMMUN, V29, P2639, DOI 10.1080/00397919908086425; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Calo D, 2011, MOL MICROBIOL, V81, P1166, DOI 10.1111/j.1365-2958.2011.07781.x; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Chaban B, 2009, J BACTERIOL, V191, P187, DOI 10.1128/JB.00885-08; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; FERRANTE G, 1986, J BIOL CHEM, V261, P7062; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P607, DOI 10.1016/j.bbalip.2011.06.022; Guan ZQ, 2010, MOL MICROBIOL, V78, P1294, DOI 10.1111/j.1365-2958.2010.07405.x; Hartley MD, 2012, ARCH BIOCHEM BIOPHYS, V517, P83, DOI 10.1016/j.abb.2011.10.018; HERSCOVICS A, 1975, J BIOL CHEM, V250, P8079; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; IMPERIALI B, 1990, TETRAHEDRON LETT, V31, P6485, DOI 10.1016/S0040-4039(00)97097-7; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d; Jones MB, 2009, BBA-GEN SUBJECTS, V1790, P485, DOI 10.1016/j.bbagen.2009.03.030; Kaminski L, 2010, J BACTERIOL, V192, P5572, DOI 10.1128/JB.00705-10; Kelly J, 2009, CARBOHYD RES, V344, P648, DOI 10.1016/j.carres.2009.01.006; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuntz C, 1997, GLYCOBIOLOGY, V7, P897, DOI 10.1093/glycob/7.7.897; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Larkin A, 2009, BIOCHEMISTRY-US, V48, P5446, DOI 10.1021/bi900186u; LECHNER J, 1985, J BIOL CHEM, V260, P860; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Magidovich H, 2009, FEMS MICROBIOL LETT, V300, P122, DOI 10.1111/j.1574-6968.2009.01775.x; Matsumoto S, 2012, BIOCHEMISTRY-US, V51, P4157, DOI 10.1021/bi300076u; MESCHER MF, 1976, J BIOL CHEM, V251, P7289; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Naparstek S, 2012, BBA-MOL CELL BIOL L, V1821, P923, DOI 10.1016/j.bbalip.2012.03.002; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; OCONNOR JV, 1979, BIOCHEMISTRY-US, V18, P500, DOI 10.1021/bi00570a020; RAMIREZ F, 1980, BIOCHIM BIOPHYS ACTA, V589, P21, DOI 10.1016/0005-2728(80)90129-2; Shams-Eldin H, 2008, J BACTERIOL, V190, P2217, DOI 10.1128/JB.01778-07; SHARMA C, 1981, EUR J BIOCHEM, V116, P101, DOI 10.1111/j.1432-1033.1981.tb05306.x; SIM MM, 1993, J AM CHEM SOC, V115, P2260, DOI 10.1021/ja00059a023; SUZUKI S, 1983, TETRAHEDRON LETT, V24, P5103, DOI 10.1016/S0040-4039(00)94052-8; Swiezewska Ewa, 1994, Acta Biochimica Polonica, V41, P221; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Tai VWF, 2001, J ORG CHEM, V66, P6217, DOI 10.1021/jo0100345; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; TKACZ JS, 1974, J BIOL CHEM, V249, P6372; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200; Wu RQ, 2012, ANGEW CHEM INT EDIT, V51, P2106, DOI 10.1002/anie.201107910; Yurist-Doutsch S, 2008, MOL MICROBIOL, V68, P1079, DOI 10.1111/j.1365-2958.2008.06224.x	54	39	42	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					367	+		10.1038/nchembio.1249	http://dx.doi.org/10.1038/nchembio.1249			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23624439	Green Accepted, Green Submitted			2022-12-27	WOS:000319328200008
J	Spitale, RC; Crisalli, P; Flynn, RA; Torre, EA; Kool, ET; Chang, HY				Spitale, Robert C.; Crisalli, Pete; Flynn, Ryan A.; Torre, Eduardo A.; Kool, Eric T.; Chang, Howard Y.			RNA SHAPE analysis in living cells	NATURE CHEMICAL BIOLOGY			English	Article							5S RIBOSOMAL-RNA; SECONDARY STRUCTURE; IN-VIVO; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; NONCODING RNAS; PREDICTION; GENOME; MODEL	RNA structure has important roles in practically every facet of gene regulation, but the paucity of in vivo structural probes limits current understanding. Here we design, synthesize and demonstrate two new chemical probes that enable selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) in living cells. RNA structures in human, mouse, fly, yeast and bacterial cells are read out at single-nucleotide resolution, revealing tertiary contacts and RNA-protein interactions.	[Spitale, Robert C.; Flynn, Ryan A.; Torre, Eduardo A.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Spitale, Robert C.; Flynn, Ryan A.; Torre, Eduardo A.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Crisalli, Pete; Kool, Eric T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Spitale, RC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kool@stanford.edu; howchang@stanford.edu		Kool, Eric/0000-0002-7310-2935; Flynn, Ryan/0000-0001-5013-0442	US National Institutes of Health [R01 GM072705, R01-HG004361]; A.P. Giannini Foundation; Stanford MedScholars Program; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A.P. Giannini Foundation; Stanford MedScholars Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Wan, G. Zheng and R. Das for comments. This work is supported by the US National Institutes of Health (R01 GM072705 to E.T.K. and R01-HG004361 to H.Y.C.), the A.P. Giannini Foundation (R.C.S.) and the Stanford MedScholars Program (R.A.F.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; BRUNEL C, 1991, J MOL BIOL, V221, P293; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; David L, 2001, METHOD ENZYMOL, V341, P518, DOI 10.1016/S0076-6879(01)41174-8; Gherghe CM, 2008, J AM CHEM SOC, V130, P12244, DOI 10.1021/ja804541s; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; Kladwang W, 2011, NAT CHEM, V3, P954, DOI [10.1038/nchem.1176, 10.1038/NCHEM.1176]; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; Leontis NB, 1998, RNA, V4, P1134, DOI 10.1017/S1355838298980566; Luo D, 1998, NUCLEIC ACIDS RES, V26, P5379, DOI 10.1093/nar/26.23.5379; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mattick JS, 2009, ANN NY ACAD SCI, V1178, P29, DOI 10.1111/j.1749-6632.2009.04991.x; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Pan T, 2001, Curr Protoc Nucleic Acid Chem, VChapter 6, DOI 10.1002/0471142700.nc0603s00; Schroeder R, 2002, CURR OPIN STRUC BIOL, V12, P296, DOI 10.1016/S0959-440X(02)00325-1; Smith MW, 2001, MOL CELL BIOL, V21, P8264, DOI 10.1128/MCB.21.24.8264-8275.2001; Spitale RC, 2011, EPIGENETICS-US, V6, P539, DOI 10.4161/epi.6.5.15221; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Trang P, 1999, NUCLEIC ACIDS RES, V27, P4590, DOI 10.1093/nar/27.23.4590; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weeks KM, 2011, ACCOUNTS CHEM RES, V44, P1280, DOI 10.1021/ar200051h; Weeks KM, 2010, CURR OPIN STRUC BIOL, V20, P295, DOI 10.1016/j.sbi.2010.04.001; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; ZAUG AJ, 1995, RNA, V1, P363; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	277	282	5	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					18	+		10.1038/NCHEMBIO.1131	http://dx.doi.org/10.1038/NCHEMBIO.1131			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23178934	Green Accepted			2022-12-27	WOS:000312484200007
J	Crespo, MD; Puorger, C; Scharer, MA; Eidam, O; Grutter, MG; Capitani, G; Glockshuber, R				Crespo, Maria D.; Puorger, Chasper; Schaerer, Martin A.; Eidam, Oliv; Gruetter, Markus G.; Capitani, Guido; Glockshuber, Rudi			Quality control of disulfide bond formation in pilus subunits by the chaperone FimC	NATURE CHEMICAL BIOLOGY			English	Article							DONOR-STRAND EXCHANGE; STRUCTURAL BASIS; TYPE-1 PILI; COMPLEX RECOGNITION; CRYSTAL-STRUCTURE; DSB PROTEINS; ADHESIN FIMH; BIOGENESIS; ISOMERASE; MECHANISM	Type 1 pili from uropathogenic Escherichia coli are filamentous, noncovalent protein complexes mediating bacterial adhesion to the host tissue. All structural pilus subunits are homologous proteins sharing an invariant disulfide bridge. Here we show that disulfide bond formation in the unfolded subunits, catalyzed by the periplasmic oxidoreductase DsbA, is required for subunit recognition by the assembly chaperone FimC and for FimC-catalyzed subunit folding. FimC thus guarantees quantitative disulfide bond formation in each of the up to 3,000 subunits of the pilus. The X-ray structure of the complex between FimC and the main pilus subunit FimA and the kinetics of FimC-catalyzed FimA folding indicate that FimC accelerates folding of pilus subunits by lowering their topological complexity. The kinetic data, together with the measured in vivo concentrations of DsbA and FimC, predict an in vivo half-life of 2 s for oxidative folding of FimA in the periplasm.	[Crespo, Maria D.; Puorger, Chasper; Glockshuber, Rudi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland; [Schaerer, Martin A.; Capitani, Guido] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Eidam, Oliv; Gruetter, Markus G.; Capitani, Guido] Univ Zurich, Dept Biochem, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich	Glockshuber, R (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland.	rudi@mol.biol.ethz.ch			Swiss National Science Foundation [310030B-138657, 31003A-122095]; Swiss Federal Institute of Technology Zurich within the framework of the Swiss National Center for Competence in Research Structural Biology Program; Research Committee of the Paul Scherrer Institute [FK-05.08.1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Institute of Technology Zurich within the framework of the Swiss National Center for Competence in Research Structural Biology Program; Research Committee of the Paul Scherrer Institute	This work was supported by the Swiss National Science Foundation (grants 310030B-138657 and 31003A-122095 to R. G.) and the Swiss Federal Institute of Technology Zurich within the framework of the Swiss National Center for Competence in Research Structural Biology Program. The PhD position of M. A. S. was supported by a grant from the Research Committee of the Paul Scherrer Institute (FK-05.08.1) to G.C.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balbach J., 2000, MECH PROTEIN FOLDING, P212; Bann JG, 2004, P NATL ACAD SCI USA, V101, P17389, DOI 10.1073/pnas.0408072101; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; Capitani G, 2006, MICROBES INFECT, V8, P2284, DOI 10.1016/j.micinf.2006.03.013; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DIEDERICHS K, 1995, PROTEINS, V23, P187, DOI 10.1002/prot.340230208; DODD DC, 1984, J BACTERIOL, V160, P227, DOI 10.1128/JB.160.1.227-232.1984; Eidam O, 2008, FEBS LETT, V582, P651, DOI 10.1016/j.febslet.2008.01.030; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hennecke J, 1997, BIOCHEMISTRY-US, V36, P6391, DOI 10.1021/bi963017w; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Hung DL, 1996, EMBO J, V15, P3792, DOI 10.1002/j.1460-2075.1996.tb00753.x; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JACOBDUBUISSON F, 1994, P NATL ACAD SCI USA, V91, P11552, DOI 10.1073/pnas.91.24.11552; JONES CH, 1993, P NATL ACAD SCI USA, V90, P8397, DOI 10.1073/pnas.90.18.8397; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUEHN MJ, 1993, SCIENCE, V262, P1234, DOI 10.1126/science.7901913; Lasica AM, 2007, FEMS MICROBIOL REV, V31, P626, DOI 10.1111/j.1574-6976.2007.00081.x; Le Trong I, 2010, J STRUCT BIOL, V172, P380, DOI 10.1016/j.jsb.2010.06.002; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Puorger C, 2011, J MOL BIOL, V412, P520, DOI 10.1016/j.jmb.2011.07.044; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Vetsch M, 2006, EMBO REP, V7, P734, DOI 10.1038/sj.embor.7400722; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; WUNDERLICH M, 1993, BIOCHEMISTRY-US, V32, P12251, DOI 10.1021/bi00096a039; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	50	39	39	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					707	713		10.1038/NCHEMBIO.1019	http://dx.doi.org/10.1038/NCHEMBIO.1019			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22772153	Green Accepted			2022-12-27	WOS:000306527600010
J	Stanger, K; Steffek, M; Zhou, LJ; Pozniak, CD; Quan, C; Franke, Y; Tom, J; Tam, C; Elliott, JM; Lewcock, JW; Zhang, YN; Murray, J; Hannoush, RN				Stanger, Karen; Steffek, Micah; Zhou, Lijuan; Pozniak, Christine D.; Quan, Clifford; Franke, Yvonne; Tom, Jeff; Tam, Christine; Elliott, J. Michael; Lewcock, Joseph W.; Zhang, Yingnan; Murray, Jeremy; Hannoush, Rami N.			Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization	NATURE CHEMICAL BIOLOGY			English	Article							MUTANT HUNTINGTIN; ALZHEIMER-DISEASE; CRYSTAL-STRUCTURE; SELF-ACTIVATION; CELL-DEATH; IN-VIVO; APOPTOSIS; CLEAVAGE; SITE; INHIBITION	The caspases are a family of cytosolic proteases with essential roles in inflammation and apoptosis. Drug discovery efforts have focused on developing molecules directed against the active sites of caspases, but this approach has proved challenging and has not yielded any approved therapeutics. Here we describe a new strategy for generating inhibitors of caspase-6, a potential therapeutic target in neurodegenerative disorders, by screening against its zymogen form. Using phage display to discover molecules that bind the zymogen, we report the identification of a peptide that specifically impairs the function of caspase-6 in vitro and in neuronal cells. Remarkably, the peptide binds at a tetramerization interface that is uniquely present in zymogen caspase-6, rather than binding into the active site, and acts via a new allosteric mechanism that promotes caspase tetramerization. Our data illustrate that screening against the zymogen holds promise as an approach for targeting caspases in drug discovery.	[Stanger, Karen; Zhou, Lijuan; Quan, Clifford; Tom, Jeff; Zhang, Yingnan; Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Steffek, Micah; Franke, Yvonne; Tam, Christine; Murray, Jeremy] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Pozniak, Christine D.; Lewcock, Joseph W.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Elliott, J. Michael] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Hannoush, RN (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	hannoush.rami@gene.com	Zhou, Li/GSE-4531-2022					Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; Denault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Linton SD, 2005, CURR TOP MED CHEM, V5, P1697, DOI 10.2174/156802605775009720; Mintzer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030376; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Salvesen G.S., 2010, HDB CELL SIGNALING, V2nd ed., P1297; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; SMITH CK, 1995, SCIENCE, V270, P980, DOI 10.1126/science.270.5238.980; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Wellington CL, 2002, J NEUROSCI, V22, P7862; Williams ST, 2003, APOPTOSIS, V8, P353, DOI 10.1023/A:1024168901003; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	47	29	30	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					655	660		10.1038/NCHEMBIO.967	http://dx.doi.org/10.1038/NCHEMBIO.967			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22683611				2022-12-27	WOS:000305471400013
J	Kopp, F; Stratton, CF; Akella, LB; Tan, DS				Kopp, Felix; Stratton, Christopher F.; Akella, Lakshmi B.; Tan, Derek S.			A diversity-oriented synthesis approach to macrocycles via oxidative ring expansion	NATURE CHEMICAL BIOLOGY			English	Article							DIELS-ALDER REACTION; INNER-OUTER-RING; POLYCYCLIC STRUCTURES; BOUND CONFORMATION; NATURAL-PRODUCTS; DRUG DISCOVERY; ANSA-STEROIDS; SIZED RINGS; INHIBITORS; LIBRARY	Macrocycles are key structural elements in numerous bioactive small molecules and are attractive targets in the diversity-oriented synthesis of natural product-based libraries. However, efficient and systematic access to diverse collections of macrocycles has proven difficult using classical macrocyclization reactions. To address this problem, we have developed a concise, modular approach to the diversity-oriented synthesis of macrolactones and macrolactams involving oxidative cleavage of a bridging double bond in polycyclic enol ethers and enamines. These substrates are assembled in only four or five synthetic steps and undergo ring expansion to afford highly functionalized macrocycles bearing handles for further diversification. In contrast to macrocyclization reactions of corresponding seco acids, the ring expansion reactions are efficient and insensitive to ring size and stereochemistry, overcoming key limitations of conventional approaches to systematic macrocycle synthesis. Cheminformatic analysis indicates that these macrocycles access regions of chemical space that overlap with natural products, distinct from currently targeted synthetic drugs.	[Kopp, Felix; Tan, Derek S.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Stratton, Christopher F.; Tan, Derek S.] Mem Sloan Kettering Canc Ctr, Triinst Training Program Chem Biol, New York, NY 10021 USA; [Akella, Lakshmi B.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Tan, Derek S.] Mem Sloan Kettering Canc Ctr, Triinst Res Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center	Kopp, F (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	tand@mskcc.org			NIH [P41 GM076267]; Starr Foundation; Alfred P. Sloan Foundation; Deutscher Akademischer Austauschdienst (DAAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM076267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dedicated to the memory of our colleague and mentor, David Y. Gin (1967-2011). We thank I. Shiina (Tokyo University of Science) for the generous gift of MNBA; G. Sukenick, H. Liu, H. Fang and S. Rusli (Memorial Sloan-Kettering Cancer Center Analytical Core Facility) for expert mass spectral analyses; and K. Kirschbaum (University of Toledo) for X-ray crystallographic analysis. Financial support from the NIH (P41 GM076267), Starr Foundation, Alfred P. Sloan Foundation (Research Fellowship to D.S.T.) and Deutscher Akademischer Austauschdienst (DAAD, postdoctoral fellowship to F.K.) is gratefully acknowledged.	Akritopoulou-Zanze I, 2007, DRUG DISCOV TODAY, V12, P948, DOI 10.1016/j.drudis.2007.08.017; Bauer RA, 2010, CURR OPIN CHEM BIOL, V14, P308, DOI 10.1016/j.cbpa.2010.02.001; Baurle S, 2004, TETRAHEDRON LETT, V45, P9569, DOI 10.1016/j.tetlet.2004.11.017; Baurle S, 2003, ANGEW CHEM INT EDIT, V42, P3961, DOI 10.1002/anie.200351385; Beeler AB, 2005, J COMB CHEM, V7, P673, DOI 10.1021/cc050064b; Benfield AP, 2006, ANGEW CHEM INT EDIT, V45, P6830, DOI 10.1002/anie.200600844; Blankenstein J, 2005, EUR J ORG CHEM, V2005, P1949, DOI 10.1002/ejoc.200400751; Borowitz I.J., 1964, TETRAHEDRON LETT, V5, P1151; Borowitz I.J., 1965, TETRAHEDR LETT, V6, P3813; BOROWITZ IJ, 1969, J ORG CHEM, V34, P1370, DOI 10.1021/jo01257a038; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; BROWN DS, 1995, J CHEM SOC PERK T 1, P1137, DOI 10.1039/p19950001137; Canales A, 2008, CHEM-EUR J, V14, P7557, DOI 10.1002/chem.200800039; CARLSEN PHJ, 1981, J ORG CHEM, V46, P3936, DOI 10.1021/jo00332a045; DANISHEFSKY S, 1982, J AM CHEM SOC, V104, P358, DOI 10.1021/ja00365a095; Dossetter AG, 1999, ANGEW CHEM INT EDIT, V38, P2398, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2398::AID-ANIE2398>3.0.CO;2-E; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Dumez E, 2002, J ORG CHEM, V67, P4882, DOI 10.1021/jo025615o; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; GEMAL AL, 1981, J AM CHEM SOC, V103, P5454, DOI 10.1021/ja00408a029; Gradillas A, 2006, ANGEW CHEM INT EDIT, V45, P6086, DOI 10.1002/anie.200600641; Huckel W, 1929, LIEBIGS ANN CHEM, V474, P121; ILLUMINATI G, 1981, ACCOUNTS CHEM RES, V14, P95, DOI 10.1021/ar00064a001; Inokuchi T, 2001, J ORG CHEM, V66, P8059, DOI 10.1021/jo010575u; Khan AR, 1998, BIOCHEMISTRY-US, V37, P16839, DOI 10.1021/bi9821364; Knust H, 2003, HELV CHIM ACTA, V86, P1871, DOI 10.1002/hlca.200390151; Kumar N, 2005, ORG LETT, V7, P2535, DOI 10.1021/ol0504345; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; Patil ML, 2002, TETRAHEDRON, V58, P6615, DOI 10.1016/S0040-4020(02)00740-8; Rincon S, 2006, TETRAHEDRON, V62, P2594, DOI 10.1016/j.tet.2005.12.036; ROXBURGH CJ, 1995, TETRAHEDRON, V51, P9767, DOI 10.1016/0040-4020(95)00629-M; ROXBURGH CJ, 1993, TETRAHEDRON, V49, P10749, DOI 10.1016/S0040-4020(01)80232-5; Sanchez-Pedregal VM, 2006, ANGEW CHEM INT EDIT, V45, P7388, DOI 10.1002/anie.200602793; Sauer WHB, 2003, J CHEM INF COMP SCI, V43, P987, DOI 10.1021/ci025599w; Schmidt DR, 2004, J COMB CHEM, V6, P286, DOI 10.1021/cc020076m; SEEBACH D, 1981, HELV CHIM ACTA, V64, P716, DOI 10.1002/hlca.19810640313; Sestelo JP, 2001, J ORG CHEM, V66, P1395, DOI 10.1021/jo0015319; Sestelo JP, 1999, TETRAHEDRON LETT, V40, P985; Shiina I, 2004, J ORG CHEM, V69, P1822, DOI 10.1021/jo030367x; Shiina I, 2002, TETRAHEDRON LETT, V43, P7535, DOI 10.1016/S0040-4039(02)01819-1; STACH H, 1988, TETRAHEDRON, V44, P1573, DOI 10.1016/S0040-4020(01)86717-X; Su QB, 2003, ORG LETT, V5, P2149, DOI 10.1021/ol034608z; Tan DS, 2005, NAT CHEM BIOL, V1, P74, DOI 10.1038/nchembio0705-74; TANNER D, 1988, TETRAHEDRON, V44, P613, DOI 10.1016/S0040-4020(01)85848-8; TORII S, 1985, J ORG CHEM, V50, P4980, DOI 10.1021/jo00224a071; Udugamasooriya DG, 2008, BIOPOLYMERS, V89, P653, DOI 10.1002/bip.20983; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wessjohann LA, 2005, MOL DIVERS, V9, P171, DOI 10.1007/s11030-005-1314-x; WOODWARD RB, 1981, J AM CHEM SOC, V103, P3213, DOI 10.1021/ja00401a050; Yang D, 2001, J ORG CHEM, V66, P4814, DOI 10.1021/jo010122p	50	109	110	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					358	365		10.1038/NCHEMBIO.911	http://dx.doi.org/10.1038/NCHEMBIO.911			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22406518	Green Accepted			2022-12-27	WOS:000301890100010
J	Carroll, MJ; Mauldin, RV; Gromova, AV; Singleton, SF; Collins, EJ; Lee, AL				Carroll, Mary J.; Mauldin, Randall V.; Gromova, Anna V.; Singleton, Scott F.; Collins, Edward J.; Lee, Andrew L.			Evidence for dynamics in proteins as a mechanism for ligand dissociation	NATURE CHEMICAL BIOLOGY			English	Article							COLI DIHYDROFOLATE-REDUCTASE; DISPERSION NMR-SPECTROSCOPY; BINDING; STATES; LOOP; RECOGNITION; FLEXIBILITY; LANDSCAPE; SUBSTRATE; CATALYSIS	Signal transduction, regulatory processes and pharmaceutical responses are highly dependent upon ligand residence times. Gaining insight into how physical factors influence residence times (1/k(off)), should enhance our ability to manipulate biological interactions. We report experiments that yield structural insight into k(off) involving a series of eight 2,4-diaminopyrimidine inhibitors of dihydrofolate reductase whose binding affinities vary by six orders of magnitude. NMR relaxation-dispersion experiments revealed a common set of residues near the binding site that undergo a concerted millisecond-timescale switching event to a previously unidentified conformation. The rate of switching from ground to excited conformations correlates exponentially with the binding affinity K-i and k(off), suggesting that protein dynamics serves as a mechanical initiator of ligand dissociation within this series and potentially for other macromolecule-ligand systems. Although the forward rate of conformational exchange, k(conf,forward,) is faster than k(offr), the use of the ligand series allowed for connections to be drawn between kinetic events on different timescales.	[Carroll, Mary J.; Gromova, Anna V.; Singleton, Scott F.; Lee, Andrew L.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA; [Mauldin, Randall V.; Collins, Edward J.; Lee, Andrew L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Collins, Edward J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carroll, MJ (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA.	drewlee@unc.edu	, UNC Biomolecular NMR Facility/AAD-7901-2022; Lee, Andrew/GVU-2817-2022	Singleton, Scott/0000-0001-8797-4438	ACS Division of Medicinal Chemistry; Pfizer Global RD; American Foundation for Pharmaceutical Education; Rho Chi Society and Schering-Plough; Graduate School at UNC; US National Institutes of Health [GM083059]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083059] Funding Source: NIH RePORTER	ACS Division of Medicinal Chemistry; Pfizer Global RD(Pfizer); American Foundation for Pharmaceutical Education; Rho Chi Society and Schering-Plough; Graduate School at UNC; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank G. Young (University of North Carolina at Chapel Hill Biomolecular NMR Facility) and K. Koshlap (University of North Carolina at Chapel Hill Eshelman School of Pharmacy NMR Facility) for their excellent technical assistance. We also acknowledge H. Kohn for assistance in assigning and interpreting the small-molecule NMR spectra as well as N. Kett for chiral resolution of 3 and the lab of P. Guengerich for use of their stopped-flow fluorimeter. M.J.C. gratefully acknowledges predoctoral fellowships from the ACS Division of Medicinal Chemistry (supported by Pfizer Global R&D), the American Foundation for Pharmaceutical Education (supported by the Rho Chi Society and Schering-Plough) and the Graduate School at UNC. This work was funded by US National Institutes of Health grant GM083059 to A.L.L.	APPLEMAN JR, 1988, J BIOL CHEM, V263, P9187; BACCANARI DP, 1981, BIOCHEMISTRY-US, V20, P1710, DOI 10.1021/bi00510a002; BERGER ARIEH, 1957, ARCH BIOCHEM AND BIOPHYS, V69, P106, DOI 10.1016/0003-9861(57)90478-2; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Bourgeois D, 2003, P NATL ACAD SCI USA, V100, P8704, DOI 10.1073/pnas.1430900100; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Carroll MJ, 2011, J AM CHEM SOC, V133, P6422, DOI 10.1021/ja2005253; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; GANGJEE A, 1995, J HETEROCYCLIC CHEM, V32, P243, DOI 10.1002/jhet.5570320141; Hansen DF, 2008, J BIOMOL NMR, V41, P113, DOI 10.1007/s10858-008-9251-5; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Ishima R, 1999, STRUCTURE, V7, P1047, DOI 10.1016/S0969-2126(99)80172-5; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; MATTHEWS DA, 1977, SCIENCE, V197, P452, DOI 10.1126/science.17920; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Namanja AT, 2010, J AM CHEM SOC, V132, P5607, DOI 10.1021/ja9096779; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Osborne MJ, 2003, PROTEIN SCI, V12, P2230, DOI 10.1110/ps.03219603; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Sapienza PJ, 2011, J MOL BIOL, V405, P378, DOI 10.1016/j.jmb.2010.10.037; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Summerfield RL, 2006, J MED CHEM, V49, P6977, DOI 10.1021/jm060570v; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Zolli-Juran M, 2003, BIOORG MED CHEM LETT, V13, P2493, DOI 10.1016/S0960-894X(03)00480-3	37	69	72	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					246	252		10.1038/NCHEMBIO.769	http://dx.doi.org/10.1038/NCHEMBIO.769			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22246400	Green Accepted, Green Submitted			2022-12-27	WOS:000300600000009
J	Paulsen, CE; Truong, TH; Garcia, FJ; Homann, A; Gupta, V; Leonard, SE; Carroll, KS				Paulsen, Candice E.; Truong, Thu H.; Garcia, Francisco J.; Homann, Arne; Gupta, Vinayak; Leonard, Stephen E.; Carroll, Kate S.			Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; SULFENIC ACID FORMATION; HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; SIGNAL-TRANSDUCTION; REDOX REGULATION; FLUORESCENT; DIMEDONE; PROBES; SRC	Protein sulfenylation is a post-translational modification of emerging importance in higher eukaryotes. However, investigation of its diverse roles remains challenging, particularly within a native cellular environment. Herein we report the development and application of DYn-2, a new chemoselective probe for detecting sulfenylated proteins in human cells. These studies show that epidermal growth factor receptor-mediated signaling results in H2O2 production and oxidation of downstream proteins. In addition, we demonstrate that DYn-2 has the ability to detect differences in sulfenylation rates within the cell, which are associated with differences in target protein localization. We also show that the direct modification of epidermal growth factor receptor by H2O2 at a critical active site cysteine (Cys797) enhances its tyrosine kinase activity. Collectively, our findings reveal sulfenylation as a global signaling mechanism that is akin to phosphorylation and has regulatory implications for other receptor tyrosine kinases and irreversible inhibitors that target oxidant-sensitive cysteines in proteins.	[Paulsen, Candice E.; Leonard, Stephen E.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Truong, Thu H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Garcia, Francisco J.; Homann, Arne; Gupta, Vinayak; Carroll, Kate S.] Scripps Res Inst, Dept Chem, Jupiter, FL USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Scripps Research Institute	Paulsen, CE (corresponding author), Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA.	kcarroll@scripps.edu	Gupta, Vinayak/I-4302-2019	Gupta, Vinayak/0000-0003-1567-1037; Paulsen, Candice/0000-0001-5317-773X; Carroll, Kate/0000-0002-7624-9617	Camille Henry Dreyfus Teacher Scholar Award; American Heart Association [0835419N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102187] Funding Source: NIH RePORTER	Camille Henry Dreyfus Teacher Scholar Award; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge funding from the Camille Henry Dreyfus Teacher Scholar Award (to K. S. C.) and the American Heart Association Scientist Development Award (0835419N to K. S. C.). The authors also wish to thank R. Petter for helpful discussions.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BENITEZ LV, 1974, J BIOL CHEM, V249, P6234; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cuddihy SL, 2011, ANTIOXID REDOX SIGN, V15, P167, DOI 10.1089/ars.2010.3843; Cunnick JM, 1998, J BIOL CHEM, V273, P14468, DOI 10.1074/jbc.273.23.14468; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leonard SE, 2011, ANGEW CHEM INT EDIT, V50, P4423, DOI 10.1002/anie.201007871; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Miller EW, 2007, NAT CHEM BIOL, V3, P349, DOI 10.1038/nchembio0607-349; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; Poole LB, 2007, BIOCONJUGATE CHEM, V18, P2004, DOI 10.1021/bc700257a; Reddie KG, 2008, MOL BIOSYST, V4, P521, DOI 10.1039/b719986d; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Seo YH, 2011, ANGEW CHEM INT EDIT, V50, P1342, DOI 10.1002/anie.201007175; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Singh J, 2010, CURR OPIN CHEM BIOL, V14, P475, DOI 10.1016/j.cbpa.2010.06.168; Takanishi CL, 2011, J PROTEOME RES, V10, P2715, DOI 10.1021/pr1009542; Tang H, 2005, J BIOL CHEM, V280, P23918, DOI 10.1074/jbc.M503498200; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Truong TH, 2011, BIOORG MED CHEM LETT, V21, P5015, DOI 10.1016/j.bmcl.2011.04.115; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	46	320	326	6	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					57	64		10.1038/nchembio.736	http://dx.doi.org/10.1038/nchembio.736			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22158416	Green Accepted			2022-12-27	WOS:000298414100012
J	Reimer, D; Pos, KM; Thines, M; Grun, P; Bode, HB				Reimer, Daniela; Pos, Klaas M.; Thines, Marco; Gruen, Peter; Bode, Helge B.			A natural prodrug activation mechanism in nonribosomal peptide synthesis	NATURE CHEMICAL BIOLOGY			English	Article							XENORHABDUS-NEMATOPHILA; GENE-CLUSTER; ESCHERICHIA-COLI; CYCLIC-PEPTIDES; BIOSYNTHESIS; ALIGNMENT; TOOL	We have identified a new mechanism for the cleavage and activation of nonribosomally made peptides and peptidepolyketide hybrids that are apparently operational in several different bacteria. This process includes the cleavage of a precursor molecule by a membrane-bound and d-asparagine-specific peptidase, as shown here in the biosynthesis of the antibiotic xenocoumacin from Xenorhabdus nematophila.	[Reimer, Daniela; Gruen, Peter; Bode, Helge B.] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Pos, Klaas M.] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Pos, Klaas M.] Goethe Univ Frankfurt, Cluster Excellence Frankfurt Macromol Complexes, Frankfurt, Germany; [Thines, Marco] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Thines, Marco] Goethe Univ Frankfurt, Inst Ecol, Dept Biol Sci, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Bode, HB (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de	Thines, Marco/H-1685-2011; Bode, Helge B/F-7022-2014; Reimer, Daniela/P-9070-2014	Bode, Helge B/0000-0001-6048-5909; 	Deutsche Forschungsgemeinschaft (DFG); Frankfurt Initiative for Microbial Sciences (FIMS); European Community [223328 (GameXP)]; Hessen's Ministry of Higher Education, Research, and the Arts	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Frankfurt Initiative for Microbial Sciences (FIMS); European Community(European Commission); Hessen's Ministry of Higher Education, Research, and the Arts	The authors thank A. Venneri for technical assistance. D. R., P. G. and H. B. B. are grateful to the Deutsche Forschungsgemeinschaft (DFG) for financial support. Work in H. B. B.'s lab is additionally supported by the Frankfurt Initiative for Microbial Sciences (FIMS), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 223328 (GameXP), and by the research funding program "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-"konomischer Exzellenz" of Hessen's Ministry of Higher Education, Research, and the Arts. Support by the DFG-EXC115 (Cluster of Excellence Macromolecular Complexes at the Goethe-University Frankfurt), DFG-SFB807 (Transport and Communication across Biological Membranes) and FIMS is gratefully acknowledged by K. M. P. M. T. is financially supported by the LOEWE program of Hessen's Ministry of Higher Education, Research, and the Arts.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Dubois D, 2011, J BIOL CHEM, V286, P35562, DOI 10.1074/jbc.M111.221960; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fujii K, 1997, ANAL CHEM, V69, P3346, DOI 10.1021/ac9701795; Goodrich-Blair H, 2007, CURR OPIN MICROBIOL, V10, P225, DOI 10.1016/j.mib.2007.05.006; Green David, 2006, Hemodial Int, V10 Suppl 2, pS2, DOI 10.1111/j.1542-4758.2006.00119.x; Hashimoto M, 2007, J ANTIBIOT, V60, P752, DOI 10.1038/ja.2007.99; Herbert EE, 2007, NAT REV MICROBIOL, V5, P634, DOI 10.1038/nrmicro1706; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Homburg S, 2007, FEMS MICROBIOL LETT, V275, P255, DOI 10.1111/j.1574-6968.2007.00889.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kevany BM, 2009, APPL ENVIRON MICROB, V75, P1144, DOI 10.1128/AEM.02518-08; Koketsu K, 2010, NAT CHEM BIOL, V6, P408, DOI 10.1038/nchembio.365; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lang G, 2008, J NAT PROD, V71, P1074, DOI 10.1021/np800053n; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Park D, 2009, MOL MICROBIOL, V73, P938, DOI 10.1111/j.1365-2958.2009.06817.x; Reimer D, 2009, CHEMBIOCHEM, V10, P1997, DOI 10.1002/cbic.200900187; Silakowski B, 1999, J BIOL CHEM, V274, P37391, DOI 10.1074/jbc.274.52.37391; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501	22	100	104	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					888	890		10.1038/NCHEMBIO.688	http://dx.doi.org/10.1038/NCHEMBIO.688			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	21926994				2022-12-27	WOS:000297166200010
J	Ojika, M; Molli, SD; Kanazawa, H; Yajima, A; Toda, K; Nukada, T; Mao, HM; Murata, R; Asano, T; Qi, JH; Sakagami, Y				Ojika, Makoto; Molli, Shylaja D.; Kanazawa, Harumi; Yajima, Arata; Toda, Kou; Nukada, Tomoo; Mao, Haimeng; Murata, Ryo; Asano, Tomoyo; Qi, Jianhua; Sakagami, Youji			The second Phytophthora mating hormone defines interspecies biosynthetic crosstalk	NATURE CHEMICAL BIOLOGY			English	Article							SEXUAL REPRODUCTION; ALPHA-HORMONES; PARASITICA; INFESTANS; HETEROTHALLISM; HOMOTHALLISM; DESTROYER; CACTORUM; PLANT	The heterothallic species of the agricultural pest Phytophthora use mating hormones alpha 1 and alpha 2 to regulate their sexual reproduction. Here we describe the absolute stereostructure of the second mating hormone alpha 2 as defined by spectroscopic analysis and total synthesis. We have uncovered not only the interspecies universality of alpha hormones but also the pathway by which alpha 2 is biosynthesized from phytol by A2-mating type strains and metabolized to alpha 1 by A1 strains.	[Ojika, Makoto; Molli, Shylaja D.; Kanazawa, Harumi; Mao, Haimeng; Murata, Ryo; Asano, Tomoyo; Qi, Jianhua; Sakagami, Youji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Yajima, Arata; Toda, Kou; Nukada, Tomoo] Tokyo Univ Agr, Fac Appl Biosci, Dept Fermentat Sci, Tokyo, Japan; [Qi, Jianhua] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China	Nagoya University; Tokyo University of Agriculture; Zhejiang University	Ojika, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	ojika@agr.nagoya-u.ac.jp	Yajima, Arata/G-7677-2011	Yajima, Arata/0000-0003-1167-6041	Japan Society for the Promotion of Science [22248012, 21710239, 18380073]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [080028]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Kawakita for P infestans strains and W.H. Ko for valuable suggestions. This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (22248012, 21710239 and 18380073). S.D.M. is a recipient of a Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) scholarship (080028).	ASHBY S. F., 1929, Trains. Brit. Mycol. Soc., V14, P18; Bajpai R, 2007, TETRAHEDRON LETT, V48, P7965, DOI 10.1016/j.tetlet.2007.09.054; Chern LL, 1996, CAN J MICROBIOL, V42, P172, DOI 10.1139/m96-025; Chern LL, 1999, BOT BULL ACAD SINICA, V40, P79; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Harutyunyan SR, 2008, P NATL ACAD SCI USA, V105, P8507, DOI 10.1073/pnas.0709289105; Jee HJ, 2002, BOT BULL ACAD SINICA, V43, P203; Jee HJ, 1997, MYCOL RES, V101, P1140, DOI 10.1017/S0953756297004127; Judelson HS, 2005, NAT REV MICROBIOL, V3, P47, DOI 10.1038/nrmicro1064; Ko WH, 2007, BOT STUD, V48, P365; KO WH, 1978, J GEN MICROBIOL, V107, P15, DOI 10.1099/00221287-107-1-15; KO WH, 1983, J GEN MICROBIOL, V129, P1397; KO WH, 1988, ANNU REV PHYTOPATHOL, V26, P57, DOI 10.1146/annurev.py.26.090188.000421; PEISKER C, 1989, J PLANT PHYSIOL, V135, P428, DOI 10.1016/S0176-1617(89)80099-9; Qi JH, 2005, SCIENCE, V309, P1828, DOI 10.1126/science.1114756; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; SAVAGE EJ, 1968, PHYTOPATHOLOGY, V58, P1004; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Wang SY, 2010, ORG LETT, V12, P5166, DOI 10.1021/ol102177j; Yajima A, 2008, NAT CHEM BIOL, V4, P235, DOI 10.1038/nchembio.74; Yajima A, 2007, TETRAHEDRON LETT, V48, P4601, DOI 10.1016/j.tetlet.2007.04.109	25	28	28	4	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					591	593		10.1038/NCHEMBIO.617	http://dx.doi.org/10.1038/NCHEMBIO.617			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21785427				2022-12-27	WOS:000294381400008
J	Cellitti, SE; Ou, WJ; Chiu, HP; Grunewald, J; Jones, DH; Hao, XS; Fan, Q; Quinn, LL; Ng, K; Anfora, AT; Lesley, SA; Uno, T; Brock, A; Geierstanger, BH				Cellitti, Susan E.; Ou, Weijia; Chiu, Hsien-Po; Gruenewald, Jan; Jones, David H.; Hao, Xueshi; Fan, Qian; Quinn, Lisa L.; Ng, Kenneth; Anfora, Andrew T.; Lesley, Scott A.; Uno, Tetsuo; Brock, Ansgar; Geierstanger, Bernhard H.			D-Ornithine coopts pyrrolysine biosynthesis to make and insert pyrroline-carboxy-lysine	NATURE CHEMICAL BIOLOGY			English	Article							TRANSFER-RNA SYNTHETASE; ENCODED AMINO-ACID; GENETIC-CODE; IN-VIVO; UAG; METHYLTRANSFERASES; EXPANSION; RESIDUE; PROTEIN	D-Ornithine has previously been suggested to enhance the expression of pyrrolysine-containing proteins. We unexpectedly discovered that uptake of D-ornithine results in the insertion of a new amino acid, pyrroline-carboxy-lysine (Pcl) instead of the anticipated pyrrolysine (Pyl). Our feeding and biochemical studies point to specific roles of the poorly understood Pyl biosynthetic enzymes PylC and PylD in converting L-lysine and D-ornithine to Pcl and confirm intermediates in the biosynthesis of Pyl.	[Cellitti, Susan E.; Ou, Weijia; Chiu, Hsien-Po; Gruenewald, Jan; Jones, David H.; Hao, Xueshi; Fan, Qian; Quinn, Lisa L.; Ng, Kenneth; Anfora, Andrew T.; Lesley, Scott A.; Uno, Tetsuo; Brock, Ansgar; Geierstanger, Bernhard H.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Novartis	Cellitti, SE (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA USA.	bgeierst@gnf.org		Anfora, Andrew/0000-0003-3849-1784				Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Cellitti SE, 2008, J AM CHEM SOC, V130, P9268, DOI 10.1021/ja801602q; Ferry JG, 1999, FEMS MICROBIOL REV, V23, P13, DOI 10.1016/S0168-6445(98)00029-1; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gaston MA, 2011, NATURE, V471, P647, DOI 10.1038/nature09918; Geierstanger B., 2010, Bio-synthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues, Patent No. [WO2010048582A1, 2010048582]; Hao B, 2004, CHEM BIOL, V11, P1317, DOI 10.1016/j.chembiol.2004.07.011; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Longstaff DG, 2007, P NATL ACAD SCI USA, V104, P1021, DOI 10.1073/pnas.0610294104; Longstaff DG, 2007, MOL MICROBIOL, V63, P229, DOI 10.1111/j.1365-2958.2006.05500.x; Mahapatra A, 2006, MOL MICROBIOL, V59, P56, DOI 10.1111/j.1365-2958.2005.04927.x; Namy O, 2007, FEBS LETT, V581, P5282, DOI 10.1016/j.febslet.2007.10.022; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045; Yuan J, 2010, FEBS LETT, V584, P342, DOI 10.1016/j.febslet.2009.11.005; Zhang Y, 2005, J BIOL CHEM, V280, P20740, DOI 10.1074/jbc.M501458200	23	24	26	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					528	530		10.1038/NCHEMBIO.586	http://dx.doi.org/10.1038/NCHEMBIO.586			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21525873				2022-12-27	WOS:000292825400013
J	Gloster, TM; Zandberg, WF; Heinonen, JE; Shen, DL; Deng, LH; Vocadlo, DJ				Gloster, Tracey M.; Zandberg, Wesley F.; Heinonen, Julia E.; Shen, David L.; Deng, Lehua; Vocadlo, David J.			Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells	NATURE CHEMICAL BIOLOGY			English	Article							O-GLCNAC TRANSFERASE; BETA-N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC PROTEINS; GLYCOSYLATION; MECHANISM; ACID; PHOSPHORYLATION; GLCNACYLATION; CATALYSIS; CLONING	Glycosyltransferases are ubiquitous enzymes that catalyze the assembly of glycoconjugates throughout all kingdoms of nature. A long-standing problem is the rational design of probes that can be used to manipulate glycosyltransferase activity in cells and tissues. Here we describe the rational design and synthesis of a nucleotide sugar analog that inhibits, with high potency both in vitro and in cells, the human glycosyltransferase responsible for the reversible post-translational modification of nucleocytoplasmic proteins with O-linked N-acetylglucosamine residues (O-GlcNAc). We show that the enzymes of the hexosamine biosynthetic pathway can transform, both in vitro and in cells, a synthetic carbohydrate precursor into the nucleotide sugar analog. Treatment of cells with the precursor lowers O-GlcNAc in a targeted manner with a single-digit micromolar EC(50). This approach to inhibition of glycosyltransferases should be applicable to other members of this superfamily of enzymes and enable their manipulation in a biological setting.	[Gloster, Tracey M.; Zandberg, Wesley F.; Heinonen, Julia E.; Deng, Lehua; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Shen, David L.; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Gloster, TM (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014; Zandberg, Wesley/AAX-5568-2021	Vocadlo, David J/0000-0001-6897-5558; 	Natural Sciences and Engineering Research Council of Canada; Simon Fraser University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Simon Fraser University	The plasmid encoding GNK was a gift from M. Berger (Charite Universitatsmedizin Berlin) and S. Hinderlich (University of Applied Sciences, Berlin), and the plasmid encoding AGX1 was a gift from V. Piller (Centre de Recherche Scientifique, UPR 4301). Polyclonal antibody to OGA was a gift from G. Hart (John Hopkins University). EMEG32 cells were a gift from T. Mak (University of Toronto). We thank G. Davies (University of York) for the E. coli expression construct of BtGH84. T. M. G. is a Sir Henry Wellcome postdoctoral fellow and a Michael Smith for Health Research (MSFHR) trainee award holder. D.J.V. is a scholar of MSFHR and holds a Canada Research Chair in Chemical Glycobiology. We thank the Natural Sciences and Engineering Research Council of Canada and Simon Fraser University for funding support.	Agard NJ, 2009, ACCOUNTS CHEM RES, V42, P788, DOI 10.1021/ar800267j; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Bourgeaux V, 2005, BIOORG MED CHEM LETT, V15, P5459, DOI 10.1016/j.bmcl.2005.08.088; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; CSUK R, 1986, J CHEM SOC CHEM COMM, P343, DOI 10.1039/c39860000343; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Granovsky M, 2000, NAT MED, V6, P306; Greig IR, 2009, J AM CHEM SOC, V131, P13415, DOI 10.1021/ja904506u; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; Jones MB, 2004, BIOTECHNOL BIOENG, V85, P394, DOI 10.1002/bit.10901; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LAMBERT JB, 1981, J ORG CHEM, V46, P3193, DOI 10.1021/jo00329a009; Lee KY, 2002, J BIOL CHEM, V277, P49341, DOI 10.1074/jbc.M209618200; LENZEN S, 1988, DIABETOLOGIA, V31, P337, DOI 10.1007/BF02341500; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; LYONS SD, 1990, J BIOL CHEM, V265, P11377; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mio T, 2000, BBA-GENE STRUCT EXPR, V1492, P369, DOI 10.1016/S0167-4781(00)00120-2; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; PLATT FM, 1994, J BIOL CHEM, V269, P8362; RALTON JE, 1993, J BIOL CHEM, V268, P24183; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; SCHNEIDER EG, 1978, J BIOL CHEM, V253, P2348; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; TANAHASHI E, 1983, CARBOHYD RES, V117, P304, DOI 10.1016/0008-6215(83)88098-7; Tsuruta O, 2003, J ORG CHEM, V68, P6400, DOI 10.1021/jo0300035; Tsuruta O, 1997, BIOORG MED CHEM LETT, V7, P2523, DOI 10.1016/S0960-894X(97)10009-9; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuasa H, 2009, CURR TOP MED CHEM, V9, P76, DOI 10.2174/156802609787354270; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3	50	217	221	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					174	181		10.1038/NCHEMBIO.520	http://dx.doi.org/10.1038/NCHEMBIO.520			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21258330	Green Accepted			2022-12-27	WOS:000287307600011
J	Landes, CF; Rambhadran, A; Taylor, JN; Salatan, F; Jayaraman, V				Landes, Christy F.; Rambhadran, Anu; Taylor, J. Nick; Salatan, Ferandre; Jayaraman, Vasanthi			Structural landscape of isolated agonist-binding domains from single AMPA receptors	NATURE CHEMICAL BIOLOGY			English	Article							MOLECULE FLUORESCENCE SPECTROSCOPY; ENZYME CONFORMATIONAL DYNAMICS; MONTE-CARLO SIMULATIONS; GLUTAMATE-RECEPTOR; FRET TRAJECTORIES; CLEFT CLOSURE; PROTEIN; MECHANISM; CHANNEL; CORE	AMPA receptors mediate fast excitatory neurotransmission by converting chemical signals into electrical signals, and thus it is important to understand the relationship between their chemical biology and their function. We used single-molecule fluorescence resonance energy transfer to examine the conformations explored by the agonist-binding domain of the AMPA receptor for wild-type and T686S mutant proteins. Each form of the agonist binding domain showed a dynamic, multistate sequential equilibrium, which could be identified only using wavelet shrinkage, a signal processing technique that removes experimental shot noise. These results illustrate that the extent of activation depends not on a rigid closed cleft but instead on the probability that a given subunit will occupy a closed-cleft conformation, which in turn is determined not only by the lowest energy state but also by the range of states that the protein explores.	[Landes, Christy F.; Taylor, J. Nick; Salatan, Ferandre] Rice Univ, Dept Chem, Houston, TX 77251 USA; [Rambhadran, Anu; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr, Ctr Membrane Biol, Dept Biochem & Mol Biol, Grad Sch Biomed Sci, Houston, TX USA	Rice University; University of Texas System; University of Texas Health Science Center Houston	Landes, CF (corresponding author), Rice Univ, Dept Chem, Houston, TX 77251 USA.	cflandes@rice.edu; vasanthi.jayaraman@uth.tmc.edu	Landes, Christy/I-5501-2014		American Chemical Society; US National Institutes of Health [R01GM073102]; American Heart Association [0855081F]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073102] Funding Source: NIH RePORTER	American Chemical Society(American Chemical Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.F.L. thanks the Norman Hackerman Welch Young Investigator Program at Rice University. We acknowledge the Donors of the American Chemical Society Petroleum Research Fund for partial support of this research (to C. F. L.). This work was supported by US National Institutes of Health Grant R01GM073102 (to V.J.) and American Heart Association Grant 0855081F (V.J.). We also thank H. Yang and R. Goldsmith for suggestions.	Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Benitez JJ, 2008, J AM CHEM SOC, V130, P2446, DOI 10.1021/ja7107867; Birdsey-Benson A, 2010, J NEUROSCI, V30, P1463, DOI 10.1523/JNEUROSCI.4558-09.2010; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Chung HS, 2010, BIOPHYS J, V98, P696, DOI 10.1016/j.bpj.2009.12.4322; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Cosa G, 2004, BIOPHYS J, V87, P2759, DOI 10.1529/biophysj.104.043083; Darugar Q, 2008, J VIROL, V82, P12164, DOI 10.1128/JVI.01158-08; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fenwick MK, 2010, J BIOL CHEM, V285, P12334, DOI 10.1074/jbc.M109.086371; FICHTHORN KA, 1991, J CHEM PHYS, V95, P1090, DOI 10.1063/1.461138; Fleming JJ, 2010, NAT CHEM BIOL, V6, P89, DOI [10.1038/nchembio.298, 10.1038/NCHEMBIO.298]; Flynn EM, 2010, J AM CHEM SOC, V132, P4772, DOI 10.1021/ja909968n; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Landes CF, 2007, J AM CHEM SOC, V129, P10181, DOI 10.1021/ja071491r; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Li CB, 2008, P NATL ACAD SCI USA, V105, P536, DOI 10.1073/pnas.0707378105; Li CB, 2009, J PHYS CHEM B, V113, P14732, DOI 10.1021/jp9059483; Madden DR, 2005, J BIOL CHEM, V280, P23637, DOI 10.1074/jbc.M414523200; Makarov DE, 2002, J CHEM PHYS, V116, P5205, DOI 10.1063/1.1450123; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mamonova T, 2008, BIOCHEMISTRY-US, V47, P11077, DOI 10.1021/bi801367d; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; METIU H, 1992, SCIENCE, V255, P1088, DOI 10.1126/science.255.5048.1088; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Robert A, 2003, J NEUROSCI, V23, P847; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Talaga DS, 2007, CURR OPIN COLLOID IN, V12, P285, DOI 10.1016/j.cocis.2007.08.014; Taylor JN, 2008, BIOCHEM BIOPH RES CO, V373, P213, DOI 10.1016/j.bbrc.2008.05.191; Taylor JN, 2011, J PHYS CHEM B, V115, P1105, DOI 10.1021/jp1050707; Taylor JN, 2010, BIOPHYS J, V98, P164, DOI 10.1016/j.bpj.2009.09.047; VOTER AF, 1986, PHYS REV B, V34, P6819, DOI 10.1103/PhysRevB.34.6819; Zeng YN, 2007, P NATL ACAD SCI USA, V104, P12651, DOI 10.1073/pnas.0700350104; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	48	75	75	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					168	173		10.1038/NCHEMBIO.523	http://dx.doi.org/10.1038/NCHEMBIO.523			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21297640	Green Accepted			2022-12-27	WOS:000287307600010
J	Sarkar, P; Saleh, T; Tzeng, SR; Birge, RB; Kalodimos, CG				Sarkar, Paramita; Saleh, Tamjeed; Tzeng, Shiou-Ru; Birge, Raymond B.; Kalodimos, Charalampos G.			Structural basis for regulation of the Crk signaling protein by a proline switch	NATURE CHEMICAL BIOLOGY			English	Article							CIS-TRANS ISOMERIZATION; TERMINAL SH3 DOMAIN; C-ABL KINASE; TYROSINE KINASE; MOLECULAR TIMER; PROLYL ISOMERIZATION; CYCLOPHILIN-A; ADAPTER; NMR; COMPLEX	Proline switches, controlled by cis-trans isomerization, have emerged as a particularly effective regulatory mechanism in a wide range of biological processes. Here we report the structures of both the cis and trans conformers of a proline switch in the Crk signaling protein. Proline isomerization toggles Crk between two conformations: an autoinhibitory conformation, stabilized by the intramolecular association of two tandem SH3 domains in the cis form, and an uninhibited, activated conformation promoted by the trans form. In addition to acting as a structural switch, the heterogeneous proline recruits cyclophilin A, which accelerates the interconversion rate between the isomers, thereby regulating the kinetics of Crk activation. The data provide atomic insight into the mechanisms that underpin the functionality of this binary switch and elucidate its remarkable efficiency. The results also reveal new SH3 binding surfaces, highlighting the binding versatility and expanding the noncanonical ligand repertoire of this important signaling domain.	[Sarkar, Paramita; Saleh, Tamjeed; Tzeng, Shiou-Ru; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Birge, Raymond B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Kalodimos, Charalampos G.] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ USA; [Kalodimos, Charalampos G.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kalodimos, CG (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Sarkar, Paramita/G-7663-2012; Kalodimos, Charalampos/Q-9846-2018; Saleh, Tamjeed/M-8698-2016	Kalodimos, Charalampos/0000-0001-6354-2796; TZENG, SHIOU-RU/0000-0002-7180-0190; Saleh, Tamjeed/0000-0002-7539-7300	US National Institutes of Health [GM80308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080308] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (GM80308 to C.G.K.).	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Calabrese MF, 2008, NAT STRUCT MOL BIOL, V15, P965, DOI 10.1038/nsmb.1483; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Donaldson LW, 2002, P NATL ACAD SCI USA, V99, P14053, DOI 10.1073/pnas.212518799; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Isakov N, 2008, TRENDS IMMUNOL, V29, P388, DOI 10.1016/j.it.2008.04.006; KizakaKondoh S, 1996, P NATL ACAD SCI USA, V93, P12177, DOI 10.1073/pnas.93.22.12177; KNUDSEN BS, 1995, EMBO J, V14, P2191, DOI 10.1002/j.1460-2075.1995.tb07213.x; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Muralidharan V, 2006, BIOCHEMISTRY-US, V45, P8874, DOI 10.1021/bi060590z; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Nicholson LK, 2007, MOL CELL, V25, P483, DOI 10.1016/j.molcel.2007.02.005; Nishihara H, 2002, CANCER LETT, V180, P55, DOI 10.1016/S0304-3835(01)00763-7; OGAWA S, 1994, ONCOGENE, V9, P1669; OuYang B, 2008, STRUCTURE, V16, P916, DOI 10.1016/j.str.2008.03.011; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reichman C, 2005, ONCOGENE, V24, P8187, DOI 10.1038/sj.onc.1208988; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Severin A, 2009, J MOL BIOL, V387, P726, DOI 10.1016/j.jmb.2009.02.012; Shishido T, 2001, GENES CELLS, V6, P431, DOI 10.1046/j.1365-2443.2001.00431.x; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zvara A, 2001, ONCOGENE, V20, P951, DOI 10.1038/sj.onc.1204173	50	62	64	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					51	57		10.1038/NCHEMBIO.494	http://dx.doi.org/10.1038/NCHEMBIO.494			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21131971	Green Accepted			2022-12-27	WOS:000285383400012
J	Kohli, RM				Kohli, Rahul M.			The chemistry of a dynamic genome	NATURE CHEMICAL BIOLOGY			English	Article							SOMATIC HYPERMUTATION; DNA DEMETHYLATION; AID; CONVERSION	In the postsequencing era, chemical biology is uniquely situated to investigate genomic DNA alterations arising through epigenetic modifications, genetic rearrangements or active mutation. These transformations significantly expand nature's diversity and may profoundly alter our view of DNA's coding potential.	[Kohli, Rahul M.] Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Kohli, Rahul M.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kohli, RM (corresponding author), Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA.	rkohli@upenn.edu		Kohli, Rahul/0000-0002-7689-5678				Barry D, 2009, NATURE, V459, P172, DOI 10.1038/459172a; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Quintas-Cardama A, 2010, NAT REV CLIN ONCOL, V7, P433, DOI 10.1038/nrclinonc.2010.87; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	20	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					866	868		10.1038/nchembio.471	http://dx.doi.org/10.1038/nchembio.471			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079591				2022-12-27	WOS:000284214700007
J	Pogoryelov, D; Krah, A; Langer, JD; Yildiz, O; Faraldo-Gomez, JD; Meier, T				Pogoryelov, Denys; Krah, Alexander; Langer, Julian D.; Yildiz, Oezkan; Faraldo-Gomez, Jose D.; Meier, Thomas			Microscopic rotary mechanism of ion translocation in the F-0 complex of ATP synthases	NATURE CHEMICAL BIOLOGY			English	Article							MEMBRANE-PROTEIN DYNAMICS; SUBUNIT-C; PROPIONIGENIUM-MODESTUM; ILYOBACTER-TARTARICUS; PROTON TRANSLOCATION; BINDING-SITE; NA+-ATPASE; ROTOR RING; DICYCLOHEXYLCARBODIIMIDE; ENVIRONMENT	The microscopic mechanism of coupled c-ring rotation and ion translocation in F1F0-ATP synthases is unknown. Here we present conclusive evidence supporting the notion that the ability of c-rings to rotate within the F-0 complex derives from the interplay between the ion-binding sites and their nonhomogenous microenvironment. This evidence rests on three atomic structures of the c(15) rotor from crystals grown at low pH, soaked at high pH and, after N,N'-dicyclohexylcarbodiimide (DCCD) modification, resolved at 1.8, 3.0 and 2.2 angstrom, respectively. Alongside a quantitative DCCD-labeling assay and free-energy molecular dynamics calculations, these data demonstrate how the thermodynamic stability of the so-called proton-locked state is maximized by the lipid membrane. By contrast, a hydrophilic environment at the a-subunit-c-ring interface appears to unlock the binding-site conformation and promotes proton exchange with the surrounding solution. Rotation thus occurs as c-subunits stochastically alternate between these environments, directionally biased by the electrochemical transmembrane gradient.	[Pogoryelov, Denys; Yildiz, Oezkan; Meier, Thomas] Max Planck Inst Biophys, Dept Biol Struct, Frankfurt, Germany; [Krah, Alexander; Faraldo-Gomez, Jose D.] Max Planck Inst Biophys, Theoret Mol Biophys Grp, D-6000 Frankfurt, Germany; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-6000 Frankfurt, Germany; [Faraldo-Gomez, Jose D.; Meier, Thomas] Cluster Excellence Macromol Complexes, Frankfurt, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Pogoryelov, D (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, Frankfurt, Germany.	jose.faraldo@biophys.mpg.de; thomas.meier@biophys.mpg.de	Meier, Thomas/AAV-6912-2021; Faraldo-Gomez, Jose/H-7127-2016; Yildiz, Ozkan/P-9207-2016	Meier, Thomas/0000-0003-3364-3320; Krah, Alexander/0000-0001-8871-5550; Yildiz, Ozkan/0000-0003-3659-2805; Langer, Julian David/0000-0002-5190-577X	DFG [EXC 115]; DFG Collaborative Research Center [(S.F.B.) 807]; European Science Foundation	DFG(German Research Foundation (DFG)); DFG Collaborative Research Center(German Research Foundation (DFG)); European Science Foundation(European Science Foundation (ESF)European Commission)	The authors thank the staff of the Swiss Light Source (PXII) and the European Synchrotron Radiation Facility (ID23-1 and ID23-2) for their assistance at the beamlines. We also thank R.H. Fillingame (University of Wisconsin) for providing unpublished data and discussions on water accessibility of the a-c interface, K.M. Pos for helpful discussions on DCCD labeling and H. Michel for his comments on this work. T.M., O.Y. and D.P. wish to express their gratitude to W. Kuhlbrandt for his exceptional scientific support. This work was funded in part by the Cluster of Excellence "Macromolecular Complexes" (DFG Project EXC 115) (to J.D.F.-G. and T.M.), the DFG Collaborative Research Center (S.F.B.) 807 (to T.M.) and a EUROCORES project (EuroSYNBIO) of the European Science Foundation (to T.M). Experimental and computational resources were provided in part by the EU ESFRI INSTRUCT program, the BMBF Membrane Protein Core Center and the Julich Supercomputing Centre.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aksimentiev A, 2004, BIOPHYS J, V86, p245A; AssadiPorter FM, 1995, BIOCHEMISTRY-US, V34, P16186, DOI 10.1021/bi00049a034; Bond PJ, 2006, P NATL ACAD SCI USA, V103, P9518, DOI 10.1073/pnas.0600398103; Bond PJ, 2003, J MOL BIOL, V329, P1035, DOI 10.1016/S0022-2836(03)00408-X; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; KLUGE C, 1993, BIOCHEMISTRY-US, V32, P10378, DOI 10.1021/bi00090a013; KLUGE C, 1993, J BIOL CHEM, V268, P14557; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; LIGHTOWLERS RN, 1987, BIOCHIM BIOPHYS ACTA, V894, P399, DOI 10.1016/0005-2728(87)90118-6; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2001, FEBS LETT, V505, P353, DOI 10.1016/S0014-5793(01)02837-X; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Neale EJ, 2007, J BIOL CHEM, V282, P37597, DOI 10.1074/jbc.M706437200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2003, J BIOENERG BIOMEMBR, V35, P427, DOI 10.1023/A:1027339814544; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SEBALD W, 1980, P NATL ACAD SCI-BIOL, V77, P785, DOI 10.1073/pnas.77.2.785; SITKOFF D, 1994, BIOPHYS CHEM, V51, P397, DOI 10.1016/0301-4622(94)00062-X; SITKOFF D, 1994, BIOPHYS CHEM, V51, P404; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Valiyaveetil F, 2002, BBA-BIOENERGETICS, V1553, P296, DOI 10.1016/S0005-2728(01)00251-1; Viard M, 2001, BIOPHYS J, V80, P347, DOI 10.1016/S0006-3495(01)76019-5; VIK SB, 1994, J BIOL CHEM, V269, P30364; von Ballmoos C, 2007, BIOCHEMISTRY-US, V46, P11800, DOI 10.1021/bi701083v; Vorburger T, 2008, FEBS J, V275, P2137, DOI 10.1111/j.1742-4658.2008.06368.x; Wiedenmann A, 2009, MOL MICROBIOL, V72, P479, DOI 10.1111/j.1365-2958.2009.06658.x	51	111	113	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					891	899		10.1038/NCHEMBIO.457	http://dx.doi.org/10.1038/NCHEMBIO.457			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	20972431				2022-12-27	WOS:000284214700018
J	Levinson, NM; Boxer, SG				Levinson, Nicholas M.; Boxer, Steven G.			A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity	NATURE CHEMICAL BIOLOGY			English	Article							TYROSINE KINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN; INHIBITION; COMPLEX; BINDING; DESIGN; MOLECULES; HYDRATION	Kinase inhibitors are important cancer drugs, but they tend to display limited target specificity, and their target profiles are often challenging to rationalize in terms of molecular mechanism. Here we report that the clinical kinase inhibitor bosutinib recognizes its kinase targets by engaging a pair of conserved structured water molecules in the active site and that many other kinase inhibitors share a similar recognition mechanism. Using the nitrile group of bosutinib as an infrared probe, we show that the gatekeeper residue and one other position in the ATP-binding site control access of the drug to the structured water molecules and that the amino acids found at these positions account for the kinome-wide target spectrum of the drug. Our work highlights the importance of structured water molecules for inhibitor recognition, reveals a new role for the kinase gatekeeper and showcases an effective approach for elucidating the molecular origins of selectivity patterns.	[Levinson, Nicholas M.; Boxer, Steven G.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Levinson, NM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	nickl@stanford.edu		Levinson, Nicholas/0000-0003-4338-8087; Boxer, Steven/0000-0001-9167-4286	Independence Award [K99/R00, 1K99GM102288-01]; US National Institutes of Health [GM27738]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027738, K99GM102288, R01GM027738] Funding Source: NIH RePORTER	Independence Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank N. Jura and P. Littlefield (University of California-San Francisco) for providing purified Her3 and J. Kuriyan and K. Engel (University of CaliforniaBerkeley) for providing purified EGFR. We also thank N. Jura and K. Shokat for critical reading of the manuscript and A. Cohen for help with X-ray crystallography. This work is supported by a K99/R00 Pathway to Independence Award (1K99GM102288-01) to N.M.L. and a long-standing grant from the US National Institutes of Health (GM27738) to S.G.B.	Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Campone M, 2012, ANN ONCOL, V23, P610, DOI 10.1093/annonc/mdr261; Choi JH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2844787; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cortes JE, 2010, J CLIN ONCOL, V28, P487; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davies TG, 2002, NAT STRUCT BIOL, V9, P745, DOI 10.1038/nsb842; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fried SD, 2013, J AM CHEM SOC, V135, P11181, DOI 10.1021/ja403917z; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Hughes S, 2012, NAT STRUCT MOL BIOL, V19, P1101, DOI 10.1038/nsmb.2404; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Levinson NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029828; Liddle J, 2011, BIOORG MED CHEM LETT, V21, P6188, DOI 10.1016/j.bmcl.2011.07.082; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuoka D, 2009, J PHYS CHEM B, V113, P11274, DOI 10.1021/jp902459n; Meijer L, 2000, CHEM BIOL, V7, P51, DOI 10.1016/S1074-5521(00)00063-6; Park JH, 2012, BIOCHEM J, V448, P417, DOI 10.1042/BJ20121513; Poornima CS, 1995, J COMPUT AID MOL DES, V9, P500, DOI 10.1007/BF00124321; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Reimers JR, 1999, J AM CHEM SOC, V121, P3730, DOI 10.1021/ja983878n; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101	43	107	109	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					127	132		10.1038/NCHEMBIO.1404	http://dx.doi.org/10.1038/NCHEMBIO.1404			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24292070	Green Accepted			2022-12-27	WOS:000330751600011
J	Bie, HY; Yin, J; He, X; Kermode, AR; Goddard-Borger, ED; Withers, SG; James, MNG				Bie, Haiying; Yin, Jiang; He, Xu; Kermode, Allison R.; Goddard-Borger, Ethan D.; Withers, Stephen G.; James, Michael N. G.			Insights into mucopolysaccharidosis I from the structure and action of alpha-L-iduronidase	NATURE CHEMICAL BIOLOGY			English	Article							GLYCOSYL-ENZYME INTERMEDIATE; THERMOANAEROBACTERIUM-SACCHAROLYTICUM; PHARMACOLOGICAL CHAPERONES; BETA-GLUCOCEREBROSIDASE; IDENTIFICATION; MUTATIONS; XYLOSIDASE; MODEL; REFINEMENT; CATALYSIS	Mucopolysaccharidosis type I (MPS I), caused by mutations in the gene encoding alpha-L-iduronidase (IDUA), is one of approximately 70 genetic disorders collectively known as the lysosomal storage diseases. To gain insight into the basis for MPS I, we crystallized human IDUA produced in an Arabidopsis thaliana cgl mutant. IDUA consists of a TIM barrel domain containing the catalytic site, a beta-sandwich domain and a fibronectin-like domain. Structures of IDUA bound to iduronate analogs illustrate the Michaelis complex and reveal a B-2,B-5 conformation in the glycosyl-enzyme intermediate, which suggest a retaining double displacement reaction involving the nucleophilic Glu299 and the general acid/base Glu182. Unexpectedly, the N-glycan attached to Asn372 interacts with iduronate analogs in the active site and is required for enzymatic activity. Finally, these IDUA structures and biochemical analysis of the disease-relevant P533R mutation have enabled us to correlate the effects of mutations in IDUA to clinical phenotypes.	[Bie, Haiying; Yin, Jiang; James, Michael N. G.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [He, Xu; Kermode, Allison R.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Goddard-Borger, Ethan D.; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of Alberta; Simon Fraser University; University of British Columbia	Bie, HY (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	michael.james@ualberta.ca		James, Michael/0000-0002-5978-4562; Goddard-Borger, Ethan/0000-0002-8181-9733	Canadian Institutes for Health Research [MOP123222]; Alberta Innovates Health Solution; Canadian Institute of Health Research; Canadian Society for Mucopolysaccharide and Related Diseases; Michael Smith Foundation for Health Research [CI-SSH-01915(07-1)]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solution; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Society for Mucopolysaccharide and Related Diseases; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This paper is dedicated to the memory of John Colter (1923-2013), chair of the Department of Biochemistry, University of Alberta, from 1961 to 1987. We thank S. Khan for his technical assistance during in-house data collection and the staff at the Canadian Light Source in Saskatoon and the Stanford Synchrotron Radiation Lightsource for their assistance in the data collection. We are grateful for the initial work done by K. Bateman on the growth of the monoclinic form of IDUA crystals, for synthetic work performed by A. Wong and for the expression and purification of CBM-PNGase-F by E. Kwan. We also thank J. Hopwood for the monoclonal antibody to human IDUA. M.N.G. J. and A.R.K. are grateful for the funding support from the Canadian Institutes for Health Research (grant no. MOP123222). H.B. thanks Alberta Innovates Health Solution for the fellowship support. E.D.G.-B. thanks the Canadian Institute of Health Research for a postdoctoral fellowship. A.R.K. is grateful for funding support from the Canadian Society for Mucopolysaccharide and Related Diseases and to the Michael Smith Foundation for Health Research for the Senior Scholar Award (award no. CI-SSH-01915(07-1)).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alif N, 1999, ANN HUM GENET, V63, P9, DOI 10.1046/j.1469-1809.1999.6310009.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armand S, 1996, EUR J BIOCHEM, V236, P706, DOI 10.1111/j.1432-1033.1996.00706.x; Babajani G, 2012, MOL GENET METAB, V106, P323, DOI 10.1016/j.ymgme.2012.04.018; BASHYAL BP, 1987, TETRAHEDRON, V43, P415, DOI 10.1016/S0040-4020(01)89972-5; Bunge S, 1998, BBA-MOL BASIS DIS, V1407, P249, DOI 10.1016/S0925-4439(98)00046-5; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Clarke Lorne A., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000550; CLEMENTS PR, 1985, EUR J BIOCHEM, V152, P29, DOI 10.1111/j.1432-1033.1985.tb09159.x; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Downing WL, 2006, PLANT BIOTECHNOL J, V4, P169, DOI 10.1111/j.1467-7652.2005.00166.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; He X, 2013, PLANT BIOTECHNOL J, V11, P1034, DOI 10.1111/pbi.12096; He X, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2070; He X, 2012, PLANT MOL BIOL, V79, P157, DOI 10.1007/s11103-012-9902-5; Heightman TD, 1999, ANGEW CHEM INT EDIT, V38, P750, DOI 10.1002/(SICI)1521-3773(19990315)38:6<750::AID-ANIE750>3.0.CO;2-6; HOPWOOD JJ, 1982, CLIN SCI, V62, P193, DOI 10.1042/cs0620193; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laradi S, 2005, J INHERIT METAB DIS, V28, P1019, DOI 10.1007/s10545-005-0197-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maita N, 2013, P NATL ACAD SCI USA, V110, P14628, DOI 10.1073/pnas.1306939110; Matte U, 2003, MOL GENET METAB, V78, P37, DOI 10.1016/S1096-7192(02)00200-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nieman CE, 2003, BIOCHEMISTRY-US, V42, P8054, DOI 10.1021/bi034293v; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Rempel BP, 2005, MOL GENET METAB, V85, P28, DOI 10.1016/j.ymgme.2004.12.006; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; ROUBICEK M, 1985, AM J MED GENET, V20, P471, DOI 10.1002/ajmg.1320200308; Ruth L, 2000, ACTA CRYSTALLOGR D, V56, P524, DOI 10.1107/S090744490000007X; Sabini E, 1999, CHEM BIOL, V6, P483, DOI 10.1016/S1074-5521(99)80066-0; Scott Hamish S., 1992, Human Mutation, V1, P333, DOI 10.1002/humu.1380010412; Sidhu G, 1999, BIOCHEMISTRY-US, V38, P5346, DOI 10.1021/bi982946f; Terlato NJ, 2003, GENET MED, V5, P286, DOI 10.1097/01.GIM.0000078027.83236.49; Tropak MB, 2008, CHEMBIOCHEM, V9, P2650, DOI 10.1002/cbic.200800304; Valenzano KJ, 2011, ASSAY DRUG DEV TECHN, V9, P213, DOI 10.1089/adt.2011.0370; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Vocadlo DJ, 1998, BIOCHEM J, V335, P449, DOI 10.1042/bj3350449; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yang JK, 2004, J MOL BIOL, V335, P155, DOI 10.1016/j.jmb.2003.10.026; Yogalingam G, 2004, HUM MUTAT, V24, P199, DOI 10.1002/humu.20081; Yu ZQ, 2007, FEBS J, V274, P4944, DOI 10.1111/j.1742-4658.2007.06042.x; Zhao KW, 1997, J BIOL CHEM, V272, P22758, DOI 10.1074/jbc.272.36.22758	50	42	45	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					739	+		10.1038/NCHEMBIO.1357	http://dx.doi.org/10.1038/NCHEMBIO.1357			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24036510	Green Accepted			2022-12-27	WOS:000325930500016
J	Fallahi-Sichani, M; Honarnejad, S; Heiser, LM; Gray, JW; Sorger, PK				Fallahi-Sichani, Mohammad; Honarnejad, Saman; Heiser, Laura M.; Gray, Joe W.; Sorger, Peter K.			Metrics other than potency reveal systematic variation in responses to cancer drugs	NATURE CHEMICAL BIOLOGY			English	Article							INDUCED APOPTOSIS; PROTEIN-LEVELS; CURVE SLOPE; CELLS; VARIABILITY; SENSITIVITY; PATHWAY; PROLIFERATION; PREDICTION	Large-scale analysis of cellular response to anticancer drugs typically focuses on variation in potency (half-maximum inhibitory concentration, (IC50)), assuming that it is the most important difference between effective and ineffective drugs or sensitive and resistant cells. We took a multiparametric approach involving analysis of the slope of the dose-response curve, the area under the curve and the maximum effect (E-max). We found that some of these parameters vary systematically with cell line and others with drug class. For cell-cycle inhibitors, E-max often but not always correlated with cell proliferation rate. For drugs targeting the Akt/PI3K/mTOR pathway, dose-response curves were unusually shallow. Classical pharmacology has no ready explanation for this phenomenon, but single-cell analysis showed that it correlated with significant and heritable cell-to-cell variability in the extent of target inhibition. We conclude that parameters other than potency should be considered in the comparative analysis of drug response, particularly at clinically relevant concentrations near and above the IC50.	[Fallahi-Sichani, Mohammad; Honarnejad, Saman; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Harvard Med Sch Lib,Integrated Network Based Cell, Boston, MA 02115 USA; [Heiser, Laura M.; Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA	Harvard University; Harvard Medical School; Oregon Health & Science University	Fallahi-Sichani, M (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Harvard Med Sch Lib,Integrated Network Based Cell, Boston, MA 02115 USA.	peter_sorger@hms.harvard.edu	Honarnejad, Saman/AAF-9436-2021; Gray, Joe/AAX-9549-2020	Honarnejad, Saman/0000-0002-4558-501X; Gray, Joe/0000-0001-9225-6756; Sorger, Peter/0000-0002-3364-1838	US National Institutes of Health-Library of Integrated Network-Based Cellular Signatures Program [HG006097]; Stand Up [AACR-SU2C-DT0409]; Life Sciences Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER	US National Institutes of Health-Library of Integrated Network-Based Cellular Signatures Program; Stand Up; Life Sciences Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank W. Chen, G. Berriz, M. Niepel, M. Hafner, D. Flusberg, T. Mitchison, D. Marks and C. Shamu for help. This work was supported by the US National Institutes of Health-Library of Integrated Network-Based Cellular Signatures Program grant HG006097 to P.K.S. and by Stand Up to Cancer grant AACR-SU2C-DT0409 to P.K.S. and J.W.G. M.F.-S. is supported by a Merck Fellowship of the Life Sciences Research Foundation.	ALIGUE R, 1994, EMBO J, V13, P6099, DOI 10.1002/j.1460-2075.1994.tb06956.x; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENBAUM MC, 1972, CANCER CHEMOTH REP 1, V56, P563; Borden EC, 2012, NAT REV DRUG DISCOV, V11, P889, DOI 10.1038/nrd3909; CHOU TC, 1976, J THEOR BIOL, V59, P253, DOI 10.1016/0022-5193(76)90169-7; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cover T. M., 1991, ELEMENTS INFORM THEO; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gaudet S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002482; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Hannah R., 2001, PROMEGA CELL NOTES, V2, P11; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; HOLFORD NHG, 1981, CLIN PHARMACOKINET, V6, P429, DOI 10.2165/00003088-198106060-00002; HOLM S, 1979, SCAND J STAT, V6, P65; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Millard BL, 2011, NAT METHODS, V8, P487, DOI [10.1038/NMETH.1600, 10.1038/nmeth.1600]; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Sampah MES, 2011, P NATL ACAD SCI USA, V108, P7613, DOI 10.1073/pnas.1018360108; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Tourassi GD, 2001, MED PHYS, V28, P2394, DOI 10.1118/1.1418724; Tyson DR, 2012, NAT METHODS, V9, P923, DOI 10.1038/nmeth.2138; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481	39	193	202	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					708	+		10.1038/NCHEMBIO.1337	http://dx.doi.org/10.1038/NCHEMBIO.1337			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24013279	Green Accepted			2022-12-27	WOS:000325930500010
J	Toraya, T				Toraya, Tetsuo			G-PROTEIN SIGNALING A switch saves B-12 radical status	NATURE CHEMICAL BIOLOGY			English	News Item							DEHYDRATASE-REACTIVATING FACTOR; DIOL DEHYDRATASE; METHYLMALONIC ACIDURIA; INSIGHT	Vitamin B-12-dependent radical enzymes that can undergo irreversible inactivation during catalysis have their own chaperones for the maintenance of catalytic activities. New research defines a mobile loop in the G protein that determines chaperone function and defines a switch III motif akin to that found in classical G proteins.	Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan	Okayama University	Toraya, T (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan.	toraya@cc.okayama-u.ac.jp						Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; Mori K, 2010, FEBS J, V277, P4931, DOI 10.1111/j.1742-4658.2010.07898.x; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Shibata N, 2005, STRUCTURE, V13, P1745, DOI 10.1016/j.str.2005.08.011; Toraya T, 2003, CHEM REV, V103, P2095, DOI 10.1021/cr020428b	10	2	2	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					530	531		10.1038/nchembio.1314	http://dx.doi.org/10.1038/nchembio.1314			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23873213				2022-12-27	WOS:000323417500001
J	Lessene, G; Czabotar, PE; Sleebs, BE; Zobel, K; Lowes, KN; Adams, JM; Baell, JB; Colman, PM; Deshayes, K; Fairbrother, WJ; Flygare, JA; Gibbons, P; Kersten, WJA; Kulasegaram, S; Moss, RM; Parisot, JP; Smith, BJ; Street, IP; Yang, H; Huang, DCS; Watson, KG				Lessene, Guillaume; Czabotar, Peter E.; Sleebs, Brad E.; Zobel, Kerry; Lowes, Kym N.; Adams, Jerry M.; Baell, Jonathan B.; Colman, Peter M.; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Gibbons, Paul; Kersten, Wilhelmus J. A.; Kulasegaram, Sanji; Moss, Rebecca M.; Parisot, John P.; Smith, Brian J.; Street, Ian P.; Yang, Hong; Huang, David C. S.; Watson, Keith G.			Structure-guided design of a selective BCL-X-L inhibitor	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; PEPTIDE COMPLEX; FAMILY PROTEINS; APOPTOSIS PATHWAY; CRYSTAL-STRUCTURE; CELL-DEATH; IN-VITRO; MCL-1; BCL-X(L); CANCER	The prosurvival BCL-2 family protein BCL-X-L is often overexpressed in solid tumors and renders malignant tumor cells resistant to anticancer therapeutics. Enhancing apoptotic responses by inhibiting BCL-X-L will most likely have widespread utility in cancer treatment and, instead of inhibiting multiple prosurvival BCL-2 family members, a BCL-X-L-selective inhibitor would be expected to minimize the toxicity to normal tissues. We describe the use of a high-throughput screen to discover a new series of small molecules targeting BCL-X-L and their structure-guided development by medicinal chemistry. The optimized compound, WEHI-539 (7), has high affinity (subnanomolar) and selectivity for BCL-X-L and potently kills cells by selectively antagonizing its prosurvival activity. WEHI-539 will be an invaluable tool for distinguishing the roles of BCL-X-L from those of its prosurvival relatives, both in normal cells and notably in malignant tumor cells, many of which may prove to rely upon BCL-X-L for their sustained growth.	[Lessene, Guillaume; Sleebs, Brad E.; Lowes, Kym N.; Baell, Jonathan B.; Kersten, Wilhelmus J. A.; Kulasegaram, Sanji; Moss, Rebecca M.; Parisot, John P.; Smith, Brian J.; Street, Ian P.; Yang, Hong; Huang, David C. S.; Watson, Keith G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Chem Biol Div, Parkville, Vic 3050, Australia; [Lessene, Guillaume; Czabotar, Peter E.; Sleebs, Brad E.; Lowes, Kym N.; Adams, Jerry M.; Baell, Jonathan B.; Colman, Peter M.; Kersten, Wilhelmus J. A.; Kulasegaram, Sanji; Moss, Rebecca M.; Parisot, John P.; Smith, Brian J.; Street, Ian P.; Yang, Hong; Huang, David C. S.; Watson, Keith G.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Czabotar, Peter E.; Colman, Peter M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3050, Australia; [Zobel, Kerry; Deshayes, Kurt; Fairbrother, Wayne J.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Adams, Jerry M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Parkville, Vic 3050, Australia; [Flygare, John A.; Gibbons, Paul] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Roche Holding; Genentech; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Roche Holding; Genentech	Lessene, G (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Chem Biol Div, Parkville, Vic 3050, Australia.	glessene@wehi.edu.au	Sleebs, Brad/J-9639-2014; Huang, David C. S./C-7586-2013; Smith, Brian J/F-8282-2011; Baell, Jonathan/E-5844-2017; Adams, Jerry M/E-1199-2013; Street, Ian/GXG-9517-2022	Sleebs, Brad/0000-0001-9117-1048; Huang, David C. S./0000-0002-3101-4873; Smith, Brian J/0000-0003-0498-1910; Baell, Jonathan/0000-0003-2114-8242; Adams, Jerry/0000-0002-4360-8628; Czabotar, Peter/0000-0002-2594-496X; Lowes, Kym/0000-0003-3506-4218; Street, Ian/0000-0003-2684-4239				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amundson SA, 2000, CANCER RES, V60, P6101; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czabotar PE, 2010, CURR PHARM DESIGN, V16, P3132; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Josefsson EC, 2011, J EXP MED, V208, P2017, DOI 10.1084/jem.20110750; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Labi V, 2008, CELL DEATH DIFFER, V15, P977, DOI 10.1038/cdd.2008.37; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Lee EF, 2009, J BIOL CHEM, V284, P30508, DOI 10.1074/jbc.M109.040725; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CM, 2008, J MED CHEM, V51, P6902, DOI 10.1021/jm800669s; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wendt MD, 2006, J MED CHEM, V49, P1165, DOI 10.1021/jm050754u; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081	55	285	309	5	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					390	+		10.1038/NCHEMBIO.1246	http://dx.doi.org/10.1038/NCHEMBIO.1246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23603658				2022-12-27	WOS:000319328200011
J	Junttila, IS; Creusot, RJ; Moraga, I; Bates, DL; Wong, MT; Alonso, MN; Suhoski, MM; Lupardus, P; Meier-Schellersheim, M; Engleman, EG; Utz, PJ; Fathman, CG; Paul, WE; Garcia, KC				Junttila, Ilkka S.; Creusot, Remi J.; Moraga, Ignacio; Bates, Darren L.; Wong, Michael T.; Alonso, Michael N.; Suhoski, Megan M.; Lupardus, Patrick; Meier-Schellersheim, Martin; Engleman, Edgar G.; Utz, Paul J.; Fathman, C. Garrison; Paul, William E.; Garcia, K. Christopher			Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines	NATURE CHEMICAL BIOLOGY			English	Article							IL-4 RECEPTOR; NOD MICE; BINDING; EXPRESSION; COMPLEX; DIFFERENTIATION; MECHANISMS; INTERFACE; SYSTEM; ALLOWS	Cytokines dimerize their receptors, with the binding of the 'second chain' triggering signaling. In the interleukin (IL)-4 and IL-13 system, different cell types express varying numbers of alternative second receptor chains (gamma c or IL-13R alpha 1), forming functionally distinct type I or type II complexes. We manipulated the affinity and specificity of second chain recruitment by human IL-4. A type I receptor-selective IL-4 'superkine' with 3,700-fold higher affinity for gamma c was three- to ten-fold more potent than wild-type IL-4. Conversely, a variant with high affinity for IL-13R alpha 1 more potently activated cells expressing the type II receptor and induced differentiation of dendritic cells from monocytes, implicating the type II receptor in this process. Superkines showed signaling advantages on cells with lower second chain numbers. Comparative transcriptional analysis reveals that the superkines induce largely redundant gene expression profiles. Variable second chain numbers can be exploited to redirect cytokines toward distinct cell subsets and elicit new actions, potentially improving the selectivity of cytokine therapy.	[Moraga, Ignacio; Bates, Darren L.; Lupardus, Patrick; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Junttila, Ilkka S.; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Junttila, Ilkka S.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Junttila, Ilkka S.] Fimlab Labs, Tampere, Finland; [Creusot, Remi J.; Wong, Michael T.; Utz, Paul J.; Fathman, C. Garrison] Stanford Univ, Dept Med, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Moraga, Ignacio; Bates, Darren L.; Lupardus, Patrick; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Moraga, Ignacio; Bates, Darren L.; Lupardus, Patrick; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Moraga, Ignacio; Bates, Darren L.; Lupardus, Patrick; Garcia, K. Christopher] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA; [Alonso, Michael N.; Suhoski, Megan M.; Engleman, Edgar G.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Meier-Schellersheim, Martin] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tampere University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Creusot, Remi/M-2642-2019	Junttila, Ilkka/0000-0002-9830-0823; Moraga, Ignacio/0000-0001-9909-0701; Creusot, Remi/0000-0002-8328-8155	US National Institute of Allergy and Infectious Diseases Division of Intramural Research; Finnish Medical Foundation; Sigrid Juselius Foundation; Howard Hughes Medical Institute; US National Institutes of Health (NIH) [RO1-AI51321]; NIH [UO1-DK078123]; Stanford Immunology Program Training Grant; NATIONAL CANCER INSTITUTE [R01CA065237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051321, ZIAAI001076, R01AI051321, T32AI007290, ZIAAI000493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078123] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases Division of Intramural Research; Finnish Medical Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Immunology Program Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank J. Gregorio and K. Weiskopf for assistance and the Stanford Human Immune Monitoring Center. This work was supported by US National Institute of Allergy and Infectious Diseases Division of Intramural Research (I. S. J. and W. E. P.), the Finnish Medical Foundation, the Sigrid Juselius Foundation (I. S. J.), the Howard Hughes Medical Institute (K. C. G.), the US National Institutes of Health (NIH) RO1-AI51321 (K. C. G.) and NIH UO1-DK078123 (C. G. F.) and the Stanford Immunology Program Training Grant (D.L.B.).	Andrews AL, 2002, J BIOL CHEM, V277, P46073, DOI 10.1074/jbc.M209560200; Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; CONRAD DH, 1987, J IMMUNOL, V139, P2290; Creusot RJ, 2008, CLIN IMMUNOL, V127, P176, DOI 10.1016/j.clim.2007.12.009; Creusot RJ, 2010, MOL THER, V18, P2112, DOI 10.1038/mt.2010.146; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Gavutis M, 2006, BIOPHYS J, V90, P3345, DOI 10.1529/biophysj.105.072546; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Ito T, 2009, J BIOL CHEM, V284, P24289, DOI 10.1074/jbc.M109.007286; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kraich M, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-13; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pillet AH, 2010, J MOL BIOL, V403, P671, DOI 10.1016/j.jmb.2010.08.056; SIEGEL JP, 1990, J IMMUNOL METHODS, V132, P287, DOI 10.1016/0022-1759(90)90040-3; SOSMAN JA, 1994, ANN ONCOL, V5, P447, DOI 10.1093/oxfordjournals.annonc.a058878; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53	31	58	62	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					990	998		10.1038/NCHEMBIO.1096	http://dx.doi.org/10.1038/NCHEMBIO.1096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103943	Green Accepted			2022-12-27	WOS:000311491200014
J	Wang, LK; Perera, BGK; Hari, SB; Bhhatarai, B; Backes, BJ; Seeliger, MA; Schurer, SC; Oakes, SA; Papa, FR; Maly, DJ				Wang, Likun; Perera, B. Gayani K.; Hari, Sanjay B.; Bhhatarai, Barun; Backes, Bradley J.; Seeliger, Markus A.; Schuerer, Stephan C.; Oakes, Scott A.; Papa, Feroz R.; Maly, Dustin J.			Divergent allosteric control of the IRE1 alpha endoribonuclease using kinase inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; CELL FATE; IRE1; PATHWAY; ACTIVATION; MECHANISM; APOPTOSIS; REVEALS	Under endoplasmic reticulum stress, unfolded protein accumulation leads to activation of the endoplasmic reticulum transmembrane kinase/endoRNase (RNase) IRE1 alpha. IRE1 alpha oligomerizes, autophosphorylates and initiates splicing of XBP1 mRNA, thus triggering the unfolded protein response (UPR). Here we show that IRE1 alpha's kinase-controlled RNase can be regulated in two distinct modes with kinase inhibitors: one class of ligands occupies IRE1 alpha's kinase ATP-binding site to activate RNase-mediated XBP1 mRNA splicing even without upstream endoplasmic reticulum stress, whereas a second class can inhibit the RNase through the same ATP-binding site, even under endoplasmic reticulum stress. Thus, alternative kinase conformations stabilized by distinct classes of ATP-competitive inhibitors can cause allosteric switching of IRE1 alpha's RNase-either on or off. As dysregulation of the UPR has been implicated in a variety of cell degenerative and neoplastic disorders, small-molecule control over IRE1 alpha should advance efforts to understand the UPR's role in pathophysiology and to develop drugs for endoplasmic reticulum stress-related diseases.	[Wang, Likun; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Wang, Likun; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Wang, Likun; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Wang, Likun; Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Perera, B. Gayani K.; Hari, Sanjay B.; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Seeliger, Markus A.] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Bhhatarai, Barun; Schuerer, Stephan C.] Univ Miami, Ctr Computat Sci, Coral Gables, FL 33124 USA; [Schuerer, Stephan C.] Univ Miami, Dept Mol & Cellular Pharmacol, Miller Sch Med, Coral Gables, FL 33124 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Miami; University of Miami	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu; maly@chem.washington.edu	Seeliger, Markus A/D-6409-2013	Seeliger, Markus/0000-0003-0990-1756; /0000-0003-0606-9896; Bhhatarai, Barun/0000-0002-0109-7487; Papa, Feroz/0000-0002-3684-9108	US National Institutes of Health Director's New Innovator Award [DP2 OD001925, RO1 DK080955, RO1 CA136577, R00 GM080097, R01 GM086858]; American Cancer Society Research Scholar Award; Burroughs Wellcome Foundation; Juvenile Diabetes Research Foundation; Sloan Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA136577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM080097, R01GM086858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	US National Institutes of Health Director's New Innovator Award; American Cancer Society Research Scholar Award(American Cancer Society); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Sloan Foundation(Alfred P. Sloan Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US National Institutes of Health Director's New Innovator Award DP2 OD001925 (F. R. P.), RO1 DK080955 (F. R. P.), RO1 CA136577 (S.A.O.), R00 GM080097 (M. A. S.) and R01 GM086858 (D.J.M.), an American Cancer Society Research Scholar Award (S.A.O.) and the Burroughs Wellcome (F. R. P.), Juvenile Diabetes Research (F. R. P.) and Sloan (D.J.M.) Foundations. S. B. H. was supported by a predoctoral fellowship from the American Heart Association.	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Dar AC, 2008, CHEM BIOL, V15, P1015, DOI 10.1016/j.chembiol.2008.09.007; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-48; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Ranjitkar P, 2010, CHEM BIOL, V17, P195, DOI 10.1016/j.chembiol.2010.01.008; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tu BP, 1999, P NATL ACAD SCI USA, V96, P4862, DOI 10.1073/pnas.96.9.4862; Underbakke ES, 2008, ANGEW CHEM INT EDIT, V47, P9677, DOI 10.1002/anie.200803378; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	34	150	168	4	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					982	989		10.1038/NCHEMBIO.1094	http://dx.doi.org/10.1038/NCHEMBIO.1094			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23086298	Green Submitted, Green Accepted			2022-12-27	WOS:000311491200013
J	Vollmer, W				Vollmer, Waldemar			Bacterial outer membrane evolution via sporulation?	NATURE CHEMICAL BIOLOGY			English	Article							PEPTIDOGLYCAN STRUCTURE; ARCHITECTURE; MECHANISM		Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Vollmer, W (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	w.vollmer@ncl.ac.uk			Biotechnology and Biological Sciences Research Council [BB/I020012/1] Funding Source: Medline; BBSRC [BB/I020012/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Broder DH, 2006, CELL, V126, P917, DOI 10.1016/j.cell.2006.06.053; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Cava F, 2004, MOL MICROBIOL, V52, P677, DOI 10.1111/j.1365-2958.2004.04011.x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Gupta RS, 2011, ANTON LEEUW INT J G, V100, P171, DOI 10.1007/s10482-011-9616-8; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kleinschnitz EM, 2011, MOL MICROBIOL, V79, P1367, DOI 10.1111/j.1365-2958.2010.07529.x; Kojima S, 2011, J BACTERIOL, V193, P2347, DOI 10.1128/JB.00106-11; Ludwig W., 2005, BERGEYS MANUAL SYSTE, P49, DOI DOI 10.1007/0-387-28021-9_; Meyer P, 2010, MOL MICROBIOL, V76, P956, DOI 10.1111/j.1365-2958.2010.07155.x; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Tocheva EI, 2011, CELL, V146, P799, DOI 10.1016/j.cell.2011.07.029; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004	24	16	16	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					14	18		10.1038/nchembio.748	http://dx.doi.org/10.1038/nchembio.748			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173345				2022-12-27	WOS:000298414100005
J	Wang, HC; Falck, JR; Hall, TMT; Shears, SB				Wang, Huanchen; Falck, J. R.; Hall, Traci M. Tanaka; Shears, Stephen B.			Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowding	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; HEXAKISPHOSPHATE; BINDING; IDENTIFICATION; POLYPHOSPHATES; PURIFICATION; SPECIFICITY; ENZYMES; FAMILY	Inositol pyrophosphates (such as IP7 and IP8) are multifunctional signaling molecules that regulate diverse cellular activities. Inositol pyrophosphates have 'high-energy' phosphoanhydride bonds, so their enzymatic synthesis requires that a substantial energy barrier to the transition state be overcome. Additionally, inositol pyrophosphate kinases can show stringent ligand specificity, despite the need to accommodate the steric bulk and intense electronegativity of nature's most concentrated three-dimensional array of phosphate groups. Here we examine how these catalytic challenges are met by describing the structure and reaction cycle of an inositol pyrophosphate kinase at the atomic level. We obtained crystal structures of the kinase domain of human PPIP5K2 complexed with nucleotide cofactors and either substrates, product or a MgF3- transition-state mimic. We describe the enzyme's conformational dynamics, its unprecedented topological presentation of nucleotide and inositol phosphate, and the charge balance that facilitates partly associative in-line phosphoryl transfer.	[Wang, Huanchen; Shears, Stephen B.] NIEHS, Inositol Signaling Grp, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Falck, J. R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hall, Traci M. Tanaka] NIEHS, Macromol Struct Grp, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wang, HC (corresponding author), NIEHS, Inositol Signaling Grp, Lab Signal Transduct, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wangh7@niehs.nih.gov	Falck, John R/B-3030-2011; Hall, Traci/F-5849-2019; Shears, Stephen B/C-6335-2019	Falck, John R/0000-0002-9219-7845; Hall, Traci/0000-0001-6166-3009; Shears, Stephen B/0000-0001-7309-8916; Wang, Huanchen/0000-0003-2701-7155	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Institutes of Health; National Institute of Environmental Health Sciences (NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080046] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Data were collected at the Southeast Regional Collaborative Access Team 22-ID/22-BM beamline at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found at http://www.ser-cat.org/members.html. The use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. This work was supported by the Intramural Research Program of the National Institutes of Health and National Institute of Environmental Health Sciences (NIEHS). We are grateful to L. C. Pedersen for advice and support. We also thank H. Ke for his assistance in writing the manuscript. Expression vectors were prepared by the NIEHS Protein Expression Core Facility.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albert C, 1997, BIOCHEM J, V327, P553, DOI 10.1042/bj3270553; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Cannon WR, 1996, NAT STRUCT BIOL, V3, P821, DOI 10.1038/nsb1096-821; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Chamberlain PP, 2007, J BIOL CHEM, V282, P28117, DOI 10.1074/jbc.M703121200; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Gokhale NA, 2011, BIOCHEM J, V434, P415, DOI 10.1042/BJ20101437; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Hand CE, 2007, BIOORG MED CHEM LETT, V17, P183, DOI 10.1016/j.bmcl.2006.09.066; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prasad A, 2011, NAT IMMUNOL, V12, P752, DOI 10.1038/ni.2052; Reddy KM, 1997, TETRAHEDRON LETT, V38, P4951, DOI 10.1016/S0040-4039(97)01088-5; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	40	81	91	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					111	116		10.1038/nchembio.733	http://dx.doi.org/10.1038/nchembio.733			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22119861	Green Accepted			2022-12-27	WOS:000298414100019
J	Ismail, SA; Chen, YX; Rusinova, A; Chandra, A; Bierbaum, M; Gremer, L; Triola, G; Waldmann, H; Bastiaens, PIH; Wittinghofer, A				Ismail, Shehab A.; Chen, Yong-Xiang; Rusinova, Alexandra; Chandra, Anchal; Bierbaum, Martin; Gremer, Lothar; Triola, Gemma; Waldmann, Herbert; Bastiaens, Philippe I. H.; Wittinghofer, Alfred			Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo	NATURE CHEMICAL BIOLOGY			English	Article							GTPASE-ACTIVATING PROTEIN; PRENYL-BINDING PROTEIN; DELTA-SUBUNIT; PDE-DELTA; DISSOCIATION INHIBITOR; STRUCTURAL BASIS; CELL-GROWTH; RAB GTPASES; RHEB; MEMBRANE	Lipidated Rho and Rab GTP-binding proteins are transported between membranes in complex with solubilizing factors called 'guanine nucleotide dissociation inhibitors' (GDIs). Unloading from GDIs using GDI displacement factors (GDFs) has been proposed but remains mechanistically elusive. PDE delta is a putative solubilizing factor for several prenylated Ras-subfamily proteins. Here we report the structure of fully modified farnesylated Rheb-GDP in complex with PDE delta. The structure explains the nucleotide-independent binding of Rheb to PDE delta and the relaxed specificity of PDE delta. We demonstrate that the G proteins Arl2 and Arl3 act in a GTP-dependent manner as allosteric release factors for farnesylated cargo. We thus describe a new transport system for farnesylated G proteins involving a GDI-like molecule and an unequivocal GDF. Considering the importance of PDE delta for proper Ras and Rheb signaling, this study is instrumental in developing a new target for anticancer therapy.	[Ismail, Shehab A.; Rusinova, Alexandra; Chandra, Anchal; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Struct Biol Grp, D-44139 Dortmund, Germany; [Chen, Yong-Xiang; Triola, Gemma; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Chem Biol, D-44139 Dortmund, Germany; [Chandra, Anchal; Bierbaum, Martin; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44139 Dortmund, Germany; [Waldmann, Herbert] Tech Univ Dortmund, Fac Chem, Dept Chem Biol, Dortmund, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Dortmund University of Technology	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Struct Biol Grp, Rheinlanddamm 201, D-44139 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Chandra, Anchal/AAT-5644-2021; Gremer, Lothar/H-9128-2013; Waldmann, Herbert/B-7406-2017; CHEN, YONG-XIANG/D-4792-2017; Triola, Gemma/E-2235-2017	Chandra, Anchal/0000-0003-4096-4771; Gremer, Lothar/0000-0001-7065-5027; Waldmann, Herbert/0000-0002-9606-7247; CHEN, YONG-XIANG/0000-0003-3518-0139; Triola, Gemma/0000-0003-4177-8989; Ismail, Shehab/0000-0002-4150-1077	German Research Foundation (DFG) [SFB 642]; European Research Council (ERC) [268782, 268309]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC))	A.W., H. W. and P. I. H. B. thank the German Research Foundation (DFG) for financial support (SFB 642). A. W. and H. W. thank the European Research Council for financial support (ERC Grants 268782 and 268309). We thank A. Itzen and R. S. Goody for help with the stopped flow and discussion, D. Kuhlmann and C. Koerner for expert technical assistance. We thank I. Vetter. and R. Gaspar for scientific discussion and I. Schlichting for X-ray data collection.	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; BOS JL, 1989, CANCER RES, V49, P4682; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Chen YX, 2010, ANGEW CHEM INT EDIT, V49, P6090, DOI 10.1002/anie.201001884; Cox AD, 2002, CURR OPIN PHARMACOL, V2, P388, DOI 10.1016/S1471-4892(02)00181-9; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Florio SK, 1996, J BIOL CHEM, V271, P24036, DOI 10.1074/jbc.271.39.24036; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Linari M, 1999, FEBS LETT, V458, P55, DOI 10.1016/S0014-5793(99)01117-5; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Nikolova S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-146; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Vartak N, 2010, EMBO J, V29, P2689, DOI 10.1038/emboj.2010.184; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Walther KA, 2011, MOL BIOSYST, V7, P322, DOI 10.1039/c0mb00132e; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang TL, 2009, STRUCTURE, V17, P602, DOI 10.1016/j.str.2009.01.014	47	184	189	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					942	949		10.1038/NCHEMBIO.686	http://dx.doi.org/10.1038/NCHEMBIO.686			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22002721				2022-12-27	WOS:000297166200018
J	Atwal, RS; Desmond, CR; Caron, N; Maiuri, T; Xia, JR; Sipione, S; Truant, R				Atwal, Randy Singh; Desmond, Carly R.; Caron, Nicholas; Maiuri, Tamara; Xia, Jianrun; Sipione, Simonetta; Truant, Ray			Kinase inhibitors modulate huntingtin cell localization and toxicity	NATURE CHEMICAL BIOLOGY			English	Article							KAPPA-B KINASE; MUTANT HUNTINGTIN; SELECTIVE INHIBITOR; PHOSPHORYLATION; PROTEIN; AGGREGATION; DISEASE; GENE; DEPHOSPHORYLATION; TRANSCRIPTION	Two serine residues within the first 17 amino acid residues of huntingtin (N17) are crucial for modulation of mutant huntingtin toxicity in cell and mouse genetic models of Huntington's disease. Here we show that the stress-dependent phosphorylation of huntingtin at Ser13 and Ser16 affects N17 conformation and targets full-length huntingtin to chromatin-dependent sub-regions of the nucleus, the mitotic spindle and cleavage furrow during cell division. Polyglutamine-expanded mutant huntingtin is hypophosphorylated in N17 in both homozygous and heterozygous cell contexts. By high-content screening in live cells, we identified kinase inhibitors that modulated N17 phosphorylation and hence huntingtin subcellular localization. N17 phosphorylation was reduced by casein kinase-2 inhibitors. Paradoxically, IKK beta kinase inhibition increased N17 phosphorylation, affecting huntingtin nuclear and subnuclear localization. These data indicate that huntingtin phosphorylation at Ser13 and Ser16 can be modulated by small-molecule drugs, which may have therapeutic potential in Huntington's disease.	[Atwal, Randy Singh; Desmond, Carly R.; Caron, Nicholas; Maiuri, Tamara; Xia, Jianrun; Truant, Ray] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Sipione, Simonetta] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada	McMaster University; University of Alberta	Atwal, RS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA.	truantr@mcmaster.ca		Caron, Nicholas/0000-0002-3877-455X; Maiuri, Tamara/0000-0002-6103-5835	Canadian Institutes of Health Research [MOP 165174]; Krembil Foundation; CHDI Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; CHDI Foundation	This work was supported by operating grants from the Canadian Institutes of Health Research (MOP 165174), the Krembil Foundation and the CHDI Foundation (to R. T.). We thank M. Prakesch (Ontario Institute for Cancer Research) for supplying multiple CK2 and IKK beta inhibitors, I. Bezprozvanny (University of Texas Southwestern) and G. Hajnocsky (Thomas Jefferson University) for the gift of huntingtin-null MEF cell lines, M. E. MacDonald (Massachusetts General Hospital) for the gift of mouse striatal STHdh cell lines, and Raquel and Richard Epand for assistance and advice with CD spectroscopy.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bamborough P, 2009, CURR TOP MED CHEM, V9, P623, DOI 10.2174/156802609789007336; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Cozza G, 2009, BIOCHEM J, V421, P387, DOI 10.1042/BJ20090069; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Di Maira G, 2009, CELL MOL LIFE SCI, V66, P3363, DOI 10.1007/s00018-009-0108-1; Fan MMY, 2008, J NEUROCHEM, V104, P790, DOI 10.1111/j.1471-4159.2007.05016.x; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Hoffner G, 2002, J CELL SCI, V115, P941; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kageura T, 2001, BIOORGAN MED CHEM, V9, P1887, DOI 10.1016/S0968-0896(01)00093-1; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin-Aparicio E, 2002, EUR J NEUROSCI, V16, P355, DOI 10.1046/j.1460-9568.2002.02075.x; McElhinny JA, 1996, MOL CELL BIOL, V16, P899; Metzler M, 2010, J NEUROSCI, V30, P14318, DOI 10.1523/JNEUROSCI.1589-10.2010; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shaul JD, 2008, BIOCHEM BIOPH RES CO, V374, P592, DOI 10.1016/j.bbrc.2008.07.082; Snyder-Keller A, 2010, J NEUROPATH EXP NEUR, V69, P1078, DOI 10.1097/NEN.0b013e3181f530ec; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021; Wetzel R, 2006, NAT CHEM BIOL, V2, P297, DOI 10.1038/nchembio0606-297; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Zhang H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-38	48	125	130	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					453	460		10.1038/NCHEMBIO.582	http://dx.doi.org/10.1038/NCHEMBIO.582			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21623356				2022-12-27	WOS:000292252100013
J	Lingwood, D; Binnington, B; Rog, T; Vattulainen, I; Grzybek, M; Coskun, U; Lingwood, CA; Simons, K				Lingwood, Daniel; Binnington, Beth; Rog, Tomasz; Vattulainen, Ilpo; Grzybek, Michal; Coskun, Unal; Lingwood, Clifford A.; Simons, Kai			Cholesterol modulates glycolipid conformation and receptor activity	NATURE CHEMICAL BIOLOGY			English	Article							ZONA-PELLUCIDA BINDING; SPERM; MEMBRANES; CAPACITATION; MURINE; GLYCOSPHINGOLIPIDS; SPERMATOZOA; EFFLUX	We document a new dimension of surface recognition in which communication is controlled through the collective behavior of lipids. Membrane cholesterol induces a tilt in glycolipid receptor headgroup, resulting in loss of access for ligand binding. This property appears to organize erythrocyte blood group presentation and glycolipid receptor function during the activation of sperm fertility, suggesting that lipid 'allostery' is a means to regulate membrane recognition processes.	[Lingwood, Daniel; Grzybek, Michal; Coskun, Unal; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Binnington, Beth; Lingwood, Clifford A.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Rog, Tomasz; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Vattulainen, Ilpo] Aalto Univ, Sch Sci & Technol, Dept Appl Phys, Espoo, Finland; [Vattulainen, Ilpo] Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Lingwood, Clifford A.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Lingwood, Clifford A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	Max Planck Society; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Tampere University; Aalto University; University of Southern Denmark; University of Toronto; University of Toronto	Simons, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	simons@mpi-cbg.de	Coskun, Ünal/F-4683-2011; Rog, Tomasz/ABE-3044-2020; Vattulainen, Ilpo T/G-4224-2014; Grzybek, Michal/D-3802-2017	Coskun, Ünal/0000-0003-4375-3144; Rog, Tomasz/0000-0001-6765-7013; Grzybek, Michal/0000-0003-2083-0506; Simons, Kai/0000-0002-9231-9996	MPI-CBG; EU [LSHB-CT2007-037740]; DFG [SI459/2-1, TRR83 TP02]; BMBF [03FO1212]; ESF [SI459/3-1]; Canadian Institutes of Health Research [MT 13747]	MPI-CBG; EU(European Commission); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); ESF(European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank I. Nuesslein, M. Gerl, I. Levental, H. Kaiser (Max Planck Institute for Molecular Cell Biology and Genetics), K. Holig (Technische Univesitat), P. Paroutis, M. Woodside (Hospital for Sick Children), U. Devi, W. Jones and M. Swann (Farfield Sensors) for their assistance in this project. This work was supported by a MPI-CBG stipend (D. L.) and funding to K. S. (EU FP6 Lipid PRISM Grant LSHB-CT2007-037740, DFG Schwerpunktprogramm 1175 Grant SI459/2-1, DFG Transregio 83 Grant: TRR83 TP02, BMBF ForMaT Grant: 03FO1212, ESF "LIPIDPROD" Grant: SI459/3-1); I. V. (Academy of Finland); and funding to C. A. L. (Canadian Institutes of Health Research Grant MT 13747, Ontario HIV Treatment Network and Canfar support).	Bedford JM, 2008, INT J DEV BIOL, V52, P415, DOI 10.1387/ijdb.072551jb; BITZAN M, 1994, INFECT IMMUN, V62, P3337, DOI 10.1128/IAI.62.8.3337-3347.1994; Cross NL, 1998, BIOL REPROD, V59, P7, DOI 10.1095/biolreprod59.1.7; Evans SV, 1999, J MOL RECOGNIT, V12, P155, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<155::AID-JMR456>3.0.CO;2-S; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Jones R, 2010, DEV BIOL, V339, P398, DOI 10.1016/j.ydbio.2009.12.044; Kawano N, 2008, BIOL REPROD, V79, P1153, DOI 10.1095/biolreprod.108.069054; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; Lingwood CA, 1996, GLYCOCONJUGATE J, V13, P495, DOI 10.1007/BF00731435; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; Merritt EA, 1997, PROTEIN SCI, V6, P1516, DOI 10.1002/pro.5560060716; Selvaraj V, 2006, J CELL PHYSIOL, V206, P636, DOI 10.1002/jcp.20504; Selvaraj V, 2007, J ANDROL, V28, P588, DOI 10.2164/jandrol.106.002279; Shi JJ, 2007, J AM CHEM SOC, V129, P5954, DOI 10.1021/ja069375w; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Weerachatyanukul W, 2001, MOL REPROD DEV, V60, P569, DOI 10.1002/mrd.1122; White D, 2000, BIOL REPROD, V63, P147, DOI 10.1095/biolreprod63.1.147; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079	22	158	167	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					260	262		10.1038/nchembio.551	http://dx.doi.org/10.1038/nchembio.551			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21460830				2022-12-27	WOS:000289617800008
J	Xiong, W; Cheng, KJ; Cui, TX; Godlewski, G; Rice, KC; Xu, Y; Zhang, L				Xiong, Wei; Cheng, KeJun; Cui, Tanxing; Godlewski, Grzegorz; Rice, Kenner C.; Xu, Yan; Zhang, Li			Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia	NATURE CHEMICAL BIOLOGY			English	Article							MODULATION; PAIN; SUBUNIT; DYNAMICS; MODEL; MICE; INHIBITION; ALPHA-1; TARGET; 2ND	Cannabinoids enhance the function of glycine receptors (GlyRs). However, little is known about the mechanisms and behavioral implication of cannabinoid-GlyR interaction. Using mutagenesis and NMR analysis, we have identified a serine at 296 in the GlyR protein critical for the potentiation of I-Gly by Delta(9)-tetrahydrocannabinol (THC), a major psychoactive component of marijuana. The polarity of the amino acid residue at 296 and the hydroxyl groups of THC are critical for THC potentiation. Removal of the hydroxyl groups of THC results in a compound that does not affect I-Gly when applied alone but selectively antagonizes cannabinoid-induced potentiating effect on I-Gly and analgesic effect in a tail-flick test in mice. The cannabinoid-induced analgesia is absent in mice lacking alpha 3GlyRs but not in those lacking CB1 and CB2 receptors. These findings reveal a new mechanism underlying cannabinoid potentiation of GlyRs, which could contribute to some of the cannabis-induced analgesic and therapeutic effects.	[Xiong, Wei; Zhang, Li] US Natl Inst Alcohol Abuse & Alcoholism, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Cheng, KeJun; Rice, Kenner C.] US Natl Inst Drug Abuse, Chem Biol Res Branch, US Natl Inst Hlth, Bethesda, MD USA; [Cui, Tanxing; Xu, Yan] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Cui, Tanxing; Xu, Yan] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Cui, Tanxing; Xu, Yan] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Godlewski, Grzegorz] US Natl Inst Alcohol Abuse & Alcoholism, Lab Physiol Studies, US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Zhang, L (corresponding author), US Natl Inst Alcohol Abuse & Alcoholism, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA.	lzhang@mail.nih.gov	Zhang, Li/W-2104-2019; Xiong, Wei/G-9027-2018; Xiong, Wei/F-8251-2011	Xu, Yan/0000-0003-2773-8024	US National Institute on Alcohol Abuse and Alcoholism; US National Institute of General Medical Sciences of the US National Institutes of Health [R37GM049202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000529] Funding Source: NIH RePORTER	US National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); US National Institute of General Medical Sciences of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. L. Cepko for providing alpha 2<SUP>-/-</SUP> Glra mice. We especially thank D. M. Lovinger for critical comments on the manuscript. This work was supported by funds from the intramural program of the US National Institute on Alcohol Abuse and Alcoholism. We acknowledge the grant support (R37GM049202 to Y.X.) from the US National Institute of General Medical Sciences of the US National Institutes of Health.	Ahrens J, 2009, PHARMACOLOGY, V83, P217, DOI 10.1159/000201556; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Canlas CG, 2008, J PHYS CHEM B, V112, P14312, DOI 10.1021/jp805952w; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Delaney AJ, 2010, NEUROSCI LETT, V469, P237, DOI 10.1016/j.neulet.2009.12.003; Demir R, 2009, PHARMACOLOGY, V83, P270, DOI 10.1159/000209291; Findlay GS, 2003, J NEUROSCI, V23, P8051; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; GROSSMAN ML, 1982, J COMP NEUROL, V206, P9, DOI 10.1002/cne.902060103; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hejazi N, 2006, MOL PHARMACOL, V69, P991, DOI 10.1124/mol.105.019174; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Klein TW, 2007, ADV EXP MED BIOL, V601, P395; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Ma DJ, 2005, BIOCHEMISTRY-US, V44, P8790, DOI 10.1021/bi050256n; Marris E, 2009, NATURE, V458, P394, DOI 10.1038/458394a; Oz M, 2006, PHARMACOL THERAPEUT, V111, P114, DOI 10.1016/j.pharmthera.2005.09.009; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pernia-Andrade AJ, 2009, SCIENCE, V325, P760, DOI 10.1126/science.1171870; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; SMITH PB, 1992, BRAIN RES, V578, P8, DOI 10.1016/0006-8993(92)90222-U; Spivak CE, 2007, MOL PHARMACOL, V72, P1024, DOI 10.1124/mol.107.036939; Tang P, 2002, BIOPHYS J, V83, P252, DOI 10.1016/S0006-3495(02)75166-7; Varvel SA, 2005, J PHARMACOL EXP THER, V314, P329, DOI 10.1124/jpet.104.080739; Welch SP, 1998, J PHARMACOL EXP THER, V286, P1301; Xiong W, 2008, MOL PHARMACOL, V73, P314, DOI 10.1124/mol.107.039149; Yang Z, 2008, BIOCHEM PHARMACOL, V76, P1014, DOI 10.1016/j.bcp.2008.07.037; Young-Pearse TL, 2006, MOL CELL BIOL, V26, P5728, DOI 10.1128/MCB.00237-06; Zeilhofer HU, 2007, BIOCHEM PHARMACOL, V73, P165, DOI 10.1016/j.bcp.2006.07.037; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; Zhang GH, 2010, EUR J NEUROSCI, V31, P225, DOI 10.1111/j.1460-9568.2009.07075.x; Zhang L, 2009, VITAM HORM, V81, P315, DOI 10.1016/S0083-6729(09)81012-1; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	44	102	105	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					296	303		10.1038/nchembio.552	http://dx.doi.org/10.1038/nchembio.552			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21460829	Green Accepted			2022-12-27	WOS:000289617800013
J	Bond-Watts, BB; Bellerose, RJ; Chang, MCY				Bond-Watts, Brooks B.; Bellerose, Robert J.; Chang, Michelle C. Y.			Enzyme mechanism as a kinetic control element for designing synthetic biofuel pathways	NATURE CHEMICAL BIOLOGY			English	Article							CLOSTRIDIUM-ACETOBUTYLICUM ATCC-824; ALCALIGENES-EUTROPHUS H16; FATTY-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; BUTANOL PRODUCTION; TRANS-2-ENOYL-COA REDUCTASE; MICROBIAL-PRODUCTION; ACETONE FORMATION; EXPRESSION; BACTERIA	Living systems have evolved remarkable molecular functions that can be redesigned for in vivo chemical synthesis as we gain a deeper understanding of the underlying biochemical principles for de novo construction of synthetic pathways. We have focused on developing pathways for next-generation biofuels as they require carbon to be channeled to product at quantitative yields. However, these fatty acid-inspired pathways must manage the highly reversible nature of the enzyme components. For targets in the biodiesel range, the equilibrium can be driven to completion by physical sequestration of an insoluble product, which is a mechanism unavailable to soluble gasoline-sized products. In this work, we report the construction of a chimeric pathway assembled from three different organisms for the high-level production of n-butanol (4,650 +/- 720 mg l(-1)) that uses an enzymatic chemical reaction mechanism in place of a physical step as a kinetic control element to achieve high yields from glucose (28%).	[Bond-Watts, Brooks B.; Bellerose, Robert J.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bond-Watts, Brooks B.; Bellerose, Robert J.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chang, Michelle C. Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bond-Watts, BB (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	mcchang@berkeley.edu			Aldo DeBenedictis Fund; University of California, Berkeley; Camille and Henry Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Dow Sustainable Products and Solutions Program	Aldo DeBenedictis Fund; University of California, Berkeley(University of California System); Camille and Henry Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Dow Sustainable Products and Solutions Program	We thank K. Hirano for her work on the ter gene assembly during her rotation. B.B.B.-W. would like to thank the Aldo DeBenedictis Fund for a predoctoral fellowship, and R.J.B. would like to acknowledge the University of California, Berkeley, Summer Undergraduate Research Fellowship program. This work was funded by generous support from University of California, Berkeley, the Camille and Henry Dreyfus Foundation, the Arnold and Mabel Beckman Foundation and the Dow Sustainable Products and Solutions Program.	AGIUS L, 1996, CHANNELING INTERMEDI; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Atsumi S, 2008, CURR OPIN BIOTECH, V19, P414, DOI 10.1016/j.copbio.2008.08.008; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523; Boynton ZL, 1996, J BACTERIOL, V178, P3015, DOI 10.1128/jb.178.11.3015-3024.1996; BRAGG JR, 1994, NATURE, V368, P413, DOI 10.1038/368413a0; Draths KM, 1999, J AM CHEM SOC, V121, P1603, DOI 10.1021/ja9830243; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Duerre Peter, 2007, Biotechnology Journal, V2, P1525, DOI 10.1002/biot.200700168; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Fontaine L, 2002, J BACTERIOL, V184, P821, DOI 10.1128/JB.184.3.821-830.2002; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Hoffmeister M, 2005, J BIOL CHEM, V280, P4329, DOI 10.1074/jbc.M411010200; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Leaf TA, 1998, BIOTECHNOL BIOENG, V57, P557, DOI 10.1002/(SICI)1097-0290(19980305)57:5<557::AID-BIT8>3.0.CO;2-F; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; LYNEN F, 1953, BIOCHIM BIOPHYS ACTA, V12, P299, DOI 10.1016/0006-3002(53)90149-8; Nair RV, 1999, J BACTERIOL, V181, P319, DOI 10.1128/JB.181.1.319-330.1999; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Papoutsakis ET, 2008, CURR OPIN BIOTECH, V19, P420, DOI 10.1016/j.copbio.2008.08.003; PEOPLES OP, 1989, J BIOL CHEM, V264, P15298; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Roca C, 2003, APPL ENVIRON MICROB, V69, P4732, DOI 10.1128/AEM.69.8.4732-4736.2003; Rohlin L, 2001, CURR OPIN MICROBIOL, V4, P330, DOI 10.1016/S1369-5274(00)00213-7; Sanchez AM, 2006, BIOTECHNOL PROGR, V22, P420, DOI 10.1021/bp050375u; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Scotcher MC, 2005, APPL ENVIRON MICROB, V71, P1987, DOI 10.1128/AEM.71.4.1987-1995.2005; SLATER SC, 1988, J BACTERIOL, V170, P4431, DOI 10.1128/jb.170.10.4431-4436.1988; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; STEPHANOPOULOS G, 1993, TRENDS BIOTECHNOL, V11, P392, DOI 10.1016/0167-7799(93)90099-U; Tucci S, 2007, FEBS LETT, V581, P1561, DOI 10.1016/j.febslet.2007.03.013; Tummala SB, 2003, J BACTERIOL, V185, P1923, DOI 10.1128/JB.185.6.1923-1934.2003; WAKIL SJ, 1954, J BIOL CHEM, V207, P631; WAKIL SJ, 1956, BIOCHIM BIOPHYS ACTA, V19, P497, DOI 10.1016/0006-3002(56)90473-5; WALLACE KK, 1995, EUR J BIOCHEM, V233, P954, DOI 10.1111/j.1432-1033.1995.954_3.x; WATERSON RM, 1972, J BIOL CHEM, V247, P5266; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wu WJ, 2000, J AM CHEM SOC, V122, P3987, DOI 10.1021/ja992286h; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zaslavskaia LA, 2001, SCIENCE, V292, P2073, DOI 10.1126/science.160015; [No title captured]	50	267	303	1	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					222	227		10.1038/NCHEMBIO.537	http://dx.doi.org/10.1038/NCHEMBIO.537			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21358636				2022-12-27	WOS:000288545000010
J	Lemieux, GA; Liu, J; Mayer, N; Bainton, RJ; Ashrafi, K; Werb, Z				Lemieux, George A.; Liu, Jason; Mayer, Nasima; Bainton, Roland J.; Ashrafi, Kaveh; Werb, Zena			A whole-organism screen identifies new regulators of fat storage	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; C-ELEGANS; LIFE-SPAN; CHEMICAL GENETICS; RECEPTOR NHR-49; FOOD RESPONSE; OBESITY; GENES; MODEL	The regulation of energy homeostasis integrates diverse biological processes ranging from behavior to metabolism and is linked fundamentally to numerous disease states. To identify new molecules that can bypass homeostatic compensatory mechanisms of energy balance in intact animals, we screened for small-molecule modulators of Caenorhabditis elegans fat content. We report on several molecules that modulate fat storage without obvious deleterious effects on feeding, growth and reproduction. A subset of these compounds also altered fat storage in mammalian and insect cell culture. We found that one of the newly identified compounds exerts its effects in C. elegans through a pathway that requires previously undescribed functions of an AMP-activated kinase catalytic subunit and a transcription factor previously unassociated with fat regulation. Thus, our strategy identifies small molecules that are effective within the context of intact animals and reveals relationships between new pathways that operate across phyla to influence energy homeostasis.	[Lemieux, George A.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Liu, Jason; Ashrafi, Kaveh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Mayer, Nasima; Bainton, Roland J.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lemieux, GA (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	kaveh.ashrafi@ucsf.edu; zena.werb@ucsf.edu			US National Cancer Institute; US National Institute of Environmental Health Sciences [ES012801, ES019458, CA056721]; US National Institute of Diabetes and Digestive and Kidney Diseases [DK070149]; US National Institute of General Medicine [GM081863]; Byers; NATIONAL CANCER INSTITUTE [R01CA056721, R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES012801, U01ES019458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081863] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institute of General Medicine; Byers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Lum for his help and advice with the initial C. elegans experiments. We are thankful to B. Mullaney and K. Cunningham for helpful discussions and comments on the manuscript. We thank K. Thorn and the Nikon Imaging Center for use of the Nikon 6D automated epifluorescence microscope and help with imaging as well as the Small Molecule Discovery Center at the University of California, San Francisco, for providing the small-molecule library. This work was supported by grants from the US National Cancer Institute and US National Institute of Environmental Health Sciences (ES012801, ES019458 and CA056721) to Z.W., the US National Institute of Diabetes and Digestive and Kidney Diseases (DK070149) to K. A., the US National Institute of General Medicine (GM081863) to R.J.B. and a Byers Award to K. A. and R.J.B.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Goldstone AP, 2008, FRONT HORM RES, V36, P37, DOI 10.1159/000115336; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jones AK, 2005, NAT REV DRUG DISCOV, V4, P321, DOI 10.1038/nrd1692; Jones KS, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-23; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Schafer WR, 1996, GENETICS, V143, P1219; Shiri-Sverdlov R, 2006, DIABETES, V55, P385, DOI 10.2337/diabetes.55.02.06.db05-0997; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang XD, 2006, DEV BIOL, V289, P456, DOI 10.1016/j.ydbio.2005.10.029; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	50	53	56	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					206	213		10.1038/NCHEMBIO.534	http://dx.doi.org/10.1038/NCHEMBIO.534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21390037	Green Accepted, Green Submitted			2022-12-27	WOS:000288545000008
J	Hagel, M; Niu, DQ; St Martin, T; Sheets, MP; Qiao, LX; Bernard, H; Karp, RM; Zhu, ZD; Labenski, MT; Chaturvedi, P; Nacht, M; Westlin, WF; Petter, RC; Singh, J				Hagel, Margit; Niu, Deqiang; St Martin, Thia; Sheets, Michael P.; Qiao, Lixin; Bernard, Hugues; Karp, Russell M.; Zhu, Zhendong; Labenski, Matthew T.; Chaturvedi, Prasoon; Nacht, Mariana; Westlin, William F.; Petter, Russell C.; Singh, Juswinder			Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine	NATURE CHEMICAL BIOLOGY			English	Article							HEPATITIS-C VIRUS; PRECLINICAL PROFILE; SERINE-PROTEASE; DISCOVERY; NS3; INFECTION; COVALENT; POTENT; DRUGS; VX-950	Designing selective inhibitors of proteases has proven problematic, in part because pharmacophores that confer potency exploit the conserved catalytic apparatus. We developed a fundamentally different approach by designing irreversible inhibitors that target noncatalytic cysteines that are structurally unique to a target in a protein family. We have successfully applied this approach to the important therapeutic target HCV protease, which has broad implications for the design of other selective protease inhibitors.	[Hagel, Margit; Niu, Deqiang; St Martin, Thia; Sheets, Michael P.; Qiao, Lixin; Karp, Russell M.; Zhu, Zhendong; Labenski, Matthew T.; Chaturvedi, Prasoon; Nacht, Mariana; Westlin, William F.; Petter, Russell C.; Singh, Juswinder] Avila Therapeut Inc, Waltham, MA USA; [Bernard, Hugues] Millenium Takeda Oncol Co, Cambridge, MA USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Takeda Oncology	Singh, J (corresponding author), Avila Therapeut Inc, Waltham, MA USA.	jsingh@avilatx.com						Bartenschlager R, 2007, VIRUS RES, V127, P127, DOI 10.1016/j.virusres.2007.07.003; CAMPBELL JA, 2003, Patent No. 2003053349; HAGEL M, 2009, REV ANTIVIRAL THERAP, V5, P15; Kou YH, 2007, J VIROL, V81, P7999, DOI 10.1128/JVI.00348-07; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lin C., 2006, Infectious Disorders - Drug Targets, V6, P3, DOI 10.2174/187152606776056706; Lin TI, 2009, ANTIMICROB AGENTS CH, V53, P1377, DOI 10.1128/AAC.01058-08; LING C, 2006, HEPATITIS C VIRUSES, P163; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; McCauley JA, 2010, J MED CHEM, V53, P2443, DOI 10.1021/jm9015526; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Njoroge FG, 2008, ACCOUNTS CHEM RES, V41, P50, DOI 10.1021/ar700109k; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Singh J, 2010, CURR OPIN CHEM BIOL, V14, P475, DOI 10.1016/j.cbpa.2010.06.168; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; Stauber RE, 2008, DRUGS, V68, P1347, DOI 10.2165/00003495-200868100-00002; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Venkatraman S, 2006, J MED CHEM, V49, P6074, DOI 10.1021/jm060325b	23	75	75	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					22	24		10.1038/NCHEMBIO.492	http://dx.doi.org/10.1038/NCHEMBIO.492			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21113170				2022-12-27	WOS:000285383400008
J	Hudak, JE; Canham, SM; Bertozzi, CR				Hudak, Jason E.; Canham, Stephen M.; Bertozzi, Carolyn R.			Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-KILLER-CELLS; BREAST-CANCER CELLS; SIALIC-ACID; MEDIATED CYTOTOXICITY; INHIBITORY RECEPTOR; IDENTIFICATION; EXPRESSION; LIGANDS; GLYCOSPHINGOLIPIDS; SPECIFICITY	The increase of cell surface sialic acid is a characteristic shared by many tumor types. A correlation between hypersialylation and immunoprotection has been observed, but few hypotheses have provided a mechanistic understanding of this immunosuppressive phenomenon. Here, we show that increasing sialylated glycans on cancer cells inhibits human natural killer (NK) cell activation through the recruitment of sialic acid-binding immunoglobulin-like lectin 7 (Siglec-7). Key to these findings was the use of glycopolymers end-functionalized with phospholipids, which enable the introduction of synthetically defined glycans onto cancer cell surfaces. Remodeling the sialylation status of cancer cells affected the susceptibility to NK cell cytotoxicity via Siglec-7 engagement in a variety of tumor types. These results support a model in which hypersialylation offers a selective advantage to tumor cells under pressure from NK immunosurveillance by increasing Siglec ligands. We also exploited this finding to protect allogeneic and xenogeneic primary cells from NK-mediated killing, suggesting the potential of Siglecs as therapeutic targets in cell transplant therapy.	[Hudak, Jason E.; Canham, Stephen M.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Hudak, JE (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	crb@berkeley.edu		Canham, Stephen/0000-0003-4750-8066	US National Institutes of Health [R01 GM59907, F32DK095521]; US National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059907, T32GM066698] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank J. Paulson (Scripps Research Institute) for the gift of plasmids encoding Siglec-7 and Siglec-9; M. Boyce (Duke University) for the gift of pMSCV retroviral plasmids and advice; D. Raulet, M. Ardolino, A. Iannello, P. Drake and C. Hudak for advice and expertise; and B. Belardi and D. Rabuka for helpful discussion and manuscript critique. This work was funded by a grant from the US National Institutes of Health (R01 GM59907). J.E.H. was supported by a predoctoral fellowship from the US National Science Foundation. S.M.C. was supported by a postdoctoral fellowship from the US National Institutes of Health (F32DK095521).	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; Attrill H, 2006, J BIOL CHEM, V281, P32774, DOI 10.1074/jbc.M601714200; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Avril T, 2006, J LEUKOCYTE BIOL, V80, P787, DOI 10.1189/jlb.1005559; Belardi B, 2012, J AM CHEM SOC, V134, P9549, DOI 10.1021/ja301694s; Belisle JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-118; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Cohen M, 2010, J IMMUNOL, V185, P5869, DOI 10.4049/jimmunol.1001635; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Courtney AH, 2009, P NATL ACAD SCI USA, V106, P2500, DOI 10.1073/pnas.0807207106; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Dall'Ozzo S, 2004, CANCER RES, V64, P4664, DOI 10.1158/0008-5472.CAN-03-2862; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Forte P, 2005, J IMMUNOL, V175, P5463, DOI 10.4049/jimmunol.175.8.5463; Fukuda M, 1996, CANCER RES, V56, P2237; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Godal R, 2006, BLOOD, V107, P3205, DOI 10.1182/blood-2005-07-2880; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hudak JE, 2011, J AM CHEM SOC, V133, P16127, DOI 10.1021/ja206023e; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; Kawasaki Y, 2010, GLYCOBIOLOGY, V20, P1373, DOI 10.1093/glycob/cwq116; Kiessling LL, 2010, ANNU REV BIOCHEM, V79, P619, DOI 10.1146/annurev.biochem.77.070606.100917; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Leivonen M, 2001, ONCOLOGY-BASEL, V61, P299, DOI 10.1159/000055337; Leonard JP, 2004, CLIN CANCER RES, V10, P5327, DOI 10.1158/1078-0432.CCR-04-0294; Li SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004; Liang YJ, 2013, P NATL ACAD SCI USA, V110, P4968, DOI 10.1073/pnas.1302825110; Maki G, 2001, J HEMATOTH STEM CELL, V10, P369, DOI 10.1089/152581601750288975; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Menard S, 2003, ONCOGENE, V22, P6570, DOI 10.1038/sj.onc.1206779; MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212; Murphy WJ, 2001, IMMUNOL REV, V181, P279, DOI 10.1034/j.1600-065X.2001.1810124.x; Nath D, 1999, IMMUNOLOGY, V98, P213; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nicoll G, 2003, EUR J IMMUNOL, V33, P1642, DOI 10.1002/eji.200323693; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; OGATA S, 1992, CANCER RES, V52, P4741; Paulson JC, 2012, ANN NY ACAD SCI, V1253, P37, DOI 10.1111/j.1749-6632.2011.06362.x; Rabuka D, 2008, J AM CHEM SOC, V130, P5947, DOI 10.1021/ja710644g; Rabuka D, 2007, J AM CHEM SOC, V129, P5462, DOI 10.1021/ja067819i; Sommaggio Roberta, 2012, Methods Mol Biol, V885, P91, DOI 10.1007/978-1-61779-845-0_7; Takamiya R, 2013, GLYCOBIOLOGY, V23, P178, DOI 10.1093/glycob/cws139; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Triulzi C, 2010, CANCER RES, V70, P7431, DOI 10.1158/0008-5472.CAN-10-0493; van der Touw W, 2010, AM J TRANSPLANT, V10, P1354, DOI 10.1111/j.1600-6143.2010.03086.x; VANRINSUM J, 1986, INT J CANCER, V38, P915, DOI 10.1002/ijc.2910380620; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; YOGEESWARAN G, 1981, INT J CANCER, V28, P517, DOI 10.1002/ijc.2910280419; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	59	252	258	8	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					69	U111		10.1038/NCHEMBIO.1388	http://dx.doi.org/10.1038/NCHEMBIO.1388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24292068	Green Accepted			2022-12-27	WOS:000328854900013
J	Brachmann, AO; Brameyer, S; Kresovic, D; Hitkova, I; Kopp, Y; Manske, C; Schubert, K; Bode, HB; Heermann, R				Brachmann, Alexander O.; Brameyer, Sophie; Kresovic, Darko; Hitkova, Ivana; Kopp, Yannick; Manske, Christian; Schubert, Karin; Bode, Helge B.; Heermann, Ralf			Pyrones as bacterial signaling molecules	NATURE CHEMICAL BIOLOGY			English	Article							III POLYKETIDE SYNTHASE; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; PHOTORHABDUS-LUMINESCENS; ALPHA-PYRONES; STARTER UNIT; QUORUM; BIOSYNTHESIS; DOCKING; QSCR	Bacteria communicate via small diffusible molecules and thereby mediate group-coordinated behavior, a process referred to as quorum sensing. The prototypical quorum sensing system found in Gram-negative bacteria consists of a LuxI-type auto-inducer synthase that produces N-acyl homoserine lactones (AHLs) as signals and a LuxR-type receptor that detects the AHLs to control expression of specific genes. However, many proteobacteria have proteins with homology to LuxR receptors yet lack any cognate LuxI-like AHL synthase. Here we show that in the insect pathogen Photorhabdus luminescens the orphan LuxR-type receptor PluR detects endogenously produced alpha-pyrones that serve as signaling molecules at low nanomolar concentrations. Additionally, the ketosynthase PpyS was identified as pyrone synthase. Reconstitution of the entire system containing PluR, the PluR-target operon we termed pcf and PpyS in Escherichia coli demonstrated that the cell-cell communication circuit is portable. Our research thus deorphanizes a signaling system and suggests that additional modes of bacterial communication may await discovery.	[Brachmann, Alexander O.; Kresovic, Darko; Kopp, Yannick; Bode, Helge B.] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Brameyer, Sophie; Hitkova, Ivana; Manske, Christian; Schubert, Karin; Heermann, Ralf] Univ Munich, Biozentrum, Bereich Mikrobiol, Munich, Germany	Goethe University Frankfurt; University of Munich	Bode, HB (corresponding author), Goethe Univ Frankfurt, D-60054 Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de; heermann@lmu.de	Heermann, Ralf/E-1793-2013; Heermann, Ralf/CAF-8609-2022; Bode, Helge B/F-7022-2014	Heermann, Ralf/0000-0003-0631-6156; Bode, Helge B/0000-0001-6048-5909; Brachmann, Alexander/0000-0002-9878-9550; Brameyer, Sophie/0000-0002-6779-2343	Deutsche Forschungsgemeinschaft (DFG) [HE 5247/4-1, SPP 1617]; European Research Council [311477]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	Work in the Heermann lab was financially supported by the Deutsche Forschungsgemeinschaft ((DFG) HE 5247/4-1 and SPP 1617). Work in the Bode lab was supported by the DFG (SPP 1617) and a European Research Council starting grant under grant agreement no. 311477. We thank K. Jung for many helpful scientific discussions; S. Scheu and P. Grun for excellent technical assistance; Q. Zhou for help with HPLC/MS analysis; E. A. Alonso and F. I. Nollmann for help with the PPY production kinetics, S. Kinski for help with ketosynthase mutant construction; and H. Janosz for generation of E. coli insect pathogenicity assays. We are grateful to M. Schobert (Braunschweig) for providing E. coli strain ST18, H. Jung (Munchen) for providing plasmid pUC19-Kan and H. Schweizer (Fort Collins, Colorado) for providing the Tn7 plasmids.	Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki Y, 2011, J ANTIBIOT, V64, P607, DOI 10.1038/ja.2011.59; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Brachmann AO, 2012, ANGEW CHEM INT EDIT, V51, P12086, DOI 10.1002/anie.201205384; Case RJ, 2008, ISME J, V2, P345, DOI 10.1038/ismej.2008.13; Chemler JA, 2012, J AM CHEM SOC, V134, P7359, DOI 10.1021/ja2112228; Chu M, 2002, J ANTIBIOT, V55, P215, DOI 10.7164/antibiotics.55.215; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Elbandy M, 2009, B KOREAN CHEM SOC, V30, P188; Erol O, 2010, CHEMBIOCHEM, V11, P1253, DOI 10.1002/cbic.201000085; FECHTELER T, 1995, J MOL BIOL, V253, P114, DOI 10.1006/jmbi.1995.0540; Ferluga S, 2007, MOL PLANT PATHOL, V8, P529, DOI [10.1111/j.1364-3703.2007.00415.x, 10.1111/J.1364-3703.2007.00415.X]; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Fuqua C, 2006, J BACTERIOL, V188, P3169, DOI 10.1128/JB.188.9.3169-3171.2006; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Goblirsch BR, 2012, BIOCHEMISTRY-US, V51, P4138, DOI 10.1021/bi300386m; Gonzalez JF, 2013, TRENDS PLANT SCI, V18, P167, DOI 10.1016/j.tplants.2012.09.007; Grundmann F, 2012, BEILSTEIN J ORG CHEM, V8, P749, DOI 10.3762/bjoc.8.85; Heermann R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-40; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Joyce SA, 2008, ANGEW CHEM INT EDIT, V47, P1942, DOI 10.1002/anie.200705148; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kong FM, 2005, J NAT PROD, V68, P920, DOI 10.1021/np050038v; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVITT M, 1988, P NATL ACAD SCI USA, V85, P7557, DOI 10.1073/pnas.85.20.7557; Lintz MJ, 2011, P NATL ACAD SCI USA, V108, P15763, DOI 10.1073/pnas.1112398108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reimer D, 2011, NAT CHEM BIOL, V7, P888, DOI [10.1038/NCHEMBIO.688, 10.1038/nchembio.688]; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sherlock O, 2004, J BACTERIOL, V186, P8058, DOI 10.1128/JB.186.23.8058-8065.2004; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WEBER K, 1969, J BIOL CHEM, V244, P4406; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833; Zou YZ, 2009, CHEM BIOL, V16, P961, DOI 10.1016/j.chembiol.2009.09.001	47	144	146	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					573	U73		10.1038/NCHEMBIO.1295	http://dx.doi.org/10.1038/NCHEMBIO.1295			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23851573				2022-12-27	WOS:000323417500009
J	Follis, AV; Chipuk, JE; Fisher, JC; Yun, MK; Grace, CR; Nourse, A; Baran, K; Ou, L; Min, L; White, SW; Green, DR; Kriwacki, RW				Follis, Ariele Viacava; Chipuk, Jerry E.; Fisher, John C.; Yun, Mi-Kyung; Grace, Christy R.; Nourse, Amanda; Baran, Katherine; Ou, Li; Min, Lie; White, Stephen W.; Green, Douglas R.; Kriwacki, Richard W.			PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis	NATURE CHEMICAL BIOLOGY			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; BH3-ONLY PROTEINS; BH3 DOMAINS; COMPLEX; ACTIVATION; BIM; BAX; RECOGNITION; NMR; DIMERIZATION	Following DNA damage, nuclear p53 induces the expression of PUMA, a BH3-only protein that binds and inhibits the antiapoptotic BCL-2 repertoire, including BCL-xL. PUMA, unique among BH3-only proteins, disrupts the interaction between cytosolic p53 and BCL-xL, allowing p53 to promote apoptosis via direct activation of the BCL-2 effector molecules BAX and BAK. Structural investigations using NMR spectroscopy and X-ray crystallography revealed that PUMA binding induced partial unfolding of two alpha-helices within BCL-xL. Wild-type PUMA or a PUMA mutant incapable of causing binding-induced unfolding of BCL-xL equivalently inhibited the antiapoptotic BCL-2 repertoire to sensitize for death receptor-activated apoptosis, but only wild-type PUMA promoted p53-dependent, DNA damage-induced apoptosis. Our data suggest that PUMA-induced partial unfolding of BCL-xL disrupts interactions between cytosolic p53 and BCL-xL, releasing the bound p53 to initiate apoptosis. We propose that regulated unfolding of BCL-xL provides a mechanism to promote PUMA-dependent signaling within the apoptotic pathways.	[Follis, Ariele Viacava; Fisher, John C.; Yun, Mi-Kyung; Grace, Christy R.; Ou, Li; Min, Lie; White, Stephen W.; Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Chipuk, Jerry E.; Baran, Katherine; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Fisher, John C.] Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA; [Nourse, Amanda] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [White, Stephen W.; Kriwacki, Richard W.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org; richard.kriwacki@stjude.org	White, Stephen W/N-8164-2018; Viacava Follis, Ariele/J-1720-2014; Green, Douglas R/N-8083-2018; Kriwacki, Richard/N-8154-2018	Viacava Follis, Ariele/0000-0002-2934-788X; Green, Douglas R/0000-0002-7332-1417; Kriwacki, Richard/0000-0002-9798-6018; Chipuk, Jerry Edward/0000-0002-1337-842X; Nourse, Amanda/0000-0003-4595-5321	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NIH [R01CA082491, 1R01GM083159, R01GM52735, R01GM96208, R01 CA157740]; JJR Foundation; William A. Spivak Fund; Fridolin Charitable Trust; National Cancer Institute Cancer Center [P30CA21765]; March of Dimes Foundation [5-FY11-74]; American Lebanese Syrian Associated Charities; University of Tennessee Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA157740, P30CA021765, R01CA082491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735, R01GM083159, R01GM096208, R01GM052735] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JJR Foundation; William A. Spivak Fund; Fridolin Charitable Trust; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); March of Dimes Foundation(March of Dimes); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); University of Tennessee Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.T. Opferman and S.W.G. Tait (St. Jude Children's Research Hospital) for the Mx-Cre bak<SUP>-/-</SUP> bax<SUP>f/-</SUP> animals and MCF7 SMAC-GFP cells, respectively. The prokaryotic expression vectors for PUMA beta and BCL-xL Delta L Delta C were kindly provided by E. Eldering (Academic Medical Center, Amsterdam) and G. Wagner (Harvard University), respectively. We would like to acknowledge D. Miller (St. Jude Children's Research Hospital) for help with synchrotron data collection. Southeast Regional Collaborative Access Team (SER-CAT) supporting institutions may be found at http://www.ser.aps.anl.gov. Use of the SER-CAT Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. We would like to thank Bruker BioSpin and R. Weismann and W Bermel for access to a 950-MHz NMR spectrometer. We also thank M. Madan Babu and A. Venkatakrishnan (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK) for stimulating discussions and comments on the manuscript. This work was supported by NIH R01CA082491 and 1R01GM083159 (to R.W.K.), NIH R01GM52735 and R01GM96208 (to D.R.G.), NIH R01 CA157740 (to J.E.C.), the JJR Foundation (to J.E.C.), the William A. Spivak Fund (to J.E.C.), the Fridolin Charitable Trust (to J.E.C.), a National Cancer Institute Cancer Center Support Grant P30CA21765 (at St. Jude Children's Research Hospital), research grant no. 5-FY11-74 from the March of Dimes Foundation (to J.E.C.) and the American Lebanese Syrian Associated Charities. J.C.F. is a recipient of the Alma and Hal Reagan Cancer Research fellowship provided by the University of Tennessee Health Sciences Center.	Berjanskii M, 2006, NAT PROTOC, V1, P683, DOI 10.1038/nprot.2006.108; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Denisov AY, 2007, BIOCHEMISTRY-US, V46, P734, DOI 10.1021/bi062080a; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Xu HB, 2009, BIOCHEMISTRY-US, V48, P12159, DOI 10.1021/bi901188s; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	37	119	124	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					163	168		10.1038/NCHEMBIO.1166	http://dx.doi.org/10.1038/NCHEMBIO.1166			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23340338	Green Accepted			2022-12-27	WOS:000315132900011
J	Guo, M; Schimmel, P				Guo, Min; Schimmel, Paul			Essential nontranslational functions of tRNA synthetases	NATURE CHEMICAL BIOLOGY			English	Review							PROTEIN-PROTEIN INTERACTIONS; AMINO-ACID; VASCULAR DEVELOPMENT; GENE-EXPRESSION; BREAST-CANCER; DIADENOSINE 5',5'''-P1,P4-TETRAPHOSPHATE; MACROMOLECULAR ASSEMBLAGE; MULTISYNTHETASE COMPLEX; TRANSLATIONAL CONTROL; NONCANONICAL FUNCTION	Nontranslational functions of vertebrate aminoacyl tRNA synthetases (aaRSs), which catalyze the production of aminoacyl-tRNAs for protein synthesis, have recently been discovered. Although these new functions were thought to be 'moonlighting activities', many are as critical for cellular homeostasis as their activity in translation. New roles have been associated with their cytoplasmic forms as well as with nuclear and secreted extracellular forms that affect pathways for cardiovascular development and the immune response and mTOR, IFN-gamma and p53 signaling. The associations of aaRSs with autoimmune disorders, cancers and neurological disorders further highlight nontranslational functions of these proteins. New architecture elaborations of the aaRSs accompany their functional expansion in higher organisms and have been associated with the nontranslational functions for several aaRSs. Although a general understanding of how these functions developed is limited, the expropriation of aaRSs for essential nontranslational functions may have been initiated by co-opting the amino acid-binding site for another purpose.	[Guo, Min] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Schimmel, Paul] Scripps Res Inst, Dept Mol Biol & Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol Biol & Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Zhang, Ning/F-1387-2014		US National Institutes of Health (NIH) [GM 23562]; NCI [CA92577]; US National Foundation for Cancer Research; NIH [GM 100136]; Kimmel Scholar Award for Cancer Research; state of Florida; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562, R01GM100136] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Scholar Award for Cancer Research; state of Florida; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grant GM 23562 and NCI grant CA92577 and by a fellowship from the US National Foundation for Cancer Research (P.S.), by NIH grant GM 100136, a Kimmel Scholar Award for Cancer Research and by funding from the state of Florida to Scripps Florida (M.G.).	Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; Banin E, 2006, INVEST OPHTH VIS SCI, V47, P2125, DOI 10.1167/iovs.05-1096; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; BLANQUET S, 1983, MOL CELL BIOCHEM, V52, P3; BOCHNER BR, 1984, CELL, V37, P225, DOI 10.1016/0092-8674(84)90318-0; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; Choi JW, 2012, J MOL CELL BIOL, V4, P164, DOI 10.1093/jmcb/mjs018; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; Choi JW, 2009, CARCINOGENESIS, V30, P1638, DOI 10.1093/carcin/bgp170; Choi JW, 2009, J CELL SCI, V122, P2710, DOI 10.1242/jcs.049767; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Froelich CA, 2011, BIOCHEMISTRY-US, V50, P7132, DOI 10.1021/bi200989h; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Fukui H, 2009, CIRC RES, V104, P1253, DOI 10.1161/CIRCRESAHA.108.191189; Ghanipour A, 2009, CANCER EPIDEM BIOMAR, V18, P2949, DOI 10.1158/1055-9965.EPI-09-0456; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Han JM, 2006, BIOCHEM BIOPH RES CO, V342, P113, DOI 10.1016/j.bbrc.2006.01.117; Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Han JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009792; Hattori K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-9; He R, 2009, BBA-PROTEINS PROTEOM, V1794, P347, DOI 10.1016/j.bbapap.2008.11.003; He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108; Herzog W, 2009, CIRC RES, V104, P1260, DOI 10.1161/CIRCRESAHA.108.191718; Hoffman RM, 2011, CURR OPIN BIOTECH, V22, P917, DOI 10.1016/j.copbio.2011.03.009; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Justin N, 2010, CURR OPIN STRUC BIOL, V20, P730, DOI 10.1016/j.sbi.2010.09.012; Kang T, 2012, J MOL BIOL, V423, P475, DOI 10.1016/j.jmb.2012.07.020; KERJAN P, 1994, BBA-GEN SUBJECTS, V1199, P293, DOI 10.1016/0304-4165(94)90009-4; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim KJ, 2008, J BIOL CHEM, V283, P14032, DOI 10.1074/jbc.M800859200; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kim SS, 2011, TUMORI, V97, P380, DOI 10.1700/912.10038; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Kron MA, 2005, MED HYPOTHESES, V65, P1124, DOI 10.1016/j.mehy.2005.06.016; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Levine SM, 2003, CURR OPIN RHEUMATOL, V15, P708, DOI 10.1097/00002281-200311000-00005; Morbt N, 2011, J PROTEOME RES, V10, P363, DOI 10.1021/pr1005718; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Mun J, 2010, ELECTROPHORESIS, V31, P3428, DOI 10.1002/elps.201000136; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paley EL, 2011, PANCREAS, V40, P1043, DOI 10.1097/MPA.0b013e318222e635; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Park SG, 2010, BIOMARKERS, V15, P358, DOI 10.3109/13547501003777823; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; PUTNEY SD, 1981, NATURE, V291, P632, DOI 10.1038/291632a0; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Ruggiero RA, 2012, CANCER RES, V72, P1043, DOI 10.1158/0008-5472.CAN-11-2964; Ryckelynck M, 2005, BIOCHIMIE, V87, P835, DOI 10.1016/j.biochi.2005.02.014; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Sarkar J, 2012, J BIOL CHEM, V287, P14772, DOI 10.1074/jbc.M111.322412; Schwarz RE, 2010, CANCER BIOL THER, V9, P632, DOI 10.4161/cbt.9.8.11265; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Segev N, 2012, MOL CELL, V46, P4, DOI 10.1016/j.molcel.2012.03.028; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shiba K, 2002, J MOL EVOL, V55, P727, DOI 10.1007/s00239-002-2368-3; Stum M, 2011, MOL CELL NEUROSCI, V46, P432, DOI 10.1016/j.mcn.2010.11.006; Torres-Larios A, 2003, J MOL BIOL, V331, P201, DOI 10.1016/S0022-2836(03)00719-8; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Tzima E, 2003, P NATL ACAD SCI USA, V100, P14903, DOI 10.1073/pnas.2436330100; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; WAHAB SZ, 1985, J BIOL CHEM, V260, P5286; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu PC, 1999, CANCER RES, V59, P205; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yamasaki Y, 2006, ARTHRITIS RHEUM-US, V54, P2004, DOI 10.1002/art.21883; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; ZAMECNIK P, 1983, ANAL BIOCHEM, V134, P1, DOI 10.1016/0003-2697(83)90255-5; Zhao Z, 2012, NEUROLOGY, V78, P1644, DOI 10.1212/WNL.0b013e3182574f8f; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706; Zhu XD, 2009, P NATL ACAD SCI USA, V106, P15944, DOI 10.1073/pnas.0901872106	100	237	247	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					145	153		10.1038/NCHEMBIO.1158	http://dx.doi.org/10.1038/NCHEMBIO.1158			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23416400	Green Accepted			2022-12-27	WOS:000315132900007
J	Zhang, YN; Zhou, LJ; Rouge, L; Phillips, AH; Lam, C; Liu, P; Sandoval, W; Helgason, E; Murray, JM; Wertz, IE; Corn, JE				Zhang, Yingnan; Zhou, Lijuan; Rouge, Lionel; Phillips, Aaron H.; Lam, Cynthia; Liu, Peter; Sandoval, Wendy; Helgason, Elizabeth; Murray, Jeremy M.; Wertz, Ingrid E.; Corn, Jacob E.			Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN GROWTH-HORMONE; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; PROTEIN; RECOGNITION; DYNAMICS; CHAINS; IDENTIFICATION; RELAXATION; ACTIVATION	Protein conformation and function are often inextricably linked, such that the states a protein adopts define its enzymatic activity or its affinity for various partners. Here we combine computational design with macromolecular display to isolate functional conformations of ubiquitin that tightly bind the catalytic core of the oncogenic ubiquitin-specific protease 7 (USP7) deubiquitinase. Structural and biochemical characterization of these ubiquitin variants suggest that remodeled backbone conformations and core packing poise these molecules for stronger interactions, leading to potent and specific inhibition of enzymatic activity. A ubiquitin variant expressed in human tumor cell lines binds and inhibits endogenous USP7, thereby enhancing Mdm2 proteasomal turnover and stabilizing p53. In sum, we have developed an approach to rationally target macromolecular libraries toward the remodeling of protein conformation, shown that engineering of ubiquitin conformation can greatly increase its interaction with deubiquitinases and developed powerful tools to probe the cellular role of USP7.	[Zhang, Yingnan; Zhou, Lijuan; Phillips, Aaron H.; Lam, Cynthia; Helgason, Elizabeth; Wertz, Ingrid E.; Corn, Jacob E.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Rouge, Lionel; Murray, Jeremy M.] Genentech Inc, Struct Biol, San Francisco, CA 94080 USA; [Liu, Peter; Sandoval, Wendy] Genentech Inc, Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Zhang, YN (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	cornj@gene.com	Zhou, Li/GSE-4531-2022	Helgason, Elizabeth/0000-0002-0397-9125; Corn, Jacob/0000-0002-7798-5309				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Friedland GD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000393; Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; GIEBEL LB, 1995, BIOCHEMISTRY-US, V34, P15430, DOI 10.1021/bi00047a006; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hansen DF, 2007, J AM CHEM SOC, V129, P11468, DOI 10.1021/ja072717t; Hansen DF, 2009, J AM CHEM SOC, V131, P16257, DOI 10.1021/ja906842s; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; Lazar GA, 1999, PROTEIN SCI, V8, P2598; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; Matsumoto ML, 2012, J MOL BIOL, V418, P134, DOI 10.1016/j.jmb.2011.12.053; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Newton K, 2012, METHODS MOL BIOL, V832, P185, DOI 10.1007/978-1-61779-474-2_13; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; ONEIL KT, 1992, PROTEINS, V14, P509, DOI 10.1002/prot.340140411; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rizk S.S., 2011, NAT STRUCT MOL BIOL; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; ULTSCH MH, 1994, J MOL BIOL, V236, P286, DOI 10.1006/jmbi.1994.1135; Wermuth C.G., 2003, PRACTICE MED CHEM, V2nd; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	52	74	76	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					51	+		10.1038/NCHEMBIO.1134	http://dx.doi.org/10.1038/NCHEMBIO.1134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23178935				2022-12-27	WOS:000312484200012
J	Schimpl, M; Zheng, XW; Borodkin, VS; Blair, DE; Ferenbach, AT; Schuttelkopf, AW; Navratilova, I; Aristotelous, T; Albarbarawi, O; Robinson, DA; Macnaughtan, MA; van Aalten, DMF				Schimpl, Marianne; Zheng, Xiaowei; Borodkin, Vladimir S.; Blair, David E.; Ferenbach, Andrew T.; Schuettelkopf, Alexander W.; Navratilova, Iva; Aristotelous, Tonia; Albarbarawi, Osama; Robinson, David A.; Macnaughtan, Megan A.; van Aalten, Daan M. F.			O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL BASIS; GLCNACYLATION; SUBSTRATE; ROLES; MECHANISM	Protein O-GlcNAcylation is an essential post-translational modification on hundreds of intracellular proteins in metazoa, catalyzed by O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT) using unknown mechanisms of transfer and substrate recognition. Through crystallographic snapshots and mechanism-inspired chemical probes, we define how human OGT recognizes the sugar donor and acceptor peptide and uses a new catalytic mechanism of glycosyl transfer, involving the sugar donor a-phosphate as the catalytic base as well as an essential lysine. This mechanism seems to be a unique evolutionary solution to the spatial constraints imposed by a bulky protein acceptor substrate and explains the unexpected specificity of a recently reported metabolic OGT inhibitor.	[Schimpl, Marianne; Zheng, Xiaowei; Borodkin, Vladimir S.; Blair, David E.; Ferenbach, Andrew T.; Schuettelkopf, Alexander W.; Navratilova, Iva; Aristotelous, Tonia; Albarbarawi, Osama; Robinson, David A.; van Aalten, Daan M. F.] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Macnaughtan, Megan A.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA	University of Dundee; Louisiana State University System; Louisiana State University	van Aalten, DMF (corresponding author), Univ Dundee, Coll Life Sci, Dundee, Scotland.	dmfvanaalten@dundee.ac.uk	Albarbarawi, Osama/P-7632-2018	Albarbarawi, Osama/0000-0002-0165-778X; Ferenbach, Andrew/0000-0002-1562-7987; Macnaughtan, Megan/0000-0003-4626-0062; Robinson, David/0000-0003-1979-5918; Schimpl, Marianne/0000-0003-2284-5250; van Aalten, Daan/0000-0002-1499-6908	Wellcome Trust [WT087590MA]; MRC [G0900138] Funding Source: UKRI; Medical Research Council [G0900138] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Senior Research Fellowship (WT087590MA) to D.M.F.v.A.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gold H, 2008, J ORG CHEM, V73, P9458, DOI 10.1021/jo802021t; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jiang JY, 2012, NAT CHEM BIOL, V8, P72, DOI 10.1038/nchembio.711; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; MEYNIAL I, 1995, ANAL CHEM, V67, P1627, DOI 10.1021/ac00105a024; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Sala RF, 1998, CARBOHYD RES, V306, P127, DOI 10.1016/S0008-6215(97)10033-7; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	30	98	99	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					969	974		10.1038/NCHEMBIO.1108	http://dx.doi.org/10.1038/NCHEMBIO.1108			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103942	Green Accepted, Green Submitted			2022-12-27	WOS:000311491200011
J	Puri, AW; Broz, P; Shen, A; Monack, DM; Bogyo, M				Puri, Aaron W.; Broz, Petr; Shen, Aimee; Monack, Denise M.; Bogyo, Matthew			Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection	NATURE CHEMICAL BIOLOGY			English	Article							CELL-DEATH; ACTIVATION; PYROPTOSIS; NECROSIS; PROTEIN; MECHANISM; SUBSTRATE; RELEASE	Here we report AWP28, an activity-based probe that can be used to biochemically monitor caspase-1 activation in response to proinflammatory stimuli. Using AWP28, we show that apoptosis is triggered upon Salmonella enterica var. Typhimurium infection in primary mouse bone marrow macrophages lacking caspase-1. Furthermore, we report that upon Salmonella infection, inflammasome-mediated caspase-1 activity is required to bypass apoptosis in favor of proinflammatory pyroptotic cell death.	[Puri, Aaron W.; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Broz, Petr; Monack, Denise M.; Bogyo, Matthew] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Shen, Aimee; Bogyo, Matthew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Bogyo, M (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mbogyo@stanford.edu	Broz, Petr/AAC-7940-2019	Broz, Petr/0000-0002-2334-7790; Shen, Aimee/0000-0002-9786-5742; Bogyo, Matthew/0000-0003-3753-4412; Monack, Denise/0000-0003-3804-2209	US National Institutes of Health (NIH) grants [R01EB005011, R01AI088541]; US National Science Foundation Graduate Research Fellowship; Stanford Institute for Immunity, Transplantation and Infection Young Investigator Award; Swiss National Science Foundation and the Human Frontiers in Science Program; NIH grant [K99 GM092934]; Burroughs Wellcome Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088541, R01AI078947, R01AI095396, R01AI089722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM092934] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Institute for Immunity, Transplantation and Infection Young Investigator Award; Swiss National Science Foundation and the Human Frontiers in Science Program; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bogyo and Monack labs for useful discussions and help with macrophage harvesting. We thank S. Lynch for help with NMR. We thank B. Van Raam for apoptosis marker protocols and S. Snipas and E. Deu for helpful discussions about kinetics. Caspases 3, 4, 6, 7 and 8 and substrates were provided by the Salvesen lab (Sanford Burnham Medical Research Institute); granzyme B and substrate was provided by the Craik lab (University of California-San Francisco), caspase-1-specific antibody was provided by P. Vandenabeele (VIB, Ghent University). This work was supported by US National Institutes of Health (NIH) grants R01EB005011 and R01AI088541 to M.B. A.W.P. was supported by an US National Science Foundation Graduate Research Fellowship. P.B. is supported by a Stanford Institute for Immunity, Transplantation and Infection Young Investigator Award and was supported by the Swiss National Science Foundation and the Human Frontiers in Science Program. A.S. is supported by the NIH grant K99 GM092934. M.B. and D.M.M. are supported by the Burroughs Wellcome Foundation.	Berger AB, 2006, CELL RES, V16, P961, DOI 10.1038/sj.cr.7310112; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bossy-Wetzel E, 1999, J BIOL CHEM, V274, P17484, DOI 10.1074/jbc.274.25.17484; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Darzynkiewicz Z, 2007, CYTOM PART A, V71A, P536, DOI 10.1002/cyto.a.20425; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Motani K, 2011, J BIOL CHEM, V286, P33963, DOI 10.1074/jbc.M111.286823; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Puri AW, 2009, ACS CHEM BIOL, V4, P603, DOI 10.1021/cb9001409; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Wannamaker W, 2007, J PHARMACOL EXP THER, V321, P509, DOI 10.1124/jpet.106.111344; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273	25	47	48	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					745	747		10.1038/NCHEMBIO.1023	http://dx.doi.org/10.1038/NCHEMBIO.1023			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22797665	Green Accepted			2022-12-27	WOS:000308077600004
J	Gonzalez, JM; Meini, MR; Tomatis, PE; Martin, FJM; Cricco, JA; Vila, AJ				Gonzalez, Javier M.; Meini, Maria-Rocio; Tomatis, Pablo E.; Medrano Martin, Francisco J.; Cricco, Julia A.; Vila, Alejandro J.			Metallo-beta-lactamases withstand low Zn(II) conditions by tuning metal-ligand interactions	NATURE CHEMICAL BIOLOGY			English	Article							BACILLUS-CEREUS; ACTIVE-SITE; CRYSTAL-STRUCTURE; BINDING; ENZYME; HYDROLYSIS; RESISTANCE; TURNOVER; CO(II); FOLD	A number of multiresistant bacterial pathogens inactivate antibiotics by producing Zn(II)-dependent beta-lactamases. We show that metal uptake leading to an active dinuclear enzyme in the periplasmic space of Gram-negative bacteria is ensured by a cysteine residue, an unusual metal ligand in oxidizing environments. Kinetic, structural and affinity data show that such Zn(II)-cysteine interaction is an adaptive trait that tunes the metal binding affinity, thus enabling antibiotic resistance at restrictive Zn(II) concentrations.	[Gonzalez, Javier M.; Meini, Maria-Rocio; Tomatis, Pablo E.; Cricco, Julia A.; Vila, Alejandro J.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Medrano Martin, Francisco J.] Lab Nacl Luz Sincrotron, Sao Paulo, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Laboratorio Nacional de Luz Sincrotron (LNLS)	Cricco, JA (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina.	cricco@ibr.gov.ar; vila@ibr.gov.ar	Medrano, Francisco Javier/ABF-9860-2020; Tomatis, Pablo Emiliano/AAV-2524-2020; Meini, María Rocío/AAC-2031-2021	Tomatis, Pablo Emiliano/0000-0002-1126-8200; Meini, María Rocío/0000-0003-2166-8707; Cricco, Julia Alejandra/0000-0002-8993-3880; Vila, Alejandro/0000-0002-7978-3233; Medrano, Francisco/0000-0002-8185-9751; Gonzalez, Javier Marcelo/0000-0002-3298-2235	CONICET; Howard Hughes Medical Institute; Agencia Nacional de Promocion Cientifica y Tecnologica; US National Institutes of Health [1R01AI100560]; Laboratorio Nacional de Luz Sincrotron, Campinas, Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100560] Funding Source: NIH RePORTER	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratorio Nacional de Luz Sincrotron, Campinas, Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by CONICET and by grants from the Howard Hughes Medical Institute, Agencia Nacional de Promocion Cientifica y Tecnologica, US National Institutes of Health (1R01AI100560 to A.J.V.) and Laboratorio Nacional de Luz Sincrotron, Campinas, Brazil. A.J.V. is a fellow of the John Simon Guggenheim Foundation.	Badarau A, 2006, BIOCHEMISTRY-US, V45, P11012, DOI 10.1021/bi0610146; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Davis AV, 2008, NAT CHEM BIOL, V4, P148, DOI 10.1038/nchembio0308-148; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Gonzalez JM, 2010, BIOCHEMISTRY-US, V49, P7930, DOI 10.1021/bi100894r; Haruta S, 2000, ANTIMICROB AGENTS CH, V44, P2304, DOI 10.1128/AAC.44.9.2304-2309.2000; Hawk MJ, 2009, J AM CHEM SOC, V131, P10753, DOI 10.1021/ja900296u; Hu ZX, 2008, J AM CHEM SOC, V130, P14207, DOI 10.1021/ja8035916; Jacquin O, 2009, J MOL BIOL, V392, P1278, DOI 10.1016/j.jmb.2009.07.092; Llarrull LI, 2007, J BIOL CHEM, V282, P30586, DOI 10.1074/jbc.M704613200; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Moran-Barrio J, 2009, ANTIMICROB AGENTS CH, V53, P2908, DOI 10.1128/AAC.01637-08; Murphy TA, 2006, J MOL BIOL, V357, P890, DOI 10.1016/j.jmb.2006.01.003; Orellano EG, 1998, BIOCHEMISTRY-US, V37, P10173, DOI 10.1021/bi980309j; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Rasia RM, 2004, J BIOL CHEM, V279, P26046, DOI 10.1074/jbc.M311373200; Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502; Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200	23	39	39	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					698	700		10.1038/NCHEMBIO.1005	http://dx.doi.org/10.1038/NCHEMBIO.1005			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22729148	Green Accepted			2022-12-27	WOS:000306527600008
J	Sullivan, KD; Padilla-Just, N; Henry, RE; Porter, CC; Kim, J; Tentler, JJ; Eckhardt, SG; Tan, AC; DeGregori, J; Espinosa, JM				Sullivan, Kelly D.; Padilla-Just, Nuria; Henry, Ryan E.; Porter, Christopher C.; Kim, Jihye; Tentler, John J.; Eckhardt, S. Gail; Tan, Aik Choon; DeGregori, James; Espinosa, Joaquin M.			ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53	NATURE CHEMICAL BIOLOGY			English	Article							CELL LUNG-CANCER; NF-KAPPA-B; DNA-DAMAGE; ATAXIA-TELANGIECTASIA; COLORECTAL-CANCER; RECEPTOR GENE; IN-VIVO; TUMOR; INHIBITOR; RESTORATION	The p53 tumor suppressor orchestrates alternative stress responses including cell cycle arrest and apoptosis, but the mechanisms defining cell fate upon p53 activation are poorly understood. Several small-molecule activators of p53 have been developed, including Nutlin-3, but their therapeutic potential is limited by the fact that they induce reversible cell cycle arrest in most cancer cell types. We report here the results of a genome-wide short hairpin RNA screen for genes that are lethal in combination with p53 activation by Nutlin-3, which showed that the ATM and MET kinases govern cell fate choice upon p53 activation. Genetic or pharmacological interference with ATM or MET activity converts the cellular response from cell cycle arrest into apoptosis in diverse cancer cell types without affecting expression of key p53 target genes. ATM and MET inhibitors also enable Nutlin-3 to kill tumor spheroids. These results identify new pathways controlling the cellular response to p53 activation and aid in the design of p53-based therapies.	[Sullivan, Kelly D.; Padilla-Just, Nuria; Henry, Ryan E.; Espinosa, Joaquin M.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Sullivan, Kelly D.; Padilla-Just, Nuria; Henry, Ryan E.; Espinosa, Joaquin M.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Porter, Christopher C.; DeGregori, James] Univ Colorado, Dept Pediat, Aurora, CO USA; [Kim, Jihye; Tentler, John J.; Eckhardt, S. Gail; Tan, Aik Choon] Univ Colorado, Div Med Oncol, Dept Med, Aurora, CO USA; [DeGregori, James] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Espinosa, JM (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	joaquin.espinosa@colorado.edu	Tan, Aik Choon/A-3135-2011; Porter, Christopher/AAE-8918-2020	Tan, Aik Choon/0000-0003-2955-8369; Porter, Christopher/0000-0001-8774-0180; SULLIVAN, KELLY/0000-0003-2725-0205; DeGregori, James/0000-0002-1287-1976	US National Institutes of Health [RO1 CA117907]; Lung SPORE Pilot Grant [P50 CA058187]; Cancer League of Colorado; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA157850, T32CA082086, P30CA046934, R01CA117907, P50CA058187] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung SPORE Pilot Grant; Cancer League of Colorado; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes of Health grant RO1 CA117907, a Lung SPORE Pilot Grant (P50 CA058187), a pilot grant from the Cancer League of Colorado and a Career Development Award from The Leukemia and Lymphoma Society to K.D.S. J.M.E. is a Howard Hughes Medical Institute Early Career Scientist. We thank members of the Espinosa lab for support and discussions and H. Kennedy and J. Kruk for inspiration.	Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chan TA, 2000, GENE DEV, V14, P1584; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ding J, 2006, TRENDS PHARMACOL SCI, V27, P338, DOI 10.1016/j.tips.2006.04.007; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hadian K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001712; Henry RE, 2012, EMBO J, V31, P1266, DOI 10.1038/emboj.2011.498; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huang BY, 2009, MOL CANCER RES, V7, P1497, DOI 10.1158/1541-7786.MCR-09-0144; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Kim J, 2012, METHODS MOL BIOL, V802, P389, DOI 10.1007/978-1-61779-400-1_26; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Li AH, 2001, CLIN CANCER RES, V7, P3298; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Miyamoto S, 2011, CELL RES, V21, P116, DOI 10.1038/cr.2010.179; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Olivero M, 1996, BRIT J CANCER, V74, P1862, DOI 10.1038/bjc.1996.646; Paris R, 2008, CELL CYCLE, V7, P2427, DOI 10.4161/cc.6420; Porter C.C., 2012, LEUKEMIA        0113, DOI [10.1038/leu.2011.392, DOI 10.1038/LEU.2011.392]; Sattler M, 2003, CANCER RES, V63, P5462; Shaw AT, 2011, CLIN CANCER RES, V17, P2081, DOI 10.1158/1078-0432.CCR-10-1591; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sugai T, 2001, ONCOGENE, V20, P6095, DOI 10.1038/sj.onc.1204731; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Takhar AS, 2004, SURG-J R COLL SURG E, V2, P251, DOI 10.1016/S1479-666X(04)80093-3; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamazaki S, 2008, DRUG METAB DISPOS, V36, P1267, DOI 10.1124/dmd.107.019711; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang YJ, 2009, MOL BIOL CELL, V20, P3077, DOI 10.1091/mbc.E08-11-1109	49	53	56	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					646	654		10.1038/NCHEMBIO.965	http://dx.doi.org/10.1038/NCHEMBIO.965			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22660439	Green Accepted			2022-12-27	WOS:000305471400012
J	[Anonymous]				[Anonymous]			Beyond blueprints	NATURE CHEMICAL BIOLOGY			English	Editorial Material							ACID-METABOLISM											2009, NAT CHEM BIOL, V5, P879; 2012, CANCER CELL, V21, P297; 2011, J BIOL CHEM, V286, P11937; 2009, NATURE, V460, P103; 2012, CELL METAB, V15, P432; 2008, NATURE, V455, P697; 2012, SCI, V335, P1099; 2011, NAT CHEM BIOL, V7, P58; 2010, SCI, V330, P1338; 2010, NATURE, V466, P774	10	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					495	495						1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22596189	Bronze			2022-12-27	WOS:000304256300001
J	Khare, SD; Kipnis, Y; Greisen, PJ; Takeuchi, R; Ashani, Y; Goldsmith, M; Song, YF; Gallaher, JL; Silman, I; Leader, H; Sussman, JL; Stoddard, BL; Tawfik, DS; Baker, D				Khare, Sagar D.; Kipnis, Yakov; Greisen, Per Jr; Takeuchi, Ryo; Ashani, Yacov; Goldsmith, Moshe; Song, Yifan; Gallaher, Jasmine L.; Silman, Israel; Leader, Haim; Sussman, Joel L.; Stoddard, Barry L.; Tawfik, Dan S.; Baker, David			Computational redesign of a mononuclear zinc metalloenzyme for organophosphate hydrolysis	NATURE CHEMICAL BIOLOGY			English	Article							CATALYTIC-ACTIVITY; NERVE AGENTS; DESIGN; PROMISCUITY; MECHANISM; EVOLUTION; MUTATION; ENZYMES	The ability to redesign enzymes to catalyze noncognate chemical transformations would have wide-ranging applications. We developed a computational method for repurposing the reactivity of metalloenzyme active site functional groups to catalyze new reactions. Using this method, we engineered a zinc-containing mouse adenosine deaminase to catalyze the hydrolysis of a model organophosphate with a catalytic efficiency (k(cat)/k(m)) of -10(4) M(-1)s(-1) after directed evolution. In the high-resolution crystal structure of the enzyme, all but one of the designed residues adopt the designed conformation. The designed enzyme efficiently catalyzes the hydrolysis of the R-p isomer of a coumarinyl analog of the nerve agent cyclosarin, and it shows marked substrate selectivity for coumarinyl leaving groups. Computational redesign of native enzyme active sites complements directed evolution methods and offers a general approach for exploring their untapped catalytic potential for new reactivities.	[Khare, Sagar D.; Kipnis, Yakov; Song, Yifan; Gallaher, Jasmine L.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Greisen, Per Jr] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark; [Takeuchi, Ryo; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Ashani, Yacov; Sussman, Joel L.] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Ashani, Yacov; Silman, Israel] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Goldsmith, Moshe; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Leader, Haim] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Technical University of Denmark; Fred Hutchinson Cancer Center; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Khare, SD (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Sussman, Joel/0000-0003-0306-3878	Defense Advanced Research Projects Agency; Defense Threat Reduction Agency; Howard Hughes Medical Institute; Novo Nordisk Danmark-Amerika Fondet; Oticon Fonden; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Novo Nordisk Danmark-Amerika Fondet(Novo Nordisk); Oticon Fonden; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Nivon for assistance with liquid chromatography, O. Khersonsky (Weizmann Institute of Science) for providing substrates and I. Damborsky for comments on the manuscript. This work was supported by the Defense Advanced Research Projects Agency, the Defense Threat Reduction Agency and the Howard Hughes Medical Institute. was supported by Novo Nordisk Danmark-Amerika Fondet and Oticon Fonden.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Ashani Y, 2010, CHEM-BIOL INTERACT, V187, P362, DOI 10.1016/j.cbi.2010.02.039; Aubert SD, 2004, BIOCHEMISTRY-US, V43, P5707, DOI 10.1021/bi0497805; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Blum MM, 2006, J AM CHEM SOC, V128, P12750, DOI 10.1021/ja061887n; Chen B, 2009, BIOCHEMISTRY-US, V48, P11496, DOI 10.1021/bi9014727; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; de Yin L.T, 2010, BIOCHEMISTRY-US, V49, P1931; Dyguda-Kazimierowicz E, 2008, J PHYS CHEM B, V112, P9982, DOI 10.1021/jp800386f; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; Gupta RD, 2011, NAT CHEM BIOL, V7, P120, DOI [10.1038/nchembio.510, 10.1038/NCHEMBIO.510]; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jochens H, 2009, ANGEW CHEM INT EDIT, V48, P3532, DOI 10.1002/anie.200806276; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leopoldseder S, 2004, J MOL BIOL, V337, P871, DOI 10.1016/j.jmb.2004.01.062; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Raushel FM, 2011, NATURE, V469, P310, DOI 10.1038/469310a; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schmidt DMZ, 2003, BIOCHEMISTRY-US, V42, P8387, DOI 10.1021/bi034769a; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Terao Y, 2006, CHEM COMMUN, P3600, DOI 10.1039/b607211a; Toscano MD, 2007, ANGEW CHEM INT EDIT, V46, P3212, DOI 10.1002/anie.200604205; Tsai PC, 2010, BIOCHEMISTRY-US, V49, P7978, DOI 10.1021/bi101056m; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; Williams SD, 2000, BIOCHEMISTRY-US, V39, P10098, DOI 10.1021/bi0004652; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xiang H, 1999, BIOCHEMISTRY-US, V38, P7638, DOI 10.1021/bi9901432; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	37	168	172	2	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					294	300		10.1038/NCHEMBIO.777	http://dx.doi.org/10.1038/NCHEMBIO.777			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22306579	Green Accepted			2022-12-27	WOS:000300600000015
J	Mata, MA; Satterly, N; Versteeg, GA; Frantz, D; Wei, SG; Williams, N; Schmolke, M; Pena-Llopis, S; Brugarolas, J; Forst, CV; White, MA; Garcia-Sastre, A; Roth, MG; Fontoura, BMA				Mata, Miguel A.; Satterly, Neal; Versteeg, Gijs A.; Frantz, Doug; Wei, Shuguang; Williams, Noelle; Schmolke, Mirco; Pena-Llopis, Samuel; Brugarolas, James; Forst, Christian V.; White, Michael A.; Garcia-Sastre, Adolfo; Roth, Michael G.; Fontoura, Beatriz M. A.			Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor	NATURE CHEMICAL BIOLOGY			English	Article							INFLUENZA-A-VIRUS; NS1 PROTEIN BINDS; NUCLEAR EXPORT; INFECTED-CELLS; UP-REGULATION; RIG-I; MTOR; INTERFERON; INDUCTION; INTERACTS	A chemical genetics approach was taken to identify inhibitors of NS1, a major influenza A virus virulence factor that inhibits host gene expression. A high-throughput screen of 200,000 synthetic compounds identified small molecules that reversed NS1-mediated inhibition of host gene expression. A counterscreen for suppression of influenza virus cytotoxicity identified naphthalimides that inhibited replication of influenza virus and vesicular stomatitis virus (VSV). The mechanism of action occurs through activation of REDD1 expression and concomitant inhibition of mammalian target of rapamycin complex 1 (mTORC1) via TSC1-TSC2 complex. The antiviral activity of naphthalimides was abolished in REDD1(-/-) cells. Inhibition of REDD1 expression by viruses resulted in activation of the mTORC1 pathway. REDD1(-/-) cells prematurely upregulated viral proteins via mTORC1 activation and were permissive to virus replication. In contrast, cells conditionally expressing high concentrations of REDD1 downregulated the amount of viral protein. Thus, REDD1 is a new host defense factor, and chemical activation of REDD1 expression represents a potent antiviral intervention strategy. (C) 2011 Nature America, Inc. All rights reserved.	[Mata, Miguel A.; Satterly, Neal; White, Michael A.; Fontoura, Beatriz M. A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Versteeg, Gijs A.; Schmolke, Mirco; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Frantz, Doug; Wei, Shuguang; Williams, Noelle; Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Pena-Llopis, Samuel; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Pena-Llopis, Samuel; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Pena-Llopis, Samuel; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Forst, Christian V.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Fontoura, BMA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	beatriz.fontoura@utsouthwestern.edu	Schmolke, Mirco/AAI-9081-2020; Peña-Llopis, Samuel/ABH-2358-2020	Schmolke, Mirco/0000-0002-2491-3029; Brugarolas, James/0000-0002-8575-499X; Versteeg, Gijs/0000-0002-6150-2165; Pena-Llopis, Samuel/0000-0003-3847-1353; Forst, Christian/0000-0003-0229-9459; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Roth, Michael/0000-0002-9056-332X	US National Institutes of Health (NIH) [R01GM07159, R01AI079110, R01AI089539]; Diane and Hal Brierley Distinguished Chair in Biomedical Research; National Center for Research Resources [C06-RR15437]; NIH [R01AI046954, P01AI058113, U54AI057158, U01AI074539, R01CA129387, R01GM06715908S1]; Center for Research on Influenza Pathogenesis; National Institute of Allergy and Infectious Diseases; Center of Excellence for Influenza Research and Surveillance [HHSN266200700010C]; NATIONAL CANCER INSTITUTE [R01CA129387, R01CA071443] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089539, U54AI057158, R01AI079110, U01AI074539, P01AI058113, R01AI046954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067159] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diane and Hal Brierley Distinguished Chair in Biomedical Research; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Research on Influenza Pathogenesis; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center of Excellence for Influenza Research and Surveillance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Sakthivel (University of Texas Southwestern) for technical assistance with plaque assays and L. Melito and J. Naidoo (University of Texas Southwestern) for technical assistance with compound synthesis. We thank S. Rubin de Celis (University of Texas Southwestern) for providing REDD1 cells, D. Levy (New York University) for providing Stat1<SUP>-/-</SUP>cells and B. Levine (University of Texas Southwestern) for providing ATG5<SUP>-/-</SUP> cells and LC3 antibodies. This work was supported by US National Institutes of Health (NIH) grants R01GM07159 to B. M. A. F.; R01AI079110 and R01AI089539 to B. M. A. F. and M. G. R.; the Diane and Hal Brierley Distinguished Chair in Biomedical Research to M. G. R; National Center for Research Resources grant C06-RR15437; NIH grants R01AI046954, P01AI058113, U54AI057158 and U01AI074539; the Center for Research on Influenza Pathogenesis, the National Institute of Allergy and Infectious Diseases-funded Center of Excellence for Influenza Research and Surveillance (HHSN266200700010C to A.G.-S.); NIH grant R01CA129387 to J. B.; and support to M. A. M. from the NIH Diversity Supplement (R01GM06715908S1).	Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas J, 2010, CANCER DRUG DISCOV D, P75, DOI 10.1007/978-1-60327-271-1_4; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Farny NG, 2008, GENE DEV, V22, P66, DOI 10.1101/gad.1616008; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Krishnamoorthy J, 2008, CELL CYCLE, V7, P2346, DOI 10.4161/cc.6323; KRUG RM, 1973, VIROLOGY, V56, P334, DOI 10.1016/0042-6822(73)90310-3; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; McNaney CA, 2008, ASSAY DRUG DEV TECHN, V6, P121, DOI 10.1089/adt.2007.103; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; QIAN XY, 1994, J VIROL, V68, P2433, DOI 10.1128/JVI.68.4.2433-2441.1994; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; QIU Y, 1995, RNA, V1, P304; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Vega-Rubin-de-Celis S, 2010, BIOCHEMISTRY-US, V49, P2491, DOI 10.1021/bi902135e; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Wolff T, 1998, J VIROL, V72, P7170, DOI 10.1128/JVI.72.9.7170-7180.1998; Zhirnov OP, 2007, APOPTOSIS, V12, P1419, DOI 10.1007/s10495-007-0071-y; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	47	60	65	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					712	719		10.1038/NCHEMBIO.645	http://dx.doi.org/10.1038/NCHEMBIO.645			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21909097	Green Accepted, Green Published, Bronze			2022-12-27	WOS:000295027100015
J	Pikovskaya, O; Polonskaia, A; Patel, DJ; Serganov, A				Pikovskaya, Olga; Polonskaia, Anna; Patel, Dinshaw J.; Serganov, Alexander			Structural principles of nucleoside selectivity in a 2 '-deoxyguanosine riboswitch	NATURE CHEMICAL BIOLOGY			English	Article							GUANINE-SENSING RIBOSWITCH; APTAMER DOMAIN; PURINE RIBOSWITCH; S-ADENOSYLMETHIONINE; LIGAND-BINDING; ADENINE RIBOSWITCH; GENE-EXPRESSION; INDUCED FIT; RNA; RECOGNITION	Purine riboswitches have an essential role in genetic regulation of bacterial metabolism. This family includes the 2'-deoxyguanosine (dG) riboswitch, which is involved in feedback control of deoxyguanosine biosynthesis. To understand the principles that define dG selectivity, we determined crystal structures of the natural Mesoplasma florum riboswitch bound to cognate dG as well as to noncognate guanosine, deoxyguanosine monophosphate and guanosine monophosphate. Comparison with related purine riboswitch structures reveals that the dG riboswitch achieves its specificity through modification of key interactions involving the nucleobase and rearrangement of the ligand-binding pocket to accommodate the additional sugar moiety. In addition, we observe new conformational changes beyond the junctional binding pocket extending as far as peripheral loop-loop interactions. It appears that re-engineering riboswitch scaffolds will require consideration of selectivity features dispersed throughout the riboswitch tertiary fold, and structure-guided drug design efforts targeted to junctional RNA scaffolds need to be addressed within such an expanded framework.	[Pikovskaya, Olga; Polonskaia, Anna; Patel, Dinshaw J.; Serganov, Alexander] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Serganov, A (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	pateld@mskcc.org; alexander.serganov@nyumc.org		Serganov, Alexander/0000-0001-8328-9310	US Department of Energy; US National Institutes of Health [GM66354]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354, R01GM073618, R01GM034504] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel of beamline X29 at the Brookhaven National Laboratory, funded by the US Department of Energy, for assistance in data collection. We thank O. Ouerfelli (Memorial Sloan-Kettering Cancer Center, New York) for the synthesis of iridium hexamine and E. Ennifar (Institut de Biologie Moleculaire et Cellulaire, Strasbourg) for the discussion of the refinement strategy. D.J.P. was supported by funds from the US National Institutes of Health grant GM66354.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Buck J, 2010, NUCLEIC ACIDS RES, V38, P4143, DOI 10.1093/nar/gkq138; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; de la Pena M, 2009, RNA, V15, P1949, DOI 10.1261/rna.1889509; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Dixon N, 2010, P NATL ACAD SCI USA, V107, P2830, DOI 10.1073/pnas.0911209107; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Edwards AL, 2009, J MOL BIOL, V385, P938, DOI 10.1016/j.jmb.2008.10.074; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Gilbert SD, 2006, J AM CHEM SOC, V128, P14214, DOI 10.1021/ja063645t; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Gilbert SD, 2009, STRUCTURE, V17, P857, DOI 10.1016/j.str.2009.04.009; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Jain N, 2010, BIOCHEMISTRY-US, V49, P3703, DOI 10.1021/bi1000036; Kim JN, 2007, P NATL ACAD SCI USA, V104, P16092, DOI 10.1073/pnas.0705884104; Kim JN, 2009, ACS CHEM BIOL, V4, P915, DOI 10.1021/cb900146k; Lemay JF, 2007, RNA, V13, P339, DOI 10.1261/rna.142007; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lu C, 2008, NAT STRUCT MOL BIOL, V15, P1076, DOI 10.1038/nsmb.1494; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Mulhbacher J, 2007, NUCLEIC ACIDS RES, V35, P5568, DOI 10.1093/nar/gkm572; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P5262, DOI 10.1093/nar/gkm565; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2010, RNA BIOL, V7, P98, DOI 10.4161/rna.7.1.10756; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Wacker A, 2011, NUCLEIC ACIDS RES, V39, P6802, DOI 10.1093/nar/gkr238	50	47	48	3	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					748	755		10.1038/NCHEMBIO.631	http://dx.doi.org/10.1038/NCHEMBIO.631			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21841796	Green Accepted			2022-12-27	WOS:000295027100019
J	Hauser, AT; Jung, M				Hauser, Alexander-Thomas; Jung, Manfred			CHEMICAL PROBES Sharpen your epigenetic tools	NATURE CHEMICAL BIOLOGY			English	News Item							G9A HISTONE METHYLTRANSFERASE; METHYLATION		[Hauser, Alexander-Thomas; Jung, Manfred] Univ Freiburg, Inst Pharmaceut Sci, D-7800 Freiburg, Germany	University of Freiburg	Hauser, AT (corresponding author), Univ Freiburg, Inst Pharmaceut Sci, D-7800 Freiburg, Germany.	manfred.jung@pharmazie.uni-freiburg.de	Jung, Manfred/Q-8029-2016	Jung, Manfred/0000-0002-6361-7716				Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Huang J, 2010, J BIOL CHEM, V285, P18122, DOI 10.1074/jbc.A109.062588; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]	11	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					499	500		10.1038/nchembio.615	http://dx.doi.org/10.1038/nchembio.615			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769094				2022-12-27	WOS:000292825400007
J	Feinstein, TN; Wehbi, VL; Ardura, JA; Wheeler, DS; Ferrandon, S; Gardella, TJ; Vilardaga, JP				Feinstein, Timothy N.; Wehbi, Vanessa L.; Ardura, Juan A.; Wheeler, David S.; Ferrandon, Sebastien; Gardella, Thomas J.; Vilardaga, Jean-Pierre			Retromer terminates the generation of cAMP by internalized PTH receptors	NATURE CHEMICAL BIOLOGY			English	Article							PARATHYROID-HORMONE RECEPTOR; PROTEIN-COUPLED-RECEPTOR; BONE-MINERAL DENSITY; BETA-ARRESTIN; KINASE-C; BETA-2-ADRENERGIC RECEPTOR; MAMMALIAN RETROMER; DESENSITIZATION; ACTIVATION; IDENTIFICATION	The generation of cAMP by G protein-coupled receptors (GPCRs) and its termination are currently thought to occur exclusively at the plasma membrane of cells. Under existing models of receptor regulation, this signal is primarily restricted by desensitization of the receptors through their binding to beta-arrestins. However, this paradigm is not consistent with recent observations that the parathyroid hormone receptor type 1 (PTHR) continues to stimulate cAMP production even after receptor internalization, as beta-arrestins are known to rapidly bind and internalize activated PTHR. Here we show that binding to beta-arrestin1 prolongs rather than terminates the generation of cAMP by PTHR, and that cAMP generation correlates with the persistence of arrestin-receptor complexes on endosomes. PTHR signaling is instead turned off by the retromer complex, which regulates the movement of internalized receptor from endosomes to the Golgi apparatus. Thus, binding by the retromer complex regulates the sustained generation of cAMP triggered by an internalized GPCR.	[Feinstein, Timothy N.; Wehbi, Vanessa L.; Ardura, Juan A.; Wheeler, David S.; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15260 USA; [Ferrandon, Sebastien; Gardella, Thomas J.; Vilardaga, Jean-Pierre] Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; [Ferrandon, Sebastien; Gardella, Thomas J.; Vilardaga, Jean-Pierre] Harvard Univ, Sch Med, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Vilardaga, JP (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15260 USA.	jpv@pitt.edu	Ardura, Juan/L-8139-2014; Ardura, Juan Antonio/F-3378-2017; Feinstein, Timothy/G-3110-2011	Ardura, Juan/0000-0002-8881-4775; Ardura, Juan Antonio/0000-0002-2827-3364; Feinstein, Timothy/0000-0002-9801-9708; Vilardaga, Jean-Pierre/0000-0002-1217-1435	US National Institutes of Health [R01DK087688]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087688] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health award R01DK087688 (to J.-P.V.). We thank J. Bonifacino for plasmids encoding retromer subunits Vps26 and Vps29<SUP>YFP</SUP> and L. Traub for plasmids encoding beta-arrestin1<SUP>tom</SUP> and beta-arrestin1[I386A, V387A]<SUP>tom</SUP>.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Castro M, 2002, ENDOCRINOLOGY, V143, P3854, DOI 10.1210/en.2002-220232; Chauvin S, 2002, MOL ENDOCRINOL, V16, P2720, DOI 10.1210/me.2002-0049; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Eaton S, 2008, DEV CELL, V14, P4, DOI 10.1016/j.devcel.2007.12.014; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Finkelstein JS, 1999, J CLIN ENDOCR METAB, V84, P1214, DOI 10.1210/jc.84.4.1214; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Garrido JL, 2009, MOL ENDOCRINOL, V23, P2048, DOI 10.1210/me.2008-0436; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P1603, DOI 10.1210/jc.2002-020773; Johnston CA, 2008, STRUCTURE, V16, P1086, DOI 10.1016/j.str.2008.04.010; Keyel PA, 2008, MOL BIOL CELL, V19, P5309, DOI 10.1091/mbc.E08-07-0712; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Lerner JM, 2004, CYTOM PART A, V62A, P8, DOI 10.1002/cyto.a.20087; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Malecz N, 1998, MOL ENDOCRINOL, V12, P1846, DOI 10.1210/me.12.12.1846; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Robben JH, 2009, P NATL ACAD SCI USA, V106, P12195, DOI 10.1073/pnas.0900130106; Rosenblatt M, 2009, NAT CHEM BIOL, V5, P707, DOI 10.1038/nchembio.225; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; Zucker RM, 2005, MICROSC RES TECHNIQ, V68, P307, DOI 10.1002/jemt.20249	49	156	158	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					278	284		10.1038/nchembio.545	http://dx.doi.org/10.1038/nchembio.545			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21445058	Green Accepted			2022-12-27	WOS:000289617800011
J	Xu, J; Reumers, J; Couceiro, JR; De Smet, F; Gallardo, R; Rudyak, S; Cornelis, A; Rozenski, J; Zwolinska, A; Marine, JC; Lambrechts, D; Suh, YA; Rousseau, F; Schymkowitz, J				Xu, Jie; Reumers, Joke; Couceiro, Jose R.; De Smet, Frederik; Gallardo, Rodrigo; Rudyak, Stanislav; Cornelis, Ann; Rozenski, Jef; Zwolinska, Aleksandra; Marine, Jean-Christophe; Lambrechts, Diether; Suh, Young-Ah; Rousseau, Frederic; Schymkowitz, Joost			Gain of function of mutant p53 by coaggregation with multiple tumor suppressors	NATURE CHEMICAL BIOLOGY			English	Article							DNA-BINDING; WILD-TYPE; PROGNOSTIC-SIGNIFICANCE; ACTIVATING MUTATIONS; PROTEIN AGGREGATION; LI-FRAUMENI; CANCER; P73; P63; TRANSFORMATION	Many p53 missense mutations possess dominant-negative activity and oncogenic gain of function. We report that for structurally destabilized p53 mutants, these effects result from mutant-induced coaggregation of wild-type p53 and its paralogs p63 and p73, thereby also inducing a heat-shock response. Aggregation of mutant p53 resulted from self-assembly of a conserved aggregation-nucleating sequence within the hydrophobic core of the DNA-binding domain, which becomes exposed after mutation. Suppressing the aggregation propensity of this sequence by mutagenesis abrogated gain of function and restored activity of wild-type p53 and its paralogs. In the p53 germline mutation database, tumors carrying aggregation-prone p53 mutations have a significantly lower frequency of wild-type allele loss as compared to tumors harboring nonaggregating mutations, suggesting a difference in clonal selection of aggregating mutants. Overall, our study reveals a novel disease mechanism for mutant p53 gain of function and suggests that, at least in some respects, cancer could be considered an aggregation-associated disease.	[Xu, Jie; Reumers, Joke; Couceiro, Jose R.; De Smet, Frederik; Gallardo, Rodrigo; Rudyak, Stanislav; Rousseau, Frederic; Schymkowitz, Joost] Vrije Univ Brussel, Flanders Inst Biotechnol, SWITCH Lab, Brussels, Belgium; [Cornelis, Ann] Reg Ziekenhuis Heilig Hart, Dept Pathol, Tienen, Belgium; [Rozenski, Jef] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Zwolinska, Aleksandra; Marine, Jean-Christophe] Katholieke Univ Leuven, Flanders Inst Biotechnol, Dept Mol & Dev Genet, Lab Mol Canc Biol, Louvain, Belgium; [Lambrechts, Diether] Katholieke Univ Leuven, Flanders Inst Biotechnol, Vesalius Res Ctr, Louvain, Belgium; [Suh, Young-Ah] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Texas System; UTMD Anderson Cancer Center	Rousseau, F (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Flanders Inst Biotechnol, SWITCH Lab, Louvain, Belgium.	frederic.rousseau@med.kuleuven.be; joost.schymkowitz@med.kuleuven.be	Marine, Jean-Christophe/K-3292-2016; Rodríguez Couceiro, Jose/F-1497-2016; Rudyak, Stanislav/U-1781-2017; Rousseau, Frederic/J-9044-2016; Marine, Jean Christophe/J-2237-2015; De Smet, Frederik/Q-7808-2016; Lambrechts, Diether/AAJ-3167-2020; Verdrengh, Evelien/H-4571-2012; Bustelo, Xose R./A-9526-2010; Xu, Jie/K-3712-2019; Schymkowitz, Joost/AAV-3680-2021; Schymkowitz, Joost/K-7764-2016	Marine, Jean-Christophe/0000-0003-2433-9837; Rodríguez Couceiro, Jose/0000-0002-5742-1071; Rousseau, Frederic/0000-0002-9189-7399; De Smet, Frederik/0000-0002-6669-3335; Lambrechts, Diether/0000-0002-3429-302X; Bustelo, Xose R./0000-0001-9398-6072; Xu, Jie/0000-0001-9163-3898; Schymkowitz, Joost/0000-0003-2020-0168; Gallardo, Rodrigo/0000-0003-1584-3564; Reumers, Joke/0000-0001-5434-6515; Rozenski, Jef/0000-0001-9624-5536	Research Foundation Flanders; Agency for Innovation by Science and Technology Flanders; Linking Sino-European Universities through Mobility and National Natural Science Foundation of China [81000861]; Research Council Katholieke Universiteit Leuven, Center of Excellence [KUL PFV/10/016 SymBioSys]; Stichting Tegen Kanker	Research Foundation Flanders(FWO); Agency for Innovation by Science and Technology Flanders; Linking Sino-European Universities through Mobility and National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Council Katholieke Universiteit Leuven, Center of Excellence; Stichting Tegen Kanker	The VIB Switch Laboratory was supported by the Research Foundation Flanders and the Agency for Innovation by Science and Technology Flanders. J.X. and A.Z. were supported by Linking Sino-European Universities through Mobility and National Natural Science Foundation of China (81000861) and the Research Foundation Flanders, respectively. D. L. was supported by the Research Council Katholieke Universiteit Leuven, Center of Excellence (KUL PFV/10/016 SymBioSys) and the Stichting Tegen Kanker. We thank G. Peuteman, D. Smeets and T. Van Brussel for technical assistance. We thank G. Lozano for access to tumor tissues from transgenic mice and G. Melino for plasmids.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Bensaad K, 2003, J BIOL CHEM, V278, P10546, DOI 10.1074/jbc.M208233200; Boominathan L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-27; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Davison TS, 1999, J BIOL CHEM, V274, P18709, DOI 10.1074/jbc.274.26.18709; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hishiya A, 2008, ONCOGENE, V27, P6489, DOI 10.1038/onc.2008.314; Huo Q, 2010, COLLOID SURFACE B, V78, P259, DOI 10.1016/j.colsurfb.2010.03.012; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kruse JP, 2009, J BIOL CHEM, V284, P3250, DOI 10.1074/jbc.M805658200; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Okorokov AL, 2009, CURR OPIN STRUC BIOL, V19, P197, DOI 10.1016/j.sbi.2009.02.003; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Powell B, 2000, CLIN CANCER RES, V6, P443; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; ROTTER V, 1983, P NATL ACAD SCI-BIOL, V80, P2613, DOI 10.1073/pnas.80.9.2613; Samowitz WS, 2002, INT J CANCER, V99, P597, DOI 10.1002/ijc.10405; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sedlacek Z, 1998, NUCLEIC ACIDS RES, V26, P214, DOI 10.1093/nar/26.1.214; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	48	358	373	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					285	295		10.1038/nchembio.546	http://dx.doi.org/10.1038/nchembio.546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21445056				2022-12-27	WOS:000289617800012
J	Patel, PD; Yan, PR; Seidler, PM; Patel, HJ; Sun, WL; Yang, CH; Que, NS; Taldone, T; Finotti, P; Stephani, RA; Gewirth, DT; Chiosis, G				Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela			Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2	NATURE CHEMICAL BIOLOGY			English	Article							SHOCK-PROTEIN GP96; PURINE-SCAFFOLD; BREAST-CANCER; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; ACCURATE DOCKING; TYROSINE KINASE; GRP94; BINDING; CELLS	Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90 alpha, Hsp90 beta, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood. This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable. Here we combine compound library screening with structural and computational analyses to identify purine-based chemical tools that are specific for Hsp90 paralogs. We show that Grp94 selectivity is due to the insertion of these compounds into a new allosteric pocket. We use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations. Finally, we provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.	[Patel, Pallav D.; Yan, Pengrong; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Taldone, Tony; Chiosis, Gabriela] Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY USA; [Patel, Pallav D.; Stephani, Ralph A.] St Johns Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Jamaica, NY 11439 USA; [Seidler, Paul M.; Que, Nanette S.; Gewirth, Daniel T.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14260 USA; [Seidler, Paul M.; Que, Nanette S.; Gewirth, Daniel T.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; [Finotti, Paola] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy	Memorial Sloan Kettering Cancer Center; Saint John's University; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Padua	Patel, PD (corresponding author), Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY USA.	gewirth@hwi.buffalo.edu; chiosisg@mskcc.org		Yan, Pengrong/0000-0003-0021-6461	Breast Cancer Research Fund [R01 CA172546-01A1, U01 AG032969-01A1, R21 AI090501, R21 CA158609-01, R01 CA155226-01]; Translational and Integrative Medicine Research Fund of Memorial Sloan-Kettering Cancer Center; St. John's University;  [R01 CA095130]; NATIONAL CANCER INSTITUTE [R01CA095130, R01CA155226, R21CA158609, R01CA172546, P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH076408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS050838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG032969] Funding Source: NIH RePORTER	Breast Cancer Research Fund; Translational and Integrative Medicine Research Fund of Memorial Sloan-Kettering Cancer Center; St. John's University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	G.C. is funded by the Breast Cancer Research Fund, R01 CA172546-01A1, U01 AG032969-01A1, R21 AI090501, R21 CA158609-01 and R01 CA155226-01. P.Y. is supported by the Translational and Integrative Medicine Research Fund of Memorial Sloan-Kettering Cancer Center. P.D.P. and R.A.S. are supported by funds and resources from St. John's University. D.T.G. is funded by R01 CA095130. We thank Y. Argon (Children's Hospital of Philadelphia) and C. Leifer (Cornell University College of Veterinary Medicine) for reagents.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Chavany C, 1996, J BIOL CHEM, V271, P4974; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chene P, 2002, NAT REV DRUG DISCOV, V1, P665, DOI 10.1038/nrd894; Chiosis G, 2001, CHEM BIOL, V8, P289, DOI 10.1016/S1074-5521(01)00015-1; Chiosis G, 2002, BIOORGAN MED CHEM, V10, P3555, DOI 10.1016/S0968-0896(02)00253-5; Chiosis G, 2008, EXPERT OPIN DRUG DIS, V3, P99, DOI 10.1517/17460441.3.1.99; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Duerfeldt AS, 2012, J AM CHEM SOC, V134, P9796, DOI 10.1021/ja303477g; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Immormino RM, 2006, J MED CHEM, V49, P4953, DOI 10.1021/jm060297x; Immormino RM, 2009, J MOL BIOL, V388, P1033, DOI 10.1016/j.jmb.2009.03.071; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kim J, 2004, J BIOMOL SCREEN, V9, P375, DOI 10.1177/1087057104265995; Kim TE, 2003, IDRUGS, V6, P886; Leskovar A, 2008, J BIOL CHEM, V283, P11677, DOI 10.1074/jbc.M709516200; Llauger L, 2005, J MED CHEM, V48, P2892, DOI 10.1021/jm049012b; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Moulick K, 2006, BIOORG MED CHEM LETT, V16, P4515, DOI 10.1016/j.bmcl.2006.06.025; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Na X, 2008, INFECT IMMUN, V76, P2862, DOI 10.1128/IAI.00326-08; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Richter K, 2007, MOL CELL, V28, P177, DOI 10.1016/j.molcel.2007.10.007; Rodina A, 2007, NAT CHEM BIOL, V3, P498, DOI 10.1038/nchembio.2007.10; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Sokolowska I, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-47; Soldano KL, 2003, J BIOL CHEM, V278, P48330, DOI 10.1074/jbc.M308661200; Sreedhar AS, 2004, FEBS LETT, V562, P11; Taldone T, 2013, J MED CHEM, V56, P6803, DOI 10.1021/jm400619b; Taldone T, 2011, BIOORGAN MED CHEM, V19, P2603, DOI 10.1016/j.bmc.2011.03.013; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Whitesell L, 2003, CURR CANCER DRUG TAR, V3, P349, DOI 10.2174/1568009033481787; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Xu WP, 2002, CELL STRESS CHAPERON, V7, P91, DOI 10.1379/1466-1268(2002)007<0091:HNGRTI>2.0.CO;2; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang LF, 2002, LAB INVEST, V82, P71, DOI 10.1038/labinvest.3780396; Zheng H, 2001, J IMMUNOL, V167, P6731, DOI 10.4049/jimmunol.167.12.6731	60	142	146	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					677	+		10.1038/NCHEMBIO.1335	http://dx.doi.org/10.1038/NCHEMBIO.1335			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	23995768	Green Accepted			2022-12-27	WOS:000325930500006
J	Amin, MN; McLellan, JS; Huang, W; Orwenyo, J; Burton, DR; Koff, WC; Kwong, PD; Wang, LX				Amin, Mohammed N.; McLellan, Jason S.; Huang, Wei; Orwenyo, Jared; Burton, Dennis R.; Koff, Wayne C.; Kwong, Peter D.; Wang, Lai-Xi			Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies	NATURE CHEMICAL BIOLOGY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; CHEMOENZYMATIC SYNTHESIS; TRANSGLYCOSYLATION ACTIVITY; GLYCOSYLATION; GLYCOPROTEINS; POTENT; BROAD; RECOGNITION; OXAZOLINES; DOMAIN	A new class of glycan-reactive HIV-neutralizing antibodies, including PG9 and PG16, has been recently discovered that seem to recognize previously uncharacterized glycopeptide epitopes on HIV-1 gp120. However, further characterization and reconstitution of the precise neutralizing epitopes are complicated by the heterogeneity of glycosylation. We report here the design, synthesis and antigenic evaluation of new cyclic V1V2 glycopeptides carrying defined N-linked glycans at the conserved glycosylation sites (Asn160 and Asn156 or Asn173) derived from gp120 of two HIV-1 isolates. Antibody binding studies confirmed the necessity of a Man(5)GlcNAc(2) glycan at Asn160 for recognition by PG9 and PG16 and further revealed a critical role of a sialylated N-glycan at the secondary site (Asn156 or Asn173) in the context of glycopeptides for antibody binding. In addition to defining the glycan specificities of PG9 and PG16, the identified synthetic glycopeptides provide a valuable template for HIV-1 vaccine design.	[Amin, Mohammed N.; Huang, Wei; Orwenyo, Jared; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Amin, Mohammed N.; Huang, Wei; Orwenyo, Jared; Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [McLellan, Jason S.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat IAVI, Neutralizing Antibody Ctr, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Burton, Dennis R.] Massachusetts Gen Hosp, Massachusetts Inst Technol & Harvard, Ragon Inst, Cambridge, MA USA; [Koff, Wayne C.] IAVI, New York, NY USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative	Wang, LX (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	LWang@som.umaryland.edu	Wang, Xin/AAN-8435-2021; wang, xl/Y-8251-2019; Huang, Wei/P-9631-2017; Wang, Lai-Xi/E-8790-2019; Wang, Lai-Xi/E-8755-2019	Wang, Xin/0000-0002-4457-7376; Huang, Wei/0000-0001-6432-1848; Wang, Lai-Xi/0000-0003-4293-5819; McLellan, Jason/0000-0003-3991-542X	National Institute of Allergy and Infectious Diseases (NIAID) (US National Institutes of Health (NIH) [1R21AI101035]; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; Intramural Research Program of the Vaccine Research Center, NIAID-NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101035, ZIAAI005024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) (US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; Intramural Research Program of the Vaccine Research Center, NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Fan (University of Maryland) for providing the recombinant Endo-D and K. Moremen and Y. Xiang (University of Georgia) for providing the recombinant mouse alpha-1,2-mannosidase. This work is supported in parts by grants from the National Institute of Allergy and Infectious Diseases (NIAID) (US National Institutes of Health (NIH) grant 1R21AI101035 to L.-X. W.), the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium and by the Intramural Research Program of the Vaccine Research Center, NIAID-NIH.	Amin MN, 2011, J AM CHEM SOC, V133, P14404, DOI 10.1021/ja204831z; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Gamblin DP, 2009, CHEM REV, V109, P131, DOI 10.1021/cr078291i; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; Huang W, 2008, CARBOHYD RES, V343, P2903, DOI 10.1016/j.carres.2008.08.033; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2010, ORG BIOMOL CHEM, V8, P5224, DOI 10.1039/c0ob00341g; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kwong P. D, 2011, PERSPECT MED, V1; Lal A, 1998, GLYCOBIOLOGY, V8, P981, DOI 10.1093/glycob/8.10.981; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li HG, 2005, J ORG CHEM, V70, P9990, DOI 10.1021/jo051729z; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Ochiai H, 2008, J AM CHEM SOC, V130, P13790, DOI 10.1021/ja805044x; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Schmaltz RM, 2011, CHEM REV, V111, P4259, DOI 10.1021/cr200113w; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	42	91	111	0	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2013	9	8					521	526		10.1038/nchembio.1288	http://dx.doi.org/10.1038/nchembio.1288			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185FV	23831758	Green Accepted			2022-12-27	WOS:000321952700012
J	Gates, KS				Gates, Kent S.			STRUCTURAL BIOLOGY FaPy lesions and DNA mutations	NATURE CHEMICAL BIOLOGY			English	News Item							DUPLEX; DG		[Gates, Kent S.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Gates, Kent S.] Univ Missouri, Dept Biochem, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Gates, KS (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	gatesk@missouri.edu						Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; BROWN T, 1986, P NATL ACAD SCI USA, V83, P2402, DOI 10.1073/pnas.83.8.2402; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Gehrke TH, 2013, NAT CHEM BIOL, V9, P455, DOI [10.1038/NCHEMBIO.1254, 10.1038/nchembio.1254]; Greenberg MM, 2012, ACCOUNTS CHEM RES, V45, P588, DOI 10.1021/ar2002182; Greenberg MM, 2001, BIOCHEMISTRY-US, V40, P15856, DOI 10.1021/bi011490q; Kalam MA, 2006, NUCLEIC ACIDS RES, V34, P2305, DOI 10.1093/nar/gkl099; Lukin M, 2012, CHEM RES TOXICOL, V25, P2423, DOI 10.1021/tx300290b; PATEL DJ, 1984, BIOCHEMISTRY-US, V23, P3207, DOI 10.1021/bi00309a015; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004	10	7	7	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					412	414		10.1038/nchembio.1274	http://dx.doi.org/10.1038/nchembio.1274			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23774871				2022-12-27	WOS:000320449700003
J	Lee, J; Wu, J; Deng, YY; Wang, J; Wang, C; Wang, JH; Chang, CQ; Dong, YH; Williams, P; Zhang, LH				Lee, Jasmine; Wu, Jien; Deng, Yinyue; Wang, Jing; Wang, Chao; Wang, Jianhe; Chang, Changqing; Dong, Yihu; Williams, Paul; Zhang, Lian-Hui			A cell-cell communication signal integrates quorum sensing and stress response	NATURE CHEMICAL BIOLOGY			English	Article							PSEUDOMONAS-AERUGINOSA; CAENORHABDITIS-ELEGANS; QUINOLONE SIGNAL; EXPRESSION; REGULATOR; PHOSPHATE; HIERARCHY; VIRULENCE; MUTANTS; SYSTEM	Pseudomonas aeruginosa uses a hierarchical quorum sensing (QS) network consisting of las, pqs and rhl regulatory elements to coordinate the expression of bacterial virulence genes. However, clinical isolates frequently contain loss-of-function mutations in the central las system. This motivated us to search for a mechanism that may functionally substitute las. Here we report identification of a new QS signal, IQS. Disruption of IQS biosynthesis paralyzes the pqs and rhl QS systems and attenuates bacterial virulence. Production of IQS is tightly controlled by las under normal culture conditions but is also activated by phosphate limitation, a common stressor that bacteria encounter during infections. Thus, these results have established an integrated QS system that connects the central las system and phosphate-stress response mechanism to the downstream pqs and rhl regulatory systems. Our discovery highlights the complexity of QS signaling systems and extends the gamut of QS and stress-response mechanisms.	[Lee, Jasmine; Wu, Jien; Deng, Yinyue; Wang, Jing; Wang, Chao; Wang, Jianhe; Chang, Changqing; Dong, Yihu; Zhang, Lian-Hui] Proteos, Inst Mol & Cell Biol, Singapore, Singapore; [Williams, Paul] Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Zhang, Lian-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Nottingham; National University of Singapore	Lee, J (corresponding author), Proteos, Inst Mol & Cell Biol, Singapore, Singapore.	lianhui@imcb.a-star.edu.sg		Williams, Paul/0000-0002-1920-5036	Biomedical Research Council, Agency of Science, Technology and Research (A<SUP>*</SUP>Star), Singapore; BBSRC [BB/F014392/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F014392/1] Funding Source: researchfish	Biomedical Research Council, Agency of Science, Technology and Research (A<SUP>*</SUP>Star), Singapore; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biomedical Research Council, Agency of Science, Technology and Research (A<SUP>*</SUP>Star), Singapore.	de Kievit TR, 2002, FEMS MICROBIOL LETT, V212, P101, DOI 10.1016/S0378-1097(02)00735-8; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Dong YH, 2005, MOL MICROBIOL, V58, P552, DOI 10.1111/j.1365-2958.2005.04851.x; Dong Yi-Hu, 2008, Commun Integr Biol, V1, P88; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gilbert KB, 2009, MOL MICROBIOL, V73, P1072, DOI 10.1111/j.1365-2958.2009.06832.x; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Houthoofd K, 2004, J GERONTOL A-BIOL, V59, P408; Jeddi R, 2011, HEMATOLOGY, V16, P160, DOI 10.1179/102453311X12953015767293; Jensen V, 2006, J BACTERIOL, V188, P8601, DOI 10.1128/JB.01378-06; Karatuna O, 2010, CLIN MICROBIOL INFEC, V16, P1770, DOI 10.1111/j.1469-0691.2010.03177.x; Lee X, 2010, J BACTERIOL, V192, P4251, DOI 10.1128/JB.00492-10; Long J, 2008, SURGERY, V144, P189, DOI 10.1016/j.surg.2008.03.045; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Miller J.H., 1992, SHORT COURSE BACTERI, P150; NICAS TI, 1984, INFECT IMMUN, V45, P470, DOI 10.1128/IAI.45.2.470-474.1984; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Shor R, 2006, ANN CLIN LAB SCI, V36, P67; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stiernagle T, 1999, C ELEGANS PRACTICAL, P1; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tingpej P, 2007, J CLIN MICROBIOL, V45, P1697, DOI 10.1128/JCM.02364-06; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Wang L.H., 2007, CURR PROTOC MICROBIO, V5; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Winstanley C, 2009, FEMS MICROBIOL LETT, V290, P1, DOI 10.1111/j.1574-6968.2008.01394.x; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106	35	255	275	2	227	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2013	9	5					339	+		10.1038/NCHEMBIO.1225	http://dx.doi.org/10.1038/NCHEMBIO.1225			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	127VT	23542643				2022-12-27	WOS:000317727600012
J	Ebrahimi, KH; Bill, E; Hagedoorn, PL; Hagen, WR				Ebrahimi, Kourosh Honarmand; Bill, Eckhard; Hagedoorn, Peter-Leon; Hagen, Wilfred R.			The catalytic center of ferritin regulates iron storage via Fe(II)-Fe(III) displacement	NATURE CHEMICAL BIOLOGY			English	Article							H-CHAIN FERRITIN; ANAEROBE PYROCOCCUS-FURIOSUS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; REDUCTION POTENTIALS; FERROXIDASE CENTER; CORE FORMATION; TRANSIT SITE; BACTERIOFERRITIN	A conserved iron-binding site, the ferroxidase center, regulates the vital iron storage role of the ubiquitous protein ferritin in iron metabolism. It is commonly thought that two Fe(II) simultaneously bind the ferroxidase center and that the oxidized Fe(III)-O(H)-Fe(III) product spontaneously enters the cavity of ferritin as a unit. In contrast, in some bacterioferritins and in archaeal ferritins a persistent di-iron prosthetic group in this center is believed to mediate catalysis of core formation. Using a combination of binding experiments and isotopically labeled Fe-57(II), we studied two systems in comparison: the ferritin from the hyperthermophilic archaeal anaerobe Pyrococcus furiosus (PfFtn) and the eukaryotic human H ferritin (HuHF). The results do not support either of the two paradigmatic models; instead they suggest a unifying mechanism in which the Fe(III)-O-Fe(III) unit resides in the ferroxidase center until it is sequentially displaced by Fe(II).	[Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands; [Bill, Eckhard] Max Planck Inst Bioanorgan Chem, Mulheim, Germany	Delft University of Technology; Max Planck Society	Ebrahimi, KH (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	w.r.hagen@tudelft.nl	Ebrahimi, Kourosh Honarmand/X-4579-2019; Hagedoorn, Peter-Leon/C-8535-2014; Hagen, Wilfred R./H-8918-2017	Ebrahimi, Kourosh Honarmand/0000-0001-6628-944X; Hagedoorn, Peter-Leon/0000-0001-6342-2022; Hagen, Wilfred R./0000-0002-1609-6671	Dutch National Research School Combination-Catalysis	Dutch National Research School Combination-Catalysis	The construct for production of recombinant HuHF was kindly provided by P. Arosio (University of Brescia). We thank L. van der Weel for assistance with expression of ferritin, M.J.F. Strampraad for technical assistance, D. Sordi for her assistance with the E129R mutation, M. M. Kabir for assistance with kinetic measurements and B. Mienert for Mossbauer measurements. This work was financially supported by a research grant from the Dutch National Research School Combination-Catalysis Controlled by Chemical Design (NRSC-C).	Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Bauminger ER, 1999, BIOCHEMISTRY-US, V38, P7791, DOI 10.1021/bi990377l; BAUMINGER ER, 1993, BIOCHEM J, V296, P709, DOI 10.1042/bj2960709; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; Bou-Abdallah F, 2005, J AM CHEM SOC, V127, P3885, DOI 10.1021/ja044355k; Bou-Abdallah F, 2002, BIOCHEM J, V364, P57, DOI 10.1042/bj3640057; CHASTEEN ND, 1985, J BIOL CHEM, V260, P2926; CHEESMAN MR, 1990, NATURE, V346, P771, DOI 10.1038/346771a0; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hagen W. R., 2009, BIOMOLECULAR EPR SPE; Hagen WR, 2006, DALTON T, P4415, DOI 10.1039/b608163k; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; LEVI S, 1989, BIOCHEMISTRY-US, V28, P5179, DOI 10.1021/bi00438a040; LEVI S, 1988, J BIOL CHEM, V263, P18086; MANN S, 1987, J MOL BIOL, V198, P405, DOI 10.1016/0022-2836(87)90290-7; Masuda T, 2010, BIOCHEM BIOPH RES CO, V400, P94, DOI 10.1016/j.bbrc.2010.08.017; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Mathevon C, 2007, P NATL ACAD SCI USA, V104, P13295, DOI 10.1073/pnas.0704338104; PAULSEN KE, 1994, BIOCHEMISTRY-US, V33, P713, DOI 10.1021/bi00169a013; Pereira AS, 1998, BIOCHEMISTRY-US, V37, P9871, DOI 10.1021/bi980847w; Rucker P, 1996, J BIOL CHEM, V271, P33352, DOI 10.1074/jbc.271.52.33352; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; STPIERRE TG, 1986, BIOCHIM BIOPHYS ACTA, V870, P127, DOI 10.1016/0167-4838(86)90015-4; Tatur J, 2006, EXTREMOPHILES, V10, P139, DOI 10.1007/s00792-005-0484-x; Tatur J, 2005, FEBS LETT, V579, P4729, DOI 10.1016/j.febslet.2005.07.045; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; TREFFRY A, 1992, FEBS LETT, V302, P108, DOI 10.1016/0014-5793(92)80417-F; TREFFRY A, 1987, J INORG BIOCHEM, V31, P1, DOI 10.1016/0162-0134(87)85001-8; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; Weeratunga SK, 2010, BIOCHEMISTRY-US, V49, P1160, DOI 10.1021/bi9015204; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119	43	95	98	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					941	948		10.1038/NCHEMBIO.1071	http://dx.doi.org/10.1038/NCHEMBIO.1071			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23001032				2022-12-27	WOS:000310052100014
J	Ersoy, BA; Pardo, L; Zhang, SM; Thompson, DA; Millhauser, G; Govaerts, C; Vaisse, C				Ersoy, Baran A.; Pardo, Leonardo; Zhang, Sumei; Thompson, Darren A.; Millhauser, Glenn; Govaerts, Cedric; Vaisse, Christian			Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; AGOUTI-RELATED PROTEIN; CONSTITUTIVE ACTIVITY; INVERSE AGONISM; DRUG DISCOVERY; IN-VITRO; ACTIVATION; MUTATIONS; BINDING; OBESITY	Most of our understanding of G protein-coupled receptor (GPCR) activation has been focused on the direct interaction between diffusible ligands and their seven-transmembrane domains. However, a number of these receptors depend on their extracellular N-terminal domain for ligand recognition and activation. To dissect the molecular interactions underlying both modes of activation at a single receptor, we used the unique properties of the melanocortin-4 receptor (MC4R), a GPCR that shows constitutive activity maintained by its N-terminal domain and is physiologically activated by the peptide alpha-melanocyte stimulating hormone (alpha MSH). We find that activation by the N-terminal domain and alpha MSH relies on different key residues in the transmembrane region. We also demonstrate that agouti-related protein, a physiological antagonist of MC4R, acts as an inverse agonist by inhibiting N terminus-mediated activation, leading to the speculation that a number of constitutively active orphan GPCRs could have physiological inverse agonists as sole regulators.	[Ersoy, Baran A.; Zhang, Sumei; Vaisse, Christian] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ersoy, Baran A.; Zhang, Sumei; Vaisse, Christian] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Pardo, Leonardo] Univ Autonoma Barcelona, Lab Med Computac, Unitat Bioestadist, E-08193 Barcelona, Spain; [Thompson, Darren A.; Millhauser, Glenn] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Govaerts, Cedric] Univ Libre Bruxelles, Brussels, Belgium	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Autonomous University of Barcelona; University of California System; University of California Santa Cruz; Universite Libre de Bruxelles	Vaisse, C (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	vaisse@medicine.ucsf.edu	Ersoy, Baran/F-8192-2012; Vaisse, Christian/F-1067-2011	Pardo, Leonardo/0000-0003-1778-7420; Thompson, Darren/0000-0002-3725-7112	US National Institutes of Health (NIH) [DK60540]; American Heart Association; NIH [DK064265]; NIH National Research Service; Spanish Ministry of Science and Innovation Award [SAF2010-22198-C02-02]; Fonds National de la Recherche Scientifique; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060540, R01DK064265] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation Award; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health (NIH) grant DK60540 and an American Heart Association Established Investigator Award to C. V., NIH DK064265 to G. M., an American Heart Association Predoctoral Fellowship and NIH National Research Service Award Endocrinology Training Grant to B. A. E. and a Spanish Ministry of Science and Innovation Award (SAF2010-22198-C02-02) to L. P. C. G. is funded as a Chercheur Qualifie by the Fonds National de la Recherche Scientifique. We would like to thank H. Bourne, B. Conklin and G. Vassart for reviewing the initial version of the manuscript and providing insightful comments.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Behan D P, 2001, Curr Opin Drug Discov Devel, V4, P548; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Bromberg Y, 2009, FASEB J, V23, P3059, DOI 10.1096/fj.08-127530; Calton MA, 2009, HUM MOL GENET, V18, P1140, DOI 10.1093/hmg/ddn431; Chai BX, 2003, PEPTIDES, V24, P603, DOI 10.1016/S0196-9781(03)00104-9; Chen G, 2000, MOL PHARMACOL, V57, P125; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Haskell-Luevano C, 2001, BIOCHEMISTRY-US, V40, P6164, DOI 10.1021/bi010025q; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; Kenakin T, 2004, MOL PHARMACOL, V65, P2, DOI 10.1124/mol.65.1.2; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lubrano-Berthelier C, 2006, J CLIN ENDOCR METAB, V91, P1811, DOI 10.1210/jc.2005-1411; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Patel MP, 2010, J MOL BIOL, V404, P45, DOI 10.1016/j.jmb.2010.08.054; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Peter JC, 2007, AM J PHYSIOL-REG I, V292, pR2151, DOI 10.1152/ajpregu.00878.2006; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Toyooka M, 2009, J NEUROSCI RES, V87, P1329, DOI 10.1002/jnr.21955; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	40	42	42	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					725	730		10.1038/NCHEMBIO.1008	http://dx.doi.org/10.1038/NCHEMBIO.1008			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22729149	Green Accepted			2022-12-27	WOS:000306527600012
J	Sauliere, A; Bellot, M; Paris, H; Denis, C; Finana, F; Hansen, JT; Altie, MF; Seguelas, MH; Pathak, A; Hansen, JL; Senard, JM; Gales, C				Sauliere, Aude; Bellot, Morgane; Paris, Herve; Denis, Colette; Finana, Frederic; Hansen, Jonas T.; Altie, Marie-Francoise; Seguelas, Marie-Helene; Pathak, Atul; Hansen, Jakob L.; Senard, Jean-Michel; Gales, Celine			Deciphering biased-agonism complexity reveals a new active AT(1) receptor entity	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; CONFORMATIONAL-CHANGES; BETA-ARRESTIN; FUNCTIONAL SELECTIVITY; SIGNALING COMPLEXES; ADENYLYL-CYCLASE; ACTIVATION; PATHWAYS; BETA-ARRESTIN-2; INCREASES	Functional selectivity of G protein-coupled receptor (GPCR) ligands toward different downstream signals has recently emerged as a general hallmark of this receptor class. However, pleiotropic and crosstalk signaling of GPCRs makes functional selectivity difficult to decode. To look from the initial active receptor point of view, we developed new, highly sensitive and direct bioluminescence resonance energy transfer-based G protein activation probes specific for all G protein isoforms, and we used them to evaluate the G protein-coupling activity of [(1)Sar(4)Ile(8)Ile]-angiotensin II (SII), previously described as an angiotensin II type 1 (AT(1)) receptor-biased agonist that is G protein independent but beta-arrestin selective. By multiplexing assays sensing sequential signaling events, from receptor conformations to downstream signaling, we decoded SII as an agonist stabilizing a G protein-dependent AT(1A) receptor signaling module different from that of the physiological agonist angiotensin II, both in recombinant and primary cells. Thus, a biased agonist does not necessarily select effects from the physiological agonist but may instead stabilize and create a new distinct active pharmacological receptor entity.	[Sauliere, Aude; Bellot, Morgane; Paris, Herve; Denis, Colette; Altie, Marie-Francoise; Seguelas, Marie-Helene; Pathak, Atul; Senard, Jean-Michel; Gales, Celine] Univ Toulouse III Paul Sabatier, Inst Natl Sante & Rech Med, Inst Maladies Metabol & Cardiovasc, Toulouse, France; [Finana, Frederic] Pierre Fabre Res Inst, Dept Cellular & Mol Biol, Castres, France; [Hansen, Jonas T.] Univ Copenhagen, Dept Diabet NBEs & Obes Biol, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Mol Cardiol Lab, Copenhagen, Denmark; [Pathak, Atul; Senard, Jean-Michel] Ctr Hosp Univ Toulouse, Dept Pharmacol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Danmarks Grundforskningsfond; University of Copenhagen; CHU de Toulouse	Gales, C (corresponding author), Univ Toulouse III Paul Sabatier, Inst Natl Sante & Rech Med, Inst Maladies Metabol & Cardiovasc, Toulouse, France.	celine.gales@inserm.fr	Denis, Colette/K-1571-2019; Pathak, Atul/ABC-5223-2020; Denis, Colette/U-5267-2017	Denis, Colette/0000-0002-8376-8351; Pathak, Atul/0000-0001-6151-0096; Senard, Jean-Michel/0000-0001-7679-1281; GALES, Celine/0000-0002-4938-1583	French National Research Agency [ANR-06-BLAN-0400-02]; Danish National Research Foundation; Danish Council for Independent Research Medical Sciences; Novo Nordisk Foundation	French National Research Agency(French National Research Agency (ANR)); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This paper is dedicated to the memory of Dr. Herve Paris, who passed away suddenly during the process of this work. We thank T. Hebert, J. Javitch and M. Lohse for their critical reading of the manuscript and R. D'Angelo for excellent technical support and advice regarding imaging (Cellular Imaging Facility I2MC, TRI Platform). Wild-type, beta-arrestin 1 knockout, and beta-arrestin 1 and 2 double-knockout MEF cells were generously provided by R. Lefkowitz (Duke University Medical Center). This work was supported by a grant from the French National Research Agency (ANR-06-BLAN-0400-02 to C. G.) J. L. H. is sponsored by the Danish National Research Foundation, the Danish Council for Independent Research Medical Sciences and the Novo Nordisk Foundation.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P289, DOI 10.1111/j.1742-7843.2007.00063.x; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; BAUKAL AJ, 1994, J BIOL CHEM, V269, P24546; Blanpain C, 1999, BLOOD, V94, P1899; Breton B, 2010, FASEB J, V24, P4733, DOI 10.1096/fj.10-164061; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; BURGEN ASV, 1981, FED PROC, V40, P2723; Christensen GL, 2011, MOL CELL ENDOCRINOL, V331, P49, DOI 10.1016/j.mce.2010.08.004; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Denis C, 2012, CURR PHARM DESIGN, V18, P128, DOI 10.2174/138161212799040466; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hansen JL, 2008, EUR J PHARMACOL, V590, P255, DOI 10.1016/j.ejphar.2008.05.010; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Leifert WR, 2005, J BIOMOL SCREEN, V10, P765, DOI 10.1177/1087057105280517; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; MacrezLepretre N, 1997, J BIOL CHEM, V272, P10095; Mervine SM, 2006, MOL PHARMACOL, V70, P194, DOI 10.1124/mol.106.022616; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; Ostrom RS, 2003, J BIOL CHEM, V278, P24461, DOI 10.1074/jbc.M212659200; PEPPERL DJ, 1993, MOL PHARMACOL, V44, P802; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Reversi A, 2005, J BIOL CHEM, V280, P16311, DOI 10.1074/jbc.M409945200; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; WONG SKF, 1990, J BIOL CHEM, V265, P6219; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	49	148	151	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					622	630		10.1038/NCHEMBIO.961	http://dx.doi.org/10.1038/NCHEMBIO.961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22634635				2022-12-27	WOS:000305471400009
J	Lehwess-Litzmann, A; Neumann, P; Parthier, C; Ludtke, S; Golbik, R; Ficner, R; Tittmann, K				Lehwess-Litzmann, Anja; Neumann, Piotr; Parthier, Christoph; Luedtke, Stefan; Golbik, Ralph; Ficner, Ralf; Tittmann, Kai			Twisted Schiff base intermediates and substrate locale revise transaldolase mechanism	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-SITE; FRUCTOSE-6-PHOSPHATE ALDOLASE; INDUCED FIT; CATALYSIS; COMPLEX; TRANSKETOLASE; 6-PHOSPHATE; ERYTHROSE	We examined the catalytic cycle of transaldolase (TAL) from Thermoplasma acidophilum by cryocrystallography and were able to structurally characterize-for the first time, to our knowledge-different genuine TAL reaction intermediates. These include the Schiff base adducts formed between the catalytic lysine and the donor ketose substrates fructose-6-phosphate and sedoheptulose-7-phosphate as well as the Michaelis complex with acceptor aldose erythrose-4-phosphate. These structural snapshots necessitate a revision of the accepted reaction mechanism with respect to functional roles of active site residues, and they further reveal fundamental insights into the general structural features of enzymatic Schiff base intermediates and the role of conformational dynamics in enzyme catalysis, substrate binding and discrimination. A nonplanar arrangement of the substituents around the Schiff base double bond was observed, suggesting that a structurally encoded reactant-state destabilization is a driving force of catalysis. Protein dynamics and the intrinsic hydrogen-bonding pattern appear to be crucial for selective recognition and binding of ketose as first substrate.	[Lehwess-Litzmann, Anja; Luedtke, Stefan; Tittmann, Kai] Univ Gottingen, Albrecht von Haller Inst, Gottingen, Germany; [Lehwess-Litzmann, Anja; Luedtke, Stefan; Tittmann, Kai] Univ Gottingen, Gottingen Ctr Mol Biosci, Gottingen, Germany; [Neumann, Piotr] Univ Gottingen, Inst Microbiol & Genet, Gottingen, Germany; [Parthier, Christoph; Golbik, Ralph] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany	University of Gottingen; University of Gottingen; University of Gottingen; Martin Luther University Halle Wittenberg	Tittmann, K (corresponding author), Univ Gottingen, Albrecht von Haller Inst, Gottingen, Germany.	ktittma@gwdg.de			Friedrich-Naumann-Stiftung; Fonds der Chemischen Industrie; Gottingen Graduate School for Neurosciences and Molecular Biosciences; Deutsche Forschungsgemeinschaft	Friedrich-Naumann-Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Gottingen Graduate School for Neurosciences and Molecular Biosciences; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We gratefully acknowledge access to synchrotron radiation beamtime at the Berliner Elektronenspeicherring-Gesellschaft fur Synchrotronstrahlung (BESSY). This work was supported by the Friedrich-Naumann-Stiftung (stipend to A. L.-L.), the Fonds der Chemischen Industrie (stipend to S. L.), and the Gottingen Graduate School for Neurosciences and Molecular Biosciences funded by the Deutsche Forschungsgemeinschaft (to K.T.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALBERY WJ, 1977, ANGEW CHEM INT EDIT, V16, P285, DOI 10.1002/anie.197702851; ANGYAL SJ, 1972, CARBOHYD RES, V23, P121, DOI 10.1016/S0008-6215(00)81583-9; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Asztalos P, 2007, BIOCHEMISTRY-US, V46, P12037, DOI 10.1021/bi700844m; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BLACKMORE PF, 1976, FEBS LETT, V64, P222, DOI 10.1016/0014-5793(76)80288-8; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charmantray F, 2009, J MOL CATAL B-ENZYM, V57, P6, DOI 10.1016/j.molcatb.2008.06.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Horecker BL, 2002, J BIOL CHEM, V277, P47965, DOI 10.1074/jbc.X200007200; Jia J, 1996, STRUCTURE, V4, P715, DOI 10.1016/S0969-2126(96)00077-9; Jia J, 1997, PROTEIN SCI, V6, P119; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kluger R, 2008, CHEM REV, V108, P1797, DOI 10.1021/cr068444m; Lehwess-Litzmann A, 2011, ACTA CRYSTALLOGR F, V67, P584, DOI 10.1107/S1744309111009274; LowKam C, 2010, J BIOL CHEM, V285, P21143, DOI 10.1074/jbc.M109.080358; Mitschke L, 2010, J BIOL CHEM, V285, P31559, DOI 10.1074/jbc.M110.149955; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Samland AK, 2009, INT J BIOCHEM CELL B, V41, P1482, DOI 10.1016/j.biocel.2009.02.001; Schneider S, 2008, J BIOL CHEM, V283, P30064, DOI 10.1074/jbc.M803184200; Schneider S, 2010, CHEMBIOCHEM, V11, P681, DOI 10.1002/cbic.200900720; Schorken U, 2001, EUR J BIOCHEM, V268, P2408, DOI 10.1046/j.1432-1327.2001.02128.x; SERIANNI AS, 1979, CARBOHYD RES, V72, P79, DOI 10.1016/S0008-6215(00)83925-7; SPECK JC, 1963, J AM CHEM SOC, V85, P1012, DOI 10.1021/ja00890a048; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; Thorell S, 2000, FEBS LETT, V475, P205, DOI 10.1016/S0014-5793(00)01658-6; Thorell S, 2002, J MOL BIOL, V319, P161, DOI 10.1016/S0022-2836(02)00258-9; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684	31	50	50	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					678	684		10.1038/NCHEMBIO.633	http://dx.doi.org/10.1038/NCHEMBIO.633			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21857661				2022-12-27	WOS:000295027100011
J	Qin, K; Dong, CM; Wu, GY; Lambert, NA				Qin, Kou; Dong, Chunmin; Wu, Guangyu; Lambert, Nevin A.			Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; PLASMA-MEMBRANE LOCALIZATION; RESONANCE ENERGY-TRANSFER; BETA-ADRENERGIC-RECEPTOR; 4TH CYTOPLASMIC LOOP; LIVING CELLS; STRUCTURAL BASIS; MUSCARINIC RECEPTOR; ADENYLATE-CYCLASE; ACTIVATION	G protein-coupled receptors (GPCRs) transmit signals by forming active-state complexes with heterotrimeric G proteins. It has been suggested that some GPCRs also assemble with G proteins before ligand-induced activation and that inactive-state preassembly facilitates rapid and specific G protein activation. However, no mechanism of preassembly has been described, and no functional consequences of preassembly have been demonstrated. Here we show that M-3 muscarinic acetylcholine receptors (M3R) form inactive-state complexes with G(q) heterotrimers in intact cells. The M3R C terminus is sufficient, and a six-amino-acid polybasic sequence distal to helix 8 ((KKKRRK570)-K-565) is necessary for preassembly with G(q). Replacing this sequence with six alanine residues prevents preassembly, slows the rate of G(q) activation and decreases steady-state agonist sensitivity. That other G(q)-coupled receptors possess similar polybasic regions and also preassemble with G(q) suggests that these GPCRs may use a common preassembly mechanism to facilitate activation of G(q) heterotrimers.	[Qin, Kou; Dong, Chunmin; Wu, Guangyu; Lambert, Nevin A.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	University System of Georgia; Augusta University	Lambert, NA (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA.	nlambert@georgiahealth.edu			US National Institutes of Health [GM076167, GM096762, GM078319]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096762, R01GM076167, R01GM078319] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Digby and S. Kuravi for invaluable assistance. This work was supported by US National Institutes of Health grants GM076167 (G. W.), GM096762 and GM078319 (N.A.L.).	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; Crouthamel M, 2008, CELL SIGNAL, V20, P1900, DOI 10.1016/j.cellsig.2008.06.019; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kuravi S, 2010, BIOPHYS J, V98, P2391, DOI 10.1016/j.bpj.2010.02.004; Lohse MJ, 2007, ADV PROTEIN CHEM, V74, P167, DOI 10.1016/S0065-3233(07)74005-6; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; Pedone KH, 2007, J BIOL CHEM, V282, P25199, DOI 10.1074/jbc.M610297200; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Rasmussen S.G., 2011, NATURE; Rebois RV, 2003, RECEPTOR CHANNEL, V9, P169, DOI 10.1080/10606820308243; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; Torrecilla I, 2006, CURR PHARM DESIGN, V12, P1797, DOI 10.2174/138161206776873716; Wess J, 1997, LIFE SCI, V60, P1007, DOI 10.1016/S0024-3205(97)00041-6; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	38	103	105	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					740	747		10.1038/NCHEMBIO.642	http://dx.doi.org/10.1038/NCHEMBIO.642			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21873996	Green Accepted			2022-12-27	WOS:000295027100018
J	Woods, LA; Platt, GW; Hellewell, AL; Hewitt, EW; Homans, SW; Ashcroft, AE; Radford, SE				Woods, Lucy A.; Platt, Geoffrey W.; Hellewell, Andrew L.; Hewitt, Eric W.; Homans, Steve W.; Ashcroft, Alison E.; Radford, Sheena E.			Ligand binding to distinct states diverts aggregation of an amyloid-forming protein	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-SYNUCLEIN; FIBRIL FORMATION; A-BETA; COMMON MECHANISM; BETA(2)-MICROGLOBULIN; RIFAMPICIN; INHIBITORS; OLIGOMERS; FIBRILLIZATION; POLYPHENOLS	Although small molecules that modulate amyloid formation in vitro have been identified, significant challenges remain in determining precisely how these species act. Here we describe the identification of rifamycin SV as a potent inhibitor of beta(2) microglobulin (beta(2)m) fibrillogenesis when added during the lag time of assembly or early during fibril elongation. Biochemical experiments demonstrate that the small molecule does not act by a colloidal mechanism. Exploiting the ability of electrospray ionization-ion mobility spectrometry-mass spectrometry (ESI-IMS-MS) to resolve intermediates of amyloid assembly, we show instead that rifamycin SV inhibits beta(2)m fibrillation by binding distinct monomeric conformers, disfavoring oligomer formation and diverting the course of assembly to the formation of spherical aggregates. The results demonstrate the power of ESI-IMS-MS to identify specific protein conformers as targets for intervention in fibrillogenesis using small molecules and reveal a mechanism of action in which ligand binding diverts unfolded protein monomers toward alternative assembly pathways.	[Woods, Lucy A.; Platt, Geoffrey W.; Hellewell, Andrew L.; Hewitt, Eric W.; Homans, Steve W.; Ashcroft, Alison E.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Woods, Lucy A.; Platt, Geoffrey W.; Hellewell, Andrew L.; Hewitt, Eric W.; Homans, Steve W.; Ashcroft, Alison E.; Radford, Sheena E.] Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	a.e.ashcroft@leeds.ac.uk; s.e.radford@leeds.ac.uk	Platt, Geoffrey/D-2416-2013	Hewitt, Eric/0000-0002-6238-6303; Platt, Geoffrey/0000-0003-1754-0110; Radford, Sheena/0000-0002-3079-8039; Hellewell, Andrew/0000-0002-7803-2884	Wellcome Trust [075675, 062164]; BBSRC [BB/526502/1]; Biotechnology and Biological Sciences Research Council (Research Equipment Initiative) [BB/E012558/1]; BBSRC [BB/E012558/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012558/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (Research Equipment Initiative)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Kalverda for advice on NMR spectroscopy, D. P. Smith for advice about alpha-synuclein, K. Ainley for technical assistance, C. Glabe for the gift of OC and A11 antibodies and A beta<INF>1-40</INF> oligomers, J. Rushworth for creating fibrillar oligomers of A beta<INF>1-42</INF>, R. Wetzel for the gift of WO1 antibodies and the Radford and Ashcroft groups for helpful discussions and advice. We acknowledge the Wellcome Trust (grant numbers 075675 and 062164) and BBSRC (Grant Number BB/526502/1) for funding. The Synapt HDMS mass spectrometer was purchased with funding from the Biotechnology and Biological Sciences Research Council (Research Equipment Initiative grant BB/E012558/1).	Armstrong AH, 2011, BIOCHEMISTRY-US, V50, P4058, DOI 10.1021/bi200268w; Armstrong DW, 1999, J PHYS CHEM B, V103, P4338, DOI 10.1021/jp990279+; Ashcroft AE, 2010, J AM SOC MASS SPECTR, V21, P1087, DOI 10.1016/j.jasms.2010.02.026; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Borysik AJH, 2004, J BIOL CHEM, V279, P27069, DOI 10.1074/jbc.M401472200; Carazzone C, 2008, ELECTROPHORESIS, V29, P1502, DOI 10.1002/elps.200700677; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee HG, 2004, ANN NY ACAD SCI, V1019, P1, DOI 10.1196/annals.1297.001; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Li J, 2004, CHEM BIOL, V11, P1513, DOI 10.1016/j.chembiol.2004.08.025; Lieu VH, 2007, BIOTECHNOL PROGR, V23, P698, DOI 10.1021/bp060353n; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Regazzoni L, 2010, CHEMMEDCHEM, V5, P1015, DOI 10.1002/cmdc.201000082; Routledge KE, 2009, J MOL BIOL, V389, P776, DOI 10.1016/j.jmb.2009.04.042; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Smith AM, 2006, J MOL BIOL, V364, P9, DOI 10.1016/j.jmb.2006.08.081; Smith DP, 2007, J AM SOC MASS SPECTR, V18, P2180, DOI 10.1016/j.jasms.2007.09.017; Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107; Smith DP, 2009, EUR J MASS SPECTROM, V15, P113, DOI 10.1255/ejms.947; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tomiyama T, 1997, BIOCHEM J, V322, P859, DOI 10.1042/bj3220859; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	50	81	82	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					730	739		10.1038/NCHEMBIO.635	http://dx.doi.org/10.1038/NCHEMBIO.635			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21873994	Green Accepted			2022-12-27	WOS:000295027100017
J	Yu, J; Wei, W; Danner, E; Ashley, RK; Israelachvili, JN; Waite, JH				Yu, Jing; Wei, Wei; Danner, Eric; Ashley, Rebekah K.; Israelachvili, Jacob N.; Waite, J. Herbert			Mussel protein adhesion depends on interprotein thiol-mediated redox modulation	NATURE CHEMICAL BIOLOGY			English	Article							MYTILUS-CALIFORNIANUS; ATTACHMENT PLAQUE; FOOT PROTEINS; BYSSUS; FILMS; DOPA	Mussel adhesion is mediated by foot proteins (mfps) rich in a catecholic amino acid, 3,4-dihydroxyphenylalanine (dopa), capable of forming strong bidentate interactions with a variety of surfaces. A tendency toward facile auto-oxidation, however, often renders dopa unreliable for adhesion. We demonstrate that mussels limit dopa oxidation during adhesive plaque formation by imposing an acidic, reducing regime based on the thiol-rich mfp-6, which restores dopa by coupling the oxidation of thiols to dopaquinone reduction.	[Yu, Jing; Israelachvili, Jacob N.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Wei, Wei] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; [Danner, Eric; Ashley, Rebekah K.; Waite, J. Herbert] Univ Calif Santa Barbara, Dept Mol Cell & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Yu, J (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	jacob@engineering.ucsb.edu; waite@lifesci.ucsb.edu	Yu, Jing/C-4138-2017; Yu, Jing/D-3625-2013	Yu, Jing/0000-0002-4288-951X; Danner, Eric/0000-0003-4630-1100; , Eric/0000-0003-3277-5727	US National Institutes of Health [R01 DE018468]; National Science Foundation Materials Science & Engineering Research Center [DM R05-20415]; Human Frontiers of Science Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Materials Science & Engineering Research Center; Human Frontiers of Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the US National Institutes of Health (R01 DE018468), the National Science Foundation Materials Science & Engineering Research Center Program (DM R05-20415) and the Human Frontiers of Science Program for supporting this research. C. Thorpe provided helpful insights about thiol chemistry. S. Nicklisch and P. Schmitt introduced us to the DPPH assay.	Anderson TH, 2010, ADV FUNCT MATER, V20, P4196, DOI 10.1002/adfm.201000932; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; FREUND J, 1995, J BIOMOL NMR, V5, P321, DOI 10.1007/BF00211760; HUNSAKER DB, 1983, TALANTA, V30, P475, DOI 10.1016/0039-9140(83)80113-1; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; Inaba K, 2010, GENES CELLS, V15, P935, DOI 10.1111/j.1365-2443.2010.01434.x; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Jensen KS, 2009, ANTIOXID REDOX SIGN, V11, P1047, DOI 10.1089/ARS.2008.2297; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Liu B, 2007, J AM CHEM SOC, V129, P12348, DOI 10.1021/ja072904r; McDowell LM, 1999, J BIOL CHEM, V274, P20293, DOI 10.1074/jbc.274.29.20293; Ohkawa K, 2009, J ADHESION, V85, P770, DOI 10.1080/00218460903291353; PROUDFOOT GM, 1983, AUST J CHEM, V36, P885, DOI 10.1071/CH9830885; RZEPECKI LM, 1991, ARCH BIOCHEM BIOPHYS, V285, P17, DOI 10.1016/0003-9861(91)90323-B; Sagert J, 2009, J EXP BIOL, V212, P2224, DOI 10.1242/jeb.029686; Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x; Stewart RJ, 2011, APPL MICROBIOL BIOT, V89, P27, DOI 10.1007/s00253-010-2913-8; TAMARIN A, 1976, J MORPHOL, V149, P199, DOI 10.1002/jmor.1051490205; WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0; Yu J, 2011, ADV MATER, V23, P2362, DOI 10.1002/adma.201003580; Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107; Zhao H, 2006, J BIOL CHEM, V281, P11090, DOI 10.1074/jbc.M510792200; Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200	24	318	328	7	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					588	590		10.1038/NCHEMBIO.630	http://dx.doi.org/10.1038/NCHEMBIO.630			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21804534	Green Accepted, Green Submitted			2022-12-27	WOS:000294381400007
J	[Anonymous]				[Anonymous]			Assembling the pieces	NATURE CHEMICAL BIOLOGY			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					321	321		10.1038/nchembio.593	http://dx.doi.org/10.1038/nchembio.593			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21587247	Bronze			2022-12-27	WOS:000290677900001
J	Mylne, JS; Colgrave, ML; Daly, NL; Chanson, AH; Elliott, AG; McCallum, EJ; Jones, A; Craik, DJ				Mylne, Joshua S.; Colgrave, Michelle L.; Daly, Norelle L.; Chanson, Aurelie H.; Elliott, Alysha G.; McCallum, Emily J.; Jones, Alun; Craik, David J.			Albumins and their processing machinery are hijacked for cyclic peptides in sunflower	NATURE CHEMICAL BIOLOGY			English	Article							SEED STORAGE PROTEINS; TRYPSIN-INHIBITOR; ARABIDOPSIS-THALIANA; PROTEASE INHIBITORS; SERINE-PROTEASE; ENZYME; POTENT; ENDOPEPTIDASE; BIOSYNTHESIS; PROPEPTIDES	The cyclic peptide sunflower trypsin inhibitor 1 (SFTI-1) blocks trypsin and is a promising drug lead and protein engineering scaffold. We show that SFTI-1 and the newfound SFT-L1 are buried within PawS1 and PawS2, precursors for seed storage protein albumins. Proalbumins are matured by asparaginyl endopeptidase, which we show is required to liberate both ends of SFTI-1 as well as to mature PawS1 albumin. Thus, these peptides emerge from within an albumin precursor by the action of albumin's own processing enzyme.	[Mylne, Joshua S.; Daly, Norelle L.; Chanson, Aurelie H.; Elliott, Alysha G.; McCallum, Emily J.; Jones, Alun; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Colgrave, Michelle L.] Commonwealth Sci & Ind Res Org Livestock Ind, Brisbane, Qld, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mylne, JS (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	j.mylne@imb.uq.edu.au; d.craik@imb.uq.edu.au	Elliott, Alysha/K-2733-2015; Mylne, Joshua S/A-5581-2009; Colgrave, Michelle/A-5710-2012; Daly, Norelle L/D-4302-2013; Mylne, Josh/GMX-4544-2022; Craik, David/B-1695-2010	Elliott, Alysha/0000-0002-2983-0484; Mylne, Joshua S/0000-0003-4957-6388; Colgrave, Michelle/0000-0001-8463-805X; Daly, Norelle L/0000-0002-4697-6602; Mylne, Josh/0000-0003-4957-6388; Craik, David/0000-0003-0007-6796; Benfield, Aurelie/0000-0002-3068-906X; McCallum, Emily/0000-0001-8783-4873	United States Department of Agriculture Initiative for Future Agriculture and Food Systems; National Science Foundation	United States Department of Agriculture Initiative for Future Agriculture and Food Systems(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	The authors thank staff at the Arizona Genomics Institute (University of Arizona) for providing Helianthus cDNA clones, the Compositae Genome Project website (http://cgpdb.ucdavis.edu/) that was supported by the United States Department of Agriculture Initiative for Future Agriculture and Food Systems program and National Science Foundation Plant Genome Program for EST data, S. Dillon (Australian Plant Genetic Resource Information Service) for Helianthus seeds, I. Hara-Nishimura (University of Kyoto) for aep null seeds, A. Argyros for technical assistance, H. Schirra (University of Queensland) for providing the structural image used in Supplementary Figure 1 as well as R. Jung, M. Anderson, D. Ortiz-Barrientos and S. Balasubramanian for comments. D.J.C. is a National Health and Medical Research Council Professorial Fellow. J.S.M. is an Australian Research Council Queen Elizabeth II Fellow (DP0879133) and The John S. Mattick Fellow. N.L.D. is a Queensland Smart State Fellow.	Autelitano DJ, 2006, DRUG DISCOV TODAY, V11, P306, DOI 10.1016/j.drudis.2006.02.003; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; DHONDT K, 1993, J BIOL CHEM, V268, P20884; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Hartl M, 2010, PLANT CELL, V22, P4158, DOI 10.1105/tpc.109.073395; Hiraiwa N, 1999, FEBS LETT, V447, P213, DOI 10.1016/S0014-5793(99)00286-0; Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Mulvenna JP, 2005, J BIOL CHEM, V280, P32245, DOI 10.1074/jbc.M506060200; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; PANERO J, 2007, FLOWERING PLANTS EUD, V8, P635; Robinson JA, 2008, ACCOUNTS CHEM RES, V41, P1278, DOI 10.1021/ar700259k; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Shewry PR, 1999, SEED PROTEINS, P883; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008	22	114	119	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					257	259		10.1038/nchembio.542	http://dx.doi.org/10.1038/nchembio.542			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21423169				2022-12-27	WOS:000289617800007
J	Di Paolo, JA; Huang, T; Balazs, M; Barbosa, J; Barck, KH; Bravo, BJ; Carano, RAD; Darrow, J; Davies, DR; DeForge, LE; Diehl, L; Ferrando, R; Gallion, SL; Giannetti, AM; Gribling, P; Hurez, V; Hymowitz, SG; Jones, R; Kropf, JE; Lee, WP; Maciejewski, PM; Mitchell, SA; Rong, H; Staker, BL; Whitney, JA; Yeh, S; Young, WB; Yu, C; Zhang, JA; Reif, K; Currie, KS				Di Paolo, Julie A.; Huang, Tao; Balazs, Mercedesz; Barbosa, James; Barck, Kai H.; Bravo, Brandon J.; Carano, Richard A. D.; Darrow, James; Davies, Douglas R.; DeForge, Laura E.; Diehl, Lauri; Ferrando, Ronald; Gallion, Steven L.; Giannetti, Anthony M.; Gribling, Peter; Hurez, Vincent; Hymowitz, Sarah G.; Jones, Randall; Kropf, Jeffrey E.; Lee, Wyne P.; Maciejewski, Patricia M.; Mitchell, Scott A.; Rong, Hong; Staker, Bart L.; Whitney, J. Andrew; Yeh, Sherry; Young, Wendy B.; Yu, Christine; Zhang, Juan; Reif, Karin; Currie, Kevin S.			Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis	NATURE CHEMICAL BIOLOGY			English	Article							BRUTONS TYROSINE KINASE; COLLAGEN-INDUCED ARTHRITIS; FC-GAMMA RECEPTORS; RHEUMATOID-ARTHRITIS; II COLLAGEN; CITRULLINATED PROTEINS; ACTIVATION; PHOSPHORYLATION; MACROPHAGES; INDUCTION	Bruton's tyrosine kinase (Btk) is a therapeutic target for rheumatoid arthritis, but the cellular and molecular mechanisms by which Btk mediates inflammation are poorly understood. Here we describe the discovery of CGI1746, a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation. CGI1746 has exquisite selectivity for Btk and inhibits both auto- and transphosphorylation steps necessary for enzyme activation. Using CGI1746, we demonstrate that Btk regulates inflammatory arthritis by two distinct mechanisms. CGI1746 blocks B cell receptor-dependent B cell proliferation and in prophylactic regimens reduces autoantibody levels in collagen-induced arthritis. In macrophages, Btk inhibition abolishes Fc gamma RIII-induced TNF alpha, IL-1 beta and IL-6 production. Accordingly, in myeloid- and Fc gamma R-dependent autoantibody-induced arthritis, CGI1746 decreases cytokine levels within joints and ameliorates disease. These results provide new understanding of the function of Btk in both B cell-or myeloid cell-driven disease processes and provide a compelling rationale for targeting Btk in rheumatoid arthritis.	[Huang, Tao; Balazs, Mercedesz; Gribling, Peter; Hurez, Vincent; Lee, Wyne P.; Zhang, Juan; Reif, Karin] Genentech Inc, Dept Immunobiol, San Francisco, CA 94080 USA; [Di Paolo, Julie A.; Jones, Randall; Maciejewski, Patricia M.; Rong, Hong; Whitney, J. Andrew] CGI Pharmaceut, Dept Discovery Biol, Branford, CT USA; [Barck, Kai H.; Carano, Richard A. D.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Bravo, Brandon J.; Giannetti, Anthony M.] Genentech Inc, Dept Biochem Pharmacol, San Francisco, CA 94080 USA; [Darrow, James; Kropf, Jeffrey E.; Mitchell, Scott A.; Currie, Kevin S.] CGI Pharmaceut, Dept Med Chem, Branford, CT USA; [Davies, Douglas R.; Staker, Bart L.] Emerald BioStruct, Bainbridge Isl, WA USA; [DeForge, Laura E.; Yeh, Sherry] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Barbosa, James; Diehl, Lauri; Ferrando, Ronald] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Gallion, Steven L.] Computat Chem CGI Pharmaceut, Branford, CT USA; [Hymowitz, Sarah G.; Yu, Christine] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Young, Wendy B.] Genentech Inc, Dept Med Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Reif, K (corresponding author), Genentech Inc, Dept Immunobiol, San Francisco, CA 94080 USA.	kreif@gene.com; kevin.currie@gilead.com	Jones, Jeffrey A/E-9827-2013; Hurez, Vincent/AAF-6765-2019; Zhang, Juan/GRX-2638-2022; Reif, Karin/AAD-4692-2020	Reif, Karin/0000-0001-5490-8389; Staker, Bart/0000-0001-9570-5086; Hurez, Vincent/0000-0003-0271-4157				Andren M, 2006, SCAND J IMMUNOL, V63, P282, DOI 10.1111/j.1365-3083.2006.01743.x; Boross P, 2006, SPRINGER SEMIN IMMUN, V28, P339, DOI 10.1007/s00281-006-0049-9; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; BRITTELLI DR, 2006, Patent No. 2006099075; Brunner C, 2005, HISTOL HISTOPATHOL, V20, P945, DOI 10.14670/HH-20.945; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Cook AD, 1996, ARTHRITIS RHEUM, V39, P1720, DOI 10.1002/art.1780391015; CURRIE KS, 2008, Patent No. 7393848; Fleischmann RM, 2005, J RHEUMATOL, V32, P29; Goldstein MD, 1996, MOL IMMUNOL, V33, P541, DOI 10.1016/0161-5890(96)00005-3; Hamilton JA, 2009, ARTHRITIS RHEUM-US, V60, P1210, DOI 10.1002/art.24505; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Humphries LA, 2004, J BIOL CHEM, V279, P37651, DOI 10.1074/jbc.M311985200; JANSSON L, 1993, CLIN EXP IMMUNOL, V94, P459, DOI 10.1111/j.1365-2249.1993.tb08218.x; Jongstra-Bilen J, 2008, J IMMUNOL, V181, P288, DOI 10.4049/jimmunol.181.1.288; Kagari T, 2003, J IMMUNOL, V170, P4318, DOI 10.4049/jimmunol.170.8.4318; Kagari T, 2002, J IMMUNOL, V169, P1459, DOI 10.4049/jimmunol.169.3.1459; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Katschke KJ, 2007, J EXP MED, V204, P1319, DOI 10.1084/jem.20070432; Khan WN, 2001, IMMUNOL RES, V23, P147, DOI 10.1385/IR:23:2-3:147; Kim YJ, 2004, MOL CELL BIOL, V24, P9986, DOI 10.1128/MCB.24.22.9986-9999.2004; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; KNOERZER DB, 1995, J CLIN INVEST, V96, P987, DOI 10.1172/JCI118146; Lee SH, 2008, J BIOL CHEM, V283, P11526, DOI 10.1074/jbc.M708935200; Lin L, 2009, BIOCHEMISTRY-US, V48, P2021, DOI 10.1021/bi8019756; Lindvall JM, 2005, IMMUNOL REV, V203, P200, DOI 10.1111/j.0105-2896.2005.00225.x; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; Marcotte DJ, 2010, PROTEIN SCI, V19, P429, DOI 10.1002/pro.321; Marshall AJ, 2000, IMMUNOL REV, V176, P30; Monach PA, 2004, ADV IMMUNOL, V82, P217, DOI 10.1016/S0065-2776(04)82005-4; Mullazehi M, 2006, ARTHRITIS RHEUM-US, V54, P1759, DOI 10.1002/art.21892; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Pan ZY, 2008, DRUG NEWS PERSPECT, V21, P357, DOI 10.1358/dnp.2008.21.7.1255308; Panayi GS, 2005, J RHEUMATOL, V32, P19; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schmidt U, 2004, INT ARCH ALLERGY IMM, V134, P65, DOI 10.1159/000078339; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Solomon S, 2005, EUR J IMMUNOL, V35, P3064, DOI 10.1002/eji.200526167; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Thabet MM, 2009, ANN RHEUM DIS, V68, P1775, DOI 10.1136/ard.2008.099309; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; Vincent C, 2005, AUTOIMMUNITY, V38, P17, DOI 10.1080/08916930400022582; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369	51	258	284	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					41	50		10.1038/NCHEMBIO.481	http://dx.doi.org/10.1038/NCHEMBIO.481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21113169	Bronze			2022-12-27	WOS:000285383400011
J	Sharma, SK; De Los Rios, P; Christen, P; Lustig, A; Goloubinoff, P				Sharma, Sandeep K.; De Los Rios, Paolo; Christen, Philipp; Lustig, Ariel; Goloubinoff, Pierre			The kinetic parameters and energy cost of the Hsp70 chaperone as a polypeptide unfoldase	NATURE CHEMICAL BIOLOGY			English	Article							HEAT-SHOCK PROTEINS; DNAK CHAPERONE; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; SUBSTRATE-SPECIFICITY; MANGANESE IONS; GRPE; MECHANISM; SYSTEM; ATP	Hsp70-Hsp40-NEF and possibly Hsp100 are the only known molecular chaperones that can use the energy of ATP to convert stably pre-aggregated polypeptides into natively refolded proteins. However, the kinetic parameters and ATP costs have remained elusive because refolding reactions have only been successful with a molar excess of chaperones over their polypeptide substrates. Here we describe a stable, misfolded luciferase species that can be efficiently renatured by substoichiometric amounts of bacterial Hsp70-Hsp40-NEF. The reactivation rates increased with substrate concentration and followed saturation kinetics, thus allowing the determination of apparent V(max)' and K(m)' values for a chaperone-mediated renaturation reaction for the first time. Under the in vitro conditions used, one Hsp70 molecule consumed five ATPs to effectively unfold a single misfolded protein into an intermediate that, upon chaperone dissociation, spontaneously refolded to the native state, a process with an ATP cost a thousand times lower than expected for protein degradation and resynthesis.	[Sharma, Sandeep K.; Goloubinoff, Pierre] Univ Lausanne, Dept Biol Mol Vegetale, Lausanne, Switzerland; [De Los Rios, Paolo] Ecole Polytech Fed Lausanne, Sch Basic Sci, Lab Biophys Stat, Lausanne, Switzerland; [Christen, Philipp] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Lustig, Ariel] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Zurich; University of Basel	Sharma, SK (corresponding author), Univ Lausanne, Dept Biol Mol Vegetale, Lausanne, Switzerland.	pierre.goloubinoff@unil.ch	De Los Rios, Paolo/B-2456-2010; Sharma, Sandeep K./F-7420-2010; Sharma, Sandeep K./ABH-2409-2021	De Los Rios, Paolo/0000-0002-5394-5062; Sharma, Sandeep K./0000-0002-0039-7883; Sharma, Sandeep K./0000-0002-0039-7883; Goloubinoff, Pierre/0000-0002-4802-0807	Swiss National Science Foundation [3100A0-109290]; Faculty of Biology and Medicine, University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Biology and Medicine, University of Lausanne	We thank A. S. Spirin (Institute of Protein Research, Russian Academy of Sciences) for the luciferase plasmid, H. J. SchOnfeld (F. Hoffmann-La Roche) for DnaK, DnaJ and GrpE, A. Azem (Tel Aviv University) for discussions and AUC analyses, M. Muriset and R. U. H. Mattoo for discussions and technical assistance, G. Lorimer and J. Buchner for suggesting, respectively, the experiments in Figures 5b and 2b, and A. Finka and S. Priya for discussions and manuscript correction. This research was financed by grant 3100A0-109290 from the Swiss National Science Foundation and in part by the Zwahlen Grant from the Faculty of Biology and Medicine, University of Lausanne.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bischofberger P, 2003, J BIOL CHEM, V278, P19044, DOI 10.1074/jbc.M300922200; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Diamant S, 1998, BIOCHEMISTRY-US, V37, P9688, DOI 10.1021/bi980338u; DIAMANT S, 1995, J BIOL CHEM, V270, P28387; DIAMANT S, 1995, BIOCHEMISTRY-US, V34, P273, DOI 10.1021/bi00001a033; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Feifel B, 1996, EUR J BIOCHEM, V237, P318, DOI 10.1111/j.1432-1033.1996.0318n.x; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; FISHBEIN WN, 1979, PROTEINS LOW TEMPERA, V180, P55; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HELLEBUST H, 1990, J BACTERIOL, V172, P5030, DOI 10.1128/jb.172.9.5030-5034.1990; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hu B, 2006, BIOPHYS J, V91, P496, DOI 10.1529/biophysj.106.083394; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Mally A, 2001, NAT STRUCT BIOL, V8, P254, DOI 10.1038/85002; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Popp S, 2005, J MOL BIOL, V347, P1039, DOI 10.1016/j.jmb.2005.02.026; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; Svetlov MS, 2007, MOL BIOL+, V41, P86, DOI 10.1134/S0026893307010128; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0	48	156	160	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					914	920		10.1038/NCHEMBIO.455	http://dx.doi.org/10.1038/NCHEMBIO.455			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	20953191				2022-12-27	WOS:000284214700021
J	Haines, AS; Dong, X; Song, ZS; Farmer, R; Williams, C; Hothersall, J; Ploskon, E; Wattana-amorn, P; Stephens, ER; Yamada, E; Gurney, R; Takebayashi, Y; Masschelein, J; Cox, RJ; Lavigne, R; Willis, CL; Simpson, TJ; Crosby, J; Winn, PJ; Thomas, CM; Crump, MP				Haines, Anthony S.; Dong, Xu; Song, Zhongshu; Farmer, Rohit; Williams, Christopher; Hothersall, Joanne; Ploskon, Eliza; Wattana-amorn, Pakorn; Stephens, Elton R.; Yamada, Erika; Gurney, Rachel; Takebayashi, Yuiko; Masschelein, Joleen; Cox, Russell J.; Lavigne, Rob; Willis, Christine L.; Simpson, Thomas J.; Crosby, John; Winn, Peter J.; Thomas, Christopher M.; Crump, Matthew P.			A conserved motif flags acyl carrier proteins for beta-branching in polyketide synthesis	NATURE CHEMICAL BIOLOGY			English	Article							GENE-CLUSTER; NATURAL-PRODUCT; NMR-SPECTROSCOPY; CURACIN-A; BIOSYNTHESIS; RECOGNITION; MUPIROCIN; PATHWAY; ACP; INTERFACE	Type I polyketide synthases often use programmed beta-branching, via enzymes of a 'hydroxymethylglutaryl-CoA synthase (HCS) cassette', to incorporate various side chains at the second carbon from the terminal carboxylic acid of growing polyketide backbones. We identified a strong sequence motif in acyl carrier proteins (ACPs) where beta-branching is known to occur. Substituting ACPs confirmed a correlation of ACP type with beta-branching specificity. Although these ACPs often occur in tandem, NMR analysis of tandem beta-branching ACPs indicated no ACP-ACP synergistic effects and revealed that the conserved sequence motif forms an internal core rather than an exposed patch. Modeling and mutagenesis identified ACP helix III as a probable anchor point of the ACP-HCS complex whose position is determined by the core. Mutating the core affects ACP functionality, whereas ACP-HCS interface substitutions modulate system specificity. Our method for predicting beta-carbon branching expands the potential for engineering new polyketides and lays a basis for determining specificity rules.	[Haines, Anthony S.; Farmer, Rohit; Hothersall, Joanne; Stephens, Elton R.; Yamada, Erika; Gurney, Rachel; Takebayashi, Yuiko; Winn, Peter J.; Thomas, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Dong, Xu; Song, Zhongshu; Williams, Christopher; Ploskon, Eliza; Wattana-amorn, Pakorn; Cox, Russell J.; Willis, Christine L.; Simpson, Thomas J.; Crosby, John; Crump, Matthew P.] Univ Bristol, Sch Chem, Bristol, Avon, England; [Masschelein, Joleen; Lavigne, Rob] Katholieke Univ Leuven, Div Gene Technol, B-3001 Heverlee, Belgium	University of Birmingham; University of Bristol; KU Leuven	Haines, AS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	c.m.thomas@bham.ac.uk; matt.crump@bristol.ac.uk	Wattana-Amorn, Pakorn/GPK-6717-2022; Simpson, Thomas J/P-5058-2015; Farmer, Rohit/J-5151-2019; Cox, Russell John/F-9190-2015; Thomas, Christopher M/J-8258-2017; Wiliams, Christopher/P-4904-2015	Wattana-Amorn, Pakorn/0000-0002-4780-7122; Farmer, Rohit/0000-0003-4197-3047; Cox, Russell John/0000-0002-1844-0157; Thomas, Christopher M/0000-0002-2810-0455; Wiliams, Christopher/0000-0001-5806-9842; Takebayashi, Yuiko/0000-0002-6224-0224; Lavigne, Rob/0000-0001-7377-1314; Crump, Matthew/0000-0002-7868-5818; Masschelein, Joleen/0000-0003-4366-3675; Haines, Anthony/0000-0003-2736-6371; Winn, Peter/0000-0003-4706-723X	Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council [BB/F014570/1, BB/I014373/1, EP/F066104/1, BB/I003355/1, BB/I014039/1]; European Union [FP6-mobility 504501]; Darwin Trust of Edinburgh; FWO Vlaanderen; Biotechnology and Biological Sciences Research Council [BB/I003355/1, BB/I014039/1, BB/I014373/1, BB/F014570/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K03927X/1] Funding Source: researchfish; BBSRC [BB/F014570/1, BB/I003355/1, BB/I014373/1, BB/I014039/1] Funding Source: UKRI; EPSRC [EP/F066104/1, EP/K03927X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); Darwin Trust of Edinburgh; FWO Vlaanderen(FWO); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council (BB/F014570/1 to P.W-a. and X.D.; BB/I014373/1 to A.S.H., R.G. and J.H.; EP/F066104/1, BB/I003355/1 and BB/I014039/1 to Z.S. and for LC/MS equipment). E.P. was supported by a European Union studentship grant (FP6-mobility 504501). R.F. and Y.T. were supported by scholarships from the Darwin Trust of Edinburgh. J.M. is supported by a PhD scholarship from the FWO Vlaanderen. P.J.W. and R.F. thank A. Bonvin for technical assistance with HADDOCK.	Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Beltran-Alvarez P, 2007, BIOCHEMISTRY-US, V46, P14672, DOI 10.1021/bi701784c; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Busche A, 2012, ACS CHEM BIOL, V7, P377, DOI 10.1021/cb200352q; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Calderone CT, 2008, NAT PROD REP, V25, P845, DOI 10.1039/b807243d; Calderone CT, 2007, CHEM BIOL, V14, P835, DOI 10.1016/j.chembiol.2007.06.008; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; DALEY DJ, 1976, ADV APPL PROBAB, V8, P395, DOI 10.2307/1425911; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DECKER H, 1994, J ANTIBIOT, V47, P54, DOI 10.7164/antibiotics.47.54; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Eswar N., 2006, CURR PROTOC PROTEIN, V5, P56; Evans SE, 2008, CHEMBIOCHEM, V9, P2424, DOI 10.1002/cbic.200800180; Evans SE, 2009, J MOL BIOL, V389, P511, DOI 10.1016/j.jmb.2009.03.072; Fukuda D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018031; FULLER AT, 1971, NATURE, V234, P416, DOI 10.1038/234416a0; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gu LC, 2006, J AM CHEM SOC, V128, P9014, DOI 10.1021/ja0626382; Gu LC, 2011, ANGEW CHEM INT EDIT, V50, P2795, DOI 10.1002/anie.201005280; Habeck Michael, 2004, Methods Mol Biol, V278, P379; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Irschik H, 2010, CHEMBIOCHEM, V11, P1840, DOI 10.1002/cbic.201000313; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KHOSLA C, 1992, MOL MICROBIOL, V6, P3237, DOI 10.1111/j.1365-2958.1992.tb01778.x; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Lepre CA, 1998, J BIOMOL NMR, V12, P493, DOI 10.1023/A:1008353000679; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mattheus W, 2010, CHEM BIOL, V17, P149, DOI 10.1016/j.chembiol.2010.01.014; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Piel J, 2004, CHEMBIOCHEM, V5, P93, DOI 10.1002/cbic.200300782; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Rahman AS, 2005, J BIOL CHEM, V280, P6399, DOI 10.1074/jbc.M409814200; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shields JA, 2010, CHEMBIOCHEM, V11, P248, DOI 10.1002/cbic.200900565; SHIOZAWA H, 1993, J ANTIBIOT, V46, P1834, DOI 10.7164/antibiotics.46.1834; Spronk CAEM, 2004, PROG NUCL MAG RES SP, V45, P315, DOI 10.1016/j.pnmrs.2004.08.003; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Thomas CM, 2010, NAT REV MICROBIOL, V8, P281, DOI 10.1038/nrmicro2278; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wattana-Amorn P, 2010, BIOCHEMISTRY-US, V49, P2186, DOI 10.1021/bi902176v	59	47	50	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					685	+		10.1038/NCHEMBIO.1342	http://dx.doi.org/10.1038/NCHEMBIO.1342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24056399	Green Submitted, Green Accepted			2022-12-27	WOS:000325930500007
J	Marzian, S; Stansfeld, PJ; Rapedius, M; Rinne, S; Nematian-Ardestani, E; Abbruzzese, JL; Steinmeyer, K; Sansom, MSP; Sanguinetti, MC; Baukrowitz, T; Decher, N				Marzian, Stefanie; Stansfeld, Phillip J.; Rapedius, Markus; Rinne, Susanne; Nematian-Ardestani, Ehsan; Abbruzzese, Jennifer L.; Steinmeyer, Klaus; Sansom, Mark S. P.; Sanguinetti, Michael C.; Baukrowitz, Thomas; Decher, Niels			Side pockets provide the basis for a new mechanism of Kv channel-specific inhibition	NATURE CHEMICAL BIOLOGY			English	Article							GATED NA+ CHANNELS; POTASSIUM CHANNEL; MOLECULAR DETERMINANTS; STRUCTURAL BASIS; DRUG-BINDING; K+ CHANNELS; LOCAL-ANESTHETICS; SODIUM-CHANNEL; CA2+ CHANNELS; RECEPTOR-SITE	Most known small-molecule inhibitors of voltage-gated ion channels have poor subtype specificity because they interact with a highly conserved binding site in the central cavity. Using alanine-scanning mutagenesis, electrophysiological recordings and molecular modeling, we have identified a new drug-binding site in Kv1.x channels. We report that Psora-4 can discriminate between related Kv channel subtypes because, in addition to binding the central pore cavity, it binds a second, less conserved site located in side pockets formed by the backsides of S5 and S6, the S4-S5 linker, part of the voltage sensor and the pore helix. Simultaneous drug occupation of both binding sites results in an extremely stable nonconducting state that confers high affinity, cooperativity, use-dependence and selectivity to Psora-4 inhibition of Kv1.x channels. This new mechanism of inhibition represents a molecular basis for the development of a new class of allosteric and selective voltage-gated channel inhibitors.	[Marzian, Stefanie; Rinne, Susanne; Decher, Niels] Univ Marburg, Inst Physiol & Pathophysiol, Marburg, Germany; [Stansfeld, Phillip J.; Sansom, Mark S. P.] Univ Oxford, Struct Bioinformat & Computat Biochem Unit, Oxford, England; [Rapedius, Markus; Nematian-Ardestani, Ehsan; Baukrowitz, Thomas] Univ Kiel, Inst Physiol, Kiel, Germany; [Abbruzzese, Jennifer L.; Sanguinetti, Michael C.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT USA; [Steinmeyer, Klaus] Sanofi Aventis, Therapeut Strateg Unit Aging, Frankfurt, Germany	Philipps University Marburg; University of Oxford; University of Kiel; Utah System of Higher Education; University of Utah; Sanofi-Aventis	Decher, N (corresponding author), Univ Marburg, Inst Physiol & Pathophysiol, Marburg, Germany.	decher@staff.uni-marburg.de	Sanguinetti, Michael/AAN-2615-2020; Sansom, Mark S.P./C-5157-2009; Stansfeld, Phillip James/AAA-9228-2020; Decher, Niels/AAF-5002-2020	Sansom, Mark S.P./0000-0001-6360-7959; Stansfeld, Phillip James/0000-0001-8800-7669; Nematian-Ardestani, Ehsan/0000-0001-9674-6138; Baukrowitz, Thomas/0000-0003-4562-0505	Deutsche Forschungsgemeinschaft [DE1482-3/2]; P.E. Kempkes Stiftung [01/2011]; Wellcome Trust; US National Institutes of Health (NIH)-NIH Heart, Lung, and Blood Institute [HL055236]; Studienstiftung des Deutschen Volkes e.V.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055236] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/16011, B19456, BB/I019855/1, BEP17032, BB/H000267/1] Funding Source: researchfish; BBSRC [BB/H000267/1, BB/I019855/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); P.E. Kempkes Stiftung; Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health (NIH)-NIH Heart, Lung, and Blood Institute; Studienstiftung des Deutschen Volkes e.V.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft grant DE1482-3/2 to N.D. and by the P.E. Kempkes Stiftung 01/2011 to S. R. and S. M. M. S. P. S. is supported by the Wellcome Trust. M. C. S. was supported by US National Institutes of Health (NIH)-NIH Heart, Lung, and Blood Institute grant HL055236. S. M. was supported by the Studienstiftung des Deutschen Volkes e.V.	Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; Baukrowitz T, 1996, P NATL ACAD SCI USA, V93, P13357, DOI 10.1073/pnas.93.23.13357; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Decher N, 2005, MOL PHARMACOL, V68, P995, DOI 10.1124/mol.105.011668; Decher N, 2004, J BIOL CHEM, V279, P394, DOI 10.1074/jbc.M307411200; Decher N, 2008, EMBO J, V27, P3164, DOI 10.1038/emboj.2008.231; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hanner M, 2001, BIOCHEMISTRY-US, V40, P11687, DOI 10.1021/bi0111698; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hockerman GH, 2000, MOL PHARMACOL, V58, P1264, DOI 10.1124/mol.58.6.1264; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Nau C, 2004, J MEMBRANE BIOL, V201, P1, DOI 10.1007/s00232-004-0702-y; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Seebohm G, 2003, MOL PHARMACOL, V64, P70, DOI 10.1124/mol.64.1.70; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Vennekamp J, 2004, MOL PHARMACOL, V65, P1364, DOI 10.1124/mol.65.6.1364; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zimin PI, 2010, MOL PHARMACOL, V78, P588, DOI 10.1124/mol.110.064014	37	49	50	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2013	9	8					507	U88		10.1038/nchembio.1271	http://dx.doi.org/10.1038/nchembio.1271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185FV	23728494	Green Accepted			2022-12-27	WOS:000321952700010
J	Meyer, D; Neumann, P; Ficner, R; Tittmann, K				Meyer, Danilo; Neumann, Piotr; Ficner, Ralf; Tittmann, Kai			Observation of a stable carbene at the active site of a thiamin enzyme	NATURE CHEMICAL BIOLOGY			English	Article							PYRUVATE OXIDASE; CRYSTAL-STRUCTURE; DIPHOSPHATE; DECARBOXYLASE; INHIBITION; ACTIVATION; MECHANISM; CATALYSIS; ANALOGS	Carbenes are highly reactive chemical compounds that are exploited as ligands in organometallic chemistry and are powerful organic catalysts. They were postulated to occur as transient intermediates in enzymes, yet their existence in a biological system could never be demonstrated directly. We present spectroscopic and structural data of a thiamin enzyme in a noncovalent complex with substrate, which implicate accumulation of a stable carbene as a major resonance contributor to deprotonated thiamin.	[Meyer, Danilo; Tittmann, Kai] Univ Gottingen, Gottingen Ctr Mol Biosci, Albrecht von Haller Inst, D-37073 Gottingen, Germany; [Neumann, Piotr; Ficner, Ralf] Univ Gottingen, Gottingen Ctr Mol Biosci, Inst Microbiol & Genet, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Tittmann, K (corresponding author), Univ Gottingen, Gottingen Ctr Mol Biosci, Albrecht von Haller Inst, D-37073 Gottingen, Germany.	ktittma@gwdg.de			Deutsche Forschungsgemeinschaft [SFB 860/B07, FOR 1296/TP3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank G. M. Sheldrick for providing a prerelease version of software SHELXL-2012 and discussion. We thank G. Bertrand, R. Kluger and F. Jordan for discussion and comments on the manuscript. We further thank A. Pohl and S. Ludtke for technical assistance. This work has been supported through grants SFB 860/B07 and FOR 1296/TP3 of the Deutsche Forschungsgemeinschaft (both to K.T.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agyei-Owusu K, 2009, FEBS J, V276, P2905, DOI 10.1111/j.1742-4658.2009.07018.x; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; Arduengo AJ, 1997, LIEBIGS ANN-RECL, P365; Baakrishnan A, 2012, J AM CHEM SOC, V134, P665, DOI 10.1021/ja209856x; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; BRESLOW R, 1957, J AM CHEM SOC, V79, P1762, DOI 10.1021/ja01564a064; Droge T, 2010, ANGEW CHEM INT EDIT, V49, P6940, DOI 10.1002/anie.201001865; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; IGAU A, 1989, ANGEW CHEM INT EDIT, V28, P621, DOI 10.1002/anie.198906211; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Kluger R, 2008, CHEM REV, V108, P1797, DOI 10.1021/cr068444m; Lee JK, 1997, SCIENCE, V276, P942, DOI 10.1126/science.276.5314.942; Mann S, 2004, ORG BIOMOL CHEM, V2, P1732, DOI 10.1039/b403619k; Melaimi M, 2010, ANGEW CHEM INT EDIT, V49, P8810, DOI 10.1002/anie.201000165; Meyer D, 2012, P NATL ACAD SCI USA, V109, P10867, DOI 10.1073/pnas.1201280109; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Pang SS, 2002, J MOL BIOL, V317, P249, DOI 10.1006/jmbi.2001.5419; Pei XY, 2010, BIOCHEMISTRY-US, V49, P1727, DOI 10.1021/bi901864j; PLETCHER J, 1977, ACTA CRYSTALLOGR B, V33, P3349, DOI 10.1107/S056774087701098X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Steinbach A, 2012, FEBS J, V279, P1209, DOI 10.1111/j.1742-4658.2012.08513.x; Tittmann K, 1998, J BIOL CHEM, V273, P12929, DOI 10.1074/jbc.273.21.12929; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788	29	41	41	2	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2013	9	8					488	U84		10.1038/nchembio.1275	http://dx.doi.org/10.1038/nchembio.1275			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185FV	23748673				2022-12-27	WOS:000321952700006
J	Banci, L; Barbieri, L; Bertini, I; Luchinat, E; Secci, E; Zhao, YG; Aricescu, AR				Banci, Lucia; Barbieri, Letizia; Bertini, Ivano; Luchinat, Enrico; Secci, Erica; Zhao, Yuguang; Aricescu, A. Radu			Atomic-resolution monitoring of protein maturation in live human cells by NMR	NATURE CHEMICAL BIOLOGY			English	Article							SUPEROXIDE-DISMUTASE; COPPER CHAPERONE; SOD1; METAL; MECHANISMS; SPECTROSCOPY; ACTIVATION; ABSENCE; CCS	We use NMR directly in live human cells to describe the complete post-translational maturation process of human superoxide dismutase 1 (SOD1). We follow, at atomic resolution, zinc binding, homodimer formation and copper uptake, and discover that copper chaperone for SOD1 oxidizes the SOD1 intrasubunit disulfide bond through both copper-dependent and copper-independent mechanisms. Our approach represents a new strategy for structural investigation of endogenously expressed proteins in a physiological (cellular) environment.	[Banci, Lucia; Barbieri, Letizia; Bertini, Ivano; Luchinat, Enrico; Secci, Erica] Univ Florence, CERM, Magnet Resonance Ctr, Florence, Italy; [Banci, Lucia; Bertini, Ivano] Univ Florence, Dept Chem, Florence, Italy; [Zhao, Yuguang; Aricescu, A. Radu] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England	University of Florence; University of Florence; University of Oxford; Wellcome Centre for Human Genetics	Banci, L (corresponding author), Univ Florence, CERM, Magnet Resonance Ctr, Florence, Italy.	banci@cerm.unifi.it; radu@strubi.ox.ac.uk	Aricescu, Alexandru/L-3891-2013; Luchinat, Enrico/O-1776-2014	Luchinat, Enrico/0000-0003-4183-4311; Barbieri, Letizia/0000-0002-7457-490X; BANCI, LUCIA/0000-0003-0562-5774; Aricescu, Alexandru ARadu/0000-0003-3783-1388	European Commission (Bio-NMR) [261863]; European Commission (P-CUBE) [227764]; Italian grant program MIUR-PRIN; European Integrated Structural Biology Infrastructure (INSTRUCT), European Strategy Forum on Research Infrastructures (ESFRI); UK Medical Research Council; Medical Research Council [G0700232] Funding Source: researchfish; MRC [G0700232] Funding Source: UKRI	European Commission (Bio-NMR)(European CommissionEuropean Commission Joint Research Centre); European Commission (P-CUBE); Italian grant program MIUR-PRIN; European Integrated Structural Biology Infrastructure (INSTRUCT), European Strategy Forum on Research Infrastructures (ESFRI); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank E.Y. Jones and D. I. Stuart for critically reading the manuscript and providing advice. This work was supported by the Access to Research Infrastructures activities in the Seventh Framework Programme of the European Commission (Bio-NMR contract 261863 and P-CUBE contract 227764), by the Italian grant program MIUR-PRIN 2009 'Biologia strutturale meccanicistica: avanzamenti metodologici e biologici' and by the European Integrated Structural Biology Infrastructure (INSTRUCT), which is part of the European Strategy Forum on Research Infrastructures (ESFRI) and supported by national member subscriptions. Specifically, we thank the INSTRUCT Core Centres CERM (Italy) and the University of Oxford. A. R. A. was supported by a UK Medical Research Council Career Development Award fellowship.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2012, P NATL ACAD SCI USA, V109, P13555, DOI 10.1073/pnas.1207493109; Banci L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023561; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Burz DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002571; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Freshney RI., 1987, CULTURE ANIMAL CELLS; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Leitch JM, 2009, J BIOL CHEM, V284, P24679, DOI 10.1074/jbc.R109.040410; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Ogino S, 2009, J AM CHEM SOC, V131, P10834, DOI 10.1021/ja904407w; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Reckel S, 2007, PROG NUCL MAG RES SP, V51, P91, DOI 10.1016/j.pnmrs.2007.02.002; Reckel S, 2012, CHEMBIOCHEM, V13, P534, DOI 10.1002/cbic.201100721; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Sturtz LA, 2001, J BIOL CHEM, V276, P38084	27	166	167	0	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2013	9	5					297	+		10.1038/NCHEMBIO.1202	http://dx.doi.org/10.1038/NCHEMBIO.1202			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	127VT	23455544	Green Accepted			2022-12-27	WOS:000317727600005
J	Ulanovskaya, OA; Zuhl, AM; Cravatt, BF				Ulanovskaya, Olesya A.; Zuhl, Andrea M.; Cravatt, Benjamin F.			NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink	NATURE CHEMICAL BIOLOGY			English	Article							NICOTINAMIDE N-METHYLTRANSFERASE; EXPRESSION; INVASION; PATHWAY; GROWTH; QUANTITATION; INHIBITION; CARCINOMA; BIOLOGY; PLASMA	Nicotinamide N-methyltransferase (NNMT) is overexpressed in a variety of human cancers, where it contributes to tumorigenesis by a mechanism that is still poorly understood. Here we show using metabolomics that NNMT impairs the methylation potential of cancer cells by consuming methyl units from S-adenosyl methionine to create the stable metabolic product 1-methylnicotinamide. As a result, NNMT-expressing cancer cells have an altered epigenetic state that includes hypomethylated histones and other cancer-related proteins combined with heightened expression of protumorigenic gene products. Our findings thus point to a direct mechanistic link between the deregulation of a metabolic enzyme and widespread changes in the methylation landscape of cancer cells.	[Ulanovskaya, Olesya A.; Zuhl, Andrea M.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Ulanovskaya, Olesya A.; Zuhl, Andrea M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Ulanovskaya, OA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu			NCI NIH HHS [CA132630, R01 CA132630] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA132630] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Cantoni G.L., 1985, Progress in Clinical and Biological Research, V198, P47; Catz P, 2005, J CHROMATOGR B, V829, P123, DOI 10.1016/j.jchromb.2005.10.003; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dreger H, 2012, HYPERTENSION, V60, P1176, DOI 10.1161/HYPERTENSIONAHA.112.191098; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Joyce T, 2009, CLIN EXP METASTAS, V26, P569, DOI 10.1007/s10585-009-9256-9; Kim J, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-20; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Luo MK, 2012, ACS CHEM BIOL, V7, P443, DOI 10.1021/cb200519y; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Peng Y, 2011, BIOCHEMISTRY-US, V50, P7800, DOI 10.1021/bi2007614; Polkowska J, 2009, J PHYS ORG CHEM, V22, P779, DOI 10.1002/poc.1519; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Puustinen P, 2009, CANCER RES, V69, P2870, DOI 10.1158/0008-5472.CAN-08-2760; Roessler M, 2005, CLIN CANCER RES, V11, P6550, DOI 10.1158/1078-0432.CCR-05-0983; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smythe GA, 2002, ANAL BIOCHEM, V301, P21, DOI 10.1006/abio.2001.5490; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Su JL, 2006, CANCER RES, V66, P2553, DOI 10.1158/0008-5472.CAN-05-2645; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tang SW, 2011, CARCINOGENESIS, V32, P138, DOI 10.1093/carcin/bgq225; Tomida M, 2008, J CANCER RES CLIN, V134, P551, DOI 10.1007/s00432-007-0318-6; Tomida M, 2009, J CANCER RES CLIN, V135, P1223, DOI 10.1007/s00432-009-0563-y; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Ulrey CL, 2005, HUM MOL GENET, V14, pR139, DOI 10.1093/hmg/ddi100; Varela-Rey M, 2010, HEPATOLOGY, V52, P105, DOI 10.1002/hep.23639; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Wang YC, 2011, J NUTR, V141, P777, DOI 10.3945/jn.110.135954; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wardman P, 2007, CLIN ONCOL-UK, V19, P397, DOI 10.1016/j.clon.2007.03.010; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wierinckx A, 2007, ENDOCR-RELAT CANCER, V14, P887, DOI 10.1677/ERC-07-0062; Wu Y, 2008, ONCOGENE, V27, P6679, DOI 10.1038/onc.2008.264; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zinellu A, 2007, ANAL BIOCHEM, V363, P91, DOI 10.1016/j.ab.2007.01.009	55	253	257	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2013	9	5					300	+		10.1038/NCHEMBIO.1204	http://dx.doi.org/10.1038/NCHEMBIO.1204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	127VT	23455543	Green Accepted			2022-12-27	WOS:000317727600006
J	Simon, GM; Niphakis, MJ; Cravatt, BF				Simon, Gabriel M.; Niphakis, Micah J.; Cravatt, Benjamin F.			Determining target engagement in living systems	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVITY-BASED PROBES; IN-VIVO; RECEPTOR-BINDING; DRUG DISCOVERY; INHIBITORS; REVEALS; TYROSINE; MECHANISMS; BIOMARKERS; PCI-32765		[Simon, Gabriel M.] Abide Therapeut, San Diego, CA USA; [Niphakis, Micah J.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Niphakis, Micah J.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Simon, GM (corresponding author), Abide Therapeut, San Diego, CA USA.	cravatt@scripps.edu			US National Institutes of Health [CA087660, CA132630, DA033760, DA032541]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA087660, R37CA087660, R01CA132630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033760, F32DA032541] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful for the support of the US National Institutes of Health (CA087660, CA132630, DA033760 and DA032541) and the Skaggs Institute for Chemical Biology.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Ashworth S, 2010, J NUCL MED, V51, P1021, DOI 10.2967/jnumed.109.071753; Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bigott-Hennkens HM, 2008, Q J NUCL MED MOL IM, V52, P245; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Carmi C, 2012, BIOCHEM PHARMACOL, V84, P1388, DOI 10.1016/j.bcp.2012.07.031; Choi HG, 2012, ACS MED CHEM LETT, V3, P658, DOI 10.1021/ml300123a; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Edgington LE, 2013, J AM CHEM SOC, V135, P174, DOI 10.1021/ja307083b; Edgington LE, 2011, CURR OPIN CHEM BIOL, V15, P798, DOI 10.1016/j.cbpa.2011.10.012; Edgington LE, 2009, NAT MED, V15, P967, DOI 10.1038/nm.1938; Erondu N, 2006, CELL METAB, V4, P275, DOI 10.1016/j.cmet.2006.08.002; Geurink PP, 2012, TOP CURR CHEM, V324, P85, DOI 10.1007/128_2011_286; Grimwood S, 2009, PHARMACOL THERAPEUT, V122, P281, DOI 10.1016/j.pharmthera.2009.03.002; Gross RW, 2011, CHEM BIOL, V18, P284, DOI 10.1016/j.chembiol.2011.01.014; HALVORSEN SW, 1987, J NEUROSCI, V7, P2547; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Krishna R, 2008, AAPS J, V10, P401, DOI 10.1208/s12248-008-9041-8; Krysiak JM, 2012, ANGEW CHEM INT EDIT, V51, P7035, DOI 10.1002/anie.201201955; Kubota K, 2009, NAT BIOTECHNOL, V27, P933, DOI 10.1038/nbt.1566; Lancelot S, 2010, TRENDS PHARMACOL SCI, V31, P411, DOI 10.1016/j.tips.2010.06.002; Ledford H, 2012, NATURE, V483, P519, DOI 10.1038/483519a; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Matthews PM, 2012, BRIT J CLIN PHARMACO, V73, P175, DOI 10.1111/j.1365-2125.2011.04085.x; Need AB, 2007, LIFE SCI, V81, P1389, DOI 10.1016/j.lfs.2007.09.005; Nodwell MB, 2012, TOP CURR CHEM, V324, P1, DOI 10.1007/128_2011_302; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Paweletz CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026459; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Shelat AA, 2007, NAT CHEM BIOL, V3, P442, DOI 10.1038/nchembio0807-442; Skaddan MB, 2012, NUCL MED BIOL, V39, P1058, DOI 10.1016/j.nucmedbio.2012.03.011; Stains CI, 2012, CHEM BIOL, V19, P210, DOI 10.1016/j.chembiol.2011.11.012; Suwaki N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002004; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Verdoes M, 2012, CHEM BIOL, V19, P619, DOI 10.1016/j.chembiol.2012.03.012; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Wagner JA, 2008, ANNU REV PHARMACOL, V48, P631, DOI 10.1146/annurev.pharmtox.48.113006.094611; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wong DF, 2009, NEUROPSYCHOPHARMACOL, V34, P187, DOI 10.1038/npp.2008.166; Yokoi F, 2002, NEUROPSYCHOPHARMACOL, V27, P248, DOI 10.1016/S0893-133X(02)00304-4; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	57	174	181	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					200	205		10.1038/nchembio.1211	http://dx.doi.org/10.1038/nchembio.1211			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23508173	Green Accepted			2022-12-27	WOS:000317025800003
J	Ban, L; Pettit, N; Li, L; Stuparu, AD; Cai, L; Chen, WL; Guan, WY; Han, WQ; Wang, PG; Mrksich, M				Ban, Lan; Pettit, Nicholas; Li, Lei; Stuparu, Andreea D.; Cai, Li; Chen, Wenlan; Guan, Wanyi; Han, Weiqing; Wang, Peng George; Mrksich, Milan			Discovery of glycosyltransferases using carbohydrate arrays and mass spectrometry	NATURE CHEMICAL BIOLOGY			English	Article							SELF-ASSEMBLED MONOLAYERS; GLYCAN MICROARRAYS; ESCHERICHIA-COLI; ENZYME-ACTIVITY; GALACTOSYLTRANSFERASE; SIALYLTRANSFERASE; GLYCOSYLATION; MECHANISMS; EXPRESSION; LIBRARIES	Glycosyltransferases catalyze the reaction between an activated sugar donor and an acceptor to form a new glycosidic linkage. Glycosyltransferases are responsible for the assembly of oligosaccharides in vivo and are also important for the in vitro synthesis of these biomolecules. However, the functional identification and characterization of new glycosyltransferases is difficult and tedious. This paper describes an approach that combines arrays of reactions on an immobilized array of acceptors with an analysis by mass spectrometry to screen putative glycosyltransferases. A total of 14,280 combinations of a glycosyltransferase, an acceptor and a donor in four buffer conditions were screened, leading to the identification and characterization of four new glycosyltransferases. This work is notable because it provides a label-free method for the rapid functional annotation of putative enzymes.	[Ban, Lan; Stuparu, Andreea D.; Mrksich, Milan] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; [Ban, Lan; Stuparu, Andreea D.; Mrksich, Milan] Northwestern Univ, Dept Chem, Evanston, IL USA; [Pettit, Nicholas; Cai, Li; Chen, Wenlan; Guan, Wanyi] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Pettit, Nicholas; Cai, Li; Chen, Wenlan; Guan, Wanyi] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Li, Lei; Guan, Wanyi] Shandong Univ, Natl Glycoengn Res Ctr, Jinan, Shandong, Peoples R China; [Li, Lei; Guan, Wanyi] Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China; [Li, Lei; Han, Weiqing; Wang, Peng George] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Han, Weiqing; Wang, Peng George] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Mrksich, Milan] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Shandong University; Shandong University; Nankai University; Nankai University; Northwestern University	Wang, PG (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	pwang@nankai.edu; milan.mrksich@northwestern.edu	Mrksich, Milan/G-2469-2011; Cai, Li/A-2214-2012; Guan, Wanyi/D-8421-2014; WANG, Peng/GSN-5263-2022	Cai, Li/0000-0002-6098-1168; Guan, Wanyi/0000-0002-5982-5512; Mrksich, Milan/0000-0002-4964-796X	National Science Foundation [EEC-01180205]; US National Institutes of Health [P50 GM086145]; Defense Advanced Research Projects Agency [FA 9550-08-1-0221]; National Basic Research Program of China (973 Program) [2012CB822100, 2012CB910300]; China Scholarship Council [2007102057]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085267, P50GM086145] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Scholarship Council(China Scholarship Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.M. acknowledges the National Science Foundation (EEC-01180205), US National Institutes of Health (P50 GM086145) and Defense Advanced Research Projects Agency (FA 9550-08-1-0221), and P.G.W. acknowledges the National Basic Research Program of China (973 Program, no. 2012CB822100 and no. 2012CB910300) for financial support. L.L. acknowledges support from the China Scholarship Council (2007102057). We thank J. Modica for assistance with synthesis. We thank Z.-J. Liu (Institute of Biophysics of the Chinese Academy of Sciences) for providing the vector pMCSG7.	Aharoni A, 2006, NAT METHODS, V3, P609, DOI 10.1038/NMETH899; Ban L, 2008, ANGEW CHEM INT EDIT, V47, P3396, DOI 10.1002/anie.200704998; BELLA A, 1977, BIOCHEM J, V167, P621, DOI 10.1042/bj1670621; Blixt O, 1999, GLYCOBIOLOGY, V9, P1061, DOI 10.1093/glycob/9.10.1061; Blixt O, 2008, GLYCOCONJUGATE J, V25, P59, DOI 10.1007/s10719-007-9062-z; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chang SH, 2010, J AM CHEM SOC, V132, P13371, DOI 10.1021/ja1046523; Cleland W W, 1979, Methods Enzymol, V63, P103; Fang JW, 1998, J AM CHEM SOC, V120, P6635, DOI 10.1021/ja9808898; Guan WY, 2011, BIOORG MED CHEM LETT, V21, P5025, DOI 10.1016/j.bmcl.2011.04.100; Gurard-Levin ZA, 2011, ACS COMB SCI, V13, P347, DOI 10.1021/co2000373; Houseman BT, 2002, CHEM BIOL, V9, P443, DOI 10.1016/S1074-5521(02)00124-2; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; Kosik O, 2010, GLYCOCONJUGATE J, V27, P79, DOI 10.1007/s10719-009-9271-8; Laurent N, 2008, CHEMBIOCHEM, V9, P883, DOI 10.1002/cbic.200700692; Leskovac, 2003, COMPREHENSIVE ENZYME; Li M, 2008, BIOCHEMISTRY-US, V47, P378, DOI 10.1021/bi701345v; Min DH, 2004, ANGEW CHEM INT EDIT, V43, P5973, DOI 10.1002/anie.200461061; Min DH, 2004, ANAL CHEM, V76, P3923, DOI 10.1021/ac049816z; Mrksich M, 2008, ACS NANO, V2, P7, DOI 10.1021/nn7004156; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PALCIC M M, 1991, Glycobiology, V1, P205, DOI 10.1093/glycob/1.2.205; Park S, 2007, ORG LETT, V9, P1675, DOI 10.1021/ol070250l; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Sanchez-Ruiz A, 2011, ANGEW CHEM INT EDIT, V50, P1801, DOI 10.1002/anie.201006304; Su J, 2002, ANGEW CHEM INT EDIT, V41, P4715, DOI 10.1002/anie.200290026; Yi W, 2008, J AM CHEM SOC, V130, P14420, DOI 10.1021/ja805844y; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690	31	91	96	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					769	773		10.1038/NCHEMBIO.1022	http://dx.doi.org/10.1038/NCHEMBIO.1022			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22820418	Green Accepted			2022-12-27	WOS:000308077600008
J	Nabel, CS; Jia, HJ; Ye, Y; Shen, L; Goldschmidt, HL; Stivers, JT; Zhang, Y; Kohli, RM				Nabel, Christopher S.; Jia, Huijue; Ye, Yu; Shen, Li; Goldschmidt, Hana L.; Stivers, James T.; Zhang, Yi; Kohli, Rahul M.			AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation	NATURE CHEMICAL BIOLOGY			English	Article							INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; THYMINE DNA; TET PROTEINS; SOMATIC HYPERMUTATION; MAMMALIAN DNA; GLYCOSYLASE; AID; 5-METHYLCYTOSINE; METHYLATION	Activation-induced deaminase (AID)/APOBEC-family cytosine deaminases, known to function in diverse cellular processes from antibody diversification to mRNA editing, have also been implicated in DNA demethylation, a major process for transcriptional activation. Although oxidation-dependent pathways for demethylation have been described, pathways involving deamination of either 5-methylcytosine (5mC) or 5-hydroxymethylcytosine (5hmC) have emerged as alternatives. Here we address the biochemical plausibility of deamination-coupled demethylation. We found that purified AID/APOBECs have substantially reduced activity on 5mC relative to cytosine, their canonical substrate, and no detectable deamination of 5hmC. This finding was explained by the reactivity of a series of modified substrates, where steric bulk was increasingly detrimental to deamination. Further, upon AID/APOBEC overexpression, the deamination product of 5hmC was undetectable in genomic DNA, whereas oxidation intermediates remained detectable. Our results indicate that the steric requirements for cytosine deamination are one intrinsic barrier to the proposed function of deaminases in DNA demethylation.	[Nabel, Christopher S.; Kohli, Rahul M.] Univ Penn, Raymond & Ruth Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Nabel, Christopher S.; Kohli, Rahul M.] Univ Penn, Raymond & Ruth Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Jia, Huijue; Shen, Li; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC USA; [Ye, Yu; Goldschmidt, Hana L.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University	Kohli, RM (corresponding author), Univ Penn, Raymond & Ruth Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.	yi_zhang@med.unc.edu; rkohli@upenn.edu	Jia, Huijue/M-3991-2015	Jia, Huijue/0000-0002-3592-126X; Goldschmidt, Hana L./0000-0002-5676-366X; Kohli, Rahul/0000-0002-7689-5678; Zhang, Yi/0000-0002-2789-0811	Rita Allen Foundation; W.W. Smith Charitable Trust; US National Institutes of Health [K08-AI089242, GM056834, U01DK089565]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER	Rita Allen Foundation; W.W. Smith Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Bartolomei, M. Weitzman and M. Lazar for helpful discussions, K. Gajula and S. Manning for technical assistance and the University of North Carolina Biomarker Mass Spectrometry Facility for guidance. We are also grateful for A. Drohat (University of Maryland), A. Guminski (Johns Hopkins University) and J. Guo and H. Song (Johns Hopkins University) for providing reagents. This work was supported in part by the Rita Allen Foundation (to R.M.K.), the W.W. Smith Charitable Trust (to R.M.K.) and US National Institutes of Health grants K08-AI089242 (to R.M.K.), GM056834 (to J.T.S.) and U01DK089565 (to Y.Z.). Y.Z. is an investigator of the Howard Hughes Medical Institute.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Grogan BC, 2011, BIOCHEMISTRY-US, V50, P618, DOI 10.1021/bi102046h; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2011, PHILOS T R SOC B, V366, P2266, DOI 10.1098/rstb.2011.0042; HANSCH C, 1973, J MED CHEM, V16, P1207, DOI 10.1021/jm00269a003; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Larijani M, 2005, IMMUNOGENETICS, V56, P840, DOI 10.1007/s00251-004-0748-0; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Munzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2012, ACS CHEM BIOL, V7, P20, DOI 10.1021/cb2002895; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Teperek-Tkacz M, 2011, REPRODUCTION, V142, P621, DOI 10.1530/REP-11-0148; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]	45	232	238	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					751	758		10.1038/NCHEMBIO.1042	http://dx.doi.org/10.1038/NCHEMBIO.1042			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22772155	Green Accepted, Green Submitted			2022-12-27	WOS:000308077600006
J	Villalobos, LIAC; Lee, S; De Oliveira, C; Ivetac, A; Brandt, W; Armitage, L; Sheard, LB; Tan, X; Parry, G; Mao, HB; Zheng, N; Napier, R; Kepinski, S; Estelle, M				Calderon Villalobos, Luz Irina A.; Lee, Sarah; De Oliveira, Cesar; Ivetac, Anthony; Brandt, Wolfgang; Armitage, Lynne; Sheard, Laura B.; Tan, Xu; Parry, Geraint; Mao, Haibin; Zheng, Ning; Napier, Richard; Kepinski, Stefan; Estelle, Mark			A combinatorial TIR1/AFB-Aux/IAA co-receptor system for differential sensing of auxin	NATURE CHEMICAL BIOLOGY			English	Article							FUNCTIONAL GENOMIC ANALYSIS; GENE FAMILY-MEMBERS; BOX PROTEIN TIR1; ARABIDOPSIS-THALIANA; AUX/IAA PROTEINS; DEGRADATION; RECEPTOR; MUTANTS; ACID; EMBRYOGENESIS	The plant hormone auxin regulates virtually every aspect of plant growth and development. Auxin acts by binding the F-box protein transport inhibitor response 1 (TIR1) and promotes the degradation of the AUXIN/INDOLE-3-ACETIC ACID (Aux/IAA) transcriptional repressors. Here we show that efficient auxin binding requires assembly of an auxin co-receptor complex consisting of TIR1 and an Aux/IAA protein. Heterologous experiments in yeast and quantitative IAA binding assays using purified proteins showed that different combinations of TIR1 and Aux/IAA proteins form co-receptor complexes with a wide range of auxin-binding affinities. Auxin affinity seems to be largely determined by the Aux/IAA. As there are 6 TIR1/AUXIN SIGNALING F-BOX proteins (AFBs) and 29 Aux/IAA proteins in Arabidopsis thaliana, combinatorial interactions may result in many co-receptors with distinct auxin-sensing properties. We also demonstrate that the AFB5-Aux/IAA co-receptor selectively binds the auxinic herbicide picloram. This co-receptor system broadens the effective concentration range of the hormone and may contribute to the complexity of auxin response.	[Calderon Villalobos, Luz Irina A.; Parry, Geraint; Estelle, Mark] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Calderon Villalobos, Luz Irina A.; Parry, Geraint; Estelle, Mark] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Lee, Sarah; Napier, Richard] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [De Oliveira, Cesar; Ivetac, Anthony] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Brandt, Wolfgang] IPB Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Saale, Germany; [Armitage, Lynne; Kepinski, Stefan] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Sheard, Laura B.; Tan, Xu; Mao, Haibin; Zheng, Ning] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Sheard, Laura B.; Tan, Xu; Mao, Haibin; Zheng, Ning] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Parry, Geraint] Univ Liverpool, Dept Plant Sci, Liverpool L69 3BX, Merseyside, England	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Warwick; University of California System; University of California San Diego; Leibniz Institut fur Pflanzenbiochemie; University of Leeds; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Liverpool	Villalobos, LIAC (corresponding author), IPB Leibniz Inst Plant Biochem, Mol Signal Proc Dept, Halle, Saale, Germany.	mestelle@ucsd.edu	Tan, Xu/E-7170-2011; Estelle, Mark/ABD-6742-2021; Villalobos, Luz Irina A Calderón/L-5876-2016; de Oliveira, Cesar Augusto/C-4397-2011	Tan, Xu/0000-0003-4861-4573; Calderon Villalobos, Luz Irina A./0000-0002-6093-1478	US National Institutes of Health (NIH) [R01 CA107134, T32 GM07270]; HHMI; UK Biotechnology and Biological Sciences Research Council [BB/F013981/1, BB/F014651/1]; NIH; US National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/F013981/1, BB/F007418/1, BB/F014651/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM043644] Funding Source: NIH RePORTER; BBSRC [BB/F013981/1, BB/F007418/1, BB/F014651/1] Funding Source: UKRI	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E.J. Chapman for helpful discussions and comments to the manuscript and R. Shao and I. Kim for technical assistance. We also thank A. McCammon for hosting part of the computational analyses. We gratefully acknowledge financial support from the US National Institutes of Health (NIH) (R01 CA107134 to N.Z. and T32 GM07270 to L. B. S.), HHMI (M. E. and N.Z.) and the UK Biotechnology and Biological Sciences Research Council (BB/F013981/1 to S. K. and BB/F014651/1 to R.N.). The McCammon group, including A. I. and C.D.O., is supported by the NIH, US National Science Foundation and HHMI. We dedicate this work to the memory of L. B. Sheard, a talented young scientist who made key contributions at the early stage of this work. Her life was tragically cut short while this manuscript was under review.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; [Anonymous], 2010, PRIM V 2 1; [Anonymous], 2009, MOL OP ENV 2008 10; Calderon-Villalobos LI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005546; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; EVANS ML, 1994, PLANTA, V194, P215, DOI 10.1007/BF01101680; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Greenham K, 2011, CURR BIOL, V21, P520, DOI 10.1016/j.cub.2011.02.029; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hao GF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010742; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Holland JJ, 2009, J EXP BOT, V60, P1969, DOI 10.1093/jxb/erp113; Jenik PD, 2005, PLANT CELL, V17, P3362, DOI 10.1105/tpc.105.036889; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Korb O, 2010, J CHEM INF MODEL, V50, P1669, DOI 10.1021/ci1000218; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Prigge MJ, 2010, CURR BIOL, V20, P1907, DOI 10.1016/j.cub.2010.08.050; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Scarpella E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001511; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Sundberg E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001628; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; TIMPTE C, 1994, GENETICS, V138, P1239; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Vernoux T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001487; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Weijers D., 2011, AUXIN SIGNALING SYNT; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Zhao YC, 2010, J PLANT PHYSIOL, V167, P879, DOI 10.1016/j.jplph.2010.01.012	50	361	372	12	205	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					477	485		10.1038/NCHEMBIO.926	http://dx.doi.org/10.1038/NCHEMBIO.926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22466420	Green Submitted, Green Accepted			2022-12-27	WOS:000302962500015
J	Vang, T; Liu, WH; Delacroix, L; Wu, SD; Vasile, S; Dahl, R; Yang, L; Musumeci, L; Francis, D; Landskron, J; Tasken, K; Tremblay, ML; Lie, BA; Page, R; Mustelin, T; Rahmouni, S; Rickert, RC; Tautz, L				Vang, Torkel; Liu, Wallace H.; Delacroix, Laurence; Wu, Shuangding; Vasile, Stefan; Dahl, Russell; Yang, Li; Musumeci, Lucia; Francis, Dana; Landskron, Johannes; Tasken, Kjetil; Tremblay, Michel L.; Lie, Benedicte A.; Page, Rebecca; Mustelin, Tomas; Rahmouni, Souad; Rickert, Robert C.; Tautz, Lutz			LYP inhibits T-cell activation when dissociated from CSK	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; KINASE P50(CSK); AUTOIMMUNE-DISEASE; PTP-PEST; RECEPTOR; VARIANT; CONFORMATION; ASSOCIATION; DOMAIN; PEP	Lymphoid tyrosine phosphatase (LYP) and C-terminal Src kinase (CSK) are negative regulators of signaling mediated through the T-cell antigen receptor (TCR) and are thought to act in a cooperative manner when forming a complex. Here we studied the spatiotemporal dynamics of the LYP-CSK complex in T cells. We demonstrate that dissociation of this complex is necessary for recruitment of LYP to the plasma membrane, where it downmodulates TCR signaling. Development of a potent and selective chemical probe of LYP confirmed that LYP inhibits T-cell activation when removed from CSK. Our findings may explain the reduced TCR-mediated signaling associated with a single-nucleotide polymorphism that confers increased risk for certain autoimmune diseases, including type 1 diabetes and rheumatoid arthritis, and results in expression of a mutant LYP that is unable to bind CSK. Our compound also represents a starting point for the development of a LYP-based treatment of autoimmunity.	[Vang, Torkel; Liu, Wallace H.; Wu, Shuangding; Mustelin, Tomas; Rickert, Robert C.; Tautz, Lutz] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Vang, Torkel; Landskron, Johannes; Tasken, Kjetil] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Delacroix, Laurence; Musumeci, Lucia; Rahmouni, Souad] Univ Liege, Grp Interdisciplinaire Genoprote Appl Signal Tran, Immunol & Infect Dis Unit, Liege, Belgium; [Vasile, Stefan; Dahl, Russell; Yang, Li] Sanford Burnham Med Res Inst, Conrad Prebys Ctr Chem Gen, La Jolla, CA USA; [Francis, Dana; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Tremblay, Michel L.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway	Sanford Burnham Prebys Medical Discovery Institute; University of Oslo; University of Liege; Sanford Burnham Prebys Medical Discovery Institute; Brown University; McGill University; University of Oslo; University of Oslo	Vang, T (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA.	tautz@burnham.org	Tautz, Lutz/M-9989-2014	Tautz, Lutz/0000-0002-4075-6238; Tasken, Kjetil/0000-0003-2841-4697; Dahl, Russell/0000-0002-2939-1004; Delacroix, Laurence/0000-0003-3440-5359; Mustelin, Tomas/0000-0001-5912-8840	Exploratory Pharmacology Core at Sanford-Burnham Medical Research Institute; US National Institutes of Health [1R21CA132121]; Norwegian Cancer Society; American Cancer Society [RSG-08-067-01-LIB]; Oxnard Foundation; Belgian Research National Scientific Fund; Liege University; NATIONAL CANCER INSTITUTE [R21CA132121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041649] Funding Source: NIH RePORTER	Exploratory Pharmacology Core at Sanford-Burnham Medical Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Society(Norwegian Cancer Society); American Cancer Society(American Cancer Society); Oxnard Foundation; Belgian Research National Scientific Fund(Fonds de la Recherche Scientifique - FNRS); Liege University(University of Liege); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Smith and the Exploratory Pharmacology Core at Sanford-Burnham Medical Research Institute for support and thoughtful discussions; S. Ormenese and the Groupe Interdisciplinaire de Genoproteomique Appliquee Imaging Core for their help with flow cytometry; and G. M. Tjorhom, S. T. Flam and J. Solheim for technical assistance. This work was supported by the US National Institutes of Health (grant 1R21CA132121 to L. T.), the Norwegian Cancer Society (T. V.), the American Cancer Society (research scholar grant RSG-08-067-01-LIB to R. P.), the Oxnard Foundation (research grant to T.M./R.C.R.), the Belgian Research National Scientific Fund (Mandat d'Impulsion Scientifique Young Investigator Starting Grant to S. R.) and the Liege University (startup grant to S.R.).	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Arimura Y, 2008, MOL IMMUNOL, V45, P3074, DOI 10.1016/j.molimm.2008.03.019; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Liu SJ, 2008, J AM CHEM SOC, V130, P17075, DOI 10.1021/ja8068177; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Tautz L, 2005, J BIOL CHEM, V280, P9400, DOI 10.1074/jbc.M413122200; Tautz L, 2007, METHODS, V42, P250, DOI 10.1016/j.ymeth.2007.02.014; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Vang T, 2011, J MED CHEM, V54, P562, DOI 10.1021/jm101004d; Viken MK, 2007, TISSUE ANTIGENS, V70, P190, DOI 10.1111/j.1399-0039.2007.00871.x; Vintonyak VV, 2009, CURR OPIN CHEM BIOL, V13, P272, DOI 10.1016/j.cbpa.2009.03.021; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Wu SD, 2009, CHEMMEDCHEM, V4, P440, DOI 10.1002/cmdc.200800375; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang X, 2010, J MED CHEM, V53, P2482, DOI 10.1021/jm901645u; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	37	105	107	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					437	446		10.1038/NCHEMBIO.916	http://dx.doi.org/10.1038/NCHEMBIO.916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22426112	Green Accepted			2022-12-27	WOS:000302962500010
J	Vega, NM; Allison, KR; Khalil, AS; Collins, JJ				Vega, Nicole M.; Allison, Kyle R.; Khalil, Ahmad S.; Collins, James J.			Signaling-mediated bacterial persister formation	NATURE CHEMICAL BIOLOGY			English	Article							GENERAL STRESS-RESPONSE; ESCHERICHIA-COLI; OXIDATIVE STRESS; INDOLE; RESISTANCE; CELLS; OPERON	Here we show that bacterial communication through indole signaling induces persistence, a phenomenon in which a subset of an isogenic bacterial population tolerates antibiotic treatment. We monitor indole-induced persister formation using microfluidics and identify the role of oxidative-stress and phage-shock pathways in this phenomenon. We propose a model in which indole signaling 'inoculates' a bacterial subpopulation against antibiotics by activating stress responses, leading to persister formation.	[Vega, Nicole M.; Allison, Kyle R.; Khalil, Ahmad S.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Vega, Nicole M.; Allison, Kyle R.; Khalil, Ahmad S.; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Vega, Nicole M.; Allison, Kyle R.; Khalil, Ahmad S.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Boston University; Harvard University	Vega, NM (corresponding author), Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu			US National Science Foundation; US National Institutes of Health; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank R. H. W. Lam for help with microfluidics. This work was supported by funding from the US National Science Foundation, the US National Institutes of Health Director's Pioneer Award Program and the Howard Hughes Medical Institute.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; CRAWFORD DR, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3432208; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Garbe TR, 2000, ARCH MICROBIOL, V173, P78, DOI 10.1007/s002030050012; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee J, 2008, ISME J, V2, P1007, DOI 10.1038/ismej.2008.54; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; STORZ G, 1990, ANTON LEEUW INT J G, V58, P157, DOI 10.1007/BF00548927; Han TH, 2011, RES MICROBIOL, V162, P108, DOI 10.1016/j.resmic.2010.11.005; Wang DD, 2001, J BACTERIOL, V183, P4210, DOI 10.1128/JB.183.14.4210-4216.2001; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; WEINER L, 1994, P NATL ACAD SCI USA, V91, P2191, DOI 10.1073/pnas.91.6.2191; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991	25	291	303	9	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					431	433		10.1038/NCHEMBIO.915	http://dx.doi.org/10.1038/NCHEMBIO.915			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22426114	Green Accepted			2022-12-27	WOS:000302962500008
J	Zeng, X; King, RW				Zeng, Xing; King, Randall W.			An APC/C inhibitor stabilizes cyclin B1 by prematurely terminating ubiquitination	NATURE CHEMICAL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; SPINDLE ASSEMBLY CHECKPOINT; SUBSTRATE-BINDING; DEGRADATION; CDC20; DRIVES; BOX; COMPLEX/CYCLOSOME; PROCESSIVITY; MAINTAINS	The anaphase-promoting complex/cyclosome (APC) is a ubiquitin ligase that is required for exit from mitosis. We previously showed that tosyl arginine methyl ester (TAME) inhibits APC-dependent proteolysis by competing with the C-terminal isoleucine-arginine tail of the APC activator cell division cycle 20 (Cdc20) for APC binding. Here we show that in the absence of APC substrates, TAME ejects Cdc20 from the APC by promoting Cdc20 autoubiquitination in its N-terminal region. Cyclin B1 antagonizes TAME's effect by promoting binding of free Cdc20 to the APC and by suppressing Cdc20 autoubiquitination. Nevertheless, TAME stabilizes cyclin B1 in Xenopus extracts by two mechanisms. First, it reduces the k(cat) of the APC-Cdc20-cyclin B1 complex without affecting the K-mr slowing the initial ubiquitination of unmodified cyclin B1. Second, as cyclin B1 becomes ubiquitinated, it loses its ability to promote Cdc20 binding to the APC in the presence of TAME. As a result, cyclin B1 ubiquitination terminates before reaching the threshold necessary for proteolysis.	[Zeng, Xing; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Zeng, X (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	randy_king@hms.harvard.edu		King, Randall/0000-0001-7882-8180	US National Institutes of Health [GM66492]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066492, R01GM066492] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Pines (University of Cambridge, UK) for providing the Cdc20<SUP>K-less</SUP> construct and J. W. Harper for critically reading the manuscript. This work was supported by US National Institutes of Health grant GM66492 to R.W.K.	Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Foe IT, 2011, CURR BIOL, V21, P1870, DOI 10.1016/j.cub.2011.09.051; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Ge S, 2009, CELL CYCLE, V8, P167, DOI 10.4161/cc.8.1.7606; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	37	48	49	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					383	392		10.1038/NCHEMBIO.801	http://dx.doi.org/10.1038/NCHEMBIO.801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22366722	Green Submitted, Green Accepted			2022-12-27	WOS:000301890100013
J	Tarrant, MK; Rho, HS; Xie, Z; Jiang, YL; Gross, C; Culhane, JC; Yan, G; Qian, J; Ichikawa, Y; Matsuoka, T; Zachara, N; Etzkorn, FA; Hart, GW; Jeong, JS; Blackshaw, S; Zhu, H; Cole, PA				Tarrant, Mary Katherine; Rho, Hee-Sool; Xie, Zhi; Jiang, Yu Lin; Gross, Christopher; Culhane, Jeffrey C.; Yan, Gai; Qian, Jiang; Ichikawa, Yoshitaka; Matsuoka, Tatsuji; Zachara, Natasha; Etzkorn, Felicia A.; Hart, Gerald W.; Jeong, Jun Seop; Blackshaw, Seth; Zhu, Heng; Cole, Philip A.			Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE CK2; BETA-SUBUNIT; GLCNAC TRANSFERASE; CASEIN KINASE-2; CELL-CYCLE; PIN1; IDENTIFICATION; FLAVOPIRIDOL; ACTIVATION; EXPRESSION	Protein serine-threonine kinase casein kinase 3II (CK2) is involved in a myriad of cellular processes including cell growth and proliferation through its phosphorylation of hundreds of substrates, yet how CK2 function is regulated is poorly understood. Here we report that the CK2 catalytic subunit CK2 alpha is modified by O-linked beta-N-acetyl-glucosamine (O-GlcNAc) on Ser347, proximal to a cyclin-dependent kinase phosphorylation site (Thr344). We use protein semisynthesis to show that phosphorylation of Thr344 increases the cellular stability of CK2 alpha by strengthening its interaction with Pin1, whereas glycosylation of Ser347 seems to be antagonistic to Thr344 phosphorylation and permissive to proteasomal degradation. By performing kinase assays with site-specifically phospho- and glyco-modified CK2 alpha in combination with CK2 beta and Pin1 binding partners on human protein microarrays, we show that the kinase substrate selectivity of CK2 is modulated by these specific post-translational modifications. This study suggests how a promiscuous protein kinase can be regulated at multiple levels to achieve particular biological outputs.	[Tarrant, Mary Katherine; Rho, Hee-Sool; Jiang, Yu Lin; Gross, Christopher; Culhane, Jeffrey C.; Yan, Gai; Ichikawa, Yoshitaka; Jeong, Jun Seop; Zhu, Heng; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Rho, Hee-Sool; Jeong, Jun Seop; Blackshaw, Seth; Zhu, Heng] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD USA; [Xie, Zhi; Qian, Jiang] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Xie, Zhi] US Natl Inst Hlth, Ctr Human Immunol, Bethesda, MD USA; [Jiang, Yu Lin] E Tennessee State Univ, Dept Chem, Johnson City, TN 37614 USA; [Matsuoka, Tatsuji; Zachara, Natasha; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Matsuoka, Tatsuji] Daiichi Sankyo Co Ltd, Kasai R&D Ctr, Biol Res Labs, Tokyo, Japan; [Etzkorn, Felicia A.] Virginia Tech, Dept Chem, Blacksburg, VA USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; East Tennessee State University; Johns Hopkins University; Daiichi Sankyo Company Limited; Virginia Polytechnic Institute & State University; Johns Hopkins University	Tarrant, MK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	pcole@jhmi.edu		Hart, Gerald/0000-0001-7812-4351; Xie, Zhi/0000-0002-5589-4836; Etzkorn, Felicia A./0000-0001-5850-3661; Matsuoka, Tatsuji/0000-0001-5982-4248	US National Institutes of Health [CA42486, GM62437, RR020839]; NATIONAL CANCER INSTITUTE [R29CA074305, R01CA042486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062437, R01GM062437] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Schwarzer, L. Szewczuk, S. Taverna and Y. Zhang as well as the Johns Hopkins University School of Medicine Microscope Facility for advice and assistance and the US National Institutes of Health (CA42486, GM62437, RR020839) for support.	BOSC DG, 1995, J BIOL CHEM, V270, P25872, DOI 10.1074/jbc.270.43.25872; Bosc DG, 1999, MOL CELL BIOCHEM, V191, P213, DOI 10.1023/A:1006840329973; Canton DA, 2006, CELL SIGNAL, V18, P267, DOI 10.1016/j.cellsig.2005.07.008; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Fischer PM, 2000, CURR MED CHEM, V7, P1213, DOI 10.2174/0929867003374048; Gussio R, 2000, ANTI-CANCER DRUG DES, V15, P53; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Homma MK, 2008, MOL CELL BIOCHEM, V316, P49, DOI 10.1007/s11010-008-9823-4; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Huang R, 2010, J AM CHEM SOC, V132, P9986, DOI 10.1021/ja103954u; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; LITCHFIELD DW, 1992, J BIOL CHEM, V267, P13943; LIU QJ, 1994, J BIOL CHEM, V269, P9221; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; MARIN O, 1995, FEBS LETT, V363, P111, DOI 10.1016/0014-5793(95)00295-K; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1992, EUR J BIOCHEM, V204, P293, DOI 10.1111/j.1432-1033.1992.tb16636.x; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Ohnishi Y, 2000, BIOORG MED CHEM LETT, V10, P1289, DOI 10.1016/S0960-894X(00)00223-7; Pagano MA, 2006, BIOCHEM SOC T, V34, P1303, DOI 10.1042/BST0341303; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Piontek C, 2009, ANGEW CHEM INT EDIT, V48, P1936, DOI 10.1002/anie.200804734; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Salvi M, 2006, FEBS LETT, V580, P3948, DOI 10.1016/j.febslet.2006.06.031; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sarno S, 2000, BIOCHEMISTRY-US, V39, P12324, DOI 10.1021/bi0011431; Sarno S, 1998, FEBS LETT, V441, P29, DOI 10.1016/S0014-5793(98)01516-6; Sarno S, 1997, BIOCHEMISTRY-US, V36, P11717, DOI 10.1021/bi9705772; Senderowicz AM, 1999, INVEST NEW DRUG, V17, P313, DOI 10.1023/A:1006353008903; Shapiro GI, 1999, CLIN CANCER RES, V5, P2925; Shen HH, 2001, GENOMICS, V71, P21, DOI 10.1006/geno.2000.6397; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Siepe D, 2009, NAT CELL BIOL, V11, P967, DOI 10.1038/ncb1908; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Tiganis T, 1996, ARCH BIOCHEM BIOPHYS, V325, P289, DOI 10.1006/abbi.1996.0036; Vila-Perello M, 2010, CELL, V143, P191, DOI 10.1016/j.cell.2010.09.031; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zheng WP, 2005, J BIOL CHEM, V280, P10462, DOI 10.1074/jbc.M412283200	50	116	118	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					262	269		10.1038/NCHEMBIO.771	http://dx.doi.org/10.1038/NCHEMBIO.771			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22267120	Green Accepted			2022-12-27	WOS:000300600000011
J	Bunnage, ME				Bunnage, Mark E.			Getting pharmaceutical R&D back on target	NATURE CHEMICAL BIOLOGY			English	Article							DRUG DISCOVERY; PROTEIN; INTERACTOME; SYSTEM; SIZE		Pfizer Labs, Med Chem, Sandwich, Kent, England	Pfizer	Bunnage, ME (corresponding author), Pfizer Labs, Med Chem, Sandwich, Kent, England.	mark.bunnage@pfizer.com						Adams CP, 2010, HEALTH ECON, V19, P130, DOI 10.1002/hec.1454; Bartfai T., 2006, DRUG DISCOVERY BEDSI; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; *BERNST, 2011, BERNST RES PIP REP F; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468851a, 10.1038/468854a, 10.1038/468852a]; Buchwald P, 2010, IUBMB LIFE, V62, P724, DOI 10.1002/iub.383; BUNNAGE ME, 2011, ROYAL SOC CHEM DRUG; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; De Luca L, 2010, BIOORGAN MED CHEM, V18, P7515, DOI 10.1016/j.bmc.2010.08.051; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Heal WP, 2011, CHEM SOC REV, V40, P246, DOI 10.1039/c0cs00004c; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kritzer JA, 2010, NAT CHEM BIOL, V6, P566, DOI 10.1038/nchembio.407; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Metz JT, 2010, CURR OPIN CHEM BIOL, V14, P498, DOI 10.1016/j.cbpa.2010.06.166; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nisius B, 2011, EXPERT OPIN DRUG DIS, V6, P1, DOI 10.1517/17460441.2011.533654; Schmid EF, 2007, DRUG DISCOV TODAY, V12, P998, DOI 10.1016/j.drudis.2007.08.013; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; [No title captured]	26	182	194	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					335	339		10.1038/nchembio.581	http://dx.doi.org/10.1038/nchembio.581			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21587251				2022-12-27	WOS:000290677900005
J	Haller, A; Rieder, U; Aigner, M; Blanchard, SC; Micura, R				Haller, Andrea; Rieder, Ulrike; Aigner, Michaela; Blanchard, Scott C.; Micura, Ronald			Conformational capture of the SAM-II riboswitch	NATURE CHEMICAL BIOLOGY			English	Article							INDUCED FIT; S-ADENOSYLMETHIONINE; RNA DYNAMICS; MOLECULAR RECOGNITION; SENSING RIBOSWITCH; APTAMER DOMAIN; BINDING; ENSEMBLES; GUANINE; MECHANISM	Riboswitches are gene regulation elements in mRNA that function by specifically responding to metabolites. Although the metabolite-bound states of riboswitches have proven amenable to structure determination efforts, knowledge of the structural features of riboswitches in their ligand-free forms and their ligand-response mechanisms giving rise to regulatory control is lacking. Here we explore the ligand-induced folding process of the S-adenosylmethionine type II (SAM-II) riboswitch using chemical and biophysical methods, including NMR and fluorescence spectroscopy, and single-molecule fluorescence imaging. The data reveal that the unliganded SAM-II riboswitch is dynamic in nature, in that its stem-loop element becomes engaged in a pseudoknot fold through base-pairing with nucleosides in the 3' overhang containing the Shine-Dalgarno sequence. Although the pseudoknot structure is highly transient in the absence of its ligand, S-adenosylmethionine (SAM), it becomes conformationally restrained upon ligand recognition, through a conformational capture mechanism. These insights provide a molecular understanding of riboswitch dynamics that shed new light on the mechanism of riboswitch-mediated translational regulation.	[Haller, Andrea; Rieder, Ulrike; Aigner, Michaela; Micura, Ronald] Univ Innsbruck, Ctr Mol Biosci, Inst Organ Chem, A-6020 Innsbruck, Austria; [Blanchard, Scott C.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA	University of Innsbruck; Cornell University	Haller, A (corresponding author), Univ Innsbruck, Ctr Mol Biosci, Inst Organ Chem, A-6020 Innsbruck, Austria.	scb2005@med.cornell.edu; ronald.micura@uibk.ac.at	Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365	Austrian Science Foundation FWF [I317, P21641]; Austrian Ministry of Science and Research [P0726-012-012]; Irma T. Hirschl/Monique Weill-Caulier Trust; Austrian Science Fund (FWF) [I 317] Funding Source: researchfish	Austrian Science Foundation FWF(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research; Irma T. Hirschl/Monique Weill-Caulier Trust; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank D. Lafontaine for discussions on labeling of riboswitches for smFRET experiments; K. Lang (University of Innsbruck; presently at Medical Research Council, Cambridge) for a previous synthesis of <SUP>15</SUP>N-labeled cytidine phosphoramidite; C. Kreutz and M. Tollinger for NMR assistance; D. S. Terry for contributions to the development and implementation of the single-molecule imaging platform and data analysis software used; and M. Souliere for critical reading of the manuscript. This work was funded by the Austrian Science Foundation FWF (I317 and P21641 to R. M.) and the Austrian Ministry of Science and Research (GenAU project consortium 'non-coding RNAs' P0726-012-012 to R. M.). S. C. B. was supported by the Irma T. Hirschl/Monique Weill-Caulier Trust.	Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Aleman EA, 2008, CURR OPIN CHEM BIOL, V12, P647, DOI 10.1016/j.cbpa.2008.09.010; Baird NJ, 2010, RNA, V16, P598, DOI 10.1261/rna.1852310; Blouin S, 2009, CHEMBIOCHEM, V10, P400, DOI 10.1002/cbic.200800593; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Duchardt-Ferner E, 2010, ANGEW CHEM INT EDIT, V49, P6216, DOI 10.1002/anie.201001339; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Frank AT, 2009, NUCLEIC ACIDS RES, V37, P3670, DOI 10.1093/nar/gkp156; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Kelley JM, 2010, NUCLEIC ACIDS RES, V38, P1392, DOI 10.1093/nar/gkp1106; Lang K, 2007, NUCLEIC ACIDS RES, V35, P5370, DOI 10.1093/nar/gkm580; Lang K, 2008, NAT PROTOC, V3, P1457, DOI 10.1038/nprot.2008.135; Lee MK, 2010, P NATL ACAD SCI USA, V107, P9192, DOI 10.1073/pnas.1001195107; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Lu CR, 2010, J MOL BIOL, V404, P803, DOI 10.1016/j.jmb.2010.09.059; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Munro JB, 2010, NAT STRUCT MOL BIOL, V17, P1470, DOI 10.1038/nsmb.1925; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P5262, DOI 10.1093/nar/gkm565; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Puffer B, 2009, NUCLEIC ACIDS RES, V37, P7728, DOI 10.1093/nar/gkp862; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rieder U, 2010, P NATL ACAD SCI USA, V107, P10804, DOI 10.1073/pnas.0914925107; Rieder U, 2009, CHEMBIOCHEM, V10, P1141, DOI 10.1002/cbic.200900155; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Schwalbe H, 2007, ANGEW CHEM INT EDIT, V46, P1212, DOI 10.1002/anie.200604163; Serganov A, 2002, J MOL BIOL, V320, P963, DOI 10.1016/S0022-2836(02)00553-3; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2010, RNA BIOL, V7, P98, DOI 10.4161/rna.7.1.10756; Staple DW, 2005, PLOS BIOL, V3, P956, DOI 10.1371/journal.pbio.0030213; Stelzer AC, 2010, ANGEW CHEM INT EDIT, V49, P5731, DOI 10.1002/anie.201000814; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Wang JX, 2008, BIOCHEM CELL BIOL, V86, P157, DOI 10.1139/O08-008; Weeks KM, 2010, CURR OPIN STRUC BIOL, V20, P295, DOI 10.1016/j.sbi.2010.04.001; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wilson RC, 2011, J MOL BIOL, V405, P926, DOI 10.1016/j.jmb.2010.10.056	50	125	130	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					393	400		10.1038/NCHEMBIO.562	http://dx.doi.org/10.1038/NCHEMBIO.562			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21532598				2022-12-27	WOS:000290677900015
J	Heppell, B; Blouin, S; Dussault, AM; Mulhbacher, J; Ennifar, E; Penedo, JC; Lafontaine, DA				Heppell, Benoit; Blouin, Simon; Dussault, Anne-Marie; Mulhbacher, Jerome; Ennifar, Eric; Penedo, J. Carlos; Lafontaine, Daniel A.			Molecular insights into the ligand-controlled organization of the SAM-I riboswitch	NATURE CHEMICAL BIOLOGY			English	Article							MESSENGER-RNA ELEMENT; S-ADENOSYLMETHIONINE; APTAMER DOMAIN; GENE-EXPRESSION; TRANSCRIPTION TERMINATION; PURINE RIBOSWITCH; BINDING; FLUORESCENCE; ELECTROPHORESIS; CONFORMATION	S-adenosylmethionine (SAM) riboswitches are widespread in bacteria, and up to five different SAM riboswitch families have been reported, highlighting the relevance of SAM regulation. On the basis of crystallographic and biochemical data, it has been postulated, but never demonstrated, that ligand recognition by SAM riboswitches involves key conformational changes in the RNA architecture. We show here that the aptamer follows a two-step hierarchical folding selectively induced by metal ions and ligand binding, each of them leading to the formation of one of the two helical stacks observed in the crystal structure. Moreover, we find that the anti-antiterminator P1 stem is rotated along its helical axis upon ligand binding, a mechanistic feature that could be common to other riboswitches. We also show that the nonconserved P4 helical domain is used as an auxiliary element to enhance the ligand-binding affinity. This work provides the first comprehensive characterization, to our knowledge, of a ligand-controlled riboswitch folding pathway.	[Heppell, Benoit; Blouin, Simon; Dussault, Anne-Marie; Mulhbacher, Jerome; Lafontaine, Daniel A.] Univ Sherbrooke, Fac Sci, Dept Biol, Grp ARN,RNA Grp, Sherbrooke, PQ J1K 2R1, Canada; [Ennifar, Eric] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, Architecture & Reactiv ARN, F-67084 Strasbourg, France; [Penedo, J. Carlos] Univ St Andrews, Sch Phys & Astron, St Andrews, Fife, Scotland	University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of St Andrews	Heppell, B (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, Grp ARN,RNA Grp, Sherbrooke, PQ J1K 2R1, Canada.	jcp10@st-andrews.ac.uk; Daniel.Lafontaine@USherbrooke.ca	Penedo, Carlos/B-5568-2009	Penedo, Carlos/0000-0002-5807-5385; Blouin, Simon/0000-0001-8433-4654	Canadian Institutes of Health Research (CIHR); National Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank A. Lavigueur for critical reading of the manuscript. We also thank D. Norman and P. St.-Pierre for discussion. This work was supported by the Canadian Institutes of Health Research (CIHR). S. B. is supported by a studentship from the National Sciences and Engineering Research Council of Canada. D. A. L. is a CIHR New Investigator scholar as well as a Chercheur-boursier Junior 2 from the Fonds de la recherche en Sante du Quebec. J.C.P. thanks the UK Biological and Biotechnological Science Research Council. We are also grateful to T. Ha and S. McKinney (University of Illinois at Urbana-Champaign) for providing the source code software for hidden Markov analysis.	Baird NJ, 2010, RNA, V16, P598, DOI 10.1261/rna.1852310; Blouin S, 2011, NUCLEIC ACIDS RES, V39, P3373, DOI 10.1093/nar/gkq1247; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Edwards TE, 2007, CURR OPIN STRUC BIOL, V17, P273, DOI 10.1016/j.sbi.2007.05.004; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; Hennelly SP, 2011, NUCLEIC ACIDS RES, V39, P2416, DOI 10.1093/nar/gkq1096; Heppell B, 2008, BIOCHEMISTRY-US, V47, P1490, DOI 10.1021/bi701164y; Huang W, 2009, NUCLEIC ACIDS RES, V37, P6528, DOI 10.1093/nar/gkp664; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JN, 2009, ACS CHEM BIOL, V4, P915, DOI 10.1021/cb900146k; Lang K, 2007, NUCLEIC ACIDS RES, V35, P5370, DOI 10.1093/nar/gkm580; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lilley DMJ, 2000, METHOD ENZYMOL, V317, P368; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; LUMPKIN OJ, 1982, BIOPOLYMERS, V21, P2315, DOI 10.1002/bip.360211116; Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307; McDaniel BA, 2005, MOL MICROBIOL, V57, P1008, DOI 10.1111/j.1365-2958.2005.04740.x; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Mulhbacher J, 2010, CURR OPIN PHARMACOL, V10, P551, DOI 10.1016/j.coph.2010.07.002; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Schwalbe H, 2007, ANGEW CHEM INT EDIT, V46, P1212, DOI 10.1002/anie.200604163; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Tomsic J, 2008, J BACTERIOL, V190, P823, DOI 10.1128/JB.01034-07; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Weinberg Z, 2008, RNA, V14, P822, DOI 10.1261/rna.988608; Whitford PC, 2009, BIOPHYS J, V96, pL7, DOI 10.1016/j.bpj.2008.10.033; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967	49	85	85	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					384	392		10.1038/NCHEMBIO.563	http://dx.doi.org/10.1038/NCHEMBIO.563			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21532599				2022-12-27	WOS:000290677900014
J	Goris, T; Wait, AF; Saggu, M; Fritsch, J; Heidary, N; Stein, M; Zebger, I; Lendzian, F; Armstrong, FA; Friedrich, B; Lenz, O				Goris, Tobias; Wait, Annemarie F.; Saggu, Miguel; Fritsch, Johannes; Heidary, Nina; Stein, Matthias; Zebger, Ingo; Lendzian, Friedhelm; Armstrong, Fraser A.; Friedrich, Baerbel; Lenz, Oliver			A unique iron-sulfur cluster is crucial for oxygen tolerance of a [NiFe]-hydrogenase	NATURE CHEMICAL BIOLOGY			English	Article							MEMBRANE-BOUND HYDROGENASE; RALSTONIA-EUTROPHA H16; ALCALIGENES-EUTROPHUS; NIFE HYDROGENASE; O-2; ACTIVATION; OXIDATION; SUBUNIT; PROTEIN; H-2	Hydrogenases are essential for H-2 cycling in microbial metabolism and serve as valuable blueprints for H-2-based biotechnological applications. However, most hydrogenases are extremely oxygen sensitive and prone to inactivation by even traces of O-2. The O-2-tolerant membrane-bound [NiFe]-hydrogenase of Ralstonia eutropha H16 is one of the few examples that can perform H-2 uptake in the presence of ambient O-2. Here we show that O-2 tolerance is crucially related to a modification of the internal electron-transfer chain. The iron-sulfur cluster proximal to the active site is surrounded by six instead of four conserved coordinating cysteines. Removal of the two additional cysteines alters the electronic structure of the proximal iron-sulfur cluster and renders the catalytic activity sensitive to O-2 as shown by physiological, biochemical, spectroscopic and electrochemical studies. The data indicate that the mechanism of O-2 tolerance relies on the reductive removal of oxygenic species guided by the unique architecture of the electron relay rather than a restricted access of O-2 to the active site.	[Goris, Tobias; Fritsch, Johannes; Friedrich, Baerbel; Lenz, Oliver] Humboldt Univ, Inst Biol Mikrobiol, Berlin, Germany; [Wait, Annemarie F.; Armstrong, Fraser A.] Univ Oxford, Dept Chem, Inorgan Chem Lab, Oxford, England; [Saggu, Miguel; Heidary, Nina; Zebger, Ingo; Lendzian, Friedhelm] Tech Univ Berlin, Inst Chem, Berlin, Germany; [Stein, Matthias] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany	Humboldt University of Berlin; University of Oxford; Technical University of Berlin; Max Planck Society	Lenz, O (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Berlin, Germany.	oliver.lenz@cms.hu-berlin.de	Goris, Tobias/I-9370-2019; Lenz, Oliver/C-1582-2019; Stein, Matthias/A-2865-2011; Saggu, Miguel/B-1224-2009; Lenz, Oliver/N-5130-2019	Goris, Tobias/0000-0002-9977-5994; Lenz, Oliver/0000-0003-4550-5128; Stein, Matthias/0000-0001-7793-0052; Lenz, Oliver/0000-0003-4550-5128	German Federal ministry of Education and Research; Deutsche Forschungsgemeinschaft; European Union; Klaus Tschira Foundation; Max Planck Society for the Advancement of Science; Engineering and Physical Sciences Research Council UK; Biotechnology and Biological Sciences Research Council UK; Biotechnology and Biological Sciences Research Council [BB/H003878/1] Funding Source: researchfish; BBSRC [BB/H003878/1] Funding Source: UKRI	German Federal ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Klaus Tschira Foundation; Max Planck Society for the Advancement of Science(Max Planck SocietyEuropean Commission); Engineering and Physical Sciences Research Council UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors wish to thank J. Priebe for obtaining preliminary EPR results, J. Hamann and A. Strack for excellent technical assistance and P. Hildebrandt and R. Bittl for generous support. This work was supported by the German Federal ministry of Education and Research (T. G.; BMBF project "H2 Design Cells"), the Deutsche Forschungsgemeinschaft (M. Saggu, N.H., I.Z., B. F., O.L.; Cluster of Excellence "UniCat"), the FP7 of the European Union (J. F.; energy network project SOLAR-H2), the Klaus Tschira Foundation and the Max Planck Society for the Advancement of Science (M. Stein), and the Engineering and Physical Sciences Research Council UK (A. F. W., F. A. A; Grant Supergen 5) and the Biotechnology and Biological Sciences Research Council UK (A. F. W., F. A. A; Grant BB/H003878/1).	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BARD AJ, 2001, ELECTROCHEMICAL METH, pCH6; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CAMMACK R, 1982, ELECTRON TRANSPORT O, P411; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Cracknell JA, 2008, J AM CHEM SOC, V130, P424, DOI 10.1021/ja078299+; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; Goldet G, 2008, J AM CHEM SOC, V130, P11106, DOI 10.1021/ja8027668; Hamann N, 2007, BIOCHEMISTRY-US, V46, P12875, DOI 10.1021/bi700679u; Happe RP, 1997, NATURE, V385, P126, DOI 10.1038/385126a0; HEERING HA, 1995, BIOCHEMISTRY-US, V34, P14675, DOI 10.1021/bi00045a008; HEERING HA, 1995, EUR J BIOCHEM, V232, P811, DOI 10.1111/j.1432-1033.1995.811zz.x; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamle SE, 2004, J AM CHEM SOC, V126, P14899, DOI 10.1021/ja047939v; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Lubner CE, 2010, BIOCHEMISTRY-US, V49, P404, DOI 10.1021/bi901704v; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Ogata H, 2009, DALTON T, P7577, DOI 10.1039/b903840j; Pandelia ME, 2010, J AM CHEM SOC, V132, P6991, DOI 10.1021/ja910838d; Saggu M, 2010, PHYS CHEM CHEM PHYS, V12, P2139, DOI 10.1039/b922236g; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; SCHWARTZ E, 2006, PROKARYOTES, V3, P496; Tran PD, 2010, ENERG ENVIRON SCI, V3, P727, DOI 10.1039/b926749b; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Volbeda A, 2002, INT J HYDROGEN ENERG, V27, P1449, DOI 10.1016/S0360-3199(02)00072-1; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0	50	189	188	3	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					310	U87		10.1038/nchembio.555	http://dx.doi.org/10.1038/nchembio.555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21390036				2022-12-27	WOS:000289617800015
J	Liu, YC; Li, YS; Lyu, SY; Hsu, LJ; Chen, YH; Huang, YT; Chan, HC; Huang, CJ; Chen, GH; Chou, CC; Tsai, MD; Li, TL				Liu, Yu-Chen; Li, Yi-Shan; Lyu, Syue-Yi; Hsu, Li-Jen; Chen, Yu-Hou; Huang, Yu-Ting; Chan, Hsiu-Chien; Huang, Chuen-Jiuan; Chen, Gan-Hong; Chou, Chia-Cheng; Tsai, Ming-Daw; Li, Tsung-Lin			Interception of teicoplanin oxidation intermediates yields new antimicrobial scaffolds	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; GENE-CLUSTER; LIPOGLYCOPEPTIDE; OXIDASE; BIOSYNTHESIS; DALBAVANCIN; ANTIBACTERIALS; GLYCOPEPTIDES; DEHYDROGENASE; INFECTIONS	In the search for new efficacious antibiotics, biosynthetic engineering offers attractive opportunities to introduce minor alterations to antibiotic structures that may overcome resistance. Dbv29, a flavin-containing oxidase, catalyzes the four-electron oxidation of a vancomycin-like glycopeptide to yield A40926. Structural and biochemical examination of Dbv29 now provides insights into residues that govern flavinylation and activity, protein conformation and reaction mechanism. In particular, the serendipitous discovery of a reaction intermediate in the crystal structure led us to identify an unexpected opportunity to intercept the normal enzyme mechanism at two different points to create new teicoplanin analogs. Using this method, we synthesized families of antibiotic analogs with amidated and aminated lipid chains, some of which showed marked potency and efficacy against multidrug resistant pathogens. This method offers a new strategy for the development of chemical diversity to combat antibacterial resistance.	[Liu, Yu-Chen; Li, Yi-Shan; Lyu, Syue-Yi; Hsu, Li-Jen; Chen, Yu-Hou; Huang, Yu-Ting; Chan, Hsiu-Chien; Huang, Chuen-Jiuan; Chen, Gan-Hong; Tsai, Ming-Daw; Li, Tsung-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Liu, Yu-Chen] Acad Sinica, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 115, Taiwan; [Liu, Yu-Chen; Tsai, Ming-Daw] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Lyu, Syue-Yi] Natl Yang Ming Univ, Dept Microbiol & Immunol, Taipei 112, Taiwan; [Chen, Yu-Hou; Tsai, Ming-Daw] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Chou, Chia-Cheng] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan; [Li, Tsung-Lin] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Synchrotron Radiation Research Center; National Chung Hsing University	Li, TL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	tlli@gate.sinica.edu.tw	Liu, Yu-Chen/B-5013-2009; HUANG, CHUEN-JIUAN/O-5472-2017; Tsai, Ming-Daw/G-4689-2019	Liu, Yu-Chen/0000-0002-7232-144X; HUANG, CHUEN-JIUAN/0000-0002-4818-0894; Tsai, Ming-Daw/0000-0003-1374-0414	National Science Council of Taiwan [96-2628B-001-026-MY3, 98-2311-B-001-014-MY3]; Academia Sinica intramural; National Research Program for Genomic Medicine; National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica intramural; National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The research was supported by the National Science Council of Taiwan (grants 96-2628B-001-026-MY3 and 98-2311-B-001-014-MY3 to T.-L. L.) and Academia Sinica intramural funding. X-ray diffraction was carried out at the Protein Crystallography Facility at the National Synchrotron Radiation Research Center, supported by the National Research Program for Genomic Medicine and the National Science Council of Taiwan. We thank C.-Y. Wu (Academia Sinica) for providing 5-azide pentylamine.	Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Bailey J, 2008, AM J HEALTH-SYST PH, V65, P599, DOI 10.2146/ajhp070255; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chan HC, 2011, MOL BIOSYST, V7, P1224, DOI 10.1039/c0mb00320d; Donadio S, 2008, CURR TOP MED CHEM, V8, P654, DOI 10.2174/156802608784221541; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Higgins DL, 2005, ANTIMICROB AGENTS CH, V49, P1127, DOI 10.1128/AAC.49.3.1127-1134.2005; Ho JY, 2006, J AM CHEM SOC, V128, P13694, DOI 10.1021/ja0644834; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kim A, 2007, EXPERT OPIN INV DRUG, V16, P717, DOI 10.1517/13543784.16.5.717; Koteva K, 2010, NAT CHEM BIOL, V6, P327, DOI 10.1038/nchembio.350; Leskovac V, 2005, INT J BIOCHEM CELL B, V37, P731, DOI 10.1016/j.biocel.2004.10.014; Li TL, 2004, CHEM BIOL, V11, P107, DOI 10.1016/j.chembiol.2004.01.001; Li YS, 2007, J AM CHEM SOC, V129, P13384, DOI 10.1021/ja075748x; Linden PK, 2008, EXPERT REV ANTI-INFE, V6, P917, DOI 10.1586/14787210.6.6.917; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rice LB, 2006, AM J INFECT CONTROL, V34, pS11, DOI 10.1016/j.ajic.2006.05.220; Roecker AM, 2008, EXPERT OPIN PHARMACO, V9, P1745, DOI [10.1517/14656566.9.10.1745, 10.1517/14656566.9.10.1745 ]; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Snook CF, 2003, BIOCHEMISTRY-US, V42, P4658, DOI 10.1021/bi027328k; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whittaker JW, 2003, CHEM REV, V103, P2347, DOI 10.1021/cr020425z; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123	32	51	52	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					304	309		10.1038/nchembio.556	http://dx.doi.org/10.1038/nchembio.556			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21478878	Green Submitted			2022-12-27	WOS:000289617800014
J	Ye, JQ; Chen, SB; Maniatis, T				Ye, Junqiang; Chen, Shuibing; Maniatis, Tom			Cardiac glycosides are potent inhibitors of interferon-beta gene expression	NATURE CHEMICAL BIOLOGY			English	Article							DOUBLE-STRANDED-RNA; RIG-I; KAPPA-B; ANTIVIRAL RESPONSES; BINDING SITE; INNATE; ADAPTER; DOMAIN; ACTIVATION; INDUCTION	Here we report that bufalin and other cardiac glycoside inhibitors of the sodium-potassium ATPase (sodium pump) potently inhibit the induction of the interferon-beta (IFN beta) gene by virus, double-stranded RNA or double-stranded DNA. Cardiac glycosides increase the intracellular sodium concentration, which appears to inhibit the ATPase activity of the RNA sensor RIG-I, an essential and early component in the IFN beta activation pathway. This, in turn, prevents the activation of the critical transcription factors IRF3 and NF kappa B. Bufalin inhibition can be overcome by expressing a drug-resistant variant of the sodium pump and knocking down the pump by short hairpin RNA inhibits IFN beta expression. Thus, bufalin acts exclusively through the sodium pump. We also show that bufalin inhibits tumor necrosis factor (TNF) signaling, at least in part by interfering with the nuclear translocation of NF kappa B. These findings suggest that bufalin could be used to treat inflammatory and autoimmune diseases in which IFN or TNF are hyperactivated.	[Ye, Junqiang; Maniatis, Tom] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Chen, Shuibing] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Maniatis, T (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	tm2472@mail.cumc.columbia.edu		Ye, Junqiang/0000-0002-4529-0713	US National Institutes of Health [5R01AI020642-26]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020642] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by US National Institutes of Health grant 5R01AI020642-26 (to T. M.). S. C. is supported by the postdoctoral fellowship from Juvenile Diabetes Research Foundation. We thank X. Sun (Brandeis University) for help with the microarray analysis. We also thank S.-L. Ng for critical reading of this manuscript and S. Schalm for helpful discussions.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Ford E, 2010, BBA-GENE REGUL MECH, V1799, P328, DOI 10.1016/j.bbagrm.2010.01.010; Fujita T, 2009, IMMUNITY, V31, P4, DOI 10.1016/j.immuni.2009.06.014; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; GARVIN JL, 1985, J MEMBRANE BIOL, V87, P45, DOI 10.1007/BF01870698; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; IZQUIERDO I, 1990, TRENDS PHARMACOL SCI, V11, P309, DOI 10.1016/0165-6147(90)90229-2; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; LANGER GA, 1977, ANNU REV MED, V28, P13, DOI 10.1146/annurev.me.28.020177.000305; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Meng ZQ, 2009, CANCER-AM CANCER SOC, V115, P5309, DOI 10.1002/cncr.24602; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Ronnblom L, 2010, NAT REV RHEUMATOL, V6, P339, DOI 10.1038/nrrheum.2010.64; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Sun LJ, 2010, CELL, V140, P436, DOI 10.1016/j.cell.2010.01.041; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yang QF, 2005, P NATL ACAD SCI USA, V102, P9631, DOI 10.1073/pnas.0504097102; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	48	40	44	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					25	33		10.1038/NCHEMBIO.476	http://dx.doi.org/10.1038/NCHEMBIO.476			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21076398	Green Accepted			2022-12-27	WOS:000285383400009
J	Flower, DR				Flower, Darren R.			Designing immunogenic peptides	NATURE CHEMICAL BIOLOGY			English	Article							IN-VITRO ANALYSIS; BIOINFORMATIC APPROACH; PREDICTION; BINDING; SUPERTYPES; SILICO	Peptides fulfill many roles in immunology, yet none are more important than their role as immunogenic epitopes driving the adaptive immune response, our ultimate bulwark against infectious disease. Peptide epitopes are mediated primarily by their interaction with major histocompatibility complexes (T-cell epitopes) and antibodies (B-cell epitopes). As pathogen genomes continue to be revealed, both experimental and computational epitope mapping are becoming crucial tools in vaccine discovery(1,2). Immunoinformatics offers many tools, techniques and approaches for in silico epitope characterization, which is capable of greatly accelerating epitope design.	Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Flower, DR (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	d.r.flower@aston.ac.uk	Flower, Darren/F-1263-2010	Flower, Darren/0000-0002-8542-7067				Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Deavin AJ, 1996, MOL IMMUNOL, V33, P145, DOI 10.1016/0161-5890(95)00120-4; Donnes P, 2005, PROTEIN SCI, V14, P2132, DOI 10.1110/ps.051352405; Doytchinova IA, 2006, J MED CHEM, V49, P2193, DOI 10.1021/jm050876m; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Doytchinova IA, 2004, J IMMUNOL, V172, P7495, DOI 10.4049/jimmunol.172.12.7495; Flower Darren R, 2010, Immunome Res, V6 Suppl 2, pS4, DOI 10.1186/1745-7580-6-S2-S4; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Knapp B, 2009, J COMPUT AID MOL DES, V23, P301, DOI 10.1007/s10822-009-9259-2; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Macdonald IK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001149; Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Ponomarenko JV, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-64; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Walshe VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008095	18	25	29	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					748	752		10.1038/nchembio.1383	http://dx.doi.org/10.1038/nchembio.1383			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24231606				2022-12-27	WOS:000327130000002
J	Hartwell, KA; Miller, PG; Mukherjee, S; Kahn, AR; Stewart, AL; Logan, DJ; Negri, JM; Duvet, M; Jaras, M; Puram, R; Dancik, V; Al-Shahrour, F; Kindler, T; Tothova, Z; Chattopadhyay, S; Hasaka, T; Narayan, R; Dai, MJ; Huang, C; Shterental, S; Chu, LP; Haydu, JE; Shieh, JH; Steensma, DP; Munoz, B; Bittker, JA; Shamji, AF; Clemons, PA; Tolliday, NJ; Carpenter, AE; Gilliland, DG; Stern, AM; Moore, MAS; Scadden, DT; Schreiber, SL; Ebert, BL; Golub, TR				Hartwell, Kimberly A.; Miller, Peter G.; Mukherjee, Siddhartha; Kahn, Alissa R.; Stewart, Alison L.; Logan, David J.; Negri, Joseph M.; Duvet, Mildred; Jaeras, Marcus; Puram, Rishi; Dancik, Vlado; Al-Shahrour, Fatima; Kindler, Thomas; Tothova, Zuzana; Chattopadhyay, Shrikanta; Hasaka, Thomas; Narayan, Rajiv; Dai, Mingji; Huang, Christina; Shterental, Sebastian; Chu, Lisa P.; Haydu, J. Erika; Shieh, Jae Hung; Steensma, David P.; Munoz, Benito; Bittker, Joshua A.; Shamji, Alykhan F.; Clemons, Paul A.; Tolliday, Nicola J.; Carpenter, Anne E.; Gilliland, D. Gary; Stern, Andrew M.; Moore, Malcolm A. S.; Scadden, David T.; Schreiber, Stuart L.; Ebert, Benjamin L.; Golub, Todd R.			Niche-based screening identifies small-molecule inhibitors of leukemia stem cells	NATURE CHEMICAL BIOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; PROGENITOR CELLS; STROMAL CELLS; PROTEIN TRANSFERASE; FREQUENCY-ANALYSIS; INDUCED APOPTOSIS; IN-VIVO; CANCER; GENES; MICE	Efforts to develop more effective therapies for acute leukemia may benefit from high-throughput screening systems that reflect the complex physiology of the disease, including leukemia stem cells (LSCs) and supportive interactions with the bone marrow microenvironment. The therapeutic targeting of LSCs is challenging because LSCs are highly similar to normal hematopoietic stem and progenitor cells (HSPCs) and are protected by stromal cells in vivo. We screened 14,718 compounds in a leukemia-stroma co-culture system for inhibition of cobblestone formation, a cellular behavior associated with stem-cell function. Among those compounds that inhibited malignant cells but spared HSPCs was the cholesterol-lowering drug lovastatin. Lovastatin showed anti-LSC activity in vitro and in an in vivo bone marrow transplantation model. Mechanistic studies demonstrated that the effect was on target, via inhibition of HMG-CoA reductase. These results illustrate the power of merging physiologically relevant models with high-throughput screening.	[Hartwell, Kimberly A.; Stewart, Alison L.; Logan, David J.; Negri, Joseph M.; Duvet, Mildred; Dancik, Vlado; Al-Shahrour, Fatima; Chattopadhyay, Shrikanta; Hasaka, Thomas; Narayan, Rajiv; Dai, Mingji; Huang, Christina; Munoz, Benito; Bittker, Joshua A.; Shamji, Alykhan F.; Clemons, Paul A.; Tolliday, Nicola J.; Carpenter, Anne E.; Gilliland, D. Gary; Stern, Andrew M.; Scadden, David T.; Schreiber, Stuart L.; Ebert, Benjamin L.; Golub, Todd R.] Broad Inst, Cambridge, MA 02142 USA; [Hartwell, Kimberly A.; Miller, Peter G.; Jaeras, Marcus; Puram, Rishi; Al-Shahrour, Fatima; Kindler, Thomas; Tothova, Zuzana; Shterental, Sebastian; Chu, Lisa P.; Haydu, J. Erika; Gilliland, D. Gary; Ebert, Benjamin L.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Hartwell, Kimberly A.; Miller, Peter G.; Jaeras, Marcus; Puram, Rishi; Al-Shahrour, Fatima; Kindler, Thomas; Tothova, Zuzana; Shterental, Sebastian; Chu, Lisa P.; Haydu, J. Erika; Steensma, David P.; Gilliland, D. Gary; Ebert, Benjamin L.; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA USA; [Mukherjee, Siddhartha; Duvet, Mildred; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Mukherjee, Siddhartha; Duvet, Mildred; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Kahn, Alissa R.; Shieh, Jae Hung] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Chattopadhyay, Shrikanta; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Dai, Mingji; Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Steensma, David P.; Gilliland, D. Gary; Ebert, Benjamin L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gilliland, D. Gary; Schreiber, Stuart L.; Golub, Todd R.] Harvard Univ, Howard Hughes Med Inst, Sch Med, Chevy Chase, MD USA; [Moore, Malcolm A. S.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Golub, TR (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	m-moore@ski.mskcc.org; dscadden@mgh.harvard.edu; stuart_schreiber@harvard.edu; bebert@partners.org; golub@broadinstitute.org	Carpenter, Anne/C-4982-2008; Kindler, Thomas/K-5995-2013; DAI, M/GPS-8291-2022	Carpenter, Anne/0000-0003-1555-8261; Miller, Peter/0000-0002-6797-9335; Kahn, Alissa/0000-0003-2248-8505; Steensma, David/0000-0001-5130-9284; Stern, Andrew/0000-0002-8437-2957; Jaras, Marcus/0000-0003-4080-7055	Starr Cancer Consortium (SCC) [l1 A50]; US National Institutes of Health [U54CA112962, U01HL1004402, T32 HL007623, T32 GM007753, N01-CO-12400, R01 GM089652, RL1CA133834, 20XS139, RL1HG004671, RL1GM084437, UL1RR024924]; US National Science Foundation [DBI 1148823]; NATIONAL CANCER INSTITUTE [RL1CA133834, K08CA158149, T32CA009172, U54CA112962, P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024924] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623, F32HL010044] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437, T32GM007753, R01GM089652] Funding Source: NIH RePORTER	Starr Cancer Consortium (SCC); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank L. VerPlank, V. Raksakulthai, A. Liberzon, M. Palmer, G. Cowley, J. Burbank, P. Aspesi Jr., M. Bliss-Moreau, D. Barker, B. Wagner, A. Krivtsov, S. A. Armstrong, R. Karmacharya, J. Perez, R. Onofrio, D. Thomas, R. Busanelli, D. Auclair, K. Masson, J. Du, C. Moore, M. Kharas, Y. Hoshida, D. Bachovchin, A. Mullally, J. Grabarek, A. Fraser, A. Basu, J. Cheah, N. Bodycombe, C. Mulrooney, S. Johnston, G. Walzer, D. Wilpitz, A. Bracha, A. Fabian, C. Hon, J. McGrath, C. Hartland, M. Hickey, T. R. Jones, M. Bray, K. Sokolnicki, R. Okabe, M. Paktinat, M. McConkey, L. Gaffney, L. Solomon, K. Rose and Broad Compound Management. We also thank the Golub, Gilliland and Ebert laboratories for scientific discussions and technical expertise. This work was funded by grants from the Starr Cancer Consortium (SCC Award l1 A50), the US National Institutes of Health (U54CA112962, U01HL1004402, T32 HL007623, T32 GM007753, N01-CO-12400, R01 GM089652, RL1CA133834, 20XS139, RL1HG004671, RL1CA133834, RL1GM084437 and UL1RR024924) and the US National Science Foundation (DBI 1148823). The content of this publication is solely the responsibility of the authors and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government. T. R. G., D. G. G. and S. L. S. are investigators at the Howard Hughes Medical Institute.	Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Costello RT, 2000, CANCER RES, V60, P4403; Despeaux M, 2011, LEUKEMIA, V25, P1789, DOI 10.1038/leu.2011.145; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Escuin D, 2009, CELL CYCLE, V8, P3914, DOI 10.4161/cc.8.23.10105; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gimble JM, 1996, MOL PHARMACOL, V50, P1087; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Konstantinopoulos PA, 2007, TRENDS PHARMACOL SCI, V28, P6, DOI 10.1016/j.tips.2006.11.005; Kornblau SM, 2007, BLOOD, V109, P2999, DOI 10.1182/blood-2006-08-044446; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Langdon Wallace Y., 2012, Critical Reviews in Oncogenesis, V17, P199; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Lobell RB, 2001, CANCER RES, V61, P8758; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Osmak M, 2012, CANCER LETT, V324, P1, DOI 10.1016/j.canlet.2012.04.011; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; PLOEMACHER RE, 1991, BLOOD, V78, P2527; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; STENTOFT J, 1990, DRUG SAFETY, V5, P7, DOI 10.2165/00002018-199005010-00003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terpstra W, 1996, BLOOD, V87, P2187, DOI 10.1182/blood.V87.6.2187.bloodjournal8762187; van Os Ronald P., 2008, V430, P143, DOI 10.1007/978-1-59745-182-6_10; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Williams AB, 2012, BLOOD, V120, P3069, DOI 10.1182/blood-2012-01-403493; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Yeh JRJ, 2009, NAT CHEM BIOL, V5, P236, DOI 10.1038/nchembio.147	52	86	88	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					840	+		10.1038/NCHEMBIO.1367	http://dx.doi.org/10.1038/NCHEMBIO.1367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24161946	Green Accepted			2022-12-27	WOS:000327130000017
J	Curanovic, D; Cohen, M; Singh, I; Slagle, CE; Leslie, CS; Jaffrey, SR				Curanovic, Dusica; Cohen, Michael; Singh, Irtisha; Slagle, Christopher E.; Leslie, Christina S.; Jaffrey, Samie R.			Global profiling of stimulus-induced polyadenylation in cells using a poly(A) trap	NATURE CHEMICAL BIOLOGY			English	Article							MATERNAL MESSENGER-RNAS; CYTOPLASMIC POLYADENYLATION; TRANSLATIONAL CONTROL; XENOPUS-OOCYTES; SACCHAROMYCES-CEREVISIAE; POLYMERASE; TAIL; FRACTIONATION; TRANSCRIPTION; ACTIVATION	Polyadenylation of mRNA leads to increased protein expression in response to diverse stimuli, but it is difficult to identify mRNAs that become polyadenylated in living cells. Here we describe a click chemistry-compatible nucleoside analog that is selectively incorporated into poly(A) tails of transcripts in cells. Next-generation sequencing of labeled mRNAs enables a transcriptome-wide profile of polyadenylation and provides insights into the mRNA sequence elements that are correlated with polyadenylation.	[Curanovic, Dusica; Cohen, Michael; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Cohen, Michael] Oregon Hlth & Sci Univ, Dept Pharmacol, Portland, OR USA; [Singh, Irtisha; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Slagle, Christopher E.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	Cornell University; Oregon Health & Science University; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill	Curanovic, D (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA.	srj2003@med.cornell.edu	Singh, Irtisha/W-6182-2019	Jaffrey, Samie/0000-0003-3615-6958; Singh, Irtisha/0000-0002-9460-3587	US National Institutes of Health-National Institute on Drug Abuse [T32DA007274]; US National Institute of Neurological Disorders and Stroke [R01NS56306]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007274] Funding Source: NIH RePORTER	US National Institutes of Health-National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Jaffrey lab for helpful comments and suggestions. We thank J. Richter (University of Massachusetts Medical School) for the antibody to CPEB. We gratefully acknowledge C. Bracken and N. Svensen for assistance with NMR spectroscopy. This work was supported by US National Institutes of Health-National Institute on Drug Abuse grant T32DA007274 (D.C. and M.C.) and US National Institute of Neurological Disorders and Stroke grant R01NS56306 (S.R.J.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beilharz TH, 2009, METHODS, V48, P294, DOI 10.1016/j.ymeth.2009.02.003; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Chen LS, 2004, J BIOL CHEM, V279, P40405, DOI 10.1074/jbc.M401752200; Cohen MS, 2011, P NATL ACAD SCI USA, V108, P11246, DOI 10.1073/pnas.1012401108; Cohen Sarah, 2009, J Vis Exp, DOI 10.3791/1106; Culp PA, 1998, DEV BIOL, V193, P63, DOI 10.1006/dbio.1997.8785; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Graindorge A, 2006, NUCLEIC ACIDS RES, V34, P986, DOI 10.1093/nar/gkj492; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; HOROWITZ B, 1976, ARCH BIOCHEM BIOPHYS, V172, P143, DOI 10.1016/0003-9861(76)90059-X; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; KREK W, 1995, METHOD ENZYMOL, V254, P114; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Martin G, 2004, J MOL BIOL, V341, P911, DOI 10.1016/j.jmb.2004.06.047; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Meijer HA, 2011, METHODS MOL BIOL, V703, P123, DOI 10.1007/978-1-59745-248-9_9; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; PARIS J, 1990, DEV BIOL, V140, P221, DOI 10.1016/0012-1606(90)90070-Y; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Rassa JC, 2000, VIROLOGY, V274, P438, DOI 10.1006/viro.2000.0494; SCHORDERET-SLATKINE S, 1972, Cell Differentiation, V1, P179, DOI 10.1016/0045-6039(72)90027-9; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311	29	46	46	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					671	+		10.1038/NCHEMBIO.1334	http://dx.doi.org/10.1038/NCHEMBIO.1334			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	23995769	Green Accepted, Green Submitted			2022-12-27	WOS:000325930500004
J	Giger, L; Caner, S; Obexer, R; Kast, P; Baker, D; Ban, N; Hilvert, D				Giger, Lars; Caner, Sami; Obexer, Richard; Kast, Peter; Baker, David; Ban, Nenad; Hilvert, Donald			Evolution of a designed retro-aldolase leads to complete active site remodeling	NATURE CHEMICAL BIOLOGY			English	Article							COMPUTATIONAL ENZYME DESIGN; SUBSTRATE-SPECIFICITY; DIRECTED EVOLUTION; MECHANISM; ANTIBODY; MODEL; OPTIMIZATION; CATALYSIS; SOFTWARE; ANALOG	Evolutionary advances are often fueled by unanticipated innovation. Directed evolution of a computationally designed enzyme suggests that pronounced molecular changes can also drive the optimization of primitive protein active sites. The specific activity of an artificial retro-aldolase was boosted >4,400-fold by random mutagenesis and screening, affording catalytic efficiencies approaching those of natural enzymes. However, structural and mechanistic studies reveal that the engineered catalytic apparatus, consisting of a reactive lysine and an ordered water molecule, was unexpectedly abandoned in favor of a new lysine residue in a substrate-binding pocket created during the optimization process. Structures of the initial in silico design, a mechanistically promiscuous intermediate and one of the most evolved variants highlight the importance of loop mobility and supporting functional groups in the emergence of the new catalytic center. Such internal competition between alternative reactive sites may have characterized the early evolution of many natural enzymes.	[Giger, Lars; Obexer, Richard; Kast, Peter; Hilvert, Donald] ETH, Lab Organ Chem, CH-8093 Zurich, Switzerland; [Caner, Sami; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch; hilvert@org.chem.ethz.ch	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217	Swiss National Science Foundation (SNSF); National Center of Excellence in Research Structural Biology program of the SNSF; ETH Zurich; Defense Advanced Research Projects Agency; Howard Hughes Medical Institute; Stipendienfonds der Schweizerischen Chemischen Industrie	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research Structural Biology program of the SNSF(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stipendienfonds der Schweizerischen Chemischen Industrie	We thank T. Tomizaki, M. Muller, V. Olieric, G. Pompidor and A. Pauluhn at the Swiss Light Source for their outstanding support and all of the members of the Ban laboratory for suggestions and discussions. We are also grateful to E. Althoff (University of Washington) for providing the genes for RA95.0 and RA95.5 and sharing data before publication and to D. Gillingham and S. Tonazzi (ETH Zurich) for inhibitor synthesis and substrate resolution. The authors acknowledge support from the Swiss National Science Foundation (SNSF) (N.B. and D. H.), the National Center of Excellence in Research Structural Biology program of the SNSF (N.B.), the ETH Zurich (P. K., N.B. and D. H.), the Defense Advanced Research Projects Agency (D. B. and D. H.) and the Howard Hughes Medical Institute (D. B.). L. G. was funded by the Stipendienfonds der Schweizerischen Chemischen Industrie.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Althoff EA, 2012, PROTEIN SCI, V21, P717, DOI 10.1002/pro.2059; Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Cauerhff A, 2004, P NATL ACAD SCI USA, V101, P3539, DOI 10.1073/pnas.0400060101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito G, 2002, FEBS LETT, V531, P152, DOI 10.1016/S0014-5793(02)03451-8; Gefflaut T, 1995, PROG BIOPHYS MOL BIO, V63, P301, DOI 10.1016/0079-6107(95)00008-9; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hennig M, 2002, J MOL BIOL, V319, P757, DOI 10.1016/S0022-2836(02)00378-9; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khersonsky O, 2012, P NATL ACAD SCI USA, V109, P10358, DOI 10.1073/pnas.1121063109; Kipnis Y, 2012, PROTEIN SCI, V21, P1388, DOI 10.1002/pro.2125; Kries H, 2013, CURR OPIN CHEM BIOL, V17, P221, DOI 10.1016/j.cbpa.2013.02.012; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lassila JK, 2010, P NATL ACAD SCI USA, V107, P4937, DOI 10.1073/pnas.0913638107; Leung DW, 1989, TECHNIQUE, V1, P11; List B, 1998, P NATL ACAD SCI USA, V95, P15351, DOI 10.1073/pnas.95.26.15351; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller MM, 2009, ANGEW CHEM INT EDIT, V48, P922, DOI 10.1002/anie.200804996; Neylon C, 2004, NUCLEIC ACIDS RES, V32, P1448, DOI 10.1093/nar/gkh315; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Ruscio JZ, 2009, J AM CHEM SOC, V131, P14111, DOI 10.1021/ja905396s; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; St-Jean M, 2009, BIOCHEMISTRY-US, V48, P4528, DOI 10.1021/bi8021558; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; TAGAKI W, 1991, TETRAHEDRON LETT, V32, P1207, DOI 10.1016/S0040-4039(00)92045-8; Tanaka F, 2005, BIOCHEMISTRY-US, V44, P7583, DOI 10.1021/bi050216j; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Turner JM, 2000, CHEM-EUR J, V6, P2772, DOI 10.1002/1521-3765(20000804)6:15<2772::AID-CHEM2772>3.0.CO;2-J; Wang L, 2012, J MOL BIOL, V415, P615, DOI 10.1016/j.jmb.2011.10.043; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Worsdorfer B, 2012, ACS CATAL, V2, P982, DOI 10.1021/cs300076t; Wymer N, 2001, STRUCTURE, V9, P1, DOI 10.1016/S0969-2126(00)00555-4; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	41	168	171	2	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2013	9	8					494	U49		10.1038/nchembio.1276	http://dx.doi.org/10.1038/nchembio.1276			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185FV	23748672	Green Accepted			2022-12-27	WOS:000321952700008
J	Grove, TL; Livada, J; Schwalm, EL; Green, MT; Booker, SJ; Silakov, A				Grove, Tyler L.; Livada, Jovan; Schwalm, Erica L.; Green, Michael T.; Booker, Squire J.; Silakov, Alexey			A substrate radical intermediate in catalysis by the antibiotic resistance protein Cfr	NATURE CHEMICAL BIOLOGY			English	Article							23S RIBOSOMAL-RNA; ADENOSYL-L-METHIONINE; STAPHYLOCOCCUS-AUREUS; 1ST REPORT; METHYLTRANSFERASE CFR; MEDIATED RESISTANCE; CONFERS RESISTANCE; BACTERIAL RIBOSOME; METHYL TRANSFER; LEADER PROGRAM	Cfr-dependent methylation of C8 of A2503 in 23S ribosomal RNA confers bacterial resistance to an array of clinically important antibiotics that target the large subunit of the ribosome, including the synthetic oxazolidinone antibiotic linezolid. The key element of the proposed mechanism for Cfr, a radical S-adenosylmethionine enzyme, is the addition of a methylene radical, generated by hydrogen-atom abstraction from the methyl group of an S-methylated cysteine, onto C8 of A2503 to form a protein-nucleic acid crosslinked species containing an unpaired electron. Herein we use continuous-wave and pulsed EPR techniques to provide direct spectroscopic evidence for this intermediate, showing a spin-delocalized radical with maximum spin density at N7 of the adenine ring. In addition, we use rapid freeze-quench EPR to show that the radical forms and decays with rate constants that are consistent with the rate of formation of the methylated product.	[Grove, Tyler L.; Livada, Jovan; Schwalm, Erica L.; Green, Michael T.; Booker, Squire J.; Silakov, Alexey] Penn State Univ, Dept Chem, University Pk, PA USA; [Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA USA.	sjb14@psu.edu; alexey.silakov@gmail.com	Silakov, Alexey/D-6318-2018	Silakov, Alexey/0000-0002-9285-1253	US National Institutes of Health [GM101957, GM101390]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101390, R01GM101957] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.M. Bollinger Jr. and C. Krebs for a critical reading of the manuscript, and we are also grateful to J. Niklas (Argonne National Laboratory) for helpful discussions. This work was supported by US National Institutes of Health grants GM101957 (S. J. B.) and GM101390 (M.T.G.).	[Anonymous], 2004, GAUSS V 3 REV E 01; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; BOLLINGER JM, 1995, METHOD ENZYMOL, V258, P278; Bonilla H, 2010, CLIN INFECT DIS, V51, P796, DOI 10.1086/656281; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Challand MR, 2011, NAT PROD REP, V28, P1696, DOI 10.1039/c1np00036e; Choffnes ER, 2010, ANTIBIOTIC RESISTANC; CLOSE DM, 1989, RADIAT RES, V117, P367, DOI 10.2307/3577344; Diaz L, 2012, ANTIMICROB AGENTS CH, V56, P3917, DOI 10.1128/AAC.00419-12; Diekema DJ, 2001, LANCET, V358, P1975, DOI 10.1016/S0140-6736(01)06964-1; Farrell DJ, 2011, ANTIMICROB AGENTS CH, V55, P3684, DOI 10.1128/AAC.01729-10; Farrell DJ, 2009, DIAGN MICR INFEC DIS, V65, P392, DOI 10.1016/j.diagmicrobio.2009.10.011; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hansen LH, 2012, ANTIMICROB AGENTS CH, V56, P3563, DOI 10.1128/AAC.00673-12; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13496, DOI 10.1021/bi048693+; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; Kim S, 2007, J PHYS CHEM A, V111, P6806, DOI 10.1021/jp070225x; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; McCusker KP, 2012, J AM CHEM SOC, V134, P18074, DOI 10.1021/ja307855d; Mendes RE, 2008, ANTIMICROB AGENTS CH, V52, P2244, DOI 10.1128/AAC.00231-08; Mendes RE, 2010, J ANTIMICROB CHEMOTH, V65, P2329, DOI 10.1093/jac/dkq331; Mendes RE, 2010, J CLIN MICROBIOL, V48, P3041, DOI 10.1128/JCM.00880-10; MINISCI F, 1973, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-1973-22123; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; PERDEW JP, 1988, PHYS REV B, V38, P12228, DOI 10.1103/PhysRevB.38.12228; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Garcia MS, 2010, JAMA-J AM MED ASSOC, V303, P2260, DOI 10.1001/jama.2010.757; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Schweiger A., 2001, PRINCIPLES PULSE ELE; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shore AC, 2010, ANTIMICROB AGENTS CH, V54, P4978, DOI 10.1128/AAC.01113-10; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Steitz TA, 2010, ANGEW CHEM INT EDIT, V49, P4381, DOI 10.1002/anie.201000708; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Weil JA, 2006, ELECT PARAMAGNETIC R, DOI [10.1002/0470084987, DOI 10.1002/0470084987]; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Zierhut M, 2004, PHYS CHEM CHEM PHYS, V6, P5178, DOI 10.1039/b411295d	59	34	34	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					422	+		10.1038/NCHEMBIO.1251	http://dx.doi.org/10.1038/NCHEMBIO.1251			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23644479	Green Accepted			2022-12-27	WOS:000320449700006
J	Lobera, M; Madauss, KP; Pohlhaus, DT; Wright, QG; Trocha, M; Schmidt, DR; Baloglu, E; Trump, RP; Head, MS; Hofmann, GA; Murray-Thompson, M; Schwartz, B; Chakravorty, S; Wu, ZN; Mander, PK; Kruidenier, L; Reid, RA; Burkhart, W; Turunen, BJ; Rong, JX; Wagner, C; Moyer, MB; Wells, C; Hong, X; Moore, JT; Williams, JD; Soler, D; Ghosh, S; Nolan, MA				Lobera, Mercedes; Madauss, Kevin P.; Pohlhaus, Denise T.; Wright, Quentin G.; Trocha, Mark; Schmidt, Darby R.; Baloglu, Erkan; Trump, Ryan P.; Head, Martha S.; Hofmann, Glenn A.; Murray-Thompson, Monique; Schwartz, Benjamin; Chakravorty, Subhas; Wu, Zining; Mander, Palwinder K.; Kruidenier, Laurens; Reid, Robert A.; Burkhart, William; Turunen, Brandon J.; Rong, James X.; Wagner, Craig; Moyer, Mary B.; Wells, Carrow; Hong, Xuan; Moore, John T.; Williams, Jon D.; Soler, Dulce; Ghosh, Shomir; Nolan, Michael A.			Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group	NATURE CHEMICAL BIOLOGY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; TRANSCRIPTION FACTOR; PROMOTES; REVEALS; KINASE; HDAC9; CSF	In contrast to studies on class I histone deacetylase (HDAC) inhibitors, the elucidation of the molecular mechanisms and therapeutic potential of class IIa HDACs (HDAC4, HDAC5, HDAC7 and HDAC9) is impaired by the lack of potent and selective chemical probes. Here we report the discovery of inhibitors that fill this void with an unprecedented metal-binding group, trifluoromethyloxadiazole (TFMO), which circumvents the selectivity and pharmacologic liabilities of hydroxamates. We confirm direct metal binding of the TFMO through crystallographic approaches and use chemoproteomics to demonstrate the superior selectivity of the TFMO series relative to a hydroxamate-substituted analog. We further apply these tool compounds to reveal gene regulation dependent on the catalytic active site of class IIa HDACs. The discovery of these inhibitors challenges the design process for targeting metalloenzymes through a chelating metal-binding group and suggests therapeutic potential for class IIa HDAC enzyme blockers distinct in mechanism and application compared to current HDAC inhibitors.	[Lobera, Mercedes; Wright, Quentin G.; Trocha, Mark; Schmidt, Darby R.; Baloglu, Erkan; Soler, Dulce; Ghosh, Shomir; Nolan, Michael A.] Tempero Pharmaceut, Cambridge, MA USA; [Madauss, Kevin P.; Pohlhaus, Denise T.; Trump, Ryan P.; Reid, Robert A.; Burkhart, William; Turunen, Brandon J.; Rong, James X.; Wagner, Craig; Moyer, Mary B.; Wells, Carrow; Moore, John T.; Williams, Jon D.] GlaxoSmithKline, Platform & Technol Sci, Res Triangle Pk, NC USA; [Head, Martha S.; Hofmann, Glenn A.; Murray-Thompson, Monique; Schwartz, Benjamin; Chakravorty, Subhas; Wu, Zining; Hong, Xuan] GlaxoSmithKline, Platform & Technol Sci, Collegeville, PA USA; [Mander, Palwinder K.; Kruidenier, Laurens] GlaxoSmithKline R&D, EpiNova DPU, Immunoinflammat Therapy Area, Med Res Ctr, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Lobera, M (corresponding author), Tempero Pharmaceut, Cambridge, MA USA.	mnolan@temperopharma.com		Wells, Carrow/0000-0003-4799-6792; Nolan, Michael/0000-0002-2581-0814; Wright, Quentin/0000-0001-9628-0200				Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baloglu E., 2011, US Provisional Patent Application, Patent No. [PCT/US2011/021089, 2011021089]; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Brockschmidt FF, 2011, BRIT J DERMATOL, V165, P1293, DOI 10.1111/j.1365-2133.2011.10708.x; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DasGupta S, 2009, BIOORGAN MED CHEM, V17, P444, DOI 10.1016/j.bmc.2008.11.067; Dorman G, 2010, DRUGS, V70, P949, DOI 10.2165/11318390-000000000-00000; Emanuele S, 2008, INT J ONCOL, V33, P637, DOI 10.3892/ijo_00000049; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Kewitz S, 2012, LEUKEMIA RES, V36, P773, DOI 10.1016/j.leukres.2012.02.021; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Quinti L., 2010, PLOS CURR-TREE LIFE, V2; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	33	227	236	3	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2013	9	5					319	+		10.1038/NCHEMBIO.1223	http://dx.doi.org/10.1038/NCHEMBIO.1223			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	127VT	23524983				2022-12-27	WOS:000317727600009
J	Polier, S; Samant, RS; Clarke, PA; Workman, P; Prodromou, C; Pearl, LH				Polier, Sigrun; Samant, Rahul S.; Clarke, Paul A.; Workman, Paul; Prodromou, Chrisostomos; Pearl, Laurence H.			ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system	NATURE CHEMICAL BIOLOGY			English	Article							HSP90 MOLECULAR CHAPERONE; B-RAF KINASE; STRUCTURAL BASIS; IN-VITRO; CDC37; BINDING; MECHANISM; DEGRADATION; ACTIVATION; BRAF	Protein kinase clients are recruited to the Hsp90 molecular chaperone system via Cdc37, which simultaneously binds Hsp90 and kinases and regulates the Hsp90 chaperone cycle. Pharmacological inhibition of Hsp90 in vivo results in degradation of kinase clients, with a therapeutic effect in dependent tumors. We show here that Cdc37 directly antagonizes ATP binding to client kinases, suggesting a role for the Hsp90-Cdc37 complex in controlling kinase activity. Unexpectedly, we find that Cdc37 binding to protein kinases is itself antagonized by ATP-competitive kinase inhibitors, including vemurafenib and lapatinib. In cancer cells, these inhibitors deprive oncogenic kinases such as B-Raf and ErbB2 of access to the Hsp90-Cdc37 complex, leading to their degradation. Our results suggest that at least part of the efficacy of ATP-competitive inhibitors of Hsp90-dependent kinases in tumor cells may be due to targeted chaperone deprivation.	[Polier, Sigrun; Prodromou, Chrisostomos; Pearl, Laurence H.] Univ Sussex, Sch Life Sci, MRC, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Samant, Rahul S.; Clarke, Paul A.; Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England	University of Sussex; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Polier, S (corresponding author), Univ Sussex, Sch Life Sci, MRC, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	sigrun.polier@sussex.ac.uk; paul.workman@icr.ac.uk; laurence.pearl@sussex.ac.uk	Prodromou, Chrisostomos/ABA-9133-2021; Samant, Rahul S/ABB-8354-2021	Prodromou, Chrisostomos/0000-0003-4320-1147; Samant, Rahul S/0000-0003-1952-259X; Pearl, Laurence/0000-0002-6910-1809; Clarke, Paul/0000-0001-9342-1290	UK National Health Service at The Institute of Cancer Research; Royal Marsden Hospital.; Medical Research Council; Cancer Research UK [C309/A8274]; European Molecular Biology Organization; Wellcome Trust [095605/Z/11/Z]; Cancer Research UK [11566] Funding Source: researchfish	UK National Health Service at The Institute of Cancer Research; Royal Marsden Hospital.(Royal Society of New ZealandMarsden Fund (NZ)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	We are grateful to L. Zhou (University of Sussex) for assistance with insect cell expression; to R. M. L. Morgan and S. Parry-Morris (both from University of Sussex) for provision of Hsp90 and Mek1 protein; S. H. Millson (University of Sheffield) for provision of Cak1p-containing pellets; J.R. Smith (The Institute of Cancer Research) for Cdc37 knockdown and overexpressing cell lines; and to A. W. Oliver and S. M. Roe (both from University of Sussex) for useful discussions. P. W., P. A. C. and R. S. S. acknowledge funding from the UK National Health Service to the National Institute for Health Research Biomedical Research Centre at The Institute of Cancer Research and Royal Marsden Hospital. L. H. P. acknowledges funding for the Genome Damage and Stability Centre from the Medical Research Council. This work was supported by Cancer Research UK Programme grant C309/A8274 (P. W.), a European Molecular Biology Organization Long-Term Fellowship (S. P.) and a Wellcome Trust Senior Investigator Award (095605/Z/11/Z to L. H. P.). P. W. is a Cancer Research UK Life Fellow.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Farrell A, 2000, MOL CELL BIOL, V20, P749, DOI 10.1128/MCB.20.3.749-754.2000; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Holford J, 1998, BRIT J CANCER, V77, P366, DOI 10.1038/bjc.1998.59; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Meier C, 2012, J STRUCT BIOL, V177, P329, DOI 10.1016/j.jsb.2012.01.002; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Nakatani H, 2005, CANCER SCI, V96, P116, DOI 10.1111/j.1349-7006.2005.00018.x; Ni DQ, 2000, PROTEIN SCI, V9, P1818, DOI 10.1110/ps.9.9.1818; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Prince T, 2005, BIOCHEM BIOPH RES CO, V338, P1447, DOI 10.1016/j.bbrc.2005.10.100; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Sharp SY, 2007, MOL CANCER THER, V6, P1198, DOI 10.1158/1535-7163.MCT-07-0149; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Smith J.R., 2008, THESIS U LONDON; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Terasawa K, 2005, FEBS J, V272, P4684, DOI 10.1111/j.1742-4658.2005.04884.x; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vaughan CK, 2009, FEBS J, V276, P199, DOI 10.1111/j.1742-4658.2008.06773.x; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhao Q, 2004, J BIOL CHEM, V279, P12560, DOI 10.1074/jbc.M308242200	48	104	109	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2013	9	5					307	+		10.1038/NCHEMBIO.1212	http://dx.doi.org/10.1038/NCHEMBIO.1212			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	127VT	23502424	Green Accepted			2022-12-27	WOS:000317727600007
J	Tang, WX; van der Donk, WA				Tang, Weixin; van der Donk, Wilfred A.			The sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry	NATURE CHEMICAL BIOLOGY			English	Article							FAECALIS CYTOLYSIN; GENETIC-ANALYSIS; HEMOLYSIN BACTERIOCIN; PROKARYOTIC CELLS; BIOSYNTHESIS; LANTIBIOTICS; TOXIN; DISCOVERY; SYSTEM; MODE	The enterococcal cytolysin is a two-component lantibiotic of unknown structure with hemolytic activity that is important for virulence. We prepared cytolysin by coexpression of each precursor peptide with the synthetase CylM in Escherichia con and characterized its structure. Unexpectedly, cytolysin is to our knowledge the first example of a lantibiotic containing lanthionine and methyllanthionine structures with different stereochemistries in the same peptide. The stereochemistry is determined by the sequence of the substrate peptide.	[Tang, Weixin; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Tang, Weixin; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	van der Donk, WA (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.	vddonk@illinois.edu	van der Donk, Wilfred/K-2961-2015	van der Donk, Wilfred/0000-0002-5467-7071; Tang, Weixin/0000-0002-5739-5416	US National Institutes of Health [GM58822]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058822, R37GM058822] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank X. Yang (University of Illinois) for providing the modified HaIA2 and Hal beta 3 peptides. This work was supported by the US National Institutes of Health (GM58822).	Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Booth MC, 1996, MOL MICROBIOL, V21, P1175, DOI 10.1046/j.1365-2958.1996.831449.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Cox CR, 2005, CURR PROTEIN PEPT SC, V6, P77, DOI 10.2174/1389203053027557; Garg N, 2012, P NATL ACAD SCI USA, V109, P5241, DOI 10.1073/pnas.1116815109; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; GILMORE MS, 1990, INFECT IMMUN, V58, P3914, DOI 10.1128/IAI.58.12.3914-3923.1990; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; Haas W, 1999, MED MICROBIOL IMMUN, V187, P183, DOI 10.1007/s004300050091; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; Hyink O, 2005, FEMS MICROBIOL LETT, V252, P235, DOI 10.1016/j.femsle.2005.09.003; IKE Y, 1990, J BACTERIOL, V172, P155, DOI 10.1128/JB.172.1.155-163.1990; IKE Y, 1984, J BACTERIOL, V158, P777, DOI 10.1128/JB.158.3.777-783.1984; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Liu W, 2011, J AM CHEM SOC, V133, P14216, DOI 10.1021/ja206017p; McClerren AL, 2006, P NATL ACAD SCI USA, V103, P17243, DOI 10.1073/pnas.0606088103; Ross AC, 2011, J ANTIBIOT, V64, P27, DOI 10.1038/ja.2010.136; SEGARRA RA, 1991, INFECT IMMUN, V59, P1239, DOI 10.1128/IAI.59.4.1239-1246.1991; Shi YX, 2011, J AM CHEM SOC, V133, P2338, DOI 10.1021/ja109044r; Tang WX, 2012, BIOCHEMISTRY-US, V51, P4271, DOI 10.1021/bi300255s; Yonezawa H, 2005, ANTIMICROB AGENTS CH, V49, P541, DOI 10.1128/AAC.49.2.541-548.2005	25	71	75	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					157	159		10.1038/NCHEMBIO.1162	http://dx.doi.org/10.1038/NCHEMBIO.1162			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23314913	Green Accepted			2022-12-27	WOS:000315132900009
J	Yoshikawa, K; Nakagawa, H; Mori, N; Watanabe, H; Touhara, K				Yoshikawa, Keiichi; Nakagawa, Hiroaki; Mori, Naoki; Watanabe, Hidenori; Touhara, Kazushige			An unsaturated aliphatic alcohol as a natural ligand for a mouse odorant receptor	NATURE CHEMICAL BIOLOGY			English	Article							VERTEBRATE OLFACTORY RECEPTORS; FUNCTIONAL EXPRESSION; RESPONSE ASSAYS; MICE; BULB; AGGRESSION; PHEROMONES	We report the identification of a physiological receptor-volatile pair in the mouse olfactory system. By activity-guided fractionation of exocrine gland extracts and subsequent chemical analysis, (Z)-5-tetradecen-1-ol was identified as a natural ligand for a mouse odorant receptor. (Z)-5-tetradecen-1-ol is excreted into male mouse urine under androgen control and enhances urine attractiveness to female mice. This report is to our knowledge the first to describe natural product-based deorphanization of an odorant receptor.	[Yoshikawa, Keiichi; Nakagawa, Hiroaki; Mori, Naoki; Watanabe, Hidenori; Touhara, Kazushige] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan	University of Tokyo	Touhara, K (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp		Yoshikawa, Keiichi/0000-0003-4790-4114	Ministry of Education, Culture, Sports, Science and Technology Japan [24227003]; Japan Society for the Promotion of Science (JSPS) [18077001]; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology Japan (grant 24227003), a Grant-in-Aid for Scientific Research on Priority Areas from the Japan Society for the Promotion of Science (JSPS) (grant 18077001) and a research grant from the Astellas Foundation for Research on Metabolic Disorders to K.T K.Y. was supported by a Grant-in-Aid for JSPS fellows. We thank T. Ando for Z8-14:OH (Tokyo University of Agriculture and Technology), and T. Kikusui and T. Hattori for advice on behavioral experiments.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; Bartell J.R., 1983, J CHEM ECOL, V9, P1343; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Civelli O, 1998, FEBS LETT, V430, P55, DOI 10.1016/S0014-5793(98)00524-9; EVANS CM, 1978, PHYSIOL BEHAV, V21, P19, DOI 10.1016/0031-9384(78)90270-6; JEMIOLO B, 1985, ANIM BEHAV, V33, P1114, DOI 10.1016/S0003-3472(85)80170-6; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; MUGFORD RA, 1972, HORM BEHAV, V3, P39, DOI 10.1016/0018-506X(72)90005-0; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Touhara K, 2007, NEUROCHEM INT, V51, P132, DOI 10.1016/j.neuint.2007.05.020; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; UEZONO Y, 1993, RECEPTOR CHANNEL, V1, P233; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Yoshikawa K, 2009, CHEM SENSES, V34, P15, DOI 10.1093/chemse/bjn047; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	23	37	38	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					160	162		10.1038/NCHEMBIO.1164	http://dx.doi.org/10.1038/NCHEMBIO.1164			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23314914				2022-12-27	WOS:000315132900010
J	Suzuki, KGN; Kasai, RS; Hirosawa, KM; Nemoto, YL; Ishibashi, M; Miwa, Y; Fujiwara, TK; Kusumi, A				Suzuki, Kenichi G. N.; Kasai, Rinshi S.; Hirosawa, Koichiro M.; Nemoto, Yuri L.; Ishibashi, Munenori; Miwa, Yoshihiro; Fujiwara, Takahiro K.; Kusumi, Akihiro			Transient GPI-anchored protein homodimers are units for raft organization and function	NATURE CHEMICAL BIOLOGY			English	Article							SINGLE-MOLECULE TRACKING; PLASMA-MEMBRANE; LIVING CELLS; LIVE CELLS; H-RAS; K-RAS; ACTIVATION; RECEPTOR; MICRODOMAINS; CHOLESTEROL	Advanced single-molecule fluorescent imaging was applied to study the dynamic organization of raft-associated glycosylphosphatidylinositol- anchored proteins (GPI-APs) in the plasma membrane and their stimulation-induced changes. In resting cells, virtually all of the GPI-APs are mobile and continually form transient (similar to 200 ms) homodimers (termed homodimer rafts) through ectodomain protein interactions, stabilized by the presence of the GPI-anchoring chain and cholesterol. Heterodimers do not form, suggesting a fundamental role for the specific ectodomain protein interaction. Under higher physiological expression conditions, homodimers coalesce to form hetero- and homo-GPI-AP oligomer rafts through raft-based lipid interactions. When CD59 was ligated, it formed stable oligomer rafts containing up to four CD59 molecules, which triggered intracellular Ca2+ responses that were dependent on GPI anchorage and cholesterol, suggesting a key part played by transient homodimer rafts. Transient homodimer rafts are most likely one of the basic units for the organization and function of raft domains containing GPI-APs.	[Suzuki, Kenichi G. N.; Hirosawa, Koichiro M.; Nemoto, Yuri L.; Ishibashi, Munenori; Fujiwara, Takahiro K.; Kusumi, Akihiro] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan; [Kasai, Rinshi S.; Kusumi, Akihiro] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan; [Suzuki, Kenichi G. N.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Miwa, Yoshihiro] Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Ibaraki, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of Tsukuba	Kusumi, A (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan.	akusumi@frontier.kyoto-u.ac.jp	Fujiwara, Takahiro/G-2755-2012; Kasai, Rinshi S./ABA-7656-2021	Fujiwara, Takahiro/0000-0001-5576-759X; Kasai, Rinshi S./0000-0002-9234-3283; Nemoto, Yuri/0000-0001-6159-3709; Ishibashi, Munenori/0000-0002-6922-573X; Suzuki, Kenichi/0000-0002-8436-5757	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government [A12020366, 23110002, 233306]; Development of Systems and Technology for Advanced Measurement and Analysis program of the Japan Science and Technology Agency [10101506]; Grants-in-Aid for Scientific Research [24115511] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Development of Systems and Technology for Advanced Measurement and Analysis program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank V. Horejsi (Institute of Molecular Genetics, Academy of Sciences of the Czech Republic), M. Tone (University of Oxford) and M. Maio (Istituto Nazionale di Ricovero e Cura a Carattere Scientifico) for the hybridoma lines that produce the CD59- and DAF-specific antibodies, the cDNA construct for human CD59, and that for CD59TM, respectively. This work was supported in part by Grants-in-Aid for Scientific Research (A12020366) and Specific Research on Innovative Areas (23110002, 233306) from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government and by the Development of Systems and Technology for Advanced Measurement and Analysis program of the Japan Science and Technology Agency (10101506).	Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Catino MA, 2008, TRAFFIC, V9, P2141, DOI 10.1111/j.1600-0854.2008.00826.x; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; De Nardo C, 2002, J CELL PHYSIOL, V190, P200, DOI 10.1002/JCP.10050; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dunne PD, 2009, BIOPHYS J, V97, pL5, DOI 10.1016/j.bpj.2009.05.046; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang YX, 2007, ACTA CRYSTALLOGR D, V63, P714, DOI 10.1107/S0907444907015557; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; KEUNING S, 1985, J BACTERIOL, V163, P635, DOI 10.1128/JB.163.2.635-639.1985; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lommerse PHM, 2006, BIOPHYS J, V91, P1090, DOI 10.1529/biophysj.105.079053; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Omidvar N, 2006, J IMMUNOL, V176, P2915, DOI 10.4049/jimmunol.176.5.2915; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Rivier AS, 2010, TRAFFIC, V11, P1017, DOI 10.1111/j.1600-0854.2010.01081.x; ROCK CO, 1979, J BIOL CHEM, V254, P9778; Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Wu M, 2004, P NATL ACAD SCI USA, V101, P13798, DOI 10.1073/pnas.0403835101; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	50	170	174	0	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					774	783		10.1038/NCHEMBIO.1028	http://dx.doi.org/10.1038/NCHEMBIO.1028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22820419				2022-12-27	WOS:000308077600009
J	Rubio-Texeira, M; Van Zeebroeck, G; Thevelein, JM				Rubio-Texeira, Marta; Van Zeebroeck, Griet; Thevelein, Johan M.			Peptides induce persistent signaling from endosomes by a nutrient transceptor	NATURE CHEMICAL BIOLOGY			English	Article							AMINO-ACID PERMEASE; YEAST SACCHAROMYCES-CEREVISIAE; INTRACELLULAR PH; PLASMA-MEMBRANE; NITROGEN-SOURCES; PROTEIN-KINASE; PATHWAY; TRAFFICKING; UBIQUITIN; ENDOCYTOSIS	The yeast Gap1 transceptor mediates amino acid activation of the protein kinase A pathway and undergoes endocytic internalization following amino acid transport. We identified three specific gamma-glutamyl dipeptides that cause persistent cyclic AMP-independent activation of protein kinase A, prevent Gap1 vacuolar sorting and cause Gap1 accumulation in endosomes. To our knowledge, these are the first examples of persistent agonists of a transceptor. In yeast mutants blocked in multivesicular body sorting, L-citrulline mimicked persistent signaling, further supporting that the internalized Gap1 transceptor keeps signaling. Unexpectedly, these dipeptides were transported by Gap1 and not by the regular dipeptide transporters. Their uptake was unusually sensitive to external pH and caused transient intracellular acidification. High external pH, NHA1 deletion or V-ATPase inhibition overcame the vacuolar sorting defect. Hence, this work has identified specific dipeptides that cause enhanced proton influx through the Gap1 symporter, resulting in its defective vacuolar sorting, and independently transform it into a persistently signaling transceptor.	[Rubio-Texeira, Marta; Van Zeebroeck, Griet; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Flanders, Belgium; [Rubio-Texeira, Marta; Van Zeebroeck, Griet; Thevelein, Johan M.] VIB, Dept Mol Microbiol, Flanders, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	Rubio-Texeira, M (corresponding author), Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Flanders, Belgium.	johan.thevelein@mmbio.vib-kuleuven.be	Thevelein, Johan M./AAK-4203-2021; Rubio-Texeira, Marta/G-5383-2013; Thevelein, Johan M./A-7897-2013	Rubio-Texeira, Marta/0000-0002-8332-2245; Thevelein, Johan M./0000-0002-2626-0180	European Commission; Fonds Wetenschappelijk Onderzoek; Fund for Scientific Research-Flanders; Interuniversity Attraction Poles Network [P6/14]; KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders)	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds Wetenschappelijk Onderzoek(FWO); Fund for Scientific Research-Flanders(FWO); Interuniversity Attraction Poles Network(Belgian Federal Science Policy Office); KU Leuven (Concerted Research Actions)(KU Leuven); Hercules Foundation (Flanders)	We would specially like to thank H. Sychrova and members of her laboratory, L. Maresova and O. Kinclova-Zimmermanova for their help and guidance in the intracellular pH measurements. We thank W. Verheyden and R. Wicik for technical help with the experiments, N. Vangoethem for help with preparation of the figures and V. Diaz for helping us with organochemistry calculations and concepts. We would also like to thank all researchers that have kindly provided us with strains, plasmids and antibodies from their laboratories (mentioned in Supplementary Tables 1 and 2). This work was supported by an European Commission-Marie Curie fellowship to M.R.-T., by Fonds Wetenschappelijk Onderzoek visiting and postdoctoral fellowships to M.R.-T. and G.V.Z. and by grants from the Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network P6/14, the Research Fund of the KU Leuven (Concerted Research Actions) and the Hercules Foundation (Flanders).	Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cai HJ, 2007, EUKARYOT CELL, V6, P1805, DOI 10.1128/EC.00257-06; Chen EJ, 2002, P NATL ACAD SCI USA, V99, P14837, DOI 10.1073/pnas.232591899; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; DURNEZ P, 1994, YEAST, V10, P1049, DOI 10.1002/yea.320100807; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Hauser M, 2000, J BIOL CHEM, V275, P3037, DOI 10.1074/jbc.275.5.3037; Hauser M, 2001, MOL MEMBR BIOL, V18, P105, DOI 10.1080/713816114; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; HOPKINS P, 1992, YEAST, V8, P1053, DOI 10.1002/yea.320081208; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Lafourcade C, 2004, MOL CELL BIOL, V24, P3815, DOI 10.1128/MCB.24.9.3815-3826.2004; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lundh F, 2009, BIOCHEMISTRY-US, V48, P4497, DOI 10.1021/bi9001198; Maresova L, 2010, YEAST, V27, P317, DOI 10.1002/yea.1755; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nikko E, 2003, J BIOL CHEM, V278, P50732, DOI 10.1074/jbc.M306953200; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Rajagopalan S, 2010, TRAFFIC, V11, P1381, DOI 10.1111/j.1600-0854.2010.01112.x; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Rubio-Texeira M, 2010, FEMS YEAST RES, V10, P134, DOI 10.1111/j.1567-1364.2009.00587.x; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sychrova H, 1999, FEMS MICROBIOL LETT, V171, P167, DOI 10.1111/j.1574-6968.1999.tb13428.x; THEVELEIN JM, 1991, MOL MICROBIOL, V5, P1301, DOI 10.1111/j.1365-2958.1991.tb00776.x; THEVELEIN JM, 1987, J GEN MICROBIOL, V133, P2191; THEVELEIN JM, 1985, J GEN MICROBIOL, V131, P3199; TREVILLYAN JM, 1979, J BACTERIOL, V138, P397, DOI 10.1128/JB.138.2.397-403.1979; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wiles AM, 2006, MICROBIOL-SGM, V152, P3133, DOI 10.1099/mic.0.29055-0	46	16	16	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					400	408		10.1038/NCHEMBIO.910	http://dx.doi.org/10.1038/NCHEMBIO.910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22388927				2022-12-27	WOS:000301890100015
J	Pless, SA; Galpin, JD; Niciforovic, AP; Ahern, CA				Pless, Stephan A.; Galpin, Jason D.; Niciforovic, Ana P.; Ahern, Christopher A.			Contributions of counter-charge in a potassium channel voltage-sensor domain	NATURE CHEMICAL BIOLOGY			English	Article							SHAKER K+ CHANNEL; FOCUSED ELECTRIC-FIELD; CATION-PI INTERACTIONS; ELECTROSTATIC INTERACTIONS; SENSING DOMAINS; GATING CURRENTS; SODIUM-CHANNELS; BINDING-SITE; TRANSMEMBRANE SEGMENTS; MEMBRANE ENVIRONMENT	Voltage-sensor domains couple membrane potential to conformational changes in voltage-gated ion channels and phosphatases. Highly coevolved acidic and aromatic side chains assist the transfer of cationic side chains across the transmembrane electric field during voltage sensing. We investigated the functional contribution of negative electrostatic potentials from these residues to channel gating and voltage sensing with unnatural amino acid mutagenesis, electrophysiology, voltage-clamp fluorometry and ab initio calculations. The data show that neutralization of two conserved acidic side chains in transmembrane segments S2 and 53, namely Glu293 and Asp316 in Shaker potassium channels, has little functional effect on conductance-voltage relationships, although Glu293 appears to catalyze S4 movement. Our results suggest that neither Glu293 nor Asp316 engages in electrostatic state-dependent charge-charge interactions with S4, likely because they occupy, and possibly help create, a water-filled vestibule.	[Pless, Stephan A.; Galpin, Jason D.; Niciforovic, Ana P.; Ahern, Christopher A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Pless, Stephan A.; Galpin, Jason D.; Niciforovic, Ana P.; Ahern, Christopher A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Pless, SA (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	cahern@interchange.ubc.ca		Pless, Stephan/0000-0001-6654-114X; Galpin, Jason/0000-0003-1923-5312; Ahern, Christopher/0000-0002-7975-2744	Canadian Institutes of Health Research [56858]; Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	We thank R. Horn, H. Kurata and S. Goodchild for helpful discussions. This work was supported by the Canadian Institutes of Health Research (56858), the Heart and Stroke Foundation of Canada, the Michael Smith Foundation for Health Research (to C.A.A.) and a postdoctoral fellowship from the Heart and Stroke Foundation of Canada (to SAP.).	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Cashin AL, 2007, BIOCHEMISTRY-US, V46, P630, DOI 10.1021/bi061638b; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chakrapani S, 2010, P NATL ACAD SCI USA, V107, P5435, DOI 10.1073/pnas.0914109107; Chanda B, 2008, NEURON, V57, P345, DOI 10.1016/j.neuron.2008.01.015; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; KELLY TR, 1994, J AM CHEM SOC, V116, P7072, DOI 10.1021/ja00095a009; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Lacroix JJ, 2011, BIOPHYS J, V100, pL28, DOI 10.1016/j.bpj.2011.01.043; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Wu D, 2010, J GEN PHYSIOL, V135, P595, DOI 10.1085/jgp.201010408; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	50	80	80	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					617	623		10.1038/NCHEMBIO.622	http://dx.doi.org/10.1038/NCHEMBIO.622			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21785425	Green Accepted			2022-12-27	WOS:000294381400012
J	Vinkenborg, JL; Karnowski, N; Famulok, M				Vinkenborg, Jan L.; Karnowski, Nora; Famulok, Michael			Aptamers for allosteric regulation	NATURE CHEMICAL BIOLOGY			English	Review							IN-VITRO SELECTION; GENE-EXPRESSION; DNA APTAMER; ARTIFICIAL RIBOSWITCHES; EXPERIMENTAL VALIDATION; SYNTHETIC RIBOSWITCHES; COLORIMETRIC DETECTION; MEDIATED REGULATION; RIBOZYME CLEAVAGE; CHEMICAL BIOLOGY	Aptamers are useful for allosteric regulation because they are nucleic acid-based structures in which ligand binding induces conformational changes that may alter the function of a connected oligonucleotide at a distant site. Through this approach, a specific input is efficiently converted into an altered output. This property makes these biomolecules ideally suited to function as sensors or switches in biochemical assays or inside living cells. The ability to select oligonucleotide-based recognition elements in vitro in combination with the availability of nucleic acids with enzymatic activity has led to the development of a wide range of engineered allosteric aptasensors and aptazymes. Here, we discuss recent progress in the screening, design and diversity of these conformational switching oligonucleotides. We cover their application in vitro and for regulating gene expression in both prokaryotes and eukaryotes.	[Vinkenborg, Jan L.; Karnowski, Nora; Famulok, Michael] Univ Bonn, Biol Chem Lab, Chem Biol & Med Chem Unit, Life & Med Sci Inst, D-5300 Bonn, Germany	University of Bonn	Vinkenborg, JL (corresponding author), Univ Bonn, Biol Chem Lab, Chem Biol & Med Chem Unit, Life & Med Sci Inst, D-5300 Bonn, Germany.	m.famulok@uni-bonn.de			Alexander von Humboldt Foundation; North Rhine-Westphalia research school 'LIMES Chemical Biology'; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; European Science Foundation; European Research Council	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); North Rhine-Westphalia research school 'LIMES Chemical Biology'; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Science Foundation(European Science Foundation (ESF)European Commission); European Research Council(European Research Council (ERC)European Commission)	We apologize to authors whose work we could not cite owing to space limitations. We are grateful for funding from the Alexander von Humboldt Foundation, the North Rhine-Westphalia research school 'LIMES Chemical Biology', the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Industrie, the European Science Foundation and the European Research Council. We also thank B. Weiche for reading the manuscript.	An CI, 2006, RNA, V12, P710, DOI 10.1261/rna.2299306; Auslander S, 2010, MOL BIOSYST, V6, P807, DOI 10.1039/b923076a; Beisel CL, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.62; Berschneider B, 2009, ANGEW CHEM INT EDIT, V48, P7564, DOI 10.1002/anie.200900851; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Buskirk AR, 2004, CHEM BIOL, V11, P1157, DOI 10.1016/j.chembiol.2004.05.017; Chelyapov N, 2006, BIOCHEMISTRY-US, V45, P2461, DOI 10.1021/bi052106i; Chen X, 2009, RNA, V15, P2035, DOI 10.1261/rna.1635209; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Chiuman W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001224; Cho EJ, 2005, J AM CHEM SOC, V127, P2022, DOI 10.1021/ja043490u; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Choi KH, 2006, MOL CANCER THER, V5, P2428, DOI 10.1158/1535-7163.MCT-05-0204; Constantin TP, 2008, ORG LETT, V10, P1561, DOI 10.1021/ol702920e; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Dixon N, 2010, P NATL ACAD SCI USA, V107, P2830, DOI 10.1073/pnas.0911209107; Elbaz J, 2010, NAT NANOTECHNOL, V5, P417, DOI [10.1038/NNANO.2010.88, 10.1038/nnano.2010.88]; Elbaz J, 2009, CHEM-EUR J, V15, P3411, DOI 10.1002/chem.200802004; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 1999, CURR TOP MICROBIOL, V243, P123; Famulok M, 2005, CURR OPIN MOL THER, V7, P137; Famulok M, 2001, CHEM BIOL, V8, P931, DOI 10.1016/S1074-5521(01)00070-9; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Fowler CC, 2008, CHEMBIOCHEM, V9, P1906, DOI 10.1002/cbic.200700713; Furutani C, 2010, MOL BIOSYST, V6, P1565, DOI 10.1039/c001230k; Golynskiy MV, 2011, CHEMBIOCHEM, V12, P353, DOI 10.1002/cbic.201000642; Hartig JS, 2002, NAT BIOTECHNOL, V20, P717, DOI 10.1038/nbt0702-717; Helm M, 2005, J AM CHEM SOC, V127, P10492, DOI 10.1021/ja052886i; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kim DE, 2004, CHEM BIOL, V11, P1505, DOI 10.1016/j.chembiol.2004.08.021; Kim DS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-23; Kim DS, 2005, RNA, V11, P1667, DOI 10.1261/rna.2162205; Klug SJ, 1997, P NATL ACAD SCI USA, V94, P6676, DOI 10.1073/pnas.94.13.6676; Kotter P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp578; Koizumi M, 1999, NAT STRUCT BIOL, V6, P1062; Kolpashchikov DM, 2005, J AM CHEM SOC, V127, P11348, DOI 10.1021/ja051362f; Kumar D, 2009, J AM CHEM SOC, V131, P13906, DOI 10.1021/ja905596t; Lam BJ, 2011, J AM CHEM SOC, V133, P3191, DOI 10.1021/ja111136d; Lam BJ, 2009, NAT BIOTECHNOL, V27, P288, DOI 10.1038/nbt.1528; Lee HK, 2007, CANCER RES, V67, P9315, DOI 10.1158/0008-5472.CAN-07-1128; Li T, 2008, CHEM COMMUN, P3654, DOI 10.1039/b805565c; Li T, 2010, ANAL CHEM, V82, P1515, DOI 10.1021/ac902638v; Li T, 2009, ANAL CHEM, V81, P2144, DOI 10.1021/ac900188y; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Liu JW, 2006, ADV MATER, V18, P1667, DOI 10.1002/adma.200600525; Liu JW, 2006, ANGEW CHEM INT EDIT, V45, P7955, DOI 10.1002/anie.200603106; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; Liu JW, 2004, ANAL CHEM, V76, P1627, DOI 10.1021/ac0351769; Lu N, 2009, ANALYST, V134, P1822, DOI 10.1039/b908018j; Lu N, 2008, CHEM COMMUN, P6161, DOI 10.1039/b810812a; Lynch SA, 2009, NUCLEIC ACIDS RES, V37, P184, DOI 10.1093/nar/gkn924; Mayer G, 2007, ANGEW CHEM INT EDIT, V46, P557, DOI 10.1002/anie.200603166; Mayer G, 2009, ANGEW CHEM INT EDIT, V48, P2672, DOI 10.1002/anie.200804643; Mazumdar D, 2010, CHEM COMMUN, V46, P1416, DOI 10.1039/b917772h; Muranaka N, 2009, CHEMBIOCHEM, V10, P2375, DOI 10.1002/cbic.200900313; Najafi-Shoushtari SH, 2007, BLOOD CELL MOL DIS, V38, P19, DOI 10.1016/j.bcmd.2006.10.007; Najafi-Shoushtari SH, 2004, NUCLEIC ACIDS RES, V32, P3212, DOI 10.1093/nar/gkh643; Nudler E, 2006, CELL, V126, P19, DOI 10.1016/j.cell.2006.06.024; Ogawa A, 2008, CHEMBIOCHEM, V9, P2204, DOI 10.1002/cbic.200800294; Ogawa A, 2008, CHEMBIOCHEM, V9, P206, DOI 10.1002/cbic.200700478; Ogawa A, 2011, RNA, V17, P478, DOI 10.1261/rna.2433111; Pelossof G, 2010, ANAL CHEM, V82, P4396, DOI 10.1021/ac100095u; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Piganeau N, 2001, J MOL BIOL, V312, P1177, DOI 10.1006/jmbi.2001.4981; Rentmeister A, 2007, NUCLEIC ACIDS RES, V35, P3713, DOI 10.1093/nar/gkm300; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Saito H, 2009, INT J BIOCHEM CELL B, V41, P398, DOI 10.1016/j.biocel.2008.08.017; Sekella PT, 2002, RNA, V8, P1242, DOI 10.1017/S1355838202028066; Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369; Soukup GA, 1999, TRENDS BIOTECHNOL, V17, P469, DOI 10.1016/S0167-7799(99)01383-9; Srinivasan J, 2004, CHEM BIOL, V11, P499, DOI 10.1016/j.chembiol.2004.03.014; Stojanovic MN, 2004, J AM CHEM SOC, V126, P9266, DOI 10.1021/ja032013t; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Suess B, 2003, NUCLEIC ACIDS RES, V31, P1853, DOI 10.1093/nar/gkg285; Suess B, 2008, RNA BIOL, V5, P24, DOI 10.4161/rna.5.1.5955; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; Teller C, 2009, ANAL CHEM, V81, P9114, DOI 10.1021/ac901773b; Tombelli S, 2005, BIOSENS BIOELECTRON, V20, P2424, DOI 10.1016/j.bios.2004.11.006; Topp S, 2008, CHEMBIOCHEM, V9, P210, DOI 10.1002/cbic.200700546; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Topp S, 2010, ACS CHEM BIOL, V5, P139, DOI 10.1021/cb900278x; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaish NK, 2002, NAT BIOTECHNOL, V20, P810, DOI 10.1038/nbt719; Vuyisich M, 2002, CHEM BIOL, V9, P907, DOI 10.1016/S1074-5521(02)00185-0; WALLIS MG, 1995, CHEM BIOL, V2, P543, DOI 10.1016/1074-5521(95)90188-4; Weigand JE, 2008, RNA, V14, P89, DOI 10.1261/rna.772408; Weigand JE, 2007, NUCLEIC ACIDS RES, V35, P4179, DOI 10.1093/nar/gkm425; Werstuck G, 1998, SCIENCE, V282, P296, DOI 10.1126/science.282.5387.296; Wieland M, 2008, CHEMBIOCHEM, V9, P1873, DOI 10.1002/cbic.200800154; Wieland M, 2008, ANGEW CHEM INT EDIT, V47, P2604, DOI 10.1002/anie.200703700; Wieland M, 2010, CHEM BIOL, V17, P236, DOI 10.1016/j.chembiol.2010.02.012; Wieland M, 2009, ANGEW CHEM INT EDIT, V48, P2715, DOI 10.1002/anie.200805311; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Win MN, 2009, P NATL ACAD SCI USA, V106, P15514, DOI 10.1073/pnas.0908785106; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yoshida W, 2007, CHEM COMMUN, P195, DOI 10.1039/b613201d; Yoshida W, 2006, ANAL CHEM, V78, P3296, DOI 10.1021/ac060254o	101	138	139	9	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					519	527		10.1038/NCHEMBIO.609	http://dx.doi.org/10.1038/NCHEMBIO.609			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769099				2022-12-27	WOS:000292825400012
J	Laue, T; Demeler, B				Laue, Tom; Demeler, Borries			A postreductionist framework for protein biochemistry	NATURE CHEMICAL BIOLOGY			English	Article							ULTRACENTRIFUGATION; ANTIBODY; ENZYME		[Laue, Tom] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University System Of New Hampshire; University of New Hampshire; University of Texas System; University of Texas Health San Antonio	Laue, T (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	tom.laue@unh.edu; demeler@biochem.uthscsa.edu	Laue, Tom/AAI-5136-2020	Laue, Tom/0000-0003-3571-9368; Demeler, Borries/0000-0002-2414-9518				Brookes E, 2008, COLLOID POLYM SCI, V286, P139, DOI 10.1007/s00396-007-1714-9; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Brookes EH, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P361; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Cao WM, 2008, BIOPHYS J, V95, P54, DOI 10.1529/biophysj.107.123950; Colfen H, 2010, EUR BIOPHYS J BIOPHY, V39, P347, DOI 10.1007/s00249-009-0438-9; Demeule B, 2009, ANAL BIOCHEM, V388, P279, DOI 10.1016/j.ab.2009.03.012; Digman MA, 2009, WIRES SYST BIOL MED, V1, P273, DOI 10.1002/wsbm.5; Durant JA, 2002, BIOPHYS CHEM, V101, P593, DOI 10.1016/S0301-4622(02)00168-0; Gierasch LM, 2009, NAT CHEM BIOL, V5, P774, DOI 10.1038/nchembio.241; Gokarn YR, 2011, PROTEIN SCI, V20, P580, DOI 10.1002/pro.591; Goodsell David, 2010, MACHINERY LIFE; HIEMANS PC, 1997, PRINCIPLES COLLOID S; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Oncley JL, 1938, J AM CHEM SOC, V60, P1115, DOI 10.1021/ja01272a035; SCATCHARD G, 1949, J PHYS COLLOID CHEM, V53, P88, DOI 10.1021/j150466a007; Schneckenburger H, 2011, J BIOPHOTONICS, V4, P143, DOI 10.1002/jbio.201000098; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Spivey HO, 1999, METHODS, V19, P306, DOI 10.1006/meth.1999.0858; STAFFORD WF, 1994, METHOD ENZYMOL, V240, P478; Strauss HM, 2008, COLLOID POLYM SCI, V286, P121, DOI 10.1007/s00396-007-1815-5; WU XM, 1991, P NATL ACAD SCI USA, V88, P497, DOI 10.1073/pnas.88.2.497; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Yadav S, 2010, J PHARM SCI-US, V99, P1152, DOI 10.1002/jps.21898	25	34	34	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					331	334		10.1038/nchembio.575	http://dx.doi.org/10.1038/nchembio.575			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21587250				2022-12-27	WOS:000290677900004
J	Backus, KM; Boshoff, HL; Barry, CS; Boutureira, O; Patel, MK; D'Hooge, F; Lee, SS; Via, LE; Tahlan, K; Barry, CE; Davis, BG				Backus, Keriann M.; Boshoff, Helena L.; Barry, Conor S.; Boutureira, Omar; Patel, Mitul K.; D'Hooge, Francois; Lee, Seung Seo; Via, Laura E.; Tahlan, Kapil; Barry, Clifton E., III; Davis, Benjamin G.			Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis	NATURE CHEMICAL BIOLOGY			English	Article							CORD FACTOR; ANTIGEN 85C; BIOSYNTHESIS; GLYCOSYLATION; TRAFFICKING; BIOGENESIS; INHIBITORS; MECHANISM; DELIVERY; BACILLI	The detection of tuberculosis currently relies upon insensitive and unspecific techniques; newer diagnostics would ideally co-opt specific bacterial processes to provide real-time readouts. The trehalose mycolyltransesterase enzymes (antigens 85A, 85B and 85C (Ag85A, Ag85B, Ag85C)) serve as essential mediators of cell envelope function and biogenesis in Mycobacterium tuberculosis. Through the construction of a systematically varied sugar library, we show here that Ag85 enzymes have exceptionally broad substrate specificity. This allowed exogenously added synthetic probes to be specifically incorporated into M. tuberculosis growing in vitro and within macrophages. Even bulky substituents, such as a fluorescein-containing trehalose probe (FITC-trehalose), were incorporated by growing bacilli, thereby producing fluorescent bacteria; microscopy revealed selective labeling of poles and membrane. Addition of FITC-trehalose to M. tuberculosis-infected macrophages allowed selective, sensitive detection of M. tuberculosis within infected mammalian macrophages. These studies suggest that analogs of trehalose may prove useful as probes of function and for other imaging modalities.	[Backus, Keriann M.; Barry, Conor S.; Boutureira, Omar; Patel, Mitul K.; D'Hooge, Francois; Lee, Seung Seo; Davis, Benjamin G.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Backus, Keriann M.; Boshoff, Helena L.; Via, Laura E.; Tahlan, Kapil; Barry, Clifton E., III] US Natl Inst Allergy & Infect Dis, TB Res Sect, Lab Clin Infect Dis, Bethesda, MD USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Backus, KM (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England.	cbarry@niaid.nih.gov; ben.davis@chem.ox.ac.uk	Barry, III, Clifton/H-3839-2012; Lee, Seung S/K-8669-2018; D'Hooge, François/C-3571-2009; Via, Laura/AAD-3917-2021; Boutureira, Omar/I-9045-2014; Davis, Benjamin G/C-5281-2011; Barry, Clifton E/ABE-7992-2020	Barry, III, Clifton/0000-0002-2927-270X; Lee, Seung S/0000-0002-8598-3303; D'Hooge, François/0000-0003-2531-085X; Via, Laura/0000-0001-6074-9521; Boutureira, Omar/0000-0002-0768-8309; Davis, Benjamin G/0000-0002-5056-407X; Barry, Clifton E/0000-0002-2927-270X	Colorado State "Tuberculosis Vaccine Testing and Research Materials"; US National Institutes of Health; US National Institute of Allergy and Infectious Disease; Rhodes Trust; Marie Curie Intra European Fellowship; Engineering and Physical Sciences Research Council; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783, ZIAAI000734] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E004350/1, BB/C510824/1, EGA17763] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I500200/1, EP/E000614/1, EP/G026688/1, EP/D023335/1, EP/D023343/1, GR/T26542/01] Funding Source: researchfish; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/I500200/1, EP/G026688/1, EP/E000614/1] Funding Source: UKRI	Colorado State "Tuberculosis Vaccine Testing and Research Materials"; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rhodes Trust; Marie Curie Intra European Fellowship(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank T. Claridge, B. Odell and T. Jackson for assistance with NMR spectra and C. Sparrow, J. McCullagh and R. Procter for their assistance with mass spectrometry. O. Schwartz, L. Koo, M. Gastinger, S. Becker and J. Kabat provided tremendous assistance on all imaging of M. tuberculosis. We thank the Colorado State "Tuberculosis Vaccine Testing and Research Materials" Contract (Colorado State University, Fort Collins) and G. J. Davies (University of York) for providing Ag85 and OtsA plasmids, respectively. We thank A. Sher (US National Institute of Allergy and Infectious Disease, US National Institutes of Health) for M. bovis BCG expressing DSRed1 and T. Oh (Yonsei University) for H37Rv carrying the mCherry-PMV261 plasmid. This study was supported (in part) by the Intramural Research Program of the US National Institutes of Health, the US National Institute of Allergy and Infectious Disease (C. E. B.), the Rhodes Trust (K. M. B.), a Marie Curie Intra European Fellowship (O. B.), the Engineering and Physical Sciences Research Council (Platform Grant to B. G. D.) and the Bill and Melinda Gates Foundation through the Tuberculosis Drug Accelerator Program (C. E. B., B. G. D.).	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Daffe M., 1999, Tubercle and Lung Disease, V79, P153, DOI 10.1054/tuld.1998.0200; Demchenko AV, 2003, CURR ORG CHEM, V7, P35, DOI 10.2174/1385272033373175; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; FUKUI Y, 1965, BIKEN J, V8, P189; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; GlatmanFreedman A, 1996, J CLIN MICROBIOL, V34, P2795, DOI 10.1128/JCM.34.11.2795-2802.1996; Gobec S, 2007, EUR J MED CHEM, V42, P54, DOI 10.1016/j.ejmech.2006.08.007; HADFIELD AF, 1979, CARBOHYD RES, V72, P93, DOI 10.1016/S0008-6215(00)83926-9; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hui Y, 2002, ORG LETT, V4, P2245, DOI 10.1021/ol026095m; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Kalscheuer R, 2010, P NATL ACAD SCI USA, V107, P21761, DOI 10.1073/pnas.1014642108; KILBURN JO, 1982, BIOCHEM BIOPH RES CO, V108, P132, DOI 10.1016/0006-291X(82)91841-1; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Li XL, 2001, TETRAHEDRON, V57, P4297, DOI 10.1016/S0040-4020(01)00321-0; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200; Namme R, 2007, EUR J ORG CHEM, V2007, P3758, DOI 10.1002/ejoc.200700145; Pratt MR, 2003, ORG LETT, V5, P3185, DOI 10.1021/ol034836t; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x; Rodriguez MA, 2007, J ORG CHEM, V72, P8998, DOI 10.1021/jo701738m; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Schorey JS, 1997, SCIENCE, V277, P1091, DOI 10.1126/science.277.5329.1091; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; SLURGILLKOSZYCK.S, 1994, SCIENCE, V263, P678; SPARGO BJ, 1991, P NATL ACAD SCI USA, V88, P737, DOI 10.1073/pnas.88.3.737; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Titgemeyer F, 2007, J BACTERIOL, V189, P5903, DOI 10.1128/JB.00257-07; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Ullrich HJ, 1999, EUR J CELL BIOL, V78, P739, DOI 10.1016/S0171-9335(99)80042-9; Weingart CL, 1999, INFECT IMMUN, V67, P4264, DOI 10.1128/IAI.67.8.4264-4267.1999; *WHO, 2008, GLOB TUB CONTR REP 2; Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200; Yamagami H, 2001, INFECT IMMUN, V69, P810, DOI 10.1128/IAI.69.2.810-815.2001; Yang M, 2005, J AM CHEM SOC, V127, P9336, DOI 10.1021/ja051482n; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	47	154	161	6	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					228	235		10.1038/NCHEMBIO.539	http://dx.doi.org/10.1038/NCHEMBIO.539			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21378984	Green Accepted			2022-12-27	WOS:000288545000011
J	Hsiao, YY; Yang, CC; Lin, CL; Lin, JLJ; Duh, Y; Yuan, HS				Hsiao, Yu-Yuan; Yang, Che-Chuan; Lin, Chia Liang; Lin, Jason L. J.; Duh, Yulander; Yuan, Hanna S.			Structural basis for RNA trimming by RNase T in stable RNA 3 '-end maturation	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; RIBOSOMAL-RNA; EXONUCLEASE TREX1; PROCESSING ENZYME; DNASE ACTIVITY; EXORIBONUCLEASE; MECHANISM; END; IDENTIFICATION; SPECIFICITY	RNA maturation relies on various exonucleases to remove nucleotides successively from the 5' or 3' end of nucleic acids. However, little is known regarding the molecular basis for substrate and cleavage preference of exonucleases. Our biochemical and structural analyses on RNase T-DNA complexes show that the RNase T dimer has an ideal architecture for binding a duplex with a short 3' overhang to produce a digestion product of a duplex with a 2-nucleotide (nt) or 1-nt 3' overhang, depending on the composition of the last base pair in the duplex. A 'C-filter' in RNase T screens out the nucleic acids with 3'-terminal cytosines for hydrolysis by inducing a disruptive conformational change at the active site. Our results reveal the general principles and the working mechanism for the final trimming step made by RNase T in the maturation of stable RNA and pave the way for the understanding of other DEDD family exonucleases.	[Hsiao, Yu-Yuan; Lin, Chia Liang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Hsiao, Yu-Yuan; Yang, Che-Chuan; Lin, Chia Liang; Lin, Jason L. J.; Duh, Yulander; Yuan, Hanna S.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Yang, Che-Chuan; Yuan, Hanna S.] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Taipei 10764, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; National Taiwan University	Hsiao, YY (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	hanna@sinica.edu.tw	Hsiao, Yu-Yuan/AAA-7408-2022; Yuan, Hanna S./AAA-4005-2021	Yuan, Hanna S./0000-0001-9671-6967; Hsiao, Yu-Yuan/0000-0002-9648-5879; Lin, Chia-Liang/0000-0002-7158-6091	Academia Sinica; National Science Council, Taiwan; National Science Council of Taiwan; National Research Program for Genomic Medicine	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Academia Sinica and the National Science Council, Taiwan. Portions of this research were carried out at the National Synchrotron Radiation Research Center (BL-13B1 and BL-13C1), a national user facility supported by the National Science Council of Taiwan. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Research Program for Genomic Medicine. We thank S. Lin-Chao (Academia Sinica) for providing the E. coli knockout strains used in this study.	Allas U, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Chin KH, 2006, PROTEINS, V65, P1036, DOI 10.1002/prot.21148; CORMACK RS, 1992, J MOL BIOL, V228, P1078, DOI 10.1016/0022-2836(92)90316-C; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; DEUTSCHER MP, 1984, P NATL ACAD SCI-BIOL, V81, P4290, DOI 10.1073/pnas.81.14.4290; Dupasquier M, 2008, J MOL BIOL, V379, P579, DOI 10.1016/j.jmb.2008.04.005; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; GUERRIERTAKADA C, 1984, SCIENCE, V223, P285, DOI 10.1126/science.6199841; GUERRIERTAKADA C, 1986, CELL, V45, P177, DOI 10.1016/0092-8674(86)90381-8; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hsiao YY, 2009, MOL CELL BIOL, V29, P448, DOI 10.1128/MCB.01006-08; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; LI ZW, 1995, P NATL ACAD SCI USA, V92, P6883, DOI 10.1073/pnas.92.15.6883; Li ZW, 1999, RNA, V5, P139, DOI 10.1017/S1355838299981669; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; LI ZW, 1994, J BIOL CHEM, V269, P6064; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MISRA TK, 1979, J BIOL CHEM, V254, P1154; PADMANABHA KP, 1991, J BACTERIOL, V173, P1376, DOI 10.1128/jb.173.4.1376-1381.1991; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; RIGGS AD, 1968, J MOL BIOL, V34, P365, DOI 10.1016/0022-2836(68)90261-1; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Viswanathan M, 1998, J BIOL CHEM, V273, P35126, DOI 10.1074/jbc.273.52.35126; Viswanathan M, 1999, GENETICS, V151, P929; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zuo YH, 1999, NUCLEIC ACIDS RES, V27, P4077, DOI 10.1093/nar/27.20.4077; Zuo YH, 2005, STRUCTURE, V13, P973, DOI 10.1016/j.str.2005.04.015; Zuo YH, 2002, J BIOL CHEM, V277, P50160, DOI 10.1074/jbc.M207707200; Zuo YH, 2002, J BIOL CHEM, V277, P50155, DOI 10.1074/jbc.M207706200; Zuo YH, 2002, J BIOL CHEM, V277, P29654, DOI 10.1074/jbc.M204252200; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	46	32	33	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					236	243		10.1038/NCHEMBIO.524	http://dx.doi.org/10.1038/NCHEMBIO.524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21317904				2022-12-27	WOS:000288545000012
J	Fleming, A; Noda, T; Yoshimori, T; Rubinsztein, DC				Fleming, Angeleen; Noda, Takeshi; Yoshimori, Tamotsu; Rubinsztein, David C.			Chemical modulators of autophagy as biological probes and potential therapeutics	NATURE CHEMICAL BIOLOGY			English	Review							ACTIVATED PROTEIN-KINASE; POLYGLUTAMINE EXPANSIONS; HUNTINGTONS-DISEASE; MEDIATED CLEAVAGE; HUMAN ATG4B; CELL-DEATH; LIFE-SPAN; COMPLEX; INHIBITORS; TREHALOSE	Autophagy is an evolutionarily conserved mechanism for protein degradation that is critical for the maintenance of homeostasis in man. Autophagy has unexpected pleiotropic functions that favor survival of the cell, including nutrient supply under starvation, cleaning of the cellular interior, defense against infection and antigen presentation. Moreover, defective autophagy is associated with a diverse range of disease states, including neurodegeneration, cancer and Crohn's disease. Here we discuss the roles of mammalian autophagy in health and disease and highlight recent advances in pharmacological manipulation of autophagic pathways as a therapeutic strategy for a variety of pathological conditions.	[Fleming, Angeleen; Rubinsztein, David C.] Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge, England; [Fleming, Angeleen] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Dept Genet, Grad Sch Med, Osaka, Japan; [Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Frontier Biosci, Lab Intracellular Membrane Dynam, Osaka, Japan	University of Cambridge; University of Cambridge; Osaka University; Osaka University	Rubinsztein, DC (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge, England.	tamyoshi@fbs.osaka-u.ac.jp; dcr1000@cam.ac.uk	Noda, Takeshi/B-7240-2008; Yoshimori, Tamotsu/K-9626-2014; Rubinsztein, David C/C-3472-2011	Noda, Takeshi/0000-0003-3581-7961; Yoshimori, Tamotsu/0000-0001-9787-3788; Fleming, Angeleen/0000-0003-3721-7126	Medical Research Council; Wellcome Trust; UK National Institute for Health Research; Biomedical Research Centre at Addenbrooke's Hospital; Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; MRC [G0901339, G0600194] Funding Source: UKRI; Medical Research Council [G0901339, G0600194] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UK National Institute for Health Research(National Institute for Health Research (NIHR)); Biomedical Research Centre at Addenbrooke's Hospital; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful for funding from the Medical Research Council (Programme Grant to D. C. R.; Skills Gap Award to A. F.), the Wellcome Trust (Senior Fellowship to D. C. R.), the UK National Institute for Health Research, Biomedical Research Centre at Addenbrooke's Hospital, Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Takeda Science Foundation.	Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Grander D, 2009, AUTOPHAGY, V5, P1198, DOI 10.4161/auto.5.8.10122; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; INHORN RC, 1988, J BIOL CHEM, V263, P14559; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2010, GENES CELLS, V15, P923, DOI 10.1111/j.1365-2443.2010.01433.x; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Laane E, 2009, CELL DEATH DIFFER, V16, P1018, DOI 10.1038/cdd.2009.46; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Lu XQ, 2010, J AM CHEM SOC, V132, P1748, DOI 10.1021/ja9088549; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizushima N, 2006, AUTOPHAGY, V2, P302, DOI 10.4161/auto.2945; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Morselli E, 2010, AUTOPHAGY, V6, P186, DOI 10.4161/auto.6.1.10817; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Noda T, 2010, SEMIN CELL DEV BIOL, V21, P671, DOI 10.1016/j.semcdb.2010.04.002; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Rose C, 2010, HUM MOL GENET, V19, P2144, DOI 10.1093/hmg/ddq093; ROUFOGALIS BD, 1983, CAN J BIOCHEM CELL B, V61, P927, DOI 10.1139/o83-118; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sczekan SR, 1996, BIOL PSYCHIAT, V40, P497, DOI 10.1016/0006-3223(95)00657-5; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Stappenbeck TS, 2011, AUTOPHAGY, V7, P355, DOI 10.4161/auto.7.2.13074; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Tsukamoto S, 2008, AUTOPHAGY, V4, P1076, DOI 10.4161/auto.7065; Vellai T, 2009, CELL DEATH DIFFER, V16, P94, DOI 10.1038/cdd.2008.126; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xia HG, 2010, AUTOPHAGY, V6, P61, DOI 10.4161/auto.6.1.10326; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838	98	277	289	5	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					9	17		10.1038/NCHEMBIO.500	http://dx.doi.org/10.1038/NCHEMBIO.500			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21164513				2022-12-27	WOS:000285383400005
J	Coelho, PS; Wang, ZJ; Ener, ME; Baril, SA; Kannan, A; Arnold, FH; Brustad, EM				Coelho, Pedro S.; Wang, Z. Jane; Ener, Maraia E.; Baril, Stefanie A.; Kannan, Arvind; Arnold, Frances H.; Brustad, Eric M.			A serine-substituted P450 catalyzes highly efficient carbene transfer to olefins in vivo	NATURE CHEMICAL BIOLOGY			English	Article							STEREOSELECTIVE CYCLOPROPANATION; HEME; SYSTEM	Whole-cell catalysts for non-natural chemical reactions will open new routes to sustainable production of chemicals. We designed a cytochrome 'P411' with unique serine-heme ligation that catalyzes efficient and selective olefin cyclopropanation in intact Escherichia coli cells. The mutation C400S in cytochrome P450(BM3) gives a signature ferrous CO Soret peak at 411 nm, abolishes monooxygenation activity, raises the resting-state Fe-III-to-Fe-II reduction potential and substantially improves NAD(P) H-driven activity.	[Coelho, Pedro S.; Wang, Z. Jane; Ener, Maraia E.; Kannan, Arvind; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Baril, Stefanie A.; Brustad, Eric M.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Brustad, Eric M.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA	California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Arnold, FH (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu; brustad@email.unc.edu	Baril, Stefanie/Q-4765-2018	Baril, Stefanie/0000-0003-3249-2866; Arnold, Frances H./0000-0002-4027-364X	Gordon and Betty Moore Foundation through the Caltech Programmable Molecular Technology Initiative; US National Institutes of Health (NIH) [F32GM087102]; University of North Carolina-Chapel Hill (UNC); NIH [1F32EB015846-01, RO1-DK019038]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F32EB015846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019038, R01DK019038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087102] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation through the Caltech Programmable Molecular Technology Initiative; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina-Chapel Hill (UNC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported by the Gordon and Betty Moore Foundation through the Caltech Programmable Molecular Technology Initiative. E. M. B. was supported by US National Institutes of Health (NIH) postdoctoral award F32GM087102 and a generous startup fund from University of North Carolina-Chapel Hill (UNC). Z.J.W. was supported by NIH 1F32EB015846-01. M. E. E. was supported by NIH grant RO1-DK019038. We thank N. Peck for help with preparative-scale experiments. We thank the Redinbo laboratory at UNC for assistance with X-ray data collection. M. E. E. thanks J.D. Blakemore and J.R. Winkler for electrodes and helpful discussions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyce M, 2011, NAT METHODS, V8, P638, DOI 10.1038/nmeth.1657; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; Davies HML, 2003, ORG LETT, V5, P1403, DOI 10.1021/ol034002a; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; Dunford AJ, 2009, BBA-PROTEINS PROTEOM, V1794, P1181, DOI 10.1016/j.bbapap.2009.03.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS DA, 1991, J AM CHEM SOC, V113, P726, DOI 10.1021/ja00002a080; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kataoka M, 2003, APPL MICROBIOL BIOT, V62, P437, DOI 10.1007/s00253-003-1347-y; Lebel H, 2003, CHEM REV, V103, P977, DOI 10.1021/cr010007e; Maas G, 2004, CHEM SOC REV, V33, P183, DOI 10.1039/b309046a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Penoni A, 2003, EUR J INORG CHEM, P1452; Perera R, 2011, ARCH BIOCHEM BIOPHYS, V507, P119, DOI 10.1016/j.abb.2010.12.010; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vatsis KP, 2002, J INORG BIOCHEM, V91, P542, DOI 10.1016/S0162-0134(02)00438-5; Watanabe N, 1996, HETEROCYCLES, V42, P537; Wessjohann LA, 2003, CHEM REV, V103, P1625, DOI 10.1021/cr0100188; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; WOLF JR, 1995, J AM CHEM SOC, V117, P9194, DOI 10.1021/ja00141a011; WUTTKE DS, 1993, CURR OPIN STRUC BIOL, V3, P555, DOI 10.1016/0959-440X(93)90083-W	30	209	218	3	200	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2013	9	8					485	U33		10.1038/nchembio.1278	http://dx.doi.org/10.1038/nchembio.1278			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185FV	23792734	Green Accepted, Green Submitted			2022-12-27	WOS:000321952700005
J	Sato, TK; Tweten, RK; Johnson, AE				Sato, Takehiro K.; Tweten, Rodney K.; Johnson, Arthur E.			Disulfide-bond scanning reveals assembly state and beta-strand tilt angle of the PFO beta-barrel	NATURE CHEMICAL BIOLOGY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; PERFRINGOLYSIN-O; PORE FORMATION; CONFORMATIONAL-CHANGES; MEMBRANE INSERTION; PREPORE COMPLEX; PROTEIN; MECHANISM; BINDING; TOXIN	Perfringolysin O (PFO), a bacterial cholesterol-dependent cytolysin, binds a mammalian cell membrane, oligomerizes into a circular prepore complex (PPC) and forms a 250-angstrom transmembrane beta-barrel pore in the cell membrane. Each PFO monomer has two sets of three short alpha-helices that unfold and ultimately refold into two transmembrane beta-hairpin (TMH) components of the membrane-embedded beta-barrel. Interstrand disulfide-bond scanning revealed that beta-strands in a fully assembled PFO beta-barrel were strictly aligned and tilted at 20 degrees to the membrane perpendicular. In contrast, in a low temperature-trapped PPC intermediate, the TMHs were unfolded and had sufficient freedom of motion to interact transiently with each other, yet the TMHs were not aligned or stably hydrogen bonded. The PFO PPC-to-pore transition therefore converts TMHs in a dynamic folding intermediate far above the membrane into TMHs that are hydrogen bonded to those of adjacent subunits in the bilayer-embedded beta-barrel.	[Sato, Takehiro K.; Johnson, Arthur E.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA; [Tweten, Rodney K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Sato, TK (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA.	ajohnson@medicine.tamhsc.edu	Johnson, Arthur E/G-3457-2012		US National Institutes of Health grant [AI-37657]; Robert A. Welch Foundation Chair grant [BE-0017]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037657, R01AI037657] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation Chair grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by US National Institutes of Health grant AI-37657 (R.K.T.) and Robert A. Welch Foundation Chair grant BE-0017 (A.E.J.).	Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CHOU KC, 1982, P NATL ACAD SCI USA, V79, P7047, DOI 10.1073/pnas.79.22.7047; CHOU KC, 1990, PROTEINS, V8, P14, DOI 10.1002/prot.340080105; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dowd KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002787; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; HARRISON PM, 1994, J MOL BIOL, V244, P448, DOI 10.1006/jmbi.1994.1742; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Hotze EM, 2012, J BIOL CHEM, V287, P24534, DOI 10.1074/jbc.M112.380139; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Nelson LD, 2010, BIOPHYS J, V99, P3255, DOI 10.1016/j.bpj.2010.09.028; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; OHNOIWASHITA Y, 1992, BIOCHIM BIOPHYS ACTA, V1109, P81, DOI 10.1016/0005-2736(92)90190-W; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2005, P NATL ACAD SCI USA, V102, P7139, DOI 10.1073/pnas.0500556102; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Reboul CF, 2012, BIOINFORMATICS, V28, P1299, DOI 10.1093/bioinformatics/bts152; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; SANSOM MSP, 1995, BIOPHYS J, V69, P1334, DOI 10.1016/S0006-3495(95)80000-7; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; YE J, 1991, J BIOL CHEM, V266, P23016	39	35	35	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					383	+		10.1038/nchembio.1228	http://dx.doi.org/10.1038/nchembio.1228			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23563525	Green Accepted			2022-12-27	WOS:000319328200010
J	Roemer, T; Boone, C				Roemer, Terry; Boone, Charles			Systems-level antimicrobial drug and drug synergy discovery	NATURE CHEMICAL BIOLOGY			English	Article							ESSENTIAL GENE IDENTIFICATION; MODE-OF-ACTION; SACCHAROMYCES-CEREVISIAE; STAPHYLOCOCCUS-AUREUS; CANDIDA-ALBICANS; IN-VITRO; DELETION MUTANTS; MYCOBACTERIUM-TUBERCULOSIS; BIOACTIVE COMPOUNDS; CHITIN SYNTHESIS	Here, we review the 'target-centric' genomic strategy to antimicrobial discovery and share our perspective on identification, validation and prioritization of potential antimicrobial drug targets in the context of emerging chemical biology, genomics and phenotypic screening strategies. We propose that coupling the dual processes of antimicrobial small-molecule screening and target identification in a whole-cell context is essential to empirically annotate 'druggable' targets and advance early stage antimicrobial discovery. We also advocate a systems-level approach to annotating synthetic-lethal genetic interactions comprehensively within yeast and bacteria models. The resulting genetic interaction networks provide a landscape to rationally predict and exploit drug synergy between cognate inhibitors. We posit that synergistic combination agents provide an important and largely unexploited strategy to 'repurpose' existing chemical space and simultaneously address issues of potency, spectrum, toxicity and drug resistance in early stages of antimicrobial drug discovery.	[Roemer, Terry] Merck Res Labs, Kenilworth, NJ USA; [Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Boone, Charles] Univ Toronto, Dept Mol Genet, Donnelly Ctr, Toronto, ON, Canada	Merck & Company; University of Toronto; University of Toronto	Roemer, T (corresponding author), Merck Res Labs, Kenilworth, NJ USA.	terry_roemer@merck.com; charlie.boone@utoronto.ca			Canadian Institutes of Health Research [MOP-57830]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank M. Costanzo, J. Piotrowski and S. Li for contributions to this manuscript. This work was supported by a grant from the Canadian Institutes of Health Research (MOP-57830) to C.B.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Akerley BJ, 1998, P NATL ACAD SCI USA, V95, P8927, DOI 10.1073/pnas.95.15.8927; Amsterdam D., 2005, ANTIBIOTICS LAB MED, P89; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balemans W, 2010, NATURE, V463, pE3, DOI 10.1038/nature08667; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P507, DOI 10.1007/s10295-005-0077-9; Barker CA, 2010, CHEM BIOL, V17, P624, DOI 10.1016/j.chembiol.2010.05.010; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Bills GF, 2009, MYCOLOGIA, V101, P449, DOI 10.3852/08-163; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Chaudhary PM, 2013, MINI-REV MED CHEM, V13, P222; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Del Poeta M, 2000, ANTIMICROB AGENTS CH, V44, P739, DOI 10.1128/AAC.44.3.739-746.2000; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Donald RGK, 2009, CHEM BIOL, V16, P826, DOI 10.1016/j.chembiol.2009.07.004; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Fera MT, 2009, EXPERT REV ANTI-INFE, V7, P981, DOI 10.1586/ERI.09.67; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Flores AR, 2005, J BACTERIOL, V187, P1892, DOI 10.1128/JB.187.6.1892-1900.2005; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Fukumoto A, 2008, J ANTIBIOT, V61, P7, DOI 10.1038/ja.2008.102; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Gomez MJ, 2006, ANTIMICROB AGENTS CH, V50, P3562, DOI 10.1128/AAC.00579-06; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Guiguemde WA, 2012, CHEM BIOL, V19, P116, DOI 10.1016/j.chembiol.2012.01.004; Hartkoorn RC, 2012, EMBO MOL MED, V4, P1032, DOI 10.1002/emmm.201201689; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Hoon S, 2008, TRENDS PHARMACOL SCI, V29, P499, DOI 10.1016/j.tips.2008.07.006; Hoon S, 2008, NAT CHEM BIOL, V4, P632, DOI 10.1038/nchembio1008-632; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jiang B, 2008, CHEM BIOL, V15, P363, DOI 10.1016/j.chembiol.2008.02.016; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; Kartsonis NA, 2003, DRUG RESIST UPDATE, V6, P197, DOI 10.1016/S1368-7646(03)00064-5; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kristiansen JE, 2007, J ANTIMICROB CHEMOTH, V59, P1271, DOI 10.1093/jac/dkm071; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lee SH, 2011, CHEM BIOL, V18, P1379, DOI 10.1016/j.chembiol.2011.08.015; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P1941, DOI 10.1093/jac/dkr262; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Meredith Timothy C, 2012, Mob Genet Elements, V2, P171; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Nakayama H, 2000, ANTIMICROB AGENTS CH, V44, P2411, DOI 10.1128/AAC.44.9.2411-2418.2000; Nakayama H, 2001, ANTIMICROB AGENTS CH, V45, P3037, DOI 10.1128/AAC.45.11.3037-3045.2001; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Nam TG, 2011, ACS CHEM BIOL, V6, P1214, DOI 10.1021/cb200105d; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Osmond BC, 1999, P NATL ACAD SCI USA, V96, P11206, DOI 10.1073/pnas.96.20.11206; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Pace NR, 2012, P NATL ACAD SCI USA, V109, P1011, DOI 10.1073/pnas.1109716109; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Projan SJ, 2008, DRUG DISCOV TODAY, V13, P279, DOI 10.1016/j.drudis.2008.03.010; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Roemer T, 2011, CHEM BIOL, V18, P148, DOI 10.1016/j.chembiol.2011.01.009; Sandovsky-Losica H, 2008, J ANTIMICROB CHEMOTH, V62, P635, DOI 10.1093/jac/dkn216; Sanglard D, 2002, CURR OPIN MICROBIOL, V5, P379, DOI 10.1016/S1369-5274(02)00344-2; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Serizawa M, 2010, ANTIMICROB AGENTS CH, V54, P2787, DOI 10.1128/AAC.01405-09; Severyn B, 2011, ACS CHEM BIOL, V6, P1391, DOI 10.1021/cb2003225; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P4922, DOI 10.1128/AAC.48.12.4922-4925.2004; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Therien AG, 2012, ANTIMICROB AGENTS CH, V56, P4662, DOI 10.1128/AAC.00726-12; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; Wallace IM, 2011, CHEM BIOL, V18, P1273, DOI 10.1016/j.chembiol.2011.07.018; Walsh C., 2003, ANTIBIOTICS ACTIONS; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Wright GD, 2010, EXPERT OPIN DRUG DIS, V5, P779, DOI 10.1517/17460441.2010.497535; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10; Yan Z, 2008, NAT METHODS, V5, P719, DOI 10.1038/nmeth.1231	124	114	116	0	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					222	231		10.1038/NCHEMBIO.1205	http://dx.doi.org/10.1038/NCHEMBIO.1205			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23508188				2022-12-27	WOS:000317025800010
J	James, LI; Barsyte-Lovejoy, D; Zhong, N; Krichevsky, L; Korboukh, VK; Herold, JM; MacNevin, CJ; Norris, JL; Sagum, CA; Tempel, W; Marcon, E; Guo, HB; Gao, C; Huang, XP; Duan, SL; Emili, A; Greenblatt, JF; Kireev, DB; Jin, J; Janzen, WP; Brown, PJ; Bedford, MT; Arrowsmith, CH; Frye, SV				James, Lindsey I.; Barsyte-Lovejoy, Dalia; Zhong, Nan; Krichevsky, Liubov; Korboukh, Victoria K.; Herold, J. Martin; MacNevin, Christopher J.; Norris, Jacqueline L.; Sagum, Cari A.; Tempel, Wolfram; Marcon, Edyta; Guo, Hongbo; Gao, Cen; Huang, Xi-Ping; Duan, Shili; Emili, Andrew; Greenblatt, Jack F.; Kireev, Dmitri B.; Jin, Jian; Janzen, William P.; Brown, Peter J.; Bedford, Mark T.; Arrowsmith, Cheryl H.; Frye, Stephen V.			Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain	NATURE CHEMICAL BIOLOGY			English	Article							LYSINE BINDING-PROTEINS; POLYCOMB PROTEIN; STRUCTURAL BASIS; DNA-REPAIR; PHD FINGER; METHYLATION; RECOGNITION; CHROMATIN; INHIBITION; MBT	We describe the discovery of UNC1215, a potent and selective chemical probe for the methyllysine (Kme) reading function of L3MBTL3, a member of the malignant brain tumor (MBT) family of chromatin-interacting transcriptional repressors. UNC1215 binds L3MBTL3 with a K-d of 120 nM, competitively displacing mono- or dimethyllysine-containing peptides, and is greater than 50-fold more potent toward L3MBTL3 than other members of the MBT family while also demonstrating selectivity against more than 200 other reader domains examined. X-ray crystallography identified a unique 2:2 polyvalent mode of interaction between UNC1215 and L3MBTL3. In cells, UNC1215 is nontoxic and directly binds L3MBTL3 via the Kme-binding pocket of the MBT domains. UNC1215 increases the cellular mobility of GFP-L3MBTL3 fusion proteins, and point mutants that disrupt the Kme-binding function of GFP-L3MBTL3 phenocopy the effects of UNC1215 on localization. Finally, UNC1215 was used to reveal a new Kme-dependent interaction of L3MBTL3 with BCLAF1, a protein implicated in DNA damage repair and apoptosis.	[James, Lindsey I.; Korboukh, Victoria K.; Herold, J. Martin; MacNevin, Christopher J.; Norris, Jacqueline L.; Gao, Cen; Kireev, Dmitri B.; Jin, Jian; Janzen, William P.; Frye, Stephen V.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Barsyte-Lovejoy, Dalia; Zhong, Nan; Krichevsky, Liubov; Tempel, Wolfram; Brown, Peter J.; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Krichevsky, Liubov; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Krichevsky, Liubov; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada; [MacNevin, Christopher J.; Huang, Xi-Ping] Univ N Carolina, Dept Pharmacol, Chapel Hill Med Sch, Chapel Hill, NC USA; [Sagum, Cari A.; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA; [Marcon, Edyta; Guo, Hongbo; Emili, Andrew; Greenblatt, Jack F.] Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON, Canada; [Huang, Xi-Ping] Univ N Carolina, Chapel Hill Med Sch, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill	Frye, SV (corresponding author), Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.	carrow@uhnres.utoronto.ca; svfrye@email.unc.edu	Kireev, Dmitri/B-7225-2012	Kireev, Dmitri/0000-0001-8479-8555; Arrowsmith, Cheryl/0000-0002-4971-3250; Brown, Peter/0000-0002-8454-0367	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; US National Institute of General Medical Sciences; US National Institutes of Health [RC1GM090732, R01GM100919]; Carolina Partnership; University Cancer Research Fund; University of North Carolina at Chapel Hill; Center for Environmental and Molecular Carcinogenesis at the M.D. Anderson Cancer Center; National Institute of Mental Health Psychoactive Drug Screening Program; Ontario Research Fund [ORF-GL2]; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Health and Long-Term Care; American Cancer Society [119169-PF-10-183-01-TBE]; Structural Genomics Consortium; Canadian Institutes of Health Research [1097737]; Eli Lilly Canada; Genome Canada; GlaxoSmithKline; Ontario Ministry of Economic Development and Innovation; Novartis Research Foundation; Pfizer; Abbott; Takeda; Wellcome Trust; US National Institute of Environmental Health Sciences [ES007784]; Cancer Prevention Research Institute of Texas [RP110471]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100919, RC1GM090732] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carolina Partnership; University Cancer Research Fund; University of North Carolina at Chapel Hill; Center for Environmental and Molecular Carcinogenesis at the M.D. Anderson Cancer Center; National Institute of Mental Health Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); American Cancer Society(American Cancer Society); Structural Genomics Consortium(University of Toronto); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Eli Lilly Canada(Eli Lilly); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Ontario Ministry of Economic Development and Innovation; Novartis Research Foundation; Pfizer(Pfizer); Abbott(Abbott Laboratories); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Vedadi, G. Wasney and F. Li for support with the protein lysine methyltransferase selectivity screening; O. Fedorov for support with the bromodomain selectivity screening; A. Tumber for support with the lysine demethylase selectivity screening; E. Hull-Ryde for support with the CellTiter-Glo cell viability assay; K. Hahn (University of North Carolina (UNC)) for providing mero76; B. Roth for helpful discussion regarding the GPCR selectivity studies; and G. Wang (UNC) for providing PHF23 and JARID1 proteins. Results shown in this report are derived from work performed at the Structural Biology Center at the Advanced Photon Source at Argonne National Laboratory. Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. The research described here was supported by the US National Institute of General Medical Sciences; US National Institutes of Health (grant RC1GM090732 and R01GM100919); the Carolina Partnership and the University Cancer Research Fund; University of North Carolina at Chapel Hill; the Center for Environmental and Molecular Carcinogenesis at the M.D. Anderson Cancer Center; the National Institute of Mental Health Psychoactive Drug Screening Program; the Ontario Research Fund (grant ORF-GL2); the Natural Sciences and Engineering Research Council of Canada; the Ontario Ministry of Health and Long-Term Care; the American Cancer Society (C.J.M.; 119169-PF-10-183-01-TBE); and the Structural Genomics Consortium, which is a registered charity (number 1097737) that receives funds from Canadian Institutes of Health Research; Eli Lilly Canada; Genome Canada; GlaxoSmithKline; the Ontario Ministry of Economic Development and Innovation; the Novartis Research Foundation; Pfizer; Abbott; Takeda; and the Wellcome Trust. M.T.B. is supported by an institutional grant from the US National Institute of Environmental Health Sciences (ES007784) and Cancer Prevention Research Institute of Texas funding (RP110471). C.H.A. holds a Canada Research Chair in Structural Genomics.	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Addou-Klouche L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-213; Arai S, 2005, EMBO J, V24, P1863, DOI 10.1038/sj.emboj.7600654; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gao C, 2011, J AM CHEM SOC, V133, P5357, DOI 10.1021/ja110432e; Gurvich N, 2010, P NATL ACAD SCI USA, V107, P22552, DOI 10.1073/pnas.1017092108; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Herold JM, 2012, MEDCHEMCOMM, V3, P45, DOI 10.1039/c1md00195g; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Honda H, 2011, P NATL ACAD SCI USA, V108, P2468, DOI 10.1073/pnas.1003403108; Hughes RM, 2007, P NATL ACAD SCI USA, V104, P11184, DOI 10.1073/pnas.0610850104; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Perna F, 2010, BLOOD, V116, P2812, DOI 10.1182/blood-2010-02-270611; Santiago C, 2011, J COMPUT AID MOL DES, V25, P1171, DOI 10.1007/s10822-011-9505-2; Takada Y, 2007, DEVELOPMENT, V134, P579, DOI 10.1242/dev.02747; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wigle TJ, 2010, J BIOMOL SCREEN, V15, P62, DOI 10.1177/1087057109352902; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	38	124	129	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					184	191		10.1038/NCHEMBIO.1157	http://dx.doi.org/10.1038/NCHEMBIO.1157			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23292653	Green Accepted, Green Submitted			2022-12-27	WOS:000315132900014
J	Mauldin, RV; Sauer, RT				Mauldin, Randall V.; Sauer, Robert T.			Allosteric regulation of DegS protease subunits through a shared energy landscape	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI SIGMA(E); ENVELOPE-STRESS-RESPONSE; SERINE-PROTEASE; CRYSTAL-STRUCTURE; DOMAIN; SENSOR; MODULATION; ACTIVATION; CLEAVAGE; SIGNALS	The PDZ domains of the trimeric DegS protease bind unassembled outer-membrane proteins (OMPs) that accumulate in the Escherichia coli periplasm. This cooperative binding reaction triggers a proteolytic cascade that activates a transcriptional stress response. To dissect the mechanism of allosteric activation, we generated hybrid DegS trimers with different numbers of PDZ domains and/or protease-domain mutations. By studying the chemical reactivity and enzymatic properties of these hybrids, we show that all subunits experience a strongly coupled energetic landscape. For example, OMP peptide binding to a single PDZ domain stimulates active site chemical modification and proteolytic cleavage in the attached and neighboring protease domains. OMP peptide binding relieves inhibitory PDZ interactions, whereas the interfaces between protease domains in the trimeric DegS core mediate positively cooperative activation driven by both substrate binding and inhibition relief.	[Mauldin, Randall V.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, Cambridge, MA USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399	US National Institutes of Health (NIH) [AI-16892]; NIH [GM097972]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097972] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grant AI-16892 (R.T.S.). R.V.M. was supported by an NIH postdoctoral fellowship (GM097972). We thank B. Stinson, A. Olivares, J. Sohn, A. Nager, A. de Regt and S. Kim for helpful discussions.	Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Bowden MA, 2010, MOL CELL ENDOCRINOL, V327, P13, DOI 10.1016/j.mce.2010.06.001; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Creighton T. E., 1993, PROTEINS STRUCTURES; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; De Las Penas A, 1997, MOL MICROBIOL, V24, P373; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; EIGEN M, 1967, Nobel Symposium, V5, P333; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; HAMMES GG, 1971, SCIENCE, V172, P1205, DOI 10.1126/science.172.3989.1205; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kimmel JL, 2001, BIOCHEMISTRY-US, V40, P11623, DOI 10.1021/bi010844a; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Milner JM, 2008, ARTHRITIS RHEUM-US, V58, P3644, DOI 10.1002/art.24046; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Schneider F, 2001, PROTEIN SCI, V10, P1606, DOI 10.1110/ps.8901; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2010, J BIOL CHEM, V285, P34039, DOI 10.1074/jbc.M110.135541; Sohn J, 2009, STRUCTURE, V17, P1411, DOI 10.1016/j.str.2009.07.017; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Waller PRH, 1996, J BACTERIOL, V178, P1146, DOI 10.1128/jb.178.4.1146-1153.1996; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Zeth K, 2004, FEBS LETT, V569, P351, DOI 10.1016/j.febslet.2004.06.012	38	12	12	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					90	96		10.1038/NCHEMBIO.1135	http://dx.doi.org/10.1038/NCHEMBIO.1135			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23201899	Green Accepted, Green Submitted			2022-12-27	WOS:000314083200007
J	Abou Hamdan, A; Burlat, B; Gutierrez-Sanz, O; Liebgott, PP; Baffert, C; De Lacey, AL; Rousset, M; Guigliarelli, B; Leger, C; Dementin, S				Abou Hamdan, Abbas; Burlat, Benedicte; Gutierrez-Sanz, Oscar; Liebgott, Pierre-Pol; Baffert, Carole; De Lacey, Antonio L.; Rousset, Marc; Guigliarelli, Bruno; Leger, Christophe; Dementin, Sebastien			O-2-independent formation of the inactive states of NiFe hydrogenase	NATURE CHEMICAL BIOLOGY			English	Article							DESULFOVIBRIO-GIGAS HYDROGENASE; ALLOCHROMATIUM-VINOSUM; CHROMATIUM-VINOSUM; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; CATALYTIC CYCLE; ACTIVE-SITE; ACTIVATION; NICKEL; UNREADY	We studied the mechanism of aerobic inactivation of Desulfovibrio fructosovorans nickel-iron (NiFe) hydrogenase by quantitatively examining the results of electrochemistry, EPR and FTIR experiments. They suggest that, contrary to the commonly accepted mechanism, the attacking O-2 is not incorporated as an active site ligand but, rather, acts as an electron acceptor. Our findings offer new ways toward the understanding of O-2 inactivation and O-2 tolerance in NiFe hydrogenases.	[Abou Hamdan, Abbas; Burlat, Benedicte; Liebgott, Pierre-Pol; Baffert, Carole; Rousset, Marc; Guigliarelli, Bruno; Leger, Christophe; Dementin, Sebastien] Aix Marseille Univ, CNRS, Lab Bioenerget & Ingn Prot, Unite Mixte Rech 7281,Inst Microbiol Mediterranee, Marseille, France; [Gutierrez-Sanz, Oscar; De Lacey, Antonio L.] CSIC, ICP, Lab Bioelectrocatalisis, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP)	Abou Hamdan, A (corresponding author), Aix Marseille Univ, CNRS, Lab Bioenerget & Ingn Prot, Unite Mixte Rech 7281,Inst Microbiol Mediterranee, Marseille, France.	dementin@imm.cnrs.fr	Baffert, Carole/C-4638-2018; De Lacey, Antonio L/H-3311-2015; LIEBGOTT, Pierre-Pol/K-1045-2016; Léger, Christophe/C-7230-2016; HAMDAN, Abbas ABOU/N-6783-2014	Baffert, Carole/0000-0003-3993-3089; De Lacey, Antonio L/0000-0002-9347-0452; LIEBGOTT, Pierre-Pol/0000-0002-2559-1738; Léger, Christophe/0000-0002-8871-6059; HAMDAN, Abbas ABOU/0000-0001-6703-772X; Gutierrez-Sanz, Oscar/0000-0001-7559-9204; Dementin, Sebastien/0000-0001-6168-5371	CNRS; Agence Nationale de la Recherche; Aix-Marseille Universite; City of Marseilles; Spanish Ministerio de Ciencia e Innovacion (MICINN) [CTQ2009-12649]; Pole de Competitivite Capenergies; Region Provence-Alpes Cote d'Azur; MICINN	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Aix-Marseille Universite; City of Marseilles(Region Provence-Alpes-Cote d'Azur); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Pole de Competitivite Capenergies; Region Provence-Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	We thank J. Hadj-Said for performing preliminary electrochemical experiments and P. Bertrand, V. Fourmond and V. Fernandez for helpful discussions. This work was funded by the CNRS, the Agence Nationale de la Recherche, the Aix-Marseille Universite, the City of Marseilles and the Spanish Ministerio de Ciencia e Innovacion (MICINN) (project CTQ2009-12649) and was supported by the Pole de Competitivite Capenergies. A.A.H. thanks the CNRS and the Region Provence-Alpes Cote d'Azur for financial support. O.G.-S. thanks the MICINN for a Formacion de Personal Investigador (FPI) grant.	Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; Carepo M, 2002, J AM CHEM SOC, V124, P281, DOI 10.1021/ja010204v; Chohan BS, 2004, INORG CHEM, V43, P7726, DOI 10.1021/ic049110n; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; FERNANDEZ VM, 1986, BIOCHIM BIOPHYS ACTA, V883, P145, DOI 10.1016/0304-4165(86)90145-5; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; KUMAR M, 1989, J AM CHEM SOC, V111, P8323, DOI 10.1021/ja00203a068; Lamle SE, 2004, J AM CHEM SOC, V126, P14899, DOI 10.1021/ja047939v; Leger C, 2004, J AM CHEM SOC, V126, P12162, DOI 10.1021/ja046548d; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Liebgott PP, 2011, J AM CHEM SOC, V133, P986, DOI 10.1021/ja108787s; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Millo D, 2009, J PHYS CHEM B, V113, P15344, DOI 10.1021/jp906575r; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Pandelia ME, 2010, J AM CHEM SOC, V132, P6991, DOI 10.1021/ja910838d; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Rudiger O, 2005, J AM CHEM SOC, V127, P16008, DOI 10.1021/ja0554312; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; van Gastel M, 2010, APPL MAGN RESON, V37, P207, DOI 10.1007/s00723-009-0044-0; VANDERZWAAN JW, 1985, FEBS LETT, V179, P271, DOI 10.1016/0014-5793(85)80533-0; VANDERZWAAN JW, 1990, BIOCHIM BIOPHYS ACTA, V1041, P101, DOI 10.1016/0167-4838(90)90051-G; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109	29	61	61	0	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					15	+		10.1038/NCHEMBIO.1110	http://dx.doi.org/10.1038/NCHEMBIO.1110			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23143415				2022-12-27	WOS:000312484200006
J	Bhave, G; Cummings, CF; Vanacore, RM; Kumagai-Cresse, C; Ero-Tolliver, IA; Rafi, M; Kang, JS; Pedchenko, V; Fessler, LI; Fessler, JH; Hudson, BG				Bhave, Gautam; Cummings, Christopher F.; Vanacore, Roberto M.; Kumagai-Cresse, Chino; Ero-Tolliver, Isi A.; Rafi, Mohamed; Kang, Jeong-Suk; Pedchenko, Vadim; Fessler, Liselotte I.; Fessler, John H.; Hudson, Billy G.			Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN MYELOPEROXIDASE; EXTRACELLULAR-MATRIX; HYDROGEN-PEROXIDE; AMINO-ACIDS; IDENTIFICATION; MUTATIONS; BIOLOGY; PROTEIN; IV; SUPERFAMILY	Collagen IV comprises the predominant protein network of basement membranes, a specialized extracellular matrix, which underlie epithelia and endothelia. These networks assemble through oligomerization and covalent crosslinking to endow mechanical strength and shape cell behavior through interactions with cell-surface receptors. A recently discovered sulfilimine (S=N) bond between a methionine sulfur and hydroxylysine nitrogen reinforces the collagen IV network. We demonstrate that peroxidasin, an enzyme found in basement membranes, catalyzes formation of the sulfilimine bond. Drosophila peroxidasin mutants have disorganized collagen IV networks and torn visceral muscle basement membranes, pointing to a critical role for the enzyme in tissue biogenesis. Peroxidasin generates hypohalous acids as reaction intermediates, suggesting a paradoxically anabolic role for these usually destructive oxidants. This work highlights sulfilimine bond formation as what is to our knowledge the first known physiologic function for peroxidasin, a role for hypohalous oxidants in tissue biogenesis, and a possible role for peroxidasin in inflammatory diseases.	[Bhave, Gautam; Vanacore, Roberto M.; Ero-Tolliver, Isi A.; Rafi, Mohamed; Pedchenko, Vadim; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Internal Med, Nashville, TN 37235 USA; [Bhave, Gautam; Vanacore, Roberto M.; Ero-Tolliver, Isi A.; Rafi, Mohamed; Pedchenko, Vadim; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN USA; [Cummings, Christopher F.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN USA; [Kumagai-Cresse, Chino; Fessler, Liselotte I.; Fessler, John H.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Kumagai-Cresse, Chino; Fessler, Liselotte I.; Fessler, John H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Nashville, TN USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Hudson, Billy G.] Kathryn W Davis Ctr Regenerat Biol & Med, Mt Desert Isl Biol Lab, Salsbury Cove, ME USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Vanderbilt University; Vanderbilt University; Vanderbilt University; Mount Desert Island Biological Laboratory	Bhave, G (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Internal Med, Nashville, TN 37235 USA.	billy.hudson@vanderbilt.edu	Ero-Tolliver, Isi/AAD-6038-2019; Vanacore, Roberto/AAD-6399-2020	Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100	US National Institutes of Health [RO1 DK18381, DK18381-38S1, 2PO1 DK065123]; Mount Desert Island Biological Laboratory Salisbury Cove Research Fund; F.H. Epstein Fellowship; Vanderbilt Division of Nephrology Faculty Development Fund; Vanderbilt Physician Scientist Development Award; Vanderbilt Academic Venture Capital Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018381, T32DK007569, R01DK099467, R01DK018381, P01DK065123] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Desert Island Biological Laboratory Salisbury Cove Research Fund; F.H. Epstein Fellowship; Vanderbilt Division of Nephrology Faculty Development Fund; Vanderbilt Physician Scientist Development Award; Vanderbilt Academic Venture Capital Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health (RO1 DK18381, DK18381-38S1 and 2PO1 DK065123 to B.G.H.), the Mount Desert Island Biological Laboratory Salisbury Cove Research Fund and F.H. Epstein Fellowship (to B. G. H.), the Vanderbilt Division of Nephrology Faculty Development Fund (to R.M.V.) and a Vanderbilt Physician Scientist Development Award (to G.B.). We are grateful to K.L. Rose and W.H. McDonald of the Mass Spectrometry Resource Center at Vanderbilt University for assistance with mass spectrometry, which was supported in part by the Vanderbilt Academic Venture Capital Fund. We acknowledge A. Chisholm and A. Page-McCaw for fruitful discussions during the writing of this manuscript. We thank M. Geizst (Semmelweis University) for the human peroxidasin coding sequence and L.Cooley (Yale University) for the viking<SUP>G454</SUP> protein trap Drosophila line. P. Todd, N.Danylevych and C. Venkov provided technical assistance.	ADENIYIJONES SK, 1981, J CLIN INVEST, V68, P365, DOI 10.1172/JCI110264; ALEXANDER NM, 1959, J BIOL CHEM, V234, P1530; ANDREWS PC, 1982, J BIOL CHEM, V257, P13240; Armesto XL, 2000, TETRAHEDRON, V56, P1103, DOI 10.1016/S0040-4020(99)01066-2; Bai YP, 2011, FREE RADICAL BIO MED, V51, P1492, DOI 10.1016/j.freeradbiomed.2011.07.004; Beal JL, 2009, BIOCHEMISTRY-US, V48, P11142, DOI 10.1021/bi901343d; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Brandes RP, 2011, CARDIOVASC RES, V91, P1, DOI 10.1093/cvr/cvr120; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Coupry I, 2010, ARCH OPHTHALMOL-CHIC, V128, P483, DOI 10.1001/archophthalmol.2010.42; DEMONTELLANO PRO, 1988, BIOCHEMISTRY-US, V27, P5470, DOI 10.1021/bi00415a013; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; Favor J, 2007, GENETICS, V175, P725, DOI 10.1534/genetics.106.064733; FESSLER LI, 1982, J BIOL CHEM, V257, P9804; Garver LS, 2008, DEV COMP IMMUNOL, V32, P519, DOI 10.1016/j.dci.2007.09.007; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Gould DB, 2007, HUM MOL GENET, V16, P798, DOI 10.1093/hmg/ddm024; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; HUWILER M, 1985, EUR J BIOCHEM, V147, P469; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; KRAMER RH, 1984, J CELL BIOL, V99, P692, DOI 10.1083/jcb.99.2.692; Labelle-Dumais C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002062; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; LAVINE TF, 1947, J BIOL CHEM, V169, P477; Li H, 2012, INFECT IMMUN, V80, P2528, DOI 10.1128/IAI.06337-11; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; NAGASAKA A, 1976, J CLIN ENDOCR METAB, V43, P152, DOI 10.1210/jcem-43-1-152; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Obinger C, 2006, ARCH BIOCHEM BIOPHYS, V445, P197, DOI 10.1016/j.abb.2005.10.015; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Peskin AV, 2009, BIOCHEMISTRY-US, V48, P10175, DOI 10.1021/bi901266w; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Shi RZ, 2011, CARDIOVASC RES, V91, P27, DOI 10.1093/cvr/cvr042; TANG SS, 1983, J BIOL CHEM, V258, P4331; TAUROG A, 1992, ARCH BIOCHEM BIOPHYS, V296, P239, DOI 10.1016/0003-9861(92)90568-H; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; WEBER S, 1988, EUR J BIOCHEM, V175, P229, DOI 10.1111/j.1432-1033.1988.tb14188.x; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Yokoyama M, 2004, CURR OPIN PHARMACOL, V4, P110, DOI 10.1016/j.coph.2003.12.004; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950	47	164	166	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					784	790		10.1038/NCHEMBIO.1038	http://dx.doi.org/10.1038/NCHEMBIO.1038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22842973	Green Accepted			2022-12-27	WOS:000308077600010
J	Gavathiotis, E; Reyna, DE; Bellairs, JA; Leshchiner, ES; Walensky, LD				Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.			Direct and selective small-molecule activation of proapoptotic BAX	NATURE CHEMICAL BIOLOGY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 FAMILY; CYTOCHROME-C; CELL-DEATH; BH3 HELIX; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL APOPTOSIS; PHASE-I; INHIBITOR; PROTEINS	BCL-2 family proteins are key regulators of the apoptotic pathway. Antiapoptotic members sequester the BCL-2 homology 3 (BH3) death domains of proapoptotic members such as BAX to maintain cell survival. The antiapoptotic BH3-binding groove has been successfully targeted to reactivate apoptosis in cancer. We recently identified a geographically distinct BH3-binding groove that mediates direct BAX activation, suggesting a new strategy for inducing apoptosis by flipping BAX's 'on switch'. Here we applied computational screening to identify a BAX activator molecule that directly and selectively activates BAX. We demonstrate by NMR and biochemical analyses that the molecule engages the BAX trigger site and promotes the functional oligomerization of BAX. The molecule does not interact with the BH3-binding pocket of antiapoptotic proteins or proapoptotic BAK and induces cell death in a BAX-dependent fashion. To our knowledge, we report the first gain-of-function molecular modulator of a BCL-2 family protein and demonstrate a new paradigm for pharmacologic induction of apoptosis.	[Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.] Childrens Hosp Boston, Div Hematol & Oncol, Boston, MA USA; [Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Reyna, Denis E.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Gavathiotis, Evripidis; Reyna, Denis E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Gavathiotis, Evripidis; Reyna, Denis E.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10467 USA; [Gavathiotis, Evripidis; Reyna, Denis E.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gavathiotis, E (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	evripidis.gavathiotis@einstein.yu.edu; loren_walensky@dfci.harvard.edu	Leshchiner, Elizaveta/F-3312-2010	Bellairs, Joseph/0000-0001-9031-6532; Gavathiotis, Evripidis/0000-0001-6319-8331	William Lawrence and Blanche Hughes Foundation; US National Institutes of Health (NIH) [4R00HL095929]; NIH [5R01CA050239]; Stand Up to Cancer Innovative Research Grant; NATIONAL CANCER INSTITUTE [R01CA050239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL095929, R00HL095929] Funding Source: NIH RePORTER	William Lawrence and Blanche Hughes Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer Innovative Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E. Smith for editorial and graphics assistance, M. Davis for help with establishing the competitive BAX binding assay, G. Bird for BIM SAHB production and characterization and CreaGen Biosciences for BAM7 resynthesis and characterization. This research program was supported by a grant from the William Lawrence and Blanche Hughes Foundation to L. D. W. Additional funding was provided by US National Institutes of Health (NIH) grant 4R00HL095929 to E. G. and NIH grant 5R01CA050239 and a Stand Up to Cancer Innovative Research Grant to L.D.W.	Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; O'Brien SM, 2009, BLOOD, V113, P299, DOI 10.1182/blood-2008-02-137943; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pitter K, 2008, METHOD ENZYMOL, V446, P387, DOI 10.1016/S0076-6879(08)01623-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Walensky LD, 2012, J CLIN ONCOL, V30, P554, DOI 10.1200/JCO.2011.37.9339; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	45	113	118	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					639	645		10.1038/NCHEMBIO.995	http://dx.doi.org/10.1038/NCHEMBIO.995			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22634637	Green Accepted			2022-12-27	WOS:000305471400011
J	Yeats, TH; Martin, LBB; Viart, HMF; Isaacson, T; He, YH; Zhao, LX; Matas, AJ; Buda, GJ; Domozych, DS; Clausen, MH; Rose, JKC				Yeats, Trevor H.; Martin, Laetitia B. B.; Viart, Helene M-F; Isaacson, Tal; He, Yonghua; Zhao, Lingxia; Matas, Antonio J.; Buda, Gregory J.; Domozych, David S.; Clausen, Mads H.; Rose, Jocelyn K. C.			The identification of cutin synthase: formation of the plant polyester cutin	NATURE CHEMICAL BIOLOGY			English	Article							FRUIT; ACYLTRANSFERASE; BIOSYNTHESIS; EXPRESSION; ESTERS; FAMILY; CELLS	A hydrophobic cuticle consisting of waxes and the polyester cutin covers the aerial epidermis of all land plants, providing essential protection from desiccation and other stresses. We have determined the enzymatic basis of cutin polymerization through characterization of a tomato extracellular acyltransferase, CD1, and its substrate, 2-mono(10,16-dihydroxyhexadecanoyl)glycerol. CD1 has in vitro polyester synthesis activity and is required for cutin accumulation in vivo, indicating that it is a cutin synthase.	[Yeats, Trevor H.; Martin, Laetitia B. B.; Isaacson, Tal; He, Yonghua; Matas, Antonio J.; Buda, Gregory J.; Rose, Jocelyn K. C.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; [Viart, Helene M-F; Clausen, Mads H.] Tech Univ Denmark, Ctr Nanomed & Theranost, DK-2800 Lyngby, Denmark; [Viart, Helene M-F; Clausen, Mads H.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Zhao, Lingxia] Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Domozych, David S.] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Domozych, David S.] Skidmore Coll, Skidmore Microscopy Imaging Ctr, Saratoga Springs, NY 12866 USA	Cornell University; Technical University of Denmark; Technical University of Denmark; Shanghai Jiao Tong University; Skidmore College; Skidmore College	Rose, JKC (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA.	jr286@cornell.edu	Matas, Antonio J./A-9325-2008; Clausen, Mads H/A-9656-2015	Matas, Antonio J./0000-0003-4348-3930; Clausen, Mads H/0000-0001-9649-1729; Martin, Laetitia/0000-0002-6921-7246	US National Science Foundation [DBI-0606595]; United States-Israel Binational Agricultural Research and Development Fund [IS-4234-09]; US Department of Agriculture Cooperative State Research, Education and Extension Service [2011-04197]; Danish Council for Strategic Research [10-093465]; US National Institutes of Health [T32 GM008500]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); US Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Lomonossoff (John Innes Centre) and Plant Bioscience Limited for the pEAQ vector, M. Toso for help with transmission electron microscopy, S. Zhang and B. Sherwood for assistance with MALDI-TOF MS and M. Pollard and K. Niklas for critical discussion. This work was supported by grants from the US National Science Foundation (Plant Genome Program; DBI-0606595), the United States-Israel Binational Agricultural Research and Development Fund (IS-4234-09); the US Department of Agriculture Cooperative State Research, Education and Extension Service (2011-04197); and the Danish Council for Strategic Research (10-093465). T.H.Y. was supported in part by a US National Institutes of Health Chemistry-Biology Interface Training Grant (T32 GM008500).	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Baker E. A., 1982, PLANT CUTICLE, P33; CROTEAU R, 1974, BIOCHEMISTRY-US, V13, P3193, DOI 10.1021/bi00712a030; EDWARDS D, 1993, NEW PHYTOL, V125, P225, DOI 10.1111/j.1469-8137.1993.tb03879.x; Graca J, 2002, PHYTOCHEMISTRY, V61, P205, DOI 10.1016/S0031-9422(02)00212-1; Graca J, 2010, J AGR FOOD CHEM, V58, P9666, DOI 10.1021/jf1015297; Heredia A, 2009, BIOINTERPHASES, V4, pP1, DOI 10.1116/1.3063816; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Isaacson T, 2009, PLANT J, V60, P363, DOI 10.1111/j.1365-313X.2009.03969.x; Jetter R, 2006, ANNU PLANT REV, V23, P145; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Li YH, 2007, PLANT PHYSIOL, V144, P1267, DOI 10.1104/pp.107.099432; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mintz-Oron S, 2008, PLANT PHYSIOL, V147, P823, DOI 10.1104/pp.108.116004; Nawrath C, 2006, CURR OPIN PLANT BIOL, V9, P281, DOI 10.1016/j.pbi.2006.03.001; Osman SF, 1999, J AGR FOOD CHEM, V47, P799, DOI 10.1021/jf980693r; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Reina JJ, 2007, J EXP BOT, V58, P2717, DOI 10.1093/jxb/erm136; Shi JX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001388; Volokita M, 2011, MOL BIOL EVOL, V28, P551, DOI 10.1093/molbev/msq226; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yeats TH, 2010, J EXP BOT, V61, P3759, DOI 10.1093/jxb/erq194	23	138	151	2	120	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					609	611		10.1038/NCHEMBIO.960	http://dx.doi.org/10.1038/NCHEMBIO.960			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22610035	Green Accepted			2022-12-27	WOS:000305471400006
J	Richter, L; de Graaf, C; Sieghart, W; Varagic, Z; Morzinger, M; de Esch, IJP; Ecker, GF; Ernst, M				Richter, Lars; de Graaf, Chris; Sieghart, Werner; Varagic, Zdravko; Moerzinger, Martina; de Esch, Iwan J. P.; Ecker, Gerhard F.; Ernst, Margot			Diazepam-bound GABA(A) receptor models identify new benzodiazepine binding-site ligands	NATURE CHEMICAL BIOLOGY			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; EMPIRICAL SCORING FUNCTIONS; A RECEPTOR; ALPHA-SUBUNIT; STRUCTURAL REQUIREMENTS; AMINO-ACID; DOCKING; AFFINITY; RECOGNITION; RESIDUES	Benzodiazepines exert their anxiolytic, anticonvulsant, muscle-relaxant and sedative-hypnotic properties by allosterically enhancing the action of GABA at GABA(A) receptors via their benzodiazepine-binding site. Although these drugs have been used clinically since 1960, the molecular basis of this interaction is still not known. By using multiple homology models and an unbiased docking protocol, we identified a binding hypothesis for the diazepam-bound structure of the benzodiazepine site, which was confirmed by experimental evidence. Moreover, two independent virtual screening approaches based on this structure identified known benzodiazepine-site ligands from different structural classes and predicted potential new ligands for this site. Receptor-binding assays and electrophysiological studies on recombinant receptors confirmed these predictions and thus identified new chemotypes for the benzodiazepine-binding site. Our results support the validity of the diazepam-bound structure of the benzodiazepine-binding pocket, demonstrate its suitability for drug discovery and pave the way for structure-based drug design.	[Richter, Lars; Ecker, Gerhard F.] Univ Vienna, Dept Med Chem, Vienna, Austria; [de Graaf, Chris; de Esch, Iwan J. P.] Vrije Univ Amsterdam, Fac Sci, Leiden Amsterdam Ctr Drug Res, Div Med Chem, Amsterdam, Netherlands; [Sieghart, Werner; Varagic, Zdravko; Moerzinger, Martina; Ernst, Margot] Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, Vienna, Austria	University of Vienna; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Medical University of Vienna	Richter, L (corresponding author), Univ Vienna, Dept Med Chem, Vienna, Austria.	margot.ernst@meduniwien.ac.at	Sieghart, Werner/A-4877-2013; Richter, Lars/D-3426-2017; de Esch, Iwan/K-4909-2017; de Graaf, Chris/J-8549-2017	Sieghart, Werner/0000-0002-0443-0302; Richter, Lars/0000-0002-9417-9042; Ernst, Margot/0000-0002-9809-2649; Ecker, Gerhard/0000-0003-4209-6883; de Graaf, Chris/0000-0002-1226-2150	Austrian Academy of Science; Austrian Science Fund [P19653]; European Commission [HEALTH-F4-2008-202088]	Austrian Academy of Science; Austrian Science Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	Financial support from the Doctoral Fellowship Programme of the Austrian Academy of Science (L. R.), the Austrian Science Fund grant P19653 (M. E.) and the European Commission Seventh Framework Programme grant HEALTH-F4-2008-202088 (W. S. and I.J.P.d.E.) is gratefully acknowledged. We also thank Inte:Ligand for providing us a free license for LigandScout 3.0 and Open Eye for an Omega license. We thank M. Mysinger and J. Irwin from the Shoichet laboratory for generating the focused 'benzodiazepine' decoy set. In addition we thank E. Sigel for helpful suggestions and discussions during generation of this work; M. Stojanovic for technical assistance in the binding assays; A. Chalikiopoulos and M. Verheij for assistance in fragment docking studies; and E. Urban, S. Haselmaier, J. Konig, H. Custers and A. van de Stolpe for providing HRMS and <SUP>1</SUP>H- and <SUP>13</SUP>C-NMR spectral data.	Amin J, 1997, MOL PHARMACOL, V51, P833, DOI 10.1124/mol.51.5.833; Berezhnoy D, 2004, J BIOL CHEM, V279, P3160, DOI 10.1074/jbc.M311371200; Berezhnoy D, 2009, MOL PHARMACOL, V76, P440, DOI 10.1124/mol.109.054650; Buhr A, 1997, MOL PHARMACOL, V52, P676, DOI 10.1124/mol.52.4.676; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Chema D, 2004, J COMPUT AID MOL DES, V18, P23, DOI 10.1023/B:JCAM.0000022561.76694.5b; Ci SQ, 2008, PROTEIN J, V27, P71, DOI 10.1007/s10930-007-9109-9; Claussen H, 2001, J MOL BIOL, V308, P377, DOI 10.1006/jmbi.2001.4551; Clayton T, 2007, CURR MED CHEM, V14, P2755, DOI 10.2174/092986707782360097; Davies M, 1998, J NEUROCHEM, V70, P2188; de Graaf C, 2008, J MED CHEM, V51, P4978, DOI 10.1021/jm800710x; Derry JMC, 2004, J NEUROCHEM, V88, P1431, DOI 10.1046/j.1471-4159.2003.02264.x; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Evers A, 2003, J MOL BIOL, V334, P327, DOI 10.1016/j.jmb.2003.09.032; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kucken AM, 2003, MOL PHARMACOL, V63, P289, DOI 10.1124/mol.63.2.289; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; MIHIC SJ, 1994, J BIOL CHEM, V269, P32768; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Mokrab Y, 2007, J MOL GRAPH MODEL, V26, P760, DOI 10.1016/j.jmgm.2007.04.012; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; POPP FD, 1980, J PHARM SCI, V69, P1235, DOI 10.1002/jps.2600691035; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sancar F, 2007, MOL PHARMACOL, V71, P38, DOI 10.1124/mol.106.029595; Sawyer GW, 2002, J BIOL CHEM, V277, P50036, DOI 10.1074/jbc.M209281200; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SIEGHART W, 1984, BIOCHEM PHARMACOL, V33, P4033, DOI 10.1016/0006-2952(84)90017-0; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 1998, MOL PHARMACOL, V54, P1097, DOI 10.1124/mol.54.6.1097; Sigel Erwin, 2002, Current Topics in Medicinal Chemistry, V2, P833, DOI 10.2174/1568026023393444; Tan KR, 2007, J BIOL CHEM, V282, P26316, DOI 10.1074/jbc.M702153200; Tan KR, 2009, J NEUROCHEM, V111, P1264, DOI 10.1111/j.1471-4159.2009.06419.x; Venhorst J, 2008, J MED CHEM, V51, P3222, DOI 10.1021/jm8001058; Verheij MHP, 2011, BIOORG MED CHEM LETT, V21, P5460, DOI 10.1016/j.bmcl.2011.06.123; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Zhang W, 1995, Drug Des Discov, V12, P193	48	148	157	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					455	464		10.1038/NCHEMBIO.917	http://dx.doi.org/10.1038/NCHEMBIO.917			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22446838	Green Accepted			2022-12-27	WOS:000302962500012
J	Valderrama-Rincon, JD; Fisher, AC; Merritt, JH; Fan, YY; Reading, CA; Chhiba, K; Heiss, C; Azadi, P; Aebi, M; DeLisa, MP				Valderrama-Rincon, Juan D.; Fisher, Adam C.; Merritt, Judith H.; Fan, Yao-Yun; Reading, Craig A.; Chhiba, Krishan; Heiss, Christian; Azadi, Parastoo; Aebi, Markus; DeLisa, Matthew P.			An engineered eukaryotic protein glycosylation pathway in Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							N-LINKED GLYCOSYLATION; DISPLAY; SPECIFICITY; DISTINCT; SYSTEM; ALG11	We performed bottom-up engineering of a synthetic pathway in Escherichia coli for the production of eukaryotic trimannosyl chitobiose glycans and the transfer of these glycans to specific asparagine residues in target proteins. The glycan biosynthesis was enabled by four eukaryotic glycosyltransferases, including the yeast uridine diphosphate-N-acetylglucosamine transferases Alg13 and Alg14 and the mannosyltransferases Alg1 and Alg2. By including the bacterial oligosaccharyltransferase PglB from Campylobacter jejuni, we successfully transferred glycans to eukaryotic proteins.	[Valderrama-Rincon, Juan D.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Fisher, Adam C.; Merritt, Judith H.; Reading, Craig A.] Glycobia Inc, Ithaca, NY USA; [Fan, Yao-Yun; Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8092 Zurich, Switzerland; [Chhiba, Krishan] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Heiss, Christian; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Cornell University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Cornell University; University System of Georgia; University of Georgia	Valderrama-Rincon, JD (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	Heiss, Christian/GPX-7678-2022; DeLisa, Matthew/AAE-7361-2019; Fan, YaoYun/AAS-5920-2020	Heiss, Christian/0000-0003-1118-8953; DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation [CBET-0449080]; New York State Office of Science; National Institutes of Health [R43 GM087766, R43 GM086965]; National Institutes of Health National Center for Research Resources [1 P41 RR018502-01]; LASPAU; Universidad Antonio Narino; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM087766, R43GM086965] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); New York State Office of Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); LASPAU; Universidad Antonio Narino; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Imperiali (Massachusetts Institute of Technology) for plasmid pBAD(ALG2)-DEST49, G. O'Toole (Dartmouth College) for plasmid pMQ70, T. Mansell for helpful discussions regarding RNaseA glycosylation, C. Hong for helpful discussions regarding glycan synthesis and individuals from the Functional Genomic Center Zurich for input and instrument support. This work was supported by the National Science Foundation Career Award CBET-0449080 (to M. P. D.), the New York State Office of Science, Technology and Academic Research Distinguished Faculty Award (to M. P. D.), the National Institutes of Health Small Business Innovation Research grants R43 GM087766 and R43 GM086965 (to A. C. F.), the National Institutes of Health National Center for Research Resources grant 1 P41 RR018502-01 (to the Complex Carbohydrate Research Center) and a graduate fellowship from LASPAU and the Universidad Antonio Narino (to J.D.V.-R.).	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Celik E, 2010, PROTEIN SCI, V19, P2006, DOI 10.1002/pro.472; Cipollo JF, 2001, J BIOL CHEM, V276, P21828, DOI 10.1074/jbc.M010896200; COUTO JR, 1984, J BIOL CHEM, V259, P378; Durr C, 2010, GLYCOBIOLOGY, V20, P1366, DOI 10.1093/glycob/cwq102; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Fisher AC, 2011, APPL ENVIRON MICROB, V77, P871, DOI 10.1128/AEM.01901-10; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Ihssen J, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-61; Ilg K, 2010, GLYCOBIOLOGY, V20, P1289, DOI 10.1093/glycob/cwq091; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Liu X, 2006, ANAL CHEM, V78, P6081, DOI 10.1021/ac060516m; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Pandhal J, 2010, BIOTECHNOL LETT, V32, P1189, DOI 10.1007/s10529-010-0289-6; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang X, 2008, STRUCTURE, V16, P965, DOI 10.1016/j.str.2008.03.010; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099	25	165	176	3	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					434	436		10.1038/NCHEMBIO.921	http://dx.doi.org/10.1038/NCHEMBIO.921			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22446837	Green Accepted			2022-12-27	WOS:000302962500009
J	Duckert, H; Pries, V; Khedkar, V; Menninger, S; Bruss, H; Bird, AW; Maliga, Z; Brockmeyer, A; Janning, P; Hyman, A; Grimme, S; Schurmann, M; Preut, H; Hubel, K; Ziegler, S; Kumar, K; Waldmann, H				Dueckert, Heiko; Pries, Verena; Khedkar, Vivek; Menninger, Sascha; Bruss, Hanna; Bird, Alexander W.; Maliga, Zoltan; Brockmeyer, Andreas; Janning, Petra; Hyman, Anthony; Grimme, Stefan; Schuermann, Markus; Preut, Hans; Huebel, Katja; Ziegler, Slava; Kumar, Kamal; Waldmann, Herbert			Natural product-inspired cascade synthesis yields modulators of centrosome integrity	NATURE CHEMICAL BIOLOGY			English	Article							BIOLOGY-ORIENTED SYNTHESIS; NUCLEOPHOSMIN; INHIBITOR; DRUGS; EFFICIENT; COMPLEX; CANCER	In biology-oriented synthesis, the scaffolds of biologically relevant compound classes inspire the synthesis of focused compound collections enriched in bioactivity. This criterion is, in particular, met by the scaffolds of natural products selected in evolution. The synthesis of natural product-inspired compound collections calls for efficient reaction sequences that preferably combine multiple individual transformations in one operation. Here we report the development of a one-pot, twelve-step cascade reaction sequence that includes nine different reactions and two opposing kinds of organocatalysis. The cascade sequence proceeds within 10-30 min and transforms readily available substrates into complex indoloquinolizines that resemble the core tetracyclic scaffold of numerous polycyclic indole alkaloids. Biological investigation of a corresponding focused compound collection revealed modulators of centrosome integrity, termed centrocountins, which caused fragmented and supernumerary centrosomes, chromosome congression defects, multipolar mitotic spindles, acentrosomal spindle poles and multipolar cell division by targeting the centrosome-associated proteins nucleophosmin and Crm1.	[Dueckert, Heiko; Pries, Verena; Khedkar, Vivek; Menninger, Sascha; Bruss, Hanna; Brockmeyer, Andreas; Janning, Petra; Huebel, Katja; Ziegler, Slava; Kumar, Kamal; Waldmann, Herbert] Max Planck Inst Mol Physiol, Abt Chem Biol, D-44139 Dortmund, Germany; [Dueckert, Heiko; Pries, Verena; Menninger, Sascha; Bruss, Hanna; Schuermann, Markus; Preut, Hans; Kumar, Kamal; Waldmann, Herbert] Tech Univ Dortmund, Fak Chem, Dortmund, Germany; [Bird, Alexander W.; Maliga, Zoltan; Hyman, Anthony] Max Planck Inst Mol Zellbiol & Genet, Dresden, Germany; [Grimme, Stefan] Univ Munster, Inst Chem, Munster, Germany	Max Planck Society; Dortmund University of Technology; Max Planck Society; University of Munster	Kumar, K (corresponding author), Max Planck Inst Mol Physiol, Abt Chem Biol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	kamal.kumar@mpi-dortmund.mpg.de; herbert.waldmann@mpi-dortmund.mpg.de	Waldmann, Herbert/B-7406-2017; Kumar, Kamal/M-7623-2018; Hyman, Tony/F-1923-2011	Waldmann, Herbert/0000-0002-9606-7247; Kumar, Kamal/0000-0003-3593-8421; Ziegler, Slava/0000-0003-4398-7741; Bird, Alexander/0000-0002-1061-0799	European Research Council under the European Union [268309]; Max Planck Gesellschaft	European Research Council under the European Union(European Research Council (ERC)); Max Planck Gesellschaft(Max Planck Society)	We would like to thank T. U. Mayer (Universitat Konstanz) for helpful discussions, S. Muller and T. Klussendorf (Max-Planck-Institut Dortmund) for assistance with the fluorescence lifetime imaging microscopy measurements, C. Nowak for technical assistance, S.J. Martin (Smurfit Institute of Genetics, Trinity College Dublin) for the pET19b-NPM plasmid, A. Wittinghofer (Max-Planck-Institut Dortmund) for the pET3a-Crm1 vector and the Dortmund Protein Facility for cloning NPM-citrine. This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 268309 to H. W.) and by the Max Planck Gesellschaft.	Amin MA, 2008, FEBS LETT, V582, P3839, DOI 10.1016/j.febslet.2008.10.023; Antonchick AP, 2010, NAT CHEM, V2, P735, DOI 10.1038/nchem.730; Bon RS, 2010, ACCOUNTS CHEM RES, V43, P1103, DOI 10.1021/ar100014h; Carlson EE, 2010, ACS CHEM BIOL, V5, P639, DOI 10.1021/cb100105c; Duflos Alain, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P55, DOI 10.2174/1568011023354452; Elders N, 2009, ANGEW CHEM INT EDIT, V48, P5856, DOI 10.1002/anie.200902683; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hung DT, 1996, CHEM BIOL, V3, P623, DOI 10.1016/S1074-5521(96)90129-5; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ishikura M, 2010, NAT PROD REP, V27, P1630, DOI 10.1039/c005345g; Islam K, 2010, ANGEW CHEM INT EDIT, V49, P8484, DOI 10.1002/anie.201004026; Khedkar V, 2010, SYNLETT, P1576; Khedkar V, 2010, SYNLETT, P403, DOI 10.1055/s-0029-1219176; Kumar K, 2009, ANGEW CHEM INT EDIT, V48, P3224, DOI 10.1002/anie.200803437; LAVILLA R, 1992, TETRAHEDRON, V48, P6445, DOI 10.1016/S0040-4020(01)88234-X; Lim MJ, 2006, CANCER DETECT PREV, V30, P481, DOI 10.1016/j.cdp.2006.10.008; Liu QY, 2009, BIOCHEM BIOPH RES CO, V384, P383, DOI 10.1016/j.bbrc.2009.04.154; Liu W, 2011, ANGEW CHEM INT EDIT, V50, P6900, DOI 10.1002/anie.201102440; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nicolaou KC, 2009, CHEM SOC REV, V38, P2993, DOI 10.1039/b903290h; Noren-Muller A, 2006, P NATL ACAD SCI USA, V103, P10606, DOI 10.1073/pnas.0601490103; Orosz F, 2006, MINI-REV MED CHEM, V6, P1145, DOI 10.2174/138955706778560094; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Plafker K, 2000, MOL CELL BIOL, V20, P3510, DOI 10.1128/MCB.20.10.3510-3521.2000; ROBERTS BJ, 1986, CANCER CHEMOTH PHARM, V16, P95; Tietze LF, 1996, CHEM REV, V96, P115, DOI 10.1021/cr950027e; Waldmann H, 2008, ANGEW CHEM INT EDIT, V47, P6869, DOI 10.1002/anie.200802413; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; WENKERT E, 1976, J AM CHEM SOC, V98, P3645, DOI 10.1021/ja00428a044; Wetzel S, 2011, ANGEW CHEM INT EDIT, V50, P10800, DOI 10.1002/anie.201007004; Wulff JE, 2007, J AM CHEM SOC, V129, P14444, DOI 10.1021/ja075327f; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791	33	97	97	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					179	184		10.1038/nchembio.758	http://dx.doi.org/10.1038/nchembio.758			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22198731				2022-12-27	WOS:000299323200010
J	Santos, AM; Schechtman, D; Cardoso, AC; Clemente, CFMZ; Silva, JC; Fioramonte, M; Pereira, MBM; Marin, TM; Oliveira, PSL; Figueira, ACM; Oliveira, SHP; Torriani, IL; Gozzo, FC; Neto, JX; Franchini, KG				Santos, Aline M.; Schechtman, Deborah; Cardoso, Alisson C.; Clemente, Carolina F. M. Z.; Silva, Julio C.; Fioramonte, Mariana; Pereira, Michelle B. M.; Marin, Talita M.; Oliveira, Paulo S. L.; Figueira, Ana Carolina M.; Oliveira, Saulo H. P.; Torriani, Iris L.; Gozzo, Fabio C.; Neto, Jose Xavier; Franchini, Kleber G.			FERM domain interaction with myosin negatively regulates FAK in cardiomyocyte hypertrophy	NATURE CHEMICAL BIOLOGY			English	Article							FOCAL ADHESION KINASE; SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; PROTEIN; PHOSPHORYLATION; INHIBITOR; PEPTIDES; GROWTH; SRC	Focal adhesion kinase (FAK) regulates cellular processes that affect several aspects of development and disease. The FAK N-terminal FERM (4.1 protein-ezrin-radixin-moesin homology) domain, a compact clover-leaf structure, binds partner proteins and mediates intramolecular regulatory interactions. Combined chemical cross-linking coupled to MS, small-angle X-ray scattering, computational docking and mutational analyses showed that the FAK FERM domain has a molecular cleft (similar to 998 angstrom(2)) that interacts with sarcomeric myosin, resulting in FAK inhibition. Accordingly, mutations in a unique short amino acid sequence of the FERM myosin cleft, FP-1, impaired the interaction with myosin and enhanced FAK activity in cardiomyocytes. An FP-1 decoy peptide selectively inhibited myosin interaction and increased FAK activity, promoting cardiomyocyte hypertrophy through activation of the AKT-mammalian target of rapamycin pathway. Our findings uncover an inhibitory interaction between the FAK FERM domain and sarcomeric myosin that presents potential opportunities to modulate the cardiac hypertrophic response through changes in FAK activity.	[Santos, Aline M.; Cardoso, Alisson C.; Pereira, Michelle B. M.; Marin, Talita M.; Franchini, Kleber G.] Univ Estadual Campinas, Sch Med, Dept Internal Med, Campinas, SP, Brazil; [Santos, Aline M.; Cardoso, Alisson C.; Clemente, Carolina F. M. Z.; Silva, Julio C.; Pereira, Michelle B. M.; Marin, Talita M.; Oliveira, Paulo S. L.; Figueira, Ana Carolina M.; Oliveira, Saulo H. P.; Torriani, Iris L.; Neto, Jose Xavier; Franchini, Kleber G.] Brazilian Assoc Synchrotron Light Technol, Brazilian Natl Lab Biosci, Campinas, SP, Brazil; [Schechtman, Deborah] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Fioramonte, Mariana; Gozzo, Fabio C.] Univ Estadual Campinas, Inst Chem, Campinas, SP, Brazil; [Torriani, Iris L.] Univ Estadual Campinas, Gleb Wataghin Phys Inst, Campinas, SP, Brazil	Universidade Estadual de Campinas; Laboratorio Nacional de Luz Sincrotron (LNLS); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Santos, AM (corresponding author), Univ Estadual Campinas, Sch Med, Dept Internal Med, Campinas, SP, Brazil.	kleber.franchini@lnbio.org.br	Torriani, Iris L/E-5686-2010; Oliveira, Paulo S/K-5588-2013; da Silva, Julio Cesar/A-5240-2011; Gozzo, Fabio/F-8123-2010; schechtman, deborah/B-7572-2012; Marin, Talita Miguel/K-1964-2019; Fioramonte, Mariana/U-2890-2019; Fioramonte, Mariana/D-7484-2014; Oliveira, Paulo/D-5463-2011; Marin, Talita M/P-1181-2016; Figueira, Ana Carolina/X-1649-2019	da Silva, Julio Cesar/0000-0001-8035-0550; Marin, Talita Miguel/0000-0002-2605-7166; Fioramonte, Mariana/0000-0002-1022-0811; Oliveira, Paulo/0000-0002-1287-8019; Marin, Talita M/0000-0002-2605-7166; Figueira, Ana Carolina/0000-0002-7023-8490; Cardoso, Alisson/0000-0002-3051-9976; Franchini, Kleber/0000-0002-0190-6635; Schechtman, Deborah/0000-0002-8874-7023	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/54878-3, 2007/55930-1, 2007/59442-1, 2008/53519-5, 2008/57805-2, 2010/02628-9]; Conselho Nacional de Pesquisa (CNPq) [304366/2009-9, 475158/2010-5, 573672/2008-3, 559698/2009-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Grants 2006/54878-3, 2007/55930-1, 2007/59442-1, 2008/53519-5, 2008/57805-2, 2010/02628-9) and Conselho Nacional de Pesquisa (CNPq: Grants 304366/2009-9, 475158/2010-5, 573672/2008-3, 559698/2009-7).	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; DiMichele LA, 2006, CIRC RES, V99, P636, DOI 10.1161/01.RES.0000240498.44752.d6; Dunty JM, 2002, J BIOL CHEM, V277, P45644, DOI 10.1074/jbc.M201779200; Eble DM, 2000, AM J PHYSIOL-HEART C, V278, pH1695, DOI 10.1152/ajpheart.2000.278.5.H1695; Fonseca PM, 2005, CIRC RES, V96, P73, DOI 10.1161/01.RES.0000152390.99806.A5; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Golubovskaya VM, 2009, HISTOL HISTOPATHOL, V24, P503, DOI 10.14670/HH-24.503; Iglesias AH, 2010, ANAL CHEM, V82, P909, DOI 10.1021/ac902051q; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135; Laser M, 2000, J BIOL CHEM, V275, P35624, DOI 10.1074/jbc.M006124200; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Marin TM, 2008, CIRC RES, V103, P813, DOI 10.1161/CIRCRESAHA.108.179754; Medley QG, 2003, J BIOL CHEM, V278, P13265, DOI 10.1074/jbc.M300277200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pham CG, 2000, AM J PHYSIOL-HEART C, V279, pH2916, DOI 10.1152/ajpheart.2000.279.6.H2916; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Taylor JM, 2000, J BIOL CHEM, V275, P19250, DOI 10.1074/jbc.M909099199; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413	39	15	15	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					102	110		10.1038/nchembio.717	http://dx.doi.org/10.1038/nchembio.717			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22101605				2022-12-27	WOS:000298414100018
J	[Anonymous]				[Anonymous]			Talking microbes	NATURE CHEMICAL BIOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					1	1		10.1038/nchembio.762	http://dx.doi.org/10.1038/nchembio.762			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173341	Bronze			2022-12-27	WOS:000298414100001
J	Huang, H; Ceccarelli, DF; Orlicky, S; St-Cyr, DJ; Ziemba, A; Garg, P; Plamondon, S; Auer, M; Sidhu, S; Marinier, A; Kleiger, G; Tyers, M; Sicheri, F				Huang, Hao; Ceccarelli, Derek F.; Orlicky, Stephen; St-Cyr, Daniel J.; Ziemba, Amy; Garg, Pankaj; Plamondon, Serge; Auer, Manfred; Sidhu, Sachdev; Marinier, Anne; Kleiger, Gary; Tyers, Mike; Sicheri, Frank			E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin	NATURE CHEMICAL BIOLOGY			English	Article							RING E3 LIGASE; COMPLEX; ACTIVATION; MECHANISM; REVEALS; DOMAIN; CDC34; SCF; TURNOVER; SUBUNIT	Weak protein interactions between ubiquitin and the ubiquitin-proteasome system (UPS) enzymes that mediate its covalent attachment to substrates serve to position ubiquitin for optimal catalytic transfer. We show that a small-molecule inhibitor of the E2 ubiquitin-conjugating enzyme Cdc34A, called CC0651, acts by trapping a weak interaction between ubiquitin and the E2 donor ubiquitin-binding site. A structure of the ternary CC0651-Cdc34A-ubiquitin complex reveals that the inhibitor engages a composite binding pocket formed from Cdc34A and ubiquitin. CC0651 also suppresses the spontaneous hydrolysis rate of the Cdc34A-ubiquitin thioester without decreasing the interaction between Cdc34A and the RING domain subunit of the E3 enzyme. Stabilization of the numerous other weak interactions between ubiquitin and UPS enzymes by small molecules may be a feasible strategy to selectively inhibit different UPS activities.	[Huang, Hao; Ceccarelli, Derek F.; Orlicky, Stephen; Sicheri, Frank] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [St-Cyr, Daniel J.; Plamondon, Serge; Marinier, Anne; Tyers, Mike] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Ziemba, Amy; Kleiger, Gary] Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA; [Garg, Pankaj; Sidhu, Sachdev; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Garg, Pankaj; Sidhu, Sachdev] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Auer, Manfred] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Auer, Manfred] Univ Edinburgh, Sch Biomed Sci, Edinburgh, Midlothian, Scotland; [Marinier, Anne] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Tyers, Mike] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Universite de Montreal; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Toronto; University of Toronto; University of Edinburgh; University of Edinburgh; Universite de Montreal; Universite de Montreal	Tyers, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	md.tyers@umontreal.ca; sicheri@lunenfeld.ca	Sicheri, Frank/F-8856-2013; St-Cyr, Daniel J/B-3558-2008; Tyers, Michael/ABE-3194-2021	St-Cyr, Daniel J/0000-0003-2432-6585; Auer, Manfred/0000-0001-8920-3522; Orlicky, Stephen/0000-0002-8172-2042; Ceccarelli, Derek/0000-0002-2674-9234	National Center for Research Resources at the US National Institutes of Health (NIH) [RR-15301]; US Department of Energy [ACO2-06CH11357]; National Center for Research Resources [5P2ORR016464-11]; National Institute of General Medical Sciences from the NIH [8 P20 GM103440-11]; Canadian Institutes of Health Research [MOP-126129, MOP-57795]; Ministere de renseignement superieur, de la recherche, de la science et de la technologie du Quebec through Genome Quebec; Canadian Institutes of Health Research Postdoctoral Fellowship; Canada Research Chair in structural biology; Canada Research Chair in systems and synthetic biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER; Medical Research Council [MC_G0802522] Funding Source: researchfish; MRC [MC_G0802522] Funding Source: UKRI	National Center for Research Resources at the US National Institutes of Health (NIH); US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the NIH; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de renseignement superieur, de la recherche, de la science et de la technologie du Quebec through Genome Quebec; Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in structural biology; Canada Research Chair in systems and synthetic biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Ernst, R. Deshaies, A. van der Sloot, R. Grunberg, J.-F. Lavallee, C. James, K. Chan and E Mercurio for helpful discussions. We also thank I. Kourinov and staff at the Argonne National Laboratory for assistance with microdiffraction experiments at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, as supported by award RR-15301 from the National Center for Research Resources at the US National Institutes of Health (NIH) and contract DE-ACO2-06CH11357 from the US Department of Energy. G.K. and A.Z. are funded by grants. from the National Center for Research Resources (5P2ORR016464-11) and the National Institute of General Medical Sciences (8 P20 GM103440-11) from the NIH. This work was supported by grants to P.S. and M.T. from the Canadian Institutes of Health Research (MOP-126129, MOP-57795); by an award from the Ministere de renseignement superieur, de la recherche, de la science et de la technologie du Quebec through Genome Quebec to MT.; by a Canadian Institutes of Health Research Postdoctoral Fellowship to D.J.S.-C.; by a Canada Research Chair in structural biology to ES.; and by a Canada Research Chair in systems and synthetic biology to M.T.	Bracher PJ, 2011, ORIGINS LIFE EVOL B, V41, P399, DOI 10.1007/s11084-011-9243-4; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Liao H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009183; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Song J, 2009, PROTEIN SCI, V18, P2492, DOI 10.1002/pro.254; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; Thiel P, 2012, ANGEW CHEM INT EDIT, V51, P2012, DOI 10.1002/anie.201107616; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	40	54	55	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					156	163		10.1038/NCHEMBIO.1412	http://dx.doi.org/10.1038/NCHEMBIO.1412			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316736	Green Accepted			2022-12-27	WOS:000330751600015
J	Nelson, JW; Sudarsan, N; Furukawa, K; Weinberg, Z; Wang, JX; Breaker, RR				Nelson, James W.; Sudarsan, Narasimhan; Furukawa, Kazuhiro; Weinberg, Zasha; Wang, Joy X.; Breaker, Ronald R.			Riboswitches in eubacteria sense the second messenger c-di-AMP	NATURE CHEMICAL BIOLOGY			English	Article							RESUSCITATION-PROMOTING FACTORS; LIGAND-BINDING; S-ADENOSYLHOMOCYSTEINE; STRUCTURAL BASIS; GENE-EXPRESSION; BACTERIA; IDENTIFICATION; TRANSCRIPTION; SPORULATION; RESISTANCE	Cyclic di-adenosine monophosphate (c-di-AMP) is a recently discovered bacterial second messenger implicated in the control of cell wall metabolism, osmotic stress responses and sporulation. However, the mechanisms by which c-di-AMP triggers these physiological responses have remained largely unknown. Notably, a candidate riboswitch class called ydaO associates with numerous genes involved in these same processes. Although a representative ydaO motif RNA recently was reported to weakly bind ATP, we report that numerous members of this noncoding RNA class selectively respond to c-di-AMP with subnanomolar affinity. Our findings resolve the mystery regarding the primary ligand for this extremely common riboswitch class and expose a major portion of the super-regulon of genes that are controlled by the widespread bacterial second messenger c-di-AMP.	[Nelson, James W.] Yale Univ, Dept Chem, New Haven, CT USA; [Sudarsan, Narasimhan; Weinberg, Zasha; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Sudarsan, Narasimhan; Furukawa, Kazuhiro; Weinberg, Zasha; Wang, Joy X.; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010; Wang, Joy Xin/D-2482-2010	Breaker, Ronald/0000-0002-2165-536X; Nelson, James/0000-0001-5033-6766; Weinberg, Zasha/0000-0002-6681-3624	NIH [RR19895-02]; Japan Society for the Promotion of Science fellowship for research abroad; US National Institutes of Health [GM022778, DE022340]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science fellowship for research abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Roth and other members of the Breaker laboratory for helpful discussions. We also thank N. Carriero and R. Bjornson for assisting our use of the Yale Life Sciences High Performance Computing Center (NIH grant RR19895-02). K. F. was supported by a Japan Society for the Promotion of Science fellowship for research abroad. This project was supported by US National Institutes of Health grants (GM022778 and DE022340) to R. R. B. Research in the Breaker laboratory is also supported by the Howard Hughes Medical Institute.	Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Block KF, 2010, J BACTERIOL, V192, P3983, DOI 10.1128/JB.00450-10; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; GERSTEIN M, 1994, J MOL BIOL, V236, P1067, DOI 10.1016/0022-2836(94)90012-4; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; Haller A, 2011, ACCOUNTS CHEM RES, V44, P1339, DOI 10.1021/ar200035g; Hofacker IL, 2009, CURR PROTOC BIOINFOR, V12, P2; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kana BD, 2010, FEMS IMMUNOL MED MIC, V58, P39, DOI 10.1111/j.1574-695X.2009.00606.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang M, 2009, MOL CELL, V33, P784, DOI 10.1016/j.molcel.2009.02.019; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Krasteva PV, 2012, PROTEIN SCI, V21, P929, DOI 10.1002/pro.2093; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Marchais A, 2011, RNA BIOL, V8, P358, DOI 10.4161/rna.8.3.14998; Markley JL, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P157; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer MM, 2011, RNA BIOL, V8, P5, DOI 10.4161/rna.8.1.13865; Moriyama R, 1999, J BACTERIOL, V181, P2373, DOI 10.1128/JB.181.8.2373-2378.1999; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Ren AM, 2012, NATURE, V486, P85, DOI 10.1038/nature11152; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Roth A., NAT CHEM BI IN PRESS; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Shanahan CA, 2013, BIOCHEMISTRY-US, V52, P365, DOI 10.1021/bi301510v; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Vidal-Aroca F, 2006, BIOTECHNIQUES, V40, P433, DOI 10.2144/000112145; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Watson PY, 2012, NAT CHEM BIOL, V8, P963, DOI [10.1038/nchembio.1095, 10.1038/NCHEMBIO.1095]; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	63	191	201	2	73	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					834	+		10.1038/NCHEMBIO.1363	http://dx.doi.org/10.1038/NCHEMBIO.1363			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24141192	Green Accepted			2022-12-27	WOS:000327130000016
J	Jones, KA; Hatori, M; Mure, LS; Bramley, JR; Artymyshyn, R; Hong, SP; Marzabadi, M; Zhong, HL; Sprouse, J; Zhu, QS; Hartwick, ATE; Sollars, PJ; Pickard, GE; Panda, S				Jones, Kenneth A.; Hatori, Megumi; Mure, Ludovic S.; Bramley, Jayne R.; Artymyshyn, Roman; Hong, Sang-Phyo; Marzabadi, Mohammad; Zhong, Huailing; Sprouse, Jeffrey; Zhu, Quansheng; Hartwick, Andrew T. E.; Sollars, Patricia J.; Pickard, Gary E.; Panda, Satchidananda			Small-molecule antagonists of melanopsin-mediated phototransduction	NATURE CHEMICAL BIOLOGY			English	Article							RETINAL GANGLION-CELLS; CRYSTAL-STRUCTURE; LIGHT; PHOTOPIGMENT; MICE; PHOTORECEPTORS; ADAPTATION; RHODOPSIN; RESPONSES; MIGRAINE	Melanopsin, expressed in a subset of retinal ganglion cells, mediates behavioral adaptation to ambient light and other non-image-forming photic responses. This has raised the possibility that pharmacological manipulation of melanopsin can modulate several central nervous system responses, including photophobia, sleep, circadian rhythms and neuroendocrine function. Here we describe the identification of a potent synthetic melanopsin antagonist with in vivo activity. New sulfonamide compounds inhibiting melanopsin (opsinamides) compete with retinal binding to melanopsin and inhibit its function without affecting rod- and cone-mediated responses. In vivo administration of opsinamides to mice specifically and reversibly modified melanopsin-dependent light responses, including the pupillary light reflex and light aversion. The discovery of opsinamides raises the prospect of therapeutic control of the melanopsin phototransduction system to regulate light-dependent behavior and remediate pathological conditions.	[Jones, Kenneth A.; Artymyshyn, Roman; Hong, Sang-Phyo; Marzabadi, Mohammad; Zhong, Huailing] Lundbeck Res USA Inc, Paramus, NJ USA; [Hatori, Megumi; Mure, Ludovic S.; Zhu, Quansheng; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Bramley, Jayne R.; Sollars, Patricia J.; Pickard, Gary E.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [Sprouse, Jeffrey] Cyanapt LLC, Stonington, CO USA; [Hartwick, Andrew T. E.] Ohio State Univ, Coll Optometry, Columbus, OH 43210 USA; [Pickard, Gary E.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA	Salk Institute; University of Nebraska System; University of Nebraska Lincoln; University System of Ohio; Ohio State University; University of Nebraska System; University of Nebraska Medical Center	Jones, KA (corresponding author), Lundbeck Res USA Inc, Paramus, NJ USA.	kenjones120@gmail.com; satchin@salk.edu	Jones, Kenneth/GXF-4945-2022; Hatori, Megumi/GTY-3770-2022; Mure, Ludovic/AAR-9132-2021	Mure, Ludovic/0000-0002-2485-1032; Hatori, Megumi/0000-0001-7888-158X; Sprouse, Jeffrey/0000-0001-7410-9015	Hearst Foundation; US National Institutes of Health (NIH) [NIH EY 016807, S10 RR027450, NS066457]; Japan Society for the Promotion of Science fellowship; Fyssen and Catharina foundation; NIH [NIH EY017809]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027450] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017809, R01EY016807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066457] Funding Source: NIH RePORTER	Hearst Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fyssen and Catharina foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Boyle, B. Li, A. Pieris, R. Li, P. Rao, M. Cajina, H. Zhang (Lundbeck), H. Le, S. Keding (Salk Institute) for expert technical help. This work was supported by grants from the Hearst Foundation; US National Institutes of Health (NIH) grants NIH EY 016807, S10 RR027450 and NS066457 to S.P.; a Japan Society for the Promotion of Science fellowship to M.H.; Fyssen and Catharina foundation fellowships to L.S.M.; and NIH grant NIH EY017809 to P.J.S. and G.E.P.	Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; GOOD PA, 1991, HEADACHE, V31, P533, DOI 10.1111/j.1526-4610.1991.hed3108533.x; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nayak SK, 2007, CELL MOL LIFE SCI, V64, P144, DOI 10.1007/s00018-006-5581-1; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; PrysePhillips WEM, 1997, CAN MED ASSOC J, V156, P1273; Pulivarthy S.R., P NATL ACAD SCI US, V104; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016	29	52	52	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					630	635		10.1038/NCHEMBIO.1333	http://dx.doi.org/10.1038/NCHEMBIO.1333			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	23974117	Green Submitted, Green Accepted			2022-12-27	WOS:000325041800010
J	Grammel, M; Hang, HC				Grammel, Markus; Hang, Howard C.			Chemical reporters for biological discovery	NATURE CHEMICAL BIOLOGY			English	Review							NEWLY SYNTHESIZED PROTEINS; GLCNAC-MODIFIED PROTEINS; IN-VIVO; GENETIC-CODE; GLYCOSYLATION; DYNAMICS; ANALOG; DNA; METHYLTRANSFERASE; PALMITOYLATION	Functional tools are needed to understand complex biological systems. Here we review how chemical reporters in conjunction with bioorthogonal labeling methods can be used to image and retrieve nucleic acids, proteins, glycans, lipids and other metabolites in vitro, in cells as well as in whole organisms. By tagging these biomolecules, researchers can now monitor their dynamics in living systems and discover specific substrates of cellular pathways. These advances in chemical biology are thus providing important tools to characterize biological pathways and are poised to facilitate our understanding of human diseases.	[Grammel, Markus; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10021 USA	Rockefeller University	Hang, HC (corresponding author), Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, 1230 York Ave, New York, NY 10021 USA.	hhang@rockefeller.edu			Ellison Medical Foundation; US National Institutes of Health-National Institute of General Medical Sciences [1R01GM087544]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087544] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); US National Institutes of Health-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rangan and N. Westcott for helpful comments on the manuscript. H. C. H. acknowledges support from Ellison Medical Foundation and US National Institutes of Health-National Institute of General Medical Sciences (1R01GM087544).	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Anderson CT, 2012, P NATL ACAD SCI USA, V109, P1329, DOI 10.1073/pnas.1120429109; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Bao XC, 2013, ANGEW CHEM INT EDIT, V52, P4883, DOI 10.1002/anie.201300252; Bianco A, 2012, NAT CHEM BIOL, V8, P748, DOI [10.1038/nchembio.1043, 10.1038/NCHEMBIO.1043]; Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Bothwell IR, 2012, J AM CHEM SOC, V134, P14905, DOI 10.1021/ja304782r; Burnaevskiy N, 2013, NATURE, V496, P106, DOI 10.1038/nature12004; Chang PV, 2010, J AM CHEM SOC, V132, P9516, DOI 10.1021/ja101080y; Charron G, 2011, MOL BIOSYST, V7, P67, DOI 10.1039/c0mb00183j; Charron G, 2013, P NATL ACAD SCI USA, V110, P11085, DOI 10.1073/pnas.1302564110; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Dalhoff C, 2006, NAT CHEM BIOL, V2, P31, DOI 10.1038/nchembio754; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; DeGraw AJ, 2010, CHEM BIOL DRUG DES, V76, P460, DOI 10.1111/j.1747-0285.2010.01037.x; Devaraj NK, 2011, ACCOUNTS CHEM RES, V44, P816, DOI 10.1021/ar200037t; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dumont A, 2012, ANGEW CHEM INT EDIT, V51, P3143, DOI 10.1002/anie.201108127; Eichelbaum K, 2012, NAT BIOTECHNOL, V30, P984, DOI 10.1038/nbt.2356; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Grammel M, 2012, CHEMBIOCHEM, V13, P1112, DOI 10.1002/cbic.201200091; Grammel M, 2012, CHEM COMMUN, V48, P1473, DOI 10.1039/c1cc14939c; Grammel M, 2011, J AM CHEM SOC, V133, P17103, DOI 10.1021/ja205137d; Grammel M, 2010, ANGEW CHEM INT EDIT, V49, P5970, DOI 10.1002/anie.201002050; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Guan LR, 2011, CHEMBIOCHEM, V12, P2184, DOI 10.1002/cbic.201100353; Hang HC, 2011, ACCOUNTS CHEM RES, V44, P699, DOI 10.1021/ar200063v; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heal WP, 2011, CHEM COMMUN, V47, P4081, DOI 10.1039/c0cc04710d; Howden AJM, 2013, NAT METHODS, V10, P343, DOI [10.1038/NMETH.2401, 10.1038/nmeth.2401]; Huisgen R., 1963, ANGEW CHEM INT EDIT, V2, P565, DOI DOI 10.1002/ANIE.196305651; Islam K, 2011, ACS CHEM BIOL, V6, P679, DOI 10.1021/cb2000567; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jao CY, 2009, P NATL ACAD SCI USA, V106, P15332, DOI 10.1073/pnas.0907864106; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Jiang H, 2010, J AM CHEM SOC, V132, P9363, DOI 10.1021/ja101588r; Johnson JA, 2010, CURR OPIN CHEM BIOL, V14, P774, DOI 10.1016/j.cbpa.2010.09.013; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu F, 2009, CHEMBIOCHEM, V10, P1317, DOI 10.1002/cbic.200900018; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Milne SB, 2010, NAT CHEM BIOL, V6, P205, DOI 10.1038/NCHEMBIO.311; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Neef AB, 2011, P NATL ACAD SCI USA, V108, P20404, DOI 10.1073/pnas.1101126108; Ngo JT, 2009, NAT CHEM BIOL, V5, P715, DOI 10.1038/nchembio.200; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Peters W, 2010, ANGEW CHEM INT EDIT, V49, P5170, DOI 10.1002/anie.201001240; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Rangan KJ, 2010, J AM CHEM SOC, V132, P10628, DOI 10.1021/ja101387b; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Shogren-Knaak MA, 2001, ANNU REV CELL DEV BI, V17, P405, DOI 10.1146/annurev.cellbio.17.1.405; Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Swarts BM, 2012, J AM CHEM SOC, V134, P16123, DOI 10.1021/ja3062419; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Thiele C, 2012, ACS CHEM BIOL, V7, P2004, DOI 10.1021/cb300414v; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang R, 2013, J AM CHEM SOC, V135, P1048, DOI 10.1021/ja309412s; Wang R, 2011, J AM CHEM SOC, V133, P7648, DOI 10.1021/ja2006719; Willnow S, 2012, CHEMBIOCHEM, V13, P1167, DOI 10.1002/cbic.201100781; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Xie R, 2012, J AM CHEM SOC, V134, P9914, DOI 10.1021/ja303853y; Yamakoshi H, 2011, J AM CHEM SOC, V133, P6102, DOI 10.1021/ja108404p; Yang J, 2012, ANGEW CHEM INT EDIT, V51, P7476, DOI 10.1002/anie.201202122; Yang YY, 2011, BIOORG MED CHEM LETT, V21, P6613, DOI 10.1016/j.bmcl.2011.08.091; Yang YY, 2010, J AM CHEM SOC, V132, P3640, DOI 10.1021/ja908871t; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yarema KJ, 2001, NAT BIOTECHNOL, V19, P553, DOI 10.1038/89305; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zaro BW, 2011, P NATL ACAD SCI USA, V108, P8146, DOI 10.1073/pnas.1102458108; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang MM, 2010, P NATL ACAD SCI USA, V107, P8627, DOI 10.1073/pnas.0912306107; Zheng TQ, 2011, ANGEW CHEM INT EDIT, V50, P4113, DOI 10.1002/anie.201100265	100	261	268	5	351	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2013	9	8					475	484		10.1038/nchembio.1296	http://dx.doi.org/10.1038/nchembio.1296			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185FV	23868317	Green Accepted			2022-12-27	WOS:000321952700004
J	Lin, YC; Niewiadomski, P; Lin, B; Nakamura, H; Phua, SC; Jiao, J; Levchenko, A; Inoue, T; Rohatgi, R; Inoue, T				Lin, Yu-Chun; Niewiadomski, Pawel; Lin, Benjamin; Nakamura, Hideki; Phua, Siew Cheng; Jiao, John; Levchenko, Andre; Inoue, Takafumi; Rohatgi, Rajat; Inoue, Takanari			Chemically inducible diffusion trap at cilia reveals molecular sieve-like barrier	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEAR-PORE COMPLEXES; PERMEABILITY BARRIER; BETA-GALACTOSIDASE; MEMBRANE; DIMERIZATION; PROTEINS; CELLS; NEPHRONOPHTHISIS; IDENTIFICATION; TRANSLOCATION	Primary cilia function as specialized compartments for signal transduction. The stereotyped structure and signaling function of cilia inextricably depend on the selective segregation of molecules in cilia. However, the fundamental principles governing the access of soluble proteins to primary cilia remain unresolved. We developed a methodology termed 'chemically inducible diffusion trap at cilia' to visualize the diffusion process of a series of fluorescent proteins ranging in size from 3.2 nm to 7.9 nm into primary cilia. We found that the interior of the cilium was accessible to proteins as large as 7.9 nm. The kinetics of ciliary accumulation of this panel of proteins was exponentially limited by their Stokes radii. Quantitative modeling suggests that the diffusion barrier operates as a molecular sieve at the base of cilia. Our study presents a set of powerful, generally applicable tools for the quantitative monitoring of ciliary protein diffusion under both physiological and pathological conditions.	[Lin, Yu-Chun; Lin, Benjamin; Phua, Siew Cheng; Jiao, John; Inoue, Takanari] Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Dept Cell Biol, Baltimore, MD 21218 USA; [Niewiadomski, Pawel] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Niewiadomski, Pawel; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA USA; [Lin, Benjamin; Levchenko, Andre] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Nakamura, Hideki; Inoue, Takafumi] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Inoue, Takanari] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Johns Hopkins University; Stanford University; Stanford University; Johns Hopkins University; Waseda University; Japan Science & Technology Agency (JST)	Inoue, T (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Dept Cell Biol, Baltimore, MD 21218 USA.	jctinoue@jhmi.edu	Inoue, Takafumi/AAM-9533-2020	Inoue, Takafumi/0000-0002-2728-0060; Lin, Benjamin/0000-0003-1095-8725; LIN, YU-CHUN/0000-0002-9629-7560; Niewiadomski, Pawel/0000-0001-6254-6162; Nakamura, Hideki/0000-0003-2749-8323; Phua, Siew Cheng/0000-0002-6786-8117	US National Institutes of Health (the Baltimore Polycystic Kidney Disease Research and Clinical Core Center) [GM092930, P30 DK090868, R00CA129174, R21NS074091, 23650197]; US National Institutes of Health (Pew Foundation); NATIONAL CANCER INSTITUTE [R00CA129174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074091] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23650197, 23300121] Funding Source: KAKEN	US National Institutes of Health (the Baltimore Polycystic Kidney Disease Research and Clinical Core Center); US National Institutes of Health (Pew Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Seki (Stanford University) for the 5HT6 construct, S. Takeda (University of Yamanashi) for the GFP-IFT88 construct and M. Wolfgang (Johns Hopkins University) for beta-Gal and luciferase constructs. We also thank D.N.R., T. K., H. I. and S. T. for helpful discussions. This study was supported in part by the US National Institutes of Health (the Baltimore Polycystic Kidney Disease Research and Clinical Core Center provided pilot funds GM092930 and P30 DK090868 to Takanari Inoue and R00CA129174 and R21NS074091 to R. R.) and other grants (Grant-in-Aid for Challenging Exploratory Research 23650197 to H.N. and Pew Foundation to R.R.).	Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; CELADA F, 1979, BIOCHEMISTRY-US, V18, P404, DOI 10.1021/bi00570a002; Chen EI, 2006, MOL CELL PROTEOMICS, V5, P53, DOI 10.1074/mcp.T500013-MCP200; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Czlapinski JL, 2008, J AM CHEM SOC, V130, P13186, DOI 10.1021/ja8037728; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Dauty E, 2004, J MOL RECOGNIT, V17, P441, DOI 10.1002/jmr.709; DeRose R, 2013, PFLUG ARCH EUR J PHY, V465, P409, DOI 10.1007/s00424-012-1208-6; Francis SS, 2011, J CELL BIOL, V193, P219, DOI 10.1083/jcb.201009001; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Karger J., 2010, CHEM-ING-TECH, V82, P779; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Matthews BW, 2005, CR BIOL, V328, P549, DOI 10.1016/j.crvi.2005.03.006; Miyamoto T, 2012, NAT CHEM BIOL, V8, P465, DOI [10.1038/NCHEMBIO.922, 10.1038/nchembio.922]; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Najafi M, 2012, P NATL ACAD SCI USA, V109, P203, DOI 10.1073/pnas.1115109109; Narita K, 2010, TRAFFIC, V11, P287, DOI 10.1111/j.1600-0854.2009.01016.x; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; SAHIMI M, 1989, PHYS REV LETT, V62, P629, DOI 10.1103/PhysRevLett.62.629; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Szymanska Katarzyna, 2012, Cilia, V1, P10, DOI 10.1186/2046-2530-1-10; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; von Schnakenburg C, 2007, PEDIATR NEPHROL, V22, P765, DOI 10.1007/s00467-007-0434-1; Yoshimura K, 2011, GLIA, V59, P333, DOI 10.1002/glia.21105	40	88	88	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					437	+		10.1038/NCHEMBIO.1252	http://dx.doi.org/10.1038/NCHEMBIO.1252			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23666116	Green Accepted			2022-12-27	WOS:000320449700008
J	Bauer, RA; Wenderski, TA; Tan, DS				Bauer, Renato A.; Wenderski, Todd A.; Tan, Derek S.			Biomimetic diversity-oriented synthesis of benzannulated medium rings via ring expansion	NATURE CHEMICAL BIOLOGY			English	Article							BIOGENETIC-TYPE APPROACH; CLOSING METATHESIS; HELIANNUOL-A; SIZED RINGS; INHIBITORS; HELIANANE; ALKALOIDS; LIGAND; ROUTE; PERMEABILITY	Nature has exploited medium-sized 8- to 11-membered rings in a variety of natural products to address diverse and challenging biological targets. However, owing to the limitations of conventional cyclization-based approaches to medium-ring synthesis, these structures remain severely underrepresented in current probe and drug discovery efforts. To address this problem, we have established an alternative, biomimetic ring expansion approach to the diversity-oriented synthesis of medium-ring libraries. Oxidative dearomatization of bicyclic phenols affords polycyclic cyclohexadienones that undergo efficient ring expansion to form benzannulated medium-ring scaffolds found in natural products. The ring expansion reaction can be induced using three complementary reagents that avoid competing dienone-phenol rearrangements and is driven by rearomatization of a phenol ring adjacent to the scissile bond. Cheminformatic analysis of the resulting first-generation library confirms that these molecules occupy chemical space overlapping with medium-ring natural products and distinct from that of synthetic drugs and drug-like libraries.	[Bauer, Renato A.; Tan, Derek S.] Mem Sloan Kettering Canc Ctr, Tri Inst Training Program Chem Biol, New York, NY 10021 USA; [Wenderski, Todd A.; Tan, Derek S.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Tan, Derek S.] Mem Sloan Kettering Canc Ctr, Tri Inst Res Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Bauer, RA (corresponding author), Mem Sloan Kettering Canc Ctr, Tri Inst Training Program Chem Biol, 1275 York Ave, New York, NY 10021 USA.	tand@mskcc.org			US National Institutes of Health [P41 GM076267, P41 GM076267-03S1, T32 CA062948-Gudas]; Commonwealth Foundation for Cancer Research; Memorial Sloan-Kettering Cancer Center Experimental Therapeutics Center; Tri-Institutional Stem Cell Initiative; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM076267] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth Foundation for Cancer Research; Memorial Sloan-Kettering Cancer Center Experimental Therapeutics Center; Tri-Institutional Stem Cell Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is dedicated to the memory of our colleague and mentor, David Y. Gin (1967-2011). We thank D. Boger for helpful discussions; C. Stratton for assistance with PCA calculations; J. Njaroarson for providing drug structures; and G. Sukenick, H. Liu, H. Fang and S. Rusli for expert mass spectral analyses. Instant JChem was generously provided by ChemAxon. Financial support from the US National Institutes of Health (P41 GM076267 to D.S.T., P41 GM076267-03S1 to R.A.B. and T32 CA062948-Gudas to T. A. W.), W.H. Goodwin and A. Goodwin and the Commonwealth Foundation for Cancer Research, the Memorial Sloan-Kettering Cancer Center Experimental Therapeutics Center and the Tri-Institutional Stem Cell Initiative is gratefully acknowledged.	Abraham D.J., 1972, TETRAHEDRON LETT, V13, P909; Barton D. H. R., 1964, PURE APPL CHEM, V9, P35; BATTERSBY AR, 1968, CHEM COMMUN, P1214, DOI 10.1039/c19680001214; Bauer RA, 2010, CURR OPIN CHEM BIOL, V14, P308, DOI 10.1016/j.cbpa.2010.02.001; BECKER HD, 1972, TETRAHEDRON LETT, V13, P4205; Benfield AP, 2006, ANGEW CHEM INT EDIT, V45, P6830, DOI 10.1002/anie.200600844; BHAKUNI DS, 1981, TETRAHEDRON, V37, P3171, DOI 10.1016/S0040-4020(01)98850-7; Biswas B, 2007, TETRAHEDRON, V63, P12026, DOI 10.1016/j.tet.2007.09.006; Brown N, 2008, J COMB CHEM, V10, P628, DOI 10.1021/cc8001102; Deb I, 2007, TETRAHEDRON, V63, P11991, DOI 10.1016/j.tet.2007.09.009; FU X, 1993, J NAT PROD, V56, P1153, DOI 10.1021/np50097a021; Furstner A, 2005, CHEM COMMUN, P5583, DOI 10.1039/b512877c; Harmata M, 2003, TETRAHEDRON, V59, P2371, DOI 10.1016/S0040-4020(03)00253-9; Hesse M., 1991, RING ENLARGEMENT IN; HOSOMI A, 1988, ACCOUNTS CHEM RES, V21, P200, DOI 10.1021/ar00149a004; ILLUMINATI G, 1981, ACCOUNTS CHEM RES, V14, P95, DOI 10.1021/ar00064a001; Khadem S, 2004, J COMB CHEM, V6, P724, DOI 10.1021/cc049941o; Khan AR, 1998, BIOCHEMISTRY-US, V37, P16839, DOI 10.1021/bi9821364; Kishuku H, 2003, CHEM COMMUN, P350, DOI 10.1039/b211227b; Kopp F, 2012, NAT CHEM BIOL, V8, P358, DOI [10.1038/NCHEMBIO.911, 10.1038/nchembio.911]; KUPCHAN SM, 1976, J CHEM SOC CHEM COMM, P86; KUPCHAN SM, 1977, J CHEM SOC CHEM COMM, P847, DOI 10.1039/c39770000847; KUPCHAN SM, 1973, J AM CHEM SOC, V95, P1335, DOI 10.1021/ja00785a054; Kwon YU, 2007, CHEM BIOL, V14, P671, DOI 10.1016/j.chembiol.2007.05.006; MACIAS FA, 1993, TETRAHEDRON LETT, V34, P1999, DOI 10.1016/S0040-4039(00)91986-5; Macias FA, 2008, TETRAHEDRON, V64, P5502, DOI 10.1016/j.tet.2008.03.105; MacMillan KS, 2009, J MED CHEM, V52, P5771, DOI 10.1021/jm9006214; Majhi TP, 2007, HETEROCYCLES, V71, P1011; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; Marino J.P., 1973, TETRAHEDR LETT, V14, P4553; MARINO JP, 1976, J ORG CHEM, V41, P179, DOI 10.1021/jo00863a053; McGrath NA, 2010, J CHEM EDUC, V87, P1348, DOI 10.1021/ed1003806; MILLER B, 1975, ACCOUNTS CHEM RES, V8, P245, DOI 10.1021/ar50091a005; Morton JGM, 2009, TETRAHEDRON LETT, V50, P1684, DOI 10.1016/j.tetlet.2009.01.134; Moura-Letts G, 2011, P NATL ACAD SCI USA, V108, P6745, DOI 10.1073/pnas.1015268108; Pospisil J, 2009, CHEM-EUR J, V15, P5956, DOI 10.1002/chem.200802681; Quideau S, 1996, CHEM REV, V96, P475, DOI 10.1021/cr940716a; Rezai T, 2006, J AM CHEM SOC, V128, P2510, DOI 10.1021/ja0563455; ROUSH WR, 1984, J ORG CHEM, V49, P4674, DOI 10.1021/jo00198a018; ROXBURGH CJ, 1993, TETRAHEDRON, V49, P10749, DOI 10.1016/S0040-4020(01)80232-5; Sabui S, 2009, TETRAHEDRON LETT, V50, P4683, DOI 10.1016/j.tetlet.2009.06.001; SHIMOKAWA T, 1985, CHEM PHARM BULL, V33, P3545; SHIRATAKI Y, 1987, CHEM PHARM BULL, V35, P1637; Singh SB, 2004, TETRAHEDRON LETT, V45, P7605, DOI 10.1016/j.tetlet.2004.08.116; Souers AJ, 1999, J AM CHEM SOC, V121, P1817, DOI 10.1021/ja983742p; Spring DR, 2002, J AM CHEM SOC, V124, P1354, DOI 10.1021/ja017248o; Stefinovic M, 1998, J ORG CHEM, V63, P2808, DOI 10.1021/jo980299s; THEUNS HG, 1984, PHYTOCHEMISTRY, V23, P1157, DOI 10.1016/S0031-9422(00)82630-8; Udugamasooriya DG, 2008, BIOPOLYMERS, V89, P653, DOI 10.1002/bip.20983; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n	50	113	112	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					21	+		10.1038/NCHEMBIO.1130	http://dx.doi.org/10.1038/NCHEMBIO.1130			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23160003	Green Accepted			2022-12-27	WOS:000312484200008
J	Michalek, M; Sonnichsen, FD; Wechselberger, R; Dingley, AJ; Hung, CW; Kopp, A; Wienk, H; Simanski, M; Herbst, R; Lorenzen, I; Marciano-Cabral, F; Gelhaus, C; Gutsmann, T; Tholey, A; Grotzinger, J; Leippe, M				Michalek, Matthias; Soennichsen, Frank D.; Wechselberger, Rainer; Dingley, Andrew J.; Hung, Chien-Wen; Kopp, Annika; Wienk, Hans; Simanski, Maren; Herbst, Rosa; Lorenzen, Inken; Marciano-Cabral, Francine; Gelhaus, Christoph; Gutsmann, Thomas; Tholey, Andreas; Groetzinger, Joachim; Leippe, Matthias			Structure and function of a unique pore-forming protein from a pathogenic acanthamoeba	NATURE CHEMICAL BIOLOGY			English	Article							FREE-LIVING AMEBAS; ENTAMOEBA-HISTOLYTICA; NK-LYSIN; NAEGLERIA-FOWLERI; PEPTIDES; MEMBRANES; AMOEBAPORES; SYSTEM; POLYPEPTIDES; MOLECULES	Human pathogens often produce soluble protein toxins that generate pores inside membranes, resulting in the death of target cells and tissue damage. In pathogenic amoebae, this has been exemplified with amoebapores of the enteric protozoan parasite Entamoeba histolytica. Here we characterize acanthaporin, to our knowledge the first pore-forming toxin to be described from acanthamoebae, which are free-living, bacteria-feeding, unicellular organisms that are opportunistic pathogens of increasing importance and cause severe and often fatal diseases. We isolated acanthaporin from extracts of virulent Acanthamoeba culbertsoni by tracking its pore-forming activity, molecularly cloned the gene of its precursor and recombinantly expressed the mature protein in bacteria. Acanthaporin was cytotoxic for human neuronal cells and exerted antimicrobial activity against a variety of bacterial strains by permeabilizing their membranes. The tertiary structures of acanthaporin's active monomeric form and inactive dimeric form, both solved by NMR spectroscopy, revealed a currently unknown protein fold and a pH-dependent trigger mechanism of activation.	[Michalek, Matthias; Simanski, Maren; Herbst, Rosa; Gelhaus, Christoph; Leippe, Matthias] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Michalek, Matthias; Lorenzen, Inken; Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Soennichsen, Frank D.] Univ Kiel, Otto Diels Inst Organ Chem, D-24098 Kiel, Germany; [Wechselberger, Rainer; Wienk, Hans] Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect Res Grp, Utrecht, Netherlands; [Dingley, Andrew J.] Univ Auckland, Sch Chem Sci, Auckland 1, New Zealand; [Dingley, Andrew J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Hung, Chien-Wen; Tholey, Andreas] Univ Kiel, Inst Expt Med, Div Systemat Proteome Res, D-24098 Kiel, Germany; [Kopp, Annika; Gutsmann, Thomas] Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, Borstel, Germany; [Marciano-Cabral, Francine] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA	University of Kiel; University of Kiel; University of Kiel; Utrecht University; University of Auckland; University of Auckland; University of Kiel; Forschungszentrum Borstel; Virginia Commonwealth University	Michalek, M (corresponding author), Univ Kiel, Inst Zool, D-24098 Kiel, Germany.	mleippe@zoologie.uni-kiel.de	Gelhaus, Christoph/D-8050-2011; Tholey, Andreas/B-3407-2010; Sönnichsen, Frank D/D-8408-2011; Wienk, Hans/P-8929-2015; Dingley, Andrew/G-6427-2013; Gutsmann, Thomas/E-6100-2011; Leippe, Matthias/AAP-1677-2020	Tholey, Andreas/0000-0002-8687-6817; Sönnichsen, Frank D/0000-0002-4539-3755; Wienk, Hans/0000-0001-9577-0064; Dingley, Andrew/0000-0002-6838-5803; Herbst, Rosa/0000-0002-2379-7433	European Union [RII3-026145]; German Research Council (DFG) [LE 1075/2-4]; excellence cluster 306 'Inflammation at Interfaces'	European Union(European Commission); German Research Council (DFG)(German Research Foundation (DFG)); excellence cluster 306 'Inflammation at Interfaces'	The authors acknowledge support in measuring the 750-MHz NMR spectra at The Netherlands Foundation for Chemical Research (SON) NMR Large Scale Facility in Utrecht, The Netherlands, funded by the European Union (contract number RII3-026145). We thank F. Buck, Institute for Cell Biochemistry and Clinical Neurobiology, University of Hamburg, for protein sequencing, C. Ott for expert technical assistance during purification of the natural acanthaporin and H. Liessegang for technical help during antibacterial activity testing. This work was supported by German Research Council (DFG) grant LE 1075/2-4 to M.L. and J.G. and the excellence cluster 306 'Inflammation at Interfaces'.	Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; Andra J, 2003, DEV COMP IMMUNOL, V27, P291, DOI 10.1016/S0145-305X(02)00106-4; ANDRA J, 1994, FEBS LETT, V354, P97, DOI 10.1016/0014-5793(94)01103-6; BAUMANN G, 1974, Journal of Supramolecular Structure, V2, P538, DOI 10.1002/jss.400020504; BOMAN HG, 1974, INFECT IMMUN, V10, P136, DOI 10.1128/IAI.10.1.136-145.1974; Bruhn H, 2003, BIOCHEM J, V375, P737, DOI 10.1042/BJ20030250; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingley Andrew J., 2008, V451, P441, DOI 10.1007/978-1-59745-102-4_30; DOUGHERTY RM, 1987, AM J CLIN NUTR, V45, P443, DOI 10.1093/ajcn/45.2.443; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gutsmann T, 2003, BIOCHEMISTRY-US, V42, P9804, DOI 10.1021/bi034686u; Hecht O, 2004, J BIOL CHEM, V279, P17834, DOI 10.1074/jbc.M312978200; Herbst R, 2004, J BIOL CHEM, V279, P25955, DOI 10.1074/jbc.M401965200; Herbst R, 2002, J BIOL CHEM, V277, P22353, DOI 10.1074/jbc.M201475200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kneller, 2003, SPARKY 3; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Leippe M, 2005, TRENDS PARASITOL, V21, P5, DOI 10.1016/j.pt.2004.10.009; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; LEIPPE M, 1994, MOL MICROBIOL, V14, P895, DOI 10.1111/j.1365-2958.1994.tb01325.x; Leippe M, 1999, DEV COMP IMMUNOL, V23, P267, DOI 10.1016/S0145-305X(99)00010-5; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; MARTINEZ AJ, 1993, MT SINAI J MED, V60, P271; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Visvesvara GS, 2010, CURR OPIN INFECT DIS, V23, P590, DOI 10.1097/QCO.0b013e32833ed78b; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	47	29	30	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					37	+		10.1038/NCHEMBIO.1116	http://dx.doi.org/10.1038/NCHEMBIO.1116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23143413				2022-12-27	WOS:000312484200010
J	Watson, PY; Fedor, MJ				Watson, Peter Y.; Fedor, Martha J.			The ydaO motif is an ATP-sensing riboswitch in Bacillus subtilis	NATURE CHEMICAL BIOLOGY			English	Article							BINDS ATP; RNA; HOMEOSTASIS; CANDIDATE; BACTERIA; REVEALS; SENSOR	We report what is to our knowledge the first natural RNA that regulates gene expression in response to intracellular ATP. Using a biochemical screen, we found that several putative riboswitches bind ATP in vitro. The ydaO motif specifically bound ATP and regulated expression of endogenous and reporter genes in response to ATP concentrations in Bacillus subtilis. This discovery demonstrates a role for RNAs in regulating gene expression in response to energy balance in bacteria.	[Watson, Peter Y.; Fedor, Martha J.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Watson, Peter Y.; Fedor, Martha J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Watson, Peter Y.; Fedor, Martha J.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Fedor, MJ (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	mfedor@scripps.edu			Skaggs Institute for Chemical Biology	Skaggs Institute for Chemical Biology	We acknowledge J. Viladoms for thoughtful conversations and critical reading of this manuscript. We thank the groups of E. Winzeler and P. Sun for access to qPCR instruments and the Skaggs Institute for Chemical Biology for graduate fellowship support of P.Y. Watson.	Allenby NEE, 2005, J BACTERIOL, V187, P8063, DOI 10.1128/JB.187.23.8063-8080.2005; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Bastet L, 2011, MOL MICROBIOL, V80, P1148, DOI 10.1111/j.1365-2958.2011.07654.x; Block KF, 2010, J BACTERIOL, V192, P3983, DOI 10.1128/JB.00450-10; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dieckmann T, 1996, RNA, V2, P628; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GUFFANTI AA, 1987, J BACTERIOL, V169, P4469, DOI 10.1128/jb.169.10.4469-4478.1987; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Kato-Yamada Y, 2005, FEBS LETT, V579, P6875, DOI 10.1016/j.febslet.2005.11.036; Lee EJ, 2012, NATURE, V486, P271, DOI 10.1038/nature11090; McCabe BC, 2004, J BACTERIOL, V186, P5157, DOI 10.1128/jb.186.15.5157-5159.2004; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Montange RK, 2010, J MOL BIOL, V396, P761, DOI 10.1016/j.jmb.2009.12.007; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; Sluse FE, 2012, ADV EXP MED BIOL, V942, P137, DOI 10.1007/978-94-007-2869-1_6; Smith AM, 2010, RNA BIOL, V7, P104, DOI 10.4161/rna.7.1.10757; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Watson PY, 2011, NAT STRUCT MOL BIOL, V18, P359, DOI 10.1038/nsmb.1989; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31	25	45	47	3	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					963	965		10.1038/NCHEMBIO.1095	http://dx.doi.org/10.1038/NCHEMBIO.1095			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23086297				2022-12-27	WOS:000311491200009
J	Nishida, M; Sawa, T; Kitajima, N; Ono, K; Inoue, H; Ihara, H; Motohashi, H; Yamamoto, M; Suematsu, M; Kurose, H; van der Vliet, A; Freeman, BA; Shibata, T; Uchida, K; Kumagai, Y; Akaike, T				Nishida, Motohiro; Sawa, Tomohiro; Kitajima, Naoyuki; Ono, Katsuhiko; Inoue, Hirofumi; Ihara, Hideshi; Motohashi, Hozumi; Yamamoto, Masayuki; Suematsu, Makoto; Kurose, Hitoshi; van der Vliet, Albert; Freeman, Bruce A.; Shibata, Takahiro; Uchida, Koji; Kumagai, Yoshito; Akaike, Takaaki			Hydrogen sulfide anion regulates redox signaling via electrophile sulfhydration	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN S-GUANYLATION; H-RAS; EXPRESSION; HYPERTROPHY; DYSFUNCTION; MECHANISMS; SENESCENCE; OXYGEN; HEART	An emerging aspect of redox signaling is the pathway mediated by electrophilic byproducts, such as nitrated cyclic nucleotide (for example, 8-nitroguanosine 3',5'-cyclic monophosphate (8-nitro-cGMP)) and nitro or keto derivatives of unsaturated fatty acids, generated via reactions of inflammation-related enzymes, reactive oxygen species, nitric oxide and secondary products. Here we report that enzymatically generated hydrogen sulfide anion (HS-) regulates the metabolism and signaling actions of various electrophiles. HS- reacts with electrophiles, best represented by 8-nitro-cGMP, via direct sulfhydration and modulates cellular redox signaling. The relevance of this reaction is reinforced by the significant 8-nitro-cGMP formation in mouse cardiac tissue after myocardial infarction that is modulated by alterations in HS- biosynthesis. Cardiac HS-, in turn, suppresses electrophile-mediated H-Ras activation and cardiac cell senescence, contributing to the beneficial effects of HS- on myocardial infarction-associated heart failure. Thus, this study reveals HS--induced electrophile sulfhydration as a unique mechanism for regulating electrophile-mediated redox signaling.	[Sawa, Tomohiro; Ono, Katsuhiko; Inoue, Hirofumi; Akaike, Takaaki] Kumamoto Univ, Dept Microbiol, Grad Sch Med Sci, Kumamoto, Japan; [Nishida, Motohiro; Kitajima, Naoyuki; Kurose, Hitoshi] Kyushu Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Nishida, Motohiro; Kitajima, Naoyuki] Kyushu Univ, Dept Drug Discovery & Evolut, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Sawa, Tomohiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Ihara, Hideshi] Osaka Prefecture Univ, Dept Biol Sci, Grad Sch Sci, Osaka, Japan; [Motohashi, Hozumi; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi 980, Japan; [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; [van der Vliet, Albert] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Freeman, Bruce A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kumagai, Yoshito] Univ Tsukuba, Doctoral Program Biomed Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	Kumamoto University; Kyushu University; Kyushu University; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Tohoku University; Keio University; University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nagoya University; University of Tsukuba	Akaike, T (corresponding author), Kumamoto Univ, Dept Microbiol, Grad Sch Med Sci, Kumamoto, Japan.	takakaik@gpo.kumamoto-u.ac.jp	Suematsu, Makoto/I-8135-2013; Yamamoto, Masayuki/A-4873-2010; Motohashi, Hozumi/AAZ-2628-2020; Freeman, Bruce A/H-9342-2012; Suematsu, Makoto/O-5762-2018; Shibata, Takahiro/I-6872-2014	Suematsu, Makoto/0000-0002-7165-6336; Yamamoto, Masayuki/0000-0002-9073-9436; Suematsu, Makoto/0000-0002-7165-6336; Uchida, Koji/0000-0003-3894-5299; Nishida, Motohiro/0000-0002-2587-5458; Shibata, Takahiro/0000-0003-3194-607X	Ministry of Education, Sciences, Sports and Technology, Japan; Japan Science and Technology Agency PRESTO program; Ministry of Health, Labor and Welfare of Japan; US National Institutes of Health; Grants-in-Aid for Scientific Research [23651239, 22500337] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085646, R01HL064937, R01HL058115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021476] Funding Source: NIH RePORTER	Ministry of Education, Sciences, Sports and Technology, Japan; Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J.B. Gandy for her editing of the manuscript. Thanks are also due to T. Okamoto, S. Fujii, Md. M. Rahaman, S. Khan, K. A. Ahmed, J. Yoshitake, T. Matsunaga, M. H. A. Rahman, J. Sakamoto, J. Minkyung, K. Hara, M. Goto, F. Sohma, K. Taguchi, T. Miura, T. Toyama, Y. Shinkai, I. Ishii and M. Toyataka for technical assistance; S. Kasamatsu, T. Ida and K. Kunieda for 8-nitro-cGMP preparation; Y. Kawai for technical assistance with LC/MS/MS experiments; H. Arimoto for helpful discussion; and J. Wu for reading our paper to evaluate its concepts and interdisciplinary accessibility. This work was supported in part by Grants-in-Aid for Scientific Research and Grants-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Area) from the Ministry of Education, Sciences, Sports and Technology, Japan; a grant from the Japan Science and Technology Agency PRESTO program; grants from the Ministry of Health, Labor and Welfare of Japan; and grants from the US National Institutes of Health.	Akaike T, 2010, NITRIC OXIDE-BIOL CH, V23, P166, DOI 10.1016/j.niox.2010.06.006; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Carballal S, 2011, FREE RADICAL BIO MED, V50, P196, DOI 10.1016/j.freeradbiomed.2010.10.705; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Forman HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC246, DOI 10.1152/ajpcell.00516.2003; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Fujii S, 2010, J BIOL CHEM, V285, P23970, DOI 10.1074/jbc.M110.145441; Gelb BD, 2011, J CLIN INVEST, V121, P844, DOI 10.1172/JCI46399; Glushchenko AV, 2007, ANTIOXID REDOX SIGN, V9, P1883, DOI 10.1089/ars.2007.1809; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hughes MN, 2009, FREE RADICAL BIO MED, V47, P1346, DOI 10.1016/j.freeradbiomed.2009.09.018; HUNTER JJ, 1995, J BIOL CHEM, V270, P23173, DOI 10.1074/jbc.270.39.23173; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Liu YH, 2005, AM J PHYSIOL-HEART C, V289, pH2616, DOI 10.1152/ajpheart.00546.2005; LoPachin RM, 2007, TOXICOL SCI, V98, P561, DOI 10.1093/toxsci/kfm127; Nishida M, 2011, P NATL ACAD SCI USA, V108, P6662, DOI 10.1073/pnas.1017640108; Ohshima H, 2006, ANTIOXID REDOX SIGN, V8, P1033, DOI 10.1089/ars.2006.8.1033; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Pechkovsky DV, 2002, AM J PHYSIOL-LUNG C, V282, pL684, DOI 10.1152/ajplung.00320.2000; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shih H, 2011, J AM COLL CARDIOL, V57, P9, DOI 10.1016/j.jacc.2010.08.623; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Wintner EA, 2010, BRIT J PHARMACOL, V160, P941, DOI 10.1111/j.1476-5381.2010.00704.x; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Yoshitake J, 2004, J VIROL, V78, P8709, DOI 10.1128/JVI.78.16.8709-8719.2004; Zaki MH, 2009, J IMMUNOL, V182, P3746, DOI 10.4049/jimmunol.0803363; Zhang P, 2007, CIRC RES, V100, P1089, DOI 10.1161/01.RES.0000264081.78659.45; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	41	223	232	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					714	724		10.1038/NCHEMBIO.1018	http://dx.doi.org/10.1038/NCHEMBIO.1018			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22772154	Green Accepted			2022-12-27	WOS:000306527600011
J	Keller, TL; Zocco, D; Sundrud, MS; Hendrick, M; Edenius, M; Yum, J; Kim, YJ; Lee, HK; Cortese, JF; Wirth, DF; Dignam, JD; Rao, A; Yeo, CY; Mazitschek, R; Whitman, M				Keller, Tracy L.; Zocco, Davide; Sundrud, Mark S.; Hendrick, Margaret; Edenius, Maja; Yum, Jinah; Kim, Yeon-Jin; Lee, Hak-Kyo; Cortese, Joseph F.; Wirth, Dyann F.; Dignam, John David; Rao, Anjana; Yeo, Chang-Yeol; Mazitschek, Ralph; Whitman, Malcolm			Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase	NATURE CHEMICAL BIOLOGY			English	Article							AMINO-ACID-METABOLISM; GENE-EXPRESSION; CELL-DIFFERENTIATION; MAMMALIAN-CELLS; DENDRITIC CELLS; STRESS-RESPONSE; INFLAMMATION; SPECIFICITY; DEPRIVATION; LIMITATION	Febrifugine, the bioactive constituent of one of the SO fundamental herbs of traditional Chinese medicine, has been characterized for its therapeutic activity, though its molecular target has remained unknown. Febrifugine derivatives have been used to treat malaria, cancer, fibrosis and inflammatory disease. We recently demonstrated that halofuginone (HF), a widely studied derivative of febrifugine, inhibits the development of T(H)17-driven autoimmunity in a mouse model of multiple sclerosis by activating the amino acid response (AAR) pathway. Here we show that HF binds glutamyl-prolyl-tRNA synthetase (EPRS), inhibiting prolyl-tRNA synthetase activity; this inhibition is reversed by the addition of exogenous proline or EPRS. We further show that inhibition of EPRS underlies the broad bioactivities of this family of natural product derivatives. This work both explains the molecular mechanism of a promising family of therapeutics and highlights the AAR pathway as an important drug target for promoting inflammatory resolution.	[Keller, Tracy L.; Zocco, Davide; Hendrick, Margaret; Edenius, Maja; Yeo, Chang-Yeol; Whitman, Malcolm] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Sundrud, Mark S.; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sundrud, Mark S.; Rao, Anjana] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Yum, Jinah; Kim, Yeon-Jin; Yeo, Chang-Yeol] Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Life Sci, Seoul, South Korea; [Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Ansung, Kyongi Do, South Korea; [Cortese, Joseph F.; Wirth, Dyann F.; Mazitschek, Ralph] Broad Inst Harvard & MIT, Infect Dis Initiat, Cambridge, MA USA; [Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Dignam, John David] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43606 USA; [Mazitschek, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Ewha Womans University; Hankyong National University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; University System of Ohio; University of Toledo; Harvard University; Massachusetts General Hospital	Keller, TL (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA.	tkeller@hms.harvard.edu; cyeo@ewha.ac.kr; rmazitschek@mgh.harvard.edu; mwhitman@hms.harvard.edu	Mazitschek, Ralph/E-3741-2013	Mazitschek, Ralph/0000-0002-1105-689X; Yeo, Chang-Yeol/0000-0002-4440-1215	US National Institutes of Health (NIH) [GM089885]; Harvard Technology Accelerator Award; Rural Development Administration, Republic of Korea [PJ00812701, PJ008196]; NIH [AI40127, AI48213]; Juvenile Diabetes Research Foundation [17-2010-421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213, R01AI040127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089885] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Technology Accelerator Award; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank R. Copeland (Epizyme) for advice on the execution of tight-binding analysis, W Kilo Harvard Catalyst Laboratory for Innovative Translational Technologies for assistance with the establishment of qPCR assays, and C. Walsh (Harvard), T. Roberts (Dana-Farber Cancer Institute) anti S. Thomas (National Institute of Environmental Health Science, USA) for their valuable comments on the manuscript. This work was supported by US National Institutes of Health (NIH) grant GM089885 and a Harvard Technology Accelerator Award (to MW); by grants PJ00812701 and PJ008196 from The Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (to C.Y.Y. and H.K.L.); and by NIH grants AI40127 and AI48213 and Juvenile Diabetes Research Foundation 17-2010-421 (to A.R.).	Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Caro P, 2009, BIOGERONTOLOGY, V10, P579, DOI 10.1007/s10522-008-9200-4; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Coatney G. R., 1950, Journal of the National Malaria Society, V9, P183; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Elkin M, 1999, CANCER RES, V59, P4111; Esposito M, 2010, J NEUROIMMUNOL, V220, P52, DOI 10.1016/j.jneuroim.2010.01.001; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAHN MJ, 1991, NUCLEIC ACIDS RES, V19, P2786, DOI 10.1093/nar/19.10.2786; Kamberov Yana G, 2011, BMC Res Notes, V4, P381, DOI 10.1186/1756-0500-4-381; Kikuchi H, 2002, J MED CHEM, V45, P2563, DOI 10.1021/jm010448q; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kobayashi S, 1999, J ORG CHEM, V64, P6833, DOI 10.1021/jo990877k; Koon HB, 2011, JAIDS-J ACQ IMM DEF, V56, P64, DOI 10.1097/QAI.0b013e3181fc0141; McGaha T, 2002, AUTOIMMUNITY, V35, P277, DOI 10.1080/0891693021000001235; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Oslejskova L, 2009, RHEUMATOLOGY, V48, P1590, DOI 10.1093/rheumatology/kep316; Palii SS, 2009, AMINO ACIDS, V37, P79, DOI 10.1007/s00726-008-0199-2; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Pines M, 1998, GEN PHARMACOL, V30, P445, DOI 10.1016/S0306-3623(97)00307-8; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Ruan BF, 2005, J BIOL CHEM, V280, P571, DOI 10.1074/jbc.M411039200; Ryley J F, 1973, Adv Pharmacol Chemother, V11, P221, DOI 10.1016/S1054-3589(08)60459-7; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; TING SM, 1992, J BIOL CHEM, V267, P17701; von Bubnoff D, 2011, J AM ACAD DERMATOL, V65, P819, DOI 10.1016/j.jaad.2010.07.050; Xiao F, 2011, DIABETES; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	50	229	245	8	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					311	317		10.1038/NCHEMBIO.790	http://dx.doi.org/10.1038/NCHEMBIO.790			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22327401	Green Accepted			2022-12-27	WOS:000300600000017
J	Mallam, AL; Jackson, SE				Mallam, Anna L.; Jackson, Sophie E.			Knot formation in newly translated proteins is spontaneous and accelerated by chaperonins	NATURE CHEMICAL BIOLOGY			English	Article							SINGLE-DOMAIN PROTEINS; PULSE PROTEOLYSIS; IN-VIVO; STABILITY; FOLD; METHYLTRANSFERASE; SPACES; CHAIN; STATE; YIBK	Topological knots are found in a considerable number of protein structures, but it is not clear how they knot and fold within the cellular environment. We investigated the behavior of knotted protein molecules as they are first synthesized by the ribosome using a cell-free translation system. We found that newly translated knotted proteins can spontaneously self-tie and do not require the assistance of molecular chaperones to fold correctly to their trefoil-knotted structures. This process is slow but efficient, and we found no evidence of misfolded species. A kinetic analysis indicates that the knotting process is rate limiting, occurs post-translationally, and is specifically and significantly (P < 0.001) accelerated by the GroEL-GroES chaperonin complex. This demonstrates a new active mechanism for this molecular chaperone and suggests that chaperonin-catalyzed knotting probably dominates in vivo. These results explain how knotted protein structures have withstood evolutionary pressures despite their topological complexity.	[Mallam, Anna L.; Jackson, Sophie E.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Jackson, SE (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sej13@cam.ac.uk		Jackson, Sophie/0000-0002-7470-9800	St. John's College, University of Cambridge, UK	St. John's College, University of Cambridge, UK	We thank E. O'Brien, D. Hsu, F. Andersson, G. Blaser and E. Werrell for helpful discussions. This research was supported by a fellowship and a grant from St. John's College, University of Cambridge, UK (to A.L.M.).	Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Baumketner A, 2003, J MOL BIOL, V332, P701, DOI 10.1016/S0022-2836(03)00929-X; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Cabrita LD, 2010, CURR OPIN STRUC BIOL, V20, P33, DOI 10.1016/j.sbi.2010.01.005; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Cheung MS, 2006, J MOL BIOL, V357, P632, DOI 10.1016/j.jmb.2005.12.048; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim MS, 2009, PROTEIN SCI, V18, P1051, DOI 10.1002/pro.115; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; Lim K, 2003, PROTEINS, V51, P56, DOI 10.1002/prot.10323; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Mallam AL, 2005, J MOL BIOL, V346, P1409, DOI 10.1016/j.jmb.2004.12.055; Mallam AL, 2008, MOL CELL, V30, P642, DOI 10.1016/j.molcel.2008.03.019; Mallam AL, 2007, J MOL BIOL, V366, P650, DOI 10.1016/j.jmb.2006.11.014; Mallam AL, 2007, STRUCTURE, V15, P111, DOI 10.1016/j.str.2006.11.007; Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032; Mallam AL, 2010, P NATL ACAD SCI USA, V107, P8189, DOI 10.1073/pnas.0912161107; Mallam AL, 2009, FEBS J, V276, P365, DOI 10.1111/j.1742-4658.2008.06801.x; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; Micheletti C, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2162886; Micheletti C, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2210476; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Prentiss MC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000835; Purta E, 2008, RNA, V14, P2234, DOI 10.1261/rna.1198108; Schlebach JP, 2011, J MOL BIOL, V406, P545, DOI 10.1016/j.jmb.2010.12.018; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Sulkowska JI, 2010, J AM CHEM SOC, V132, P13954, DOI 10.1021/ja102441z; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Taylor WR, 2007, COMPUT BIOL CHEM, V31, P151, DOI 10.1016/j.compbiolchem.2007.03.002; Virnau P, 2005, J AM CHEM SOC, V127, P15102, DOI 10.1021/ja052438a; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Virnau P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/3/033101; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Ying BW, 2004, BIOCHEM BIOPH RES CO, V320, P1359, DOI 10.1016/j.bbrc.2004.06.095	47	110	110	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					147	153		10.1038/nchembio.742	http://dx.doi.org/10.1038/nchembio.742			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22179065				2022-12-27	WOS:000299323200006
J	Bieschke, J; Herbst, M; Wiglenda, T; Friedrich, RP; Boeddrich, A; Schiele, F; Kleckers, D; del Amo, JML; Gruning, BA; Wang, QW; Schmidt, MR; Lurz, R; Anwyl, R; Schnoegl, S; Fandrich, M; Frank, RF; Reif, B; Gunther, S; Walsh, DM; Wanker, EE				Bieschke, Jan; Herbst, Martin; Wiglenda, Thomas; Friedrich, Ralf P.; Boeddrich, Annett; Schiele, Franziska; Kleckers, Daniela; del Amo, Juan Miguel Lopez; Gruening, Bjoern A.; Wang, Qinwen; Schmidt, Michael R.; Lurz, Rudi; Anwyl, Roger; Schnoegl, Sigrid; Faendrich, Marcus; Frank, Ronald F.; Reif, Bernd; Guenther, Stefan; Walsh, Dominic M.; Wanker, Erich E.			Small-molecule conversion of toxic oligomers to nontoxic beta-sheet-rich amyloid fibrils	NATURE CHEMICAL BIOLOGY			English	Article							LONG-TERM POTENTIATION; A-BETA; HUNTINGTONS-DISEASE; MISFOLDING DISEASES; COMMON MECHANISM; ALPHA-SYNUCLEIN; IN-VITRO; AGGREGATION; PEPTIDE; INHIBITORS	Several lines of evidence indicate that prefibrillar assemblies of amyloid-beta (A beta) polypeptides, such as soluble oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease. These findings suggest that reducing the prevalence of transient intermediates by small molecule-mediated stimulation of amyloid polymerization might decrease toxicity. Here we demonstrate the acceleration of A beta fibrillogenesis through the action of the orcein-related small molecule O4, which directly binds to hydrophobic amino acid residues in A beta peptides and stabilizes the self-assembly of seeding-competent, beta-sheet-rich protofibrils and fibrils. Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concentration of small, toxic A beta oligomers in complex, heterogeneous aggregation reactions. In addition, O4 treatment suppresses inhibition of long-term potentiation by A beta oligomers in hippocampal brain slices. These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.	[Bieschke, Jan; Herbst, Martin; Wiglenda, Thomas; Friedrich, Ralf P.; Boeddrich, Annett; Schiele, Franziska; Kleckers, Daniela; Schmidt, Michael R.; Schnoegl, Sigrid; Wanker, Erich E.] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Herbst, Martin] Charite, Dept Neurol, D-13353 Berlin, Germany; [del Amo, Juan Miguel Lopez; Reif, Bernd] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Gruening, Bjoern A.; Guenther, Stefan] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany; [Wang, Qinwen; Anwyl, Roger] Trinity Coll Dublin, Sch Med, Dept Physiol, Dublin, Ireland; [Lurz, Rudi] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Faendrich, Marcus] Max Planck Res Unit Enzymol Prot Folding, Halle, Saale, Germany; [Frank, Ronald F.] Helmholtz Ctr Infect Res, Dept Chem, Braunschweig, Germany; [Reif, Bernd] Tech Univ Munich, Munich, Germany; [Walsh, Dominic M.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Lab Neurodegenerat Res, Dublin, Ireland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center for Infection Research; University of Freiburg; Trinity College Dublin; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center for Infection Research; Technical University of Munich; University College Dublin	Bieschke, J (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	ewanker@mdc-berlin.de	Günther, Stefan/AAY-8944-2020; del Amo, Juan Miguel Lopez/I-9392-2012; Friedrich, Ralf P/R-2580-2016; Bieschke, Jan/AAG-2705-2019	del Amo, Juan Miguel Lopez/0000-0002-2315-5414; Friedrich, Ralf P/0000-0001-6370-3545; Reif, Bernd/0000-0001-7368-7198; Boddrich, Annett/0000-0001-9118-050X; Bieschke, Jan/0000-0002-3485-9767; Gruning, Bjorn/0000-0002-3079-6586; Wiglenda, Thomas/0000-0002-8460-9459; Wanker, Erich/0000-0001-8072-1630	European Commission [241498, 242167]; European Integrated Project APOPIS [503330]; European Integrated Project EUROSCA [503304]; Helmholtz Association; Helmholtz Alliance for Mental Health in an Ageing Society; Deutsche Forschungsgemeinschaft (DFG) [WA 1151/5]; Bundesministerium fur Bildung und Forschung (BMBF) [NGFN1, 01KW0015, NGFN2, 01GR0471, 0311853, 0313881, 01GS08132]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Integrated Project APOPIS; European Integrated Project EUROSCA; Helmholtz Association(Helmholtz Association); Helmholtz Alliance for Mental Health in an Ageing Society; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank S. Kostka, G. Grelle and S. Rautenberg for technical assistance; A. Otto for analysis of compound mixtures by MS; and M. Peters for expert discussions. The research leading to these results has received funding from the European Commission FP7 grants EUROSPIN (241498) and SYNSYS (242167) and from the European Integrated Projects APOPIS (503330) and EUROSCA (503304) as well as from the Initiative and Networking Fund of the Helmholtz Association (MSBN, TP3, TP5) and the Helmholtz Alliance for Mental Health in an Ageing Society to E. E. W. Furthermore, this work was supported by grants from Deutsche Forschungsgemeinschaft (DFG) (WA 1151/5), Bundesministerium fur Bildung und Forschung (BMBF) (NGFN1, 01KW0015; NGFN2, 01GR0471; BioFuture, 0311853; GO-Bio, 0313881) to E. E. W., BMBF (NGFN-Plus, 01GS08132) to J.B. and E. E. W. and DFG (BI 1409/2-1) to J.B.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Beecken H, 2003, BIOTECH HISTOCHEM, V78, P289, DOI 10.1080/10520290410001671362; Beutling U, 2008, ADV BIOCHEM ENG BIOT, V110, P115, DOI 10.1007/10_2008_096; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; CAPUTO CB, 1992, ARCH BIOCHEM BIOPHYS, V292, P199, DOI 10.1016/0003-9861(92)90068-8; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hamaguchi T, 2006, CELL MOL LIFE SCI, V63, P1538, DOI 10.1007/s00018-005-5599-9; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Heiser V, 2002, P NATL ACAD SCI USA, V99, P16400, DOI 10.1073/pnas.182426599; Herbst M, 2006, CURR PHARM DESIGN, V12, P2543, DOI 10.2174/138161206777698828; Howlett DR, 1999, BIOCHEM J, V340, P283, DOI 10.1042/0264-6021:3400283; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LeVine H, 2002, CURR MED CHEM, V9, P1121, DOI 10.2174/0929867023370167; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e; PAZ MA, 1991, J BIOL CHEM, V266, P689; Reixach N, 2000, J STRUCT BIOL, V130, P247, DOI 10.1006/jsbi.2000.4245; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Williams AD, 2005, P NATL ACAD SCI USA, V102, P7115, DOI 10.1073/pnas.0408582102; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905	49	345	347	4	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					93	101		10.1038/nchembio.719	http://dx.doi.org/10.1038/nchembio.719			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22101602	Green Accepted			2022-12-27	WOS:000298414100017
J	Hothorn, M; Dabi, T; Chory, J				Hothorn, Michael; Dabi, Tsegaye; Chory, Joanne			Structural basis for cytokinin recognition by Arabidopsis thaliana histidine kinase 4	NATURE CHEMICAL BIOLOGY			English	Article							PLANT HORMONE; LIGAND-BINDING; CHASE DOMAIN; TRANSFER-RNA; RECEPTOR; FAMILY; AHK4; MOLECULE; KINETIN; ROOT	Cytokinins are classic hormones that orchestrate plant growth and development and the integrity of stem cell populations. Cytokinin receptors are eukaryotic sensor histidine kinases that are activated by both naturally occurring adenine-type cytokinins and urea-based synthetic compounds. Crystal structures of the Arabidopsis thaliana histidine kinase 4 sensor domain in complex with different cytokinin ligands now rationalize the hormone-binding specificity of the receptor and may spur the design of new cytokinin ligands.	[Hothorn, Michael; Dabi, Tsegaye; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Dabi, Tsegaye; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu	Hothorn, Michael/C-6807-2011	Hothorn, Michael/0000-0002-3597-5698	European Molecular Biology Organization; International Human Frontier Science Program Organization; Marc and Eva Stern foundation; US National Institutes of Health (NIH) [5R01GM52413]; US National Science Foundation [IOS-0649389]; Howard Hughes Medical Institute; NIH [P30 NS057096]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization(Human Frontier Science Program); Marc and Eva Stern foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Mizuno for providing plasmid pCold IV-AHK4 and strain KMI001, M. Jinek and Y. Jaillais for comments on the manuscript and W. Kwiatkowski and staff at beamlines BL 8.2.1 and 8.2.2 of the Advanced Light Source in Berkeley, California, for technical support. This work was supported by long-term fellowships from the European Molecular Biology Organization, the International Human Frontier Science Program Organization and the Marc and Eva Stern foundation (M.H.) and by grants from the US National Institutes of Health (NIH) (5R01GM52413), the US National Science Foundation (IOS-0649389) and the Howard Hughes Medical Institute (J.C.). Maintenance of the Salk X-ray equipment is supported by NIH grant P30 NS057096.	Amasino R, 2005, PLANT PHYSIOL, V138, P1177, DOI 10.1104/pp.104.900160; Bajguz A, 2009, PHYTOCHEMISTRY, V70, P957, DOI 10.1016/j.phytochem.2009.05.006; CAILLET J, 1988, J BACTERIOL, V170, P4147, DOI 10.1128/jb.170.9.4147-4152.1988; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gray J, 1996, PLANT PHYSIOL, V110, P431, DOI 10.1104/pp.110.2.431; Heyl A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-62; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; MILLER CO, 1956, J AM CHEM SOC, V78, P1375, DOI 10.1021/ja01588a032; Mizuno T, 2010, METHOD ENZYMOL, V471, P335, DOI 10.1016/S0076-6879(10)71018-1; Pas J, 2004, FEBS LETT, V576, P287, DOI 10.1016/j.febslet.2004.09.020; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P751, DOI 10.1093/pcp/pce094; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Zhang Z, 2010, J MOL BIOL, V400, P335, DOI 10.1016/j.jmb.2010.04.049; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010	24	111	116	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					766	768		10.1038/nchembio.667	http://dx.doi.org/10.1038/nchembio.667			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21964459	Green Accepted			2022-12-27	WOS:000296381600005
J	Gantt, RW; Peltier-Pain, P; Cournoyer, WJ; Thorson, JS				Gantt, Richard W.; Peltier-Pain, Pauline; Cournoyer, William J.; Thorson, Jon S.			Using simple donors to drive the equilibria of glycosyltransferase-catalyzed reactions	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-PRODUCT GLYCODIVERSIFICATION; IN-VITRO CHARACTERIZATION; DIRECTED EVOLUTION; MACROLIDE GLYCOSYLTRANSFERASES; CHEMOENZYMATIC SYNTHESIS; SUGAR BIOSYNTHESIS; GLYCORANDOMIZATION; GLYCOSYLATION; REVERSIBILITY; OLIGOSACCHARIDES	We report that simple glycoside donors can drastically shift the equilibria of glycosyltransferase-catalyzed reactions, transforming NDP-sugar formation from an endothermic to an exothermic process. To demonstrate the utility of this thermodynamic adaptability, we highlight the glycosyltransferase-catalyzed synthesis of 22 sugar nucleotides from simple aromatic sugar donors, as well as the corresponding in situ formation of sugar nucleotides as a driving force in the context of glycosyltransferase-catalyzed reactions for small-molecule glycodiversification. These simple aromatic donors also enabled a general colorimetric assay for glycosyltransfer, applicable to drug discovery, protein engineering and other fundamental sugar nucleotide-dependent investigations. This study directly challenges the general notion that NDP-sugars are 'high-energy' sugar donors when taken out of their traditional biological context.	[Gantt, Richard W.; Peltier-Pain, Pauline; Cournoyer, William J.; Thorson, Jon S.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Wisconsin Ctr Nat Prod Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Thorson, JS (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Wisconsin Ctr Nat Prod Res, 425 N Charter St, Madison, WI 53706 USA.	jsthorson@pharmacy.wisc.edu	Thorson, Jon S/L-3696-2013	Thorson, Jon S/0000-0002-7148-0721	US National Institutes of Health [AI52218]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052218, R01AI052218] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This manuscript is dedicated to the late C. Richard Hutchinson for his pioneering contributions to engineered natural product glycosylation. We thank the School of Pharmacy Analytical Instrumentation Center (University of Wisconsin-Madison) for analytical support and G.J. Williams (North Carolina State University) for materials and helpful discussion. R. W. G. is an American Foundation for Pharmaceutical Education -Pre-Doctoral Fellow. J.S.T. is a University of Wisconsin H. I. Romnes Fellow and holds the Laura and Edward Kremers Chair in Natural Products. This work was supported by US National Institutes of Health grant AI52218.	Bojarova P, 2009, GLYCOBIOLOGY, V19, P509, DOI 10.1093/glycob/cwp010; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Dickmanns A, 2011, J MOL BIOL, V405, P461, DOI 10.1016/j.jmb.2010.10.057; Fu X, 2003, NAT BIOTECHNOL, V21, P1467, DOI 10.1038/nbt909; Gantt RW, 2008, ANGEW CHEM INT EDIT, V47, P8889, DOI 10.1002/anie.200803508; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Hanson S, 2004, TRENDS BIOCHEM SCI, V29, P656, DOI 10.1016/j.tibs.2004.10.004; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Kittl R, 2010, CARBOHYD RES, V345, P1272, DOI 10.1016/j.carres.2010.04.002; Ko HJ, 2009, BIOORGAN MED CHEM, V17, P5298, DOI 10.1016/j.bmc.2009.05.024; Lairson LL, 2007, CHEM COMMUN, P365, DOI 10.1039/b614636h; Lau K, 2010, CHEM COMMUN, V46, P6066, DOI 10.1039/c0cc01381a; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Losey HC, 2002, CHEM BIOL, V9, P1305, DOI 10.1016/S1074-5521(02)00270-3; Lougheed B, 1999, J BIOL CHEM, V274, P37717, DOI 10.1074/jbc.274.53.37717; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Minami A, 2005, TETRAHEDRON LETT, V46, P6187, DOI 10.1016/j.tetlet.2005.07.083; Modolo LV, 2009, FEBS LETT, V583, P2131, DOI 10.1016/j.febslet.2009.05.046; Okada T, 2009, GLYCOBIOLOGY, V19, P368, DOI 10.1093/glycob/cwn145; Pesnot T, 2010, CHEMBIOCHEM, V11, P1392, DOI 10.1002/cbic.201000013; Quiros LM, 2000, J BIOL CHEM, V275, P11713, DOI 10.1074/jbc.275.16.11713; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rupprath C, 2005, CURR MED CHEM, V12, P1637, DOI 10.2174/0929867054367167; Rupprath C, 2007, ADV SYNTH CATAL, V349, P1489, DOI 10.1002/adsc.200700058; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Schitter G, 2009, EXPERT OPIN DRUG DIS, V4, P315, DOI 10.1517/17460440902778725; Takahashi H, 2006, J AM CHEM SOC, V128, P1432, DOI 10.1021/ja0562144; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Timmons SC, 2007, ORG LETT, V9, P857, DOI 10.1021/ol0630853; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wagner GK, 2010, CHEMBIOCHEM, V11, P1939, DOI 10.1002/cbic.201000201; Wagner GK, 2009, NAT PROD REP, V26, P1172, DOI 10.1039/b909621n; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Williams GJ, 2008, CHEM BIOL, V15, P393, DOI 10.1016/j.chembiol.2008.02.017; Williams GJ, 2008, NAT PROTOC, V3, P357, DOI 10.1038/nprot.2007.538; Williams GJ, 2007, NAT CHEM BIOL, V3, P657, DOI 10.1038/nchembio.2007.28; Williams GJ, 2011, ACS CHEM BIOL, V6, P95, DOI 10.1021/cb100267k; Williams GJ, 2008, CURR OPIN CHEM BIOL, V12, P556, DOI 10.1016/j.cbpa.2008.07.013; Yang J, 2004, BIOORGAN MED CHEM, V12, P1577, DOI 10.1016/j.bmc.2003.12.046; Yang M, 2005, J AM CHEM SOC, V127, P9336, DOI 10.1021/ja051482n; Zhang BC, 2011, P NATL ACAD SCI USA, V108, P5110, DOI 10.1073/pnas.1016144108; Zhang CS, 2008, CHEMBIOCHEM, V9, P2506, DOI 10.1002/cbic.200800349; Zhang CS, 2006, J AM CHEM SOC, V128, P16420, DOI 10.1021/ja065950k; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028	46	98	106	11	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					685	691		10.1038/NCHEMBIO.638	http://dx.doi.org/10.1038/NCHEMBIO.638			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21857660	Green Accepted			2022-12-27	WOS:000295027100012
J	Takahashi, N; Kuwaki, T; Kiyonaka, S; Numata, T; Kozai, D; Mizuno, Y; Yamamoto, S; Naito, S; Knevels, E; Carmeliet, P; Oga, T; Kaneko, S; Suga, S; Nokami, T; Yoshida, J; Mori, Y				Takahashi, Nobuaki; Kuwaki, Tomoyuki; Kiyonaka, Shigeki; Numata, Tomohiro; Kozai, Daisuke; Mizuno, Yusuke; Yamamoto, Shinichiro; Naito, Shinji; Knevels, Ellen; Carmeliet, Peter; Oga, Toru; Kaneko, Shuji; Suga, Seiji; Nokami, Toshiki; Yoshida, Jun-ichi; Mori, Yasuo			TRPA1 underlies a sensing mechanism for O-2	NATURE CHEMICAL BIOLOGY			English	Article							ION-CHANNEL TRPA1; COVALENT MODIFICATION; SENSORY NEURONS; ZINC FINGERS; ACTIVATION; HYPOXIA; COLD; PAIN; INHIBITION; CYSTEINES	Oxygen (O-2) is a prerequisite for cellular respiration in aerobic organisms but also elicits toxicity. To understand how animals cope with the ambivalent physiological nature of O-2, it is critical to elucidate the molecular mechanisms responsible for O-2 sensing. Here our systematic evaluation of transient receptor potential (TRP) cation channels using reactive disulfides with different redox potentials reveals the capability of TRPA1 to sense O-2. O-2 sensing is based upon disparate processes: whereas prolyl hydroxylases (PHDs) exert O-2-dependent inhibition on TRPA1 activity in normoxia, direct O-2 action overrides the inhibition via the prominent sensitivity of TRPA1 to cysteine-mediated oxidation in hyperoxia. Unexpectedly, TRPA1 is activated through relief from the same PHD-mediated inhibition in hypoxia. In mice, disruption of the Trpa1 gene abolishes hyperoxia- and hypoxia-induced cationic currents in vagal and sensory neurons and thereby impedes enhancement of in vivo vagal discharges induced by hyperoxia and hypoxia. The results suggest a new O-2-sensing mechanism mediated by TRPA1.	[Takahashi, Nobuaki; Kiyonaka, Shigeki; Numata, Tomohiro; Kozai, Daisuke; Mizuno, Yusuke; Yamamoto, Shinichiro; Suga, Seiji; Nokami, Toshiki; Yoshida, Jun-ichi; Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan; [Takahashi, Nobuaki; Kiyonaka, Shigeki; Numata, Tomohiro; Kozai, Daisuke; Mizuno, Yusuke; Yamamoto, Shinichiro; Mori, Yasuo] Kyoto Univ, Dept Technol & Ecol, Kyoto, Japan; [Takahashi, Nobuaki] Kyoto Univ, Adv Biomed Engn Res Unit, Kyoto, Japan; [Kuwaki, Tomoyuki] Kagoshima Univ, Dept Physiol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Japan Sci & Technol Agcy, Tokyo, Japan; [Naito, Shinji] Natl Ureshino Hosp, Div Pathol, Ureshino, Japan; [Knevels, Ellen; Carmeliet, Peter] Catholic Univ Louvain, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Knevels, Ellen; Carmeliet, Peter] Flanders Inst Biotechnol, Vesalius Res Ctr, Louvain, Belgium; [Oga, Toru] Kyoto Univ, Dept Resp Care & Sleep Control Med, Grad Sch Med, Kyoto, Japan; [Kaneko, Shuji] Kyoto Univ, Dept Mol Pharmacol, Grad Sch Pharmaceut Sci, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kagoshima University; Japan Science & Technology Agency (JST); Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Kyoto University; Kyoto University	Mori, Y (corresponding author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan.	mori@sbchem.kyoto-u.ac.jp	Nokami, Toshiki/ABA-2915-2021; Numata, Tomohiro/AAW-2453-2020; KOZAI, Daisuke/ABG-3019-2021; Carmeliet, Peter/AAQ-5140-2020; Kiyonaka, Shigeki/AAM-7303-2021; Kaneko, Shuji/AAR-1005-2021; Kuwaki, Tomoyuki/B-3247-2019; Numata, Tomohiro/AAC-2330-2021; Yoshida, Jun-ichi/E-8786-2010; Nokami, Toshiki/H-4380-2013; Takahashi, Nobuaki/AAG-9411-2019	Numata, Tomohiro/0000-0002-5719-4884; Carmeliet, Peter/0000-0001-7961-1821; Kuwaki, Tomoyuki/0000-0003-4226-3610; Numata, Tomohiro/0000-0002-5719-4884; Yoshida, Jun-ichi/0000-0001-8439-2272; Takahashi, Nobuaki/0000-0002-0606-3921; Kaneko, Shuji/0000-0001-5152-5809	Grants-in-Aid for Scientific Research [22681033, 21106002, 20249015] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DESANCTIS GT, 1991, J APPL PHYSIOL, V70, P1168, DOI 10.1152/jappl.1991.70.3.1168; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gruss M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-12; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hathout Y, 1996, DRUG METAB DISPOS, V24, P1395; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; HOWE A, 1981, J PHYSIOL-LONDON, V320, P309, DOI 10.1113/jphysiol.1981.sp013951; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lane N., 2002, OXYGEN MOL MADE WORL; Longhurst JC, 2001, ANN NY ACAD SCI, V940, P74; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McElroy M.B., 2002, ATMOSPHERIC ENV EFFE; MELLER ST, 1992, NEUROSCIENCE, V48, P501, DOI 10.1016/0306-4522(92)90398-L; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nagatomo K, 2008, P NATL ACAD SCI USA, V105, P17373, DOI 10.1073/pnas.0809769105; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Neubauer JA, 2004, J APPL PHYSIOL, V96, P367, DOI 10.1152/japplphysiol.00831.2003; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Topol IA, 2001, PROTEIN SCI, V10, P1434, DOI 10.1110/ps.52601; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; WALLACE TJ, 1963, J ORG CHEM, V28, P1311, DOI 10.1021/jo01040a038; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	50	195	199	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					701	711		10.1038/NCHEMBIO.640	http://dx.doi.org/10.1038/NCHEMBIO.640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21873995	Green Published			2022-12-27	WOS:000295027100014
J	Lee, KJ; Jeong, CS; An, YJ; Lee, HJ; Park, SJ; Seok, YJ; Kim, P; Lee, JH; Lee, KH; Cha, SS				Lee, Kyung-Jo; Jeong, Chang-Sook; An, Young Jun; Lee, Hyun-Jung; Park, Soon-Jung; Seok, Yeong-Jae; Kim, Pil; Lee, Jung-Hyun; Lee, Kyu-Ho; Cha, Sun-Shin			FrsA functions as a cofactor-independent decarboxylase to control metabolic flux	NATURE CHEMICAL BIOLOGY			English	Article							OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; ENZYME PYRUVATE DECARBOXYLASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROFICIENT ENZYME; ZYMOMONAS-MOBILIS; MECHANISM; RESOLUTION; IIA(GLC); BINDING	The interaction between fermentation-respiration switch (FrsA) protein and glucose-specific enzyme IIA(Glc) increases glucose fermentation under oxygen-limited conditions. We show that FrsA converts pyruvate to acetaldehyde and carbon dioxide in a cofactor-independent manner and that its pyruvate decarboxylation activity is enhanced by the dephosphorylated form of IIA(Glc) (d-IIA(Glc)). Crystal structures of FrsA and its complex with d-IIA(Glc) revealed residues required for catalysis as well as the structural basis for the activation by d-IIA(Glc).	[Lee, Kyung-Jo; Lee, Hyun-Jung; Lee, Kyu-Ho] Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea; [Jeong, Chang-Sook; An, Young Jun; Lee, Jung-Hyun; Cha, Sun-Shin] KORDI, Marine Biotechnol Res Ctr, Ansan, South Korea; [Park, Soon-Jung] Yonsei Univ, Coll Med, Dept Environm Med Biol, Seoul, South Korea; [Park, Soon-Jung] Yonsei Univ, Coll Med, Inst Trop Med, Brain Korea Project 21, Seoul, South Korea; [Seok, Yeong-Jae] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul, South Korea; [Kim, Pil] Catholic Univ Korea, Dept Biotechnol, Puchon, South Korea; [Lee, Jung-Hyun; Cha, Sun-Shin] Univ Sci & Technol, Dept Marine Biotechnol, Taejon, South Korea	Hankuk University Foreign Studies; Korea Institute of Ocean Science & Technology (KIOST); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Catholic University of Korea	Lee, KJ (corresponding author), Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea.	khlee@hufs.ac.kr; chajung@kordi.re.kr		Kim, Pil/0000-0002-6285-2466; Seok, Yeong-Jae/0000-0003-0379-3619; Cha, Sun-Shin/0000-0002-0913-8706; Park, Soon-Jung/0000-0002-0423-1944	Ministry of Land, Transport and Maritime Affairs; Ministry of Education, Science and Technology [2009-0092822]; KORDI in-house program [PE98513]	Ministry of Land, Transport and Maritime Affairs(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); KORDI in-house program	We are grateful to Y.-J. Lee, H.-S. Lee, S.J. Chung and J.K. Lee for comments on the manuscript. This work was supported by the Marine and Extreme Genome Research Center program of Ministry of Land, Transport and Maritime Affairs, the Mid-career Researcher Program through National Research Foundation grant funded by the Ministry of Education, Science and Technology (2009-0092822), a KORDI in-house program (PE98513) and the Development of Biohydrogen Production Technology Using Hyperthermophilic Archaea program of Ministry of Land, Transport and Maritime Affairs.	Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; Arjunan P, 1996, J MOL BIOL, V256, P590, DOI 10.1006/jmbi.1996.0111; BRINGERMEYER S, 1986, ARCH MICROBIOL, V146, P105, DOI 10.1007/BF00402334; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; Chan KK, 2009, BIOCHEMISTRY-US, V48, P5518, DOI 10.1021/bi900623r; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Dobritzsch D, 1998, J BIOL CHEM, V273, P20196, DOI 10.1074/jbc.273.32.20196; DYDA F, 1993, BIOCHEMISTRY-US, V32, P6165, DOI 10.1021/bi00075a008; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Harris P, 2000, BIOCHEMISTRY-US, V39, P4217, DOI 10.1021/bi992952r; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; Kim YJ, 2010, FEBS LETT, V584, P4537, DOI 10.1016/j.febslet.2010.10.035; Koo BM, 2004, J BIOL CHEM, V279, P31613, DOI 10.1074/jbc.M405048200; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Nam TW, 2008, P NATL ACAD SCI USA, V105, P3751, DOI 10.1073/pnas.0709295105; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PETERKOFSKY A, 1993, PROG NUCLEIC ACID RE, V44, P31, DOI 10.1016/S0079-6603(08)60216-0; SAIER MH, 1983, J BACTERIOL, V155, P1351, DOI 10.1128/JB.155.3.1351-1357.1983; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; Sergienko EA, 2001, BIOCHEMISTRY-US, V40, P7369, DOI 10.1021/bi002856m; STEPHENSON MP, 1971, J GEN MICROBIOL, V69, P331, DOI 10.1099/00221287-69-3-331; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797	25	18	20	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					434	436		10.1038/NCHEMBIO.589	http://dx.doi.org/10.1038/NCHEMBIO.589			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21623357				2022-12-27	WOS:000292252100010
J	Pezacki, JP; Blake, JA; Danielson, DC; Kennedy, DC; Lyn, RK; Singaravelu, R				Pezacki, John Paul; Blake, Jessie A.; Danielson, Dana C.; Kennedy, David C.; Lyn, Rodney K.; Singaravelu, Ragunath			Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy	NATURE CHEMICAL BIOLOGY			English	Review							STOKES-RAMAN SCATTERING; C VIRUS-REPLICATION; IN-VIVO; LIPID-METABOLISM; SINGLE-MOLECULE; CAENORHABDITIS-ELEGANS; 2-PHOTON FLUORESCENCE; HIGH-SENSITIVITY; HCV RNA; CELLS	Cellular biomolecules contain unique molecular vibrations that can be visualized by coherent anti-Stokes Raman scattering (CARS) microscopy without the need for labels. Here we review the application of CARS microscopy for label-free imaging of cells and tissues using the natural vibrational contrast that arises from biomolecules like lipids as well as for imaging of exogenously added probes or drugs. High-resolution CARS microscopy combined with multimodal imaging has allowed for dynamic monitoring of cellular processes such as lipid metabolism and storage, the movement of organelles, adipogenesis and host-pathogen interactions and can also be used to track molecules within cells and tissues. The CARS imaging modality provides a unique tool for biological chemists to elucidate the state of a cellular environment without perturbing it and to perceive the functional effects of added molecules.	[Pezacki, John Paul; Blake, Jessie A.; Danielson, Dana C.; Kennedy, David C.; Lyn, Rodney K.; Singaravelu, Ragunath] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON, Canada; [Pezacki, John Paul; Blake, Jessie A.; Lyn, Rodney K.] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Pezacki, John Paul; Danielson, Dana C.; Singaravelu, Ragunath] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	National Research Council Canada; University of Ottawa; University of Ottawa	Pezacki, JP (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON, Canada.	john.pezacki@nrc.ca	Foss, Dana V./AAR-4828-2021; Foss, Dana/K-4671-2016	Foss, Dana V./0000-0003-2937-4703; Foss, Dana/0000-0003-2937-4703; Kennedy, David/0000-0002-5110-1886; Singaravelu, Ragunath/0000-0002-2692-3650	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council (NSERC) of Canada. We thank D. Cote (Laval), A. Enejder (Chalmers), D. W. Moon (Korea Research Institute of Standards and Science) and M. Bonn (FOM Institute for Atomic and Molecular Physics) for contributing images to this review. We thank Y. Jia (Olympus America Inc.), A. F. Pegoraro (Queens University and National Research Council of Canada (NRC)), D. Moffat (NRC), A. Ridsdale (NRC) and A. D. Slepkov (NRC) for advice and help with CARS microscopy. R. S. thanks NSERC for a Vanier Graduate Scholarship and the CIHR National Canadian Research Training Program in Hepatitis C for additional support and training. D. C. D. thanks NSERC for a Canadian Graduate Scholarship. R. K. L. thanks the NSERC Collaborative Research and Training Experience Program in Medicinal Chemistry and Biopharmaceutical Development for support and training. J.P.P. would like to thank X. S. Xie and A. Stolow for many fruitful discussions and collaborations in CARS microscopy.	Agard NJ, 2009, ACCOUNTS CHEM RES, V42, P788, DOI 10.1021/ar800267j; Balu M, 2010, OPT EXPRESS, V18, P2380, DOI 10.1364/OE.18.002380; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Begin S, 2009, J BIOPHOTONICS, V2, P632, DOI 10.1002/jbio.200910071; Blais DR, 2010, J BIOL CHEM, V285, P25602, DOI 10.1074/jbc.M110.135483; Bonn M, 2009, J RAMAN SPECTROSC, V40, P763, DOI 10.1002/jrs.2253; Campion A, 1998, CHEM SOC REV, V27, P241, DOI 10.1039/a827241z; Chan RB, 2010, CHEM PHYS LIPIDS, V163, P449, DOI 10.1016/j.chemphyslip.2010.03.002; Chen HP, 2009, PATHOBIOLOGY, V76, P117, DOI 10.1159/000209389; Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; Day JPR, 2010, J AM CHEM SOC, V132, P8433, DOI 10.1021/ja102069d; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Ditzler MA, 2007, BIOPOLYMERS, V87, P302, DOI 10.1002/bip.20819; DUNCAN MD, 1982, OPT LETT, V7, P350, DOI 10.1364/OL.7.000350; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Evans CL, 2007, OPT EXPRESS, V15, P12076, DOI 10.1364/OE.15.012076; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Ganikhanov F, 2006, OPT LETT, V31, P1872, DOI 10.1364/OL.31.001872; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Hu QY, 2007, J AM CHEM SOC, V129, P14, DOI 10.1021/ja0670005; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Ile KE, 2006, NAT CHEM BIOL, V2, P576, DOI 10.1038/nchembio835; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kang EN, 2006, ANAL CHEM, V78, P8036, DOI 10.1021/ac061218s; Kennedy AP, 2005, LANGMUIR, V21, P6478, DOI 10.1021/la046820x; Kennedy DC, 2010, NANOSCALE, V2, P1413, DOI 10.1039/c0nr00122h; Kennedy DC, 2009, CHEM COMMUN, P6750, DOI 10.1039/b916561d; Kennedy DC, 2009, ACS NANO, V3, P2329, DOI 10.1021/nn900488u; Kennedy DC, 2009, J AM CHEM SOC, V131, P2444, DOI 10.1021/ja809451w; Kim SH, 2010, CIRC RES, V106, P1332, DOI 10.1161/CIRCRESAHA.109.208678; Kneipp J, 2008, CHEM SOC REV, V37, P1052, DOI 10.1039/b708459p; Kojima S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011264; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Konorov SO, 2007, ANAL CHEM, V79, P7221, DOI 10.1021/ac070544k; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Le TT, 2007, MOL IMAGING, V6, P205, DOI 10.2310/7290.2007.00018; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Le TT, 2010, J LIPID RES, V51, P672, DOI 10.1194/jlr.D000638; Le TT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-42; Le TT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005189; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Li L, 2005, BIOPHYS J, V89, P3480, DOI 10.1529/biophysj.105.065607; Lim RS, 2010, J LIPID RES, V51, P1729, DOI 10.1194/jlr.M003616; Lyn RK, 2010, BIOCHEM BIOPH RES CO, V399, P518, DOI 10.1016/j.bbrc.2010.07.101; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Mamidyala SK, 2010, CHEM SOC REV, V39, P1252, DOI 10.1039/b901969n; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Meyer T, 2008, J PHYS CHEM B, V112, P1420, DOI 10.1021/jp709643h; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Moffatt R., 2006, LIPID METABOLISM HLT; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Nan XL, 2006, CHEMBIOCHEM, V7, P1895, DOI 10.1002/cbic.200600330; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Noestheden M, 2007, BIOORG CHEM, V35, P284, DOI 10.1016/j.bioorg.2006.12.004; Noestheden M, 2007, ORG BIOMOL CHEM, V5, P2380, DOI 10.1039/b704812b; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pegoraro AF, 2009, OPT EXPRESS, V17, P2984, DOI 10.1364/OE.17.002984; Pezacki JP, 2010, MOL BIOSYST, V6, P1131, DOI 10.1039/b924668c; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pliss A, 2010, P NATL ACAD SCI USA, V107, P12771, DOI 10.1073/pnas.1006374107; Potma EO, 2001, P NATL ACAD SCI USA, V98, P1577, DOI 10.1073/pnas.031575698; Prasad P. N., 2003, INTRO BIOPHOTONICS; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Qian XM, 2008, CHEM SOC REV, V37, P912, DOI 10.1039/b708839f; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rakic B, 2006, CHEM BIOL, V13, P23, DOI 10.1016/j.chembiol.2005.10.006; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rinia HA, 2008, BIOPHYS J, V95, P4908, DOI 10.1529/biophysj.108.137737; Robinson I, 2010, J BIOPHOTONICS, V3, P138, DOI 10.1002/jbio.200910054; Saar BG, 2010, SCIENCE, V330, P1368, DOI 10.1126/science.1197236; Sagan SM, 2006, BIOCHEM CELL BIOL, V84, P67, DOI 10.1139/O05-149; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schnabl J, 2010, CURR OPIN CHEM BIOL, V14, P269, DOI 10.1016/j.cbpa.2009.11.024; Slipchenko MN, 2009, J PHYS CHEM B, V113, P7681, DOI 10.1021/jp902231y; Sowa MG, 2009, MEAS SCI REV, V9, P93, DOI 10.2478/v10048-009-0018-2; Sund J, 2010, NATURE, V465, P947, DOI 10.1038/nature09082; Tong L, 2007, J PHYS CHEM B, V111, P9980, DOI 10.1021/jp073478z; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Windbergs M, 2009, ANAL CHEM, V81, P2085, DOI 10.1021/ac8020856; Wu YM, 2009, ANAL CHEM, V81, P1496, DOI 10.1021/ac8026838; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xie XS, 2006, SCIENCE, V312, P228, DOI 10.1126/science.1127566; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	100	169	172	5	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					137	145		10.1038/NCHEMBIO.525	http://dx.doi.org/10.1038/NCHEMBIO.525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21321552	Green Published			2022-12-27	WOS:000287307600006
J	Child, MA; Hall, CI; Beck, JR; Ofori, LO; Albrow, VE; Garland, M; Bowyer, PW; Bradley, PJ; Powers, JC; Boothroyd, JC; Weerapana, E; Bogyo, M				Child, Matthew A.; Hall, Carolyn I.; Beck, Josh R.; Ofori, Leslie O.; Albrow, Victoria E.; Garland, Megan; Bowyer, Paul W.; Bradley, Peter J.; Powers, James C.; Boothroyd, John C.; Weerapana, Eranthie; Bogyo, Matthew			Small-molecule inhibition of a depalmitoylase enhances Toxoplasma host-cell invasion	NATURE CHEMICAL BIOLOGY			English	Article							CALCIUM; DISSECTION; GLIDEOSOME; REGULATOR; SECRETION; PROTEINS; SITES	Although there have been numerous advances in our understanding of how apicomplexan parasites such as Toxoplasma gondii enter host cells, many of the signaling pathways and enzymes involved in the organization of invasion mediators remain poorly defined. We recently performed a forward chemical-genetic screen in T. gondii and identified compounds that markedly enhanced infectivity. Although molecular dissection of invasion has benefited from the use of small-molecule inhibitors, the mechanisms underlying induction of invasion by small-molecule enhancers have never been described. Here we identify the Toxoplasma ortholog of human APT1, palmitoyl protein thioesterase-1 (TgPPT1), as the target of one class of small-molecule enhancers. Inhibition of this uncharacterized thioesterase triggered secretion of invasion-associated organelles, increased motility and enhanced the invasive capacity of tachyzoites. We demonstrate that TgPPT1 is a bona fide depalmitoylase, thereby establishing an important role for dynamic and reversible palmitoylation in host-cell invasion by T. gondii.	[Child, Matthew A.; Ofori, Leslie O.; Albrow, Victoria E.; Garland, Megan; Bowyer, Paul W.; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Hall, Carolyn I.; Boothroyd, John C.; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Beck, Josh R.; Bradley, Peter J.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA USA; [Powers, James C.] Georgia Inst Technol, Dept Chem, Atlanta, GA 30332 USA; [Weerapana, Eranthie] Boston Coll, Dept Chem, Chestnut Hill, MA 02167 USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; University System of Georgia; Georgia Institute of Technology; Boston College	Bogyo, M (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mbogyo@stanford.edu		Bogyo, Matthew/0000-0003-3753-4412; Child, Matthew/0000-0002-1565-5638; /0000-0002-4046-9191; Garland, Megan/0000-0002-5622-5095; Boothroyd, John C./0000-0001-9719-745X	Burroughs Wellcome Trust New Investigators in Pathogenesis Award; US National Institutes of Health [R01-AI078947, EB005011, RO1 AI21423]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078947, R01AI021423, R01AI064616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	Burroughs Wellcome Trust New Investigators in Pathogenesis Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the Bogyo and Boothroyd labs for discussions that shaped the direction of the project; G. Ward (University of Vermont) for discussions and the GAP45 antibody; B. Martin for discussions regarding the 17-ODA metabolic labeling experiments; G. Arrizabalaga (Indiana University) and M. Treeck (Stanford University) for the TgCDPK3-HA parasite line; B. Cravatt (Scripps Research Institute) for FP-rho; T. Wandless (Stanford University) for Shield-1; and the Stanford high-throughput imaging facility for assistance with imaging the attachment and invasion assays. This work was funded by a Burroughs Wellcome Trust New Investigators in Pathogenesis Award (to M.B.), by the US National Institutes of Health grants R01-AI078947 and EB005011 (to M.B.) and RO1 AI21423 (to J.C.B.).	Alonso AM, 2012, MOL BIOCHEM PARASIT, V184, P39, DOI 10.1016/j.molbiopara.2012.03.006; Arrizabalaga G, 2004, INT J PARASITOL, V34, P361, DOI 10.1016/j.ijpara.2003.11.017; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Haedke U, 2012, BIOORGAN MED CHEM, V20, P633, DOI 10.1016/j.bmc.2011.03.014; Hall CI, 2011, P NATL ACAD SCI USA, V108, P10568, DOI 10.1073/pnas.1105622108; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Heynekamp JJ, 2008, BIOORGAN MED CHEM, V16, P5285, DOI 10.1016/j.bmc.2008.03.016; Hirakawa S, 2011, J IMMUNOL, V186, P4762, DOI 10.4049/jimmunol.1000791; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; Mueller C, 2013, CELL HOST MICROBE, V13, P289, DOI 10.1016/j.chom.2013.02.001; POWERS JC, 1989, J CELL BIOCHEM, V39, P33, DOI 10.1002/jcb.240390105; Prescott G.R., 2009, CELL MICROBIOL, V110, P1135; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Soldati D, 2001, INT J PARASITOL, V31, P1293, DOI 10.1016/S0020-7519(01)00257-0; Soldati-Favre D., 2011, APICOMPLEXAN PARASIT, V2, P335; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194	38	45	46	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					651	656		10.1038/nchembio.1315	http://dx.doi.org/10.1038/nchembio.1315			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	23934245	Green Accepted			2022-12-27	WOS:000325041800013
J	Esselborn, J; Lambertz, C; Adamska-Venkatesh, A; Simmons', T; Berggren, G; Nothl, J; Siebel, J; Hemschemeier, A; Artero, V; Reijerse, E; Fontecave, M; Lubitz, W; Happe, T				Esselborn, Julian; Lambertz, Camilla; Adamska-Venkatesh, Agnieszka; Simmons', Trevor; Berggren, Gustav; Nothl, Jens; Siebel, Judith; Hemschemeier, Anja; Artero, Vincent; Reijerse, Edward; Fontecave, Marc; Lubitz, Wolfgang; Happe, Thomas			Spontaneous activation of [FeFe]-hydrogenases by an inorganic [2Fe] active site mimic	NATURE CHEMICAL BIOLOGY			English	Article							H-CLUSTER; CHLAMYDOMONAS-REINHARDTII; MEGASPHAERA-ELSDENII; HYDROGEN-PRODUCTION; FEFE HYDROGENASES; ONLY HYDROGENASE; IRON HYDROGENASE; COFACTOR; MATURATION; FRAMEWORK	Hydrogenases catalyze the formation of hydrogen. The cofactor ('H-cluster') of [FeFe]-hydrogenases consists of a [4Fe-4S] cluster bridged to a unique [2Fe] subcluster whose biosynthesis in vivo requires hydrogenase-specific maturases. Here we show that a chemical mimic of the [2Fe] subcluster can reconstitute apo-hydrogenase to full activity, independent of helper proteins. The assembled H-cluster is virtually indistinguishable from the native cofactor. This procedure will be a powerful tool for developing new artificial H-2-producing catalysts.	[Esselborn, Julian; Lambertz, Camilla; Nothl, Jens; Hemschemeier, Anja; Happe, Thomas] Ruhr Univ Bochum, Fak Biol & Biotechnol, AG Photobiotechnol, Bochum, Germany; [Adamska-Venkatesh, Agnieszka; Siebel, Judith; Reijerse, Edward; Lubitz, Wolfgang] Max Planck Inst Chem Energiekonvers, Mulheim, Germany; [Simmons', Trevor; Berggren, Gustav; Artero, Vincent; Fontecave, Marc] Univ Grenoble 1, CNRS, Lab Chim & Biol Metaux, Commissariat Energie Atom & Energies Alternat, Grenoble, France; [Fontecave, Marc] Coll France, F-75231 Paris, France; [Berggren, Gustav] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Ruhr University Bochum; Max Planck Society; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Stockholm University	Happe, T (corresponding author), Ruhr Univ Bochum, Fak Biol & Biotechnol, AG Photobiotechnol, Univ Str 150, Bochum, Germany.	thomas.happe@rub.de	Artero, Vincent/C-6853-2008; Simmons, Trevor/B-8182-2016; Berggren, Gustav/H-8659-2013	Artero, Vincent/0000-0002-6148-8471; Simmons, Trevor/0000-0002-6057-7704; Berggren, Gustav/0000-0002-6717-6612; Hemschemeier, Anja/0000-0001-8879-3348; Esselborn, Julian/0000-0002-3499-8417; Happe, Thomas/0000-0003-1206-5234	Bundesministerium fur Bildung und Forschung Bio-H2 project; Max Planck Society; French National Research Agency [NiFe-Cat ANR-10-BLAN-711, ARCANE 11-LABX-003]; European Research Council under the European Union's Seventh Framework Programme (FP/ERC) [306398]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [213-2010-563]; Deutsche Forschungsgemeinschaft [HA 255/2-1]; Volkswagen foundation (LigH2t); Studienstiftung des deutschen Volkes	Bundesministerium fur Bildung und Forschung Bio-H2 project; Max Planck Society(Max Planck Society); French National Research Agency(French National Research Agency (ANR)); European Research Council under the European Union's Seventh Framework Programme (FP/ERC)(European Research Council (ERC)); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen foundation (LigH2t); Studienstiftung des deutschen Volkes	This work was supported by the Bundesministerium fur Bildung und Forschung Bio-H2 project (to T.H. and W.L.), the Max Planck Society, the French National Research Agency (NiFe-Cat ANR-10-BLAN-711 and Labex Program ARCANE 11-LABX-003 to T.S.,V.A. and M.F.) and the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013/ERC grant agreement no. 306398 to V.A.). G.B. gratefully acknowledges the Bengt Lundqvist Minnesfond, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (contract no. 213-2010-563) and the Swedish Royal Academy of Sciences. T.H. gratefully acknowledges support from the Deutsche Forschungsgemeinschaft (HA 255/2-1) and the Volkswagen foundation (LigH2t). J.E. is financed by the Studienstiftung des deutschen Volkes.	Adamska A, 2012, ANGEW CHEM INT EDIT, V51, P11458, DOI 10.1002/anie.201204800; Atta M, 2000, BBA-PROTEIN STRUCT M, V1476, P368, DOI 10.1016/S0167-4838(99)00245-9; Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; Knorzer P, 2012, J BIOL CHEM, V287, P1489, DOI 10.1074/jbc.M111.305797; Li HX, 2002, J AM CHEM SOC, V124, P726, DOI 10.1021/ja016964n; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Noth J, 2013, J BIOL CHEM, V288, P4368, DOI 10.1074/jbc.M112.429985; Peters JW, 2012, ANNU REV BIOCHEM, V81, P429, DOI 10.1146/annurev-biochem-052610-094911; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Razavet M, 2002, CHEM COMMUN, P700, DOI 10.1039/b111613b; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; Tard C, 2005, NATURE, V433, P610, DOI 10.1038/nature03298; VANDIJK C, 1981, EUR J BIOCHEM, V114, P209; Winkler M, 2013, BBA-BIOENERGETICS, V1827, P974, DOI 10.1016/j.bbabio.2013.03.004; Winkler M, 2009, J BIOL CHEM, V284, P36620, DOI 10.1074/jbc.M109.053496	24	254	255	2	183	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					607	609		10.1038/NCHEMBIO.1311	http://dx.doi.org/10.1038/NCHEMBIO.1311			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	23934246	Green Accepted			2022-12-27	WOS:000325041800006
J	O'Donoghue, P; Ling, JQ; Wang, YS; Soll, D				O'Donoghue, Patrick; Ling, Jiqiang; Wang, Yane-Shih; Soell, Dieter			Upgrading protein synthesis for synthetic biology	NATURE CHEMICAL BIOLOGY			English	Article							TRANSFER-RNA SYNTHETASE; UNNATURAL AMINO-ACIDS; GENETIC-CODE; ESCHERICHIA-COLI; QUALITY-CONTROL; IN-VIVO; EXPANSION; MISTRANSLATION; TRANSLATION; SPECIFICITY	Genetic code expansion for synthesis of proteins containing noncanonical amino acids is a rapidly growing field in synthetic biology. Creating optimal orthogonal translation systems will require re-engineering central components of the protein synthesis machinery on the basis of a solid mechanistic biochemical understanding of the synthetic process.	[O'Donoghue, Patrick; Ling, Jiqiang; Wang, Yane-Shih; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT USA	Yale University; Yale University	O'Donoghue, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	dieter.soll@yale.edu	Ling, Jiqiang/AAU-1097-2021	Ling, Jiqiang/0000-0003-4466-8304; Wang, Yane-Shih/0000-0003-2356-9577; O'Donoghue, Patrick/0000-0002-9500-8640	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-98ER20311]; National Institute of General Medical Sciences [GM22854]; DARPA [N66001-12-C-4020, N66001-12-C-4211]; National Science Foundation [MCB-0950474]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Englert, I. Heinemann, F. Isaacs and J. Rinehart for inspired discussions. Work in the authors' laboratory was supported by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DE-FG02-98ER20311); the National Institute of General Medical Sciences (GM22854); DARPA contracts N66001-12-C-4020 and N66001-12-C-4211; and by the National Science Foundation (MCB-0950474).	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; Bock A, 1988, Biofactors, V1, P245; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Gaston MA, 2011, CURR OPIN MICROBIOL, V14, P342, DOI 10.1016/j.mib.2011.04.001; Glege R., 1998, NUCLEIC ACIDS RES, V26, P5017; Ieong KW, 2012, J AM CHEM SOC, V134, P17955, DOI 10.1021/ja3063524; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Krishnakumar R, 2013, CHEMBIOCHEM, V14, P1967, DOI 10.1002/cbic.201300444; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; O'Donoghue P, 2012, FEBS LETT, V586, P3931, DOI 10.1016/j.febslet.2012.09.033; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Prat L, 2012, P NATL ACAD SCI USA, V109, P21070, DOI 10.1073/pnas.1218613110; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; RICHMOND MH, 1962, BACTERIOL REV, V26, P398, DOI 10.1128/MMBR.26.4.398-420.1962; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Su D, 2011, NUCLEIC ACIDS RES, V39, P4866, DOI 10.1093/nar/gkr073; Tanrikulu IC, 2009, P NATL ACAD SCI USA, V106, P15285, DOI 10.1073/pnas.0905735106; Umehara T, 2012, FEBS LETT, V586, P729, DOI 10.1016/j.febslet.2012.01.029; Wang YS, 2012, J AM CHEM SOC, V134, P2950, DOI 10.1021/ja211972x; Wiltschi B, 2008, YEAST, V25, P775, DOI 10.1002/yea.1632; Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e	29	111	117	3	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					594	598		10.1038/nchembio.1339	http://dx.doi.org/10.1038/nchembio.1339			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	24045798	Green Accepted			2022-12-27	WOS:000325041800002
J	Anguiano, J; Garner, TP; Mahalingam, M; Das, BC; Gavathiotis, E; Cuervo, AM				Anguiano, Jaime; Garner, Thomas P.; Mahalingam, Murugesan; Das, Bhaskar C.; Gavathiotis, Evripidis; Cuervo, Ana Maria			Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives	NATURE CHEMICAL BIOLOGY			English	Article							LYSOSOMAL DEGRADATION; ACCURATE DOCKING; ALPHA-SYNUCLEIN; PROTEIN; DESIGN; GLIDE; BIOGENESIS; METABOLISM; CANCER; RAR	Chaperone-mediated autophagy (CMA) contributes to cellular quality control and the cellular response to stress through the selective degradation of cytosolic proteins in lysosomes. A decrease in CMA activity occurs in aging and in age-related disorders (for example, neurodegenerative diseases and diabetes). Although prevention of this age-dependent decline through genetic manipulation in mice has proven beneficial, chemical modulation of CMA is not currently possible, owing in part to the lack of information on the signaling mechanisms that modulate this pathway. In this work, we report that signaling through retinoic acid receptor alpha (RAR alpha) inhibits CMA and apply structure-based chemical design to develop synthetic derivatives of all-trans-retinoic acid to specifically neutralize this inhibitory effect. We demonstrate that chemical enhancement of CMA protects cells from oxidative stress and from proteotoxicity, supporting a potential therapeutic opportunity when reduced CMA contributes to cellular dysfunction and disease.	[Anguiano, Jaime; Mahalingam, Murugesan; Das, Bhaskar C.; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Garner, Thomas P.; Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Gavathiotis, Evripidis] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10467 USA; [Gavathiotis, Evripidis; Cuervo, Ana Maria] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Anguiano, J (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	bdas@kumc.edu; evripidis.gavathiotis@einstein.yu.edu; ana-maria.cuervo@einstein.yu.edu		Gavathiotis, Evripidis/0000-0001-6319-8331; Cuervo, Ana Maria/0000-0002-0771-700X	US National Institutes of Health (NIH)-National Institute on Aging [AG021904, AG031782]; Albert Einstein College of Medicine; NIH-National Heart, Lung, and Blood Institute [HL095929]; NIH-National Institute on Alcohol Abuse and Alcoholism [AA020630]; Rainwaters Foundation; Beatrice and Roy Backus Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL095929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021904, P01AG031782, R01AG021904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020630] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)-National Institute on Aging; Albert Einstein College of Medicine; NIH-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH-National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Rainwaters Foundation; Beatrice and Roy Backus Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank R. Valdor for technical assistance with the luciferase assay, R. Kiffin for assistance with the quantitative RT-PCR, F. Macian for help with fluorescence-activated cell sorting procedures, T. Evans and I. Torregroza for advice with the RAR alpha luciferase assay, C.-L. Towse for advice on the simulated annealing and molecular dynamics simulations and S. Kaushik for critically reviewing this manuscript. This work was supported by grants from the US National Institutes of Health (NIH)-National Institute on Aging (AG021904 and AG031782 to A.M.C.); Albert Einstein College of Medicine start-up funds (to E.G.); NIH-National Heart, Lung, and Blood Institute (HL095929 to E.G.); NIH-National Institute on Alcohol Abuse and Alcoholism (AA020630 to B.C.D.); and by the Rainwaters Foundation, the Beatrice and Roy Backus Foundation and a Robert and Renee Belfer gift (to A.M.C.).	Ahlemeyer B, 2001, FREE RADICAL BIO MED, V30, P1067, DOI 10.1016/S0891-5849(01)00495-6; Arias E, 2011, CURR OPIN CELL BIOL, V23, P184, DOI 10.1016/j.ceb.2010.10.009; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Bowers KJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191489; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Das BC, 2011, TETRAHEDRON LETT, V52, P2433, DOI 10.1016/j.tetlet.2011.03.011; Das BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010004; Das BC, 2010, TETRAHEDRON LETT, V51, P1462, DOI 10.1016/j.tetlet.2010.01.003; Das BC, 2009, TETRAHEDRON LETT, V50, P5670, DOI 10.1016/j.tetlet.2009.07.119; Das BC, 2009, BIOORG MED CHEM LETT, V19, P4204, DOI 10.1016/j.bmcl.2009.05.110; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Duong V, 2011, BBA-MOL BASIS DIS, V1812, P1023, DOI 10.1016/j.bbadis.2010.10.007; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; FROLIK CA, 1980, J BIOL CHEM, V255, P8057; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Isakson P, 2010, BLOOD, V116, P2324, DOI 10.1182/blood-2010-01-261040; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Mizushima N, 2011, COLD SH Q B, V76, P397, DOI 10.1101/sqb.2011.76.011023; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Njar VCO, 2006, BIOORGAN MED CHEM, V14, P4323, DOI 10.1016/j.bmc.2006.02.041; Rajawat Y, 2011, ANTIOXID REDOX SIGN, V14, P2165, DOI 10.1089/ars.2010.3491; Rochette-Egly C., 2009, NUCL RECEPT SIGNAL, V7, pe005; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; SHRIDHAR DR, 1981, SYNTHESIS-STUTTGART, P912; Sooparb S, 2004, KIDNEY INT, V65, P2135, DOI 10.1111/j.1523-1755.2004.00639.x; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Trocoli A, 2011, AUTOPHAGY, V7, P1108, DOI 10.4161/auto.7.10.16623; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wang Z, 2011, AUTOPHAGY, V7, P401, DOI 10.4161/auto.7.4.14397; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	49	138	142	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					374	+		10.1038/nchembio.1230	http://dx.doi.org/10.1038/nchembio.1230			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23584676	Green Accepted			2022-12-27	WOS:000319328200009
J	Fu, Y; Tsui, HCT; Bruce, KE; Sham, LT; Higgins, KA; Lisher, JP; Kazmierczak, KM; Maroney, MJ; Dann, CE; Winkler, ME; Giedroc, DP				Fu, Yue; Tsui, Ho-Ching Tiffany; Bruce, Kevin E.; Sham, Lok-To; Higgins, Khadine A.; Lisher, John P.; Kazmierczak, Krystyna M.; Maroney, Michael J.; Dann, Charles E., III; Winkler, Malcolm E.; Giedroc, David P.			A new structural paradigm in copper resistance in Streptococcus pneumoniae	NATURE CHEMICAL BIOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; METAL; VIRULENCE; HOMEOSTASIS; MECHANISM; INTERPLAY; DELIVERY; TARGETS; CSOR	Copper resistance has emerged as an important virulence determinant of microbial pathogens. In Streptococcus pneumoniae, copper resistance is mediated by the copper-responsive repressor CopY, CupA and the copper-effluxing P-18-type ATPase CopA. We show here that CupA is a previously uncharacterized cell membrane-anchored Cu-(I) chaperone and that a Cu-(I) binding-competent, membrane-localized CupA is obligatory for copper resistance. The crystal structures of the soluble domain of CupA and the N-terminal metal-binding domain (MBD) of CopA (CopA(MBD)) reveal isostructural cupredoxin-like folds that each harbor a binuclear Cu-(I) cluster unprecedented in bacterial copper trafficking. NMR studies reveal unidirectional Cu-(I) transfer from the low-affinity site on the soluble domain of CupA to the high-affinity site of CopA(MBD). However, copper binding by CopA(MBD) is not essential for cellular copper resistance, consistent with a primary role of CupA in cytoplasmic Cu-(I) sequestration and/or direct delivery to the transmembrane site of CopA for cellular efflux.	[Fu, Yue; Higgins, Khadine A.; Lisher, John P.; Dann, Charles E., III; Giedroc, David P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Fu, Yue; Lisher, John P.; Dann, Charles E., III; Winkler, Malcolm E.; Giedroc, David P.] Indiana Univ, Interdisciplinary Grad Program Biochem, Bloomington, IN USA; [Tsui, Ho-Ching Tiffany; Bruce, Kevin E.; Sham, Lok-To; Kazmierczak, Krystyna M.; Winkler, Malcolm E.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Maroney, Michael J.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Massachusetts System; University of Massachusetts Amherst	Giedroc, DP (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	giedroc@indiana.edu	Johnson, Michael D. L./B-4352-2012; Dann, Charles E/C-2747-2018; Giedroc, David/A-8608-2018; Sham, Lok To/L-8149-2016	Giedroc, David/0000-0002-2342-1620; Sham, Lok To/0000-0001-9047-0310; Maroney, Michael/0000-0002-5598-3038	US National Institutes of Health (NIH) [GM042569, GM094472, AI095814, GM069696]; Lilly Endowment; Indiana University Quantitative and Chemical Biology Training Fellowship; US Department of Energy, Office of Biological and Environmental Research; NIH National Center for Research Resources, Biomedical Technology Program; Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering [P30-EB-009998]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094472, R01GM069696, T32GM109825, R01GM042569, R29GM042569] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Endowment; Indiana University Quantitative and Chemical Biology Training Fellowship; US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support from the US National Institutes of Health (NIH; GM042569 to D.P.G., GM094472 to C.E.D. III, AI095814 to M.E.W and GM069696 to M.J.M.), the Lilly Endowment (to M.E.W.) and an Indiana University Quantitative and Chemical Biology Training Fellowship (to J.P.L.). We thank L. Christiansen for assistance in strain construction, members of the Giedroc laboratory for help in acquiring the NMR data and H. Hu and N. Giri from of the Maroney laboratory for XAS data collection. Crystallographic data collection at the Advanced Light Source at the Lawrence Berkeley National Laboratory is supported by the US Department of Energy and Indiana University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the US Department of Energy, Office of Biological and Environmental Research and by the NIH National Center for Research Resources, Biomedical Technology Program. XAS data collected at the National Synchrotron Light Source (NSLS) at Brookhaven National Laboratory was supported by the US Department of Energy, Division of Materials Sciences and Division of Chemical Sciences. Beamline X3B at NSLS is supported by the Center for Synchrotron Biosciences (grant P30-EB-009998) from the National Institute of Biomedical Imaging and Bioengineering.	Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Arnesano F, 2001, J BIOL CHEM, V276, P41365, DOI 10.1074/jbc.M104807200; Badarau A, 2011, P NATL ACAD SCI USA, V108, P13007, DOI 10.1073/pnas.1101448108; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; Banci L, 2005, J BIOL CHEM, V280, P38259, DOI 10.1074/jbc.M506219200; Banci L, 2005, P NATL ACAD SCI USA, V102, P3994, DOI 10.1073/pnas.0406150102; Banci L, 2001, BIOCHEMISTRY-US, V40, P15660, DOI 10.1021/bi0112715; Banci L, 2006, P NATL ACAD SCI USA, V103, P8320, DOI 10.1073/pnas.0600142103; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Bersch B, 2011, BIOCHEMISTRY-US, V50, P2194, DOI 10.1021/bi200005k; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Chillappagari S, 2009, J BACTERIOL, V191, P2362, DOI 10.1128/JB.01616-08; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Kazmierczak KM, 2009, MOL MICROBIOL, V72, P590, DOI 10.1111/j.1365-2958.2009.06669.x; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Percival SS, 1998, AM J CLIN NUTR, V67, p1064S, DOI 10.1093/ajcn/67.5.1064S; Portmann R, 2006, BIOMETALS, V19, P61, DOI 10.1007/s10534-005-5381-3; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Rowland JL, 2012, TUBERCULOSIS, V92, P202, DOI 10.1016/j.tube.2011.12.006; Samanovic MI, 2012, CELL HOST MICROBE, V11, P106, DOI 10.1016/j.chom.2012.01.009; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Tottey S, 2012, P NATL ACAD SCI USA, V109, P95, DOI 10.1073/pnas.1117515109; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Zaballa ME, 2012, P NATL ACAD SCI USA, V109, P9254, DOI 10.1073/pnas.1119460109	47	69	69	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					177	183		10.1038/NCHEMBIO.1168	http://dx.doi.org/10.1038/NCHEMBIO.1168			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23354287	Green Accepted			2022-12-27	WOS:000315132900013
J	Wang, XX; Lord, DM; Cheng, HY; Osbourne, DO; Hong, SH; Sanchez-Torres, V; Quiroga, C; Zheng, K; Herrmann, T; Peti, W; Benedik, MJ; Page, R; Wood, TK				Wang, Xiaoxue; Lord, Dana M.; Cheng, Hsin-Yao; Osbourne, Devon O.; Hong, Seok Hoon; Sanchez-Torres, Viviana; Quiroga, Cecilia; Zheng, Kevin; Herrmann, Torsten; Peti, Wolfgang; Benedik, Michael J.; Page, Rebecca; Wood, Thomas K.			A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS	NATURE CHEMICAL BIOLOGY			English	Article							GENERAL STRESS-RESPONSE; NMR STRUCTURE DETERMINATION; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; MULTIDRUG TOLERANCE; BIOFILM FORMATION; PROTEIN; EXPRESSION; CELLS; REGULATOR	Among bacterial toxin-antitoxin systems, to date no antitoxin has been identified that functions by cleaving toxin mRNA. Here we show that YjdO (renamed GhoT) is a membrane lytic peptide that causes ghost cell formation (lysed cells with damaged membranes) and increases persistence (persister cells are tolerant to antibiotics without undergoing genetic change). GhoT is part of a new toxin-antitoxin system with YjdK (renamed GhoS) because in vitro RNA degradation studies, quantitative real-time reverse-transcription PCR and whole-transcriptome studies revealed that GhoS masks GhoT toxicity by cleaving specifically yjdO (ghoT) mRNA. Alanine substitutions showed that Arg28 is important for GhoS activity, and RNA sequencing indicated that the GhoS cleavage site is rich in U and A. The NMR structure of GhoS indicates it is related to the CRISPR-associated-2 RNase, and GhoS is a monomer. Hence, GhoT-GhoS is to our knowledge the first type V toxin-antitoxin system where a protein antitoxin inhibits the toxin by cleaving specifically its mRNA.	[Zheng, Kevin; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Wang, Xiaoxue] Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China; [Wang, Xiaoxue; Hong, Seok Hoon; Sanchez-Torres, Viviana; Wood, Thomas K.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Lord, Dana M.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Cheng, Hsin-Yao; Osbourne, Devon O.; Quiroga, Cecilia; Wood, Thomas K.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Herrmann, Torsten] Univ Lyon, Ctr Europeen Resonance Magnet Nucl Tres Champ, CNRS, Ecole Normale Super Lyon, Lyon, France; [Benedik, Michael J.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Wood, Thomas K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Brown University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Texas A&M University System; Texas A&M University College Station; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Page, R (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	Rebecca_Page@brown.edu; TWood@engr.psu.edu	Hong, Seok Hoon/E-1289-2014; Peti, Wolfgang/L-3492-2014; Quiroga, Cecilia/AAK-2933-2020; Benedik, Michael J/H-2478-2011; Hong, Seok Hoon/AAF-7163-2021; Wood, Thomas/GWZ-2481-2022; Herrmann, Torsten/B-9978-2008	Hong, Seok Hoon/0000-0003-2401-6368; Benedik, Michael J/0000-0002-7435-0092; Hong, Seok Hoon/0000-0003-2401-6368; Wood, Thomas/0000-0001-8962-8571; Herrmann, Torsten/0000-0003-2115-4781; Zheng, Kevin/0000-0003-4654-1809; Quiroga, Cecilia/0000-0002-5552-3349; Wang, Xiaoxue/0000-0002-7257-1916; Sanchez-Torres, Viviana/0000-0002-0047-9459; Wood, Thomas/0000-0002-6258-529X	US National Institutes of Health [R01 GM089999]; US National Science Foundation (CAREER award) [MCB 0952550]; 1000-Youth Elite Program from China.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089999] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (CAREER award)(National Science Foundation (NSF)); 1000-Youth Elite Program from China.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (R01 GM089999 to T.K.W.) and the US National Science Foundation (CAREER award MCB 0952550 to R.P.). X.W. is partially supported by the 1000-Youth Elite Program from China. We are grateful for the Keio and ASKA strains provided by the Genome Analysis Project in Japan and for the initial growth studies conducted by X. Yan and T. Benefield. We also thank S. Vitha for assistance with microscope imaging and Y. Hu for assistance with western blotting. T.K.W. is the Biotechnology Endowed Professor at the Pennsylvania State University.	Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; DONEGAN K, 1991, APPL ENVIRON MICROB, V57, P51, DOI 10.1128/AEM.57.1.51-56.1991; Donegan NP, 2009, J BACTERIOL, V191, P2795, DOI 10.1128/JB.01713-08; Faridani OR, 2006, NUCLEIC ACIDS RES, V34, P5915, DOI 10.1093/nar/gkl750; FLETCHER M, 1977, CAN J MICROBIOL, V23, P1, DOI 10.1139/m77-001; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 1988, NAT BIOTECHNOL, V6, P1402; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Jayaraman R, 2008, J BIOSCIENCES, V33, P795, DOI 10.1007/s12038-008-0099-3; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kwon AR, 2012, NUCLEIC ACIDS RES, V40, P4216, DOI 10.1093/nar/gkr1305; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Pecota DC, 1996, J BACTERIOL, V178, P2044, DOI 10.1128/jb.178.7.2044-2050.1996; Pedersen K, 1999, MOL MICROBIOL, V32, P1090, DOI 10.1046/j.1365-2958.1999.01431.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Samai P, 2010, ACTA CRYSTALLOGR F, V66, P1552, DOI 10.1107/S1744309110039801; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904	48	204	223	5	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					855	861		10.1038/NCHEMBIO.1062	http://dx.doi.org/10.1038/NCHEMBIO.1062			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22941047	Green Accepted			2022-12-27	WOS:000309056200011
J	De Rybel, B; Audenaert, D; Xuan, W; Overvoorde, P; Strader, LC; Kepinski, S; Hoye, R; Brisbois, R; Parizot, B; Vanneste, S; Liu, X; Gilday, A; Graham, IA; Nguyen, L; Jansen, L; Njo, MF; Inze, D; Bartel, B; Beeckman, T				De Rybel, Bert; Audenaert, Dominique; Xuan, Wei; Overvoorde, Paul; Strader, Lucia C.; Kepinski, Stefan; Hoye, Rebecca; Brisbois, Ronald; Parizot, Boris; Vanneste, Steffen; Liu, Xing; Gilday, Alison; Graham, Ian A.; Nguyen, Long; Jansen, Leentje; Njo, Maria Fransiska; Inze, Dirk; Bartel, Bonnie; Beeckman, Tom			A role for the root cap in root branching revealed by the non-auxin probe naxillin	NATURE CHEMICAL BIOLOGY			English	Article							PEROXISOMAL BETA-OXIDATION; BOX PROTEIN TIR1; INDOLE-3-BUTYRIC ACID; ARABIDOPSIS-THALIANA; MULTIFUNCTIONAL PROTEIN; GENE; IDENTIFICATION; DEGRADATION; TRANSPORTER; ACTIVATION	The acquisition of water and nutrients by plant roots is a fundamental aspect of agriculture and strongly depends on root architecture. Root branching and expansion of the root system is achieved through the development of lateral roots and is to a large extent controlled by the plant hormone auxin. However, the pleiotropic effects of auxin or auxin-like molecules on root systems complicate the study of lateral root development. Here we describe a small-molecule screen in Arabidopsis thaliana that identified naxillin as what is to our knowledge the first non-auxin-like molecule that promotes root branching. By using naxillin as a chemical tool, we identified a new function for root cap-specific conversion of the auxin precursor indole-3-butyric acid into the active auxin indole-3-acetic acid and uncovered the involvement of the root cap in root branching. Delivery of an auxin precursor in peripheral tissues such as the root cap might represent an important mechanism shaping root architecture.	[De Rybel, Bert; Audenaert, Dominique; Xuan, Wei; Parizot, Boris; Vanneste, Steffen; Jansen, Leentje; Njo, Maria Fransiska; Inze, Dirk; Beeckman, Tom] VIB, Dept Plant Syst Biol, Ghent, Belgium; [De Rybel, Bert; Audenaert, Dominique; Xuan, Wei; Parizot, Boris; Vanneste, Steffen; Jansen, Leentje; Njo, Maria Fransiska; Inze, Dirk; Beeckman, Tom] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Overvoorde, Paul] Macalester Coll, Dept Biol, St Paul, MN 55105 USA; [Strader, Lucia C.; Bartel, Bonnie] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Kepinski, Stefan] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Hoye, Rebecca; Brisbois, Ronald] Macalester Coll, Dept Chem, St Paul, MN 55105 USA; [Liu, Xing] Univ Minnesota, Dept Hort Sci, Plant Biol Sci Grad Program, St Paul, MN USA; [Liu, Xing] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Gilday, Alison; Graham, Ian A.] Univ York, Ctr Novel Agr Prod, Dept Biol, York YO10 5DD, N Yorkshire, England; [Nguyen, Long] VIB, Compound Screening Facil, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Macalester College; Rice University; University of Leeds; Macalester College; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of York - UK; Flanders Institute for Biotechnology (VIB)	Beeckman, T (corresponding author), VIB, Dept Plant Syst Biol, Ghent, Belgium.	Tom.Beeckman@psb.vib-ugent.be	Beeckman, Tom/ABI-1703-2020; Bartel, Bonnie/D-3550-2011; Inzé, Dirk/AAW-6381-2021; Beeckman, Tom/ABA-1164-2020; Bartel, Bonnie/O-8119-2019; Vanneste, Steffen/K-8353-2013	Beeckman, Tom/0000-0001-8656-2060; Bartel, Bonnie/0000-0002-6367-346X; Inzé, Dirk/0000-0002-3217-8407; Bartel, Bonnie/0000-0002-6367-346X; Vanneste, Steffen/0000-0002-9948-9672; De Rybel, Bert/0000-0002-9551-042X; Strader, Lucia/0000-0002-7600-7204; Liu, Xing/0000-0001-9677-4470; PARIZOT, Boris/0000-0003-1445-6925	Interuniversity Attraction Poles Programme [IUAP VI/33]; Belgian State Science Policy Office; Special Research Fund of Ghent University; long-term Federation of European Biochemical Societies fellowship; Robert A. Welch Foundation [C-1309]; US National Institutes of Health [R00-GM089987-03]; US National Science Foundation [DBI-1039655, DBI-0923960]; Research Foundation Flanders (FWO) [3G002911]; BBSRC [BB/F013981/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F013981/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM089987] Funding Source: NIH RePORTER	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian State Science Policy Office(Belgian Federal Science Policy Office); Special Research Fund of Ghent University(Ghent University); long-term Federation of European Biochemical Societies fellowship; Robert A. Welch Foundation(The Welch Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Research Foundation Flanders (FWO)(FWO); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Cohen and J. Normanly for helpful discussions, and E. Feraru and M. Feraru for help with mapping the nar1 mutant. This work was supported by the Interuniversity Attraction Poles Programme (IUAP VI/33) initiated by the Belgian State Science Policy Office, the Special Research Fund of Ghent University, a long-term Federation of European Biochemical Societies fellowship (pre- and post-doctoral fellowships to B.D.R.), the Robert A. Welch Foundation (C-1309 to B.B.), the US National Institutes of Health (R00-GM089987-03 to L.C.S.), the US National Science Foundation (DBI-1039655 to P.J.O., R.H. and R.B.; DBI-0923960 to P.J.O. and R.H.) and the Research Foundation Flanders (FWO, research project 3G002911). S.V. is a postdoctoral fellow of the Research Foundation-Flanders. D.A. is a postdoctoral fellow of the FWO. D.A. and L.N. are part of the VIB Compound Screening Facility.	Arent S, 2010, J BIOL CHEM, V285, P24066, DOI 10.1074/jbc.M110.106005; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Choi YM, 2006, CHEM BIOL, V13, P241, DOI 10.1016/j.chembiol.2005.12.011; De Rybel B, 2011, PLANT PHYSIOL, V156, P1292, DOI 10.1104/pp.111.177337; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; De Rybel B, 2009, ACS CHEM BIOL, V4, P987, DOI 10.1021/cb9001624; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Du XH, 2002, J MED CHEM, V45, P2695, DOI 10.1021/jm010459j; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lingard MJ, 2009, P NATL ACAD SCI USA, V106, P4561, DOI 10.1073/pnas.0811329106; Liu X, 2011, PLANT PHYSIOL, V157, P891, DOI 10.1104/pp.111.181388; Malamy JE, 1997, DEVELOPMENT, V124, P33; Moreno-Risueno MA, 2010, SCIENCE, V329, P1306, DOI 10.1126/science.1191937; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Richmond TA, 1999, PLANT CELL, V11, P1911, DOI 10.1105/tpc.11.10.1911; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Rylott EL, 2006, PLANT J, V45, P930, DOI 10.1111/j.1365-313X.2005.02650.x; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Strader LC, 2011, PLANT CELL, V23, P984, DOI 10.1105/tpc.111.083071; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161; Zolman BK, 2007, PLANT MOL BIOL, V64, P59, DOI 10.1007/s11103-007-9134-2; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550; Zolman BK, 2000, GENETICS, V156, P1323	49	88	90	3	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					798	805		10.1038/NCHEMBIO.1044	http://dx.doi.org/10.1038/NCHEMBIO.1044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22885787	Green Accepted, Green Published			2022-12-27	WOS:000308077600012
J	Ptashne, M				Ptashne, Mark			Principles of a switch	NATURE CHEMICAL BIOLOGY			English	Article							SIGNAL-TRANSDUCTION; GENE-REGULATION; ARCHITECTURE; SEQUENCE; LOGIC; CELL		Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Ptashne, M (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	m-ptashne@mskcc.org						Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Davidson EH, 2006, REG GEN GEN REG; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Gomes JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004485; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Ptashne M, 2004, GENETIC SWITCH PHAGE; PTASHNE M, 2002, GENES SIGNALS; Ptashne M, 2007, CURR BIOL, V17, pR740, DOI 10.1016/j.cub.2007.06.053; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang X, 2011, NAT STRUCT MOL BIOL, V18, P507, DOI 10.1038/nsmb.2017; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	26	42	42	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					484	487		10.1038/nchembio.611	http://dx.doi.org/10.1038/nchembio.611			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769089				2022-12-27	WOS:000292825400003
J	Veeravalli, K; Boyd, D; Iverson, BL; Beckwith, J; Georgiou, G				Veeravalli, Karthik; Boyd, Dana; Iverson, Brent L.; Beckwith, Jon; Georgiou, George			Laboratory evolution of glutathione biosynthesis reveals natural compensatory pathways	NATURE CHEMICAL BIOLOGY			English	Article							GLUTAMYL-TRANSFERASE KINASE; ESCHERICHIA-COLI; GAMMA-GLUTAMYL; PROLINE BIOSYNTHESIS; CRYSTAL-STRUCTURE; ACID KINASE; IDENTIFICATION; PEROXIDASE; BACTERIA; THIOL	The first and highly conserved step in glutathione (GSH) biosynthesis is formation of gamma-glutamyl cysteine by the enzyme glutamate-cysteine ligase (GshA). However, bioinformatic analysis revealed that many prokaryotic species that encode GSH-dependent proteins lack the gene for this enzyme. To understand how bacteria cope without gshA, we isolated Escherichia coli Delta gshA multigenic suppressors that accumulated physiological levels of GSH. Mutations in both proB and proA, the first two genes in L-proline biosynthesis, provided a new pathway for gamma-glutamyl cysteine formation via the selective interception of ProB-bound gamma-glutamyl phosphate by amino acid thiols, likely through an S-to-N acyl shift mechanism. Bioinformatic analysis suggested that the L-proline biosynthetic pathway may have a second role in gamma-glutamyl cysteine formation in prokaryotes. Also, we showed that this mechanism could be exploited to generate cytoplasmic redox buffers bioorthogonal to GSH.	[Veeravalli, Karthik; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Boyd, Dana; Beckwith, Jon] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Iverson, Brent L.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Iverson, Brent L.; Georgiou, George] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Harvard University; Harvard Medical School; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Veeravalli, K (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu			US National Institutes of Health [GMO41883, GM55090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883, R01GM055090] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Stone and M. Faulkner for discussions. This work was supported by US National Institutes of Health grant GMO41883 to J.B. and US National Institutes of Health grant GM55090 to G.G.	BAICH A, 1969, BIOCHIM BIOPHYS ACTA, V192, P462, DOI 10.1016/0304-4165(69)90395-X; Brenot A, 2004, INFECT IMMUN, V72, P408, DOI 10.1128/IAI.72.1.408-413.2004; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Faulkner MJ, 2008, P NATL ACAD SCI USA, V105, P6735, DOI 10.1073/pnas.0801986105; Fujita T, 2003, J BIOL CHEM, V278, P14203, DOI 10.1074/jbc.M212177200; HAYZER DJ, 1980, J GEN MICROBIOL, V118, P287; Lehmann C, 2004, PROTEINS, V56, P376, DOI 10.1002/prot.20103; Marco-Marin C, 2007, J MOL BIOL, V367, P1431, DOI 10.1016/j.jmb.2007.01.073; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; ODEN KL, 1994, MOL MICROBIOL, V12, P301, DOI 10.1111/j.1365-2958.1994.tb01018.x; OMORI K, 1992, J GEN MICROBIOL, V138, P693, DOI 10.1099/00221287-138-4-693; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Perez-Arellano I, 2006, FEBS LETT, V580, P6247, DOI 10.1016/j.febslet.2006.10.031; RUSHLOW KE, 1985, GENE, V39, P109, DOI 10.1016/0378-1119(85)90115-5; SCHNOLZER M, 1992, SCIENCE, V256, P221, DOI 10.1126/science.1566069; SMITH CJ, 1984, J BACTERIOL, V157, P545, DOI 10.1128/JB.157.2.545-551.1984; Spector D, 2001, J BIOL CHEM, V276, P7011, DOI 10.1074/jbc.M009814200; Zhan XM, 2004, J BACTERIOL, V186, P654, DOI 10.1128/JB.186.3.654-660.2004	20	33	34	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					101	105		10.1038/NCHEMBIO.499	http://dx.doi.org/10.1038/NCHEMBIO.499			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21186348	Green Accepted			2022-12-27	WOS:000286324600010
J	Bailey, RC				Bailey, Ryan C.			Informative diagnostics for personalized medicine	NATURE CHEMICAL BIOLOGY			English	Article							LUNG-CANCER; DISCOVERY; INHIBITOR; MUTATIONS; GEFITINIB; THERAPY; P53	Some of the most celebrated triumphs of chemical biology are molecularly targeted therapeutics to combat human disease. However, a grand challenge looms as informative diagnostic strategies must be developed to realize the full impact of these promising pharmaceutical agents.	[Bailey, Ryan C.] Univ Illinois, Inst Genom Biol, Dept Chem, Urbana, IL USA; [Bailey, Ryan C.] Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bailey, RC (corresponding author), Univ Illinois, Inst Genom Biol, Dept Chem, Urbana, IL USA.	baileyrc@illinois.edu		Bailey, Ryan/0000-0003-1021-4267	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002190] Funding Source: NIH RePORTER; NIH HHS [DP2 OD002190-01, DP2 OD002190] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agnew HD, 2009, ANGEW CHEM INT EDIT, V48, P4944, DOI 10.1002/anie.200900488; Cho EJ, 2009, ANNU REV ANAL CHEM, V2, P241, DOI 10.1146/annurev.anchem.1.031207.112851; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Garber K, 2009, SCIENCE, V326, P1619, DOI 10.1126/science.326.5960.1619; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kodadek T, 2004, ACCOUNTS CHEM RES, V37, P711, DOI 10.1021/ar030145l; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peterson QP, 2010, CANCER RES, V70, P7232, DOI 10.1158/0008-5472.CAN-10-0766; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Street JM, 2010, BRIT J CLIN PHARMACO, V69, P367, DOI 10.1111/j.1365-2125.2009.03610.x; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188	19	4	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					857	859		10.1038/nchembio.488	http://dx.doi.org/10.1038/nchembio.488			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079587	Green Accepted			2022-12-27	WOS:000284214700003
J	Gao, XX; Hannoush, RN				Gao, Xinxin; Hannoush, Rami N.			Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine	NATURE CHEMICAL BIOLOGY			English	Article							FATTY ACYLATION; PROTEINS; INHIBITION; PORCN; GENE; GLYCOSYLATION; RECOGNITION; BIOGENESIS; LIPIDATION; MUTATIONS	Wnts are secreted palmitoylated glycoproteins that are important in embryonic development and human cancers. Here we report a method for imaging the palmitoylated form of Wnt proteins with subcellular resolution using clickable bioorthogonal fatty acids and in situ proximity ligation. Palmitoylated Wnt3a is visualized throughout the secretory pathway and trafficks to multivesicular bodies that act as export sites in secretory cells. We establish that glycosylation is not required for Wnt3a palmitoylation, which is necessary but not sufficient for Wnt3a secretion. Wnt3a is palmitoylated by fatty acids 13-16 carbons in length at Ser209 but not at Cys77, consistent with a slow turnover rate. We find that porcupine (PORCN) itself is palmitoylated, demonstrating what is to our knowledge the first example of palmitoylation of an MBOAT protein, and this modification partially regulates Wnt palmitoylation and signaling. Our data reveal the role of O-palmitoylation in Wnt signaling and suggest another layer of cellular control over PORCN function and Wnt secretion.	[Gao, Xinxin; Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Roche Holding; Genentech	Gao, XX (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	hannoush.rami@gene.com						Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Beckett K, 2013, TRAFFIC, V14, P82, DOI 10.1111/tra.12016; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bornholdt D, 2009, HUM MUTAT, V30, pE618, DOI 10.1002/humu.20992; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Covey TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034532; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; OMARY MB, 1981, J BIOL CHEM, V256, P2888; PATTERSON SI, 1995, METHOD ENZYMOL, V250, P284; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Schweizer A, 1996, J CELL BIOL, V132, P577, DOI 10.1083/jcb.132.4.577; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; STAUFENBIEL M, 1987, MOL CELL BIOL, V7, P2981, DOI 10.1128/MCB.7.8.2981; Steinhauer J, 2009, CURR OPIN GENET DEV, V19, P308, DOI 10.1016/j.gde.2009.04.006; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Tang XF, 2012, DEV BIOL, V364, P32, DOI 10.1016/j.ydbio.2012.01.009; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Yang PT, 2012, EMBO MOL MED, V4, P1294, DOI 10.1002/emmm.201201486; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	52	116	120	1	65	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					61	U102		10.1038/NCHEMBIO.1392	http://dx.doi.org/10.1038/NCHEMBIO.1392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24292069				2022-12-27	WOS:000328854900012
J	Hao, ZY; Lou, HB; Zhu, RF; Zhu, JH; Zhang, DM; Zhao, BXS; Zeng, SZ; Chen, X; Chan, J; He, C; Chen, PR				Hao, Ziyang; Lou, Hubing; Zhu, Rongfeng; Zhu, Jiuhe; Zhang, Dianmu; Zhao, Boxuan Simen; Zeng, Shizhe; Chen, Xing; Chan, Jefferson; He, Chuan; Chen, Peng R.			The multiple antibiotic resistance regulator MarR is a copper sensor in Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							DNA-BINDING MECHANISM; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; HYDROPEROXIDE; DAMAGE; STRESS; OPERON; DEATH; SALMONELLA; METABOLISM	The widely conserved multiple antibiotic resistance regulator (MarR) family of transcription factors modulates bacterial detoxification in response to diverse antibiotics, toxic chemicals or both. The natural inducer for Escherichia coli MarR, the prototypical transcription repressor within this family, remains unknown. Here we show that copper signaling potentiates MarR derepression in E. coli. Copper(II) oxidizes a cysteine residue (Cys80) on MarR to generate disulfide bonds between two MarR dimers, thereby inducing tetramer formation and the dissociation of MarR from its cognate promoter DNA. We further discovered that salicylate, a putative MarR inducer, and the clinically important bactericidal antibiotics norfloxacin and ampicillin all stimulate intracellular copper elevation, most likely through oxidative impairment of copper-dependent envelope proteins, including NADH dehydrogenase-2. This membrane-associated copper oxidation and liberation process derepresses MarR, causing increased bacterial antibiotic resistance. Our study reveals that this bacterial transcription regulator senses copper(II) as a natural signal to cope with stress caused by antibiotics or the environment.	[Hao, Ziyang; Lou, Hubing; Zhang, Dianmu; Zhao, Boxuan Simen; Chen, Xing; He, Chuan; Chen, Peng R.] Peking Univ, Synthet & Funct Biomol Ctr, Beijing Natl Lab Mol Sci, Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Zhu, Rongfeng; Chen, Peng R.] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Zhu, Jiuhe] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhao, Boxuan Simen; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Zhao, Boxuan Simen; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Zeng, Shizhe] Renmin Univ, Int Curriculum Ctr, High Sch, Beijing, Peoples R China; [Chan, Jefferson] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [He, Chuan; Chen, Peng R.] Shanghai Univ, E Inst Chem Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Peking University; China Agricultural University; University of Chicago; University of Chicago; Renmin University of China; University of California System; University of California Berkeley; Shanghai University	Hao, ZY (corresponding author), Peking Univ, Synthet & Funct Biomol Ctr, Beijing Natl Lab Mol Sci, Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	chuanhe@uchicago.edu; pengchen@pku.edu.cn	Zhao, Boxuan/Q-2159-2019; Lou, Hubing/D-3507-2014	Zhao, Boxuan/0000-0002-3729-4511; Chan, Jefferson/0000-0003-4139-4379	National Basic Research Foundation of China [2010CB912302, 2012CB917301, 2011CB809103]; National Natural Science Foundation of China [21225206, 91013005, 21001010]; US National Science Foundation [CHE-1213598]; E-Institutes of Shanghai Municipal Education Commission [E09013]	National Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation(National Science Foundation (NSF)); E-Institutes of Shanghai Municipal Education Commission	We thank J. Rosner (National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health) for providing the strains of M2073 (WT E. coli) and M2076 (marRAB mutant strains) bearing the marR::lacZ reporter, J.J. Collins (Department of Biomedical Engineering, Boston University) for providing the pL(lexO)GFP reporter, C.J. Chang (College of Chemistry, University of California-Berkeley) for providing the Cu(I)-specific fluorescent probe CS-1 and S.F. Reichard for editing. The E. coli WT (K12) strain (BW25113) and all of the single-gene deletion mutants were obtained from the National BioResource Project (National Institute of Genetics, Japan). We also thank the staff members of the Shanghai Synchrotron Radiation Facility and the Beijing Synchrotron Radiation Facility. This work was supported by research grants from the National Basic Research Foundation of China (2010CB912302 and 2012CB917301 to P.R.C.; 2011CB809103 to C.H.), the National Natural Science Foundation of China (21225206, 91013005 and 21001010 to P.R.C.), the US National Science Foundation (CHE-1213598 to C.H.) and the E-Institutes of Shanghai Municipal Education Commission (project number E09013 to C.H. and P.R.C.).	Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Deng X, 2013, CELL HOST MICROBE, V13, P358, DOI 10.1016/j.chom.2013.02.004; Ding XQ, 2011, J NUTR BIOCHEM, V22, P301, DOI 10.1016/j.jnutbio.2010.06.010; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Domain F, 2007, MOL MICROBIOL, V66, P383, DOI 10.1111/j.1365-2958.2007.05928.x; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frawley ER, 2013, P NATL ACAD SCI USA, V110, P12054, DOI 10.1073/pnas.1218274110; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Kumarevel T, 2009, NUCLEIC ACIDS RES, V37, P4723, DOI 10.1093/nar/gkp496; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; MARTIN RG, 1995, J BACTERIOL, V177, P4176, DOI 10.1128/jb.177.14.4176-4178.1995; Martin RG, 1996, J BACTERIOL, V178, P2216, DOI 10.1128/jb.178.8.2216-2223.1996; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Patikarnmonthon N, 2010, FEMS MICROBIOL LETT, V313, P75, DOI 10.1111/j.1574-6968.2010.02124.x; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Price CTD, 2000, INT J BIOCHEM CELL B, V32, P1029, DOI 10.1016/S1357-2725(00)00042-X; Rapisarda VA, 2002, ARCH BIOCHEM BIOPHYS, V405, P87, DOI 10.1016/S0003-9861(02)00277-1; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rodriguez-Montelongo L, 2006, ARCH BIOCHEM BIOPHYS, V451, P1, DOI 10.1016/j.abb.2006.04.019; RODRIGUEZMONTELONGO L, 1993, BIOCHIM BIOPHYS ACTA, V1144, P77, DOI 10.1016/0005-2728(93)90033-C; RODRIGUEZMONTELONGO L, 1995, ARCH BIOCHEM BIOPHYS, V323, P19, DOI 10.1006/abbi.1995.0004; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Uversky VN, 1998, BBA-PROTEIN STRUCT M, V1388, P133, DOI 10.1016/S0167-4838(98)00173-3; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Zeng L, 2006, J AM CHEM SOC, V128, P10, DOI 10.1021/ja055064u; Zhao BS, 2010, J AM CHEM SOC, V132, P17065, DOI 10.1021/ja1071114	55	103	107	5	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					21	U48		10.1038/NCHEMBIO.1380	http://dx.doi.org/10.1038/NCHEMBIO.1380			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24185215				2022-12-27	WOS:000328854900006
J	Andersen, OS				Andersen, Olaf S.			MEMBRANE PROTEINS Through thick and thin	NATURE CHEMICAL BIOLOGY			English	News Item							ACETYLCHOLINE-RECEPTOR FUNCTION; MODULATION; LIPIDS; MODEL		Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA	Cornell University	Andersen, OS (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA.	sparre@med.cornell.edu						CRIADO M, 1984, J BIOL CHEM, V259, P9188; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; FATTAL DR, 1993, BIOPHYS J, V65, P1795, DOI 10.1016/S0006-3495(93)81249-9; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; HERZ JM, 1987, J BIOL CHEM, V262, P7238; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; LEVINE YK, 1971, NATURE-NEW BIOL, V230, P69, DOI 10.1038/newbio230069a0; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G	12	5	5	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					667	668		10.1038/nchembio.1368	http://dx.doi.org/10.1038/nchembio.1368			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24141219				2022-12-27	WOS:000325930500002
J	Gouzy, A; Larrouy-Maumus, G; Wu, TD; Peixoto, A; Levillain, F; Lugo-Villarino, G; Guerquin-Kern, JL; de Carvalho, LPS; Poquet, Y; Neyrolles, O				Gouzy, Alexandre; Larrouy-Maumus, Gerald; Wu, Ting-Di; Peixoto, Antonio; Levillain, Florence; Lugo-Villarino, Geanncarlo; Guerquin-Kern, Jean-Luc; de Carvalho, Luiz Pedro Sorio; Poquet, Yannick; Neyrolles, Olivier			Mycobacterium tuberculosis nitrogen assimilation and host colonization require aspartate	NATURE CHEMICAL BIOLOGY			English	Article							AMINO-ACIDS; ESCHERICHIA-COLI; L-ASPARAGINE; MACROPHAGES; PERSISTENCE; METABOLISM; GENE	Here we identify the amino acid transporter AnsP1 as the unique aspartate importer in the human pathogen Mycobacterium tuberculosis. Metabolomic analysis of a mutant with an inactive AnsP1 revealed that the transporter is essential for M. tuberculosis to assimilate nitrogen from aspartate. Virulence of the AnsP1 mutant is impaired in vivo, revealing that aspartate is a primary nitrogen source required for host colonization by the tuberculosis bacillus.	[Gouzy, Alexandre; Peixoto, Antonio; Levillain, Florence; Lugo-Villarino, Geanncarlo; Poquet, Yannick; Neyrolles, Olivier] CNRS, INSERM, Toulouse, France; [Gouzy, Alexandre; Peixoto, Antonio; Levillain, Florence; Lugo-Villarino, Geanncarlo; Poquet, Yannick; Neyrolles, Olivier] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Larrouy-Maumus, Gerald; de Carvalho, Luiz Pedro Sorio] Natl Inst Med Res, MRC, Mycobacterial Res Div, London NW7 1AA, England; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Inst Curie, Lab Microscopie Ion, F-91405 Orsay, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] INSERM, U759, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); MRC National Institute for Medical Research; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gouzy, A (corresponding author), CNRS, INSERM, Toulouse, France.	olivier.neyrolles@ipbs.fr	Neyrolles, Olivier/AAG-3692-2019; Guerquin-Kern, Jean-Luc/M-5000-2018; Lugo, Geanncarlo/H-4674-2019	Neyrolles, Olivier/0000-0003-0047-5885; Guerquin-Kern, Jean-Luc/0000-0002-8610-0146; Lugo, Geanncarlo/0000-0003-4620-8491; Larrouy-Maumus, Gerald/0000-0001-6614-8698; Sorio de Carvalho, Luiz Pedro/0000-0003-2875-4552; WU, Ting-Di/0000-0002-6398-0363; Gouzy, Alexandre/0000-0001-6671-7408; Peixoto, Antonio/0000-0001-9493-1954	Agence Nationale de la Recherche; UK Medical Research Council [MC_UP_A253_1111]; European Union [241745]; Region Midi-Pyrenees (Contrat de Projets Etat-Region Midi-Pyrenees (CPER)); Grand Toulouse community; Agence pour la Recherche sur le Cancer (ARC) [8505]; Centre National de la Recherche Scientifique; European Union-European Regional Development Fund program; Fondation pour la Recherche Medicale; MRC [MR/J006874/1, MC_UP_A253_1111] Funding Source: UKRI; Medical Research Council [MC_UP_A253_1111] Funding Source: researchfish	Agence Nationale de la Recherche(French National Research Agency (ANR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Region Midi-Pyrenees (Contrat de Projets Etat-Region Midi-Pyrenees (CPER))(Region Occitanie); Grand Toulouse community; Agence pour la Recherche sur le Cancer (ARC); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Union-European Regional Development Fund program; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Gutierrez and D. Hudrisier for carefully reading the manuscript and for their helpful suggestions. We thank L. Lepourry and F. Moreau for technical assistance with mouse infections. We thank A. Benard (IPBS, Toulouse, France) for providing mouse cells and R. Brosch (Institut Pasteur, Paris, France) for providing the I257 cosmid. We thank Y. Verkindere (YV Photographiste, Toulouse, France) for help with graphical work. We thank the PICT-IBiSA imaging facility in the Institut Curie. This work was supported by Agence Nationale de la Recherche (contracts SLC-TB and TB-HITS), the UK Medical Research Council (MC_UP_A253_1111) and the European Union Seventh Framework Programme NEWTBVAC (contract no. 241745). This work also benefited from the TRI RIO Optical Imaging Platform at the Institute of Pharmacology and Structural Biology (Genotoul, Toulouse, France) and was supported by grants from the Region Midi-Pyrenees (Contrat de Projets Etat-Region Midi-Pyrenees (CPER)), the Grand Toulouse community, the Agence pour la Recherche sur le Cancer (ARC equipement no. 8505), the Centre National de la Recherche Scientifique and the European Union-European Regional Development Fund program. A.G. and G.L.-V. hold a fellowship from the Fondation pour la Recherche Medicale. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amon J, 2009, J MOL MICROB BIOTECH, V17, P20, DOI 10.1159/000159195; Bange F.-C., 1999, Tubercle and Lung Disease, V79, P171, DOI 10.1054/tuld.1998.0201; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cook GM, 2009, ADV MICROB PHYSIOL, V55, P81, DOI 10.1016/S0065-2911(09)05502-7; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; Guerquin-Kern JL, 2005, BBA-GEN SUBJECTS, V1724, P228, DOI 10.1016/j.bbagen.2005.05.013; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JENNINGS MP, 1995, MICROBIOL-SGM, V141, P141, DOI 10.1099/00221287-141-1-141; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; LYON RH, 1974, J BACTERIOL, V117, P151, DOI 10.1128/JB.117.1.151-156.1974; Marrero J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003116; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pesek JJ, 2008, J CHROMATOGR A, V1204, P48, DOI 10.1016/j.chroma.2008.07.077; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Rhee KY, 2011, TRENDS MICROBIOL, V19, P307, DOI 10.1016/j.tim.2011.03.008; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Song HH, 2012, J BACTERIOL, V194, P956, DOI 10.1128/JB.06132-11; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; XU SM, 1994, J IMMUNOL, V153, P2568; YOUMANS AS, 1953, J BACTERIOL, V65, P96, DOI 10.1128/JB.65.1.96-99.1953; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816	28	72	72	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					674	+		10.1038/NCHEMBIO.1355	http://dx.doi.org/10.1038/NCHEMBIO.1355			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24077180	Green Accepted			2022-12-27	WOS:000325930500005
J	Liberman, JA; Salim, M; Krucinska, J; Wedekind, JE				Liberman, Joseph A.; Salim, Mohammad; Krucinska, Jolanta; Wedekind, Joseph E.			Structure of a class II preQ(1) riboswitch reveals ligand recognition by a new fold	NATURE CHEMICAL BIOLOGY			English	Article							RNA-GUANINE TRANSGLYCOSYLASE; APTAMER; BINDING; BIOSYNTHESIS; QUEUOSINE; SYSTEM; BASE	PreQ(1) riboswitches regulate genes by binding the pyrrolopyrimidine intermediate preQ(1) during the biosynthesis of the essential tRNA base queuosine. We report what is to our knowledge the first preQ(1)-II riboswitch structure at 2.3-angstrom resolution, which uses a previously uncharacterized fold to achieve effector recognition at the confluence of a three-way helical junction flanking a pseudoknotted ribosome-binding site. The results account for translational control mediated by the preQ(1)-II riboswitch class and expand the known repertoire of ligand-binding modes used by regulatory RNAs.	[Liberman, Joseph A.; Salim, Mohammad; Krucinska, Jolanta; Wedekind, Joseph E.] Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Dept Biochem & Biophys, Rochester, NY 14627 USA	University of Rochester	Liberman, JA (corresponding author), Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Dept Biochem & Biophys, Rochester, NY 14627 USA.	joseph.wedekind@rochester.edu			US National Institutes of Health (NIH) grant [T32 GM068411]; Hooker fellowship; NIH [RR026501, GM063162, GM103393, RR001209]; US Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209, S10RR026501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM063162, T32GM068411] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hooker fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jenkins, D. Turner and C. Kielkopf for suggestions and V. Bandarian for preQ<INF>0</INF>. J.A.L. was funded by US National Institutes of Health (NIH) grant T32 GM068411 and a Hooker fellowship. This research was funded by NIH grants RR026501 and GM063162 to J.E.W. Portions of this research were conducted at the Stanford Synchrotron Radiation Lightsource, which is funded by the US Department of Energy and NIH grants GM103393 and RR001209.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKIMOTO H, 1988, J CHEM SOC PERK T 1, P1637, DOI 10.1039/p19880001637; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avlami A, 2001, J INFECTION, V42, P283, DOI 10.1053/jinf.2001.0793; Bastet L, 2011, MOL MICROBIOL, V80, P1148, DOI 10.1111/j.1365-2958.2011.07654.x; Batey RT, 2012, Q REV BIOPHYS, V45, P345, DOI 10.1017/S0033583512000078; Batey RT, 2011, WIRES RNA, V2, P299, DOI 10.1002/wrna.63; BIENZ M, 1981, NATURE, V294, P188, DOI 10.1038/294188a0; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Deigan KE, 2011, ACCOUNTS CHEM RES, V44, P1329, DOI 10.1021/ar200039b; DURAND JM, 1994, J BACTERIOL, V176, P4627, DOI 10.1128/JB.176.15.4627-4634.1994; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Grosjean H, 2004, TRENDS BIOCHEM SCI, V29, P519, DOI 10.1016/j.tibs.2004.08.005; Hoops GC, 1996, J HETEROCYCLIC CHEM, V33, P767, DOI 10.1002/jhet.5570330341; Huang LL, 2011, P NATL ACAD SCI USA, V108, P14801, DOI 10.1073/pnas.1111701108; Jenkins JL, 2011, J BIOL CHEM, V286, P24626, DOI 10.1074/jbc.M111.230375; Kang M, 2009, MOL CELL, V33, P784, DOI 10.1016/j.molcel.2009.02.019; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Klepper F, 2005, HELV CHIM ACTA, V88, P2610, DOI 10.1002/hlca.200590201; Lippa Geoffrey M, 2012, Methods Mol Biol, V848, P159, DOI 10.1007/978-1-61779-545-9_11; McCarty RM, 2012, BIOORG CHEM, V43, P15, DOI 10.1016/j.bioorg.2012.01.001; Meyer MM, 2008, RNA, V14, P685, DOI 10.1261/rna.937308; Morita H, 2009, J BACTERIOL, V191, P7630, DOI 10.1128/JB.01287-09; NOGUCHI S, 1982, J BIOL CHEM, V257, P6544; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Trausch JJ, 2011, STRUCTURE, V19, P1413, DOI 10.1016/j.str.2011.06.019; Wedekind JE, 2011, METAL IONS LIFE SCI, V9, P299, DOI 10.1039/978184973251200299; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; YOKOYAMA S, 1979, NATURE, V282, P107, DOI 10.1038/282107a0	35	54	57	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					353	+		10.1038/nchembio.1231	http://dx.doi.org/10.1038/nchembio.1231			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23584677	Green Accepted			2022-12-27	WOS:000319328200005
J	Hsu, KL; Tsuboi, K; Adibekian, A; Pugh, H; Masuda, K; Cravatt, BF				Hsu, Ku-Lung; Tsuboi, Katsunori; Adibekian, Alexander; Pugh, Holly; Masuda, Kim; Cravatt, Benjamin F.			DAGL beta inhibition perturbs a lipid network involved in macrophage inflammatory responses	NATURE CHEMICAL BIOLOGY			English	Article							DIACYLGLYCEROL-LIPASE-ALPHA; CYTOSOLIC PHOSPHOLIPASE A(2); RECEPTOR KNOCKOUT MICE; ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; CANNABINOID RECEPTORS; MOLECULAR CHARACTERIZATION; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; ARACHIDONIC-ACID; C-BETA	The endocannabinoid 2-arachidonoylglycerol (2-AG) is biosynthesized by diacylglycerol lipases DAGL alpha and DAGL beta. Chemical probes to perturb DAGLs are needed to characterize endocannabinoid function in biological processes. Here we report a series of 1,2,3-triazole urea inhibitors, along with paired negative-control and activity-based probes, for the functional analysis of DAGL beta in living systems. Optimized inhibitors showed high selectivity for DAGL beta over other serine hydrolases, including DAGL alpha (similar to 60-fold selectivity), and the limited off-targets, such as ABHD6, were also inhibited by the negative-control probe. Using these agents and Daglb(-/-) mice, we show that DAGL beta inactivation lowers 2-AG, as well as arachidonic acid and eicosanoids, in mouse peritoneal macrophages in a manner that is distinct and complementary to disruption of cytosolic phospholipase-A2. We observed a corresponding reduction in lipopolysaccharide-induced tumor necrosis factor-alpha release. These findings indicate that DAGL beta is a key metabolic hub within a lipid network that regulates proinflammatory responses in macrophages.	[Hsu, Ku-Lung; Tsuboi, Katsunori; Adibekian, Alexander; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hsu, Ku-Lung; Tsuboi, Katsunori; Adibekian, Alexander; Pugh, Holly; Masuda, Kim; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	Hsu, Ku-Lung/J-2885-2014; Hsu, Ku-Lung/L-6256-2019	Hsu, Ku-Lung/0000-0001-5620-3972; Hsu, Ku-Lung/0000-0001-5620-3972	US National Institutes of Health [DA009789, DA033760, MH084512]; Hewitt Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789, R01DA033760] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hewitt Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Niphakis, H.-C. Lee and G. Simon for helpful discussions and C. Joslyn for technical assistance. We thank M. Watanabe (Hokkaido University School of Medicine) for providing the antibody to DAGL alpha. This work was supported by the US National Institutes of Health (DA009789, DA033760, MH084512) and a Hewitt Foundation Postdoctoral Fellowship (K.-L.H.).	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Bondeson J, 1997, GEN PHARMACOL-VASC S, V29, P127, DOI 10.1016/S0306-3623(96)00419-3; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Burstein SH, 2009, AAPS J, V11, P109, DOI 10.1208/s12248-009-9084-5; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gregg LC, 2012, J NEUROSCI, V32, P9457, DOI 10.1523/JNEUROSCI.0013-12.2012; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Hashimotodani Y, 2007, J PHYSIOL-LONDON, V584, P373, DOI 10.1113/jphysiol.2007.137497; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jung KM, 2007, MOL PHARMACOL, V72, P612, DOI 10.1124/mol.107.037796; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kunos G, 2001, NEUROCHEM RES, V26, P1015, DOI 10.1023/A:1012301021419; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Lin Hen-I, 2004, Journal of Microbiology Immunology and Infection, V37, P8; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Oudin MJ, 2011, EUR J NEUROSCI, V34, P1634, DOI 10.1111/j.1460-9568.2011.07831.x; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Pedicord DL, 2011, BIOCHEM BIOPH RES CO, V411, P809, DOI 10.1016/j.bbrc.2011.07.037; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Rouzer CA, 2005, J LIPID RES, V46, P1027, DOI 10.1194/jlr.M500006-JLR200; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Turunen PM, 2012, MOL PHARMACOL, V82, P156, DOI 10.1124/mol.112.078063; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WATANABE S, 1994, J LIPID MEDIAT CELL, V10, P283; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	50	157	158	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					999	1007		10.1038/NCHEMBIO.1105	http://dx.doi.org/10.1038/NCHEMBIO.1105			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103940	Green Accepted			2022-12-27	WOS:000311491200015
J	Bar-Even, A; Flamholz, A; Noor, E; Milo, R				Bar-Even, Arren; Flamholz, Avi; Noor, Elad; Milo, Ron			Rethinking glycolysis: on the biochemical logic of metabolic pathways	NATURE CHEMICAL BIOLOGY			English	Review							MIXED-ACID FERMENTATION; LIPID BILAYER-MEMBRANES; MILD AQUEOUS CONDITIONS; ESCHERICHIA-COLI; CELL-METABOLISM; AMINO-ACIDS; EVOLUTIONARY OPTIMIZATION; METHYLGLYOXAL SYNTHASE; ANAEROBIC-BACTERIA; GLYCINE REDUCTASE	Metabolic pathways may seem arbitrary and unnecessarily complex. In many cases, a chemist might devise a simpler route for the biochemical transformation, so why has nature chosen such complex solutions? In this review, we distill lessons from a century of metabolic research and introduce new observations suggesting that the intricate structure of metabolic pathways can be explained by a small set of biochemical principles. Using glycolysis as an example, we demonstrate how three key biochemical constraints-thermodynamic favorability, availability of enzymatic mechanisms and the physicochemical properties of pathway intermediates-eliminate otherwise plausible metabolic strategies. Considering these constraints, glycolysis contains no unnecessary steps and represents one of the very few pathway structures that meet cellular demands. The analysis presented here can be applied to metabolic engineering efforts for the rational design of pathways that produce a desired product while satisfying biochemical constraints.	[Bar-Even, Arren; Flamholz, Avi; Noor, Elad; Milo, Ron] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bar-Even, A (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	ron.milo@weizmann.ac.il	Milo, Hilla/C-8767-2016; Noor, Elad/AAN-9042-2020	Noor, Elad/0000-0001-8776-4799; Milo, Ron/0000-0003-1641-2299; Flamholz, Avi/0000-0002-9278-5479; Bar-Even, Arren/0000-0002-1039-4328	Israel Academy of Sciences and Humanities; Azrieli Foundation; European Research Council [260392-SYMPAC]; Israel Science Foundation [750/09]	Israel Academy of Sciences and Humanities; Azrieli Foundation; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	We thank D. Tawfik for helpful discussions, scientific support and critique regarding the manuscript. We also would like to thank D. Arlow, R. Burton, D. Fraenkel, R. Last, W. Liebermeister, A. Weber and members of the Milo laboratory for helpful comments. A.B.-E. is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. E.N. is grateful to the Azrieli Foundation for the award of an Azrieli Fellowship. This study was supported by the European Research Council (grant 260392-SYMPAC) and by the Israel Science Foundation (Grant 750/09).	Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; Andreesen JR, 2004, CURR OPIN CHEM BIOL, V8, P454, DOI 10.1016/j.cbpa.2004.08.002; Aoshima M, 2006, MOL MICROBIOL, V62, P748, DOI 10.1111/j.1365-2958.2006.05399.x; Bagramyan K, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1159, DOI 10.1023/B:BIRY.0000009129.18714.a4; BANZON JA, 1995, BIOCHEMISTRY-US, V34, P743, DOI 10.1021/bi00003a006; Bar-Even A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002166; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Barnett JA, 2003, YEAST, V20, P509, DOI 10.1002/yea.986; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI 10.1038/NCHEMBIO.537; BROWNLEE M, 1984, ANN INTERN MED, V101, P527, DOI 10.7326/0003-4819-101-4-527; Buckel W, 1996, FEBS LETT, V389, P20, DOI 10.1016/0014-5793(96)00530-3; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Bustos DM, 2008, J PLANT PHYSIOL, V165, P456, DOI 10.1016/j.jplph.2007.06.005; CHAKRABARTI AC, 1992, BIOCHIM BIOPHYS ACTA, V1111, P171, DOI 10.1016/0005-2736(92)90308-9; CHAKRABARTI AC, 1994, J MOL EVOL, V39, P1; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; DAVIS BD, 1958, ARCH BIOCHEM BIOPHYS, V78, P497, DOI 10.1016/0003-9861(58)90374-6; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Dolfing J, 2008, APPL ENVIRON MICROB, V74, P6126, DOI 10.1128/AEM.01428-08; Feierberg I, 2002, THEOR CHEM ACC, V108, P71, DOI 10.1007/s00214-002-0365-7; Fersht A, 1999, STRUCTURE MECH PROTE, P77; Fersht A., 1999, STRUCTURE MECH PROTE; FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Foroozesh M, 1997, CHEM RES TOXICOL, V10, P91, DOI 10.1021/tx960064g; FOTHERGILLGILMORE LA, 1986, TRENDS BIOCHEM SCI, V11, P47, DOI 10.1016/0968-0004(86)90233-1; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; Frey P. A., 2007, ENZYMATIC REACTION M; Frey PA, 2001, CHEM REC, V1, P277, DOI 10.1002/tcr.1013; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Garrigues C, 1997, J BACTERIOL, V179, P5282, DOI 10.1128/jb.179.17.5282-5287.1997; GUIHARD G, 1993, J BIOL CHEM, V268, P17775; HASSETT A, 1982, BIOCHEMISTRY-US, V21, P6335, DOI 10.1021/bi00268a002; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Heinrich R, 1997, EUR J BIOCHEM, V243, P191; Holliday GL, 2012, NUCLEIC ACIDS RES, V40, pD783, DOI 10.1093/nar/gkr799; HOPPER DJ, 1971, FEBS LETT, V13, P213, DOI 10.1016/0014-5793(71)80538-0; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Hynne R, 2001, BIOPHYS CHEM, V94, P121; Jiang XL, 2009, APPL MICROBIOL BIOT, V82, P995, DOI 10.1007/s00253-009-1898-7; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalapos MP, 2008, CHEM-BIOL INTERACT, V171, P251, DOI 10.1016/j.cbi.2007.11.009; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kim J, 2004, FEMS MICROBIOL REV, V28, P455, DOI 10.1016/j.femsre.2004.03.001; Klitgord N, 2011, CURR OPIN BIOTECH, V22, P541, DOI 10.1016/j.copbio.2011.04.018; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; Marinoni I, 2008, FEBS J, V275, P5090, DOI 10.1111/j.1742-4658.2008.06641.x; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; MARNETT LJ, 1985, MUTAT RES, V148, P25; McInerney MJ, 2008, ANN NY ACAD SCI, V1125, P58, DOI 10.1196/annals.1419.005; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; MELENDEZHEVIA E, 1985, J THEOR BIOL, V117, P251, DOI 10.1016/S0022-5193(85)80220-4; MelendezHevia E, 1997, EUR J BIOCHEM, V244, P527, DOI 10.1111/j.1432-1033.1997.t01-1-00527.x; MILLS SG, 1985, J ORG CHEM, V50, P1216, DOI 10.1021/jo00208a014; Mittenthal JE, 2001, J THEOR BIOL, V208, P361, DOI 10.1006/jtbi.2000.2225; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Ovadi J, 2000, INT REV CYTOL, V192, P255; Palm K, 1999, J PHARMACOL EXP THER, V291, P435; Paula S, 1996, BIOPHYS J, V70, P339, DOI 10.1016/S0006-3495(96)79575-9; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pharkya P, 2003, METAB ENG, V5, P71, DOI 10.1016/S1096-7176(03)00008-9; Qian H, 2003, EUR J BIOCHEM, V270, P415, DOI 10.1046/j.1432-1033.2003.03357.x; Ray LB, 2010, SCIENCE, V330, P1337, DOI 10.1126/science.330.6009.1337; Reaves ML, 2011, CURR OPIN BIOTECH, V22, P17, DOI 10.1016/j.copbio.2010.10.001; Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2; Sato K, 1999, J BIOCHEM-TOKYO, V126, P668, DOI 10.1093/oxfordjournals.jbchem.a022501; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; SCHRADER T, 1992, EUR J BIOCHEM, V206, P79, DOI 10.1111/j.1432-1033.1992.tb16903.x; SELKOV EE, 1968, EUR J BIOCHEM, V4, P79, DOI 10.1111/j.1432-1033.1968.tb00175.x; Shen CR, 2011, APPL ENVIRON MICROB, V77, P2905, DOI 10.1128/AEM.03034-10; Stephani A, 1999, J THEOR BIOL, V199, P45, DOI 10.1006/jtbi.1999.0942; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Ukeda H, 1997, BIOSCI BIOTECH BIOCH, V61, P2039, DOI 10.1271/bbb.61.2039; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Weber AL, 2004, ORIGINS LIFE EVOL B, V34, P473, DOI 10.1023/B:ORIG.0000043128.30559.fe; Weber AL, 2002, ORIGINS LIFE EVOL B, V32, P333, DOI 10.1023/A:1020588925703; Weber AL, 1997, J MOL EVOL, V44, P354, DOI 10.1007/PL00006154; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Winiwarter S, 1998, J MED CHEM, V41, P4939, DOI 10.1021/jm9810102; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zhang XD, 2002, J AM CHEM SOC, V124, P14871, DOI 10.1021/ja027063x	98	150	152	6	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					509	517		10.1038/NCHEMBIO.971	http://dx.doi.org/10.1038/NCHEMBIO.971			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22596202				2022-12-27	WOS:000304256300006
J	Sajish, M; Zhou, QS; Kishi, S; Valdez, DM; Kapoor, M; Guo, M; Lee, S; Kim, S; Yang, XL; Schimmel, P				Sajish, Mathew; Zhou, Quansheng; Kishi, Shuji; Valdez, Delgado M., Jr.; Kapoor, Mili; Guo, Min; Lee, Sunhee; Kim, Sunghoon; Yang, Xiang-Lei; Schimmel, Paul			Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-gamma and p53 signaling	NATURE CHEMICAL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; INTERFERON-GAMMA; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE; INDOLEAMINE 2,3-DIOXYGENASE; CRYSTAL-STRUCTURE; RELEASE FACTOR; ACTIVE-SITE; ANGIOGENESIS; INHIBITION	Interferon-gamma (IFN-gamma) engenders strong antiproliferative responses, in part through activation of p53. However, the long-known IFN-gamma-dependent upregulation of human Trp-tRNA synthetase (TrpRS), a cytoplasmic enzyme that activates tryptophan to form Trp-AMP in the first step of protein synthesis, is unexplained. Here we report a nuclear complex of TrpRS with the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) and with poly(ADP-ribose) polymerase 1 (PARP-1), the major PARP in human cells. The IFN-gamma-dependent poly(ADP-ribosyl) ation of DNA-PKcs (which activates its kinase function) and concomitant activation of the tumor suppressor p53 were specifically prevented by Trp-SA, an analog of Trp-AMP that disrupted the TrpRS-DNA-PKcs-PARP-1 complex. The connection of TrpRS to p53 signaling in vivo was confirmed in a vertebrate system. These and further results suggest an unexpected evolutionary expansion of the protein synthesis apparatus to a nuclear role that links major signaling pathways.	[Sajish, Mathew; Zhou, Quansheng; Kapoor, Mili; Lee, Sunhee; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kishi, Shuji; Valdez, Delgado M., Jr.; Guo, Min] Scripps Res Inst, Jupiter, FL USA; [Lee, Sunhee; Kim, Sunghoon] Seoul Natl Univ, World Class Univ, Dept Mol Med & Biopharmaceut Sci, Med Bioconvergence Res Ctr, Seoul, South Korea	Scripps Research Institute; Scripps Research Institute; Seoul National University (SNU)	Sajish, M (corresponding author), Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Kim, Sunghoon/AAE-8314-2020; Yang, Xiang-Lei/AAR-7107-2020; Thekkel, Sajish Mathew/AAM-3548-2021	Thekkel, Sajish Mathew/0000-0001-6715-5953; kim, sunghoon/0000-0002-1570-3230; Zhou, Quansheng/0000-0003-4712-0731; Yang, Xiang-Lei/0000-0003-2554-084X	US National Institutes of Health [GM15539, GM23562, GM088278]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278, R37GM015539, R01GM023562, R01GM015539] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Chen (University of Texas Southwestern Medical School) for the DNA-PKcs clone and P. Chang (Massachusetts Institute of Technology) for the ZZ-PARP-1 clone. This work was supported by grants GM15539 and GM23562 (to P.S.) and GM088278 (to X.-L.Y.) from the US National Institutes of Health and by a fellowship from the National Foundation for Cancer Research.	Aggad D, 2010, J IMMUNOL, V185, P6774, DOI 10.4049/jimmunol.1000549; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Ariumi Y, 1999, ONCOGENE, V18, P4616, DOI 10.1038/sj.onc.1202823; BANGE FC, 1992, FEBS LETT, V300, P162, DOI 10.1016/0014-5793(92)80187-L; Beckert S, 2006, BIOCHEM BIOPH RES CO, V341, P67, DOI 10.1016/j.bbrc.2005.12.148; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FLECKNER J, 1991, P NATL ACAD SCI USA, V88, P11520, DOI 10.1073/pnas.88.24.11520; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16490, DOI 10.1073/pnas.0806578105; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; Kapoor M, 2008, J BIOL CHEM, V283, P2070, DOI 10.1074/jbc.M706028200; Kim KS, 2009, MECH AGEING DEV, V130, P179, DOI 10.1016/j.mad.2008.11.004; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Lindner Daniel J, 2002, Curr Oncol Rep, V4, P510, DOI 10.1007/s11912-002-0065-4; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240; POPENKO V I, 1989, Molekulyarnaya Biologiya (Moscow), V23, P1669; POPENKO VI, 1993, EUR J CELL BIOL, V62, P248; RUBIN BY, 1991, J BIOL CHEM, V266, P24245; Ruscetti T, 1998, J BIOL CHEM, V273, P14461, DOI 10.1074/jbc.273.23.14461; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Sgadari C, 1997, BLOOD, V89, P2635, DOI 10.1182/blood.V89.8.2635; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Sieger D, 2009, DIS MODEL MECH, V2, P571, DOI 10.1242/dmm.003509; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; Yang G, 2007, ONCOGENE, V26, P594, DOI 10.1038/sj.onc.1209807; Yang XL, 2007, STRUCTURE, V15, P793, DOI 10.1016/j.str.2007.05.009; Yang XL, 2006, EMBO J, V25, P2919, DOI 10.1038/sj.emboj.7601154; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; YOSHIDA R, 1979, P NATL ACAD SCI USA, V76, P4084, DOI 10.1073/pnas.76.8.4084; YOSHIDA R, 1981, P NATL ACAD SCI-BIOL, V78, P129, DOI 10.1073/pnas.78.1.129; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	44	63	67	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					547	554		10.1038/NCHEMBIO.937	http://dx.doi.org/10.1038/NCHEMBIO.937			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22504299	Green Accepted			2022-12-27	WOS:000304256300010
J	Potowski, M; Schurmann, M; Preut, H; Antonchick, AP; Waldmann, H				Potowski, Marco; Schuermann, Markus; Preut, Hans; Antonchick, Andrey P.; Waldmann, Herbert			Programmable enantioselective one-pot synthesis of molecules with eight stereocenters	NATURE CHEMICAL BIOLOGY			English	Article							DIELS-ALDER REACTIONS; AZOMETHINE YLIDES; 1,3-DIPOLAR CYCLOADDITIONS; NATURAL-PRODUCTS; CONSTRUCTION; CATALYSIS	We developed an enantioselectively catalyzed tandem synthesis of structurally and stereochemically complex molecules that forms four carbon-carbon bonds and sets eight stereocenters with high regio-, diastereo- and enantioselectivity. It can be programmed to yield different stereoisomers by varying only the order of combination of a common set of reagents and catalysts. We report what is to our knowledge the first synthesis of both enantiomers of a chiral compound using the same chiral catalyst.	[Potowski, Marco; Antonchick, Andrey P.; Waldmann, Herbert] Max Planck Inst Mol Physiol, Abt Chem Biol, D-44139 Dortmund, Germany; [Potowski, Marco; Schuermann, Markus; Preut, Hans; Waldmann, Herbert] Tech Univ Dortmund, Fak Chem, Dortmund, Germany	Max Planck Society; Dortmund University of Technology	Potowski, M (corresponding author), Max Planck Inst Mol Physiol, Abt Chem Biol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	andrey.antonchick@mpi-dortmund.mpg.de; herbert.waldmann@mpi-dortmund.mpg.de	Antonchick, Andrey/P-1529-2016; Waldmann, Herbert/B-7406-2017	Antonchick, Andrey/0000-0003-0435-9443; Waldmann, Herbert/0000-0002-9606-7247	Fonds der Chemischen Industrie; European Research Council (ERC) under the European Union; ERC [268309]	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Research Council (ERC) under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission)	M.P. thanks the Fonds der Chemischen Industrie for a fellowship. The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) and ERC grant agreement no. 268309.	Adrio J, 2011, CHEM COMMUN, V47, P6784, DOI 10.1039/c1cc10779h; Antonchick AP, 2010, NAT CHEM, V2, P735, DOI 10.1038/nchem.730; Bertelsen S, 2008, CHEM COMMUN, P3016, DOI 10.1039/b806418k; BRECKNELL DJ, 1989, AUST J CHEM, V42, P511, DOI 10.1071/CH9890511; BURNELL DJ, 1987, CAN J CHEM, V65, P154, DOI 10.1139/v87-024; Cabrera S, 2006, PURE APPL CHEM, V78, P257, DOI 10.1351/pac200678020257; Cabrera S, 2005, J AM CHEM SOC, V127, P16394, DOI 10.1021/ja0552186; Cabrera S, 2007, TETRAHEDRON, V63, P6587, DOI 10.1016/j.tet.2007.03.130; Enders D, 2006, NATURE, V441, P861, DOI 10.1038/nature04820; GARRATT PJ, 1986, TETRAHEDRON LETT, V27, P2761, DOI 10.1016/S0040-4039(00)84637-7; Koch MA, 2005, P NATL ACAD SCI USA, V102, P17272, DOI 10.1073/pnas.0503647102; Morton D, 2009, ANGEW CHEM INT EDIT, V48, P104, DOI 10.1002/anie.200804486; Pandey G, 2006, CHEM REV, V106, P4484, DOI 10.1021/cr050011g; Pellissier H, 2007, TETRAHEDRON, V63, P3235, DOI 10.1016/j.tet.2007.01.009; Rainbolt JE, 2007, J ORG CHEM, V72, P3020, DOI 10.1021/jo062675b; Rendler S, 2010, J AM CHEM SOC, V132, P5027, DOI 10.1021/ja100185p; Stanley LM, 2008, CHEM REV, V108, P2887, DOI 10.1021/cr078371m; Valiulin RA, 2010, ORG LETT, V12, P3398, DOI 10.1021/ol101297b; Yu J, 2011, ACCOUNTS CHEM RES, V44, P1156, DOI 10.1021/ar2000343	19	66	66	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					428	430		10.1038/NCHEMBIO.901	http://dx.doi.org/10.1038/NCHEMBIO.901			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22426113				2022-12-27	WOS:000302962500007
J	Lawrence, R; Brown, JR; Al-Mafraji, K; Lamanna, WC; Beitel, JR; Boons, GJ; Esko, JD; Crawford, BE				Lawrence, Roger; Brown, Jillian R.; Al-Mafraji, Kanar; Lamanna, William C.; Beitel, James R.; Boons, Geert-Jan; Esko, Jeffrey D.; Crawford, Brett E.			Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses	NATURE CHEMICAL BIOLOGY			English	Article							TANDEM MASS-SPECTROMETRY; DRIED BLOOD SPOTS; HEPARAN-SULFATE; DERMATAN SULFATE; DISACCHARIDES; DEFICIENCY; PLASMA; ASSAY; OLIGOSACCHARIDES; ACCUMULATION	A considerable need exists for improved biomarkers for differential diagnosis, prognosis and monitoring of therapeutic interventions for mucopolysaccharidoses (MPS), inherited metabolic disorders that involve lysosomal storage of glycosaminoglycans. Here we report a simple, reliable method based on the detection of abundant nonreducing ends of the glycosaminoglycans that accumulate in cells, blood and urine of individuals with MPS. In this method, glycosaminoglycans are enzymatically depolymerized, releasing unique mono-, di- or trisaccharides from the nonreducing ends of the chains. The composition of the released mono-and oligosaccharides depends on the nature of the lysosomal enzyme deficiency, and therefore they serve as diagnostic biomarkers. Analysis by LC/MS allowed qualitative and quantitative assessment of the biomarkers in biological samples. We provide a simple conceptual scheme for diagnosing MPS in uncharacterized samples and a method to monitor efficacy of enzyme replacement therapy or other forms of treatment.	[Brown, Jillian R.; Beitel, James R.; Crawford, Brett E.] Zacharon Pharmaceut Inc, San Diego, CA USA; [Lawrence, Roger; Lamanna, William C.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Al-Mafraji, Kanar; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	BioMarin Pharmaceutical Inc.; Zacharon Pharmaceuticals Inc.; University of California System; University of California San Diego; University System of Georgia; University of Georgia	Crawford, BE (corresponding author), Zacharon Pharmaceut Inc, San Diego, CA USA.	jesko@ucsd.edu; bcrawford@zacharon.com	Boons, Geert-Jan P H/J-3211-2016	Boons, Geert-Jan P H/0000-0003-3111-5954	US National Institutes of Health [R01 GM077471, P41 RR005351]; Kirschstein National Research Service Award [DK085905]; National MPS Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK085905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM077471] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MPS Society; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by US National Institutes of Health grants R01 GM077471 to J.D.E. and P41 RR005351 to G.J.B. for synthesis of disaccharide standards, a Kirschstein National Research Service Award DK085905 to W.C L. and grants from the National MPS Society to J.D.E. and B.E.C.	Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Blanchard S, 2008, CLIN CHEM, V54, P2067, DOI 10.1373/clinchem.2008.115410; Byers S, 1998, MOL GENET METAB, V65, P282, DOI 10.1006/mgme.1998.2761; Camelier MV, 2011, CLIN CHIM ACTA, V412, P1805, DOI 10.1016/j.cca.2011.06.001; Clarke Lorne A., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000550; Dean CJ, 2006, CLIN CHEM, V52, P643, DOI 10.1373/clinchem.2005.061838; Duffey TA, 2010, CLIN CHEM, V56, P1854, DOI 10.1373/clinchem.2010.152009; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Freeze H. H., 2009, ESSENTIALS GLYCOBIOL; Fuller M, 2006, GLYCOBIOLOGY, V16, P318, DOI 10.1093/glycob/cwj072; Fuller M, 2004, GLYCOBIOLOGY, V14, P443, DOI 10.1093/glycob/cwh049; Fuller M, 2011, J MED GENET, V48, P422, DOI 10.1136/jmg.2010.088096; HE W, 1993, J INHERIT METAB DIS, V16, P935, DOI 10.1007/BF00711508; Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; KIMURA A, 1982, TOHOKU J EXP MED, V136, P61, DOI 10.1620/tjem.136.61; KIMURA A, 1980, TOHOKU J EXP MED, V131, P241, DOI 10.1620/tjem.131.241; KIMURA A, 1984, TOHOKU J EXP MED, V144, P227, DOI 10.1620/tjem.144.227; King B, 2006, MOL GENET METAB, V87, P107, DOI 10.1016/j.ymgme.2005.09.026; Komosinska-Vassev KB, 2008, CLIN CHEM LAB MED, V46, P219, DOI 10.1515/CCLM.2008.048; KRESSE H, 1980, P NATL ACAD SCI-BIOL, V77, P6822, DOI 10.1073/pnas.77.11.6822; Lamanna WC, 2011, J BIOL CHEM, V286, P6955, DOI 10.1074/jbc.M110.192062; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Linhardt R.J, 2001, CURR PROTOC MOL BIOL, V48; Mason KE, 2006, ANAL CHEM, V78, P4534, DOI 10.1021/ac052083d; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nielsen TC, 2010, ANAL BIOCHEM, V402, P113, DOI 10.1016/j.ab.2010.04.002; OBRIEN JF, 1974, BIOCHEM BIOPH RES CO, V60, P1170, DOI 10.1016/0006-291X(74)90435-5; Oguma T, 2007, ANAL BIOCHEM, V368, P79, DOI 10.1016/j.ab.2007.05.016; Peterson SB, 2010, J BIOL CHEM, V285, P14504, DOI 10.1074/jbc.M110.104166; Ramsay SL, 2003, MOL GENET METAB, V78, P193, DOI 10.1016/S1096-7192(03)00018-0; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; SJOBERG I, 1973, BIOCHEM BIOPH RES CO, V54, P1125, DOI 10.1016/0006-291X(73)90809-7; Toma L, 1996, LAB INVEST, V75, P771; Tomatsu S, 2005, J INHERIT METAB DIS, V28, P743, DOI 10.1007/s10545-005-0069-y; Tomatsu S, 2010, J INHERIT METAB DIS, V33, P141, DOI 10.1007/s10545-009-9036-3; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Wei W, 2011, ANAL CHEM, V83, P3703, DOI 10.1021/ac2001077; Wolfe BJ, 2011, ANAL CHEM, V83, P1152, DOI 10.1021/ac102777s; Xia BY, 2009, ANAL BIOCHEM, V387, P162, DOI 10.1016/j.ab.2009.01.028; Zhou H, 2011, J PEDIATR-US, V159, P7, DOI 10.1016/j.jpeds.2011.02.026	43	100	103	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					197	204		10.1038/nchembio.766	http://dx.doi.org/10.1038/nchembio.766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22231271	Green Accepted			2022-12-27	WOS:000299323200012
J	Long, JZ; Cisar, JS; Milliken, D; Niessen, S; Wang, C; Trauger, SA; Siuzdak, G; Cravatt, BF				Long, Jonathan Z.; Cisar, Justin S.; Milliken, David; Niessen, Sherry; Wang, Chu; Trauger, Sunia A.; Siuzdak, Gary; Cravatt, Benjamin F.			Metabolomics annotates ABHD3 as a physiologic regulator of medium-chain phospholipids	NATURE CHEMICAL BIOLOGY			English	Article							MASS-SPECTROMETRY; OXIDIZED PHOSPHOLIPIDS; SERINE HYDROLASES; ENZYME; SUPERFAMILIES	All organisms, including humans, possess a huge number of uncharacterized enzymes. Here we describe a general cell-based screen for enzyme substrate discovery by untargeted metabolomics and its application to identify the protein alpha/beta-hydrolase domain-containing 3 (ABHD3) as a lipase that selectively cleaves medium-chain and oxidatively truncated phospholipids. Abhd3(-/-) mice possess elevated myristoyl (C14)-phospholipids, including the bioactive lipid C14-lysophosphatidylcholine, confirming the physiological relevance of our substrate assignments.	[Long, Jonathan Z.; Cisar, Justin S.; Milliken, David; Niessen, Sherry; Wang, Chu; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Long, Jonathan Z.; Cisar, Justin S.; Milliken, David; Niessen, Sherry; Wang, Chu; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Niessen, Sherry] Scripps Res Inst, Ctr Physiol Prote, La Jolla, CA 92037 USA; [Trauger, Sunia A.; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	wang, chu/GYJ-2191-2022; Wang, Chu/AAE-8759-2021; Wang, Chu/C-4442-2015; cisar, justin/C-4002-2012	Wang, Chu/0000-0002-6925-1268; Wang, Chu/0000-0002-6925-1268; Siuzdak, Gary/0000-0002-4749-0014; Long, Jonathan/0000-0003-2631-7463; Trauger, Sunia/0000-0002-1678-8715	US National Institutes of Health [CA132630]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA132630] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge D. Bachovchin and S. Ji (both at The Scripps Research Institute) for providing the serine hydrolase expression plasmids, A. Saghatelian for the fatty acyl-CoA extraction protocol, and S. Palmer for the Matlab script used to generate Figure 2a. This work was supported by the US National Institutes of Health (CA132630) and the Skaggs Institute for Chemical Biology.	Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Nakanishi H, 2009, J CHROMATOGR B, V877, P1366, DOI 10.1016/j.jchromb.2008.09.041; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rottig M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000636; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yea K, 2009, J BIOL CHEM, V284, P33833, DOI 10.1074/jbc.M109.024869	24	46	48	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					763	765		10.1038/nchembio.659	http://dx.doi.org/10.1038/nchembio.659			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21926997	Green Accepted			2022-12-27	WOS:000296381600004
J	Bonger, KM; Chen, LC; Liu, CW; Wandless, TJ				Bonger, Kimberly M.; Chen, Ling-chun; Liu, Corey W.; Wandless, Thomas J.			Small-molecule displacement of a cryptic degron causes conditional protein degradation	NATURE CHEMICAL BIOLOGY			English	Article							FKBP; UBIQUITINATION; SPECIFICITY; SYSTEM; IDENTIFICATION; DESTRUCTION; FIBROBLASTS; EXPRESSION; RECEPTOR; LIGANDS	The ability to rapidly regulate the functions of specific proteins in living cells is a valuable tool for biological research. Here we describe a new technique by which the degradation of a specific protein is induced by a small molecule. A protein of interest is fused to a ligand-induced degradation (LID) domain, resulting in the expression of a stable and functional fusion protein. The LID domain is comprised of the FK506- and rapamycin-binding protein (FKBP) and a 19-amino-acid degron fused to the C terminus of FKBP. In the absence of the small molecule Shield-1, the degron is bound to the FKBP fusion protein and the protein is stable. When present, Shield-1 binds tightly to FKBP, displacing the degron and inducing rapid and processive degradation of the LID domain and any fused partner protein. Structure-function studies of the 19-residue peptide showed that a 4-amino-acid sequence within the peptide is responsible for degradation.	[Bonger, Kimberly M.; Chen, Ling-chun; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Liu, Corey W.] Stanford Univ, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA	Stanford University; Stanford University	Bonger, KM (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wandless@stanford.edu	Bonger, Kimberly M/A-5900-2015	Bonger, Kimberly M/0000-0001-9498-2620	US National Institutes of Health [GM073046]; Human Frontiers Science Program fellowship; Stanford University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program fellowship(Human Frontier Science Program); Stanford University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health (GM073046). K.M.B. gratefully acknowledges the support of a Human Frontiers Science Program fellowship. C.W.L. and the Stanford Magnetic Resonance Laboratory are supported in part by the Stanford University School of Medicine. We would like to thank J. Lee and M. Verdoes for technical assistance.	ALBERS MW, 1990, J ORG CHEM, V55, P4984, DOI 10.1021/jo00304a003; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOSINK MM, 1995, P NATL ACAD SCI USA, V92, P9117, DOI 10.1073/pnas.92.20.9117; Grimley JS, 2008, BIOORG MED CHEM LETT, V18, P759, DOI 10.1016/j.bmcl.2007.11.044; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Lawson TG, 1999, J BIOL CHEM, V274, P9871, DOI 10.1074/jbc.274.14.9871; Matsuzawa S, 2005, P NATL ACAD SCI USA, V102, P14982, DOI 10.1073/pnas.0507512102; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Raina K, 2010, J BIOL CHEM, V285, P11057, DOI 10.1074/jbc.R109.078105; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5	29	124	133	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					531	537		10.1038/NCHEMBIO.598	http://dx.doi.org/10.1038/NCHEMBIO.598			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21725303	Green Accepted			2022-12-27	WOS:000292825400014
J	Carling, D; Mayer, FV; Sanders, MJ; Gamblin, SJ				Carling, David; Mayer, Faith V.; Sanders, Matthew J.; Gamblin, Steven J.			AMP-activated protein kinase: nature's energy sensor	NATURE CHEMICAL BIOLOGY			English	Article							ACETYL-COA CARBOXYLASE; RAT-LIVER; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; REDUCTASE KINASE; SKELETAL-MUSCLE; YEAST SNF1; ALLOSTERIC ACTIVATION; GLUCOSE REPRESSION; STRUCTURAL INSIGHT; METABOLIC SYNDROME	Maintaining sufficient levels of ATP (the immediate source of cellular energy) is essential for the proper functioning of all living cells. As a consequence, cells require mechanisms to balance energy demand with supply. In eukaryotic cells the AMP-activated protein kinase (AMPK) cascade has an important role in this homeostasis. AMPK is activated by a fall in ATP (concomitant with a rise in ADP and AMP), which leads to the activation of catabolic pathways and the inhibition of anabolic pathways. Here we review the role of AMPK as an energy sensor and consider the recent finding that ADP, as well as AMP, causes activation of mammalian AMPK. We also review recent progress in structural studies on phosphorylated AMPK that provides a mechanism for the regulation of AMPK in which AMP and ADP protect it against dephosphorylation. Finally, we briefly survey some of the outstanding questions concerning the regulation of AMPK.	[Carling, David; Mayer, Faith V.] Univ London Imperial Coll Sci Technol & Med, Cellular Stress Grp, Ctr Clin Sci, MRC, London, England; [Sanders, Matthew J.; Gamblin, Steven J.] Natl Inst Med Res, MRC, London NW7 1AA, England	Imperial College London; MRC National Institute for Medical Research	Carling, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Cellular Stress Grp, Ctr Clin Sci, MRC, Hammersmith Hosp Campus, London, England.	dcarling@imperial.ac.uk	Carling, David/F-1943-2014; Sanders, Matthew J/B-4077-2009	Carling, David/0000-0002-2316-1830; Sanders, Matthew James/0000-0001-6185-6337; Gamblin, Steve/0000-0001-5331-639X	MRC; MRC [MC_U117584222] Funding Source: UKRI; Medical Research Council [MC_U117584222, MC_U120027537] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all members of the D.C. and S.J.G. groups for helpful comments. Work in the authors' laboratories was supported by the MRC.	Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; BEG ZH, 1979, P NATL ACAD SCI USA, V76, P4375, DOI 10.1073/pnas.76.9.4375; BEG ZH, 1973, BIOCHEM BIOPH RES CO, V54, P1362, DOI 10.1016/0006-291X(73)91137-6; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; BOYER PD, 1977, ANNU REV BIOCHEM, V46, P955, DOI 10.1146/annurev.bi.46.070177.004515; BROWN MS, 1975, J BIOL CHEM, V250, P2502; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; CARLING D, 1994, J BIOL CHEM, V269, P11442; CARLSON CA, 1973, J BIOL CHEM, V248, P378; CARLSON M, 1984, GENETICS, V107, P19; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CARLSON M, 1981, GENETICS, V98, P25; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Frederich M, 2002, J BIOL CHEM, V277, P1928, DOI 10.1074/jbc.M107128200; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; GOLLOB MH, 2001, NEW ENGL J MED, V345, P552; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; HARWOOD HJ, 1984, J BIOL CHEM, V259, P2810; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Hellsten Y, 1999, J PHYSIOL-LONDON, V520, P909, DOI 10.1111/j.1469-7793.1999.00909.x; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; INGEBRITSEN TS, 1981, J BIOL CHEM, V256, P1138; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; MOORE F, 1991, EUR J BIOCHEM, V199, P691, DOI 10.1111/j.1432-1033.1991.tb16172.x; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; STAPLETON D, 1994, J BIOL CHEM, V269, P29343; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Thornton C, 2008, J BIOL CHEM, V283, P17116, DOI 10.1074/jbc.M708987200; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Voss M, 2011, CELL SIGNAL, V23, P114, DOI 10.1016/j.cellsig.2010.08.010; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	81	301	312	3	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					512	518		10.1038/NCHEMBIO.610	http://dx.doi.org/10.1038/NCHEMBIO.610			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769098				2022-12-27	WOS:000292825400011
J	Makhortova, NR; Hayhurst, M; Cerqueira, A; Sinor-Anderson, AD; Zhao, WN; Heiser, PW; Arvanites, AC; Davidow, LS; Waldon, ZO; Steen, JA; Lam, K; Ngo, HD; Rubin, LL				Makhortova, Nina R.; Hayhurst, Monica; Cerqueira, Antonio; Sinor-Anderson, Amy D.; Zhao, Wen-Ning; Heiser, Patrick W.; Arvanites, Anthony C.; Davidow, Lance S.; Waldon, Zachary O.; Steen, Judith A.; Lam, Kelvin; Ngo, Hien D.; Rubin, Lee L.			A screen for regulators of survival of motor neuron protein levels	NATURE CHEMICAL BIOLOGY			English	Article							SPINAL MUSCULAR-ATROPHY; SMN PROTEIN; MESSENGER-RNA; KINASE INHIBITORS; SMALL-MOLECULE; GROWTH CONES; GENE-PRODUCT; STEM-CELLS; INACTIVATION; EXPRESSION	The motor neuron disease spinal muscular atrophy (SMA) results from mutations that lead to low levels of the ubiquitously expressed protein survival of motor neuron (SMN). An ever-increasing collection of data suggests that therapeutics that elevate SMN may be effective in treating SMA. We executed an image-based screen of annotated chemical libraries and discovered several classes of compounds that were able to increase cellular SMN. Among the most important was the RTK-PI3K-AKT-GSK-3 signaling cascade. Chemical inhibitors of glycogen synthase kinase 3 (GSK-3) and short hairpin RNAs (shRNAs) directed against this target elevated SMN levels primarily by stabilizing the protein. It was particularly notable that GSK-3 chemical inhibitors were also effective in motor neurons, not only in elevating SMN levels, but also in blocking the death that was produced when SMN was acutely reduced by an SMN-specific shRNA. Thus, we have established a screen capable of detecting drug-like compounds that correct the main phenotypic change underlying SMA.	[Makhortova, Nina R.; Hayhurst, Monica; Cerqueira, Antonio; Sinor-Anderson, Amy D.; Zhao, Wen-Ning; Heiser, Patrick W.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Makhortova, Nina R.; Hayhurst, Monica; Cerqueira, Antonio; Arvanites, Anthony C.; Davidow, Lance S.; Lam, Kelvin; Ngo, Hien D.; Rubin, Lee L.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Waldon, Zachary O.; Steen, Judith A.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA	Harvard University; Harvard University; Harvard University; Boston Children's Hospital	Makhortova, NR (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lee_rubin@harvard.edu		Heiser, Patrick/0000-0002-8831-4973; Rubin, Lee/0000-0002-8658-841X	Spinal Muscular Atrophy Foundation; Harvard Stem Cell Institute; US National Institute of Neurological Disorders and Stroke (NINDS) [P01NS066888-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER	Spinal Muscular Atrophy Foundation; Harvard Stem Cell Institute; US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank K. Kotkow, Y. M. Yang and K. Chen for helpful comments, K. Krumholz for technical help and J. LaLonde for editorial assistance. Additionally, we would like to thank R. Sivasankaran and C. Song at Novartis for sharing the conditions of the splicing assay design. The work was supported by the Spinal Muscular Atrophy Foundation, by the Harvard Stem Cell Institute and by a P01 grant (P01NS066888-01A1) from the US National Institute of Neurological Disorders and Stroke (NINDS). Mouse Hb9::CFP was a gift from K. Eggan, Harvard University.	Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; BURT JM, 1982, CIRC RES, V51, P543, DOI 10.1161/01.RES.51.5.543; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Cheng H, 2011, J MOL CELL CARDIOL, V51, P607, DOI 10.1016/j.yjmcc.2010.11.020; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Dodson AW, 2007, VIROLOGY, V366, P340, DOI 10.1016/j.virol.2007.05.001; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kunick C, 2005, CHEMBIOCHEM, V6, P541, DOI 10.1002/cbic.200400099; Lahusen T, 2003, MOL CARCINOGEN, V36, P183, DOI 10.1002/mc.10114; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Man NT, 2008, NEUROLOGY, V71, P1757, DOI 10.1212/01.wnl.0000313038.34337.b1; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Patrizi AL, 1999, EUR J HUM GENET, V7, P301, DOI 10.1038/sj.ejhg.5200286; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pessa HKJ, 2008, P NATL ACAD SCI USA, V105, P8655, DOI 10.1073/pnas.0803646105; Pullen MA, 2004, J PHARMACOL EXP THER, V310, P319, DOI 10.1124/jpet.104.065250; Rak K, 2009, NEUROBIOL DIS, V36, P477, DOI 10.1016/j.nbd.2009.08.014; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Shafey D, 2008, J NEUROSCI RES, V86, P2839, DOI 10.1002/jnr.21743; Steitz JA, 2008, P NATL ACAD SCI USA, V105, P8485, DOI 10.1073/pnas.0804024105; Takadera T, 2010, CELL MOL NEUROBIOL, V30, P193, DOI 10.1007/s10571-009-9442-y; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; YEH HJ, 1993, P NATL ACAD SCI USA, V90, P1952, DOI 10.1073/pnas.90.5.1952; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	50	66	77	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					544	552		10.1038/NCHEMBIO.595	http://dx.doi.org/10.1038/NCHEMBIO.595			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21685895	Green Accepted, Green Submitted			2022-12-27	WOS:000292825400016
J	Counago, RM; Ween, MP; Begg, SL; Bajaj, M; Zuegg, J; O'Mara, ML; Cooper, MA; McEwan, AG; Paton, JC; Kobe, B; McDevitt, CA				Counago, Rafael M.; Ween, Miranda P.; Begg, Stephanie L.; Bajaj, Megha; Zuegg, Johannes; O'Mara, Megan L.; Cooper, Matthew A.; McEwan, Alastair G.; Paton, James C.; Kobe, Bostjan; McDevitt, Christopher A.			Imperfect coordination chemistry facilitates metal ion release in the Psa permease	NATURE CHEMICAL BIOLOGY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; OXIDATIVE STRESS RESISTANCE; TREPONEMA-PALLIDUM TROA; ZINC TRANSPORT PROTEIN; X-RAY-STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BINDING-PROTEIN; SUPEROXIDE-DISMUTASE	The relative stability of divalent first-row transition metal ion complexes, as defined by the Irving-Williams series, poses a fundamental chemical challenge for selectivity in bacterial metal ion acquisition. Here we show that although the substratebinding protein of Streptococcus pneumoniae, PsaA, is finely attuned to bind its physiological substrate manganese, it can also bind a broad range of other divalent transition metal cations. By combining high-resolution structural data, metal-binding assays and mutational analyses, we show that the inability of open-state PsaA to satisfy the preferred coordination chemistry of manganese enables the protein to undergo the conformational changes required for cargo release to the Psa permease. This is specific for manganese ions, whereas zinc ions remain bound to PsaA. Collectively, these findings suggest a new ligand binding and release mechanism for PsaA and related substrate-binding proteins that facilitate specificity for divalent cations during competition from zinc ions, which are more abundant in biological systems.	[Counago, Rafael M.; O'Mara, Megan L.; McEwan, Alastair G.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Counago, Rafael M.; Bajaj, Megha; O'Mara, Megan L.; McEwan, Alastair G.; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Counago, Rafael M.; Bajaj, Megha; Zuegg, Johannes; Cooper, Matthew A.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Ween, Miranda P.; Begg, Stephanie L.; Paton, James C.; McDevitt, Christopher A.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [O'Mara, Megan L.] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Adelaide; University of Queensland	Counago, RM (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	b.kobe@uq.edu.au; christopher.mcdevitt@adelaide.edu.au	Couñago, Rafael/AAX-1577-2020; Counago, Rafael/F-4418-2016; Cooper, Matthew A./C-7988-2009; O'Mara, Megan/ABF-8913-2020; McDevitt, Christopher A./A-4940-2009; Zuegg, Johannes/C-1347-2014; O'Mara, Megan/AAY-5934-2021; Neville (née Begg), Stephanie/AAZ-1380-2021; Kobe, Bostjan/D-1292-2009; O'Mara, Megan L/A-4962-2011	Couñago, Rafael/0000-0003-1847-5090; Counago, Rafael/0000-0003-1847-5090; Cooper, Matthew A./0000-0003-3147-3460; McDevitt, Christopher A./0000-0003-1596-4841; Zuegg, Johannes/0000-0001-6240-6020; O'Mara, Megan/0000-0002-8764-1585; Neville (née Begg), Stephanie/0000-0002-7298-9335; Kobe, Bostjan/0000-0001-9413-9166; O'Mara, Megan L/0000-0002-8764-1585; McEwan, Alastair/0000-0002-2419-1003; ween, miranda/0000-0002-0600-4585	Australian Research Council (ARC) [DP0986578, DP120103957]; National Health and Medical Research Council (NHMRC) [1022240, 565526]; ARC Discovery Early Career Researcher Award	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC Discovery Early Career Researcher Award(Australian Research Council)	This work was supported by the Australian Research Council (ARC) grants DP0986578 to A.G.M. and DP120103957 to C.A.M. and the National Health and Medical Research Council (NHMRC) project grant 1022240 to C.A.M. and program grant 565526 to J. C. P., A.G.M. and B.K. M.L.O. holds an ARC Discovery Early Career Researcher Award. B.K. is a NHMRC Senior Research Fellow. J.C.P. is a NHMRC Senior Principal Research Fellow. We thank A.E. Mark for discussions.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Counago RM, 2012, CURR DRUG TARGETS, V13, P1400; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Felder CB, 1999, AAPS PHARMSCI, V1; Gat O, 2005, MOL MICROBIOL, V58, P533, DOI 10.1111/j.1365-2958.2005.04848.x; Giedroc DP, 2007, DALTON T, P3107, DOI 10.1039/b706769k; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilari A, 2011, J MOL BIOL, V409, P630, DOI 10.1016/j.jmb.2011.04.036; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; MAO B, 1982, J BIOL CHEM, V257, P1131; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pennella MA, 2003, P NATL ACAD SCI USA, V100, P3713, DOI 10.1073/pnas.0636943100; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rukhman V, 2005, J MOL BIOL, V348, P961, DOI 10.1016/j.jmb.2005.03.006; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Wu HJ, 2010, J PROTEOMICS, V73, P899, DOI 10.1016/j.jprot.2009.12.001; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000	59	104	105	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					35	U66		10.1038/NCHEMBIO.1382	http://dx.doi.org/10.1038/NCHEMBIO.1382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24212134				2022-12-27	WOS:000328854900008
J	Lofgren, M; Padovani, D; Koutmos, M; Banerjee, R				Lofgren, Michael; Padovani, Dominique; Koutmos, Markos; Banerjee, Ruma			A switch III motif relays signaling between a B-12 enzyme and its G-protein chaperone	NATURE CHEMICAL BIOLOGY			English	Article							METHYLMALONYL-COA MUTASE; METHIONINE SYNTHASE; REACTIVATING FACTOR; DUAL FLAVOPROTEIN; DIOL DEHYDRATASE; ALPHA-SUBUNIT; COENZYME; ACTIVATION; GENE; MEAB	Fidelity during cofactor assembly is essential for the proper functioning of metalloenzymes and is ensured by specific chaperones. MeaB, a G-protein chaperone for the coenzyme B-12-dependent radical enzyme methylmalonyl-CoA mutase (MCM), uses the energy of GTP binding, hydrolysis or both to regulate cofactor loading into MCM, protect MCM from inactivation and rescue MCM that is inactivated during turnover. Typically, G proteins signal to client proteins using the conformationally mobile switch I and II loops. Crystallographic snapshots of MeaB reported herein reveal a new switch III element that has substantial conformational plasticity. Using alanine-scanning mutagenesis, we demonstrate that the switch III motif is critical for bidirectional signal transmission of the GTPase-activating protein activity of MCM and the chaperone functions of MeaB in the MeaB-MCM complex. Mutations in the switch III loop identified in patients corrupt this interprotein communication and lead to methylmalonic aciduria, an inborn error of metabolism.	[Lofgren, Michael; Padovani, Dominique; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	University of Michigan System; University of Michigan; Uniformed Services University of the Health Sciences - USA	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Dominique, PADOVANI/EUS-9660-2022	PADOVANI, Dominique/0000-0003-1166-5801; Koutmos, Markos/0000-0003-0933-6312	US National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from the US National Institutes of Health (DK45776).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmed SF, 1998, CLIN ENDOCRINOL, V49, P525, DOI 10.1046/j.1365-2265.1998.00572.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dempsey-Nunez L, 2012, MOL GENET METAB, V107, P363, DOI 10.1016/j.ymgme.2012.09.012; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Grishina G, 1998, J BIOL CHEM, V273, P15053, DOI 10.1074/jbc.273.24.15053; Hennig SE, 2012, P NATL ACAD SCI USA, V109, P5235, DOI 10.1073/pnas.1117126109; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; Lofgren M, 2011, BIOCHEMISTRY-US, V50, P5790, DOI 10.1021/bi2006306; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori K, 2004, J BACTERIOL, V186, P6845, DOI 10.1128/JB.186.20.6845-6854.2004; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; Mori K, 1997, J BIOL CHEM, V272, P32034, DOI 10.1074/jbc.272.51.32034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olteanu H, 2003, J BIOL CHEM, V278, P38310, DOI 10.1074/jbc.M306282200; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padovani D, 2006, BIOCHEMISTRY-US, V45, P2951, DOI 10.1021/bi051742d; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Padovani D, 2009, BIOCHEMISTRY-US, V48, P5350, DOI 10.1021/bi900454s; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shibata N, 2005, STRUCTURE, V13, P1745, DOI 10.1016/j.str.2005.08.011; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Takahashi-Iniguez T, 2011, BIOCHEM BIOPH RES CO, V404, P443, DOI 10.1016/j.bbrc.2010.11.141; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yamanishi M, 2005, TRENDS BIOCHEM SCI, V30, P304, DOI 10.1016/j.tibs.2005.04.008	43	17	18	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					535	U22		10.1038/NCHEMBIO.1298	http://dx.doi.org/10.1038/NCHEMBIO.1298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23873214	Green Accepted			2022-12-27	WOS:000323417500004
J	Panne, D				Panne, Daniel			IMMUNOLOGY Cytosolic DNA sensing unraveled	NATURE CHEMICAL BIOLOGY			English	News Item							CYCLIC GMP-AMP; 2ND-MESSENGER; CGAS; SENSOR; DINUCLEOTIDE; SYNTHASE	DNA in the cytosol activates immune responses by binding sensors such as cGAMP synthase (cGAS). A set of studies reveal the structural mechanism of DNA sensing and show that cGAS produces a cyclic 2'-5'-linked dinucleotide, a new cellular second messenger.	European Mol Biol Lab, F-38042 Grenoble, France	European Molecular Biology Laboratory (EMBL)	Panne, D (corresponding author), European Mol Biol Lab, F-38042 Grenoble, France.	panne@embl.fr	Panne, Daniel/I-8368-2017	Panne, Daniel/0000-0001-9158-5507				Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X., 2013, MOL CELL, DOI DOI 10.1016/J.M0LCEL.2013.05.022	11	2	9	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					533	534		10.1038/nchembio.1318	http://dx.doi.org/10.1038/nchembio.1318			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23959130				2022-12-27	WOS:000323417500003
J	Gehrke, TH; Lischke, U; Gasteiger, KL; Schneider, S; Arnold, S; Muller, HC; Stephenson, DS; Zipse, H; Carell, T				Gehrke, Tim H.; Lischke, Ulrike; Gasteiger, Karola L.; Schneider, Sabine; Arnold, Simone; Mueller, Heiko C.; Stephenson, David S.; Zipse, Hendrik; Carell, Thomas			Unexpected non-Hoogsteen-based mutagenicity mechanism of FaPy-DNA lesions	NATURE CHEMICAL BIOLOGY			English	Article							CENTER-DOT-DA; FORMAMIDOPYRIMIDINE; REPLICATION; DG; BYPASS; DEOXYGUANOSINE; REFINEMENT; INSERTION; PRODUCTS; OPPOSITE	8-Oxopurines (8-oxodG and 8-oxodA) and formamidopyrimidines (FaPydG and FaPydA) are major oxidative DNA lesions involved in cancer development and aging. Their mutagenicity is believed to result from a conformational shift of the N9-C1' glycosidic bonds from anti to syn, which allows the lesions to form noncanonical Hoogsteen-type base pairs with incoming triphosphates during DNA replication. Here we present biochemical data and what are to our knowledge the first crystal structures of carbocyclic FaPydA and FaPydG containing DNA in complex with a high-fidelity polymerase. Crystallographic snapshots show that the cFaPy lesions keep the anti geometry of the glycosidic bond during error-free and error-prone replication. The observed dG center dot dC -> dT center dot dA transversion mutations are the result of base shifting and tautomerization.	[Gehrke, Tim H.; Lischke, Ulrike; Gasteiger, Karola L.; Schneider, Sabine; Arnold, Simone; Mueller, Heiko C.; Stephenson, David S.; Zipse, Hendrik; Carell, Thomas] Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Munich, Germany	University of Munich	Carell, T (corresponding author), Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Munich, Germany.	thomas.carell@cup.uni-muenchen.de	Zipse, Hendrik/D-2141-2014; Schneider, Sabine/G-2908-2013; Carell, Thomas/G-4799-2012	Schneider, Sabine/0000-0003-1054-8689; Carell, Thomas/0000-0001-7898-2831	Deutsche Forschungsgemeinschaft [SFB 646, SFB 749]; Volkswagen Foundation; Excellence Cluster CiPSM	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); Excellence Cluster CiPSM	We are grateful to the beamline scientists at the Swiss Light Source and European Synchrotron Radiation Facility for setting up the beamlines. This research project was supported by the Deutsche Forschungsgemeinschaft through SFB 646 and SFB 749. Further support was obtained by the Volkswagen Foundation and in particular by the Excellence Cluster CiPS<SUP>M</SUP>. We thank K. Karaghiosoff and K. Lux for solving the crystal structures of the small molecules. We thank M. Muller for critical reading of the manuscript and many helpful discussions.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Asagoshi K, 2002, J BIOL CHEM, V277, P14589, DOI 10.1074/jbc.M200316200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Brieba LG, 2003, STRUCTURE, V11, P1, DOI 10.1016/S0969-2126(02)00917-6; Buesch F, 2008, CHEM-EUR J, V14, P2125, DOI 10.1002/chem.200701373; Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e; Cadet J, 2010, FREE RADICAL BIO MED, V49, P9, DOI 10.1016/j.freeradbiomed.2010.03.025; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Delaney MO, 2002, ANGEW CHEM INT EDIT, V41, P771, DOI 10.1002/1521-3773(20020301)41:5<771::AID-ANIE771>3.0.CO;2-V; Dizdaroglu M, 2008, FREE RADICAL BIO MED, V45, P1610, DOI 10.1016/j.freeradbiomed.2008.07.004; Duarte V, 1999, NUCLEIC ACIDS RES, V27, P496, DOI 10.1093/nar/27.2.496; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Evans P., 1997, NEWSLETT PROTEIN CRY, V33, P22; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Graziewicz MA, 2000, FREE RADICAL BIO MED, V28, P75, DOI 10.1016/S0891-5849(99)00208-7; Greenberg MM, 2012, ACCOUNTS CHEM RES, V45, P588, DOI 10.1021/ar2002182; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Jena NR, 2012, FREE RADICAL BIO MED, V53, P81, DOI 10.1016/j.freeradbiomed.2012.04.008; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalam MA, 2006, NUCLEIC ACIDS RES, V34, P2305, DOI 10.1093/nar/gkl099; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lukin M, 2011, NUCLEIC ACIDS RES, V39, P5776, DOI 10.1093/nar/gkr082; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munzel M, 2011, CHEM-EUR J, V17, P13782, DOI 10.1002/chem.201102782; Munzel M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq724; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ober M, 2005, J AM CHEM SOC, V127, P18143, DOI 10.1021/ja0549188; Ober M, 2004, ACTA CRYSTALLOGR E, V60, pO1191, DOI 10.1107/S1600536804013959; Ober M, 2003, ANGEW CHEM INT EDIT, V42, P4947, DOI 10.1002/anie.200351287; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Patro JN, 2007, BIOCHEMISTRY-US, V46, P10202, DOI 10.1021/bi700628c; Patro JN, 2004, BIOCHEMISTRY-US, V43, P13397, DOI 10.1021/bi049035s; RAOUL S, 1995, CHEM RES TOXICOL, V8, P924, DOI 10.1021/tx00049a005; Stathis D, 2012, J AM CHEM SOC, V134, P4925, DOI 10.1021/ja211435d; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; TOPAL MD, 1976, NATURE, V263, P285, DOI 10.1038/263285a0; Tudek B, 1999, ACTA BIOCHIM POL, V46, P785, DOI 10.18388/abp.1999_4151; Wang WN, 2011, P NATL ACAD SCI USA, V108, P17644, DOI 10.1073/pnas.1114496108; Wiederholt CJ, 2002, J AM CHEM SOC, V124, P7278, DOI 10.1021/ja026522r; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	49	29	29	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					455	U78		10.1038/NCHEMBIO.1254	http://dx.doi.org/10.1038/NCHEMBIO.1254			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23685671				2022-12-27	WOS:000320449700010
J	Bunnage, ME; Chekler, ELP; Jones, LH				Bunnage, Mark E.; Chekler, Eugene L. Piatnitski; Jones, Lyn H.			Target validation using chemical probes	NATURE CHEMICAL BIOLOGY			English	Article							SMALL MOLECULES; INHIBITOR; IDENTIFICATION; PROTEOMICS; DISCOVERY; POTENT		[Bunnage, Mark E.; Chekler, Eugene L. Piatnitski; Jones, Lyn H.] Pfizer, Worldwide Med Chem, Cambridge, MA USA	Pfizer	Bunnage, ME (corresponding author), Pfizer, Worldwide Med Chem, Cambridge, MA USA.	mark.bunnage@pfizer.com; eugene.chekler@pfizer.com; lyn.jones@pfizer.com		Jones, Lyn/0000-0002-8388-5865				Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Barkovich KJ, 2012, CANCER DISCOV, V2, P450, DOI 10.1158/2159-8290.CD-11-0287; Bunnage ME, 2011, NAT CHEM BIOL, V7, P335, DOI 10.1038/nchembio.581; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fish PV, 2012, J MED CHEM, V55, P9831, DOI 10.1021/jm3010515; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Jones Lyn H, 2011, J Chem Biol, V4, P49, DOI 10.1007/s12154-010-0047-1; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Peterson RT, 2011, METHOD CELL BIOL, V105, P525, DOI 10.1016/B978-0-12-381320-6.00023-0; Sachidanandan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001947; Sarker D, 2007, ADV CANCER RES, V96, P213, DOI 10.1016/S0065-230X(06)96008-4; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Westlin WF, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-1745; Wissing J, 2007, MOL CELL PROTEOMICS, V6, P537, DOI 10.1074/mcp.T600062-MCP200; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435; Zheng N, 2011, MOL PHARMACEUT, V8, P1619, DOI 10.1021/mp200092v	31	291	293	2	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					195	199		10.1038/nchembio.1197	http://dx.doi.org/10.1038/nchembio.1197			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23508172	Bronze			2022-12-27	WOS:000317025800002
J	Knapp, S; Arruda, P; Blagg, J; Burley, S; Drewry, DH; Edwards, A; Fabbro, D; Gillespie, P; Gray, NS; Kuster, B; Lackey, KE; Mazzafera, P; Tomkinson, NCO; Willson, TM; Workman, P; Zuercher, WJ				Knapp, Stefan; Arruda, Paulo; Blagg, Julian; Burley, Stephen; Drewry, David H.; Edwards, Aled; Fabbro, Doriano; Gillespie, Paul; Gray, Nathanael S.; Kuster, Bernhard; Lackey, Karen E.; Mazzafera, Paulo; Tomkinson, Nicholas C. O.; Willson, Timothy M.; Workman, Paul; Zuercher, William J.			A public-private partnership to unlock the untargeted kinome	NATURE CHEMICAL BIOLOGY			English	Article							KINASE INHIBITOR; SELECTIVE INHIBITOR; CELL; DISCOVERY; CANCER; POTENT; ABL		[Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Arruda, Paulo; Mazzafera, Paulo] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Blagg, Julian; Workman, Paul] Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England; [Burley, Stephen] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Edwards, Aled] Struct Genom Consortium, Toronto, ON, Canada; [Fabbro, Doriano] Novartis, Expertise Platform Kinases, Basel, Switzerland; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kuster, Bernhard] Tech Univ Munich, Munich, Germany; [Gillespie, Paul; Lackey, Karen E.] Hoffmann La Roche Inc, Pharmaceut Res & Early Dev, Nutley, NJ 07110 USA; [Tomkinson, Nicholas C. O.] Univ Strathclyde, Glasgow, Lanark, Scotland; [Drewry, David H.; Willson, Timothy M.; Zuercher, William J.] GlaxoSmithKline, Dept Biol Chem, Res Triangle Pk, NC USA	University of Oxford; University of Oxford; Universidade de Sao Paulo; Universidade Estadual de Campinas; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of California System; University of California San Diego; University of Toronto; Structural Genomics Consortium; Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Technical University of Munich; Roche Holding; University of Strathclyde; GlaxoSmithKline	Knapp, S (corresponding author), Univ Oxford, Dept Clin Pharmacol, Oxford, England.	william.j.zuercher@gsk.com	Kuster, Bernhard/Q-6031-2016; Arruda, Paulo/H-1440-2011; Knapp, Stefan/AAG-2347-2019; Mazzafera, Paulo/D-4766-2012; feinstein, doug/M-9414-2019	Kuster, Bernhard/0000-0002-9094-1677; Knapp, Stefan/0000-0001-5995-6494; Mazzafera, Paulo/0000-0001-9073-4056; Drewry, David Harold/0000-0001-5973-5798; Tomkinson, Nicholas/0000-0002-5509-0133; Burley, Stephen K./0000-0002-2487-9713; Edwards, Aled/0000-0002-4782-6016	Cancer Research UK [11566] Funding Source: Medline; Wellcome Trust [092809] Funding Source: Medline; EPSRC [EP/H031111/2, EP/H031111/1, EP/I037229/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I037229/1, EP/H031111/2, EP/H031111/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/NCHEMBIO.957, 10.1038/nchembio.957]; Cohen P, 2010, BIOCHEM J, V425, P53, DOI 10.1042/BJ20091428; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; Dowling JE, 2012, ACS MED CHEM LETT, V3, P278, DOI 10.1021/ml200257n; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Lin XY, 2012, J MED CHEM, V55, P5749, DOI 10.1021/jm300338m; Medina JR, 2011, J MED CHEM, V54, P1871, DOI 10.1021/jm101527u; Mott BT, 2009, BIOORG MED CHEM LETT, V19, P6700, DOI 10.1016/j.bmcl.2009.09.121; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Shimomura T, 2010, MOL CANCER THER, V9, P157, DOI 10.1158/1535-7163.MCT-09-0609; Weigelt J, 2009, EMBO REP, V10, P941, DOI 10.1038/embor.2009.193; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	24	110	111	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					3	7		10.1038/nchembio.1113	http://dx.doi.org/10.1038/nchembio.1113			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23238671				2022-12-27	WOS:000312484200002
J	Suthers, PF; Maranas, CD				Suthers, Patrick F.; Maranas, Costas D.			Orchestrating hi-fi annotations	NATURE CHEMICAL BIOLOGY			English	News Item							TOOLS		[Suthers, Patrick F.; Maranas, Costas D.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Suthers, PF (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398; Suthers, Patrick/0000-0002-5560-9986				Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Plata G, 2012, NAT CHEM BIOL, V8, P848, DOI 10.1038/NCHEMBIO.1063	6	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					810	811		10.1038/nchembio.1067	http://dx.doi.org/10.1038/nchembio.1067			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22987007				2022-12-27	WOS:000309056200002
J	Serafimova, IM; Pufall, MA; Krishnan, S; Duda, K; Cohen, MS; Maglathlin, RL; McFarland, JM; Miller, RM; Frodin, M; Taunton, J				Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Duda, Katarzyna; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Frodin, Morten; Taunton, Jack			Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles	NATURE CHEMICAL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; KINASE; INHIBITOR; RSK; ACTIVATION; DESIGN; EGFR	Targeting noncatalytic cysteine residues with irreversible acrylamide-based inhibitors is a powerful approach for enhancing pharmacological potency and selectivity. Nevertheless, concerns about off-target modification motivate the development of reversible cysteine-targeting strategies. Here we show that electron-deficient olefins, including acrylamides, can be tuned to react with cysteine thiols in a rapidly reversible manner. Installation of a nitrile group increased the olefins' intrinsic reactivity, but, paradoxically, eliminated the formation of irreversible adducts. Incorporation of these electrophiles into a noncovalent kinase-recognition scaffold produced slowly dissociating, covalent inhibitors of the p90 ribosomal protein S6 kinase RSK2. A cocrystal structure revealed specific noncovalent interactions that stabilize the complex by positioning the electrophilic carbon near the targeted cysteine. Disruption of these interactions by protein unfolding or proteolysis promoted instantaneous cleavage of the covalent bond. Our results establish a chemistry-based framework for engineering sustained covalent inhibition without accumulating permanently modified proteins and peptides.	[Serafimova, Iana M.; Cohen, Michael S.; Maglathlin, Rebecca L.; Miller, Rand M.; Taunton, Jack] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94143 USA; [Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Pufall, Miles A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Duda, Katarzyna; Frodin, Morten] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-1168 Copenhagen, Denmark; [Duda, Katarzyna; Frodin, Morten] Univ Copenhagen, Ctr Epigenet, DK-1168 Copenhagen, Denmark; [Cohen, Michael S.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Taunton, Jack] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa; University of Copenhagen; University of Copenhagen; Cornell University; Howard Hughes Medical Institute	Serafimova, IM (corresponding author), Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94143 USA.	taunton@cmp.ucsf.edu		Pufall, Miles/0000-0002-7022-6916; Frodin, Morten/0000-0003-3691-9820	US National Institutes of Health (NIH) [GM071434, CA020535, K99CA149088, F32GM087052]; Leukemia and Lymphoma Society [5416-7]; California Tobacco Related Disease Research Program [19FT-0091]; NIH [P41RR001614]; NATIONAL CANCER INSTITUTE [R37CA020535, R01CA020535, K99CA149088] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087052, R01GM071434] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF11OC1015111] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Tobacco Related Disease Research Program(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank D. King (Howard Hughes Medical Institute Mass Spectrometry Laboratory) for protein mass spectrometry expertise, members of the Taunton laboratory for insight, and the staff of Advanced Light Source (ALS) Beamline 8.3.1 for help with data collection. This work was supported by grants from the US National Institutes of Health (NIH) (GM071434 to J.T., CA020535 and K99CA149088 to M. A. P., F32GM087052 to J.M.M.), the Leukemia and Lymphoma Society (5416-7 to M. A. P.), and the California Tobacco Related Disease Research Program (19FT-0091 to S. K.). We acknowledge the University of California San Francisco (UCSF) Mass Spectrometry Facility (supported by NIH grant P41RR001614).	Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Evans DC, 2004, CHEM RES TOXICOL, V17, P3, DOI 10.1021/tx034170b; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Lee G, 2006, J MOL BIOL, V357, P1051, DOI 10.1016/j.jmb.2006.01.032; Leproult E, 2011, J MED CHEM, V54, P1347, DOI 10.1021/jm101396q; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Park BK, 2011, NAT REV DRUG DISCOV, V10, P292, DOI 10.1038/nrd3408; Patch RJ, 2011, J MED CHEM, V54, P788, DOI 10.1021/jm101063h; PEARSON RG, 1953, J AM CHEM SOC, V75, P2439, DOI 10.1021/ja01106a048; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; PRITCHARD RB, 1968, CAN J CHEMISTRY, V46, P775, DOI 10.1139/v68-128; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Uetrecht J, 2008, CHEM RES TOXICOL, V21, P84, DOI 10.1021/tx700186p; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou WJ, 2010, CHEM BIOL, V17, P285, DOI 10.1016/j.chembiol.2010.02.007; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	28	321	339	10	177	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					471	476		10.1038/NCHEMBIO.925	http://dx.doi.org/10.1038/NCHEMBIO.925			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22466421	Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000302962500014
J	Kusch, J; Thon, S; Schulz, E; Biskup, C; Nache, V; Zimmer, T; Seifert, R; Schwede, F; Benndorf, K				Kusch, Jana; Thon, Susanne; Schulz, Eckhard; Biskup, Christoph; Nache, Vasilica; Zimmer, Thomas; Seifert, Reinhard; Schwede, Frank; Benndorf, Klaus			How subunits cooperate in cAMP-induced activation of homotetrameric HCN2 channels	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEOTIDE-GATED CHANNELS; PATCH-CLAMP FLUOROMETRY; CURRENT I-H; PACEMAKER CHANNELS; CATION CHANNELS; LIGAND-BINDING; MOLECULAR-MECHANISM; VOLTAGE SENSOR; ION CHANNELS; CYCLIC-AMP	Hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels are tetrameric membrane proteins that generate electrical rhythmicity in specialized neurons and cardiomyocytes. The channels are primarily activated by voltage but are receptors as well, binding the intracellular ligand cyclic AMP. The molecular mechanism of channel activation is still unknown. Here we analyze the complex activation mechanism of homotetrameric HCN2 channels by confocal patch-clamp fluorometry and kinetically quantify all ligand binding steps and closed-open isomerizations of the intermediate states. For the binding affinity of the second, third and fourth ligand, our results suggest pronounced cooperativity in the sequence positive, negative and positive, respectively. This complex interaction of the subunits leads to a preferential stabilization of states with zero, two or four ligands and suggests a dimeric organization of the activation process: within the dimers the cooperativity is positive, whereas it is negative between the dimers.	[Kusch, Jana; Thon, Susanne; Biskup, Christoph; Nache, Vasilica; Zimmer, Thomas; Benndorf, Klaus] Univ Jena, Inst Physiol 2, Univ Klinikum Jena, Jena, Germany; [Schulz, Eckhard] Fachhsch Schmalkalden, Fak Elektrotech, Blechhammer, Schmalkalden, Germany; [Biskup, Christoph] Univ Jena, Arbeitsgrp Biomol Photon, Univ Klinikum Jena, Jena, Germany; [Seifert, Reinhard] Ctr Adv European Studies & Res, Abt Mol Neurosensor, Bonn, Germany; [Schwede, Frank] BIOLOG Life Sci Inst, Bremen, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Center of Advanced European Studies & Research (CAESAR)	Benndorf, K (corresponding author), Univ Jena, Inst Physiol 2, Univ Klinikum Jena, Jena, Germany.	Klaus.Benndorf@mti.uni-jena.de	Kusch, Jana/ABC-9738-2020	Kusch, Jana/0000-0001-7206-8133; Benndorf, Klaus/0000-0002-0707-4083	Deutsche Forschungsgemeinschaft; Friedrich-Schiller-University; Bremen Innovation Agency	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Schiller-University; Bremen Innovation Agency	We are indebted to U.B. Kaupp for providing the cDNA and to F. Lehmann (Dyomics GmbH, Jena, Germany) for providing the dyes. We would also like to thank G. Ditze, G. Sammler, F. Horn, M. Handel, K. Schoknecht, S. Bernhardt, A. Kolchmeier and B. Tietsch for excellent technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (to K.B.) and from the Friedrich-Schiller-University (to J.K.). F.S. acknowledges support from the Bremen Innovation Agency.	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; BANKS MI, 1993, J NEUROPHYSIOL, V70, P1420, DOI 10.1152/jn.1993.70.4.1420; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Bruening-Wright A, 2007, J GEN PHYSIOL, V130, P71, DOI 10.1085/jgp.200709769; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Elinder F, 2006, J PHYSIOL-LONDON, V575, P417, DOI 10.1113/jphysiol.2006.110437; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Gauss R, 2000, CHRONOBIOL INT, V17, P453, DOI 10.1081/CBI-100101057; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; Jonas Peter, 1995, P231; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mannikko R, 2005, J GEN PHYSIOL, V125, P305, DOI 10.1085/jgp.200409130; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Nache V, 2005, J PHYSIOL-LONDON, V569, P91, DOI 10.1113/jphysiol.2005.092304; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Saitow F, 2000, J NEUROPHYSIOL, V84, P2026, DOI 10.1152/jn.2000.84.4.2026; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Yifrach O, 2004, BIOPHYS J, V87, P822, DOI 10.1529/biophysj.104.040410; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3; ZHENG J, 2003, SCI STKE, pPL7	48	59	59	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					162	169		10.1038/nchembio.747	http://dx.doi.org/10.1038/nchembio.747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22179066				2022-12-27	WOS:000299323200008
J	Kersten, RD; Yang, YL; Xu, YQ; Cimermancic, P; Nam, SJ; Fenical, W; Fischbach, MA; Moore, BS; Dorrestein, PC				Kersten, Roland D.; Yang, Yu-Liang; Xu, Yuquan; Cimermancic, Peter; Nam, Sang-Jip; Fenical, William; Fischbach, Michael A.; Moore, Bradley S.; Dorrestein, Pieter C.			A mass spectrometry-guided genome mining approach for natural product peptidogenomics	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; STREPTOMYCES-COELICOLOR; BIOSYNTHESIS; DIVERSITY; IDENTIFICATION; SEQUENCE; ANTIBIOTICS; ANNOTATION; MORPHOGEN; BACTERIAL	Peptide natural products show broad biological properties and are commonly produced by orthogonal ribosomal and nonribosomal pathways in prokaryotes and eukaryotes. To harvest this large and diverse resource of bioactive molecules, we introduce here natural product peptidogenomics (NPP), a new MS-guided genome-mining method that connects the chemotypes of peptide natural products to their biosynthetic gene clusters by iteratively matching de novo tandem MS (MSn) structures to genomics-based structures following biosynthetic logic. In this study, we show that NPP enabled the rapid characterization of over ten chemically diverse ribosomal and nonribosomal peptide natural products of previously unidentified composition from Streptomycete bacteria as a proof of concept to begin automating the genome-mining process. We show the identification of lantipeptides, lasso peptides, linardins, formylated peptides and lipopeptides, many of which are from well-characterized model Streptomycetes, highlighting the power of NPP in the discovery of new peptide natural products from even intensely studied organisms.	[Kersten, Roland D.; Nam, Sang-Jip; Fenical, William; Moore, Bradley S.; Dorrestein, Pieter C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Yang, Yu-Liang; Xu, Yuquan; Fenical, William; Moore, Bradley S.; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Cimermancic, Peter; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Cimermancic, Peter; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	Dorrestein, PC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu; pdorrestein@ucsd.edu	Dorrestein, Pieter/ABF-2930-2020; Dorrestein, Pieter/D-5012-2012	Moore, Bradley/0000-0002-4652-1253; Fischbach, Michael/0000-0003-3079-8247; Fenical, William/0000-0002-8955-1735	US National Institutes of Health [GM085770, GM086283]; Beckman Foundation; NATIONAL CANCER INSTITUTE [R37CA044848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085770, R01GM086283] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Castellana and V. Bafna for providing the algorithm to enable the six-frame translations of supercontigs. We also thank M. Meehan for FTMS training. Financial support was provided by the US National Institutes of Health (GM085770 to B.S.M. and GM086283 to P.C.D.) and the Beckman Foundation.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BODANSZKY M, 1969, J AM CHEM SOC, V91, P2351, DOI 10.1021/ja01037a028; Caboche S, 2010, J BACTERIOL, V192, P5143, DOI 10.1128/JB.00315-10; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Claesen J, 2010, P NATL ACAD SCI USA, V107, P16297, DOI 10.1073/pnas.1008608107; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Daffre S, 2008, STUD NAT PROD CHEM, V35, P597; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Duncan MW, 2010, NAT BIOTECHNOL, V28, P659, DOI 10.1038/nbt0710-659; Duquesne S, 2007, J MOL MICROB BIOTECH, V13, P200, DOI 10.1159/000104748; Duquesne S, 2007, CHEM BIOL, V14, P793, DOI 10.1016/j.chembiol.2007.06.004; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Gressler M, 2011, CHEM BIOL, V18, P198, DOI 10.1016/j.chembiol.2010.12.011; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Knappe TA, 2010, FEBS LETT, V584, P785, DOI 10.1016/j.febslet.2009.12.046; Koal T, 2010, CURR MOL MED, V10, P216, DOI 10.2174/156652410790963312; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; LIU WT, J AM CHEM S IN PRESS; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Moore BS, 2008, ANGEW CHEM INT EDIT, V47, P9386, DOI 10.1002/anie.200803868; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Ng J, 2009, NAT METHODS, V6, P596, DOI 10.1038/nmeth.1350; Nolan EM, 2009, CHEMBIOCHEM, V10, P34, DOI 10.1002/cbic.200800438; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Romano A, 2011, J NAT PROD, V74, P145, DOI 10.1021/np100408y; Roongsawang N, 2011, INT J MOL SCI, V12, P141, DOI 10.3390/ijms12010141; Strieker M, 2009, CHEMBIOCHEM, V10, P607, DOI 10.1002/cbic.200800546; Tsur D, 2005, NAT BIOTECHNOL, V23, P1562, DOI 10.1038/nbt1168; Ueda K, 2002, J BACTERIOL, V184, P1488, DOI 10.1128/JB.184.5.1488-1492.2002; Vats P, 2007, P NATL ACAD SCI USA, V104, P17795, DOI 10.1073/pnas.0708739104; Velasquez JE, 2011, CURR OPIN CHEM BIOL, V15, P11, DOI 10.1016/j.cbpa.2010.10.027; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; Wilkinson B, 2009, METHOD ENZYMOL, V458, P353, DOI 10.1016/S0076-6879(09)04814-9; Willey JM, 2006, MOL MICROBIOL, V59, P731, DOI 10.1111/j.1365-2958.2005.05018.x; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252	50	278	291	1	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					794	802		10.1038/nchembio.684	http://dx.doi.org/10.1038/nchembio.684			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21983601	Green Submitted, Green Accepted			2022-12-27	WOS:000296381600009
J	Kahsai, AW; Xiao, KH; Rajagopal, S; Ahn, S; Shukla, AK; Sun, JP; Oas, TG; Lefkowitz, RJ				Kahsai, Alem W.; Xiao, Kunhong; Rajagopal, Sudarshan; Ahn, Seungkirl; Shukla, Arun K.; Sun, Jinpeng; Oas, Terrence G.; Lefkowitz, Robert J.			Multiple ligand-specific conformations of the beta(2)-adrenergic receptor	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; CRYSTAL-STRUCTURE; FUNCTIONAL-ROLE; DRUG DISCOVERY; ARRESTIN; RHODOPSIN; ACTIVATION; STATE	Seven-transmembrane receptors (7TMRs), also called G protein-coupled receptors (GPCRs), represent the largest class of drug targets, and they can signal through several distinct mechanisms including those mediated by G proteins and the multifunctional adaptor proteins beta-arrestins. Moreover, several receptor ligands with differential efficacies toward these distinct signaling pathways have been identified. However, the structural basis and mechanism underlying this 'biased agonism' remains largely unknown. Here, we develop a quantitative mass spectrometry strategy that measures specific reactivities of individual side chains to investigate dynamic conformational changes in the beta(2)-adrenergic receptor occupied by nine functionally distinct ligands. Unexpectedly, only a minority of residues showed reactivity patterns consistent with classical agonism, whereas the majority showed distinct patterns of reactivity even between functionally similar ligands. These findings demonstrate, contrary to two-state models for receptor activity, that there is significant variability in receptor conformations induced by different ligands, which has significant implications for the design of new therapeutic agents.	[Kahsai, Alem W.; Xiao, Kunhong; Rajagopal, Sudarshan; Ahn, Seungkirl; Shukla, Arun K.; Sun, Jinpeng; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kahsai, Alem W.; Shukla, Arun K.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Oas, Terrence G.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	khxiao@receptor-biol.duke.edu; lefko001@receptor-biol.duke.edu	sun, Jinpeng/AAR-9196-2020; SUN, JINPENG/F-9551-2013; Lefkowitz, Robert/AAW-2649-2021; Xiao, Kunhong/AAG-4275-2020; Oas, Terrence/F-8916-2011; Rajagopal, Sudarshan/G-8975-2013	Xiao, Kunhong/0000-0002-1069-1226; Oas, Terrence/0000-0002-3067-2743; Rajagopal, Sudarshan/0000-0002-3443-5040; shukla, arun/0000-0003-2910-8288	US National Institutes of Health [HL16037, HL70631]; US National Institute of General Medical Sciences [5RO1GM081666]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081666] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.J.L. is an investigator with the Howard Hughes Medical Institute. This work was supported in part by grants from the US National Institutes of Health (HL16037 and HL70631) to R.J.L. T.G.O. is supported by a grant from the US National Institute of General Medical Sciences (5RO1GM081666). We gratefully acknowledge T. Haystead (Duke University) and D. Loiselle for valuable assistance with the mass spectrometry experiments, and Theravance, Inc. (South San Francisco, California, USA) for the supply of THRX-144877; we are also grateful to R. T. Strachan, J. Kovacs, R. Dror (D. E. Shaw Research, New York, New York, USA), C. H. Borchers (University of Victoria, Victoria, British Columbia, Canada), I. A. Kaltashov (University of Massachusetts), B. Donald (Duke University) and members of his laboratory for stimulating ideas and helpful discussions; we also thank X. Jiang and C. M. Lam for excellent technical assistance and D. Addison and Q. Lennon for secretarial assistance.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bouley R, 2003, AM J PHYSIOL-CELL PH, V285, pC750, DOI 10.1152/ajpcell.00477.2002; CANTOR CR, 1980, BEHAV BIOL MACROMOLE, P915; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Kelly BL, 2003, NAT STRUCT BIOL, V10, P280, DOI 10.1038/nsb908; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2002, J CELL SCI, V115, P455; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Raman D, 2003, J NEUROCHEM, V84, P1040, DOI 10.1046/j.1471-4159.2003.01598.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; STADEL JM, 1979, MOL PHARMACOL, V16, P709; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	50	196	205	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					692	700		10.1038/NCHEMBIO.634	http://dx.doi.org/10.1038/NCHEMBIO.634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21857662	Green Accepted			2022-12-27	WOS:000295027100013
J	Dickinson, BC; Chang, CJ				Dickinson, Bryan C.; Chang, Christopher J.			Chemistry and biology of reactive oxygen species in signaling or stress responses	NATURE CHEMICAL BIOLOGY			English	Article							CELLULAR HYDROGEN-PEROXIDE; TYROSINE-PHOSPHATASE 1B; CYSTEINE-SULFINIC ACID; LIVING CELLS; OXIDATIVE STRESS; NITRIC-OXIDE; IN-VIVO; TRANSCRIPTION FACTOR; FLUORESCENT-PROBES; REDOX REGULATION	Reactive oxygen species (ROS) are a family of molecules that are continuously generated, transformed and consumed in all living organisms as a consequence of aerobic life. The traditional view of these reactive oxygen metabolites is one of oxidative stress and damage that leads to decline of tissue and organ systems in aging and disease. However, emerging data show that ROS produced in certain situations can also contribute to physiology and increased fitness. This Perspective provides a focused discussion on what factors lead ROS molecules to become signal and/or stress agents, highlighting how increasing knowledge of the underlying chemistry of ROS can lead to advances in understanding their disparate contributions to biology. An important facet of this emerging area at the chemistry-biology interface is the development of new tools to study these small molecules and their reactivity in complex biological systems.	[Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dickinson, BC (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	chrischang@berkeley.edu			Packard Foundation; Amgen; Astra Zeneca; Novartis; US National Institutes of Health (NIH) [GM 79465]; NIH [T32 GM066698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, T32GM066698] Funding Source: NIH RePORTER	Packard Foundation(The David & Lucile Packard Foundation); Amgen(Amgen); Astra Zeneca(AstraZeneca); Novartis(Novartis); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Packard Foundation, Amgen, Astra Zeneca and Novartis and the US National Institutes of Health (NIH; GM 79465) for providing funding for this work. C.J.C. is an Investigator with the Howard Hughes Medical Institute. B.C.D. was partially supported by a Chemical Biology Training Grant from the NIH (T32 GM066698). Due to space limitations, we apologize if we inadvertently omitted citations of major contributions to this area.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Bao L, 2009, J NEUROSCI, V29, P9002, DOI 10.1523/JNEUROSCI.1706-09.2009; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Bryan NS, 2009, FRONT BIOSCI-LANDMRK, V14, P1, DOI 10.2741/3228; Chang MCY, 2004, J AM CHEM SOC, V126, P15392, DOI 10.1021/ja0441716; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; DELRIO LA, 1992, FREE RADICAL BIO MED, V13, P557, DOI 10.1016/0891-5849(92)90150-F; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dickinson BC, 2010, CURR OPIN CHEM BIOL, V14, P50, DOI 10.1016/j.cbpa.2009.10.014; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Garner AL, 2009, NAT CHEM, V1, P316, DOI [10.1038/NCHEM.240, 10.1038/nchem.240]; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Kenmoku S, 2007, J AM CHEM SOC, V129, P7313, DOI 10.1021/ja068740g; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Lippert AR, 2011, J AM CHEM SOC, V133, P3776, DOI 10.1021/ja111589a; Mahon KP, 2007, CHEM BIOL, V14, P923, DOI 10.1016/j.chembiol.2007.07.011; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller EW, 2007, J AM CHEM SOC, V129, P3458, DOI 10.1021/ja0668973; Miller EW, 2007, NAT CHEM BIOL, V3, P263, DOI 10.1038/nchembio871; Miller EW, 2010, J AM CHEM SOC, V132, P17071, DOI 10.1021/ja107783j; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Miller EW, 2005, J AM CHEM SOC, V127, P16652, DOI 10.1021/ja054474f; Mishina NM, 2011, ANTIOXID REDOX SIGN, V14, P1, DOI 10.1089/ars.2010.3539; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Poole LB, 2007, BIOCONJUGATE CHEM, V18, P2004, DOI 10.1021/bc700257a; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sasaki E, 2005, J AM CHEM SOC, V127, P3684, DOI 10.1021/ja042967z; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Seo YH, 2011, ANGEW CHEM INT EDIT, V50, P1342, DOI 10.1002/anie.201007175; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Srikun D, 2008, J AM CHEM SOC, V130, P4596, DOI 10.1021/ja711480f; Srikun D, 2011, CHEM SCI, V2, P1156, DOI 10.1039/c1sc00064k; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Thomson E, 2010, FREE RADICAL BIO MED, V49, P1354, DOI 10.1016/j.freeradbiomed.2010.07.010; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Veeramani S, 2008, ONCOGENE, V27, P5057, DOI 10.1038/onc.2008.143; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yang D, 2006, J AM CHEM SOC, V128, P6004, DOI 10.1021/ja0603756	100	1144	1174	26	483	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					504	511		10.1038/NCHEMBIO.607	http://dx.doi.org/10.1038/NCHEMBIO.607			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769097	Green Accepted			2022-12-27	WOS:000292825400010
J	Vedadi, M; Barsyte-Lovejoy, D; Liu, F; Rival-Gervier, S; Allali-Hassani, A; Labrie, V; Wigle, TJ; DiMaggio, PA; Wasney, GA; Siarheyeva, A; Dong, AP; Tempel, W; Wang, SC; Chen, X; Chau, I; Mangano, TJ; Huang, XP; Simpson, CD; Pattenden, SG; Norris, JL; Kireev, DB; Tripathy, A; Edwards, A; Roth, BL; Janzen, WP; Garcia, BA; Petronis, A; Ellis, J; Brown, PJ; Frye, SV; Arrowsmith, CH; Jin, J				Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Liu, Feng; Rival-Gervier, Sylvie; Allali-Hassani, Abdellah; Labrie, Viviane; Wigle, Tim J.; DiMaggio, Peter A.; Wasney, Gregory A.; Siarheyeva, Alena; Dong, Aiping; Tempel, Wolfram; Wang, Sun-Chong; Chen, Xin; Chau, Irene; Mangano, Thomas J.; Huang, Xi-ping; Simpson, Catherine D.; Pattenden, Samantha G.; Norris, Jacqueline L.; Kireev, Dmitri B.; Tripathy, Ashutosh; Edwards, Aled; Roth, Bryan L.; Janzen, William P.; Garcia, Benjamin A.; Petronis, Arturas; Ellis, James; Brown, Peter J.; Frye, Stephen V.; Arrowsmith, Cheryl H.; Jin, Jian			A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells	NATURE CHEMICAL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; HISTONE METHYLTRANSFERASES; DNA METHYLATION; LYSINE-9 METHYLATION; CHROMATIN-STRUCTURE; CANCER-CELLS; P53; TRANSCRIPTION; REPRESSION; COMPLEXES	Protein lysine methyltransferases G9a and GLP modulate the transcriptional repression of a variety of genes via dimethylation of Lys9 on histone H3 (H3K9me2) as well as dimethylation of non-histone targets. Here we report the discovery of UNC0638, an inhibitor of G9a and GLP with excellent potency and selectivity over a wide range of epigenetic and non-epigenetic targets. UNC0638 treatment of a variety of cell lines resulted in lower global H3K9me2 levels, equivalent to levels observed for small hairpin RNA knockdown of G9a and GLP with the functional potency of UNC0638 being well separated from its toxicity. UNC0638 markedly reduced the clonogenicity of MCF7 cells, reduced the abundance of H3K9me2 marks at promoters of known G9a-regulated endogenous genes and disproportionately affected several genomic loci encoding microRNAs. In mouse embryonic stem cells, UNC0638 reactivated G9a-silenced genes and a retroviral reporter gene in a concentration-dependent manner without promoting differentiation.	[Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Allali-Hassani, Abdellah; Wasney, Gregory A.; Siarheyeva, Alena; Dong, Aiping; Tempel, Wolfram; Chau, Irene; Edwards, Aled; Brown, Peter J.; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Liu, Feng; Wigle, Tim J.; Chen, Xin; Simpson, Catherine D.; Pattenden, Samantha G.; Norris, Jacqueline L.; Kireev, Dmitri B.; Janzen, William P.; Frye, Stephen V.; Jin, Jian] Univ N Carolina, UNC Eshelman Sch Pharm, Div Med Chem & Nat Prod, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA; [Rival-Gervier, Sylvie; Ellis, James] SickKids Hosp, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Ellis, James] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rival-Gervier, Sylvie] INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France; [Labrie, Viviane; Wang, Sun-Chong; Petronis, Arturas] Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, Toronto, ON, Canada; [DiMaggio, Peter A.; Garcia, Benjamin A.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Wang, Sun-Chong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Mangano, Thomas J.; Huang, Xi-ping; Roth, Bryan L.] Univ N Carolina, Drug Screening Program, Natl Inst Mental Hlth Psychoact, Chapel Hill, NC USA; [Tripathy, Ashutosh] Univ N Carolina, Dept Biochem & Biophys, UNC Macromol Interact Facil, Chapel Hill, NC USA; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Princeton University; National Central University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Vedadi, M (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	carrow@uhnres.utoronto.ca; jianjin@unc.edu	Roth, Bryan L/F-3928-2010; Ellis, James/F-4789-2011; Kireev, Dmitri/B-7225-2012; Rival-Gervier, Sylvie/M-7649-2014; Petronis, Art/AAD-4491-2019	Ellis, James/0000-0002-4400-0091; Kireev, Dmitri/0000-0001-8479-8555; Rival-Gervier, Sylvie/0000-0001-8266-8095; Labrie, Viviane/0000-0002-8851-0093; Arrowsmith, Cheryl/0000-0002-4971-3250; Edwards, Aled/0000-0002-4782-6016; Labrie, Viviane/0000-0003-1037-1967; Brown, Peter/0000-0002-8454-0367; Chen, Xin/0000-0002-5208-2154; DiMaggio, Peter/0000-0003-1996-0813	National Institute of General Medical Sciences; US National Institutes of Health (NIH) [RC1GM090732]; University of North Carolina at Chapel Hill; US National Science Foundation (NSF); Ontario Research Fund; Ontario Ministry of Health and Long-term Care; Structural Genomics Consortium; Canadian Institutes for Health Research (CIHR) [199170, 186007, IG1-102956]; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co. Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NIH [MH074127, MH088413, DP3DK085698, HG004535]; NSF [CBET-0941143]; American Society for Mass Spectrometry; NIH Office of the Director [DP2OD007447]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK085698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM090732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074127, R01MH088413] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; US National Science Foundation (NSF)(National Science Foundation (NSF)); Ontario Research Fund; Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co. Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American Society for Mass Spectrometry; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Tumber for JMJD2E assay support; J. Moffat (University of Toronto) for the gift of shRNAs; R. Bristow (University Health Network) for RV221 and PC3 cells; T. Hajian and F. Syeda for protein purification; G. Senisterra for contributing to DSF and DSLS data analysis; M. Herold for graphical design and illustration; I. Korboukh, M. Herold and J. Yost for critical reading of the manuscript; and R. Trump and C. Yates for helpful discussion. The research described here was supported by the National Institute of General Medical Sciences, US National Institutes of Health (NIH; grant RC1GM090732), the Carolina Partnership and University Cancer Research Fund from the University of North Carolina at Chapel Hill, the US National Science Foundation (NSF), the Ontario Research Fund, the Ontario Ministry of Health and Long-term Care and the Structural Genomics Consortium. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research (CIHR), the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co. Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. C.H.A. holds a Canada Research Chair in Structural Genomics. V.L. is supported by a CIHR fellowship. A.P. is supported by grants from the CIHR (199170 and 186007) and from the NIH (MH074127, MH088413, DP3DK085698 and HG004535). A.P. is Tapscott Chair in Schizophrenia Studies and a Senior Fellow of the Ontario Mental Health Foundation. J.E. is supported by CIHR grant IG1-102956. B.A.G. is supported by grants from the NSF (Early Faculty CAREER award and CBET-0941143), the American Society for Mass Spectrometry and the NIH Office of the Director (DP2OD007447). P.A.D. is supported by NIH postdoctoral fellowship F32 NRSA.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Chang YQ, 2010, J MOL BIOL, V400, P1, DOI 10.1016/j.jmb.2010.04.048; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Chen LH, 2010, EMBO J, V29, P2538, DOI 10.1038/emboj.2010.140; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gelato KA, 2008, BIOL CHEM, V389, P353, DOI 10.1515/BC.2008.048; Goyama S, 2010, LEUKEMIA, V24, P81, DOI 10.1038/leu.2009.202; Hosey AM, 2010, EPIGENETICS-US, V5, P273, DOI 10.4161/epi.5.4.11522; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Imai K, 2010, J BIOL CHEM, V285, P16538, DOI 10.1074/jbc.M110.103531; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Link PA, 2009, MOL CANCER RES, V7, P851, DOI 10.1158/1541-7786.MCR-08-0497; Liu F, 2010, J MED CHEM, V53, P5844, DOI 10.1021/jm100478y; Liu F, 2009, J MED CHEM, V52, P7950, DOI 10.1021/jm901543m; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Plazas-Mayorca MD, 2010, MOL BIOSYST, V6, P1719, DOI 10.1039/c003307c; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Wigle TJ, 2010, CHEM BIOL, V17, P695, DOI 10.1016/j.chembiol.2010.04.014; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784	50	376	391	4	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					566	574		10.1038/NCHEMBIO.599	http://dx.doi.org/10.1038/NCHEMBIO.599			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21743462	Green Published, Green Accepted			2022-12-27	WOS:000292825400019
J	Ullrich, SJ; Hellmich, UA; Ullrich, S; Glaubitz, C				Ullrich, Sandra J.; Hellmich, Ute A.; Ullrich, Stefan; Glaubitz, Clemens			Interfacial enzyme kinetics of a membrane bound kinase analyzed by real-time MAS-NMR	NATURE CHEMICAL BIOLOGY			English	Article							COLI DIACYLGLYCEROL KINASE; ESCHERICHIA-COLI; SN-1,2-DIACYLGLYCEROL KINASE; PHOSPHOROTHIOATE ANALOGS; TRANSITION-STATE; PROTEIN; ATP; HYDROLYSIS; SITES; LOCALIZATION	The simultaneous observation of interdependent reactions within different phases as catalyzed by membrane-bound enzymes is still a challenging task. One such enzyme, the Escherichia coli integral membrane protein diacylglycerol kinase (DGK), is a key player in lipid regulation. It catalyzes the generation of phosphatidic acid within the membrane through the transfer of the gamma-phosphate from soluble MgATP to membrane-bound diacylglycerol. We demonstrate that time-resolved P-31 magic angle spinning NMR offers a unique opportunity to simultaneously and directly detect both ATP hydrolysis and diacylglycerol phosphorylation. This experiment demonstrates that solid-state NMR provides a general approach for the kinetic analysis of coupled reactions at the membrane interface regardless of their compartmentalization. The enzymatic activity of DGK was probed with different lipid substrates as well as ATP analogs. Our data yield conclusions about intersubunit cooperativity, reaction stoichiometries and phosphoryl transfer mechanism and are discussed in the context of known structural data.	[Ullrich, Sandra J.; Hellmich, Ute A.; Glaubitz, Clemens] Goethe Univ Frankfurt, Inst Biophys Chem, Frankfurt, Germany; [Ullrich, Sandra J.; Hellmich, Ute A.; Glaubitz, Clemens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Frankfurt, Germany; [Ullrich, Stefan] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Glaubitz, C (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Frankfurt, Germany.	glaubitz@em.uni-frankfurt.de	Glaubitz, Clemens/D-5714-2011	Glaubitz, Clemens/0000-0002-3554-6586; Hellmich, Ute/0000-0001-7162-285X	Lipid Signalling Forschungszentrum Frankfurt (LiFF); SFB [807]; EU; Cluster of Excellence Macromolecular Complexes Frankfurt; Studienstiftung des deutschen Volkes	Lipid Signalling Forschungszentrum Frankfurt (LiFF); SFB(Austrian Science Fund (FWF)); EU(European Commission); Cluster of Excellence Macromolecular Complexes Frankfurt; Studienstiftung des deutschen Volkes	We are grateful to J. Becker Baldus, L. Buchner, S. Holper, C. Kaiser, N. Pfleger and L. Reggie for technical assistance. Plasmids were kindly provided by C. R. Sanders (Vanderbilt University). We thank D. O'Donovan and J.J. Lopez for initial help with data analysis. We thank M. Gobel for enabling access to his laboratory for substrate synthesis and B. Ludwig for helpful discussions. M. Lorch is acknowledged for valuable comments to the manuscript. The work was supported by the Lipid Signalling Forschungszentrum Frankfurt (LiFF) and by SFB 807 "Membrane Transport." Further support by the EU consortium Lipid-PRISM and the Cluster of Excellence Macromolecular Complexes Frankfurt is acknowledged. S.J.U. is grateful for a stipend from the "Studienstiftung des deutschen Volkes."	ALBERY WJ, 1977, ANGEW CHEM INT EDIT, V16, P285, DOI 10.1002/anie.197702851; Badola P, 1997, J BIOL CHEM, V272, P24176, DOI 10.1074/jbc.272.39.24176; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; Catrina IE, 1999, J AM CHEM SOC, V121, P2156, DOI 10.1021/ja983862x; Chen P, 1998, J BACTERIOL, V180, P167, DOI 10.1128/JB.180.1.167-170.1998; Cherepanov AV, 2008, P NATL ACAD SCI USA, V105, P8563, DOI 10.1073/pnas.0709140105; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Clarke K, 1996, J BIOL CHEM, V271, P21142, DOI 10.1074/jbc.271.35.21142; COHN M, 1962, J BIOL CHEM, V237, P176; COHN M, 1982, ACCOUNTS CHEM RES, V15, P326, DOI 10.1021/ar00082a005; CREPEAU RH, 1994, BIOPHYS J, V66, P1489, DOI 10.1016/S0006-3495(94)80940-3; Czerski L, 2000, ANAL BIOCHEM, V284, P327, DOI 10.1006/abio.2000.4720; Daly CJ, 2003, PHARMACOL THERAPEUT, V100, P101, DOI 10.1016/j.pharmthera.2003.08.001; ECKSTEIN F, 1983, ANGEW CHEM INT EDIT, V22, P423, DOI 10.1002/anie.198304233; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; Forneris F, 2008, SCIENCE, V321, P213, DOI 10.1126/science.1151118; FREY PA, 1985, SCIENCE, V228, P541, DOI 10.1126/science.2984773; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; GOODNO CC, 1982, P NATL ACAD SCI-BIOL, V79, P21, DOI 10.1073/pnas.79.1.21; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Hellmich UA, 2008, FEBS LETT, V582, P3557, DOI 10.1016/j.febslet.2008.09.033; HOLLFELDER F, 1995, BIOCHEMISTRY-US, V34, P12255, DOI 10.1021/bi00038a021; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; KANOH H, 1990, TRENDS BIOCHEM SCI, V15, P47, DOI 10.1016/0968-0004(90)90172-8; KENNEDY EP, 1982, P NATL ACAD SCI-BIOL, V79, P1092, DOI 10.1073/pnas.79.4.1092; Koehler J, 2010, BIOCHEMISTRY-US, V49, P7089, DOI 10.1021/bi100575s; Lau FW, 1999, BIOCHEMISTRY-US, V38, P5521, DOI 10.1021/bi982763t; Maly T, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2833582; McDermott A, 2007, CURR OPIN STRUC BIOL, V17, P617, DOI 10.1016/j.sbi.2007.10.001; Nagy JK, 2000, BIOCHEMISTRY-US, V39, P4154, DOI 10.1021/bi991781n; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Oxenoid K, 2002, BIOCHEMISTRY-US, V41, P12876, DOI 10.1021/bi020335o; RAETZ CRH, 1979, J BACTERIOL, V137, P860, DOI 10.1128/JB.137.2.860-868.1979; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Sanders CR, 1996, BIOCHEMISTRY-US, V35, P8610, DOI 10.1021/bi9604892; SCHAAP D, 1994, BIOCHEM J, V304, P661, DOI 10.1042/bj3040661; SCHELLENBERGER A, 1989, ENZYMKATALYSE EINFUH; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Sperling LJ, 2010, J MOL BIOL, V399, P268, DOI 10.1016/j.jmb.2010.04.012; STRATER N, 1996, ANGEW CHEM, V108, P2158; TAKAHASHI K, 1987, J BIOCHEM-TOKYO, V101, P1107, DOI 10.1093/oxfordjournals.jbchem.a121975; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Vann LR, 1997, BIOCHEM J, V327, P569; WALSH JP, 1990, J BIOL CHEM, V265, P4374; WALSH JP, 1986, J BIOL CHEM, V261, P6239; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; YAMASHITA Y, 1993, J BACTERIOL, V175, P6220, DOI 10.1128/JB.175.19.6220-6228.1993; Zhang YL, 1999, BIOCHEMISTRY-US, V38, P12111, DOI 10.1021/bi990836i	50	37	37	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					263	270		10.1038/nchembio.543	http://dx.doi.org/10.1038/nchembio.543			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21423170				2022-12-27	WOS:000289617800009
J	Sato, A; Nagasaka, S; Furihata, K; Nagata, S; Arai, I; Saruwatari, K; Kogure, T; Sakuda, S; Nagasawa, H				Sato, Ai; Nagasaka, Seiji; Furihata, Kazuo; Nagata, Shinji; Arai, Isao; Saruwatari, Kazuko; Kogure, Toshihiro; Sakuda, Shohei; Nagasawa, Hiromichi			Glycolytic intermediates induce amorphous calcium carbonate formation in crustaceans	NATURE CHEMICAL BIOLOGY			English	Article							PROCAMBARUS-CLARKII; MATRIX PROTEIN; BIOMINERALIZATION; CRAYFISH	It has been thought that phosphorus in biominerals made of amorphous calcium carbonate (ACC) might be related to ACC formation, but no such phosphorus-containing compounds have ever been identified. Crustaceans use ACC biominerals in exoskeleton and gastroliths so that they will have easy access to calcium carbonate inside the body before and after molting. We have identified phosphoenolpyruvate and 3-phosphoglycerate, intermediates of the glycolytic pathway, in exoskeleton and gastroliths and found them important for stabilizing ACC.	[Sato, Ai; Nagasaka, Seiji; Furihata, Kazuo; Nagata, Shinji; Sakuda, Shohei; Nagasawa, Hiromichi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Nagasaka, Seiji] Toyo Univ, Grad Sch Life Sci, Itakura, Gunma, Japan; [Arai, Isao; Saruwatari, Kazuko; Kogure, Toshihiro] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 113, Japan; [Arai, Isao] Mitsubishi Mat Corp, Cent Res Inst, Naka, Ibaraki, Japan; [Saruwatari, Kazuko] Natl Inst Mat Sci, Soft Chem Grp, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan	University of Tokyo; Toyo University; University of Tokyo; Mitsubishi Materials Corporation; National Institute for Materials Science	Sato, A (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan.	anagahi@mail.ecc.u-tokyo.ac.jp	Kogure, Toshihiro/K-7857-2015	Kogure, Toshihiro/0000-0002-3494-8989; Sakuda, Shohei/0000-0001-7966-1167	Japan Society for the Promotion of Science [17GS0311, 22248037, 22228006]; Grants-in-Aid for Scientific Research [22228006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to J.J. Hull for critical reading of the manuscript. We also thank Y. Kagayama (Fisheries Station of Yamagata Prefecture, Japan) for supplying us with the mitten crab. This work was supported by Grants-in-Aid for Scientific Research (nos. 17GS0311, 22248037 and 22228006) from the Japan Society for the Promotion of Science.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bentov S, 2010, J STRUCT BIOL, V171, P207, DOI 10.1016/j.jsb.2010.04.007; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Faatz M, 2004, ADV MATER, V16, P996, DOI 10.1002/adma.200306565; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Hikida T., 2003, BIOMINERALIATION FOR, P81; HOUSE WA, 1987, J COLLOID INTERF SCI, V119, P505, DOI 10.1016/0021-9797(87)90296-7; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Koga N, 1998, THERMOCHIM ACTA, V318, P239, DOI 10.1016/S0040-6031(98)00348-7; Levi-Kalisman Y, 2002, ADV FUNCT MATER, V12, P43, DOI 10.1002/1616-3028(20020101)12:1<43::AID-ADFM43>3.0.CO;2-C; Loste E, 2001, CHEM COMMUN, P901, DOI 10.1039/b101563j; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Sawada K, 2003, DALTON T, P342, DOI 10.1039/b209758n; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tohse H, 2009, CRYST GROWTH DES, V9, P4897, DOI 10.1021/cg9006857; Tsutsui N, 1999, ZOOL SCI, V16, P619, DOI 10.2108/zsj.16.619; WEINER S, 1984, AM ZOOL, V24, P945	25	65	65	3	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					197	199		10.1038/NCHEMBIO.532	http://dx.doi.org/10.1038/NCHEMBIO.532			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21336282				2022-12-27	WOS:000288545000005
J	Inobe, T; Fishbain, S; Prakash, S; Matouschek, A				Inobe, Tomonao; Fishbain, Susan; Prakash, Sumit; Matouschek, Andreas			Defining the geometry of the two-component proteasome degron	NATURE CHEMICAL BIOLOGY			English	Article							UBIQUITIN-LIKE DOMAIN; 26S PROTEASOME; TAGGING SYSTEM; DIHYDROFOLATE-REDUCTASE; PROTEIN-BINDING; DNA-REPAIR; IN-VITRO; DEGRADATION; RECOGNITION; SUBUNIT	The eukaryotic 26S proteasome controls cellular processes by degrading specific regulatory proteins. Most proteins are targeted for degradation by a signal or degron that consists of two parts: a proteasome-binding tag, typically covalently attached polyubiquitin chains, and an unstructured region that serves as the initiation region for proteasomal proteolysis. Here we have characterized how the arrangement of the two degron parts in a protein affects degradation. We found that a substrate is degraded efficiently only when its initiation region is of a certain minimal length and is appropriately separated in space from the proteasome-binding tag. Regions that are located too close or too far from the proteasome-binding tag cannot access the proteasome and induce degradation. These spacing requirements are different for a polyubiquitin chain and a ubiquitin-like domain. Thus, the arrangement and location of the proteasome initiation region affect a protein's fate and are important in selecting proteins for proteasome-mediated degradation.	[Inobe, Tomonao; Fishbain, Susan; Prakash, Sumit; Matouschek, Andreas] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Inobe, Tomonao; Fishbain, Susan; Prakash, Sumit; Matouschek, Andreas] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; [Inobe, Tomonao] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama, Japan	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; RIKEN	Inobe, T (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	matouschek@northwestern.edu	Prakash, Sumit/B-2679-2009; Matouschek, Andreas/L-9379-2013	Prakash, Sumit/0000-0002-0608-3420; Matouschek, Andreas/0000-0001-6016-2341; Inobe, Tomonao/0000-0002-5864-6889	US National Institutes of Health [R01GM063004, U54CA143869]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22770137]; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063004] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Robert H. Lurie Comprehensive Cancer Center at Northwestern University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Elsasser (Harvard University Medical School), D. Finley (Harvard University Medical School), B. S. Glick (University of Chicago) and Y. Saeki (Tokyo Metropolitan Institute of Medical Science) for providing plasmids and yeast strains and members of the Matouschek lab for advice and comments. The authors greatly appreciate and gratefully acknowledge N. Nukina (RIKEN) for his support and the use of his laboratory equipment. We also thank G. Leigh for editing the manuscript. The work was supported by grants R01GM063004 and U54CA143869 from the US National Institutes of Health, by Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-Aid 22770137 (T. I.) and by the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. T. I. also gratefully acknowledges a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad and the RIKEN Special Postdoctoral Researchers Program.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Djuranovic S, 2009, MOL CELL, V34, P580, DOI 10.1016/j.molcel.2009.04.030; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gonzalez M, 1998, GENE DEV, V12, P3889, DOI 10.1101/gad.12.24.3889; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Larsen CN, 1997, CELL, V91, P431, DOI 10.1016/S0092-8674(00)80427-4; Levchenko I, 2005, NAT STRUCT MOL BIOL, V12, P520, DOI 10.1038/nsmb934; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; McGinness KE, 2007, J BIOL CHEM, V282, P11465, DOI 10.1074/jbc.M610671200; MILLER WG, 1968, BIOCHEMISTRY-US, V7, P3925, DOI 10.1021/bi00851a021; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; POLITOU AS, 1994, BIOCHEMISTRY-US, V33, P4730, DOI 10.1021/bi00181a604; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; ROOD JI, 1980, GENE, V8, P255, DOI 10.1016/0378-1119(80)90003-7; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Stack JH, 2000, NAT BIOTECHNOL, V18, P1298, DOI 10.1038/82422; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Verhoef LGGC, 2009, FASEB J, V23, P123, DOI 10.1096/fj.08-115055; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	50	121	121	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					161	167		10.1038/NCHEMBIO.521	http://dx.doi.org/10.1038/NCHEMBIO.521			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21278740	Green Accepted			2022-12-27	WOS:000287307600009
J	Vickers, CE; Blank, LM; Kromer, JO				Vickers, Claudia E.; Blank, Lars M.; Kroemer, Jens O.			Chassis cells for industrial biochemical production	NATURE CHEMICAL BIOLOGY			English	Article							GENOME	Hyper-performing whole-cell catalysts are required for the renewable and sustainable production of petrochemical replacements. Chassis cells-self-replicating minimal machines that can be tailored for the production of specific chemicals-will provide the starting point for designing these hyper-performing 'turbo cells'.	[Vickers, Claudia E.; Kroemer, Jens O.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Blank, Lars M.] TU Dortmund Univ, Lab Chem Biotechnol, Dortmund, Germany	University of Queensland; Dortmund University of Technology	Vickers, CE (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	c.vickers@uq.edu.au	Krömer, Jens O./C-5958-2009; Vickers, Claudia E/A-1288-2009; Blank, Lars M./A-6761-2012	Krömer, Jens O./0000-0001-5006-0819; Vickers, Claudia E/0000-0002-0792-050X; Blank, Lars M./0000-0003-0961-4976				Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Blank LM, 2008, FEBS J, V275, P5173, DOI 10.1111/j.1742-4658.2008.06648.x; Buntin K, 2010, CHEMBIOCHEM, V11, P1137, DOI 10.1002/cbic.200900712; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Koopman F, 2010, P NATL ACAD SCI USA, V107, P4919, DOI 10.1073/pnas.0913039107; Lee SY, 2010, ADV BIOCHEM ENG BIOT, V120, P1, DOI 10.1007/10_2009_57; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Luisi PL, 2002, HELV CHIM ACTA, V85, P1759, DOI 10.1002/1522-2675(200206)85:6<1759::AID-HLCA1759>3.0.CO;2-7; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Morimoto T, 2008, DNA RES, V15, P73, DOI 10.1093/dnares/dsn002; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Schmid A, 2010, CURR OPIN BIOTECH, V21, P12, DOI 10.1016/j.copbio.2010.01.007	16	47	50	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					875	877		10.1038/nchembio.484	http://dx.doi.org/10.1038/nchembio.484			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079595				2022-12-27	WOS:000284214700011
J	Stanton, BC; Nielsen, AAK; Tamsir, A; Clancy, K; Peterson, T; Voigt, CA				Stanton, Brynne C.; Nielsen, Alec A. K.; Tamsir, Alvin; Clancy, Kevin; Peterson, Todd; Voigt, Christopher A.			Genomic mining of prokaryotic repressors for orthogonal logic gates	NATURE CHEMICAL BIOLOGY			English	Article							GENE-EXPRESSION; MAMMALIAN-CELLS; ESCHERICHIA-COLI; TAL EFFECTORS; OPERATOR; TRANSCRIPTION; DNA; CONSTRUCTION; SPECIFICITY; SELECTION	Genetic circuits perform computational operations based on interactions between freely diffusing molecules within a cell. When transcription factors are combined to build a circuit, unintended interactions can disrupt its function. Here, we apply 'part mining' to build a library of 73 TetR-family repressors gleaned from prokaryotic genomes. The operators of a subset were determined using an in vitro method, and this information was used to build synthetic promoters. The promoters and repressors were screened for cross-reactions. Of these, 16 were identified that both strongly repress their cognate promoter (5- to 207-fold) and exhibit minimal interactions with other promoters. Each repressor-promoter pair was converted to a NOT gate and characterized. Used as a set of 16 NOT/NOR gates, there are >10(54) circuits that could be built by changing the pattern of input and output promoters. This represents a large set of compatible gates that can be used to construct user-defined circuits.	[Stanton, Brynne C.; Nielsen, Alec A. K.; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Tamsir, Alvin] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Clancy, Kevin; Peterson, Todd] Life Technol, Synthet Biol R&D Unit, Carlsbad, CA USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; Thermo Fisher Scientific	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com			Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a [FA9550-11-C-0028]; Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO) [N66001-12-C-4016]; Office of Naval Research [N00014-13-1-0074]; US National Institutes of Health [GM095765]; US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC) [SA5284-11210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095765] Funding Source: NIH RePORTER	Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a; Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank C. Warren of Illumavista Biosciences for aid with array design, array experiments, data analysis and Peel scripts that were used for array data extraction. Research for this publication was conducted with government support under FA9550-11-C-0028 and was awarded by the Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a to A.A.K.N. C.A.V. is supported by Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO) (N66001-12-C-4016), Office of Naval Research (N00014-13-1-0074), US National Institutes of Health (GM095765) and the US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC, SA5284-11210).	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brown S., 2008, FUNDAMENTALS DIGITAL, V3rd; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Chen YJ, 2013, NAT METHODS, V10, P659, DOI [10.1038/NMETH.2515, 10.1038/nmeth.2515]; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; DINGERMANN T, 1992, EMBO J, V11, P1487, DOI 10.1002/j.1460-2075.1992.tb05193.x; Durai S, 2006, COMB CHEM HIGH T SCR, V9, P301, DOI 10.2174/138620706776843147; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; GATZ C, 1988, P NATL ACAD SCI USA, V85, P1394, DOI 10.1073/pnas.85.5.1394; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; Guss Adam M., 2008, Archaea, V2, P193, DOI 10.1155/2008/534081; Helbl V, 1998, J MOL BIOL, V276, P319, DOI 10.1006/jmbi.1997.1539; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Itzkovitz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-239; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kittleson JT, 2012, CURR OPIN CHEM BIOL, V16, P329, DOI 10.1016/j.cbpa.2012.06.009; Krueger M, 2007, GENE, V404, P93, DOI 10.1016/j.gene.2007.09.002; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Lycett GJ, 2004, GENETICS, V167, P1781, DOI 10.1534/genetics.104.028175; Moser F, 2012, ACS SYNTH BIOL, V1, P555, DOI 10.1021/sb3000832; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Politz MC, 2013, CHEM COMMUN, V49, P4325, DOI 10.1039/c2cc37107c; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rudell R. L., 1986, MUTIPLE VALUED LOGIC; Saez E, 1997, CURR OPIN BIOTECH, V8, P608, DOI 10.1016/S0958-1669(97)80037-7; Sleight SC, 2013, ACS SYNTH BIOL, V2, P519, DOI 10.1021/sb400055h; Stanton BC, 2009, MOL MICROBIOL, V72, P1334, DOI 10.1111/j.1365-2958.2009.06719.x; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Thompson KE, 2012, ACS SYNTH BIOL, V1, P118, DOI 10.1021/sb200015u; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Weber W, 2011, CURR OPIN CHEM BIOL, V15, P414, DOI 10.1016/j.cbpa.2011.03.003; Weiss R., 2001, DNA Computing. 6th International Workshop on DNA-Based Computers, DNA 2000. Revised Papers (Lecture Notes in Computer Science Vol.2054), P1; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	50	230	243	4	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					99	105		10.1038/nchembio.1411	http://dx.doi.org/10.1038/nchembio.1411			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316737	Green Accepted, Green Submitted			2022-12-27	WOS:000330751600007
J	Sutton, BJ				Sutton, Brian J.			IMMUNOLOGY Allergy's Achilles' heel?	NATURE CHEMICAL BIOLOGY			English	News Item							MAST-CELLS; IGE; RECEPTOR; DEGRANULATION; BINDING	Allergic reactions to otherwise innocuous substances involve a complex interplay of molecular interactions-some strong, some weak. This study reveals a key role for low-affinity antibodies and thus a possible point of weakness that may be exploited for therapeutic intervention.	[Sutton, Brian J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Sutton, Brian J.] Kings Coll London, MRC, London WC2R 2LS, England; [Sutton, Brian J.] Kings Coll London, Asthma UK Ctr Allerg Mech Asthma, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Sutton, BJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	brian.sutton@kcl.ac.uk			Medical Research Council [G1000758, G1100090] Funding Source: Medline; MRC [G1100090] Funding Source: UKRI; Medical Research Council [G1000758B] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK		Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Handlogten MW, 2013, NAT CHEM BIOL, V9, P789, DOI [10.1038/NCHEMBIO.1358, 10.1038/nchembio.1358]; Handlogten MW, 2011, CHEM BIOL, V18, P1179, DOI 10.1016/j.chembiol.2011.06.012; Hunt J, 2012, J BIOL CHEM, V287, P17459, DOI 10.1074/jbc.M111.331967; Metzger H, 2002, MOL IMMUNOL, V38, P1207, DOI 10.1016/S0161-5890(02)00065-2; Posner RG, 2007, ORG LETT, V9, P3551, DOI 10.1021/ol071175h; Rajagopalan K, 1996, P NATL ACAD SCI USA, V93, P6019, DOI 10.1073/pnas.93.12.6019; Sil D, 2007, ACS CHEM BIOL, V2, P674, DOI 10.1021/cb7001472	10	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					756	759		10.1038/nchembio.1390	http://dx.doi.org/10.1038/nchembio.1390			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24231615				2022-12-27	WOS:000327130000004
J	Ogawa-Ohnishi, M; Matsushita, W; Matsubayashi, Y				Ogawa-Ohnishi, Mari; Matsushita, Wataru; Matsubayashi, Yoshikatsu			Identification of three hydroxyproline O-arabinosyltransferases in Arabidopsis thaliana	NATURE CHEMICAL BIOLOGY			English	Article							CELL-WALL GLYCOPROTEIN; MEDICAGO-TRUNCATULA; POLLEN GERMINATION; RICH GLYCOPROTEIN; SECRETED PEPTIDE; EXTENSIN; PROTEINS; CONFORMATION; NODULATION; ROOT	Hydroxyproline (Hyp) O-arabinosylation is a post-translational modification that is prominent in extracellular glycoproteins in plants. Hyp O-arabinosylation is generally found in these glycoproteins in the form of linear oligoarabinoside chains and has a key role in their function by contributing to conformational stability. However, Hyp O-arabinosyltransferase (HPAT), a key enzyme that catalyzes the transfer of the L-arabinose to the hydroxyl group of Hyp residues, has remained undiscovered. Here, we purified and identified Arabidopsis HPAT as a Golgi-localized transmembrane protein that is structurally similar to the glycosyltransferase GT8 family. Loss-of-function mutations in HPAT-encoding genes cause pleiotropic phenotypes that include enhanced hypocotyl elongation, defects in cell wall thickening, early flowering, early senescence and impaired pollen tube growth. Our results indicate essential roles of Hyp O-arabinosylation in both vegetative and reproductive growth in plants.	[Ogawa-Ohnishi, Mari; Matsubayashi, Yoshikatsu] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; [Matsushita, Wataru] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University	Ogawa-Ohnishi, M (corresponding author), Natl Inst Basic Biol, Okazaki, Aichi 444, Japan.	ymatsu@nibb.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019	Matsubayashi, Yoshikatsu/0000-0002-2669-2119; Ogawa-Ohnishi, Mari/0000-0002-7581-2607	Japan Society for the Promotion of Science [GS025]; Ministry of Education, Culture, Sports, Science and Technology [25221105]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the National Institute for Basic Biology Functional Genomics Facility for MALDI-TOF MS analysis and T. Ueda (University of Tokyo) for providing the mRFP-SYP31 expression vector. This research was supported by the Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (no. GS025) and Grants-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology (no. 25221105).	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; AKIYAMA Y, 1980, AGR BIOL CHEM TOKYO, V44, P2487, DOI 10.1080/00021369.1980.10864347; Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Basu D, 2013, J BIOL CHEM, V288, P10132, DOI 10.1074/jbc.M112.432609; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Hall Q, 2002, PLANT CELL, V14, P1161, DOI 10.1105/tpc.010477; KIELISZEWSKI M, 1992, PLANT PHYSIOL, V98, P919, DOI 10.1104/pp.98.3.919; Kieliszewski MJ, 2011, ANNU PLANT REV, V41, P321, DOI 10.1002/9781444391015.ch13; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; LAMPORT DTA, 1967, NATURE, V216, P1322, DOI 10.1038/2161322a0; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Matsubayashi Y, 2011, PLANT CELL PHYSIOL, V52, P5, DOI 10.1093/pcp/pcq169; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Mortier V, 2010, PLANT PHYSIOL, V153, P222, DOI 10.1104/pp.110.153718; MUSCHIETTI J, 1994, PLANT J, V6, P321, DOI 10.1046/j.1365-313X.1994.06030321.x; Nikolovski N, 2012, PLANT PHYSIOL, V160, P1037, DOI 10.1104/pp.112.204263; Ohyama K, 2008, PLANT J, V55, P152, DOI 10.1111/j.1365-313X.2008.03464.x; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Okamoto S, 2009, PLANT CELL PHYSIOL, V50, P67, DOI 10.1093/pcp/pcn194; Okamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3191; OWENS RJ, 1981, BIOCHEM J, V195, P661, DOI 10.1042/bj1950661; Pearce G, 2001, NATURE, V411, P817, DOI 10.1038/35081107; Reid DE, 2011, MOL PLANT MICROBE IN, V24, P606, DOI 10.1094/MPMI-09-10-0207; Schnabel EL, 2011, PLANT PHYSIOL, V157, P328, DOI 10.1104/pp.111.178756; Schnabelrauch LS, 1996, PLANT J, V9, P477, DOI 10.1046/j.1365-313X.1996.09040477.x; Shinohara H, 2013, PLANT CELL PHYSIOL, V54, P369, DOI 10.1093/pcp/pcs174; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; STAFSTROM JP, 1986, PLANT PHYSIOL, V81, P242, DOI 10.1104/pp.81.1.242; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; VANHOLST GJ, 1984, PLANT PHYSIOL, V74, P247, DOI 10.1104/pp.74.2.247; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657	40	102	112	5	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					726	+		10.1038/NCHEMBIO.1351	http://dx.doi.org/10.1038/NCHEMBIO.1351			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24036508				2022-12-27	WOS:000325930500014
J	Weng, JH; Liang, MR; Chen, CH; Tong, SK; Huang, TC; Lee, SP; Chen, YR; Chen, CT; Chung, BC				Weng, Jui-Hsia; Liang, Ming-Ren; Chen, Chien-Han; Tong, Sok-Keng; Huang, Tzu-Chiao; Lee, Sue-Ping; Chen, Yet-Ran; Chen, Chao-Tsen; Chung, Bon-chu			Pregnenolone activates CLIP-170 to promote microtubule growth and cell migration	NATURE CHEMICAL BIOLOGY			English	Article							DYNAMIC-BEHAVIOR; PLUS ENDS; RECEPTOR; PHOSPHORYLATION; BINDING; SYSTEM; IQGAP1; MICE; EB1; SCHIZOPHRENIA	Pregnenolone (P5) is a neurosteroid that improves memory and neurological recovery. It is also required for zebrafish embryonic development. However, its mode of action is unclear. Here we show that P5 promotes cell migration and microtubule polymerization by binding a microtubule plus end-tracking protein, cytoplasmic linker protein 1 (CLIP-170). We captured CLIP-170 from zebrafish embryonic extract using a P5 photoaffinity probe conjugated to diaminobenzophenone. P5 interacted with CLIP-170 at its coiled-coil domain and changed it into an extended conformation. This increased CLIP-170 interaction with microtubules, dynactin subunit p150(Glued) and LIS1; it also promoted CLIP-170-dependent microtubule polymerization. CLIP-170 was essential for P5 to promote microtubule abundance and zebrafish epiboly cell migration during embryogenesis, and overexpression of the P5-binding region of CLIP-170 delayed this migration. P5 also sustained migration directionality of cultured mammalian cells. Our results show that P5 activates CLIP-170 to promote microtubule polymerization and cell migration.	[Weng, Jui-Hsia; Chung, Bon-chu] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Weng, Jui-Hsia; Tong, Sok-Keng; Lee, Sue-Ping; Chung, Bon-chu] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Liang, Ming-Ren; Chen, Chien-Han; Huang, Tzu-Chiao; Chen, Chao-Tsen] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Chen, Yet-Ran] Acad Sinica, Agri Biotechnol Res Ctr, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chen, CT (corresponding author), Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan.	chenct@ntu.edu.tw; mbchung@sinica.edu.tw	Tong, Sok-Keng/Y-6513-2019; Weng, Jui-Hsia/AAW-6551-2021	Weng, Jui-Hsia/0000-0002-5878-3920; Tong, Sok Keng/0000-0002-8504-9473; Chung, Bon-chu/0000-0002-8612-0219	National Science Council [NSC 97-2113-M-002-002-MY3, NSC99-3112-B-001-002, NSC101-2321-B-001-001, NSC 102-2311-B-001-013-MY3]; National Taiwan University; National Health Research Institute [NHRI-EX102-10210SI]; Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Health Research Institute(National Health Research Institutes - Taiwan); Academia Sinica(Academia Sinica - Taiwan)	We thank S. Takashima (Osaka University) and N. Galjart (Erasmus Medical Center) for CLIP-170 plasmids, S. Tsukita (Kyoto University) for the EB1-GFP plasmid, S. Halpain (University of California-San Diego) for the MAP2c plasmid and Y. Mimori-Kiyosue (RIKEN) for the GFP-CLIP-115 plasmid, generated by A. Akhmanova (Utrecht University). We thank W.-y. Ku and C.-w. Hsu for help in drawing the graphical abstract. RNAi reagents were obtained from the National RNAi Core Facility Platform at Academia Sinica (NSC 97-3112-B-001-016). The wild-type zebrafish were from Taiwan Zebrafish Core Facility at Academia Sinica (NSC 100-2321-B-001-030). C.-T.C. was supported by the National Science Council (NSC 97-2113-M-002-002-MY3 and NSC99-3112-B-001-002) and the National Taiwan University, and B.-c.C, was supported by the National Science Council (NSC101-2321-B-001-001, NSC 102-2311-B-001-013-MY3), the National Health Research Institute (NHRI-EX102-10210SI) and Academia Sinica.	Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Bianchi M, 2012, P NATL ACAD SCI USA, V109, P1713, DOI 10.1073/pnas.1121485109; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Choudhary MI, 2011, STEROIDS, V76, P1554, DOI 10.1016/j.steroids.2011.09.006; CLARK MA, 1981, ENDOCRINOLOGY, V109, P2261, DOI 10.1210/endo-109-6-2261; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Dragestein KA, 2008, J CELL BIOL, V180, P729, DOI 10.1083/jcb.200707203; FLOOD JF, 1992, P NATL ACAD SCI USA, V89, P1567, DOI 10.1073/pnas.89.5.1567; Fontaine-Lenoir V, 2006, P NATL ACAD SCI USA, V103, P4711, DOI 10.1073/pnas.0600113103; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Grigoryev DN, 1999, ANAL BIOCHEM, V267, P319, DOI 10.1006/abio.1998.2993; Grigoryev DN, 2000, J STEROID BIOCHEM, V75, P1, DOI 10.1016/S0960-0760(00)00131-X; GUTH L, 1994, P NATL ACAD SCI USA, V91, P12308, DOI 10.1073/pnas.91.25.12308; Hamdi M, 2008, MICROELECTRON J, V39, P190, DOI 10.1016/j.mejo.2006.12.003; Heal WP, 2011, CHEM SOC REV, V40, P246, DOI 10.1039/c0cs00004c; Hsu HJ, 2006, NATURE, V439, P480, DOI 10.1038/nature04436; Hu MC, 2002, MOL ENDOCRINOL, V16, P1943, DOI 10.1210/me.2002-0055; IRWIN RP, 1992, NEUROSCI LETT, V141, P30, DOI 10.1016/0304-3940(92)90327-4; KAVALIERS M, 1987, BRAIN RES, V415, P393, DOI 10.1016/0006-8993(87)90228-9; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Lee HS, 2010, MOL BIOL CELL, V21, P2661, DOI 10.1091/mbc.E09-12-1036; Li HC, 2010, EMBO J, V29, P2953, DOI 10.1038/emboj.2010.174; Lomakin AJ, 2009, DEV CELL, V17, P323, DOI 10.1016/j.devcel.2009.07.010; Marx CE, 2009, NEUROPSYCHOPHARMACOL, V34, P1885, DOI 10.1038/npp.2009.26; Matsunaga M, 2004, P NATL ACAD SCI USA, V101, P17282, DOI 10.1073/pnas.0407176101; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Moore Jeffrey R, 2011, Bioarchitecture, V1, P250; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; RHEAUME E, 1991, MOL ENDOCRINOL, V5, P1147, DOI 10.1210/mend-5-8-1147; Ritsner MS, 2010, J CLIN PSYCHIAT, V71, P1351, DOI 10.4088/JCP.09m05031yel; Romeo E, 1998, AM J PSYCHIAT, V155, P910, DOI 10.1176/ajp.155.7.910; Sabeti J, 2007, HIPPOCAMPUS, V17, P349, DOI 10.1002/hipo.20273; Schumacher M, 2003, PROG NEUROBIOL, V71, P3, DOI 10.1016/j.pneurobio.2003.09.004; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Sun XD, 2012, J PATHOL, V226, P666, DOI 10.1002/path.3026; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999	44	35	36	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					636	642		10.1038/NCHEMBIO.1321	http://dx.doi.org/10.1038/NCHEMBIO.1321			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	23955365				2022-12-27	WOS:000325041800011
J	Tzeng, SR; Kalodimos, CG				Tzeng, Shiou-Ru; Kalodimos, Charalampos G.			Allosteric inhibition through suppression of transient conformational states	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CAMP RECEPTOR PROTEIN; NMR-SPECTROSCOPY; ROTATIONAL DIFFUSION; CHEMICAL-EXCHANGE; ESCHERICHIA-COLI; MILLISECOND MOTIONS; STRUCTURAL BASIS; BINDING PROTEIN; RELAXATION DATA	The ability to inhibit binding or enzymatic activity is key to preventing aberrant behaviors of proteins. Allosteric inhibition is desirable as it offers several advantages over competitive inhibition, but the mechanisms of action remain poorly understood in most cases. Here we show that allosteric inhibition can be effected by destabilizing a low-populated conformational state that serves as an on-pathway intermediate for ligand binding, without altering the protein's ground-state structure. As standard structural approaches are typically concerned with changes in the ground-state structure of proteins, the presence of such a mechanism can go easily undetected. Our data strongly argue for the routine use of NMR tools suited to detect and characterize transiently formed conformational states in allosteric systems. Structure information on such important intermediates can ultimately result in more efficient design of allosteric inhibitors.	[Tzeng, Shiou-Ru; Kalodimos, Charalampos G.] Rutgers State Univ, Ctr Integrat Prote Res, Piscataway, NJ 08854 USA; [Tzeng, Shiou-Ru; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Tzeng, SR (corresponding author), Rutgers State Univ, Ctr Integrat Prote Res, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Kalodimos, Charalampos/Q-9846-2018	Kalodimos, Charalampos/0000-0001-6354-2796; TZENG, SHIOU-RU/0000-0002-7180-0190	US National Science Foundation [MCB1121896]	US National Science Foundation(National Science Foundation (NSF))	This work was supported by the US National Science Foundation grant MCB1121896 to C.G.K.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Chen L, 2011, MOL CELL, V44, P734, DOI 10.1016/j.molcel.2011.09.022; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Gekko K, 2004, BIOCHEMISTRY-US, V43, P3844, DOI 10.1021/bi036271e; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Groebe DR, 2009, DRUG DISCOV TODAY, V14, P41, DOI 10.1016/j.drudis.2008.09.011; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hwang PM, 2001, J BIOMOL NMR, V20, P83, DOI 10.1023/A:1011226512421; Korzhnev DM, 2004, J AM CHEM SOC, V126, P3964, DOI 10.1021/ja039587i; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lipchock JM, 2010, STRUCTURE, V18, P1596, DOI 10.1016/j.str.2010.09.020; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Maksay G, 2011, PROG BIOPHYS MOL BIO, V106, P463, DOI 10.1016/j.pbiomolbio.2011.01.001; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Takeuchi K, 2007, J BIOMOL NMR, V38, P89, DOI 10.1007/s10858-007-9152-z; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vendruscolo M, 2011, J MOL BIOL, V412, P153, DOI 10.1016/j.jmb.2011.07.047; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Youn H, 2006, J BIOL CHEM, V281, P1119, DOI 10.1074/jbc.M509421200; Youn H, 2008, J BACTERIOL, V190, P4532, DOI 10.1128/JB.00074-08	45	78	79	2	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					462	+		10.1038/NCHEMBIO.1250	http://dx.doi.org/10.1038/NCHEMBIO.1250			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23644478				2022-12-27	WOS:000320449700011
J	Gut, P; Baeza-Raja, B; Andersson, O; Hasenkamp, L; Hsiao, J; Hesselson, D; Akassoglou, K; Verdin, E; Hirschey, MD; Stainier, DYR				Gut, Philipp; Baeza-Raja, Bernat; Andersson, Olov; Hasenkamp, Laura; Hsiao, Joseph; Hesselson, Daniel; Akassoglou, Katerina; Verdin, Eric; Hirschey, Matthew D.; Stainier, Didier Y. R.			Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN 18 KDA; GLUCOSE-HOMEOSTASIS; HEPATIC GLUCONEOGENESIS; BINDING; TARGET; ALPHA; MICE; RAT; RESISTANCE; HEALTH	Improving the control of energy homeostasis can lower cardiovascular risk in metabolically compromised individuals. To identify new regulators of whole-body energy control, we conducted a high-throughput screen in transgenic reporter zebrafish for small molecules that modulate the expression of the fasting-inducible gluconeogenic gene pck1. We show that this in vivo strategy identified several drugs that affect gluconeogenesis in humans as well as metabolically uncharacterized compounds. Most notably, we find that the translocator protein ligands PK 11195 and Ro5-4864 are glucose-lowering agents despite a strong inductive effect on pck1 expression. We show that these drugs are activators of a fasting-like energy state and, notably, that they protect high-fat diet-induced obese mice from hepatosteatosis and glucose intolerance, two pathological manifestations of metabolic dysregulation. Thus, using a whole-organism screening strategy, this study has identified new small-molecule activators of fasting metabolism.	[Gut, Philipp; Andersson, Olov; Hasenkamp, Laura; Hsiao, Joseph; Hesselson, Daniel; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Gut, Philipp; Andersson, Olov; Hasenkamp, Laura; Hsiao, Joseph; Hesselson, Daniel; Stainier, Didier Y. R.] Univ Calif San Francisco, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; [Gut, Philipp; Andersson, Olov; Hasenkamp, Laura; Hsiao, Joseph; Hesselson, Daniel; Stainier, Didier Y. R.] Univ Calif San Francisco, Program Genet & Human Genet, San Francisco, CA 94143 USA; [Gut, Philipp; Andersson, Olov; Hasenkamp, Laura; Hsiao, Joseph; Hesselson, Daniel; Stainier, Didier Y. R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Gut, Philipp; Andersson, Olov; Hasenkamp, Laura; Hsiao, Joseph; Hesselson, Daniel; Stainier, Didier Y. R.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Gut, Philipp; Andersson, Olov; Hasenkamp, Laura; Hsiao, Joseph; Hesselson, Daniel; Stainier, Didier Y. R.] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Baeza-Raja, Bernat; Akassoglou, Katerina] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Verdin, Eric; Hirschey, Matthew D.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Verdin, Eric; Hirschey, Matthew D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Duke University; Duke University; Duke University	Gut, P (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	philipp.gut@ucsf.edu; didier.stainier@mpi-bn.mpg.de	Verdin, Eric/AAB-7999-2019	Gut, Philipp/0000-0002-0689-9518; Verdin, Eric/0000-0003-3703-3183; Akassoglou, Katerina/0000-0002-2632-1465; Hirschey, Matthew/0000-0003-4541-5376; Andersson, Olov/0000-0001-6715-781X; Stainier, Didier/0000-0002-0382-0026; Hesselson, Daniel/0000-0002-8675-9426	German Research Foundation [DFG GU 1082/101]; University of California-San Francisco Liver Center [P30 DK026743]; Diabetes and Endocrinology Center [P30 DK063720]; US National Institutes of Health (NIH) [NS051470]; Gladstone Institutes; Glenn Foundation for Medical Research; American Heart Association [12SDG8840004]; NIH [RO1 DK60322, U01 DK089541]; University of California-San Fransisco diabetes center; Packard Foundation;  [DK59637]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418, R01DK060322, P30DK063720, U2CDK059637, U01DK089541, P30DK026743, U24DK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051470] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); University of California-San Francisco Liver Center(University of California System); Diabetes and Endocrinology Center; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gladstone Institutes(University of California System); Glenn Foundation for Medical Research; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-San Fransisco diabetes center; Packard Foundation(The David & Lucile Packard Foundation); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank A. Schlegel, O. Stone and K. Ashrafi for critical reading of the manuscript; the members of the Stainier lab for technical advice throughout the project; and A. Ayala, M. Alva, P. Lopez Pazmino and M. Sklar for zebrafish care. We are grateful to C. Miller from the Gladstone Histology Core for histological processing of mouse livers. We also thank R. Peterson for sharing knowledge on in vivo bioluminescence measurements in zebrafish. This study was supported in part by a postdoctoral fellowship DFG GU 1082/101 from the German Research Foundation to P.G., grant DK59637 to the Mouse Metabolic Phenotypic Centers lipid lab, Pilot/Feasibility grants from the University of California-San Francisco Liver Center (P30 DK026743) and Diabetes and Endocrinology Center (P30 DK063720), US National Institutes of Health (NIH) grant NS051470 to K.A., funds from the Gladstone Institutes and the Glenn Foundation for Medical Research to E.V., the American Heart Association grant 12SDG8840004 to M.D.H., NIH grant RO1 DK60322, a pilot and feasibility award from the University of California-San Fransisco diabetes center funded by NIH U01 DK089541 and the Packard Foundation to D.Y.R.S.	Andersohn F, 2009, AM J PSYCHIAT, V166, P591, DOI 10.1176/appi.ajp.2008.08071065; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Barth E, 2007, CRIT CARE MED, V35, pS508, DOI 10.1097/01.CCM.0000278047.06965.20; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Croniger CM, 2001, J BIOL CHEM, V276, P629, DOI 10.1074/jbc.M007576200; EISENSTEIN AB, 1967, AM J CLIN NUTR, V20, P282, DOI 10.1093/ajcn/20.3.282; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gonzalez-Polo RA, 2005, ONCOGENE, V24, P7503, DOI 10.1038/sj.onc.1208907; Guhan AR, 2000, THORAX, V55, P650, DOI 10.1136/thorax.55.8.650; GUPTA B, 1992, METHOD FIND EXP CLIN, V14, P61; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; HIRSCH JD, 1989, MOL PHARMACOL, V35, P164; JOOST HG, 1974, N-S ARCH PHARMACOL, V285, P99, DOI 10.1007/BF00499530; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Mackay J., 2008, ATLAS HEART DIS STRO, P48; MARANGOS PJ, 1982, MOL PHARMACOL, V22, P26; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Newcomer JW, 2005, CNS DRUGS, V19, P1; Pan A, 2012, DIABETOLOGIA, V55, P63, DOI 10.1007/s00125-011-2268-4; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Patel R, 2011, J CLIN INVEST, V121, P431, DOI 10.1172/JCI41681; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Silber BM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000169; Smith GC, 2008, DIABETOLOGIA, V51, P2309, DOI 10.1007/s00125-008-1152-3; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Taubes G, 2009, SCIENCE, V325, P256, DOI 10.1126/science.325_256; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Tulipano G, 2007, NEUROENDOCRINOLOGY, V85, P61, DOI 10.1159/000100981; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Ye Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021551; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	44	132	134	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					97	104		10.1038/NCHEMBIO.1136	http://dx.doi.org/10.1038/NCHEMBIO.1136			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23201900	Green Submitted, Green Accepted			2022-12-27	WOS:000314083200008
J	Slavoff, SA; Mitchell, AJ; Schwaid, AG; Cabili, MN; Ma, J; Levin, JZ; Karger, AD; Budnik, BA; Rinn, JL; Saghatelian, A				Slavoff, Sarah A.; Mitchell, Andrew J.; Schwaid, Adam G.; Cabili, Moran N.; Ma, Jiao; Levin, Joshua Z.; Karger, Amir D.; Budnik, Bogdan A.; Rinn, John L.; Saghatelian, Alan			Peptidomic discovery of short open reading frame-encoded peptides in human cells	NATURE CHEMICAL BIOLOGY			English	Article							HYDROPHILIC INTERACTION CHROMATOGRAPHY; LOW ABUNDANCE PROTEINS; AMINO-ACID-SEQUENCES; NONCODING RNAS; MESSENGER-RNA; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; BINDING PROTEIN; GENE-EXPRESSION	The complete extent to which the human genome is translated into polypeptides is of fundamental importance. We report a peptidomic strategy to detect short open reading frame (sORF)-encoded polypeptides (SEPs) in human cells. We identify 90 SEPs, 86 of which are previously uncharacterized, which is the largest number of human SEPs ever reported. SEP abundances range from 10-1,000 molecules per cell, identical to abundances of known proteins. SEPs arise from sORFs in noncoding RNAs as well as multicistronic mRNAs, and many SEPs initiate with non-AUG start codons, indicating that noncanonical translation may be more widespread in mammals than previously thought. In addition, coding sORFs are present in a small fraction (8 out of 1,866) of long intergenic noncoding RNAs. Together, these results provide strong evidence that the human proteome is more complex than previously appreciated.	[Slavoff, Sarah A.; Schwaid, Adam G.; Ma, Jiao; Saghatelian, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Mitchell, Andrew J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Levin, Joshua Z.] Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, Cambridge, MA USA; [Cabili, Moran N.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Cabili, Moran N.; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Karger, Amir D.] Harvard Univ, Fac Arts & Sci, Div Sci, Cambridge, MA 02138 USA; [Budnik, Bogdan A.] Harvard Univ, Fac Arts & Sci, Mass Spectrometry & Prote Lab, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University	Slavoff, SA (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	saghatelian@chemistry.harvard.edu	slavoff, sarah/HIK-2036-2022; Budnik, Bogdan/AAH-9987-2019; Budnik, Bogdan/AGG-8824-2022	Budnik, Bogdan/0000-0003-3622-2003; Rinn, John/0000-0002-7231-7539; Levin, Joshua/0000-0002-0170-3598; Karger, Amir/0000-0002-4561-3850; Slavoff, Sarah/0000-0002-4443-2070	Howard Hughes Medical Institute International Student Research Fellowship; National Research Service Award postdoctoral fellowship [1F32GM099408-01]; Damon Runyon-Rachleff Innovator Award; Searle Scholars Award; Richard and Susan Smith Family Foundation Fellowship; Burroughs Wellcome Fund Career Award in Biomedical Sciences; Alfred P. Sloan Fellowship; US National Institutes of Health [T32GM007598]; US National Human Genome Research Institute [3U54HG003067]; Director's New Innovator Awards [DP2OD00667, DP2OD002374]; National Institute of General Medical Sciences [R01GM102491]; Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102491, F32GM099408, T32GM007598] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670, DP2OD002374] Funding Source: NIH RePORTER	Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon-Rachleff Innovator Award; Searle Scholars Award; Richard and Susan Smith Family Foundation Fellowship; Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Director's New Innovator Awards; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Adiconis and L. Fan for constructing the cDNA libraries used in this study. M.N.C. is supported by a Howard Hughes Medical Institute International Student Research Fellowship, and S.A.S. is supported by an National Research Service Award postdoctoral fellowship (1F32GM099408-01). J.L.R. is supported by a Damon Runyon-Rachleff Innovator Award, a Searle Scholars Award and a Richard and Susan Smith Family Foundation Fellowship. A.S. is supported by a Burroughs Wellcome Fund Career Award in Biomedical Sciences, a Searle Scholars Award and an Alfred P. Sloan Fellowship. This work was also supported by the US National Institutes of Health training grant T32GM007598 (A.J.M.), the US National Human Genome Research Institute grant 3U54HG003067 (J.Z.L.), Director's New Innovator Awards DP2OD00667 (J.L.R.) and DP2OD002374 (A.S.), National Institute of General Medical Sciences grant R01GM102491 (A.S.) and support from Harvard University (A.S.).	ABASTADO JP, 1991, NEW BIOL, V3, P511; Alpert AJ, 2008, ANAL CHEM, V80, P62, DOI 10.1021/ac070997P; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Casson SA, 2002, PLANT CELL, V14, P1705, DOI 10.1105/tpc.002618; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fonslow BR, 2011, J PROTEOME RES, V10, P3690, DOI 10.1021/pr200304u; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hao PL, 2010, J PROTEOME RES, V9, P3520, DOI 10.1021/pr100037h; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; JAY G, 1981, NATURE, V291, P346, DOI 10.1038/291346a0; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Oyama M, 2007, MOL CELL PROTEOMICS, V6, P1000, DOI 10.1074/mcp.M600297-MCP200; PAROLA AL, 1994, J BIOL CHEM, V269, P4497; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rohrig H, 2002, P NATL ACAD SCI USA, V99, P1915, DOI 10.1073/pnas.022664799; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Svensson M, 2003, J PROTEOME RES, V2, P213, DOI 10.1021/pr020010u; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Tinoco AD, 2010, J AM CHEM SOC, V132, P3819, DOI 10.1021/ja909524e; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang F, 2011, NUCLEIC ACIDS RES, V39, P3128, DOI 10.1093/nar/gkq1251	50	384	395	6	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					59	+		10.1038/NCHEMBIO.1120	http://dx.doi.org/10.1038/NCHEMBIO.1120			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23160002	Green Submitted, Green Accepted			2022-12-27	WOS:000312484200013
J	Dunbar, KL; Melby, JO; Mitchell, DA				Dunbar, Kyle L.; Melby, Joel O.; Mitchell, Douglas A.			YcaO domains use ATP to activate amide backbones during peptide cyclodehydrations	NATURE CHEMICAL BIOLOGY			English	Article							AMINOIMIDAZOLE RIBONUCLEOTIDE SYNTHETASE; INHIBITOR MICROCIN B17; ESCHERICHIA-COLI; BIOSYNTHESIS; HETEROCYCLIZATION; PATHWAY; AUTOPROTEOLYSIS; SUBSTITUTION; PHOSPHATE; COMPLEX	Thiazole/oxazole-modified microcins (TOMMs) encompass a recently defined class of ribosomally synthesized natural products with a diverse set of biological activities. Although TOMM biosynthesis has been investigated for over a decade, the mechanism of heterocycle formation by the synthetase enzymes remains poorly understood. Using substrate analogs and isotopic labeling, we demonstrate that ATP is used to directly phosphorylate the peptide amide backbone during TOMM heterocycle formation. Moreover, we present what is to our knowledge the first experimental evidence that the D-protein component of the heterocycle-forming synthetase (YcaO/domain of unknown function 181 family member), formerly annotated as a docking protein involved in complex formation and regulation, is able to perform the ATP-dependent cyclodehydration reaction in the absence of the other TOMM biosynthetic proteins. Together, these data reveal the role of ATP in the biosynthesis of azole and azoline heterocycles in ribosomal natural products and prompt a reclassification of the enzymes involved in their installation.	[Dunbar, Kyle L.; Melby, Joel O.; Mitchell, Douglas A.] Univ Illinois, Dept Chem, Urbana, IL USA; [Dunbar, Kyle L.; Melby, Joel O.; Mitchell, Douglas A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Mitchell, Douglas A.] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Dunbar, KL (corresponding author), Univ Illinois, Dept Chem, Urbana, IL USA.	douglasm@illinois.edu	Mitchell, Doug/B-6349-2012; Mitchell, Douglas/C-4400-2011	Mitchell, Doug/0000-0002-9564-0953; Dunbar, Kyle L./0000-0002-7410-5169	University of Illinois; US National Institutes of Health (NIH) [1R01 GM097142]; NIH [DP2 OD008463, 2T32 GM070421]; University of Illinois Department of Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421, R01GM097142] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008463] Funding Source: NIH RePORTER	University of Illinois; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois Department of Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to W. van der Donk for technical advice and for suggestions in the preparation of the manuscript. We thank members of the Mitchell lab and M. Marletta for critical review of this manuscript. This work was supported in part by the institutional funds provided by the University of Illinois and the US National Institutes of Health (NIH) (1R01 GM097142 to D.A.M). D.A.M. is also the recipient of the NIH Director's New Innovator Award (DP2 OD008463). K.L.D. was supported by the NIH Training Program in the Chemistry-Biology Interface (2T32 GM070421). J.O.M. was supported by the University of Illinois Department of Chemistry Chinoree T. Kimiyo Enta Fellowship.	BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P734, DOI 10.1039/c39760000734; Bowers AA, 2010, J AM CHEM SOC, V132, P7519, DOI 10.1021/ja102339q; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; COHN M, 1978, P NATL ACAD SCI USA, V75, P200, DOI 10.1073/pnas.75.1.200; Ghilarov D, 2011, J BIOL CHEM, V286, P26308, DOI 10.1074/jbc.M111.241315; Kelleher NL, 1999, BIOCHEMISTRY-US, V38, P15623, DOI 10.1021/bi9913698; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Li CL, 1999, STRUCTURE, V7, P1155, DOI 10.1016/S0969-2126(99)80182-8; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Ludwig C, 2008, J BIOL CHEM, V283, P25264, DOI 10.1074/jbc.M802972200; McIntosh JA, 2010, CHEMBIOCHEM, V11, P1413, DOI 10.1002/cbic.201000196; McIntosh JA, 2010, J AM CHEM SOC, V132, P4089, DOI 10.1021/ja9107116; Melby JO, 2012, J AM CHEM SOC, V134, P5309, DOI 10.1021/ja211675n; Melby JO, 2011, CURR OPIN CHEM BIOL, V15, P369, DOI 10.1016/j.cbpa.2011.02.027; Milne JC, 1998, BIOCHEMISTRY-US, V37, P13250, DOI 10.1021/bi980996e; Milne JC, 1999, BIOCHEMISTRY-US, V38, P4768, DOI 10.1021/bi982975q; Molohon KJ, 2011, ACS CHEM BIOL, V6, P1307, DOI 10.1021/cb200339d; Morar M, 2006, BIOCHEMISTRY-US, V45, P14880, DOI 10.1021/bi061591u; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Myers CL, 2010, BIOORGAN MED CHEM, V18, P4231, DOI 10.1016/j.bmc.2010.04.098; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; Roy RS, 1998, BIOCHEMISTRY-US, V37, P4125, DOI 10.1021/bi9728250; SCHENDEL FJ, 1989, BIOCHEMISTRY-US, V28, P2459, DOI 10.1021/bi00432a017; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; SCHRIMSHER JL, 1986, BIOCHEMISTRY-US, V25, P4366, DOI 10.1021/bi00363a028; Strader MB, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005199; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x; Zamble DB, 2000, BIOCHEMISTRY-US, V39, P16190, DOI 10.1021/bi001398e; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8	35	97	96	1	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					569	575		10.1038/NCHEMBIO.944	http://dx.doi.org/10.1038/NCHEMBIO.944			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22522320	Green Accepted			2022-12-27	WOS:000304256300013
J	Laggner, C; Kokel, D; Setola, V; Tolia, A; Lin, H; Irwin, JJ; Keiser, MJ; Cheung, CYJ; Minor, DL; Roth, BL; Peterson, RT; Shoichet, BK				Laggner, Christian; Kokel, David; Setola, Vincent; Tolia, Alexandra; Lin, Henry; Irwin, John J.; Keiser, Michael J.; Cheung, Chung Yan J.; Minor, Daniel L., Jr.; Roth, Bryan L.; Peterson, Randall T.; Shoichet, Brian K.			Chemical informatics and target identification in a zebrafish phenotypic screen	NATURE CHEMICAL BIOLOGY			English	Article							SMALL MOLECULES; PHARMACOLOGY	Target identification is a core challenge in chemical genetics. Here we use chemical similarity to computationally predict the targets of 586 compounds that were active in a zebrafish behavioral assay. Among 20 predictions tested, 11 compounds had activities ranging from 1 nM to 10,000 nM on the predicted targets. The roles of two of these targets were tested in the original zebrafish phenotype. Prediction of targets from chemotype is rapid and may be generally applicable.	[Setola, Vincent; Roth, Bryan L.] Univ N Carolina Chapel Hill Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Laggner, Christian; Lin, Henry; Irwin, John J.; Keiser, Michael J.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Kokel, David; Cheung, Chung Yan J.; Peterson, Randall T.] Harvard Univ, Sch Med, Cardiovasc Res Ctr, Dept Med,Massachusetts Gen Hosp, Charlestown, MA USA; [Kokel, David; Cheung, Chung Yan J.; Peterson, Randall T.] Harvard Univ, Sch Med, Div Cardiol, Dept Med,Massachusetts Gen Hosp, Charlestown, MA USA; [Kokel, David; Cheung, Chung Yan J.; Peterson, Randall T.] Broad Inst, Cambridge, MA USA; [Setola, Vincent; Roth, Bryan L.] Univ N Carolina Chapel Hill Sch Med, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC USA; [Tolia, Alexandra; Minor, Daniel L., Jr.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Tolia, Alexandra; Minor, Daniel L., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Roth, BL (corresponding author), Univ N Carolina Chapel Hill Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.	bryan_roth@med.unc.edu; peterson@cvrc.mgh.harvard.edu; shoichet@cgl.ucsf.edu	Roth, Bryan L/F-3928-2010; Keiser, Michael J./F-2825-2016	Keiser, Michael J./0000-0002-1240-2192; Irwin, John/0000-0002-1195-6417; Setola, Vincent/0000-0002-9791-2270; kokel, david/0000-0002-1981-1511; Peterson, Randall/0000-0003-0727-3469	US National Institutes of Health [GM71896, AG02132, MH085205, MH086867, MH091449, R01 MH093603, R01 NS49272]; Rogers Family Foundation; National Institutes of Mental Health [U19MH82441]; Michael Hooker Chair; Max Kade Foundation; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093603, R21MH085205, R01MH086867, K01MH091449, U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rogers Family Foundation; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Chair; Max Kade Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Morris for help with Cytoscape. This work was supported by US National Institutes of Health grants GM71896 (to J.J.I. and B.K.S.), AG02132 (to S. Prusiner and B.K.S.), MH085205 and MH086867 (to R.P.), MH091449 (to D.K.), R01 MH093603 and R01 NS49272 (to D.L.M.); a Rogers Family Foundation award (to M.J.K.); the National Institutes of Mental Health Psychoactive Drug Screening Program, grant U19MH82441; the Michael Hooker Chair (to B.L.R.); and fellowships from the Max Kade Foundation (to C.L.) and the European Molecular Biology Organization (to A.T.).	Alderton W., 2010, DRUGS FUTURE, V35, P517; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Haggarty SJ, 2000, CHEM BIOL, V7, P275, DOI 10.1016/S1074-5521(00)00101-0; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Hert J, 2008, J CHEM INF MODEL, V48, P755, DOI 10.1021/ci8000259; James CA, 2011, DAYLIGHT THEORY MANU; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2010, BIOCHEMISTRY-US, V49, P10267, DOI 10.1021/bi101540g; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kinnings SL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000423; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Palchaudhuri R, 2011, ACS CHEM BIOL, V6, P21, DOI 10.1021/cb100310h; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schreiber SL, 2005, NAT CHEM BIOL, V1, P64, DOI 10.1038/nchembio0705-64; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	25	96	100	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					144	146		10.1038/nchembio.732	http://dx.doi.org/10.1038/nchembio.732			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22179068	Green Accepted, Green Submitted			2022-12-27	WOS:000299323200005
J	Cottee, MA; Raff, JW; Lea, SM; Roque, H				Cottee, Matthew A.; Raff, Jordan W.; Lea, Susan M.; Roque, Helio			SAS-6 oligomerization: the key to the centriole?	NATURE CHEMICAL BIOLOGY			English	Article							9-FOLD SYMMETRY; BASAL BODY; CENTROSOME BIOGENESIS; DROSOPHILA SPD-2; PROTEIN; DUPLICATION; CARTWHEEL; BLD10P; CEP192; DSAS-6		[Cottee, Matthew A.; Raff, Jordan W.; Lea, Susan M.; Roque, Helio] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Cottee, MA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	jordan.raff@path.ox.ac.uk	Lea, Susan M/B-7678-2009	Lea, Susan M/0000-0001-9287-8053; Cottee, Matthew/0000-0002-3619-3057; Roque, Helio/0000-0002-5930-1989	Biotechnology and Biological Sciences Research Council [984451] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Mottier-Pavie V, 2009, MOL BIOL CELL, V20, P2605, DOI 10.1091/mbc.E08-11-1115; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	22	17	18	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					650	653		10.1038/nchembio.660	http://dx.doi.org/10.1038/nchembio.660			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21931303				2022-12-27	WOS:000295027100002
J	Sakmar, TP				Sakmar, Thomas P.			RECEPTORS Clicking class B GPCR ligands	NATURE CHEMICAL BIOLOGY			English	News Item							PROTEIN-COUPLED RECEPTORS; BINDING; DOMAINS; PROBES; SITE		Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Sakmar, TP (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA.	sakmar@rockefeller.edu	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953				Devigny C, 2011, J AM CHEM SOC, V133, P8927, DOI 10.1021/ja200160s; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; Huber T, 2011, TRENDS PHARMACOL SCI, V32, P410, DOI 10.1016/j.tips.2011.03.004; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Unson CG, 2002, BIOCHEMISTRY-US, V41, P11795, DOI 10.1021/bi025711j; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167	9	5	5	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					500	501		10.1038/nchembio.621	http://dx.doi.org/10.1038/nchembio.621			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769095				2022-12-27	WOS:000292825400008
J	He, CA				He, Chuan			RNA epigenetics?	NATURE CHEMICAL BIOLOGY			English	Article							OXIDATIVE DEMETHYLATION; ESCHERICHIA-COLI; ADULT OBESITY; FTO GENE; DNA; CONTRIBUTES; DAMAGE; METHYLATION; CHILDHOOD; HOMOLOG	Post-transcriptional RNA modifications can be dynamic and might have functions beyond fine-tuning the structure and function of RNA. Understanding these RNA modification pathways and their functions may allow researchers to identify new layers of gene regulation at the RNA level.	[He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, CA (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu						Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; GROSJEAN H, 2005, TOPICS CURRENT GENET, V12; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Yi CQ, 2009, ACCOUNTS CHEM RES, V42, P519, DOI 10.1021/ar800178j	20	288	308	4	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					863	865		10.1038/nchembio.482	http://dx.doi.org/10.1038/nchembio.482			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079590				2022-12-27	WOS:000284214700006
J	Witte, MD; Kallemeijn, WW; Aten, J; Li, KY; Strijland, A; Donker-Koopman, WE; van den Nieuwendijk, AMCH; Bleijlevens, B; Kramer, G; Florea, BI; Hooibrink, B; Hollak, CEM; Ottenhoff, R; Boot, RG; van der Marel, GA; Overkleeft, HS; Aerts, JMFG				Witte, Martin D.; Kallemeijn, Wouter W.; Aten, Jan; Li, Kah-Yee; Strijland, Anneke; Donker-Koopman, Wilma E.; van den Nieuwendijk, Adrianus M. C. H.; Bleijlevens, Boris; Kramer, Gertjan; Florea, Bogdan I.; Hooibrink, Berend; Hollak, Carla E. M.; Ottenhoff, Roelof; Boot, Rolf G.; van der Marel, Gijsbert A.; Overkleeft, Herman S.; Aerts, Johannes M. F. G.			Ultrasensitive in situ visualization of active glucocerebrosidase molecules	NATURE CHEMICAL BIOLOGY			English	Article							ACID BETA-GLUCOSIDASE; TYPE-1 GAUCHER-DISEASE; N-BUTYLDEOXYNOJIRIMYCIN; ISOFAGOMINE INCREASES; CHAPERONES INCREASE; REPLACEMENT THERAPY; ENZYME; FIBROBLASTS; BIOSYNTHESIS; INHIBITORS	Deficiency of glucocerebrosidase (GBA) underlies Gaucher disease, a common lysosomal storage disorder. Carriership for Gaucher disease has recently been identified as major risk for parkinsonism. Presently, no method exists to visualize active GBA molecules in situ. We here report the design, synthesis and application of two fluorescent activity-based probes allowing highly specific labeling of active GBA molecules in vitro and in cultured cells and mice in vivo. Detection of in vitro labeled recombinant GBA on slab gels after electrophoresis is in the low attomolar range. Using cell or tissue lysates, we obtained exclusive labeling of GBA molecules. We present evidence from fluorescence-activated cell sorting analysis, fluorescence microscopy and pulse-chase experiments of highly efficient labeling of GBA molecules in intact cells as well as tissues of mice. In addition, we illustrate the use of the fluorescent probes to study inhibitors and tentative chaperones in living cells.	[Witte, Martin D.; Li, Kah-Yee; van den Nieuwendijk, Adrianus M. C. H.; Florea, Bogdan I.; van der Marel, Gijsbert A.; Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Kallemeijn, Wouter W.; Strijland, Anneke; Donker-Koopman, Wilma E.; Bleijlevens, Boris; Kramer, Gertjan; Ottenhoff, Roelof; Boot, Rolf G.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Biochem Med, NL-1105 AZ Amsterdam, Netherlands; [Aten, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Kramer, Gertjan] Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Hooibrink, Berend] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Hollak, Carla E. M.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Witte, MD (corresponding author), Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands.	h.s.overkleeft@chem.LeidenUniv.nl; j.m.aerts@amc.uva.nl	Kallemeijn, W. W./P-2768-2019; Aerts, Johannes/A-1028-2009; Florea, Bogdan I./AAM-9975-2020; Kallemeijn, Wouter W./F-6801-2014	Kallemeijn, W. W./0000-0002-3660-2930; Aerts, Johannes/0000-0001-8168-2565; Kallemeijn, Wouter W./0000-0002-3660-2930; Aten, Jan/0000-0002-0997-6777; Kramer, Gertjan/0000-0002-8541-0337; Hollak, Carla/0000-0003-0464-1078; Overkleeft, Herman/0000-0001-6976-7005; Florea, Bogdan Iulius/0000-0001-7114-2266; Boot, Rolf/0000-0002-7031-3390	The Netherlands Organization for Scientific Research (NWO-CW); The Netherlands Proteomics Centre	The Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); The Netherlands Proteomics Centre	Funding from The Netherlands Organization for Scientific Research (NWO-CW, to M.D.W., W.W.K., R.G.B., G.v.d.M., H.S.O. and J.M.F.G.A.) and The Netherlands Proteomics Centre (to B.I.F. and H.S.O.) is acknowledged.	AERTS JMFG, 1986, ANAL BIOCHEM, V154, P655, DOI 10.1016/0003-2697(86)90043-6; AERTS JMFG, 1988, BIOCHIM BIOPHYS ACTA, V964, P303, DOI 10.1016/0304-4165(88)90030-X; Aerts JMFG, 2006, J INHERIT METAB DIS, V29, P449, DOI 10.1007/s10545-006-0272-5; Andersson U, 2000, BIOCHEM PHARMACOL, V59, P821, DOI 10.1016/S0006-2952(99)00384-6; Arribas JCD, 2000, EUR J BIOCHEM, V267, P6996, DOI 10.1046/j.1432-1327.2000.01784.x; ATSUMI S, 1993, ARCH BIOCHEM BIOPHYS, V304, P302, DOI 10.1006/abbi.1993.1353; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Boot RG, 1997, HUM MUTAT, V10, P348, DOI 10.1002/(SICI)1098-1004(1997)10:5<348::AID-HUMU3>3.0.CO;2-B; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; Brumshtein B, 2007, J BIOL CHEM, V282, P29052, DOI 10.1074/jbc.M705005200; Chang HH, 2006, FEBS J, V273, P4082, DOI 10.1111/j.1742-4658.2006.05410.x; Gloster TM, 2007, ORG BIOMOL CHEM, V5, P444, DOI 10.1039/b616590g; Goker-Alpan O, 2008, ARCH NEUROL-CHICAGO, V65, P1353, DOI 10.1001/archneur.65.10.1353; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Hansen FG, 2005, J ORG CHEM, V70, P10139, DOI 10.1021/jo051645q; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; Kacher Y, 2008, BIOL CHEM, V389, P1361, DOI 10.1515/BC.2008.163; Kornhaber GJ, 2008, CHEMBIOCHEM, V9, P2643, DOI 10.1002/cbic.200800249; Lachmann RH, 2004, QJM-INT J MED, V97, P199, DOI 10.1093/qjmed/hch036; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Liou B, 2009, MOL GENET METAB, V97, P65, DOI 10.1016/j.ymgme.2009.01.006; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; OHASHI T, 1991, J BIOL CHEM, V266, P3661; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Phenix CP, 2010, P NATL ACAD SCI USA, V107, P10842, DOI 10.1073/pnas.1003247107; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Rudensky B, 2003, BLOOD CELL MOL DIS, V30, P97, DOI 10.1016/S1079-9796(03)00010-X; Sawkar AR, 2005, CHEM BIOL, V12, P1235, DOI 10.1016/j.chembiol.2005.09.007; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Shen JS, 2008, BIOCHEM BIOPH RES CO, V369, P1071, DOI 10.1016/j.bbrc.2008.02.125; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; VANWEELY S, 1991, BIOCHIM BIOPHYS ACTA, V1096, P301, DOI 10.1016/0925-4439(91)90066-I; VANWEELY S, 1993, J CLIN INVEST, V91, P1167, DOI 10.1172/JCI116276; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h	38	167	195	0	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					907	913		10.1038/NCHEMBIO.466	http://dx.doi.org/10.1038/NCHEMBIO.466			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079602	Green Submitted, Green Published			2022-12-27	WOS:000284214700020
J	Wang, WJ; Wang, Y; Chen, HZ; Xing, YZ; Li, FW; Zhang, Q; Zhou, B; Zhang, HK; Zhang, J; Bian, XL; Li, L; Liu, Y; Zhao, BX; Chen, Y; Wu, R; Li, AZ; Yao, LM; Chen, P; Zhang, Y; Tian, XY; Beermann, F; Wu, M; Han, JH; Huang, PQ; Lin, TW; Wu, Q				Wang, Wei-jia; Wang, Yuan; Chen, Hang-zi; Xing, Yong-zhen; Li, Feng-wei; Zhang, Qian; Zhou, Bo; Zhang, Hong-kui; Zhang, Jie; Bian, Xue-li; Li, Li; Liu, Yuan; Zhao, Bi-xing; Chen, Yan; Wu, Rong; Li, An-zhong; Yao, Lu-ming; Chen, Ping; Zhang, Yi; Tian, Xu-yang; Beermann, Friedrich; Wu, Mian; Han, Jiahuai; Huang, Pei-qiang; Lin, Tianwei; Wu, Qiao			Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway	NATURE CHEMICAL BIOLOGY			English	Article							APOPTOSIS; MITOPHAGY; SURVIVAL; NUR77; P53; VEMURAFENIB; ACTIVATION; MECHANISMS; CROSSTALK; INDUCTION	Autophagy is linked to cell death, yet the associated mechanisms are largely undercharacterized. We discovered that melanoma, which is generally resistant to drug-induced apoptosis, can undergo autophagic cell death with the participation of orphan nuclear receptor TR3. A sequence of molecular events leading to cellular demise is launched by a specific chemical compound, 1-(3,4,5-trihydroxyphenyl)nonan-1-one, newly acquired from screening a library of TR3-targeting compounds. The autophagic cascade comprises TR3 translocation to mitochondria through interaction with the mitochondrial outer membrane protein Nix, crossing into the mitochondrial inner membrane through Tom40 and Tom70 channel proteins, dissipation of mitochondrial membrane potential by the permeability transition pore complex ANT1-VDAC1 and induction of autophagy. This process leads to excessive mitochondria clearance and irreversible cell death. It implicates a new approach to melanoma therapy through activation of a mitochondrial signaling pathway that integrates a nuclear receptor with autophagy for cell death.	[Wang, Wei-jia; Wang, Yuan; Chen, Hang-zi; Xing, Yong-zhen; Li, Feng-wei; Zhang, Qian; Zhou, Bo; Bian, Xue-li; Li, Li; Liu, Yuan; Zhao, Bi-xing; Chen, Yan; Wu, Rong; Li, An-zhong; Yao, Lu-ming; Chen, Ping; Zhang, Yi; Tian, Xu-yang; Han, Jiahuai; Lin, Tianwei; Wu, Qiao] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen, Fujian Province, Peoples R China; [Zhang, Hong-kui; Zhang, Jie; Huang, Pei-qiang] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Fujian Province, Peoples R China; [Beermann, Friedrich] SV EPFL, Swiss Inst Expt Canc Res, ISREC, Lausanne, Switzerland; [Wu, Mian] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Wu, Mian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Xiamen University; Xiamen University; Swiss Institute Experimental Cancer Research; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Lin, TW (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen, Fujian Province, Peoples R China.	twlin@xmu.edu.cn; qiaow@xmu.edu.cn	Han, J/G-4671-2010	Li, Li/0000-0002-7720-6731; Bian, Xueli/0000-0001-9940-8396; Huang, Pei-Qiang/0000-0003-3230-0457; Luming, Yao/0000-0002-9417-4356; Wu, Mian/0000-0002-2714-0500	National Natural Science Fund of China; '973' Project of the Ministry of Science and Technology [31230019, 2014CB910602, 31370724, 31221065, 30971525]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2012KF002]; 111 Project of Education of China [B06016]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); '973' Project of the Ministry of Science and Technology(National Basic Research Program of China); Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University; 111 Project of Education of China(Ministry of Education, China - 111 Project)	We thank L. Yu from Tsinghua University; S.C. Lin from Xiamen University; and Q. Chen from the Institute of Zoology, Chinese Academy of Science, China for their critical suggestions. We would like to thank G.Q. Wang from the Zhongshan Hospital of Xiamen University for providing MeWo melanoma cells. This work was supported by grants from the National Natural Science Fund of China and the '973' Project of the Ministry of Science and Technology (31230019, 2014CB910602, 31370724, 31221065 and 30971525); the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University (SKLCSB2012KF002); and the 111 Project of Education of China (no. B06016). The crystallographic data collection at Beamline BL17U1 at Shanghai Synchrotron Radiation Facility is gratefully acknowledged.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Chen HZ, 2012, ONCOGENE, V31, P2876, DOI 10.1038/onc.2011.463; Chen HZ, 2008, CARCINOGENESIS, V29, P2078, DOI 10.1093/carcin/bgn197; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu JJ, 2010, CANCER RES, V70, P3628, DOI 10.1158/0008-5472.CAN-09-3160; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Rambold AS, 2011, CELL CYCLE, V10, P4032, DOI 10.4161/cc.10.23.18384; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vogelzang NJ, 2012, J CLIN ONCOL, V30, P88, DOI 10.1200/JCO.2011.40.1919; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Wang RH, 2013, EMBO MOL MED, V5, P137, DOI 10.1002/emmm.201201369; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu H, 2007, CANCER BIOL THER, V6, P405, DOI 10.4161/cbt.6.3.3755; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zabirnyk O, 2010, CARCINOGENESIS, V31, P446, DOI 10.1093/carcin/bgp299; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhan Yan-Yan, 2004, Ai Zheng, V23, P1593; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhao BX, 2011, MOL ENDOCRINOL, V25, P1337, DOI 10.1210/me.2011-0081	44	103	111	1	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					133	140		10.1038/NCHEMBIO.1406	http://dx.doi.org/10.1038/NCHEMBIO.1406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316735				2022-12-27	WOS:000330751600012
J	Peti, W; Page, R				Peti, Wolfgang; Page, Rebecca			ENZYME MECHANISMS What's up 'Doc'?	NATURE CHEMICAL BIOLOGY			English	News Item							ADENYLYLATION; TRANSFERASE	The Doc-Phd pair forms a bacterial toxin-antitoxin system, but the mechanism by which the Fic-family member Doc causes toxicity is not fully defined. New research shows that Doc unexpectedly functions as a kinase to phosphorylate elongation factor TU, thus inhibiting translation and leading to Doc-mediated growth arrest.	[Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Peti, W (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	rebecca_page@brown.edu	Peti, Wolfgang/L-3492-2014					Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Castro-Roa K., 2013, NAT CHEM BIOL, DOI [10.1038/nchembio.1364, DOI 10.1038/NCHEMBI0.1364]; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867	10	1	1	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					755	756		10.1038/nchembio.1379	http://dx.doi.org/10.1038/nchembio.1379			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24141194				2022-12-27	WOS:000327130000003
J	Jurgens, MC; Voros, J; Rautureau, GJP; Shepherd, DA; Pye, VE; Muldoon, J; Johnson, CM; Ashcroft, AE; Freund, SMV; Ferguson, N				Juergens, Maike C.; Voeroes, Judit; Rautureau, Gilles J. P.; Shepherd, Dale A.; Pye, Valerie E.; Muldoon, Jimmy; Johnson, Christopher M.; Ashcroft, Alison E.; Freund, Stefan M. V.; Ferguson, Neil			The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry	NATURE CHEMICAL BIOLOGY			English	Article							LARGE ENVELOPE PROTEIN; UBIQUITIN-INTERACTING ADAPTER; GAMMA-2-ADAPTIN; COMPLEXES; CONFORMATIONS; MATURATION; PEPTIDES; SEQUENCE; REGION; NEDD4	Hepatitis B virus (HBV) is an infectious, potentially lethal human pathogen. However, there are no effective therapies for chronic HBV infections. Antiviral development is hampered by the lack of high-resolution structures for essential HBV protein-protein interactions. The interaction between preS1, an HBV surface-protein domain, and its human binding partner, gamma 2-adaptin, subverts the membrane-trafficking apparatus to mediate virion export. This interaction is a putative drug target. We report here atomic-resolution descriptions of the binding thermodynamics and structural biology of the interaction between preS1 and the EAR domain of gamma 2-adaptin. NMR, protein engineering, X-ray crystallography and MS showed that preS1 contains multiple gamma 2-EAR-binding motifs that mimic the membrane-trafficking motifs (and binding modes) of host proteins. These motifs localize together to a relatively rigid, functionally important region of preS1, an intrinsically disordered protein. The preS1-gamma 2-EAR interaction was relatively weak and efficiently outcompeted by a synthetic peptide. Our data provide the structural road map for developing peptidomimetic antivirals targeting the gamma 2-EAR-preS1 interaction.	[Juergens, Maike C.; Ferguson, Neil] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Voeroes, Judit; Rautureau, Gilles J. P.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Shepherd, Dale A.; Ashcroft, Alison E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Pye, Valerie E.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Muldoon, Jimmy] Univ Coll Dublin, Ctr Synth & Chem Biol, Dublin 2, Ireland; [Johnson, Christopher M.; Freund, Stefan M. V.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University College Dublin; University College Dublin; University of Leeds; Trinity College Dublin; University College Dublin; MRC Laboratory Molecular Biology	Ferguson, N (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.	neil.ferguson@ucd.ie	muldoon, jimmy/C-7326-2009; Rautureau, Gilles J. P./M-7115-2014; Ferguson, Neil/B-8578-2008	muldoon, jimmy/0000-0002-2187-9478; Rautureau, Gilles J. P./0000-0002-1064-0293; Ferguson, Neil/0000-0002-1154-8093; Cooper-Shepherd, Dale/0000-0001-9301-1777; Voros, Judit/0000-0002-0762-3070; Pye, Valerie E/0000-0001-9616-2992	Science Foundation Ireland (SFI)-President of Ireland Young Researcher Award [09/YI/B1682]; Stokes Lecturer Award [07/SK/B1224a]; Royal Irish Academy-Royal Society Exchange award [IE111031]; SFI grant [07/IN.1/B1836]; US National Institutes of Health [GM75915, P50GM073210 U54GM094599]; Engineering and Physical Sciences Research Council PhD Studentship; Biotechnology and Biological Sciences Research Council UK [BB/E012558/1]; BBSRC [BB/E012558/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075915, U54GM094599, P50GM073210] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E012558/1] Funding Source: researchfish	Science Foundation Ireland (SFI)-President of Ireland Young Researcher Award(Science Foundation Ireland); Stokes Lecturer Award(Science Foundation Ireland); Royal Irish Academy-Royal Society Exchange award; SFI grant(Science Foundation Ireland); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council PhD Studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank K. Nakayama (University of Kyoto) for the gamma 2-adaptin clone; J. Lyons (Trinity College Dublin) and Deutsches Elektronen-Synchrotron-European Molecular Biology Laboratory beamline scientists for assistance with X-ray data collection; N. Moran (Royal College of Surgeons in Ireland) for access to biophysical instrumentation; M. Caffrey (Trinity College Dublin) for access to X-ray apparatus; and D. Shields and C. Mooney for bioinformatics help. This work was supported by Science Foundation Ireland (SFI)-President of Ireland Young Researcher Award (09/YI/B1682 to N. F.), Stokes Lecturer Award (07/SK/B1224a to N. F.), Royal Irish Academy-Royal Society Exchange award (IE111031 to N. F. and A. E. A.), SFI grant (07/IN.1/B1836) and US National Institutes of Health grants (GM75915, P50GM073210 U54GM094599) to M. Caffrey (funding V. E. P. and X-ray generator). D. A. S. was funded by an Engineering and Physical Sciences Research Council PhD Studentship. The Synapt mass spectrometer was purchased with Biotechnology and Biological Sciences Research Council UK funds (BB/E012558/1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Awe K, 2008, FEBS LETT, V582, P3179, DOI 10.1016/j.febslet.2008.07.062; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bottcher B, 1998, EMBO J, V17, P6839, DOI 10.1093/emboj/17.23.6839; BRUSS V, 1994, J VIROL, V68, P1643, DOI 10.1128/JVI.68.3.1643-1650.1994; Bruss V, 2004, VIRUS RES, V106, P199, DOI 10.1016/j.virusres.2004.08.016; Chi SW, 2007, PROTEIN SCI, V16, P2108, DOI 10.1110/ps.072983507; CLEMMER DE, 1995, J AM CHEM SOC, V117, P10141, DOI 10.1021/ja00145a037; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Doring T, 2010, BBA-MOL CELL RES, V1803, P1252, DOI 10.1016/j.bbamcr.2010.08.001; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferguson N, 2007, NATURE, V445, pE14, DOI 10.1038/nature05643; Freund SMV, 2008, J MOL BIOL, V384, P1301, DOI 10.1016/j.jmb.2008.10.020; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; Hartmann-Stuhler C, 2001, J VIROL, V75, P5343, DOI 10.1128/JVI.75.11.5343-5351.2001; Inoue M, 2007, TRAFFIC, V8, P904, DOI 10.1111/j.1600-0854.2007.00577.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kent HM, 2002, STRUCTURE, V10, P1139, DOI 10.1016/S0969-2126(02)00801-8; Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Le Seyec J, 1999, J VIROL, V73, P2052, DOI 10.1128/JVI.73.3.2052-2057.1999; Lewin DA, 1998, FEBS LETT, V435, P263, DOI 10.1016/S0014-5793(98)01083-7; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maritzen T, 2010, J BIOL CHEM, V285, P4074, DOI 10.1074/jbc.M109.049197; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Miller GJ, 2003, NAT STRUCT BIOL, V10, P599, DOI 10.1038/nsb953; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nassal M, 1999, INTERVIROLOGY, V42, P100, DOI 10.1159/000024970; Nogi T, 2002, NAT STRUCT BIOL, V9, P527, DOI 10.1038/nsb808; Pagel K, 2013, ANGEW CHEM INT EDIT, V52, P361, DOI 10.1002/anie.201203047; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; Reddy T, 2010, BIOCHEM CELL BIOL, V88, P131, DOI [10.1139/O09-152, 10.1139/o09-152]; Roseman AM, 2005, P NATL ACAD SCI USA, V102, P15821, DOI 10.1073/pnas.0504874102; Rost M, 2008, J BIOL CHEM, V283, P32119, DOI 10.1074/jbc.M802632200; Rost M, 2006, J BIOL CHEM, V281, P29297, DOI 10.1074/jbc.M603517200; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2006, CURR OPIN CHEM BIOL, V10, P402, DOI 10.1016/j.cbpa.2006.08.020; Saikusa K, 2013, ANALYST, V138, P1441, DOI 10.1039/c2an35878f; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; Seitz S, 2007, EMBO J, V26, P4160, DOI 10.1038/sj.emboj.7601841; Smith DP, 2007, J AM SOC MASS SPECTR, V18, P2180, DOI 10.1016/j.jasms.2007.09.017; Smith DP, 2009, EUR J MASS SPECTROM, V15, P113, DOI 10.1255/ejms.947; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Yamada Y, 2005, ACTA CRYSTALLOGR D, V61, P731, DOI 10.1107/S0907444905009595; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	59	22	22	0	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					540	U32		10.1038/NCHEMBIO.1294	http://dx.doi.org/10.1038/NCHEMBIO.1294			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23851574				2022-12-27	WOS:000323417500005
J	Okiyoneda, T; Veit, G; Dekkers, JF; Bagdany, M; Soya, N; Xu, HJ; Roldan, A; Verkman, AS; Kurth, M; Simon, A; Hegedus, T; Beekman, JM; Lukacs, GL				Okiyoneda, Tsukasa; Veit, Guido; Dekkers, Johanna F.; Bagdany, Miklos; Soya, Naoto; Xu, Haijin; Roldan, Ariel; Verkman, Alan S.; Kurth, Mark; Simon, Agnes; Hegedus, Tamas; Beekman, Jeffrey M.; Lukacs, Gergely L.			Mechanism-based corrector combination restores Delta F508-CFTR folding and function	NATURE CHEMICAL BIOLOGY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SMALL-MOLECULE CORRECTORS; CYSTIC-FIBROSIS MUTATION; CHANNEL FUNCTION; PHARMACOLOGICAL CHAPERONES; CONFORMATIONAL MATURATION; TRAFFICKING DEFECT; CFTR POTENTIATOR; QUALITY-CONTROL; CELL-SURFACE	The most common cystic fibrosis mutation, Delta F508 in nucleotide binding domain 1 (NBD1), impairs cystic fibrosis transmembrane conductance regulator (CFTR)-coupled domain folding, plasma membrane expression, function and stability. VX-809, a promising investigational corrector of Delta F508-CFTR misprocessing, has limited clinical benefit and an incompletely understood mechanism, hampering drug development. Given the effect of second-site suppressor mutations, robust Delta F508-CFTR correction most likely requires stabilization of NBD1 energetics and the interface between membrane-spanning domains (MSDs) and NBD1, which are both established primary conformational defects. Here we elucidate the molecular targets of available correctors: class I stabilizes the NBD1-MSD1 and NBD1-MSD2 interfaces, and class II targets NBD2. Only chemical chaperones, surrogates of class III correctors, stabilize human Delta F508-NBD1. Although VX-809 can correct missense mutations primarily destabilizing the NBD1-MSD1/2 interface, functional plasma membrane expression of Delta F508-CFTR also requires compounds that counteract the NBD1 and NBD2 stability defects in cystic fibrosis bronchial epithelial cells and intestinal organoids. Thus, the combination of structure-guided correctors represents an effective approach for cystic fibrosis therapy.	[Okiyoneda, Tsukasa; Veit, Guido; Bagdany, Miklos; Soya, Naoto; Xu, Haijin; Roldan, Ariel; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Dekkers, Johanna F.; Beekman, Jeffrey M.] Univ Med Ctr, Dept Pediat Pulmonol, Utrecht, Netherlands; [Dekkers, Johanna F.; Beekman, Jeffrey M.] Univ Med Ctr, Dept Immunol, Utrecht, Netherlands; [Dekkers, Johanna F.; Beekman, Jeffrey M.] Univ Med Ctr, Ctr Mol & Cellular Intervent, Utrecht, Netherlands; [Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Kurth, Mark] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Simon, Agnes] Hungarian Acad Sci, Res Ctr Nat Sci, Dept Mol Pharmacol, Budapest, Hungary; [Hegedus, Tamas] Hungarian Acad Sci, MTA SE Mol Biophys Res Grp, Budapest, Hungary; [Hegedus, Tamas] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Lukacs, Gergely L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Lukacs, Gergely L.] McGill Univ, GRASP, Montreal, PQ, Canada	McGill University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Hungarian Academy of Sciences; Semmelweis University; McGill University; McGill University	Lukacs, GL (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	gergely.lukacs@mcgill.ca	Simon, Agnes/F-9186-2012; Veit, Guido/C-9596-2009; Beekman, Jeffrey M/I-7781-2014; Hegedus, Tamas/P-8625-2015; Soya, Naoto/B-2821-2011	Simon, Agnes/0000-0002-0151-0120; Veit, Guido/0000-0002-6758-2696; Beekman, Jeffrey M/0000-0003-4886-3756; Hegedus, Tamas/0000-0002-5195-749X; Roldan, Ariel/0000-0002-8159-5450; Okiyoneda, Tsukasa/0000-0002-5175-2224; Lukacs, Gergely/0000-0003-0900-0675; Soya, Naoto/0000-0003-0086-4389	Dutch Cystic Fibrosis foundation; Wilhelmina Children's Hospital Research fund; Hungarian National Science Foundation [MB08C-80039]; European Union [FP7-IRG 239270]; European Research Area (ERA)Chemistry Hungarian Scientific Research Fund (OTKA) [102166]; Tara K. Telford Fund for Cystic Fibrosis Research at the University of California-Davis; US National Institutes of Health (NIH) [DK072517, GM089153]; NIH-National Institute of Diabetes and Digestive and Kidney Diseases [R01DK75302]; CFFT Inc.; Cystic Fibrosis Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation; European Molecular Biology Association; Fonds de Recherche Sante Quebec Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, R01DK075302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM089153] Funding Source: NIH RePORTER	Dutch Cystic Fibrosis foundation; Wilhelmina Children's Hospital Research fund; Hungarian National Science Foundation; European Union(European Commission); European Research Area (ERA)Chemistry Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Tara K. Telford Fund for Cystic Fibrosis Research at the University of California-Davis; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CFFT Inc.; Cystic Fibrosis Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); European Molecular Biology Association; Fonds de Recherche Sante Quebec Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Konerman, T. Wales, J. Engen, M. J. Chalmers and P. R. Griffin for valuable advice on setting up the HDX-MS technique; D. Gruenert (University of California-San Francisco) for the parental CFBE41o-cell line; R. J. Bridges (Rosalind Franklin University of Medicine and Science) and Cystic Fibrosis Foundation Therapeutics (CFFT) Inc. for CFTR modulator panels; D. Thomas (McGill University, Canada) for kindly providing RDR compounds; and W. R. Skach for advice. We are grateful for the financial support of the Dutch Cystic Fibrosis foundation and the Wilhelmina Children's Hospital Research fund to J. M. B., the Hungarian National Science Foundation (MB08C-80039) and the European Union (FP7-IRG 239270) to T. H., the European Research Area (ERA)Chemistry Hungarian Scientific Research Fund (OTKA) (102166) to A. S., the Tara K. Telford Fund for Cystic Fibrosis Research at the University of California-Davis and the US National Institutes of Health (NIH; grants DK072517 and GM089153) to M. K., NIH-National Institute of Diabetes and Digestive and Kidney Diseases (R01DK75302), CFFT Inc., Cystic Fibrosis Canada, Canadian Institutes of Health Research and Canada Foundation for Innovation to G. L. L. T. H. is a Bolyai Fellow of the Hungarian Academy of Sciences. G. V. was partly supported by a European Molecular Biology Association and Fonds de Recherche Sante Quebec Fellowship. G. L. L. is a Canada Research Chair.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Balch WE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004499; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Chiaw PK, 2010, MOL PHARMACOL, V78, P411, DOI 10.1124/mol.110.065862; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; DEKKERS J, NAT MED IN PRESS; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Hanrahan JW, 2013, TRENDS PHARMACOL SCI, V34, P119, DOI 10.1016/j.tips.2012.11.006; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Kim SJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00201; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2011, J BIOL CHEM, V286, P15215, DOI 10.1074/jbc.M110.184267; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Phuan PW, 2011, MOL PHARMACOL, V80, P683, DOI 10.1124/mol.111.073056; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rajesh D, 2003, J BIOL CHEM, V278, P35968, DOI 10.1074/jbc.M303280200; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Sampson HM, 2011, CHEM BIOL, V18, P231, DOI 10.1016/j.chembiol.2010.11.016; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Veit G, 2012, MOL BIOL CELL, V23, P4188, DOI 10.1091/mbc.E12-06-0424; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Yu GJ, 2008, J MED CHEM, V51, P6044, DOI 10.1021/jm800533c; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	60	297	303	3	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					444	U69		10.1038/NCHEMBIO.1253	http://dx.doi.org/10.1038/NCHEMBIO.1253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23666117	Green Accepted			2022-12-27	WOS:000320449700009
J	Gradisar, H; Bozic, S; Doles, T; Vengust, D; Hafner-Bratkovic, I; Mertelj, A; Webb, B; Sali, A; Klavzar, S; Jerala, R				Gradisar, Helena; Bozic, Sabina; Doles, Tibor; Vengust, Damjan; Hafner-Bratkovic, Iva; Mertelj, Alenka; Webb, Ben; Sali, Andrej; Klavzar, Sandi; Jerala, Roman			Design of a single-chain polypeptide tetrahedron assembled from coiled-coil segments	NATURE CHEMICAL BIOLOGY			English	Article							DE-NOVO DESIGN; COMPUTATIONAL DESIGN; PROTEIN; DNA; SPECIFICITY; PEPTIDE	Protein structures evolved through a complex interplay of cooperative interactions, and it is still very challenging to design new protein folds de novo. Here we present a strategy to design self-assembling polypeptide nanostructured polyhedra based on modularization using orthogonal dimerizing segments. We designed and experimentally demonstrated the formation of the tetrahedron that self-assembles from a single polypeptide chain comprising 12 concatenated coiled coil-forming segments separated by flexible peptide hinges. The path of the polypeptide chain is guided by a defined order of segments that traverse each of the six edges of the tetrahedron exactly twice, forming coiled-coil dimers with their corresponding partners. The coincidence of the polypeptide termini in the same vertex is demonstrated by reconstituting a split fluorescent protein in the polypeptide with the correct tetrahedral topology. Polypeptides with a deleted or scrambled segment order fail to self-assemble correctly. This design platform provides a foundation for constructing new topological polypeptide folds based on the set of orthogonal interacting polypeptide segments.	[Gradisar, Helena; Bozic, Sabina; Doles, Tibor; Hafner-Bratkovic, Iva; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia; [Gradisar, Helena; Doles, Tibor; Jerala, Roman] Excellent NMR Future Innovat Sustainable Technol, Ljubljana, Slovenia; [Vengust, Damjan; Mertelj, Alenka] Jozef Stefan Inst, Ljubljana, Slovenia; [Mertelj, Alenka; Klavzar, Sandi] Univ Ljubljana, Fac Math & Phys, Ljubljana, Slovenia; [Webb, Ben; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Webb, Ben; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Webb, Ben; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Klavzar, Sandi] Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Maribor; University of Ljubljana	Gradisar, H (corresponding author), Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.	roman.jerala@ki.si	Klavžar, Sandi/AAS-9666-2020; Jerala, Roman/H-9850-2015; Mertelj, Alenka/C-6209-2011	Jerala, Roman/0000-0002-6337-5251; Mertelj, Alenka/0000-0002-2766-9121; Klavzar, Sandi/0000-0002-1556-4744; Hafner Bratkovic, Iva/0000-0001-5635-931X	Slovenian Research Agency [J2-2131, P4-0176]; Excellent NMR-Future Innovation for Sustainable Technologies Centre of Excellence; European Union regional development funds; US National Institutes of Health [R01 GM083960, R01 GM54762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054762, R01GM083960] Funding Source: NIH RePORTER	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Excellent NMR-Future Innovation for Sustainable Technologies Centre of Excellence; European Union regional development funds(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the Slovenian Research Agency (J2-2131, P4-0176 to R.J.) and the Excellent NMR-Future Innovation for Sustainable Technologies Centre of Excellence, which is financed in part by the European Union regional development funds. B.W. and A.S. acknowledge US National Institutes of Health grants R01 GM083960 and R01 GM54762 (both to A.S.). We thank the rest of the members of the 2009 Slovenian International Genetically Engineered Machine (iGEM) competition team (students M. Verce, A. Lukan, N. Debeljak, S. Miklavic and U. Jelercic and mentors O. Fekonja, J. Pohar, R. Bremsak and M. Bencina) for their pioneering work on the development of concatenated coiled coil-based nanostructures (http://2009.igem.org/Team:Slovenia), underlying the development of the polypeptide polyhedra; R. Bremsak for excellent technical support; J. Rus for calculations regarding the number of polyhedral topology; the Centre for Electron Microscopy at the Jozef Stefan Institute for the use of electron microscopes; and K. Djinovic Carugo for comments on the manuscript.	Boyle AL, 2012, J AM CHEM SOC, V134, P15457, DOI 10.1021/ja3053943; Bromley EHC, 2009, J AM CHEM SOC, V131, P928, DOI 10.1021/ja804231a; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CRICK FHC, 1952, NATURE, V170, P882, DOI 10.1038/170882b0; Doles T, 2012, BIOCHEM SOC T, V40, P629, DOI 10.1042/BST20120025; Eswar N., 2006, CURR PROTOC BIOINFOR, V15; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Gradisar H, 2011, J PEPT SCI, V17, P100, DOI 10.1002/psc.1331; Gribbon C, 2008, BIOCHEMISTRY-US, V47, P10365, DOI 10.1021/bi801072s; Gurnon DG, 2003, J AM CHEM SOC, V125, P7518, DOI 10.1021/ja0357590; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; HECHT MH, 1990, SCIENCE, V249, P884, DOI 10.1126/science.2392678; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lakshmanan A, 2012, TRENDS BIOTECHNOL, V30, P155, DOI 10.1016/j.tibtech.2011.11.001; Li Z, 2009, J AM CHEM SOC, V131, P13093, DOI 10.1021/ja903768f; LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Potekhin SA, 2001, CHEM BIOL, V8, P1025, DOI 10.1016/S1074-5521(01)00073-4; Rackham OJL, 2010, J MOL BIOL, V403, P480, DOI 10.1016/j.jmb.2010.08.032; REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666; Reinke AW, 2010, J AM CHEM SOC, V132, P6025, DOI 10.1021/ja907617a; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Taylor CM, 2005, BIOCHEMISTRY-US, V44, P16246, DOI 10.1021/bi051493t; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2	34	231	236	3	213	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					362	+		10.1038/nchembio.1248	http://dx.doi.org/10.1038/nchembio.1248			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23624438	Green Accepted, Green Submitted			2022-12-27	WOS:000319328200007
J	Forouhar, F; Arragain, S; Atta, M; Gambarelli, S; Mouesca, JM; Hussain, M; Xiao, R; Kieffer-Jaquinod, S; Seetharaman, J; Acton, TB; Montelione, GT; Mulliez, E; Hunt, JF; Fontecave, M				Forouhar, Farhad; Arragain, Simon; Atta, Mohamed; Gambarelli, Serge; Mouesca, Jean-Marie; Hussain, Munif; Xiao, Rong; Kieffer-Jaquinod, Sylvie; Seetharaman, Jayaraman; Acton, Thomas B.; Montelione, Gaetano T.; Mulliez, Etienne; Hunt, John F.; Fontecave, Marc			Two Fe-S clusters catalyze sulfur insertion by radical-SAM methylthiotransferases	NATURE CHEMICAL BIOLOGY			English	Article							DEPENDENT ENZYME MOAA; TRANSFER-RNA; BIOTIN SYNTHASE; CRYSTAL-STRUCTURE; MIAB PROTEIN; IRON; METHYLATION; THIOLATION; IDENTIFICATION; APPROXIMATION	How living organisms create carbon-sulfur bonds during the biosynthesis of critical sulfur-containing compounds is still poorly understood. The methylthiotransferases MiaB and RimO catalyze sulfur insertion into tRNAs and ribosomal protein S12, respectively. Both belong to a subgroup of radical-S-adenosylmethionine (radical-SAM) enzymes that bear two [4Fe-4S] clusters. One cluster binds S-adenosylmethionine and generates an Ado radical via a well-established mechanism. However, the precise role of the second cluster is unclear. For some sulfur-inserting radical-SAM enzymes, this cluster has been proposed to act as a sacrificial source of sulfur for the reaction. In this paper, we report parallel enzymological, spectroscopic and crystallographic investigations of RimO and MiaB, which provide what is to our knowledge the first evidence that these enzymes are true catalysts and support a new sulfation mechanism involving activation of an exogenous sulfur cosubstrate at an exchangeable coordination site on the second cluster, which remains intact during the reaction.	[Forouhar, Farhad; Hussain, Munif; Seetharaman, Jayaraman; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Arragain, Simon; Atta, Mohamed; Mulliez, Etienne; Fontecave, Marc] Univ Grenoble 1, CNRS, Commissariat Energie Atom & Energies Alternat CEA, CEA Grenoble,UMR 5249, Grenoble, France; [Gambarelli, Serge; Mouesca, Jean-Marie] CEA Grenoble, Lab Resonance Magnet, SCIB, DSM,Inst Nanosci & Cryogen INaC,UMR E3 CEA UJF, Grenoble, France; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08855 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ USA; [Kieffer-Jaquinod, Sylvie] CEA UJF, INSERM, IRTSV, Etud Dynam Proteomes,Lab Biol Grande Echelle,U103, Grenoble, France; [Fontecave, Marc] Coll France, F-75231 Paris, France	Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; College de France		etienne.mulliez@cea.fr; jfhunt@biology.columbia.edu; mfontecave@cea.fr	Arragain, Simon/AAA-6356-2019	Arragain, Simon/0000-0002-6500-0066; Montelione, Gaetano/0000-0002-9440-3059	US National Institutes of Health Protein Structure Initiative [U54-GM074958, U54-GM094597]; Groupement d'Interet Scientifique-CNRS fellowship; Agence Nationale de la Recherche-Blanc; Region Rhone-Alpes grant CIBLE; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958, U54GM094597] Funding Source: NIH RePORTER	US National Institutes of Health Protein Structure Initiative; Groupement d'Interet Scientifique-CNRS fellowship; Agence Nationale de la Recherche-Blanc(French National Research Agency (ANR)); Region Rhone-Alpes grant CIBLE(Region Auvergne-Rhone-Alpes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Abramowitz and J. Schwanof for assistance with synchrotron data collection, B. Gibney for advice on Fe-S reconstitution for crystallization and R. Breslow for discussion of the reaction mechanism. We thank O. Hamelin for GC/MS analysis and J.-M. Moulis for providing <SUP>77</SUP>Se (both from Chemistry and Biology of Metals Laboratory, Grenoble). This work was supported by the US National Institutes of Health Protein Structure Initiative grants U54-GM074958 and U54-GM094597 to the NeSG (http://www.nesg.org/), a Groupement d'Interet Scientifique-CNRS fellowship to S.A., Agence Nationale de la Recherche-Blanc 2010 grant INSERAD and Region Rhone-Alpes grant CIBLE 2008-2011.	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Anantharaman V, 2001, FEMS MICROBIOL LETT, V197, P215, DOI 10.1111/j.1574-6968.2001.tb10606.x; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Arragain S, 2010, J BIOL CHEM, V285, P28425, DOI 10.1074/jbc.M110.106831; Arragain S, 2010, J BIOL CHEM, V285, P5792, DOI 10.1074/jbc.M109.065516; Atta M, 2010, CURR OPIN STRUC BIOL, V20, P684, DOI 10.1016/j.sbi.2010.09.009; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Booker SJ, 2007, CURR OPIN CHEM BIOL, V11, P543, DOI 10.1016/j.cbpa.2007.08.028; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bui BTS, 2006, BIOCHEMISTRY-US, V45, P3824, DOI 10.1021/bi052388m; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fontecave M, 2003, CHEM REV, V103, P2149, DOI 10.1021/cr020427j; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13496, DOI 10.1021/bi048693+; Jansson M, 1996, J BIOMOL NMR, V7, P131; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Kowalak JA, 1996, PROTEIN SCI, V5, P1625, DOI 10.1002/pro.5560050816; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Lees NS, 2009, J AM CHEM SOC, V131, P9184, DOI 10.1021/ja903978u; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; NOODLEMAN L, 1995, COORDIN CHEM REV, V144, P199, DOI 10.1016/0010-8545(95)07011-L; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pierrel F, 2003, J BIOL CHEM, V278, P29515, DOI 10.1074/jbc.M301518200; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Schnell R, 2008, ACTA CRYSTALLOGR F, V64, P1096, DOI 10.1107/S1744309108035203; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; SYPER L, 1984, SYNTHESIS-STUTTGART, P439; Szilagyi RK, 2006, J COMPUT CHEM, V27, P1385, DOI 10.1002/jcc.20449; THEN J, 1983, ARCH MICROBIOL, V135, P254, DOI 10.1007/BF00413477; Tooze J., 1999, INTRO PROTEIN STRUCT, V2, P59; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8352, DOI 10.1021/bi010463x; VELDE GT, 1992, J COMPUT PHYS, V99, P84, DOI 10.1016/0021-9991(92)90277-6; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Wilker JJ, 1999, INORG CHEM, V38, P3569, DOI 10.1021/ic9808899; Zhang Q, 2011, J BIOL CHEM, V286, P30245, DOI 10.1074/jbc.R111.272690; Zheng B, 2012, J AM CHEM SOC, V134, P6479, DOI 10.1021/ja3010539	52	84	88	2	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2013	9	5					333	338		10.1038/NCHEMBIO.1229	http://dx.doi.org/10.1038/NCHEMBIO.1229			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	127VT	23542644	Green Accepted			2022-12-27	WOS:000317727600011
J	Miyauchi, K; Kimura, S; Suzuki, T				Miyauchi, Kenjyo; Kimura, Satoshi; Suzuki, Tsutomu			A cyclic form of N-6-threonylcarbamoyladenosine as a widely distributed tRNA hypermodification	NATURE CHEMICAL BIOLOGY			English	Article							POSTTRANSCRIPTIONAL MODIFICATIONS; ANTICODON; NUCLEOSIDES; TRNA(LYS); N-(PURIN-6-YLCARBAMOYL)THREONINE; BIOSYNTHESIS; SYNTHETASE; ADJACENT; FAMILY; COLI	N-6-threonylcarbamoyladenosine (t(6)A) is a universally conserved, essential modified nucleoside found in transfer RNAs (tRNAs) responsible for ANN codons in all three domains of life. t(6)A has a crucial role in maintaining decoding accuracy during protein synthesis. The presence of t(6)A in cellular tRNAs has been well documented for more than four decades. However, under conditions optimized for nucleoside preparation, we detected little t(6)A in tRNAs from Escherichia coli. Instead, we identified a new modified base named 'cyclic t(6)A' (ct(6)A), which is a cyclized active ester with an oxazolone ring. An El-like enzyme, CsdL (renamed as TcdA), which catalyzes ATP-dependent dehydration of t(6)A to form ct(6)A, was also identified. Two yeast homologs of tcdA, YHR003C (TCD1) and YKL027W (TCD2), were required for ct(6)A formation and respiratory cell growth. ct(6)A was involved in promoting decoding efficiency. Structural modeling suggests that ct(6)A recognizes the first adenine base of ANN codon at the ribosomal A site.	[Miyauchi, Kenjyo; Kimura, Satoshi; Suzuki, Tsutomu] Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Tokyo, Japan	University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Tokyo, Japan.	ts@chembio.t.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731; Kimura, Satoshi/0000-0003-3555-5877	Ministry of Education, Science, Sports and Culture of Japan; New Energy and Industrial Technology Development Organization	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	We are grateful to the members of the Suzuki laboratory, especially T. Suzuki, A. Nagao, Y. Sakaguchi, T. Ohira, M. Ohara, T. Chujo, H. Takeda, Y. Ikeuchi, T. Taniguchi and T. Sakashita for technical assistance and fruitful discussions. Special thanks are due to R.W. Adamiak (Polish Academy of Sciences) for providing t<SUP>6</SUP>A. This work was supported by the Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan (to T.S.) and by a grant from the New Energy and Industrial Technology Development Organization (to T.S.).	ADAMIAK RW, 1975, B ACAD POL SCI-CHIM, V23, P241; Bolstad HM, 2010, J PROTEOME RES, V9, P5358, DOI 10.1021/pr1006087; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; ELKINS BN, 1974, BIOCHEMISTRY-US, V13, P4622, DOI 10.1021/bi00719a024; Hashimoto C, 2011, J BACTERIOL, V193, P6075, DOI 10.1128/JB.05733-11; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; KASAI H, 1976, EUR J BIOCHEM, V69, P435, DOI 10.1111/j.1432-1033.1976.tb10928.x; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Krog JS, 2011, FEBS J, V278, P4782, DOI 10.1111/j.1742-4658.2011.08379.x; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; MARTIN D, 1994, Z NATURFORSCH C, V49, P834; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; NIIMI T, 1994, NUCLEOS NUCLEOT NUCL, V13, P1231, DOI 10.1080/15257779408012147; Nishimura S, 1972, Prog Nucleic Acid Res Mol Biol, V12, P49; PARTHASARATHY R, 1974, BIOCHEM BIOPH RES CO, V60, P211, DOI 10.1016/0006-291X(74)90193-4; Phelps SS, 2004, J MOL BIOL, V338, P439, DOI 10.1016/j.jmb.2004.02.070; Salazar JC, 2004, P NATL ACAD SCI USA, V101, P7536, DOI 10.1073/pnas.0401982101; SCHWEIZE.MP, 1969, BIOCHEMISTRY-US, V8, P3283, DOI 10.1021/bi00836a023; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Stuart JW, 2000, BIOCHEMISTRY-US, V39, P13396, DOI 10.1021/bi0013039; Sundaram M, 2000, BIOCHEMISTRY-US, V39, P15652, DOI 10.1021/bi005120y; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Trotter V, 2009, MOL MICROBIOL, V74, P1527, DOI 10.1111/j.1365-2958.2009.06954.x; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	29	119	127	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					105	111		10.1038/NCHEMBIO.1137	http://dx.doi.org/10.1038/NCHEMBIO.1137			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23242255				2022-12-27	WOS:000314083200009
J	Lazarus, MB; Jiang, JY; Gloster, TM; Zandberg, WF; Whitworth, GE; Vocadlo, DJ; Walker, S				Lazarus, Michael B.; Jiang, Jiaoyang; Gloster, Tracey M.; Zandberg, Wesley F.; Whitworth, Garrett E.; Vocadlo, David J.; Walker, Suzanne			Structural snapshots of the reaction coordinate for O-GlcNAc transferase	NATURE CHEMICAL BIOLOGY			English	Article							SUBSTRATE; INHIBITORS; ANALOGS; GLYCOSYLTRANSFERASES; GLYCOSYLATION; INSIGHTS; ACCEPTOR; PATHWAY; COMPLEX; STRESS	Visualization of the reaction coordinate undertaken by glycosyltransferases has remained elusive but is critical for understanding this important class of enzyme. Using substrates and substrate mimics, we describe structural snapshots of all species along the kinetic pathway for human O-linked beta-N-acetylglucosamine transferase (O-GlcNAc transferase), an intracellular enzyme that catalyzes installation of a dynamic post-translational modification. The structures reveal key features of the mechanism and show that substrate participation is important during catalysis.	[Lazarus, Michael B.; Jiang, Jiaoyang; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA; [Lazarus, Michael B.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gloster, Tracey M.; Zandberg, Wesley F.; Whitworth, Garrett E.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Harvard University; Harvard Medical School; Harvard University; Simon Fraser University; Simon Fraser University	Walker, S (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA.	suzanne_walker@hms.harvard.edu	Zandberg, Wesley/AAX-5568-2021; Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Lazarus, Michael/0000-0002-6738-2563	US National Institutes of Health (NIH) [R01GM094263]; Natural Sciences and Engineering Research Council of Canada; Simon Fraser University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Simon Fraser University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (NIH) grant R01GM094263 to S. W. and the Natural Sciences and Engineering Research Council of Canada and Simon Fraser University. T. M. G. is a Sir Henry Wellcome postdoctoral fellow and a Michael Smith for Health Research (MSFHR) trainee award holder. D.J.V. is an E. W. R. Steacie Memorial Fellow and holds a Canada Research Chair in Chemical Glycobiology. We thank L. Deng for assistance with the chemical synthesis. We thank L. Cai (University of South Carolina, Salkehatchie) for the kind gift of UDP-2-ketoGlc.	Burkart MD, 2000, BIOORGAN MED CHEM, V8, P1937, DOI 10.1016/S0968-0896(00)00139-5; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dorfmueller HC, 2011, AMINO ACIDS, V40, P781, DOI 10.1007/s00726-010-0688-y; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Schramm VL, 2001, CURR OPIN STRUC BIOL, V11, P657, DOI 10.1016/S0959-440X(01)00269-X; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602	25	106	106	3	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					966	968		10.1038/NCHEMBIO.1109	http://dx.doi.org/10.1038/NCHEMBIO.1109			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103939	Green Accepted, Green Submitted			2022-12-27	WOS:000311491200010
J	Weiss, SJ				Weiss, Stephen J.			PEROXIDASIN Tying the collagen-sulfilimine knot	NATURE CHEMICAL BIOLOGY			English	News Item							BASEMENT-MEMBRANE; IDENTIFICATION; PROTEIN; IV		[Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Weiss, Stephen J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weiss, SJ (corresponding author), Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	sjweiss@umich.edu						Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Gu SQ, 2012, RNA, V18, P1186, DOI 10.1261/rna.031369.111; HUDSON BG, 1972, J BIOL CHEM, V247, P4229; Khan K, 2011, AM J HUM GENET, V89, P464, DOI 10.1016/j.ajhg.2011.08.005; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Li H, 2012, INFECT IMMUN, V80, P2528, DOI 10.1128/IAI.06337-11; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; WEISS SJ, 1989, NEW ENGL J MED, V320, P365	12	14	15	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					740	741		10.1038/nchembio.1050	http://dx.doi.org/10.1038/nchembio.1050			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22907088				2022-12-27	WOS:000308077600001
J	Jankowski, W; Saleh, T; Pai, MT; Sriram, G; Birge, RB; Kalodimos, CG				Jankowski, Wojciech; Saleh, Tamjeed; Pai, Ming-Tao; Sriram, Ganapathy; Birge, Raymond B.; Kalodimos, Charalampos G.			Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII	NATURE CHEMICAL BIOLOGY			English	Article							TERMINAL SH3 DOMAIN; ADAPTER PROTEIN; STRUCTURAL BASIS; C-CRK; SIGNAL-TRANSDUCTION; CANCER; CELLS; PHOSPHORYLATION; IDENTIFICATION; LEUKEMIA	CrkL is a key signaling protein that mediates the leukemogenic activity of Bcr-Abl. CrkL is thought to adopt a structure that is similar to that of its CrkII homolog. The two proteins share high sequence identity and indistinguishable ligand binding preferences, yet they have distinct physiological roles. Here we show that the structures of CrkL and phosphorylated CrkL are markedly different than the corresponding structures of CrkII. As a result, the binding activities of the Src homology 2 and Src homology 3 domains in the two proteins are regulated in a distinct manner and to a different extent. The different structural architecture of CrkL and CrkII may account for their distinct functional roles. The data show that CrkL forms a constitutive complex with Abl, thus explaining the strong preference of Bcr-Abl for CrkL. The results also highlight how the structural organization of the modular domains in adaptor proteins can control signaling outcome.	[Jankowski, Wojciech; Saleh, Tamjeed; Pai, Ming-Tao; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Sriram, Ganapathy; Birge, Raymond B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Jankowski, W (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Kalodimos, Charalampos/Q-9846-2018; Saleh, Tamjeed/M-8698-2016	Kalodimos, Charalampos/0000-0001-6354-2796; Saleh, Tamjeed/0000-0002-7539-7300	US Department of Defense; US National Institutes of Health [GM80308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080308] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Karamanou for performing the MALLS experiments and D. Duffield for collecting the mass spectrometry data. This work was supported by the US Department of Defense (R.B.B.) and the US National Institutes of Health (GM80308 to C.G.K.).	Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Cheerathodi M, 2011, J PROTEOME RES, V10, P4453, DOI 10.1021/pr200229a; Cho JH, 2011, NAT STRUCT MOL BIOL, V18, P550, DOI 10.1038/nsmb.2039; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; Donaldson LW, 2002, P NATL ACAD SCI USA, V99, P14053, DOI 10.1073/pnas.212518799; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Isakov N, 2008, TRENDS IMMUNOL, V29, P388, DOI 10.1016/j.it.2008.04.006; Kardinal C, 2000, FASEB J, V14, P1529, DOI 10.1096/fj.14.11.1529; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lucas CM, 2010, BRIT J HAEMATOL, V149, P458, DOI 10.1111/j.1365-2141.2009.08066.x; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mintz PJ, 2009, P NATL ACAD SCI USA, V106, P2182, DOI 10.1073/pnas.0807543105; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Muralidharan V, 2006, BIOCHEMISTRY-US, V45, P8874, DOI 10.1021/bi060590z; NICHOLS GL, 1994, BLOOD, V84, P2912; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; Seo JH, 2010, CANCER RES, V70, P7325, DOI 10.1158/0008-5472.CAN-10-0607; Seo JH, 2009, MOL CELL BIOL, V29, P3076, DOI 10.1128/MCB.01686-08; Severin A, 2009, J MOL BIOL, V387, P726, DOI 10.1016/j.jmb.2009.02.012; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sriram G, 2011, ONCOGENE, V30, P4645, DOI 10.1038/onc.2011.170; TENHOEVE J, 1994, BLOOD, V84, P1731; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Wang H, 2010, TUMOR BIOL, V31, P59, DOI 10.1007/s13277-009-0009-9; Wang J, 2011, MOL CARCINOGEN, V50, P506, DOI 10.1002/mc.20745; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	50	38	39	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					590	596		10.1038/NCHEMBIO.954	http://dx.doi.org/10.1038/NCHEMBIO.954			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22581121	Green Accepted, Green Submitted			2022-12-27	WOS:000304256300016
J	Rabinowitz, JD; Vastag, L				Rabinowitz, Joshua D.; Vastag, Livia			Teaching the design principles of metabolism	NATURE CHEMICAL BIOLOGY			English	Article							PYRUVATE-KINASE; METABOLOMICS; PLATFORM; CYCLE; M2		[Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ USA; [Vastag, Livia] Castleton Coll, Dept Chem, Castleton, VT USA	Princeton University; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	joshr@princeton.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	NATIONAL CANCER INSTITUTE [RC1CA147961] Funding Source: NIH RePORTER; NCI NIH HHS [RC1 CA147961] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Chen M, 2012, NAT STRUCT MOL BIOL, V19, P346, DOI 10.1038/nsmb.2219; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Garrett R., 2010, BIOCHEMISTRY; Goyal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000802; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Lehninger A., 2005, LEHNINGER PRINCIPLES; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; MELENDEZHEVIA E, 1990, BIOMED BIOCHIM ACTA, V49, P903; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Vazquez A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000195; Voet D., 2010, BIOCHEMISTRY; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547	25	19	20	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					497	501		10.1038/nchembio.969	http://dx.doi.org/10.1038/nchembio.969			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22596190	Green Accepted			2022-12-27	WOS:000304256300002
J	Shestopalov, IA; Pitt, CLW; Chen, JK				Shestopalov, Ilya A.; Pitt, Cameron L. W.; Chen, James K.			Spatiotemporal resolution of the Ntla transcriptome in axial mesoderm development	NATURE CHEMICAL BIOLOGY			English	Article							T-BOX GENES; IN-SITU HYBRIDIZATION; NO-TAIL; ZEBRAFISH NOTOCHORD; FLOOR PLATE; EXPRESSION; EMBRYOS; MOUSE; PROTEIN; INHIBITION	Transcription factors have diverse roles during embryonic development, combinatorially controlling cellular states in a spatially and temporally defined manner. Resolving the dynamic transcriptional profiles that underlie these patterning processes is essential for understanding embryogenesis at the molecular level. Here we show how temporal, tissue-specific changes in embryonic transcription factor function can be discerned by integrating caged morpholino oligonucleotides with photoactivatable fluorophores, fluorescence-activated cell sorting and microarray technologies. As a proof of principle, we have dynamically profiled No tail a (Ntla)-dependent genes at different stages of axial mesoderm development in zebrafish, discovering discrete sets of transcripts that are coincident with either notochord cell fate commitment or differentiation. Our studies reveal new regulators of notochord development and the sequential activation of distinct transcriptomes within a cell lineage by a single transcriptional factor and demonstrate how optically controlled chemical tools can dissect developmental processes with spatiotemporal precision.	[Shestopalov, Ilya A.; Pitt, Cameron L. W.; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Shestopalov, IA (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	jameschen@stanford.edu	Chen, James/G-9972-2011	Chen, James/0000-0002-9220-8436	US National Institutes of Health [R01 GM072600, R01 GM087292, DP1 OD003792]; March of Dimes Foundation [1-FY-08-433]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072600, R01GM087292] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003792] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Amacher and A. Garnett for helpful discussions, M. Halpern (Carnegie Institution) for providing ntla and flh cDNA, W Talbot (Stanford University) for pax2a cDNA, J. Mich and X. Ouyang (both from Stanford University) for sharing in situ hybridization probes and C. Crumpton for technical assistance with FACS. This work was supported by funding from the US National Institutes of Health (R01 GM072600, R01 GM087292 and DP1 OD003792) and the March of Dimes Foundation (1-FY-08-433).	Amacher SL, 2002, DEVELOPMENT, V129, P3311; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Brand Michael, 2002, P7; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; Conlon FL, 1996, DEVELOPMENT, V122, P2427; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Deiters A, 2010, J AM CHEM SOC, V132, P15644, DOI 10.1021/ja1053863; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Gajewski M, 2003, DEVELOPMENT, V130, P4269, DOI 10.1242/dev.00627; Gansner JM, 2008, DEV DYNAM, V237, P3715, DOI 10.1002/dvdy.21779; Garnett AT, 2009, DEVELOPMENT, V136, P749, DOI 10.1242/dev.024703; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Halpern ME, 1997, DEV BIOL, V187, P154, DOI 10.1006/dbio.1997.8605; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Melby AE, 1996, DEVELOPMENT, V122, P2225; Melby AE, 1997, DEV DYNAM, V209, P156; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Moulton J.D., 2008, CURR PROTOC MOL BIOL, V83, P2681; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Ochi H, 2008, J BIOL CHEM, V283, P3529, DOI 10.1074/jbc.M708594200; Ouyang XH, 2010, CHEM BIOL, V17, P590, DOI 10.1016/j.chembiol.2010.04.013; Ouyang XH, 2009, J AM CHEM SOC, V131, P13255, DOI 10.1021/ja809933h; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Shestopalov IA, 2007, NAT CHEM BIOL, V3, P650, DOI 10.1038/nchembio.2007.30; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Stemple DL, 1996, DEVELOPMENT, V123, P117; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Tang XJ, 2007, J AM CHEM SOC, V129, P11000, DOI 10.1021/ja073723s; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tomasini AJ, 2009, GENESIS, V47, P736, DOI 10.1002/dvg.20554; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0	38	31	31	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					270	276		10.1038/NCHEMBIO.772	http://dx.doi.org/10.1038/NCHEMBIO.772			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22286130	Green Accepted			2022-12-27	WOS:000300600000012
J	Maeda, A; Golczak, M; Chen, Y; Okano, K; Kohno, H; Shiose, S; Ishikawa, K; Harte, W; Palczewska, G; Maeda, T; Palczewski, K				Maeda, Akiko; Golczak, Marcin; Chen, Yu; Okano, Kiichiro; Kohno, Hideo; Shiose, Satomi; Ishikawa, Kaede; Harte, William; Palczewska, Grazyna; Maeda, Tadao; Palczewski, Krzysztof			Primary amines protect against retinal degeneration in mouse models of retinopathies	NATURE CHEMICAL BIOLOGY			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; STARGARDT MACULAR DYSTROPHY; LIGHT-INDUCED DAMAGE; ALL-TRANS-RETINOL; DISEASE GENE ABCR; VISUAL CYCLE; EPITHELIAL-CELLS; LIPOFUSCIN FLUOROPHORE; COUPLED RECEPTOR; OUTER SEGMENTS	Vertebrate vision is initiated by photoisomerization of the visual pigment chromophore 11-cis-retinal and is maintained by continuous regeneration of this retinoid through a series of reactions termed the retinoid cycle. However, toxic side reaction products, especially those involving reactive aldehyde groups of the photoisomerized product, all-trans-retinal, can cause severe retinal pathology. Here we lowered peak concentrations of free all-trans-retinal with primary amine-containing Food and Drug Administration (FDA)-approved drugs that did not inhibit chromophore regeneration in mouse models of retinal degeneration. Schiff base adducts between all-trans-retinal and these amines were identified by MS. Adducts were observed in mouse eyes only when an experimental drug protected the retina from degeneration in both short-term and long-term treatment experiments. This study demonstrates a molecular basis of all-trans-retinal-induced retinal pathology and identifies an assemblage of FDA-approved compounds with protective effects against this pathology in a mouse model that shows features of Stargardt's disease and age-related retinal degeneration.	[Maeda, Akiko; Golczak, Marcin; Chen, Yu; Okano, Kiichiro; Kohno, Hideo; Shiose, Satomi; Ishikawa, Kaede; Maeda, Tadao; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Akiko; Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Harte, William] Polgenix Inc, Cleveland, OH USA; [Palczewska, Grazyna] Visum Inc, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	kxp65@case.edu			US National Institutes of Health [EY009339, EY021126, EY019031, EY019880, P30 EY11373]; State of Ohio Department of Development [TECH 09-004]; Third Frontier Commission; Research to Prevent Blindness; Ohio Lion Eye Research Foundation; Foundation Fighting Blindness; Fight for Sight; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY011373, R01EY009339, K08EY019880, K08EY019031, R24EY021126] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Ohio Department of Development; Third Frontier Commission; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lion Eye Research Foundation; Foundation Fighting Blindness(European Commission); Fight for Sight; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank Z. Dong for expert handling of mice, S. Roos for block preparation and plastic sectioning, J. Zhang for NMR analyses, and M. Matosky for retinoid analyses. We also thank L. Webster Jr, J. Saari, M. E. Maguire and members of the Palczewski laboratory for critical comments on the manuscript. This research was supported in part by grants EY009339, EY021126, EY019031, EY019880 and P30 EY11373 from the US National Institutes of Health; TECH 09-004 from the State of Ohio Department of Development; the Third Frontier Commission; Research to Prevent Blindness; Ohio Lion Eye Research Foundation; Foundation Fighting Blindness; and Fight for Sight.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Dean DM, 2002, P NATL ACAD SCI USA, V99, P8372, DOI 10.1073/pnas.122681899; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Field MJ, 2001, BRIT J PHARMACOL, V132, P1, DOI 10.1038/sj.bjp.0703794; Fishkin N, 2005, BIOORGAN MED CHEM, V13, P5189, DOI 10.1016/j.bmc.2005.05.001; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Molday RS, 2010, PROG LIPID RES, V49, P476, DOI 10.1016/j.plipres.2010.07.002; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; Murdaugh LS, 2010, J MASS SPECTROM, V45, P1139, DOI 10.1002/jms.1795; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Stecher H, 2000, METHOD ENZYMOL, V316, P330; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Sun H, 2001, J BIOL CHEM, V276, P11766, DOI 10.1074/jbc.M010152200; TAYLOR CP, 1993, EPILEPSY RES, V14, P11, DOI 10.1016/0920-1211(93)90070-N; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsybovsky Y, 2010, ADV EXP MED BIOL, V703, P105, DOI 10.1007/978-1-4419-5635-4_8; Vollmer-Snarr HR, 2006, ADV EXP MED BIOL, V572, P69; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035; Zhang QJ, 2005, HUM GENET, V118, P356, DOI 10.1007/s00439-005-0054-4; Zhong M, 2009, J BIOL CHEM, V284, P3640, DOI 10.1074/jbc.M806580200	49	104	118	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					170	178		10.1038/nchembio.759	http://dx.doi.org/10.1038/nchembio.759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22198730	Green Accepted			2022-12-27	WOS:000299323200009
J	Doucette, CD; Schwab, DJ; Wingreen, NS; Rabinowitz, JD				Doucette, Christopher D.; Schwab, David J.; Wingreen, Ned S.; Rabinowitz, Joshua D.			alpha-ketoglutarate coordinates carbon and nitrogen utilization via enzyme I inhibition	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI K-12; DEPENDENT PHOSPHOTRANSFERASE SYSTEM; ADENYLATE ENERGY-CHARGE; GROWTH-RATE; METABOLISM; PROTEIN; PHOSPHORYLATION; CYANOBACTERIUM; METABOLOMICS; FERMENTATION	Microbes survive in a variety of nutrient environments by modulating their intracellular metabolism. Balanced growth requires coordinated uptake of carbon and nitrogen, the primary substrates for biomass production. Yet the mechanisms that balance carbon and nitrogen uptake are poorly understood. We find in Escherichia coli that a sudden increase in nitrogen availability results in an almost immediate increase in glucose uptake. The concentrations of glycolytic intermediates and known regulators, however, remain homeostatic. Instead, we find that alpha-ketoglutarate, which accumulates in nitrogen limitation, directly blocks glucose uptake by inhibiting enzyme I, the first step of the sugar-phosphoenolpyruvate phosphotransferase system (PTS). This inhibition enables rapid modulation of glycolytic flux without marked changes in the concentrations of glycolytic intermediates by simultaneously altering import of glucose and consumption of the terminal glycolytic intermediate phosphoenolpyruvate. Quantitative modeling shows that this previously unidentified regulatory connection is, in principle, sufficient to coordinate carbon and nitrogen utilization.	[Doucette, Christopher D.; Schwab, David J.; Wingreen, Ned S.; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Doucette, Christopher D.; Schwab, David J.; Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	joshr@princeton.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	US National Science Foundation [MCB-0643859]; Department of Energy-Air Force Office of Scientific Research [DOE DE-SC0002077-AFOSR FA9550-09-1-0580]; US National Institutes of Health Center for Quantitative Biology [P50 GM071508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Department of Energy-Air Force Office of Scientific Research; US National Institutes of Health Center for Quantitative Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Yuan, whose experiments laid the groundwork for the current study; D. Yan for providing the GOGAT strain; and G. Gosset for providing the W3110 and VH33 strains. This research was funded by US National Science Foundation CAREER award MCB-0643859, joint Department of Energy-Air Force Office of Scientific Research Award DOE DE-SC0002077-AFOSR FA9550-09-1-0580, and the US National Institutes of Health Center for Quantitative Biology Award P50 GM071508.	AMIN N, 1992, BIOCHEM BIOPH RES CO, V182, P1218, DOI 10.1016/0006-291X(92)91861-J; Aoyama K, 1997, J FERMENT BIOENG, V83, P17, DOI 10.1016/S0922-338X(97)87320-5; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; CHULAVATNATOL M, 1973, J BIOL CHEM, V248, P2712; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; DANIEL J, 1986, BIOCHIMIE, V68, P303, DOI 10.1016/S0300-9084(86)80027-X; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Anda R, 2006, METAB ENG, V8, P281, DOI 10.1016/j.ymben.2006.01.002; Goyal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000802; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HOVING H, 1981, BIOCHEMISTRY-US, V20, P87, DOI 10.1021/bi00504a015; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Ikeda TP, 1996, J MOL BIOL, V259, P589, DOI 10.1006/jmbi.1996.0342; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kessler B, 2001, ADV BIOCHEM ENG BIOT, V71, P159; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KUMAZAWA S, 1981, INT J HYDROGEN ENERG, V6, P339, DOI 10.1016/0360-3199(81)90060-4; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2007, J AM SOC MASS SPECTR, V18, P898, DOI 10.1016/j.jasms.2007.01.017; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; MONOT F, 1983, BIOTECHNOL LETT, V5, P213, DOI 10.1007/BF00161117; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Nishio Y, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100201; PEREIRA DS, 1994, J BIOL CHEM, V269, P412; Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185; Rohwer JM, 2000, J BIOL CHEM, V275, P34909, DOI 10.1074/jbc.M002461200; SEOL WG, 1992, J BIOL CHEM, V267, P6409; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Troshina O, 2002, INT J HYDROGEN ENERG, V27, P1283, DOI 10.1016/S0360-3199(02)00103-9; Wacker I, 2003, MICROBIOL-SGM, V149, P3001, DOI 10.1099/mic.0.26479-0; Wu PSC, 2005, J MAGN RESON, V176, P115, DOI 10.1016/j.jmr.2005.05.018; Yan DL, 2007, P NATL ACAD SCI USA, V104, P9475, DOI 10.1073/pnas.0703360104; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	42	167	171	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					894	901		10.1038/NCHEMBIO.685	http://dx.doi.org/10.1038/NCHEMBIO.685			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22002719	Green Accepted			2022-12-27	WOS:000297166200012
J	Deng, XM; Dzamko, N; Prescott, A; Davies, P; Liu, QS; Yang, QK; Lee, JD; Patricelli, MP; Nomanbhoy, TK; Alessi, DR; Gray, NS				Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.			Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2	NATURE CHEMICAL BIOLOGY			English	Article							CYTOPLASMIC LOCALIZATION; 14-3-3 BINDING; MUTATIONS; MAP	Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. We employed a new, parallel, compound-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures. LRRK2-IN-1 will serve as a versatile tool to pharmacologically interrogate LRRK2 biology and study its role in Parkinson's disease.	[Deng, Xianming; Liu, Qingsong; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Deng, Xianming; Liu, Qingsong; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Dzamko, Nicolas; Davies, Paul; Alessi, Dario R.] Univ Dundee, MRC Prot Phosphorylat Unit, Coll Life Sci, Dundee, Scotland; [Prescott, Alan] Univ Dundee, Div Cell Biol & Immunol, Coll Life Sci, Dundee, Scotland; [Yang, Qingkai; Lee, Jiing-Dwan] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.] ActivX Biosci, La Jolla, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Dundee; University of Dundee; Scripps Research Institute; Kyorin Pharmaceutical Co Ltd	Deng, XM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	r.alessi@dundee.ac.uk; nathanael_gray@dfci.harvard.edu	Yang, Qingkai/AAK-5111-2021; Prescott, Alan/Y-5956-2018; Dzamko, Nicolas/AAD-6922-2019; Liu, Qingsong/AFS-0714-2022; 刘, 青松/AEM-1932-2022	Yang, Qingkai/0000-0001-6628-5393; Prescott, Alan/0000-0002-0747-7317; Liu, Qingsong/0000-0002-7829-2547; 刘, 青松/0000-0002-7829-2547; Dzamko, Nicolas/0000-0002-9121-0294; Alessi, Dario/0000-0002-2140-9185; Deng, Xianming/0000-0002-9354-5864; Davies, Paul/0000-0001-8022-2719	US National Institutes of Health [P41 GM079575-03, CA079871, CA114059]; Medical Research Council; National Health and Medical Research Council; Michael J. Fox Foundation for Parkinson's Disease Research; University of California [19XT-0084]; Medical Research Council [MC_U127070193, G0700656] Funding Source: researchfish; MRC [G0700656, MC_U127070193] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA079871, R01CA114059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM079575] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Michael J. Fox Foundation for Parkinson's Disease Research; University of California(University of California System); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank staff at the National Centre for Protein Kinase Profiling (http://www.kinase-screen.mrc.ac.uk) for undertaking Dundee kinase specificity screening, F. Hentati (Institut National de Neurologie, Tunisia) and A. Reith (GlaxoSmithKline Pharmaceuticals Research and Development) for providing EBV immortalized human lymphoblastoid cells, P. Bamborough (GlaxoSmithKline Pharmaceuticals Research and Development) for providing LRRK2 homology model and the antibody purification teams (Division of Signal Transduction Therapy (DSTT), University of Dundee) coordinated by H. McLauchlan and J. Hastie for generation of antibodies. This work was supported by US National Institutes of Health grant P41 GM079575-03 (N.S.G.), the Medical Research Council Technology Industry Collaboration Award and a National Health and Medical Research Council postdoctoral fellowship (N.D.), the Medical Research Council (D. R. A.), the Michael J. Fox Foundation for Parkinson's Disease Research (D. R. A.), the pharmaceutical companies supporting the DSTT (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KgaA and Pfizer) (D. R. A.), the US National Institutes of Health grants CA079871 and CA114059 (J.-D.L.) and funds from the Tobacco-Related Disease Research Program of the University of California, 19XT-0084, (J.-D.L.).	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gandhi PN, 2009, J NEUROSCI RES, V87, P1283, DOI 10.1002/jnr.21949; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	22	327	345	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					203	205		10.1038/NCHEMBIO.538	http://dx.doi.org/10.1038/NCHEMBIO.538			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21378983	Green Accepted			2022-12-27	WOS:000288545000007
J	Spiegel, DA				Spiegel, David A.			Synthetic immunology to engineer human immunity	NATURE CHEMICAL BIOLOGY			English	Article							SMALL MOLECULES; CELLS; DIFFERENTIATION; THERAPY; VACCINE; CANCER	Rationally designing new strategies to control the human immune response stands as a key challenge for the scientific community. Chemical biologists have the opportunity to address specific issues in this area that have important implications for both basic science and clinical medicine.	[Spiegel, David A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Spiegel, David A.] Yale Univ, Dept Pharmacol, New Haven, CT USA	Yale University; Yale University	Spiegel, DA (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	david.spiegel@yale.edu						Adams MM, 2010, J AM CHEM SOC, V132, P1939, DOI 10.1021/ja9082842; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Budynek P, 2010, ARCH MICROBIOL, V192, P315, DOI 10.1007/s00203-010-0559-7; Carlson CB, 2007, ACS CHEM BIOL, V2, P119, DOI 10.1021/cb6003788; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Grunewald J, 2009, P NATL ACAD SCI USA, V106, P4337, DOI 10.1073/pnas.0900507106; Kaiser A, 2009, ANGEW CHEM INT EDIT, V48, P7551, DOI 10.1002/anie.200902564; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kodadek T, 2010, CURR OPIN CHEM BIOL, V14, P721, DOI 10.1016/j.cbpa.2010.07.002; Liu SC, 2008, CANCER RES, V68, P7995, DOI 10.1158/0008-5472.CAN-08-1698; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; Nelson JW, 2010, ACS CHEM BIOL, V5, P1147, DOI 10.1021/cb100195d; Popkov M, 2009, P NATL ACAD SCI USA, V106, P4378, DOI 10.1073/pnas.0900147106; Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g; Shaha SP, 2009, CLIN EXP IMMUNOL, V158, P186, DOI 10.1111/j.1365-2249.2009.04003.x; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhang AX, 2010, J AM CHEM SOC, V132, P12711, DOI 10.1021/ja104591m; Zhou HY, 2010, CURR OPIN HEMATOL, V17, P276, DOI 10.1097/MOH.0b013e328339f2ee; Zhu JL, 2009, EXPERT REV VACCINES, V8, P1399, DOI 10.1586/ERV.09.95; Zhu ST, 2010, FUTURE MED CHEM, V2, P965, DOI [10.4155/fmc.10.190, 10.4155/FMC.10.190]	20	17	22	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					871	872		10.1038/nchembio.477	http://dx.doi.org/10.1038/nchembio.477			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079593				2022-12-27	WOS:000284214700009
J	Wagner, BK				Wagner, Bridget K.			Chemical transdifferentiation and regenerative medicine	NATURE CHEMICAL BIOLOGY			English	Article							TRANSCRIPTIONAL CONTROL; BETA-CELLS; EXPRESSION; FIBROBLASTS; INDUCERS; ALPHA	The ability to alter cell identity with small molecules represents a powerful approach to restore biological function lost because of cellular deficiency. Developing this capability through advances in chemical biology could have an enormous impact on human health.	[Wagner, Bridget K.] Broad Inst Harvard, Chem Biol Program, Cambridge, MA USA; [Wagner, Bridget K.] MIT, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Wagner, BK (corresponding author), Broad Inst Harvard, Chem Biol Program, Cambridge, MA USA.	bwagner@broadinstitute.org						Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Fomina-Yadlin D, 2010, P NATL ACAD SCI USA, V107, P15099, DOI 10.1073/pnas.1010018107; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Koehler AN, 2003, J AM CHEM SOC, V125, P8420, DOI 10.1021/ja0352698; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Morgan CT, 2010, NAT CHEM BIOL, V6, P102, DOI [10.1038/nchembio.282, 10.1038/NCHEMBIO.282]; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	15	6	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					877	879		10.1038/nchembio.472	http://dx.doi.org/10.1038/nchembio.472			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079596				2022-12-27	WOS:000284214700012
J	Masterson, LR; Cheng, C; Yu, T; Tonelli, M; Kornev, A; Taylor, SS; Veglia, G				Masterson, Larry R.; Cheng, Cecilia; Yu, Tao; Tonelli, Marco; Kornev, Alexandr; Taylor, Susan S.; Veglia, Gianluigi			Dynamics connect substrate recognition to catalysis in protein kinase A	NATURE CHEMICAL BIOLOGY			English	Article							CONFORMATIONAL ENTROPY; BACKBONE DYNAMICS; NMR-SPECTROSCOPY; DRUG-BINDING; RELAXATION; MECHANISM; MOTION; DOMAIN; FLEXIBILITY; REVEALS	Atomic resolution studies of protein kinases have traditionally been carried out in the inhibitory state, limiting our current knowledge on the mechanisms of substrate recognition and catalysis. Using NMR, X-ray crystallography and thermodynamic measurements, we analyzed the substrate recognition process of cAMP-dependent protein kinase (PKA), finding that entropy and protein dynamics play a prominent role. The nucleotide acts as a dynamic and allosteric activator by coupling the two lobes of apo PKA, enhancing the enzyme dynamics synchronously and priming it for catalysis. The formation of the ternary complex is entropically driven, and NMR spin relaxation data reveal that both substrate and PKA are dynamic in the closed state. Our results show that the enzyme toggles between open and closed states, which indicates that a conformational selection rather than an induced-fit mechanism governs substrate recognition.	[Masterson, Larry R.; Veglia, Gianluigi] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Masterson, Larry R.; Yu, Tao; Veglia, Gianluigi] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Cheng, Cecilia; Kornev, Alexandr; Taylor, Susan S.] Univ San Diego, Dept Chem & Biochem, San Diego, CA 92110 USA; [Tonelli, Marco] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53705 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of San Diego; University of Wisconsin System; University of Wisconsin Madison	Masterson, LR (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	staylor@ucsd.edu; vegli001@umn.edu	Kornev, Alexandr Petrovich/O-7826-2015; Yu, Tao/F-5732-2014	Kornev, Alexandr Petrovich/0000-0002-1543-3795; 	US National Institutes of Health [GM64742, HL080081, GM19301]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002781, P41RR002301, S10RR008438] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL080081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072701, P41GM066326, R01GM019301, R01GM064742, R37GM019301] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (GM64742 and HL080081 to G. V. and GM19301 to S. S. T.). NMR data were collected at the National Magnetic Resonance Facility at Madison (NMRFAM) (US National Institutes of Health: P41RR02301, P41GM66326, RR02781 and RR08438; US National Science Foundation: DMB-8415048, OIA-9977486 and BIR-9214394) and the University of Minnesota NMR Facility (US National Science Foundation BIR-961477). We thank J.P. Loria (Yale University) for providing the TROSY Hahn echo pulse sequence, and we would also like to thank J.P. Loria, E.E. Metcalfe and G. Melacini for critical analysis of the paper.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hyeon C, 2009, P NATL ACAD SCI USA, V106, P3023, DOI 10.1073/pnas.0813266106; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kumar S, 2000, PROTEIN SCI, V9, P10; Lew J, 1997, BIOCHEMISTRY-US, V36, P6717, DOI 10.1021/bi963164u; Li F, 2002, J MOL BIOL, V315, P459, DOI 10.1006/jmbi.2001.5256; Mao DYL, 2008, MOL CELL, V29, P535, DOI 10.1016/j.molcel.2008.02.009; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Massi F, 2006, BIOCHEMISTRY-US, V45, P10787, DOI 10.1021/bi060764c; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Masterson LR, 2009, BIOMOL NMR ASSIGN, V3, P115, DOI 10.1007/s12104-009-9154-8; Masterson LR, 2009, PROTEIN EXPRES PURIF, V64, P231, DOI 10.1016/j.pep.2008.10.016; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wang CY, 2003, J AM CHEM SOC, V125, P8968, DOI 10.1021/ja035139z; Wu J, 2005, PROTEIN SCI, V14, P2871, DOI 10.1110/ps.051715205; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99	50	165	167	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					821	828		10.1038/NCHEMBIO.452	http://dx.doi.org/10.1038/NCHEMBIO.452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20890288	Green Accepted			2022-12-27	WOS:000283197800011
J	Kim, DG; Lee, JY; Kwon, NH; Fang, PF; Zhang, Q; Wang, J; Young, NL; Guo, M; Cho, HY; Mushtaq, AU; Jeon, YH; Choi, JW; Han, JM; Kang, HW; Joo, JE; Hur, Y; Kang, W; Yang, H; Nam, DH; Lee, MS; Lee, JW; Kim, ES; Moon, A; Kim, K; Kim, D; Kang, EJ; Moon, Y; Rhee, KH; Han, BW; Yang, JS; Han, G; Yang, WS; Lee, C; Wang, MW; Kim, S				Kim, Dae Gyu; Lee, Jin Young; Kwon, Nam Hoon; Fang, Pengfei; Zhang, Qian; Wang, Jing; Young, Nicolas L.; Guo, Min; Cho, Hye Young; Mushtaq, Ameeq Ul; Jeon, Young Ho; Choi, Jin Woo; Han, Jung Min; Kang, Ho Woong; Joo, Jae Eun; Hur, Youn; Kang, Wonyoung; Yang, Heekyoung; Nam, Do-Hyun; Lee, Mi-Sook; Lee, Jung Weon; Kim, Eun-Sook; Moon, Aree; Kim, Kibom; Kim, Doyeun; Kang, Eun Joo; Moon, Youngji; Rhee, Kyung Hee; Han, Byung Woo; Yang, Jee Sun; Han, Gyoonhee; Yang, Won Suk; Lee, Cheolju; Wang, Ming-Wei; Kim, Sunghoon			Chemical inhibition of prometastatic lysyl-tRNA synthetase-laminin receptor interaction	NATURE CHEMICAL BIOLOGY			English	Article							ION-CYCLOTRON RESONANCE; MASS-SPECTROMETRY; SCATTERING SAXS; GENE-EXPRESSION; CELL INVASION; SYSTEM; CANCER; METASTASIS; CARCINOMA; PROTEINS	Lysyl-tRNA synthetase (KRS), a protein synthesis enzyme in the cytosol, relocates to the plasma membrane after a laminin signal and stabilizes a 67-kDa laminin receptor (67LR) that is implicated in cancer metastasis; however, its potential as an antimetastatic therapeutic target has not been explored. We found that the small compound BC-K-YH16899, which binds KRS, impinged on the interaction of KRS with 67LR and suppressed metastasis in three different mouse models. The compound inhibited the KRS-67LR interaction in two ways. First, it directly blocked the association between KRS and 67LR. Second, it suppressed the dynamic movement of the N-terminal extension of KRS and reduced membrane localization of KRS. However, it did not affect the catalytic activity of KRS. Our results suggest that specific modulation of a cancer-related KRS-67LR interaction may offer a way to control metastasis while avoiding the toxicities associated with inhibition of the normal functions of KRS.	[Kim, Dae Gyu; Lee, Jin Young; Kwon, Nam Hoon; Han, Jung Min; Kim, Kibom; Kim, Doyeun; Kang, Eun Joo; Moon, Youngji; Yang, Won Suk; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea; [Kim, Dae Gyu; Lee, Jin Young; Kwon, Nam Hoon; Han, Jung Min; Lee, Mi-Sook; Lee, Jung Weon; Kim, Kibom; Kim, Doyeun; Rhee, Kyung Hee; Han, Byung Woo; Yang, Won Suk; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul, South Korea; [Fang, Pengfei; Wang, Jing; Guo, Min] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Zhang, Qian] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Young, Nicolas L.] Florida State Univ, Ion Cyclotron Resonance Program, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Cho, Hye Young; Mushtaq, Ameeq Ul; Jeon, Young Ho] Korea Univ, Coll Pharm, Sejong, South Korea; [Choi, Jin Woo] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Kang, Ho Woong; Joo, Jae Eun; Hur, Youn] Yuhan Res Inst, Yongin, South Korea; [Kang, Wonyoung; Yang, Heekyoung; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Kim, Eun-Sook; Moon, Aree] Duksung Womens Univ, Coll Pharm, Seoul, South Korea; [Han, Gyoonhee] Yonsei Univ, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea; [Lee, Cheolju] Korea Inst Sci & Technol, BRI, Seoul, South Korea; [Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai, Peoples R China; [Kim, Sunghoon] Seoul Natl Univ, World Class Univ, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Scripps Research Institute; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Korea University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Duksung Women's University; Yonsei University; Korea Institute of Science & Technology (KIST); Chinese Academy of Sciences; Seoul National University (SNU)	Kim, DG (corresponding author), Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea.	sungkim@snu.ac.kr	Young, Nicolas/AAI-5242-2020; Kim, Sunghoon/AAE-8314-2020; Fang, Pengfei/O-3696-2015; Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Young, Nicolas/0000-0002-3323-2815; Fang, Pengfei/0000-0002-3448-5494; Lee, Jung Weon/0000-0003-2722-8200; Han, Jung Min/0000-0003-3372-7575; Mushtaq, Ameeq Ul/0000-0002-5636-2567; Wang, Jing/0000-0002-7566-1212; kim, sunghoon/0000-0002-1570-3230	Global Frontier Project [M1AXA002-20100029785, NRF-M1AXA002-2010-0029765, NRF-2012M3A6A4054271, NRF-2012-054237]; World Class University [R31-2008000- 10086-0]; Proteogenomic Research Program [2012M3A9B9036679]; National Research Foundation; Ministry of Education, Science and Technology of Korea [ROA-2012-0006262]; Ministry for Health and Welfare Affairs of Korea [A092255]; Gyeonggi Research Development Program; US National Institutes of Health [GM100136]; US National Science Foundation Division of Materials Research [DMR-11-57490]; Kimmel Scholar Award for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106134, R01GM100136] Funding Source: NIH RePORTER	Global Frontier Project; World Class University; Proteogenomic Research Program; National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health and Welfare Affairs of Korea; Gyeonggi Research Development Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation Division of Materials Research(National Science Foundation (NSF)); Kimmel Scholar Award for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Global Frontier Project (grants NRF-M1AXA002-20100029785 (S. K.), NRF-M1AXA002-2010-0029765 (Y. H. J.), NRF-2012M3A6A4054271 (J. W. L.) and NRF-2012-054237 (B. W. H.)), the World Class University (grant R31-2008000- 10086-0 (G. H.)), the Proteogenomic Research Program (2012M3A9B9036679 (C. L.)) and by the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea (grant ROA-2012-0006262 (A. M.)). This study was also funded by the Ministry for Health and Welfare Affairs of Korea through the Korea Healthcare Technology Research and Development Project (A092255 (D.-H. N.)) and by a grant from Gyeonggi Research Development Program (S. K.). This work was supported in part by grants from the US National Institutes of Health (GM100136 (M. G.)); the US National Science Foundation Division of Materials Research through DMR-11-57490 (A. G. Marshall, Florida State University); by the state of Florida (M. G.) and by a Kimmel Scholar Award for Cancer Research (M. G.). We appreciate A. G. Marshall for supporting the HDX-MS program and facility, M.-S. Seok (Korea University) for the preparation of the nanodisc and S. W. Lee (Sungkyunkwan University) for X-ray analysis.	Allen Bibb Jr, 2009, J Am Coll Radiol, V6, P606, DOI 10.1016/j.jacr.2009.06.007; ARGUELLO F, 1992, CANCER RES, V52, P2304; Batissoco AC, 2009, BRAZ J MED BIOL RES, V42, P168, DOI 10.1590/S0100-879X2009000200004; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; Cardin V, 2011, CEREB CORTEX, V21, P550, DOI 10.1093/cercor/bhq122; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; Fontanini G, 1997, CLIN CANCER RES, V3, P227; Ford CL, 1999, CANCER RES, V59, P704; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Givant-Horwitz V, 2005, CANCER LETT, V223, P1, DOI 10.1016/j.canlet.2004.08.030; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; Hippo Y, 2002, CANCER RES, V62, P233; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kawamata H, 2008, J BIOL CHEM, V283, P28321, DOI 10.1074/jbc.M805599200; Kazazic S, 2010, J AM SOC MASS SPECTR, V21, P550, DOI 10.1016/j.jasms.2009.12.016; Kim DG, 2012, FASEB J, V26, P4142, DOI 10.1096/fj.12-207639; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim KA, 2004, FEBS LETT, V565, P181, DOI 10.1016/j.febslet.2004.03.062; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Li D, 2009, EUR SURG RES, V42, P168, DOI 10.1159/000198234; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Nyberg P, 2003, J BIOL CHEM, V278, P22404, DOI 10.1074/jbc.M210325200; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Schmidlin K, 2010, CLIN ORAL IMPLAN RES, V21, P550, DOI 10.1111/j.1600-0501.2009.01907.x; Sevenich L, 2011, ONCOGENE, V30, P54, DOI 10.1038/onc.2010.387; Shenkarev ZO, 2009, BIOCHEMISTRY-MOSCOW+, V74, P756, DOI 10.1134/S0006297909070086; Soares Mônica Regina Pereira Senra, 2010, Braz. Dent. J., V21, P550, DOI 10.1590/S0103-64402010000600012; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; VandenBrule FA, 1996, HUM PATHOL, V27, P1185, DOI 10.1016/S0046-8177(96)90313-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Young IS, 2010, CURR OPIN LIPIDOL, V21, P550, DOI 10.1097/MOL.0b013e328340b4d9; Zhang HM, 2010, ANAL CHEM, V82, P1450, DOI 10.1021/ac902550n; Zhang HM, 2009, J AM SOC MASS SPECTR, V20, P520, DOI 10.1016/j.jasms.2008.11.010; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	54	44	49	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					29	U57		10.1038/NCHEMBIO.1381	http://dx.doi.org/10.1038/NCHEMBIO.1381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24212136	Green Accepted			2022-12-27	WOS:000328854900007
J	Farid, TA; Kodali, G; Solomon, LA; Lichtenstein, BR; Sheehan, MM; Fry, BA; Bialas, C; Ennist, NM; Siedlecki, JA; Zhao, ZY; Stetz, MA; Valentine, KG; Anderson, JLR; Wand, AJ; Discher, BM; Moser, CC; Dutton, PL				Farid, Tammer A.; Kodali, Goutham; Solomon, Lee A.; Lichtenstein, Bruce R.; Sheehan, Molly M.; Fry, Bryan A.; Bialas, Chris; Ennist, Nathan M.; Siedlecki, Jessica A.; Zhao, Zhenyu; Stetz, Matthew A.; Valentine, Kathleen G.; Anderson, J. L. Ross; Wand, A. Joshua; Discher, Bohdana M.; Moser, Christopher C.; Dutton, P. Leslie			Elementary tetrahelical protein design for diverse oxidoreductase functions	NATURE CHEMICAL BIOLOGY			English	Article							COMPUTATIONAL ENZYME DESIGN; DE-NOVO; CYTOCHROME-C; TRANSPORT PROTEIN; ELECTRON-TRANSFER; HELICAL PROTEIN; LIGAND-BINDING; 4-HELIX BUNDLE; HEME-PROTEINS; MAQUETTE	Emulating functions of natural enzymes in man-made constructs has proven challenging. Here we describe a man-made protein platform that reproduces many of the diverse functions of natural oxidoreductases without importing the complex and obscure interactions common to natural proteins. Our design is founded on an elementary, structurally stable 4-alpha-helix protein monomer with a minimalist interior malleable enough to accommodate various light-and redox-active cofactors and with an exterior tolerating extensive charge patterning for modulation of redox cofactor potentials and environmental interactions. Despite its modest size, the construct offers several independent domains for functional engineering that targets diverse natural activities, including dioxygen binding and superoxide and peroxide generation, interprotein electron transfer to natural cytochrome c and light-activated intraprotein energy transfer and charge separation approximating the core reactions of photosynthesis, cryptochrome and photolyase. The highly stable, readily expressible and biocompatible characteristics of these open-ended designs promise development of practical in vitro and in vivo applications.	[Farid, Tammer A.; Kodali, Goutham; Solomon, Lee A.; Lichtenstein, Bruce R.; Sheehan, Molly M.; Fry, Bryan A.; Bialas, Chris; Ennist, Nathan M.; Siedlecki, Jessica A.; Zhao, Zhenyu; Stetz, Matthew A.; Valentine, Kathleen G.; Anderson, J. L. Ross; Wand, A. Joshua; Discher, Bohdana M.; Moser, Christopher C.; Dutton, P. Leslie] Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA; [Lichtenstein, Bruce R.] Max Planck Inst Dev Biol, Tubingen, Germany; [Anderson, J. L. Ross] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Pennsylvania; Max Planck Society; University of Bristol	Dutton, PL (corresponding author), Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA.	dutton@mail.med.upenn.edu	Moser, Christopher C/O-6559-2014; Lichtenstein, Bruce/P-8923-2015; Sheehan, Molly Marie/GYQ-5371-2022; Lichtenstein, Bruce/AAR-7795-2020	Moser, Christopher C/0000-0003-4814-8568; Lichtenstein, Bruce/0000-0001-6796-9826; Sheehan, Molly Marie/0000-0001-9114-5528; Anderson, Ross/0000-0002-6796-0482; Ennist, Nathan/0000-0002-4823-9497; Solomon, Lee/0000-0003-1471-9510; Stetz, Matthew/0000-0002-4590-2871	US National Institutes of Health (NIH)-General Medical Institutes [RO1 GM 41048]; NIH United States Public Health Service [DK39806, GM102477]; US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-05ER46223]; US Department of Energy Office of Basic Energy Sciences, Energy Frontier Research Center (PARC) [DE-PSE02-08ER15944]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041048, R01GM102447, T32GM008275] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)-General Medical Institutes; NIH United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); US Department of Energy Office of Basic Energy Sciences, Energy Frontier Research Center (PARC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	In this research, the US National Institutes of Health (NIH)-General Medical Institutes (RO1 GM 41048) funded the design and development of the maquette proteins A, B, F, G and H, including gene design, cloning, protein expression, purification and characterization; it also funded the thermal stability measurements using CD and demonstrations of control of oxygen binding and redox chemistry. Basic to these developments was NMR spectroscopy performed by M. A. S., K. G. V. and A. J. W., supported by NIH United States Public Health Service grants DK39806 and GM102477 to A. J. W. The US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (DE-FG02-05ER46223) funded the synthesis and characterization of flavins and also the design, expression, purification and characterization of C, K, J protein maquettes promoting light-activated charge separation and oxidation-reduction using flavin and Zn- and Fe-tetrapyrroles as cofactors. The US Department of Energy Office of Basic Energy Sciences, Energy Frontier Research Center (PARC) (DE-PSE02-08ER15944 to P. L. D. and C. C. M.) funded development of light excitation energy transfer in maquettes (L and its mutants), synthesis and purification of Zn pyropheophoribide a and covalent attachments of Alexa Fluor to the maquettes. In this work, the synthetic chlorin ZnC was a generous gift from O. Mass and J. S. Lindsey at North Carolina State University.	Anderson JLR, 2008, BIOCHEM SOC T, V36, P1106, DOI 10.1042/BST0361106; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Bender GM, 2007, J AM CHEM SOC, V129, P10732, DOI 10.1021/ja071199j; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brustad EM, 2011, CURR OPIN CHEM BIOL, V15, P201, DOI 10.1016/j.cbpa.2010.11.020; CAFFREY MS, 1994, BBA-BIOENERGETICS, V1187, P277, DOI 10.1016/0005-2728(94)90001-9; CROSS AR, 1985, BIOCHEM J, V226, P881, DOI 10.1042/bj2260881; DAVIES AM, 1993, BIOCHEMISTRY-US, V32, P5431, DOI 10.1021/bi00071a019; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Fischer E, 1966, NOBEL LECT CHEM 1901, V1, P21; Fisher MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015364; Fry HC, 2010, J AM CHEM SOC, V132, P3997, DOI 10.1021/ja907407m; Gibney BR, 1996, P NATL ACAD SCI USA, V93, P15041, DOI 10.1073/pnas.93.26.15041; Grosset AM, 2001, BIOCHEMISTRY-US, V40, P5474, DOI 10.1021/bi002504f; Grzyb J, 2012, BBA-BIOENERGETICS, V1817, P1256, DOI 10.1016/j.bbabio.2012.02.001; Hamdane D, 2005, FEBS J, V272, P2076, DOI 10.1111/j.1742-4658.2005.04635.x; Huang SS, 2003, J MOL BIOL, V326, P1219, DOI 10.1016/S0022-2836(02)01441-9; Kiger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020478; Koder RL, 2006, J AM CHEM SOC, V128, P14450, DOI 10.1021/ja064883r; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q; KU J, 1995, P NATL ACAD SCI USA, V92, P6552, DOI 10.1073/pnas.92.14.6552; Lichtenstein BR, 2012, BIOCHEM SOC T, V40, P561, DOI 10.1042/BST20120067; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; MARGOLIASH E, 1983, TRENDS BIOCHEM SCI, V8, P316, DOI 10.1016/0968-0004(83)90100-7; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P1, DOI 10.1021/bi00594a001; Miner KD, 2012, ANGEW CHEM INT EDIT, V51, P5589, DOI 10.1002/anie.201201981; Monien BH, 2007, J MOL BIOL, V371, P739, DOI 10.1016/j.jmb.2007.05.047; MOSER CC, 1988, BIOCHEMISTRY-US, V27, P2450, DOI 10.1021/bi00407a031; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Moser CC, 2010, BBA-BIOENERGETICS, V1797, P1573, DOI 10.1016/j.bbabio.2010.04.441; MUIRWOOD P, 1974, FEBS LETT, V44, P22, DOI 10.1016/0014-5793(74)80297-8; Muthiah C, 2007, J ORG CHEM, V72, P7736, DOI 10.1021/jo701500d; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Patel SC, 2012, PROTEIN ENG DES SEL, V25, P445, DOI 10.1093/protein/gzs025; Prabhulkar S, 2012, ANTIOXID REDOX SIGN, V17, P1796, DOI 10.1089/ars.2011.4001; PREDKI PF, 1995, BIOCHEMISTRY-US, V34, P9834, DOI 10.1021/bi00031a003; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666; Reig AJ, 2012, NAT CHEM, V4, P900, DOI [10.1038/NCHEM.1454, 10.1038/nchem.1454]; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sharp RE, 1998, P NATL ACAD SCI USA, V95, P10465, DOI 10.1073/pnas.95.18.10465; Shifman JM, 1998, BIOCHEMISTRY-US, V37, P16815, DOI 10.1021/bi9816857; Smith BA, 2011, CURR OPIN CHEM BIOL, V15, P421, DOI 10.1016/j.cbpa.2011.03.006; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Westerlund K, 2008, PROTEIN ENG DES SEL, V21, P645, DOI 10.1093/protein/gzn043; Zhang L, 2013, BIOCHEMISTRY-US, V52, P447, DOI 10.1021/bi301066z	51	103	101	2	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					826	+		10.1038/NCHEMBIO.1362	http://dx.doi.org/10.1038/NCHEMBIO.1362			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24121554	Green Accepted			2022-12-27	WOS:000327130000015
J	Wang, S; Yin, JL; Chen, DZ; Nie, F; Song, XM; Fei, C; Miao, HF; Jing, CB; Ma, WJ; Wang, L; Xie, SC; Li, C; Zeng, R; Pan, WJ; Hao, XJ; Li, L				Wang, Sheng; Yin, Junlin; Chen, Duozhi; Nie, Fen; Song, Xiaomin; Fei, Cong; Miao, Haofei; Jing, Changbin; Ma, Wenjing; Wang, Lei; Xie, Sichun; Li, Chen; Zeng, Rong; Pan, Weijun; Hao, Xiaojiang; Li, Lin			Small-molecule modulation of Wnt signaling via modulating the Axin-LRP5/6 interaction	NATURE CHEMICAL BIOLOGY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; NEGATIVE REGULATOR; DIX DOMAIN; STEM-CELLS; IN-VIVO; AXIN; ACTIVATION; PATHWAY; PHOSPHORYLATION	The Wnt/beta-catenin signaling pathway has a crucial role in embryonic development, stem cell maintenance and human disease. By screening a synthetic chemical library of lycorine derivatives, we identified 4-ethyl-5-methyl-5,6-dihydro-[1,3]dioxolo[4,5-j]phenanthridine (HLY78) as an activator of the Wnt/beta-catenin signaling pathway, which acts in a Wnt ligand-dependent manner. HLY78 targets the DIX domain of Axin and potentiates the Axin-LRP6 association, thus promoting LRP6 phosphorylation and Wnt signaling transduction. Moreover, we identified the critical residues on Axin for HLY78 binding and showed that HLY78 may weaken the autoinhibition of Axin. In addition, HLY78 acts synergistically with Wnt in the embryonic development of zebrafish and increases the expression of the conserved hematopoietic stem cell (HSC) markers, runx1 and cmyb, in zebrafish embryos. Collectively, our study not only provides new insights into the regulation of the Wnt/beta-catenin signaling pathway by a Wnt-specific small molecule but also will facilitate therapeutic applications, such as HSC expansion.	[Wang, Sheng; Nie, Fen; Song, Xiaomin; Fei, Cong; Miao, Haofei; Xie, Sichun; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Yin, Junlin; Chen, Duozhi; Wang, Lei; Hao, Xiaojiang] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Peoples R China; [Jing, Changbin; Ma, Wenjing; Pan, Weijun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Jing, Changbin; Ma, Wenjing; Pan, Weijun] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Li, Chen; Zeng, Rong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Hao, XJ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Peoples R China.	haoxj@mail.kib.ac.cn; lli@sibs.ac.cn	Jing, Changbin/X-2726-2019; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; yin, junlin/AAJ-4522-2021; LI, LI/GVS-5344-2022; li, chen/ABG-9343-2020	Jing, Changbin/0000-0003-0037-2712; 	Ministry of Science and Technology of China [2010CB912100, 2011CB966300, 2013CB910900]; National Natural Science Foundation of China [30930052, 31230044, 30830114]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We greatly appreciate the gift of LRP6 and MESD plasmids from X. He (Boston Children's Hospital), and we thank the Zebrafish Core Facility-Shanghai Institute of Biochemistry and Cell Biology for providing zebrafish embryos. This work is supported by the Ministry of Science and Technology of China (grant 2010CB912100 to L. L., 2011CB966300 to X. S. and 2013CB910900 to W. P.) and the National Natural Science Foundation of China (grants 30930052 and 31230044 to L. L. and 30830114 to X.H.).	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; CHATTOPADHYAY U, 1984, PHARMAZIE, V39, P855; Chen T, 2009, J BIOL CHEM, V284, P6683, DOI 10.1074/jbc.M807753200; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Deeb SJ, 2012, MOL CELL PROTEOMICS, V11, P77, DOI 10.1074/mcp.M111.015362; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Engler TA, 2004, J MED CHEM, V47, P3934, DOI 10.1021/jm049768a; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Graham JA, 2010, J BIOL CHEM, V285, P32852, DOI 10.1074/jbc.M110.150904; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lamoral-Theys D, 2009, J MED CHEM, V52, P6244, DOI 10.1021/jm901031h; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu YT, 2011, J BIOL CHEM, V286, P8597, DOI 10.1074/jbc.M110.186742; Luo W, 2005, J BIOL CHEM, V280, P5054, DOI 10.1074/jbc.M412340200; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sakanaka C, 1999, J BIOL CHEM, V274, P14090, DOI 10.1074/jbc.274.20.14090; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Szeto DR, 2004, DEVELOPMENT, V131, P3751, DOI 10.1242/dev.01236; Trowbridge JJ, 2006, NAT IMMUNOL, V7, P1021, DOI 10.1038/ni1006-1021; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Youssef DTA, 2001, J NAT PROD, V64, P839, DOI 10.1021/np0005816; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zimmerman ZF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008086	51	60	67	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					579	U82		10.1038/NCHEMBIO.1309	http://dx.doi.org/10.1038/NCHEMBIO.1309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23892894				2022-12-27	WOS:000323417500010
J	Srinivasan, S; Nwachukwu, JC; Parent, AA; Cavett, V; Nowak, J; Hughes, TS; Kojetin, DJ; Katzenellenbogen, JA; Nettles, KW				Srinivasan, Sathish; Nwachukwu, Jerome C.; Parent, Alex A.; Cavett, Valerie; Nowak, Jason; Hughes, Travis S.; Kojetin, Douglas J.; Katzenellenbogen, John A.; Nettles, Kendall W.			Ligand-binding dynamics rewire cellular signaling via estrogen receptor-alpha	NATURE CHEMICAL BIOLOGY			English	Article							COACTIVATOR RECRUITMENT; STRUCTURAL BASIS; CYCLIN D1; TRANSCRIPTION; ANTIESTROGEN; SPECIFICITY; ACTIVATION; EXPRESSION; REGULATOR; MECHANISM	Ligand-binding dynamics control allosteric signaling through the estrogen receptor-alpha (ER alpha), but the biological consequences of such dynamic binding orientations are unknown. Here, we compare a set of ER ligands having dynamic binding orientation (dynamic ligands) with a control set of isomers that are constrained to bind in a single orientation (constrained ligands). Proliferation of breast cancer cells directed by constrained ligands is associated with DNA binding, coactivator recruitment and activation of the estrogen-induced gene GREB1, reflecting a highly interconnected signaling network. In contrast, proliferation driven by dynamic ligands is associated with induction of ER alpha-mediated transcription in a DNA-binding domain (DBD)-dependent manner. Further, dynamic ligands showed enhanced anti-inflammatory activity. The DBD-dependent profile was predictive of these signaling patterns in a larger diverse set of natural and synthetic ligands. Thus, ligand dynamics directs unique signaling pathways and reveals a new role of the DBD in allosteric control of ER alpha-mediated signaling.	[Srinivasan, Sathish; Nwachukwu, Jerome C.; Cavett, Valerie; Nowak, Jason; Nettles, Kendall W.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Parent, Alex A.; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Hughes, Travis S.; Kojetin, Douglas J.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA	Scripps Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute	Srinivasan, S (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA.	knettles@scripps.edu		Nwachukwu, Jerome/0000-0003-4313-9187; Hughes, Travis/0000-0002-5764-5884	US National Institutes of Health [PHS 5R37 DK015556, 5R33CA132022, 5R01DK077085]; Frenchman's Creek Women for Cancer Research; NATIONAL CANCER INSTITUTE [R33CA132022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK015556, R01DK015556, F32DK097890, R01DK077085] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frenchman's Creek Women for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J.L. Cleveland for critically evaluating the manuscript. This research was supported by the US National Institutes of Health (PHS 5R37 DK015556 to J.A.K.; 5R33CA132022 and 5R01DK077085 to K.W.N.). S. S. is supported by the Frenchman's Creek Women for Cancer Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bapat AR, 2003, J STEROID BIOCHEM, V86, P143, DOI 10.1016/S0960-0760(03)00262-0; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI 10.1038/NCHEMBIO.451; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; Carroll MJ, 2011, J AM CHEM SOC, V133, P6422, DOI 10.1021/ja2005253; Chadwick CC, 2005, P NATL ACAD SCI USA, V102, P2543, DOI 10.1073/pnas.0405841102; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Connelly T., 2009, NEW BIOL 21 CENTURY, V12; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hammes SR, 2011, ENDOCRINOLOGY, V152, P4489, DOI 10.1210/en.2011-1470; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Hughes TS, 2012, STRUCTURE, V20, P139, DOI 10.1016/j.str.2011.10.018; Kong EH, 2005, P NATL ACAD SCI USA, V102, P3593, DOI 10.1073/pnas.0407189102; Laughlin JD, 2012, STRUCTURE, V20, P2174, DOI 10.1016/j.str.2012.09.021; Likhite VS, 2004, J BIOL CHEM, V279, P16875, DOI 10.1074/jbc.M313155200; Loven MA, 2001, J BIOL CHEM, V276, P45282, DOI 10.1074/jbc.M106211200; Lupien M, 2007, MOL ENDOCRINOL, V21, P797, DOI 10.1210/me.2006-0074; McInerney EM, 1996, J BIOL CHEM, V271, P24172, DOI 10.1074/jbc.271.39.24172; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; Nettles KW, 2007, EMBO REP, V8, P610, DOI 10.1038/sj.embor.7401006; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Nettles KW, 2004, MOL CELL, V13, P317, DOI 10.1016/S1097-2765(04)00054-1; Nwachukwu JC, 2012, EMBO J, V31, P251, DOI 10.1038/emboj.2011.475; PHAM TA, 1991, P NATL ACAD SCI USA, V88, P3125, DOI 10.1073/pnas.88.8.3125; Planas-Silva MD, 2001, CANCER RES, V61, P3858; Powell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030993; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Schulltz-Norton JR, 2011, TRENDS ENDOCRIN MET, V22, P124, DOI 10.1016/j.tem.2010.11.005; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sun Z, 2012, ONCOGENE, V31, P2653, DOI 10.1038/onc.2011.448; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Wang JC, 2006, GENE DEV, V20, P689, DOI 10.1101/gad.1400506; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]	51	46	46	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2013	9	5					326	+		10.1038/NCHEMBIO.1214	http://dx.doi.org/10.1038/NCHEMBIO.1214			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	127VT	23524984	Green Accepted			2022-12-27	WOS:000317727600010
J	Kesavan, S; Marcaurelle, LA				Kesavan, Sarathy; Marcaurelle, Lisa A.			Translational synthetic chemistry	NATURE CHEMICAL BIOLOGY			English	Article							DIVERSITY-ORIENTED SYNTHESIS; SMALL MOLECULES; DISCOVERY; CORTISTATIN; INHIBITORS; FRAGMENTS; YIELDS; ROUTE; BIND; LEAD		[Kesavan, Sarathy; Marcaurelle, Lisa A.] H3 Biomed Inc, Cambridge, MA USA		Kesavan, S (corresponding author), H3 Biomed Inc, Cambridge, MA USA.	Lisa_Marcaurelle@H3Biomedicine.com						[Anonymous], 2012, Drug Discov Today Technol, V9, pe1, DOI 10.1016/j.ddtec.2012.01.004; Austad BC, 2013, SYNLETT, V24, P333, DOI 10.1055/s-0032-1318026; Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Bamborough P, 2012, J MED CHEM, V55, P587, DOI 10.1021/jm201283q; Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Clemons PA, 2011, P NATL ACAD SCI USA, V108, P6817, DOI 10.1073/pnas.1015024108; Dai HX, 2011, J AM CHEM SOC, V133, P7222, DOI 10.1021/ja201708f; Grossmann TN, 2012, P NATL ACAD SCI USA, V109, P17942, DOI 10.1073/pnas.1208396109; Hajduk PJ, 2011, NATURE, V470, P42, DOI 10.1038/470042a; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Heidebrecht RW, 2012, ACS MED CHEM LETT, V3, P112, DOI 10.1021/ml200244k; Hili R, 2010, J AM CHEM SOC, V132, P2889, DOI 10.1021/ja910544p; Hung AW, 2011, P NATL ACAD SCI USA, V108, P6799, DOI 10.1073/pnas.1015271108; Madden MM, 2011, BIOORG MED CHEM LETT, V21, P1472, DOI 10.1016/j.bmcl.2011.01.004; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; Marcaurelle LA, 2009, BIOORG MED CHEM LETT, V19, P2500, DOI 10.1016/j.bmcl.2009.03.037; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Mousseau G, 2012, CELL HOST MICROBE, V12, P97, DOI 10.1016/j.chom.2012.05.016; O'Connor CJ, 2012, CHEM SOC REV, V41, P4444, DOI 10.1039/c2cs35023h; Over B, 2013, NAT CHEM, V5, P21, DOI [10.1038/NCHEM.1506, 10.1038/nchem.1506]; Schulz MN, 2009, CURR OPIN PHARMACOL, V9, P615, DOI 10.1016/j.coph.2009.04.009; Shi J, 2011, J AM CHEM SOC, V133, P8014, DOI 10.1021/ja202103e; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Walji AM, 2007, SYNLETT, P1477, DOI 10.1055/s-2007-980382; Yan CH, 2013, BBA-REV CANCER, V1835, P76, DOI 10.1016/j.bbcan.2012.11.002; Zhou HB, 2013, J MED CHEM, V56, P1113, DOI 10.1021/jm3015298	26	9	9	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					210	213		10.1038/nchembio.1207	http://dx.doi.org/10.1038/nchembio.1207			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23508175				2022-12-27	WOS:000317025800005
J	Pierre, S; Guillot, A; Benjdia, A; Sandstrom, C; Langella, P; Berteau, O				Pierre, Stephane; Guillot, Alain; Benjdia, Alhosna; Sandstrom, Corine; Langella, Philippe; Berteau, Olivier			Thiostrepton tryptophan methyltransferase expands the chemistry of radical SAM enzymes	NATURE CHEMICAL BIOLOGY			English	Article							SULFATASE-MATURATING ENZYME; S-ADENOSYLMETHIONINE; DEPENDENT METHYLTRANSFERASES; BIOSYNTHESIS; METHYLATION; CONFIGURATION; METHIONINE; RETENTION; FOXM1	Methylation is among the most widespread chemical modifications encountered in biomolecules and has a pivotal role in many major biological processes. In the biosynthetic pathway of the antibiotic thiostrepton A, we identified what is to our knowledge the first tryptophan methyltransferase. We show that it uses unprecedented chemistry to methylate inactivated sp(2)-hybridized carbon atoms, despite being predicted to be a radical SAM enzyme.	[Pierre, Stephane; Guillot, Alain; Langella, Philippe; Berteau, Olivier] INRA, UMR Micalis 1319, Jouy En Josas, France; [Pierre, Stephane; Guillot, Alain; Langella, Philippe; Berteau, Olivier] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Benjdia, Alhosna] Max Planck Inst Med Res, Dept Biomol Mech, Heidelberg, Germany; [Sandstrom, Corine] Swedish Univ Agr Sci, Dept Chem, S-75007 Uppsala, Sweden	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Swedish University of Agricultural Sciences	Berteau, O (corresponding author), INRA, UMR Micalis 1319, Jouy En Josas, France.	olivier.berteau@jouy.inra.fr	Berteau, Olivier/AAF-9080-2019; Benjdia, Alhosna/AAM-7415-2021; Langella, Philippe/N-8368-2017	Berteau, Olivier/0000-0002-3434-5168; Benjdia, Alhosna/0000-0002-3544-2541; Langella, Philippe/0000-0001-5960-4341	French National Research Agency	French National Research Agency(French National Research Agency (ANR))	We are grateful to J. Ulmer for critical reading of this manuscript. MS experiments were performed at Plateforme d'Analyse Proteomique de Paris Sud Ouest. This work was supported by grants from the French National Research Agency to S.P.	Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; FRENZEL T, 1990, ARCH BIOCHEM BIOPHYS, V278, P35, DOI 10.1016/0003-9861(90)90227-P; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; HOUCK DR, 1986, J AM CHEM SOC, V108, P5365, DOI 10.1021/ja00277a063; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Matthews RG, 2008, CURR OPIN STRUC BIOL, V18, P658, DOI 10.1016/j.sbi.2008.11.005; Menon S, 1998, BIOCHEMISTRY-US, V37, P5689, DOI 10.1021/bi9727996; Moore BN, 2012, PHYS CHEM CHEM PHYS, V14, P3148, DOI 10.1039/c2cp23443b; Mosimann H, 2000, ANGEW CHEM INT EDIT, V39, P393, DOI 10.1002/(SICI)1521-3773(20000117)39:2<393::AID-ANIE393>3.0.CO;2-M; Nicolaou KC, 2005, J AM CHEM SOC, V127, P15042, DOI 10.1021/ja0552803; Tarr SJ, 2011, MOL BIOCHEM PARASIT, V179, P37, DOI 10.1016/j.molbiopara.2011.05.004; Walsh CT, 2010, J BIOL CHEM, V285, P27525, DOI 10.1074/jbc.R110.135970; Werner WJ, 2011, BIOCHEMISTRY-US, V50, P8986, DOI 10.1021/bi201220r; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c; ZHOU P, 1989, J AM CHEM SOC, V111, P7274, DOI 10.1021/ja00200a065	22	88	91	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					957	959		10.1038/NCHEMBIO.1091	http://dx.doi.org/10.1038/NCHEMBIO.1091			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23064318				2022-12-27	WOS:000311491200007
J	Schlame, M; Acehan, D; Berno, B; Xu, Y; Valvo, S; Ren, MD; Stokes, DL; Epand, RM				Schlame, Michael; Acehan, Devrim; Berno, Bob; Xu, Yang; Valvo, Salvatore; Ren, Mindong; Stokes, David L.; Epand, Richard M.			The physical state of lipid substrates provides transacylation specificity for tafazzin	NATURE CHEMICAL BIOLOGY			English	Article							BARTH-SYNDROME; CARDIOLIPIN METABOLISM; DEUTERIUM-NMR; ATP SYNTHASE; MITOCHONDRIA; MEMBRANES; MODEL; ORGANIZATION; POLYMORPHISM; MUTANT	Cardiolipin is a mitochondrial phospholipid with a characteristic acyl chain composition that depends on the function of tafazzin, a phospholipid-lysophospholipid transacylase, although the enzyme itself lacks acyl specificity. We incubated isolated tafazzin with various mixtures of phospholipids and lysophospholipids, characterized the lipid phase by P-31-NMR and measured newly formed molecular species by MS. Substantial transacylation was observed only in nonbilayer lipid aggregates, and the substrate specificity was highly sensitive to the lipid phase. In particular, tetralinoleoyl-cardiolipin, a prototype molecular species, formed only under conditions that favor the inverted hexagonal phase. In isolated mitochondria, <1% of lipids participated in transacylations, suggesting that the action of tafazzin was limited to privileged lipid domains. We propose that tafazzin reacts with non-bilayer-type lipid domains that occur in curved or hemifused membrane zones and that acyl specificity is driven by the packing properties of these domains.	[Schlame, Michael; Xu, Yang] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Schlame, Michael; Ren, Mindong] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Acehan, Devrim; Valvo, Salvatore; Stokes, David L.] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; [Berno, Bob; Epand, Richard M.] McMaster Univ, Dept Chem, Hamilton, ON, Canada; [Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	New York University; New York University; New York University; McMaster University; McMaster University	Schlame, M (corresponding author), NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA.	michael.schlame@med.nyu.edu	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	Barth Syndrome Foundation; National Institutes of Health [HL078788, HL091154, 1U54GM094598]; Canadian Natural Sciences and Engineering Research Council [9848]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091154, R01HL078788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094598] Funding Source: NIH RePORTER	Barth Syndrome Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to B. De Kruijff for stimulating discussions. This work was supported by the Barth Syndrome Foundation, by the National Institutes of Health (HL078788 to M.S., HL091154 to M. R., 1U54GM094598 to D.L.S.) and by the Canadian Natural Sciences and Engineering Research Council (9848 to R.M.E.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Cook A M, 1981, Methods Enzymol, V72, P292, DOI 10.1016/S0076-6879(81)72017-2; CULLIS PR, 1980, BIOCHIM BIOPHYS ACTA, V600, P625, DOI 10.1016/0005-2736(80)90466-6; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V684, P47, DOI 10.1016/0005-2736(82)90047-5; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V693, P1, DOI 10.1016/0005-2736(82)90464-3; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; MCLAUGHLIN AC, 1975, J MAGN RESON, V20, P146, DOI 10.1016/0022-2364(75)90162-6; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; NICOLAY K, 1985, BIOCHIM BIOPHYS ACTA, V819, P55, DOI 10.1016/0005-2736(85)90195-6; Nishizawa Manami, 2010, Journal of Biophysical Chemistry, V1, P86, DOI 10.4236/jbpc.2010.12011; OTTEN D, 1995, BIOPHYS J, V68, P584, DOI 10.1016/S0006-3495(95)80220-1; RAND RP, 1972, BIOCHIM BIOPHYS ACTA, V225, P484, DOI 10.1016/0005-2736(72)90152-6; SANKARAM MB, 1989, BIOCHIM BIOPHYS ACTA, V980, P389, DOI 10.1016/0005-2736(89)90331-3; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2012, CHEM PHYS LIPIDS, V165, P512, DOI 10.1016/j.chemphyslip.2012.03.001; Schlame M, 2009, BBA-MOL CELL BIOL L, V1791, P321, DOI 10.1016/j.bbalip.2009.01.018; Shulga YV, 2011, J MOL BIOL, V409, P101, DOI 10.1016/j.jmb.2011.03.071; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; THURMOND RL, 1993, BIOCHEMISTRY-US, V32, P5394, DOI 10.1021/bi00071a015; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Xu Y, 2009, J BIOL CHEM, V284, P29230, DOI 10.1074/jbc.M109.016642; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200	39	94	95	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					862	869		10.1038/NCHEMBIO.1064	http://dx.doi.org/10.1038/NCHEMBIO.1064			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22941046	Green Accepted			2022-12-27	WOS:000309056200012
J	Peil, L; Starosta, AL; Virumae, K; Atkinson, GC; Tenson, T; Remme, J; Wilson, DN				Peil, Lauri; Starosta, Agata L.; Virumaee, Kai; Atkinson, Gemma C.; Tenson, Tanel; Remme, Jaanus; Wilson, Daniel N.			Lys34 of translation elongation factor EF-P is hydroxylated by YfcM	NATURE CHEMICAL BIOLOGY			English	Article							PEPTIDE-BOND SYNTHESIS; SALMONELLA-ENTERICA; POSTTRANSLATIONAL MODIFICATION; PROTEIN-SYNTHESIS; POXA; IDENTIFICATION; VIRULENCE; RIBOSOME; PARALOG; GENE	Lys34 of the conserved translation elongation factor P (EF-P) is post-translationally lysinylated by YjeK and YjeA-a modification that is critical for bacterial virulence. Here we show that the currently accepted Escherichia coli EF-P modification pathway is incomplete and lacks a final hydroxylation step mediated by YfcM, an enzyme distinct from deoxyhypusine hydroxylase that catalyzes the final maturation step of eukaryotic initiation factor 5A, the eukaryotic EF-P homolog.	[Virumaee, Kai; Remme, Jaanus] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Peil, Lauri; Atkinson, Gemma C.; Tenson, Tanel] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Gene Ctr, Munich, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci Munich, Munich, Germany	University of Tartu; University of Tartu; University of Munich; University of Munich	Remme, J (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	jremme@ebc.ee; wilson@lmb.uni-muenchen.de	Remme, Jaanus/A-4614-2011; Remme, Jaanus/L-1830-2019; Starosta, Agata/D-9535-2017; Wilson, Daniel/AAE-8504-2019; Atkinson, Gemma/L-9655-2019; Peil, Lauri/G-9944-2012; Tenson, Tanel/I-6431-2015	Remme, Jaanus/0000-0002-4011-6580; Remme, Jaanus/0000-0002-4011-6580; Starosta, Agata/0000-0003-3915-5723; Wilson, Daniel/0000-0003-3816-3828; Atkinson, Gemma/0000-0002-4861-4584; Peil, Lauri/0000-0001-6906-7113; Tenson, Tanel/0000-0002-0260-3601	Deutsche Forschungsgemeinschaft [WI3285/1-1]; Human Frontiers of Science Foundation [RGY88/2008]; European Molecular Biology Organization young investigator program; Estonian Science Foundation [9289]; European Social Fund program Mobilitas [MJD144, MJD99]; European Regional Development Fund through the Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontiers of Science Foundation; European Molecular Biology Organization young investigator program; Estonian Science Foundation; European Social Fund program Mobilitas; European Regional Development Fund through the Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu)	We thank N. Morrice and J. Rappsilber for invaluable help and advice on amino acid analyses and L. Arike and T. Tammsalu for help with MS analyses. This research was supported by grants from the Deutsche Forschungsgemeinschaft WI3285/1-1, the Human Frontiers of Science Foundation (RGY88/2008), the European Molecular Biology Organization young investigator program (to D. N. W.) and the Estonian Science Foundation grant no. 9289 (to J. R.). L. P. and G. C. A. are supported by the European Social Fund program Mobilitas grants MJD144 and MJD99, respectively. MS analyses were, in part, supported by the European Regional Development Fund through the Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu).	Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Bearson SMD, 2006, APPL ENVIRON MICROB, V72, P2829, DOI 10.1128/AEM.72.4.2829-2836.2006; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Peng WT, 2001, J BACTERIOL, V183, P36, DOI 10.1128/JB.183.1.36-45.2001; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Swaney S, 2006, J BIOMOL SCREEN, V11, P736, DOI 10.1177/1087057106291634; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889	19	61	68	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					695	697		10.1038/NCHEMBIO.1001	http://dx.doi.org/10.1038/NCHEMBIO.1001			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22706199				2022-12-27	WOS:000306527600007
J	Botte, CY; Deligny, M; Roccia, A; Bonneau, AL; Saidani, N; Hardre, H; Aci, S; Yamaryo-Botte, Y; Jouhet, J; Dubots, E; Loizeau, K; Bastien, O; Brehelin, L; Joyard, J; Cintrat, JC; Falconet, D; Block, MA; Rousseau, B; Lopez, R; Marechal, E				Botte, Cyrille Y.; Deligny, Michael; Roccia, Aymeric; Bonneau, Anne-Laure; Saidani, Nadia; Hardre, Helene; Aci, Samia; Yamaryo-Botte, Yoshiki; Jouhet, Juliette; Dubots, Emmanuelle; Loizeau, Karen; Bastien, Olivier; Brehelin, Laurent; Joyard, Jacques; Cintrat, Jean-Christophe; Falconet, Denis; Block, Maryse A.; Rousseau, Bernard; Lopez, Roman; Marechal, Eric			Chemical inhibitors of monogalactosyldiacylglycerol synthases in Arabidopsis thaliana	NATURE CHEMICAL BIOLOGY			English	Article							PHOSPHATE DEPRIVATION; PLANT-CELLS; PHOSPHOLIPASES D-ZETA-1; SPINACH-CHLOROPLASTS; OUTER ENVELOPE; BIOSYNTHESIS; STARVATION; MEMBRANE; GALACTOLIPIDS; PROTEIN	Monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG) are the main lipids in photosynthetic membranes in plant cells. They are synthesized in the envelope surrounding plastids by MGD and DGD galactosyltransferases. These galacto-lipids are critical for the biogenesis of photosynthetic membranes, and they act as a source of polyunsaturated fatty acids for the whole cell and as phospholipid surrogates in phosphate shortage. Based on a high-throughput chemical screen, we have characterized a new compound, galvestine-1, that inhibits MGDs in vitro by competing with diacylglycerol binding. Consistent effects of galvestine-1 on Arabidopsis thaliana include root uptake, circulation in the xylem and mesophyll, inhibition of MGDs in vivo causing a reduction of MGDG content and impairment of chloroplast development. The effects on pollen germination shed light on the contribution of galactolipids to pollen-tube elongation. The whole-genome transcriptional response of Arabidopsis points to the potential benefits of galvestine-1 as a unique tool to study lipid homeostasis in plants.	[Botte, Cyrille Y.; Roccia, Aymeric; Saidani, Nadia; Hardre, Helene; Yamaryo-Botte, Yoshiki; Jouhet, Juliette; Dubots, Emmanuelle; Loizeau, Karen; Bastien, Olivier; Joyard, Jacques; Falconet, Denis; Block, Maryse A.; Marechal, Eric] Univ Grenoble 1, CNRS, CEA, Inst Rech Technol & Sci Vivant,INRA,UMR 5168, Grenoble, France; [Botte, Cyrille Y.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Botte, Cyrille Y.] Univ Grenoble 1, CNRS, Inst Jean Roget, UMR 5163, Grenoble, France; [Deligny, Michael; Bonneau, Anne-Laure; Cintrat, Jean-Christophe; Rousseau, Bernard; Lopez, Roman] CEA, Inst Biol & Technol Saclay, Chim Bioorgan Lab, Gif Sur Yvette, France; [Saidani, Nadia] Univ Montpellier 2, CNRS, UMR 5235, Montpellier, France; [Aci, Samia] CNRS, Ctr Biophys Mol, Orleans, France; [Brehelin, Laurent] Univ Montpellier 2, CNRS, Lab Informat Robot & Microelect Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Marechal, E (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Rech Technol & Sci Vivant,INRA,UMR 5168, Grenoble, France.	eric.marechal@cea.fr	Botte, Cyrille/G-1972-2014; Bastien, Olivier/B-9723-2008; Bastien, Olivier/J-3827-2014	Botte, Cyrille/0000-0002-2245-536X; Cintrat, Jean-Christophe/0000-0001-5758-8077; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411	Agence Nationale de la Recherche, France [ANR-05-EMPB-017-01, ANR-06-MDCA-014, ANR-10-BLAN-1524-01, ANR-2010-JCJC-1606-01]; European Commission	Agence Nationale de la Recherche, France(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank C. Albrieux, L. Caillot, C. Cataye, G. Merer, J. Revol and A. Zoppe for technical assistance and L. Lafanechere, P. Legrain and C. Vincent for helpful discussions. This work was supported by ANR-05-EMPB-017-01, ANR-06-MDCA-014, ANR-10-BLAN-1524-01 and ANR-2010-JCJC-1606-01 grants from the Agence Nationale de la Recherche, France. C.Y.B. was supported by a Marie Curie International Outgoing Fellowship action from the European Commission.	ANDERSSON L, 1995, J LIPID RES, V36, P1392; Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Aronsson H, 2008, PLANT PHYSIOL, V148, P580, DOI 10.1104/pp.108.123372; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; Benning C, 2008, PROG LIPID RES, V47, P381, DOI 10.1016/j.plipres.2008.04.001; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; Chen LJ, 1998, PLANT J, V16, P33, DOI 10.1046/j.1365-313x.1998.00270.x; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; DOUCE R, 1974, SCIENCE, V183, P852, DOI 10.1126/science.183.4127.852; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Gaude N, 2008, PLANT J, V56, P28, DOI 10.1111/j.1365-313X.2008.03582.x; GOUNARIS K, 1983, TRENDS BIOCHEM SCI, V8, P378, DOI 10.1016/0968-0004(83)90366-3; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; HEEMSKERK JWM, 1986, BIOCHIM BIOPHYS ACTA, V877, P281, DOI 10.1016/0005-2760(86)90305-X; Hicks GR, 2009, NAT CHEM BIOL, V5, P268, DOI 10.1038/nchembio0509-268; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; Jouhet J, 2003, FEBS LETT, V544, P63, DOI 10.1016/S0014-5793(03)00477-0; Jouhet J, 2007, PROG LIPID RES, V46, P37, DOI 10.1016/j.plipres.2006.06.002; Joyard J, 1998, PLANT PHYSIOL, V118, P715, DOI 10.1104/pp.118.3.715; Kobayashi K, 2004, PLANT PHYSIOL, V134, P640, DOI 10.1104/pp.103.032656; Kobayashi K, 2009, PLANT J, V57, P322, DOI 10.1111/j.1365-313X.2008.03692.x; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Kobayashi K, 2009, PLANT PHYSIOL BIOCH, V47, P518, DOI 10.1016/j.plaphy.2008.12.012; Li MY, 2006, PLANT PHYSIOL, V142, P750, DOI 10.1104/pp.106.085647; Li MY, 2006, PLANT PHYSIOL, V140, P761, DOI 10.1104/pp.105.070995; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; Nakamura Y, 2007, J BIOL CHEM, V282, P29013, DOI 10.1074/jbc.M704385200; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Nakamura Y, 2009, PLANT PHYSIOL BIOCH, V47, P535, DOI 10.1016/j.plaphy.2008.12.018; Nishiyama Y, 2003, PROTEIN EXPRES PURIF, V31, P79, DOI 10.1016/S1046-5928(03)00158-X; Padham AK, 2007, PLANT PHYSIOL, V143, P1372, DOI 10.1104/pp.106.090811; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Tjellstrom H, 2008, PLANT CELL ENVIRON, V31, P1388, DOI 10.1111/j.1365-3040.2008.01851.x; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2006, PLANT J, V47, P296, DOI 10.1111/j.1365-313X.2006.02790.x; Youssef A, 2010, PLANT J, V61, P436, DOI 10.1111/j.1365-313X.2009.04067.x	50	57	57	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					834	842		10.1038/nchembio.658	http://dx.doi.org/10.1038/nchembio.658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21946275				2022-12-27	WOS:000296381600014
J	Park, JW; Park, SR; Nepal, KK; Han, AR; Ban, YH; Yoo, YJ; Kim, EJ; Kim, EM; Kim, D; Sohng, JK; Yoon, YJ				Park, Je Won; Park, Sung Ryeol; Nepal, Keshav Kumar; Han, Ah Reum; Ban, Yeon Hee; Yoo, Young Ji; Kim, Eun Ji; Kim, Eui Min; Kim, Dooil; Sohng, Jae Kyung; Yoon, Yeo Joon			Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation	NATURE CHEMICAL BIOLOGY			English	Article							STREPTOMYCES-FRADIAE NCIMB-8233; GENE-CLUSTER; AMINOGLYCOSIDE ANTIBIOTICS; HETEROLOGOUS EXPRESSION; NEOMYCIN; BUTIROSIN; GENTAMICIN; 2-DEOXYSTREPTAMINE; KANAMYCETICUS; DERIVATIVES	Kanamycin is one of the most widely used antibiotics, yet its biosynthetic pathway remains unclear. Current proposals suggest that the kanamycin biosynthetic products are linearly related via single enzymatic transformations. To explore this system, we have reconstructed the entire biosynthetic pathway through the heterologous expression of combinations of putative biosynthetic genes from Streptomyces kanamyceticus in the non-aminoglycoside-producing Streptomyces venezuelae. Unexpectedly, we discovered that the biosynthetic pathway contains an early branch point, governed by the substrate promiscuity of a glycosyltransferase, that leads to the formation of two parallel pathways in which early intermediates are further modified. Glycosyltransferase exchange can alter flux through these two parallel pathways, and the addition of other biosynthetic enzymes can be used to synthesize known and new highly active antibiotics. These results complete our understanding of kanamycin biosynthesis and demonstrate the potential of pathway engineering for direct in vivo production of clinically useful antibiotics and more robust aminoglycosides.	[Park, Je Won; Nepal, Keshav Kumar; Kim, Eui Min; Sohng, Jae Kyung] Sun Moon Univ, Dept Pharmaceut Engn, Inst Biomol Reconstruct, Chungnam, South Korea; [Park, Je Won; Park, Sung Ryeol; Ban, Yeon Hee; Yoo, Young Ji; Kim, Eun Ji; Yoon, Yeo Joon] Ewha Womans Univ, Dept Chem & Nanosci, Seoul, South Korea; [Han, Ah Reum] Seoul Natl Univ, Interdisciplinary Program Biochem Engn & Biotechn, Seoul, South Korea; [Kim, Dooil] Korea Res Inst Biosci & Biotechnol, Syst Microbiol Res Ctr, Taejon, South Korea	Sun Moon University; Ewha Womans University; Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Sohng, JK (corresponding author), Sun Moon Univ, Dept Pharmaceut Engn, Inst Biomol Reconstruct, Chungnam, South Korea.	sohng@sunmoon.ac.kr; joonyoon@ewha.ac.kr		Park, Je Won/0000-0001-9460-2296; Nepal, Keshav/0000-0002-8991-716X	National Research Laboratory (NRL) [R0A-2008-000-20030-0]; National Research Foundation of Korea (NRF) [2010-0001487, 2010-0028193]; Ministry of Education, Science Technology; Ministry of Land, Transportation and Maritime Affairs, Republic of Korea; Ministry for Food, Agriculture and Fisheries, Republic of Korea [20100623]	National Research Laboratory (NRL)(Korea Science and Engineering Foundation); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Land, Transportation and Maritime Affairs, Republic of Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); Ministry for Food, Agriculture and Fisheries, Republic of Korea	We thank E. Cundliffe for discussions and for critically reading this manuscript. This work was supported by the National Research Laboratory (NRL) program (R0A-2008-000-20030-0) and Global Frontier Program for Intelligent Synthetic Biology through the National Research Foundation of Korea (NRF), NRF grants (2010-0001487 and 2010-0028193) funded by the Ministry of Education, Science & Technology and the Marine and Extreme Genome Research Center Program of the Ministry of Land, Transportation and Maritime Affairs, Republic of Korea. J.W.P. gratefully acknowledges a grant (20100623) from the Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture and Fisheries, Republic of Korea.	Adams E., 1996, European Journal of Pharmaceutical Sciences, V4, pS110, DOI 10.1016/S0928-0987(97)86331-2; Chang L. T., 1980, DEV IND MICROBIOL, V21, P233; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Fan QZ, 2008, ORG BIOMOL CHEM, V6, P3306, DOI 10.1039/b808734b; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Guo JT, 2002, J AM CHEM SOC, V124, P10642, DOI 10.1021/ja026628m; Hainrichson M, 2008, ORG BIOMOL CHEM, V6, P227, DOI 10.1039/b712690p; HOWELLS JD, 1972, ANTIMICROB AGENTS CH, V2, P79, DOI 10.1128/AAC.2.2.79; Huang FL, 2007, CHEMBIOCHEM, V8, P283, DOI 10.1002/cbic.200600371; Huang FL, 2005, ORG BIOMOL CHEM, V3, P1410, DOI 10.1039/b501199j; Jnawali HN, 2009, BIOTECHNOL LETT, V31, P869, DOI 10.1007/s10529-009-9937-0; Jones D, 1944, SCIENCE, V100, P103, DOI 10.1126/science.100.2588.103; Kharel MK, 2004, ARCH BIOCHEM BIOPHYS, V429, P204, DOI 10.1016/j.abb.2004.06.009; Kharel MK, 2004, FEMS MICROBIOL LETT, V230, P185, DOI 10.1016/S0378-1097(03)00881-4; KOCH KF, 1978, J ORG CHEM, V43, P1430, DOI 10.1021/jo00401a030; KOJIMA M, 1969, AGR BIOL CHEM TOKYO, V33, P1181, DOI 10.1080/00021369.1969.10859438; KOJIMA M, 1968, AGR BIOL CHEM TOKYO, V32, P467, DOI 10.1080/00021369.1968.10859074; Kondo S., 1999, J Infect Chemother, V5, P1, DOI 10.1007/s101560050001; KONDO S, 1977, J ANTIBIOT, V30, P1150, DOI 10.7164/antibiotics.30.1150; Kudo F, 1999, J ANTIBIOT, V52, P559, DOI 10.7164/antibiotics.52.559; Kudo F, 2005, J ANTIBIOT, V58, P766, DOI 10.1038/ja.2005.104; Kudo F, 2009, J ANTIBIOT, V62, P707, DOI 10.1038/ja.2009.107; Kudo F, 2009, J ANTIBIOT, V62, P471, DOI 10.1038/ja.2009.76; Kudo F, 2009, METHOD ENZYMOL, V459, P493, DOI 10.1016/S0076-6879(09)04620-5; LEMIEUX RU, 1973, CAN J CHEM, V51, P53, DOI 10.1139/v73-008; Llewellyn NM, 2008, CHEM COMMUN, P3786, DOI 10.1039/b802248h; Llewellyn NM, 2006, NAT PROD REP, V23, P864, DOI 10.1039/b604709m; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; NAGABHUSHAN TL, 1982, AMINOGLYCOSIDES MICR, P3; Nepal KK, 2009, MOL CELLS, V27, P601, DOI 10.1007/s10059-009-0080-5; Park JW, 2008, P NATL ACAD SCI USA, V105, P8399, DOI 10.1073/pnas.0803164105; Park JW, 2010, ANAL CHIM ACTA, V661, P76, DOI 10.1016/j.aca.2009.12.014; Piepersberg W., 2007, AMINOGLYCOSIDE ANTIB, P15, DOI DOI 10.1002/9780470149676; Stark W M, 1967, Antimicrob Agents Chemother (Bethesda), V7, P314; Thapa LP, 2007, APPL MICROBIOL BIOT, V76, P1357, DOI 10.1007/s00253-007-1096-4; Thuy ML, 2005, BIOTECHNOL LETT, V27, P465, DOI 10.1007/s10529-005-2222-y; Truman AW, 2007, ANGEW CHEM INT EDIT, V46, P1462, DOI 10.1002/anie.200604194; UMEZAWA H, 1957, J ANTIBIOT, V10, P181; UMEZAWA S, 1971, J ANTIBIOT, V24, P274, DOI 10.7164/antibiotics.24.274; WAKSMAN SA, 1949, SCIENCE, V109, P305, DOI 10.1126/science.109.2830.305; Wehmeier UF, 2009, METHOD ENZYMOL, V459, P459, DOI 10.1016/S0076-6879(09)04619-9; WEINSTEIN MJ, 1963, J MED CHEM, V6, P463, DOI 10.1021/jm00340a034; YAMADA Y, 1968, JPN J MED SCI BIOL, V21, P223; Yokoyama K, 2008, CHEMBIOCHEM, V9, P865, DOI 10.1002/cbic.200700717	44	61	70	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					843	852		10.1038/nchembio.671	http://dx.doi.org/10.1038/nchembio.671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21983602				2022-12-27	WOS:000296381600015
J	Roy, H; Zou, SB; Bullwinkle, TJ; Wolfe, BS; Gilreath, MS; Forsyth, CJ; Navarre, WW; Ibba, M				Roy, Herve; Zou, S. Betty; Bullwinkle, Tammy J.; Wolfe, Benjamin S.; Gilreath, Marla S.; Forsyth, Craig J.; Navarre, William W.; Ibba, Michael			The tRNA synthetase paralog PoxA modifies elongation factor-P with (R)-beta-lysine	NATURE CHEMICAL BIOLOGY			English	Article							FACTOR EF-P; TRANSLATION ELONGATION; SALMONELLA-ENTERICA; PEPTIDE-BOND; CLASS-I; LYSINE; RECOGNITION; MECHANISM; VIRULENCE; RIBOSOME	The lysyl-tRNA synthetase paralog PoxA modifies elongation factor P (EF-P) with alpha-lysine at low efficiency. Cell-free extracts containing non-alpha-lysine substrates of PoxA modified EF-P with a change in mass consistent with addition of beta-lysine, a substrate also predicted by genomic analyses. EF-P was efficiently functionally modified with (R)-beta-lysine but not (S)-beta-lysine or genetically encoded alpha-amino acids, indicating that PoxA has evolved an activity orthogonal to that of the canonical aminoacyl-tRNA synthetases.	[Roy, Herve; Bullwinkle, Tammy J.; Ibba, Michael] Ohio State Univ, Dept Microbiol, Ctr RNA Biol, Columbus, OH 43210 USA; [Zou, S. Betty; Navarre, William W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Wolfe, Benjamin S.; Forsyth, Craig J.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Gilreath, Marla S.; Ibba, Michael] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Toronto; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, Ctr RNA Biol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu		Navarre, William/0000-0002-9293-9220	US National Institutes of Health [GM65183]; Canada Institutes for Health Research [MOP-86683, MSH-87729]; Natural Sciences and Engineering Research Council of Canada [RGPIN 386286-10]; Ohio State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ohio State University(Ohio State University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Michael Thomas (University of Wisconsin) for the generous gift of (S)-beta-lysine. This work was supported by the US National Institutes of Health (GM65183, M. I.), the Canada Institutes for Health Research (MOP-86683 and MSH-87729, W.W.N.) and the Natural Sciences and Engineering Research Council of Canada (RGPIN 386286-10, W.W.N.; Vanier Graduate Scholarship, S.B.Z). We also acknowledge The Ohio State University for partial financial support.	Alexander RW, 2001, PROG NUCLEIC ACID RE, V69, P317, DOI 10.1016/S0079-6603(01)69050-0; Ambrogelly A, 2010, FEBS LETT, V584, P3055, DOI 10.1016/j.febslet.2010.05.036; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Aravind L, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-48; Ataide SF, 2004, BIOCHEMISTRY-US, V43, P11836, DOI 10.1021/bi0490542; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Commans S, 1998, J MOL BIOL, V278, P801, DOI 10.1006/jmbi.1998.1711; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FRANCKLYN C, 2005, AMINOACYL TRNA SYNTH, P285; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sakurama H, 2009, J BIOCHEM, V145, P555, DOI 10.1093/jb/mvp014; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; TAMURA K, 1992, NUCLEIC ACIDS RES, V20, P2335, DOI 10.1093/nar/20.9.2335; Vetting MW, 2010, NAT CHEM BIOL, V6, P797, DOI 10.1038/NCHEMBIO.440; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889	25	72	75	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2011	7	10					667	669		10.1038/NCHEMBIO.632	http://dx.doi.org/10.1038/NCHEMBIO.632			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	822EQ	21841797	Green Accepted, Green Submitted			2022-12-27	WOS:000295027100009
J	Filipovska, A; Razif, MFM; Nygard, KKA; Rackham, O				Filipovska, Aleksandra; Razif, Muhammad F. M.; Nygard, Karoline K. A.; Rackham, Oliver			A universal code for RNA recognition by PUF proteins	NATURE CHEMICAL BIOLOGY			English	Article							PUMILIO-HOMOLOGY DOMAIN; BINDING PROTEINS; 3-HYBRID SYSTEM; GENE-EXPRESSION; MESSENGER-RNAS; MECHANISMS; YEAST; CELL	The design of proteins that can bind any RNA sequence of interest has many potential biological and medical applications. Here we have expanded the recognition of Pumilio and FBF homology protein (PUF) repeats beyond adenine, guanine and uracil and evolved them to specifically bind cytosine. These repeat sequences can be used to create PUF domains capable of selectively binding RNA targets of diverse sequence and structure.	[Filipovska, Aleksandra] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6009, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Filipovska, A (corresponding author), Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6009, Australia.	rackham@waimr.uwa.edu.au	Razif, Muhammad Fazril Mohamad/AAR-8101-2021; Rackham, Oliver/E-1264-2013; Razif, Muhammad Fazril Mohamad/K-4968-2016; Rackham, Oliver/AGO-0005-2022	Razif, Muhammad Fazril Mohamad/0000-0002-3951-8136; Rackham, Oliver/0000-0002-5301-9624; Razif, Muhammad Fazril Mohamad/0000-0002-3951-8136; Rackham, Oliver/0000-0002-5301-9624; Filipovska, Aleksandra/0000-0002-6998-8403	Australian Research Council; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank M. Wickens (University of Wisconsin-Madison) for the YBZ1 yeast strain, T. Ito (University of Tokyo) for the pGAD-RC plasmid, R. King for advice on oligonucleotide synthesis with trimer phosphoramidites and K. L. Hamilton for technical assistance. This work was supported by fellowships and grants from the Australian Research Council and the National Health and Medical Research Council.	Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Filipovska A, 2008, ACS CHEM BIOL, V3, P51, DOI 10.1021/cb700185e; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gupta YK, 2008, STRUCTURE, V16, P549, DOI 10.1016/j.str.2008.01.006; Hook B, 2005, RNA, V11, P227, DOI 10.1261/rna.7202705; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Tilsner J, 2009, PLANT J, V57, P758, DOI 10.1111/j.1365-313X.2008.03720.x; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; Zamore PD, 1997, RNA, V3, P1421; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106	25	130	141	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					425	427		10.1038/NCHEMBIO.577	http://dx.doi.org/10.1038/NCHEMBIO.577			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21572425				2022-12-27	WOS:000292252100007
J	Jiang, H; Pritchard, JR; Williams, RT; Lauffenburger, DA; Hemann, MT				Jiang, Hai; Pritchard, Justin R.; Williams, Richard T.; Lauffenburger, Douglas A.; Hemann, Michael T.			A mammalian functional-genetic approach to characterizing cancer therapeutics	NATURE CHEMICAL BIOLOGY			English	Article							RNA-POLYMERASE-II; CELL-DEATH; BIOACTIVE COMPOUNDS; MISMATCH REPAIR; STRESS-RESPONSE; SMALL MOLECULES; IN-VIVO; P53; YEAST; DNA	Identifying mechanisms of drug action remains a fundamental impediment to the development and effective use of chemotherapeutics. Here we describe an RNA interference (RNAi)-based strategy to characterize small-molecule function in mammalian cells. By examining the response of cells expressing short hairpin RNAs (shRNAs) to a diverse selection of chemotherapeutics, we could generate a functional shRNA signature that was able to accurately group drugs into established biochemical modes of action. This, in turn, provided a diversely sampled reference set for high-resolution prediction of mechanisms of action for poorly characterized small molecules. We could further reduce the predictive shRNA target set to as few as eight genes and, by using a newly derived probability-based nearest-neighbors approach, could extend the predictive power of this shRNA set to characterize additional drug categories. Thus, a focused shRNA phenotypic signature can provide a highly sensitive and tractable approach for characterizing new anticancer drugs.	[Jiang, Hai; Pritchard, Justin R.; Lauffenburger, Douglas A.; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Williams, Richard T.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Lauffenburger, Douglas A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); St Jude Children's Research Hospital; Massachusetts Institute of Technology (MIT)	Jiang, H (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hemann@mit.edu	Pritchard, Justin/AAI-2475-2021	Pritchard, Justin/0000-0001-7749-4473; jiang, hai/0000-0002-2508-5413	US National Institutes of Health [RO1 CA128803-03]; Massachusetts Institute of Technology Department of Biology; American Association for Cancer Research; Integrated Cancer Biology Program [1-U54-CA112967]; NATIONAL CANCER INSTITUTE [R01CA128803, U54CA112967] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Institute of Technology Department of Biology; American Association for Cancer Research; Integrated Cancer Biology Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The MM1S cell line was a generous gift from S. Rosen (Northwestern University). CY190602 and Hsp90 inhibitors were kindly provided by Nextwave Biotech. We thank L. Gilbert, H. Criscione, Stephanie Wu, S. Alford and Shan Wu for their experimental or analytical assistance. We are grateful to L. Samson, C. Pallasch and C. Meacham for critically reading the manuscript and the entire Hemann lab for helpful discussions. M. T. H. is a Rita Allen Fellow, and M. T. H. and H.J. are supported by US National Institutes of Health grant RO1 CA128803-03. J.R.P. is supported by the Massachusetts Institute of Technology Department of Biology training grant. R. T. W. is the recipient of an American Association for Cancer Research Career Development Award. Additional funding was provided by the Integrated Cancer Biology Program grant 1-U54-CA112967 to D. A. L. and M.T.H.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hillenmeyer ME, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r30; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lindemann RK, 2007, P NATL ACAD SCI USA, V104, P8071, DOI 10.1073/pnas.0702294104; Ljungman M, 2001, MOL PHARMACOL, V60, P785; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Pritchard JR, 2009, MOL CANCER THER, V8, P2183, DOI 10.1158/1535-7163.MCT-08-1203; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Sato S, 2010, CHEM BIOL, V17, P616, DOI 10.1016/j.chembiol.2010.05.015; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	37	73	77	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					92	100		10.1038/NCHEMBIO.503	http://dx.doi.org/10.1038/NCHEMBIO.503			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21186347	Green Published, Green Accepted			2022-12-27	WOS:000286324600009
J	Zhang, ZH; Tan, MJ; Xie, ZY; Dai, LZ; Chen, Y; Zhao, YM				Zhang, Zhihong; Tan, Minjia; Xie, Zhongyu; Dai, Lunzhi; Chen, Yue; Zhao, Yingming			Identification of lysine succinylation as a new post-translational modification	NATURE CHEMICAL BIOLOGY			English	Article							DEFICIENCY; PROPIONYLATION; BUTYRYLATION; ACETYLATION; HISTONES; SOFTWARE	Of the 20 ribosomally coded amino acid residues, lysine is the most frequently post-translationally modified, which has important functional and regulatory consequences. Here we report the identification and verification of a previously unreported form of protein post-translational modification (PTM): lysine succinylation. The succinyllysine residue was initially identified by mass spectrometry and protein sequence alignment. The identified succinyllysine peptides derived from in vivo proteins were verified by western blot analysis, in vivo labeling with isotopic succinate, MS/MS and HPLC coelution of their synthetic counterparts. We further show that lysine succinylation is evolutionarily conserved and that this PTM responds to different physiological conditions. Our study also implies that succinyl-CoA might be a cofactor for lysine succinylation. Given the apparent high abundance of lysine succinylation and the significant structural changes induced by this PTM, it is expected that lysine succinylation has important cellular functions.	[Zhang, Zhihong; Tan, Minjia; Xie, Zhongyu; Dai, Lunzhi; Chen, Yue; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Zhao, YM (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	yingming.zhao@uchicago.edu	Tan, Minjia/C-4491-2014; zhang, zh/GWV-4677-2022	Tan, Minjia/0000-0002-6784-9653; Dai, Lunzhi/0000-0002-3003-8910; Xie, Zhongyu/0000-0001-5394-8282	US National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Z. Cheng and Z. Wang for their assistance during the course of this study. This work was supported by US National Institutes of Health grants to Y.Z.	ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; Bandeira N, 2007, P NATL ACAD SCI USA, V104, P6140, DOI 10.1073/pnas.0701130104; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P624; Berry GT, 2001, J INHERIT METAB DIS, V24, P587, DOI 10.1023/A:1012419911789; BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Chen Y, 2009, P NATL ACAD SCI USA, V106, P761, DOI 10.1073/pnas.0811739106; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Hake S B, 2007, Br J Cancer, V96 Suppl, pR31; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; NELSON DL, 2005, LEHNINGER PRINCIPLES, P200; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Ostergaard E, 2008, J INHERIT METAB DIS, V31, P226, DOI 10.1007/s10545-008-0828-7; Sadygov RG, 2004, NAT METHODS, V1, P195, DOI 10.1038/NMETH725; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155	23	535	568	12	225	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					58	63		10.1038/NCHEMBIO.495	http://dx.doi.org/10.1038/NCHEMBIO.495			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21151122	Green Accepted			2022-12-27	WOS:000285383400013
J	Bucci, M; Goodman, C; Sheppard, TL				Bucci, Mirella; Goodman, Catherine; Sheppard, Terry L.			A decade of chemical biology	NATURE CHEMICAL BIOLOGY			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INHIBITOR; CELLS; IDENTIFICATION; PREDICTION; KINASE; ENZYME						Goodman, Catherine/AAO-6148-2020	Goodman, Catherine/0000-0003-3415-8554; Bucci, Mirella/0000-0003-1654-3758; Sheppard, Terry/0000-0001-8667-3633				Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baran PS, 2007, NATURE, V446, P404, DOI 10.1038/nature05569; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Borman S, 2007, CHEM ENG NEWS, V85, P31, DOI 10.1021/cen-v085n040.p031; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DHARMASIRI N, 2005, NATURE, V441, P431; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lewis WG, 2002, ANGEW CHEM INT EDIT, V41, P1053, DOI 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Noren-Muller A, 2006, P NATL ACAD SCI USA, V103, P10606, DOI 10.1073/pnas.0601490103; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Runguphan W, 2009, NAT CHEM BIOL, V5, P151, DOI 10.1038/nchembio.141; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Singh V, 2005, J BIOL CHEM, V280, P18265, DOI 10.1074/jbc.M414472200; Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369; Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138; 2010, NAT CHEM BIOL, V6, P385	53	23	27	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					847	854		10.1038/nchembio.489	http://dx.doi.org/10.1038/nchembio.489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079586				2022-12-27	WOS:000284214700002
J	Kritzer, JA				Kritzer, Joshua A.			Beyond discovery: probes that see, grab and poke	NATURE CHEMICAL BIOLOGY			English	Article							CHEMICAL GENETICS; IN-VIVO; CHEMISTRY; PEPTIDES; BIOLOGY	Chemical biology is now able to discover molecules that manipulate virtually any biological target or process. It remains a grand challenge to leverage these molecules into useful probes that can be used to address unsolved problems in biology.	Tufts Univ, Dept Chem, Medford, MA 02155 USA	Tufts University	Kritzer, JA (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	joshua.kritzer@tufts.edu						Ahn YH, 2007, ACCOUNTS CHEM RES, V40, P1025, DOI 10.1021/ar700030k; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; Lee LW, 2010, J BIOL CHEM, V285, P11033, DOI 10.1074/jbc.R109.075044; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Nielsen TE, 2008, ANGEW CHEM INT EDIT, V47, P48, DOI 10.1002/anie.200703073; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; Raina K, 2010, J BIOL CHEM, V285, P11057, DOI 10.1074/jbc.R109.078105; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Rothman DM, 2005, TRENDS CELL BIOL, V15, P502, DOI 10.1016/j.tcb.2005.07.003; Stewart KM, 2008, ORG BIOMOL CHEM, V6, P2242, DOI 10.1039/b719950c; Terreno E, 2010, CHEM REV, V110, P3019, DOI 10.1021/cr100025t; Vegas AJ, 2008, CHEM SOC REV, V37, P1385, DOI 10.1039/b703568n; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walsh DP, 2006, CHEM REV, V106, P2476, DOI 10.1021/cr0404141	20	6	6	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					868	870		10.1038/nchembio.469	http://dx.doi.org/10.1038/nchembio.469			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079592				2022-12-27	WOS:000284214700008
J	Jasper, H				Jasper, Heinrich			SIRTUINS Longevity focuses on NAD(+)	NATURE CHEMICAL BIOLOGY			English	News Item							SIRT4		Buck Inst Res Aging, Novato, CA USA	Buck Institute for Research on Aging	Jasper, H (corresponding author), Buck Inst Res Aging, Novato, CA USA.	hjasper@buckinstitute.org						Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; FUKUSHIMA T, 1995, J NEUROSCI RES, V42, P385, DOI 10.1002/jnr.490420313; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/nchembio.1352, 10.1038/NCHEMBIO.1352]	11	9	9	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					666	667		10.1038/nchembio.1369	http://dx.doi.org/10.1038/nchembio.1369			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24141218				2022-12-27	WOS:000325930500001
J	Jenkins, JL				Jenkins, Jeremy L.			DRUG DISCOVERY Rethinking cellular drug response	NATURE CHEMICAL BIOLOGY			English	News Item							CANCER; DATABASE		Novartis Inst BioMed Res, Dept Dev & Mol Pathways, Cambridge, MA USA	Novartis	Jenkins, JL (corresponding author), Novartis Inst BioMed Res, Dept Dev & Mol Pathways, Cambridge, MA USA.	jeremy.jenkins@novartis.com		Jenkins, Jeremy/0000-0001-9795-0771				Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Covell DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044631; Fallahi-Sichani M, 2013, NAT CHEM BIOL, V9, P708, DOI [10.1038/nchembio.1337, 10.1038/NCHEMBIO.1337]; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Rabow AA, 2002, J MED CHEM, V45, P818, DOI 10.1021/jm010385b; Sampah MES, 2011, P NATL ACAD SCI USA, V108, P7613, DOI 10.1073/pnas.1018360108; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699	9	5	5	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					669	670		10.1038/nchembio.1365	http://dx.doi.org/10.1038/nchembio.1365			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24141220				2022-12-27	WOS:000325930500003
J	Berndsen, CE; Wiener, R; Yu, IW; Ringel, AE; Wolberger, C				Berndsen, Christopher E.; Wiener, Reuven; Yu, Ian W.; Ringel, Alison E.; Wolberger, Cynthia			A conserved asparagine has a structural role in ubiquitin-conjugating enzymes	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; E3 LIGASE; INSIGHTS; REVEALS; HEXOKINASE; ACTIVATION; MECHANISM; COMPLEX	It is widely accepted that ubiquitin-conjugating enzymes contain an active site asparagine that serves as an oxyanion hole, thereby stabilizing a negatively charged transition state intermediate and promoting ubiquitin transfer. Using structural and biochemical approaches to study the role of the conserved asparagine to ubiquitin conjugation by Ubc13-Mms2, we conclude that the importance of this residue stems primarily from its structural role in stabilizing an active site loop.	[Berndsen, Christopher E.; Wiener, Reuven; Yu, Ian W.; Ringel, Alison E.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Berndsen, Christopher E.; Wiener, Reuven; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		Wolberger, Cynthia/0000-0001-8578-2969; Ringel, Alison/0000-0002-6451-9376; Berndsen, Christopher/0000-0002-4285-4341	US National Science Foundation [MCB-0920082]; Ruth Kirchstein Fellowship from the National Institute of General Medical Science [F32GM089037]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089037] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Ruth Kirchstein Fellowship from the National Institute of General Medical Science; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hurley (National Institute of Diabetes and Digestive and Kidney Diseases) for the UbcI3-Mms2 coexpression plasmid and X. Zhang (Johns Hopkins University) for human El protein. We also thank J. Stivers, A. Hengge and L. Spyracopoulos for helpful discussions. This work was supported in part by a grant from the US National Science Foundation (MCB-0920082). C.E.B. was supported in part by a Ruth Kirchstein Fellowship from the National Institute of General Medical Science (F32GM089037). General Medical Sciences and Cancer Institutes Structural Biology Facility at the Advanced Photon Source has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BRUICE TC, 1960, P NATL ACAD SCI USA, V46, P402, DOI 10.1073/pnas.46.4.402; Carlile CM, 2009, J BIOL CHEM, V284, P29326, DOI 10.1074/jbc.M109.043885; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; WILKINSON KD, 1981, J BIOL CHEM, V256, P9890; WILKINSON KD, 1979, J BIOL CHEM, V254, P2567; Wu PY, 2007, EMBO J, V26, P4051, DOI 10.1038/sj.emboj.7601829; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	22	49	49	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					154	156		10.1038/NCHEMBIO.1159	http://dx.doi.org/10.1038/NCHEMBIO.1159			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23292652	Green Accepted			2022-12-27	WOS:000315132900008
J	Ge, W; Wolf, A; Feng, TS; Ho, CH; Sekirnik, R; Zayer, A; Granatino, N; Cockman, ME; Loenarz, C; Loik, ND; Hardy, AP; Claridge, TDW; Hamed, RB; Chowdhury, R; Gong, LZ; Robinson, CV; Trudgian, DC; Jiang, M; Mackeen, MM; Mccullagh, JS; Gordiyenko, Y; Thalhammer, A; Yamamoto, A; Yang, M; Liu-Yi, P; Zhang, ZH; Schmidt-Zachmann, M; Kessler, BM; Ratcliffe, PJ; Preston, GM; Coleman, ML; Schofield, CJ				Ge, Wei; Wolf, Alexander; Feng, Tianshu; Ho, Chia-hua; Sekirnik, Rok; Zayer, Adam; Granatino, Nicolas; Cockman, Matthew E.; Loenarz, Christoph; Loik, Nikita D.; Hardy, Adam P.; Claridge, Timothy D. W.; Hamed, Refaat B.; Chowdhury, Rasheduzzaman; Gong, Lingzhi; Robinson, Carol V.; Trudgian, David C.; Jiang, Miao; Mackeen, Mukram M.; Mccullagh, James S.; Gordiyenko, Yuliya; Thalhammer, Armin; Yamamoto, Atsushi; Yang, Ming; Liu-Yi, Phebee; Zhang, Zhihong; Schmidt-Zachmann, Marion; Kessler, Benedikt M.; Ratcliffe, Peter J.; Preston, Gail M.; Coleman, Mathew L.; Schofield, Christopher J.			Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans	NATURE CHEMICAL BIOLOGY			English	Article							MYC TARGET GENE; LUNG-CANCER; JMJC-DOMAIN; CELL CARCINOMA; MINA53; PROTEIN; RNA; IDENTIFICATION; EXPRESSION; MDIG	The finding that oxygenase-catalyzed protein hydroxylation regulates animal transcription raises questions as to whether the translation machinery and prokaryotic proteins are analogously modified. Escherichia coli ycfD is a growth-regulating 2-oxoglutarate oxygenase catalyzing arginyl hydroxylation of the ribosomal protein Rpl16. Human ycfD homologs, Myc-induced nuclear antigen (MINA53) and NO66, are also linked to growth and catalyze histidyl hydroxylation of Rpl27a and Rpl8, respectively. This work reveals new therapeutic possibilities via oxygenase inhibition and by targeting modified over unmodified ribosomes.	[Ge, Wei; Wolf, Alexander; Ho, Chia-hua; Sekirnik, Rok; Granatino, Nicolas; Loenarz, Christoph; Loik, Nikita D.; Hardy, Adam P.; Claridge, Timothy D. W.; Hamed, Refaat B.; Chowdhury, Rasheduzzaman; Gong, Lingzhi; Robinson, Carol V.; Jiang, Miao; Mackeen, Mukram M.; Mccullagh, James S.; Gordiyenko, Yuliya; Thalhammer, Armin; Zhang, Zhihong; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford, England; [Ge, Wei; Wolf, Alexander; Ho, Chia-hua; Sekirnik, Rok; Granatino, Nicolas; Loenarz, Christoph; Loik, Nikita D.; Hardy, Adam P.; Claridge, Timothy D. W.; Hamed, Refaat B.; Chowdhury, Rasheduzzaman; Gong, Lingzhi; Robinson, Carol V.; Jiang, Miao; Mackeen, Mukram M.; Mccullagh, James S.; Gordiyenko, Yuliya; Thalhammer, Armin; Zhang, Zhihong; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Trudgian, David C.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Trudgian, David C.] Univ Texas SW Med Ctr Dallas, Prote Core, Dallas, TX 75390 USA; [Schmidt-Zachmann, Marion] German Canc Res Ctr, Clin Cooperat Unit Mol Hematol Oncol, D-6900 Heidelberg, Germany; [Preston, Gail M.] Univ Oxford, Dept Plant Sci, Oxford, England	University of Oxford; University of Oxford; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Chem Res Lab, Oxford, England.	mcoleman@well.ox.ac.uk; christopher.schofield@chem.ox.ac.uk	Chowdhury, Rashed/I-7697-2014; Cockman, Matthew/V-9619-2019; Hamed, Refaat/K-5669-2019; Trudgian, David/D-4785-2012; Wolf, Alexander/K-2178-2013; Mackeen, Mukram Mohamed/AAN-6344-2020; McCullagh, James/AAD-2669-2022; zhang, zh/GWV-4677-2022; Kessler, Benedikt/AAY-8614-2021; Claridge, Tim/A-8324-2018; Coleman, Mathew L/C-1676-2014	Chowdhury, Rashed/0000-0002-8058-6149; Cockman, Matthew/0000-0002-3310-4821; Hamed, Refaat/0000-0002-9160-9414; Trudgian, David/0000-0002-7084-6787; Mackeen, Mukram Mohamed/0000-0001-7344-2932; McCullagh, James/0000-0003-4733-1205; Kessler, Benedikt/0000-0002-8160-2446; Claridge, Tim/0000-0001-5583-6460; Coleman, Mathew L/0000-0001-6020-9023; Wolf, Alexander/0000-0003-0649-3363; Loenarz, Christoph/0000-0002-8843-2531; robinson, carol/0000-0001-7829-5505; Sekirnik, Rok/0000-0001-6008-9500; Preston, Gail/0000-0003-3882-4438; Schofield, Christopher/0000-0002-0290-6565; Ratcliffe, Peter/0000-0002-2853-806X	Biotechnology and Biological Sciences Research Council [BB/G014124/1]; Wellcome Trust [091857/Z/10/Z]; Cancer Research UK; Slovenian Academy of Sciences and Arts; Oxford Cancer Research Centre; Oak Foundation; BBSRC [BB/D011523/1, BB/J003018/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011523/1, BB/J003018/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Slovenian Academy of Sciences and Arts; Oxford Cancer Research Centre; Oak Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Biotechnology and Biological Sciences Research Council (BB/G014124/1 to P.J.R. and C.J.S.), Wellcome Trust (091857/Z/10/Z to P.J.R. and C.J.S.), Cancer Research UK for studentships (to R. S. and A.Z.), the Slovenian Academy of Sciences and Arts (R. S.), the Oxford Cancer Research Centre (M. L. C.) and the Oak Foundation (M. L. C.) for funding. We thank C. Ducho (Georg-August University, Gottingen, Germany) for the kind gift of standards of hydroxyarginine stereoisomers, R. Fischer for generating MS data and U. Ackermann and C. Tessmer for technical assistance in antibody preparation. R. B. H. is on leave from the Department of Pharmacognosy, Assiut University, Egypt.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Coleman ML, 2009, CURR PHARM DESIGN, V15, P3904, DOI 10.2174/138161209789649448; Eilbracht J, 2005, EUR J CELL BIOL, V84, P279, DOI 10.1016/j.ejcb.2004.12.022; Eilbracht J, 2004, MOL BIOL CELL, V15, P1816, DOI 10.1091/mbc.e03-08-0623; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Fukahori S, 2007, J PEDIATR SURG, V42, P1831, DOI 10.1016/j.jpedsurg.2007.07.008; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Ishizaki H, 2007, PATHOL INT, V57, P672, DOI 10.1111/j.1440-1827.2007.02156.x; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Lu YJ, 2009, CELL CYCLE, V8, P2101, DOI 10.4161/cc.8.13.8927; Mullen AR, 2012, TRENDS ENDOCRIN MET, V23, P552, DOI 10.1016/j.tem.2012.06.009; Noma A, 2010, J BIOL CHEM, V285, P34503, DOI 10.1074/jbc.M110.156398; Ogasawara S, 2010, HEPATOL RES, V40, P330, DOI 10.1111/j.1872-034X.2009.00604.x; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Suzuki C, 2007, MOL CANCER THER, V6, P542, DOI 10.1158/1535-7163.MCT-06-0659; Teye K, 2004, AM J PATHOL, V164, P205, DOI 10.1016/S0002-9440(10)63111-2; Tsuneoka M, 2004, CLIN CANCER RES, V10, P7347, DOI 10.1158/1078-0432.CCR-03-0543; Tsuneoka M, 2002, J BIOL CHEM, V277, P35450, DOI 10.1074/jbc.M204458200; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Yin XH, 2004, CHEMBIOCHEM, V5, P1274, DOI 10.1002/cbic.200400082; Zhang YD, 2005, ONCOGENE, V24, P4873, DOI 10.1038/sj.onc.1208668	25	114	125	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					960	962		10.1038/NCHEMBIO.1093	http://dx.doi.org/10.1038/NCHEMBIO.1093			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103944	Green Accepted			2022-12-27	WOS:000311491200008
J	Zhan, YY; Chen, Y; Zhang, Q; Zhuang, JJ; Tian, M; Chen, HZ; Zhang, LR; Zhang, HK; He, JP; Wang, WJ; Wu, R; Wang, Y; Shi, CF; Yang, K; Li, AZ; Xin, YZ; Li, TY; Yang, JY; Zheng, ZH; Yu, CD; Lin, SC; Chang, CS; Huang, PQ; Lin, TW; Wu, Q				Zhan, Yan-yan; Chen, Yan; Zhang, Qian; Zhuang, Jia-jia; Tian, Min; Chen, Hang-zi; Zhang, Lian-ru; Zhang, Hong-kui; He, Jian-ping; Wang, Wei-jia; Wu, Rong; Wang, Yuan; Shi, Chunfang; Yang, Kai; Li, An-zhong; Xin, Yong-zhen; Li, Terytty Yang; Yang, James Y.; Zheng, Zhong-hui; Yu, Chun-dong; Lin, Sheng-Cai; Chang, Chawnshang; Huang, Pei-qiang; Lin, Tianwei; Wu, Qiao			The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK	NATURE CHEMICAL BIOLOGY			English	Article							ACETYL-COA CARBOXYLASE; LIGAND-BINDING DOMAIN; FATTY-ACID OXIDATION; PROTEIN-KINASE AMPK; GLUCOSE-METABOLISM; TUMOR-SUPPRESSOR; SKELETAL-MUSCLE; RETINOIC ACID; PHOSPHORYLATION; LIVER	Liver kinase B1 (LKB1) has important roles in governing energy homeostasis by regulating the activity of the energy sensor kinase AMP-activated protein kinase (AMPK). The regulation of LKB1 function, however, is still poorly understood. Here we demonstrate that the orphan nuclear receptor Nur77 binds and sequesters LKB1 in the nucleus, thereby attenuating AMPK activation. This Nur77 function is antagonized by the chemical compound ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), which interacts with Nur77 with high affinity and at specific sites. TMPA binding of Nur77 results in the release and shuttling of LKB1 to the cytoplasm to phosphorylate AMPK alpha. Moreover, TMPA effectively reduces blood glucose and alleviates insulin resistance in type II db/db and high-fat diet-and streptozotocin-induced diabetic mice but not in diabetic littermates with the Nur77 gene knocked out. This study attains a mechanistic understanding of the regulation of LKB1-AMPK axis and implicates Nur77 as a new and amenable target for the design and development of therapeutics to treat metabolic diseases.	[Zhan, Yan-yan; Chen, Yan; Zhang, Qian; Tian, Min; Chen, Hang-zi; Zhang, Lian-ru; He, Jian-ping; Wang, Wei-jia; Wu, Rong; Wang, Yuan; Shi, Chunfang; Yang, Kai; Li, An-zhong; Xin, Yong-zhen; Li, Terytty Yang; Yang, James Y.; Zheng, Zhong-hui; Yu, Chun-dong; Lin, Sheng-Cai; Lin, Tianwei; Wu, Qiao] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Zhuang, Jia-jia; Zhang, Hong-kui; Huang, Pei-qiang] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Jiangsu, Peoples R China; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA	Xiamen University; Xiamen University; University of Rochester; University of Rochester; University of Rochester	Zhan, YY (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	twlin@xmu.edu.cn; qiaow@xmu.edu.cn	Zheng, ZH/G-4657-2010; Huang, Peiqiang/G-4094-2010; Yu, C/G-4626-2010; Zhang, HK/G-3428-2010; Li, Terytty Yang/HCI-2446-2022; Lin, SC/G-4666-2010; Yang, Kai S./AAC-9906-2021; Wu, Q/G-4646-2010	Huang, Peiqiang/0000-0003-3230-0457; Li, Terytty Yang/0000-0003-3684-7935; Yang, Kai S./0000-0002-1890-4169; 	Ministry of Science and Technology [2011CB910802]; National Natural Science Fund of China [30810103905, 30630070, 30921005, 30870479]; Program of Introducing Talents of Discipline to Universities [B12001, B06016]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2012KF002]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University	We are grateful to P. Li (Tsinghua University) for the plasmids encoding AMPK beta, AMPK gamma and AMPK alpha(1-312) and to J. Wu (Tsinghua University) for the tricistronic expression plasmids for all three subunits of AMPK. This work was supported by the grants from '973' Project of the Ministry of Science and Technology (2011CB910802), the National Natural Science Fund of China (30810103905, 30630070, 30921005 and 30870479), the Program of Introducing Talents of Discipline to Universities (B12001 and B06016) and the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University (SKLCSB2012KF002). We also gratefully acknowledge the use of Beamline BL17U1 at Shanghai Synchrotron Radiation Facility for crystallographic data collection.	Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gilbert ER, 2011, EXP DIABETES RES, DOI 10.1155/2011/416254; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Huypens P, 2005, EUR J PHARMACOL, V518, P90, DOI 10.1016/j.ejphar.2005.06.016; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kim EJ, 2012, HEPATOLOGY, V55, P1379, DOI 10.1002/hep.25529; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kishi K, 2000, BIOCHEM BIOPH RES CO, V276, P16, DOI 10.1006/bbrc.2000.3417; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Linher-Melville K, 2012, BIOCHEM BIOPH RES CO, V417, P1063, DOI 10.1016/j.bbrc.2011.12.096; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Nath-Sain S, 2009, MOL BIOL CELL, V20, P2785, DOI 10.1091/mbc.E08-11-1138; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sambandam N, 2003, PROG LIPID RES, V42, P238, DOI 10.1016/S0163-7827(02)00065-6; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106	44	110	121	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					897	904		10.1038/NCHEMBIO.1069	http://dx.doi.org/10.1038/NCHEMBIO.1069			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	22983157				2022-12-27	WOS:000310052100008
J	Verrier, F; An, SO; Ferrie, AM; Sun, HY; Kyoung, M; Deng, HY; Fang, Y; Benkovic, SJ				Verrier, Florence; An, Songon; Ferrie, Ann M.; Sun, Haiyan; Kyoung, Minjoung; Deng, Huayun; Fang, Ye; Benkovic, Stephen J.			GPCRs regulate the assembly of a multienzyme complex for purine biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; DYNAMIC MASS REDISTRIBUTION; KINASE CK2; 7-TRANSMEMBRANE RECEPTORS; CELL-METABOLISM; LIVING CELLS; INHIBITORS; ADRENOCEPTORS; SELECTIVITY; PATHWAYS	G protein-coupled receptors (GPCRs) transmit exogenous signals to the nucleus, promoting a myriad of biological responses via multiple signaling pathways in both healthy and cancerous cells. However, little is known about the response of cytosolic metabolic pathways to GPCR-mediated signaling. Here we applied fluorescent live-cell imaging and label-free dynamic mass redistribution assays to study whether purine metabolism is associated with GPCR signaling. Through a library screen of GPCR ligands in conjunction with live-cell imaging of a metabolic multienzyme complex for de novo purine biosynthesis, the purinosome, we demonstrated that the activation of endogenous G(alpha 1)-coupled receptors correlates with purinosome assembly and disassembly in native HeLa cells. Given the implications of GPCRs in mitogenic signaling and of the purinosome in controlling metabolic flux via de novo purine biosynthesis, we hypothesize that regulation of purinosome assembly and disassembly may be one of the downstream events of mitogenic GPCR signaling in human cancer cells.	[Verrier, Florence; Ferrie, Ann M.; Sun, Haiyan; Deng, Huayun; Fang, Ye] Corning Inc, Div Sci & Technol, Biochem Technol, Corning, NY 14831 USA; [An, Songon; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Kyoung, Minjoung] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Corning Inc; State University of New York (SUNY) System; SUNY Community College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University	Fang, Y (corresponding author), Corning Inc, Div Sci & Technol, Biochem Technol, Corning, NY 14831 USA.	fangy2@corning.com; sjb1@psu.edu		An, Songon/0000-0003-2189-7374; Fang, Ye/0000-0002-1322-7365	US National Institutes of Health [GM24129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024129, R01GM024129] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by US National Institutes of Health grant GM24129 (S.J.B.).	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; BARBIERI JT, 1988, INFECT IMMUN, V56, P1934, DOI 10.1128/IAI.56.8.1934-1941.1988; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Duncan JS, 2008, MOL CELL PROTEOMICS, V7, P1077, DOI 10.1074/mcp.M700559-MCP200; Fang Y, 2005, ANAL CHEM, V77, P5720, DOI 10.1021/ac050887n; Fang Y., 2011, DRUG DISCOV TODAY TE, V7, pe5; Fang Ye, 2007, Journal of Pharmacological and Toxicological Methods, V55, P314, DOI 10.1016/j.vascn.2006.11.001; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Hanyaloglu AC, 2001, J BIOL CHEM, V276, P18066, DOI 10.1074/jbc.M009275200; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Musnier A, 2010, CELL SIGNAL, V22, P707, DOI 10.1016/j.cellsig.2009.10.012; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rebholz H, 2009, P NATL ACAD SCI USA, V106, P14096, DOI 10.1073/pnas.0906857106; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018	28	64	64	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					909	915		10.1038/NCHEMBIO.690	http://dx.doi.org/10.1038/NCHEMBIO.690			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22020552	Green Accepted			2022-12-27	WOS:000297166200014
J	Lee, SS; Hong, SY; Errey, JC; Izumi, A; Davies, GJ; Davis, BG				Lee, Seung Seo; Hong, Sung You; Errey, James C.; Izumi, Atsushi; Davies, Gideon J.; Davis, Benjamin G.			Mechanistic evidence for a front-side, S(N)i-type reaction in a retaining glycosyltransferase	NATURE CHEMICAL BIOLOGY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; ENZYMATIC GLYCOSYL TRANSFER; TRANSITION-STATE; ALPHA-GALACTOSYLTRANSFERASE; TREHALOSE PHOSPHORYLASE; NEISSERIA-MENINGITIDIS; SCHIZOPHYLLUM-COMMUNE; COVALENT INTERMEDIATE; GLUCOSYL TRANSFER; ACTIVE-SITE	A previously determined crystal structure of the ternary complex of trehalose-6-phosphate synthase identified a putative transition state-like arrangement based on validoxylamine A 6'-O-phosphate and uridine diphosphate in the active site. Here linear free energy relationships confirm that these inhibitors are synergistic transition state mimics, supporting front-face nucleophilic attack involving hydrogen bonding between leaving group and nucleophile. Kinetic isotope effects indicate a highly dissociative oxocarbenium ion-like transition state. Leaving group O-18 effects identified isotopically sensitive bond cleavages and support the existence of a hydrogen bond between the nucleophile and departing group. Bronsted analysis of nucleophiles and Taft analysis highlight participation of the nucleophile in the transition state, also consistent with a front-face mechanism. Together, these comprehensive, quantitative data substantiate this unusual enzymatic reaction mechanism. Its discovery should prompt useful reassessment of many biocatalysts and their substrates and inhibitors.	[Lee, Seung Seo; Hong, Sung You; Errey, James C.; Davis, Benjamin G.] Univ Oxford, Dept Chem, Oxford, England; [Izumi, Atsushi; Davies, Gideon J.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Lee, SS (corresponding author), Univ Oxford, Dept Chem, Oxford, England.	ben.davis@chem.ox.ac.uk	Davies, Gideon J/A-9042-2011; Hong, Sung You/G-2323-2011; Davis, Benjamin G/C-5281-2011; Lee, Seung S/K-8669-2018	Davies, Gideon J/0000-0002-7343-776X; Hong, Sung You/0000-0002-5785-4475; Davis, Benjamin G/0000-0002-5056-407X; Lee, Seung S/0000-0002-8598-3303	Bill and Melinda Gates Foundation; Samsung Fellowship; Biotechnology and Biological Sciences Research Council; Royal Society; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/C510824/1, BB/E004350/1, BB/E001696/1, EGA17763, B20376] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G026688/1, EP/D023343/1, EP/D023335/1, GR/T26542/01, EP/E000614/1, EP/I500200/1] Funding Source: researchfish; BBSRC [BB/E004350/1, BB/E001696/1] Funding Source: UKRI; EPSRC [EP/E000614/1, EP/G026688/1, EP/I500200/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Samsung Fellowship(Samsung); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the Bill and Melinda Gates Foundation, the Samsung Fellowship and the Biotechnology and Biological Sciences Research Council for financial support. R. Zhang and S.G. Withers (University of British Columbia) are acknowledged for providing 2-deoxy-2,2-difluoroglucose; R. Gibson (currently at the University of Liverpool) is thanked for initial construction of some OtsA mutants. B.G.D. and G.J.D. are both Royal Society Wolfson Research Merit Award recipients, and B.G.D. is supported by an Engineering and Physical Sciences Research Council Life Sciences Interface Platform grant.	Baxter NJ, 2006, P NATL ACAD SCI USA, V103, P14732, DOI 10.1073/pnas.0604448103; BENNET AJ, 1986, J AM CHEM SOC, V108, P7287, DOI 10.1021/ja00283a025; Berti PJ, 2006, CHEM REV, V106, P506, DOI 10.1021/cr040461t; Bruner M, 1998, BIOCHEMISTRY-US, V37, P289, DOI 10.1021/bi971624t; Chan J, 2010, NAT CHEM BIOL, V6, P405, DOI 10.1038/nchembio.352; Chenault HK, 1997, J ORG CHEM, V62, P331, DOI 10.1021/jo961715g; Cleland WW, 2005, ARCH BIOCHEM BIOPHYS, V433, P2, DOI 10.1016/j.abb.2004.08.027; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cowdrey WA, 1937, J CHEM SOC, P1252, DOI 10.1039/jr9370001252; Du XL, 2004, P NATL ACAD SCI USA, V101, P8858, DOI 10.1073/pnas.0401675101; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Glad SS, 1997, J AM CHEM SOC, V119, P227, DOI 10.1021/ja962733i; Gloster TM, 2010, ORG BIOMOL CHEM, V8, P305, DOI 10.1039/b915870g; Goedl C, 2006, BIOCHEM J, V397, P491, DOI 10.1042/BJ20060029; Goedl C, 2009, CHEMBIOCHEM, V10, P2333, DOI 10.1002/cbic.200900429; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Greig IR, 2010, CHEM SOC REV, V39, P2272, DOI 10.1039/b902741f; GUTHRIE RD, 1989, ACCOUNTS CHEM RES, V22, P343, DOI 10.1021/ar00166a001; Hansch C, 1979, SUBSTITUENT CONSTANT; Huang XC, 1997, J AM CHEM SOC, V119, P11147, DOI 10.1021/ja963733l; Indurugalla D, 2001, J AM CHEM SOC, V123, P10889, DOI 10.1021/ja011232g; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; JONES CS, 1980, J BIOL CHEM, V255, P1861; KIM SC, 1988, ARCH BIOCHEM BIOPHYS, V267, P54, DOI 10.1016/0003-9861(88)90007-0; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Lee JK, 2004, J AM CHEM SOC, V126, P3769, DOI 10.1021/ja0394028; Luo M, 2008, J AM CHEM SOC, V130, P2649, DOI 10.1021/ja078008x; Ly HD, 2002, BIOCHEMISTRY-US, V41, P5075, DOI 10.1021/bi012031s; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Mader MM, 1997, CHEM REV, V97, P1281, DOI 10.1021/cr960435y; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Monegal A, 2006, J AM CHEM SOC, V128, P16030, DOI 10.1021/ja0659931; Nidetzky B, 2001, BIOCHEM J, V360, P727, DOI 10.1042/0264-6021:3600727; NORTHROP DB, 1981, BIOCHEMISTRY-US, V20, P4056, DOI 10.1021/bi00517a017; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; ROSENBERG S, 1981, BIOCHEMISTRY-US, V20, P3196, DOI 10.1021/bi00514a032; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SINNOTT ML, 1980, J AM CHEM SOC, V102, P2026, DOI 10.1021/ja00526a043; Soya N, 2011, GLYCOBIOLOGY, V21, P547, DOI 10.1093/glycob/cwq190; SUNKO DE, 1977, J AM CHEM SOC, V99, P5000, DOI 10.1021/ja00457a018; Tvaroska I, 2006, ACS SYM SER, V930, P285; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178; Ye JD, 2007, ANGEW CHEM INT EDIT, V46, P3714, DOI 10.1002/anie.200605124	50	118	120	1	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					631	638		10.1038/NCHEMBIO.628	http://dx.doi.org/10.1038/NCHEMBIO.628			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21822275	Green Accepted			2022-12-27	WOS:000294381400014
J	Ni, QA; Ganesan, A; Aye-Han, NN; Gao, XX; Allen, MD; Levchenko, A; Zhang, J				Ni, Qiang; Ganesan, Ambhighainath; Aye-Han, Nwe-Nwe; Gao, Xinxin; Allen, Michael D.; Levchenko, Andre; Zhang, Jin			Signaling diversity of PKA achieved via a Ca2+-cAMP-PKA oscillatory circuit	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE-A; PANCREATIC BETA-CELL; INSULIN-SECRETION; GENE-EXPRESSION; CALCIUM OSCILLATIONS; CA2+ CHANNEL; CYCLIC-AMP; CAMP; PHOSPHORYLATION; GLUCOSE	Many protein kinases are key nodal signaling molecules that regulate a wide range of cellular functions. These functions may require complex spatiotemporal regulation of kinase activities. Here, we show that protein kinase A (PKA), Ca2+ and cyclic AMP (cAMP) oscillate in sync in insulin-secreting MIN6 beta cells, forming a highly integrated oscillatory circuit. We found that PKA activity was essential for this oscillatory circuit and was capable of not only initiating the signaling oscillations but also modulating their frequency, thereby diversifying the spatiotemporal control of downstream signaling. Our findings suggest that exquisite temporal control of kinase activity, mediated via signaling circuits resulting from cross-regulation of signaling pathways, can encode diverse inputs into temporal parameters such as oscillation frequency, which in turn contribute to proper regulation of complex cellular functions in a context-dependent manner.	[Ni, Qiang; Aye-Han, Nwe-Nwe; Gao, Xinxin; Allen, Michael D.; Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Ganesan, Ambhighainath; Levchenko, Andre] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Zhang, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	alev@jhu.edu; jzhang32@jhmi.edu			US National Institutes of Health [R01 DK073368, DP1OD006419, GM072024, RR020839]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072024] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006419] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J.-I. Miyazaki (Osaka University), G. G. Holz (SUNY Upstate Medical University) and G. H. Hart (Johns Hopkins University) for providing cell lines. We also thank X. Li (Johns Hopkins University) for initial technical assistance. This work was supported by US National Institutes of Health grants R01 DK073368 and DP1OD006419 (to J.Z.) and GM072024 and RR020839 (to A.L.).	Allen MD, 2008, ANGEW CHEM INT EDIT, V47, P500, DOI 10.1002/anie.200703493; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; BORODINSKY LN, 2006, SCI STKE, pPE22; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Bugrim AE, 1999, CELL CALCIUM, V25, P219, DOI 10.1054/ceca.1999.0027; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; CHAY TR, 1983, BIOPHYS J, V42, P181, DOI 10.1016/S0006-3495(83)84384-7; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Gromada J, 2004, BASIC CLIN PHARMACOL, V95, P252, DOI 10.1111/j.1742-7843.2004.t01-1-pto950502.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hatakeyama H, 2006, J PHYSIOL-LONDON, V570, P271, DOI 10.1113/jphysiol.2005.096560; HENQUIN JC, 1984, ENDOCRINOLOGY, V115, P1125, DOI 10.1210/endo-115-3-1125; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Leiser M, 1996, DIABETES, V45, P1412, DOI 10.2337/diabetes.45.10.1412; Lester LB, 2001, ENDOCRINOLOGY, V142, P1218, DOI 10.1210/en.142.3.1218; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Markoulaki S, 2004, DEV BIOL, V272, P15, DOI 10.1016/j.ydbio.2004.04.008; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; VAAG A, 1995, J CLIN INVEST, V95, P690, DOI 10.1172/JCI117715; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Zaccolo M, 2003, TRENDS NEUROSCI, V26, P53, DOI 10.1016/S0166-2236(02)00017-6; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	44	84	86	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					34	40		10.1038/NCHEMBIO.478	http://dx.doi.org/10.1038/NCHEMBIO.478			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21102470	Green Accepted			2022-12-27	WOS:000285383400010
J	Igarashi, K				Igarashi, Kiyohiko			CELLULASES Cooperative biomass breakdown	NATURE CHEMICAL BIOLOGY			English	News Item									Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan	University of Tokyo	Igarashi, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan.	aquarius@mail.ecc.u-tokyo.ac.jp	Igarashi, Kiyohiko/E-6799-2016	Igarashi, Kiyohiko/0000-0001-5152-7177	Grants-in-Aid for Scientific Research [24114008] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Teeri TT, 1998, BIOCHEM SOC T, V26, P173, DOI 10.1042/bst0260173; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231	10	15	15	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					350	351		10.1038/nchembio.1237	http://dx.doi.org/10.1038/nchembio.1237			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23563527				2022-12-27	WOS:000319328200003
J	Johnston, CW; Wyatt, MA; Li, X; Ibrahim, A; Shuster, J; Southam, G; Magarvey, NA				Johnston, Chad W.; Wyatt, Morgan A.; Li, Xiang; Ibrahim, Ashraf; Shuster, Jeremiah; Southam, Gordon; Magarvey, Nathan A.			Gold biomineralization by a metallophore from a gold-associated microbe	NATURE CHEMICAL BIOLOGY			English	Article							SIDEROPHORE; NANOPARTICLES; BACTERIA; BIOFILMS; COPPER	Microorganisms produce and secrete secondary metabolites to assist in their survival. We report that the gold resident bacterium Delftia acidovorans produces a secondary metabolite that protects from soluble gold through the generation of solid gold forms. This finding is the first demonstration that a secreted metabolite can protect against toxic gold and cause gold biomineralization.	[Johnston, Chad W.; Wyatt, Morgan A.; Li, Xiang; Ibrahim, Ashraf; Magarvey, Nathan A.] McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Johnston, Chad W.; Wyatt, Morgan A.; Li, Xiang; Ibrahim, Ashraf; Magarvey, Nathan A.] McMaster Univ, Dept Chem & Chem Biol, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Shuster, Jeremiah; Southam, Gordon] Univ Western Ontario, Dept Earth Sci, London, ON, Canada; [Southam, Gordon] Univ Western Ontario, Dept Biol, London, ON, Canada	McMaster University; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Magarvey, NA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	magarv@mcmaster.ca	Southam, Gordon/D-1983-2013	Southam, Gordon/0000-0002-8941-1249; Johnston, Chad/0000-0002-1988-709X; Shuster, Jeremiah/0000-0002-9839-6618; Ibrahim, Ashraf/0000-0001-5775-7037	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 371576-2009, 101997-2006]; NSERC [STPGP385235-09]; Canadian Foundation for Innovation [2010M00022]; Canadian Institutes of Health (CIHR); CIHR	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded through Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery grants (RGPIN 371576-2009; 101997-2006), an NSERC Strategic grant (STPGP385235-09) and a Canadian Foundation for Innovation grant (2010M00022). M.A.W. is funded through a Canadian Institutes of Health (CIHR) Doctoral Research Award. N.A.M. is funded by a CIHR New Investigator Award.	Amin SA, 2007, J AM CHEM SOC, V129, P478, DOI 10.1021/ja067369u; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; DIELS L, 1995, J IND MICROBIOL, V14, P142, DOI 10.1007/BF01569896; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hough RM, 2008, GEOLOGY, V36, P571, DOI 10.1130/G24749A.1; Kashefi K, 2001, APPL ENVIRON MICROB, V67, P3275, DOI 10.1128/AEM.67.7.3275-3279.2001; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Miller MC, 2010, MICROBIOL-SGM, V156, P2226, DOI 10.1099/mic.0.037945-0; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Ojea-Jimenez I, 2010, J PHYS CHEM C, V114, P1800, DOI 10.1021/jp9091305; Reith F, 2007, ISME J, V1, P567, DOI 10.1038/ismej.2007.75; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Reith F, 2010, GEOLOGY, V38, P843, DOI 10.1130/G31052.1; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Salem I.B., 2012, ANN MICROBIOL, DOI [10.1007/s13213-012-0462-3, DOI 10.1007/S13213-012-0462-3]; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Usher A, 2009, GEOCHIM COSMOCHIM AC, V73, P3359, DOI 10.1016/j.gca.2009.01.036; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143	18	148	153	10	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					241	243		10.1038/NCHEMBIO.1179	http://dx.doi.org/10.1038/NCHEMBIO.1179			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23377039				2022-12-27	WOS:000317025800012
J	Maruyama, C; Toyoda, J; Kato, Y; Izumikawa, M; Takagi, M; Shin-ya, K; Katano, H; Utagawa, T; Hamano, Y				Maruyama, Chitose; Toyoda, Junya; Kato, Yasuo; Izumikawa, Miho; Takagi, Motoki; Shin-ya, Kazuo; Katano, Hajime; Utagawa, Takashi; Hamano, Yoshimitsu			A stand-alone adenylation domain forms amide bonds in streptothricin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; LABORATORY-ANIMALS; SELECTABLE MARKER; GENE DISRUPTION; STREPTOMYCES; NOURSEOTHRICIN; ANTIBIOTICS; CASSETTES; TOXICITY; PRODUCTS	The streptothricin (ST) antibiotics, produced by Streptomyces bacteria, contain L-beta-lysine ((3S)-3,6-diaminohexanoic acid) oligopeptides as pendant chains. Here we describe three unusual nonribosomal peptide synthetases (NRPSs) involved in ST biosynthesis: ORF 5 (a stand-alone adenylation (A) domain), ORF 18 (containing thiolation (T) and condensation (C) domains) and ORF 19 (a stand-alone A domain). We demonstrate that ST biosynthesis begins with adenylation of L-beta-lysine by ORF 5, followed by transfer to the T domain of ORF 18. In contrast, L-beta-lysine molecules adenylated by ORF 19 are used to elongate an L-beta-lysine peptide chain on ORF 18, a reaction unexpectedly catalyzed by ORF 19 itself. Finally, the C domain of ORF 18 catalyzes the condensation of L-beta-lysine oligopeptides covalently bound to ORF 18 with a freely diffusible intermediate to release the ST products. These results highlight an unusual activity for an A domain and unique mechanisms of crosstalk within NRPS machinery.	[Maruyama, Chitose; Toyoda, Junya; Katano, Hajime; Utagawa, Takashi; Hamano, Yoshimitsu] Fukui Prefectural Univ, Dept Biosci, Fukui, Japan; [Kato, Yasuo] Toyama Prefectural Univ, Dept Biotechnol, Toyama, Japan; [Izumikawa, Miho; Takagi, Motoki] Japan Biol Informat Consortium, Tokyo, Japan; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan	Fukui Prefectural University; Toyama Prefectural University; National Institute of Advanced Industrial Science & Technology (AIST)	Hamano, Y (corresponding author), Fukui Prefectural Univ, Dept Biosci, Fukui, Japan.	hamano@fpu.ac.jp	Takagi, Motoki/Q-7390-2019; Shin-ya, Kazuo/L-9613-2018	Shin-ya, Kazuo/0000-0002-4702-0661; Maruyama, Chitose/0000-0001-7354-9342; Katano, Hajime/0000-0001-6937-3858; Hamano, Yoshimitsu/0000-0001-5117-5116	Japan Society for the Promotion of Science (JSPS) [22688007]; Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan; JSPS [23108520]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank N. Iwasaki and J. Seta (Bruker Daltonics K.K.) for assistance with HPLC/Q-TOF MS data collection. Plasmids pKD46 and pCP 20 and E. coli BW25113 were supplied by H. Mori (Nara Institute of Science and Technology). This work was supported, in part, by Grant-in-Aid for Young Scientists (A) (22688007) from the Japan Society for the Promotion of Science (JSPS; to Y.H.), the Industrial Technology Research Grant Program in 2008 from the New Energy and Industrial Technology Development Organization of Japan (to Y.H.) and by Grant-in-Aid for Scientific Research on Innovative Area (23108520) from the JSPS (to Y.H.).	BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; CHAMBERLAIN DA, 1994, AUST J PLANT PHYSIOL, V21, P95, DOI 10.1071/PP9940095; FernandezMoreno MA, 1997, J BACTERIOL, V179, P6929, DOI 10.1128/jb.179.22.6929-6936.1997; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grammel N, 2002, EUR J BIOCHEM, V269, P347, DOI 10.1046/j.0014-2956.2001.02657.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hamano Y, 2006, J BIOL CHEM, V281, P16842, DOI 10.1074/jbc.M602294200; HARTL A, 1986, ARCH EXP VET MED, V40, P727; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hisamoto M, 1998, J ANTIBIOT, V51, P607, DOI 10.7164/antibiotics.51.607; HOFFMANN H, 1986, ARCH EXP VET MED, V40, P710; HOFFMANN H, 1986, ARCH EXP VET MED, V40, P699; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Ji ZQ, 2007, J ANTIBIOT, V60, P739, DOI 10.1038/ja.2007.96; JOSHI PB, 1995, GENE, V156, P145, DOI 10.1016/0378-1119(95)00042-5; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KUSUMOTO S, 1982, J ANTIBIOT, V35, P925, DOI 10.7164/antibiotics.35.925; KUSUMOTO S, 1982, TETRAHEDRON LETT, V23, P2961, DOI 10.1016/S0040-4039(00)87506-1; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Schmutz E, 2003, EUR J BIOCHEM, V270, P4413, DOI 10.1046/j.1432-1033.2003.03830.x; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; TAKEMOTO T, 1980, CHEM PHARM BULL, V28, P2884; Waksman SA, 1943, J BACTERIOL, V46, P299, DOI 10.1128/JB.46.3.299-310.1943; Walsh C., 2003, ANTIBIOTICS ACTION O; Zhang WJ, 2011, J AM CHEM SOC, V133, P5240, DOI 10.1021/ja2011109	29	79	81	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					791	797		10.1038/NCHEMBIO.1040	http://dx.doi.org/10.1038/NCHEMBIO.1040			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22820420				2022-12-27	WOS:000308077600011
J	Bergamini, G; Bell, K; Shimamura, S; Werner, T; Cansfield, A; Muller, K; Perrin, J; Rau, C; Ellard, K; Hopf, C; Doce, C; Leggate, D; Mangano, R; Mathieson, T; O'Mahony, A; Plavec, I; Rharbaoui, F; Reinhard, F; Savitski, MM; Ramsden, N; Hirsch, E; Drewes, G; Rausch, O; Bantscheff, M; Neubauer, G				Bergamini, Giovanna; Bell, Kathryn; Shimamura, Satoko; Werner, Thilo; Cansfield, Andrew; Mueller, Katrin; Perrin, Jessica; Rau, Christina; Ellard, Katie; Hopf, Carsten; Doce, Carola; Leggate, Daniel; Mangano, Raffaella; Mathieson, Toby; O'Mahony, Alison; Plavec, Ivan; Rharbaoui, Faiza; Reinhard, Friedrich; Savitski, Mikhail M.; Ramsden, Nigel; Hirsch, Emilio; Drewes, Gerard; Rausch, Oliver; Bantscheff, Marcus; Neubauer, Gitte			A selective inhibitor reveals PI3K gamma dependence of T(H)17 cell differentiation	NATURE CHEMICAL BIOLOGY			English	Article							RHEUMATOID-ARTHRITIS; KINASE INHIBITORS; INDUCED INFLAMMATION; JOINT INFLAMMATION; INSULIN-RESISTANCE; CLASS-IB; KEY ROLE; PI3K; CHEMOPROTEOMICS; IDENTIFICATION	We devised a high-throughput chemoproteomics method that enabled multiplexed screening of 16,000 compounds against native protein and lipid kinases in cell extracts. Optimization of one chemical series resulted in CZC24832, which is to our knowledge the first selective inhibitor of phosphoinositide 3-kinase gamma (PI3K gamma) with efficacy in in vitro and in vivo models of inflammation. Extensive target- and cell-based profiling of CZC24832 revealed regulation of interleukin-17-producing T helper cell (T(H)17) differentiation by PI3K gamma, thus reinforcing selective inhibition of PI3K gamma as a potential treatment for inflammatory and autoimmune diseases.	[Bergamini, Giovanna; Shimamura, Satoko; Werner, Thilo; Mueller, Katrin; Perrin, Jessica; Rau, Christina; Hopf, Carsten; Doce, Carola; Mathieson, Toby; Rharbaoui, Faiza; Reinhard, Friedrich; Savitski, Mikhail M.; Drewes, Gerard; Bantscheff, Marcus; Neubauer, Gitte] Cellzome AG, Heidelberg, Germany; [Bell, Kathryn; Cansfield, Andrew; Ellard, Katie; Leggate, Daniel; Mangano, Raffaella; Ramsden, Nigel; Rausch, Oliver] Cellzome Ltd, Cambridge, England; [O'Mahony, Alison; Plavec, Ivan] BioSeek LLC, San Francisco, CA USA; [Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, Turin, Italy	GlaxoSmithKline; Cellzome GmbH; GlaxoSmithKline; Cellzome GmbH; University of Turin	Bergamini, G (corresponding author), Cellzome AG, Heidelberg, Germany.	marcus.bantscheff@cellzome.com; gitte.neubauer@cellzome.com	Bantscheff, Marcus/AAQ-2903-2021; Hirsch, Emilio/F-4848-2013; Hopf, Carsten/A-3275-2015	Bantscheff, Marcus/0000-0002-8343-8977; Hirsch, Emilio/0000-0002-9073-6024; Hopf, Carsten/0000-0003-0802-6451; Drewes, Gerard/0000-0003-0575-6766; Mathieson, Toby/0000-0002-6153-3113; Bergamini, Giovanna/0000-0002-9662-9502				Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Berg EL, 2010, J PHARMACOL TOX MET, V61, P3, DOI 10.1016/j.vascn.2009.10.001; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Bohnacker T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000259; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cansfield A., 2011, European patent EP, Patent No. 2245181; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Fadden P, 2010, CHEM BIOL, V17, P686, DOI 10.1016/j.chembiol.2010.04.015; Fougerat A, 2008, CIRCULATION, V117, P1310, DOI 10.1161/CIRCULATIONAHA.107.720466; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Ghigo A, 2010, BIOESSAYS, V32, P185, DOI 10.1002/bies.200900150; Graves PR, 2002, MOL PHARMACOL, V62, P1364, DOI 10.1124/mol.62.6.1364; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Haylock-Jacobs S, 2011, J AUTOIMMUN, V36, P278, DOI 10.1016/j.jaut.2011.02.006; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Jones GE, 2003, EXP CELL RES, V290, P120, DOI 10.1016/S0014-4827(03)00318-5; Kageyama Y, 2009, MOD RHEUMATOL, V19, P657, DOI 10.1007/s10165-009-0217-6; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kobayashi N, 2011, P NATL ACAD SCI USA, V108, P5753, DOI 10.1073/pnas.1016430108; Konrad S, 2008, J BIOL CHEM, V283, P33296, DOI 10.1074/jbc.M804617200; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Kruse U, 2011, LEUKEMIA, V25, P89, DOI 10.1038/leu.2010.233; Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/1540658041850607; Kunkel EJ, 2004, FASEB J, V18, P1279, DOI 10.1096/fj.04-1538fje; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Savitski MM, 2011, ANAL CHEM, V83, P8959, DOI 10.1021/ac201760x; Savitski MM, 2010, ANAL CHEM, V82, P9843, DOI 10.1021/ac102083q; Savitski MM, 2010, J AM SOC MASS SPECTR, V21, P1668, DOI 10.1016/j.jasms.2010.01.012; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Sharma K, 2009, NAT METHODS, V6, P741, DOI [10.1038/NMETH.1373, 10.1038/nmeth.1373]; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vecchione C, 2005, J EXP MED, V201, P1217, DOI 10.1084/jem.20040995; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Williams O, 2010, CHEM BIOL, V17, P123, DOI 10.1016/j.chembiol.2010.01.010; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	49	107	119	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					576	582		10.1038/NCHEMBIO.957	http://dx.doi.org/10.1038/NCHEMBIO.957			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22544264				2022-12-27	WOS:000304256300014
J	Zhou, H; Gao, ZZ; Qiao, KJ; Wang, JJ; Vederas, JC; Tang, Y				Zhou, Hui; Gao, Zhizeng; Qiao, Kangjian; Wang, Jingjing; Vederas, John C.; Tang, Yi			A fungal ketoreductase domain that displays substrate-dependent stereospecificity	NATURE CHEMICAL BIOLOGY			English	Article							MODULAR POLYKETIDE SYNTHASES; SHORT-CHAIN DEHYDROGENASES/REDUCTASES; FATTY-ACID; CATALYSIS; BIOSYNTHESIS; STEREOCHEMISTRY; HYPOTHEMYCIN; MUTAGENESIS; RESIDUES; GENES	Iterative highly reducing polyketide synthases from filamentous fungi are the most complex and enigmatic type of polyketide synthase discovered to date. Here we uncover an unusual degree of programming by the hypothemycin highly reducing polyketide synthase, in which a single ketoreductase domain shows stereospecificity that is controlled by substrate length. Mapping of the structural domains responsible for this feature allowed for the biosynthesis of an unnatural diastereomer of the natural product dehydrozearalenol.	[Zhou, Hui; Qiao, Kangjian; Wang, Jingjing; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA; [Gao, Zhizeng; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of Alberta; University of California System; University of California Los Angeles	Zhou, H (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA.	john.vederas@ualberta.ca; yitang@ucla.edu	wang, jing/GRS-7509-2022; Gao, Zhizeng/E-2963-2019	Vederas, John/0000-0002-2996-0326; Gao, Zhizeng/0000-0002-8176-0727	US National Institutes of Health [1R01GM085128]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085128] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grant 1R01GM085128 to Y.T., the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair in Bioorganic and Medicinal Chemistry to J.C.V. We thank C. Reeves (Amyris Inc.) for the hpm genes.	Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Castonguay R, 2008, J AM CHEM SOC, V130, P11598, DOI 10.1021/ja804453p; Castonguay R, 2007, J AM CHEM SOC, V129, P13758, DOI 10.1021/ja0753290; CELMER WD, 1965, J AM CHEM SOC, V87, P1801, DOI 10.1021/ja01086a038; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fisch KM, 2011, J AM CHEM SOC, V133, P16635, DOI 10.1021/ja206914q; HAGLER WM, 1979, APPL ENVIRON MICROB, V37, P849, DOI 10.1128/AEM.37.5.849-853.1979; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; O'Hare HM, 2006, CHEM BIOL, V13, P287, DOI 10.1016/j.chembiol.2006.01.003; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; ROSSMANN MG, 1981, ANNU REV BIOCHEM, V50, P497, DOI 10.1146/annurev.bi.50.070181.002433; Siskos AP, 2005, CHEM BIOL, V12, P1145, DOI 10.1016/j.chembiol.2005.08.017; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Valenzano CR, 2009, J AM CHEM SOC, V131, P18501, DOI 10.1021/ja908296m; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015; Zhou H, 2010, J AM CHEM SOC, V132, P4530, DOI 10.1021/ja100060k	25	61	64	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					331	333		10.1038/NCHEMBIO.912	http://dx.doi.org/10.1038/NCHEMBIO.912			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22406519	Green Accepted			2022-12-27	WOS:000301890100006
J	Schonhoft, JD; Stivers, JT				Schonhoft, Joseph D.; Stivers, James T.			Timing facilitated site transfer of an enzyme on DNA	NATURE CHEMICAL BIOLOGY			English	Article							ONE-DIMENSIONAL DIFFUSION; DAMAGED DNA; REPAIR; GLYCOSYLASE; PROTEIN; SEARCH; URACIL; RECOGNITION; BINDING; TRANSLOCATION	Many enzymes that react with specific sites in DNA have the property of facilitated diffusion, in which the DNA chain is used as a conduit to accelerate site location. Despite the importance of such mechanisms in gene regulation and DNA repair, there have been few viable approaches to elucidate the microscopic process of facilitated diffusion. Here we describe a new method in which a small-molecule trap (uracil) is used to clock a DNA repair enzyme as it hops and slides between damaged sites in DNA. The 'molecular clock' provides unprecedented information: the mean length for DNA sliding, the one-dimensional diffusion constant, the maximum hopping radius and the time frame for DNA hopping events. In addition, the data establish that the DNA phosphate backbone is a sufficient requirement for DNA sliding.	[Schonhoft, Joseph D.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Stivers, JT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	jstivers@jhmi.edu	Schonhoft, Joseph/C-1797-2013	Schonhoft, Joseph/0000-0002-5860-5040	US National Institutes of Health [GM056834]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Parker (Harvard Medical School) for purified hUNG used in this study. This work was supported by US National Institutes of Health grant GM056834.	AMYES TL, 1989, J AM CHEM SOC, V111, P7888, DOI 10.1021/ja00202a033; Bagchi B, 2008, J PHYS CHEM B, V112, P6282, DOI 10.1021/jp077568f; Belotserkovskii BP, 2004, J THEOR BIOL, V226, P195, DOI 10.1016/j.jtbi.2003.08.013; Berg, 2018, RANDOM WALKS BIOL; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cao CY, 2004, NAT STRUCT MOL BIOL, V11, P1230, DOI 10.1038/nsmb864; DOWD DR, 1989, BIOCHEMISTRY-US, V28, P8699, DOI 10.1021/bi00448a005; Dunn AR, 2011, NUCLEIC ACIDS RES, V39, P7487, DOI 10.1093/nar/gkr459; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; FISHBEIN JC, 1988, J AM CHEM SOC, V110, P5075, DOI 10.1021/ja00223a028; Friedman JI, 2009, NUCLEIC ACIDS RES, V37, P3493, DOI 10.1093/nar/gkp161; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; GRILLER D, 1980, ACCOUNTS CHEM RES, V13, P317, DOI 10.1021/ar50153a004; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; Jiang YL, 2005, J AM CHEM SOC, V127, P17412, DOI 10.1021/ja055846n; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kampmann M, 2004, J BIOL CHEM, V279, P38715, DOI 10.1074/jbc.M404504200; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Krosky DJ, 2005, BIOCHEMISTRY-US, V44, P5949, DOI 10.1021/bi050084u; Kuznetsov NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P118, DOI 10.1134/S0006297911010123; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; NISHIDA K, 1983, COLLOID POLYM SCI, V261, P70, DOI 10.1007/BF01411520; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Parker JB, 2011, BIOCHEMISTRY-US, V50, P612, DOI 10.1021/bi101536k; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; SCHURR JM, 1979, BIOPHYS CHEM, V9, P413, DOI 10.1016/0301-4622(75)80057-3; Sidorenko VS, 2008, BIOCHEMISTRY-US, V47, P8970, DOI 10.1021/bi800569e; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Wang YM, 2011, BIOL MED PHYS BIOMED, P9, DOI 10.1007/978-0-387-92808-1_2; Xiao GY, 1999, PROTEINS, V35, P13; Young MA, 1997, BIOPHYS J, V73, P2313, DOI 10.1016/S0006-3495(97)78263-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	62	63	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					205	210		10.1038/nchembio.764	http://dx.doi.org/10.1038/nchembio.764			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22231272	Green Accepted, Green Submitted			2022-12-27	WOS:000299323200013
J	Jiang, JY; Lazarus, MB; Pasquina, L; Sliz, P; Walker, S				Jiang, Jiaoyang; Lazarus, Michael B.; Pasquina, Lincoln; Sliz, Piotr; Walker, Suzanne			A neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferase	NATURE CHEMICAL BIOLOGY			English	Article							BETA-N-ACETYLGLUCOSAMINE; COVALENT INHIBITORS; ACCURATE DOCKING; GLYCOSYLTRANSFERASE; GLIDE; IDENTIFICATION; GLCNACYLATION; TALK	Glycosyltransferases (Gtfs) catalyze the formation of a diverse array of glycoconjugates. Small-molecule inhibitors to manipulate Gtf activity in cells have long been sought as tools for understanding Gtf function. Success has been limited because of challenges in designing inhibitors that mimic the negatively charged diphosphate substrates. Here we report the mechanism of action of a small molecule that inhibits O-linked N-acetylglucosamine transferase (OGT), an essential human enzyme that modulates cell signaling pathways by catalyzing a unique intracellular post-translational modification, beta-O-GlcNAcylation. The molecule contains a five-heteroatom dicarbamate core that functions as a neutral diphosphate mimic. One dicarbamate carbonyl reacts with an essential active site lysine that anchors the diphosphate of the nucleotide-sugar substrate. A nearby cysteine then reacts with the lysine adduct to form a carbonyl crosslink in the OGT active site. Though this unprecedented double-displacement mechanism reflects the unique architecture of the OGT active site, related dicarbamate scaffolds may inhibit other enzymes that bind nucleotide-containing substrates.	[Jiang, Jiaoyang; Lazarus, Michael B.; Pasquina, Lincoln; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Lazarus, Michael B.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Sliz, Piotr] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Sliz, Piotr] Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Jiang, JY (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA.	suzanne_walker@hms.harvard.edu		Lazarus, Michael/0000-0002-6738-2563; Sliz, Piotr/0000-0002-6522-0835	Taplin Funds for Discovery Program; NIH [GM076710]; Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263, R01GM076710] Funding Source: NIH RePORTER	Taplin Funds for Discovery Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Brugge (Harvard Medical School) for the MCF-10A ErbB2 cells, L. Tabak (US National Institutes of Health, NIH) for ppGalNAcT2 protein, T. Lupoli (Harvard University) for MurG protein, C. Walsh, N. Gray (Harvard Medical School), E. Jacobson and D. Ford (Harvard University) for helpful discussions and A. Saghatelian (Harvard University) for critical reading of the manuscript. LC/MS data was acquired on an Agilent 6520 Q-TOF spectrophotometer supported by the Taplin Funds for Discovery Program (S. Walker). This work was supported in part by the NIH (GM076710) and the Harvard Biomedical Accelerator Fund.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Bricogne G., 2010, BUSTER VERSION 2 9; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; DELANO WL, 2002, PYMOL GMOLECULAR GRA; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2010, CHEM BIOL, V17, P1250, DOI 10.1016/j.chembiol.2010.09.014; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frantom PA, 2010, J AM CHEM SOC, V132, P6626, DOI 10.1021/ja101231a; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gloster TM, 2010, ORG BIOMOL CHEM, V8, P305, DOI 10.1039/b915870g; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hajduch J, 2008, CARBOHYD RES, V343, P189, DOI 10.1016/j.carres.2007.10.027; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hang HC, 2004, CHEM BIOL, V11, P337, DOI 10.1016/j.chembiol.2004.02.023; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Helm JS, 2003, J AM CHEM SOC, V125, P11168, DOI 10.1021/ja036494s; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Hu Y, 2004, CHEM BIOL, V11, P703, DOI 10.1016/j.chembiol.2004.02.024; Izumi M, 2009, CURR TOP MED CHEM, V9, P87, DOI 10.2174/156802609787354351; Kiessling LL, 2010, ANNU REV BIOCHEM, V79, P619, DOI 10.1146/annurev.biochem.77.070606.100917; Kim EJ, 2006, J AM CHEM SOC, V128, P4234, DOI 10.1021/ja0582915; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Skropeta D, 2004, GLYCOCONJUGATE J, V21, P205, DOI 10.1023/B:GLYC.0000045093.96413.62; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Trunkfield AE, 2010, BIOORGAN MED CHEM, V18, P2651, DOI 10.1016/j.bmc.2010.02.026; Varki A., 2009, ESSENTIALS GLYCOBIOL; VIJAYALAKSHMI J, 1991, BIOCHEMISTRY-US, V30, P2175, DOI 10.1021/bi00222a022; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Wagner GK, 2010, CHEMBIOCHEM, V11, P1939, DOI 10.1002/cbic.201000201; Wang R, 1997, BIOORGAN MED CHEM, V5, P661, DOI 10.1016/S0968-0896(97)00005-9; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	48	77	82	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					72	77		10.1038/nchembio.711	http://dx.doi.org/10.1038/nchembio.711			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22082911	Green Accepted			2022-12-27	WOS:000298414100014
J	Nieto-Posadas, A; Picazo-Juarez, G; Llorente, I; Jara-Oseguera, A; Morales-Lazaro, S; Escalante-Alcalde, D; Islas, LD; Rosenbaum, T				Nieto-Posadas, Andres; Picazo-Juarez, Giovanni; Llorente, Itzel; Jara-Oseguera, Andres; Morales-Lazaro, Sara; Escalante-Alcalde, Diana; Islas, Leon D.; Rosenbaum, Tamara			Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site	NATURE CHEMICAL BIOLOGY			English	Article							BONE CANCER PAIN; NEUROPATHIC PAIN; CAPSAICIN RECEPTOR; FARNESYL PYROPHOSPHATE; PROTEIN-KINASE; LPA RECEPTORS; CHANNELS; AUTOTAXIN; LYSOPHOSPHOLIPIDS; IDENTIFICATION	Since 1992, there has been growing evidence that the bioactive phospholipid lysophosphatidic acid (LPA), whose amounts are increased upon tissue injury, activates primary nociceptors resulting in neuropathic pain. The TRPV1 ion channel is expressed in primary afferent nociceptors and is activated by physical and chemical stimuli. Here we show that in control mice LPA produces acute pain-like behaviors, which are substantially reduced in Trpv1-null animals. Our data also demonstrate that LPA activates TRPV1 through a unique mechanism that is independent of G protein-coupled receptors, contrary to what has been widely shown for other ion channels, by directly interacting with the C terminus of the channel. We conclude that TRPV1 is a direct molecular target of the pain-producing molecule LPA and that this constitutes, to our knowledge, the first example of LPA binding directly to an ion channel to acutely regulate its function.	[Nieto-Posadas, Andres; Picazo-Juarez, Giovanni; Llorente, Itzel; Morales-Lazaro, Sara; Escalante-Alcalde, Diana; Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Jara-Oseguera, Andres; Islas, Leon D.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Nieto-Posadas, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico.	descalante@ifc.unam.mx; islas@liceaga.facmed.unam.mx; trosenba@ifc.unam.mx	Islas, Leon D/AAW-9845-2020	Islas, Leon D/0000-0002-7461-5214; Nieto-Posadas, Andres/0000-0002-3339-8604; Rosenbaum, Tamara/0000-0002-4791-3195; Jara Oseguera, Andres/0000-0001-5921-9320; Escalante-Alcalde, Diana/0000-0003-0325-6602	Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (DGAPA-PAPIIT) [IN209209]; Instituto de Ciencia y Tecnolog a del Distrito Federal (ICYT-DF) [PIFUTP09-262]; PAPIIT [IN216009, IN294111-3]; CONACyT [53777, CB-129474]; Fundacion Miguel Aleman	Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (DGAPA-PAPIIT); Instituto de Ciencia y Tecnolog a del Distrito Federal (ICYT-DF); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Miguel Aleman	We thank D. Julius at University of California, San Francisco for providing the TRPV1 and TRPV2 cDNA, A. Patapoutian at the Scripps Research Institute for the TRPA1 cDNA, A. Toker at Harvard Medical School for PKC epsilon dominant-negative and wild-type plasmids, J. A. Garcia-Sainz for his kind gift of BIM I and M. Calcagno for helpful discussion. We also thank L. Ongay, A. Escalante and F. Perez at Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico (UNAM) for expert technical support and F. Sierra for expert help with DRG neuron culture. We are grateful to C. C. Duran and V. G. Soto for very valuable help with paw-withdrawal experiments. This work was supported by Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (DGAPA-PAPIIT) grant IN209209 and Instituto de Ciencia y Tecnolog a del Distrito Federal (ICYT-DF) grant PIFUTP09-262 to L. D. I., PAPIIT grants IN216009 and CONACyT 53777 to D.E.-A., and PAPIIT grants IN294111-3 and CONACyT CB-129474 and a grant from Fundacion Miguel Aleman to T. R. This study was performed in partial fulfillment of the requirements for A.N.-P.'s doctoral degree in biomedical sciences at the UNAM.	Alderton F, 2001, BRIT J PHARMACOL, V134, P6, DOI 10.1038/sj.bjp.0704278; Bang S, 2010, J BIOL CHEM, V285, P19362, DOI 10.1074/jbc.M109.087742; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caccin P, 2006, FEBS LETT, V580, P6317, DOI 10.1016/j.febslet.2006.10.039; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cenni V, 2002, BIOCHEM J, V363, P537, DOI 10.1042/0264-6021:3630537; Chaytor AT, 2003, P NATL ACAD SCI USA, V100, P15212, DOI 10.1073/pnas.2435030100; Chemin J, 2005, J BIOL CHEM, V280, P4415, DOI 10.1074/jbc.M408246200; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Cohen A, 2009, MOL CELL NEUROSCI, V40, P382, DOI 10.1016/j.mcn.2008.12.004; Escalante-Alcalde D, 2007, GENESIS, V45, P465, DOI 10.1002/dvg.20314; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Hama K, 2002, FEBS LETT, V523, P187, DOI 10.1016/S0014-5793(02)02976-9; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Inoue M, 2008, NEUROSCIENCE, V152, P296, DOI 10.1016/j.neuroscience.2007.12.041; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jara-Oseguera Andres, 2008, Curr Mol Pharmacol, V1, P255; Jiang GW, 2007, CHEMMEDCHEM, V2, P679, DOI 10.1002/cmdc.200600280; Karliner JS, 2002, BBA-MOL CELL BIOL L, V1582, P216, DOI 10.1016/S1388-1981(02)00174-9; KELLY JJ, 1983, NEUROLOGY, V33, P202, DOI 10.1212/WNL.33.2.202; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Ma L, 2010, J NEUROCHEM, V115, P643, DOI 10.1111/j.1471-4159.2010.06955.x; Marincsak R, 2009, ORAL DIS, V15, P328, DOI 10.1111/j.1601-0825.2009.01526.x; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Mintzer E, 2006, BBA-BIOMEMBRANES, V1758, P85, DOI 10.1016/j.bbamem.2005.12.009; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Pan HL, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-85; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Renback K, 2000, MOL BRAIN RES, V75, P350, DOI 10.1016/S0169-328X(99)00333-2; Roedding AS, 2006, LIFE SCI, V80, P89, DOI 10.1016/j.lfs.2006.08.021; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Sams HH, 2001, J AM ACAD DERMATOL, V44, P561, DOI 10.1067/mjd.2001.112385; Schwei MJ, 1999, J NEUROSCI, V19, P10886, DOI 10.1523/JNEUROSCI.19-24-10886.1999; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Tang L, 2007, J PHARMACOL EXP THER, V321, P791, DOI 10.1124/jpet.106.117572; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ueda H, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-11; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302	50	140	142	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					78	85		10.1038/nchembio.712	http://dx.doi.org/10.1038/nchembio.712			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22101604				2022-12-27	WOS:000298414100015
J	Zaccai, NR; Chi, B; Thomson, AR; Boyle, AL; Bartlett, GJ; Bruning, M; Linden, N; Sessions, RB; Booth, PJ; Brady, RL; Woolfson, DN				Zaccai, Nathan R.; Chi, Bertie; Thomson, Andrew R.; Boyle, Aimee L.; Bartlett, Gail J.; Bruning, Marc; Linden, Noah; Sessions, Richard B.; Booth, Paula J.; Brady, R. Leo; Woolfson, Derek N.			A de novo peptide hexamer with a mutable channel	NATURE CHEMICAL BIOLOGY			English	Article							COILED-COIL; CRYSTAL-STRUCTURE; PROTEIN FOLD; DESIGN; SPECIFICITY; REVEALS; PROGRAM; PACKING; MODEL	The design of new proteins that expand the repertoire of natural protein structures represents a formidable challenge. Success in this area would increase understanding of protein structure and present new scaffolds that could be exploited in biotechnology and synthetic biology. Here we describe the design, characterization and X-ray crystal structure of a new coiled-coil protein. The de novo sequence forms a stand-alone, parallel, six-helix bundle with a channel running through it. Although lined exclusively by hydrophobic leucine and isoleucine side chains, the 6-angstrom channel is permeable to water. One layer of leucine residues within the channel is mutable, accepting polar aspartic acid and histidine side chains, which leads to subdivision and organization of solvent within the lumen. Moreover, these mutants can be combined to form a stable and unique (Asp-His)(3) heterohexamer. These new structures provide a basis for engineering de novo proteins with new functions.	[Zaccai, Nathan R.; Chi, Bertie; Sessions, Richard B.; Booth, Paula J.; Brady, R. Leo; Woolfson, Derek N.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Chi, Bertie; Thomson, Andrew R.; Boyle, Aimee L.; Bartlett, Gail J.; Bruning, Marc; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol, Avon, England; [Linden, Noah] Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England	University of Bristol; University of Bristol; University of Bristol	Woolfson, DN (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	R.L.Brady@bris.ac.uk; D.N.Woolfson@bristol.ac.uk	Woolfson, Dek Neil/ABC-4338-2021; Bartlett, Gail/F-3064-2015	Thomson, Andrew/0000-0002-1066-1369; Woolfson, Derek/0000-0002-0394-3202; Booth, Paula Jane/0000-0003-3893-360X; Boyle, Aimee/0000-0003-4176-6080; Sessions, Richard/0000-0003-0320-0895; Zaccai, Nathan/0000-0002-1476-2044	Biotechnology and Biological Sciences Research Council of the UK [BB/G008833/1, BB/F007256/1]; Biotechnology and Biological Sciences Research Council [BB/F01872X/1, BB/F007256/1, BB/G008833/1] Funding Source: researchfish; BBSRC [BB/G008833/1, BB/F007256/1, BB/F01872X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank members of the Woolfson group, in particular C. Armstrong and J. Fletcher, for discussions, and H. Bayley, A. Lupas and J. Spencer for comments on the manuscript. We are grateful to the Biotechnology and Biological Sciences Research Council of the UK for grants to D. N. W. and P. J. B. (BB/G008833/1) and to R. L. B. and D. N. W. (BB/F007256/1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armstrong CT, 2011, BIOINFORMATICS, V27, P1908, DOI 10.1093/bioinformatics/btr299; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bromley EHC, 2009, J AM CHEM SOC, V131, P928, DOI 10.1021/ja804231a; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Donald JE, 2011, P NATL ACAD SCI USA, V108, P3958, DOI 10.1073/pnas.1019668108; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghirlanda G, 2002, J MOL BIOL, V319, P243, DOI 10.1016/S0022-2836(02)00233-4; Grainger B, 2010, J COMPUT BIOL, V17, P1371, DOI 10.1089/cmb.2009.0265; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Jeoung JH, 2007, J MOL BIOL, V368, P1122, DOI 10.1016/j.jmb.2007.02.079; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Levitt M, 2007, P NATL ACAD SCI USA, V104, P3183, DOI 10.1073/pnas.0611678104; Liu J, 2004, P NATL ACAD SCI USA, V101, P16156, DOI 10.1073/pnas.0405319101; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; MacDonald JT, 2010, PROTEINS, V78, P1311, DOI 10.1002/prot.22651; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAUTIYAL S, 1995, BIOCHEMISTRY-US, V34, P11645, DOI 10.1021/bi00037a001; North B, 2001, J MOL BIOL, V311, P1081, DOI 10.1006/jmbi.2001.4900; Opella SJ, 1999, NAT STRUCT BIOL, V6, P374, DOI 10.1038/7610; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Reinke AW, 2010, J AM CHEM SOC, V132, P6025, DOI 10.1021/ja907617a; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Taylor WR, 2009, STRUCTURE, V17, P1244, DOI 10.1016/j.str.2009.07.012; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901; Walshaw J, 2003, J STRUCT BIOL, V144, P349, DOI 10.1016/j.jsb.2003.10.014; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2	49	146	159	2	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					935	941		10.1038/NCHEMBIO.692	http://dx.doi.org/10.1038/NCHEMBIO.692			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22037471	Green Accepted			2022-12-27	WOS:000297166200017
J	Kosman, DJ				Kosman, Daniel J.			TRANSPORT Plutonium's Trojan horse	NATURE CHEMICAL BIOLOGY			English	News Item							HUMAN TRANSFERRIN RECEPTOR		SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA.	camkos@buffalo.edu						CHARLES D, 2011, PLUTONIUM FUEL RODS; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Gorden AEV, 2003, CHEM REV, V103, P4207, DOI 10.1021/cr990114x; Jensen MP, 2011, NAT CHEM BIOL, V7, P560, DOI [10.1038/nchembio.594, 10.1038/NCHEMBIO.594]; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; LEIBMAN A, 1979, BLOOD, V53, P1058; SEABORG GT, 1947, NATURE, V159, P863, DOI 10.1038/159863a0	7	2	2	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					498	499		10.1038/nchembio.616	http://dx.doi.org/10.1038/nchembio.616			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769093				2022-12-27	WOS:000292825400006
J	Reaper, PM; Griffiths, MR; Long, JM; Charrier, JD; MacCormick, S; Charlton, PA; Golec, JMC; Pollard, JR				Reaper, Philip M.; Griffiths, Matthew R.; Long, Joanna M.; Charrier, Jean-Damien; MacCormick, Somhairle; Charlton, Peter A.; Golec, Julian M. C.; Pollard, John R.			Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR	NATURE CHEMICAL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; LUNG-CANCER; CISPLATIN; ACTIVATION; CARCINOMA; CHROMATIN; REPAIR; MODEL; CHK2	Here we report a comprehensive biological characterization of a potent and selective small-molecule inhibitor of the DNA damage response (DDR) kinase ATR. We show a profound synthetic lethal interaction between ATR and the ATM-p53 tumor suppressor pathway in cells treated with DNA-damaging agents and establish ATR inhibition as a way to transform the outcome for patients with cancer treated with ionizing radiation or genotoxic drugs.	[Reaper, Philip M.; Griffiths, Matthew R.; Long, Joanna M.; Charrier, Jean-Damien; MacCormick, Somhairle; Charlton, Peter A.; Golec, Julian M. C.; Pollard, John R.] Vertex Pharmaceut Europe, Abingdon, Oxon, England	Vertex Pharmaceuticals	Reaper, PM (corresponding author), Vertex Pharmaceut Europe, Abingdon, Oxon, England.	john_pollard@vrtx.com	MacCormick, Somhairle/C-5665-2015	MacCormick, Somhairle/0000-0002-2537-2471				Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bolt J, 2005, ORAL ONCOL, V41, P1013, DOI 10.1016/j.oraloncology.2005.06.003; Borst P, 2008, CELL CYCLE, V7, P1353, DOI 10.4161/cc.7.10.5930; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wilsker D, 2007, MOL CANCER THER, V6, P1406, DOI 10.1158/1535-7163.MCT-06-0679	25	418	457	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					428	430		10.1038/NCHEMBIO.573	http://dx.doi.org/10.1038/NCHEMBIO.573			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21490603				2022-12-27	WOS:000292252100008
J	Cahalan, SM; Gonzalez-Cabrera, PJ; Sarkisyan, G; Nguyen, N; Schaeffer, MT; Huang, LM; Yeager, A; Clemons, B; Scott, F; Rosen, H				Cahalan, Stuart M.; Gonzalez-Cabrera, Pedro J.; Sarkisyan, Gor; Nhan Nguyen; Schaeffer, Marie-Therese; Huang, Liming; Yeager, Adam; Clemons, Bryan; Scott, Fiona; Rosen, Hugh			Actions of a picomolar short-acting S1P(1) agonist in S1P(1)-eGFP knock-in mice	NATURE CHEMICAL BIOLOGY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; PROTEIN-COUPLED RECEPTOR; ORAL FINGOLIMOD FTY720; LYMPHOCYTE EGRESS; T-CELLS; CONTROLLED-TRIAL; PHASE-II; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; EDG-1	Sphingosine 1-phosphate receptor 1 (S1P(1)) is critical for lymphocyte recirculation and is a clinical target for treatment of multiple sclerosis. By generating a short-duration S1P(1) agonist and mice in which fluorescently tagged S1P(1) replaces wild-type receptor, we elucidate physiological and agonist-perturbed changes in expression of S1P(1) at a subcellular level in vivo. We demonstrate differential downregulation of S1P(1) on lymphocytes and endothelia after agonist treatment.	[Cahalan, Stuart M.; Gonzalez-Cabrera, Pedro J.; Nhan Nguyen; Schaeffer, Marie-Therese; Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Cahalan, Stuart M.; Sarkisyan, Gor; Rosen, Hugh] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Huang, Liming; Yeager, Adam; Clemons, Bryan; Scott, Fiona] Receptos Pharmaceut Inc, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute	Rosen, H (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	hrosen@scripps.edu			US National Institutes of Health Immunology [T32 AI007606]; US National Institutes of Health [NIH U01 AI074564, R01 AI055509, U54 MH084512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509, U01AI074564, T32AI007606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404, U54MH084512] Funding Source: NIH RePORTER	US National Institutes of Health Immunology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge R. Proia and M. Capecchi for providing plasmids used in the generation of the Edg1<SUP>eGFP</SUP> targeting construct. We thank G. Martin and S. Kupriyanov for aid in generating Edg1<SUP>eGFP/eGFP</SUP> mice. We thank B. Webb for aid with mass spectrometry. S. M. C. is supported by a US National Institutes of Health Immunology Training Grant T32 AI007606. H. R. is supported by US National Institutes of Health Grants NIH U01 AI074564, R01 AI055509 and U54 MH084512.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Allende ML, 2002, BBA-MOL CELL BIOL L, V1582, P222, DOI 10.1016/S1388-1981(02)00175-0; Comi G, 2010, MULT SCLER, V16, P197, DOI 10.1177/1352458509357065; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marsolais D, 2008, MOL PHARMACOL, V74, P896, DOI 10.1124/mol.108.048769; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Okamoto H, 1998, J BIOL CHEM, V273, P27104, DOI 10.1074/jbc.273.42.27104; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Salvadori M, 2006, AM J TRANSPLANT, V6, P2912, DOI 10.1111/j.1600-6143.2006.01552.x; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Wang WG, 2007, J IMMUNOL, V178, P4885, DOI 10.4049/jimmunol.178.8.4885; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269	25	57	59	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					254	256		10.1038/nchembio.547	http://dx.doi.org/10.1038/nchembio.547			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21445057	Green Accepted			2022-12-27	WOS:000289617800006
J	Gupta, RD; Goldsmith, M; Ashani, Y; Simo, Y; Mullokandov, G; Bar, H; Ben-David, M; Leader, H; Margalit, R; Silman, I; Sussman, JL; Tawfik, DS				Gupta, Rinkoo D.; Goldsmith, Moshe; Ashani, Yacov; Simo, Yair; Mullokandov, Gavriel; Bar, Hagit; Ben-David, Moshe; Leader, Haim; Margalit, Raanan; Silman, Israel; Sussman, Joel L.; Tawfik, Dan S.			Directed evolution of hydrolases for prevention of G-type nerve agent intoxication	NATURE CHEMICAL BIOLOGY			English	Article							STEREOSELECTIVE HYDROLYSIS; ENZYME LIBRARIES; ORGANOPHOSPHATES; TOXICITY; PROPHYLAXIS; PROTECTION; VARIANTS; ANALOGS; PON1	Organophosphate nerve agents are extremely lethal compounds. Rapid in vivo organophosphate clearance requires bioscavenging enzymes with catalytic efficiencies of >10(7) (M-1 min(-1)). Although serum paraoxonase (PON1) is a leading candidate for such a treatment, it hydrolyzes the toxic S-p isomers of G-agents with very slow rates. We improved PON1's catalytic efficiency by combining random and targeted mutagenesis with high-throughput screening using fluorogenic analogs in emulsion compartments. We thereby enhanced PON1's activity toward the coumarin analog of S-p-cyclosarin by similar to 10(5)-fold. We also developed a direct screen for protection of acetylcholinesterase from inactivation by nerve agents and used it to isolate variants that degrade the toxic isomer of the coumarin analog and cyclosarin itself with k(cat)/K-M similar to 10(7) M-1 min(-1). We then demonstrated the in vivo prophylactic activity of an evolved variant. These evolved variants and the newly developed screens provide the basis for engineering PON1 for prophylaxis against other G-type agents.	[Gupta, Rinkoo D.; Goldsmith, Moshe; Simo, Yair; Mullokandov, Gavriel; Bar, Hagit; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Ashani, Yacov; Ben-David, Moshe; Sussman, Joel L.] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Ashani, Yacov; Silman, Israel] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Leader, Haim] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; [Margalit, Raanan] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Gupta, RD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	Gupta, Rinkoo Devi/AAI-9528-2021	Gupta, Rinkoo Devi/0000-0003-1156-9596; Sussman, Joel/0000-0003-0306-3878	US National Institutes of Health [W81XWH-07-2-0020]; Defense Threat Reduction Agency [HDTRA 1-07-C-0024]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS058183] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support by US National Institutes of Health (W81XWH-07-2-0020) and the Defense Threat Reduction Agency (HDTRA 1-07-C-0024) is gratefully acknowledged. We thank D. Tal and the Israel Structural Proteomics Centre for assistance with protein production and T. Magliery, D. Lenz and D. Cerasoli for a fruitful collaboration.	Aharoni A, 2005, CHEM BIOL, V12, P1281, DOI 10.1016/j.chembiol.2005.09.012; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Amitai G, 2006, FEBS J, V273, P1906, DOI 10.1111/j.1742-4658.2006.05198.x; Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; Ashani Y, 2004, TOXICOL SCI, V77, P358, DOI 10.1093/toxsci/kfh012; Ashani Y, 2010, CHEM-BIOL INTERACT, V187, P362, DOI 10.1016/j.cbi.2010.02.039; ASHANI Y, 1991, LIFE SCI, V49, P367, DOI 10.1016/0024-3205(91)90444-G; BROOMFIELD CA, 1993, CHEM-BIOL INTERACT, V87, P279, DOI 10.1016/0009-2797(93)90055-4; Cho CMH, 2006, PROTEIN ENG DES SEL, V19, P99, DOI 10.1093/protein/gzj007; Ditargiani RC, 2010, CHEM-BIOL INTERACT, V187, P349, DOI 10.1016/j.cbi.2010.02.021; Doctor BP, 2005, CHEM-BIOL INTERACT, V157, P167, DOI 10.1016/j.cbi.2005.10.024; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Gaidukov Leonid, 2009, BMC Clin Pharmacol, V9, P18, DOI 10.1186/1472-6904-9-18; Ghanem Eman, 2005, Toxicol Appl Pharmacol, V207, P459, DOI 10.1016/j.taap.2005.02.025; Gupta RD, 2008, NAT METHODS, V5, P939, DOI 10.1038/nmeth.1262; Harvey SP, 2005, ENZYME MICROB TECH, V37, P547, DOI 10.1016/j.enzmictec.2005.04.004; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Kassa J, 2009, TOXICOL MECH METHOD, V19, P547, DOI 10.3109/15376510903350371; Lenz DE, 2007, TOXICOLOGY, V233, P31, DOI 10.1016/j.tox.2006.11.066; LI WF, 1995, TOXICOL LETT, V76, P219, DOI 10.1016/0378-4274(95)80006-Y; Li WS, 2001, BIOORGAN MED CHEM, V9, P2083, DOI 10.1016/S0968-0896(01)00113-4; Luo CY, 2010, CHEM-BIOL INTERACT, V187, P185, DOI 10.1016/j.cbi.2010.01.018; Mastrobattista E, 2005, CHEM BIOL, V12, P1291, DOI 10.1016/j.chembiol.2005.09.016; Melzer M, 2009, J AM CHEM SOC, V131, P17226, DOI 10.1021/ja905444g; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Romano J. A., 2008, CHEM WARFARE AGENTS; Shapiro MG, 2010, NAT BIOTECHNOL, V28, P264, DOI 10.1038/nbt.1609; Tsai PC, 2010, BIOCHEMISTRY-US, V49, P7978, DOI 10.1021/bi101056m	28	156	165	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					120	125		10.1038/NCHEMBIO.510	http://dx.doi.org/10.1038/NCHEMBIO.510			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21217689				2022-12-27	WOS:000286324600013
J	Bayer, TS				Bayer, Travis S.			Transforming biosynthesis into an information science	NATURE CHEMICAL BIOLOGY			English	Article							ACID	Engineering biosynthetic pathways to natural products is a challenging endeavor that promises to provide new therapeutics and tools to manipulate biology. Information-guided design strategies and tools could unlock the creativity of a wide spectrum of scientists and engineers by decoupling expertise from implementation.	Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England	Imperial College London	Bayer, TS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England.	t.bayer@imperial.ac.uk						Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bachmann BO, 2010, NAT CHEM BIOL, V6, P390, DOI 10.1038/nchembio.377; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Cheng Q, 2007, NAT CHEM BIOL, V3, P557, DOI 10.1038/nchembio.2007.22; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jung YK, 2010, BIOTECHNOL BIOENG, V105, P161, DOI 10.1002/bit.22548; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318	13	3	4	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					859	861		10.1038/nchembio.487	http://dx.doi.org/10.1038/nchembio.487			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079588				2022-12-27	WOS:000284214700004
J	Neefjes, J; Ovaa, H				Neefjes, Jacques; Ovaa, Huib			A peptide's perspective on antigen presentation to the immune system	NATURE CHEMICAL BIOLOGY			English	Review							MHC-CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN DISULFIDE-ISOMERASE; TAP-TRANSLOCATED PEPTIDES; T-CELL-RECEPTOR; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; COUPLING REAGENTS; VIRAL PEPTIDES; MOLECULES	Specific immune responses are critically dependent on protein degradation products in the form of peptides. These peptides are presented by major histocompatibility complexes (MHCs), and recognition of MHC-peptide complexes by the immune system determines successful pathogen elimination, transplant rejection, autoimmunity or death. Here we review the immune response from the peptide's perspective and discuss the fate of peptides in cells before presentation by MHC complexes. We then discuss how peptides are altered post-translationally to yield immune responses and how peptides can be engineered to achieve strong immune responses following vaccination. Although peptides are simple from a chemical perspective, they are complex in their immunological consequences.	[Neefjes, Jacques; Ovaa, Huib] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Netherlands Cancer Institute	Neefjes, J (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	j.neefjes@nki.nl; h.ovaa@nki.nl	Neefjes, Jacques J.C./H-8780-2017; ovaa, huib/M-2334-2016	Neefjes, Jacques J.C./0000-0001-6763-2211; ovaa, huib/0000-0002-0068-054X	Netherlands Genomics Initiative; European Research Council; Netherlands Organisation for Scientific Research-Chemische Wetenschappen (NWO-CW) TOP	Netherlands Genomics Initiative; European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research-Chemische Wetenschappen (NWO-CW) TOP	This work was supported by a Horizon grant from the Netherlands Genomics Initiative to H. O., a European Research Council advanced grant to J. N. and a Netherlands Organisation for Scientific Research-Chemische Wetenschappen (NWO-CW) TOP grant jointly to H. O. and J. N. We thank P. Celie and M. Garstka for help with figures.	Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; Andersen MH, 1999, J IMMUNOL, V163, P3812; Andersson IE, 2007, J MED CHEM, V50, P5627, DOI 10.1021/jm0705410; Bontrop RE, 2006, HUM IMMUNOL, V67, P388, DOI 10.1016/j.humimm.2006.03.007; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; DeNardo SJ, 2003, CLIN CANCER RES, V9, p3854S; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; El-Faham A, 2011, CHEM REV, V111, P6557, DOI 10.1021/cr100048w; Engels B, 2013, CANCER CELL, V23, P516, DOI 10.1016/j.ccr.2013.03.018; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Falta MT, 2013, J EXP MED, V210, P1403, DOI 10.1084/jem.20122426; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gromme M, 1997, EUR J IMMUNOL, V27, P898, DOI 10.1002/eji.1830270415; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Haurum JS, 1999, J EXP MED, V190, P145, DOI 10.1084/jem.190.1.145; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Jorritsma A, 2009, IMMUNOTHERAPY-UK, V1, P679, DOI [10.2217/imt.09.20, 10.2217/IMT.09.20]; Kammertoens T, 2013, CANCER CELL, V23, P429, DOI 10.1016/j.ccr.2013.04.004; KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Khan S, 2009, MOL IMMUNOL, V46, P1084, DOI 10.1016/j.molimm.2008.10.006; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Lammert E, 1997, EUR J IMMUNOL, V27, P1685, DOI 10.1002/eji.1830270714; Larche M, 2005, NAT MED, V11, pS69, DOI 10.1038/nm1226; Lo W.L., 2013, CURR TOP MICROBIOL I; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Mallone R, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/513210; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; Mohan JF, 2013, MOL IMMUNOL, V55, P166, DOI 10.1016/j.molimm.2012.10.024; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; Murata S, 2008, CURR OPIN IMMUNOL, V20, P192, DOI 10.1016/j.coi.2008.03.002; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; NEEFJES JJ, 1992, EUR J IMMUNOL, V22, P1609, DOI 10.1002/eji.1830220639; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Nitta T, 2008, ADV IMMUNOL, V99, P59, DOI 10.1016/S0065-2776(08)00603-2; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Paulis LE, 2013, CURR OPIN IMMUNOL, V25, P389, DOI 10.1016/j.coi.2013.03.001; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Reinelt S, 2001, J BIOL CHEM, V276, P24525, DOI 10.1074/jbc.M102772200; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; Roche PA, 2011, J IMMUNOL, V187, P3150; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; ROMAGNOLI P, 1991, EMBO J, V10, P1303, DOI 10.1002/j.1460-2075.1991.tb07648.x; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; STROMINGER JL, 1995, JAMA-J AM MED ASSOC, V274, P1074, DOI 10.1001/jama.274.13.1074; THOMSON G, 1988, AM J HUM GENET, V43, P799; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Wang Y, 2013, IMMUNOL RES, V55, P83, DOI 10.1007/s12026-012-8351-1; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; WUCHERPFENNIG KW, 1995, ANN NY ACAD SCI, V756, P241, DOI 10.1111/j.1749-6632.1995.tb44522.x; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	69	56	59	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					769	775		10.1038/NCHEMBIO.1391	http://dx.doi.org/10.1038/NCHEMBIO.1391			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24231618				2022-12-27	WOS:000327130000007
J	Nedelcu, D; Liu, J; Xu, YQ; Jao, C; Salic, A				Nedelcu, Daniel; Liu, Jing; Xu, Yangqing; Jao, Cindy; Salic, Adrian			Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling	NATURE CHEMICAL BIOLOGY			English	Article							PRIMARY CILIUM; PATHWAY ACTIVITY; LUMINAL LOOP; PROTEIN; CELLS; LOCALIZATION; TRANSDUCTION; CYCLOPAMINE; MODULATION; ACTIVATORS	Oxysterols bind the seven-transmembrane protein Smo (Smo) and potently activate vertebrate Hedgehog (Hh) signaling, a pathway essential in embryonic development, adult stem cell maintenance and cancer. It is unknown, however, whether oxysterols are important for normal vertebrate Hh signaling and whether antagonizing oxysterols can inhibit the Hh pathway. We developed azasterols that block Hh signaling by binding the oxysterol-binding site of Smo. We show that the binding site for oxysterols and azasterols maps to the extracellular, cysteine-rich domain of Smo and is completely separable from the site bound by other small-molecule modulators, located within the heptahelical bundle of Smo. Smo mutants in which oxysterol binding is abolished no longer respond to oxysterols and cannot be maximally activated by the Hh ligand. Our results show that oxysterol binding to vertebrate Smo is required for normal Hh signaling and that targeting the oxysterol-binding site is an effective strategy to inhibit Smo.	[Nedelcu, Daniel; Liu, Jing; Xu, Yangqing; Jao, Cindy; Salic, Adrian] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Salic, A (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02114 USA.	asalic@hms.harvard.edu	Liu, Jing/C-9666-2014; Salic, Adrian/GXG-1611-2022	Liu, Jing/0000-0001-9513-3591; 	US National Institutes of Health [RO1 GM092924]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092924] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Kishi and members of his laboratory for help with chiral chromatography and R. Rohatgi (Stanford University) for the initial gift of 20-OHC beads. A. S. is supported in part by US National Institutes of Health grant RO1 GM092924.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Bazan JF, 2009, CELL, V138, P1055, DOI 10.1016/j.cell.2009.09.006; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Dorn KV, 2012, DEV CELL, V23, P823, DOI 10.1016/j.devcel.2012.07.004; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kim WK, 2007, J BONE MINER RES, V22, P1711, DOI 10.1359/JBMR.070710; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Wang Y, 2012, CHEM BIOL, V19, P972, DOI 10.1016/j.chembiol.2012.06.012; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106	31	153	172	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					557	U54		10.1038/NCHEMBIO.1290	http://dx.doi.org/10.1038/NCHEMBIO.1290			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23831757	Green Submitted, Green Accepted			2022-12-27	WOS:000323417500007
J	Barry, SM; Kers, JA; Johnson, EG; Song, LJ; Aston, PR; Patel, B; Krasnoff, SB; Crane, BR; Gibson, DM; Loria, R; Challis, GL				Barry, Sarah M.; Kers, Johan A.; Johnson, Evan G.; Song, Lijiang; Aston, Philip R.; Patel, Bhumit; Krasnoff, Stuart B.; Crane, Brian R.; Gibson, Donna M.; Loria, Rosemary; Challis, Gregory L.			Cytochrome P450-catalyzed L-tryptophan nitration in thaxtomin phytotoxin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; REGIOSELECTIVE NITRATION; STREPTOMYCES; SYNTHETASE; SUBSTRATE; PROTEINS; BINDING	Thaxtomin phytotoxins produced by plant-pathogenic Streptomyces species contain a nitro group that is essential for phytotoxicity. The N,N'-dimethyldiketopiperazine core of thaxtomins is assembled from L-phenylalanine and L-4-nitrotryptophan by a nonribosomal peptide synthetase, and nitric oxide synthase-generated NO is incorporated into the nitro group, but the biosynthesis of the nonproteinogenic amino acid L-4-nitrotryptophan is unclear. Here we report that TxtE, a unique cytochrome P450, catalyzes L-tryptophan nitration using NO and O-2.	[Barry, Sarah M.; Song, Lijiang; Aston, Philip R.; Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Kers, Johan A.; Johnson, Evan G.; Loria, Rosemary] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Patel, Bhumit; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Krasnoff, Stuart B.; Gibson, Donna M.] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	University of Warwick; Cornell University; Cornell University; United States Department of Agriculture (USDA)	Challis, GL (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	rloria@ufl.edu; g.l.challis@warwick.ac.uk	Johnson, Evan G/B-9864-2008	Johnson, Evan G/0000-0001-7672-2120; Barry, Sarah/0000-0001-8188-2153; Challis, Gregory/0000-0001-5976-3545	UK Biotechnology and Biological Sciences Research Council [BB/H006281/1]; National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [2008-35319-19202]; Advantage West Midlands; European Regional Development Fund; BBSRC [BB/H006265/1, BB/H006281/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H006265/1, BB/H006281/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Advantage West Midlands(General Electric); European Regional Development Fund(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank P. Patel for assistance with fitting the L-tryptophan binding data to the one-site binding model. We also thank The UK Biotechnology and Biological Sciences Research Council (grant ref. BB/H006281/1 to G.L.C.) and the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (grant no. 2008-35319-19202 to R.L.) for funding this research. The Bruker maXis mass spectrometer used in this research was obtained through Birmingham Science City: Innovative Uses for Advanced Materials in the Modern World with support from Advantage West Midlands and was partially funded by the European Regional Development Fund.	BOURN WR, 1995, NUCLEIC ACIDS RES, V23, P3696, DOI 10.1093/nar/23.18.3696; Buddha MR, 2004, J BIOL CHEM, V279, P49567, DOI 10.1074/jbc.C400418200; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Franke A, 2004, J AM CHEM SOC, V126, P4181, DOI 10.1021/ja038774d; Ishii Y, 2007, J PHARMACEUT BIOMED, V44, P150, DOI 10.1016/j.jpba.2007.01.012; Johnson EG, 2009, MOL MICROBIOL, V73, P409, DOI 10.1111/j.1365-2958.2009.06780.x; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; NAKAHARA K, 1993, J BIOL CHEM, V268, P8350; OMURA T, 1964, J BIOL CHEM, V239, P2379; Osborne AS, 2008, BIOORG MED CHEM LETT, V18, P5750, DOI 10.1016/j.bmcl.2008.09.086; Ottoni O, 1999, TETRAHEDRON LETT, V40, P1117, DOI 10.1016/S0040-4039(98)02636-7; Quaroni LG, 2004, BIOCHEMISTRY-US, V43, P16416, DOI 10.1021/bi049163g; Roncone R, 2006, COORDIN CHEM REV, V250, P1286, DOI 10.1016/j.ccr.2005.11.015; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Wach MJ, 2005, NITRIC OXIDE-BIOL CH, V12, P46, DOI 10.1016/j.niox.2004.11.004; Winkler R, 2007, CHEMBIOCHEM, V8, P973, DOI 10.1002/cbic.200700042	19	136	142	10	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					814	816		10.1038/nchembio.1048	http://dx.doi.org/10.1038/nchembio.1048			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22941045	Green Accepted			2022-12-27	WOS:000309056200005
J	Van Melderen, L				Van Melderen, Laurence			GhoSTly bacterial persisters	NATURE CHEMICAL BIOLOGY			English	News Item							TOXIN-ANTITOXIN SYSTEMS		Univ Libre Brussels, Bacterial Genet & Physiol Lab, Brussels, Belgium	Universite Libre de Bruxelles	Van Melderen, L (corresponding author), Univ Libre Brussels, Bacterial Genet & Physiol Lab, Brussels, Belgium.	lvmelder@ulb.ac.be		Van Melderen, Laurence/0000-0002-7778-1736				Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Guglielmini Julien, 2011, Mob Genet Elements, V1, P283; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11	10	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					812	813		10.1038/nchembio.1066	http://dx.doi.org/10.1038/nchembio.1066			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22987009				2022-12-27	WOS:000309056200004
J	Chaturvedi, KS; Hung, CS; Crowley, JR; Stapleton, AE; Henderson, JP				Chaturvedi, Kaveri S.; Hung, Chia S.; Crowley, Jan R.; Stapleton, Ann E.; Henderson, Jeffrey P.			The siderophore yersiniabactin binds copper to protect pathogens during infection	NATURE CHEMICAL BIOLOGY			English	Article							URINARY-TRACT-INFECTION; ESCHERICHIA-COLI; IRON ACQUISITION; PSEUDOMONAS-AERUGINOSA; ESCHETICHIA-COLI; METHANOBACTIN; VIRULENCE; MECHANISMS; TOXICITY; RESISTANCE	Bacterial pathogens secrete chemically diverse iron chelators called siderophores, which may exert additional distinctive functions in vivo. Among these, uropathogenic Escherichia coli often coexpress the virulence-associated siderophore yersiniabactin (Ybt) with catecholate siderophores. Here we used a new MS screening approach to reveal that Ybt is also a physiologically favorable Cu(II) ligand. Direct MS detection of the resulting Cu(II)-Ybt complex in mice and humans with E. coli urinary tract infections demonstrates copper binding to be a physiologically relevant in vivo interaction during infection. Ybt expression corresponded to higher copper resistance among human urinary tract isolates, suggesting a protective role for this interaction. Chemical and genetic characterization showed that Ybt helps bacteria resist copper toxicity by sequestering host-derived Cu(II) and preventing its catechol-mediated reduction to Cu(I). Together, these studies reveal a new virulence-associated function for Ybt that is distinct from iron binding.	[Chaturvedi, Kaveri S.; Hung, Chia S.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63130 USA; [Chaturvedi, Kaveri S.; Hung, Chia S.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Chaturvedi, Kaveri S.; Hung, Chia S.; Crowley, Jan R.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Stapleton, Ann E.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle	Henderson, JP (corresponding author), Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63130 USA.	jhenderson@dom.wustl.edu	Stapleton, Ann E/N-2428-2015; Henderson, Jeffrey P/D-3337-2015; Hung, Chia-Suei/G-6167-2010	Stapleton, Ann E/0000-0003-0130-8659; Hung, Chia-Suei/0000-0001-9844-9954	Burroughs-Wellcome Fund; US National Institutes of Health [K12 HD001459-09, AI 07172-24, P30 HL101263-01, P50 DK64540, U01 DK082315, UL1 RR024992];  [P41-RR00954];  [8-P41 GM103422-35];  [P60-DK20579];  [P30-DK56341]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088830, U01DK082315, P60DK020579, R01DK070906, P50DK064540, P30DK056341, P01DK053369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	Burroughs-Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. Gross, H. Rohrs and Y. Zhang for high-resolution MS analysis and J. Pinker for assistance with small-molecule purification. We are grateful to S. Hultgren, G. Marshall and B. Ford for helpful discussions. J. P. H. holds a Career Award for Medical Scientists from the Burroughs-Wellcome Fund. We additionally acknowledge US National Institutes of Health grants K12 HD001459-09, AI 07172-24, P30 HL101263-01, P50 DK64540, U01 DK082315 and UL1 RR024992. MS was supported by P41-RR00954, 8-P41 GM103422-35 (NCRR), P60-DK20579 and P30-DK56341.	ARCENEAUX JEL, 1984, ANTIMICROB AGENTS CH, V25, P650, DOI 10.1128/AAC.25.5.650; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; Balasubramanian R, 2008, CURR OPIN CHEM BIOL, V12, P245, DOI 10.1016/j.cbpa.2008.01.043; Behling LA, 2008, J AM CHEM SOC, V130, P12604, DOI 10.1021/ja804747d; BESWICK PH, 1976, CHEM-BIOL INTERACT, V14, P347, DOI 10.1016/0009-2797(76)90113-7; Braud A, 2009, J BACTERIOL, V191, P3517, DOI 10.1128/JB.00010-09; Brickman TJ, 2011, J BACTERIOL, V193, P4798, DOI 10.1128/JB.05136-11; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Caza M, 2011, MOL MICROBIOL, V80, P266, DOI 10.1111/j.1365-2958.2011.07570.x; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Clark H W, 1905, Public Health Pap Rep, V31, P175; CLARKE SE, 1987, APPL ENVIRON MICROB, V53, P917, DOI 10.1128/AEM.53.5.917-922.1987; Crouch MLV, 2008, MOL MICROBIOL, V67, P971, DOI 10.1111/j.1365-2958.2007.06089.x; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Grass G, 2004, J BACTERIOL, V186, P5826, DOI 10.1128/JB.186.17.5826-5833.2004; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hellman NE, 2002, J BIOL CHEM, V277, P46632, DOI 10.1074/jbc.M206246200; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Kenney GE, 2012, ACS CHEM BIOL, V7, pA, DOI 10.1021/cb2003913; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Kim HJ, 2005, BIOCHEMISTRY-US, V44, P5140, DOI 10.1021/bi047367r; Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x; Leary SC, 2007, EMBO REP, V8, P224, DOI 10.1038/sj.embor.7400915; Lide D.R., 1991, CRC HDB CHEM PHYS, P44; Luo MK, 2005, NAT CHEM BIOL, V1, P149, DOI 10.1038/nchembio717; Mabbett AN, 2009, INT J MED MICROBIOL, V299, P53, DOI 10.1016/j.ijmm.2008.06.003; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; MCKNIGHT DM, 1980, LIMNOL OCEANOGR, V25, P62, DOI 10.4319/lo.1980.25.1.0062; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mokracka J, 2004, FEMS IMMUNOL MED MIC, V40, P51, DOI 10.1016/S0928-8244(03)00276-1; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Nandakumar R, 2011, BIOMETALS, V24, P429, DOI 10.1007/s10534-011-9434-5; Nataro J.P., 2011, MANUAL CLIN MICROBIO; Ogawa S, 2009, ANAL CHEM, V81, P9199, DOI 10.1021/ac901782d; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Prentice AM, 2007, J NUTR, V137, P1334, DOI 10.1093/jn/137.5.1334; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Seifert M, 2008, IMMUNOBIOLOGY, V213, P767, DOI 10.1016/j.imbio.2008.07.010; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Thiele DJ, 2008, NAT CHEM BIOL, V4, P145, DOI 10.1038/nchembio0308-145; VISCA P, 1992, APPL ENVIRON MICROB, V58, P2886, DOI 10.1128/AEM.58.9.2886-2893.1992; Wagner P, 1997, ARTERIOSCL THROM VAS, V17, P3338, DOI 10.1161/01.ATV.17.11.3338; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108	49	191	193	5	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					731	736		10.1038/NCHEMBIO.1020	http://dx.doi.org/10.1038/NCHEMBIO.1020			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22772152	Green Accepted			2022-12-27	WOS:000306527600013
J	Arakawa, K				Arakawa, Kenji			BIOSYNTHESIS Diversity between PKS and FAS	NATURE CHEMICAL BIOLOGY			English	News Item							MODULAR POLYKETIDE SYNTHASES; KETOREDUCTASE DOMAINS; CRYSTAL-STRUCTURE; CATALYSIS; STEREOCHEMISTRY; MUTAGENESIS		Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima, Japan	Hiroshima University	Arakawa, K (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima, Japan.	karakawa@hiroshima-u.ac.jp	Arakawa, Kenji/A-9407-2018	Arakawa, Kenji/0000-0001-5129-0042				Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kwan DH, 2010, ACS CHEM BIOL, V5, P829, DOI 10.1021/cb100175a; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1; Zheng JT, 2012, NAT CHEM BIOL, V8, P615, DOI [10.1038/nchembio.964, 10.1038/NCHEMBIO.964]	9	1	1	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					604	605		10.1038/nchembio.1007	http://dx.doi.org/10.1038/nchembio.1007			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22710306				2022-12-27	WOS:000305471400003
J	Felnagle, LA; Chaubey, A; Noey, EL; Houk, KN; Liao, JC				Felnagle, Lizabeth A.; Chaubey, Asha; Noey, Elizabeth L.; Houk, Kendall N.; Liao, James C.			Engineering synthetic recursive pathways to generate non-natural small molecules	NATURE CHEMICAL BIOLOGY			English	Review							ERYTHROMYCIN POLYKETIDE SYNTHASE; ESCHERICHIA-COLI; NATURAL-PRODUCTS; ISOPROPYLMALATE SYNTHASE; COMPUTATIONAL DESIGN; ENZYME DESIGN; FATTY-ACID; METHYLTHIOALKYLMALATE SYNTHASE; BACTERIAL MICROCOMPARTMENTS; MYCOBACTERIUM-TUBERCULOSIS	Recursive pathways are broadly defined as those that catalyze a series of reactions such that the key, bond-forming functional group of the substrate is always regenerated in each cycle, allowing for a new cycle of reactions to begin. Recursive carbon-chain elongation pathways in nature produce fatty acids, polyketides, isoprenoids and alpha-keto acids (alpha KAs), which all use modular or iterative approaches for chain elongation. Recently, an artificial pathway for alpha KA elongation has been built that uses an engineered isopropylmalate synthase to recursively condense acetyl-CoA with alpha KAs. This synthetic approach expands the possibilities for recursive pathways beyond the modular or iterative synthesis of natural products and serves as a case study for understanding the challenges of building recursive pathways from nonrecursive enzymes. There exists the potential to design synthetic recursive pathways far beyond what nature has evolved.	[Felnagle, Lizabeth A.; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Chaubey, Asha; Noey, Elizabeth L.; Houk, Kendall N.; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Chaubey, Asha] Indian Inst Integrat Med, Jammu, India	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Felnagle, LA (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	liaoj@seas.ucla.edu		Liao, James/0000-0002-4580-7276				Acevedo O, 2010, ACCOUNTS CHEM RES, V43, P142, DOI 10.1021/ar900171c; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Baran PS, 2007, NATURE, V446, P404, DOI 10.1038/nature05569; Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; Benderoth M, 2009, PHYTOCHEM REV, V8, P255, DOI 10.1007/s11101-008-9097-1; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; Chan YA, 2009, METHOD ENZYMOL, V459, P143, DOI 10.1016/S0076-6879(09)04607-2; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; Crawford JM, 2010, NAT REV MICROBIOL, V8, P879, DOI 10.1038/nrmicro2465; Das A, 2010, J AM CHEM SOC, V132, P8831, DOI 10.1021/ja102517q; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; de Kraker JW, 2011, PLANT CELL, V23, P38, DOI 10.1105/tpc.110.079269; Dechancie J, 2007, PROTEIN SCI, V16, P1851, DOI 10.1110/ps.072963707; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Drevland RM, 2008, J BIOL CHEM, V283, P28888, DOI 10.1074/jbc.M802159200; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Felnagle EA, 2008, MOL PHARMACEUT, V5, P191, DOI 10.1021/mp700137g; Field B, 2006, PLANT MOL BIOL, V60, P717, DOI 10.1007/s11103-005-5547-y; Goh EB, 2012, APPL ENVIRON MICROB, V78, P70, DOI 10.1128/AEM.06785-11; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Gridnev AA, 2001, CHEM REV, V101, P3611, DOI 10.1021/cr9901236; Grondal C, 2010, NAT CHEM, V2, P167, DOI [10.1038/NCHEM.539, 10.1038/nchem.539]; Hahn M, 2006, P NATL ACAD SCI USA, V103, P275, DOI 10.1073/pnas.0508409103; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harper MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016517; Himo F, 2005, BBA-BIOENERGETICS, V1707, P24, DOI 10.1016/j.bbabio.2004.04.006; Howell DM, 1998, BIOCHEMISTRY-US, V37, P10108, DOI 10.1021/bi980662p; Hutchinson CR, 2003, P NATL ACAD SCI USA, V100, P3010, DOI 10.1073/pnas.0730689100; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Khosla C, 2001, NATURE, V409, P247, DOI 10.1038/35051723; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Kroumova AB, 2003, PLANTA, V216, P1013, DOI 10.1007/s00425-002-0954-7; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Leonard E, 2007, APPL ENVIRON MICROB, V73, P3877, DOI 10.1128/AEM.00200-07; Liu T, 2011, J AM CHEM SOC, V133, P13314, DOI 10.1021/ja205780g; Lo PK, 2009, J AM CHEM SOC, V131, P4182, DOI 10.1021/ja809613n; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Lopez-Gallego F, 2010, CHEMBIOCHEM, V11, P1093, DOI 10.1002/cbic.200900671; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Ma SM, 2008, J AM CHEM SOC, V130, P38, DOI 10.1021/ja078091o; Marcheschi RJ, 2012, ACS CHEM BIOL, V7, P689, DOI 10.1021/cb200313e; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Moss SJ, 2004, NAT PROD REP, V21, P575, DOI 10.1039/b315020h; Nair N., 2009, METABOLIC PATHWAY EN, P2; Napier JA, 2010, CURR OPIN PLANT BIOL, V13, P330, DOI 10.1016/j.pbi.2010.01.008; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0; Pickens LB, 2011, ANNU REV CHEM BIOMOL, V2, P211, DOI 10.1146/annurev-chembioeng-061010-114209; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Reeves CD, 2001, BIOCHEMISTRY-US, V40, P15464, DOI 10.1021/bi015864r; Reeves CD, 2004, CHEM BIOL, V11, P1465, DOI 10.1016/j.chembiol.2004.08.019; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Santos CNS, 2011, METAB ENG, V13, P392, DOI 10.1016/j.ymben.2011.02.002; Satoh K, 2009, CHEM REV, V109, P5120, DOI 10.1021/cr900115u; Shen CR, 2008, METAB ENG, V10, P312, DOI 10.1016/j.ymben.2008.08.001; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Singh K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-39; Slocombe SP, 2008, PLANT PHYSIOL, V148, P1830, DOI 10.1104/pp.108.129510; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; TAKAMURA Y, 1988, J GEN MICROBIOL, V134, P2249; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Thattai M, 2007, PLOS COMPUT BIOL, V3, P1827, DOI 10.1371/journal.pcbi.0030186; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Tran L, 2008, CHEMBIOCHEM, V9, P905, DOI 10.1002/cbic.200700738; Villiers BRM, 2009, CHEMBIOCHEM, V10, P671, DOI 10.1002/cbic.200800553; Wang K, 1999, TRENDS BIOCHEM SCI, V24, P445, DOI 10.1016/S0968-0004(99)01464-4; Wang M, 2009, BIOCHEMISTRY-US, V48, P6288, DOI 10.1021/bi9009049; Weissman KJ, 2007, TRENDS BIOTECHNOL, V25, P139, DOI 10.1016/j.tibtech.2007.02.004; Werneburg M, 2010, J AM CHEM SOC, V132, P10407, DOI 10.1021/ja102751h; Withers ST, 2007, APPL MICROBIOL BIOT, V73, P980, DOI 10.1007/s00253-006-0593-1; Yang YT, 2001, METAB ENG, V3, P115, DOI 10.1006/mben.2000.0166; Yoshikuni Y, 2006, CHEM BIOL, V13, P91, DOI 10.1016/j.chembiol.2005.10.016; Zha WJ, 2009, METAB ENG, V11, P192, DOI 10.1016/j.ymben.2009.01.005; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106; Zhou YJJ, 2012, J AM CHEM SOC, V134, P3234, DOI 10.1021/ja2114486; Zhu XL, 2009, J COMPUT CHEM, V30, P256, DOI 10.1002/jcc.21050	95	41	47	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					518	526		10.1038/NCHEMBIO.959	http://dx.doi.org/10.1038/NCHEMBIO.959			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22596203				2022-12-27	WOS:000304256300007
J	Rexach, JE; Clark, PM; Mason, DE; Neve, RL; Peters, EC; Hsieh-Wilson, LC				Rexach, Jessica E.; Clark, Peter M.; Mason, Daniel E.; Neve, Rachael L.; Peters, Eric C.; Hsieh-Wilson, Linda C.			Dynamic O-GlcNAc modification regulates CREB-mediated gene expression and memory formation	NATURE CHEMICAL BIOLOGY			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; DEPENDENT TRANSCRIPTION; N-ACETYLGLUCOSAMINE; PHOSPHORYLATION; GLYCOSYLATION; NEURONS; KINASE; CONSOLIDATION	The transcription factor cyclic AMP-response element binding protein (CREB) is a key regulator of many neuronal processes, including brain development, circadian rhythm and long-term memory. Studies of CREB have focused on its phosphorylation, although the diversity of CREB functions in the brain suggests additional forms of regulation. Here we expand on a chemoenzymatic strategy for quantifying glycosylation stoichiometries to characterize the functional roles of CREB glycosylation in neurons. We show that CREB is dynamically modified with an O-linked beta-N-acetyl-D-glucosamine sugar in response to neuronal activity and that glycosylation represses CREB-dependent transcription by impairing its association with CREB-regulated transcription coactivator (CRTC; also known as transducer of regulated CREB activity). Blocking glycosylation of CREB alters cellular function and behavioral plasticity, enhancing both axonal and dendritic growth and long-term memory consolidation. Our findings demonstrate a new role for O-glycosylation in memory formation and provide a mechanistic understanding of how glycosylation contributes to critical neuronal functions. Moreover, we identify a previously unknown mechanism for the regulation of activity-dependent gene expression, neural development and memory.	[Rexach, Jessica E.; Clark, Peter M.; Hsieh-Wilson, Linda C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Rexach, Jessica E.; Clark, Peter M.; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Mason, Daniel E.; Peters, Eric C.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Neve, Rachael L.] MIT, Picower Inst, Cambridge, MA 02139 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Novartis; Massachusetts Institute of Technology (MIT)	Rexach, JE (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	lhw@caltech.edu	Peters, Eric/W-2739-2019		US National Institutes of Health [R01 GM084724, F31 NS056525, 5T32 GM07737]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084724, T32GM007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056525] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Antoniou (King's College London School of Medicine) for the pA2UCOE-EGFP construct, M. Greenberg (Harvard University) for the pLEMPRA-GOI and pLLX-shRNA constructs, G. Hart (The John Hopkins University School of Medicine) for the OGT-specific antibody, S. Josselyn (University of Toronto) for the p1005-CREB construct, R. Lansford (California Institute of Technology) for the pLenti PGK-H2B-mCherry construct, R. Malenka (Stanford University) and X. Yu (Shanghai Institutes for Biological Sciences) for the pcDNA3-Dkk-1-Flag and Ncad(intra) constructs, P. Qasba (US National Cancer Institute) for the Y289L GalT construct and L. Wells (University of Georgia) for the pDEST-HA-OGA construct. We thank S.-H. Yu (California Institute of Technology) for synthesizing the UDP-ketogalactose substrate and D. Anderson (California Institute of Technology) for providing the fear conditioning apparatus. We thank A. Silva for a critical reading of the manuscript. This work was supported by grants from the US National Institutes of Health (R01 GM084724 to L.C.H.-W, F31 NS056525 to J.E.R. and National Research Service Award Training Grant 5T32 GM07737 to P.M.C.).	Aguado F, 2009, J NEUROSCI, V29, P328, DOI 10.1523/JNEUROSCI.5252-08.2009; Barco A, 2008, TRANSCRIPTIONAL REGULATION BY NEURONAL ACTIVITY, P127, DOI 10.1007/978-0-387-73609-9_7; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lu Q, 2003, J BIOL CHEM, V278, P15727, DOI 10.1074/jbc.M300546200; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xiong W, 2006, BRAIN RES, V1085, P68, DOI 10.1016/j.brainres.2006.02.015; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	136	141	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					253	261		10.1038/NCHEMBIO.770	http://dx.doi.org/10.1038/NCHEMBIO.770			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22267118	Green Accepted			2022-12-27	WOS:000300600000010
J	Bretschneider, T; Zocher, G; Unger, M; Scherlach, K; Stehle, T; Hertweck, C				Bretschneider, Tom; Zocher, Georg; Unger, Michelle; Scherlach, Kirstin; Stehle, Thilo; Hertweck, Christian			A ketosynthase homolog uses malonyl units to form esters in cervimycin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN SYNTHASE-III; GENE-CLUSTER; BETA-KETOACYL; CRYSTAL-STRUCTURE; POLYKETIDE SYNTHASES; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; MOLECULAR ANALYSIS; ACYL-TRANSFER; STARTER UNIT	Ketosynthases produce the carbon backbones of a vast number of biologically active polyketides by catalyzing Claisen condensations of activated acyl and malonyl building blocks. Here we report that a ketosynthase homolog from Streptomyces tendae, CerJ, unexpectedly forms malonyl esters during the biosynthesis of cervimycin, a glycoside antibiotic against methicillinresistant Staphylococcus aureus (MRSA). Deletion of cerJ yielded a substantially more active cervimycin variant lacking the malonyl side chain, and in vitro biotransformations revealed that CerJ is capable of transferring malonyl, methylmalonyl and dimethylmalonyl units onto the glycoside. According to phylogenetic analyses and elucidation of the crystal structure, CerJ is functionally and structurally positioned between the ketosynthase catalyzing Claisen condensations and acyl-ACP shuttles, and it features a noncanonical catalytic triad. Site-directed mutagenesis and structures of CerJ in complex with substrates not only allowed us to establish a model for the reaction mechanism but also provided insights into the evolution of this important subclass of the thiolase superfamily.	[Zocher, Georg; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Bretschneider, Tom; Unger, Michelle; Scherlach, Kirstin; Hertweck, Christian] Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Hertweck, Christian] Univ Jena, Chair Nat Prod Chem, Jena, Germany	Eberhard Karls University of Tubingen; Hans Knoll Institute (HKI); Vanderbilt University; Friedrich Schiller University of Jena	Zocher, G (corresponding author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.	georg.zocher@uni-tuebingen.de; christian.hertweck@hki-jena.de	Hertweck, Christian/AAZ-8452-2021; Hertweck, Christian/G-1896-2014	Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X; Scherlach, Kirstin/0000-0002-1326-3761	German Federal Ministry of Education and Research (GenoMik)	German Federal Ministry of Education and Research (GenoMik)	We thank the German Federal Ministry of Education and Research (GenoMik) for financial support and the Swiss light source beamline X06DA for offering beamtime.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Anderle C, 2007, ARCH MICROBIOL, V187, P227, DOI 10.1007/s00203-006-0190-9; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Balibar CJ, 2007, CHEM BIOL, V14, P679, DOI 10.1016/j.chembiol.2007.05.007; Bao WL, 1999, J BACTERIOL, V181, P4690, DOI 10.1128/JB.181.15.4690-4695.1999; Bao WL, 1999, BIOCHEMISTRY-US, V38, P9752, DOI 10.1021/bi990751h; Bera AK, 2009, BIOCHEMISTRY-US, V48, P8644, DOI 10.1021/bi9009055; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Daum M, 2009, CHEMBIOCHEM, V10, P1073, DOI 10.1002/cbic.200800823; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Durr C, 2006, CHEM BIOL, V13, P365, DOI 10.1016/j.chembiol.2006.01.011; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Freitag A, 2005, CHEMBIOCHEM, V6, P2316, DOI 10.1002/cbic.200500252; Fullone MR, 2007, BIOCHEM BIOPH RES CO, V364, P201, DOI 10.1016/j.bbrc.2007.09.116; Gajiwala KS, 2009, FEBS LETT, V583, P2939, DOI 10.1016/j.febslet.2009.08.001; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; He QL, 2009, CHEMBIOCHEM, V10, P813, DOI 10.1002/cbic.200800714; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Herold K, 2005, CHEM-EUR J, V11, P5523, DOI 10.1002/chem.200500320; Herold K, 2004, ORG BIOMOL CHEM, V2, P2411, DOI 10.1039/b409221j; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; IGUAL JC, 1992, J MOL EVOL, V35, P147; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Khosla C, 2009, J ORG CHEM, V74, P6416, DOI 10.1021/jo9012089; Kwon HJ, 2002, SCIENCE, V297, P1327, DOI 10.1126/science.1073175; MATHIEU M, 1994, STRUCTURE, V2, P797, DOI 10.1016/S0969-2126(94)00081-6; Mollmann U, 2004, German patent, Patent No. [DE 10 2004 010 219 B4 2007.02.01, 102004010219]; Moore BS, 2002, NAT PROD REP, V19, P70, DOI 10.1039/b003939j; NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Pan H, 2002, STRUCTURE, V10, P1559, DOI 10.1016/S0969-2126(02)00889-4; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Qiu XY, 2005, PROTEIN SCI, V14, P2087, DOI 10.1110/ps.051501605; Qiu XY, 2001, J MOL BIOL, V307, P341, DOI 10.1006/jmbi.2000.4457; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Strieter ER, 2007, BIOCHEMISTRY-US, V46, P7549, DOI 10.1021/bi700243h; TSAY JT, 1992, J BIOL CHEM, V267, P6807; Wang ZX, 2000, ANTIMICROB AGENTS CH, V44, P3040, DOI 10.1128/AAC.44.11.3040-3048.2000; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xu Z, 2007, J AM CHEM SOC, V129, P6022, DOI 10.1021/ja069045b; Xu ZL, 2009, J BIOTECHNOL, V140, P107, DOI 10.1016/j.jbiotec.2008.10.013	46	48	49	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					154	161		10.1038/nchembio.746	http://dx.doi.org/10.1038/nchembio.746			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22179067				2022-12-27	WOS:000299323200007
J	Luciani, GM; Magomedova, L; Puckrin, R; Urbanus, ML; Wallace, IM; Giaever, G; Nislow, C; Cummins, CL; Roy, PJ				Luciani, Genna M.; Magomedova, Lilia; Puckrin, Rachel; Urbanus, Malene L.; Wallace, Iain M.; Giaever, Guri; Nislow, Corey; Cummins, Carolyn L.; Roy, Peter J.			Dafadine inhibits DAF-9 to promote dauer formation and longevity of Caenorhabditis elegans	NATURE CHEMICAL BIOLOGY			English	Article							LIFE-SPAN; LARVAL DEVELOPMENT; DEVELOPMENTAL AGE; NUCLEAR RECEPTOR; ENCODES; GENE; METABOLISM; DIAPAUSE	The DAF-9 cytochrome P450 is a key regulator of dauer formation, developmental timing and longevity in the nematode Caenorhabditis elegans. Here we describe the first identified chemical inhibitor of DAF-9 and the first reported small-molecule tool that robustly induces dauer formation in typical culture conditions. This molecule (called dafadine) also inhibits the mammalian ortholog of DAF-9(CYP27A1), suggesting that dafadine can be used to interrogate developmental control and longevity in other animals.	[Luciani, Genna M.; Giaever, Guri; Nislow, Corey; Roy, Peter J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Luciani, Genna M.; Puckrin, Rachel; Urbanus, Malene L.; Wallace, Iain M.; Giaever, Guri; Nislow, Corey; Roy, Peter J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Magomedova, Lilia; Giaever, Guri; Cummins, Carolyn L.] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Urbanus, Malene L.; Wallace, Iain M.; Nislow, Corey] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto	Roy, PJ (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	carolyn.cummins@utoronto.ca; peter.roy@utoronto.ca	Giaever, Guri/D-3930-2009; Roy, Peter/G-5357-2014; Wallace, Iain/B-9464-2009	Cummins, Carolyn/0000-0001-7603-6577; Nislow, Corey/0000-0002-4016-8874; Luciani, Genna/0000-0001-8107-2708; Roy, Peter/0000-0003-2959-2276; Wallace, Iain/0000-0002-9491-7025	Canadian Institutes of Health Research [MOP-68813, MOP-97904, MOP-81340, MOP-84305]; Natural Sciences and Engineering Research Council [356873-08]; Canadian Cancer Society [020380]; Marie Curie fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Marie Curie fellowship(European Commission)	We thank A. Antebi, N. Strushkevich, Y. Kohara, H.-J. Knolker, R. Martin, K. S. Pang, D. Mangelsdorf, R. Auchus, S. Wu, A. Orellana and J. Lund for reagents and advice. This work was supported by Canadian Institutes of Health Research grants to P. J. R. (MOP-68813), C. L. C. (MOP-97904), G. G. (MOP-81340) and C. N. (MOP-84305), a Natural Sciences and Engineering Research Council grant to C. L. C. (356873-08), a grant from the Canadian Cancer Society to G. G. (020380), and a Marie Curie fellowship to I. M. W. G. G. and P. J. R. are Canadian Research Chairs in Chemical Biology and Molecular Neurobiology, respectively.	Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Cho SC, 2010, P NATL ACAD SCI USA, V107, P19326, DOI 10.1073/pnas.1005078107; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jia KL, 2002, DEVELOPMENT, V129, P221; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; VOWELS JJ, 1992, GENETICS, V130, P105	25	19	21	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					891	893		10.1038/NCHEMBIO.698	http://dx.doi.org/10.1038/NCHEMBIO.698			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22057127				2022-12-27	WOS:000297166200011
J	Hakkim, A; Fuchs, TA; Martinez, NE; Hess, S; Prinz, H; Zychlinsky, A; Waldmann, H				Hakkim, Abdul; Fuchs, Tobias A.; Martinez, Nancy E.; Hess, Simone; Prinz, Heino; Zychlinsky, Arturo; Waldmann, Herbert			Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE; INHIBITOR; RESPONSES; SURVIVAL; MCL-1	The signaling mechanisms leading to the formation of neutrophil extracellular traps (NETs), relevant in infections, sepsis and autoimmune diseases, are poorly understood. Neutrophils are not amenable to studies with conventional genetic techniques. Using a new chemical genetic analysis we show that the Raf-MEK-ERK pathway is involved in NET formation through activation of NADPH oxidase and upregulation of antiapoptotic proteins. We identify potential targets for drugs addressing NET-associated diseases.	[Hakkim, Abdul; Fuchs, Tobias A.; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany; [Martinez, Nancy E.; Prinz, Heino; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany; [Martinez, Nancy E.; Waldmann, Herbert] Tech Univ Dortmund, Fac Chem, Dortmund, Germany; [Hess, Simone] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany	Max Planck Society; Max Planck Society; Dortmund University of Technology; Max Planck Society	Hakkim, A (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany.	zychlinsky@mpiib-berlin.mpg.de; herbert.waldmann@mpi-dortmund.mpg.de	Fuchs, Tobias/F-1189-2013; Waldmann, Herbert/B-7406-2017	Waldmann, Herbert/0000-0002-9606-7247				Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; GAY JC, 1986, BLOOD, V67, P931; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; MAUER AM, 1960, J CLIN INVEST, V39, P1481, DOI 10.1172/JCI104167; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Nishioka H, 2003, EUR J IMMUNOL, V33, P840, DOI 10.1002/eji.200323726; O'Donnell BV, 1993, BIOCH J 1, V290, P41; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yost CC, 2010, BIOCHIMIE, V92, P692, DOI 10.1016/j.biochi.2010.02.011	25	448	474	3	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					75	77		10.1038/NCHEMBIO.496	http://dx.doi.org/10.1038/NCHEMBIO.496			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21170021				2022-12-27	WOS:000286324600006
J	Maeda, H; Yoo, HJ; Dudareva, N				Maeda, Hiroshi; Yoo, Heejin; Dudareva, Natalia			Prephenate aminotransferase directs plant phenylalanine biosynthesis via arogenate	NATURE CHEMICAL BIOLOGY			English	Article							ASPARTATE-AMINOTRANSFERASE; TYROSINE BIOSYNTHESIS; PURIFICATION; PATHWAY; IDENTIFICATION; ACCUMULATION	The aromatic amino acids L-phenylalanine and L-tyrosine and their plant-derived natural products are essential in human and plant metabolism and physiology. Here we identified Petunia hybrida and Arabidopsis thaliana genes encoding prephenate aminotransferases (PPA-ATs), thus completing the identification of the genes involved in phenylalanine and tyrosine biosyntheses. Biochemical and genetic characterization of enzymes showed that PPA-AT directs carbon flux from prephenate toward arogenate, making the arogenate pathway predominant in plant phenylalanine biosynthesis.	[Maeda, Hiroshi; Yoo, Heejin; Dudareva, Natalia] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dudareva, N (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	dudareva@purdue.edu	Yoo, Heejin/L-3207-2019; Dudareva, Natalia/S-8710-2017	Dudareva, Natalia/0000-0003-0777-7763; Yoo, Heejin/0000-0002-9630-8207	US Agriculture and Food Research Initiative, US Department of Agriculture National Institute of Food and Agriculture [2010-65115-20385]; US National Science Foundation [MCB-0615700]; Japan Society for the Promotion of Science	US Agriculture and Food Research Initiative, US Department of Agriculture National Institute of Food and Agriculture; US National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank J. Zheng and C. M. Kish (Purdue University) for technical assistance in the quantitative real-time PCR experiments, G. Taguchi and E. Pichersky (University of Michigan) for the pLISG vector and N. Bonawitz, D. Rhodes (Purdue University) and members of Dudareva laboratory for critical reading of the manuscript. This work was supported by the US Agriculture and Food Research Initiative competitive grant no. 2010-65115-20385 from US Department of Agriculture National Institute of Food and Agriculture and by grant MCB-0615700 from the US National Science Foundation to N. D. H. M. was supported in part by the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad.	BICKEL H, 1979, PHYTOCHEMISTRY, V18, P498, DOI 10.1016/S0031-9422(00)81902-0; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; BONNER CA, 1985, ARCH BIOCHEM BIOPHYS, V238, P237, DOI 10.1016/0003-9861(85)90161-4; Bramley PM, 2000, J SCI FOOD AGR, V80, P913, DOI [10.1002/(SICI)1097-0010(20000515)80:7<913::AID-JSFA600>3.0.CO;2-3, 10.1002/(SICI)1097-0010(20000515)80:7&lt;913::AID-JSFA600&gt;3.0.CO;2-3]; Cho MH, 2007, J BIOL CHEM, V282, P30827, DOI 10.1074/jbc.M702662200; de la Torre F, 2006, PLANT J, V46, P414, DOI 10.1111/j.1365-313X.2006.02713.x; DEEKNAMKUL W, 1988, ARCH BIOCHEM BIOPHYS, V267, P87, DOI 10.1016/0003-9861(88)90011-2; FAZEL AM, 1979, J BACTERIOL, V138, P805, DOI 10.1128/JB.138.3.805-815.1979; GORLACH J, 1995, P NATL ACAD SCI USA, V92, P3166, DOI 10.1073/pnas.92.8.3166; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; Maeda H, 2010, PLANT CELL, V22, P832, DOI 10.1105/tpc.109.073247; MARINO G, 1988, J BIOL CHEM, V263, P12305; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Nobe Y, 1998, J BIOL CHEM, V273, P29554, DOI 10.1074/jbc.273.45.29554; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; REDKINA TV, 1969, BIOCHEMISTRY-MOSCOW+, V34, P247; Rippert P, 2002, EUR J BIOCHEM, V269, P4753, DOI 10.1046/j.1432-1033.2002.03172.x; RUBIN JL, 1979, PLANT PHYSIOL, V64, P727, DOI 10.1104/pp.64.5.727; SIEHL DL, 1986, PLANT PHYSIOL, V81, P711, DOI 10.1104/pp.81.2.711; SIEHL DL, 1986, Z NATURFORSCH C, V41, P79; Siehl DL, 1999, BOOK SOIL P, P171; Verdonk JC, 2003, PHYTOCHEMISTRY, V62, P997, DOI 10.1016/S0031-9422(02)00707-0; WIGHTMAN F, 1978, PHYTOCHEMISTRY, V17, P1455, DOI 10.1016/S0031-9422(00)94622-3; Yamada T, 2008, PLANT CELL, V20, P1316, DOI 10.1105/tpc.107.057455; ZAMIR LO, 1983, TETRAHEDRON LETT, V24, P2815, DOI 10.1016/S0040-4039(00)88031-4	25	104	112	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					19	21		10.1038/NCHEMBIO.485	http://dx.doi.org/10.1038/NCHEMBIO.485			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21102469				2022-12-27	WOS:000285383400006
J	Hartkoorn, RC; Pojer, F; Read, JA; Gingell, H; Neres, J; Horlacher, OP; Altmann, KH; Cole, ST				Hartkoorn, Ruben C.; Pojer, Florence; Read, Jon A.; Gingell, Helen; Neres, Joao; Horlacher, Oliver P.; Altmann, Karl-Heinz; Cole, Stewart T.			Pyridomycin bridges the NADH- and substratebinding pockets of the enoyl reductase InhA	NATURE CHEMICAL BIOLOGY			English	Article							CARRIER PROTEIN REDUCTASE; MYCOBACTERIUM-TUBERCULOSIS; LACTATE-DEHYDROGENASE; CRYSTAL-STRUCTURE; ACP REDUCTASE; INHIBITORS; BINDING	Pyridomycin, a natural product with potent antituberculosis activity, inhibits a major drug target, the InhA enoyl reductase. Here, we unveil the co-crystal structure and unique ability of pyridomycin to block both the NADH cofactor- and lipid substrate-binding pockets of InhA. This is to our knowledge a first-of-a-kind binding mode that discloses a new means of InhA inhibition. Proof-of-principle studies show how structure-assisted drug design can improve the activity of new pyridomycin derivatives.	[Hartkoorn, Ruben C.; Pojer, Florence; Neres, Joao; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Read, Jon A.; Gingell, Helen] AstraZeneca, Discovery Sci, Innovat Med, Macclesfield, Cheshire, England; [Horlacher, Oliver P.; Altmann, Karl-Heinz] ETH, Swiss Fed Inst Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; AstraZeneca; Swiss Federal Institutes of Technology Domain; ETH Zurich	Cole, ST (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland.	stewart.cole@epfl.ch	Hartkoorn, Ruben C/U-2698-2017; Neres, Joao/A-1241-2011	Hartkoorn, Ruben C/0000-0001-7315-1553; Neres, Joao/0000-0003-4488-2423	European Community's Seventh Framework Programme [260872]; European Commission	European Community's Seventh Framework Programme; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors would like to thank S. Surade (University of Cambridge) for providing the InhA expression plasmid (pIH51), S. Boy-Rottger and G. Cuanoud (both from EPFL) for technical assistance and G. Shiek (AstraZeneca) for protein supply. The research leading to these results received funding from the European Community's Seventh Framework Programme (grant 260872). J. Neres is the recipient of a Marie Curie fellowship from the European Commission.	Ballell Pages L., PYRAZOL 3 YL 1 3 4 T; Cameron A, 2004, J BIOL CHEM, V279, P31429, DOI 10.1074/jbc.M402433200; Cegielski JP, 2010, CLIN INFECT DIS, V50, pS195, DOI 10.1086/651491; Dias MVB, 2007, J STRUCT BIOL, V159, P369, DOI 10.1016/j.jsb.2007.04.009; Dutta D, 2013, BIOCHEM J, V450, P127, DOI 10.1042/BJ20121107; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; Glaziou P, 2009, CLIN CHEST MED, V30, P621, DOI 10.1016/j.ccm.2009.08.017; Hartkoorn RC, 2012, EMBO MOL MED, V4, P1032, DOI 10.1002/emmm.201201689; He X, 2006, J MED CHEM, V49, P6308, DOI 10.1021/jm060715y; Hea X, 2007, BIOORGAN MED CHEM, V15, P6649, DOI 10.1016/j.bmc.2007.08.013; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Horlacher OP, 2013, ACS MED CHEM LETT, V4, P264, DOI 10.1021/ml300385q; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KOYAMA G, 1967, TETRAHEDRON LETT, P3587; Kuo MR, 2003, J BIOL CHEM, V278, P20851, DOI 10.1074/jbc.M211968200; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; MAEDA KENJI, 1953, JOUR ANTIBIOTICS [TOKYO], V6, P140; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; Pan P, 2012, CURR TOP MED CHEM, V12, P672, DOI 10.2174/156802612799984535; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Shirude PS, 2013, J MED CHEM, V56, P9701, DOI 10.1021/jm401382v; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Ward RA, 2012, J MED CHEM, V55, P3285, DOI 10.1021/jm201734r	24	49	52	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					96	98		10.1038/nchembio.1405	http://dx.doi.org/10.1038/nchembio.1405			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24292073				2022-12-27	WOS:000330751600006
J	Kramer, A; Mentrup, T; Kleizen, B; Rivera-Milla, E; Reichenbach, D; Enzensperger, C; Nohl, R; Tauscher, E; Gorls, H; Ploubidou, A; Englert, C; Werz, O; Arndt, HD; Kaether, C				Kraemer, Andreas; Mentrup, Torben; Kleizen, Bertrand; Rivera-Milla, Eric; Reichenbach, Daniela; Enzensperger, Christoph; Nohl, Richard; Taeuscher, Eric; Goerls, Helmar; Ploubidou, Aspasia; Englert, Christoph; Werz, Oliver; Arndt, Hans-Dieter; Kaether, Christoph			Small molecules intercept Notch signaling and the early secretory pathway	NATURE CHEMICAL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; BREFELDIN-A; REAL-TIME; GOLGI; PROTEIN; PRESENILIN; INHIBITION; EXPRESSION; TRANSPORT; COMPLEX	Notch signaling has a pivotal role in numerous cell-fate decisions, and its aberrant activity leads to developmental disorders and cancer. To identify molecules that influence Notch signaling, we screened nearly 17,000 compounds using automated microscopy to monitor the trafficking and processing of a ligand-independent Notch-enhanced GFP (eGFP) reporter. Characterization of hits in vitro by biochemical and cellular assays and in vivo using zebrafish led to five validated compounds, four of which induced accumulation of the reporter at the plasma membrane by inhibiting gamma-secretase. One compound, the dihydropyridine FLI-06, disrupted the Golgi apparatus in a manner distinct from that of brefeldin A and golgicide A. FLI-06 inhibited general secretion at a step before exit from the endoplasmic reticulum (ER), which was accompanied by a tubule-to-sheet morphological transition of the ER, rendering FLI-06 the first small molecule acting at such an early stage in secretory traffic. These data highlight the power of phenotypic screening to enable investigations of central cellular signaling pathways.	[Kraemer, Andreas; Mentrup, Torben; Rivera-Milla, Eric; Reichenbach, Daniela; Ploubidou, Aspasia; Englert, Christoph; Kaether, Christoph] Fritz Lipmann Inst, Leibniz Inst Altersforsch, Jena, Germany; [Kleizen, Bertrand] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Cellular Prot Chem, Utrecht, Netherlands; [Enzensperger, Christoph; Werz, Oliver] Univ Jena, Inst Pharm, Jena, Germany; [Nohl, Richard; Taeuscher, Eric; Arndt, Hans-Dieter] Univ Jena, Inst Organ & Makromol Chem, Jena, Germany; [Goerls, Helmar] Univ Jena, Inst Anorgan & Analyt Chem, D-07743 Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Utrecht University; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kramer, A (corresponding author), Fritz Lipmann Inst, Leibniz Inst Altersforsch, Jena, Germany.	ckaether@fli-leibniz.de		Kleizen, Bertrand/0000-0002-4640-1796	Deutsche Forschungsgemeinschaft [KA1751/4-1]; Leibniz Gemeinschaft; Thuringer Ministerium fur Bildung, Wissenschaft und Kultur (TMBWK) [43-5572-321-12040-12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Gemeinschaft; Thuringer Ministerium fur Bildung, Wissenschaft und Kultur (TMBWK)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to C.K. (KA1751/4-1), the Leibniz Gemeinschaft to A.P. and C.K. (PAKT) and the Thuringer Ministerium fur Bildung, Wissenschaft und Kultur (TMBWK; 43-5572-321-12040-12) to H.-D.A. We are especially grateful to S. Radetzki, M. Neuenschwander and J. von Kries (Leibniz-Institut fur Molekulare Pharmakologie Berlin) for the primary screen of the ChemBioNet library, ChemBioNet for setting up the library and B. Bulic for initial assistance with NMR data interpretation. We thank L. Bally-Cuif (Ecole des Neurosciences), C. Haass (German Center for Neurodegenerative Diseases (DZNE) Munchen), E. L. Snapp (Albert Einstein College of Medicine), M. Kuro-o (University of Texas Southwestern), E. Sztul (University of Alabama, Birmingham) and P. Keller (European Molecular Biology Laboratory Heidelberg) for kind gifts of reagents, C. Hahn for zebrafish stock maintenance and J. Reiling for help in analyzing ER stress.	Blader P, 2000, HUM MOL GENET, V9, P945, DOI 10.1093/hmg/9.6.945; Blader P, 1997, DEVELOPMENT, V124, P4557; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Dukhovny A, 2008, J CELL SCI, V121, P865, DOI 10.1242/jcs.019463; Edraki N, 2009, DRUG DISCOV TODAY, V14, P1058, DOI 10.1016/j.drudis.2009.08.004; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; GOLDMANN S, 1991, ANGEW CHEM INT EDIT, V30, P1559, DOI 10.1002/anie.199115591; Groth C, 2012, SEMIN CELL DEV BIOL, V23, P465, DOI 10.1016/j.semcdb.2012.01.016; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Huenniger K, 2010, CELL MOL LIFE SCI, V67, P3187, DOI 10.1007/s00018-010-0378-7; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirk SJ, 2007, SEMIN CELL DEV BIOL, V18, P435, DOI 10.1016/j.semcdb.2007.07.007; Kitzmann M, 2006, J CELL PHYSIOL, V208, P538, DOI 10.1002/jcp.20688; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Koch U, 2011, TRENDS IMMUNOL, V32, P434, DOI 10.1016/j.it.2011.06.005; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Meredith PA, 2004, J HYPERTENS, V22, P1641, DOI 10.1097/00004872-200409000-00002; PAVELKA M, 1983, J CELL BIOL, V97, P737, DOI 10.1083/jcb.97.3.737; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Real PJ, 2009, LEUKEMIA, V23, P1374, DOI 10.1038/leu.2009.75; Ritz C, 2005, J STAT SOFTW, V12, P1; ROGALSKI AA, 1984, J CELL BIOL, V99, P1101, DOI 10.1083/jcb.99.3.1101; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Toomre D, 1999, J CELL SCI, V112, P21; von Kleist L, 2012, TRAFFIC, V13, P495, DOI 10.1111/j.1600-0854.2011.01292.x; Wacker I, 1997, J CELL SCI, V110, P1453; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wolfe MS, 2012, J NEUROCHEM, V120, P89, DOI 10.1111/j.1471-4159.2011.07501.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005; Zanetti G, 2012, NAT CELL BIOL, V14, P221, DOI 10.1038/ncb2434; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	53	43	44	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					731	+		10.1038/NCHEMBIO.1356	http://dx.doi.org/10.1038/NCHEMBIO.1356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24077179				2022-12-27	WOS:000325930500015
J	Snider, J; Hanif, A; Lee, ME; Jin, K; Yu, AR; Graham, C; Chuk, M; Damjanovic, D; Wierzbicka, M; Tang, P; Balderes, D; Wong, V; Jessulat, M; Darowski, KD; San Luis, BJ; Shevelev, I; Sturley, SL; Boone, C; Greenblatt, JF; Zhang, ZL; Paumi, CM; Babu, M; Park, HO; Michaelis, S; Stagljar, I				Snider, Jamie; Hanif, Asad; Lee, Mid Eum; Jin, Ke; Yu, Analyn R.; Graham, Chris; Chuk, Matthew; Damjanovic, Dunja; Wierzbicka, Marta; Tang, Priscilla; Balderes, Dina; Wong, Victoria; Jessulat, Matthew; Darowski, Katelyn D.; San Luis, Bryan-Joseph; Shevelev, Igor; Sturley, Stephen L.; Boone, Charles; Greenblatt, Jack F.; Zhang, Zhaolei; Paumi, Christian M.; Babu, Mohan; Park, Hay-Oak; Michaelis, Susan; Stagljar, Igor			Mapping the functional yeast ABC transporter interactome	NATURE CHEMICAL BIOLOGY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; BINDING CASSETTE TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; IN-VIVO; MULTIDRUG-RESISTANCE; PROTEIN-INTERACTION; ZINC TRANSPORTER; SPLIT-UBIQUITIN; GENE ONTOLOGY	ATP-binding cassette (ABC) transporters are a ubiquitous class of integral membrane proteins of immense clinical interest because of their strong association with human disease and pharmacology. To improve our understanding of these proteins, we used membrane yeast two-hybrid technology to map the protein interactome of all of the nonmitochondrial ABC transporters in the model organism Saccharomyces cerevisiae and combined this data with previously reported yeast ABC transporter interactions in the BioGRID database to generate a comprehensive, integrated 'interactome'. We show that ABC transporters physically associate with proteins involved in an unexpectedly diverse range of functions. We specifically examine the importance of the physical interactions of ABC transporters in both the regulation of one another and in the modulation of proteins involved in zinc homeostasis. The interaction network presented here will be a powerful resource for increasing our fundamental understanding of the cellular role and regulation of ABC transporters.	[Snider, Jamie; Hanif, Asad; Jin, Ke; Yu, Analyn R.; Graham, Chris; Chuk, Matthew; Damjanovic, Dunja; Wierzbicka, Marta; Tang, Priscilla; Wong, Victoria; Darowski, Katelyn D.; San Luis, Bryan-Joseph; Shevelev, Igor; Boone, Charles; Greenblatt, Jack F.; Zhang, Zhaolei; Stagljar, Igor] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Hanif, Asad; Jin, Ke; Chuk, Matthew; Damjanovic, Dunja; Tang, Priscilla; San Luis, Bryan-Joseph; Boone, Charles; Greenblatt, Jack F.; Zhang, Zhaolei; Stagljar, Igor] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Lee, Mid Eum; Park, Hay-Oak] Ohio State Univ, Mol Cellular Dev Biol Program, Columbus, OH 43210 USA; [Jin, Ke; San Luis, Bryan-Joseph; Boone, Charles; Greenblatt, Jack F.; Zhang, Zhaolei] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Graham, Chris; Jessulat, Matthew; Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Balderes, Dina; Sturley, Stephen L.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Darowski, Katelyn D.; Stagljar, Igor] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Paumi, Christian M.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Park, Hay-Oak] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Michaelis, Susan] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD USA	University of Toronto; University of Toronto; University System of Ohio; Ohio State University; University of Toronto; University of Regina; Columbia University; University of Toronto; University of Kentucky; University System of Ohio; Ohio State University; Johns Hopkins University; Johns Hopkins Medicine	Stagljar, I (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.	igor.stagljar@utoronto.ca	Mohan, Babu P./I-7362-2019; Zhang, Zhaolei/G-2369-2017	Park, Hay-Oak/0000-0001-5782-2257	Canadian Institutes of Health Research; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; Ontario Genomics Institute; Canadian Cystic Fibrosis Foundation; Canadian Cancer Society; University Health Network; National Institutes of Health [R01-GM76375, R01-GM51508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076375, R01GM051508] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Genomics Institute; Canadian Cystic Fibrosis Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS)); University Health Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is dedicated to our late friend and colleague Igor Shevelev. We thank B. Andrews, C. Nislow, F. Vizeacoumar, C. Kurat and S. Alfred (University of Toronto) for providing reagents, assistance and equipment; L. Miller, S. Pagant, K. Kuchler and C. Klein for experimental assistance; and W. K. Huh (Seoul National University) for providing BiFC plasmids. We also thank V. Kanelis, K. Sokolina and M. Ali for reviewing the manuscript. This work was supported by grants from the Canadian Institutes of Health Research, Canadian Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, Ontario Genomics Institute, Canadian Cystic Fibrosis Foundation, Canadian Cancer Society, University Health Network to I. Stagljar and National Institutes of Health (R01-GM76375 to H.-O.P. and R01-GM51508 to S.M.).	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu M, 2009, METHODS MOL BIOL, V548, P187, DOI 10.1007/978-1-59745-540-4_11; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Burke MA, 2008, CIRC RES, V102, P164, DOI 10.1161/CIRCRESAHA.107.165324; Cabrito TR, 2011, BIOCHEM J, V440, P195, DOI 10.1042/BJ20110876; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DEGRYSE E, 1995, YEAST, V11, P629, DOI 10.1002/yea.320110704; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gitan RS, 2003, J BIOL CHEM, V278, P39558, DOI 10.1074/jbc.M302760200; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kelm KB, 2004, TRAFFIC, V5, P165, DOI 10.1111/j.1600-0854.2004.00168.x; Kolaczkowska A, 2008, FEBS LETT, V582, P977, DOI 10.1016/j.febslet.2008.02.045; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Kovalchuk A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-177; Lee ME, 2011, GENETICS, V188, P859, DOI 10.1534/genetics.111.130724; Lewis VG, 2012, PROTOPLASMA, V249, P919, DOI 10.1007/s00709-011-0360-8; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacDiarmid CW, 2003, J BIOL CHEM, V278, P15065, DOI 10.1074/jbc.M300568200; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Mason DL, 2003, EUKARYOT CELL, V2, P588, DOI 10.1128/EC.2.3.588-598.2003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Rockwell NC, 2009, J MEMBRANE BIOL, V229, P27, DOI 10.1007/s00232-009-9173-5; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Shani N, 1996, P NATL ACAD SCI USA, V93, P11901, DOI 10.1073/pnas.93.21.11901; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	49	60	61	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					565	U64		10.1038/NCHEMBIO.1293	http://dx.doi.org/10.1038/NCHEMBIO.1293			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23831759	Green Accepted			2022-12-27	WOS:000323417500008
J	Hett, EC; Slater, LH; Mark, KG; Kawate, T; Monks, BG; Stutz, A; Latz, E; Hung, DT				Hett, Erik C.; Slater, Louise H.; Mark, Kevin G.; Kawate, Tomohiko; Monks, Brian G.; Stutz, Andrea; Latz, Eicke; Hung, Deborah T.			Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis	NATURE CHEMICAL BIOLOGY			English	Article							ANTHRAX LETHAL TOXIN; NF-KAPPA-B; INFLAMMASOME ACTIVATION; MACROPHAGE APOPTOSIS; PKR; EXPRESSION; MAP; SUSCEPTIBILITY; INHIBITORS; PATHWAY	Formation of the inflammasome, a scaffolding complex that activates caspase-1, is important in numerous diseases. Pyroptotic cell death induced by anthrax lethal toxin (LT) is a model for inflammasome-mediated caspase-1 activation. We discovered 7-desacetoxy-6,7-dehydrogedunin (7DG) in a phenotypic screen as a small molecule that protects macrophages from LT-induced death. Using chemical proteomics, we identified protein kinase R (PKR) as the target of 7DG and show that RNAi knockdown of PKR phenocopies treatment with 7DG. Further, we show that PKR's role in ASC assembly and caspase-1 activation induced by several different inflammasome stimuli is independent of PKR's kinase activity, demonstrating that PKR has a previously uncharacterized role in caspase-1 activation and pyroptosis that is distinct from its reported kinase-dependent roles in apoptosis and inflammasome formation in lipopolysaccharide-primed cells. Remarkably, PKR has different roles in two distinct cell death pathways and has a broad role in inflammasome function relevant in other diseases.	[Hett, Erik C.; Slater, Louise H.; Mark, Kevin G.; Kawate, Tomohiko; Hung, Deborah T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Hett, Erik C.; Slater, Louise H.; Mark, Kevin G.; Kawate, Tomohiko; Hung, Deborah T.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hett, Erik C.; Slater, Louise H.; Mark, Kevin G.; Kawate, Tomohiko; Hung, Deborah T.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Hett, Erik C.; Slater, Louise H.; Mark, Kevin G.; Kawate, Tomohiko; Hung, Deborah T.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Monks, Brian G.; Latz, Eicke] Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA USA; [Monks, Brian G.; Stutz, Andrea; Latz, Eicke] Univ Bonn, Inst Innate Immun, Bonn, Germany; [Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Hett, EC (corresponding author), Pfizer, Worldwide Med Chem, Chem Biol Grp, Cambridge, MA USA.	hett@molbio.mgh.harvard.edu; hung@molbio.mgh.harvard.edu	Monks, Brian/B-8362-2015; Latz, Eicke/H-3951-2014	Monks, Brian/0000-0003-4008-3093; Latz, Eicke/0000-0003-1488-5666; Mark, Kevin/0000-0001-5132-031X	US National Institutes of Health (NIH) National Research Service Award fellowship [F32AI084323]; NIH [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, F32AI084323] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Research Service Award fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E.C.H. was funded by an US National Institutes of Health (NIH) National Research Service Award fellowship F32AI084323. This work was supported in part by NIH U54 AI057159 to D.T.H.).	Agrawal A, 2004, CELL MOL LIFE SCI, V61, P2859, DOI 10.1007/s00018-004-4251-4; Alileche A, 2006, CELL CYCLE, V5, P100, DOI 10.4161/cc.5.1.2283; Ascenzi P, 2002, FEBS LETT, V531, P384, DOI 10.1016/S0014-5793(02)03609-8; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BEALL FA, 1966, J INFECT DIS, V116, P377, DOI 10.1093/infdis/116.3.377; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Gaddis BD, 2007, BIOORG MED CHEM LETT, V17, P4575, DOI 10.1016/j.bmcl.2007.05.089; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; He Y., 2013, EUR J IMMUNOL; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Ishii T, 2001, ONCOGENE, V20, P1900, DOI 10.1038/sj.onc.1204267; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Kalai M, 2007, CELL DEATH DIFFER, V14, P1050, DOI 10.1038/sj.cdd.4402110; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liang XD, 2010, VET MICROBIOL, V146, P111, DOI 10.1016/j.vetmic.2010.04.028; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Moayeri M, 2004, INFECT IMMUN, V72, P4439, DOI 10.1128/IAI.72.8.4439-4447.2004; Moayeri M, 2012, MICROBES INFECT, V14, P392, DOI 10.1016/j.micinf.2011.12.005; Newman ZL, 2011, ANTIMICROB AGENTS CH, V55, P1028, DOI 10.1128/AAC.00772-10; Newman ZL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000906; Panchal RG, 2007, CHEM BIOL, V14, P245, DOI 10.1016/j.chembiol.2007.01.007; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Sanchez AM, 2007, ANTIMICROB AGENTS CH, V51, P2403, DOI 10.1128/AAC.01184-06; Slater LH, 2013, ACS CHEM BIOL, V8, P812, DOI 10.1021/cb300555n; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; THOMIS DC, 1992, P NATL ACAD SCI USA, V89, P10837, DOI 10.1073/pnas.89.22.10837; WEK RC, 1994, TRENDS BIOCHEM SCI, V19, P491, DOI 10.1016/0968-0004(94)90136-8; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x	45	66	68	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					398	+		10.1038/NCHEMBIO.1236	http://dx.doi.org/10.1038/NCHEMBIO.1236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23603659	Green Submitted, Green Accepted			2022-12-27	WOS:000319328200012
J	Kim, E; Lee, S; Jeon, A; Choi, JM; Lee, HS; Hohng, S; Kim, HS				Kim, Eunkyung; Lee, Sanghwa; Jeon, Aram; Choi, Jung Min; Lee, Hee-Seung; Hohng, Sungchul; Kim, Hak-Sung			A single-molecule dissection of ligand binding to a protein with intrinsic dynamics	NATURE CHEMICAL BIOLOGY			English	Article							CONFORMATIONAL SELECTION; INDUCED FIT; ENERGY LANDSCAPES; NMR; RECOGNITION; TRANSITION; TRANSIENT; CATALYSIS; MOTIONS; SYSTEM	Protein dynamics have been suggested to have a crucial role in biomolecular recognition, but the precise molecular mechanisms remain unclear. Herein, we performed single-molecule fluorescence resonance energy transfer measurements for wild-type maltose-binding protein (MBP) and its variants to demonstrate the interplay of conformational dynamics and molecular recognition. Kinetic analysis provided direct evidence that MBP recognizes a ligand through an 'induced-fit' mechanism, not through the generally proposed selection mechanism for proteins with conformational dynamics such as MBP. Our results indicated that the mere presence of intrinsic dynamics is insufficient for a 'selection' mechanism. An energetic analysis of ligand binding implicated the critical role of conformational dynamics in facilitating a structural change that occurs upon ligand binding.	[Kim, Eunkyung; Choi, Jung Min; Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Sanghwa; Hohng, Sungchul] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea; [Lee, Sanghwa; Hohng, Sungchul] Seoul Natl Univ, Natl Ctr Creat Res Initiat, Seoul, South Korea; [Jeon, Aram; Lee, Hee-Seung] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Jeon, Aram; Lee, Hee-Seung] Korea Adv Inst Sci & Technol, Mol Level Interface Res Ctr, Taejon 305701, South Korea; [Hohng, Sungchul] Seoul Natl Univ, Seoul, South Korea; [Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	shohng@snu.ac.kr; hskim76@kaist.ac.kr	Kim, Hak-Sung/C-1929-2011; Lee, Hee-Seung/C-1627-2011	Lee, Sanghwa/0000-0001-6986-7583; Hohng, Sungchul/0000-0002-7131-2138; Choi, Jung Min/0000-0003-2450-3916	Pioneer Research Program for Converging Technology [2008-2000218]; Advanced Biomass RD Center [2011-0031363]; Intelligent Synthetic Biology Center [2011-0031950]; Brain Korea 21 program of the Ministry of Education, Science and Technology and Creative Research Initiatives [2009-0081562]; World-Class University program of the National Research Foundation of Kore	Pioneer Research Program for Converging Technology; Advanced Biomass RD Center; Intelligent Synthetic Biology Center; Brain Korea 21 program of the Ministry of Education, Science and Technology and Creative Research Initiatives; World-Class University program of the National Research Foundation of Kore	This work was supported by the Pioneer Research Program for Converging Technology (2008-2000218), Advanced Biomass R&D Center (2011-0031363), the Intelligent Synthetic Biology Center (2011-0031950) and the Brain Korea 21 program of the Ministry of Education, Science and Technology (H.-S.K.) and Creative Research Initiatives (2009-0081562) and the World-Class University program of the National Research Foundation of Korea (S. H.). We thank S. Mowbray and D. D. Boehr for helpful discussions.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Akke M, 2002, CURR OPIN STRUC BIOL, V12, P642, DOI 10.1016/S0959-440X(02)00369-X; Antikainen NM, 2005, BIOCHEMISTRY-US, V44, P16835, DOI 10.1021/bi051378i; Bae S, 2011, J AM CHEM SOC, V133, P668, DOI 10.1021/ja107498y; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Bermejo GA, 2010, BIOCHEMISTRY-US, V49, P1893, DOI 10.1021/bi902045p; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Bucher D, 2011, BIOCHEMISTRY-US, V50, P10530, DOI 10.1021/bi201481a; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; FLOCCO MM, 1994, J BIOL CHEM, V269, P8931; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Kondo HX, 2011, J PHYS CHEM B, V115, P7629, DOI 10.1021/jp111902t; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012270; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Muschielok A, 2008, NAT METHODS, V5, P965, DOI 10.1038/nmeth.1259; OH BH, 1993, J BIOL CHEM, V268, P11348; Oswald C, 2009, BIOL CHEM, V390, P1163, DOI 10.1515/BC.2009.113; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Ravindranathan KP, 2005, J MOL BIOL, V353, P196, DOI 10.1016/j.jmb.2005.08.009; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Silva DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002054; Sooriyaarachchi S, 2010, J MOL BIOL, V402, P657, DOI 10.1016/j.jmb.2010.07.038; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Theriot J., 2009, PHYS BIOL CELL; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Vallurupalli P, 2006, P NATL ACAD SCI USA, V103, P11910, DOI 10.1073/pnas.0602310103; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wolynes PG, 2005, Q REV BIOPHYS, V38, P405, DOI 10.1017/S0033583505004075	45	79	80	0	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2013	9	5					313	+		10.1038/NCHEMBIO.1213	http://dx.doi.org/10.1038/NCHEMBIO.1213			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	127VT	23502425				2022-12-27	WOS:000317727600008
J	Barbuto, S; Idoyaga, J; Vila-Perello, M; Longhi, MP; Breton, G; Steinman, RM; Muir, TW				Barbuto, Scott; Idoyaga, Juliana; Vila-Perello, Miquel; Longhi, Maria P.; Breton, Gaelle; Steinman, Ralph M.; Muir, Tom W.			Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells	NATURE CHEMICAL BIOLOGY			English	Article							SENSITIVE ANTIGEN-DETECTION; EXPRESSED PROTEIN LIGATION; HIV-GAG; CYTOSOLIC DNA; DEC-205 RECEPTOR; MHC-I; ANTIBODY; RNA; PCR; SEMISYNTHESIS	Targeted delivery of antigens to dendritic cells (DCs) is a promising vaccination strategy. However, to ensure immunity, the approach depends on coadministration of an adjuvant. Here we ask whether targeting of both adjuvant and antigen to DCs is sufficient to induce immunity. Using a protein ligation method, we develop a general approach for linking the immune stimulant, poly dA:dT (pdA:dT), to a monoclonal antibody (mAb) specific for DEC205 (DEC). We show that DEC-specific mAbs deliver pdA:dT to DCs for the efficient production of type I interferon in human monocyte-derived DCs and in mice. Notably, adaptive T-cell immunity is elicited when mAbs specific for DEC-pdA:dT are used as the activation stimuli and are administered together with a DC-targeted antigen. Collectively, our studies indicate that DCs can integrate innate and adaptive immunity in vivo and suggest that dual delivery of antigen and adjuvant to DCs might be an efficient approach to vaccine development.	[Barbuto, Scott; Vila-Perello, Miquel; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA; [Barbuto, Scott; Idoyaga, Juliana; Longhi, Maria P.; Breton, Gaelle; Steinman, Ralph M.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Barbuto, Scott; Idoyaga, Juliana; Longhi, Maria P.; Breton, Gaelle] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University	Muir, TW (corresponding author), Princeton Univ, Dept Chem, Frick Chem Lab, Princeton, NJ 08544 USA.	muir@princeton.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344; Longhi, Paula/0000-0003-1854-4594	National Institutes of Health [GM086868, AI013013]; Foundation for the National Institutes of Health Gates Foundation [334]; NIH MSTP [GM07739]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013013, R37AI013013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM086868, R01GM086868, T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health Gates Foundation; NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank members of the Steinman and Muir laboratories for many valuable discussions. Funding was provided by National Institutes of Health Grants GM086868 (to T.W.M.), AI013013 (to R.M.S.), a Foundation for the National Institutes of Health Gates Foundation grant no. 334 (to R.M.S.) and a graduate fellowship to S. Barbuto by NIH MSTP grant GM07739.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Bar-On L, 2010, METHODS MOL BIOL, V595, P429, DOI 10.1007/978-1-60761-421-0_28; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Batista-Duharte A, 2011, TOXICOL LETT, V203, P97, DOI 10.1016/j.toxlet.2011.03.001; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Burbulis I, 2007, NAT METHODS, V4, P1011, DOI 10.1038/nmeth1127; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Ebensen T, 2008, HUM VACCINES, V4, P13, DOI 10.4161/hv.4.1.5560; Flinsenberg TWH, 2011, CLIN EXP IMMUNOL, V165, P8, DOI 10.1111/j.1365-2249.2011.04411.x; HENDRICKSON ER, 1995, NUCLEIC ACIDS RES, V23, P522, DOI 10.1093/nar/23.3.522; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Katashiba Y, 2011, IMMUNOLOGY, V132, P165, DOI 10.1111/j.1365-2567.2010.03350.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kis-Toth K, 2011, J IMMUNOL, V187, P1222, DOI 10.4049/jimmunol.1100469; Kotlyar AB, 2005, NUCLEIC ACIDS RES, V33, P525, DOI 10.1093/nar/gki178; Kreutz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040208; LAMPKIN BC, 1985, CANCER RES, V45, P5904; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lovrinovic M, 2005, BIOCHEM BIOPH RES CO, V335, P943, DOI 10.1016/j.bbrc.2005.08.001; Mata M, 1998, J IMMUNOL, V161, P2985; McKie A, 2002, J IMMUNOL METHODS, V261, P167, DOI 10.1016/S0022-1759(02)00003-0; Mohlmann S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-76; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Niemeyer CM, 2010, ANGEW CHEM INT EDIT, V49, P1200, DOI 10.1002/anie.200904930; Niemeyer CM, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng090; Nolte MA, 2007, J EXP MED, V204, P1487, DOI 10.1084/jem.20070325; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Singla N, 2008, PROTEIN SCI, V17, P1740, DOI 10.1110/ps.035659.108; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Tacken PJ, 2011, BLOOD, V118, P6836, DOI 10.1182/blood-2011-07-367615; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Trumpfheller C, 2012, J INTERN MED, V271, P183, DOI 10.1111/j.1365-2796.2011.02496.x; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; Vila-Perello M, 2013, J AM CHEM SOC, V135, P286, DOI 10.1021/ja309126m; WITMERPACK MD, 1995, CELL IMMUNOL, V163, P157, DOI 10.1006/cimm.1995.1110; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	50	29	35	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					250	256		10.1038/NCHEMBIO.1186	http://dx.doi.org/10.1038/NCHEMBIO.1186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23416331	Green Accepted, Bronze			2022-12-27	WOS:000317025800015
J	Cymes, GD; Grosman, C				Cymes, Gisela D.; Grosman, Claudio			The unanticipated complexity of the selectivity-filter glutamates of nicotinic receptors	NATURE CHEMICAL BIOLOGY			English	Article							GATED ION-CHANNEL; ACIDIC SIDE-CHAINS; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTOR; DEUTERIUM OXIDE; PROTON-TRANSFER; PK(A) VALUES; IONIZATION; EQUILIBRIA; PROTEINS	In ion channels, 'rings' of ionized side chains that decorate the walls of the permeation pathway often lower the energetic barrier to ion conduction. Using single-channel electrophysiological recordings, we studied the poorly understood ring of four glutamates (and one glutamine) that dominates this catalytic effect in the muscle nicotinic acetylcholine receptor ('the intermediate ring of charge'). We show that all four wild-type glutamate side chains are deprotonated in the range of 6.0-9.0 pH, that only two of them contribute to the size of the single-channel current, that these side chains must be able to adopt alternate conformations that either allow or prevent their negative charges from increasing the rate of cation conduction and that the location of these glutamate side chains squarely at one of the ends of the transmembrane pore is critical for their largely unshifted pK(a) values and for the unanticipated impact of their conformational flexibility on cation permeation.	[Cymes, Gisela D.; Grosman, Claudio] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61802 USA; [Grosman, Claudio] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Grosman, Claudio] Univ Illinois, Neurosci Program, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Grosman, C (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61802 USA.	grosman@illinois.edu		Grosman, Claudio/0000-0001-8093-8362; Cymes, Gisela/0000-0002-4155-585X	US National Institutes of Health [R01-NS042169]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042169] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Sine (Mayo Clinic College of Medicine, Rochester, MN, USA) for wild-type muscle AChR cDNA, M. Slaughter (University at Buffalo School of Medicine, Buffalo, NY, USA) for wild-type alpha 1 GlyR cDNA, and A. Holmstrom, M. Pasquini, J. Pizarek and M. Rigby for technical assistance. This work was supported by a grant from the US National Institutes of Health (R01-NS042169 to C.G.).	BASHFORD D, 1992, J MOL BIOL, V224, P473, DOI 10.1016/0022-2836(92)91009-E; Bell R. P, 1973, PROTON CHEM, P250; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bombarda E, 2010, J PHYS CHEM B, V114, P1994, DOI 10.1021/jp908926w; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2011, PROTEINS, V79, P3485, DOI 10.1002/prot.23087; DAHLGREN G, 1960, J AM CHEM SOC, V82, P1303, DOI 10.1021/ja01491a007; Elenes S, 2006, J GEN PHYSIOL, V128, P615, DOI 10.1085/jgp.200609570; Elenes S, 2009, J GEN PHYSIOL, V133, P151, DOI 10.1085/jgp.200810089; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fayer MD, 2010, ANNU REV ANAL CHEM, V3, P89, DOI 10.1146/annurev-anchem-070109-103410; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GLASOE PK, 1964, J PHYS CHEM-US, V68, P1560, DOI 10.1021/j100788a501; GLASOE PK, 1964, J PHYS CHEM-US, V68, P1562, DOI 10.1021/j100788a502; GUTMAN M, 1992, BIOCHIM BIOPHYS ACTA, V1109, P141, DOI 10.1016/0005-2736(92)90077-Y; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Lancaster CRD, 1996, BIOPHYS J, V70, P2469, DOI 10.1016/S0006-3495(96)79820-X; Lindman S, 2006, BIOCHEMISTRY-US, V45, P13993, DOI 10.1021/bi061555v; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; MCDANIEL DH, 1953, SCIENCE, V118, P370, DOI 10.1126/science.118.3066.370; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin J, 1996, BIOCHEMISTRY-US, V35, P7, DOI 10.1021/bi952299h; RAJASEKARAN E, 1994, J AM CHEM SOC, V116, P8238, DOI 10.1021/ja00097a033; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; SALOMAA P, 1964, J AM CHEM SOC, V86, P1, DOI 10.1021/ja01055a001; Sondergaard CR, 2008, J MOL BIOL, V376, P269, DOI 10.1016/j.jmb.2007.09.070; Wohlfahrt G, 2005, PROTEINS, V58, P396, DOI 10.1002/prot.20328	39	28	29	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					975	981		10.1038/NCHEMBIO.1092	http://dx.doi.org/10.1038/NCHEMBIO.1092			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23064317	Green Accepted			2022-12-27	WOS:000311491200012
J	Deery, E; Schroeder, S; Lawrence, AD; Taylor, SL; Seyedarabi, A; Waterman, J; Wilson, KS; Brown, D; Geeves, MA; Howard, MJ; Pickersgill, RW; Warren, MJ				Deery, Evelyne; Schroeder, Susanne; Lawrence, Andrew D.; Taylor, Samantha L.; Seyedarabi, Arefeh; Waterman, Jitka; Wilson, Keith S.; Brown, David; Geeves, Michael A.; Howard, Mark J.; Pickersgill, Richard W.; Warren, Martin J.			An enzyme-trap approach allows isolation of intermediates in cobalamin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PSEUDOMONAS-DENITRIFICANS; HYDROGENOBYRINIC ACID; MAXIMUM-LIKELIHOOD; VITAMIN-B12; PRECORRIN-8X; PURIFICATION; SUBSTRATE; CRYSTALLOGRAPHY; IDENTIFICATION; REFINEMENT	The biosynthesis of many vitamins and coenzymes has often proven difficult to elucidate owing to a combination of low abundance and kinetic lability of the pathway intermediates. Through a serial reconstruction of the cobalamin (vitamin B-12) pathway in Escherichia coli and by His tagging the terminal enzyme in the reaction sequence, we have observed that many unstable intermediates can be isolated as tightly bound enzyme-product complexes. Together, these approaches have been used to extract intermediates between precorrin-4 and hydrogenobyrinic acid in their free acid form and permitted the delineation of the overall reaction catalyzed by CobL, including the formal elucidation of precorrin-7 as a metabolite. Furthermore, a substrate-carrier protein, CobE, that can also be used to stabilize some of the transient metabolic intermediates and enhance their onward transformation, has been identified. The tight association of pathway intermediates with enzymes provides evidence for a form of metabolite channeling.	[Deery, Evelyne; Schroeder, Susanne; Lawrence, Andrew D.; Taylor, Samantha L.; Brown, David; Geeves, Michael A.; Howard, Mark J.; Warren, Martin J.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Seyedarabi, Arefeh; Pickersgill, Richard W.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Waterman, Jitka; Wilson, Keith S.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England	University of Kent; University of London; Queen Mary University London; University of York - UK	Deery, E (corresponding author), Univ Kent, Sch Biosci, Canterbury, Kent, England.	r.w.pickersgill@qmul.ac.uk; m.j.warren@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Lodge, Samantha/0000-0001-9193-0462; Howard, Mark/0000-0002-0762-2887; Wilson, Keith/0000-0002-3581-2194; Warren, Martin/0000-0002-6028-6456; Schroeder, Susanne/0000-0003-1703-9158	Biotechnology and Biological Sciences Research Council [BB/E024203, BB/I013334]; Wellcome Trust [091163/Z/10/Z]; BBSRC [BB/E024203/1, BB/I012079/1, BB/I013334/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I012079/1, BB/I013334/1, BB/E024203/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/E024203 and BB/I013334) and the Wellcome Trust (091163/Z/10/Z). We thank M. Rowe for additional NMR technical support. Diffraction data were collected at the European Synchrotron Radiation Facility, Grenoble, France (for CobE) and the Diamond Light Source, Oxfordshire, UK (for CobL and CobH). We thank C. Roessner (Texas A&M University) for a clone of the P. denitrificans cobG.	BATTERSBY AR, 1994, SCIENCE, V264, P1551, DOI 10.1126/science.8202709; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BLANCHE F, 1989, J BACTERIOL, V171, P4222, DOI 10.1128/JB.171.8.4222-4231.1989; BLANCHE F, 1995, ANGEW CHEM INT EDIT, V34, P383, DOI 10.1002/anie.199503831; BLANCHE F, 1990, ANGEW CHEM INT EDIT, V29, P884, DOI 10.1002/anie.199008841; BLANCHE F, 1992, J BACTERIOL, V174, P1036, DOI 10.1128/jb.174.3.1036-1042.1992; BLANCHE F, 1992, J BACTERIOL, V174, P1050, DOI 10.1128/jb.174.3.1050-1052.1992; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DEBUSSCHE L, 1993, J CHEM SOC CHEM COMM, P1100, DOI 10.1039/c39930001100; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dogutan DK, 2011, J AM CHEM SOC, V133, P131, DOI 10.1021/ja108904s; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Lee CH, 2011, J AM CHEM SOC, V133, P8775, DOI 10.1021/ja202136y; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; MIN CH, 1993, J AM CHEM SOC, V115, P10380, DOI 10.1021/ja00075a072; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PETTERSSON G, 1991, J THEOR BIOL, V152, P65, DOI 10.1016/S0022-5193(05)80512-0; ROBINSON JB, 1987, J BIOL CHEM, V262, P1786; Sambrook J., 2001, MOL CLONING LAB MANU; Santander PJ, 2006, BIOORGAN MED CHEM, V14, P724, DOI 10.1016/j.bmc.2005.08.062; SCOTT AI, 1993, FEBS LETT, V331, P105, DOI 10.1016/0014-5793(93)80306-F; SCOTT AI, 1990, J CHEM SOC CHEM COMM, P593, DOI 10.1039/c39900000593; Seyedarabi A, 2010, ACTA CRYSTALLOGR F, V66, P1652, DOI 10.1107/S1744309110042910; Shipman LW, 2001, STRUCTURE, V9, P587, DOI 10.1016/S0969-2126(01)00618-9; THIBAUT D, 1990, P NATL ACAD SCI USA, V87, P8800, DOI 10.1073/pnas.87.22.8800; THIBAUT D, 1992, J BACTERIOL, V174, P1043, DOI 10.1128/jb.174.3.1043-1049.1992; THIBAUT D, 1993, J CHEM SOC CHEM COMM, P513, DOI 10.1039/c39930000513; UZAR HC, 1987, J CHEM SOC PERK T 1, P1689, DOI 10.1039/p19870001689; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vevodova J, 2005, ACTA CRYSTALLOGR F, V61, P442, DOI 10.1107/S1744309105006731; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; WARREN MJ, 1992, BIOCHEMISTRY-US, V31, P603, DOI 10.1021/bi00117a043; Webb ME, 2007, NAT PROD REP, V24, P988, DOI 10.1039/b703105j; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WU XM, 1991, P NATL ACAD SCI USA, V88, P497, DOI 10.1073/pnas.88.2.497	45	40	42	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					933	940		10.1038/NCHEMBIO.1086	http://dx.doi.org/10.1038/NCHEMBIO.1086			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23042036	Green Accepted			2022-12-27	WOS:000310052100013
J	Winter, GE; Rix, U; Carlson, SM; Gleixner, KV; Grebien, F; Gridling, M; Muller, AC; Breitwieser, FP; Bilban, M; Colinge, J; Valent, P; Bennett, KL; White, FM; Superti-Furga, G				Winter, Georg E.; Rix, Uwe; Carlson, Scott M.; Gleixner, Karoline V.; Grebien, Florian; Gridling, Manuela; Mueller, Andre C.; Breitwieser, Florian P.; Bilban, Martin; Colinge, Jacques; Valent, Peter; Bennett, Keiryn L.; White, Forest M.; Superti-Furga, Giulio			Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML	NATURE CHEMICAL BIOLOGY			English	Article							CHRONIC MYELOID-LEUKEMIA; C-MYC; GENE-EXPRESSION; SMALL MOLECULES; CANCER; INHIBITOR; MUTATION; PHOSPHORYLATION; TRANSFORMATION; NETWORK	Occurrence of the BCR-ABL(T315I) gatekeeper mutation is among the most pressing challenges in the therapy of chronic myeloid leukemia (CML). Several BCR-ABL inhibitors have multiple targets and pleiotropic effects that could be exploited for their synergistic potential. Testing combinations of such kinase inhibitors identified a strong synergy between danusertib and bosutinib that exclusively affected CML cells harboring BCR-ABL(T315I). To elucidate the underlying mechanisms, we applied a systems-level approach comprising phosphoproteomics, transcriptomics and chemical proteomics. Data integration revealed that both compounds targeted Mapk pathways downstream of BCR-ABL, resulting in impaired activity of c-Myc. Using pharmacological validation, we assessed that the relative contributions of danusertib and bosutinib could be mimicked individually by Mapk inhibitors and collectively by downregulation of c-Myc through Brd4 inhibition. Thus, integration of genome-and proteome-wide technologies enabled the elucidation of the mechanism by which a new drug synergy targets the dependency of BCR-ABL(T315I) CML cells on c-Myc through nonobvious off targets.	[Winter, Georg E.; Rix, Uwe; Grebien, Florian; Gridling, Manuela; Mueller, Andre C.; Breitwieser, Florian P.; Colinge, Jacques; Bennett, Keiryn L.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Carlson, Scott M.; White, Forest M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Carlson, Scott M.; White, Forest M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Gleixner, Karoline V.; Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria; [Valent, Peter] Ludwig Boltzmann Cluster Oncol, Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute	Winter, GE (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Test, Test/Y-7921-2019; Grebien, Florian/H-9234-2019; Valent, Peter/B-8533-2016; Colinge, Jacques/D-1578-2017; Gamperl, Susi/V-2715-2019; Superti-Furga, Giulio/AAE-5681-2019; Colinge, Jacques/Z-2613-2019; Carlson, Scott/E-4606-2010; Superti-Furga, Giulio/F-4755-2015; Test, PV/U-9451-2019	Grebien, Florian/0000-0003-4289-2281; Valent, Peter/0000-0003-0456-5095; Colinge, Jacques/0000-0003-2466-4824; Gamperl, Susi/0000-0003-0456-5095; Colinge, Jacques/0000-0003-2466-4824; Carlson, Scott/0000-0003-1996-0012; Superti-Furga, Giulio/0000-0002-0570-1768; Mueller, Andre/0000-0002-0608-8176; White, Forest/0000-0002-1545-1651; Bennett, Keiryn L./0000-0001-9356-7708; Winter, Georg/0000-0001-6606-1437; Bilban, Martin/0000-0001-7043-7142; Gleixner, Karoline/0000-0001-5753-0203; Breitwieser, Florian P/0000-0001-6192-0853	'GEN-AU' initiative of the Austrian Federal Ministry for Science and Research [PLACEBO GZ BMWF-70.081/0018-II/1a/2008]; Austrian Science Fund [P 24321-B21]; Austrian Science Fund (FWF) [P 24321] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U54CA112967, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083273] Funding Source: NIH RePORTER	'GEN-AU' initiative of the Austrian Federal Ministry for Science and Research; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Bradner (Dana Faber Cancer Institute-Harvard Medical School) for providing JQ1S and JQ1R and R. Giambruno, C. Tan, J. Bigenzahn and O. Hantschel for skillful advice and help. We also thank J. Lehar for inspiring discussions and S. Nijman and O. Hantschel for carefully reading this manuscript. We thank Cell Signaling Technology for allowing reproduction of the kinome map. We acknowledge L. Brecker for measuring NMR spectra. The present work was, in part, financed by the 'GEN-AU' initiative of the Austrian Federal Ministry for Science and Research (PLACEBO GZ BMWF-70.081/0018-II/1a/2008) as well as the Austrian Science Fund (P 24321-B21).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Bixby D, 2011, LEUKEMIA, V25, P7, DOI 10.1038/leu.2010.238; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cortes JE, 2011, BLOOD, V118, P4567, DOI 10.1182/blood-2011-05-355594; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donato NJ, 2004, CANCER RES, V64, P2306; Dopazo J, 1997, J MOL EVOL, V44, P226, DOI 10.1007/PL00006139; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Eide CA, 2011, CANCER RES, V71, P3189, DOI 10.1158/0008-5472.CAN-10-3224; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P2796, DOI 10.1074/mcp.M900285-MCP200; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Rix U, 2010, LEUKEMIA, V24, P44, DOI 10.1038/leu.2009.228; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; SETH A, 1991, J BIOL CHEM, V266, P23521; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	45	79	83	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					905	912		10.1038/NCHEMBIO.1085	http://dx.doi.org/10.1038/NCHEMBIO.1085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23023260	Green Accepted, Green Published			2022-12-27	WOS:000310052100009
J	Blattermann, S; Peters, L; Ottersbach, PA; Bock, A; Konya, V; Weaver, CD; Gonzalez, A; Schroder, R; Tyagi, R; Luschnig, P; Gab, J; Hennen, S; Ulven, T; Pardo, L; Mohr, K; Gutschow, M; Heinemann, A; Kostenis, E				Blaettermann, Stefanie; Peters, Lucas; Ottersbach, Philipp Aaron; Bock, Andreas; Konya, Viktoria; Weaver, C. David; Gonzalez, Angel; Schroeder, Ralf; Tyagi, Rahul; Luschnig, Petra; Gaeb, Juergen; Hennen, Stephanie; Ulven, Trond; Pardo, Leonardo; Mohr, Klaus; Guetschow, Michael; Heinemann, Akos; Kostenis, Evi			A biased ligand for OXE-R uncouples G alpha and G beta gamma signaling within a heterotrimer	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; FUNCTIONAL SELECTIVITY; PHOSPHOLIPASE-C; LIVING CELLS; ACTIVATION; IDENTIFICATION; GPCR; SUBUNIT; COMPLEX	Differential targeting of heterotrimeric G protein versus beta-arrestin signaling are emerging concepts in G protein-coupled receptor (GPCR) research and drug discovery, and biased engagement by GPCR ligands of either beta-arrestin or G protein pathways has been disclosed. Herein we report on a new mechanism of ligand bias to titrate the signaling specificity of a cell-surface GPCR. Using a combination of biomolecular and virtual screening, we identified the small-molecule modulator Gue1654, which inhibits G beta gamma but not G alpha signaling triggered upon activation of G alpha(1)-beta gamma by the chemoattractant receptor OXE-R in both recombinant and human primary cells. Gue1654 does not interfere nonspecifically with signaling directly at or downstream of G beta gamma. This hitherto unappreciated mechanism of ligand bias at a GPCR highlights both a new paradigm for functional selectivity and a potentially new strategy to develop pathway-specific therapeutics.	[Blaettermann, Stefanie; Peters, Lucas; Schroeder, Ralf; Hennen, Stephanie; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany; [Ottersbach, Philipp Aaron; Gaeb, Juergen; Guetschow, Michael] Univ Bonn, Inst Pharmaceut, Bonn, Germany; [Konya, Viktoria; Luschnig, Petra; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Weaver, C. David] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Weaver, C. David] Vanderbilt Univ, Inst Biol Chem, Nashville, TN USA; [Gonzalez, Angel; Pardo, Leonardo] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, E-08193 Barcelona, Spain; [Tyagi, Rahul; Ulven, Trond] Univ So Denmark, Dept Phys & Chem, Odense, Denmark	University of Bonn; University of Bonn; Medical University of Graz; Vanderbilt University; Vanderbilt University; Autonomous University of Barcelona; University of Barcelona; University of Southern Denmark	Kostenis, E (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany.	akos.heinemann@medunigraz.at; kostenis@uni-bonn.de	Gonzalez, Angel/B-2492-2010; Ulven, Trond/H-5500-2015; Gonzalez, Angel/AAU-5927-2020	Gonzalez, Angel/0000-0002-2284-8307; Ulven, Trond/0000-0002-8135-1755; Gonzalez, Angel/0000-0002-2284-8307; Bock, Andreas/0000-0002-6344-6494; Konya, Viktoria/0000-0002-7999-9093; Pardo, Leonardo/0000-0003-1778-7420; Heinemann, Akos/0000-0002-8554-2372	Austrian Science Funds FWF [P-22521]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF2010-22198-C01-02]; L'Oreal Fellowship; German Research Foundation (Graduate College) [804]; Austrian Science Fund (FWF) [P 22521] Funding Source: researchfish	Austrian Science Funds FWF(Austrian Science Fund (FWF)); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); L'Oreal Fellowship(L'Oreal Group); German Research Foundation (Graduate College); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank U. Rick and M. Vasmer-Ehses for excellent technical assistance and Corning Inc. for their support on the Epic system. C. D. W. acknowledges E. Days and Y. Du for valuable technical assistance with cell culture and transient transfections. All thallium flux assays were performed in the Vanderbilt Institute of Chemical Biology High-Throughput Screening Facility. This work was funded by a grant from the Austrian Science Funds FWF (P-22521 to A. H.), a grant from the Spanish Ministerio de Ciencia e Innovacion (MICINN, SAF2010-22198-C01-02 to L. Pardo), a L'Oreal Fellowship to P. L. and a fellowship of the German Research Foundation (Graduate College 804) to P.A.O.	Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bosier B, 2007, TRENDS PHARMACOL SCI, V28, P438, DOI 10.1016/j.tips.2007.06.001; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Grant GE, 2009, PROSTAG OTH LIPID M, V89, P98, DOI 10.1016/j.prostaglandins.2009.05.002; Hartnell A, 2004, J IMMUNOL, V173, P6448, DOI 10.4049/jimmunol.173.10.6448; Hosoi T, 2002, J BIOL CHEM, V277, P31459, DOI 10.1074/jbc.M203194200; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jiang HP, 1996, J BIOL CHEM, V271, P13430, DOI 10.1074/jbc.271.23.13430; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Jones CE, 2003, MOL PHARMACOL, V63, P471, DOI 10.1124/mol.63.3.471; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Maillet EL, 2007, FASEB J, V21, P2124, DOI 10.1096/fj.06-7683com; Mathiesen JM, 2005, MOL PHARMACOL, V68, P393, DOI 10.1124/mol.104.010520; Niswender CM, 2008, MOL PHARMACOL, V73, P1213, DOI 10.1124/mol.107.041053; O'Flaherty JT, 2000, J IMMUNOL, V164, P3345, DOI 10.4049/jimmunol.164.6.3345; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schroder R, 2009, J BIOL CHEM, V284, P1324, DOI 10.1074/jbc.M806867200; Schuligoi R, 2007, BIOCHEM PHARMACOL, V74, P107, DOI 10.1016/j.bcp.2007.03.023; Smith NJ, 2011, MOL CELL ENDOCRINOL, V331, P241, DOI 10.1016/j.mce.2010.07.009; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu DQ, 2000, J CELL SCI, V113, P2935	48	68	71	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					631	638		10.1038/NCHEMBIO.962	http://dx.doi.org/10.1038/NCHEMBIO.962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22634634				2022-12-27	WOS:000305471400010
J	Rodriguez, R; Miller, KM; Forment, JV; Bradshaw, CR; Nikan, M; Britton, S; Oelschlaegel, T; Xhemalce, B; Balasubramanian, S; Jackson, SP				Rodriguez, Raphael; Miller, Kyle M.; Forment, Josep V.; Bradshaw, Charles R.; Nikan, Mehran; Britton, Sebastien; Oelschlaegel, Tobias; Xhemalce, Blerta; Balasubramanian, Shankar; Jackson, Stephen P.			Small-molecule-induced DNA damage identifies alternative DNA structures in human genes	NATURE CHEMICAL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; G-QUADRUPLEX; HUMAN GENOME; IN-VIVO; HELICASE; INHIBITOR; TELOMERE; PROTEIN; CANCER; TRANSCRIPTION	Guanine-rich DNA sequences that can adopt non-Watson-Crick structures in vitro are prevalent in the human genome. Whether such structures normally exist in mammalian cells has, however, been the subject of active research for decades. Here we show that the G-quadruplex-interacting drug pyridostatin promotes growth arrest in human cancer cells by inducing replication-and transcription-dependent DNA damage. A chromatin immunoprecipitation sequencing analysis of the DNA damage marker gamma H2AX provided the genome-wide distribution of pyridostatin-induced sites of damage and revealed that pyridostatin targets gene bodies containing clusters of sequences with a propensity for G-quadruplex formation. As a result, pyridostatin modulated the expression of these genes, including the proto-oncogene SRC. We observed that pyridostatin reduced SRC protein abundance and SRC-dependent cellular motility in human breast cancer cells, validating SRC as a target of this drug. Our unbiased approach to define genomic sites of action for a drug establishes a framework for discovering functional DNA-drug interactions.	[Rodriguez, Raphael; Nikan, Mehran; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Rodriguez, Raphael; Miller, Kyle M.; Forment, Josep V.; Bradshaw, Charles R.; Britton, Sebastien; Oelschlaegel, Tobias; Xhemalce, Blerta; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Miller, Kyle M.; Forment, Josep V.; Britton, Sebastien; Oelschlaegel, Tobias; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Miller, Kyle M.; Xhemalce, Blerta] Univ Texas Austin, Inst Mol & Cellular Biol, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Balasubramanian, Shankar] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge, England; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Texas System; University of Texas Austin; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Rodriguez, R (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sb10031@cam.ac.uk; s.jackson@gurdon.cam.ac.uk	Balasubramanian, Shankar/C-1671-2009; Jackson, Stephen Philip/R-4548-2019; Forment, Josep/J-3678-2015; Britton, Sébastien/AAL-1862-2020; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Forment, Josep/0000-0002-7797-2583; Britton, Sébastien/0000-0002-7008-5316; Rodriguez, Raphael/0000-0001-7668-446X; Balasubramanian, Shankar/0000-0002-0281-5815; Xhemalce, Blerta/0000-0002-0517-9607; Bradshaw, Charles/0000-0002-3528-458X; Miller, Kyle/0000-0002-4544-0013	Wellcome Trust [086861/Z/08/Z]; Cancer Research UK (CRUK) [C6/A11224, C9681/A11961]; Biotechnology and Biological Sciences Research Council [BB/G008337/1]; EMBO (ALTF) [93-2010]; European Research Council; European Community; Wellcome Trust; University of Cambridge; BBSRC [BB/G008337/1] Funding Source: UKRI; Cancer Research UK [11224, 11961] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Cancer Research UK (CRUK)(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO (ALTF); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank AstraZeneca for providing the Chk1/ChK2i (AZD7762), S. Miller for technical assistance with FRET melting experiments and the US National Cancer Institute for screening pyridostatin on a panel of 60 cancer-cell lines. R.R. is a Herchel Smith Research Fellow, K.M.M. is funded by the Wellcome Trust project grant 086861/Z/08/Z, and J.V.F. is funded by Cancer Research UK (CRUK) program grant C6/A11224. Research in the S. Balasubramanian laboratory is funded by CRUK program grant C9681/A11961 and a project grant from the Biotechnology and Biological Sciences Research Council (BB/G008337/1). S. Britton is funded by an EMBO long-term fellowship (ALTF 93-2010). Research in the S.P.J. laboratory is funded by CRUK program grant C6/A11224, the European Research Council and the European Community Seventh Framework Programme (GENICA and DDResponse). Core infrastructure funding was provided by CRUK and the Wellcome Trust. S.P.J. receives his salary from the University of Cambridge, supplemented by CRUK.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Gavathiotis E, 2001, ANGEW CHEM INT EDIT, V40, P4749, DOI 10.1002/1521-3773(20011217)40:24<4749::AID-ANIE4749>3.0.CO;2-I; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Koirala D, 2011, NAT CHEM, V3, P782, DOI [10.1038/NCHEM.1126, 10.1038/nchem.1126]; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Massip L, 2010, CELL CYCLE, V9, P2963, DOI 10.4161/cc.9.15.12412; Mergny JL, 2001, CHEMBIOCHEM, V2, P124, DOI 10.1002/1439-7633(20010202)2:2<124::AID-CBIC124>3.0.CO;2-L; Miller Kyle M, 2011, Expert Rev Clin Pharmacol, V4, P139, DOI 10.1586/ecp.11.4; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Salvati E, 2010, ONCOGENE, V29, P6280, DOI 10.1038/onc.2010.344; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Takebayashi Y, 2001, NAT MED, V7, P961, DOI 10.1038/91008; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492	50	472	476	6	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					301	310		10.1038/NCHEMBIO.780	http://dx.doi.org/10.1038/NCHEMBIO.780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22306580	Green Accepted, Green Submitted			2022-12-27	WOS:000300600000016
J	Razzak, M; De Brabander, JK				Razzak, Mina; De Brabander, Jef K.			Lessons and revelations from biomimetic syntheses	NATURE CHEMICAL BIOLOGY			English	Article							PYRROLE-IMIDAZOLE ALKALOIDS; PRENYLATED INDOLE ALKALOIDS; MARINE-DERIVED FUNGUS; EPOXIDE-OPENING CASCADES; ENDIANDRIC ACID CASCADE; NATURAL-PRODUCTS; BERKELIC ACID; RELATIVE CONFIGURATION; BIOSYNTHETIC PRECURSOR; EUDESMANE TERPENES	Biomimetic synthesis describes the field of organic chemistry that aims to emulate the natural, biosynthetic processes toward natural products. As well as providing insight into how molecules are formed in nature, the benefits of this approach to total synthesis are numerous and extend beyond the gains typical of traditional synthesis. For example, using biosynthetic proposals to design a synthetic route can highlight alternative methods to the desired target. The pursuit of biomimetic syntheses also promotes the development of new reactions to prove or disprove a biosynthetic proposal or to unravel mechanistic implications of a proposed biosynthesis and can lead to the identification of new natural products. Here we look at some recent compelling examples and examine how biomimetic synthesis has led to the discovery of new procedures and principles that would not have been found by other approaches.	[Razzak, Mina; De Brabander, Jef K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	De Brabander, JK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Jef.debrabander@utsouthwestern.edu		Razzak, Mina/0000-0002-4761-5534	National Institutes of Health [CA 90349]; Robert A. Welch Foundation [I-1422]; NATIONAL CANCER INSTITUTE [R01CA090349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. M. Ready and U. K. Tambar (University of Texas Southwestern) for critical reading of this manuscript. We gratefully acknowledge financial support by the National Institutes of Health (CA 90349) and the Robert A. Welch Foundation (I-1422).	Al Mourabit A, 2001, EUR J ORG CHEM, V2001, P237; ALVAREZ E, 1995, CHEM REV, V95, P1953, DOI 10.1021/cr00038a008; Artman GD, 2007, J AM CHEM SOC, V129, P6336, DOI 10.1021/ja070259i; BALDWIN JE, 1988, NAT PROD REP, V5, P129, DOI 10.1039/np9880500129; BALDWIN JE, 1976, J CHEM SOC CHEM COMM, V734, P1976; Baran PS, 2004, ANGEW CHEM INT EDIT, V43, P2674, DOI 10.1002/anie.200453937; Barton D.H.R, 1996, REASON IMAGINATION R; Beaudry CM, 2005, CHEM REV, V105, P4757, DOI 10.1021/cr0406110; Bender CF, 2009, J AM CHEM SOC, V131, P11350, DOI 10.1021/ja905387r; Bentley R, 1999, ANNU REV MICROBIOL, V53, P411, DOI 10.1146/annurev.micro.53.1.411; Brastianos HC, 2006, J AM CHEM SOC, V128, P16046, DOI 10.1021/ja067211+; BRESLOW R, 1972, CHEM SOC REV, V1, P553, DOI 10.1039/cs9720100553; Brunoldi E, 2006, CURR ORG CHEM, V10, P2259, DOI 10.2174/138527206778742614; Buchanan MS, 2007, TETRAHEDRON LETT, V48, P4573, DOI 10.1016/j.tetlet.2007.04.128; Buchanan MS, 2007, J ORG CHEM, V72, P2309, DOI 10.1021/jo062007q; Buchgraber P, 2008, ANGEW CHEM INT EDIT, V47, P8450, DOI 10.1002/anie.200803339; Bulger PG, 2008, NAT PROD REP, V25, P254, DOI 10.1039/b705909b; Byers JA, 2009, J AM CHEM SOC, V131, P6383, DOI 10.1021/ja9004909; Campbell CD, 2010, BIOPOLYMERS, V93, P755, DOI 10.1002/bip.21428; Chen K, 2010, TETRAHEDRON, V66, P4738, DOI 10.1016/j.tet.2010.02.088; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Cherney EC, 2011, ISR J CHEM, V51, P391, DOI 10.1002/ijch.201100005; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Davis EM, 2000, TOP CURR CHEM, V209, P53; De Brabander JK, 2008, ORG LETT, V10, P2533, DOI 10.1021/ol8008107; de la Torre MC, 2004, ANGEW CHEM INT EDIT, V43, P160, DOI 10.1002/anie.200200545; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Dehn R, 2011, ANGEW CHEM INT EDIT, V50, P3882, DOI 10.1002/anie.201006880; Ding YS, 2010, J AM CHEM SOC, V132, P12733, DOI 10.1021/ja1049302; Engelin CJ, 2011, MOLECULES, V16, P951, DOI 10.3390/molecules16010951; ESCHENMOSER A, 1988, ANGEW CHEM INT EDIT, V27, P5, DOI 10.1002/anie.198800051; Finefield JM, 2010, J ORG CHEM, V75, P2785, DOI 10.1021/jo100332c; Giri R, 2009, CHEM SOC REV, V38, P3242, DOI 10.1039/b816707a; Greshock TJ, 2008, ANGEW CHEM INT EDIT, V47, P3573, DOI 10.1002/anie.200800106; Greshock TJ, 2007, ANGEW CHEM INT EDIT, V46, P2262, DOI 10.1002/anie.200604378; Grubbs AW, 2007, ANGEW CHEM INT EDIT, V46, P2257, DOI 10.1002/anie.200604377; Grube A, 2007, ANGEW CHEM INT EDIT, V46, P6721, DOI 10.1002/anie.200701935; Grube A, 2007, ANGEW CHEM INT EDIT, V46, P2320, DOI 10.1002/anie.200604076; HEATHCOCK CH, 1992, ANGEW CHEM INT EDIT, V31, P665, DOI 10.1002/anie.199206653; Heathcock CH, 1996, P NATL ACAD SCI USA, V93, P14323, DOI 10.1073/pnas.93.25.14323; Hoberg JO, 1998, TETRAHEDRON, V54, P12631, DOI 10.1016/S0040-4020(98)00596-1; Hoffmann H, 2003, SYNTHESIS-STUTTGART, P1753, DOI 10.1055/s-2003-41005; Ishihara Y, 2010, SYNLETT, P1733, DOI 10.1055/s-0030-1258123; Jacquot DEN, 2005, CURR ORG CHEM, V9, P1551, DOI 10.2174/138527205774370531; Kato H, 2007, ANGEW CHEM INT EDIT, V46, P2254, DOI 10.1002/anie.200604381; KATO T, 1995, TETRAHEDRON LETT, V36, P2133, DOI 10.1016/0040-4039(95)00194-H; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; Kinnel RB, 1998, J ORG CHEM, V63, P3281, DOI 10.1021/jo971987z; KINNEL RB, 1993, J AM CHEM SOC, V115, P3376, DOI 10.1021/ja00061a065; Kobayashi H, 2007, TETRAHEDRON LETT, V48, P2127, DOI 10.1016/j.tetlet.2007.01.113; KOBAYASHI J, 1990, TETRAHEDRON, V46, P5579, DOI 10.1016/S0040-4020(01)87756-5; Kobayashi J, 1997, TETRAHEDRON, V53, P15681, DOI 10.1016/S0040-4020(97)10022-9; Kock M, 2007, ANGEW CHEM INT EDIT, V46, P6586, DOI 10.1002/anie.200701798; Lane AL, 2011, NAT PROD REP, V28, P411, DOI 10.1039/c0np90032j; Lanman BA, 2007, J AM CHEM SOC, V129, P12896, DOI 10.1021/ja074939x; LEE MS, 1989, J AM CHEM SOC, V111, P6234, DOI 10.1021/ja00198a039; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; Liu B, 2006, ORG LETT, V8, P4907, DOI 10.1021/ol0619819; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Ma ZQ, 2011, CHEM COMMUN, V47, P427, DOI 10.1039/c0cc02214d; Maimone TJ, 2007, NAT CHEM BIOL, V3, P396, DOI 10.1038/nchembio.2007.1; Marmsater FP, 2002, CHEM-EUR J, V8, P4347, DOI 10.1002/1521-3765(20021004)8:19<4346::AID-CHEM4346>3.0.CO;2-S; Morten CJ, 2011, J AM CHEM SOC, V133, P1902, DOI 10.1021/ja1088748; Morten CJ, 2009, CHEM SOC REV, V38, P3175, DOI 10.1039/b816697h; Morten CJ, 2009, J AM CHEM SOC, V131, P6678, DOI 10.1021/ja9025243; NAKAJIMA H, 1993, J ORG CHEM, V58, P4526, DOI 10.1021/jo00069a008; NAKANISHI K, 1985, TOXICON, V23, P473, DOI 10.1016/0041-0101(85)90031-5; Nakata T, 2005, CHEM REV, V105, P4314, DOI 10.1021/cr040627q; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; NICOLAOU KC, 1982, J AM CHEM SOC, V104, P5558, DOI 10.1021/ja00384a079; NICOLAOU KC, 1982, J AM CHEM SOC, V104, P5560, DOI 10.1021/ja00384a080; Nicolaou KC, 1996, ANGEW CHEM INT EDIT, V35, P589; Northrop BH, 2006, ANGEW CHEM INT EDIT, V45, P4126, DOI 10.1002/anie.200600514; O'Malley DP, 2007, J AM CHEM SOC, V129, P4762, DOI 10.1021/ja069035a; Paz B, 2008, MAR DRUGS, V6, P73, DOI 10.3390/md20080005; Pohnert G, 2003, CHEMBIOCHEM, V4, P713, DOI 10.1002/cbic.200300651; Robinson R, 1917, J CHEM SOC, V111, P762, DOI 10.1039/ct9171100762; Sasaki M, 2008, NAT PROD REP, V25, P401, DOI 10.1039/b705664h; Scholz U, 2000, NAT PROD REP, V17, P349, DOI 10.1039/a902278c; Seiple IB, 2010, ANGEW CHEM INT EDIT, V49, P1095, DOI 10.1002/anie.200907112; SHIMIZU Y, 1986, NATURAL TOXINS ANIMA, P123; Snyder SA, 2007, ANGEW CHEM INT EDIT, V46, P8186, DOI 10.1002/anie.200703333; Snyder SA, 2009, J AM CHEM SOC, V131, P1753, DOI 10.1021/ja806183r; Stierle AA, 2006, J ORG CHEM, V71, P5357, DOI 10.1021/jo060018d; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Stork G., 2001, BIOGRAPHICAL MEMOIRS, V23-24, P182; TAYLOR SK, 1992, ORG PREP PROCED INT, V24, P245, DOI 10.1080/00304949209355890; Tsukamoto S, 2010, J NAT PROD, V73, P1438, DOI 10.1021/np1002498; Tsukamoto S, 2009, J AM CHEM SOC, V131, P3834, DOI 10.1021/ja810029b; Tsukamoto S, 2008, J NAT PROD, V71, P2064, DOI 10.1021/np800471y; Tsukamoto S, 2009, ORG LETT, V11, P1297, DOI 10.1021/ol900071c; Vilotijevic I, 2007, SCIENCE, V317, P1189, DOI 10.1126/science.1146421; Vilotijevic I, 2010, MAR DRUGS, V8, P763, DOI 10.3390/md8030763; Vilotijevic I, 2009, ANGEW CHEM INT EDIT, V48, P5250, DOI 10.1002/anie.200900600; Volgraf M, 2008, NAT CHEM BIOL, V4, P535, DOI 10.1038/nchembio.107; WALKER RP, 1981, J AM CHEM SOC, V103, P6772, DOI 10.1021/ja00412a052; Weinreb SM, 2007, NAT PROD REP, V24, P931, DOI 10.1039/b700206h; Williams RM, 2011, J ORG CHEM, V76, P4221, DOI 10.1021/jo2003693; Wu XX, 2009, ANGEW CHEM INT EDIT, V48, P1283, DOI 10.1002/anie.200805488; YASUMOTO T, 1976, B JPN SOC SCI FISH, V42, P359; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l	104	89	89	0	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					865	875		10.1038/NCHEMBIO.709	http://dx.doi.org/10.1038/NCHEMBIO.709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22086288				2022-12-27	WOS:000297166200007
J	Stephanopoulos, N; Francis, MB				Stephanopoulos, Nicholas; Francis, Matthew B.			Choosing an effective protein bioconjugation strategy	NATURE CHEMICAL BIOLOGY			English	Review							BIOMIMETIC TRANSAMINATION REACTION; COPPER(I)-CATALYZED AZIDE-ALKYNE; UNNATURAL AMINO-ACIDS; VIRUS-LIKE PARTICLES; COWPEA MOSAIC-VIRUS; IN-VIVO; GENETIC-CODE; RECOMBINANT PROTEINS; ESCHERICHIA-COLI; LIVING CELLS	The collection of chemical techniques that can be used to attach synthetic groups to proteins has expanded substantially in recent years. Each of these approaches allows new protein targets to be addressed, leading to advances in biological understanding, new protein-drug conjugates, targeted medical imaging agents and hybrid materials with complex functions. The protein modification reactions in current use vary widely in their inherent site selectivity, overall yields and functional group compatibility. Some are more amenable to large-scale bioconjugate production, and a number of techniques can be used to label a single protein in a complex biological mixture. This review examines the way in which experimental circumstances influence one's selection of an appropriate protein modification strategy. It also provides a simple decision tree that can narrow down the possibilities in many instances. The review concludes with example studies that examine how this decision process has been applied in different contexts.	[Stephanopoulos, Nicholas; Francis, Matthew B.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Stephanopoulos, Nicholas; Francis, Matthew B.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Francis, MB (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	francis@cchem.berkeley.edu			Office of Science, Materials Sciences and Engineering Division, US Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072700] Funding Source: NIH RePORTER	Office of Science, Materials Sciences and Engineering Division, US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our efforts to develop new bioconjugation strategies, capsid-based delivery agents, and protein-polymer hybrid materials have been generously supported by the US National Institutes of Health (GM072700), the Department of Defense Breast Cancer Research Program (BC061995) and the US National Science Foundation (0449772). While writing this manuscript, N. S. was supported by the Director of the Office of Science, Materials Sciences and Engineering Division, US Department of Energy under contract no. DE-AC02-05CH11231.	Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228; Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; Antos JM, 2004, J AM CHEM SOC, V126, P10256, DOI 10.1021/ja047272c; Baker DP, 2006, BIOCONJUGATE CHEM, V17, P179, DOI 10.1021/bc050237q; Banerjee D, 2010, CHEMBIOCHEM, V11, P1273, DOI 10.1002/cbic.201000125; Beatty KE, 2010, CHEMBIOCHEM, V11, P2092, DOI 10.1002/cbic.201000419; Bernardes GJL, 2008, ANGEW CHEM INT EDIT, V47, P2244, DOI 10.1002/anie.200704381; Bernardes GJL, 2008, J AM CHEM SOC, V130, P5052, DOI 10.1021/ja800800p; Buehler MJ, 2010, HFSP J, V4, P26, DOI 10.2976/1.3267779; Carrico IS, 2007, NAT CHEM BIOL, V3, P321, DOI 10.1038/nchembio878; Carrico ZM, 2008, CHEM COMMUN, P1205, DOI 10.1039/b717826c; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chalker JM, 2009, CHEM-ASIAN J, V4, P630, DOI 10.1002/asia.200800427; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Cornish VW, 1996, J AM CHEM SOC, V118, P8150, DOI 10.1021/ja961216x; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dedeo MT, 2010, NANO LETT, V10, P181, DOI 10.1021/nl9032395; Deiters A, 2003, J AM CHEM SOC, V125, P11782, DOI 10.1021/ja0370037; Destito G, 2007, CHEM BIOL, V14, P1152, DOI 10.1016/j.chembiol.2007.08.015; Dirksen A, 2006, ANGEW CHEM INT EDIT, V45, P7581, DOI 10.1002/anie.200602877; Doolittle R.F., 1989, PREDICTION PROTEIN S, P599; Duckworth BP, 2006, BIOCONJUGATE CHEM, V17, P967, DOI 10.1021/bc060125e; Esser-Kahn AP, 2008, J AM CHEM SOC, V130, P15820, DOI 10.1021/ja807095r; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fernandez-Suarez M, 2007, NAT BIOTECHNOL, V25, P1483, DOI 10.1038/nbt1355; Garimella PD, 2011, J AM CHEM SOC, V133, P14704, DOI 10.1021/ja204516p; Gauchet C, 2006, J AM CHEM SOC, V128, P9274, DOI 10.1021/ja061131o; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gautier A, 2011, J AM CHEM SOC, V133, P2124, DOI 10.1021/ja1109979; GEOGHEGAN KF, 1992, BIOCONJUGATE CHEM, V3, P138, DOI 10.1021/bc00014a008; Gilmore JM, 2006, ANGEW CHEM INT EDIT, V45, P5307, DOI 10.1002/anie.200600368; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; Guo JT, 2009, ANGEW CHEM INT EDIT, V48, P9148, DOI 10.1002/anie.200904035; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Hong V, 2010, BIOCONJUGATE CHEM, V21, P1912, DOI 10.1021/bc100272z; HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.bi.54.070185.004103; Hooker JM, 2006, J AM CHEM SOC, V128, P15558, DOI 10.1021/ja064088d; Hooker JM, 2004, J AM CHEM SOC, V126, P3718, DOI 10.1021/ja031790q; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Hughes CC, 2009, J AM CHEM SOC, V131, P12094, DOI 10.1021/ja903149u; JENCKS WP, 1959, J AM CHEM SOC, V81, P475, DOI 10.1021/ja01511a053; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Joshi NS, 2004, J AM CHEM SOC, V126, P15942, DOI 10.1021/ja0439017; Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Koshi Y, 2008, J AM CHEM SOC, V130, P245, DOI 10.1021/ja075684q; Kovacs EW, 2007, BIOCONJUGATE CHEM, V18, P1140, DOI 10.1021/bc070006e; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Li XF, 2000, TETRAHEDRON LETT, V41, P4069, DOI 10.1016/S0040-4039(00)00592-X; Lin YA, 2008, J AM CHEM SOC, V130, P9642, DOI 10.1021/ja8026168; Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; MASTICO RA, 1993, J GEN VIROL, V74, P541, DOI 10.1099/0022-1317-74-4-541; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; Meier JL, 2006, J AM CHEM SOC, V128, P12174, DOI 10.1021/ja063217n; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Nam YS, 2010, NAT NANOTECHNOL, V5, P340, DOI [10.1038/NNANO.2010.57, 10.1038/nnano.2010.57]; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Oh IK, 2006, BIOCONJUGATE CHEM, V17, P721, DOI 10.1021/bc060030c; Ottesen JJ, 2004, BIOCHEMISTRY-US, V43, P5698, DOI 10.1021/bi0498407; Pauly H, 1904, H-S Z PHYSIOL CHEM, V42, P508, DOI 10.1515/bchm2.1904.42.5-6.508; Popp BV, 2010, J AM CHEM SOC, V132, P6660, DOI 10.1021/ja101456c; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Raja KS, 2003, BIOMACROMOLECULES, V4, P472, DOI 10.1021/bm025740+; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Ryan CP, 2011, CHEM COMMUN, V47, P5452, DOI 10.1039/c1cc11114k; Sato H, 1996, BIOCHEMISTRY-US, V35, P13072, DOI 10.1021/bi952616k; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Scheck RA, 2008, J AM CHEM SOC, V130, P11762, DOI 10.1021/ja802495w; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Smith MEB, 2010, J AM CHEM SOC, V132, P1960, DOI 10.1021/ja908610s; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Stephanopoulos N, 2010, ACS NANO, V4, P6014, DOI 10.1021/nn1014769; Stephanopoulos N, 2009, ANGEW CHEM INT EDIT, V48, P9498, DOI 10.1002/anie.200902727; Strable E, 2008, BIOCONJUGATE CHEM, V19, P866, DOI 10.1021/bc700390r; Suci PA, 2007, LANGMUIR, V23, P12280, DOI 10.1021/la7021424; Tam JP, 1999, BIOPOLYMERS, V51, P311, DOI 10.1002/(SICI)1097-0282(1999)51:5<311::AID-BIP2>3.0.CO;2-A; Tilley S. D., 2008, WILEY ENCY CHEM BIOL, P1; Tilley SD, 2006, J AM CHEM SOC, V128, P1080, DOI 10.1021/ja057106k; Tolbert TJ, 2000, J AM CHEM SOC, V122, P5421, DOI 10.1021/ja0000192; Tong GJ, 2009, J AM CHEM SOC, V131, P11174, DOI 10.1021/ja903857f; Tsukiji S, 2009, NAT CHEM BIOL, V5, P341, DOI 10.1038/nchembio.157; Valiyaveetil FI, 2004, P NATL ACAD SCI USA, V101, P17045, DOI 10.1073/pnas.0407820101; van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; White MA, 2005, ANNU REV PHARMACOL, V45, P587, DOI 10.1146/annurev.pharmtox.45.120403.095807; Witus LS, 2010, J AM CHEM SOC, V132, P16812, DOI 10.1021/ja105429n; Wu P, 2009, P NATL ACAD SCI USA, V106, P3000, DOI 10.1073/pnas.0807820106; Wu W, 2009, ANGEW CHEM INT EDIT, V48, P9493, DOI 10.1002/anie.200902426; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xu R, 1999, P NATL ACAD SCI USA, V96, P388, DOI 10.1073/pnas.96.2.388; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	102	410	420	5	427	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					876	884		10.1038/NCHEMBIO.720	http://dx.doi.org/10.1038/NCHEMBIO.720			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22086289				2022-12-27	WOS:000297166200008
J	Burgett, AWG; Poulsen, TB; Wangkanont, K; Anderson, DR; Kikuchi, C; Shimada, K; Okubo, S; Fortner, KC; Mimaki, Y; Kuroda, M; Murphy, JP; Schwalb, DJ; Petrella, EC; Cornella-Taracido, I; Schirle, M; Tallarico, JA; Shair, MD				Burgett, Anthony W. G.; Poulsen, Thomas B.; Wangkanont, Kittikhun; Anderson, D. Ryan; Kikuchi, Chikako; Shimada, Kousei; Okubo, Shuichi; Fortner, Kevin C.; Mimaki, Yoshihiro; Kuroda, Minpei; Murphy, Jason P.; Schwalb, David J.; Petrella, Eugene C.; Cornella-Taracido, Ivan; Schirle, Markus; Tallarico, John A.; Shair, Matthew D.			Natural products reveal cancer cell dependence on oxysterol-binding proteins	NATURE CHEMICAL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; CHOLESTANE GLYCOSIDES; STEROL-BINDING; TUMOR-CELLS; GOLGI; TRANSPORT; 25-HYDROXYCHOLESTEROL; EXPRESSION; IDENTIFICATION; TRAFFICKING	Cephalostatin 1, OSW-1, ritterazine B and schweinfurthin A are natural products that potently, and in some cases selectively, inhibit the growth of cultured human cancer cell lines. The cellular targets of these small molecules have yet to be identified. We have discovered that these molecules target oxysterol binding protein (OSBP) and its closest paralog, OSBP-related protein 4L (ORP4L)-proteins not known to be involved in cancer cell survival. OSBP and the ORPs constitute an evolutionarily conserved protein superfamily, members of which have been implicated in signal transduction, lipid transport and lipid metabolism. The functions of OSBP and the ORPs, however, remain largely enigmatic. Based on our findings, we have named the aforementioned natural products ORPphilins. Here we used ORPphilins to reveal new cellular activities of OSBP. The ORPphilins are powerful probes of OSBP and ORP4L that will be useful in uncovering their cellular functions and their roles in human diseases.	[Burgett, Anthony W. G.; Poulsen, Thomas B.; Wangkanont, Kittikhun; Anderson, D. Ryan; Kikuchi, Chikako; Shimada, Kousei; Okubo, Shuichi; Fortner, Kevin C.; Shair, Matthew D.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Mimaki, Yoshihiro; Kuroda, Minpei] Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo, Japan; [Murphy, Jason P.; Schwalb, David J.; Petrella, Eugene C.; Cornella-Taracido, Ivan; Schirle, Markus; Tallarico, John A.] Novartis Inst Biomed Res, Cambridge, MA USA	Harvard University; Tokyo University of Pharmacy & Life Sciences; Novartis	Burgett, AWG (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	shair@chemistry.harvard.edu	Poulsen, Thomas/C-5953-2017; Wangkanont, Kittikhun/AAF-8664-2019	Poulsen, Thomas/0000-0002-0763-9996; Cornella-Taracido, Ivan/0000-0002-9433-5041; Shimada, Kousei/0000-0002-9765-526X; Wangkanont, Kittikhun/0000-0002-7190-2955	Lundbeck foundation; Danish Council for Independent Research-Natural Sciences; Susan G. Komen for the Cure Foundation; Novartis Institutes of Biomedical Research; US NIH [R01GM090068]; Harvard Clinical and Translational Science Center (NIH) [UL1RR025758]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090068] Funding Source: NIH RePORTER	Lundbeck foundation(Lundbeckfonden); Danish Council for Independent Research-Natural Sciences(Det Frie Forskningsrad (DFF)); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Novartis Institutes of Biomedical Research; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NCI for the generous gifts of schweinfurthin A. (J.A. Beutler) and ritterazine B. We gratefully acknowledge the aforementioned reagents provided by G. Romeo (Joslin Diabetes Center), M. Brown and J. Goldstein (University of Texas Southwestern Medical Center), H. Arai (University of Tokyo), B. Vogelstein (Johns Hopkins University) and D. Ory (Washington University, St. Louis). The beta-tubulin monoclonal antibody (E7) developed by M. Klymkowsky was obtained from the Developmental Studies Hybridoma Bank (National Institute of Child Health and Human Development, US National Institutes of Health (NIH) and University of Iowa, Department of Biology). R. King is acknowledged for helpful comments and discussions. T.B.P. would like to thank the Lundbeck foundation for a post-doctoral fellowship and the Danish Council for Independent Research-Natural Sciences for additional financial support. A.W.G.B gratefully thanks the Susan G. Komen for the Cure Foundation for providing a postdoctoral research fellowship. Financial support from the Novartis Institutes of Biomedical Research, the US NIH (grant no. R01GM090068), the Harvard Catalyst and The Harvard Clinical and Translational Science Center (NIH award no. UL1RR025758) is acknowledged. This work was conducted with support and financial contributions from Harvard University and its affiliated academic health care centers.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Beh CT, 2001, GENETICS, V157, P1117; Beutler JA, 1998, J NAT PROD, V61, P1509, DOI 10.1021/np980208m; BEUTLER JA, 2006, MED AROMATIC PLANTS, pCH22; Boyd MR, 2004, CANC DRUG DISC DEV, P41; Collingwood TN, 1997, P NATL ACAD SCI USA, V94, P248, DOI 10.1073/pnas.94.1.248; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dirsch VM, 2003, CANCER RES, V63, P8869; El Khissiin A, 1999, FEBS LETT, V448, P160, DOI 10.1016/S0014-5793(99)00343-9; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; Fortner KC, 2010, J AM CHEM SOC, V132, P275, DOI 10.1021/ja906996c; Fournier, 2001, CANCER RES, V61, P792; Fournier MV, 1999, CANCER RES, V59, P3748; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Komiya T, 2003, CANCER CHEMOTH PHARM, V51, P202, DOI 10.1007/s00280-002-0558-8; KUBO S, 1992, PHYTOCHEMISTRY, V31, P3969, DOI 10.1016/S0031-9422(00)97565-4; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Mimaki Y, 1997, BIOORG MED CHEM LETT, V7, P633, DOI 10.1016/S0960-894X(97)00071-1; Moser BR, 2008, J NAT PROD, V71, P487, DOI 10.1021/np070536z; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nishimura T, 2005, GENES CELLS, V10, P793, DOI 10.1111/j.1365-2443.2005.00879.x; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; PETTIT GR, 1988, J AM CHEM SOC, V110, P2006, DOI 10.1021/ja00214a078; Rabow AA, 2002, J MED CHEM, V45, P818, DOI 10.1021/jm010385b; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; RIDGWAY ND, 1995, J LIPID RES, V36, P1345; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Romeo GR, 2008, J BIOL CHEM, V283, P9595, DOI 10.1074/jbc.M710092200; Rudy A, 2008, J NAT PROD, V71, P482, DOI 10.1021/np070534e; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tasdemir D, 2002, J NAT PROD, V65, P210, DOI 10.1021/np0104020; TAYLOR FR, 1985, CHEM PHYS LIPIDS, V38, P187, DOI 10.1016/0009-3084(85)90066-0; Turbyville TJ, 2010, MOL CANCER THER, V9, P1234, DOI 10.1158/1535-7163.MCT-09-0834; Wang PY, 2008, J BIOL CHEM, V283, P8034, DOI 10.1074/jbc.M707631200; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wyles JP, 2007, EXP CELL RES, V313, P1426, DOI 10.1016/j.yexcr.2007.01.018; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4; Yan D, 2007, ARTERIOSCL THROM VAS, V27, P1618, DOI 10.1161/ATVBAHA.107.144121; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Zerbinatti CV, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-5; Zhou Y, 2005, JNCI-J NATL CANCER I, V97, P1781, DOI 10.1093/jnci/dji404	50	173	174	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					639	647		10.1038/nchembio.625	http://dx.doi.org/10.1038/nchembio.625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21822274	Green Accepted, Green Published			2022-12-27	WOS:000294381400015
J	Lee, J; Culyba, EK; Powers, ET; Kelly, JW				Lee, Jiyong; Culyba, Elizabeth K.; Powers, Evan T.; Kelly, Jeffery W.			Amyloid-beta forms fibrils by nucleated conformational conversion of oligomers	NATURE CHEMICAL BIOLOGY			English	Article							ALZHEIMERS-DISEASE; PLASMALOGEN DEFICIENCY; PROTEIN; MECHANISM; FLASH; FIBRILLOGENESIS; PROTOFIBRILS; AGGREGATION; MODELS; STATE	Amyloid-beta amyloidogenesis is reported to occur via a nucleated polymerization mechanism. If this is true, the energetically unfavorable oligomeric nucleus should be very hard to detect. However, many laboratories have detected early nonfibrillar amyloid-beta oligomers without observing amyloid fibrils, suggesting that a mechanistic revision may be needed. Here we introduce Cys-Cys-amyloid-beta(1-40r) which cannot bind to the latent fluorophore FlAsH as a monomer, but can bind FlAsH as an nonfibrillar oligomer or as a fibril, rendering the conjugates fluorescent. Through FlAsH monitoring of Cys-Cys-amyloid-beta(1-40) aggregation, we found that amyloid-beta(1-40) rapidly and efficiently forms spherical oligomers in vitro (85% yield) that are kinetically competent to slowly convert to amyloid fibrils by a nucleated conformational conversion mechanism. This methodology was used to show that plasmalogen ethanolamine vesicles eliminate the proteotoxicity-associated oligomerization phase of amyloid-beta amyloidogenesis while allowing fibril formation, rationalizing how low concentrations of plasmalogen ethanolamine in the brain are epidemiologically linked to Alzheimer's disease.	[Lee, Jiyong; Culyba, Elizabeth K.; Powers, Evan T.; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Lee, Jiyong; Culyba, Elizabeth K.; Powers, Evan T.; Kelly, Jeffery W.] Skaggs Inst Chem Biol, La Jolla, CA USA; [Lee, Jiyong; Culyba, Elizabeth K.; Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Lee, J (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	jkelly@scripps.edu	Lee, Jiyong/B-4894-2017	Powers, Evan/0000-0001-8185-8487; Lee, Jiyong/0000-0002-4455-3358	US National Institutes of Health [NS050636]; Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050636] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the US National Institutes of Health (NS050636), The Skaggs Institute for Chemical Biology and the Lita Annenberg Hazen Foundation for financial support and C. Fearns for critical feedback on the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bieschke J, 2005, BIOCHEMISTRY-US, V44, P4977, DOI 10.1021/bi0501030; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Cloe AL, 2011, BIOCHEMISTRY-US, V50, P2026, DOI 10.1021/bi1016217; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Goodman JL, 2009, CHEMBIOCHEM, V10, P1644, DOI 10.1002/cbic.200900207; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Holtzman DM, 2011, SCI TRANSL MED, V3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Krishnan B, 2008, CHEM BIOL, V15, P1104, DOI 10.1016/j.chembiol.2008.09.006; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Luedtke NW, 2007, NAT CHEM BIOL, V3, P779, DOI 10.1038/nchembio.2007.49; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Roberti MJ, 2007, NAT METHODS, V4, P345, DOI 10.1038/NMETH1026; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sabate R, 2005, J PHYS CHEM B, V109, P11027, DOI 10.1021/jp050716m; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Webber TM, 2009, BIOCHEM BIOPH RES CO, V384, P66, DOI 10.1016/j.bbrc.2009.04.073; Wei L, 2011, J BIOL CHEM, V286, P6291, DOI 10.1074/jbc.M110.166678; Wells K, 1995, NEUROCHEM RES, V20, P1329, DOI 10.1007/BF00992508; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yushchenko DA, 2010, J AM CHEM SOC, V132, P7860, DOI 10.1021/ja102838n	51	315	319	8	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					602	609		10.1038/NCHEMBIO.624	http://dx.doi.org/10.1038/NCHEMBIO.624			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21804535	Green Accepted			2022-12-27	WOS:000294381400010
J	Jensen, MP; Gorman-Lewis, D; Aryal, B; Paunesku, T; Vogt, S; Rickert, PG; Seifert, S; Lai, B; Woloschak, GE; Soderholm, L				Jensen, Mark P.; Gorman-Lewis, Drew; Aryal, Baikuntha; Paunesku, Tatjana; Vogt, Stefan; Rickert, Paul G.; Seifert, Soenke; Lai, Barry; Woloschak, Gayle E.; Soderholm, L.			An iron-dependent and transferrin-mediated cellular uptake pathway for plutonium	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN SERUM TRANSFERRIN; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; SEQUESTERING AGENTS; BINDING-SITES; CHEMISTRY; RECEPTOR; DESIGN; FORM	Plutonium is a toxic synthetic element with no natural biological function, but it is strongly retained by humans when ingested. Using small-angle X-ray scattering, receptor binding assays and synchrotron X-ray fluorescence microscopy, we find that rat adrenal gland (PC12) cells can acquire plutonium in vitro through the major iron acquisition pathway-receptor-mediated endocytosis of the iron transport protein serum transferrin; however, only one form of the plutonium-transferrin complex is active. Low-resolution solution models of plutonium-loaded transferrins derived from small-angle scattering show that only transferrin with plutonium bound in the protein's C-terminal lobe (C-lobe) and iron bound in the N-terminal lobe (N-lobe) (PuCFeNTf) adopts the proper conformation for recognition by the transferrin receptor protein. Although the metal-binding site in each lobe contains the same donors in the same configuration and both lobes are similar, the differences between transferrin's two lobes act to restrict, but not eliminate, cellular Pu uptake.	[Jensen, Mark P.; Gorman-Lewis, Drew; Aryal, Baikuntha; Rickert, Paul G.; Soderholm, L.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Aryal, Baikuntha] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Paunesku, Tatjana; Woloschak, Gayle E.] Northwestern Univ, Feinberg Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA; [Paunesku, Tatjana; Woloschak, Gayle E.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Vogt, Stefan; Seifert, Soenke; Lai, Barry] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; United States Department of Energy (DOE); Argonne National Laboratory	Jensen, MP (corresponding author), Argonne Natl Lab, Chem Sci & Engn Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	mjensen@anl.gov	Woloschak, Gayle E/A-3799-2017; Vogt, Stefan/J-7937-2013; Jensen, Mark P/G-9131-2012; Vogt, Stefan/B-9547-2009; Paunesku, Tatjana/A-3488-2017; Soderholm, Lynda/H-4432-2011; Paunesku, Tatjana/AAF-8529-2021	Woloschak, Gayle E/0000-0001-9209-8954; Vogt, Stefan/0000-0002-8034-5513; Jensen, Mark P/0000-0003-4494-6693; Vogt, Stefan/0000-0002-8034-5513; Paunesku, Tatjana/0000-0001-8698-2938; Soderholm, Lynda/0000-0003-4435-2721; Paunesku, Tatjana/0000-0001-8698-2938	US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; US National Institutes of Health [EB002100, U54CA119341]; NATIONAL CANCER INSTITUTE [U54CA119341, R01CA107467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002100] Funding Source: NIH RePORTER	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work at Argonne National Laboratory, including the use of the Advanced Photon Source, was supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357, whereas work at Northwestern University was supported by US National Institutes of Health grants EB002100 and U54CA119341.	ALLARD B, 1980, J INORG NUCL CHEM, V42, P1015, DOI 10.1016/0022-1902(80)80394-0; Antonio MR, 2009, J ELECTROANAL CHEM, V626, P103, DOI 10.1016/j.jelechem.2008.11.009; Baker E., 1994, ADV INORG CHEM, P389, DOI [10.1016/S0898-8838(08)60176-2, DOI 10.1016/S0898-8838(08)60176-2]; Baker HM, 2000, J BIOL INORG CHEM, V5, P692, DOI 10.1007/s007750000157; BALI PK, 1990, ARCH BIOCHEM BIOPHYS, V281, P251, DOI 10.1016/0003-9861(90)90440-A; BOOCOCK G, 1965, NATURE, V208, P282, DOI 10.1038/208282a0; BOOCOCK G, 1970, RADIAT RES, V42, P381, DOI 10.2307/3572805; Cai Z, 2003, J PHYS IV, V104, P17, DOI 10.1051/jp4:200300020; CHASTEEN ND, 1981, BIOCHEM J, V193, P717, DOI 10.1042/bj1930717; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; CHOPPIN GR, 1983, RADIOCHIM ACTA, V32, P43, DOI 10.1524/ract.1983.32.13.43; CLARK D.L., 2006, CHEM ACTINIDE TRANSA, DOI DOI 10.1007/1-4020-3598-5_7; DUFFIELD JR, 1986, INT J NUCL MED BIOL, V12, P483, DOI 10.1016/S0047-0740(86)80012-2; DUFFIELD JR, 1994, HANDB PHYSI, V18, P591; DUFFIELD JR, 1986, HDB PHYSICS CHEM ACT, V4, P129; Durbin P.W., 2006, CHEM ACTINIDE TRANSA, V3, P3339; Durbin PW, 1998, RADIAT PROT DOSIM, V79, P433, DOI 10.1093/oxfordjournals.rpd.a032445; Fang XW, 2000, BIOCHEMISTRY-US, V39, P11107, DOI 10.1021/bi000724n; Giannetti AM, 2003, PLOS BIOL, V1, P341, DOI 10.1371/journal.pbio.0000051; Gorden AEV, 2003, CHEM REV, V103, P4207, DOI 10.1021/cr990114x; GROSSMANN JG, 1993, J MOL BIOL, V229, P585, DOI 10.1006/jmbi.1993.1063; GROSSMANN JG, 1992, J MOL BIOL, V225, P811, DOI 10.1016/0022-2836(92)90402-6; HAGLER HK, 1999, INTERACTIVE CASE STU; Hall DR, 2002, ACTA CRYSTALLOGR D, V58, P70, DOI 10.1107/S0907444901017309; HARRIS WR, 1981, J AM CHEM SOC, V103, P2231, DOI 10.1021/ja00399a016; HE QY, 2002, MOL CELLULAR IRON TR, P95; Hemadi M, 2003, BIOCHEMISTRY-US, V42, P3120, DOI 10.1021/bi020627p; Hoyes KP, 1996, INT J RADIAT BIOL, V70, P467; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; Jeanson A, 2010, CHEM-EUR J, V16, P1378, DOI 10.1002/chem.200901209; Jeffrey PD, 1998, BIOCHEMISTRY-US, V37, P13978, DOI 10.1021/bi9812064; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; LEIBMAN A, 1979, BLOOD, V53, P1058; Mason AB, 2005, BIOCHEMISTRY-US, V44, P8013, DOI 10.1021/bi050015f; Mcrae R, 2006, J STRUCT BIOL, V155, P22, DOI 10.1016/j.jsb.2005.09.013; PARK I, 1985, P NATL ACAD SCI USA, V82, P3149, DOI 10.1073/pnas.82.10.3149; PLANASBOHNE F, 1990, HUM EXP TOXICOL, V9, P17, DOI 10.1177/096032719000900105; RAYMOND KN, 1981, STRUCT BOND, V43, P159; Seifert S, 2000, J APPL CRYSTALLOGR, V33, P782, DOI 10.1107/S0021889800001333; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHIH YJ, 1990, J BIOL CHEM, V265, P19077; Sun HZ, 1999, CHEM REV, V99, P2817, DOI 10.1021/cr980430w; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Taylor DM, 1998, J ALLOY COMPD, V271, P6, DOI 10.1016/S0925-8388(98)00014-0; TAYLOR DM, 1973, HDB EXPT PHARM, P323; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Wessling-Resnick M, 2000, ANNU REV NUTR, V20, P129, DOI 10.1146/annurev.nutr.20.1.129; ZUCCOLA HJ, 1992, CRYSTAL STRUCTURE MO	49	65	67	0	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					560	565		10.1038/NCHEMBIO.594	http://dx.doi.org/10.1038/NCHEMBIO.594			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21706034	Green Accepted			2022-12-27	WOS:000292825400018
J	Koksal, M; Hu, HY; Coates, RM; Peters, RJ; Christianson, DW				Koeksal, Mustafa; Hu, Huayou; Coates, Robert M.; Peters, Reuben J.; Christianson, David W.			Structure and mechanism of the diterpene cyclase ent-copalyl diphosphate synthase	NATURE CHEMICAL BIOLOGY			English	Article							SQUALENE-HOPENE CYCLASE; CRYSTAL-STRUCTURE; BIOSYNTHESIS; CHEMISTRY; MOTIF	The structure of ent-copalyl diphosphate synthase reveals lthree alpha-helical domains (alpha, beta and gamma), as also observed in the related diterpene cyclase taxadiene synthase. However, active sites are located at the interface of the beta gamma domains in ent-copalyl diphosphate synthase but exclusively in the alpha domain of taxadiene synthase. Modular domain architecture in plant diterpene cyclases enables the evolution of alternative active sites and chemical strategies for catalyzing isoprenoid cyclization reactions.	[Koeksal, Mustafa; Christianson, David W.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; [Hu, Huayou; Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA	University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; Iowa State University	Koksal, M (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	chris@sas.upenn.edu	Peters, Reuben J./D-1196-2010; Hu, Huayou/B-9521-2013	Peters, Reuben J./0000-0003-4691-8477; Hu, Huayou/0000-0003-4795-0866	US National Institutes of Health [GM56838, GM13956, GM76324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0919735] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the US National Institutes of Health for grants GM56838 (D. W. C.), GM13956 (R. M. C.) and GM76324 (R.J.P.) for support of this research. Additionally, we thank the Advanced Photon Source at Argonne National Laboratory for beamline access.	Bohlmann J, 2008, PLANT J, V54, P656, DOI 10.1111/j.1365-313X.2008.03449.x; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Corey EJ, 1997, J AM CHEM SOC, V119, P1277, DOI 10.1021/ja963227w; GANDOUR RD, 1981, BIOORG CHEM, V10, P169, DOI 10.1016/0045-2068(81)90020-1; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; OCHS D, 1990, EUR J BIOCHEM, V194, P75, DOI 10.1111/j.1432-1033.1990.tb19429.x; Prisic S, 2007, CHEMBIOCHEM, V8, P869, DOI 10.1002/cbic.200700045; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Reinert DJ, 2004, CHEM BIOL, V11, P121, DOI 10.1016/j.chembiol.2003.12.013; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sato T, 1999, BIOSCI BIOTECH BIOCH, V63, P2189, DOI 10.1271/bbb.63.2189; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099	25	114	124	3	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					431	433		10.1038/NCHEMBIO.578	http://dx.doi.org/10.1038/NCHEMBIO.578			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21602811	Green Accepted			2022-12-27	WOS:000292252100009
J	Lee, G; Yoo, J; Leslie, BJ; Ha, T				Lee, Gwangrog; Yoo, Jungmin; Leslie, Benjamin J.; Ha, Taekjip			Single-molecule analysis reveals three phases of DNA degradation by an exonuclease	NATURE CHEMICAL BIOLOGY			English	Article							LAMBDA-EXONUCLEASE; POLYNUCLEOTIDE PHOSPHORYLASE; FLUORESCENCE SPECTROSCOPY; BACTERIOPHAGE LAMBDA; ENERGY-TRANSFER; RNA-POLYMERASE; LOOP FORMATION; STRANDED-DNA; PROTEIN; HELICASE	lambda exonuclease degrades one strand of duplex DNA in the 5'-to-3' direction to generate a 3' overhang required for recombination. Its ability to hydrolyze thousands of nucleotides processively is attributed to its ring structure, and most studies have focused on the processive phase. Here we have used single-molecule fluorescence resonance energy transfer ( FRET) to reveal three phases of l exonuclease reactions: the initiation, distributive and processive phases. The distributive phase comprises early reactions in which the 3' overhang is too short to stably engage with the enzyme. A mismatched base is digested one-fifth as quickly as a Watson-Crick-paired base, and multiple concatenated mismatches have a cooperatively negative effect, highlighting the crucial role of base pairing in aligning the 5' end toward the active site. The rate-limiting step during processive degradation seems to be the post-cleavage melting of the terminal base pair. We also found that an escape from a known pausing sequence requires enzyme backtracking.	[Lee, Gwangrog; Yoo, Jungmin; Leslie, Benjamin J.; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Lee, Gwangrog; Yoo, Jungmin; Leslie, Benjamin J.; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Lee, Gwangrog; Leslie, Benjamin J.; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Lee, G (corresponding author), Univ Illinois, Dept Phys, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Lee, Gwangrog/0000-0002-1720-8524	Jane Coffin Childs Medical Institute; US National Science Foundation [0646550, 0822613]; US National Institutes of Health [GM065367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	Jane Coffin Childs Medical Institute; US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Roy and X. Shi for experimental help, and J. Park for helpful discussions. G. L. was supported by the Jane Coffin Childs Medical Institute. Funds were provided by grants from the US National Science Foundation (0646550, 0822613) and the US National Institutes of Health (GM065367). T. H. is an investigator with the Howard Hughes Medical Institute.	BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; CARTER DM, 1971, J BIOL CHEM, V246, P2502; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Ceska TA, 1998, TRENDS BIOCHEM SCI, V23, P331, DOI 10.1016/S0968-0004(98)01259-6; Dapprich J, 1999, CYTOMETRY, V36, P163, DOI 10.1002/(SICI)1097-0320(19990701)36:3<163::AID-CYTO3>3.0.CO;2-R; Grossman D, 2006, NAT STRUCT MOL BIOL, V13, P760, DOI 10.1038/nsmb0906-760; GUISSANI A, 1977, EUR J BIOCHEM, V79, P233, DOI 10.1111/j.1432-1033.1977.tb11801.x; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; Hingorani MM, 1998, CURR BIOL, V8, pR83, DOI 10.1016/S0960-9822(98)70052-1; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; KLEE CB, 1968, J BIOL CHEM, V243, P923; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; LITTLE JW, 1967, J BIOL CHEM, V242, P672; LITTLE JW, 1967, J BIOL CHEM, V242, P679; Lucius AL, 2004, J MOL BIOL, V339, P731, DOI 10.1016/j.jmb.2004.04.009; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; Mitsis PG, 1999, NUCLEIC ACIDS RES, V27, P3057, DOI 10.1093/nar/27.15.3057; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; Muyrers JPP, 2000, GENE DEV, V14, P1971; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Perkins TT, 2003, SCIENCE, V301, P1914, DOI 10.1126/science.1088047; RADDING CM, 1966, J MOL BIOL, V18, P235, DOI 10.1016/S0022-2836(66)80243-7; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Roberts JW, 2006, SCIENCE, V314, P1097, DOI 10.1126/science.1135746; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Selvin P. R., 2008, SINGLE MOL TECHNIQUE, P3; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shi J, 2006, P NATL ACAD SCI USA, V103, P5775, DOI 10.1073/pnas.0510482103; SRIPRAKASH KS, 1975, J BIOL CHEM, V250, P5438; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Subramanian K, 2003, NUCLEIC ACIDS RES, V31, P1585, DOI 10.1093/nar/gkg266; THOMAS KR, 1978, J BIOL CHEM, V253, P424; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; Wong CJ, 2006, J MOL BIOL, V362, P26, DOI 10.1016/j.jmb.2006.07.016; Wong CJ, 2005, J MOL BIOL, V352, P765, DOI 10.1016/j.jmb.2005.07.056; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Yin J, 2005, CHEM BIOL, V12, P999, DOI 10.1016/j.chembiol.2005.07.006; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	48	43	43	5	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					367	374		10.1038/NCHEMBIO.561	http://dx.doi.org/10.1038/NCHEMBIO.561			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21552271	Green Accepted			2022-12-27	WOS:000290677900012
J	Wang, YF; Fisher, JC; Mathew, R; Ou, L; Otieno, S; Sublet, J; Xiao, LM; Chen, JH; Roussel, MF; Kriwacki, RW				Wang, Yuefeng; Fisher, John C.; Mathew, Rose; Ou, Li; Otieno, Steve; Sublet, Jack; Xiao, Limin; Chen, Jianhan; Roussel, Martine F.; Kriwacki, Richard W.			Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21	NATURE CHEMICAL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASES; UNSTRUCTURED PROTEINS; CRYSTAL-STRUCTURE; CHEMICAL-SHIFTS; CELL-DIVISION; P27(KIP1); COMPLEX; BINDING; FLEXIBILITY; ACTIVATION	Traditionally, well-defined three-dimensional structure has been thought to be essential for protein function. However, myriad biological functions are performed by highly dynamic, intrinsically disordered proteins (IDPs). IDPs often fold upon binding their biological targets and frequently show 'binding diversity' by targeting multiple ligands. We sought to understand the physical basis of IDP binding diversity and report here that the cyclin-dependent kinase (Cdk) inhibitor p21(Cip1) adaptively binds to and inhibits the various Cdk-cyclin complexes that regulate eukaryotic cell division. Using results from NMR spectroscopy and biochemical and cellular assays, we show that structural adaptability of a helical subdomain within p21, termed LH, enables two other subdomains, D1 and D2, to specifically bind conserved surface features of the cyclin and Cdk subunits, respectively, within otherwise structurally distinct Cdk-cyclin complexes. Adaptive folding upon binding is likely to mediate the diverse biological functions of the thousands of IDPs present in eukaryotes.	[Wang, Yuefeng; Fisher, John C.; Ou, Li; Otieno, Steve; Xiao, Limin; Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Fisher, John C.; Roussel, Martine F.; Kriwacki, Richard W.] Univ Tennessee, Hlth Sci Ctr, Integrated Program Biomed Sci, Memphis, TN USA; [Fisher, John C.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Memphis, TN USA; [Chen, Jianhan] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Roussel, Martine F.; Kriwacki, Richard W.] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Kansas State University; University of Tennessee System; University of Tennessee Health Science Center	Wang, YF (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.kriwacki@stjude.org	Roussel, Martine F/F-1469-2016; Kriwacki, Richard/N-8154-2018; Chen, Jianhan/C-7680-2009; WANG, YUE/GWQ-9256-2022; Ou, Li/F-8416-2012	Roussel, Martine F/0000-0002-1740-8139; Kriwacki, Richard/0000-0002-9798-6018; 	US National Institutes of Health [P30CA21765, 5R01CA082491, R01CA71907]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; US National Science Foundation [NSF MCB 0952514]; NATIONAL CANCER INSTITUTE [P01CA071907, P30CA021765, R01CA082491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007405] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge S. I. Reed (Scripps Research Institute) for providing a vector to express a cyclin D1-Cdk4 fusion protein, L. Hengst (Innsbruck Medical University) for providing baculoviruses that coexpress Cdk6 and cyclin D1, B. Schulman (St. Jude Children's Research Hospital) and P. D. Adams (Fox Chase Cancer Center) for providing Rb constructs, C.J. Sherr (St. Jude Children's Research Hospital) for providing anti-sera for Cdk2 and Cdk4 and for stimulating discussions, M. Assem (St. Jude Children's Research Hospital) for technical assistance with cell cycle assays, C.-G. Park (St. Jude Children's Research Hospital) for preparation of Cdk-cyclin complexes for kinase assays, N. Pytel (St. Jude Children's Research Hospital) for preparation of p21-KID protein samples, E. Tuomanen (St. Jude Children's Research Hospital) for assistance with kinase assays and R. Ashmun (St. Jude Children's Research Hospital) for FACS analysis. The authors acknowledge support from US National Institutes of Health core grant P30CA21765 (St. Jude Children's Research Hospital), 5R01CA082491 (to R. W. K.), R01CA71907 (to M. F. R.), the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital and a US National Science Foundation CAREER Award (NSF MCB 0952514 to J.C.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bowman P, 2006, BBA-PROTEINS PROTEOM, V1764, P182, DOI 10.1016/j.bbapap.2005.12.016; Brown NR, 2007, CELL CYCLE, V6, P1350, DOI 10.4161/cc.6.11.4278; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Creighton T. E., 1993, PROTEINS STRUCTURES; CREIGHTON TE, 1989, PROTEIN STRUCTURE PR; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARPER JW, 1993, CELL, V75, P805; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Kriwacki RW, 1996, J AM CHEM SOC, V118, P5320, DOI 10.1021/ja960752m; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Martin AC, 1998, STRUCTURE, V6, P875, DOI 10.1016/S0969-2126(98)00089-6; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Wang YF, 2005, CHEMBIOCHEM, V6, P2242, DOI 10.1002/cbic.200500260; WEINBEG RA, 2006, BIOL CANC; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	46	102	106	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					214	221		10.1038/NCHEMBIO.536	http://dx.doi.org/10.1038/NCHEMBIO.536			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21358637	Green Accepted			2022-12-27	WOS:000288545000009
J	Weiss, IM				Weiss, Ingrid M.			BIOMATERIALS Metabolites empowering minerals	NATURE CHEMICAL BIOLOGY			English	News Item							AMORPHOUS CALCIUM-CARBONATE; BIOMINERALIZATION		Leibniz Inst New Mat, Dept Mat Biol, Saarbrucken, Germany	Leibniz Institut fur Neue Materialien (INM)	Weiss, IM (corresponding author), Leibniz Inst New Mat, Dept Mat Biol, Saarbrucken, Germany.	ingrid.weiss@inm-gmbh.de		Weiss, Ingrid/0000-0002-7345-341X				Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Cornish-Bowden A., 1997, NEW BEER OLD BOTTLE; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; Lippmann F, 1973, SEDIMENTARY CARBONAT; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Oparin AI., 1957, ORIGIN LIFE EARTH; Radha AV, 2010, P NATL ACAD SCI USA, V107, P16438, DOI 10.1073/pnas.1009959107; Sato A, 2011, NAT CHEM BIOL, V7, P197, DOI 10.1038/NCHEMBIO.532; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001	10	2	2	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					192	193		10.1038/nchembio.550	http://dx.doi.org/10.1038/nchembio.550			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21423159				2022-12-27	WOS:000288545000001
J	Titov, DV; Gilman, B; He, QL; Bhat, S; Low, WK; Dang, YJ; Smeaton, M; Demain, AL; Miller, PS; Kugel, JF; Goodrich, JA; Liu, JO				Titov, Denis V.; Gilman, Benjamin; He, Qing-Li; Bhat, Shridhar; Low, Woon-Kai; Dang, Yongjun; Smeaton, Michael; Demain, Arnold L.; Miller, Paul S.; Kugel, Jennifer F.; Goodrich, James A.; Liu, Jun O.			XPB, a subunit of TFIIH, is a target of the natural product triptolide	NATURE CHEMICAL BIOLOGY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR IIH; TRIPTERYGIUM-WILFORDII; COMMON TARGET; INHIBITION; PROTEIN; CYTOTOXICITY; CHEMOTHERAPY; TRANSLATION; INITIATION	Triptolide (1) is a structurally unique diterpene triepoxide isolated from a traditional Chinese medicinal plant with anti-inflammatory, immunosuppressive, contraceptive and antitumor activities. Its molecular mechanism of action, however, has remained largely elusive to date. We report that triptolide covalently binds to human XPB (also known as ERCC3), a subunit of the transcription factor TFIIH, and inhibits its DNA-dependent ATPase activity, which leads to the inhibition of RNA polymerase II-mediated transcription and likely nucleotide excision repair. The identification of XPB as the target of triptolide accounts for the majority of the known biological activities of triptolide. These findings also suggest that triptolide can serve as a new molecular probe for studying transcription and, potentially, as a new type of anticancer agent through inhibition of the ATPase activity of XPB.	[Titov, Denis V.; He, Qing-Li; Bhat, Shridhar; Low, Woon-Kai; Dang, Yongjun; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Gilman, Benjamin; Kugel, Jennifer F.; Goodrich, James A.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Smeaton, Michael; Miller, Paul S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA; [Demain, Arnold L.] Drew Univ, Charles A Dana Res Inst Scientists Emeriti, Madison, NJ 07940 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Colorado System; University of Colorado Boulder; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Drew University; Johns Hopkins University	Titov, DV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu	Titov, Denis/AAI-1600-2021; Titov, Denis/L-5943-2015; dang, yongjun/M-6531-2016; dang, yongjun/A-8095-2011; Bhat, Shridhar/C-5412-2012	Titov, Denis/0000-0001-5677-0651; Titov, Denis/0000-0001-5677-0651; dang, yongjun/0000-0001-7237-1132; He, Qing-Li/0000-0001-9417-8958; Low, Woon-Kai/0000-0003-2207-9509	NATIONAL CANCER INSTITUTE [T32CA009243] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009243] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALONSO MA, 1980, EUR J BIOCHEM, V109, P535, DOI 10.1111/j.1432-1033.1980.tb04825.x; Aoyagi Y, 2006, BIOORG MED CHEM LETT, V16, P1947, DOI 10.1016/j.bmcl.2005.12.098; Aoyagi Y, 2008, BIOORG MED CHEM LETT, V18, P2459, DOI 10.1016/j.bmcl.2008.02.039; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fidler JM, 2003, MOL CANCER THER, V2, P855; Gilman B, 2009, J BIOL CHEM, V284, P9093, DOI 10.1074/jbc.M900019200; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; Gu WZ, 1998, INT J IMMUNOPHARMACO, V20, P389, DOI 10.1016/S0192-0561(98)00035-6; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hieb AR, 2006, EMBO J, V25, P3100, DOI 10.1038/sj.emboj.7601197; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kitzen JJEM, 2009, EUR J CANCER, V45, P1764, DOI 10.1016/j.ejca.2009.01.026; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kugel JF, 2002, MOL CELL BIOL, V22, P762, DOI 10.1128/MCB.22.3.762-773.2002; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; KUPCHAN SM, 1974, SCIENCE, V185, P791, DOI 10.1126/science.185.4153.791; LeRoy G, 1998, J BIOL CHEM, V273, P7134, DOI 10.1074/jbc.273.12.7134; Leuenroth SJ, 2008, CANCER RES, V68, P5257, DOI 10.1158/0008-5472.CAN-07-6207; Leuenroth SJ, 2007, P NATL ACAD SCI USA, V104, P4389, DOI 10.1073/pnas.0700499104; Li Z, 2009, J MED CHEM, V52, P5115, DOI 10.1021/jm900342g; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Mason TM, 2008, BIOCONJUGATE CHEM, V19, P1064, DOI 10.1021/bc7004363; Matsui Y, 2008, ONCOGENE, V27, P4603, DOI 10.1038/onc.2008.89; McCallum C., 2005, THERAPY, V2, P261; McCallum C, 2007, IMMUNOBIOLOGY, V212, P549, DOI 10.1016/j.imbio.2007.02.002; MIESFELD R, 1982, NUCLEIC ACIDS RES, V10, P3933, DOI 10.1093/nar/10.13.3933; Ning LL, 2003, PLANTA MED, V69, P804, DOI 10.1055/s-2003-43220; Pan JX, 2010, CANCER LETT, V292, P149, DOI 10.1016/j.canlet.2009.11.018; Pugh B F, 1995, Methods Mol Biol, V37, P349; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; REICH E, 1961, SCIENCE, V134, P556, DOI 10.1126/science.134.3478.556; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Shamon LA, 1997, CANCER LETT, V112, P113, DOI 10.1016/S0304-3835(96)04554-5; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; Smeaton MB, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm974; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Yakovchuk P, 2010, J MOL BIOL, V397, P57, DOI 10.1016/j.jmb.2010.01.025; YANG SX, 1992, INT J IMMUNOPHARMACO, V14, P963; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; ZHAO XM, 1965, SUPPLEMENT MAT MED	50	316	338	5	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					182	188		10.1038/NCHEMBIO.522	http://dx.doi.org/10.1038/NCHEMBIO.522			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21278739	Green Accepted			2022-12-27	WOS:000287307600012
J	Jenkins, LMM; Ott, DE; Hayashi, R; Coren, LV; Wang, DY; Xu, Q; Schito, ML; Inman, JK; Appella, DH; Appella, E				Jenkins, Lisa M. Miller; Ott, David E.; Hayashi, Ryo; Coren, Lori V.; Wang, Deyun; Xu, Qun; Schito, Marco L.; Inman, John K.; Appella, Daniel H.; Appella, Ettore			Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer	NATURE CHEMICAL BIOLOGY			English	Article							VIRAL NUCLEOCAPSID PROTEIN; DRUG-RESISTANCE; INHIBITORS; SPECIFICITY; THIOESTERS; INFECTION; TARGET	The zinc fingers of the HIV-1 nucleocapsid protein, NCp7, are prime targets for antiretroviral therapeutics. Here we show that S-acyl-2-mercaptobenzamide thioester (SAMT) chemotypes inhibit HIV by modifying the NCp7 region of Gag in infected cells, thereby blocking Gag processing and reducing infectivity. The thiol produced by SAMT reaction with NCp7 is acetylated by cellular enzymes to regenerate active SAMTs via a recycling mechanism unique among small-molecule inhibitors of HIV.	[Jenkins, Lisa M. Miller; Hayashi, Ryo; Schito, Marco L.; Appella, Ettore] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Ott, David E.; Coren, Lori V.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Wang, Deyun; Xu, Qun; Appella, Daniel H.] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA; [Inman, John K.] NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jenkins, LMM (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	appellae@mail.nih.gov	Xu, Qun/C-6996-2011; Jenkins, Lisa/AAI-2490-2021	Wang, Deyun/0000-0002-0356-2848	US National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; US National Cancer Institute [HHSN261200800001E, N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC009101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031124] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank T. Hartman (ImQuest Biosciences) for antiviral assays, E. Chertova (US National Cancer Institute at Frederick) for HPLC separation of Gag and P. Srivastava (US National Cancer Institute) for synthesis of <SUP>14</SUP>C-SAMT-247. The authors thank J.A. Turpin and P.F. Kiser for helpful discussion. This research was supported by the US National Institutes of Health Intramural AIDS Targeted Antiretroviral Program (L.M.M.J., R.H., M.L.S., E.A.), the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (D.W., Q.X., D.H.A.) and with federal funds from the US National Cancer Institute under Contracts No. HHSN261200800001E and No. N01-CO-12400 (D.E.O., L.V.C.).	COFFIN JM, 1997, RETROVIRUSES, V843; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; de Rocquigny H, 2008, MINI-REV MED CHEM, V8, P24; Goldschmidt Valerie, 2010, HIV Therapy, V4, P179, DOI 10.2217/HIV.10.3; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Jenkins LMM, 2006, J AM CHEM SOC, V128, P11964, DOI 10.1021/ja063329e; Jenkins LMM, 2007, J AM CHEM SOC, V129, P11067, DOI 10.1021/ja071254o; Jenkins LMM, 2005, J MED CHEM, V48, P2847, DOI 10.1021/jm0492195; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Rahim S, 2009, HIV CLIN TRIALS, V10, P94, DOI 10.1310/hct1002-94; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Schito ML, 2003, AIDS RES HUM RETROV, V19, P91, DOI 10.1089/088922203762688595; Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012; Srivastava P, 2004, BIOORGAN MED CHEM, V12, P6437, DOI 10.1016/j.bmc.2004.09.032; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Turpin JA, 1996, J VIROL, V70, P6180, DOI 10.1128/JVI.70.9.6180-6189.1996; Turpin JA, 1999, J MED CHEM, V42, P67, DOI 10.1021/jm9802517; Turpin Jim A, 2003, Expert Rev Anti Infect Ther, V1, P97, DOI 10.1586/14787210.1.1.97; Turpin JA, 2008, ADV PHARMACOL, V56, P229, DOI 10.1016/S1054-3589(07)56008-4; Wallace GS, 2009, J VIROL, V83, P9175, DOI 10.1128/JVI.00820-09; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Yovandich JL, 2001, J VIROL, V75, P115, DOI 10.1128/JVI.75.1.115-124.2001	24	35	37	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					887	889		10.1038/NCHEMBIO.456	http://dx.doi.org/10.1038/NCHEMBIO.456			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	20953192	Green Accepted			2022-12-27	WOS:000284214700017
J	Liu, JZ; Yue, YN; Han, DL; Wang, X; Fu, Y; Zhang, L; Jia, GF; Yu, M; Lu, ZK; Deng, X; Dai, Q; Chen, WZ; He, C				Liu, Jianzhao; Yue, Yanan; Han, Dali; Wang, Xiao; Fu, Ye; Zhang, Liang; Jia, Guifang; Yu, Miao; Lu, Zhike; Deng, Xin; Dai, Qing; Chen, Weizhong; He, Chuan			A METTL3-METTL14 complex mediates mammalian nuclear RNA N-6-adenosine methylation	NATURE CHEMICAL BIOLOGY			English	Article							MESSENGER-RNA; N6-METHYLADENOSINE; PURIFICATION; SUBUNIT; PROTEIN; IME4	N-6-methyladenosine (m(6)A) is the most prevalent and reversible internal modification in mammalian messenger and noncoding RNAs. We report here that human methyltransferase-like 14 (METTL14) catalyzes m(6)A RNA methylation. Together with METTL3, the only previously known m(6)A methyltransferase, these two proteins form a stable heterodimer core complex of METTL3-METTL14 that functions in cellular m(6)A deposition on mammalian nuclear RNAs. WTAP, a mammalian splicing factor, can interact with this complex and affect this methylation.	[Liu, Jianzhao; Yue, Yanan; Han, Dali; Wang, Xiao; Fu, Ye; Zhang, Liang; Jia, Guifang; Yu, Miao; Lu, Zhike; Deng, Xin; Dai, Qing; Chen, Weizhong; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Liu, Jianzhao; Yue, Yanan; Han, Dali; Wang, Xiao; Fu, Ye; Zhang, Liang; Jia, Guifang; Yu, Miao; Lu, Zhike; Deng, Xin; Dai, Qing; Chen, Weizhong; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Han, Dali/I-4145-2016; Liu, Jianzhao/AAO-2359-2020; Zhang, Liang/F-8064-2013; Dai, Qing/ABD-8444-2021; Liu, Jianzhao/E-9165-2011	Liu, Jianzhao/0000-0001-9465-6075; Zhang, Liang/0000-0002-7672-1168; Liu, Jianzhao/0000-0001-9465-6075; Fu, Ye/0000-0002-3807-9717; Wang, Xiao/0000-0002-3090-9894; Fu, Ye/0000-0003-4434-6014	US National Institutes of Health [GM071440, GM088599]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440, R01GM088599] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by US National Institutes of Health (GM071440 and GM088599). We thank P. Faber and L. Dore for helping with high-throughput sequencing experiments and S.F. Reichard for editing the manuscript.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Bokar JA, 1997, RNA, V3, P1233; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; BOKAR JA, 1994, J BIOL CHEM, V269, P17697; Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	19	1581	1679	38	394	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					93	95		10.1038/nchembio.1432	http://dx.doi.org/10.1038/nchembio.1432			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316715	Green Accepted			2022-12-27	WOS:000330751600005
J	Handlogten, MW; Kiziltepe, T; Serezani, AP; Kaplan, MH; Bilgicer, B				Handlogten, Michael W.; Kiziltepe, Tanyel; Serezani, Ana P.; Kaplan, Mark H.; Bilgicer, Basar			Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation	NATURE CHEMICAL BIOLOGY			English	Article							FC-EPSILON-RI; SYNTHETIC ALLERGEN; CROSS-REACTIVITY; BINDING EPITOPES; RECEPTOR-BINDING; ANTIBODY; DESIGN; PURIFICATION; BASOPHIL; REVEALS	Development of specific inhibitors of allergy has had limited success, in part, owing to a lack of experimental models that reflect the complexity of allergen-IgE interactions. We designed a heterotetravalent allergen (HtTA) system, which reflects epitope heterogeneity, polyclonal response and number of immunodominant epitopes observed in natural allergens, thereby providing a physiologically relevant experimental model to study mast cell degranulation. The HtTA design revealed the importance of weak-affinity epitopes in allergy, particularly when presented with high-affinity epitopes. The effect of selective inhibition of weak-affinity epitope-IgE interactions was investigated with heterobivalent inhibitors (HBIs) designed to simultaneously target the antigen-and nucleotide-binding sites on the IgE Fab. HBI demonstrated enhanced avidity for the target IgE and was a potent inhibitor of degranulation in vitro and in vivo. These results demonstrate that partial inhibition of allergen-IgE interactions was sufficient to prevent mast cell degranulation, thus establishing the therapeutic potential of the HBI design.	[Handlogten, Michael W.; Kiziltepe, Tanyel; Bilgicer, Basar] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA; [Kiziltepe, Tanyel; Bilgicer, Basar] Univ Notre Dame, Notre Dame, IN 46556 USA; [Serezani, Ana P.; Kaplan, Mark H.] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Bilgicer, Basar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University Bloomington; University of Notre Dame	Bilgicer, B (corresponding author), Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA.	bbilgicer@nd.edu		Handlogten, Michael/0000-0002-6508-3228	National Institutes of Health-National Institute of Allergy and Infectious Diseases [R03 AI085485, R01 AI095282]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095282, R03AI085485] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Wilson (University of New Mexico) for generously providing us with IgE<SUP>DNP</SUP> and the RBL cells, and P. Bryce (Northwestern University) for providing protocols and advice on the PCA model. We thank B. Boggess at the Mass Spectrometry and Proteomics Facility in the University of Notre Dame for the use of MS instrumentation. This work was supported by the National Institutes of Health-National Institute of Allergy and Infectious Diseases (grant number R03 AI085485 (to B. B.) and R01 AI095282 (to M.H.K.)).	Alves NJ, 2013, BIOMATERIALS, V34, P5700, DOI 10.1016/j.biomaterials.2013.03.082; Alves NJ, 2012, ANAL CHEM, V84, P7721, DOI 10.1021/ac300952r; Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; BAIRD B, 1993, ACCOUNTS CHEM RES, V26, P428, DOI 10.1021/ar00032a006; Baird EJ, 2003, BIOCHEMISTRY-US, V42, P12739, DOI 10.1021/bi034884l; Bilgicer B, 2007, J AM CHEM SOC, V129, P3722, DOI 10.1021/ja067159h; Bilgicer B, 2009, J AM CHEM SOC, V131, P9361, DOI 10.1021/ja9023836; Blank U., 2006, CURR PROTOC CELL BIO, V15, P32; Cerecedo I, 2008, J ALLERGY CLIN IMMUN, V122, P589, DOI 10.1016/j.jaci.2008.06.040; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Collins AM, 1996, CLIN EXP ALLERGY, V26, P964, DOI 10.1111/j.1365-2222.1996.tb00634.x; Cong YJ, 2008, FOOD AGR IMMUNOL, V19, P175, DOI 10.1080/09540100802172599; Denery-Papini S, 2011, CLIN EXP ALLERGY, V41, P1478, DOI 10.1111/j.1365-2222.2011.03808.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Handlogten MW, 2013, BIOCHEM J, V449, P91, DOI 10.1042/BJ20121088; Handlogten MW, 2012, ACS CHEM BIOL, V7, P1796, DOI 10.1021/cb300193f; Handlogten MW, 2011, CHEM BIOL, V18, P1179, DOI 10.1016/j.chembiol.2011.06.012; Hlavacek WS, 1999, BIOPHYS J, V76, P3031, DOI 10.1016/S0006-3495(99)77456-4; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Hunt J, 2012, J BIOL CHEM, V287, P17459, DOI 10.1074/jbc.M111.331967; James LC, 2003, PROTEIN SCI, V12, P2183, DOI 10.1110/ps.03172703; Lopez-Torrejon G, 2007, J ALLERGY CLIN IMMUN, V119, P1481, DOI 10.1016/j.jaci.2007.02.004; Lund G, 2012, J IMMUNOL METHODS, V383, P4, DOI 10.1016/j.jim.2012.05.021; METZGER H, 1992, J IMMUNOL, V149, P1477; Pacios LF, 2008, MOL IMMUNOL, V45, P2269, DOI 10.1016/j.molimm.2007.11.022; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; Posner RG, 2007, ORG LETT, V9, P3551, DOI 10.1021/ol071175h; Rajagopalan K, 1996, P NATL ACAD SCI USA, V93, P6019, DOI 10.1073/pnas.93.12.6019; Reddy GD, 2012, J MED CHEM, V55, P6438, DOI 10.1021/jm300421h; Rouge P, 2009, MOL IMMUNOL, V46, P1067, DOI 10.1016/j.molimm.2008.09.030; SCHWEITZERSTENNER R, 1987, BIOCHEMISTRY-US, V26, P3602, DOI 10.1021/bi00386a053; Sil D, 2007, ACS CHEM BIOL, V2, P674, DOI 10.1021/cb7001472; Stanley JS, 1997, ARCH BIOCHEM BIOPHYS, V342, P244, DOI 10.1006/abbi.1997.9998; Stefanick JF, 2012, J PHYS CHEM LETT, V3, P598, DOI 10.1021/jz201682z; Tanabe S, 2007, CURR PROTEIN PEPT SC, V8, P109, DOI 10.2174/138920307779941569; Tordesillas L, 2010, CLIN EXP ALLERGY, V40, P174, DOI 10.1111/j.1365-2222.2009.03401.x; Wang J, 2010, J ALLERGY CLIN IMMUN, V125, P695, DOI 10.1016/j.jaci.2009.12.017; Xu KL, 1998, J IMMUNOL, V160, P3225	38	30	31	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					789	+		10.1038/NCHEMBIO.1358	http://dx.doi.org/10.1038/NCHEMBIO.1358			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24096304	Green Submitted, Green Accepted			2022-12-27	WOS:000327130000010
J	Kokel, D; Cheung, CYJ; Mills, R; Coutinho-Budd, J; Huang, LY; Setola, V; Sprague, J; Jin, S; Jin, YN; Huang, XP; Bruni, G; Woolf, CJ; Roth, BL; Hamblin, MR; Zylka, MJ; Milan, DJ; Peterson, RT				Kokel, David; Cheung, Chung Yan J.; Mills, Robert; Coutinho-Budd, Jaeda; Huang, Liyi; Setola, Vincent; Sprague, Jared; Jin, Shan; Jin, Youngnam N.; Huang, Xi-Ping; Bruni, Giancarlo; Woolf, Clifford J.; Roth, Bryan L.; Hamblin, Michael R.; Zylka, Mark J.; Milan, David J.; Peterson, Randall T.			Photochemical activation of TRPA1 channels in neurons and animals	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; ION CHANNELS; GLUTAMATE-RECEPTOR; REMOTE-CONTROL; COVALENT MODIFICATION; CAGED GLUTAMATE; OPTICAL CONTROL; ZEBRAFISH; LIGHT; PHOTOSTIMULATION	Optogenetics is a powerful research tool because it enables high-resolution optical control of neuronal activity. However, current optogenetic approaches are limited to transgenic systems expressing microbial opsins and other exogenous photoreceptors. Here, we identify optovin, a small molecule that enables repeated photoactivation of motor behaviors in wild-type zebrafish and mice. To our surprise, optovin's behavioral effects are not visually mediated. Rather, photodetection is performed by sensory neurons expressing the cation channel TRPA1. TRPA1 is both necessary and sufficient for the optovin response. Optovin activates human TRPA1 via structure-dependent photochemical reactions with redox-sensitive cysteine residues. In animals with severed spinal cords, optovin treatment enables control of motor activity in the paralyzed extremities by localized illumination. These studies identify a light-based strategy for controlling endogenous TRPA1 receptors in vivo, with potential clinical and research applications in nontransgenic animals, including humans.	[Kokel, David; Cheung, Chung Yan J.; Mills, Robert; Jin, Shan; Jin, Youngnam N.; Bruni, Giancarlo; Milan, David J.; Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiovasc Res Ctr, Charlestown, MA USA; [Kokel, David; Cheung, Chung Yan J.; Mills, Robert; Jin, Shan; Jin, Youngnam N.; Bruni, Giancarlo; Milan, David J.; Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, Charlestown, MA USA; [Kokel, David; Cheung, Chung Yan J.; Jin, Shan; Jin, Youngnam N.; Bruni, Giancarlo; Peterson, Randall T.] Broad Inst, Cambridge, MA USA; [Coutinho-Budd, Jaeda; Zylka, Mark J.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC USA; [Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Huang, Liyi; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Huang, Liyi; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Huang, Liyi] Guangxi Med Univ, Affiliated Coll & Hosp 1, Dept Infect Dis, Nanning, Peoples R China; [Setola, Vincent; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Setola, Vincent; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, NIMH, Psychoact Drug Screening Program, Chapel Hill, NC USA; [Sprague, Jared; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp Boston, Boston, MA 02115 USA; [Sprague, Jared] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Hamblin, Michael R.] Harvard Massachusetts Inst Technol Div Hlth Sci &, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Guangxi Medical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kokel, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiovasc Res Ctr, Charlestown, MA USA.	dkokel@cvrc.mgh.harvard.edu; peterson@cvrc.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019; Roth, Bryan L/F-3928-2010; Woolf, Clifford/A-9784-2010; Roth, Bryan/ABE-7032-2020; Hamblin, Mike/AAB-2511-2022	Hamblin, Michael R/0000-0001-6431-4605; Roth, Bryan/0000-0002-0561-6520; kokel, david/0000-0002-1981-1511; Mills, Robert/0000-0003-4201-7137; Bruni, Giancarlo/0000-0003-2850-4633; Huang, Xi-Ping/0000-0002-2585-653X; Setola, Vincent/0000-0002-9791-2270; Peterson, Randall/0000-0003-0727-3469	US National Institutes of Health (NIH) [K01MH091449, MH086867, MH085205, P01 NS072040, R01 AI050875]; Charles and Ann Sanders Massachusetts General Hospital; Michael Hooker Chair; NIMH PDSP; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS060725, R01NS067688]; NINDS [F31NS068038]; NIH [HL109004, DA026982]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE023033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH091449, R01MH086867, R21MH085205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067688, F31NS068038, P01NS072040, R01NS060725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026982] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Ann Sanders Massachusetts General Hospital; Michael Hooker Chair; NIMH PDSP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Kwan and D. Corey (Harvard Medical School), T. Miyamoto and A. Patapoutian (Scripps Research Institute), and T. Numata and Y. Mori (Kyoto University) for human TrpA1 constructs. A. Schier, D. Prober and D. Robson (Harvard University) generously provided TrpA1 mutant zebrafish. We thank R. Gaudet, A. Vakkasglu, B. Shoichet, T. Dunn, M. Ahrens, F. Engert, R. Mazitschek and members of our research groups for helpful advice. This work was supported by US National Institutes of Health (NIH) grants K01MH091449 (D.K.), MH086867 and MH085205 (R.T.P.), P01 NS072040 (C.J.W.), R01 AI050875 (L.H. and M.R.H.); the Charles and Ann Sanders Massachusetts General Hospital Research Scholar award (R.T.P.); and the Michael Hooker Chair and the NIMH PDSP (B.L.R.). M.J.Z. was supported by grants from National Institute of Neurological Disorders and Stroke (NINDS; R01NS060725, R01NS067688), J.C.-B. was supported by a National Research Service Award training grant from NINDS (F31NS068038) and D.J.M. was supported by NIH grants HL109004 and DA026982.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BARTON HJ, 1990, J PHOTOCH PHOTOBIO A, V54, P187, DOI 10.1016/1010-6030(90)85031-Q; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brain SD, 2011, ANN NY ACAD SCI, V1245, P36, DOI 10.1111/j.1749-6632.2011.06326.x; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Escalera J, 2008, J BIOL CHEM, V283, P24136, DOI 10.1074/jbc.M710280200; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Fortin DL, 2011, J NEUROPHYSIOL, V106, P488, DOI 10.1152/jn.00251.2011; Herrou J, 2011, NAT REV MICROBIOL, V9, P713, DOI 10.1038/nrmicro2622; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Jordt S. E., 2007, V45, P253; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LAUSTRIAT G, 1986, BIOCHIMIE, V68, P771, DOI 10.1016/S0300-9084(86)80092-X; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; Marinado T, 2009, PHYS CHEM CHEM PHYS, V11, P133, DOI 10.1039/b812154k; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Mourot A, 2012, NAT METHODS, V9, P396, DOI [10.1038/NMETH.1897, 10.1038/nmeth.1897]; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; OUANNES C, 1968, J AM CHEM SOC, V90, P6527, DOI 10.1021/ja01025a059; Patch RJ, 2011, J MED CHEM, V54, P788, DOI 10.1021/jm101063h; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Schwartz ES, 2011, GASTROENTEROLOGY, V140, P1283, DOI 10.1053/j.gastro.2010.12.033; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Volgraf M, 2007, J AM CHEM SOC, V129, P260, DOI 10.1021/ja067269o; Wang S, 2007, NANO LETT, V7, P3859, DOI 10.1021/nl072783t; WIEBOLDT R, 1994, P NATL ACAD SCI USA, V91, P8752, DOI 10.1073/pnas.91.19.8752; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	45	69	98	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					257	263		10.1038/NCHEMBIO.1183	http://dx.doi.org/10.1038/NCHEMBIO.1183			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23396078	Green Accepted, Green Submitted			2022-12-27	WOS:000317025800016
J	Krishnamurty, R; Brigham, JL; Leonard, SE; Ranjitkar, P; Larson, ET; Dale, EJ; Merritt, EA; Maly, DJ				Krishnamurty, Ratika; Brigham, Jennifer L.; Leonard, Stephen E.; Ranjitkar, Pratistha; Larson, Eric T.; Dale, Edward J.; Merritt, Ethan A.; Maly, Dustin J.			Active site profiling reveals coupling between domains in SRC-family kinases	NATURE CHEMICAL BIOLOGY			English	Article							TYROSINE KINASE; C-SRC; CRYSTAL-STRUCTURE; PROTEIN-KINASES; ACTIVATION; INHIBITORS; HCK; MECHANISM; ABL; PROTEOMICS	Protein kinases, key regulators of intracellular signal transduction, have emerged as an important class of drug targets. Chemical proteomic tools that facilitate the functional interrogation of protein kinase active sites are powerful reagents for studying the regulation of this large enzyme family and performing inhibitor selectivity screens. Here we describe a new crosslinking strategy that enables rapid and quantitative profiling of protein kinase active sites in lysates and live cells. Applying this methodology to the SRC-family kinases (SFKs) SRC and HCK led to the identification of a series of conformation-specific, ATP-competitive inhibitors that have a distinct preference for the autoinhibited forms of these kinases. Furthermore, we show that ligands that have this selectivity are able to modulate the ability of the regulatory domains of SRC and HCK to engage in intermolecular binding interactions. These studies provide insight into the regulation of this important family of tyrosine kinases.	[Krishnamurty, Ratika; Brigham, Jennifer L.; Leonard, Stephen E.; Ranjitkar, Pratistha; Dale, Edward J.; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Larson, Eric T.; Merritt, Ethan A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Krishnamurty, R (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	maly@chem.washington.edu		Maly, Dustin/0000-0003-0094-0177; Larson, Eric T./0000-0002-2862-4291	US National Institutes of Health [R01GM086858, R01AI089441]; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086858] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Several ATP-competitive inhibitors were provided by R. Murphy (University of Washington, Seattle) and G. Perera (University of Washington, Seattle). This research was supported by US National Institutes of Health grants R01GM086858 (D.J.M.) and R01AI089441 (E.A.M.) and the Alfred P. Sloan Foundation (D.J.M.).	Alvarado JJ, 2010, J BIOL CHEM, V285, P35455, DOI 10.1074/jbc.M110.145102; Ayrapetov MK, 2006, J BIOL CHEM, V281, P23776, DOI 10.1074/jbc.M604219200; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Cheng HC, 2010, CLIN EXP PHARMACOL P, V37, P93, DOI 10.1111/j.1440-1681.2009.05237.x; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Dar AC, 2008, CHEM BIOL, V15, P1015, DOI 10.1016/j.chembiol.2008.09.007; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Georghiou G, 2012, NAT CHEM BIOL, V8, P366, DOI [10.1038/nchembio.792, 10.1038/NCHEMBIO.792]; Getlik M, 2009, J MED CHEM, V52, P3915, DOI 10.1021/jm9002928; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Katsuta H, 1998, J IMMUNOL, V160, P1547; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Garcia-Martinez JM, 2010, CELL SIGNAL, V22, P415, DOI 10.1016/j.cellsig.2009.10.013; Marcotte DJ, 2010, PROTEIN SCI, V19, P429, DOI 10.1002/pro.321; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; OSUSKY M, 1995, J BIOL CHEM, V270, P25729, DOI 10.1074/jbc.270.43.25729; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Sharma K, 2009, NAT METHODS, V6, P741, DOI [10.1038/NMETH.1373, 10.1038/nmeth.1373]; Shi HB, 2012, J AM CHEM SOC, V134, P3001, DOI 10.1021/ja208518u; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Simard JR, 2009, NAT CHEM BIOL, V5, P394, DOI 10.1038/nchembio.162; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	50	48	48	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					43	+		10.1038/NCHEMBIO.1118	http://dx.doi.org/10.1038/NCHEMBIO.1118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23143416	Green Accepted			2022-12-27	WOS:000312484200011
J	Peer, WA				Peer, Wendy Ann			PROTEIN EVOLUTION The enzyme perfected	NATURE CHEMICAL BIOLOGY			English	News Item									Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Peer, WA (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	peerw@purdue.edu						Ikura T, 2008, PROTEIN ENG DES SEL, V21, P83, DOI 10.1093/protein/gzm087; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Ngaki, 2012, NATURE          0513, DOI [10.1038/nature11009, DOI 10.1038/NATURE11009]; Oteiza Patricia I, 2005, Clin Dev Immunol, V12, P19, DOI 10.1080/10446670410001722168; Peer W.A., 2006, SCI FLAVONOIDS, P239, DOI [10.1007/978-0-387-28822-2_9, DOI 10.1007/978-0-387-28822-2_9]; Rausher MD., 2006, SCI FLAVONOIDS, P175, DOI [10.1007/978-0-387-28822-2_7, DOI 10.1007/978-0-387-28822-2_7]; STAFFORD HA, 1991, PLANT PHYSIOL, V96, P680, DOI 10.1104/pp.96.3.680; VERWOERT IIGS, 1992, J BACTERIOL, V174, P2851, DOI 10.1128/JB.174.9.2851-2857.1992; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485	10	2	2	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					607	608		10.1038/nchembio.1006	http://dx.doi.org/10.1038/nchembio.1006			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22710308				2022-12-27	WOS:000305471400005
J	Agapakis, CM; Boyle, PM; Silver, PA				Agapakis, Christina M.; Boyle, Patrick M.; Silver, Pamela A.			Natural strategies for the spatial optimization of metabolism in synthetic biology	NATURE CHEMICAL BIOLOGY			English	Review							POLYKETIDE SYNTHASE; ALCOHOL OXIDASE; METHANOGENIC BACTERIA; CARBONIC-ANHYDRASE; SLUDGE BED; PROTEIN; BIOSYNTHESIS; COMPLEX; SPECIFICITY; EXPRESSION	Metabolism is a highly interconnected web of chemical reactions that power life. Though the stoichiometry of metabolism is well understood, the multidimensional aspects of metabolic regulation in time and space remain difficult to define, model and engineer. Complex metabolic conversions can be performed by multiple species working cooperatively and exchanging metabolites via structured networks of organisms and resources. Within cells, metabolism is spatially regulated via sequestration in subcellular compartments and through the assembly of multienzyme complexes. Metabolic engineering and synthetic biology have had success in engineering metabolism in the first and second dimensions, designing linear metabolic pathways and channeling metabolic flux. More recently, engineering of the third dimension has improved output of engineered pathways through isolation and organization of multicell and multienzyme complexes. This review highlights natural and synthetic examples of three-dimensional metabolism both inter- and intracellularly, offering tools and perspectives for biological design.	[Agapakis, Christina M.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Boyle, Patrick M.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Silver, Pamela A.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; Harvard University	Agapakis, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	pamela_silver@hms.harvard.edu			Harvard University Center for the Environment; US National Science Foundation Synthetic Biology Engineering Research Center; Radcliffe Institute of Advanced Study; Wyss Institute for Biologically Inspired Engineering; Department of Defense Army Research Office; Department of Energy Advanced Research Projects Agency-Energy	Harvard University Center for the Environment; US National Science Foundation Synthetic Biology Engineering Research Center(National Science Foundation (NSF)); Radcliffe Institute of Advanced Study; Wyss Institute for Biologically Inspired Engineering; Department of Defense Army Research Office(United States Department of Defense); Department of Energy Advanced Research Projects Agency-Energy	The authors would like to thank J. Hackstein, Z. Summers, D. Lovley, D. Savage and B. Afonso for the use of images. P.M.B. is supported by fellowships from the Harvard University Center for the Environment and the US National Science Foundation Synthetic Biology Engineering Research Center. P.A.S. acknowledges support from the Radcliffe Institute of Advanced Study, the Wyss Institute for Biologically Inspired Engineering, the Department of Defense Army Research Office and the Department of Energy Advanced Research Projects Agency-Energy.	Agapakis CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018877; Agapakis Christina M, 2010, J Biol Eng, V4, P3, DOI 10.1186/1754-1611-4-3; Akhmanova A, 1998, NATURE, V396, P527, DOI 10.1038/25023; Aldaye FA, 2010, J AM CHEM SOC, V132, P14727, DOI 10.1021/ja105431h; Aliverti A, 1997, BIOCHEMISTRY-US, V36, P14771, DOI 10.1021/bi971791t; Anderson TD, 2011, APPL ENVIRON MICROB, V77, P4849, DOI 10.1128/AEM.02599-10; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; BOONE DR, 1980, APPL ENVIRON MICROB, V40, P626, DOI 10.1128/AEM.40.3.626-632.1980; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cheng SQ, 2010, J BACTERIOL, V192, P5071, DOI 10.1128/JB.00575-10; Choudhary S, 2010, APPL MICROBIOL BIOT, V86, P1267, DOI 10.1007/s00253-010-2521-7; Conrado RJ, 2012, NUCLEIC ACIDS RES, V40, P1879, DOI 10.1093/nar/gkr888; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Dodhia VR, 2006, J BIOL INORG CHEM, V11, P903, DOI 10.1007/s00775-006-0144-3; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; DWYER DF, 1988, APPL ENVIRON MICROB, V54, P1354, DOI 10.1128/AEM.54.6.1354-1359.1988; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Fischbach M, 2010, BIOTECHNOL J, V5, P1277, DOI 10.1002/biot.201000181; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; GIJZEN HJ, 1992, APPL ENVIRON MICROB, V58, P2565, DOI 10.1128/AEM.58.8.2565-2570.1992; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Gonzalez-Gil G, 2001, APPL ENVIRON MICROB, V67, P3683, DOI 10.1128/AEM.67.8.3683-3692.2001; Goyal G, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-89; Howe CJ, 2008, PHILOS T R SOC B, V363, P2675, DOI 10.1098/rstb.2008.0050; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kim HJ, 2011, INTEGR BIOL-UK, V3, P126, DOI 10.1039/c0ib00019a; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Lanthier M, 2002, APPL ENVIRON MICROB, V68, P4035, DOI 10.1128/AEM.68.8.4035-4043.2002; Lee H, 2012, METAB ENG, V14, P242, DOI 10.1016/j.ymben.2011.09.003; LEE MJ, 1987, CURR MICROBIOL, V15, P337, DOI 10.1007/BF01577591; Lilly M, 2009, FEMS YEAST RES, V9, P1236, DOI 10.1111/j.1567-1364.2009.00564.x; Lin HP, 2004, BIOCHEM ENG J, V21, P19, DOI 10.1016/j.bej.2004.04.013; Liu WT, 2002, WATER RES, V36, P1767, DOI 10.1016/S0043-1354(01)00377-3; Lubner CE, 2011, P NATL ACAD SCI USA, V108, P20988, DOI 10.1073/pnas.1114660108; MACLEOD FA, 1990, APPL ENVIRON MICROB, V56, P1598, DOI 10.1128/AEM.56.6.1598-1607.1990; Markx GH, 2004, TRENDS BIOTECHNOL, V22, P417, DOI 10.1016/j.tibtech.2004.06.009; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Morais S, 2010, MBIO, V1, DOI 10.1128/mBio.00285-10; Morais S, 2010, APPL ENVIRON MICROB, V76, P3787, DOI 10.1128/AEM.00266-10; Ozimek P, 2005, FEMS YEAST RES, V5, P975, DOI 10.1016/j.femsyr.2005.06.005; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Phelan VV, 2012, NAT CHEM BIOL, V8, P26, DOI 10.1038/nchembio.739; PRICE GD, 1989, PLANT PHYSIOL, V91, P505, DOI 10.1104/pp.91.2.505; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; ROGGENKAMP R, 1992, CELL BIOCHEM FUNCT, V10, P193, DOI 10.1002/cbf.290100309; Sabathe F, 2003, J BACTERIOL, V185, P1092, DOI 10.1128/JB.185.3.1092-1096.2003; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Sekiguchi Y, 1999, APPL ENVIRON MICROB, V65, P1280; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Shin HD, 2010, APPL ENVIRON MICROB, V76, P8150, DOI 10.1128/AEM.00908-10; Shiota N, 2000, BIOSCI BIOTECH BIOCH, V64, P2025, DOI 10.1271/bbb.64.2025; Shong J, 2012, CURR OPIN BIOTECH, V23, P798, DOI 10.1016/j.copbio.2012.02.001; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Solomon KV, 2011, BIOTECHNOL J, V6, P1064, DOI 10.1002/biot.201100086; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stevenson BS, 2011, INT J SYST EVOL MICR, V61, P2439, DOI 10.1099/ijs.0.025353-0; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Tang L, 2000, CHEM BIOL, V7, P77, DOI 10.1016/S1074-5521(00)00073-9; Thattai M, 2007, PLOS COMPUT BIOL, V3, P1827, DOI 10.1371/journal.pcbi.0030186; Tsai SL, 2009, APPL ENVIRON MICROB, V75, P6087, DOI 10.1128/AEM.01538-09; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; TVEDE M, 1989, LANCET, V1, P1156; Urlacher VB, 2006, TRENDS BIOTECHNOL, V24, P324, DOI 10.1016/j.tibtech.2006.05.002; Ushida K, 2010, MICROBIOL MONOGR, V19, P25, DOI 10.1007/978-3-642-13615-3_3; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P251, DOI 10.1093/oxfordjournals.molbev.a026304; VANDERKLEI IJ, 1991, YEAST, V7, P195, DOI 10.1002/yea.320070302; VOGELS GD, 1980, APPL ENVIRON MICROB, V40, P608, DOI 10.1128/AEM.40.3.608-612.1980; VONCK J, 1992, J BACTERIOL, V174, P5391, DOI 10.1128/JB.174.16.5391-5399.1992; Watanabe K, 2003, J BIOL CHEM, V278, P42020, DOI 10.1074/jbc.M305339200; Weeks A, 2006, CURR OPIN CHEM BIOL, V10, P465, DOI 10.1016/j.cbpa.2006.08.008; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Yurimoto H., 2011, INT J MICROBIOL, V2011; Zuroff TR, 2012, APPL MICROBIOL BIOT, V93, P1423, DOI 10.1007/s00253-011-3762-9	101	269	277	9	237	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					527	535		10.1038/NCHEMBIO.975	http://dx.doi.org/10.1038/NCHEMBIO.975			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22596204				2022-12-27	WOS:000304256300008
J	Xu, YF; Amador-Noguez, D; Reaves, ML; Feng, XJ; Rabinowitz, JD				Xu, Yi-Fan; Amador-Noguez, Daniel; Reaves, Marshall Louis; Feng, Xiao-Jiang; Rabinowitz, Joshua D.			Ultrasensitive regulation of anapleurosis via allosteric activation of PEP carboxylase	NATURE CHEMICAL BIOLOGY			English	Article							COLI PHOSPHOENOLPYRUVATE CARBOXYLASE; MULTIPLE EFFECTORS INVIVO; ESCHERICHIA-COLI; GENE KNOCKOUT; ISOCITRATE DEHYDROGENASE; PYRUVATE-KINASE; SITE; METABOLISM; EXPRESSION; DYNAMICS	Anapleurosis is the filling of the tricarboxylic acid cycle with four-carbon units. The common substrate for both anapleurosis and glucose phosphorylation in bacteria is the terminal glycolytic metabolite phosphoenolpyruvate (PEP). Here we show that Escherichia coli quickly and almost completely turns off PEP consumption upon glucose removal. The resulting buildup of PEP is used to quickly import glucose if it becomes available again. The switch-like termination of anapleurosis results from depletion of fructose-1,6-bisphosphate (FBP), an ultrasensitive allosteric activator of PEP carboxylase. E. coli expressing an FBP-insensitive point mutant of PEP carboxylase grow normally when glucose is steadily available. However, they fail to build up PEP upon glucose removal, grow poorly when glucose availability oscillates and suffer from futile cycling at the PEP node on gluconeogenic substrates. Thus, bacterial central carbon metabolism is intrinsically programmed with ultrasensitive allosteric regulation to enable rapid adaptation to changing environmental conditions.	[Xu, Yi-Fan; Amador-Noguez, Daniel; Reaves, Marshall Louis; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Xu, Yi-Fan; Feng, Xiao-Jiang; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Reaves, Marshall Louis] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Xu, YF (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	joshr@princeton.edu	xu, yifan/GWZ-7154-2022; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	US National Science Foundation (NSF) CAREER [MCB-0643859]; Joint US Department of Energy-Air Force Office of Scientific Research [DOE DE-SC0002077-AFOSR FA9550-09-1-0580]; US National Institutes of Health Center for Quantitative Biology [P50 GM071508]; NSF [CBET-0941143, DGE-0646086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	US National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Joint US Department of Energy-Air Force Office of Scientific Research; US National Institutes of Health Center for Quantitative Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Princeton University colleagues C. Doucette for the ppc deletion strain and A. Hottes for the pCA24N-ppc plasmid; J. Park for the flux calculations; A. Michaelis and Z. Gitai for the microscopy; D. Perlman, W. Lu, K. Saw and H. Shwe for protein mass spectrometry; and N. Wingreen for helpful discussions. This research was funded by US National Science Foundation (NSF) CAREER award MCB-0643859, Joint US Department of Energy-Air Force Office of Scientific Research award DOE DE-SC0002077-AFOSR FA9550-09-1-0580, the US National Institutes of Health Center for Quantitative Biology award P50 GM071508 and NSF grant CBET-0941143. M.L.R. was supported by NSF Graduate Research Fellowship DGE-0646086.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bhasin M, 2003, BIOCHEMISTRY-US, V42, P13496, DOI 10.1021/bi035224j; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; BROGLIE KE, 1983, J BIOL CHEM, V258, P2940; Brown G, 2009, J BIOL CHEM, V284, P3784, DOI 10.1074/jbc.M808186200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; EISENSTEIN E, 1994, J BIOL CHEM, V269, P29423; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; GARNAK M, 1979, SCIENCE, V203, P1111, DOI 10.1126/science.34215; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; IZUI K, 1981, J BIOCHEM-TOKYO, V90, P1321, DOI 10.1093/oxfordjournals.jbchem.a133597; Kai Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P170, DOI 10.1016/S0003-9861(03)00170-X; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KODAKI T, 1984, J BIOCHEM-TOKYO, V95, P637, DOI 10.1093/oxfordjournals.jbchem.a134652; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Lee M, 2005, J MOL BIOL, V348, P523, DOI 10.1016/j.jmb.2005.01.067; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; MORIKAWA M, 1980, J BIOCHEM-TOKYO, V87, P441, DOI 10.1093/oxfordjournals.jbchem.a132764; Ogawa T, 2007, RES MICROBIOL, V158, P159, DOI 10.1016/j.resmic.2006.11.003; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Salleh HM, 1996, BIOCHEMISTRY-US, V35, P8942, DOI 10.1021/bi952373w; SANWAL BD, 1966, BIOCHEM BIOPH RES CO, V22, P194, DOI 10.1016/0006-291X(66)90431-1; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Schaub J, 2008, BIOTECHNOL PROGR, V24, P1402, DOI 10.1002/btpr.59; Siddiquee KA, 2004, FEMS MICROBIOL LETT, V235, P25, DOI 10.1016/j.femsle.2004.04.004; Siddiquee KA, 2004, APPL MICROBIOL BIOT, V63, P407, DOI 10.1007/s00253-003-1357-9; SILVERSTEIN R, 1973, J BIOL CHEM, V248, P8402; SONG WJ, 1994, J BIOL CHEM, V269, P27051; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; Takahashi-Terada A, 2005, J BIOL CHEM, V280, P11798, DOI 10.1074/jbc.M408768200; Theobald U, 1997, BIOTECHNOL BIOENG, V55, P305, DOI 10.1002/(SICI)1097-0290(19970720)55:2<305::AID-BIT8>3.0.CO;2-M; van Rijsewijk BRBH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.9; WALSH K, 1985, J BIOL CHEM, V260, P8430; WOHL RC, 1972, J BIOL CHEM, V247, P5785; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Yuan J, 2007, J AM CHEM SOC, V129, P9294, DOI 10.1021/ja072997c; Zhao J, 2004, METAB ENG, V6, P164, DOI 10.1016/j.ymben.2004.02.004; Zhu T, 2010, BIOCHIMIE, V92, P116, DOI 10.1016/j.biochi.2009.09.016	50	61	61	4	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					562	568		10.1038/NCHEMBIO.941	http://dx.doi.org/10.1038/NCHEMBIO.941			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22522319	Green Accepted			2022-12-27	WOS:000304256300012
J	Liu, CX; Yin, QQ; Zhou, HC; Wu, YL; Pu, JX; Xia, L; Liu, W; Huang, X; Jiang, T; Wu, MX; He, LC; Zhao, YX; Wang, XL; Xiao, WL; Chen, HZ; Zhao, Q; Zhou, AW; Wang, LS; Sun, HD; Chen, GQ				Liu, Chuan-Xu; Yin, Qian-Qian; Zhou, Hu-Chen; Wu, Ying-Li; Pu, Jian-Xin; Xia, Li; Liu, Wei; Huang, Xin; Jiang, Tao; Wu, Ming-Xuan; He, Li-Cai; Zhao, Ya-Xue; Wang, Xiao-Lin; Xiao, Wei-Lie; Chen, Hong-Zhuan; Zhao, Qian; Zhou, Ai-Wu; Wang, Li-Shun; Sun, Han-Dong; Chen, Guo-Qiang			Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells	NATURE CHEMICAL BIOLOGY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACTIVATED PROTEIN-KINASE; RETINOIC ACID; SIGNAL-TRANSDUCTION; ALPHA ONCOPROTEIN; PMLRAR-ALPHA; C/EBP-BETA; STRESS; H2O2; RAR	Peroxiredoxins (Prxs) are potential therapeutic targets for major diseases such as cancers. However, isotype-specific inhibitors remain to be developed. We report that adenanthin, a diterpenoid isolated from the leaves of Rabdosia adenantha, induces differentiation of acute promyelocytic leukemia (APL) cells. We show that adenanthin directly targets the conserved resolving cysteines of Prx I and Prx II and inhibits their peroxidase activities. Consequently, cellular H2O2 is elevated, leading to the activation of extracellular signal-regulated kinases and increased transcription of CCAAT/enhancer-binding protein beta, which contributes to adenanthin-induced differentiation. Adenanthin induces APL-like cell differentiation, represses tumor growth in vivo and prolongs the survival of mouse APL models that are sensitive and resistant to retinoic acid. Thus, adenanthin can serve as what is to our knowledge the first lead natural compound for the development of Prx I-and Prx II-targeted therapeutic agents, which may represent a promising approach to inducing differentiation of APL cells.	[Liu, Chuan-Xu; Wu, Ying-Li; Xia, Li; Liu, Wei; He, Li-Cai; Zhao, Qian; Zhou, Ai-Wu; Wang, Li-Shun; Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Univ E Inst Chem Biol,Chinese Minist Edu, Dept Pathophysiol,Key Lab Cell Differentiat Apopt, Shanghai 200030, Peoples R China; [Yin, Qian-Qian; Huang, Xin; Chen, Guo-Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Zhou, Hu-Chen; Wu, Ming-Xuan; Zhao, Ya-Xue] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Pu, Jian-Xin; Xiao, Wei-Lie; Sun, Han-Dong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Yunnan, Peoples R China; [Jiang, Tao; Wang, Xiao-Lin; Chen, Hong-Zhuan] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200030, Peoples R China; [Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Ren Ji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, GQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Univ E Inst Chem Biol,Chinese Minist Edu, Dept Pathophysiol,Key Lab Cell Differentiat Apopt, Shanghai 200030, Peoples R China.	chengq@shsmu.edu.cn	Wu, Mingxuan/G-8519-2017	chen, guo qiang/0000-0003-4936-2363; Wang, Li-Shun/0000-0003-3972-683X; Liu, Chuanxu/0000-0002-3125-9547	National Basic Research Program of China [NO2009CB918404]; National Natural Science Foundation of China (NSFC) [90813034, 81070433]; Shanghai Science and Technology Commission [11IC1406800, 11JC1406500]; NSFC joint Foundation of Yunnan Province [U0832602]; Shanghai Committee of Education	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); NSFC joint Foundation of Yunnan Province; Shanghai Committee of Education	We thank S. C. Kogan at the University of California-San Francisco for providing us with leukemic blasts from transgenic mice and F. Besancon at Hopital St. Louis-Paris for providing NB4-MAD and NB4-GFP cells. We are also grateful to L. Zheng of the Department of Pathology in Shanghai Jiao Tong University School of Medicine for her technological assistance in pathologic examinations. This work was supported, in part, by grants from the National Basic Research Program of China (NO2009CB918404 to G.-Q.C.), the National Natural Science Foundation of China (NSFC; 90813034 to G.-Q.C. and 81070433 to Y.-L.W.), key projects for basic research of Shanghai Science and Technology Commission (11IC1406800 to G.-Q.C. and 11JC1406500 to Y.-L.W.), the NSFC joint Foundation of Yunnan Province (U0832602 to H.-D.S.) and grants from the Shanghai Committee of Education (to G.-Q.C). C.-X. L. and Q.-Q.Y. are PhD candidates at Shanghai Jiao Tong University and the Shanghai Institutes for Biological Sciences of the Chinese Academy of Sciences, respectively, and this work was submitted in partial fulfillment of the requirement for their PhD degrees.	Abdel-Wahab O, 2010, J EXP MED, V207, P677, DOI 10.1084/jem.20100523; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Callens C, 2010, J EXP MED, V207, P731, DOI 10.1084/jem.20091488; Cassinat B, 2011, MOL CELL BIOL, V31, P1409, DOI 10.1128/MCB.00756-10; de las Heras B., 2009, Inflammation & Allergy Drug Targets, V8, P28; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Duprez E, 2004, CELL CYCLE, V3, P389; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Gierse JK, 1999, BIOCHEM J, V339, P607, DOI 10.1042/0264-6021:3390607; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; Guerzoni C, 2006, CELL CYCLE, V5, P1254, DOI 10.4161/cc.5.12.2808; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hanson JR, 2009, NAT PROD REP, V26, P1156, DOI 10.1039/b807311m; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hu XT, 2000, CELL GROWTH DIFFER, V11, P191; Ji Y, 2004, CANCER RES, V64, P370, DOI 10.1158/0008-5472.CAN-03-3029; Jiang B, 2002, J NAT PROD, V65, P1111, DOI 10.1021/np020084k; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kim JH, 2008, CLIN CANCER RES, V14, P2326, DOI 10.1158/1078-0432.CCR-07-4457; Kogan SC, 2000, BLOOD, V95, P1541, DOI 10.1182/blood.V95.5.1541.005k28_1541_1550; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lopez-Pedrera C, 2006, PROTEOMICS, V6, pS293, DOI 10.1002/pmic.200500384; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Miranda MB, 2007, LEUKEMIA, V21, P1363, DOI 10.1038/sj.leu.2404690; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Raelson JV, 1996, BLOOD, V88, P2826, DOI 10.1182/blood.V88.8.2826.bloodjournal8882826; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Tirapelli Carlos R, 2008, Recent Pat Cardiovasc Drug Discov, V3, P1; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	46	144	171	16	212	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					486	493		10.1038/NCHEMBIO.935	http://dx.doi.org/10.1038/NCHEMBIO.935			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22484541				2022-12-27	WOS:000302962500016
J	Liu, F; Park, JE; Qian, WJ; Lim, D; Graber, M; Berg, T; Yaffe, MB; Lee, KS; Burke, TR				Liu, Fa; Park, Jung-Eun; Qian, Wen-Jian; Lim, Dan; Graeber, Martin; Berg, Thorsten; Yaffe, Michael B.; Lee, Kyung S.; Burke, Terrence R., Jr.			Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel	NATURE CHEMICAL BIOLOGY			English	Article							POLO-LIKE KINASES; SMALL-MOLECULE INHIBITOR; BOX DOMAIN; CANCER-CELLS; PEPTIDE; POLO-LIKE-KINASE-1; RECOGNITION; CHEMISTRY; DISCOVERY; DELIVERY	We obtained unanticipated synthetic byproducts from alkylation of the delta(1) nitrogen (N3) of the histidine imidazole ring of the polo-like kinase-1 (Plk1) polo-box domain (PBD)-binding peptide PLHSpT. For the highest-affinity byproduct, bearing a C6H5(CH2)(8)- group, a Plk1 PBD cocrystal structure revealed a new binding channel that had previously been occluded. An N-terminal PEGylated version of this peptide containing a hydrolytically stable phosphothreonyl residue (pT) bound the Plk1 PBD with affinity equal to that of the non-PEGylated parent but showed markedly less interaction with the PBDs of the two closely related proteins Plk2 and Plk3. Treatment of cultured cells with this PEGylated peptide resulted in delocalization of Plk1 from centrosomes and kinetochores and in chromosome misalignment that effectively induced mitotic block and apoptotic cell death. This work provides insights that might advance efforts to develop Plk1 PBD-binding inhibitors as potential Plk1-specific anticancer agents.	[Liu, Fa; Qian, Wen-Jian; Burke, Terrence R., Jr.] NCI, Biol Chem Lab, Mol Discovery Program, Ctr Canc Res, Frederick, MD 21701 USA; [Park, Jung-Eun; Lee, Kyung S.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lim, Dan; Yaffe, Michael B.] MIT, Ctr Canc Res, Dept Biol & Biol Engn, Cambridge, MA 02139 USA; [Graeber, Martin; Berg, Thorsten] Univ Leipzig, Inst Organ Chem, Leipzig, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Massachusetts Institute of Technology (MIT); Leipzig University	Liu, F (corresponding author), NCI, Biol Chem Lab, Mol Discovery Program, Ctr Canc Res, Frederick, MD 21701 USA.	kyunglee@mail.nih.gov; tburke@helix.nih.gov	Qian, Wenjian/L-4982-2017; Burke, Terrence R/N-2601-2014; Berg, Thorsten/A-1306-2012	Qian, Wenjian/0000-0002-0063-8405; Burke, Terrence/0000-0001-9925-8586	US National Institutes of Health [ZIA BC 006198, ZIA BC 010681, GM60594, GM68762, CA112967]; Center for Cancer Research; National Cancer Institute-Frederick; US National Cancer Institute; Deutsche Forschungsgemeinschaft [BE 4572/1-1]; NATIONAL CANCER INSTITUTE [Z01BC006198, ZIABC006198, ZIABC010681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R01GM060594] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute-Frederick; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants ZIA BC 006198 (T.R.B.) and ZIA BC 010681 (K.S.L..) of the Intramural Research Program of the US National Institutes of Health, Center for Cancer Research, National Cancer Institute-Frederick and the US National Cancer Institute, US National Institutes of Health (F.L., J.-E.P., W.-J.Q., K.S.L. and T.R.B.), US National Institutes of Health grants GM60594, GM68762 and CA112967 (M. BY.) and the Deutsche Forschungsgemeinschaft (grant BE 4572/1-1) (TB.). We thank M. Dyba of the Biophysics Resource of the Structural Biophysics Laboratory, National Cancer Institute Frederick for assistance in performing tandem MS studies and W. Dai, New York University School of Medicine for the Flag-Plk3 construct. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial product or organizations imply endorsement by the US government.	Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bellouard F, 1999, EUR J ORG CHEM, V1999, P3257; Bhadra D, 2002, PHARMAZIE, V57, P5; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Coan KED, 2009, J MED CHEM, V52, P2067, DOI 10.1021/jm801605r; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; Goh KC, 2004, DRUG DEVELOP RES, V62, P349, DOI 10.1002/ddr.10392; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Huggins DJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000880; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kanda Y, 2003, BIOORG MED CHEM LETT, V13, P455, DOI 10.1016/S0960-894X(02)00949-6; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Khedkar A, 2010, DIABETES OBES METAB, V12, P659, DOI 10.1111/j.1463-1326.2010.01213.x; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li L, 2009, ACTA PHARMACOL SIN, V30, P1443, DOI 10.1038/aps.2009.141; Liu F, 2009, TETRAHEDRON, V65, P9673, DOI 10.1016/j.tet.2009.09.093; Liu XQ, 2003, CELL CYCLE, V2, P424, DOI 10.4161/cc.2.5.505; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lu LY, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-4; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; McGovern S. L., 2006, COMPR MED CHEM 2, V2, P737; McInnes C, 2005, CURR TOP MED CHEM, V5, P181, DOI 10.2174/1568026053507660; Miller MA, 2006, BIOCONJUGATE CHEM, V17, P267, DOI 10.1021/bc0501000; Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; Reindl W, 2009, CHEMBIOCHEM, V10, P1145, DOI 10.1002/cbic.200900059; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sledz P, 2011, ANGEW CHEM INT EDIT, V50, P4003, DOI 10.1002/anie.201008019; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Swamy KCK, 2009, CHEM REV, V109, P2551, DOI 10.1021/cr800278z; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tsuchida E, 2009, BIOCONJUGATE CHEM, V20, P1419, DOI 10.1021/bc800431d; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Watanabe N, 2009, J BIOL CHEM, V284, P2344, DOI 10.1074/jbc.M805308200; Wipf P, 2009, CURR TOP MED CHEM, V9, P1194, DOI 10.2174/156802609789753590; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	49	83	93	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					595	601		10.1038/nchembio.614	http://dx.doi.org/10.1038/nchembio.614			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21765407	Green Accepted, Green Submitted			2022-12-27	WOS:000294381400009
J	Soboloff, J; Madesh, M; Gill, DL				Soboloff, Jonathan; Madesh, Muniswamy; Gill, Donald L.			Sensing cellular stress through STIM proteins	NATURE CHEMICAL BIOLOGY			English	Article							TRPC CHANNELS; S-GLUTATHIONYLATION; CALCIUM; BINDING; SENSOR; ORAI		[Soboloff, Jonathan; Madesh, Muniswamy; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Soboloff, J (corresponding author), Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19122 USA.	dgill@temple.edu	Soboloff, Jonathan/I-6995-2012	Soboloff, Jonathan/0000-0001-5192-1297	NIAID NIH HHS [R01 AI058173] Funding Source: Medline; NIGMS NIH HHS [R01 GM097335] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097335] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Mancarella S, 2009, CURR BIOL, V19, pR950, DOI 10.1016/j.cub.2009.08.051; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roberts-Thomson SJ, 2010, PHARMACOL THERAPEUT, V127, P121, DOI 10.1016/j.pharmthera.2010.04.016; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	28	33	34	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					488	492		10.1038/nchembio.619	http://dx.doi.org/10.1038/nchembio.619			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769090	Green Accepted			2022-12-27	WOS:000292825400004
J	Takahashi, S; Toyoda, A; Sekiyama, Y; Takagi, H; Nogawa, T; Uramoto, M; Suzuki, R; Koshino, H; Kumano, T; Panthee, S; Dairi, T; Ishikawa, J; Ikeda, H; Sakaki, Y; Osada, H				Takahashi, Shunji; Toyoda, Atsushi; Sekiyama, Yasuyo; Takagi, Hiroshi; Nogawa, Toshihiko; Uramoto, Masakazu; Suzuki, Ryuichiro; Koshino, Hiroyuki; Kumano, Takuto; Panthee, Suresh; Dairi, Tohru; Ishikawa, Jun; Ikeda, Haruo; Sakaki, Yoshiyuki; Osada, Hiroyuki			Reveromycin A biosynthesis uses RevG and RevJ for stereospecific spiroacetal formation	NATURE CHEMICAL BIOLOGY			English	Article							MODULAR POLYKETIDE SYNTHASES; MYXOBACTERIUM SORANGIUM-CELLULOSUM; EPIDERMAL-GROWTH-FACTOR; EUKARYOTIC CELL-GROWTH; GENE-CLUSTER; SACCHAROPOLYSPORA-ERYTHRAEA; SACCHAROMYCES-CEREVISIAE; OXIDATIVE CYCLIZATION; ENZYMATIC DOMAINS; OKADAIC ACID	Spiroacetal compounds are ubiquitous in nature, and their stereospecific structures are responsible for diverse pharmaceutical activities. Elucidation of the biosynthetic mechanisms that are involved in spiroacetal formation will open the door to efficient generation of stereospecific structures that are otherwise hard to synthesize chemically. However, the biosynthesis of these compounds is poorly understood, owing to difficulties in identifying the responsible enzymes and analyzing unstable intermediates. Here we comprehensively describe the spiroacetal formation involved in the biosynthesis of reveromycin A, which inhibits bone resorption and bone metastases of tumor cells by inducing apoptosis in osteoclasts. We performed gene disruption, systematic metabolite analysis, feeding of labeled precursors and conversion studies with recombinant enzymes. We identified two key enzymes, dihydroxy ketone synthase and spiroacetal synthase, and showed in vitro reconstruction of the stereospecific spiroacetal structure from a stable acyclic precursor. Our findings provide insights into the creation of a variety of biologically active spiroacetal compounds for drug leads.	[Takahashi, Shunji; Sekiyama, Yasuyo; Takagi, Hiroshi; Nogawa, Toshihiko; Uramoto, Masakazu; Suzuki, Ryuichiro; Koshino, Hiroyuki; Kumano, Takuto; Panthee, Suresh; Osada, Hiroyuki] RIKEN Adv Sci Inst, Dept Biol Chem, Saitama, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Shizuoka, Japan; [Dairi, Tohru] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 060, Japan; [Ishikawa, Jun] Natl Inst Infect Dis, Dept Bioact Mol, Tokyo, Japan; [Ikeda, Haruo] Kitasato Univ, Kitasato Inst Life Sci, Kanagawa, Japan; [Sakaki, Yoshiyuki] Toyohashi Univ Technol, Aichi, Japan	RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Hokkaido University; National Institute of Infectious Diseases (NIID); Kitasato University; Toyohashi University of Technology	Takahashi, S (corresponding author), RIKEN Adv Sci Inst, Dept Biol Chem, Saitama, Japan.	hisyo@riken.jp	Nogawa, Toshihiko/ABG-2652-2020; Osada, Hiroyuki/AAY-6254-2020; Osada, Hiroyuki/N-4305-2014; Takahashi, Shunji/N-6921-2015; Sekiyama, Yasuyo/F-2561-2017; Takahashi, Shunji/GLT-3245-2022; Dairi, Tohru/A-5448-2012; Koshino, Hiroyuki/N-7948-2015; Koshino, Hiroyuki/ABF-4899-2021; Kumano, Takuto/ABC-3242-2020; Panthee, Suresh/H-2754-2013; Nogawa, Toshihiko/C-4095-2017	Takahashi, Shunji/0000-0003-1684-9298; Sekiyama, Yasuyo/0000-0002-7057-0864; Takahashi, Shunji/0000-0003-1684-9298; Koshino, Hiroyuki/0000-0002-0954-9839; Koshino, Hiroyuki/0000-0002-0954-9839; Kumano, Takuto/0000-0002-9240-4074; Panthee, Suresh/0000-0003-4021-7936; Dairi, Tohru/0000-0002-3406-7970; Nogawa, Toshihiko/0000-0003-1270-5270	Naito Foundation; RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan	Naito Foundation(Naito Memorial Foundation); RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Shimizu for discussions on spiroacetal formation; K. Wierzba for reading this paper; T. Nakamura for mass analysis; N. Dohmae for MALDI-TOF and N-terminal sequencing; and E. Oowada for technical assistance. We thank all the technical staff of the Sequence Technology Team at RIKEN Genomic Sciences Center for their assistance. This work was supported in part by the Naito Foundation, the Strategic Programs for R&D of RIKEN, a Grant-in-Aid for Creative Scientific Research and a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AGTARAP A, 1967, J AM CHEM SOC, V89, P5737, DOI 10.1021/ja00998a062; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Benach J, 2002, BIOCHEMISTRY-US, V41, P14659, DOI 10.1021/bi0203684; BEVITT DJ, 1992, EUR J BIOCHEM, V204, P39, DOI 10.1111/j.1432-1033.1992.tb16603.x; Bhatt A, 2005, ANGEW CHEM INT EDIT, V44, P7075, DOI 10.1002/anie.200501757; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Cui ZF, 1996, J BIOL CHEM, V271, P14712, DOI 10.1074/jbc.271.25.14712; DONADIO S, 1992, GENE, V111, P51, DOI 10.1016/0378-1119(92)90602-L; Frank B, 2007, CHEM BIOL, V14, P221, DOI 10.1016/j.chembiol.2006.11.013; Gallimore AR, 2006, CHEM BIOL, V13, P453, DOI 10.1016/j.chembiol.2006.01.013; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Holtzel A, 1998, J ANTIBIOT, V51, P699; Ikeda H, 1999, P NATL ACAD SCI USA, V96, P9509, DOI 10.1073/pnas.96.17.9509; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; KOSHINO H, 1992, J ANTIBIOT, V45, P1420, DOI 10.7164/antibiotics.45.1420; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Li WL, 2008, J BIOL CHEM, V283, P28607, DOI 10.1074/jbc.M804279200; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; Mayerhofer LE, 1998, ARCH MICROBIOL, V169, P339, DOI 10.1007/s002030050580; Miyamoto Y, 2002, J BIOL CHEM, V277, P28810, DOI 10.1074/jbc.M203827200; Muguruma H, 2005, CLIN CANCER RES, V11, P8822, DOI 10.1158/1078-0432.CCR-05-1335; Niggemann J, 2005, EUR J ORG CHEM, V2005, P5013, DOI 10.1002/ejoc.200500425; Oliynyk M, 2003, MOL MICROBIOL, V49, P1179, DOI 10.1046/j.1365-2958.2003.03571.x; OSADA H, 1991, J ANTIBIOT, V44, P259, DOI 10.7164/antibiotics.44.259; Paterson I, 2009, CHEM-ASIAN J, V4, P594, DOI 10.1002/asia.200800445; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Shafqat N, 2003, BIOCHEM J, V376, P49, DOI 10.1042/BJ20030877; Sheppeck JE, 1997, J ORG CHEM, V62, P387, DOI 10.1021/jo961633s; Shimizu T, 2000, ORG LETT, V2, P2153, DOI 10.1021/ol0060634; Shimizu T, 2005, ORG LETT, V7, P5573, DOI 10.1021/ol052039k; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; TAKAHASHI H, 1992, J ANTIBIOT, V45, P1414, DOI 10.7164/antibiotics.45.1414; Takahashi H, 1997, ONCOL RES, V9, P7; Tanaka Y, 2002, J ANTIBIOT, V55, P904, DOI 10.7164/antibiotics.55.904; UBUKATA M, 1994, J CHEM SOC CHEM COMM, P1877, DOI 10.1039/c39940001877; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; WITKOWSKI A, 1991, J BIOL CHEM, V266, P18514; Woo JT, 2006, P NATL ACAD SCI USA, V103, P4729, DOI 10.1073/pnas.0505663103; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105	48	65	67	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					461	468		10.1038/NCHEMBIO.583	http://dx.doi.org/10.1038/NCHEMBIO.583			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21642985				2022-12-27	WOS:000292252100014
J	Murphy, RF				Murphy, Robert F.			An active role for machine learning in drug development	NATURE CHEMICAL BIOLOGY			English	Article							SYSTEMS BIOLOGY; MICROSCOPY; MODELS		[Murphy, Robert F.] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Machine Learning, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Freiburg Inst Adv Studies, Freiburg, Germany	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Murphy, RF (corresponding author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	murphy@cmu.edu			NIH [GM075205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Much of the work from my group referred to here was supported by NIH grant GM075205.	Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Danziger SA, 2007, BIOINFORMATICS, V23, pI104, DOI 10.1093/bioinformatics/btm166; Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498; Fujiwara Y, 2008, J CHEM INF MODEL, V48, P930, DOI 10.1021/ci700085q; Giuliano KA, 2009, COMB CHEM HIGH T SCR, V12, P838, DOI 10.2174/138620709789383286; Liu Y, 2004, J CHEM INF COMP SCI, V44, P1936, DOI 10.1021/ci049810a; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Merino A, 2010, DRUG DISCOV TODAY, V15, P749, DOI 10.1016/j.drudis.2010.06.006; Mohamed TP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S57; Peng T, 2011, CYTOM PART A, V79A, P383, DOI 10.1002/cyto.a.21066; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pournara I, 2004, BIOINFORMATICS, V20, P2934, DOI 10.1093/bioinformatics/bth337; Shariff A, 2010, J BIOMOL SCREEN, V15, P726, DOI 10.1177/1087057110370894; Shariff A, 2010, CYTOM PART A, V77A, P457, DOI 10.1002/cyto.a.20854; Stegle O, 2009, BIOINFORMATICS, V25, pI374, DOI 10.1093/bioinformatics/btp210; Taylor DL, 2007, METH MOL B, V356, P3; Warmuth MK, 2003, J CHEM INF COMP SCI, V43, P667, DOI 10.1021/ci025620t; Zhao T, 2007, CYTOM PART A, V71A, P978, DOI 10.1002/cyto.a.20487	19	78	85	6	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					327	330		10.1038/nchembio.576	http://dx.doi.org/10.1038/nchembio.576			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21587249	Green Submitted, Green Accepted			2022-12-27	WOS:000290677900003
J	Bujara, M; Schumperli, M; Pellaux, R; Heinemann, M; Panke, S				Bujara, Matthias; Schuemperli, Michael; Pellaux, Rene; Heinemann, Matthias; Panke, Sven			Optimization of a blueprint for in vitro glycolysis by metabolic real-time analysis	NATURE CHEMICAL BIOLOGY			English	Article							FLUX CONTROL COEFFICIENTS; ESCHERICHIA-COLI; MASS-SPECTROMETRY; DYNAMICS; GENOME; CELLS; TRANSCRIPTOME; EXPRESSION; EVOLUTION; PATHWAYS	Recruiting complex metabolic reaction networks for chemical synthesis has attracted considerable attention but frequently requires optimization of network composition and dynamics to reach sufficient productivity. As a design framework to predict optimal levels for all enzymes in the network is currently not available, state-of-the-art pathway optimization relies on high-throughput phenotype screening. We present here the development and application of a new in vitro real-time analysis method for the comprehensive investigation and rational programming of enzyme networks for synthetic tasks. We used this first to rationally and rapidly derive an optimal blueprint for the production of the fine chemical building block dihydroxyacetone phosphate (DHAP) via Escherichia coli's highly evolved glycolysis. Second, the method guided the three-step genetic implementation of the blueprint, yielding a synthetic operon with the predicted 2.5-fold-increased glycolytic flux toward DHAP. The new analytical setup drastically accelerates rational optimization of synthetic multienzyme networks.	[Bujara, Matthias; Pellaux, Rene; Panke, Sven] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Bujara, Matthias; Schuemperli, Michael; Pellaux, Rene; Heinemann, Matthias; Panke, Sven] Swiss Fed Inst Technol, Inst Proc Engn, Dept Mech & Proc Engn, Zurich, Switzerland; [Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Groningen	Panke, S (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	sven.panke@bsse.ethz.ch	Heinemann, Matthias/B-9421-2008	Heinemann, Matthias/0000-0002-5512-9077; Panke, Sven/0000-0002-9368-539X	EU	EU(European Commission)	We would like to thank N. Zamboni, U. Sauer, M. Oldiges and C. Wandrey for help with MS analyses. This work was supported by the EU-FP6 projects EUROBIOSYN and NANOMOT.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Bujara M, 2010, BIOTECHNOL BIOENG, V106, P376, DOI 10.1002/bit.22666; Buziol S, 2002, BIOTECHNOL BIOENG, V80, P632, DOI 10.1002/bit.10427; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; Chen HW, 2008, NAT PROTOC, V3, P1467, DOI 10.1038/nprot.2008.109; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; DELGADO J, 1992, BIOCHEM J, V285, P965, DOI 10.1042/bj2850965; DELGADO J, 1992, BIOCHEM J, V282, P919, DOI 10.1042/bj2820919; Ehlde M, 1996, BIOCHEM J, V313, P721, DOI 10.1042/bj3130721; El Massaoudi M, 2003, METAB ENG, V5, P86, DOI 10.1016/S1096-7176(03)00004-1; Emmerling M, 2000, BIOTECHNOL BIOENG, V67, P623, DOI [10.1002/(SICI)1097-0290(20000305)67:5<623::AID-BIT13>3.0.CO;2-W, 10.1002/(SICI)1097-0290(20000305)67:5&lt;623::AID-BIT13&gt;3.0.CO;2-W]; Fell D., 1997, UNDERSTANDING CONTRO; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Hadlich F, 2009, METAB ENG, V11, P87, DOI 10.1016/j.ymben.2008.10.002; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Jamshidi N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000177; Jewett MC, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.57; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Linshiz G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.26; Meyer D, 1997, J BACTERIOL, V179, P1298, DOI 10.1128/jb.179.4.1298-1306.1997; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schumperli M, 2007, APPL MICROBIOL BIOT, V75, P33, DOI 10.1007/s00253-007-0882-3; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Stephanopoulos G., 1998, METAB ENG; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; van den Brink J, 2008, APPL ENVIRON MICROB, V74, P5710, DOI 10.1128/AEM.01121-08; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Woodward J, 2000, NATURE, V405, P1014, DOI 10.1038/35016633; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhu L, 2008, RAPID COMMUN MASS SP, V22, P2993, DOI 10.1002/rcm.3700	41	100	111	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					271	277		10.1038/nchembio.541	http://dx.doi.org/10.1038/nchembio.541			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21423171	Green Submitted, Green Published			2022-12-27	WOS:000289617800010
J	Fierz, B; Chatterjee, C; McGinty, RK; Bar-Dagan, M; Raleigh, DP; Muir, TW				Fierz, Beat; Chatterjee, Champak; McGinty, Robert K.; Bar-Dagan, Maya; Raleigh, Daniel P.; Muir, Tom W.			Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction	NATURE CHEMICAL BIOLOGY			English	Article							RNA-POLYMERASE-II; H4-K16 ACETYLATION; GENE-EXPRESSION; HUMAN-CELLS; NUCLEOSOME; FIBER; DYNAMICS; METHYLATION; UBIQUITIN; REVEALS	Regulation of chromatin structure involves histone posttranslational modifications that can modulate intrinsic properties of the chromatin fiber to change the chromatin state. We used chemically defined nucleosome arrays to demonstrate that H2B ubiquitylation (uH2B), a modification associated with transcription, interferes with chromatin compaction and leads to an open and biochemically accessible fiber conformation. Notably, these effects were specific for ubiquitin, as compaction of chromatin modified with a similar ubiquitin-sized protein, Hub1, was only weakly affected. Applying a fluorescence-based method, we found that uH2B acts through a mechanism distinct from H4 tail acetylation, a modification known to disrupt chromatin folding. Finally, incorporation of both uH2B and acetylated H4 resulted in synergistic inhibition of higher-order chromatin structure formation, possibly a result of their distinct modes of action.	[Fierz, Beat; Chatterjee, Champak; McGinty, Robert K.; Bar-Dagan, Maya; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA; [Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Rockefeller University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fierz, B (corresponding author), Rockefeller Univ, Lab Synthet Prot Chem, 1230 York Ave, New York, NY 10021 USA.	muirt@rockefeller.edu	Muir, Tom/AHD-0860-2022; Fierz, Beat/H-3143-2012; Chatterjee, Champak/R-7214-2017	Muir, Tom/0000-0001-9635-0344; Fierz, Beat/0000-0002-2991-3044; raleigh, daniel/0000-0003-3248-7493	US National Institutes of Health [RC2CA148354]; Starr Cancer Consortium; Swiss National Science Foundation [PBBSA-118839, PA00P3_129130/1]; Novartis Foundation; NATIONAL CANCER INSTITUTE [RC2CA148354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095880, T32GM007739] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Deng and H. Yu (The Rockefeller University) for mass spectrometric analysis of histones, J. Kim and R. Subramanian for assistance with preparing hDot1L, K. Chiang for help with DNA preparation, H. Yang and D. Montiel for help with fluorescence lifetime measurements and A. Ruthenburg, R. Sadeh, P. Moyle and M. Vila-Perello for assistance with cell experiments and discussions. This work was funded by the US National Institutes of Health (grant number RC2CA148354) and the Starr Cancer Consortium. B.F. was funded by the Swiss National Science Foundation (Nr. PBBSA-118839 and PA00P3_129130/1) and by the Novartis Foundation.	Bergstrom F, 1999, P NATL ACAD SCI USA, V96, P12477, DOI 10.1073/pnas.96.22.12477; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; DELCUVE GP, 1989, BIOCHEM J, V263, P179, DOI 10.1042/bj2630179; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; DEMELER B, 2009, ULTRASCAN VERSION 9; Dittmar GAG, 2002, SCIENCE, V295, P2442, DOI 10.1126/science.1069989; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Jason LJM, 2001, J BIOL CHEM, V276, P14597, DOI 10.1074/jbc.M011153200; KAWSKI A, 1983, PHOTOCHEM PHOTOBIOL, V38, P487, DOI 10.1111/j.1751-1097.1983.tb03372.x; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; KNOX RS, 1968, PHYSICA, V39, P361, DOI 10.1016/0031-8914(68)90090-6; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kruithof M, 2009, NAT STRUCT MOL BIOL, V16, P534, DOI 10.1038/nsmb.1590; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P958, DOI 10.1021/bi00429a006; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; Ramelot Theresa A., 2003, Journal of Structural and Functional Genomics, V4, P25, DOI 10.1023/A:1024674220425; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; WOODCOCK CL, 1995, TRENDS CELL BIOL, V5, P272, DOI 10.1016/S0962-8924(00)89038-8; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	50	309	322	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					113	119		10.1038/NCHEMBIO.501	http://dx.doi.org/10.1038/NCHEMBIO.501			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21196936	Green Accepted, Green Submitted			2022-12-27	WOS:000286324600012
J	Fox, JM; Jess, P; Jambusaria, RB; Moo, GM; Liphardt, J; Clark, DS; Blanch, HW				Fox, Jerome M.; Jess, Phillip; Jambusaria, Rakesh B.; Moo, Genny M.; Liphardt, Jan; Clark, Douglas S.; Blanch, Harvey W.			A single-molecule analysis reveals morphological targets for cellulase synergy	NATURE CHEMICAL BIOLOGY			English	Article							CARBOHYDRATE-BINDING MODULE; ACIDOTHERMUS-CELLULOLYTICUS; CRYSTAL-STRUCTURE; DEGRADATION; BIOMASS; SPECIFICITY; AFFINITY; OLIGOSACCHARIDES; RECOGNITION; FLEXIBILITY	The mechanisms of enzyme activity on solid substrates are not well understood. Unlike enzyme catalysis in aqueous solutions, enzyme activity on surfaces is complicated by adsorption steps and structural heterogeneities that make enzyme-substrate interactions difficult to characterize. Cellulase enzymes, which catalyze the depolymerization of cellulose, show binding specificities for different cellulose surface morphologies, but the influence of these specificities on the activity of multienzyme mixtures has remained unclear. We developed a metric to quantify binding-target arrangements determined by photoactivated localization microscopy, and we used that metric to show that combinations of cellulases designed to bind within similar but nonidentical morphologies can have synergistic activity. This phenomenon cannot be explained with the binary crystalline or amorphous classifications commonly used to characterize cellulase-binding targets. Our results reveal a strategy for improving the activity of cellulolytic mixtures and demonstrate a versatile method for investigating protein organization on heterogeneous surfaces.	[Fox, Jerome M.; Jess, Phillip; Liphardt, Jan; Clark, Douglas S.; Blanch, Harvey W.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Fox, Jerome M.; Clark, Douglas S.; Blanch, Harvey W.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Jess, Phillip; Liphardt, Jan] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Jambusaria, Rakesh B.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Moo, Genny M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Liphardt, Jan] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Liphardt, Jan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Fox, JM (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	liphardt@berkeley.edu; clark@berkeley.edu; blanch@berkeley.edu		Liphardt, Jan/0000-0003-2835-5025; FOX, JEROME/0000-0002-3739-1899	US National Science Foundation; Energy Biosciences Institute [50000029463]	US National Science Foundation(National Science Foundation (NSF)); Energy Biosciences Institute	We thank S. Bauer for his assistance in conducting the compositional analysis on cotton and miscanthus. We thank A.L. McEvoy for providing image processing software and J.W. Chu, A.S. Gross, K. Haas and A.L. McEvoy for helpful discussions. J.M.F. is the recipient of a US National Science Foundation predoctoral fellowship and J.L., H.W.B and D.S.C. acknowledge support from the Energy Biosciences Institute (grant no. 50000029463).	Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2000, BIOCHEMISTRY-US, V39, P11129, DOI 10.1021/bi0007728; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dai ZY, 2000, TRANSGENIC RES, V9, P43, DOI 10.1023/A:1008922404834; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Harris D, 2010, PLANT PHYSIOL, V153, P420, DOI 10.1104/pp.110.154203; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jamal S, 2004, J MOL BIOL, V339, P253, DOI 10.1016/j.jmb.2004.03.069; Kim TW, 2011, BIOTECHNOL BIOENG, V108, P2247, DOI 10.1002/bit.23241; Kim TW, 2010, BIOTECHNOL BIOENG, V107, P601, DOI 10.1002/bit.22856; LEE SB, 1983, BIOTECHNOL BIOENG, V25, P33, DOI 10.1002/bit.260250105; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Poon DKY, 2007, J BIOL CHEM, V282, P2091, DOI 10.1074/jbc.M609670200; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Receveur V, 2002, J BIOL CHEM, V277, P40887, DOI 10.1074/jbc.M205404200; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Taylor J. R., 1982, INTRO ERROR ANAL STU; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; TUCKER MP, 1989, BIO-TECHNOL, V7, P817, DOI 10.1038/nbt0889-817	44	57	58	7	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					356	+		10.1038/nchembio.1227	http://dx.doi.org/10.1038/nchembio.1227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23563526				2022-12-27	WOS:000319328200006
J	Jaremko, M; Jaremko, L; Kim, HY; Cho, MK; Schwieters, CD; Giller, K; Becker, S; Zweckstetter, M				Jaremko, Mariusz; Jaremko, Lukasz; Kim, Hai-Young; Cho, Min-Kyu; Schwieters, Charles D.; Giller, Karin; Becker, Stefan; Zweckstetter, Markus			Cold denaturation of a protein dimer monitored at atomic resolution	NATURE CHEMICAL BIOLOGY			English	Article							FOLDING INTERMEDIATE; RELAXATION; PATHWAY; STATE; MECHANISM; RESIDUES; DYNAMICS; MONOMER; MODEL; FORM	Protein folding and unfolding are crucial for a range of biological phenomena and human diseases. Defining the structural properties of the involved transient species is therefore of prime interest. Using a combination of cold denaturation with NMR spectroscopy, we reveal detailed insight into the unfolding of the homodimeric repressor protein CylR2. Seven three-dimensional structures of CylR2 at temperatures from 25 degrees C to 16 degrees C reveal a progressive dissociation of the dimeric protein into a native-like monomeric intermediate followed by transition into a highly dynamic, partially folded state. The core of the partially folded state seems critical for biological function and misfolding.	[Jaremko, Mariusz; Jaremko, Lukasz; Kim, Hai-Young; Cho, Min-Kyu; Giller, Karin; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Jaremko, Mariusz] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Jaremko, Lukasz] Warsaw Univ, Fac Chem, Warsaw, Poland; [Schwieters, Charles D.] US Natl Inst Hlth, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD USA; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, Gottingen, Germany	Max Planck Society; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Zweckstetter, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany.	Markus.Zweckstetter@dzne.de	Cho, Min-Kyu/H-1303-2011; Jaremko, Lukasz/GQB-5017-2022; Jaremko, Lukasz/A-3101-2009	Cho, Min-Kyu/0000-0003-0537-2340; Jaremko, Lukasz/0000-0001-7684-9359; Jaremko, Mariusz/0000-0002-0787-702X; Zweckstetter, Markus/0000-0002-2536-6581	START; Ventures Programmes of Foundation for Polish Science (Fundacja narzecz Nauki Polskiej); Polish Ministry of Sciences and Higher Education; Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center; Center for Information Technology at the US National Institutes of Health; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090] Funding Source: NIH RePORTER	START(Austrian Science Fund (FWF)); Ventures Programmes of Foundation for Polish Science (Fundacja narzecz Nauki Polskiej); Polish Ministry of Sciences and Higher Education(Ministry of Science and Higher Education, Poland); Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center; Center for Information Technology at the US National Institutes of Health; CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT))	We thank N. Rezaei-Ghaleh for useful discussions. This work was supported by the START and Ventures Programmes of Foundation for Polish Science (Fundacja narzecz Nauki Polskiej; http://www.frip.org.pl/)operated within the Innovative Economy Operational Programme (IE OP) 2007-2013 within European Regional Development Fund (L.J. and M.J.), the Iuventus Plus project no. IP2011 019471 from Polish Ministry of Sciences and Higher Education (M.J.) and the Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center "Nanoscale Microscopy and Molecular Physiology of the Brain" (to M.Z.). C.D.S. was supported by the Intramural Research Program of the Center for Information Technology at the US National Institutes of Health.	Babu CR, 2004, NAT STRUCT MOL BIOL, V11, P352, DOI 10.1038/nsmb739; Balbach J, 1996, SCIENCE, V274, P1161, DOI 10.1126/science.274.5290.1161; Bernstein R, 2011, P NATL ACAD SCI USA, V108, P10532, DOI 10.1073/pnas.1103629108; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Campbell JC, 2012, PROTEINS, V80, P184, DOI 10.1002/prot.23178; Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768; Davidovic M, 2009, J AM CHEM SOC, V131, P1025, DOI 10.1021/ja8056419; Ecroyd H, 2010, BIOCHEM J, V429, P251, DOI 10.1042/BJ20091949; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Feng HQ, 2003, BIOCHEMISTRY-US, V42, P12461, DOI 10.1021/bi035561s; Feng HQ, 2005, P NATL ACAD SCI USA, V102, P5026, DOI 10.1073/pnas.0501372102; FERSHT A, 1992, TRENDS BIOCHEM SCI, V17, P292, DOI 10.1016/0968-0004(92)90438-F; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; FOGUEL D, 1994, P NATL ACAD SCI USA, V91, P8244, DOI 10.1073/pnas.91.17.8244; Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; Kato H, 2007, J MOL BIOL, V365, P870, DOI 10.1016/j.jmb.2006.10.047; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kiefhaber T, 1995, Methods Mol Biol, V40, P313; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Lassalle MW, 2003, PROTEIN SCI, V12, P66, DOI 10.1110/ps.0221303; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Neudecker P, 2009, BIOPHYS J, V96, P2045, DOI 10.1016/j.bpj.2008.12.3907; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Ramboarina S, 2008, J AM CHEM SOC, V130, P15318, DOI 10.1021/ja802967k; Redfield Christina, 2004, Methods Mol Biol, V278, P233; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Religa TL, 2007, P NATL ACAD SCI USA, V104, P9272, DOI 10.1073/pnas.0703434104; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Skalicky JJ, 2000, J AM CHEM SOC, V122, P3230, DOI 10.1021/ja9938884; Szyperski Thomas, 2011, Journal of Structural and Functional Genomics, V12, P1, DOI 10.1007/s10969-011-9111-5; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Whittaker SBM, 2007, J MOL BIOL, V366, P1001, DOI 10.1016/j.jmb.2006.11.012; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; Zhou Z, 2008, J MOL BIOL, V384, P531, DOI 10.1016/j.jmb.2008.09.044	47	27	27	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					264	270		10.1038/NCHEMBIO.1181	http://dx.doi.org/10.1038/NCHEMBIO.1181			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23396077	Green Published, Green Accepted			2022-12-27	WOS:000317025800017
J	Zheng, ZY; Guo, YX; Novak, O; Dai, XH; Zhao, YD; Ljung, K; Noel, JP; Chory, J				Zheng, Zuyu; Guo, Yongxia; Novak, Ondrej; Dai, Xinhua; Zhao, Yunde; Ljung, Karin; Noel, Joseph P.; Chory, Joanne			Coordination of auxin and ethylene biosynthesis by the aminotransferase VAS1	NATURE CHEMICAL BIOLOGY			English	Article							ARABIDOPSIS; PATHWAY; TRYPTOPHAN; METHIONINE; EXPRESSION; RESPONSES; PROTEINS; GENE	We identify an Arabidopsis pyridoxal-phosphate-dependent aminotransferase, VAS1, whose loss-of-function simultaneously increases amounts of the phytohormone auxin and the ethylene precursor 1-aminocyclopropane-1-carboxylate. VAS1 uses the ethylene biosynthetic intermediate methionine as an amino donor and the auxin biosynthetic intermediate indole-3-pyruvic acid as an amino acceptor to produce L-tryptophan and 2-oxo-4-methylthiobutyric acid. Our data indicate that VAS1 serves key roles in coordinating the amounts of these two vital hormones.	[Zheng, Zuyu; Noel, Joseph P.; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Zheng, Zuyu; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Guo, Yongxia; Noel, Joseph P.] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Novak, Ondrej; Ljung, Karin] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Novak, Ondrej] Palacky Univ, Fac Sci, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Novak, Ondrej] Acad Sci Czech Republ, Inst Expt Bot, Olomouc, Czech Republic; [Dai, Xinhua; Zhao, Yunde] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute; Swedish University of Agricultural Sciences; Umea University; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of California System; University of California San Diego	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	noel@salk.edu; chory@salk.edu	Noel, Joseph P/A-9459-2009; Zhao, Yunde/AAC-5360-2019; Ljung, Karin/AAE-8691-2019; NOVAK, Ondrej/F-7031-2014; Zheng, Zuyu/I-1134-2013	Ljung, Karin/0000-0003-2901-189X; NOVAK, Ondrej/0000-0003-3452-0154; 	US National Institutes of Health (NIH) [5R01GM52413]; Internal Grant Agency of Palacky University [PrF_2012_016]; Grant Agency of the Academy of Sciences of the Czech Republic [KAN200380801]; NIH [R01GM6863I]; National Science Foundation [EEC-0813570, MCB-0645794]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068631, R01GM052413] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Internal Grant Agency of Palacky University; Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Chen for technical assistance and the Arabidopsis Biological Resource Center for mutant seeds. These studies were supported by US National Institutes of Health (NIH) grant 5R01GM52413 to J.C., the Internal Grant Agency of Palacky University (PrF_2012_016) and the Grant Agency of the Academy of Sciences of the Czech Republic (KAN200380801) to (IN., the Swedish Governmental Agency for Innovation Systems and the Swedish Research Council (K.L.), NIH grant R01GM6863I to Y.Z., the National Science Foundation under award nos. EEC-0813570 and MCB-0645794 to J.P.N. and the Howard Hughes Medical Institute (Z.Z., J.P.N., J.C.).	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; BAUR AH, 1972, PHYTOCHEMISTRY, V11, P3207, DOI 10.1016/S0031-9422(00)86375-X; Burstenbinder K, 2007, PLANT J, V49, P238, DOI 10.1111/j.1365-313X.2006.02942.x; Chowdhury G, 2009, CHEM RES TOXICOL, V22, P1905, DOI 10.1021/tx9000418; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Liepman AH, 2004, CRIT REV PLANT SCI, V23, P73, DOI 10.1080/07352680490273419; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Pierik R, 2009, PLANT PHYSIOL, V149, P1701, DOI 10.1104/pp.108.133496; Poeggeler B, 1999, BRAIN RES, V815, P382, DOI 10.1016/S0006-8993(98)01027-0; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Yamada M, 2009, PLANT PHYSIOL, V151, P168, DOI 10.1104/pp.109.138859; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104	21	75	78	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					244	246		10.1038/NCHEMBIO.1178	http://dx.doi.org/10.1038/NCHEMBIO.1178			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23377040	Green Accepted			2022-12-27	WOS:000317025800013
J	Saalau-Bethell, SM; Woodhead, AJ; Chessari, G; Carr, MG; Coyle, J; Graham, B; Hiscock, SD; Murray, CW; Pathuri, P; Rich, SJ; Richardson, CJ; Williams, PA; Jhoti, H				Saalau-Bethell, Susanne M.; Woodhead, Andrew J.; Chessari, Gianni; Carr, Maria G.; Coyle, Joseph; Graham, Brent; Hiscock, Steven D.; Murray, Christopher W.; Pathuri, Puja; Rich, Sharna J.; Richardson, Caroline J.; Williams, Pamela A.; Jhoti, Harren			Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function	NATURE CHEMICAL BIOLOGY			English	Article							RNA HELICASE; BINDING; DOMAIN; HIV; INHIBITORS; INTEGRASE; DESIGN	Here we report a highly conserved new binding site located at the interface between the protease and helicase domains of the hepatitis C virus (HCV) NS3 protein. Using a chemical lead, identified by fragment screening and structure-guided design, we demonstrate that this site has a regulatory function on the protease activity via an allosteric mechanism. We propose that compounds binding at this allosteric site inhibit the function of the NS3 protein by stabilizing an inactive conformation and thus represent a new class of direct-acting antiviral agents.	[Saalau-Bethell, Susanne M.; Woodhead, Andrew J.; Chessari, Gianni; Carr, Maria G.; Coyle, Joseph; Graham, Brent; Hiscock, Steven D.; Murray, Christopher W.; Pathuri, Puja; Rich, Sharna J.; Richardson, Caroline J.; Williams, Pamela A.; Jhoti, Harren] Astex Pharmaceut, Cambridge, England	Astex Pharmaceuticals	Saalau-Bethell, SM (corresponding author), Astex Pharmaceut, Cambridge Sci Pk, Cambridge, England.	jhoti@astx.com		Murray, Chris/0000-0003-3733-0700; Williams, Pamela/0000-0002-1257-2351; Chessari, Gianni/0000-0002-8151-7778	Wellcome Trust [087738]	Wellcome Trust(Wellcome TrustEuropean Commission)	We acknowledge the contributions of M. Vinkovic, H. Angove, G. E. Besong, F. Holding, E. Chiarparin and M. L. Verdonk. We thank C. Cartwright for producing figures. X-ray data were collected at the European Synchrotron Radiation Facility and at the Diamond Lightsource. Sedimentation velocity experiments were performed by C. May and T. Laue at the Center to Advance Molecular Interaction Science at the University of New Hampshire. This research was supported by grant 087738 from the Wellcome Trust.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bartenschlager R, 2002, NAT REV DRUG DISCOV, V1, P911, DOI 10.1038/nrd942; Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Bricogne G., 2011, BUSTER VERSION 1 11; Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804; Chen KX, 2009, CURR OPIN INVEST DR, V10, P821; Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Ding SC, 2011, J VIROL, V85, P4343, DOI 10.1128/JVI.02130-10; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Hopkins AL, 1996, J MED CHEM, V39, P1589, DOI 10.1021/jm960056x; Horner SM, 2012, J VIROL, V86, P3112, DOI 10.1128/JVI.06727-11; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Krimm I, 2012, J MED CHEM, V55, P1287, DOI 10.1021/jm201439b; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Mooij WTM, 2006, CHEMMEDCHEM, V1, P827, DOI 10.1002/cmdc.200600074; Morgenstern KA, 1997, J VIROL, V71, P3767, DOI 10.1128/JVI.71.5.3767-3775.1997; Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perryman AL, 2010, CHEM BIOL DRUG DES, V75, P257, DOI 10.1111/j.1747-0285.2009.00943.x; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Rajagopal V, 2010, J BIOL CHEM, V285, P17821, DOI 10.1074/jbc.M110.114785; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rhodes David I., 2011, Antiviral Chemistry & Chemotherapy, V21, P155, DOI 10.3851/IMP1716; Richman DD, 2000, HEPATOLOGY, V32, P866, DOI 10.1053/jhep.2000.18194; Thibeault D, 2009, BIOCHEMISTRY-US, V48, P744, DOI 10.1021/bi801931e; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Walker MA, 2009, CURR OPIN INVEST DR, V10, P129; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8	44	83	86	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					920	925		10.1038/NCHEMBIO.1081	http://dx.doi.org/10.1038/NCHEMBIO.1081			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23023261	Green Accepted			2022-12-27	WOS:000310052100011
J	Watanabe, R; Okuno, D; Sakakihara, S; Shimabukuro, K; Iino, R; Yoshida, M; Noji, H				Watanabe, Rikiya; Okuno, Daichi; Sakakihara, Shouichi; Shimabukuro, Katsuya; Iino, Ryota; Yoshida, Masasuke; Noji, Hiroyuki			Mechanical modulation of catalytic power on F-1-ATPase	NATURE CHEMICAL BIOLOGY			English	Article							ATP SYNTHASE; ESCHERICHIA-COLI; MOLECULAR MACHINE; ENZYME CATALYSIS; GAMMA-SUBUNIT; F-1 MOTOR; ROTATION; FORCE; ADP; RESOLUTION	The conformational fluctuation of enzymes has a crucial role in reaction acceleration. However, the contribution to catalysis enhancement of individual substates with conformations far from the average conformation remains unclear. We studied the catalytic power of the rotary molecular motor F-1-ATPase from thermophilic Bacillus PS3 as it was stalled in transient conformations far from a stable pausing angle. The rate constants of ATP binding and hydrolysis were determined as functions of the rotary angle. Both rates exponentially increase with rotation, revealing the molecular basis of positive cooperativity among three catalytic sites: elementary reaction steps are accelerated via the mechanical rotation driven by other reactions on neighboring catalytic sites. The rate enhancement induced by ATP binding upon rotation was greater than that brought about by hydrolysis, suggesting that the ATP binding step contributes more to torque generation than does the hydrolysis step. Additionally, 9% of the ATP-driven rotary step was supported by thermal diffusion, suggesting that acceleration of the ATP docking process occurs via thermally agitated conformational fluctuations.	[Watanabe, Rikiya; Okuno, Daichi; Iino, Ryota; Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo, Japan; [Sakakihara, Shouichi] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Shimabukuro, Katsuya] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Yoshida, Masasuke] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 603, Japan	University of Tokyo; Osaka University; State University System of Florida; Florida State University; Kyoto Sangyo University	Watanabe, R (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Watanabe, Rikiya/AAO-1390-2021; Iino, Ryota/B-7746-2011	Watanabe, Rikiya/0000-0001-7146-2745; Iino, Ryota/0000-0003-0110-5704	Ministry of Education, Culture, Sports, Science and Technology, Japan [18074005]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank all members of the Noji laboratory. This work was partially supported by a Grant-in-Aid for Scientific Research (no. 18074005) to H.N. and by a Special Education and Research Expenses grant to H.N. from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Cross RL, 2000, BBA-BIOENERGETICS, V1458, P270, DOI 10.1016/S0005-2728(00)00079-7; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; Iko Y, 2009, FEBS LETT, V583, P3187, DOI 10.1016/j.febslet.2009.08.042; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; KOSHLAND DE, 1958, FED PROC, V17, P1145; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Senior AE, 2007, CELL, V130, P220, DOI 10.1016/j.cell.2007.07.004; Shimabukuro K, 2006, BIOPHYS J, V90, P1028, DOI 10.1529/biophysj.105.067298; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shimo-Kon R, 2010, BIOPHYS J, V98, P1227, DOI 10.1016/j.bpj.2009.11.050; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	46	76	76	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					86	92		10.1038/nchembio.715	http://dx.doi.org/10.1038/nchembio.715			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22101603				2022-12-27	WOS:000298414100016
J	Moulick, K; Ahn, JH; Zong, HL; Rodina, A; Cerchietti, L; DaGama, EMG; Caldas-Lopes, E; Beebe, K; Perna, F; Hatzi, K; Vu, LP; Zhao, XY; Zatorska, D; Taldone, T; Smith-Jones, P; Alpaugh, M; Gross, SS; Pillarsetty, N; Ku, T; Lewis, JS; Larson, SM; Levine, R; Erdjument-Bromage, H; Guzman, ML; Nimer, SD; Melnick, A; Neckers, L; Chiosis, G				Moulick, Kamalika; Ahn, James H.; Zong, Hongliang; Rodina, Anna; Cerchietti, Leandro; DaGama, Erica M. Gomes; Caldas-Lopes, Eloisi; Beebe, Kristin; Perna, Fabiana; Hatzi, Katerina; Vu, Ly P.; Zhao, Xinyang; Zatorska, Danuta; Taldone, Tony; Smith-Jones, Peter; Alpaugh, Mary; Gross, Steven S.; Pillarsetty, Nagavarakishore; Ku, Thomas; Lewis, Jason S.; Larson, Steven M.; Levine, Ross; Erdjument-Bromage, Hediye; Guzman, Monica L.; Nimer, Stephen D.; Melnick, Ari; Neckers, Len; Chiosis, Gabriela			Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90	NATURE CHEMICAL BIOLOGY			English	Article							BCR-ABL; SIGNAL TRANSDUCER; STAT5 ACTIVATION; TYROSINE KINASE; LEUKEMIA; CHAPERONE; TRANSCRIPTION; CELLS; TRANSFORMATION; DISCOVERY	Most cancers are characterized by multiple molecular alterations, but identification of the key proteins involved in these signaling pathways is currently beyond reach. We show that the inhibitor PU-H71 preferentially targets tumor-enriched Hsp90 complexes and affinity captures Hsp90-dependent oncogenic client proteins. We have used PU-H71 affinity capture to design a proteomic approach that, when combined with bioinformatic pathway analysis, identifies dysregulated signaling networks and key oncoproteins in chronic myeloid leukemia. The identified interactome overlaps with the well-characterized altered proteome in this cancer, indicating that this method can provide global insights into the biology of individual tumors, including primary patient specimens. In addition, we show that this approach can be used to identify previously uncharacterized oncoproteins and mechanisms, potentially leading to new targeted therapies. We further show that the abundance of the PU-H71-enriched Hsp90 species, which is not dictated by Hsp90 expression alone, is predictive of the cell's sensitivity to Hsp90 inhibition.	[Moulick, Kamalika; Ahn, James H.; Rodina, Anna; DaGama, Erica M. Gomes; Caldas-Lopes, Eloisi; Perna, Fabiana; Vu, Ly P.; Zhao, Xinyang; Zatorska, Danuta; Taldone, Tony; Alpaugh, Mary; Nimer, Stephen D.; Chiosis, Gabriela] Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY USA; [Zong, Hongliang; Cerchietti, Leandro; Hatzi, Katerina; Guzman, Monica L.; Melnick, Ari] Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY USA; [Beebe, Kristin; Neckers, Len] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Smith-Jones, Peter; Pillarsetty, Nagavarakishore; Ku, Thomas; Lewis, Jason S.; Larson, Steven M.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Gross, Steven S.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA; [Levine, Ross] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Levine, Ross] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; [Erdjument-Bromage, Hediye] Mem Sloan Kettering Canc Ctr, Microchem & Prote Core Mol Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chiosis, G (corresponding author), Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY USA.	nimers@mskcc.org; amm2014@med.cornell.edu; neckers@nih.gov; chiosisg@mskcc.org	Zong, Hongliang/F-9366-2013; Melnick, Ari/AAA-5763-2020; Moulick, Kamalika/E-1723-2018; levine, ross/AAE-7658-2019	Zong, Hongliang/0000-0002-5855-5733; Moulick, Kamalika/0000-0002-6131-1270; Cerchietti, Leandro/0000-0003-0608-1350; Perna, Fabiana/0000-0002-3744-8672; Vu, Ly/0000-0002-1682-7702; Lewis, Jason/0000-0001-7065-4534; Zhao, Xinyang/0000-0001-6677-7072; Pillarsetty, Naga Vara Kishore/0000-0002-1750-7436; Erdjument-Bromage, Hediye/0000-0003-0224-3594	Geoffrey Beene Cancer Research Center of the Memorial Sloan-Kettering Cancer Center; Leukemia and Lymphoma Society; Breast Cancer Research Fund; SPORE Pilot Award and Research & Therapeutics Program in Prostate Cance; Hirshberg Foundation for Pancreatic Cancer; Byrne Fund [1U01 AG032969-01A1, 1R01 CA155226-01]; US National Cancer Institute (NCI) Cancer Center [P30 CA08748]; NCI [P50-CA86483]; Ludwig Center for Cancer Immunotherapy at MSKCC; US National Institutes of Health (NIH) through the NIH [1 DP2 OD007399-01]; V foundation; American Italian Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA172546, R01CA155226, ZIASC010074, P30CA008748, R21CA158609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG032969] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007399] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Center of the Memorial Sloan-Kettering Cancer Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Breast Cancer Research Fund; SPORE Pilot Award and Research & Therapeutics Program in Prostate Cance; Hirshberg Foundation for Pancreatic Cancer; Byrne Fund; US National Cancer Institute (NCI) Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Center for Cancer Immunotherapy at MSKCC; US National Institutes of Health (NIH) through the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V foundation; American Italian Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the Geoffrey Beene Cancer Research Center of the Memorial Sloan-Kettering Cancer Center (G.C.), Leukemia and Lymphoma Society (G.C., M.L.G., S.D.N., X.Z. and R.L.), Breast Cancer Research Fund (G.C.), the SPORE Pilot Award and Research & Therapeutics Program in Prostate Cancer (G.C.), the Hirshberg Foundation for Pancreatic Cancer (G.C.), the Byrne Fund (G.C.), 1U01 AG032969-01A1 (G.C.), 1R01 CA155226-01 (G.C. and A.M.) and US National Cancer Institute (NCI) Cancer Center Support Grant P30 CA08748 (H.E.B.). K.B. and L.N. were supported by funds from the Intramural Program of the NCI. S.M.L. and P.M.S.-J. are supported by the Ludwig Center for Cancer Immunotherapy at MSKCC and by NCI Grant P50-CA86483. M.L.G. is funded by the US National Institutes of Health (NIH) through the NIH Director's New Innovator Award Program, 1 DP2 OD007399-01 and the V foundation. F.P. is funded by the American Italian Cancer Foundation. We thank D. Toft (Mayo Clinic) and M. Cox (University of Texas) for the gifts of H9010 Hsp90-specific antibodies, L.A. Fabrizio, A.M. Morrishow, H. Deng and J. Fernandez for help with MS analysis, A. Perl, C.T. Jordan, M. Becker and J. Nicoll for providing the primary CML samples or suggestions on their use, and B. Clarkson, J. Bromberg and P. Gregor for suggestions with the manuscript.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Ashman K, 2009, CLIN TRANSL ONCOL, V11, P356, DOI 10.1007/s12094-009-0369-z; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Burke BA, 2010, LEUKEMIA, V24, P1105, DOI 10.1038/leu.2010.67; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; de Groot RP, 1999, BLOOD, V94, P1108, DOI 10.1182/blood.V94.3.1108.415k07_1108_1112; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hanash S, 2010, NAT REV CANCER, V10, P652, DOI 10.1038/nrc2918; Hendriks RW, 2006, SEMIN IMMUNOL, V18, P67, DOI 10.1016/j.smim.2005.10.002; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Janin YL, 2010, DRUG DISCOV TODAY, V15, P342, DOI 10.1016/j.drudis.2010.03.002; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Le Y, 2009, AM J HEMATOL, V84, P273, DOI 10.1002/ajh.21381; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Mahajan S, 2001, J BIOL CHEM, V276, P31216, DOI 10.1074/jbc.M104874200; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nobukuni T, 2007, CURR OPIN CELL BIOL, V19, P135, DOI 10.1016/j.ceb.2007.02.019; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Oda A, 2002, BLOOD, V99, P1850, DOI 10.1182/blood.V99.5.1850; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; SALGIA R, 1995, ONCOGENE, V11, P1149; SAWYERS CL, 1993, LEUKEMIA LYMPHOMA, V11, P45, DOI 10.3109/10428199309047862; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Taldone T, 2009, CURR TOP MED CHEM, V9, P1436, DOI 10.2174/156802609789895737; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	46	201	206	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					818	826		10.1038/nchembio.670	http://dx.doi.org/10.1038/nchembio.670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21946277	Green Accepted			2022-12-27	WOS:000296381600012
J	Patgiri, A; Yadav, KK; Arora, PS; Bar-Sagi, D				Patgiri, Anupam; Yadav, Kamlesh K.; Arora, Paramjit S.; Bar-Sagi, Dafna			An orthosteric inhibitor of the Ras-Sos interaction	NATURE CHEMICAL BIOLOGY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; ALPHA-HELICES; ACTIVATOR SON; PROTEIN; RECOGNITION; SEVENLESS; ERK/MAPK; COMPLEX	Mimics of alpha-helices on protein surfaces have emerged as powerful reagents for antagonizing protein-protein interactions, which are difficult to target with small molecules. Here we describe the design of a cell-permeable synthetic alpha-helix, based on the guanine nucleotide exchange factor Sos, that interferes with Ras-Sos interaction and downregulates Ras signaling in response to receptor tyrosine kinase activation.	[Patgiri, Anupam; Arora, Paramjit S.] NYU, Dept Chem, New York, NY 10012 USA; [Yadav, Kamlesh K.; Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University; New York University	Patgiri, A (corresponding author), NYU, Dept Chem, New York, NY 10012 USA.	arora@nyu.edu; dafna.bar-sagi@nyumc.org	Arora, Paramjit/AAR-3086-2020	Patgiri, Anupam/0000-0002-4184-5961; Bar-Sagi, Dafna/0000-0003-2597-8948	US National Institutes of Health [GM073943, GM078266]; ARRA [GM078266S1]; New York University; New York State Office of Science, Technology and Academic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073943, R01GM078266] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University; New York State Office of Science, Technology and Academic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (GM073943 to P.S.A. and GM078266 and an ARRA stimulus supplement (GM078266S1) to D.B.-S.). A.P. thanks New York University for the Margaret and Herman Sokol Fellowship. NMR data were collected at the New York Structural Biology Center, a Strategically Targeted Academic Research (STAR) center supported by the New York State Office of Science, Technology and Academic Research. We thank C. Lin (New York University) and A. Natarajan and R. Ghosh (City College, City University of New York) for help with the NMR studies.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Cummings CG, 2010, CURR OPIN CHEM BIOL, V14, P341, DOI 10.1016/j.cbpa.2010.04.001; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Harrison RS, 2010, P NATL ACAD SCI USA, V107, P11686, DOI 10.1073/pnas.1002498107; Henchey LK, 2010, CHEMBIOCHEM, V11, P2104, DOI 10.1002/cbic.201000378; Henchey LK, 2010, J AM CHEM SOC, V132, P941, DOI 10.1021/ja9082864; Horne WS, 2009, P NATL ACAD SCI USA, V106, P14751, DOI 10.1073/pnas.0902663106; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; KORTEMME T, 2004, SCI STKE, pPL2; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Patgiri A, 2008, ACCOUNTS CHEM RES, V41, P1289, DOI 10.1021/ar700264k; Patgiri A, 2010, NAT PROTOC, V5, P1857, DOI 10.1038/nprot.2010.146; Sacco E, 2005, FEBS LETT, V579, P6851, DOI 10.1016/j.febslet.2005.11.024; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005	24	220	245	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					585	587		10.1038/NCHEMBIO.612	http://dx.doi.org/10.1038/NCHEMBIO.612			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21765406	Green Accepted			2022-12-27	WOS:000294381400006
J	Lemke, EA; Schultz, C				Lemke, Edward A.; Schultz, Carsten			Principles for designing fluorescent sensors and reporters	NATURE CHEMICAL BIOLOGY			English	Article							IN-VIVO; PROTEIN; INDICATORS; PROBES; CHEMISTRY; PEPTIDES; BUFFERS; FRET; DYE		[Lemke, Edward A.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Lemke, EA (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	lemke@embl.de; schultz@embl.de	Lemke, Edward A/J-3337-2015	Lemke, Edward A/0000-0002-0634-0503; Schultz, Carsten/0000-0002-5824-2171				Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Bradley J, 2009, J NEUROSCI, V29, P9197, DOI 10.1523/JNEUROSCI.1240-09.2009; Brun MA, 2009, J AM CHEM SOC, V131, P5873, DOI 10.1021/ja900149e; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cobos-Correa A, 2009, NAT CHEM BIOL, V5, P628, DOI 10.1038/nchembio.196; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Fonovic M, 2008, EXPERT REV PROTEOMIC, V5, P721, DOI 10.1586/14789450.5.5.721; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Kuhn B, 2008, P NATL ACAD SCI USA, V105, P7588, DOI 10.1073/pnas.0802462105; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; PILJIC A, 2011, ACS CHEM BIOL, V6, DOI DOI 10.2021/CB100402N; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Plass T, 2011, ANGEW CHEM INT EDIT, V50, P3878, DOI 10.1002/anie.201008178; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; WAGGONER A, 1976, J MEMBRANE BIOL, V27, P317, DOI 10.1007/BF01869143; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	26	79	81	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					480	483		10.1038/nchembio.620	http://dx.doi.org/10.1038/nchembio.620			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769088				2022-12-27	WOS:000292825400002
J	Van Damme, P; Menschaert, G				Van Damme, Petra; Menschaert, Gerben			ANTIGENIC PEPTIDES Reviving nuclear translation	NATURE CHEMICAL BIOLOGY			English	News Item							MESSENGER-RNA TRANSLATION; GENOME-WIDE SEARCH; REVEALS	Noncanonical translation of prespliced mRNA provides physiological meaning to nuclear translation in generating antigenic peptide substrates for the endogenous major histocompatibility complex class I pathway.	[Van Damme, Petra] VIB, Dept Med Prot Res, Ghent, Belgium; [Van Damme, Petra] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Menschaert, Gerben] Univ Ghent, Lab Bioinformat & Computat Genom, Dept Math Modeling Stat & Bioinformat, Fac Biosci Engn, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Van Damme, P (corresponding author), VIB, Dept Med Prot Res, Ghent, Belgium.	petra.vandamme@vib-ugent.be	Van Damme, Petra/C-7269-2008	Van Damme, Petra/0000-0001-9090-027X; Menschaert, Gerben/0000-0002-7575-2085				ALLFREY VG, 1955, NATURE, V176, P1042, DOI 10.1038/1761042a0; Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Apcher S, 2011, P NATL ACAD SCI USA, V108, P11572, DOI 10.1073/pnas.1104104108; Aviner R, 2013, GENE DEV, V27, P1834, DOI 10.1101/gad.219105.113; Crappe J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-648; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Yewdell JW, 2011, TRENDS IMMUNOL, V32, P548, DOI 10.1016/j.it.2011.08.001	11	0	0	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					759	760		10.1038/nchembio.1394	http://dx.doi.org/10.1038/nchembio.1394			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24231616				2022-12-27	WOS:000327130000005
J	Dacosta, CJB; Dey, L; Therien, JPD; Baenziger, JE				daCosta, Corrie J. B.; Dey, Lopamudra; Therien, J. P. Daniel; Baenziger, John E.			A distinct mechanism for activating uncoupled nicotinic acetylcholine receptors	NATURE CHEMICAL BIOLOGY			English	Article							NONCOMPETITIVE INHIBITORS; TRANSMEMBRANE DOMAIN; LIPID-COMPOSITION; PROTEIN FUNCTION; CHOLESTEROL; CHANNEL; LIGAND; SPECTROSCOPY; MODULATION; DYNAMICS	The ability of the nicotinic acetylcholine receptor (nAChR) to undergo conformational transitions is exquisitely sensitive to its surrounding lipid environment. Previous work has highlighted a conformational selection mechanism, whereby different lipids stabilize different proportions of activatable resting versus nonactivatable conformations. In the absence of anionic lipids and cholesterol, the nAChR adopts an uncoupled conformation, which binds agonist with resting state-like affinity but does not usually undergo agonist-induced conformational transitions. Very slow (minutes to hours) transitions from uncoupled to coupled (resting, open and/or desensitized) conformations, however, can occur in membranes with relatively thick hydrophobic cores. Increasing membrane hydrophobic thickness 'awakens' uncoupled nAChRs by reducing the large activation energy barrier (or barriers) leading to coupled states, thus allowing conformational transitions to occur on an experimentally tractable timescale. Lipids shape activity by modulating the relative proportions of activatable versus nonactivatable conformations and by controlling the transitions between uncoupled and coupled conformations.	[daCosta, Corrie J. B.; Dey, Lopamudra; Therien, J. P. Daniel; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Dacosta, CJB (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA.	john.baenziger@uottawa.ca		Baenziger, John/0000-0002-2888-5328	Canadian Institutes of Health Research (CIHR) [12197, 111243]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded by research grants 12197 and 111243 to J.E.B. from the Canadian Institutes of Health Research (CIHR) as well as a CIHR Fellowship to C.J.B.d.	Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; BAENZIGER JE, 1993, BIOCHEMISTRY-US, V32, P5448, DOI 10.1021/bi00071a022; BAENZIGER JE, 1995, J BIOL CHEM, V270, P29129, DOI 10.1074/jbc.270.49.29129; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Baenziger John E, 2013, Biophys Rev, V5, P1, DOI 10.1007/s12551-012-0078-7; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Baier CJ, 2010, EUR BIOPHYS J BIOPHY, V39, P213, DOI 10.1007/s00249-009-0521-2; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; BLUME A, 1988, BIOCHEMISTRY-US, V27, P8239, DOI 10.1021/bi00421a038; Borroni V, 2011, J BIOL CHEM, V286, P17122, DOI 10.1074/jbc.M110.211870; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; daCosta CJB, 2011, BIOCHEM BIOPH RES CO, V407, P456, DOI 10.1016/j.bbrc.2011.03.026; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; De Almeida RFM, 2006, MOL MEMBR BIOL, V23, P305, DOI 10.1080/09687860600703613; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Gleason NJ, 2012, BIOCHEMISTRY-US, V51, P2044, DOI 10.1021/bi201732e; Greisen P, 2011, P NATL ACAD SCI USA, V108, P12717, DOI 10.1073/pnas.1103192108; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HEIDMANN T, 1980, EUR J BIOCHEM, V110, P35, DOI 10.1111/j.1432-1033.1980.tb04839.x; HERZ JM, 1991, J BIOL CHEM, V266, P16691; HERZ JM, 1987, J BIOL CHEM, V262, P7238; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Labriola JM, 2010, J BIOL CHEM, V285, P10337, DOI 10.1074/jbc.M109.071993; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Li P, 2010, BRIT J PHARMACOL, V160, P1906, DOI 10.1111/j.1476-5381.2010.00761.x; Lundbaek JA, 2003, BIOPHYS J, V84, P2080, DOI 10.1016/S0006-3495(03)75015-2; METHOT N, 1995, BIOCHEMISTRY-US, V34, P15142, DOI 10.1021/bi00046a021; METHOT N, 1994, BIOCHEMISTRY-US, V33, P7709, DOI 10.1021/bi00190a026; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Ryan SE, 2002, J BIOL CHEM, V277, P10420, DOI 10.1074/jbc.M107412200; Ryan SE, 1996, J BIOL CHEM, V271, P24590, DOI 10.1074/jbc.271.40.24590; Ryan SE, 1999, MOL PHARMACOL, V55, P348, DOI 10.1124/mol.55.2.348; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Sturgeon RM, 2010, BIOPHYS J, V98, P989, DOI 10.1016/j.bpj.2009.11.030; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Xu YC, 2005, J AM CHEM SOC, V127, P1291, DOI 10.1021/ja044577i	51	72	72	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					701	+		10.1038/NCHEMBIO.1338	http://dx.doi.org/10.1038/NCHEMBIO.1338			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24013278				2022-12-27	WOS:000325930500009
J	Aranko, AS; Oeemig, JS; Kajander, T; Iwai, H				Aranko, A. Sesilja; Oeemig, Jesper S.; Kajander, Tommi; Iwai, Hideo			Intermolecular domain swapping induces intein-mediated protein alternative splicing	NATURE CHEMICAL BIOLOGY			English	Article							SPLIT DNAE INTEINS; HIGHLY EFFICIENT; IN-VITRO; ADENOSINE-TRIPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; NOSTOC-PUNCTIFORME; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; GENE; EVOLUTION	Protein sequences are diversified on the DNA level by recombination and mutation and can be further increased on the RNA level by alternative RNA splicing, involving introns that have important roles in many biological processes. The protein version of introns (inteins), which catalyze protein splicing, were first reported in the 1990s. The biological roles of protein splicing still remain elusive because inteins neither provide any clear benefits nor have an essential role in their host organisms. We now report protein alternative splicing, in which new protein sequences can be produced by protein recombination by intermolecular domain swapping of inteins, as elucidated by NMR spectroscopy and crystal structures. We demonstrate that intein-mediated protein alternative splicing could be a new strategy to increase protein diversity (that is, functions) without any modification in genetic backgrounds. We also exploited it as a post-translational protein conformation-driven switch of protein functions (for example, as highly specific protein interference).	[Aranko, A. Sesilja; Oeemig, Jesper S.; Kajander, Tommi; Iwai, Hideo] Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, Helsinki, Finland	University of Helsinki	Aranko, AS (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, Helsinki, Finland.	hideo.iwai@helsinki.fi	Iwaï, Hideo/A-6416-2009	Iwaï, Hideo/0000-0001-7376-5264; Kajander, Tommi/0000-0002-5094-227X; Aranko, Aino Sesilja/0000-0001-9425-3524	Academy of Finland [131413, 137995]; Sigrid Juselius Foundation; Viikki Doctoral Programme in Molecular Biosciences; National Doctoral Programme in Informational and Structural Biology; Biocenter Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Viikki Doctoral Programme in Molecular Biosciences; National Doctoral Programme in Informational and Structural Biology; Biocenter Finland	This work was supported by the Academy of Finland (131413 and 137995) and the Sigrid Juselius Foundation and Biocenter Finland (to H.I., for crystallization, MS and NMR facilities at the Institute of Biotechnology). A.S.A. and J.S.O. acknowledge Viikki Doctoral Programme in Molecular Biosciences and the National Doctoral Programme in Informational and Structural Biology for financial support, respectively. The authors thank G. Volkmann for his help at the very early stage of the project. The authors also thank F. Perler for providing us with the latest InBase data set and S. Ferkau and C. Albert for their technical support.	Amstutz P, 2001, CURR OPIN BIOTECH, V12, P400, DOI 10.1016/S0958-1669(00)00234-2; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Aranko AS, 2013, FEBS J, V280, P3256, DOI 10.1111/febs.12307; Aranko AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005185; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Callahan BP, 2011, NAT STRUCT MOL BIOL, V18, P630, DOI 10.1038/nsmb.2041; Caspi J, 2003, MOL MICROBIOL, V50, P1569, DOI 10.1046/j.1365-2958.2003.03825.x; Clerissi C, 2013, EVOLUTION, V67, P18, DOI 10.1111/j.1558-5646.2012.01738.x; Clerissi C, 2012, J VIROL, V86, P4611, DOI 10.1128/JVI.07221-11; Dassa B, 2007, BIOCHEMISTRY-US, V46, P322, DOI 10.1021/bi0611762; Dassa B, 2009, NUCLEIC ACIDS RES, V37, P2560, DOI 10.1093/nar/gkp095; Ellila S, 2011, FEBS LETT, V585, P3471, DOI 10.1016/j.febslet.2011.10.005; Gogarten JP, 2002, ANNU REV MICROBIOL, V56, P263, DOI 10.1146/annurev.micro.56.012302.160741; Heinamaki K, 2013, BIOMOL NMR ASSIGN, V7, P115, DOI 10.1007/s12104-012-9435-5; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kawasaki M, 1997, FEBS LETT, V412, P518, DOI 10.1016/S0014-5793(97)00850-8; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Liu XQ, 2004, FEBS LETT, V572, P46, DOI 10.1016/j.febslet.2004.07.016; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muona M, 2010, NAT PROTOC, V5, P574, DOI 10.1038/nprot.2009.240; Nogami S, 2002, YEAST, V19, P773, DOI 10.1002/yea.872; Oeemig JS, 2012, J MOL BIOL, V421, P85, DOI 10.1016/j.jmb.2012.04.029; Oeemig JS, 2009, FEBS LETT, V583, P1451, DOI 10.1016/j.febslet.2009.03.058; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Paulus H, 2003, FRONT BIOSCI, V8, pS1157, DOI 10.2741/1195; Perler FB, 1999, TRENDS BIOCHEM SCI, V24, P209, DOI 10.1016/S0968-0004(99)01403-6; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Swithers KS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-303; Tori K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026361; Tori K, 2011, J BACTERIOL, V193, P2035, DOI 10.1128/JB.01407-10; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	42	39	41	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					616	622		10.1038/NCHEMBIO.1320	http://dx.doi.org/10.1038/NCHEMBIO.1320			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	23974115				2022-12-27	WOS:000325041800008
J	Tang, XY; Eitel, K; Kaysser, L; Kulik, A; Grond, S; Gust, B				Tang, Xiaoyu; Eitel, Kornelia; Kaysser, Leonard; Kulik, Andreas; Grond, Stephanie; Gust, Bertolt			A two-step sulfation in antibiotic biosynthesis requires a type III polyketide synthase	NATURE CHEMICAL BIOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ARYL SULFOTRANSFERASE; STREPTOMYCES SP; FAMILY; MICROORGANISMS; IDENTIFICATION; MECHANISM; CHALCONE; BACTERIA; PATHWAY	Caprazamycins (CPZs) belong to a group of liponucleoside antibiotics inhibiting the bacterial MraY translocase, an essential enzyme involved in peptidoglycan biosynthesis. We have recently identified analogs that are decorated with a sulfate group at the 2 ''-hydroxy of the aminoribosyl moiety, and we now report an unprecedented two-step sulfation mechanism during the biosynthesis of CPZs. A type III polyketide synthase (PKS) known as Cpz6 is used in the biosynthesis of a group of new triketide pyrones that are subsequently sulfated by an unusual 3'-phosphoadenosine-5'-phosphosulfate (PAPS)-dependent sulfotransferase (Cpz8) to yield phenolic sulfate esters, which serve as sulfate donors for a PAPS-independent arylsulfate sulfotransferase (Cpz4) to generate sulfated CPZs. This finding is to our knowledge the first demonstration of genuine sulfate donors for an arylsulfate sulfotransferase and the first report of a type Ill PKS to generate a chemical reagent in bacterial sulfate metabolism.	[Tang, Xiaoyu; Eitel, Kornelia; Kaysser, Leonard; Gust, Bertolt] Univ Tubingen, Inst Pharmaceut, Tubingen, Germany; [Kulik, Andreas] Univ Tubingen, Inst Microbiol & Infect Med, Tubingen, Germany; [Grond, Stephanie] Univ Tubingen, Inst Organ Chem, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Tang, XY (corresponding author), Univ Tubingen, Inst Pharmaceut, Tubingen, Germany.	bertolt.gust@uni-tuebingen.de	Kaysser, Leonard/Q-2091-2019; Tang, Xiaoyu/AFJ-2531-2022	Kaysser, Leonard/0000-0002-3943-993X; Grond, Stephanie/0000-0002-7549-4936; Tang, Xiaoyu/0000-0002-7855-5984; Kulik, Andreas/0000-0002-6914-7313	Deutsche Forschungsgemeinschaft [SFB766]; Graduate School 'Promotionsverbund Antibakterielle Wirkstoffe' of the University of Tuebingen; European Commission [IP005224]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School 'Promotionsverbund Antibakterielle Wirkstoffe' of the University of Tuebingen; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank G. Challis (University of Warwick) for providing S. coelicolor M145/Delta sco7221 and germicidin A. We are grateful to R. Machinek and C. Zolke (Institute of Organic Chemistry, University of Gottingen) for carrying out NMR measurements. We also thank A. Jones for reviewing the manuscript. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB766) to K.E. and X.T., a grant from the Graduate School 'Promotionsverbund Antibakterielle Wirkstoffe' of the University of Tuebingen to X.T. and by the European Commission (IP005224, ActinoGen) to L.K.	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Aoki Y, 2011, J ANTIBIOT, V64, P607, DOI 10.1038/ja.2011.59; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Funabashi M, 2008, J BIOL CHEM, V283, P13983, DOI 10.1074/jbc.M710461200; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hatzios SK, 2008, BIOCHEMISTRY-US, V47, P5823, DOI 10.1021/bi702453s; Hatzios SK, 2011, BIOORG MED CHEM LETT, V21, P4956, DOI 10.1016/j.bmcl.2011.06.057; Igarahi M, 2003, J ANTIBIOT, V56, P580, DOI 10.7164/antibiotics.56.580; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Katsuyama Y, 2012, METHOD ENZYMOL, V515, P359, DOI 10.1016/B978-0-12-394290-6.00017-3; Kaysser L, 2010, J BIOL CHEM, V285, P12684, DOI 10.1074/jbc.M109.094490; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOBASHI K, 1986, ARCH BIOCHEM BIOPHYS, V245, P537, DOI 10.1016/0003-9861(86)90247-X; Malojcic G, 2010, ANTIOXID REDOX SIGN, V13, P1247, DOI 10.1089/ars.2010.3119; Mechold U, 2006, NUCLEIC ACIDS RES, V34, P2364, DOI 10.1093/nar/gkl247; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Moore BS, 2002, J NAT PROD, V65, P1956, DOI 10.1021/np020230m; Pi N, 2005, ANAL BIOCHEM, V341, P94, DOI 10.1016/j.ab.2005.02.004; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Surup F, 2007, J ORG CHEM, V72, P5085, DOI 10.1021/jo0703303; Watanabe K, 2007, CURR OPIN CHEM BIOL, V11, P279, DOI 10.1016/j.cbpa.2006.11.041; Yu DY, 2012, IUBMB LIFE, V64, P285, DOI 10.1002/iub.1005	28	27	28	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					610	615		10.1038/NCHEMBIO.1310	http://dx.doi.org/10.1038/NCHEMBIO.1310			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	23912167				2022-12-27	WOS:000325041800007
J	Jeng, PS; Cheng, EH				Jeng, Paul S.; Cheng, Emily H.			CANCER THERAPEUTICS Pulling the plug on BCL-X-L	NATURE CHEMICAL BIOLOGY			English	News Item							PUMA; BIM; BAX; ACTIVATION; FAMILY		[Jeng, Paul S.; Cheng, Emily H.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Jeng, Paul S.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Program Pharmacol, New York, NY 10021 USA; [Cheng, Emily H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Cheng, Emily H.] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Cornell University	Jeng, PS (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chenge1@mskcc.org						Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Davids MS, 2012, J CLIN ONCOL, V30, P3127, DOI 10.1200/JCO.2011.37.0981; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Walensky LD, 2012, J CLIN ONCOL, V30, P554, DOI 10.1200/JCO.2011.37.9339; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	10	10	10	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2013	9	6					351	352		10.1038/nchembio.1256	http://dx.doi.org/10.1038/nchembio.1256			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	149NS	23689630				2022-12-27	WOS:000319328200004
J	Anastasiou, D; Yu, YM; Israelsen, WJ; Jiang, JK; Boxer, MB; Hong, BS; Tempel, W; Dimov, S; Shen, M; Jha, A; Yang, H; Mattaini, KR; Metallo, CM; Fiske, BP; Courtney, KD; Malstrom, S; Khan, TM; Kung, C; Skoumbourdis, AP; Veith, H; Southall, N; Walsh, MJ; Brimacombe, KR; Leister, W; Lunt, SY; Johnson, ZR; Yen, KE; Kunii, K; Davidson, SM; Christofk, HR; Austin, CP; Inglese, J; Harris, MH; Asara, JM; Stephanopoulos, G; Salituro, FG; Jin, SF; Dang, L; Auld, DS; Park, HW; Cantley, LC; Thomas, CJ; Heiden, MGV				Anastasiou, Dimitrios; Yu, Yimin; Israelsen, William J.; Jiang, Jian-Kang; Boxer, Matthew B.; Hong, Bum Soo; Tempel, Wolfram; Dimov, Svetoslav; Shen, Min; Jha, Abhishek; Yang, Hua; Mattaini, Katherine R.; Metallo, Christian M.; Fiske, Brian P.; Courtney, Kevin D.; Malstrom, Scott; Khan, Tahsin M.; Kung, Charles; Skoumbourdis, Amanda P.; Veith, Henrike; Southall, Noel; Walsh, Martin J.; Brimacombe, Kyle R.; Leister, William; Lunt, Sophia Y.; Johnson, Zachary R.; Yen, Katharine E.; Kunii, Kaiko; Davidson, Shawn M.; Christofk, Heather R.; Austin, Christopher P.; Inglese, James; Harris, Marian H.; Asara, John M.; Stephanopoulos, Gregory; Salituro, Francesco G.; Jin, Shengfang; Dang, Lenny; Auld, Douglas S.; Park, Hee-Won; Cantley, Lewis C.; Thomas, Craig J.; Heiden, Matthew G. Vander			Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis	NATURE CHEMICAL BIOLOGY			English	Article							CANCER-CELL METABOLISM; TUMOR-GROWTH; NUCLEAR TRANSLOCATION; THYROID-HORMONE; BINDING PROTEIN; ISOFORM; FRUCTOSE-1,6-BISPHOSPHATE; ISOZYME; INHIBITION; CONVERSION	Cancer cells engage in a metabolic program to enhance biosynthesis and support cell proliferation. The regulatory properties of pyruvate kinase M2 (PKM2) influence altered glucose metabolism in cancer. The interaction of PKM2 with phosphotyrosine-containing proteins inhibits enzyme activity and increases the availability of glycolytic metabolites to support cell proliferation. This suggests that high pyruvate kinase activity may suppress tumor growth. We show that expression of PKM1, the pyruvate kinase isoform with high constitutive activity, or exposure to published small-molecule PKM2 activators inhibits the growth of xenograft tumors. Structural studies reveal that small-molecule activators bind PKM2 at the subunit interaction interface, a site that is distinct from that of the endogenous activator fructose-1,6-bisphosphate (FBP). However, unlike FBP, binding of activators to PKM2 promotes a constitutively active enzyme state that is resistant to inhibition by tyrosine-phosphorylated proteins. These data support the notion that small-molecule activation of PKM2 can interfere with anabolic metabolism.	[Anastasiou, Dimitrios; Courtney, Kevin D.; Christofk, Heather R.; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA; [Anastasiou, Dimitrios; Courtney, Kevin D.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Yu, Yimin; Israelsen, William J.; Mattaini, Katherine R.; Fiske, Brian P.; Malstrom, Scott; Khan, Tahsin M.; Lunt, Sophia Y.; Johnson, Zachary R.; Davidson, Shawn M.; Heiden, Matthew G. Vander] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jiang, Jian-Kang; Boxer, Matthew B.; Shen, Min; Skoumbourdis, Amanda P.; Veith, Henrike; Southall, Noel; Walsh, Martin J.; Brimacombe, Kyle R.; Leister, William; Austin, Christopher P.; Inglese, James; Auld, Douglas S.; Thomas, Craig J.] Natl Ctr Adv Translat Sci, NIH, Chem Genom Ctr, Bethesda, MD USA; [Hong, Bum Soo; Tempel, Wolfram; Dimov, Svetoslav; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Jha, Abhishek; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Yang, Hua; Kung, Charles; Yen, Katharine E.; Kunii, Kaiko; Salituro, Francesco G.; Jin, Shengfang; Dang, Lenny] Agios Pharmaceut, Cambridge, MA USA; [Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Courtney, Kevin D.; Heiden, Matthew G. Vander] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Harris, Marian H.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Toronto; Structural Genomics Consortium; Massachusetts Institute of Technology (MIT); Agios Pharmaceuticals; University of California System; University of California San Diego; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Toronto	Anastasiou, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA.	mvh@mit.edu	Cantley, Lewis C/D-1800-2014; Metallo, Christian/HCH-3476-2022; Southall, Noel T/H-8991-2012; Harris, Marian/R-7049-2019	Cantley, Lewis C/0000-0002-1298-7653; Metallo, Christian/0000-0003-2404-3040; Southall, Noel T/0000-0003-4500-880X; Thomas, Craig/0000-0001-9386-9001; Israelsen, William/0000-0002-3653-9353; Fiske, Brian/0000-0001-5891-4268; Christofk, Heather/0000-0002-8662-4425; Dang, Lenny/0000-0002-2073-6109; Anastasiou, Dimitrios/0000-0002-1269-843X; Lunt, Sophia/0000-0003-4522-6065; Jha, Abhishek/0000-0001-9161-0450	NATIONAL CANCER INSTITUTE [P01CA120964, P30CA006516, R01CA160458, P30CA014051] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085679] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [5P01CA120964, 5P30CA1405141, P30 CA006516, 5P30CA006516, P01 CA120964, R01 CA160458] Funding Source: Medline; NIGMS NIH HHS [R01 GM56203, R01 GM056203] Funding Source: Medline; NIMH NIH HHS [R03MH085679, R03 MH085679] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CIHR(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ASHIZAWA K, 1991, BIOCHEMISTRY-US, V30, P7105, DOI 10.1021/bi00243a010; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Ikeda Y, 1998, J BIOL CHEM, V273, P12227, DOI 10.1074/jbc.273.20.12227; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; Ikeda Y, 2000, J BIOL CHEM, V275, P9150, DOI 10.1074/jbc.275.13.9150; Jiang JK, 2010, BIOORG MED CHEM LETT, V20, P3387, DOI 10.1016/j.bmcl.2010.04.015; KATO H, 1989, P NATL ACAD SCI USA, V86, P7861, DOI 10.1073/pnas.86.20.7861; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Locasale JW, 2010, CELL CYCLE, V9, P4253, DOI 10.4161/cc.9.21.13925; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHUMACKER PT, 1993, AM J PHYSIOL, V265, pL395, DOI 10.1152/ajplung.1993.265.4.L395; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yamada E, 1999, BIOCHEM BIOPH RES CO, V256, P257, DOI 10.1006/bbrc.1999.0228; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	43	485	502	13	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					839	847		10.1038/NCHEMBIO.1060	http://dx.doi.org/10.1038/NCHEMBIO.1060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22922757	Green Submitted, Green Accepted			2022-12-27	WOS:000309056200009
J	You, CJ; Dai, XX; Yuan, BF; Wang, J; Wang, JS; Brooks, PJ; Niedernhofer, LJ; Wang, YS				You, Changjun; Dai, Xiaoxia; Yuan, Bifeng; Wang, Jin; Wang, Jianshuang; Brooks, Philip J.; Niedernhofer, Laura J.; Wang, Yinsheng			A quantitative assay for assessing the effects of DNA lesions on transcription	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI; MAMMALIAN-CELLS; RNA-POLYMERASE; IN-VIVO; TRANSLESION SYNTHESIS; MUTAGENESIS CAUSES; BYPASS; DAMAGE; 8,5'-CYCLOPURINE-2'-DEOXYNUCLEOSIDES	Most mammalian cells in nature are quiescent but actively transcribing mRNA for normal physiological processes; thus, it is important to investigate how endogenous and exogenous DNA damage compromises transcription in cells. Here we describe a new competitive transcription and adduct bypass (CTAB) assay to determine the effects of DNA lesions on the fidelity and efficiency of transcription. Using this strategy, we demonstrate that the oxidatively induced lesions 8,5'-cyclo-2'-deoxyadenosine (cdA) and 8,5'-cyclo-2'-deoxyguanosine (cdG) and the methylglyoxal-induced lesion N-2-(1-carboxyethyl)-2'-deoxyguanosine (N-2-CEdG) strongly inhibited transcription in vitro and in mammalian cells. In addition, cdA and cdG, but not N-2-CEdG, induced transcriptional mutagenesis in vitro and in vivo. Furthermore, when located on the template DNA strand, all examined lesions were primarily repaired by transcription-coupled nucleotide excision repair in mammalian cells. This newly developed CTAB assay should be generally applicable for quantitatively assessing how other DNA lesions affect DNA transcription in vitro and in cells.	[You, Changjun; Dai, Xiaoxia; Yuan, Bifeng; Wang, Jin; Wang, Jianshuang; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Brooks, Philip J.] NIAAA, Lab Neurogenet, Rockville, MD 20852 USA; [Niedernhofer, Laura J.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	You, CJ (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Yuan, Bi-Feng/K-5803-2013; Wang, Jin/AAE-3809-2022	Yuan, Bi-Feng/0000-0001-5223-4659; Wang, Jin/0000-0001-5511-3983; You, Changjun/0000-0003-4301-2098; Dai, Xiaoxia/0000-0002-3514-5061	NATIONAL CANCER INSTITUTE [R01CA101864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019873, R01ES016114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA101864] Funding Source: Medline; NIDDK NIH HHS [R01 DK082779] Funding Source: Medline; NIEHS NIH HHS [R01 ES016114, R01 ES019873] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Belmadoui N, 2010, ORG BIOMOL CHEM, V8, P3211, DOI 10.1039/c004531d; Bregeon D, 2003, MOL CELL, V12, P959, DOI 10.1016/S1097-2765(03)00360-5; Bregeon D, 2011, NAT REV CANCER, V11, P218, DOI 10.1038/nrc3006; Bregeon D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000577; Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Chatgilialoglu C, 2011, CHEM SOC REV, V40, P1368, DOI 10.1039/c0cs00061b; Cheng TF, 2008, J BIOL CHEM, V283, P27820, DOI 10.1074/jbc.M804086200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Clauson CL, 2010, DNA REPAIR, V9, P842, DOI 10.1016/j.dnarep.2010.04.004; Clauson CL, 2010, P NATL ACAD SCI USA, V107, P3657, DOI 10.1073/pnas.0913191107; Cohen SE, 2010, P NATL ACAD SCI USA, V107, P15517, DOI 10.1073/pnas.1005203107; D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Frischmann M, 2005, CHEM RES TOXICOL, V18, P1586, DOI 10.1021/tx0501278; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Jasti VP, 2011, BIOCHEMISTRY-US, V50, P3862, DOI 10.1021/bi2004944; Kornberg R, 2007, ANGEW CHEM INT EDIT, V46, P6957, DOI 10.1002/anie.200701832; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Kuraoka I, 2001, J BIOL CHEM, V276, P49283, DOI 10.1074/jbc.M107779200; Kuraoka I, 2006, METHOD ENZYMOL, V408, P214, DOI 10.1016/S0076-6879(06)08013-X; Li H, 2006, KIDNEY INT, V69, P388, DOI 10.1038/sj.ki.5000064; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Marietta C, 2007, EMBO REP, V8, P388, DOI 10.1038/sj.embor.7400932; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Murata-Kamiya N, 1999, MUTAT RES-GEN TOX EN, V442, P19, DOI 10.1016/S1383-5718(99)00054-6; Rodriguez H, 2007, BIOCHEMISTRY-US, V46, P2488, DOI 10.1021/bi062022p; Rolig RL, 1997, MUTAGENESIS, V12, P277, DOI 10.1093/mutage/12.4.277; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Schneider M, 2004, CHEM RES TOXICOL, V17, P1385, DOI 10.1021/tx049929d; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Synold T, 2008, CHEM RES TOXICOL, V21, P2148, DOI 10.1021/tx800224y; Tamae D, 2011, BIOCHEMISTRY-US, V50, P2321, DOI 10.1021/bi101933p; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; Viswanathan A, 1999, SCIENCE, V284, P159, DOI 10.1126/science.284.5411.159; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835	47	64	63	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					817	822		10.1038/NCHEMBIO.1046	http://dx.doi.org/10.1038/NCHEMBIO.1046			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22902614	Green Accepted			2022-12-27	WOS:000309056200006
J	Adler-Abramovich, L; Vaks, L; Carny, O; Trudler, D; Magno, A; Caflisch, A; Frenkel, D; Gazit, E				Adler-Abramovich, Lihi; Vaks, Lilach; Carny, Ohad; Trudler, Dorit; Magno, Andrea; Caflisch, Amedeo; Frenkel, Dan; Gazit, Ehud			Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria	NATURE CHEMICAL BIOLOGY			English	Article							BETA; FIBRILLOGENESIS; PENTAPEPTIDE; DISEASE; MODEL	Phenylketonuria (PKU) is characterized by phenylalanine accumulation and progressive mental retardation caused by an unknown mechanism. We demonstrate that at pathological concentrations, phenylalanine self-assembles into fibrils with amyloid-like morphology and well-ordered electron diffraction. These assemblies are specifically recognized by antibodies, show cytotoxicity that can be neutralized by the antibodies and are present in the hippocampus of model mice and in parietal cortex brain tissue from individuals with PKU. This is, to our knowledge, the first demonstration that a single amino acid can form amyloid-like deposits, suggesting a new amyloidosis-like etiology for PKU.	[Adler-Abramovich, Lihi; Vaks, Lilach; Carny, Ohad; Gazit, Ehud] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Trudler, Dorit; Frenkel, Dan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Trudler, Dorit; Frenkel, Dan] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Magno, Andrea; Caflisch, Amedeo] Univ Zurich, Dept Biochem, Zurich, Switzerland	Tel Aviv University; Tel Aviv University; Tel Aviv University; University of Zurich	Gazit, E (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	ehudg@post.tau.ac.il	Gazit, Ehud/M-8026-2019; Adler-Abramovich, Lihi/AAN-1430-2020; Caflisch, Amedeo/I-3459-2012; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/C-3715-2011	Gazit, Ehud/0000-0001-5764-1720; Adler-Abramovich, Lihi/0000-0003-3433-0625; Gazit, Ehud/0000-0001-5764-1720	Israel Science Foundation-Legacy Heritage Biomedical Science Partnership grant [862/09]; Alzheimer's Association [NIRG-11-205535]; Swiss National Science Foundation; Colton Foundation; Medical Research Council [G1100695] Funding Source: researchfish; MRC [G1100695] Funding Source: UKRI	Israel Science Foundation-Legacy Heritage Biomedical Science Partnership grant; Alzheimer's Association(Alzheimer's Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Colton Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Shaltiel-Karyo for confocal microscopy analysis, S. Wolf for the electron diffraction analysis, L. Buzhansky for help with the NMR and HPLC analysis, J. Delarea for help with TEM and SEM experiments, Z. Barkay for help with the SEM and ESEM analysis, S.-C. Jung (Ewha Womans University, Korea) for BTBR-Pah<SUP>enu2</SUP> mouse plasma and tissue samples, C. Troakes (London Neurodegenerative Diseases Brain Bank, King's College London and part of BrainNet Europe) and T. Arzberger (Centre for Neuropathology and Prion Research, Munchen) for brain tissue samples, I. Benhar and members of the Gazit laboratory for helpful discussions. L. A.-A. gratefully acknowledges the support of the Colton Foundation. This work was partly supported by the Israel Science Foundation-Legacy Heritage Biomedical Science Partnership grant 862/09 and the Alzheimer's Association grant NIRG-11-205535 (to D. F.). The work in the A. C. group was supported by the Swiss National Science Foundation.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHOI TB, 1986, J BIOL CHEM, V261, P6536; CORDERO ME, 1983, EARLY HUM DEV, V8, P157, DOI 10.1016/0378-3782(83)90072-5; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gazit E, 2002, BIOINFORMATICS, V18, P880, DOI 10.1093/bioinformatics/18.6.880; Gazit V, 2003, BEHAV BRAIN RES, V143, P1, DOI 10.1016/S0166-4328(03)00075-5; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hanley WB, 2004, AM J MED, V117, P590, DOI 10.1016/j.amjmed.2004.03.042; Horster F, 2006, PEDIATR RES, V59, P544, DOI 10.1203/01.pdr.0000203091.45988.8d; Inouye H, 2006, BIOPHYS J, V90, P1774, DOI 10.1529/biophysj.105.070136; KRAUSE W, 1985, J CLIN INVEST, V75, P40, DOI 10.1172/JCI111695; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MacDonald A, 2010, J INHERIT METAB DIS, V33, P665, DOI 10.1007/s10545-010-9073-y; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; Solomon B, 2007, EXPERT OPIN INV DRUG, V16, P819, DOI 10.1517/13543784.16.6.819; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Surtees R, 2000, EUR J PEDIATR, V159, pS109, DOI 10.1007/PL00014370; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545	28	289	292	4	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					701	706		10.1038/NCHEMBIO.1002	http://dx.doi.org/10.1038/NCHEMBIO.1002			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22706200				2022-12-27	WOS:000306527600009
J	Zheng, JT; Gay, DC; Demeler, B; White, MA; Keatinge-Clay, AT				Zheng, Jianting; Gay, Darren C.; Demeler, Borries; White, Mark A.; Keatinge-Clay, Adrian T.			Divergence of multimodular polyketide synthases revealed by a didomain structure	NATURE CHEMICAL BIOLOGY			English	Article							ISOLATED KETOREDUCTASE DOMAINS; FATTY-ACID SYNTHASE; X-RAY SOLUTION; CRYSTAL-STRUCTURE; THIOESTER REDUCTASE; FUNCTIONAL-ANALYSIS; STEREOCHEMISTRY; SCATTERING; CATALYSIS; MUTAGENESIS	The enoylreductase (ER) is the final common enzyme from modular polyketide synthases (PKSs) to be structurally characterized. The 3.0 angstrom-resolution structure of the didomain comprising the ketoreductase (KR) and ER from the second module of the spinosyn PKS reveals that ER shares an similar to 600-angstrom(2) interface with KR distinct from that of the related mammalian fatty acid synthase (FAS). In contrast to the ER domains of the mammalian FAS, the ER domains of the second module of the spinosyn PKS do not make contact across the two-fold axis of the synthase. This monomeric organization may have been necessary in the evolution of multimodular PKSs to enable acyl carrier proteins to access each of their cognate enzymes. The isolated ER domain showed activity toward a substrate analog, enabling us to determine the contributions of its active site residues.	[Zheng, Jianting; Gay, Darren C.; Keatinge-Clay, Adrian T.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [White, Mark A.] Univ Texas Med Branch Galveston, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA; [White, Mark A.] Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Keatinge-Clay, AT (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	adriankc@mail.utexas.edu	White, Mark Andrew/B-1723-2012	White, Mark Andrew/0000-0003-1057-4203; Demeler, Borries/0000-0002-2414-9518	Welch Foundation [F-1712]; Sealy and Smith Foundation; US National Institutes of Health [RR022200]; US National Science Foundation [TG-MCB070038]; San Antonio Cancer Institute [P30 CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Sealy and Smith Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); San Antonio Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank A.F. Monzingo for helping with in-house diffraction experiments and C. D. Fage for helping optimize crystals. Synchrotron data were obtained at the ALS Beamlines 8.2.1 and 5.0.2. Financial support was provided by Welch Foundation Grant F-1712 (A.T.K.-C.) as well as the Sealy and Smith Foundation grant to the Sealy Center for Structural Biology and Molecular Biophysics (M. A. W.). The development of the UltraScan software is supported by the US National Institutes of Health through grant RR022200 (B. D.). Supercomputer time allocations were provided through the US National Science Foundation grant TG-MCB070038 (B. D.). We acknowledge the support of the San Antonio Cancer Institute grant P30 CA054174 for the Center for Analytical Ultracentrifugation of Macromolecular Assemblies at the University of Texas Health Science Center at San Antonio.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Airenne TT, 2003, J MOL BIOL, V327, P47, DOI 10.1016/S0022-2836(03)00038-X; Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kim KH, 2011, J MOL BIOL, V406, P403, DOI 10.1016/j.jmb.2010.12.003; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kwan DH, 2010, ACS CHEM BIOL, V5, P829, DOI 10.1021/cb100175a; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lu H, 2010, BIOCHEMISTRY-US, V49, P1281, DOI 10.1021/bi902001a; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedelacq JD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr548; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Piasecki SK, 2011, CHEM BIOL, V18, P1331, DOI 10.1016/j.chembiol.2011.07.021; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Siskos AP, 2005, CHEM BIOL, V12, P1145, DOI 10.1016/j.chembiol.2005.08.017; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; THORN JM, 1995, J MOL BIOL, V249, P785, DOI 10.1006/jmbi.1995.0337; Torkko JM, 2003, J BIOL CHEM, V278, P41213, DOI 10.1074/jbc.M307664200; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Valenzano CR, 2009, J AM CHEM SOC, V131, P18501, DOI 10.1021/ja908296m; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Witkowski A, 2004, BIOCHEMISTRY-US, V43, P10458, DOI 10.1021/bi048988n; Zheng JT, 2011, J MOL BIOL, V410, P105, DOI 10.1016/j.jmb.2011.04.065; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015	46	58	58	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					615	621		10.1038/NCHEMBIO.964	http://dx.doi.org/10.1038/NCHEMBIO.964			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22634636	Green Accepted			2022-12-27	WOS:000305471400008
J	Grzegorzewicz, AE; Pham, H; Gundi, VAKB; Scherman, MS; North, EJ; Hess, T; Jones, V; Gruppo, V; Born, SEM; Kordulakova, J; Chavadi, SS; Morisseau, C; Lenaerts, AJ; Lee, RE; McNeil, MR; Jackson, M				Grzegorzewicz, Anna E.; Ha Pham; Gundi, Vijay A. K. B.; Scherman, Michael S.; North, Elton J.; Hess, Tamara; Jones, Victoria; Gruppo, Veronica; Born, Sarah E. M.; Kordulakova, Jana; Chavadi, Sivagami Sundaram; Morisseau, Christophe; Lenaerts, Anne J.; Lee, Richard E.; McNeil, Michael R.; Jackson, Mary			Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane	NATURE CHEMICAL BIOLOGY			English	Article							CELL-WALL; DRUG-RESISTANCE; OUTER-MEMBRANE; BIOSYNTHESIS; VIRULENCE; TREHALOSE; SMEGMATIS; ARABINOGALACTAN; PERMEABILITY; BIOGENESIS	New chemotherapeutics active against multidrug-resistant Mycobacterium tuberculosis are urgently needed. We report on the identification of an adamantyl urea compound that shows potent bactericidal activity against M. tuberculosis and a unique mode of action, namely the abolition of the translocation of mycolic acids from the cytoplasm, where they are synthesized to the periplasmic side of the plasma membrane and are in turn transferred onto cell wall arabinogalactan or used in the formation of virulence-associated, outer membrane, trehalose-containing glycolipids. Whole-genome sequencing of spontaneous-resistant mutants of M. tuberculosis selected in vitro followed by genetic validation experiments revealed that our prototype inhibitor targets the inner membrane transporter MmpL3. Conditional gene expression of mmpL3 in mycobacteria and analysis of inhibitor-treated cells validate MmpL3 as essential for mycobacterial growth and support the involvement of this transporter in the translocation of trehalose monomycolate across the plasma membrane.	[Grzegorzewicz, Anna E.; Ha Pham; Gundi, Vijay A. K. B.; Scherman, Michael S.; Hess, Tamara; Jones, Victoria; Gruppo, Veronica; Born, Sarah E. M.; Chavadi, Sivagami Sundaram; Lenaerts, Anne J.; McNeil, Michael R.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [North, Elton J.; Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Kordulakova, Jana] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava, Slovakia; [Morisseau, Christophe] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Morisseau, Christophe] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA	Colorado State University; Comenius University Bratislava; University of California System; University of California Davis; University of California System; University of California Davis	Grzegorzewicz, AE (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	m.mcneil@colostate.edu; mary.jackson@colostate.edu	Lee, Richard/AAX-3996-2021; McNeil, Michael/G-3325-2019; Lenaerts, Anne/F-1353-2017; Jackson, Mary/D-5345-2017; Lee, Richard/J-4997-2013; Gundi, Vijay A.K.B./B-6121-2013; Kordulakova, Jana/I-3887-2014	Lee, Richard/0000-0002-2397-0443; Jackson, Mary/0000-0002-9212-0258; Lee, Richard/0000-0002-2397-0443; Kordulakova, Jana/0000-0003-2834-0165; Born, Sarah/0000-0001-5964-3121	NIAID; NIH [AI085992, AI063054, AI057836]; American Lebanese Syrian Associated Charities; Slovak Research and Development Agency [APVV-0441-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057836, R01AI063054, RC1AI085992] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Slovak Research and Development Agency(Slovak Research and Development Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID and NIH grants AI085992, AI063054 and AI057836; the American Lebanese Syrian Associated Charities; and the Slovak Research and Development Agency under contract no. APVV-0441-10. We thank R. Dhiman for helpful scientific discussions and D. Dick for LC/MS analyses. Purified recombinant FbpC (Ag85C) was kindly provided by K. Dobos (Colorado State University).	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Brown JR, 2011, BIOORGAN MED CHEM, V19, P5585, DOI 10.1016/j.bmc.2011.07.034; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Glickman MS, 2008, MYCOBACTERIAL CELL ENVELOPE, P63; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Jain M, 2008, MYCOBACTERIAL CELL ENVELOPE, P201; Kalscheuer R, 2010, P NATL ACAD SCI USA, V107, P21761, DOI 10.1073/pnas.1014642108; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sanki AK, 2009, GLYCOCONJUGATE J, V26, P589, DOI 10.1007/s10719-008-9211-z; SATHYAMOORTHY N, 1987, J BIOL CHEM, V262, P13417; Schroeder E. K., 2002, Current Pharmaceutical Biotechnology, V3, P197, DOI 10.2174/1389201023378328; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Stadthagen G, 2005, J BIOL CHEM, V280, P40699, DOI 10.1074/jbc.M508332200; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Vander Beken S, 2011, EUR J IMMUNOL, V41, P450, DOI 10.1002/eji.201040719; Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200; World Health Organization, 2009, GLOB TUB CONTR EP ST; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	49	304	317	5	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					334	341		10.1038/NCHEMBIO.794	http://dx.doi.org/10.1038/NCHEMBIO.794			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22344175	Green Accepted			2022-12-27	WOS:000301890100007
J	Patti, GJ; Yanes, O; Shriver, LP; Courade, JP; Tautenhahn, R; Manchester, M; Siuzdak, G				Patti, Gary J.; Yanes, Oscar; Shriver, Leah P.; Courade, Jean-Phillipe; Tautenhahn, Ralf; Manchester, Marianne; Siuzdak, Gary			Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin	NATURE CHEMICAL BIOLOGY			English	Article							PERIPHERAL-NERVE INJURY; SPINAL-CORD; SPHINGOSINE 1-PHOSPHATE; GENE-EXPRESSION; N,N-DIMETHYLSPHINGOSINE; METABOLISM; ASTROCYTES; CERAMIDE; NEURONS; BRAIN	Neuropathic pain is a debilitating condition for which the development of effective treatments has been limited by an incomplete understanding of its chemical basis. We show by using untargeted metabolomics that sphingomyelin-ceramide metabolism is altered in the dorsal horn of rats with neuropathic pain and that the upregulated, endogenous metabolite N,N-dimethylsphingosine induces mechanical hypersensitivity in vivo. These results demonstrate the utility of metabolomics to implicate unexplored biochemical pathways in disease.	[Patti, Gary J.] Washington Univ, Sch Med, Dept Chem, St Louis, MO 63130 USA; [Patti, Gary J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Patti, Gary J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Yanes, Oscar; Tautenhahn, Ralf; Siuzdak, Gary] Scripps Res Inst, Dept Chem, Scripps Ctr Metabol & Mass Spectrometry, La Jolla, CA 92037 USA; [Yanes, Oscar; Tautenhahn, Ralf; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, Scripps Ctr Metabol & Mass Spectrometry, La Jolla, CA 92037 USA; [Yanes, Oscar] Univ Rovira & Virgili, Metabol Platform Spanish Biomed Res Ctr Diabet &, Tarragona, Spain; [Shriver, Leah P.; Manchester, Marianne] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Courade, Jean-Phillipe] Pfizer Global Res & Dev, Pain Res Unit, Sandwich, Kent, England	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Scripps Research Institute; Scripps Research Institute; Universitat Rovira i Virgili; University of California System; University of California San Diego; Pfizer	Patti, GJ (corresponding author), Washington Univ, Sch Med, Dept Chem, St Louis, MO 63130 USA.	mmanchester@ucsd.edu; siuzdak@scripps.edu	Yanes, Oscar/N-3630-2016; Courade, Jean-Philippe/H-4411-2013	Yanes, Oscar/0000-0003-3695-7157; Courade, Jean-Philippe/0000-0001-6722-2263; Siuzdak, Gary/0000-0002-4749-0014; Manchester, Marianne/0000-0002-7143-5744	US National Institutes of Health (NIH) [1224 EY017540-04, P30 MH062261]; NIH-National Institute of Aging [L30 AG0 038036]; NIH-National Institute of Neurological Disorders and Stroke [F32NS068015, T32 NSO41219]; US Department of Energy [FG02-07ER64325, DE-AC0205CH11231];  [P01 DA026146-02]; NATIONAL CANCER INSTITUTE [R01CA112075] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY017540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041219, F32NS068015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026146] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Department of Energy(United States Department of Energy (DOE)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the US National Institutes of Health (NIH) 1224 EY017540-04 (G.S.), P30 MH062261 (M.M., G.S.) and P01 DA026146-02 (G.S.) in addition to RR025774 (MM.); NIH-National Institute of Aging L30 AG0 038036 (G.J.P.); and NIH-National Institute of Neurological Disorders and Stroke F32NS068015 and T32 NSO41219 (L.P.S.). We also acknowledge financial support front the US Department of Energy FG02-07ER64325 and DE-AC0205CH11231).	Alexander GM, 2005, PAIN, V116, P213, DOI 10.1016/j.pain.2005.04.013; Coste O, 2008, J BIOL CHEM, V283, P32442, DOI 10.1074/jbc.M806410200; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hofmann HA, 2003, EUR J PHARMACOL, V470, P17, DOI 10.1016/S0014-2999(03)01753-9; IGARASHI Y, 1990, J BIOL CHEM, V265, P5385; IGARASHI Y, 1989, BIOCHEM BIOPH RES CO, V164, P1411, DOI 10.1016/0006-291X(89)91827-5; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; KNYIHARCSILLIK E, 1987, CELL TISSUE RES, V247, P599, DOI 10.1007/BF00215754; Latorre E, 1999, EUR J BIOCHEM, V262, P308, DOI 10.1046/j.1432-1327.1999.00358.x; Lee YK, 2007, MOL CELLS, V23, P11; Morales PR, 2007, DRUG CHEM TOXICOL, V30, P197, DOI 10.1080/01480540701375018; Nie H, 2010, J NEUROPHYSIOL, V103, P2570, DOI 10.1152/jn.00013.2010; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Singh OV, 2009, PROTEOMICS, V9, P1241, DOI 10.1002/pmic.200800636; Sung YJ, 2004, NEUROL RES, V26, P195, DOI 10.1179/016164104225013761; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Warfield C. A., 2002, MANUAL PAIN MANAGEME, P193; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	25	135	151	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					232	234		10.1038/NCHEMBIO.767	http://dx.doi.org/10.1038/NCHEMBIO.767			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22267119	Green Accepted			2022-12-27	WOS:000300600000006
J	Calamini, B; Silva, MC; Madoux, F; Hutt, DM; Khanna, S; Chalfant, MA; Saldanha, SA; Hodder, P; Tait, BD; Garza, D; Balch, WE; Morimoto, RI				Calamini, Barbara; Silva, Maria Catarina; Madoux, Franck; Hutt, Darren M.; Khanna, Shilpi; Chalfant, Monica A.; Saldanha, S. Adrian; Hodder, Peter; Tait, Bradley D.; Garza, Dan; Balch, William E.; Morimoto, Richard I.			Small-molecule proteostasis regulators for protein conformational diseases	NATURE CHEMICAL BIOLOGY			English	Article							HEAT-SHOCK RESPONSE; POLYGLUTAMINE AGGREGATION; TRANSCRIPTION; INDUCTION; STRESS; MODEL; HSP90; NEURODEGENERATION; EXPRESSION; CELASTROL	Protein homeostasis (proteostasis) is essential for cellular and organismal health. Stress, aging and the chronic expression of misfolded proteins, however, challenge the proteostasis machinery and the vitality of the cell. Enhanced expression of molecular chaperones, regulated by heat shock transcription factor-1 (HSF-1), has been shown to restore proteostasis in a variety of conformational disease models, suggesting this mechanism as a promising therapeutic approach. We describe the results of a screen comprised of similar to 900,000 small molecules that identified new classes of small-molecule proteostasis regulators that induce HSF-1-dependent chaperone expression and restore protein folding in multiple conformational disease models. These beneficial effects to proteome stability are mediated by HSF-1, FOXO, Nrf-2 and the chaperone machinery through mechanisms that are distinct from current known small-molecule activators of the heat shock response. We suggest that modulation of the proteostasis network by proteostasis regulators may be a promising therapeutic approach for the treatment of a variety of protein conformational diseases.	[Calamini, Barbara; Silva, Maria Catarina; Morimoto, Richard I.] Northwestern Univ, Dept Mol Biosci, Rice Inst Biomed Res, Evanston, IL 60208 USA; [Silva, Maria Catarina] Univ Lisbon, Fac Sci, Ctr Biodivers Funct & Integrat Genom BioFIG, P-1699 Lisbon, Portugal; [Madoux, Franck; Saldanha, S. Adrian; Hodder, Peter] Scripps Res Inst, Mol Screening Ctr, Lead Identificat Div, Jupiter, FL USA; [Hutt, Darren M.; Chalfant, Monica A.; Balch, William E.] Scripps Res Inst, Dept Cell Biol & Chem Physiol, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; [Khanna, Shilpi; Tait, Bradley D.; Garza, Dan] Proteostasis Therapeut Inc, Cambridge, MA USA	Northwestern University; Universidade de Lisboa; Scripps Research Institute; Scripps Research Institute	Morimoto, RI (corresponding author), Northwestern Univ, Dept Mol Biosci, Rice Inst Biomed Res, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu			US National Institutes of Health (NIH) [T32 CA70085]; NIH [T32 AG000260, HL 079442, GM42336, DK785483, GM038109, GM081192, AG026647, NS047331]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/28461/2006]; Canadian Institutes for Health Research (CIHR); NIH Molecular Library Screening Center Network [MH084512]; NATIONAL CANCER INSTITUTE [T32CA070085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442, R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038109, R01GM033301, R01GM042336, R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026647, R01AG026647, T32AG000260] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NIH Molecular Library Screening Center Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge J. Maddry, the SRI and the NINDS for support in performing the primary screen; P. Chase and P. Baillargeon of Scripps Florida for executing the SRIMSC screening activities; S. Fox, J. West, S. Westerheide, J. Moran, M. Beam and K. Orton for technical assistance; J. S. Pedersen for help developing the worm tracker system; and the Morimoto laboratory, in particular T. Gidalevitz, J. Kirstein, C. Voisine and A. Yu, for helpful comments. PC12 httQ74-GFP cells were provided by D. Rubinsztein (University of Cambridge). Purified Hsp90 beta was a gift of A. Chadli (Georgia Health Science University). We thank A. Ciechanover for the rabbit polyclonal ubiquitin antibody (Israel Institute of Technology). The CFBE41o-YFP cells were a gift from L. Galietta (Istituto Giannina Gaslini). This work was supported by the US National Institutes of Health (NIH) Training Grant in Signal Transduction and Cancer T32 CA70085 and the NIH Training Grant in Drug Discovery in Age Related Diseases T32 AG000260 (to B. C.), Portuguese PhD fellowship from the Fundacao para a Ciencia e Tecnologia (SFRH/BD/28461/2006) (to M. C. S.), NIH grants HL 079442, GM42336 and DK785483 (to W. E. B.), a fellowship from the Canadian Institutes for Health Research (CIHR) (to D. M. H.), the NIH Molecular Library Screening Center Network MH084512 (to F. M., S. A. S. and P. H.) and NIH grants GM038109, GM081192, AG026647 and NS047331 (to R.I.M.).	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; AMICI C, 1992, P NATL ACAD SCI USA, V89, P6227, DOI 10.1073/pnas.89.14.6227; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Butina D, 1999, J CHEM INF COMP SCI, V39, P747, DOI 10.1021/ci9803381; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Roesslein M, 2008, J PHARMACOL EXP THER, V325, P217, DOI 10.1124/jpet.107.133108; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Stringer JR, 2011, ACS COMB SCI, V13, P175, DOI 10.1021/co100053p; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Tam LCS, 2010, HUM MOL GENET, V19, P4421, DOI 10.1093/hmg/ddq369; Tangallapally RP, 2004, J MED CHEM, V47, P5276, DOI 10.1021/jm049972y; Teiten MH, 2009, CANCER LETT, V279, P145, DOI 10.1016/j.canlet.2009.01.031; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WILLIAMS GT, 1990, MOL CELL BIOL, V10, P3125, DOI 10.1128/MCB.10.6.3125; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yadav VR, 2011, INT IMMUNOPHARMACOL, V11, P295, DOI 10.1016/j.intimp.2010.12.006; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang YQ, 2007, J MOL MED-JMM, V85, P1421, DOI 10.1007/s00109-007-0251-9	50	171	175	0	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					185	196		10.1038/nchembio.763	http://dx.doi.org/10.1038/nchembio.763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22198733	Green Accepted			2022-12-27	WOS:000299323200011
J	Koeberle, SC; Romir, J; Fischer, S; Koeberle, A; Schattel, V; Albrecht, W; Grutter, C; Werz, O; Rauh, D; Stehle, T; Laufer, SA				Koeberle, Solveigh C.; Romir, Johannes; Fischer, Stefan; Koeberle, Andreas; Schattel, Verena; Albrecht, Wolfgang; Gruetter, Christian; Werz, Oliver; Rauh, Daniel; Stehle, Thilo; Laufer, Stefan A.			Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor	NATURE CHEMICAL BIOLOGY			English	Article							MAP KINASE; SIGNALING PATHWAYS; KAPPA-B; CELLS; EXPRESSION; ADHESION; DESIGN; INFLAMMATION; PLAYS	Until now, a lack of inhibitors with high potency and selectivity in vivo has hampered investigation of the p38 mitogen-activated protein kinase (MAPK) signaling pathway. We describe the design of skepinone-L, which is, to our knowledge, the first ATP-competitive p38 MAPK inhibitor with excellent in vivo efficacy and selectivity. Therefore, skepinone-L is a valuable probe for chemical biology research, and it may foster the development of a unique class of kinase inhibitors.	[Romir, Johannes; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Koeberle, Solveigh C.; Fischer, Stefan; Schattel, Verena; Laufer, Stefan A.] Univ Tubingen, Inst Pharm, Tubingen, Germany; [Koeberle, Solveigh C.] Fritz Lipmann Inst, Inst Age Res, Jena, Germany; [Koeberle, Andreas; Werz, Oliver] Univ Jena, Inst Pharm, Jena, Germany; [Albrecht, Wolfgang] CAIR Biosci GmbH, Tubingen, Germany; [Gruetter, Christian; Rauh, Daniel] Tech Univ Dortmund, Fac Chem Chem Biol, Dortmund, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena; Dortmund University of Technology; Vanderbilt University	Stehle, T (corresponding author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.	thilo.stehle@uni-tuebingen.de; stefan.laufer@uni-tuebingen.de	Koeberle, Andreas/ABB-2356-2020; Rauh, Daniel/G-1595-2013	Koeberle, Andreas/0000-0001-6269-5088; Koeberle, Solveigh/0000-0002-8008-494X; Rauh, Daniel/0000-0002-1970-7642; Laufer, Stefan/0000-0001-6952-1486	German Federal Ministry for Education [BMBF 01GS08104]	German Federal Ministry for Education	We thank S. Luik, M Goettert and K. Bauer for biological testing. We thank M. Fecker, J.R. Simard, S. Mayer-Wrangowski and A. Richters for expert assistance during protein production and crystallization. D. R. is grateful for funds from the German Federal Ministry for Education (grant no. BMBF 01GS08104). We thank T. Joos, N. Schneiderhan-Marra, K. Hefner, M. Schmohl and G. M. Stein (Naturwissenschaftliches und Medizinisches Institut and Experimentelle und Diagnostische Immunologie Reutlingen) for cytokine profiling of skepinone-L in hPMBCs.	Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Dinarello CA, 2009, SEMIN DIALYSIS, V22, P256, DOI 10.1111/j.1525-139X.2009.00568.x; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Goldstein DM, 2006, J MED CHEM, V49, P1562, DOI 10.1021/jm050736c; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Hill RJ, 2008, J PHARMACOL EXP THER, V327, P610, DOI 10.1124/jpet.108.139006; Ip WK, 2006, CLIN EXP IMMUNOL, V145, P162, DOI 10.1111/j.1365-2249.2006.03085.x; Ip WK, 2005, IMMUNOPHARM IMMUNOT, V27, P371, DOI 10.1080/08923970500240925; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karcher SC, 2009, CURR TOP MED CHEM, V9, P655, DOI 10.2174/156802609789007363; Karcher SC, 2009, J MED CHEM, V52, P1778, DOI 10.1021/jm801291f; Kurihara Y, 2011, CELL IMMUNOL, V270, P25, DOI 10.1016/j.cellimm.2011.03.017; Laufer SA, 2006, J MED CHEM, V49, P7912, DOI 10.1021/jm061072p; Lee MR, 2005, CURR MED CHEM, V12, P2979, DOI 10.2174/092986705774462914; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mutou Y, 2010, J HEALTH SCI, V56, P675, DOI 10.1248/jhs.56.675; Pan SL, 2008, SHOCK, V30, P496, DOI 10.1097/SHK.0b013e3181673233; Peng H, 2011, J BIOL CHEM, V286, P24508, DOI 10.1074/jbc.M111.234062; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Schieven GL, 2009, CURR TOP MED CHEM, V9, P1038, DOI 10.2174/156802609789630974; Shimada H, 2010, J BIOL CHEM, V285, P12536, DOI 10.1074/jbc.M109.099630; Tibbles LA, 2002, J VIROL, V76, P1559, DOI 10.1128/JVI.76.4.1559-1568.2002; Veillat V, 2010, J CLIN ENDOCR METAB, V95, pE403, DOI 10.1210/jc.2010-0417; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Xie NC, 2010, NEUROPHARMACOLOGY, V59, P444, DOI 10.1016/j.neuropharm.2010.06.006	25	93	93	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					141	143		10.1038/nchembio.761	http://dx.doi.org/10.1038/nchembio.761			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22198732				2022-12-27	WOS:000299323200004
J	Lee, HH; Collins, JJ				Lee, Henry H.; Collins, James J.			Microbial environments confound antibiotic efficacy	NATURE CHEMICAL BIOLOGY			English	Article							BACTERIAL PERSISTERS; ESCHERICHIA-COLI; RESISTANCE; DEATH; EMERGENCE; SPECTRUM; MUTANTS; DAMAGE; CELLS; LEADS		[Lee, Henry H.; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Lee, Henry H.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Harvard University	Lee, HH (corresponding author), Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu	Lee, Henry/GVS-2114-2022	Lee, Henry/0000-0002-0577-2275	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD003644] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bernier SP, 2011, MOL MICROBIOL, V81, P705, DOI 10.1111/j.1365-2958.2011.07724.x; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Butler MM, 2010, ANTIMICROB AGENTS CH, V54, P3974, DOI 10.1128/AAC.00484-10; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; HELLING RB, 1971, J BACTERIOL, V105, P1224, DOI 10.1128/JB.105.3.1224-1226.1971; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Oethinger M, 1998, ANTIMICROB AGENTS CH, V42, P2089, DOI 10.1128/AAC.42.8.2089; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Thornton RB, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-94; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	25	51	54	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					6	9		10.1038/nchembio.740	http://dx.doi.org/10.1038/nchembio.740			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173343	Green Accepted			2022-12-27	WOS:000298414100003
J	Neklesa, TK; Tae, HS; Schneekloth, AR; Stulberg, MJ; Corson, TW; Sundberg, TB; Raina, K; Holley, SA; Crews, CM				Neklesa, Taavi K.; Tae, Hyun Seop; Schneekloth, Ashley R.; Stulberg, Michael J.; Corson, Timothy W.; Sundberg, Thomas B.; Raina, Kanak; Holley, Scott A.; Crews, Craig M.			Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins	NATURE CHEMICAL BIOLOGY			English	Article							SCREEN; GENOME; ADAMANTANE; STABILITY; KINASE; CANCER; CELLS; DRUG	The ability to regulate any protein of interest in living systems with small molecules remains a challenge. We hypothesized that appending a hydrophobic moiety to the surface of a protein would mimic the partially denatured state of the protein, thus engaging the cellular quality control machinery to induce its proteasomal degradation. We designed and synthesized bifunctional small molecules to bind a bacterial dehalogenase (the HaloTag protein) and present a hydrophobic group on its surface. Hydrophobic tagging of the HaloTag protein with an adamantyl moiety induced the degradation of cytosolic, isoprenylated and trans-membrane HaloTag fusion proteins in cell culture. We demonstrated the in vivo utility of hydrophobic tagging by degrading proteins expressed in zebrafish embryos and by inhibiting Hras1(G12V)-driven tumor progression in mice. Therefore, hydrophobic tagging of HaloTag fusion proteins affords small-molecule control over any protein of interest, making it an ideal system for validating potential drug targets in disease models.	[Neklesa, Taavi K.; Tae, Hyun Seop; Stulberg, Michael J.; Corson, Timothy W.; Sundberg, Thomas B.; Holley, Scott A.; Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Schneekloth, Ashley R.; Raina, Kanak; Crews, Craig M.] Yale Univ, Dept Chem, New Haven, CT USA; [Crews, Craig M.] Yale Univ, Dept Pharmacol, New Haven, CT USA	Yale University; Yale University; Yale University	Neklesa, TK (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	craig.crews@yale.edu	Crews, Craig M./ABH-9346-2020; Corson, Timothy W./B-6851-2009	Crews, Craig M./0000-0002-8456-2005; Corson, Timothy W./0000-0002-1402-7875; Stulberg, Michael/0000-0001-8640-1291	US National Institutes of Health [R01AI084140]; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084140] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to acknowledge financial support from the US National Institutes of Health (R01AI084140) and to thank the members of the Crews lab for critical reading of the manuscript. S. Stricker at the Max Planck Institute for Molecular Genetics kindly provided Mouse Ror2, and R. Weinberg at the Massachusetts Institute of Technology (MIT) contributed Addgene plasmid 9051 from which Hras1<SUP>G12V</SUP> was obtained. G. Daley at MIT kindly provided the retroviral pEYK3.1 vector. T.W.C. was the Canadian Institutes of Health Research Jean-Fran ois St-Denis Fellow in Cancer Research and a Bisby Fellow. T.B.S. is a recipient of an American Cancer Society fellowship.	AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BOS JL, 1989, CANCER RES, V49, P4682; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Crews CM, 2010, CHEM BIOL, V17, P551, DOI 10.1016/j.chembiol.2010.05.011; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Dixon SJ, 2009, CURR OPIN CHEM BIOL, V13, P549, DOI 10.1016/j.cbpa.2009.08.003; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Elofsson M, 1999, CHEM BIOL, V6, P811, DOI 10.1016/S1074-5521(99)80128-8; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Gies E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014410; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kirikoshi H, 1999, BIOCHEM BIOPH RES CO, V264, P955, DOI 10.1006/bbrc.1999.1612; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; LINS L, 1995, FASEB J, V9, P535, DOI 10.1096/fasebj.9.7.7737462; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; MASELLISSMITH A, 1994, J IMMUNOL, V152, P2768; MATHIAS LJ, 1996, ACS SYM SER, V624, P197; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ostrand-Rosenberg S, 2004, CURR OPIN IMMUNOL, V16, P143, DOI 10.1016/j.coi.2004.01.003; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Porteus Matthew, 2008, V435, P47, DOI 10.1007/978-1-59745-232-8_4; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Schrader EK, 2010, CHEM BIOL, V17, P917, DOI 10.1016/j.chembiol.2010.09.004; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; TSUZUKI N, 1994, J PHARM SCI, V83, P481, DOI 10.1002/jps.2600830407; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742	43	215	256	17	166	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					538	543		10.1038/NCHEMBIO.597	http://dx.doi.org/10.1038/NCHEMBIO.597			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21725302	Green Submitted, Green Accepted			2022-12-27	WOS:000292825400015
J	Chidley, C; Haruki, H; Pedersen, MG; Muller, E; Johnsson, K				Chidley, Christopher; Haruki, Hirohito; Pedersen, Miriam Gronlund; Muller, Evelyne; Johnsson, Kai			A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; IN-VIVO; DIHYDROFOLATE-REDUCTASE; SEPIAPTERIN REDUCTASE; SELECTIVE-INHIBITION; GTP CYCLOHYDROLASE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; SMALL MOLECULES; SYNOVIAL-FLUID	We introduce an approach for detection of drug-protein interactions that combines a new yeast three-hybrid screening for identification of interactions with affinity chromatography for their unambiguous validation. We applied the methodology to the profiling of clinically approved drugs, resulting in the identification of previously known and unknown drug-protein interactions. In particular, we were able to identify off-targets for erlotinib and atorvastatin, as well as an enzyme target for the antiinflammatory drug sulfasalazine. We demonstrate that sulfasalazine and its metabolites, sulfapyridine and mesalamine, are inhibitors of the enzyme catalyzing the final step in the biosynthesis of the cofactor tetrahydrobiopterin. The interference with tetrahydrobiopterin metabolism provides an explanation for some of the beneficial and deleterious properties of sulfasalazine and furthermore suggests new and improved therapies for the drug. This work thus establishes a powerful approach for drug profiling and provides new insights in the mechanism of action of clinically approved drugs.	[Chidley, Christopher; Haruki, Hirohito; Pedersen, Miriam Gronlund; Muller, Evelyne; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res Chem Biol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Chidley, C (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res Chem Biol, Lausanne, Switzerland.	kai.johnsson@epfl.ch	johnsson, kai/P-4222-2014	johnsson, kai/0000-0002-8002-1981; Chidley, Christopher/0000-0002-8212-3148	Swiss National Science Foundation; Federal Office for Professional Education and Technology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Professional Education and Technology	We thank D. Auerbach (Dualsystems Biotech) for sharing plasmid pU6H3VSV, strain NMY51, BG-purvalanol B and cDNA libraries; N. Johnsson (Ulm University) for sharing plasmid pSH47; and O. Hantschel and G. Superti-Furga (Center for Molecular Medicine of the Austrian Academy of Sciences) for sharing plasmid pETM30-NQO2. We thank S. Moser, L. Reymond and C. Fellay for technical assistance. We acknowledge R. Chidley, M.J. Hinner and G. Lukinavicius for critically reading the manuscript. This work was supported by the Swiss National Science Foundation and the Federal Office for Professional Education and Technology.	BAGGOTT JE, 1992, BIOCHEM J, V282, P197, DOI 10.1042/bj2820197; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Becker F, 2004, CHEM BIOL, V11, P211, DOI 10.1016/j.chembiol.2004.02.001; Berti-Mattera LN, 2008, DIABETES, V57, P2801, DOI 10.2337/db07-1274; Blau N, 2001, MOL GENET METAB, V74, P172, DOI 10.1006/mgme.2001.3213; BOLIN JT, 1982, J BIOL CHEM, V257, P13650; Bune AJ, 1996, BIOCHEM BIOPH RES CO, V220, P13, DOI 10.1006/bbrc.1996.0348; Caprilli R, 2009, J CROHNS COLITIS, V3, P149, DOI 10.1016/j.crohns.2009.05.001; Chan JNY, 2010, TRENDS PHARMACOL SCI, V31, P82, DOI 10.1016/j.tips.2009.11.002; CONNOR JR, 1995, EUR J PHARMACOL, V273, P15, DOI 10.1016/0014-2999(94)00672-T; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Dahan A, 2010, INT J PHARMACEUT, V386, P216, DOI 10.1016/j.ijpharm.2009.11.021; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; FARR M, 1985, RHEUMATOL INT, V5, P247, DOI 10.1007/BF00541351; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gendreizig S, 2003, J AM CHEM SOC, V125, P14970, DOI 10.1021/ja037883p; Gierse JK, 1999, BIOCHEM J, V339, P607, DOI 10.1042/0264-6021:3390607; GROSS SS, 1992, J BIOL CHEM, V267, P25722; Hori T, 2006, J BIOCHEM, V140, P457, DOI 10.1093/jb/mvj176; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Kankuri E, 2001, J PHARMACOL EXP THER, V298, P1128; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Klotz U, 2005, DIGEST LIVER DIS, V37, P381, DOI 10.1016/j.dld.2004.12.011; Koegl Manfred, 2007, Briefings in Functional Genomics & Proteomics, V6, P302, DOI 10.1093/bfgp/elm035; Kolaczkowski M, 1998, MICROB DRUG RESIST, V4, P143, DOI 10.1089/mdr.1998.4.143; LAURITSEN K, 1984, GASTROENTEROLOGY, V86, P1496; Licitra EJ, 1996, P NATL ACAD SCI USA, V93, P12817, DOI 10.1073/pnas.93.23.12817; LOCKHART DJ, 2008, Patent No. 7323490; Lotsch J, 2010, PAIN, V148, P103, DOI 10.1016/j.pain.2009.10.021; MAYER RJ, 1986, P NATL ACAD SCI USA, V83, P7718, DOI 10.1073/pnas.83.20.7718; McMurray MA, 2008, CURR BIOL, V18, P1203, DOI 10.1016/j.cub.2008.07.020; MURPHY DJ, 1989, BIOCHEMISTRY-US, V28, P3025, DOI 10.1021/bi00433a043; PULLAR T, 1985, BRIT MED J, V290, P1535, DOI 10.1136/bmj.290.6481.1535; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; SMITH GK, 1992, J BIOL CHEM, V267, P5599; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Sutherland L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000544.pub2; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Temperini C, 2009, BIOORGAN MED CHEM, V17, P1214, DOI 10.1016/j.bmc.2008.12.023; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Wilson SJ, 2006, J BIOL CHEM, V281, P11780, DOI 10.1074/jbc.M513110200; Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7	50	95	98	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					375	383		10.1038/NCHEMBIO.557	http://dx.doi.org/10.1038/NCHEMBIO.557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21499265	Green Published			2022-12-27	WOS:000290677900013
J	Metz, JT; Johnson, EF; Soni, NB; Merta, PJ; Kifle, L; Hajduk, PJ				Metz, James T.; Johnson, Eric F.; Soni, Niru B.; Merta, Philip J.; Kifle, Lemma; Hajduk, Philip J.			Navigating the kinome	NATURE CHEMICAL BIOLOGY			English	Article							DRUG-TARGET NETWORKS; SPACE; DESCRIPTOR; BIOLOGY	Although it is increasingly being recognized that drug-target interaction networks can be powerful tools for the interrogation of systems biology and the rational design of multitargeted drugs, there is no generalized, statistically validated approach to harmonizing sequence-dependent and pharmacology-dependent networks. Here we demonstrate the creation of a comprehensive kinome interaction network based not only on sequence comparisons but also on multiple pharmacology parameters derived from activity profiling data. The framework described for statistical interpretation of these network connections also enables rigorous investigation of chemotype-specific interaction networks, which is critical for multitargeted drug design.	[Metz, James T.; Johnson, Eric F.; Soni, Niru B.; Merta, Philip J.; Kifle, Lemma; Hajduk, Philip J.] Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA	Abbott Laboratories	Metz, JT (corresponding author), Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA.	philip.hajduk@abbott.com						Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Godden JW, 2000, J MOL GRAPH MODEL, V18, P73; Godden JW, 2003, QSAR COMB SCI, V22, P487, DOI 10.1002/qsar.200310001; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Metz JT, 2010, CURR OPIN CHEM BIOL, V14, P498, DOI 10.1016/j.cbpa.2010.06.166; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Vieth M, 2005, DRUG DISCOV TODAY, V10, P839, DOI 10.1016/S1359-6446(05)03477-X; Vieth M, 2004, BBA-PROTEINS PROTEOM, V1697, P243, DOI 10.1016/j.bbapap.2003.11.028; Vogt I, 2010, MOL INFORM, V29, P10, DOI 10.1002/minf.200900069	16	187	193	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					200	202		10.1038/NCHEMBIO.530	http://dx.doi.org/10.1038/NCHEMBIO.530			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21336281				2022-12-27	WOS:000288545000006
J	Sainlos, M; Tigaret, C; Poujol, C; Olivier, NB; Bard, L; Breillat, C; Thiolon, K; Choquet, D; Imperiali, B				Sainlos, Matthieu; Tigaret, Cezar; Poujol, Christel; Olivier, Nelson B.; Bard, Lucie; Breillat, Christelle; Thiolon, Kevin; Choquet, Daniel; Imperiali, Barbara			Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization	NATURE CHEMICAL BIOLOGY			English	Article							ENVIRONMENT-SENSITIVE FLUOROPHORES; TANDEM PDZ DOMAINS; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURES; BIVALENT PEPTIDES; RECEPTOR; STARGAZIN; PSD-95; BINDING; TRAFFICKING	The interactions of the AMPA receptor (AMPAR) auxiliary subunit Stargazin with PDZ domain-containing scaffold proteins such as PSD-95 are critical for the synaptic stabilization of AMPARs. To investigate these interactions, we have developed biomimetic competing ligands that are assembled from two Stargazin-derived PSD-95/DLG/ZO-1 (PDZ) domain-binding motifs using 'click' chemistry. Characterization of the ligands in vitro and in a cellular FRET-based model revealed an enhanced affinity for the multiple PDZ domains of PSD-95 compared to monovalent peptides. In cultured neurons, the divalent ligands competed with transmembrane AMPAR regulatory protein (TARP) for the intracellular membrane-associated guanylate kinase resulting in increased lateral diffusion and endocytosis of surface AMPARs, while showing strong inhibition of synaptic AMPAR currents. This provides evidence for a model in which the TARP-containing AMPARs are stabilized at the synapse by engaging in multivalent interactions. In light of the prevalence of PDZ domain clusters, these new biomimetic chemical tools could find broad application for acutely perturbing multivalent complexes.	[Sainlos, Matthieu; Olivier, Nelson B.; Imperiali, Barbara] MIT, Dept Chem, Cambridge, MA 02139 USA; [Sainlos, Matthieu; Olivier, Nelson B.; Imperiali, Barbara] MIT, Dept Biol, Cambridge, MA USA; [Sainlos, Matthieu; Tigaret, Cezar; Bard, Lucie; Breillat, Christelle; Thiolon, Kevin; Choquet, Daniel] CNRS, UMR 5091, Bordeaux, France; [Sainlos, Matthieu; Tigaret, Cezar; Poujol, Christel; Bard, Lucie; Breillat, Christelle; Thiolon, Kevin; Choquet, Daniel] Univ Bordeaux, Bordeaux, France; [Poujol, Christel] Bordeaux Imaging Ctr, Bordeaux, France	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Sainlos, M (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	dchoquet@u-bordeaux2.fr; imper@mit.edu	Choquet, Daniel/E-4203-2013; Tigaret, Cezar/AAS-6577-2021; Choquet, Daniel/GOJ-8825-2022; Sainlos, Matthieu/H-4253-2013; Choquet, Daniel/K-7893-2018	Tigaret, Cezar/0000-0001-5848-6697; Choquet, Daniel/0000-0003-4726-9763; Sainlos, Matthieu/0000-0001-5465-5641; Choquet, Daniel/0000-0003-4726-9763; Imperiali, Barbara/0000-0002-5749-7869; Poujol, Christel/0000-0002-5222-9064	Human Frontiers Science Program [RGP0007/2006]; European Commission; Agence Nationale pour la Recherche; Conseil Regional d'Aquitaine	Human Frontiers Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This research was supported by the Human Frontiers Science Program (RGP0007/2006, M. S., D. C. and B. I.), the European Commission Marie Curie postdoctoral fellowship (PICK-CPP to M. S.), grants from the Agence Nationale pour la Recherche (ChemTraffic to M. S. and D. C) and the Conseil Regional d'Aquitaine. The microscopy was done in the Bordeaux Imaging Center of the Neurosciences Institute of the University of Bordeaux II. The help of P. Legros is acknowledged. We are grateful to the staff at the National Synchrotron Light Source beamline X6A for access via the General User program and especially to J. Jackonic for assistance in data collection and reduction.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Bertaso F, 2008, NAT NEUROSCI, V11, P940, DOI 10.1038/nn.2142; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Diaz E, 2010, EUR J NEUROSCI, V32, P261, DOI 10.1111/j.1460-9568.2010.07357.x; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Goult BT, 2007, BIOCHEMISTRY-US, V46, P14117, DOI 10.1021/bi701257z; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Ives JH, 2004, J BIOL CHEM, V279, P31002, DOI 10.1074/jbc.M402214200; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Klosi E, 2007, BIOORG MED CHEM LETT, V17, P6147, DOI 10.1016/j.bmcl.2007.09.035; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marks DR, 2007, J NEUROCHEM, V103, P1608, DOI 10.1111/j.1471-4159.2007.04870.x; Medina I, 1999, EUR J NEUROSCI, V11, P2422, DOI 10.1046/j.1460-9568.1999.00664.x; Paduch M, 2007, CHEMBIOCHEM, V8, P443, DOI 10.1002/cbic.200600389; Pegan S, 2007, BIOCHEMISTRY-US, V46, P5315, DOI 10.1021/bi062228q; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Piserchio A, 2002, J BIOL CHEM, V277, P6967, DOI 10.1074/jbc.M109453200; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sainlos M, 2007, NAT PROTOC, V2, P3201, DOI 10.1038/nprot.2007.442; Sainlos M, 2007, NAT PROTOC, V2, P3219, DOI 10.1038/nprot.2007.444; Sainlos M, 2009, J AM CHEM SOC, V131, P6680, DOI 10.1021/ja900371q; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Vazquez ME, 2004, ORG BIOMOL CHEM, V2, P1965, DOI 10.1039/b408001g; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027	50	81	83	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					81	91		10.1038/NCHEMBIO.498	http://dx.doi.org/10.1038/NCHEMBIO.498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21186349				2022-12-27	WOS:000286324600008
J	Erb, TJ; Evans, BS; Cho, K; Warlick, BP; Sriram, J; Wood, BM; Imker, HJ; Sweedler, JV; Tabita, FR; Gerlt, JA				Erb, Tobias J.; Evans, Bradley S.; Cho, Kyuil; Warlick, Benjamin P.; Sriram, Jaya; Wood, B. McKay; Imker, Heidi J.; Sweedler, Jonathan V.; Tabita, F. Robert; Gerlt, John A.			A RubisCO-like protein links SAM metabolism with isoprenoid biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							METHIONINE SALVAGE PATHWAY; PHOTOSYNTHETIC RUBISCO; EVOLUTIONARY RELATIONSHIPS; MECHANISTIC DIVERSITY; SULFUR METABOLISM; METHANETHIOL; SUPERFAMILY; INHIBITION; POLYAMINES; BACTERIA	Functional assignment of uncharacterized proteins is a challenge in the era of large-scale genome sequencing. Here, we combine in extracto NMR, proteomics and transcriptomics with a newly developed (knock-out) metabolomics platform to determine a potential physiological role for a ribulose-1,5-bisphosphate carboxylase/oxygenase (RubisCO)-like protein from Rhodospirillum rubrum. Our studies unraveled an unexpected link in bacterial central carbon metabolism between S-adenosylmethionine-dependent polyamine metabolism and isoprenoid biosynthesis and also provide an alternative approach to assign enzyme function at the organismic level.	[Erb, Tobias J.; Evans, Bradley S.; Cho, Kyuil; Warlick, Benjamin P.; Wood, B. McKay; Imker, Heidi J.; Sweedler, Jonathan V.; Gerlt, John A.] Univ Illinois, Inst Genom Biol, Champaign, IL USA; [Erb, Tobias J.; Warlick, Benjamin P.; Gerlt, John A.] Univ Illinois, Dept Biochem, Champaign, IL USA; [Evans, Bradley S.; Cho, Kyuil; Sweedler, Jonathan V.; Gerlt, John A.] Univ Illinois, Dept Chem, Champaign, IL USA; [Sriram, Jaya; Tabita, F. Robert] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Ohio State University	Erb, TJ (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland.	j-gerlt@uiuc.edu	Evans, Bradley S/M-2842-2013; Erb, Tobias/J-5214-2013; Sweedler, Jonathan V/A-9405-2009	Evans, Bradley S/0000-0002-1207-9006; Erb, Tobias/0000-0003-3685-0894; Sweedler, Jonathan V/0000-0003-3107-9922; Imker, Heidi/0000-0003-4748-7453	Deutsche Forschungsgemeinschaft [ER 646/1-1]; US National Institutes of Health [R01GM065155, R01GM095742, P01GM071790, U54GM093342]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095742, U54GM093342, P01GM071790, R01GM065155] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a fellowship to T.J.E. from the Deutsche Forschungsgemeinschaft (ER 646/1-1) and research grants from the US National Institutes of Health (R01GM065155, R01GM095742, P01GM071790 and U54GM093342). We would like to thank J.E. Cronan for critical comments and C. Deane and T. Miyairi for excellent technical assistance. We also acknowledge S. C. Almo and B. S. Hillerich (New York Structural Genomics Research Consortium) for providing expression plasmids and purified cupin for in vitro assays.	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Ashida H, 2005, RES MICROBIOL, V156, P611, DOI 10.1016/j.resmic.2005.01.014; Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Ashida H, 2008, J EXP BOT, V59, P1543, DOI 10.1093/jxb/ern104; Bolten CJ, 2010, J MICROBIOL BIOTECHN, V20, P1196, DOI 10.4014/jmb.1002.02018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carre-Mlouka A, MICROCYSTIS J BIOL C, V281, P24462; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Gopishetty B, 2009, J AM CHEM SOC, V131, P1243, DOI 10.1021/ja808206w; HAMANA K, 1985, J BIOCHEM-TOKYO, V97, P1653, DOI 10.1093/oxfordjournals.jbchem.a135223; HAMANA K, 1992, CRIT REV MICROBIOL, V18, P261, DOI 10.3109/10408419209113518; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Imker HJ, 2008, BIOCHEMISTRY-US, V47, P11171, DOI 10.1021/bi801685f; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; PAECH C, 1978, BIOCHEM BIOPH RES CO, V83, P1084, DOI 10.1016/0006-291X(78)91506-1; PAULIN LG, 1985, ANTIMICROB AGENTS CH, V28, P157, DOI 10.1128/AAC.28.1.157; Pearce FG, 2006, BIOCHEM J, V399, P525, DOI 10.1042/BJ20060430; Phillips R, 2009, P NATL ACAD SCI USA, V106, P21465, DOI 10.1073/pnas.0907732106; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Salim HMW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000701; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2001, BMC Microbiol, V1, P15, DOI 10.1186/1471-2180-1-15; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Sekowska A, 2001, GENOME BIOL, V2; Singh J, 2010, J BACTERIOL, V192, P1324, DOI 10.1128/JB.01442-09; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810	36	61	65	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					926	932		10.1038/NCHEMBIO.1087	http://dx.doi.org/10.1038/NCHEMBIO.1087			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23042035	Green Accepted			2022-12-27	WOS:000310052100012
J	Oddershede, LB				Oddershede, Lene B.			Force probing of individual molecules inside the living cell is now a reality	NATURE CHEMICAL BIOLOGY			English	Review							BACTERIAL OUTER-MEMBRANE; SINGLE-MOLECULE; OPTICAL TWEEZERS; GOLD NANOPARTICLES; MAGNETIC TWEEZERS; ESCHERICHIA-COLI; PLASMA-MEMBRANE; LIVE CELLS; MICROMECHANICAL PROPERTIES; PROTEIN MOTILITY	Biological systems can be quantitatively explored using single-molecule manipulation techniques such as optical or magnetic tweezers or atomic force microscopy. Though a plethora of discoveries have been accomplished using single-molecule manipulation techniques in vitro, such investigations constantly face the criticism that conditions are too far from being physiologically relevant. Technical achievements now allow scientists to take the next step: to use single-molecule manipulation techniques quantitatively in vivo. Considerable progress has been accomplished in this realm; for example, the interaction between a protein and the membrane of a living cell has been probed, the mechanical properties of individual proteins central for cellular adhesion have been measured and even the action of molecular motors in living cells has been quantified. Here, we review the progress of in vivo single-molecule manipulation with a focus on the special challenges posed by in vivo conditions and how these can be overcome.	Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Oddershede, LB (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	oddershede@nbi.dk		Oddershede, Lene Broeng/0000-0003-2923-2844	University of Copenhagen Excellence Program; Lundbeck Foundation	University of Copenhagen Excellence Program; Lundbeck Foundation(Lundbeckfonden)	The author acknowledges useful comments from E.J.G. Peterman, N.H. Dekker, C. Selhuber-Unkel and M. A. Sorensen and assistance with the illustrations from artist M. Host. The author acknowledges financial support from the University of Copenhagen Excellence Program and from the Lundbeck Foundation.	Amblard F, 1996, REV SCI INSTRUM, V67, P818, DOI 10.1063/1.1146816; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; Bendix PM, 2010, ACS NANO, V4, P2256, DOI 10.1021/nn901751w; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Charvin G, 2005, ANNU REV BIOPH BIOM, V34, P201, DOI 10.1146/annurev.biophys.34.040204.144433; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; de Vries AHB, 2005, BIOPHYS J, V88, P2137, DOI 10.1529/biophysj.104.052035; Dufrene YF, 2011, NAT METHODS, V8, P123, DOI 10.1038/nmeth0211-123; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; EVANS E, 1995, BIOPHYS J, V68, P2580, DOI 10.1016/S0006-3495(95)80441-8; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Finkelstein IJ, 2010, NATURE, V468, P983, DOI 10.1038/nature09561; Fischer M, 2007, J OPT A-PURE APPL OP, V9, pS239, DOI 10.1088/1464-4258/9/8/S18; Fischer M, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3280222; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; FRANZ CM, 2007, SCI STKE, P15; Gibbs KA, 2004, MOL MICROBIOL, V53, P1771, DOI 10.1111/j.1365-2958.2004.04242.x; Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gross P, 2011, NAT PHYS, V7, P731, DOI [10.1038/nphys2002, 10.1038/NPHYS2002]; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Hansen PM, 2005, NANO LETT, V5, P1937, DOI 10.1021/nl051289r; Heinisch JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011104; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hernando J, 2004, ANGEW CHEM INT EDIT, V43, P4045, DOI 10.1002/anie.200453745; Hsiao SC, 2008, ANGEW CHEM INT EDIT, V47, P8473, DOI 10.1002/anie.200802525; Huang J, 2009, BIOCHEMISTRY-US, V48, P11834, DOI 10.1021/bi901756n; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Iwai S, 2008, P NATL ACAD SCI USA, V105, P16882, DOI 10.1073/pnas.0805513105; Jauffred L, 2008, NANO LETT, V8, P3376, DOI 10.1021/nl801962f; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; La Porta A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190801; Laan L, 2008, P NATL ACAD SCI USA, V105, P8920, DOI 10.1073/pnas.0710311105; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Lee WM, 2007, NAT PROTOC, V2, P3226, DOI 10.1038/nprot.2007.446; Leitz G, 2002, BIOPHYS J, V82, P2224, DOI 10.1016/S0006-3495(02)75568-9; Liang H, 1996, BIOPHYS J, V70, P1529, DOI 10.1016/S0006-3495(96)79716-3; Lipfert J, 2010, NAT METHODS, V7, P977, DOI [10.1038/nmeth.1520, 10.1038/NMETH.1520]; Ma HY, 2012, NANO LETT, V12, P3954, DOI 10.1021/nl3010918; Marchington RF, 2010, BIOMED OPT EXPRESS, V1, P527, DOI 10.1364/BOE.1.000527; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; NICKLAS RB, 1969, J CELL BIOL, V43, P40, DOI 10.1083/jcb.43.1.40; Oddershede L, 2002, BIOPHYS J, V83, P3152, DOI 10.1016/S0006-3495(02)75318-6; Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7; Pierobon P, 2009, BIOPHYS J, V96, P4268, DOI 10.1016/j.bpj.2009.02.045; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Rasmussen MB, 2008, APPL ENVIRON MICROB, V74, P2441, DOI 10.1128/AEM.02265-07; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rieger B, 2004, MICROSC RES TECHNIQ, V65, P218, DOI 10.1002/jemt.20128; Robert D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010046; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SAKO Y, 1995, J CELL BIOL, V129, P1559, DOI 10.1083/jcb.129.6.1559; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Selhuber-Unkel C, 2008, NANO LETT, V8, P2998, DOI 10.1021/nl802053h; Seol Y, 2006, OPT LETT, V31, P2429, DOI 10.1364/OL.31.002429; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shimamoto Y, 2011, CELL, V145, P1062, DOI 10.1016/j.cell.2011.05.038; Shtridelman Y, 2008, CELL BIOCHEM BIOPHYS, V52, P19, DOI 10.1007/s12013-008-9021-8; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Sims PA, 2009, CHEMPHYSCHEM, V10, P1511, DOI 10.1002/cphc.200900113; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Stevenson DJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3475958; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Sun MX, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015003; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Tolic-Norrelykke IM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.078102; Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852; Tomishige M, 1999, MOL BIOL CELL, V10, P2475, DOI 10.1091/mbc.10.8.2475; Valle F, 2008, ANGEW CHEM INT EDIT, V47, P2431, DOI 10.1002/anie.200704526; van Mameren J, 2009, P NATL ACAD SCI USA, V106, P18231, DOI 10.1073/pnas.0904322106; Veigel C, 2011, NAT REV MOL CELL BIO, V12, P163, DOI 10.1038/nrm3062; Vickery SA, 2001, J MICROSC-OXFORD, V202, P408, DOI 10.1046/j.1365-2818.2001.00857.x; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wang SH, 2010, J NANOBIOTECHNOL, V8, DOI 10.1186/1477-3155-8-33; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Winther T, 2009, BIOPHYS J, V97, P1305, DOI 10.1016/j.bpj.2009.06.027; Winther T, 2009, CURR PHARM BIOTECHNO, V10, P486, DOI 10.2174/138920109788922083; Xu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1760; Zlatanova J, 2003, BIOCHEM CELL BIOL, V81, P151, DOI 10.1139/o03-048	100	55	60	2	135	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					879	886		10.1038/NCHEMBIO.1082	http://dx.doi.org/10.1038/NCHEMBIO.1082			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23076067				2022-12-27	WOS:000310052100005
J	Mutalik, VK; Qi, L; Guimaraes, JC; Lucks, JB; Arkin, AP				Mutalik, Vivek K.; Qi, Lei; Guimaraes, Joao C.; Lucks, Julius B.; Arkin, Adam P.			Rationally designed families of orthogonal RNA regulators of translation	NATURE CHEMICAL BIOLOGY			English	Article							ANTISENSE RNA; ESCHERICHIA-COLI; GENE-EXPRESSION; MESSENGER-RNA; SYNTHETIC BIOLOGY; RIBOSOME BINDING; IN-VIVO; TRANSCRIPTION; NETWORKS; PROTEIN	Our ability to routinely engineer genetic networks for applications is limited by the scarcity of highly specific and non-crossreacting (orthogonal) gene regulators with predictable behavior. Though antisense RNAs are attractive contenders for this purpose, quantitative understanding of their specificity and sequence-function relationship sufficient for their design has been limited. Here, we use rationally designed variants of the RNA-IN-RNA-OUT antisense RNA-mediated translation system from the insertion sequence IS10 to quantify >500 RNA-RNA interactions in Escherichia coli and integrate the data set with sequence-activity modeling to identify the thermodynamic stability of the duplex and the seed region as the key determinants of specificity. Applying this model, we predict the performance of an additional similar to 2,600 antisense-regulator pairs, forecast the possibility of large families of orthogonal mutants, and forward engineer and experimentally validate two RNA pairs orthogonal to an existing group of five from the training data set. We discuss the potential use of these regulators in next-generation synthetic biology applications.	[Mutalik, Vivek K.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Mutalik, Vivek K.] Joint BioEnergy Inst, BioFAB, Emeryville, CA USA; [Mutalik, Vivek K.; Arkin, Adam P.] QB3 Calif Inst Quantitat Sci, Berkeley, CA USA; [Qi, Lei; Guimaraes, Joao C.; Lucks, Julius B.; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Guimaraes, Joao C.] Univ Minho, Dept Informat, Comp Sci & Technol Ctr, Braga, Portugal; [Lucks, Julius B.] Miller Inst Basic Sci Res, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; Universidade do Minho	Mutalik, VK (corresponding author), Joint BioEnergy Inst, BioFAB, Emeryville, CA USA.	aparkin@lbl.gov	Guimaraes, Joao/A-8572-2012; Qi, Lei S/AAC-5088-2019; Arkin, Adam P/A-6751-2008; Mutalik, Vivek/AAB-6827-2021; Arkin, Adam/M-9941-2019; Lucks, Julius/L-2801-2016	Guimaraes, Joao/0000-0002-1664-472X; Arkin, Adam P/0000-0002-4999-2931; Mutalik, Vivek/0000-0001-7934-0400; Arkin, Adam/0000-0002-4999-2931; Qi, Lei S/0000-0002-3965-3223	British Petroleum at the Joint BioEnergy Institute [LB08004883]; Synthetic Biology Engineering Research Center under US National Science Foundation [04-570/0540879]; Portuguese Fundacao para a Ciencia e a Tecnologia [SFRH/BD/47819/2008]; Miller Institute for Basic Scientific Research; Office of Science, Office of Biological and Environmental Research, of the US Department of Energy [DE-AC02-05CH11231]	British Petroleum at the Joint BioEnergy Institute; Synthetic Biology Engineering Research Center under US National Science Foundation; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Miller Institute for Basic Scientific Research; Office of Science, Office of Biological and Environmental Research, of the US Department of Energy(United States Department of Energy (DOE))	The authors would like to thank G. Cambray, E. Gogol, C. Liu and J. Skerker for comments on the manuscript. V. K. M. was supported by British Petroleum under contract number LB08004883 at the Joint BioEnergy Institute. A. P. A. and L. Q. acknowledge support from the Synthetic Biology Engineering Research Center under US National Science Foundation grant number 04-570/0540879. J. C. G. acknowledges financial support by the Portuguese Fundacao para a Ciencia e a Tecnologia (SFRH/BD/47819/2008). J. B. L. acknowledges the financial support of the Miller Institute for Basic Scientific Research. This work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the US Department of Energy under Contract No. DE-AC02-05CH11231.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; An WL, 2009, P NATL ACAD SCI USA, V106, P8477, DOI 10.1073/pnas.0900267106; Babiskin AH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.4; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Benenson Y, 2009, CURR OPIN BIOTECH, V20, P471, DOI 10.1016/j.copbio.2009.08.002; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Carrier TA, 1999, BIOTECHNOL PROGR, V15, P58, DOI 10.1021/bp9801143; CASE CC, 1990, EMBO J, V9, P1259, DOI 10.1002/j.1460-2075.1990.tb08234.x; Chubiz LM, 2008, NUCLEIC ACIDS RES, V36, P4038, DOI 10.1093/nar/gkn354; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; Dixon N, 2010, P NATL ACAD SCI USA, V107, P2830, DOI 10.1073/pnas.0911209107; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Engdahl HM, 1997, NUCLEIC ACIDS RES, V25, P3218, DOI 10.1093/nar/25.16.3218; Franch T, 1999, J MOL BIOL, V294, P1115, DOI 10.1006/jmbi.1999.3306; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; JAIN C, 1995, J MOL BIOL, V246, P585, DOI 10.1006/jmbi.1994.0110; Jain C, 1997, J THEOR BIOL, V186, P431, DOI 10.1006/jtbi.1996.0371; JONSSON J, 1993, NUCLEIC ACIDS RES, V21, P733, DOI 10.1093/nar/21.3.733; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; KITTLE JD, 1989, J MOL BIOL, V210, P561, DOI 10.1016/0022-2836(89)90132-0; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Liu CC, 2011, NAT BIOTECHNOL, V29, P164, DOI 10.1038/nbt.1741; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; MA C, 1990, EMBO J, V9, P1267, DOI 10.1002/j.1460-2075.1990.tb08235.x; Man SA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr034; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Nakashima N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp498; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Sahota G, 2010, BIOINFORMATICS, V26, P2672, DOI 10.1093/bioinformatics/btq501; Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/NCHEMBIO.273, 10.1038/nchembio.273]; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Smolke CD, 2002, BIOTECHNOL BIOENG, V78, P412, DOI 10.1002/bit.10218; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Wagner EGH, 2002, ADV GENET, V46, P361; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Zhan JA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.42	50	129	132	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					447	454		10.1038/NCHEMBIO.919	http://dx.doi.org/10.1038/NCHEMBIO.919			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22446835				2022-12-27	WOS:000302962500011
J	Yuzwa, SA; Shan, XY; Macauley, MS; Clark, T; Skorobogatko, Y; Vosseller, K; Vocadlo, DJ				Yuzwa, Scott A.; Shan, Xiaoyang; Macauley, Matthew S.; Clark, Thomas; Skorobogatko, Yuliya; Vosseller, Keith; Vocadlo, David J.			Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation	NATURE CHEMICAL BIOLOGY			English	Article							LINKED N-ACETYLGLUCOSAMINE; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; PROTEIN-TAU; POSTTRANSLATIONAL MODIFICATIONS; TETRATRICOPEPTIDE REPEATS; NEUROFIBRILLARY TANGLES; CYTOSOLIC PROTEINS; GLUCOSE-METABOLISM; INSULIN-RESISTANCE	Oligomerization of tau is a key process contributing to the progressive death of neurons in Alzheimer's disease. Tau is modified by O-linked N-acetylglucosamine (O-GlcNAc), and O-GlcNAc can influence tau phosphorylation in certain cases. We therefore speculated that increasing tau O-GlcNAc could be a strategy to hinder pathological tau-induced neurodegeneration. Here we found that treatment of hemizygous JNPL3 tau transgenic mice with an O-GlcNAcase inhibitor increased tau O-GlcNAc, hindered formation of tau aggregates and decreased neuronal cell loss. Notably, increases in tau O-GlcNAc did not alter tau phosphorylation in vivo. Using in vitro biochemical aggregation studies, we found that O-GlcNAc modification, on its own, hinders tau oligomerization. O-GlcNAc also inhibits thermally induced aggregation of an unrelated protein, TAK-1 binding protein, suggesting that a basic biochemical function of O-GlcNAc may be to prevent protein aggregation. These results also suggest O-GlcNAcase as a potential therapeutic target that could hinder progression of Alzheimer's disease.	[Yuzwa, Scott A.; Shan, Xiaoyang; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Macauley, Matthew S.; Clark, Thomas; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Skorobogatko, Yuliya; Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Simon Fraser University; Simon Fraser University; Drexel University	Yuzwa, SA (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Macauley, Matthew/0000-0003-4579-1048	Scottish Rite Charitable Foundation; Canadian Institutes of Health Research (CIHR); Alzheimer Society of Canada; Canada Research Chairs program; Michael Smith Foundation for Health Research (MSFHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Human Frontier Science Program	Scottish Rite Charitable Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Canada Research Chairs program(Canada Research Chairs); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Human Frontier Science Program(Human Frontier Science Program)	We thank the Scottish Rite Charitable Foundation, the Canadian Institutes of Health Research (CIHR) and the Alzheimer Society of Canada for financial support of this research. The Canada Research Chairs program, the Michael Smith Foundation for Health Research (MSFHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC, E.W.R. Steacie Award) are thanked for awards to D.J.V. NSERC is thanked for an award to S.A.Y. The MSFHR and the CIHR are thanked for awards to X. S. The MSFHR, NSERC and Human Frontier Science Program are thanked for awards to M. S. M. We thank the staff at the animal care facility at Simon Fraser University for assistance with the animal studies. P. Davies (Albert Einstein College of Medicine) is thanked for the kind gift of the CP27 and PHF-1 antibodies used in this work. Y. Deng, R. Kaul and E. McEachern are thanked for assistance with preliminary studies, large-scale synthesis of thiamet-G and productive discussion.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; HEISS WD, 1991, ANN NY ACAD SCI, V640, P65; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu Y, 2009, J NEUROCHEM, V111, P242, DOI 10.1111/j.1471-4159.2009.06320.x; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Marcus JN, 2011, J NEUROGENET, V25, P127, DOI 10.3109/01677063.2011.626471; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; MIELKE R, 1994, DEMENTIA, V5, P36, DOI 10.1159/000106692; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Reynolds MR, 2006, J NEUROSCI, V26, P10636, DOI 10.1523/JNEUROSCI.2143-06.2006; Robertson LA, 2004, J ALZHEIMERS DIS, V6, P489; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; Shulman JM, 2011, AM J HUM GENET, V88, P232, DOI 10.1016/j.ajhg.2011.01.006; Smet-Nocca C, 2011, MOL BIOSYST, V7, P1420, DOI 10.1039/c0mb00337a; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Taniguchi T, 2005, FEBS LETT, V579, P1399, DOI 10.1016/j.febslet.2005.01.039; Uno Y, 2009, BRAIN RES, V1296, P148, DOI 10.1016/j.brainres.2009.08.034; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wilson DM, 1997, AM J PATHOL, V150, P2181; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1	50	384	410	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					393	399		10.1038/NCHEMBIO.797	http://dx.doi.org/10.1038/NCHEMBIO.797			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22366723				2022-12-27	WOS:000301890100014
J	Zhang, L; Lu, XY; Lu, JY; Liang, HH; Dai, Q; Xu, GL; Luo, C; Jiang, HL; He, C				Zhang, Liang; Lu, Xingyu; Lu, Junyan; Liang, Haihua; Dai, Qing; Xu, Guo-Liang; Luo, Cheng; Jiang, Hualiang; He, Chuan			Thymine DNA glycosylase specifically recognizes 5-carboxylcytosine-modified DNA	NATURE CHEMICAL BIOLOGY			English	Article							BASE EXCISION-REPAIR; MAMMALIAN DNA; TET PROTEINS; DEMETHYLATION; 5-FORMYLCYTOSINE; 5-METHYLCYTOSINE; SUBSTRATE; CONVERSION; CHEMISTRY; CPG	Human thymine DNA glycosylase (hTDG) efficiently excises 5-carboxylcytosine (5caC), a key oxidation product of 5-methylcytosine in genomic DNA, in a recently discovered cytosine demethylation pathway. We present here the crystal structures of the hTDG catalytic domain in complex with duplex DNA containing either 5caC or a fluorinated analog. These structures, together with biochemical and computational analyses, reveal that 5caC is specifically recognized in the active site of hTDG, supporting the role of TDG in mammalian 5-methylcytosine demethylation.	[Zhang, Liang; Lu, Xingyu; Liang, Haihua; Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Zhang, Liang; Lu, Xingyu; Liang, Haihua; Dai, Qing; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Lu, Junyan; Luo, Cheng; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China; [Xu, Guo-Liang] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	University of Chicago; University of Chicago; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, L (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Liang, Haihua/T-2441-2017; Dai, Qing/ABD-8444-2021; Zhang, Liang/F-8064-2013	Zhang, Liang/0000-0002-7672-1168; Lu, Junyan/0000-0002-9211-0746	US National Institutes of Health [GM071440]; 973 grant [2009CB918502]; Chinese Academy of Sciences [XDA01040305]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 grant(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the US National Institutes of Health (GM071440 to C.H.), the 973 grant (2009CB918502 to H.J.), the Chinese Academy of Sciences (XDA01040305 to C.L.) and beamlines 23ID-B (General Medicine and Cancer Institutes Collaborative Access Team) and 24ID-E (Northeastern Collaborative Access Team) at the Advanced Photon Source at Argonne National Laboratory. We thank X. Yang from the University of Chicago and D. Borek from the University of Texas Southwestern Medical Center for structure data processing and discussion.	Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang YL, 2003, BIOCHEMISTRY-US, V42, P1922, DOI 10.1021/bi027014x; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wibley JEA, 2003, MOL CELL, V11, P1647, DOI 10.1016/S1097-2765(03)00235-1; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	25	230	239	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					328	330		10.1038/NCHEMBIO.914	http://dx.doi.org/10.1038/NCHEMBIO.914			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22327402	Green Accepted, Green Submitted			2022-12-27	WOS:000301890100005
J	Bandyopadhyay, A; Saxena, K; Kasturia, N; Dalal, V; Bhatt, N; Rajkumar, A; Maity, S; Sengupta, S; Chakraborty, K				Bandyopadhyay, Anannya; Saxena, Kanika; Kasturia, Neha; Dalal, Vijit; Bhatt, Niraj; Rajkumar, Asher; Maity, Shuvadeep; Sengupta, Shantanu; Chakraborty, Kausik			Chemical chaperones assist intracellular folding to buffer mutational variations	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI K-12; IN-VITRO; CRYSTAL-STRUCTURE; SEQUENCE SPACE; PROTEIN; TREHALOSE; HSP90; MUTAGENESIS; EVOLUTION; CAPACITOR	Hidden genetic variations have the potential to lead to the evolution of new traits. Molecular chaperones, which assist protein folding, may conceal genetic variations in protein-coding regions. Here we investigate whether the chemical milieu of cells has the potential to alleviate intracellular protein folding, a possibility that could implicate osmolytes in concealing genetic variations. We found that the model osmolyte trimethylamine N-oxide (TMAO) can buffer mutations that impose kinetic traps in the folding pathways of two model proteins. Using this information, we rationally designed TMAO-dependent mutants in vivo, starting from a TMAO-independent protein. We show that different osmolytes buffer a unique spectrum of mutations. Consequently, the chemical milieu of cells may alter the folding pathways of unique mutant variants in polymorphic populations and lead to unanticipated spectra of genetic buffering.	[Bandyopadhyay, Anannya; Saxena, Kanika; Kasturia, Neha; Dalal, Vijit; Bhatt, Niraj; Rajkumar, Asher; Maity, Shuvadeep; Sengupta, Shantanu; Chakraborty, Kausik] Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Bandyopadhyay, A (corresponding author), Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India.	kausik@igib.in	Maity, Shuvadeep/I-7846-2019; dalal, vijit/A-2708-2019; Chakraborty, Kausik/AAL-5748-2021; Bhatt, Niraj/F-7658-2012	Maity, Shuvadeep/0000-0002-6031-4744; dalal, vijit/0000-0003-1624-845X; Bhatt, Niraj/0000-0001-8345-956X; chakraborty, kausik/0000-0001-6000-8379	Council of Scientific and Industrial Research (CSIR) EMPOWER; Wellcome Trust-Department of Biotechnology India alliance; CSIR	Council of Scientific and Industrial Research (CSIR) EMPOWER; Wellcome Trust-Department of Biotechnology India alliance(Wellcome Trust DBT India Alliance); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by the Council of Scientific and Industrial Research (CSIR) EMPOWER program and in part by grants from the Wellcome Trust-Department of Biotechnology India alliance. K.C. acknowledges CSIR for funds to the Institute of Genomics and Integrative Biology and infrastructural support. We thank R. Varadarajan (Indian Institute of Science) for the CcdB mutant library, J. Weissman (University of California San Francisco) for the ymj003 strain and U. Hard and Si. Hayer-Hartl (Max Planck Institute of Biochemistry) for their generous gifts of DM-MBP mutant plasmids. We acknowledge the National BioResource Project-E. coli at the National Institute of Genetics (Japan) for providing strains from the Keio Collection.	Ando T, 2010, P NATL ACAD SCI USA, V107, P18457, DOI 10.1073/pnas.1011354107; Bajaj K, 2005, P NATL ACAD SCI USA, V102, P16221, DOI 10.1073/pnas.0505089102; Bajaj K, 2008, BIOCHEMISTRY-US, V47, P12964, DOI 10.1021/bi8014345; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Eggers DK, 2001, J MOL BIOL, V314, P911, DOI 10.1006/jmbi.2001.5166; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Holthauzen LMF, 2010, BIOCHEMISTRY-US, V49, P1310, DOI 10.1021/bi9015499; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Lindquist S, 2010, COLD SPRING HARB SYM, V74, P103; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; MEURY J, 1991, J BACTERIOL, V173, P4404, DOI 10.1128/JB.173.14.4404-4410.1991; Moczek AP, 2008, BIOESSAYS, V30, P432, DOI 10.1002/bies.20754; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nascimento C, 2008, PROTEIN J, V27, P392, DOI 10.1007/s10930-008-9149-9; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; ROD ML, 1988, J BACTERIOL, V170, P3601, DOI 10.1128/jb.170.8.3601-3610.1988; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schultz T, 2007, BIOCHEM BIOPH RES CO, V355, P234, DOI 10.1016/j.bbrc.2007.01.149; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang JD, 1998, P NATL ACAD SCI USA, V95, P12163, DOI 10.1073/pnas.95.21.12163; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	47	77	79	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					238	245		10.1038/NCHEMBIO.768	http://dx.doi.org/10.1038/NCHEMBIO.768			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22246401	Green Accepted			2022-12-27	WOS:000300600000008
J	Nachtergaele, S; Mydock, LK; Krishnan, K; Rammohan, J; Schlesinger, PH; Covey, DF; Rohatgi, R				Nachtergaele, Sigrid; Mydock, Laurel K.; Krishnan, Kathiresan; Rammohan, Jayan; Schlesinger, Paul H.; Covey, Douglas F.; Rohatgi, Rajat			Oxysterols are allosteric activators of the oncoprotein Smoothened	NATURE CHEMICAL BIOLOGY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; SONIC HEDGEHOG; CHOLESTEROL HOMEOSTASIS; CELL-MIGRATION; PRIMARY CILIUM; RECEPTOR; BINDING; PATHWAY; INHIBITION; MEMBRANES	Oxysterols are a class of endogenous signaling molecules that can activate the Hedgehog pathway, which has critical roles in development, regeneration and cancer. However, it has been unclear how oxysterols influence Hedgehog signaling, including whether their effects are mediated through a protein target or indirectly through effects on membrane properties. To answer this question, we synthesized the enantiomer and an epimer of the most potent oxysterol, 20(S)-hydroxycholesterol. Using these molecules, we show that the effects of oxysterols on Hedgehog signaling are exquisitely stereoselective, consistent with the hypothesis that they function through a specific protein target. We present several lines of evidence that this protein target is the seven-pass transmembrane protein Smoothened, a major drug target in oncology. Our work suggests that these enigmatic sterols, which have multiple effects on cell physiology, may act as ligands for signaling receptors and provides a generally applicable framework for probing sterol signaling mechanisms.	[Rohatgi, Rajat] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Nachtergaele, Sigrid] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Mydock, Laurel K.; Krishnan, Kathiresan; Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Rammohan, Jayan; Schlesinger, Paul H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Stanford University; Stanford University; Washington University (WUSTL); Washington University (WUSTL)	Rohatgi, R (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	dcovey@wustl.edu; rrohatgi@stanford.edu	Schlesinger, Paul H/C-6049-2012		NIH [RR00954, DK020579, DK056341, GM47969, HL67773, 5 T32 GM007276, 5 T32 HL007275]; Stand Up to Cancer - American Association for Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R00CA129174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, P01GM047969] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer - American Association for Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Rohatgi lab for helpful discussions, G. Luchetti for help with ligand affinity chromatography, P. Niewiadomski and A. Lebensohn for critical reading of the manuscript, E. Lee (Vanderbilt University) for Wnt-L cells, K. Mykytyn (Ohio State University) for the SSTR3-GFP and HTR6-GFP constructs, A. Sweet-Cordero for use of a Li-Cor Odyssey imager and M. Scott for support and use of a confocal microscope. MS analysis was conducted at the NIH - National Center for Research Resources MS facility at Washington University, supported by the NIH (RR00954, DK020579, DK056341). This work was supported by a Pew Scholar Award and an Innovation Research Grant from the Stand Up to Cancer - American Association for Cancer Research Foundation to R. R., by NIH grants to D. F. C. (GM47969 and HL67773) and P. H. S. (HL67773), and by NIH training grants to S.N. (5 T32 GM007276) and L.K.M. (5 T32 HL007275).	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Covey DF, 2009, STEROIDS, V74, P577, DOI 10.1016/j.steroids.2008.11.019; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Heretsch P, 2010, ANGEW CHEM INT EDIT, V49, P3418, DOI 10.1002/anie.200906967; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Johnson JS, 2011, J CELL BIOCHEM, V112, P1673, DOI 10.1002/jcb.23082; Kenakin T, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P101, DOI 10.1016/B978-0-12-374585-9.00006-2; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; LeBlanc MA, 2010, J BIOL CHEM, V285, P33875, DOI 10.1074/jbc.M110.147264; Lin YY, 2003, J STEROID BIOCHEM, V85, P57, DOI 10.1016/S0960-0760(03)00137-7; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mannock DA, 2003, BIOPHYS J, V84, P1038, DOI 10.1016/S0006-3495(03)74920-0; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; MIJARES A, 1967, J ORG CHEM, V32, P810, DOI 10.1021/jo01278a066; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; Panini SR, 2001, CURR OPIN LIPIDOL, V12, P529, DOI 10.1097/00041433-200110000-00008; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; ROBERTS KD, 1969, BIOCHEMISTRY-US, V8, P1259, DOI 10.1021/bi00831a061; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rominger CM, 2009, J PHARMACOL EXP THER, V329, P995, DOI 10.1124/jpet.109.152090; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; THEUNISSEN JJH, 1986, BIOCHIM BIOPHYS ACTA, V860, P66, DOI 10.1016/0005-2736(86)90499-2; Torocsik D, 2009, MOL ASPECTS MED, V30, P134, DOI 10.1016/j.mam.2009.02.002; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200	48	199	207	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					211	220		10.1038/nchembio.765	http://dx.doi.org/10.1038/nchembio.765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22231273	Green Accepted			2022-12-27	WOS:000299323200014
J	Falconer, SB; Czarny, TL; Brown, ED				Falconer, Shannon B.; Czarny, Tomasz L.; Brown, Eric D.			Antibiotics as probes of biological complexity	NATURE CHEMICAL BIOLOGY			English	Review							PENICILLIN-BINDING COMPONENTS; CELL-DIVISION MACHINERY; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; TEICHOIC-ACIDS; SOS RESPONSE; TRANSFER-RNA; DNA GYRASE; ANTIBACTERIAL COMPOUNDS	The utility of antibiotics has largely been based on their therapeutic application. However, in addition to clinical use, antibiotics have served as vital agents in probing bacterial complexity. Although not principally regarded as tools for dissecting bacterial genetics and biochemistry, antibiotics have nonetheless proved indispensable to understanding such essential functions as cell-wall biogenesis, DNA biosynthesis and the translation process. Herein we provide an overarching account of recent and landmark instances in which antibiotics have yielded critical information regarding many bacterial processes. We also elaborate on the importance of antibiotics and new chemical probes to the comprehension of genetic networks in the future. Given that antibiotics were among the first small molecules used to methodically perturb and understand biological systems, the past, present and future of antibiotics as probes of bacterial complexity offer some illustrative lessons for the broader field of chemical biology.	[Falconer, Shannon B.; Czarny, Tomasz L.; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Falconer, Shannon B.; Czarny, Tomasz L.; Brown, Eric D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	ebrown@mcmaster.ca		Czarny, Tomasz/0000-0002-0972-8116	Canada Research Chairs program; Canadian Institutes of Health Research [MOP-15496, MOP-64292, MOP-81330]; Cystic Fibrosis Canada	Canada Research Chairs program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada	E.D.B. acknowledges salary support from the Canada Research Chairs program and operating funds from the Canadian Institutes of Health Research (MOP-15496, MOP-64292 and MOP-81330) and Cystic Fibrosis Canada.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Bhavsar AP, 2001, J BACTERIOL, V183, P6688, DOI 10.1128/JB.183.22.6688-6693.2001; Blanchard SC, 2010, CHEM BIOL, V17, P633, DOI 10.1016/j.chembiol.2010.06.003; Bowers CW, 2003, J BACTERIOL, V185, P5697, DOI 10.1128/JB.185.19.5697-5705.2003; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Chung HS, 2009, P NATL ACAD SCI USA, V106, P21872, DOI 10.1073/pnas.0911674106; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; D'Elia MA, 2009, CHEM BIOL, V16, P548, DOI 10.1016/j.chembiol.2009.04.009; DELPORTILLO FG, 1990, J BACTERIOL, V172, P5863; Donald RGK, 2009, CHEM BIOL, V16, P826, DOI 10.1016/j.chembiol.2009.07.004; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Farha MA, 2010, CHEM BIOL, V17, P852, DOI 10.1016/j.chembiol.2010.06.008; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; Garcia-Ortega L, 2008, MOL CELL, V32, P292, DOI 10.1016/j.molcel.2008.09.012; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; HIGGINS NP, 1978, P NATL ACAD SCI USA, V75, P1773, DOI 10.1073/pnas.75.4.1773; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Jiang LH, 2009, J MOL BIOL, V386, P1357, DOI 10.1016/j.jmb.2008.10.079; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Koteva K, 2010, NAT CHEM BIOL, V6, P327, DOI 10.1038/nchembio.350; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Li XM, 2004, CHEM BIOL, V11, P1423, DOI 10.1016/j.chembiol.2004.08.014; LOCKWOOD AH, 1971, P NATL ACAD SCI USA, V68, P3122, DOI 10.1073/pnas.68.12.3122; LUTTINGER A, 1995, MOL MICROBIOL, V15, P601, DOI 10.1111/j.1365-2958.1995.tb02369.x; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Miller C, 2003, J BACTERIOL, V185, P6025, DOI 10.1128/JB.185.20.6025-6031.2003; MONRO RE, 1967, J MOL BIOL, V26, P147, DOI 10.1016/0022-2836(67)90271-9; NATHANS D, 1964, P NATL ACAD SCI USA, V51, P585, DOI 10.1073/pnas.51.4.585; NGUYENDISTECHE M, 1974, EUR J BIOCHEM, V41, P457, DOI 10.1111/j.1432-1033.1974.tb03287.x; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; PARK JT, 1952, J BIOL CHEM, V194, P897; PARK JT, 1952, J BIOL CHEM, V194, P885; PARK JT, 1957, SCIENCE, V125, P99, DOI 10.1126/science.125.3238.99; PARK JT, 1949, J BIOL CHEM, V179, P585; PARK JT, 1952, J BIOL CHEM, V194, P877; PARKER RF, 1948, J BACTERIOL, V56, P75, DOI 10.1128/JB.56.1.75-81.1948; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Piton J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012245; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Shinagawa H, 1996, EXS, V77, P221; SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Sternberg SH, 2009, NAT STRUCT MOL BIOL, V16, P861, DOI 10.1038/nsmb.1622; STROMING.JL, 1974, ANN NY ACAD SCI, V235, P210, DOI 10.1111/j.1749-6632.1974.tb43267.x; SUGINAKA H, 1972, J BIOL CHEM, V247, P5279; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; TRAUT RR, 1964, J MOL BIOL, V10, P63, DOI 10.1016/S0022-2836(64)80028-0; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; van den Ent F, 2010, EMBO J, V29, P1081, DOI 10.1038/emboj.2010.9; van Stelten J, 2009, SCIENCE, V325, P753, DOI 10.1126/science.1172221; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; YARMOLINSKY MB, 1959, P NATL ACAD SCI USA, V45, P1721, DOI 10.1073/pnas.45.12.1721; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Young K, 2006, ANTIMICROB AGENTS CH, V50, P519, DOI 10.1128/AAC.50.2.519-526.2006; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	78	47	49	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					416	424		10.1038/NCHEMBIO.590	http://dx.doi.org/10.1038/NCHEMBIO.590			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21685879				2022-12-27	WOS:000292252100006
J	Oman, TJ; Boettcher, JM; Wang, HA; Okalibe, XN; van der Donk, WA				Oman, Trent J.; Boettcher, John M.; Wang, Huan; Okalibe, Xenia N.; van der Donk, Wilfred A.			Sublancin is not a lantibiotic but an S-linked glycopeptide	NATURE CHEMICAL BIOLOGY			English	Article							ACID-CONTAINING PEPTIDES; BACILLUS-SUBTILIS; SOLUTION-PHASE; PRODUCT; IDENTIFICATION; BIOSYNTHESIS; TOOLS	Sublancin is shown to be an S-linked glycopeptide containing a glucose attached to a cysteine residue, establishing a new post-translational modification. The activity of the S-glycosyl transferase was reconstituted in vitro, and the enzyme is shown to have relaxed substrate specificity, allowing the preparation of analogs of sublancin. Glycosylation is essential for its antimicrobial activity.	[Oman, Trent J.; Boettcher, John M.; Wang, Huan; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL USA; [Oman, Trent J.; Boettcher, John M.; Wang, Huan; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA; [Okalibe, Xenia N.] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan	Oman, TJ (corresponding author), Univ Illinois, Dept Chem, Urbana, IL USA.	vddonk@illinois.edu	van der Donk, Wilfred/K-2961-2015	van der Donk, Wilfred/0000-0002-5467-7071	US National Institutes of Health [GM58822]; US National Institutes of Health Cellular and Molecular Biology [T32 GM007283]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007283, R01GM058822] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Cellular and Molecular Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (GM58822 to W.A.v.d.D.) and a US National Institutes of Health Cellular and Molecular Biology Training Grant (T32 GM007283 to T.J.O.). X.N.O. was supported by the EXROP summer research program of the Howard Hughes Medical Institute.	BARAN E, 1978, POL J CHEM, V52, P941; Blanchard S, 2006, CURR OPIN CHEM BIOL, V10, P263, DOI 10.1016/j.cbpa.2006.04.001; Cohen SB, 2002, J AM CHEM SOC, V124, P2534, DOI 10.1021/ja011932l; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Driguez H, 2001, CHEMBIOCHEM, V2, P311; Dubois JYF, 2009, ANTIMICROB AGENTS CH, V53, P651, DOI 10.1128/AAC.01189-08; Fuller E, 2005, FEBS J, V272, P1727, DOI 10.1111/j.1742-4658.2005.04602.x; Galonic DP, 2004, J AM CHEM SOC, V126, P12712, DOI 10.1021/ja046793x; Galonic DP, 2003, CHEM-EUR J, V9, P5997, DOI 10.1002/chem.200305290; Galonic DP, 2005, J AM CHEM SOC, V127, P7359, DOI 10.1021/ja050304r; Goto Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000339; HEMPHILL HE, 1980, CAN J MICROBIOL, V26, P1328, DOI 10.1139/m80-220; Hili R, 2010, J AM CHEM SOC, V132, P2889, DOI 10.1021/ja910544p; Jahn M, 2003, ANGEW CHEM INT EDIT, V42, P352, DOI 10.1002/anie.200390114; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LOTE CJ, 1971, FEBS LETT, V16, P81, DOI 10.1016/0014-5793(71)80337-X; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Paik SH, 1998, J BIOL CHEM, V273, P23134, DOI 10.1074/jbc.273.36.23134; Siezen RJ, 1996, ANTON LEEUW INT J G, V69, P171, DOI 10.1007/BF00399422; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501	25	159	170	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					78	80		10.1038/NCHEMBIO.509	http://dx.doi.org/10.1038/NCHEMBIO.509			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21196935	Green Accepted			2022-12-27	WOS:000286324600007
J	Avasthi, P				Avasthi, Prachee			SIGNALING Sifting at the ciliary base	NATURE CHEMICAL BIOLOGY			English	News Item							SOLUBLE-PROTEIN; MEMBRANE; ENTRY		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Avasthi, P (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	pacrofts@gmail.com	Avasthi, Prachee/H-6386-2019	Avasthi, Prachee/0000-0002-1688-722X				Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Francis SS, 2011, J CELL BIOL, V193, P219, DOI 10.1083/jcb.201009001; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lin YC, 2013, NAT CHEM BIOL, V9, P437, DOI [10.1038/NCHEMBIO.1252, 10.1038/nchembio.1252]; Najafi M, 2012, P NATL ACAD SCI USA, V109, P203, DOI 10.1073/pnas.1115109109; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116	10	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					414	415		10.1038/nchembio.1272	http://dx.doi.org/10.1038/nchembio.1272			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23774872				2022-12-27	WOS:000320449700004
J	Lavoie, H; Thevakumaran, N; Gavory, G; Li, JJ; Padeganeh, A; Guiral, S; Duchaine, J; Mao, DYL; Bouvier, M; Sicheri, F; Therrien, M				Lavoie, Hugo; Thevakumaran, Neroshan; Gavory, Gwenalle; Li, John J.; Padeganeh, Abbas; Guiral, Sebastien; Duchaine, Jean; Mao, Daniel Y. L.; Bouvier, Michel; Sicheri, Frank; Therrien, Marc			Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization	NATURE CHEMICAL BIOLOGY			English	Article							WILD-TYPE; BRET TECHNOLOGY; ONCOGENIC BRAF; C-RAF; PROTEIN; ACTIVATION; MECHANISM; HETERODIMERIZATION; ELF2-ALPHA; RESISTANCE	RAF kinases have a prominent role in cancer. Their mode of activation is complex but critically requires dimerization of their kinase domains. Unexpectedly, several ATP-competitive RAF inhibitors were recently found to promote dimerization and transactivation of RAF kinases in a RAS-dependent manner and, as a result, undesirably stimulate RAS/ERK pathway-mediated cell growth. The mechanism by which these inhibitors induce RAF kinase domain dimerization remains unclear. Here we describe bioluminescence resonance energy transfer-based biosensors for the extended RAF family that enable the detection of RAF dimerization in living cells. Notably, we demonstrate the utility of these tools for profiling kinase inhibitors that selectively modulate RAF dimerization and for probing structural determinants of RAF dimerization in vivo. Our findings, which seem generalizable to other kinase families allosterically regulated by kinase domain dimerization, suggest a model whereby ATP-competitive inhibitors mediate RAF dimerization by stabilizing a rigid closed conformation of the kinase domain.	[Lavoie, Hugo; Gavory, Gwenalle; Padeganeh, Abbas; Guiral, Sebastien; Duchaine, Jean; Bouvier, Michel; Therrien, Marc] Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signalling, Montreal, PQ, Canada; [Thevakumaran, Neroshan; Li, John J.; Mao, Daniel Y. L.; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Thevakumaran, Neroshan; Sicheri, Frank] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Li, John J.; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Mao, Daniel Y. L.] Ryerson Univ, Dept Chem & Biol, Toronto, ON, Canada; [Bouvier, Michel] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Therrien, Marc] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada	Universite de Montreal; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Toronto Metropolitan University; Universite de Montreal; Universite de Montreal	Therrien, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signalling, Montreal, PQ, Canada.	sicheri@lunenfeld.ca; marc.therrien@umontreal.ca	Bouvier, Michel/H-2758-2014; Sicheri, Frank/F-8856-2013	Bouvier, Michel/0000-0003-1128-0100; Lavoie, Hugo/0000-0003-0560-2409	Canadian Center of Excellence in Commercialization and Research; Canada Foundation for Innovation; Fonds de Recherche du Quebec en Sante; Cancer Research Society; Canadian Institutes for Health Research (CIHR); CIHR Canadian Graduate Scholarship; Canadian Cancer Society [018046]; CIHR [MOP119443, MOP36399]	Canadian Center of Excellence in Commercialization and Research; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de Recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); Cancer Research Society; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR(Canadian Institutes of Health Research (CIHR))	We thank B. Breton and M. Audet for advice with the BRET2 system, D. Uehling and co-workers at the Ontario Institute for Cancer Research for GSK2606414, and the Institut de recherche en immunologie et en cancerologie (IRIC) high-throughput screening platform. IRIC is supported by the Canadian Center of Excellence in Commercialization and Research, the Canada Foundation for Innovation and by the Fonds de Recherche du Quebec en Sante. H. L. is a recipient of Cancer Research Society and Canadian Institutes for Health Research (CIHR) Banting postdoctoral fellowships. N.T. is a recipient of the CIHR Canadian Graduate Scholarship. M. B., F. S. and M. T. hold Canada Research Chairs. This work was supported by operating funds from the Canadian Cancer Society to M. T. (018046) and from the CIHR to M. T. (MOP119443) and F. S. (MOP36399).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Bukhtiyarova M, 2007, BIOCHEMISTRY-US, V46, P5687, DOI 10.1021/bi0622221; Ciruela F, 2008, CURR OPIN BIOTECH, V19, P338, DOI 10.1016/j.copbio.2008.06.003; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Halilovic E, 2008, CURR OPIN PHARMACOL, V8, P419, DOI 10.1016/j.coph.2008.06.014; Hall-Jackson CA, 1999, ONCOGENE, V18, P2047, DOI 10.1038/sj.onc.1202603; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kalmes A, 1999, FEBS LETT, V444, P71, DOI 10.1016/S0014-5793(99)00034-4; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roring M, 2012, EMBO J, V31, P2629, DOI 10.1038/emboj.2012.100; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sen B, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003513; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	52	113	115	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					428	+		10.1038/NCHEMBIO.1257	http://dx.doi.org/10.1038/NCHEMBIO.1257			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23685672	Green Accepted			2022-12-27	WOS:000320449700007
J	Ouchi, T; Tomita, T; Horie, A; Yoshida, A; Takahashi, K; Nishida, H; Lassak, K; Taka, H; Mineki, R; Fujimura, T; Kosono, S; Nishiyama, C; Masui, R; Kuramitsu, S; Albers, SV; Kuzuyama, T; Nishiyama, M				Ouchi, Takuya; Tomita, Takeo; Horie, Akira; Yoshida, Ayako; Takahashi, Kento; Nishida, Hiromi; Lassak, Kerstin; Taka, Hikari; Mineki, Reiko; Fujimura, Tsutomu; Kosono, Saori; Nishiyama, Chiharu; Masui, Ryoji; Kuramitsu, Seiki; Albers, Sonja-Verena; Kuzuyama, Tomohisa; Nishiyama, Makoto			Lysine and arginine biosyntheses mediated by a common carrier protein in Sulfolobus	NATURE CHEMICAL BIOLOGY			English	Article							THERMUS-THERMOPHILUS; EVOLUTION; BACTERIUM; PATHWAYS; ENZYME; ACID	LysW has been identified as a carrier protein in the lysine biosynthetic pathway that is active through the conversion of alpha-aminoadipate (AAA) to lysine. In this study, we found that the hyperthermophilic archaeon, Sulfolobus acidocaldarius, not only biosynthesizes lysine through LysW-mediated protection of AAA but also uses LysW to protect the amino group of glutamate in arginine biosynthesis. In this archaeon, after LysW modification, AAA and glutamate are converted to lysine and ornithine, respectively, by a single set of enzymes with dual functions. The crystal structure of ArgX, the enzyme responsible for modification and protection of the amino moiety of glutamate with LysW, was determined in complex with LysW. Structural comparison and enzymatic characterization using Sulfolobus LysX, Sulfolobus ArgX and Thermus LysX identify the amino acid motif responsible for substrate discrimination between AAA and glutamate. Phylogenetic analysis reveals that gene duplication events at different stages of evolution led to ArgX and LysX.	[Ouchi, Takuya; Tomita, Takeo; Horie, Akira; Yoshida, Ayako; Takahashi, Kento; Kosono, Saori; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan; [Nishida, Hiromi] Univ Tokyo, Agr Bioinformat Res Unit, Grad Sch Agr & Life Sci, Tokyo, Japan; [Lassak, Kerstin; Albers, Sonja-Verena] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Taka, Hikari; Mineki, Reiko; Fujimura, Tsutomu] Juntendo Univ, Sch Med, Div Biochem Anal, Cent Lab Med Sci, Tokyo 113, Japan; [Nishiyama, Chiharu] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Tokyo 113, Japan; [Masui, Ryoji; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan; [Masui, Ryoji; Kuramitsu, Seiki; Nishiyama, Makoto] RIKEN SPring 8 Ctr, Kobe, Hyogo, Japan	University of Tokyo; University of Tokyo; Max Planck Society; Juntendo University; Juntendo University; Osaka University; RIKEN	Nishiyama, M (corresponding author), Nihon Unisys Ltd, Tokyo, Japan.	umanis@mail.ecc.u-tokyo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022; Albers, Sonja-Verena/H-8689-2019; Nishida, Hiromi/B-1635-2008	Albers, Sonja-Verena/0000-0003-2459-2226; Nishiyama, Makoto/0000-0001-8143-8052; Fujimura, Tsutomu/0000-0003-1744-7725; Yoshida, Ayako/0000-0002-3668-9001; Kuzuyama, Tomohisa/0000-0002-7221-5858	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21380057, 24228001]; Nagase Science and Technology Foundation; Asahi Glass Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagase Science and Technology Foundation; Asahi Glass Foundation	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant nos. 21380057 and 24228001 to M.N.), Nagase Science and Technology Foundation to M.N., and from the Asahi Glass Foundation to M.N.	Baetens M, 1998, MICROBIOL-SGM, V144, P479, DOI 10.1099/00221287-144-2-479; Brinkman AB, 2002, J BIOL CHEM, V277, P29537, DOI 10.1074/jbc.M203528200; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; LEISINGER T, 1975, J BIOL CHEM, V250, P1690; MARTIN PR, 1992, J BACTERIOL, V174, P2694, DOI 10.1128/jb.174.8.2694-2701.1992; Miyazaki J, 2001, J BACTERIOL, V183, P5067, DOI 10.1128/JB.183.17.5067-5073.2001; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Sakai H, 2003, J MOL BIOL, V332, P729, DOI 10.1016/S0022-2836(03)00946-X; STRASSMAN M, 1953, J AM CHEM SOC, V75, P1680, DOI 10.1021/ja01103a049; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06	20	34	48	2	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					277	283		10.1038/NCHEMBIO.1200	http://dx.doi.org/10.1038/NCHEMBIO.1200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23434852				2022-12-27	WOS:000317025800019
J	Plata, G; Fuhrer, T; Hsiao, TL; Sauer, U; Vitkup, D				Plata, German; Fuhrer, Tobias; Hsiao, Tzu-Lin; Sauer, Uwe; Vitkup, Dennis			Global probabilistic annotation of metabolic networks enables enzyme discovery	NATURE CHEMICAL BIOLOGY			English	Article							GENOME-SCALE RECONSTRUCTION; BACILLUS-SUBTILIS; HIGH-THROUGHPUT; PROTEIN FUNCTION; GENE; OPTIMIZATION; SEQUENCE; TOOLS; EXPRESSION; GENERATION	Annotation of organism-specific metabolic networks is one of the main challenges of systems biology. Importantly, owing to inherent uncertainty of computational annotations, predictions of biochemical function need to be treated probabilistically. We present a global probabilistic approach to annotate genome-scale metabolic networks that integrates sequence homology and context-based correlations under a single principled framework. The developed method for global biochemical reconstruction using sampling (GLOBUS) not only provides annotation probabilities for each functional assignment but also suggests likely alternative functions. GLOBUS is based on statistical Gibbs sampling of probable metabolic annotations and is able to make accurate functional assignments even in cases of remote sequence identity to known enzymes. We apply GLOBUS to genomes of Bacillus subtilis and Staphylococcus aureus and validate the method predictions by experimentally demonstrating the 6-phosphogluconolactonase activity of YkgB and the role of the Sps pathway for rhamnose biosynthesis in B. subtilis.	[Plata, German; Hsiao, Tzu-Lin; Vitkup, Dennis] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Plata, German] Columbia Univ, Integrated Program Cellular Mol Struct & Genet St, New York, NY USA; [Fuhrer, Tobias; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Hsiao, Tzu-Lin; Vitkup, Dennis] Columbia Univ, Dept Biomed Informat, New York, NY USA	Columbia University; Columbia University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Columbia University	Plata, G (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	dv2121@columbia.edu	Fuhrer, Tobias/B-5667-2013; Sauer, Uwe/Y-3556-2019	Fuhrer, Tobias/0000-0001-5006-6874; Plata, German/0000-0002-6470-7748	US National Institutes of Health [GM079759]; National Centers for Biomedical Computing grant [U54CA121852]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079759] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Biomedical Computing grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Huttenhain for technical assistance and measuring the peptide samples. We thank P. Eichenberger from the Biology Department at New York University for providing mutant strains. This work was supported in part by US National Institutes of Health grant GM079759 to D.V. and National Centers for Biomedical Computing grant U54CA121852 to Columbia University.	Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bower S, 1996, J BACTERIOL, V178, P4122, DOI 10.1128/jb.178.14.4122-4130.1996; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Faille C, 2010, INT J FOOD MICROBIOL, V143, P125, DOI 10.1016/j.ijfoodmicro.2010.07.038; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hecker M, 2009, RES MICROBIOL, V160, P245, DOI 10.1016/j.resmic.2009.03.008; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Henry CS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r69; Hsiao TL, 2010, NAT CHEM BIOL, V6, P34, DOI [10.1038/NCHEMBIO.266, 10.1038/nchembio.266]; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kharchenko P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-177; Kharchenko P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100023; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Li S. Z., 2001, COMP SCI W; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Price ND, 2007, CURR OPIN BIOTECH, V18, P365, DOI 10.1016/j.copbio.2007.07.009; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; STAMFORD NPJ, 1995, EUR J BIOCHEM, V231, P236, DOI 10.1111/j.1432-1033.1995.tb20692.x; Tam LT, 2006, PROTEOMICS, V6, P4565, DOI 10.1002/pmic.200600100; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Timmons SC, 2007, ORG LETT, V9, P857, DOI 10.1021/ol0630853; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298	50	44	46	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					848	854		10.1038/NCHEMBIO.1063	http://dx.doi.org/10.1038/NCHEMBIO.1063			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22960854	Green Accepted, Green Published			2022-12-27	WOS:000309056200010
J	Bratton, SB				Bratton, Shawn B.			PEPTIDE INHIBITORS Four of a kind beats a pair	NATURE CHEMICAL BIOLOGY			English	News Item							MUTANT HUNTINGTIN; ACTIVATION; DEGENERATION; CASPASE-6; CLEAVAGE; SITE; MICE		Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	University of Texas System; UTMD Anderson Cancer Center	Bratton, SB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX USA.	sbbratton@mdanderson.org			NCI NIH HHS [R01 CA129521] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA129521] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Stanger K, 2012, NAT CHEM BIOL, V8, P655, DOI [10.1038/nchembio.967, 10.1038/NCHEMBIO.967]; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P2770, DOI 10.1093/hmg/ddr176; Uribe V, 2012, HUM MOL GENET, V21, P1954, DOI 10.1093/hmg/dds005; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141	10	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					606	607		10.1038/nchembio.1000	http://dx.doi.org/10.1038/nchembio.1000			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22710307	Green Accepted			2022-12-27	WOS:000305471400004
J	Rillahan, CD; Antonopoulos, A; Lefort, CT; Sonon, R; Azadi, P; Ley, K; Dell, A; Haslam, SM; Paulson, JC				Rillahan, Cory D.; Antonopoulos, Aristotelis; Lefort, Craig T.; Sonon, Roberto; Azadi, Parastoo; Ley, Klaus; Dell, Anne; Haslam, Stuart M.; Paulson, James C.			Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome	NATURE CHEMICAL BIOLOGY			English	Article							CHEMOENZYMATIC SYNTHESIS; GDP-MANNOSE; E-SELECTIN; BIOSYNTHESIS; GLYCOSYLATION; ACID; SIALYLTRANSFERASE; CELLS; GLYCOSYLTRANSFERASES; ATHEROSCLEROSIS	Despite the fundamental roles of sialyl- and fucosyltransferases in mammalian physiology, there are few pharmacological tools to manipulate their function in a cellular setting. Although fluorinated analogs of the donor substrates are well-established transition state inhibitors of these enzymes, they are not membrane permeable. By exploiting promiscuous monosaccharide salvage pathways, we show that fluorinated analogs of sialic acid and fucose can be taken up and metabolized to the desired donor substrate-based inhibitors inside the cell. Because of the existence of metabolic feedback loops, they also act to prevent the de novo synthesis of the natural substrates, resulting in a global, family-wide shutdown of sialyl- and/or fucosyltransferases and remodeling of cell-surface glycans. As an example of the functional consequences, the inhibitors substantially reduce expression of the sialylated and fucosylated ligand sialyl Lewis X on myeloid cells, resulting in loss of selectin binding and impaired leukocyte rolling.	[Rillahan, Cory D.; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Antonopoulos, Aristotelis; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London, England; [Lefort, Craig T.; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA; [Sonon, Roberto; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Scripps Research Institute; Imperial College London; La Jolla Institute for Immunology; University System of Georgia; University of Georgia	Paulson, JC (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	Paulson, James/AAG-3565-2019	Dell, Anne/0000-0003-1380-2347	US National Institutes of Health [R01AI050143, P01HL107151, T32AI007606, R01HL111969]; Complex Carbohydrate Research Center [1 P41 RR018502-01]; Biotechnology and Biological Sciences Research Council [BBF0083091]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111969, P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143, T32AI060536, T32AI007606] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Complex Carbohydrate Research Center; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grants to J.C.P. (R01AI050143 and P01HL107151), C. D. R. (T32AI007606), K. L. (R01HL111969), C. T. L. (T32AI060536) and the Complex Carbohydrate Research Center (1 P41 RR018502-01) as well as by funding from the Biotechnology and Biological Sciences Research Council to A. D. and S. M. H. (BBF0083091).	Alley S.C.J, 2009, US Patent Application, Patent No. 200903178691; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BEYER TA, 1979, J BIOL CHEM, V254, P2531; Brown JR, 2006, CLIN CANCER RES, V12, P2894, DOI 10.1158/1078-0432.CCR-05-2745; Burkart MD, 1997, J AM CHEM SOC, V119, P11743, DOI 10.1021/ja9723904; Burkart MD, 2000, BIOORGAN MED CHEM, V8, P1937, DOI 10.1016/S0968-0896(00)00139-5; Campbell CT, 2007, MOL BIOSYST, V3, P187, DOI 10.1039/b614939c; Chesnutt BC, 2006, MICROCIRCULATION, V13, P99, DOI 10.1080/10739680500466376; Chiaramonte M, 2001, BIOCHEMISTRY-US, V40, P14260, DOI 10.1021/bi011262w; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Dimitroff CJ, 2003, J CLIN INVEST, V112, P1008, DOI 10.1172/JCI200319220; Foster MM, 2003, CANCER RES, V63, P2775; Frantom PA, 2010, J AM CHEM SOC, V132, P6626, DOI 10.1021/ja101231a; Gainers ME, 2007, J IMMUNOL, V179, P8509, DOI 10.4049/jimmunol.179.12.8509; Gitlin JM, 2009, AM J PATHOL, V174, P343, DOI 10.2353/ajpath.2009.080036; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; Gross BJ, 2008, J AM CHEM SOC, V130, P440, DOI 10.1021/ja078125s; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Hayashi T, 1997, BIOORGAN MED CHEM, V5, P497, DOI 10.1016/S0968-0896(96)00263-5; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Homeister JW, 2004, ARTERIOSCL THROM VAS, V24, P1897, DOI 10.1161/01.ATV.0000141844.28073.df; Hosoguchi K, 2010, J MED CHEM, V53, P5607, DOI 10.1021/jm100612r; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Luchansky SJ, 2004, CHEMBIOCHEM, V5, P371, DOI 10.1002/cbic.200300789; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marathe DD, 2008, FASEB J, V22, P4154, DOI 10.1096/fj.07-104257; MENDLA K, 1988, BIOCHEM J, V250, P261, DOI 10.1042/bj2500261; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Nishimura S.I., 2012, ANGEW CHEM INT EDN E; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Weston BW, 1999, EUR J HAEMATOL, V63, P42	50	263	274	0	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					661	668		10.1038/NCHEMBIO.999	http://dx.doi.org/10.1038/NCHEMBIO.999			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22683610	Green Accepted			2022-12-27	WOS:000305471400014
J	Georghiou, G; Kleiner, RE; Pulkoski-Gross, M; Liu, DR; Seeliger, MA				Georghiou, George; Kleiner, Ralph E.; Pulkoski-Gross, Michael; Liu, David R.; Seeliger, Markus A.			Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles	NATURE CHEMICAL BIOLOGY			English	Article							KINASE DOMAIN MUTATIONS; TYROSINE KINASE; CRYSTAL-STRUCTURE; ORGANIC-SYNTHESIS; PROTEIN-KINASES; IMATINIB; ABL; CONFORMATION; RESISTANCE; LIBRARY	Protein kinases are attractive therapeutic targets, but their high sequence and structural conservation complicates the development of specific inhibitors. We recently identified, in a DNA-templated macrocycle library, inhibitors with unusually high selectivity among Src-family kinases. Starting from these compounds, we developed and characterized in molecular detail potent macrocyclic inhibitors of Src kinase and its cancer-associated 'gatekeeper' mutant. We solved two cocrystal structures of macro-cycles bound to Src kinase. These structures reveal the molecular basis of the combined ATP- and substrate peptide-competitive inhibitory mechanism and the remarkable kinase specificity of the compounds. The most potent compounds inhibit Src activity in cultured mammalian cells. Our work establishes that macrocycles can inhibit protein kinases through a bisubstrate-competitive mechanism with high potency and exceptional specificity, reveals the precise molecular basis for their desirable properties and provides new insights into the development of Src-specific inhibitors with potential therapeutic relevance.	[Georghiou, George; Pulkoski-Gross, Michael; Seeliger, Markus A.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Kleiner, Ralph E.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kleiner, Ralph E.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Harvard University; Howard Hughes Medical Institute	Georghiou, G (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	drliu@fas.harvard.edu; markus@pharm.stonybrook.edu	Liu, David R./HCH-3132-2022; Seeliger, Markus A/D-6409-2013	Georghiou, George/0000-0001-5067-3199; Seeliger, Markus/0000-0003-0990-1756; Pulkoski-Gross, Michael/0000-0003-4644-1795	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; Howard Hughes Medical Institute; US National Institutes of Health (NIH)-National Institute of General Medical Sciences [GM065865, GM080097]; NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM080097, K99GM080097, T32GM007518, R01GM065865] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)-National Institute of General Medical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	3T3 (Src<SUP>-/-</SUP>) cells transfected with a plasmid encoding c-Src<SUP>Y529F</SUP> or null vector were a gift from J. Cooper (Fred Hutchinson Cancer Research Center). We thank the beamline staff at X29A at the National Synchrotron Light Source at Brookhaven National Laboratory, the use of which was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences contract DE-AC02-98CH10886. G.G. and M.A.S. thank L. Malone for her assistance. This research was supported by the Howard Hughes Medical Institute (D.R.L.) and US National Institutes of Health (NIH)-National Institute of General Medical Sciences grants GM065865 (D.R.L.) and GM080097 (M.A.S.). R.E.K. acknowledges NIH training grant support to the Harvard University Training Program in Molecular, Cellular and Chemical Biology. G.G. acknowledges NIH training grant support to the Graduate Program in Molecular and Cellular Pharmacology at Stony Brook University.	Abbott L, 2007, BIOORG MED CHEM LETT, V17, P1167, DOI 10.1016/j.bmcl.2006.12.035; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Barouch-Bentov R, 2009, MOL CELL, V33, P43, DOI 10.1016/j.molcel.2008.12.024; Bikker JA, 2009, J MED CHEM, V52, P1493, DOI 10.1021/jm8010542; Biron E, 2006, J PEPT SCI, V12, P213, DOI 10.1002/psc.711; Burchat AF, 2002, BIOORG MED CHEM LETT, V12, P1687, DOI 10.1016/S0960-894X(02)00196-8; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cools J, 2003, CANCER CELL, V3, P459, DOI 10.1016/S1535-6108(03)00108-9; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Doyon JB, 2003, J AM CHEM SOC, V125, P12372, DOI 10.1021/ja036065u; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gartner ZJ, 2004, SCIENCE, V305, P1601, DOI 10.1126/science.1102629; Gartner ZJ, 2001, J AM CHEM SOC, V123, P6961, DOI 10.1021/ja015873n; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kleiner RE, 2011, CHEM SOC REV, V40, P5707, DOI 10.1039/c1cs15076f; Kleiner RE, 2010, J AM CHEM SOC, V132, P11779, DOI 10.1021/ja104903x; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Krishnamurty R, 2010, ACS CHEM BIOL, V5, P121, DOI 10.1021/cb9002656; Laszlo GS, 2009, CURR BIOL, V19, P157, DOI 10.1016/j.cub.2008.12.007; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Levitzki A, 1999, PHARMACOL THERAPEUT, V82, P231, DOI 10.1016/S0163-7258(98)00066-7; Li XY, 2004, ANGEW CHEM INT EDIT, V43, P4848, DOI 10.1002/anie.200400656; Maly DJ, 2000, P NATL ACAD SCI USA, V97, P2419, DOI 10.1073/pnas.97.6.2419; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Tse BN, 2008, J AM CHEM SOC, V130, P15611, DOI 10.1021/ja805649f; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	46	55	59	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					366	374		10.1038/NCHEMBIO.792	http://dx.doi.org/10.1038/NCHEMBIO.792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22344177	Green Accepted, Green Submitted			2022-12-27	WOS:000301890100011
J	Grembecka, J; He, SH; Shi, AB; Purohit, T; Muntean, AG; Sorenson, RJ; Showalter, HD; Murai, MJ; Belcher, AM; Hartley, T; Hess, JL; Cierpicki, T				Grembecka, Jolanta; He, Shihan; Shi, Aibin; Purohit, Trupta; Muntean, Andrew G.; Sorenson, Roderick J.; Showalter, Hollis D.; Murai, Marcelo J.; Belcher, Amalia M.; Hartley, Thomas; Hess, Jay L.; Cierpicki, Tomasz			Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia	NATURE CHEMICAL BIOLOGY			English	Article							MIXED LINEAGE LEUKEMIA; HOX GENE-EXPRESSION; HISTONE METHYLTRANSFERASE COMPLEX; ACUTE MYELOID-LEUKEMIA; HEMATOPOIESIS; TRANSFORMATION; LEUKEMOGENESIS; TRANSLOCATIONS; MEIS1; IMMORTALIZATION	Translocations involving the mixed lineage leukemia (MLL) gene result in human acute leukemias with very poor prognosis. The leukemogenic activity of MLL fusion proteins is critically dependent on their direct interaction with menin, a product of the multiple endocrine neoplasia (MEND gene. Here we present what are to our knowledge the first small-molecule inhibitors of the menin-MLL fusion protein interaction that specifically bind menin with nanomolar affinities. These compounds effectively reverse MLL fusion protein-mediated leukemic transformation by downregulating the expression of target genes required for MLL fusion protein oncogenic activity. They also selectively block proliferation and induce both apoptosis and differentiation of leukemia cells harboring MLL translocations. Identification of these compounds provides a new tool for better understanding MLL-mediated leukemogenesis and represents a new approach for studying the role of menin as an oncogenic cofactor of MLL fusion proteins. Our findings also highlight a new therapeutic strategy for aggressive leukemias with MLL rearrangements.	[Grembecka, Jolanta; He, Shihan; Shi, Aibin; Purohit, Trupta; Muntean, Andrew G.; Murai, Marcelo J.; Hartley, Thomas; Hess, Jay L.; Cierpicki, Tomasz] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Sorenson, Roderick J.; Showalter, Hollis D.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Belcher, Amalia M.] Univ Virginia, Charlottesville, VA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Virginia	Grembecka, J (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	jolantag@umich.edu; tomaszc@umich.edu	he, shihan/N-8067-2014	he, shihan/0000-0001-5806-8583; Muntean, Andrew/0000-0003-3034-0682	Leukemia and Lymphoma Society [6070-09]; Leukemia and Lymphoma Society Specialized Center of Research; US National Institutes of Health [R01 (1R01 CA-160467-01)]; Cancer Center (University of Virginia); Children's Leukemia Research Association; American Cancer Society [RSG-11-082-01-DMC]; Department of Pathology (University of Michigan); University of Virginia; NATIONAL CANCER INSTITUTE [R01CA151425, R01CA160467, P50CA130810] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Leukemia and Lymphoma Society Specialized Center of Research(Leukemia and Lymphoma Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (University of Virginia); Children's Leukemia Research Association; American Cancer Society(American Cancer Society); Department of Pathology (University of Michigan)(University of Michigan System); University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Leukemia and Lymphoma Society (Translational Research Program grant 6070-09 to J.G. and Leukemia and Lymphoma Society Specialized Center of Research grant to J.L.H.), US National Institutes of Health R01 (1R01 CA-160467-01 to J.G.), Cancer Center (University of Virginia to J.G. and T.C.), Children's Leukemia Research Association (to J.G.), American Cancer Society (RSG-11-082-01-DMC to T.C.) and startup funds to J.G. and T.C. provided by the Department of Pathology (University of Michigan). The authors greatly appreciate support from J. Bushweller (University of Virginia) for providing the research environment for carrying out part of these studies. We are grateful to M. Larsen from the Center for Chemical Genomics, University of Michigan, for technical expertise during HTS. We would like to thank). Tan (University of Michigan) for discussion of experimental procedures and R. Craig from the Department of Pathology (University of Michigan) for technical support with flow cytometry experiments.	Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Cox MC, 2004, AM J CLIN PATHOL, V122, P298, DOI 10.1309/RX27R8GJQM330C22; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Ernst P, 2002, CURR OPIN HEMATOL, V9, P282, DOI 10.1097/00062752-200207000-00004; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Murai MJ, 2011, J BIOL CHEM, V286, P31742, DOI 10.1074/jbc.M111.258186; Popovic R, 2005, J CELL BIOCHEM, V95, P234, DOI 10.1002/jcb.20430; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Quentmeier H, 2004, LEUKEMIA LYMPHOMA, V45, P567, DOI 10.1080/10428190310001609942; Rice KL, 2007, J CLIN INVEST, V117, P865, DOI 10.1172/JCI31861; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; Slany RK, 2005, HEMATOL ONCOL, V23, P1, DOI 10.1002/hon.739; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; SORENSEN PHB, 1994, J CLIN INVEST, V93, P429, DOI 10.1172/JCI116978; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Thomas M, 2005, BLOOD, V106, P3559, DOI 10.1182/blood-2005-03-1283; Thompson A, 2003, BLOOD, V101, P1558, DOI 10.1182/blood.V101.4.1558; Wong P, 2007, GENE DEV, V21, P3017; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	43	274	292	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					277	284		10.1038/NCHEMBIO.773	http://dx.doi.org/10.1038/NCHEMBIO.773			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22286128	Green Accepted			2022-12-27	WOS:000300600000013
J	Quade, N; Huo, LJ; Rachid, S; Heinz, DW; Muller, R				Quade, Nick; Huo, Liujie; Rachid, Shwan; Heinz, Dirk W.; Mueller, Rolf			Unusual carbon fixation gives rise to diverse polyketide extender units	NATURE CHEMICAL BIOLOGY			English	Article							CROTONYL-COA CARBOXYLASE/REDUCTASE; ACYL CARRIER PROTEIN; BIOSYNTHESIS; SUBSTRATE; ORIGIN; ACP	Polyketides are structurally diverse and medically important natural products that have various biological activities. During biosynthesis, chain elongation uses activated dicarboxylic acid building blocks, and their availability therefore limits side chain variation in polyketides. Recently, the crotonyl-CoA carboxylase-reductase (CCR) class of enzymes was identified in primary metabolism and was found to be involved in extender-unit biosynthesis of polyketides. These enzymes are, in theory, capable of forming dicarboxylic acids that show any side chain from the respective unsaturated fatty acid precursor. To our knowledge, we here report the first crystal structure of a CCR, the hexylmalonyl-CoA synthase from Streptomyces sp. JS360, in complex with its substrate. Structural analysis and biochemical characterization of the enzyme, including active site mutations, are reported. Our analysis reveals how primary metabolic CCRs can evolve to produce various dicarboxylic acid building blocks, setting the stage to use CCRs for the production of unique extender units and, consequently, altered polyketides.	[Quade, Nick; Heinz, Dirk W.] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany; [Huo, Liujie; Rachid, Shwan; Mueller, Rolf] Univ Saarland, Helmholtz Inst Pharmaceut Res Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Dept Microbial Nat Prod, D-6600 Saarbrucken, Germany; [Rachid, Shwan] Univ Koya, Fac Sci & Hlth, Koya, Kurdistan, Iraq	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University	Quade, N (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany.	dirk.heinz@helmholtz-hzi.de; rom@helmholtz-hzi.de	Müller, Rolf/B-1559-2008; Huo, Liujie/L-6090-2019	Müller, Rolf/0000-0002-1042-5665; Huo, Liujie/0000-0002-1406-8466; Rachid, Shwan/0000-0003-0834-5153	Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung (BMBF)	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	D.W.H. acknowledges support from the Fonds der Chemischen Industrie. Research in R.M.'s laboratory was funded by the Deutsche Forschungsgemeinschaft and the Bundesministerium fur Bildung und Forschung (BMBF). We thank V. Wray for critically reviewing this manuscript. We also would like to thank T. Hoffmann for technical support, K. Harmrolfs for the NMR measurement and S. C. Wenzel for advice during the course of this project. In addition, we appreciate the work of A. Ullrich and K. Schultz from U. Kazmaier's work group for the syntheses of 2-octenoyl-CoA and 2-octenoyl-SNAC.	Buntin K, 2010, CHEM BIOL, V17, P342, DOI 10.1016/j.chembiol.2010.02.013; Chan YA, 2006, P NATL ACAD SCI USA, V103, P14349, DOI 10.1073/pnas.0603748103; Dorrestein PC, 2006, J AM CHEM SOC, V128, P10386, DOI 10.1021/ja0639362; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Esposito L, 2003, BIOCHEMISTRY-US, V42, P14397, DOI 10.1021/bi035271b; Eustaquio AS, 2009, P NATL ACAD SCI USA, V106, P12295, DOI 10.1073/pnas.0901237106; Goranovic D, 2010, J BIOL CHEM, V285, P14292, DOI 10.1074/jbc.M109.059600; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Kopp M, 2011, MOL BIOSYST, V7, P1549, DOI 10.1039/c0mb00240b; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Porte S, 2009, J BIOL CHEM, V284, P17194, DOI 10.1074/jbc.M109.001800; Qu XD, 2011, MOL BIOSYST, V7, P852, DOI 10.1039/c0mb00234h; Rachid S, 2011, CHEMBIOCHEM, V12, P922, DOI 10.1002/cbic.201100024; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Wenzel SC, 2006, J AM CHEM SOC, V128, P14325, DOI 10.1021/ja064408t; Wilson MC, 2011, J AM CHEM SOC, V133, P1971, DOI 10.1021/ja109226s; Xu LH, 2010, J BIOL CHEM, V285, P16844, DOI 10.1074/jbc.M109.092460; Xu ZL, 2011, ANGEW CHEM INT EDIT, V50, P4667, DOI 10.1002/anie.201008265; Yoo HG, 2011, BIOSCI BIOTECH BIOCH, V75, P1191, DOI 10.1271/bbb.110003	26	52	52	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					117	124		10.1038/nchembio.734	http://dx.doi.org/10.1038/nchembio.734			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22138621				2022-12-27	WOS:000298414100020
J	Urizar, E; Yano, H; Kolster, R; Gales, C; Lambert, N; Javitch, JA				Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Gales, Celine; Lambert, Nevin; Javitch, Jonathan A.			CODA-RET reveals functional selectivity as a result of GPCR heteromerization	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; DOPAMINE-RECEPTOR AGONISTS; MEDIATED CALCIUM SIGNAL; D2 RECEPTOR; LIVING CELLS; CROSS-TALK; ACTIVATION; COMPLEMENTATION; DIMERS; OLIGOMERIZATION	Here we present a new method that combines protein complementation with resonance energy transfer to study conformational changes in response to activation of a defined G protein-coupled receptor heteromer, and we apply the approach to the putative dopamine D1-D2 receptor heteromer. Remarkably, the potency of the D2 dopamine receptor (D2R) agonist R-(-)-10,11-dihydroxy-N-n-propylnoraporphine (NPA) to change the G alpha(i) conformation via the D2R protomer in the D1-D2 heteromer was enhanced ten-fold relative to its potency in the D2R homomer. In contrast, the potencies of the D2R agonists dopamine and quinpirole were the same in the homomer and heteromer. Thus, we have uncovered a molecular mechanism for functional selectivity in which a drug acts differently at a G protein-coupled receptor (GPCR) protomer depending on the identity of the second protomer participating in the formation of the signaling unit-opening the door to enhancing pharmacological specificity by targeting differences between homomeric and heteromeric signaling.	[Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY USA; [Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA; [Urizar, Eneko; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Gales, Celine] Fac Med Toulouse, INSERM, F-31073 Toulouse, France; [Gales, Celine] Univ Toulouse 3, F-31062 Toulouse, France; [Lambert, Nevin] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University System of Georgia; Augusta University	Urizar, E (corresponding author), Inst Rech Interdisciplinaire Biol Humaine & Mol, Brussels, Belgium.	jaj2@columbia.edu	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Yano, Hideaki/0000-0001-9242-3884; Javitch, Jonathan/0000-0001-7395-2967; GALES, Celine/0000-0002-4938-1583	US National Institutes of Health (NIH) [DA022413, MH054137, GM078319]; NIH [TL1 RR024158-04]; Lieber Center for Schizophrenia Research and Treatment; E.U.; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319, R01GM096762, T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lieber Center for Schizophrenia Research and Treatment; E.U.(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by US National Institutes of Health (NIH) grants DA022413 and MH054137 (J.A.J.), GM078319 (N.L.) and NIH TL1 RR024158-04 (H.Y.) as well as by the Lieber Center for Schizophrenia Research and Treatment and EMBO Long-Term and Basque Country fellowships (E.U.).	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Bosier B, 2007, TRENDS PHARMACOL SCI, V28, P438, DOI 10.1016/j.tips.2007.06.001; BYGRAVE FL, 1995, FASEB J, V9, P1297, DOI 10.1096/fasebj.9.13.7557019; Costagliola S, 1998, FEBS LETT, V436, P427, DOI 10.1016/S0014-5793(98)01177-6; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Guo NN, 2010, NEUROPSYCHOPHARMACOL, V35, P806, DOI 10.1038/npp.2009.189; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kilts JD, 2002, J PHARMACOL EXP THER, V301, P1179, DOI 10.1124/jpet.301.3.1179; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; MANSOUR A, 1992, EUR J PHARM-MOLEC PH, V227, P205, DOI 10.1016/0922-4106(92)90129-J; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; MELLER E, 1992, J PHARMACOL EXP THER, V263, P462; Mervine SM, 2006, MOL PHARMACOL, V70, P194, DOI 10.1124/mol.106.022616; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Mottola DM, 2002, J PHARMACOL EXP THER, V301, P1166, DOI 10.1124/jpet.301.3.1166; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; O'Dowd BF, 2005, J BIOL CHEM, V280, P37225, DOI 10.1074/jbc.M504562200; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; So CH, 2005, MOL PHARMACOL, V68, P568, DOI 10.1124/mol.105.012229; So CH, 2007, MOL PHARMACOL, V72, P450, DOI 10.1124/mol.107.034884; Sponger D, 1993, NATURE, V365, P170; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urban JD, 2007, NEUROPSYCHOPHARMACOL, V32, P67, DOI 10.1038/sj.npp.1301071; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Zhang J, 2009, MED RES REV, V29, P272, DOI 10.1002/med.20130	48	88	88	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					624	630		10.1038/NCHEMBIO.623	http://dx.doi.org/10.1038/NCHEMBIO.623			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21785426	Green Accepted			2022-12-27	WOS:000294381400013
J	Wagner, BK				Wagner, Bridget K.			SCREENING Low-fat worms on drugs	NATURE CHEMICAL BIOLOGY			English	News Item							C-ELEGANS; CAENORHABDITIS-ELEGANS; IDENTIFICATION; ZEBRAFISH; STORAGE; MODEL		Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Wagner, BK (corresponding author), Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA USA.	bwagner@broadinstitute.org						Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lemieux GA, 2011, NAT CHEM BIOL, V7, P206, DOI [10.1038/nchembio.534, 10.1038/NCHEMBIO.534]; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Petrascheck M, 2009, ANN NY ACAD SCI, V1170, P698, DOI 10.1111/j.1749-6632.2009.04377.x; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012	10	0	0	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					194	195		10.1038/nchembio.540	http://dx.doi.org/10.1038/nchembio.540			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21423161				2022-12-27	WOS:000288545000003
J	Palsson, B; Zengler, K				Palsson, Bernhard; Zengler, Karsten			The challenges of integrating multi-omic data sets	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; GENOME; RECONSTRUCTION; TRANSCRIPTOME; BIOLOGY; MODELS	The capability to generate multi-omic data sets raises the issue of resource allocation for data generation versus data curation and integration. The initial experience of researchers shows that the effort required for the latter can be much greater than that for the former.	[Palsson, Bernhard; Zengler, Karsten] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Palsson, B (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	palsson@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785; Zengler, Karsten/0000-0002-8062-3296				Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; MAAS WK, 1964, J MOL BIOL, V8, P365, DOI 10.1016/S0022-2836(64)80200-X; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Palsson B, 2002, NAT BIOTECHNOL, V20, P649, DOI 10.1038/nbt0702-649; Palsson B, 2009, FEBS LETT, V583, P3900, DOI 10.1016/j.febslet.2009.09.031; Palsson BO, 1997, NAT BIOTECHNOL, V15, P3, DOI 10.1038/nbt0197-3; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Qiu Y, 2010, GENOME RES, V20, P1304, DOI 10.1101/gr.107540.110; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Thiele I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.15; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203	16	113	114	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					787	789		10.1038/nchembio.462	http://dx.doi.org/10.1038/nchembio.462			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20976870				2022-12-27	WOS:000283197800003
J	Zhou, SM; Narukami, T; Masuo, S; Shimizu, M; Fujita, T; Doi, Y; Kamimura, Y; Takaya, N				Zhou, Shengmin; Narukami, Toshiaki; Masuo, Shunsuke; Shimizu, Motoyuki; Fujita, Tomoya; Doi, Yuki; Kamimura, Yosuke; Takaya, Naoki			NO-inducible nitrosothionein mediates NO removal in tandem with thioredoxin	NATURE CHEMICAL BIOLOGY			English	Article							OXIDATIVE STRESS-RESPONSE; NITRIC-OXIDE; ASPERGILLUS-NIDULANS; NITROSATIVE STRESS; S-NITROSOGLUTATHIONE; INTRACELLULAR GLUTATHIONE; METALLOTHIONEIN PROTECTS; DENITROSYLATION; IDENTIFICATION; NITROSYLATION	Nitric oxide (NO) is a toxic reactive nitrogen species that induces microbial adaption mechanisms. Screening a genomic DNA library identified a new gene, ntpA, that conferred growth tolerance upon Aspergillus nidulans against exogenous NO The gene encoded a cysteine-rich 23-amino-acid peptide that reacted with NO and S-nitrosoglutathione to generate an S-nitrosated peptide. Disrupting ntpA increased amounts of cellular S-nitrosothiol and NO susceptibility. Thioredoxin and its reductase denitrosated the S-nitrosated peptide, decreased cellular S-nitrosothiol and conferred tolerance against NO, indicating peptide-mediated catalytic NO removal. The peptide binds copper(1) in vitro but is dispensable for metal tolerance in vivo. NO but not metal ions induced production of the peptide and ntpA transcripts. We discovered that the thionein family of peptides has NO-related functions and propose that the new peptide be named NO-inducible nitrosothionein (iNT). The ubiquitous distribution of iNT-like polypeptides constitutes a potent NO-detoxifying mechanism that is conserved among various organisms.	[Zhou, Shengmin; Narukami, Toshiaki; Masuo, Shunsuke; Shimizu, Motoyuki; Fujita, Tomoya; Doi, Yuki; Kamimura, Yosuke; Takaya, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	takaya.naoki.ge@u.tsukuba.ac.jp		Masuo, Shunsuke/0000-0002-0454-3315	Japan Society for the Promotion of Science [23-01090, 21380055]; Grants-in-Aid for Scientific Research [25850057] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Shoun and S. Fushinobu for help with fluorometry and S. Osmani for his valuable suggestions in fungal transformation. We thank N. Foster for helpful discussion and critical reading of the manuscript. This study was supported by Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (23-01090 to S.Z. and 21380055 to N.T.).	Asano Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1800, DOI 10.1271/bbb.70133; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; CAI L, 1995, CHEM-BIOL INTERACT, V96, P143, DOI 10.1016/0009-2797(94)03585-V; Capdevila M, 2011, J BIOL INORG CHEM, V16, P977, DOI 10.1007/s00775-011-0798-3; CLANCY RM, 1994, P NATL ACAD SCI USA, V91, P3680, DOI 10.1073/pnas.91.9.3680; Datra PK, 2006, TRANSL RES, V148, P180, DOI 10.1016/j.trsl.2006.04.002; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; de Oliveira MG, 2002, J PHYS CHEM A, V106, P8963, DOI 10.1021/jp025756u; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Forrester MT, 2012, FREE RADICAL BIO MED, V52, P1620, DOI 10.1016/j.freeradbiomed.2012.01.028; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; GORETSKI J, 1990, J BIOL CHEM, V265, P11535; Gow A, 2007, J CHROMATOGR B, V851, P140, DOI 10.1016/j.jchromb.2007.01.052; Hausladen A, 1999, METHOD ENZYMOL, V300, P389; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kroncke KD, 2003, BIOL CHEM, V384, P1365, DOI 10.1515/BC.2003.153; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Liu SX, 2000, CHEM RES TOXICOL, V13, P922, DOI 10.1021/tx0000623; Lushchak OV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P629, DOI 10.1134/S0006297910050135; MUNGER K, 1985, EMBO J, V4, P2665, DOI 10.1002/j.1460-2075.1985.tb03985.x; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Nittler MP, 2005, MOL BIOL CELL, V16, P4792, DOI 10.1091/mbc.E05-05-0434; Romero JM, 2009, J NEUROSCI RES, V87, P701, DOI 10.1002/jnr.21897; Sarver A, 2005, MOL BIOL CELL, V16, P4781, DOI 10.1091/mbc.E05-05-0436; Schinko T, 2010, MOL MICROBIOL, V78, P720, DOI 10.1111/j.1365-2958.2010.07363.x; SCHWARZ MA, 1995, P NATL ACAD SCI USA, V92, P4452, DOI 10.1073/pnas.92.10.4452; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Shimizu M, 2009, PROTEOMICS, V9, P7, DOI 10.1002/pmic.200701163; SHOUN H, 1991, J BIOL CHEM, V266, P11078; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; Thon M, 2010, NUCLEIC ACIDS RES, V38, P1098, DOI 10.1093/nar/gkp1091; Tucker SL, 2004, PLANT CELL, V16, P1575, DOI 10.1105/tpc.021279; Vasak M, 2011, J BIOL INORG CHEM, V16, P1067, DOI 10.1007/s00775-011-0799-2; Wei W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000328; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; Zhou SM, 2011, FUNGAL GENET BIOL, V48, P200, DOI 10.1016/j.fgb.2010.08.011; Zhou SM, 2012, APPL ENVIRON MICROB, V78, P103, DOI 10.1128/AEM.06195-11	48	26	26	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2013	9	10					657	663		10.1038/NCHEMBIO.1316	http://dx.doi.org/10.1038/NCHEMBIO.1316			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226MZ	23955366				2022-12-27	WOS:000325041800014
J	Shan, J; Schwartz, RE; Ross, NT; Logan, DJ; Thomas, D; Duncan, SA; North, TE; Goessling, W; Carpenter, AE; Bhatia, SN				Shan, Jing; Schwartz, Robert E.; Ross, Nathan T.; Logan, David J.; Thomas, David; Duncan, Stephen A.; North, Trista E.; Goessling, Wolfram; Carpenter, Anne E.; Bhatia, Sangeeta N.			Identification of small molecules for human hepatocyte expansion and iPS differentiation	NATURE CHEMICAL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; ADULT-RAT HEPATOCYTES; IMAGE-BASED SCREENS; C VIRUS-INFECTION; LIVER-REGENERATION; BIOARTIFICIAL LIVER; PRIMARY CULTURES; IN-VIVO; MICE; GROWTH	Cell-based therapies hold the potential to alleviate the growing burden of liver diseases. Such therapies require human hepatocytes, which, within the stromal context of the liver, are capable of many rounds of replication. However, this ability is lost ex vivo, and human hepatocyte sourcing has limited many fields of research for decades. Here we developed a high-throughput screening platform for primary human hepatocytes to identify small molecules in two different classes that can be used to generate renewable sources of functional human hepatocytes. The first class induced functional proliferation of primary human hepatocytes in vitro. The second class enhanced hepatocyte functions and promoted the differentiation of induced pluripotent stem cell-derived hepatocytes toward a more mature phenotype than what was previously obtainable. The identification of these small molecules can help address a major challenge affecting many facets of liver research and may lead to the development of new therapeutics for liver diseases.	[Shan, Jing; Schwartz, Robert E.; Bhatia, Sangeeta N.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Schwartz, Robert E.; Bhatia, Sangeeta N.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Ross, Nathan T.; Logan, David J.; Carpenter, Anne E.; Bhatia, Sangeeta N.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Thomas, David] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA USA; [Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [North, Trista E.; Goessling, Wolfram] Harvard Univ, Sch Med, Boston, MA USA; [North, Trista E.; Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA USA; [North, Trista E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Goessling, Wolfram] Brigham & Womens Hosp, Genet Div, Boston, MA 02115 USA; [Bhatia, Sangeeta N.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] Howard Hughes Med Inst, Chevy Chase, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical College of Wisconsin; Harvard University; Harvard Medical School; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Bhatia, SN (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	sbhatia@mit.edu	Schwartz, Robert/AAE-7153-2021; Carpenter, Anne/C-4982-2008; North, Trista/ABG-4789-2020	Carpenter, Anne/0000-0003-1555-8261; North, Trista/0000-0003-1249-563X; Shan, Jing/0000-0003-0590-9937; Duncan, Stephen/0000-0002-2507-7827; Goessling, Wolfram/0000-0001-9972-1569	Broad Institute Scientific Planning and Allocation of Resources Committee; US National Institutes of Health (NIH) [NIH R01-DK065152, NIH R01-DK56966, NIH R01 GM089652]; National Science Foundation [DBI 1148823]; National Institute of Diabetes and Digestive and Kidney Diseases [DK085445, DK55743, DK087377, HL094857, HG006398]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094857] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098241, R01DK056966, R01DK055743, R01DK090311, RC1DK087377, R01DK065152, R01DK085713, R03DK085445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1148823] Funding Source: National Science Foundation	Broad Institute Scientific Planning and Allocation of Resources Committee; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by a Broad Institute Scientific Planning and Allocation of Resources Committee grant (S.N.B.), US National Institutes of Health (NIH) grants NIH R01-DK065152 (S.N.B.), NIH R01-DK56966 (S.N.B.) and NIH R01 GM089652 (A. E. C.), National Science Foundation CAREER award DBI 1148823 (A. E. C.) and National Institute of Diabetes and Digestive and Kidney Diseases grants DK085445 (W. G.), DK55743 (S. A. D.), DK087377 (S. A. D.), HL094857 (S. A. D.) and HG006398 (S. A. D.). S.N.B. is a Howard Hughes Medical Institute investigator. We thank H. Fleming for help with manuscript preparation, T. Golub and R. Gould for discussions and H. Green (Harvard University) for providing J2-3T3 fibroblasts. The authors dedicate this paper to the memory of Officer Sean Collier, for his caring service to the MIT community and his sacrifice.	Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Chen AA, 2011, P NATL ACAD SCI USA, V108, P11842, DOI 10.1073/pnas.1101791108; Chen SB, 2006, MOL BIOSYST, V2, P18, DOI 10.1039/b512000b; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Higgins GM, 1931, ARCH PATHOL, V12, P186; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Jozefczuk J, 2011, STEM CELLS DEV, V20, P1259, DOI 10.1089/scd.2010.0361; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Khetani S, 2007, HEPATOLOGY, V46, p773A; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lin HM, 1998, JAMA-J AM MED ASSOC, V280, P1153, DOI 10.1001/jama.280.13.1153; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; MICHALOPOULOS G, 1982, CANCER RES, V42, P4673; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MITAKA T, 1991, HEPATOLOGY, V13, P21, DOI 10.1016/0270-9139(91)90211-D; Mitaka T, 1998, INT J EXP PATHOL, V79, P393, DOI 10.1046/j.1365-2613.1998.00083.x; Mizuguchi T, 2001, J CELL PHYSIOL, V189, P106, DOI 10.1002/jcp.1136; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; NYBERG SL, 1994, ANN SURG, V220, P59; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Payne CM, 2011, LIVER INT, V31, P254, DOI 10.1111/j.1478-3231.2010.02414.x; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; RICHMAN RA, 1976, P NATL ACAD SCI USA, V73, P3589, DOI 10.1073/pnas.73.10.3589; Runge D, 2000, BIOCHEM BIOPH RES CO, V274, P1, DOI 10.1006/bbrc.2000.2912; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SHIMAOKA S, 1987, EXP CELL RES, V172, P228, DOI 10.1016/0014-4827(87)90109-1; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; STOCKER E, 1973, VIRCHOWS ARCH B, V14, P93; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Touboul T, 2010, M S-MED SCI, V26, P1061, DOI 10.1051/medsci/201026121061; Uyama N, 2002, J HEPATOL, V36, P590, DOI 10.1016/S0168-8278(02)00023-5; Wang WD, 2009, P NATL ACAD SCI USA, V106, P1427, DOI 10.1073/pnas.0811848106; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; 2010, P NATL ACAD SCI US, V107, P17315	48	188	201	3	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2013	9	8					514	U77		10.1038/nchembio.1270	http://dx.doi.org/10.1038/nchembio.1270			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185FV	23728495	Green Submitted, Green Accepted			2022-12-27	WOS:000321952700011
J	Turner, NJ; O'Reilly, E				Turner, Nicholas J.; O'Reilly, Elaine			Biocatalytic retrosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							ASYMMETRIC-SYNTHESIS; INTERMEDIATE; REDUCTION	The recent development of a broad range of biocatalysts that can be applied in organic synthesis has brought into focus the need to rethink the way in which organic target molecules might be constructed in the future. To aid synthetic chemists in identifying where biocatalysts might be usefully applied, we propose that guidelines and rules for 'biocatalytic retrosynthesis' be developed and that this new approach be embedded in the future training and education of organic chemists.	[Turner, Nicholas J.; O'Reilly, Elaine] Univ Manchester, Sch Chem, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Manchester	Turner, NJ (corresponding author), Univ Manchester, Sch Chem, Manchester Inst Biotechnol, Manchester, Lancs, England.	nicholas.turner@manchester.ac.uk	O'Reilly, Elaine/K-6216-2019	O'Reilly, Elaine/0000-0002-7906-9216; Turner, Nicholas/0000-0002-8708-0781				Andexer J, 2007, ANGEW CHEM INT EDIT, V46, P8679, DOI 10.1002/anie.200701455; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Carey JS, 2006, ORG BIOMOL CHEM, V4, P2337, DOI 10.1039/b602413k; COREY EJ, 1991, ANGEW CHEM INT EDIT, V30, P455, DOI 10.1002/anie.199104553; Crawley M.L., 2012, APPL TRANSITION META; de Lange B, 2011, CHEMCATCHEM, V3, P289, DOI 10.1002/cctc.201000435; Fesko K, 2013, CHEMCATCHEM, V5, P1248, DOI 10.1002/cctc.201200709; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kohler V, 2013, NAT CHEM, V5, P93, DOI [10.1038/NCHEM.1498, 10.1038/nchem.1498]; Kohler V, 2010, ANGEW CHEM INT EDIT, V49, P2182, DOI 10.1002/anie.200906655; Li T, 2012, J AM CHEM SOC, V134, P6467, DOI 10.1021/ja3010495; Liang J, 2010, ORG PROCESS RES DEV, V14, P193, DOI 10.1021/op900272d; Ma SK, 2010, GREEN CHEM, V12, P81, DOI 10.1039/b919115c; Meyer HP, 2009, MINI-REV ORG CHEM, V6, P300, DOI 10.2174/157019309789371550; Moore JC, 2007, ACCOUNTS CHEM RES, V40, P1412, DOI 10.1021/ar700167a; Muller M, 2005, ANGEW CHEM INT EDIT, V44, P362, DOI 10.1002/anie.200460852; Nicolaou KC, 1998, J CHEM EDUC, V75, P1225, DOI 10.1021/ed075p1225; Patel RN, 2011, ACS CATAL, V1, P1056, DOI 10.1021/cs200219b; Rozzell D., 2008, SPECIALTY CHEM MAGAZ, V28, P36; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wang ZJ, 2013, NAT CHEM, V5, P100, DOI [10.1038/NCHEM.1531, 10.1038/nchem.1531]; Warren S. G., 2008, ORGANIC SYNTHESIS DI, V2nd; Znabet A, 2010, CHEM COMMUN, V46, P7918, DOI 10.1039/c0cc02823a	24	225	227	9	171	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2013	9	5					285	288		10.1038/nchembio.1235	http://dx.doi.org/10.1038/nchembio.1235			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	127VT	23594772				2022-12-27	WOS:000317727600001
J	Gawrisch, K				Gawrisch, Klaus			Tafazzin senses curvature	NATURE CHEMICAL BIOLOGY			English	News Item							BARTH SYNDROME; CARDIOLIPIN		NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Gawrisch, K (corresponding author), NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA.	gawrisch@helix.nih.gov			Intramural NIH HHS [Z01 AA000003-15] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000003, ZIAAA000003] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Acehan D, 2009, MITOCHONDRION, V9, P86, DOI 10.1016/j.mito.2008.12.001; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; Neuwald AF, 1997, CURR BIOL, V7, pR465; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200	10	13	19	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					811	812		10.1038/nchembio.1068	http://dx.doi.org/10.1038/nchembio.1068			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22987008	Green Accepted			2022-12-27	WOS:000309056200003
J	Sample, V; DiPilato, LM; Yang, JH; Ni, Q; Saucerman, JJ; Zhang, J				Sample, Vedangi; DiPilato, Lisa M.; Yang, Jason H.; Ni, Qiang; Saucerman, Jeffrey J.; Zhang, Jin			Regulation of nuclear PKA revealed by spatiotemporal manipulation of cyclic AMP	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE-A; SOLUBLE ADENYLYL-CYCLASE; CATALYTIC SUBUNIT; GENE-EXPRESSION; CELLULAR CAMP; ACTIVATION; DYNAMICS; CELLS; STIMULATION; COMPLEXES	Understanding how specific cyclic AMP (cAMP) signals are organized and relayed to their effectors in different compartments of the cell to achieve functional specificity requires molecular tools that allow precise manipulation of cAMP in these compartments. Here we characterize a new method using bicarbonate-activatable and genetically targetable soluble adenylyl cyclase to control the location, kinetics and magnitude of the cAMP signal. Using this live-cell cAMP manipulation in conjunction with fluorescence imaging and mechanistic modeling, we uncovered the activation of a resident pool of protein kinase A (PKA) holoenzyme in the nuclei of HEK-293 cells, modifying the existing dogma of cAMP-PKA signaling in the nucleus. Furthermore, we show that phosphodiesterases and A-kinase anchoring proteins (AKAPs) are critical in shaping nuclear PKA responses. Collectively, our data suggest a new model in which AKAP-localized phosphodiesterases tune an activation threshold for nuclear PKA holoenzyme, thereby converting spatially distinct second messenger signals to temporally controlled nuclear kinase activity.	[Sample, Vedangi; DiPilato, Lisa M.; Ni, Qiang; Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Yang, Jason H.; Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Virginia; Johns Hopkins University; Johns Hopkins University	Sample, V (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	jsaucerman@virginia.edu; jzhang32@jhmi.edu	Yang, Jason H./AAB-2608-2019	Yang, Jason H./0000-0003-0921-4657; Saucerman, Jeffrey/0000-0001-9464-8374	US National Institutes of Health (NIH) [R01 DK073368, DP1 OD006419, F31 DK074381, R01 HL094476]; American Heart Association [0830470N]; NIH [GM08715]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK074381, R01DK073368, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008715] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006419] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Levin (Weill Cornell Medical College, Cornell University) for the gift of sAC<INF>t</INF> cDNA. We thank M. Houslay (Institute of Biomedical and Life Sciences, University of Glasgow) and K. Xiang (University of Illinois, Urbana-Champaign) for the gift of dnPDE4 isoforms. We thank L. Hersh (University of Kentucky College of Medicine) for giving us the A126.1B2 and A126.1B2 Cat beta cell line. We also thank S. Mehta, G. Mo, T. Ueno, C. Pohlmeyer and T. Inoue for their technical help. This work was funded by US National Institutes of Health (NIH) grants R01 DK073368, DP1 OD006419 (to J.Z.), F31 DK074381 (to L.M.D.) and R01 HL094476, American Heart Association grant 0830470N (to J.J.S.) and NIH grant GM08715 (to J.H.Y.).	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Burnham KP, 2002, MODEL SELECTION MULT, P66; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Greenberg M.E., 2007, CURR PROTOC MOL BIOL, V4, P410; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Jarnaess E, 2009, J BIOL CHEM, V284, P35154, DOI 10.1074/jbc.M109.056465; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Meoli E, 2008, CANCER RES, V68, P3133, DOI 10.1158/0008-5472.CAN-08-0064; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Ni QA, 2011, NAT CHEM BIOL, V7, P34, DOI 10.1038/NCHEMBIO.478; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119	42	95	95	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					375	382		10.1038/NCHEMBIO.799	http://dx.doi.org/10.1038/NCHEMBIO.799			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22366721	Green Accepted			2022-12-27	WOS:000301890100012
J	Netz, DJA; Stith, CM; Stumpfig, M; Kopf, G; Vogel, D; Genau, HM; Stodola, JL; Lill, R; Burgers, PMJ; Pierik, AJ				Netz, Daili J. A.; Stith, Carrie M.; Stuempfig, Martin; Koepf, Gabriele; Vogel, Daniel; Genau, Heide M.; Stodola, Joseph L.; Lill, Roland; Burgers, Peter M. J.; Pierik, Antonio J.			Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes	NATURE CHEMICAL BIOLOGY			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION FACTOR-C; SACCHAROMYCES-CEREVISIAE; RIBONUCLEOTIDE REDUCTASE; TRANSLESION SYNTHESIS; PROTEIN BIOGENESIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; ZINC-FINGER	The eukaryotic replicative DNA polymerases (Pol alpha, delta and epsilon) and the major DNA mutagenesis enzyme Pol zeta contain two conserved cysteine-rich metal-binding motifs (CysA and CysB) in the C-terminal domain (CTD) of their catalytic subunits. Here we demonstrate by in vivo and in vitro approaches the presence of an essential [4Fe-4S] cluster in the CysB motif of all four yeast B-family DNA polymerases. Loss of the [4Fe-4S] cofactor by cysteine ligand mutagenesis in Pol3 destabilized the CTD and abrogated interaction with the Pol31 and Pol32 subunits. Reciprocally, overexpression of accessory subunits increased the amount of the CTD-bound Fe-S cluster. This implies an important physiological role of the Fe-S cluster in polymerase complex stabilization. Further, we demonstrate that the Zn-binding CysA motif is required for PCNA-mediated Pol d processivity. Together, our findings show that the function of eukaryotic replicative DNA polymerases crucially depends on different metallocenters for accessory subunit recruitment and replisome stability.	[Netz, Daili J. A.; Stuempfig, Martin; Koepf, Gabriele; Vogel, Daniel; Genau, Heide M.; Lill, Roland; Pierik, Antonio J.] Univ Marburg, Inst Zytobiol & Zytopathol, Marburg, Germany; [Stith, Carrie M.; Stodola, Joseph L.; Burgers, Peter M. J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Philipps University Marburg; Washington University (WUSTL)	Netz, DJA (corresponding author), Univ Marburg, Inst Zytobiol & Zytopathol, Marburg, Germany.	lill@staff.uni-marburg.de; burgers@biochem.wustl.edu; pierik@staff.uni-marburg.de	Burgers, Peter M/AAW-6621-2021; Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518; Duevel, Heide Marika/0000-0002-7687-8683	US National Institutes of Health [GM032431]; Deutsche Forschungsgemeinschaft [SFB 593, GRK 1216]; Rhon Klinikum, von Behring-Rontgen Stiftung; LOEWE-Program of State Hessen; Max-Planck Gesellschaft; Fonds der Chemischen Industrie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rhon Klinikum, von Behring-Rontgen Stiftung; LOEWE-Program of State Hessen; Max-Planck Gesellschaft(Max Planck Society); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Yoder for yeast two-hybrid analysis and M. Reuter for help with cloning. This work was supported by grant GM032431 from the US National Institutes of Health (P.M.J.B.), the Deutsche Forschungsgemeinschaft (SFB 593, Gottfried-Wilhelm Leibniz program, and GRK 1216), Rhon Klinikum, von Behring-Rontgen Stiftung, LOEWE-Program of State Hessen, Max-Planck Gesellschaft and Fonds der Chemischen Industrie.	Abbouni B, 2009, FREE RADICAL RES, V43, P943, DOI 10.1080/10715760903140568; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Chanet R, 2003, CURR GENET, V43, P337, DOI 10.1007/s00294-003-0407-2; Dauter Z, 1996, P NATL ACAD SCI USA, V93, P8836, DOI 10.1073/pnas.93.17.8836; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Evanics F, 2003, BBA-PROTEINS PROTEOM, V1651, P163, DOI 10.1016/S1570-9639(03)00266-8; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; KENT TA, 1982, P NATL ACAD SCI-BIOL, V79, P1096, DOI 10.1073/pnas.79.4.1096; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; NAR H, 1992, EUR J BIOCHEM, V205, P1123, DOI 10.1111/j.1432-1033.1992.tb16881.x; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; ORMEJOHNSON WH, 1982, IRON SULFUR PROTEINS, P67; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Tahirov TH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-11; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; Urzica E, 2009, BIOCHEMISTRY-US, V48, P4946, DOI 10.1021/bi900312x; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; WONG SW, 1989, J BIOL CHEM, V264, P5924; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	49	277	287	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					125	132		10.1038/nchembio.721	http://dx.doi.org/10.1038/nchembio.721			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22119860	Green Accepted			2022-12-27	WOS:000298414100021
J	Phelan, VV; Liu, WT; Pogliano, K; Dorrestein, PC				Phelan, Vanessa V.; Liu, Wei-Ting; Pogliano, Kit; Dorrestein, Pieter C.			Microbial metabolic exchange-the chemotype-to-phenotype link	NATURE CHEMICAL BIOLOGY			English	Article							IMAGING MASS-SPECTROMETRY; COMPLETE GENOME SEQUENCE; PROTEIN SECRETION; STREPTOMYCES-COELICOLOR; INDUSTRIAL APPLICATIONS; BACTERIAL INTERACTIONS; BACILLUS-SUBTILIS; MEMBRANE; SIGNALS; NETWORK	The function of microbial interactions is to enable microorganisms to survive by establishing a homeostasis between microbial neighbors and local environments. A microorganism can respond to environmental stimuli using metabolic exchange-the transfer of molecular factors, including small molecules and proteins. Microbial interactions not only influence the survival of the microbes but also have roles in morphological and developmental processes of the organisms themselves and their neighbors. This, in turn, shapes the entire habitat of these organisms. Here we highlight our current understanding of metabolic exchange as well as the emergence of new technologies that are allowing us to eavesdrop on microbial conversations comprising dozens to hundreds of secreted metabolites that control the behavior, survival and differentiation of members of the community. The goal of the rapidly advancing field studying multifactorial metabolic exchange is to devise a microbial 'Rosetta stone' in order to understand the language by which microbial interactions are negotiated and, ultimately, to control the outcome of these conversations.	[Phelan, Vanessa V.; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Liu, Wei-Ting; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Pogliano, Kit] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Phelan, VV (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA.		Dorrestein, Pieter/ABF-2930-2020; Dorrestein, Pieter/D-5012-2012	Pogliano, Kit/0000-0002-7868-3345; Phelan, Vanessa/0000-0001-7156-9294	US National Institutes of Health [GM094802, GM086283, AI095125, GM057045]; Beckman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045, R01GM094802, R01GM086283] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge J. Yang, W. Moree and C. Rath (University of California, San Diego) for providing critical reviews of the manuscript and E. Shank (Harvard Medical School) for insightful discussions. The P.C.D. laboratory is supported by US National Institutes of Health grants GM094802, GM086283 and AI095125 and by the Beckman Foundation. The K. P. laboratory is supported by US National Institutes of Health grants GM057045 and AI095125.	Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Angelini TE, 2009, P NATL ACAD SCI USA, V106, P18109, DOI 10.1073/pnas.0905890106; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Bores-Walmsley MI, 2000, TRENDS MICROBIOL, V8, P133, DOI 10.1016/S0966-842X(00)01698-X; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; COLEMAN DC, 1989, J GEN MICROBIOL, V135, P1679; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Davies J, 2009, CLIN MICROBIOL INFEC, V15, P1, DOI 10.1111/j.1469-0691.2008.02682.x; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; De Sordi L, 2009, FEMS YEAST RES, V9, P990, DOI 10.1111/j.1567-1364.2009.00573.x; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Fujinami S, 2010, ENVIRON TECHNOL, V31, P845, DOI 10.1080/09593331003762807; Fusetani N, 2011, NAT PROD REP, V28, P400, DOI 10.1039/c0np00034e; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Gonzalez DJ, 2011, MICROBIOL-SGM, V157, P2485, DOI 10.1099/mic.0.048736-0; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Haeder S, 2009, P NATL ACAD SCI USA, V106, P4742, DOI 10.1073/pnas.0812082106; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Holland IB, 2010, METHODS MOL BIOL, V619, P1, DOI 10.1007/978-1-60327-412-8_1; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lewis K, 2010, J ANTIBIOT, V63, P468, DOI 10.1038/ja.2010.87; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Lowery CA, 2008, CHEM SOC REV, V37, P1337, DOI 10.1039/b702781h; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; McLean JS, 2008, J MICROBIOL METH, V74, P47, DOI 10.1016/j.mimet.2008.02.015; McLean JS, 2008, ISME J, V2, P121, DOI 10.1038/ismej.2007.107; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Minerdi D, 2009, ENVIRON MICROBIOL, V11, P844, DOI 10.1111/j.1462-2920.2008.01805.x; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ratcliff WC, 2011, SCIENCE, V332, P547, DOI 10.1126/science.1205970; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Schloss PD, 2007, ANNU REV MICROBIOL, V61, P23, DOI 10.1146/annurev.micro.61.011507.151712; Schoenian I, 2011, P NATL ACAD SCI USA, V108, P1955, DOI 10.1073/pnas.1008441108; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Straight PD, 2006, J BACTERIOL, V188, P4918, DOI 10.1128/JB.00162-06; Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248; Strauss E, 2010, NAT CHEM BIOL, V6, P873, DOI 10.1038/nchembio.483; Ubbink J, 2005, MICRON, V36, P293, DOI 10.1016/j.micron.2004.11.005; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020; Yang YL, 2011, ANGEW CHEM INT EDIT, V50, P5839, DOI 10.1002/anie.201101225; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	98	156	161	4	127	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					26	35		10.1038/nchembio.739	http://dx.doi.org/10.1038/nchembio.739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173357	Green Accepted			2022-12-27	WOS:000298414100009
J	Roemer, T; Davies, J; Giaever, G; Nislow, C				Roemer, Terry; Davies, Julian; Giaever, Guri; Nislow, Corey			Bugs, drugs and chemical genomics	NATURE CHEMICAL BIOLOGY			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; WALL TEICHOIC-ACID; SACCHAROMYCES-CEREVISIAE GENOME; ESSENTIAL GENE IDENTIFICATION; BETA-LACTAM ANTIBIOTICS; CANDIDA-ALBICANS; ESCHERICHIA-COLI; BIOLOGICAL-ACTIVITY; ANTIBACTERIAL DISCOVERY; ASPERGILLUS-FUMIGATUS	The serendipitous discovery of penicillin inspired intensive research into how small molecules affect basic cellular processes and their potential to treat disease. Biochemical and genetic approaches have been fundamental for clarifying small-molecule modes of action. Genomic technologies have permitted the use of chemical-genetic strategies that comprehensively study compound-target relationships in the context of a living cell, providing a systems biology view of both the cellular targets and the interdependent networks that respond to chemical stress. These studies highlight the fact that in vitro determinations of mechanism rarely translate into a complete understanding of drug behavior in the cell. Here, we review key discoveries that gave rise to the field of chemical genetics, with particular attention to chemical-genetic strategies developed for bakers' yeast, their extension to clinically relevant microbial pathogens, and the potential of these approaches to affect antimicrobial drug discovery.	[Roemer, Terry] Merck, Dept Infect Dis, Kenilworth, NJ 07033 USA; [Davies, Julian] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Giaever, Guri] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Giaever, Guri; Nislow, Corey] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Giaever, Guri; Nislow, Corey] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	Merck & Company; University of British Columbia; University of Toronto; University of Toronto; University of Toronto	Roemer, T (corresponding author), Merck, Dept Infect Dis, Kenilworth, NJ 07033 USA.	terry_roemer@merck.com; corey.nislow@utoronto.ca	Giaever, Guri/D-3930-2009	Nislow, Corey/0000-0002-4016-8874				Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P507, DOI 10.1007/s10295-005-0077-9; Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Barker CA, 2010, CHEM BIOL, V17, P624, DOI 10.1016/j.chembiol.2010.05.010; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bills GF, 2009, MYCOLOGIA, V101, P449, DOI 10.3852/08-163; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; D'Elia MA, 2009, TRENDS MICROBIOL, V17, P433, DOI 10.1016/j.tim.2009.08.005; D'Elia MA, 2009, CHEM BIOL, V16, P548, DOI 10.1016/j.chembiol.2009.04.009; DAVIES J, 2010, F1000 BIOL REPROD, V12, P26; Davies J, 2011, CURR OPIN CHEM BIOL, V15, P5, DOI 10.1016/j.cbpa.2010.11.001; Donald RGK, 2009, CHEM BIOL, V16, P826, DOI 10.1016/j.chembiol.2009.07.004; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Farha MA, 2010, CHEM BIOL, V17, P852, DOI 10.1016/j.chembiol.2010.06.008; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Flores AR, 2005, J BACTERIOL, V187, P1892, DOI 10.1128/JB.187.6.1892-1900.2005; Fritsche TR, 2008, DIAGN MICR INFEC DIS, V61, P86, DOI 10.1016/j.diagmicrobio.2008.02.008; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Gomez MJ, 2006, ANTIMICROB AGENTS CH, V50, P3562, DOI 10.1128/AAC.00579-06; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Herath K, 2009, BIOORGAN MED CHEM, V17, P1361, DOI 10.1016/j.bmc.2008.12.009; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoon S, 2008, TRENDS PHARMACOL SCI, V29, P499, DOI 10.1016/j.tips.2008.07.006; Hoon S, 2008, NAT CHEM BIOL, V4, P632, DOI 10.1038/nchembio1008-632; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Hughes D, 2003, NAT REV GENET, V4, P432, DOI 10.1038/nrg1084; Hughes T, 2004, CELL, V116, P5, DOI 10.1016/S0092-8674(03)01070-5; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Jiang B, 2008, CHEM BIOL, V15, P363, DOI 10.1016/j.chembiol.2008.02.016; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; Kammler S, 2008, MOL CANCER RES, V6, P990, DOI 10.1158/1541-7786.MCR-07-2217; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lee K, 2010, BIOORG MED CHEM LETT, V20, P1767, DOI 10.1016/j.bmcl.2010.01.036; Lee SH, 2011, CHEM BIOL, V18, P1379, DOI 10.1016/j.chembiol.2011.08.015; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Oh J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq419; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Ondeyka J, 2009, J NAT PROD, V72, P136, DOI 10.1021/np800511r; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Projan SJ, 2008, DRUG DISCOV TODAY, V13, P279, DOI 10.1016/j.drudis.2008.03.010; Raisner RM, 2008, GENETICS, V179, P1933, DOI 10.1534/genetics.108.088443; RINE J, 1983, P NATL ACAD SCI-BIOL, V80, P6750, DOI 10.1073/pnas.80.22.6750; Rodriguez-Suarez R, 2007, CHEM BIOL, V14, P1163, DOI 10.1016/j.chembiol.2007.09.009; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Roemer T, 2011, CHEM BIOL, V18, P148, DOI 10.1016/j.chembiol.2011.01.009; Serizawa M, 2010, ANTIMICROB AGENTS CH, V54, P2787, DOI 10.1128/AAC.01405-09; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Shuman HA, 2003, NAT REV GENET, V4, P419, DOI 10.1038/nrg1087; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Suzuki T, 2011, ANTIMICROB AGENTS CH, V55, P767, DOI 10.1128/AAC.00879-10; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wallace IM, 2011, CHEM BIOL, V18, P1273, DOI 10.1016/j.chembiol.2011.07.018; Wang H, 2011, NAT CHEM BIOL, V7, P720, DOI [10.1038/NCHEMBIO.643, 10.1038/nchembio.643]; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Weidenmaier C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013227; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wright PK, 2008, RECENT PAT ANTI-CANC, V3, P137, DOI 10.2174/157489208784638730; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Xu DM, 2009, J BIOL CHEM, V284, P19754, DOI 10.1074/jbc.M109.019877; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10	97	83	85	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					46	56		10.1038/nchembio.744	http://dx.doi.org/10.1038/nchembio.744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173359				2022-12-27	WOS:000298414100011
J	Patton, GC; Stenmark, P; Gollapalli, DR; Sevastik, R; Kursula, P; Flodin, S; Schuler, H; Swales, CT; Eklund, H; Himo, F; Nordlund, P; Hedstrom, L				Patton, Gregory C.; Stenmark, Pal; Gollapalli, Deviprasad R.; Sevastik, Robin; Kursula, Petri; Flodin, Susanne; Schuler, Herwig; Swales, Colin T.; Eklund, Hans; Himo, Fahmi; Nordlund, Par; Hedstrom, Lizbeth			Cofactor mobility determines reaction outcome in the IMPDH and GMPR (beta-alpha)(8) barrel enzymes	NATURE CHEMICAL BIOLOGY			English	Article							INOSINE MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EVOLUTION; COMPLEX; MECHANISM; BINDING; GENES; SELECTIVITY; INHIBITION	Inosine monophosphate dehydrogenase (IMPDH) and guanosine monophosphate reductase (GMPR) belong to the same structural family, share a common set of catalytic residues and bind the same ligands. The structural and mechanistic features that determine reaction outcome in the IMPDH and GMPR family have not been identified. Here we show that the GMPR reaction uses the same intermediate E-XMP star as IMPDH, but in this reaction the intermediate reacts with ammonia instead of water. A single crystal structure of human GMPR type 2 with IMP and NADPH fortuitously captures three different states, each of which mimics a distinct step in the catalytic cycle of GMPR. The cofactor is found in two conformations: an 'in' conformation poised for hydride transfer and an 'out' conformation in which the cofactor is 6 angstrom from IMP. Mutagenesis along with substrate and cofactor analog experiments demonstrate that the out conformation is required for the deamination of GMP. Remarkably, the cofactor is part of the catalytic machinery that activates ammonia.	[Stenmark, Pal; Kursula, Petri; Flodin, Susanne; Schuler, Herwig; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden; [Patton, Gregory C.; Gollapalli, Deviprasad R.; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Sevastik, Robin; Himo, Fahmi] Stockholm Univ, Arrhenius Lab, Dept Organ Chem, S-10691 Stockholm, Sweden; [Swales, Colin T.; Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA; [Eklund, Hans] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, Uppsala, Sweden; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Karolinska Institutet; Brandeis University; Stockholm University; Stockholm University; Brandeis University; Swedish University of Agricultural Sciences; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Nordlund, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden.	par.nordlund@ki.se; hedstrom@brandeis.edu	Schuler, Herwig/E-5751-2011; Patton, George C/B-5246-2013; Ribeiro, Ana Cristina/HHN-7466-2022; Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012	Schuler, Herwig/0000-0003-4059-3501; Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376; Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Stenmark, Pal/0000-0003-4777-3417	US National Institutes of Health (NIH) [GM54403, P41 RR001081]; Swedish Research Council; Swedish Cancer Society; Wenner-Gren Foundations; Swedish Foundation for Strategic Research; National Science Foundation, Division of Biological Infrastructure [DBI-0100085]; Canadian Institutes for Health Research; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Wellcome Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054403] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Foundations; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Science Foundation, Division of Biological Infrastructure(National Science Foundation (NSF)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute(Genome CanadaCanada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Andrews at the University of Sheffield for supplying the pUC plasmid carrying the E. coli K12 GMPR gene. We also are grateful for construction of pET28a GMPR by I. S. MacPherson. We also thank the staff at BESSY (Berlin, Germany) for support at beamline BL14.1. This work was supported by the US National Institutes of Health (NIH) GM54403 (L. H.) and by grants from the Swedish Research Council (P. N. and P. S.), the Swedish Cancer Society (P. N.), the Wenner-Gren Foundations (P. S.) and the Swedish Foundation for Strategic Research (P. S.). The Q-Tof Ultima mass spectrometer at the University of Illinois was purchased in part with a grant from the National Science Foundation, Division of Biological Infrastructure (DBI-0100085). Molecular graphics images were produced using the University of California, San Fransisco (UCSF) Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the UCSF (supported by NIH P41 RR001081). The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust.	Anantharaman V, 2003, CURR OPIN CHEM BIOL, V7, P12, DOI 10.1016/S1367-5931(02)00018-2; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Martinelli LKB, 2011, MOL BIOSYST, V7, P1289, DOI 10.1039/c0mb00245c; BRADY K, 1990, BIOCHEMISTRY-US, V29, P7608, DOI 10.1021/bi00485a010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Deng YF, 2002, INT J BIOCHEM CELL B, V34, P1035, DOI 10.1016/S1357-2725(02)00024-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisch M.J., 2016, GAUSSIAN16 REV B01; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Hughes R, 2000, Curr Issues Intest Microbiol, V1, P51; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Ji R, 2006, BIOGEOCHEMISTRY, V78, P267, DOI 10.1007/s10533-005-4279-z; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim HS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-351; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li JX, 2006, J MOL BIOL, V355, P980, DOI 10.1016/j.jmb.2005.11.047; Lo Conte L, 2002, NUCLEIC ACIDS RES, V30, P264; MacPherson IS, 2010, J AM CHEM SOC, V132, P1230, DOI 10.1021/ja909947a; Min DH, 2008, PLOS BIOL, V6, P1802, DOI 10.1371/journal.pbio.0060206; Minegishi S, 2003, J AM CHEM SOC, V125, P286, DOI 10.1021/ja021010y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prosise GL, 2003, J MOL BIOL, V326, P517, DOI 10.1016/S0022-2836(02)01383-9; Riera TV, 2008, BIOCHEMISTRY-US, V47, P8689, DOI 10.1021/bi800674a; ROBERTS RE, 1988, J BACTERIOL, V170, P463, DOI 10.1128/jb.170.1.463-467.1988; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P11700, DOI 10.1021/bi048342v; Schlippe YVG, 2004, BIOCHEMISTRY-US, V43, P4511, DOI 10.1021/bi035823q; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; SPECTOR T, 1979, J BIOL CHEM, V254, P2308; Talfournier F, 2009, CHEM-BIOL INTERACT, V178, P79, DOI 10.1016/j.cbi.2008.10.045; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; WEBER G, 1992, ADV ENZYME REGUL, V32, P57; Wise EL, 2004, ACCOUNTS CHEM RES, V37, P149, DOI 10.1021/ar030250v; Zahnle K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004895; Zalatan JG, 2009, NAT CHEM BIOL, V5, P516, DOI 10.1038/nchembio0809-516; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang RG, 1999, CURR MED CHEM, V6, P537	50	30	33	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					950	958		10.1038/NCHEMBIO.693	http://dx.doi.org/10.1038/NCHEMBIO.693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22037469	Green Accepted			2022-12-27	WOS:000297166200019
J	Johnson, DBF; Xu, JF; Shen, ZX; Takimoto, JK; Schultz, MD; Schmitz, RJ; Xiang, Z; Ecker, JR; Briggs, SP; Wang, L				Johnson, David B. F.; Xu, Jianfeng; Shen, Zhouxin; Takimoto, Jeffrey K.; Schultz, Matthew D.; Schmitz, Robert J.; Xiang, Zheng; Ecker, Joseph R.; Briggs, Steven P.; Wang, Lei			RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sites	NATURE CHEMICAL BIOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; SUPPRESSOR TRANSFER-RNAS; ESCHERICHIA-COLI; GENETIC-CODE; RELEASE FACTOR-2; SYSTEM; TRANSLATION; NONSENSE; CODONS; MUTANT	Stop codons have been exploited for genetic incorporation of unnatural amino acids (Uaas) in live cells, but their low incorporation efficiency, which is possibly due to competition from release factors, limits the power and scope of this technology. Here we show that the reportedly essential release factor 1 (RF1) can be knocked out from Escherichia coli by 'fixing' release factor 2 (RF2). The resultant strain JX33 is stable and independent, and it allows UAG to be reassigned from a stop signal to an amino acid when a UAG-decoding tRNA-synthetase pair is introduced. Uaas were efficiently incorporated at multiple UAG sites in the same gene without translational termination in JX33. We also found that amino acid incorporation at endogenous UAG codons is dependent on RF1 and mRNA context, which explains why E. coli tolerates apparent global suppression of UAG. JX33 affords a unique autonomous host for synthesizing and evolving new protein functions by enabling Uaa incorporation at multiple sites.	[Johnson, David B. F.; Xu, Jianfeng; Takimoto, Jeffrey K.; Xiang, Zheng; Wang, Lei] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Schultz, Matthew D.; Schmitz, Robert J.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Schultz, Matthew D.] Univ Calif San Diego, Grad Bioinformat Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego	Wang, L (corresponding author), Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lwang@salk.edu	Ecker, Joseph R/B-9144-2008; Schmitz, Robert/AAY-7659-2020; Wang, Lei/E-7912-2011; Xiang, Zheng/D-9625-2011	Ecker, Joseph R/0000-0001-5799-5895; Schmitz, Robert/0000-0001-7538-6663; Wang, Lei/0000-0002-5859-2526; Xiang, Zheng/0000-0003-2925-842X	Pioneer Fellowship; National Science Foundation [DGE-0504645]; US National Institutes of Health National Research Service [F32-HG004830]; Mary K. Chapman Foundation; Ray Thomas Edwards Foundation [06-I-119]; March of Dimes Foundation [5-FY08-110]; California Institute for Regenerative Medicine [RN1-00577-1]; US National Institutes of Health [1DP2OD004744-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004830] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004744] Funding Source: NIH RePORTER	Pioneer Fellowship; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary K. Chapman Foundation; Ray Thomas Edwards Foundation; March of Dimes Foundation(March of Dimes); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are very grateful to R. Sauer (MIT) for providing strain X90 ssrA1::cat, to L. Isaksson (Stockholm University) for providing strain MRA8, to W. Liu (Texas A&M University) for providing plasmid pET-L11C and to J. Kadonaga (University of California San Diego) for suggestions on H3a purification. We thank V.K. Lacey for proofreading the manuscript. J.X. was partially funded by the Pioneer Fellowship. M.D.S. was supported by National Science Foundation IGERT training grant (DGE-0504645). R.J.S. was supported by an US National Institutes of Health National Research Service Award postdoctoral fellowship (F32-HG004830). J.R.E. acknowledges support from the Mary K. Chapman Foundation. L.W. acknowledges support from the Ray Thomas Edwards Foundation, Searle Scholar Program (06-I-119), Beckman Young Investigator Program, March of Dimes Foundation (#5-FY08-110), California Institute for Regenerative Medicine (RN1-00577-1) and US National Institutes of Health (1DP2OD004744-01).	Abe H, 1999, GENES CELLS, V4, P87, DOI 10.1046/j.1365-2443.1999.00246.x; Agafonov DE, 2001, EMBO REP, V2, P399; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; BENZER S, 1962, P NATL ACAD SCI USA, V48, P1114, DOI 10.1073/pnas.48.7.1114; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; Dahlgren A, 2000, BIOCHIMIE, V82, P683, DOI 10.1016/S0300-9084(00)01160-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Huang Y, 2010, MOL BIOSYST, V6, P683, DOI 10.1039/b920120c; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Kaczanowska M, 2004, J BACTERIOL, V186, P3046, DOI 10.1128/JB.186.10.3046-3055.2004; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Lee JH, 2004, MOL MICROBIOL, V51, P1745, DOI 10.1111/j.1365-2958.2003.03946.x; Luger K, 1999, METHOD ENZYMOL, V304, P3; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; Schrader JM, 2011, P NATL ACAD SCI USA, V108, P5215, DOI 10.1073/pnas.1102128108; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Takimoto JK, 2009, MOL BIOSYST, V5, P931, DOI 10.1039/b904228h; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ueda K, 2002, GENES CELLS, V7, P509, DOI 10.1046/j.1365-2443.2002.00537.x; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang L, 2003, J ORG CHEM, V68, P174, DOI 10.1021/jo026570u; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; Yokoyama Shigeyuki, 1995, P207; ZHANG SP, 1994, J MOL BIOL, V242, P614, DOI 10.1006/jmbi.1994.1611	40	245	256	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					779	786		10.1038/nchembio.657	http://dx.doi.org/10.1038/nchembio.657			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21926996	Green Accepted, Green Submitted			2022-12-27	WOS:000296381600007
J	Dickinson, BC; Peltier, J; Stone, D; Schaffer, DV; Chang, CJ				Dickinson, Bryan C.; Peltier, Joseph; Stone, Daniel; Schaffer, David V.; Chang, Christopher J.			Nox2 redox signaling maintains essential cell populations in the brain	NATURE CHEMICAL BIOLOGY			English	Article							IMAGING HYDROGEN-PEROXIDE; CHRONIC GRANULOMATOUS-DISEASE; TUMOR-SUPPRESSOR PTEN; NEURAL STEM-CELLS; LIVING CELLS; FLUORESCENT-PROBES; REACTIVE OXYGEN; NADPH-OXIDASE; OXIDATIVE STRESS; NITRIC-OXIDE	Reactive oxygen species (ROS) are conventionally classified as toxic consequences of aerobic life, and the brain is particularly susceptible to ROS-induced oxidative stress and damage owing to its high energy and oxygen demands. NADPH oxidases (Nox) are a widespread source of brain ROS implicated in seizures, stroke and neurodegeneration. A physiological role for ROS generation in normal brain function has not been established, despite the fact that mice and humans lacking functional Nox proteins have cognitive deficits. Using molecular imaging with Peroxyfluor-6 (PF6), a new selective fluorescent indicator for hydrogen peroxide (H2O2), we show that adult hippocampal stem/progenitor cells (AHPs) generate H2O2 through Nox2 to regulate intracellular growth signaling pathways, which in turn maintains their normal proliferation in vitro and in vivo. Our results challenge the traditional view that brain ROS are solely deleterious by demonstrating that controlled ROS chemistry is needed for maintaining specific cell populations.	[Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Peltier, Joseph; Stone, Daniel; Schaffer, David V.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dickinson, BC (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	schaffer@berkeley.edu; chrischang@berkeley.edu		Stone, Daniel/0000-0003-1619-7541	Packard and Sloan Foundations; UC Berkeley Hellman Faculty Fund; Amgen; Astra Zeneca; Novartis; US National Institutes of Health [GM 79465, EB 007295, T32 GM066698)]; California Institute for Regenerative Medicine [T1-00007]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, T32GM066698] Funding Source: NIH RePORTER	Packard and Sloan Foundations; UC Berkeley Hellman Faculty Fund; Amgen(Amgen); Astra Zeneca(AstraZeneca); Novartis(Novartis); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Packard and Sloan Foundations (C.J.C.), the UC Berkeley Hellman Faculty Fund (C.J.C.), Amgen, Astra Zeneca and Novartis (C.J.C.) and the US National Institutes of Health (GM 79465 to C.J.C. and EB 007295 to D.V.S.) for providing funding for this work. C.J.C. is an Investigator with the Howard Hughes Medical Institute. B. C. D. was partially supported by a Chemical Biology Training Grant from the US National Institutes of Health. (T32 GM066698). J.P. was partially supported by a training grant fellowship from the California Institute for Regenerative Medicine (T1-00007). We thank M. Quinn (Montana State University) for generous donation of Nox2 antibodies and T. Kawahara for helpful advice.	Albers AE, 2008, BIOORG MED CHEM LETT, V18, P5948, DOI 10.1016/j.bmcl.2008.08.035; Albers AE, 2006, J AM CHEM SOC, V128, P9640, DOI 10.1021/ja063308k; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Chang MCY, 2004, J AM CHEM SOC, V126, P15392, DOI 10.1021/ja0441716; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dickinson BC, 2010, CURR OPIN CHEM BIOL, V14, P50, DOI 10.1016/j.cbpa.2009.10.014; FLOYD RA, 1991, SCIENCE, V254, P1597, DOI 10.1126/science.1684251; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Izumi S, 2009, J AM CHEM SOC, V131, P10189, DOI 10.1021/ja902511p; Kishida KT, 2006, MOL CELL BIOL, V26, P5908, DOI 10.1128/MCB.00269-06; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; McQuade LE, 2010, INORG CHEM, V49, P9535, DOI 10.1021/ic1012507; McQuade LE, 2010, P NATL ACAD SCI USA, V107, P8525, DOI 10.1073/pnas.0914794107; Miller EW, 2007, CURR OPIN CHEM BIOL, V11, P620, DOI 10.1016/j.cbpa.2007.09.018; Miller EW, 2007, NAT CHEM BIOL, V3, P263, DOI 10.1038/nchembio871; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Miller EW, 2005, J AM CHEM SOC, V127, P16652, DOI 10.1021/ja054474f; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pao M, 2004, PSYCHOSOMATICS, V45, P230, DOI 10.1176/appi.psy.45.3.230; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Pluth MD, 2010, ORG LETT, V12, P2318, DOI 10.1021/ol1006289; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Srikun D, 2008, J AM CHEM SOC, V130, P4596, DOI 10.1021/ja711480f; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	204	207	8	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					106	112		10.1038/NCHEMBIO.497	http://dx.doi.org/10.1038/NCHEMBIO.497			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21186346	Green Accepted, Green Submitted			2022-12-27	WOS:000286324600011
J	Strauss, E				Strauss, Erick			Exploiting single-cell variation for new antibiotics	NATURE CHEMICAL BIOLOGY			English	Article							TUBERCULOSIS; PERSISTENCE	Variations between single members of a bacterial population can lead to antibiotic resistance that is not gene based. The future of effective infectious disease management might depend on a better understanding of this phenomenon and the potential to manipulate both it and microbial population dynamics in general.	Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa	Stellenbosch University	Strauss, E (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa.	estrauss@sun.ac.za	Strauss, Erick/G-1783-2010	Strauss, Erick/0000-0002-9898-8226				Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bigger JW, 1944, LANCET, V2, P497; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Schmid A, 2010, CURR OPIN BIOTECH, V21, P12, DOI 10.1016/j.copbio.2010.01.007; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	20	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					873	875		10.1038/nchembio.483	http://dx.doi.org/10.1038/nchembio.483			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079594				2022-12-27	WOS:000284214700010
J	Bock, A; Chirinda, B; Krebs, F; Messerer, R; Batz, J; Muth, M; Dallanoce, C; Klingenthal, D; Trankle, C; Hoffmann, C; De Amici, M; Holzgrabe, U; Kostenis, E; Mohr, K				Bock, Andreas; Chirinda, Brian; Krebs, Fabian; Messerer, Regina; Baetz, Julia; Muth, Mathias; Dallanoce, Clelia; Klingenthal, Dominika; Traenkle, Christian; Hoffmann, Carsten; De Amici, Marco; Holzgrabe, Ulrike; Kostenis, Evi; Mohr, Klaus			Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor	NATURE CHEMICAL BIOLOGY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; ALLOSTERIC MODULATION; LIVING CELLS; ACTIVATION; EFFICACY; OXOTREMORINE; SELECTIVITY	We present a new concept of partial agonism at G protein-coupled receptors. We demonstrate the coexistence of two functionally distinct populations of the muscarinic M-2 receptor stabilized by one dynamic ligand, which binds in two opposite orientations. The ratio of orientations determines the cellular response. Our concept allows predicting and virtually titrating ligand efficacy, which opens unprecedented opportunities for the design of drugs with graded activation of the biological system.	[Bock, Andreas; Chirinda, Brian; Krebs, Fabian; Klingenthal, Dominika; Traenkle, Christian; Mohr, Klaus] Univ Bonn, Pharmacol & Toxicol Sect, Inst Pharm, Bonn, Germany; [Messerer, Regina; Muth, Mathias; Holzgrabe, Ulrike] Univ Wurzburg, Inst Pharm, Dept Pharmaceut Chem, D-97070 Wurzburg, Germany; [Baetz, Julia; Hoffmann, Carsten] Univ Wurzburg, Bioimaging Ctr, Rudolf Virchow Zentrum, D-97070 Wurzburg, Germany; [Bock, Andreas; Chirinda, Brian; Krebs, Fabian; Baetz, Julia; Klingenthal, Dominika; Traenkle, Christian; Hoffmann, Carsten; Mohr, Klaus] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Dallanoce, Clelia; De Amici, Marco] Univ Milan, Sez Chim Farmaceut Pietro Pratesi, Dipartimento Sci Farmaceut, Milan, Italy; [Kostenis, Evi] Univ Bonn, Mol Cellular & Pharmacobiol Sect, Inst Pharmaceut Biol, Bonn, Germany	University of Bonn; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Milan; University of Bonn	Bock, A (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	k.mohr@uni-bonn.de	; De Amici, Marco/F-9684-2015	Holzgrabe, Ulrike/0000-0002-0364-7278; Dallanoce, Clelia/0000-0002-7383-1484; De Amici, Marco/0000-0002-0236-0662; Bock, Andreas/0000-0002-6344-6494	Deutsche Forschungsgemeinschaft (DFG) [MO 821/2-1, HO 1368/12-1, KO 1583/3-1, SFB487 TPA1]; North-Rhine-Westphalia International Graduate Research School BIOTECH-PHARMA at the University of Bonn	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); North-Rhine-Westphalia International Graduate Research School BIOTECH-PHARMA at the University of Bonn	We thank M. Kepe for excellent technical assistance and Corning Inc. for their support on the Epic system. A. B. is a member of the graduate school Theoretical and Experimental Medicine at the University of Bonn. This work was funded by the Deutsche Forschungsgemeinschaft (DFG) by grants to K.M. (MO 821/2-1), U.H. (HO 1368/12-1), E.K. (KO 1583/3-1) and C.H. (SFB487 TPA1). B.C. is funded by the North-Rhine-Westphalia International Graduate Research School BIOTECH-PHARMA at the University of Bonn.	Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI 10.1038/NCHEMBIO.451; Dallanoce C, 1999, BIOORGAN MED CHEM, V7, P1539, DOI 10.1016/S0968-0896(99)00107-8; Disingrini T, 2006, J MED CHEM, V49, P366, DOI 10.1021/jm050769s; Ehlert FJ, 1999, J PHARMACOL EXP THER, V289, P981; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Griffin MT, 2007, J PHARMACOL EXP THER, V321, P1193, DOI 10.1124/jpet.107.120857; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kloeckner J, 2010, TETRAHEDRON LETT, V51, P3470, DOI 10.1016/j.tetlet.2010.04.130; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schrage R, 2013, BRIT J PHARMACOL, V169, P357, DOI 10.1111/bph.12003; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	31	45	45	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					18	U37		10.1038/nchembio.1384	http://dx.doi.org/10.1038/nchembio.1384			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24212135				2022-12-27	WOS:000328854900005
J	Nile, AH; Tripathi, A; Yuan, PH; Mousley, CJ; Suresh, S; Wallace, IM; Shah, SD; Pohlhaus, DT; Temple, B; Nislow, C; Giaever, G; Tropsha, A; Davis, RW; Onge, RPS; Bankaitis, VA				Nile, Aaron H.; Tripathi, Ashutosh; Yuan, Peihua; Mousley, Carl J.; Suresh, Sundari; Wallace, Iain M.; Shah, Sweety D.; Pohlhaus, Denise Teotico; Temple, Brenda; Nislow, Corey; Giaever, Guri; Tropsha, Alexander; Davis, Ronald W.; Onge, Robert P. St.; Bankaitis, Vytas A.			PITPs as targets for selectively interfering with phosphoinositide signaling in cells	NATURE CHEMICAL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; YEAST SACCHAROMYCES-CEREVISIAE; OXYSTEROL BINDING-PROTEIN; PHOSPHOLIPASE-D ACTIVITY; GOLGI-COMPLEX; IN-VIVO; TRANSPORT; SEC14; GENE; HOMEOSTASIS	Sec14-like phosphatidylinositol transfer proteins (PITPs) integrate diverse territories of intracellular lipid metabolism with stimulated phosphatidylinositol-4-phosphate production and are discriminating portals for interrogating phosphoinositide signaling. Yet, neither Sec14-like PITPs nor PITPs in general have been exploited as targets for chemical inhibition for such purposes. Herein, we validate what is to our knowledge the first small-molecule inhibitors (SMIs) of the yeast PITP Sec14. These SMIs are nitrophenyl(4-(2-methoxyphenyl)piperazin-1-yl)methanones (NPPMs) and are effective inhibitors in vitro and in vivo. We further establish that Sec14 is the sole essential NPPM target in yeast and that NPPMs exhibit exquisite targeting specificities for Sec14 (relative to related Sec14-like PITPs), propose a mechanism for how NPPMs exert their inhibitory effects and demonstrate that NPPMs exhibit exquisite pathway selectivity in inhibiting phosphoinositide signaling in cells. These data deliver proof of concept that PITP-directed SMIs offer new and generally applicable avenues for intervening with phosphoinositide signaling pathways with selectivities superior to those afforded by contemporary lipid kinase-directed strategies.	[Nile, Aaron H.; Tripathi, Ashutosh; Yuan, Peihua; Mousley, Carl J.; Bankaitis, Vytas A.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Nile, Aaron H.; Tripathi, Ashutosh; Yuan, Peihua; Mousley, Carl J.; Bankaitis, Vytas A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Nile, Aaron H.; Tripathi, Ashutosh; Yuan, Peihua; Mousley, Carl J.; Bankaitis, Vytas A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Nile, Aaron H.; Shah, Sweety D.; Bankaitis, Vytas A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Sch Med, Chapel Hill, NC 27599 USA; [Tripathi, Ashutosh; Pohlhaus, Denise Teotico; Tropsha, Alexander] Univ N Carolina, Lab Mol Modeling, Eshelman Sch Pharm, Chapel Hill, NC USA; [Suresh, Sundari; Davis, Ronald W.; Onge, Robert P. St.] Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Wallace, Iain M.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Temple, Brenda] Univ N Carolina, RL Juliano Struct Bioinformat Core, Chapel Hill, NC USA; [Nislow, Corey; Giaever, Guri] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; University of Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia	Nile, AH (corresponding author), Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	tripathi@tamhsc.edu; vytas@tamhsc.edu	Tropsha, Alexander/AAB-8324-2020; Tropsha, Alexander/G-6245-2014; Wallace, Iain/B-9464-2009; Yuan, Peihua/G-9088-2013	Wallace, Iain/0000-0002-9491-7025; Nile, Aaron/0000-0002-7370-8769; Nislow, Corey/0000-0002-4016-8874; Yuan, Peihua/0000-0002-4633-0692; Mousley, Carl/0000-0002-0192-7030	Robert A. Welch Foundation; US National Institutes of Health (NIH) [GM44530]; NIH [HG003317]; National Human Genome Research Institute [5RO1-003317-08]; Canadian Cancer Society [020380]; Texas A&M Laboratory for Molecular Simulation provided software; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044530] Funding Source: NIH RePORTER	Robert A. Welch Foundation(The Welch Foundation); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Texas A&M Laboratory for Molecular Simulation provided software; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Robert A. Welch Foundation (V.A.B.) and grant GM44530 (V.A.B.) from the US National Institutes of Health (NIH). R.W.D. was supported by the NIH (HG003317). G. Giaever and C. Nislow were supported by the National Human Genome Research Institute (5RO1-003317-08) and the Canadian Cancer Society (020380). The Texas A&M Laboratory for Molecular Simulation provided software, support and computer time. G.E. Kellogg and eduSoft LC donated HINT software, U. Schlecht (Stanford) assisted with growth analyses, A. Holzenburg and R. Littleton (Texas A&M) assisted with electron microscopy. We are grateful to D. Lew (Duke University) for donating mss4ts alleles.	Abraham DJ, 1997, J MOL BIOL, V272, P613, DOI 10.1006/jmbi.1997.1249; Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Alb JG, 2003, J BIOL CHEM, V278, P33501, DOI 10.1074/jbc.M303591200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Cho AE, 2005, J COMPUT CHEM, V26, P915, DOI 10.1002/jcc.20222; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; Cleves A, 1991, Trends Cell Biol, V1, P30, DOI 10.1016/0962-8924(91)90067-J; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; Desfougeres T, 2008, BIOCHEM J, V409, P299, DOI 10.1042/BJ20071028; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Goldstein A, 1975, Methods Enzymol, V42, P504; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kennedy MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001299; Li XM, 2000, MOL BIOL CELL, V11, P1989, DOI 10.1091/mbc.11.6.1989; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; LOPEZ MC, 1994, J CELL BIOL, V125, P113, DOI 10.1083/jcb.125.1.113; Lu YX, 2009, J PHYS CHEM B, V113, P12615, DOI 10.1021/jp906352e; MENG EC, 1994, J COMPUT AID MOL DES, V8, P299, DOI 10.1007/BF00126747; Metrangolo P, 2001, CHEM-EUR J, V7, P2511, DOI 10.1002/1521-3765(20010618)7:12<2511::AID-CHEM25110>3.0.CO;2-T; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Phillips SE, 2006, CRIT REV BIOCHEM MOL, V41, P21, DOI 10.1080/10409230500519573; Phillips SE, 1999, MOL CELL, V4, P187, DOI 10.1016/S1097-2765(00)80366-4; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Ryan MM, 2007, MOL BIOL CELL, V18, P1928, DOI 10.1091/mbc.E06-11-1024; SALAMA SR, 1990, J BACTERIOL, V172, P4510, DOI 10.1128/jb.172.8.4510-4521.1990; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schaaf G, 2011, MOL BIOL CELL, V22, P892, DOI 10.1091/mbc.E10-11-0903; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sherman F., 1983, METHODS YEAST GENETI; SKINNER HB, 1993, EMBO J, V12, P4775, DOI 10.1002/j.1460-2075.1993.tb06166.x; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Stolz LE, 1998, J BIOL CHEM, V273, P11852, DOI 10.1074/jbc.273.19.11852; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Sykes P., 1986, GUIDEBOOK MECH ORGAN; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu WI, 2000, J BIOL CHEM, V275, P14446, DOI 10.1074/jbc.275.19.14446; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	59	25	27	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					76	U123		10.1038/NCHEMBIO.1389	http://dx.doi.org/10.1038/NCHEMBIO.1389			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24292071	Green Submitted, Green Accepted			2022-12-27	WOS:000328854900014
J	Lim, HH; Stockbridge, RB; Miller, C				Lim, Hyun-Ho; Stockbridge, Randy B.; Miller, Christopher			Fluoride-dependent interruption of the transport cycle of a CLC Cl-/H+ antiporter	NATURE CHEMICAL BIOLOGY			English	Article							MUSCLE CHLORIDE CHANNEL; HIGH-LEVEL EXPRESSION; ION PERMEATION; PROKARYOTIC HOMOLOG; SUBSTRATE-BINDING; SELECTIVITY; INHIBITION; RESISTANCE; ANION	Cl-/H+ antiporters of the CLC superfamily transport anions across biological membranes in varied physiological contexts. These proteins are weakly selective among anions commonly studied, including Cl-, Br-, I-, NO3- and SCN-, but they seem to be very selective against F-. The recent discovery of a new CLC clade of F-/H+ antiporters, which are highly selective for F- over Cl-, led us to investigate the mechanism of Cl--over-F- selectivity by a CLC Cl-/H+ antiporter, CLC-ec1. By subjecting purified CLC-ec1 to anion transport measurements, electrophysiological recording, equilibrium ligand-binding studies and X-ray crystallography, we show that F- binds in the Cl- transport pathway with affinity similar to Cl- but stalls the transport cycle. Examination of various mutant antiporters implies a 'lock-down' mechanism of F- inhibition, in which F-, by virtue of its unique hydrogen-bonding chemistry, greatly retards a proton-linked conformational change essential for the transport cycle of CLC-ec1.	[Lim, Hyun-Ho; Stockbridge, Randy B.; Miller, Christopher] Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA; [Lim, Hyun-Ho; Stockbridge, Randy B.; Miller, Christopher] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02254 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute	Lim, HH (corresponding author), Korea Brain Res Inst, Taegu, South Korea.	cmiller@brandeis.edu		Stockbridge, Randy/0000-0001-8848-3032	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM107023] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Cametti M, 2013, CHEM SOC REV, V42, P2016, DOI 10.1039/c2cs35439j; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Stefano S, 2011, J BIOL CHEM, V286, P44134, DOI 10.1074/jbc.M111.272815; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fahlke C, 1997, J GEN PHYSIOL, V110, P551, DOI 10.1085/jgp.110.5.551; Fahlke C, 2001, AM J PHYSIOL-RENAL, V280, pF748, DOI 10.1152/ajprenal.2001.280.5.F748; Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hummer G, 1996, J PHYS CHEM-US, V100, P1206, DOI 10.1021/jp951011v; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jayaram H, 2011, BIOCHEMISTRY-US, V50, P788, DOI 10.1021/bi1019258; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Lim HH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001441; Lim HH, 2009, J GEN PHYSIOL, V133, P131, DOI 10.1085/jgp.200810112; Lobet S, 2006, EMBO J, V25, P24, DOI 10.1038/sj.emboj.7600909; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; PALADE PT, 1977, J GEN PHYSIOL, V69, P879, DOI 10.1085/jgp.69.6.879; Picollo A, 2012, NAT STRUCT MOL BIOL, V19, P525, DOI 10.1038/nsmb.2277; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Qin R, 2006, BIOCHEMISTRY-US, V45, P793, DOI 10.1021/bi051558s; Ren AM, 2012, NATURE, V486, P85, DOI 10.1038/nature11152; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Samygina VR, 2007, J MOL BIOL, V366, P1305, DOI 10.1016/j.jmb.2006.11.082; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756	40	28	28	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					721	+		10.1038/NCHEMBIO.1336	http://dx.doi.org/10.1038/NCHEMBIO.1336			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24036509	Green Accepted			2022-12-27	WOS:000325930500013
J	Morgan, B; Ezerina, D; Amoako, TNE; Riemer, J; Seedorf, M; Dick, TP				Morgan, Bruce; Ezerina, Daria; Amoako, Theresa N. E.; Riemer, Jan; Seedorf, Matthias; Dick, Tobias P.			Multiple glutathione disulfide removal pathways mediate cytosolic redox homeostasis	NATURE CHEMICAL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDIZED GLUTATHIONE; THIOREDOXIN SYSTEM; OXIDATIVE STRESS; IN-VIVO; REDUCTASE; RESISTANCE; TRANSPORTER; METABOLISM; BIOLOGY	Glutathione is central to cellular redox chemistry. The majority of glutathione redox research has been based on the chemical analysis of whole-cell extracts, which unavoidably destroy subcellular compartment-specific information. Compartment-specific real-time measurements based on genetically encoded fluorescent probes now suggest that the cytosolic glutathione redox potential is about 100 mV more reducing than previously thought. Using these probes in yeast, we show that even during severe oxidative stress, the cytosolic glutathione disulfide (GSSG) concentration is much more tightly regulated than expected and provide a mechanistic explanation for the discrepancy with conventional measurements. GSSG that is not immediately reduced in the cytosol is rapidly transported into the vacuole by the ABC-C transporter Ycf1. The amount of whole-cell GSSG is entirely dependent on Ycf1 and uninformative about the cytosolic glutathione pool. Applying these insights, we identify Trx2 and Grx2 as efficient backup systems to glutathione reductase for cytosolic GSSG reduction.	[Morgan, Bruce; Ezerina, Daria; Amoako, Theresa N. E.; Dick, Tobias P.] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Redox Regulat, Heidelberg, Germany; [Riemer, Jan] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany; [Seedorf, Matthias] Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Kaiserslautern; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Dick, TP (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Redox Regulat, Heidelberg, Germany.	t.dick@dkfz.de	Ezeriņa, Daria/GXM-5832-2022; Ezerina, Daria/ABH-9010-2020; Riemer, Jan/AAC-1072-2021	Ezeriņa, Daria/0000-0002-3104-7093; Ezerina, Daria/0000-0002-3104-7093; Morgan, Bruce/0000-0001-9393-1071; Riemer, Jan/0000-0002-7574-8457	European Molecular Biology Organization [313-2009]; DKFZ; Chica and Heinz Schaller Foundation	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); DKFZ(Helmholtz Association); Chica and Heinz Schaller Foundation	B.M. was funded by a European Molecular Biology Organization short-term fellowship (313-2009) and a DKFZ visiting scientist fellowship. Support by the Chica and Heinz Schaller Foundation is gratefully acknowledged. We thank B. Schwappach for critical reading of the manuscript.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Aw TY, 2003, NEWS PHYSIOL SCI, V18, P201, DOI 10.1152/nips.01448.2003; Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001; Bonilla M, 2011, J BIOL CHEM, V286, P4959, DOI 10.1074/jbc.M110.170761; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Brechbuhl HM, 2010, J BIOL CHEM, V285, P16582, DOI 10.1074/jbc.M109.090506; BULGER JE, 1971, J BIOL CHEM, V246, P5570; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dardalhon M, 2012, FREE RADICAL BIO MED, V52, P2254, DOI 10.1016/j.freeradbiomed.2012.04.004; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jones DP, 2009, FREE RADICAL BIO MED, V47, P1329, DOI 10.1016/j.freeradbiomed.2009.08.021; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Knollema S, 1996, J COMP NEUROL, V373, P157, DOI 10.1002/(SICI)1096-9861(19960916)373:2<157::AID-CNE1>3.0.CO;2-2; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lazard M, 2011, FEBS J, V278, P4112, DOI 10.1111/j.1742-4658.2011.08318.x; Lee ME, 2011, GENETICS, V188, P859, DOI 10.1534/genetics.111.130724; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Lopez-Mirabal HR, 2007, FEMS YEAST RES, V7, P391, DOI 10.1111/j.1567-1364.2006.00202.x; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Paumi CM, 2012, FEBS LETT, V586, P847, DOI 10.1016/j.febslet.2012.02.010; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Porras P, 2002, BIOCHEM BIOPH RES CO, V295, P1046, DOI 10.1016/S0006-291X(02)00771-4; Rebrin I, 2004, BIOCHEM J, V382, P131, DOI 10.1042/BJ20040506; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844	38	206	209	0	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					119	125		10.1038/NCHEMBIO.1142	http://dx.doi.org/10.1038/NCHEMBIO.1142			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23242256				2022-12-27	WOS:000314083200011
J	Wang, GL; Wang, XM; Yu, H; Wei, SG; Williams, N; Holmes, DL; Halfmann, R; Naidoo, J; Wang, L; Li, L; Chen, S; Harran, P; Lei, XG; Wang, XD				Wang, Gelin; Wang, Xiaoming; Yu, Hong; Wei, Shuguang; Williams, Noelle; Holmes, Daniel L.; Halfmann, Randal; Naidoo, Jacinth; Wang, Lai; Li, Lin; Chen, She; Harran, Patrick; Lei, Xiaoguang; Wang, Xiaodong			Small-molecule activation of the TRAIL receptor DR5 in human cancer cells	NATURE CHEMICAL BIOLOGY			English	Article							APOPTOSIS-INDUCING LIGAND; DEATH RECEPTORS; CYTOCHROME-C; CASPASE-8; PATHWAYS; PROTEINS	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) activates apoptosis through the death receptors DR4 and DR5. Because of its superior safety profile and high tumor specificity compared to other TNF family members, recombinant soluble TRAIL and agonistic antibodies against its receptors are actively being developed for clinical cancer therapy. Here, we describe the identification and characterization of the small molecules that directly target DR5 to initiate apoptosis in human cancer cells. The activity was initially discovered through a high-throughput chemical screen for compounds that promote cell death in synergy with a small-molecule mimetic of Smac, the antagonist for inhibitor of apoptosis protein. Structure-activity relationship studies yielded a more potent analog called bioymifi, which can act as a single agent to induce DR5 clustering and aggregation, leading to apoptosis. Thus, this study identified potential lead compounds for the development of small-molecule TRAIL mimics targeting DR5 for cancer therapy.	[Wang, Gelin; Yu, Hong; Wei, Shuguang; Williams, Noelle; Holmes, Daniel L.; Halfmann, Randal; Naidoo, Jacinth] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wang, Xiaoming; Lei, Xiaoguang] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China; [Wang, Lai; Li, Lin] Joyant Pharmaceut, Dallas, TX USA; [Chen, She; Lei, Xiaoguang; Wang, Xiaodong] Natl Inst Biol Sci, Beijing, Peoples R China; [Harran, Patrick] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Tianjin University; National Institute of Biological Sciences, Beijing; University of California System; University of California Los Angeles	Wang, GL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	gelin.wang@utsouthwestern.edu; leixiaoguang@nibs.ac.cn; wangxiaodong@nibs.ac.cn		Wang, Xiaodong/0000-0001-9885-356X; Holmes, Daniel/0000-0002-0489-4043; Halfmann, Randal/0000-0002-6592-1471	US National Cancer Institute [2P01 CA095471-06]; National Natural Science Foundation of China [21072150, 21222209]; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009152] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Zhao for NMR and HPLC/MS analysis; S.L. Petersen for reagents and discussions; L. Zhao for the toxicological experiments; S.L. McKnight for helpful suggestions; M. Roth for proposing the chemical library screen; D. Frantz, J. Ready and A. Wang for synthesis of initial hits; Y. Liu, Z. Zhang, Q. Liu and L. Shang for comments of the manuscript; S.-C. Tso and T. Scheuermann for detecting the interaction between DR5 and bioymifi; and K. Phelps and A. Budge for the cell imaging. This work is supported by a program project grant from the US National Cancer Institute (2P01 CA095471-06 to Xiaodong Wang and G.W.) and the National Natural Science Foundation of China (21072150 and 21222209 to X.L.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	28	82	96	4	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					84	89		10.1038/NCHEMBIO.1153	http://dx.doi.org/10.1038/NCHEMBIO.1153			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23292651				2022-12-27	WOS:000314083200006
J	Dumelin, CE; Chen, YY; Leconte, AM; Chen, YG; Liu, DR				Dumelin, Christoph E.; Chen, Yiyun; Leconte, Aaron M.; Chen, Y. Grace; Liu, David R.			Discovery and biological characterization of geranylated RNA in bacteria	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; MODIFIED NUCLEOSIDE; TRANSLATION; BIOSYNTHESIS; SEQUENCES; GENE; CODON; EXPRESSION; ANTICODON; DIVERSITY	A general MS-based screen for unusually hydrophobic cellular small molecule-RNA conjugates revealed geranylated RNA in Escherichia coli, Enterobacter aerogenes, Pseudomonas aeruginosa and Salmonella enterica var. Typhimurium. The geranyl group is conjugated to the sulfur atom in two 5-methylaminomethyl-2-thiouridine nucleotides. These geranylated nucleotides occur in the first anticodon position of tRNA(UUC)(Glu), tRNA(UUU)(Lys) and tRNA(UUG)(Gln) at a frequency of up to 6.7% (similar to 400 geranylated nucleotides per cell). RNA geranylation can be increased or abolished by mutation or deletion of the selU (ybbB) gene in E. coli, and purified SelU protein in the presence of geranyl pyrophosphate and tRNA can produce geranylated tRNA. The presence or absence of the geranyl group in tRNA(UUC)(Glu), tRNA(UUU)(Lys) and tRNA(UUG)(Gln) affects codon bias and frameshifting during translation. These RNAs represent the first reported examples of oligoisoprenylated cellular nucleic acids.	[Dumelin, Christoph E.; Chen, Yiyun; Leconte, Aaron M.; Chen, Y. Grace; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Dumelin, Christoph E.; Chen, Yiyun; Leconte, Aaron M.; Chen, Y. Grace; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	Dumelin, CE (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Chen, Yiyun/Q-9895-2016; Liu, David R./HCH-3132-2022	Chen, Yiyun/0000-0003-0916-0994; 	US National Institutes of Health (NIH)-National Institute of General Medical Sciences (NIGMS) [R01GM065865]; Novartis Foundation; NIH National Research Service Award Postdoctoral Fellowship [F32GM095028]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865, F32GM095028] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)-National Institute of General Medical Sciences (NIGMS); Novartis Foundation(Novartis); NIH National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute and the US National Institutes of Health (NIH)-National Institute of General Medical Sciences (NIGMS) (R01GM065865). C. E. D. acknowledges fellowship from the Novartis Foundation. A. M. L. was supported by a NIH National Research Service Award Postdoctoral Fellowship (F32GM095028). We thank S.-L. Zheng for his help with X-ray diffraction and structural determination of synthetic geranyl-2-thiouracil. We thank A. Saghatelian (Harvard University) for providing P. aeruginosa and I. Chen (Harvard University) for providing S. Typhimurium and BL2 facilities. We are also grateful to J. Carlson for his assistance and M. Ibba for helpful discussions.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; Chen P, 2005, EMBO J, V24, P1842, DOI 10.1038/sj.emboj.7600666; Chen YG, 2009, NAT CHEM BIOL, V5, P879, DOI 10.1038/nchembio.235; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Gurvich OL, 2003, EMBO J, V22, P5941, DOI 10.1093/emboj/cdg561; HAGERVALL TG, 1987, J BIOL CHEM, V262, P8488; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; JAKUBOWSKI H, 1984, J BACTERIOL, V158, P769, DOI 10.1128/JB.158.3.769-776.1984; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Keller KC, 2011, CURR OPIN MICROBIOL, V14, P155, DOI 10.1016/j.mib.2011.01.009; Kowtoniuk WE, 2009, P NATL ACAD SCI USA, V106, P7768, DOI 10.1073/pnas.0900528106; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; Lane BG, 1998, MODIFICATION EDITING, P1; Licznar P, 2003, EMBO J, V22, P4770, DOI 10.1093/emboj/cdg465; LINDSLEY D, 1993, P NATL ACAD SCI USA, V90, P5469, DOI 10.1073/pnas.90.12.5469; LOOMAN AC, 1987, EMBO J, V6, P2489, DOI 10.1002/j.1460-2075.1987.tb02530.x; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miles ZD, 2011, P NATL ACAD SCI USA, V108, P7368, DOI 10.1073/pnas.1018636108; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nicolas EC, 1998, J PHARMACEUT BIOMED, V16, P825, DOI 10.1016/S0731-7085(97)00132-5; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Scott AI, 1997, TETRAHEDRON LETT, V38, P4961, DOI 10.1016/S0040-4039(97)01143-X; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; SYLVERS LA, 1993, BIOCHEMISTRY-US, V32, P3836, DOI 10.1021/bi00066a002; TSUCHIHASHI Z, 1992, GENE DEV, V6, P511, DOI 10.1101/gad.6.3.511; VOLKIN E, 1953, J BIOL CHEM, V205, P767; WITTWER A J, 1989, Biofactors, V2, P27; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; YANIV M, 1975, J BIOL CHEM, V250, P3243; Yarian C, 2000, BIOCHEMISTRY-US, V39, P13390, DOI 10.1021/bi001302g; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Yokogawa T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1182	45	81	82	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					913	919		10.1038/NCHEMBIO.1070	http://dx.doi.org/10.1038/NCHEMBIO.1070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	22983156	Green Accepted, Green Submitted			2022-12-27	WOS:000310052100010
J	Reitman, ZJ; Choi, BD; Spasojevic, I; Bigner, DD; Sampson, JH; Yan, H				Reitman, Zachary J.; Choi, Bryan D.; Spasojevic, Ivan; Bigner, Darell D.; Sampson, John H.; Yan, Hai			Enzyme redesign guided by cancer-derived IDH1 mutations	NATURE CHEMICAL BIOLOGY			English	Article							HOMOISOCITRATE DEHYDROGENASE; ADIPIC ACID; ISOCITRATE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; MECHANISM; SUBSTRATE	Mutations in an enzyme can result in a neomorphic catalytic activity in cancers. We applied cancer-associated mutations from isocitrate dehydrogenases to homologous residues in the active sites of homoisocitrate dehydrogenases to derive enzymes that catalyze the conversion of 2-oxoadipate to (R)-2-hydroxyadipate, a critical step for adipic acid production. Thus, we provide a prototypic example of how insights from cancer genome sequencing and functional studies can aid in enzyme redesign.	[Reitman, Zachary J.; Choi, Bryan D.; Bigner, Darell D.; Sampson, John H.; Yan, Hai] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Univ, Med Ctr, Duke Canc Inst, Bioanalyt Core Lab, Durham, NC 27710 USA	Duke University; Duke University	Reitman, ZJ (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	hai.yan@dm.duke.edu		Sampson, John/0000-0002-0104-7658; Reitman, Zachary/0000-0002-9122-9550	US National Institutes of Health [R01 CA1403160]; NATIONAL CANCER INSTITUTE [R01CA140310, R01CA140316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by US National Institutes of Health grant R01 CA1403160 (H.Y.). We thank P. F. Cook at the University of Oklahoma for an HIDH expression plasmid, E. Spana at Duke University for S. cerevisiae genomic DNA, P. Fan for technical assistance and I. Fridovich and I. Batinic-Haberle for feedback on the manuscript.	Aktas DF, 2009, BIOCHEMISTRY-US, V48, P3565, DOI 10.1021/bi8022976; Bulfer SL, 2012, PROTEINS, V80, P661, DOI 10.1002/prot.23231; Burgard AP, 2010, Google Patents, Patent No. [US 2010/0330626 A1, 20100330626]; Chen RD, 2000, PROTEIN SCI, V9, P2344, DOI 10.1110/ps.9.12.2344; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Lin Y, 2008, BIOCHEMISTRY-US, V47, P4169, DOI 10.1021/bi702361j; Lin Y, 2007, BIOCHEMISTRY-US, V46, P890, DOI 10.1021/bi062067q; Lin Y, 2009, BIOCHEMISTRY-US, V48, P7305, DOI 10.1021/bi900175z; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Niu W, 2002, BIOTECHNOL PROGR, V18, P201, DOI 10.1021/bp010179x; Noack H, 2011, INORG CHEM, V50, P1194, DOI 10.1021/ic101405u; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parthasarathy A, 2011, BIOCHEMISTRY-US, V50, P3540, DOI 10.1021/bi1020056; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Sato K, 1998, SCIENCE, V281, P1646, DOI 10.1126/science.281.5383.1646; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; UHR ML, 1974, J BIOL CHEM, V249, P2920; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	23	16	19	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					887	889		10.1038/NCHEMBIO.1065	http://dx.doi.org/10.1038/NCHEMBIO.1065			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23001033	Green Accepted			2022-12-27	WOS:000310052100006
J	Gildersleeve, JC				Gildersleeve, Jeffrey C.			GLYCOSYLTRANSFERASES Carb loading strategy is spot on	NATURE CHEMICAL BIOLOGY			English	News Item							MICROARRAYS; SPECIFICITIES; GLYCANS		NCI, Biol Chem Lab, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gildersleeve, JC (corresponding author), NCI, Biol Chem Lab, Frederick, MD 21701 USA.	gildersj@mail.nih.gov	Gildersleeve, Jeffrey/N-3392-2014	Gildersleeve, Jeffrey/0000-0002-3744-6423				Ban L, 2012, NAT CHEM BIOL, V8, P769, DOI [10.1038/NCHEMBIO.1022, 10.1038/nchembio.1022]; Blixt O, 2008, GLYCOCONJUGATE J, V25, P59, DOI 10.1007/s10719-007-9062-z; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Laurent N, 2008, CHEMBIOCHEM, V9, P883, DOI 10.1002/cbic.200700692; Muthana SM, 2012, ACS CHEM BIOL, V7, P31, DOI 10.1021/cb2004466; Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P406, DOI 10.1016/j.cbpa.2009.06.021; Park S, 2007, ORG LETT, V9, P1675, DOI 10.1021/ol070250l; Sanchez-Ruiz A, 2011, ANGEW CHEM INT EDIT, V50, P1801, DOI 10.1002/anie.201006304; Seibel J, 2006, CHEMBIOCHEM, V7, P310, DOI 10.1002/cbic.200500350; Su J, 2002, ANGEW CHEM INT EDIT, V41, P4715, DOI 10.1002/anie.200290026	10	2	2	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					741	742		10.1038/nchembio.1049	http://dx.doi.org/10.1038/nchembio.1049			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22907089				2022-12-27	WOS:000308077600002
J	Lee, JW; Na, D; Park, JM; Lee, J; Choi, S; Lee, SY				Lee, Jeong Wook; Na, Dokyun; Park, Jong Myoung; Lee, Joungmin; Choi, Sol; Lee, Sang Yup			Systems metabolic engineering of microorganisms for natural and non-natural chemicals	NATURE CHEMICAL BIOLOGY			English	Review							PSEUDOMONAS-PUTIDA S12; ESCHERICHIA-COLI-C; PATHWAY OPTIMIZATION; CORYNEBACTERIUM-GLUTAMICUM; TRANSCRIPTOME ANALYSIS; COMPUTATIONAL DESIGN; MICROBIAL-PRODUCTION; GENE-EXPRESSION; POLYLACTIC ACID; CARBON DIAMINE	Growing concerns over limited fossil resources and associated environmental problems are motivating the development of sustainable processes for the production of chemicals, fuels and materials from renewable resources. Metabolic engineering is a key enabling technology for transforming microorganisms into efficient cell factories for these compounds. Systems metabolic engineering, which incorporates the concepts and techniques of systems biology, synthetic biology and evolutionary engineering at the systems level, offers a conceptual and technological framework to speed the creation of new metabolic enzymes and pathways or the modification of existing pathways for the optimal production of desired products. Here we discuss the general strategies of systems metabolic engineering and examples of its application and offer insights as to when and how each of the different strategies should be used. Finally, we highlight the limitations and challenges to be overcome for the systems metabolic engineering of microorganisms at more advanced levels.	[Lee, Jeong Wook; Na, Dokyun; Park, Jong Myoung; Lee, Joungmin; Choi, Sol; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Brain Korea Program 21, Ctr Syst & Synthet Biotechnol,Inst BioCentury, Taejon 305701, South Korea; [Lee, Jeong Wook; Lee, Sang Yup] Korea Adv Inst Sci & Technol, BioProc Engn Res Ctr, Taejon 305701, South Korea; [Na, Dokyun; Park, Jong Myoung; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Bioinformat Res Ctr, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, JW (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Brain Korea Program 21, Ctr Syst & Synthet Biotechnol,Inst BioCentury, Taejon 305701, South Korea.	leesy@kaist.ac.kr	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091; Lee, Jeong Wook/0000-0003-0705-0177; Na, Dokyun/0000-0002-9107-7040	Advanced Biomass Research and Development Center of Korea through the Ministry of Education, Science and Technology (MEST) [ABC-2010-0029799]; Intelligent Synthetic Biology Center through the MEST [2011-0031963]; MEST [R32-2008-000-10142-0]	Advanced Biomass Research and Development Center of Korea through the Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Intelligent Synthetic Biology Center through the MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank H.U. Kim for helpful discussion. This work was supported by the Advanced Biomass Research and Development Center of Korea (ABC-2010-0029799) through the Global Frontier Research Program (GFRP) of the Ministry of Education, Science and Technology (MEST) and also by the Intelligent Synthetic Biology Center (2011-0031963) through the GFRP of MEST. We also thank the World Class University program (R32-2008-000-10142-0) of MEST for additional support.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.98; Auriol C, 2011, P NATL ACAD SCI USA, V108, P1278, DOI 10.1073/pnas.1010431108; Bastian S, 2011, METAB ENG, V13, P345, DOI 10.1016/j.ymben.2011.02.004; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Becker J, 2010, ENG LIFE SCI, V10, P430, DOI 10.1002/elsc.201000008; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burk M.J., 2010, US Patent, Patent No. 0317069; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Charusanti P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001186; Chemler JA, 2010, METAB ENG, V12, P96, DOI 10.1016/j.ymben.2009.07.003; Cho A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-35; Choi HS, 2010, APPL ENVIRON MICROB, V76, P3097, DOI 10.1128/AEM.00115-10; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Ehsani M, 2009, BIOTECHNOL BIOENG, V104, P381, DOI 10.1002/bit.22391; Eiteman Mark A, 2008, J Biol Eng, V2, P3, DOI 10.1186/1754-1611-2-3; Feldman HJ, 2005, FEBS LETT, V579, P4685, DOI 10.1016/j.febslet.2005.07.039; Finley SD, 2009, BIOTECHNOL BIOENG, V104, P1086, DOI 10.1002/bit.22489; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Henry CS, 2010, BIOTECHNOL BIOENG, V106, P462, DOI 10.1002/bit.22673; Jantama K, 2008, BIOTECHNOL BIOENG, V101, P881, DOI 10.1002/bit.22005; Jantama K, 2008, BIOTECHNOL BIOENG, V99, P1140, DOI 10.1002/bit.21694; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jung YK, 2010, BIOTECHNOL BIOENG, V105, P161, DOI 10.1002/bit.22548; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3; Lale R, 2011, APPL ENVIRON MICROB, V77, P2648, DOI 10.1128/AEM.02091-10; Lee JW, 2011, TRENDS BIOTECHNOL, V29, P370, DOI 10.1016/j.tibtech.2011.04.001; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Lee SJ, 2006, APPL ENVIRON MICROB, V72, P1939, DOI 10.1128/AEM.72.3.1939-1948.2006; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Lindner SN, 2011, APPL ENVIRON MICROB, V77, P3571, DOI 10.1128/AEM.02713-10; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; Ma SM, 2011, METAB ENG, V13, P588, DOI 10.1016/j.ymben.2011.07.001; Martinez I, 2008, METAB ENG, V10, P352, DOI 10.1016/j.ymben.2008.09.001; McKenna R, 2011, METAB ENG, V13, P544, DOI 10.1016/j.ymben.2011.06.005; McShan D, 2005, COMPUT CHEM ENG, V29, P499, DOI 10.1016/j.compchemeng.2004.08.038; McShan DC, 2003, BIOINFORMATICS, V19, P1692, DOI 10.1093/bioinformatics/btg217; Medema MH, 2012, NAT REV MICROBIOL, V10, P191, DOI 10.1038/nrmicro2717; Moon TS, 2010, METAB ENG, V12, P298, DOI 10.1016/j.ymben.2010.01.003; Moriya Y, 2010, NUCLEIC ACIDS RES, V38, pW138, DOI 10.1093/nar/gkq318; Na D, 2010, CURR OPIN MICROBIOL, V13, P363, DOI 10.1016/j.mib.2010.02.004; Na D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-71; Nichols NN, 2001, APPL MICROBIOL BIOT, V56, P120, DOI 10.1007/s002530100628; Noirel J, 2009, MOL BIOSYST, V5, P1214, DOI 10.1039/b904729h; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Park JM, 2010, P NATL ACAD SCI USA, V107, P14931, DOI 10.1073/pnas.1003740107; Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Prather KLJ, 2008, CURR OPIN BIOTECH, V19, P468, DOI 10.1016/j.copbio.2008.07.009; Qian ZG, 2011, BIOTECHNOL BIOENG, V108, P93, DOI 10.1002/bit.22918; Qian ZG, 2009, BIOTECHNOL BIOENG, V104, P651, DOI 10.1002/bit.22502; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Ren C, 2009, MICROB CELL FACT, V8, DOI [10.1186/1475-2859-8-66, 10.1186/1475-2859-8-67]; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shen CR, 2011, APPL ENVIRON MICROB, V77, P2905, DOI 10.1128/AEM.03034-10; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Solomon KV, 2011, BIOTECHNOL J, V6, P1064, DOI 10.1002/biot.201100086; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Wierckx NJP, 2008, J BACTERIOL, V190, P2822, DOI 10.1128/JB.01379-07; Wierckx NJP, 2005, APPL ENVIRON MICROB, V71, P8221, DOI 10.1128/AEM.71.12.8221-8227.2005; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; Yang L, 2011, METAB ENG, V13, P272, DOI 10.1016/j.ymben.2011.03.002; Yang TH, 2010, BIOTECHNOL BIOENG, V105, P150, DOI 10.1002/bit.22547; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang KC, 2010, P NATL ACAD SCI USA, V107, P6234, DOI 10.1073/pnas.0912903107; Zhang X, 2007, APPL MICROBIOL BIOT, V77, P355, DOI 10.1007/s00253-007-1170-y; Zhang XL, 2009, P NATL ACAD SCI USA, V106, P20180, DOI 10.1073/pnas.0905396106; Zhao YR, 2011, APPL MICROBIOL BIOT, V90, P1915, DOI 10.1007/s00253-011-3199-1; Zhuang K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.34	92	497	537	26	462	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					536	546		10.1038/NCHEMBIO.970	http://dx.doi.org/10.1038/NCHEMBIO.970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22596205				2022-12-27	WOS:000304256300009
J	Zhang, L; Yan, F; Zhang, SL; Lei, DS; Charles, MA; Cavigiolio, G; Oda, M; Krauss, RM; Weisgraber, KH; Rye, KA; Pownall, HJ; Qiu, XY; Ren, G				Zhang, Lei; Yan, Feng; Zhang, Shengli; Lei, Dongsheng; Charles, M. Arthur; Cavigiolio, Giorgio; Oda, Michael; Krauss, Ronald M.; Weisgraber, Karl H.; Rye, Kerry-Anne; Pownall, Henry J.; Qiu, Xiayang; Ren, Gang			Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein	NATURE CHEMICAL BIOLOGY			English	Article							HIGH-DENSITY-LIPOPROTEIN; NEGATIVE-STAINING PROTOCOL; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; NEUTRAL LIPIDS; HEART-DISEASE; A-I; RESOLUTION; VISUALIZATION; BINDING	Human cholesteryl ester transfer protein (CETP) mediates the net transfer of cholesteryl ester mass from atheroprotective high-density lipoproteins to atherogenic low-density lipoproteins by an unknown mechanism. Delineating this mechanism would be an important step toward the rational design of new CETP inhibitors for treating cardiovascular diseases. Using EM, single-particle image processing and molecular dynamics simulation, we discovered that CETP bridges a ternary complex with its N-terminal beta-barrel domain penetrating into high-density lipoproteins and its C-terminal domain interacting with low-density lipoprotein or very-low-density lipoprotein. In our mechanistic model, the CETP lipoprotein-interacting regions, which are highly mobile, form pores that connect to a hydrophobic central cavity, thereby forming a tunnel for transfer of neutral lipids from donor to acceptor lipoproteins. These new insights into CETP transfer provide a molecular basis for analyzing mechanisms for CETP inhibition.	[Zhang, Lei; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Zhang, Lei; Yan, Feng; Charles, M. Arthur; Ren, Gang] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Zhang, Lei; Zhang, Shengli; Lei, Dongsheng; Ren, Gang] Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Peoples R China; [Cavigiolio, Giorgio; Oda, Michael; Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; [Rye, Kerry-Anne] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia; [Rye, Kerry-Anne] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Rye, Kerry-Anne] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Pownall, Henry J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Qiu, Xiayang] Pfizer Inc, Groton, CT 06340 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Xi'an Jiaotong University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Sydney; Heart Research Institute; University of Sydney; University of Melbourne; Baylor College of Medicine; Pfizer	Zhang, L (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA.	gren@lbl.gov	Zhang, Lei/G-6427-2012; Ren, Gang/B-1567-2012; Zhang, Shengli/G-5219-2010; Lei, Dongsheng/AAH-4177-2020; Lei, Dongsheng/K-3485-2012	Zhang, Lei/0000-0002-4880-824X; Ren, Gang/0000-0002-8036-2321; Zhang, Shengli/0000-0002-5866-7591; Lei, Dongsheng/0000-0003-1640-0693; Pownall, Henry/0000-0001-8412-506X; Cavigiolio, Giorgio/0000-0002-1622-0628	Basic Energy Sciences-US Department of Energy [DE-AC02-05CH11231]; W. M. Keck Foundation [011808]; Chinese Ministry of Education [708082]; US National Institutes of Health [NIH-HL077268]; Tobacco-Related Disease Research Program of California [16FT-0163]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153, R01HL077268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104427] Funding Source: NIH RePORTER	Basic Energy Sciences-US Department of Energy(United States Department of Energy (DOE)); W. M. Keck Foundation(W.M. Keck Foundation); Chinese Ministry of Education(Ministry of Education, China); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program of California(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D.A. Agard, I. Bahar and K. Dill for valuable discussions and A. Cheng and J. Song for helpful comments. This work was supported by Basic Energy Sciences-US Department of Energy (DE-AC02-05CH11231) and the W. M. Keck Foundation (no. 011808); the Keygrant Project of the Chinese Ministry of Education no. 708082 (S.Z.); US National Institutes of Health grant NIH-HL077268 and Tobacco-Related Disease Research Program of California grant 16FT-0163 (M.O.).	Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; BARTER PJ, 1980, J LIPID RES, V21, P238; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; CAMEJO G, 1976, ATHEROSCLEROSIS, V24, P341, DOI 10.1016/0021-9150(76)90126-X; Chen B, 2009, PROTEIN SCI, V18, P921, DOI 10.1002/pro.101; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Han M, 2009, BIOCHEMISTRY-US, V48, P1481, DOI 10.1021/bi802287q; Hayat M.A.M., 1990, NEGATIVE STAINING; HAYEK T, 1993, J CLIN INVEST, V92, P1143, DOI 10.1172/JCI116683; IHM J, 1982, J LIPID RES, V23, P1328; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Kappelle PJWH, 2011, CARDIOVASC THER, V29, pE89, DOI 10.1111/j.1755-5922.2010.00201.x; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Miyares MA, 2011, ANN PHARMACOTHER, V45, P84, DOI 10.1345/aph.1P446; Morton RE, 2003, J LIPID RES, V44, P1364, DOI 10.1194/jlr.M300063-JLR200; Niesor EJ, 2011, CURR OPIN LIPIDOL, V22, P288, DOI 10.1097/MOL.0b013e3283475e00; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; SWENSON TL, 1988, J BIOL CHEM, V263, P5150; TALL AR, 1993, J LIPID RES, V34, P1255; WANG SK, 1995, J BIOL CHEM, V270, P612, DOI 10.1074/jbc.270.2.612; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493	41	103	104	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					342	349		10.1038/NCHEMBIO.796	http://dx.doi.org/10.1038/NCHEMBIO.796			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22344176	Green Accepted			2022-12-27	WOS:000301890100008
J	Hantschel, O; Warsch, W; Eckelhart, E; Kaupe, I; Grebien, F; Wagner, KU; Superti-Furga, G; Sexl, V				Hantschel, Oliver; Warsch, Wolfgang; Eckelhart, Eva; Kaupe, Ines; Grebien, Florian; Wagner, Kay-Uwe; Superti-Furga, Giulio; Sexl, Veronika			BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia	NATURE CHEMICAL BIOLOGY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; PATIENTS RECEIVING IMATINIB; DNA-BINDING ACTIVITY; JAK2 INHIBITOR; KINASE INHIBITOR; MYELOPROLIFERATIVE NEOPLASMS; TYROSINE PHOSPHORYLATION; PHILADELPHIA-CHROMOSOME; POLYCYTHEMIA-VERA; FOLLOW-UP	Constitutive activation of STAT5 is critical for the maintenance of chronic myeloid leukemia (CML) characterized by the BCR-ABL oncoprotein. Tyrosine kinase inhibitors (TKIs) for the STAT5-activating kinase JAK2 have been discussed as a treatment option for CML patients. Using murine leukemia models combined with inducible ablation of JAK2, we show JAK2 dependence for initial lymphoid transformation, which is lost once leukemia is established. In contrast, initial myeloid transformation and leukemia maintenance were independent of JAK2. Nevertheless, several JAK2 TKIs induced apoptosis in BCR-ABL(+) cells irrespective of the presence of JAK2. This is caused by the previously unknown direct 'off-target' inhibition of BCR-ABL. Cellular and enzymatic analyses suggest that BCR-ABL phosphorylates STAT5 directly. Our findings suggest uncoupling of the canonical JAK2-STAT5 module upon BCR-ABL expression, thereby making JAK2 targeting dispensable. Thus, attempts to pharmacologically target STAT5 in BCR-ABL+ diseases need to focus on STAT5 itself.	[Hantschel, Oliver; Kaupe, Ines; Grebien, Florian; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Hantschel, Oliver] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Warsch, Wolfgang; Sexl, Veronika] Vet Univ Vienna, Inst Pharmacol & Toxicol, A-1030 Vienna, Austria; [Eckelhart, Eva] Med Univ Vienna, Ctr Pharmacol & Physiol, Vienna, Austria; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Nebraska System; University of Nebraska Medical Center	Hantschel, O (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	gsuperti@cemm.oeaw.ac; veronika.sexl@vetmeduni.ac.at	Hantschel, Oliver/M-7016-2019; Grebien, Florian/H-9234-2019; Wagner, Kay-Uwe/B-6044-2009; Superti-Furga, Giulio/AAE-5681-2019; Hantschel, Oliver D/H-4705-2013; Superti-Furga, Giulio/F-4755-2015; Sexl, Veronika/B-8657-2016	Hantschel, Oliver/0000-0001-8569-8169; Grebien, Florian/0000-0003-4289-2281; Hantschel, Oliver D/0000-0001-8569-8169; Superti-Furga, Giulio/0000-0002-0570-1768; Sexl, Veronika/0000-0001-9363-0412; Wagner, Kay-Uwe/0000-0002-5081-0226	GenAU-PLACEBO;  [WWTF-LS037];  [SFB-28-10]	GenAU-PLACEBO; ; 	This work was supported by grants WWTF-LS037 and SFB-28-10 to VS. and GenAU-PLACEBO to G.S-F. and V.S. We thank S. Georgeon for expert technical assistance. We thank all members of participating laboratories and R. Moriggl and T. Decker for continuous support and discussions.	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Geron I, 2008, CANCER CELL, V13, P321, DOI 10.1016/j.ccr.2008.02.017; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Lasho TL, 2008, LEUKEMIA, V22, P1790, DOI 10.1038/leu.2008.56; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Miyamoto N, 2001, LEUKEMIA, V15, P1758, DOI 10.1038/sj.leu.2402260; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nicolini FE, 2009, BLOOD, V114, P5271, DOI 10.1182/blood-2009-04-219410; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Pardanani A, 2011, LEUKEMIA, V25, P218, DOI 10.1038/leu.2010.269; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Samanta A, 2011, LEUKEMIA, V25, P463, DOI 10.1038/leu.2010.287; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Shuai K, 1996, ONCOGENE, V13, P247; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Titz B, 2010, ONCOGENE, V29, P5895, DOI 10.1038/onc.2010.331; Wagner KU, 2004, MOL CELL BIOL, V24, P5510, DOI 10.1128/MCB.24.12.5510-5520.2004; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Ye D, 2006, BLOOD, V107, P4917, DOI 10.1182/blood-2005-10-4110	50	128	129	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					285	293		10.1038/NCHEMBIO.775	http://dx.doi.org/10.1038/NCHEMBIO.775			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22286129				2022-12-27	WOS:000300600000014
J	Francis, DM; Rozycki, B; Koveal, D; Hummer, G; Page, R; Peti, W				Francis, Dana M.; Rozycki, Bartosz; Koveal, Dorothy; Hummer, Gerhard; Page, Rebecca; Peti, Wolfgang			Structural basis of p38 alpha regulation by hematopoietic tyrosine phosphatase	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; DOCKING INTERACTIONS; CATALYTIC DOMAIN; SUBSTRATE RECOGNITION; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; PTP-SL; ERK2; P38	MAP kinases regulate essential cellular events, including cell growth, differentiation and inflammation. The solution structure of a complete MAPK-MAPK-regulatory protein complex, p38 alpha-HePTP, was determined, enabling a comprehensive investigation of the molecular basis of specificity and fidelity in MAPK regulation. Structure determination was achieved by combining NMR spectroscopy and small-angle X-ray scattering data with a new ensemble calculation-refinement procedure. We identified 25 residues outside of the HePTP kinase interaction motif necessary for p38 alpha recognition. The complex adopts an extended conformation in solution and rarely samples the conformation necessary for kinase deactivation. Complex formation also does not affect the N-terminal lobe, the activation loop of p38 alpha or the catalytic domain of HePTP. Together, these results show how the downstream tyrosine phosphatase HePTP regulates p38 alpha and provide for fundamentally new insights into MAPK regulation and specificity.	[Koveal, Dorothy; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Francis, Dana M.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Rozycki, Bartosz; Hummer, Gerhard] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	Brown University; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Page, R (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	rebecca_page@brown.edu; wolfgang_peti@brown.edu	Rozycki, Bartosz/B-7005-2009; Peti, Wolfgang/L-3492-2014; Hummer, Gerhard/A-2546-2013	Rozycki, Bartosz/0000-0001-5938-7308; Hummer, Gerhard/0000-0001-7768-746X	American Cancer Society [RSG-08-067-01-LIB]; Seventh European Community; National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health (NIH); US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100910, T32GM007601] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Seventh European Community; National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Yang and M. Allaire (National Synchrotron Light Source, NSLS) for their support at NSLS beamline X9. The authors thank P. Vogel (Southern Methodist University) for providing SL-ATP for the titration studies. This research was supported by grant RSG-08-067-01-LIB from the American Cancer Society to R. P. B. R. was supported by a Marie Curie International Outgoing Fellowship within the Seventh European Community Framework Program. B. R. and G. H. were supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health (NIH). Use of the NSLS at Brookhaven National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-98CH10886. 800 MHz NMR data were recorded at Brandeis University and were purchased with support from NIH S10-RR017269. Molecular simulations were performed on the Biowulf computing cluster at NIH.	Akella R, 2010, STRUCTURE, V18, P1571, DOI 10.1016/j.str.2010.09.015; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Balasu MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005432; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; COBB MH, 1994, CELL MOL BIOL RES, V40, P253; Critton DA, 2008, BIOCHEMISTRY-US, V47, P13336, DOI 10.1021/bi801724n; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; Esposito V, 2006, J BIOMOL NMR, V36, P64, DOI 10.1007/s10858-006-9050-9; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gong HP, 2010, BIOPHYS J, V98, P470, DOI 10.1016/j.bpj.2009.10.031; HENDRIKS W, 1995, BIOCHEM J, V305, P499, DOI 10.1042/bj3050499; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hoffman AD, 2010, PROTEIN J, V29, P373, DOI 10.1007/s10930-010-9262-4; Jeeves M, 2008, BIOMOL NMR ASSIGN, V2, P101, DOI 10.1007/s12104-008-9095-7; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Ma WF, 2010, STRUCTURE, V18, P1502, DOI 10.1016/j.str.2010.08.011; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Mustelin T, 2005, J MOL BIOL, V354, P150, DOI 10.1016/j.jmb.2005.09.049; Perry JJP, 2009, J MOL BIOL, V391, P1, DOI 10.1016/j.jmb.2009.06.005; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Piserchio A, 2011, BIOCHEMISTRY-US, V50, P3660, DOI 10.1021/bi2000559; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Vajpai N, 2008, BIOMOL NMR ASSIGM, V2, P41, DOI 10.1007/s12104-008-9079-7; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Vogtherr M, 2005, J BIOMOL NMR, V32, P175, DOI 10.1007/s10858-005-2449-x; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	47	64	64	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					916	924		10.1038/NCHEMBIO.707	http://dx.doi.org/10.1038/NCHEMBIO.707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22057126	Green Accepted			2022-12-27	WOS:000297166200015
J	Cherfils, J; Zeghouf, M				Cherfils, Jacqueline; Zeghouf, Mahel			Chronicles of the GTPase switch	NATURE CHEMICAL BIOLOGY			English	Article							CONFORMATIONAL SWITCH; SIGNAL-TRANSDUCTION; EXCHANGE FACTOR; G-PROTEINS; RAS; DOMAIN; DIMERIZATION; INHIBITION		[Cherfils, Jacqueline; Zeghouf, Mahel] Ctr Rech Gif, CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cherfils, J (corresponding author), Ctr Rech Gif, CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.	cherfils@lebs.cnrs-gif.fr		Zeghouf, Mahel/0000-0003-3686-2510				Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Biou V, 2010, J MOL BIOL, V402, P696, DOI 10.1016/j.jmb.2010.08.002; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brown ED, 2005, BIOCHEM CELL BIOL, V83, P738, DOI 10.1139/O05-162; Buosi V, 2010, J BIOL CHEM, V285, P37987, DOI 10.1074/jbc.M110.134445; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Stalder D, 2011, J BIOL CHEM, V286, P3873, DOI 10.1074/jbc.M110.145532; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	26	38	38	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					493	495		10.1038/nchembio.608	http://dx.doi.org/10.1038/nchembio.608			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769091				2022-12-27	WOS:000292825400005
J	Xiao, BL; Coste, B; Mathur, J; Patapoutian, A				Xiao, Bailong; Coste, Bertrand; Mathur, Jayanti; Patapoutian, Ardem			Temperature-dependent STIM1 activation induces Ca2+ influx and modulates gene expression	NATURE CHEMICAL BIOLOGY			English	Article							STROMAL INTERACTION MOLECULE-1; OPERATED CALCIUM-ENTRY; T-CELL; IMMUNE-RESPONSE; PLASMA-MEMBRANE; ORAI CHANNELS; TRPC CHANNELS; CRAC CHANNELS; STORE; SENSOR	Intracellular Ca2+ is essential for diverse cellular functions. Ca2+ entry into many cell types including immune cells is triggered by depleting endoplasmic reticulum ( ER) Ca2+, a process termed store-operated Ca2+ entry (SOCE). STIM1 is an ER Ca2+ sensor. Upon Ca2+ store depletion, STIM1 clusters at ER-plasma membrane junctions where it interacts with and gates Ca2+-permeable Orai1 ion channels. Here we show that STIM1 is also activated by temperature. Heating cells caused clustering of STIM1 at temperatures above 35 degrees C without depleting Ca2+ stores and led to Orai1-mediated Ca2+ influx as a heat off-response ( response after cooling). Notably, the functional coupling of STIM1 and Orai1 is prevented at high temperatures, potentially explaining the heat off-response. Additionally, physiologically relevant temperature shifts modulate STIM1-dependent gene expression in Jurkat T cells. Therefore, temperature is an important regulator of STIM1 function.	[Xiao, Bailong; Coste, Bertrand; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Mathur, Jayanti; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; Novartis	Xiao, BL (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	apatapou@gnf.org	Xiao, Bailong/B-6187-2012	Coste, Bertrand/0000-0002-0163-2494	US National Institutes of Health [DE016927, NS046303]; Novartis Research Foundation; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; American Heart Association; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R.Y. Tsien (University of California, San Diego), P. Shultz (The Scripps Research Institute), S.-S. Tian (Genomics Institute of the Novartis Research Foundation, GNF), A. Parker (GNF), D. Tully (GNF) and S. F. Pan (GNF) for providing reagents; E. Rodrigo, E. Peters, J. Liu, K. Spencer, T. Earley, D. Li and J. Mitsios for experimental help; M. Schmidt for providing advice on GFP-STIM1 puncta analysis; C. Schmedt, M. Cooke, D. Geurini, S.-S. Tian and S. Sanford for discussions; and N. Hong and J. Grandl for reading the manuscript. This research was supported by US National Institutes of Health grants DE016927 and NS046303 and by the Novartis Research Foundation. B. X. is a postdoctoral fellowship recipient from Canadian Institutes of Health Research, Alberta Heritage Foundation for Medical Research and American Heart Association. B. C. is a postdoctoral fellowship recipient from American Heart Association.	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Feske S, 2010, CLIN IMMUNOL, V135, P169, DOI 10.1016/j.clim.2010.01.011; GERN JE, 1991, CYTOKINE, V3, P389, DOI 10.1016/1043-4666(91)90042-C; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hanson DF, 1997, ANN NY ACAD SCI, V813, P453, DOI 10.1111/j.1749-6632.1997.tb51733.x; HANSON DF, 1983, J IMMUNOL, V130, P216; HANSON DF, 1993, J IMMUNOL, V151, P436; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kenny GP, 2003, J APPL PHYSIOL, V94, P2350, DOI 10.1152/japplphysiol.01107.2002; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; LEDERMAN HM, 1987, J IMMUNOL, V138, P3808; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Oliver AE, 2000, BIOPHYS J, V78, P2116, DOI 10.1016/S0006-3495(00)76758-0; PaltaufDoburzynska J, 1997, CELL CALCIUM, V21, P43, DOI 10.1016/S0143-4160(97)90095-6; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xie Y., 2006, Compounds for inflammation and immune-related uses, Patent No. [2006081391 A2, 2006081391]; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129	47	95	101	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					351	358		10.1038/NCHEMBIO.558	http://dx.doi.org/10.1038/NCHEMBIO.558			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21499266	Green Accepted			2022-12-27	WOS:000290677900010
J	Dandapani, S; Marcaurelle, LA				Dandapani, Sivaraman; Marcaurelle, Lisa A.			Accessing new chemical space for 'undruggable' targets	NATURE CHEMICAL BIOLOGY			English	Article							DIVERSITY-ORIENTED SYNTHESIS; SMALL-MOLECULE; DISCOVERY; CHEMISTRY	The synthesis and biological annotation of small molecules from underexplored chemical space will play a central role in the development of drugs for challenging targets currently being identified in frontier areas of biological research such as human genetics.				sivaram@broadinstitute.org; lisa@broadinstitute.org						Blake JF, 2004, CURR OPIN CHEM BIOL, V8, P407, DOI 10.1016/j.cbpa.2004.04.017; Clemons PA, 2010, P NATL ACAD SCI USA, V107, P18787, DOI 10.1073/pnas.1012741107; Dandapani S, 2010, CURR OPIN CHEM BIOL, V14, P362, DOI 10.1016/j.cbpa.2010.03.018; Danishefsky S, 2010, NAT PROD REP, V27, P1114, DOI 10.1039/c003211p; Drewry DH, 2010, CURR OPIN CHEM BIOL, V14, P289, DOI 10.1016/j.cbpa.2010.03.024; Francotte E, 2006, CHIRALITY DRUG RES; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Marcaurelle LA, 2009, BIOORG MED CHEM LETT, V19, P2500, DOI 10.1016/j.bmcl.2009.03.037; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Shelat AA, 2007, CURR OPIN CHEM BIOL, V11, P244, DOI 10.1016/j.cbpa.2007.05.003; Stanton BZ, 2009, NAT CHEM BIOL, V5, P154, DOI 10.1038/nchembio.142; Tan DS, 2005, NAT CHEM BIOL, V1, P74, DOI 10.1038/nchembio0705-74; Tepper RI, 2009, GENOMIC AND PERSONALIZED MEDICINE, VOL 1, P335; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013	15	166	166	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					861	863		10.1038/nchembio.479	http://dx.doi.org/10.1038/nchembio.479			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079589				2022-12-27	WOS:000284214700005
J	Bruning, JB; Parent, AA; Gil, G; Zhao, M; Nowak, J; Pace, MC; Smith, CL; Afonine, PV; Adams, PD; Katzenellenbogen, JA; Nettles, KW				Bruning, John B.; Parent, Alexander A.; Gil, German; Zhao, Min; Nowak, Jason; Pace, Margaret C.; Smith, Carolyn L.; Afonine, Pavel V.; Adams, Paul D.; Katzenellenbogen, John A.; Nettles, Kendall W.			Coupling of receptor conformation and ligand orientation determine graded activity	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL BASIS; MOLECULAR-BASIS; HIGH-THROUGHPUT; BINDING; AGONISTS; AUTOINHIBITION; SPECIFICITY; ANTAGONISM; MODULATION; MODE	Small molecules stabilize specific protein conformations from a larger ensemble, enabling molecular switches that control diverse cellular functions. We show here that the converse also holds true: the conformational state of the estrogen-receptor can direct distinct orientations of the bound ligand. 'Gain-of-allostery' mutations that mimic the effects of ligand in driving protein conformation allowed crystallization of the partial agonist ligand WAY-169916 with both the canonical active and inactive-conformations of the estrogen receptor. The intermediate transcriptional activity induced by WAY-169916 is-associated with the ligand binding differently to the active and inactive conformations of the receptor. Analyses of a series of chemical derivatives demonstrated that altering the ensemble of ligand binding orientations changes signaling output. The coupling of different ligand binding orientations to distinct active and inactive protein conformations defines a new mechanism for titrating allosteric signaling activity.	[Bruning, John B.; Gil, German; Zhao, Min; Nowak, Jason; Nettles, Kendall W.] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Parent, Alexander A.; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Pace, Margaret C.; Smith, Carolyn L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Afonine, Pavel V.; Adams, Paul D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bruning, JB (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA.	knettles@scripps.edu	Adams, Paul David/A-1977-2013; GIL, GERMAN A./T-3018-2019; Bruning, John/AAW-8567-2020	Adams, Paul David/0000-0001-9333-8219; GIL, GERMAN A./0000-0001-6714-2693; Bruning, John/0000-0002-6919-1824	US National Institutes of Health [PHS R37 DK15556, DK53002, CA132022, DK077085]; Frenchman's Creek Women for Cancer Research; NATIONAL CANCER INSTITUTE [R33CA132022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053002, R37DK015556, R01DK077085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056998] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frenchman's Creek Women for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the US National Institutes of Health PHS R37 DK15556 (J.A.K.), DK53002 (C.L.S.), CA132022 and DK077085 (K.W.N.) and the Frenchman's Creek Women for Cancer Research (G.G.). We would like to thank J. Cleveland for comments on the manuscript, L. Potterton and S. McNicholas (University of York) for help with CCP4MG and K. Carlson (University of Illinois) for performing the ER alpha ligand-binding assays.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angell RM, 2008, BIOORG MED CHEM LETT, V18, P4433, DOI 10.1016/j.bmcl.2008.06.028; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhavnani BR, 1998, P SOC EXP BIOL MED, V217, P6; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bramlett KS, 2003, J PHARMACOL EXP THER, V307, P291, DOI 10.1124/jpet.103.052852; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chadwick CC, 2005, P NATL ACAD SCI USA, V102, P2543, DOI 10.1073/pnas.0405841102; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelman L, 2007, BBA-MOL CELL BIOL L, V1771, P1094, DOI 10.1016/j.bbalip.2007.03.004; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Lewis JA, 2008, CURR OPIN CHEM BIOL, V12, P269, DOI 10.1016/j.cbpa.2008.02.014; Love JD, 2002, J BIOL CHEM, V277, P11385, DOI 10.1074/jbc.M110869200; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Norman BH, 2006, J MED CHEM, V49, P6155, DOI 10.1021/jm060491j; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sablin EP, 2001, CURR OPIN STRUC BIOL, V11, P716, DOI 10.1016/S0959-440X(01)00265-2; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Shan L, 2004, MOL CELL, V16, P907, DOI 10.1016/S1097-2765(04)00728-2; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Steffan RJ, 2004, J MED CHEM, V47, P6435, DOI 10.1021/jm049194+; Steitz TA, 2006, EMBO J, V25, P3458, DOI 10.1038/sj.emboj.7601211; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Velyvis A, 2007, P NATL ACAD SCI USA, V104, P8815, DOI 10.1073/pnas.0703347104; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yamasaki K, 2002, TOXICOLOGY, V170, P21, DOI 10.1016/S0300-483X(01)00505-4; Zhou HB, 2007, CHEM BIOL, V14, P659, DOI 10.1016/j.chembiol.2007.04.009	48	102	104	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					837	843		10.1038/NCHEMBIO.451	http://dx.doi.org/10.1038/NCHEMBIO.451			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20924370	Green Accepted			2022-12-27	WOS:000283197800013
J	Castro-Roa, D; Garcia-Pino, A; De Gieter, S; van Nuland, NAJ; Loris, R; Zenkin, N				Castro-Roa, Daniel; Garcia-Pino, Abel; De Gieter, Steven; van Nuland, Nico A. J.; Loris, Remy; Zenkin, Nikolay			The Fic protein Doc uses an inverted substrate to phosphorylate and inactivate EF-Tu	NATURE CHEMICAL BIOLOGY			English	Article							INHIBITS TRANSLATION; CRYSTAL-STRUCTURE; PROPHAGE P1; AMPYLATION; PHD; ELONGATION; SYSTEM; RNA; MECHANISM; DOCKING	Fic proteins are ubiquitous in all of the domains of life and have critical roles in multiple cellular processes through AMPylation of (transfer of AMP to) target proteins. Doc from the doc-phd toxin-antitoxin module is a member of the Fic family and inhibits bacterial translation by an unknown mechanism. Here we show that, in contrast to having AMPylating activity, Doc is a new type of kinase that inhibits bacterial translation by phosphorylating the conserved threonine (Thr382) of the translation elongation factor EF-Tu, rendering EF-Tu unable to bind aminoacylated tRNAs. We provide evidence that EF-Tu phosphorylation diverged from AMPylation by antiparallel binding of the NTP relative to the catalytic residues of the conserved Fic catalytic core of Doc. The results bring insights into the mechanism and role of phosphorylation of EF-Tu in bacterial physiology as well as represent an example of the catalytic plasticity of enzymes and a mechanism for the evolution of new enzymatic activities.	[Castro-Roa, Daniel; Zenkin, Nikolay] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Garcia-Pino, Abel; De Gieter, Steven; van Nuland, Nico A. J.; Loris, Remy] VUB, Struct Biol Brussels, Dept Biotechnol, Brussels, Belgium; [Garcia-Pino, Abel; De Gieter, Steven; van Nuland, Nico A. J.; Loris, Remy] VIB, Mol Recognit Unit, Dept Biol Struct, Brussels, Belgium	Newcastle University - UK; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Zenkin, N (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	agarciap@vub.ac.be; n.zenkin@ncl.ac.uk	Loris, Remy/GPG-0894-2022	Garcia-Pino, Abel/0000-0002-0634-0300; DE GIETER, STEVEN/0000-0002-2776-3791; Loris, Remy/0000-0002-8862-3338; Zenkin, Nikolay/0000-0003-2212-9545	UK Biotechnology and Biological Sciences Research Council; European Research Council [ERC-2007-StG 202994-MTP]; Onderzoeksraad of the VUB; Fonds Wetenschappelijk Onderzoek (FWO)-Vlaanderen; Hercules Foundation; VIB; Biotechnology and Biological Sciences Research Council [BB/J006378/1] Funding Source: researchfish; BBSRC [BB/J006378/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Onderzoeksraad of the VUB; Fonds Wetenschappelijk Onderzoek (FWO)-Vlaanderen(FWO); Hercules Foundation; VIB; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. van Nues and D. Forrest for critical reading of the manuscript, A. Talavera for assistance with the docking experiments and J. Gray for support with MS. This work was supported by UK Biotechnology and Biological Sciences Research Council and the European Research Council (ERC-2007-StG 202994-MTP) to N. Z., the Onderzoeksraad of the VUB, Fonds Wetenschappelijk Onderzoek (FWO)-Vlaanderen, VIB and the Hercules Foundation. The authors acknowledge the use of the EMBL beamline P12 at the DESY synchrotron (Hamburg, Germany).	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Campanacci V, 2013, EMBO J, V32, P1469, DOI 10.1038/emboj.2013.82; Castro-Roa D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1262; CUSACK NJ, 1983, BIOCHEM J, V214, P975, DOI 10.1042/bj2140975; De Gieter S, 2014, BIOMOL NMR ASSIGN, V8, P145, DOI 10.1007/s12104-013-9471-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Garcia-Pino A, 2008, ACTA CRYSTALLOGR F, V64, P1034, DOI 10.1107/S1744309108031722; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; LIPPMANN C, 1993, J BIOL CHEM, V268, P601; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; LYCAN DE, 1983, J VIROL, V45, P264, DOI 10.1128/JVI.45.1.264-274.1983; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Sakai A, 2009, BIOCHEMISTRY-US, V48, P1445, DOI 10.1021/bi802277h; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shaffer J, 1999, BIOCHEMISTRY-US, V38, P12072, DOI 10.1021/bi991109q; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Yarbrough ML, 2009, NAT CHEM BIOL, V5, P378, DOI 10.1038/nchembio0609-378; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	46	119	130	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					811	+		10.1038/NCHEMBIO.1364	http://dx.doi.org/10.1038/NCHEMBIO.1364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24141193	Green Accepted, Green Published			2022-12-27	WOS:000327130000013
J	Gisin, J; Schneider, A; Nagele, B; Borisova, M; Mayer, C				Gisin, Jonathan; Schneider, Alexander; Naegele, Bettina; Borisova, Marina; Mayer, Christoph			A cell wall recycling shortcut that bypasses peptidoglycan de novo biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							N-ACETYLMURAMIC ACID; ACETYL-D-GLUCOSAMINE; ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; IDENTIFICATION; MUREIN; METABOLISM; FOSFOMYCIN; TRANSPORT; BACTERIA	We report a salvage pathway in Gram-negative bacteria that bypasses de novo biosynthesis of UDP N-acetylmuramic acid (UDP-MurNAc), the first committed peptidoglycan precursor, and thus provides a rationale for intrinsic fosfomycin resistance. The anomeric sugar kinase AmgK and the MurNAc alpha-1-phosphate uridylyl transferase MurU, defining this new cell wall sugar-recycling route in Pseudomonas putida, were characterized and engineered into Escherichia coli, channeling external MurNAc directly to peptidoglycan biosynthesis.	[Gisin, Jonathan; Mayer, Christoph] Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Biol, Constance, Germany; [Gisin, Jonathan; Schneider, Alexander; Naegele, Bettina; Borisova, Marina; Mayer, Christoph] Univ Tubingen, Dept Biol, Interfac Inst Microbiol & Infect Med Tubingen, Tubingen, Germany	University of Konstanz; Eberhard Karls University of Tubingen	Mayer, C (corresponding author), Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Biol, Constance, Germany.	christoph.mayer@uni-tuebingen.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851	Graduate School of Chemical Biology-University of Konstanz; German Research Foundation (DFG) [MA2436/4, SFB766/A15]; Baden-Wurttemberg Stiftung [P-BWS-Glyko11]	Graduate School of Chemical Biology-University of Konstanz; German Research Foundation (DFG)(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung	We gratefully thank B. Phillip (University of Munster), H. P. Schweizer (Colorado State University), S. P. Levy (Tufts University), A. Roth and C. Hauck (both from University of Konstanz), T. Jaeger and U. Jenal (both from Biozentrum, University of Basel) and F. Gotz (University of Tubingen) for providing plasmids and bacterial strains and A. Friemel for implementing NMR studies. J.G. gratefully acknowledges a Dr. Marietta Lutze stipend from the Graduate School of Chemical Biology-University of Konstanz that was generously supported by the company Dr. Kade GmbH, Konstanz and Berlin. This work was further supported by the German Research Foundation (DFG, MA2436/4 and SFB766/A15) and the Baden-Wurttemberg Stiftung (P-BWS-Glyko11).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bacik JP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198317; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Dahl U, 2004, J BACTERIOL, V186, P2385, DOI 10.1128/JB.186.8.2385-2392.2004; Falagas ME, 2008, CLIN INFECT DIS, V46, P1069, DOI 10.1086/527442; Geszvain K, 2010, APPL ENVIRON MICROB, V76, P1224, DOI 10.1128/AEM.02473-09; GOODELL EW, 1985, J BACTERIOL, V163, P305, DOI 10.1128/JB.163.1.305-310.1985; Jaeger T, 2008, CELL MOL LIFE SCI, V65, P928, DOI 10.1007/s00018-007-7399-x; Jaeger T, 2005, J BIOL CHEM, V280, P30100, DOI 10.1074/jbc.M502208200; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Klebensberger J, 2009, ENVIRON MICROBIOL, V11, P3073, DOI 10.1111/j.1462-2920.2009.02012.x; Litzinger S, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P3, DOI 10.1007/978-3-642-05062-6_1; Liu XX, 2009, J BACTERIOL, V191, P2909, DOI 10.1128/JB.01708-08; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; MENGINLECREULX D, 1990, FEMS MICROBIOL LETT, V66, P129; MenginLecreulx D, 1996, J BACTERIOL, V178, P5347, DOI 10.1128/jb.178.18.5347-5352.1996; Michalopoulos AS, 2011, INT J INFECT DIS, V15, pE732, DOI 10.1016/j.ijid.2011.07.007; Mirakhur A, 2003, J Cyst Fibros, V2, P19, DOI 10.1016/S1569-1993(02)00143-1; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; PARQUET C, 1983, EUR J BIOCHEM, V133, P371, DOI 10.1111/j.1432-1033.1983.tb07472.x; Pompeo F, 2001, J BIOL CHEM, V276, P3833, DOI 10.1074/jbc.M004788200; Reith J, 2011, J BACTERIOL, V193, P5386, DOI 10.1128/JB.05514-11; Shiba Y, 2006, GENES GENET SYST, V81, P51, DOI 10.1266/ggs.81.51; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; Uehara T, 2004, J BACTERIOL, V186, P7273, DOI 10.1128/JB.186.21.7273-7279.2004; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; WHITE RJ, 1970, BIOCHEM J, V118, P89, DOI 10.1042/bj1180089; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804	35	65	71	2	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2013	9	8					491	U86		10.1038/nchembio.1289	http://dx.doi.org/10.1038/nchembio.1289			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185FV	23831760				2022-12-27	WOS:000321952700007
J	Knutson, SK; Wigle, TJ; Warholic, NM; Sneeringer, CJ; Allain, CJ; Klaus, CR; Sacks, JD; Raimondi, A; Majer, CR; Song, J; Scott, MP; Jin, L; Smith, JJ; Olhava, EJ; Chesworth, R; Moyer, MP; Richon, VM; Copeland, RA; Keilhack, H; Pollock, RM; Kuntz, KW				Knutson, Sarah K.; Wigle, Tim J.; Warholic, Natalie M.; Sneeringer, Christopher J.; Allain, Christina J.; Klaus, Christine R.; Sacks, Joelle D.; Raimondi, Alejandra; Majer, Christina R.; Song, Jeffrey; Scott, Margaret Porter; Jin, Lei; Smith, Jesse J.; Olhava, Edward J.; Chesworth, Richard; Moyer, Mikel P.; Richon, Victoria M.; Copeland, Robert A.; Keilhack, Heike; Pollock, Roy M.; Kuntz, Kevin W.			A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells	NATURE CHEMICAL BIOLOGY			English	Article							METHYLTRANSFERASE GENE EZH2; NON-HODGKIN-LYMPHOMA; HISTONE H3; SOMATIC MUTATIONS; LYSINE 27; PROTEIN METHYLTRANSFERASES; HUMAN CANCER; DISCOVERY; COMPLEX; JMJD3	EZH2 catalyzes trimethylation of histone H3 lysine 27 (H3K27). Point mutations of EZH2 at Tyr641 and Ala677 occur in subpopulations of non-Hodgkin's lymphoma, where they drive H3K27 hypertrimethylation. Here we report the discovery of EPZ005687, a potent inhibitor of EZH2 (K-i of 24 nM). EPZ005687 has greater than 500-fold selectivity against 15 other protein methyltransferases and has 50-fold selectivity against the closely related enzyme EZH1. The compound reduces H3K27 methylation in various lymphoma cells; this translates into apoptotic cell killing in heterozygous Tyr641 or Ala677 mutant cells, with minimal effects on the proliferation of wild-type cells. These data suggest that genetic alteration of EZH2 (for example, mutations at Tyr641 or Ala677) results in a critical dependency on enzymatic activity for proliferation (that is, the equivalent of oncogene addiction), thus portending the clinical use of EZH2 inhibitors for cancers in which EZH2 is genetically altered.	[Knutson, Sarah K.; Wigle, Tim J.; Warholic, Natalie M.; Sneeringer, Christopher J.; Allain, Christina J.; Klaus, Christine R.; Sacks, Joelle D.; Raimondi, Alejandra; Majer, Christina R.; Song, Jeffrey; Scott, Margaret Porter; Jin, Lei; Smith, Jesse J.; Olhava, Edward J.; Chesworth, Richard; Moyer, Mikel P.; Richon, Victoria M.; Copeland, Robert A.; Keilhack, Heike; Pollock, Roy M.; Kuntz, Kevin W.] Epizyme Inc, Cambridge, MA USA		Knutson, SK (corresponding author), Epizyme Inc, Cambridge, MA USA.	kkuntz@epizyme.com	Suarez, Joelle S/H-9582-2014	Suarez, Joelle S/0000-0003-1528-2701				Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Burgess J. L., 2012, Patent No. [WO2012005805, 2012005805]; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Copeland R. A., 2005, EVALUATION ENZYME IN; Copeland RA, 2012, DRUG DISCOV TODAY TH, V9, pe83, DOI DOI 10.1016/J.DDSTR.2011.08.001; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dornan D, 2009, BLOOD, V114, P2721, DOI 10.1182/blood-2009-02-205500; Duquenne C., 2011, Indazoles, Patent No. 2011140325; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Kaelin WG, 1999, J CLIN INVEST, V104, P1503, DOI 10.1172/JCI8888; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li R., 2009, KINASE INHIBITOR DRU; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; RENAN MJ, 1993, MOL CARCINOGEN, V7, P139; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; YONETANI T, 1964, ARCH BIOCHEM BIOPHYS, V106, P243, DOI 10.1016/0003-9861(64)90184-5	47	593	638	3	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					890	896		10.1038/NCHEMBIO.1084	http://dx.doi.org/10.1038/NCHEMBIO.1084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23023262				2022-12-27	WOS:000310052100007
J	Gao, X; Haynes, SW; Ames, BD; Wang, P; Vien, LP; Walsh, CT; Tang, Y				Gao, Xue; Haynes, Stuart W.; Ames, Brian D.; Wang, Peng; Vien, Linda P.; Walsh, Christopher T.; Tang, Yi			Cyclization of fungal nonribosomal peptides by a terminal condensation-like domain	NATURE CHEMICAL BIOLOGY			English	Article							BIOSYNTHETIC GENE-CLUSTER; IN-VITRO; FUNCTIONAL-CHARACTERIZATION; ALKALOID BIOSYNTHESIS; ASPERGILLUS-FUMIGATUS; MOLECULAR-MECHANISMS; POLYKETIDE SYNTHASE; MUTATIONAL ANALYSIS; CYCLOSPORINE-A; SYNTHETASE	Cyclization of linear peptidyl precursors produced by nonribosomal peptide synthetases (NRPSs) is an important step in the biosynthesis of bioactive cyclic peptides. Whereas bacterial NRPSs use thioesterase domains to perform the cyclization, fungal NRPSs have apparently evolved to use a different enzymatic route. In verified fungal NRPSs that produce macrocyclic peptides, each megasynthetase terminates with a condensation-like (C-T) domain that may perform the macrocyclization reaction. To probe the role of such a C-T domain, we reconstituted the activities of the Penicillium aethiopicum trimodular NPRS TqaA in Saccharomyces cerevisiae and in vitro. Together with the reconstituted bimodular NRPS AnaPS, we dissected the cyclization steps of TqaA in transforming the linear anthranilate-(D)-tryptophan-(L)-alanyl tripeptide into fumiquinazoline F. Extensive biochemical and mutational studies confirmed the essential role of the C-T domain in catalyzing cyclization in a thiolation domain-dependent fashion. Our work provides evidence of a likely universal macrocyclization strategy used by fungal NRPSs.	[Gao, Xue; Wang, Peng; Vien, Linda P.; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA; [Haynes, Stuart W.; Ames, Brian D.; Walsh, Christopher T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles	Gao, X (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA.	christopher_walsh@hms.harvard.edu; yitang@ucla.edu	WANG, Peng/GSN-5263-2022; gao, xue/J-7037-2016	gao, xue/0000-0003-3213-9704	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020011, R01GM020011, F32GM090475, R01GM092217, DP1GM106413, F32GM020011] Funding Source: NIH RePORTER; NIGMS NIH HHS [DP1 GM106413, F32GM090475, GM20011, 1R01GM092217, F32 GM020011, R01 GM092217, R01 GM020011, F32 GM090475] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames BD, 2011, BIOCHEMISTRY-US, V50, P8756, DOI 10.1021/bi201302w; Ames BD, 2010, BIOCHEMISTRY-US, V49, P8564, DOI 10.1021/bi1012029; Ames BD, 2010, BIOCHEMISTRY-US, V49, P3351, DOI 10.1021/bi100198y; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15029, DOI 10.1021/bi061845b; Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Chen SCA, 2011, DRUGS, V71, P11, DOI 10.2165/11585270-000000000-00000; Daniel JFD, 2007, NAT PROD REP, V24, P1128, DOI 10.1039/b618086h; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Eisfeld K., 2009, PHYSL GENETICS, V15, P315; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gao X, 2011, J AM CHEM SOC, V133, P2729, DOI 10.1021/ja1101085; Gatto GJ, 2005, BIOCHEMISTRY-US, V44, P5993, DOI 10.1021/bi050230w; Grindberg RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018565; Jin JM, 2010, MOL MICROBIOL, V76, P456, DOI 10.1111/j.1365-2958.2010.07109.x; Keating TA, 2000, BIOCHEMISTRY-US, V39, P4729, DOI 10.1021/bi992923g; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Kohli RM, 2002, NATURE, V418, P658, DOI 10.1038/nature00907; Kopp F, 2007, NAT PROD REP, V24, P735, DOI 10.1039/b613652b; LAWEN A, 1990, J BIOL CHEM, V265, P11355; Lee JH, 2009, BIOCHEMISTRY-US, V48, P5054, DOI 10.1021/bi900164d; Linne U, 2000, BIOCHEMISTRY-US, V39, P10439, DOI 10.1021/bi000768w; Liu XY, 2009, BIOCHEMISTRY-US, V48, P8746, DOI 10.1021/bi901123r; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; RUSNAK F, 1991, BIOCHEMISTRY-US, V30, P2916, DOI 10.1021/bi00225a027; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Sieber SA, 2004, ANGEW CHEM INT EDIT, V43, P493, DOI 10.1002/anie.200352787; Sieber SA, 2003, J AM CHEM SOC, V125, P10862, DOI 10.1021/ja0361852; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Sims JW, 2008, J AM CHEM SOC, V130, P11149, DOI 10.1021/ja803078z; Slightom JL, 2009, GENE, V431, P67, DOI 10.1016/j.gene.2008.11.011; Stachelhaus T, 2000, BIOCHEMISTRY-US, V39, P5775, DOI 10.1021/bi9929002; von Dohren H, 2009, FUNGAL GENET BIOL, V46, pS45, DOI 10.1016/j.fgb.2008.08.008; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Winterberg B, 2010, MOL MICROBIOL, V75, P1260, DOI 10.1111/j.1365-2958.2010.07048.x; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g; Xu W, 2010, J AM CHEM SOC, V132, P13604, DOI 10.1021/ja107084d; Yin WB, 2009, J BIOL CHEM, V284, P100, DOI 10.1074/jbc.M807606200; ZOCHER R, 1986, BIOCHEMISTRY-US, V25, P550, DOI 10.1021/bi00351a005	44	116	120	4	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					823	830		10.1038/NCHEMBIO.1047	http://dx.doi.org/10.1038/NCHEMBIO.1047			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22902615	Green Accepted, Green Submitted			2022-12-27	WOS:000309056200007
J	Granier, S; Kobilka, B				Granier, Sebastien; Kobilka, Brian			A new era of GPCR structural and chemical biology	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; OPIOID RECEPTOR; COMPLEX; ANTAGONIST; INSIGHTS; RHODOPSIN	G protein-coupled receptors (GPCRs) are versatile molecular machines that regulate the majority of physiological responses to chemically diverse hormones and neurotransmitters. Recent breakthroughs in structural studies have advanced our understanding of GPCR signaling, particularly the selectivity of ligand recognition and receptor activation of G proteins.	[Granier, Sebastien; Kobilka, Brian] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Granier, S (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kobilka@stanford.edu	Granier, Sebastien/J-1089-2016; Centeno, Patricia Pacios/O-8368-2016	Kobilka, Brian/0000-0001-5958-3990	NINDS NIH HHS [R01 NS028471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schertler GFX, 1998, EYE, V12, P504, DOI 10.1038/eye.1998.138; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	25	152	156	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					670	673		10.1038/nchembio.1025	http://dx.doi.org/10.1038/nchembio.1025			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22810761	Green Accepted			2022-12-27	WOS:000306527600002
J	Onaran, HO; Costa, T				Onaran, H. Ongun; Costa, Tommaso			Where have all the active receptor states gone?	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; TERNARY COMPLEX MODEL; 7-TRANSMEMBRANE RECEPTORS; ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; PLAUSIBLE MODEL; BINDING; AGONIST; ADRENOCEPTOR; ALLOSTERY	Defining G protein-coupled receptor ligand efficacy and biased agonism in precise chemical terms is one challenge posed by the current structural data that exists for this receptor family. Concepts classically used for understanding enzymes and other nonreceptor proteins may lead us in the right direction.	[Onaran, H. Ongun] Ankara Univ, Fac Med, Dept Pharmacol, TR-06100 Ankara, Turkey; [Costa, Tommaso] Ist Super Sanita, Dipartimento Farmaco, I-00161 Rome, Italy	Ankara University; Istituto Superiore di Sanita (ISS)	Onaran, HO (corresponding author), Ankara Univ, Fac Med, Dept Pharmacol, TR-06100 Ankara, Turkey.	ongun.onaran@medicine.ankara.edu.tr; tommaso.costa@iss.it	costa, tommaso/AAD-3714-2019; Onaran, Ongun/AAI-5348-2020	costa, tommaso/0000-0002-8729-3357; Onaran, Ongun/0000-0001-6766-4774				COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Freire E, 2000, P NATL ACAD SCI USA, V97, P11680, DOI 10.1073/pnas.97.22.11680; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kenakin TP, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P1; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Onaran HO, 2009, CURR PROTEIN PEPT SC, V10, P110, DOI 10.2174/138920309787847644; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; WYMAN J, 1965, J MOL BIOL, V11, P631, DOI 10.1016/S0022-2836(65)80017-1; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	25	26	26	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					674	677		10.1038/nchembio.1024	http://dx.doi.org/10.1038/nchembio.1024			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22810762				2022-12-27	WOS:000306527600003
J	Tompa, P				Tompa, Peter			On the supertertiary structure of proteins	NATURE CHEMICAL BIOLOGY			English	Article							BINDING; DOMAIN; KINASE; AUTOINHIBITION; ALLOSTERY; DYNAMICS; DISORDER; AFFINITY		[Tompa, Peter] Vrije Univ Brussel, VIB Dept Struct Biol, Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Tompa, P (corresponding author), Vrije Univ Brussel, VIB Dept Struct Biol, Brussels, Belgium.	ptompa@vub.ac.be		Tompa, Peter/0000-0001-8042-9939				Atkins AR, 2004, J BIOL CHEM, V279, P49633, DOI 10.1074/jbc.M409159200; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Burmann BM, 2011, BIOCHEM J, V435, P783, DOI 10.1042/BJ20101679; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fisher CK, 2011, CURR OPIN STRUC BIOL, V21, P426, DOI 10.1016/j.sbi.2011.04.001; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Leung DW, 2005, P NATL ACAD SCI USA, V102, P5685, DOI 10.1073/pnas.0406472102; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Lim RWL, 1999, BIOCHEMISTRY-US, V38, P16323, DOI 10.1021/bi991100o; LITVINOVICH SV, 1995, J MOL BIOL, V248, P611, DOI 10.1006/jmbi.1995.0246; Luo R, 2008, CELL SIGNAL, V20, P1968, DOI 10.1016/j.cellsig.2008.07.007; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107; Zhang J, 2011, J BIOL CHEM, V286, P41776, DOI 10.1074/jbc.M111.272583	25	55	56	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					597	600		10.1038/nchembio.1009	http://dx.doi.org/10.1038/nchembio.1009			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22710296				2022-12-27	WOS:000305471400001
J	Rigo, F; Hua, YM; Chun, SJ; Prakash, TP; Krainer, AR; Bennett, CF				Rigo, Frank; Hua, Yimin; Chun, Seung J.; Prakash, Thazha P.; Krainer, Adrian R.; Bennett, C. Frank			Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing	NATURE CHEMICAL BIOLOGY			English	Article							LOCKED NUCLEIC-ACID; SINGLE-STRANDED RNA; ANTISENSE OLIGONUCLEOTIDES; BINDING PROTEINS; PYRUVATE-KINASE; HIGH-AFFINITY; GENE; THERAPEUTICS; MECHANISMS; EXPRESSION	We describe a new technology for recruiting specific proteins to RNA through selective recognition of heteroduplexes formed with chemically modified antisense oligonucleotides (ASOs). Typically, ASOs function by hybridizing to their RNA targets and blocking the binding of single-stranded RNA-binding proteins. Unexpectedly, we found that ASOs with 2'-deoxy-2'-fluoro (2'-F) nucleotides, but not with other 2' chemical modifications, have an additional property: they form heteroduplexes with RNA that are specifically recognized by the interleukin enhancer-binding factor 2 and 3 complex (ILF2/3). 2'-F ASO-directed recruitment of ILF2/3 to RNA can be harnessed to control gene expression by modulating alternative splicing of target transcripts. ILF2/3 recruitment to precursor mRNA near an exon results in omission of the exon from the mature mRNA, both in cell culture and in mice. We discuss the possibility of using chemically engineered ASOs that recruit specific proteins to modulate gene expression for therapeutic intervention.	[Rigo, Frank; Chun, Seung J.; Prakash, Thazha P.; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Hua, Yimin; Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Isis Pharmaceuticals Inc; Cold Spring Harbor Laboratory	Rigo, F (corresponding author), ISIS Pharmaceut, 2280 Faraday Ave, Carlsbad, CA 92008 USA.	fbennett@isisph.com	Hua, Yimin/U-6911-2018	Hua, Yimin/0000-0003-0905-7989; Krainer, Adrian/0000-0001-9024-9501	NCI NIH HHS [P30 CA045508] Funding Source: Medline; NIGMS NIH HHS [R37 GM042699, R01 GM042699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Barber GN, 2009, RNA BIOL, V6, P35, DOI 10.4161/rna.6.1.7565; Baughan TD, 2009, HUM MOL GENET, V18, P1600, DOI 10.1093/hmg/ddp076; Bauman J, 2009, OLIGONUCLEOTIDES, V19, P1, DOI 10.1089/oli.2008.0161; Bennett C. F., 2009, GENE CELL THERAPY TH, P497; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Calarco JA, 2011, RNA, V17, P775, DOI 10.1261/rna.2603911; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cohen J S, 1991, Antisense Res Dev, V1, P191; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P183; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Goraczniak R, 2009, NAT BIOTECHNOL, V27, P257, DOI 10.1038/nbt.1525; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; Jepsen JS, 2004, OLIGONUCLEOTIDES, V14, P130, DOI 10.1089/1545457041526317; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; Li F, 2006, BIOCHEMISTRY-US, V45, P4141, DOI 10.1021/bi052322r; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Liu J, 2012, NUCLEIC ACIDS RES, V40, P1240, DOI 10.1093/nar/gkr780; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Seth PP, 2010, J ORG CHEM, V75, P1569, DOI 10.1021/jo902560f; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Swayze EE., 2008, ANTISENSE DRUG TECHN, P143; Teplova M, 1999, NAT STRUCT BIOL, V6, P535; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Villemaire J, 2003, J BIOL CHEM, V278, P50031, DOI 10.1074/jbc.M308897200; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wilds CJ, 2000, NUCLEIC ACIDS RES, V28, P3625, DOI 10.1093/nar/28.18.3625; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011	47	71	73	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					555	561		10.1038/NCHEMBIO.939	http://dx.doi.org/10.1038/NCHEMBIO.939			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22504300	Green Accepted			2022-12-27	WOS:000304256300011
J	Cho, BK; Federowicz, S; Park, YS; Zengler, K; Palsson, BO				Cho, Byung-Kwan; Federowicz, Stephen; Park, Young-Seoub; Zengler, Karsten; Palsson, Bernhard O.			Deciphering the transcriptional regulatory logic of amino acid metabolism	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI K-12; ARGININE REGULON; BINDING; REPRESSOR; SYSTEM; DNA; EXPRESSION; NETWORK; PROTEIN; GENES	Although metabolic networks have been reconstructed on a genome scale, the corresponding reconstruction and integration of governing transcriptional regulatory networks has not been fully achieved. Here we reconstruct such an integrated network for amino acid metabolism in Escherichia coli. Analysis of ChIP-chip and gene expression data for the transcription factors ArgR, Lrp and TrpR showed that 19 out of 20 amino acid biosynthetic pathways are either directly or indirectly controlled by these regulators. Classifying the regulated genes into three functional categories of transport, biosynthesis and metabolism leads to the elucidation of regulatory motifs that constitute the integrated network's basic building blocks. The regulatory logic of these motifs was determined on the basis of relationships between transcription factor binding and changes in the amount of transcript in response to exogenous amino acids. Remarkably, the resulting logic shows how amino acids are differentiated as signaling and nutrient molecules, revealing the overarching regulatory principles of the amino acid stimulon.	[Cho, Byung-Kwan] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Cho, Byung-Kwan; Federowicz, Stephen; Park, Young-Seoub; Zengler, Karsten; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California San Diego	Cho, BK (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea.	bkcho01@gmail.com; palsson@ucsd.edu	Cho, Byung-Kwan/C-1830-2011	Palsson, Bernhard/0000-0003-2357-6785; Zengler, Karsten/0000-0002-8062-3296	US National Institutes of Health [GM062791]; Office of Science-Biological and Environmental Research, US Department of Energy [DE-FOA-0000143]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062791] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science-Biological and Environmental Research, US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Abrams and J. Lerman for critical reading of the manuscript. The US National Institutes of Health (through grant GM062791) and the Office of Science-Biological and Environmental Research, US Department of Energy (through grant DE-FOA-0000143) supported this work.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Caldara M, 2007, J MOL BIOL, V373, P251, DOI 10.1016/j.jmb.2007.08.013; Caldara M, 2006, MICROBIOL-SGM, V152, P3343, DOI 10.1099/mic.0.29088-0; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; CHARLIER D, 1992, J MOL BIOL, V226, P367, DOI 10.1016/0022-2836(92)90953-H; Cho BK, 2006, BIOTECHNIQUES, V40, P67, DOI 10.2144/000112039; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Cho Byung-Kwan, 2008, V439, P131, DOI 10.1007/978-1-59745-188-8_9; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Hershberg R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r62; Jeeves M, 1999, EUR J BIOCHEM, V265, P919, DOI 10.1046/j.1432-1327.1999.00792.x; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Kiupakis AK, 2002, J BACTERIOL, V184, P2940, DOI 10.1128/JB.184.11.2940-2950.2002; KLIG LS, 1988, GENETICS, V120, P651; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; MAAS WK, 1964, J MOL BIOL, V8, P365, DOI 10.1016/S0022-2836(64)80200-X; Makarova KS, 2001, GENOME BIOL, V2; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Semsey S, 2007, MOL MICROBIOL, V65, P465, DOI 10.1111/j.1365-2958.2007.05798.x; Semsey S, 2006, NUCLEIC ACIDS RES, V34, P4960, DOI 10.1093/nar/gkl627; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; VanDuyne GD, 1996, J MOL BIOL, V256, P377, DOI 10.1006/jmbi.1996.0093; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang J, 1996, J MOL BIOL, V258, P37, DOI 10.1006/jmbi.1996.0232; ZHANG RG, 1987, NATURE, V327, P591, DOI 10.1038/327591a0	39	68	70	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					65	71		10.1038/nchembio.710	http://dx.doi.org/10.1038/nchembio.710			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22082910	Green Accepted			2022-12-27	WOS:000298414100013
J	Jia, GF; Fu, Y; Zhao, X; Dai, Q; Zheng, GQ; Yang, Y; Yi, CQ; Lindahl, T; Pan, T; Yang, YG; He, C				Jia, Guifang; Fu, Ye; Zhao, Xu; Dai, Qing; Zheng, Guanqun; Yang, Ying; Yi, Chengqi; Lindahl, Tomas; Pan, Tao; Yang, Yun-Gui; He, Chuan			N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO	NATURE CHEMICAL BIOLOGY			English	Article							GENOME-WIDE ASSOCIATION; MESSENGER-RNA; ADULT OBESITY; DNA; GENE; ALKB; RESIDUES; REPAIR; METHYLATION; SPECIFICITY	We report here that fat mass and obesity-associated protein (FTO) has efficient oxidative demethylation activity targeting the abundant N6-methyladenosine (m(6)A) residues in RNA in vitro. FTO knockdown with siRNA led to increased amounts of m(6)A in mRNA, whereas overexpression of FTO resulted in decreased amounts of m(6)A in human cells. We further show the partial colocalization of FTO with nuclear speckles, which supports the notion that m(6)A in nuclear RNA is a major physiological substrate of FTO.	[Jia, Guifang; Fu, Ye; Dai, Qing; Zheng, Guanqun; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Zhao, Xu; Yang, Ying; Yang, Yun-Gui] Chinese Acad Sci, Beijing Inst Genom, Genome Struct & Stabil Grp, Dis Genom & Individualized Med Lab, Beijing, Peoples R China; [Yi, Chengqi; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Lindahl, Tomas] London Res Inst, Clare Hall Labs, Canc Res UK, S Mimms, Herts, England; [Pan, Tao] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Chicago; Cancer Research UK; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Yang, Yungui/ABF-2507-2021; Dai, Qing/ABD-8444-2021	Fu, Ye/0000-0003-4434-6014; Zhao, Xu/0000-0002-0233-9660; Fu, Ye/0000-0002-3807-9717; Yi, Chengqi/0000-0003-2540-9729; Yang, Yun-Gui/0000-0002-2821-8541	US National Institutes of Health (NIH) [GM071440]; NIH EUREKA [GM088599]; Chinese Academy of Sciences (CAS); Chicago Biomedical Consortium (CBC); Beijing Institute of Genomics at CAS; CAS [2009S2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440, R01GM088599] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH EUREKA; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Chicago Biomedical Consortium (CBC); Beijing Institute of Genomics at CAS; CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the US National Institutes of Health (NIH) (GM071440 to C. H.), an NIH EUREKA award (GM088599 to C. H. and T. P.) and the Chinese Academy of Sciences (CAS) '100 Talents' Professor Program to Y.-G. Y. Q. D. is supported by the Chicago Biomedical Consortium (CBC). X. Z. and Y. Y. are supported by the Graduate Student Program of the Beijing Institute of Genomics at CAS. T. L. is supported by the CAS Senior Foreign Research Fellow Award (2009S2-1). We thank the CBC and University of Illinois at Chicago Research Resources Center Proteomics and Informatics Services Facility for performing the LC-MS/MS analysis, L. A. Godley for the suggestion and P. Jin for providing the pcDNA3-FTO plasmid. We thank S. F. Reichard for editing the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Bokar JA, 1997, RNA, V3, P1233; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; HARPER JE, 1990, NUCLEIC ACIDS RES, V18, P5735, DOI 10.1093/nar/18.19.5735; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lawrence JB, 2008, J CELL BIOL, V182, P1035, DOI 10.1083/jcb.200808121; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726	25	2063	2172	47	542	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					885	887		10.1038/NCHEMBIO.687	http://dx.doi.org/10.1038/NCHEMBIO.687			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22002720	Green Accepted			2022-12-27	WOS:000297166200009
J	Miller, J; Arrasate, M; Brooks, E; Libeu, CP; Legleiter, J; Hatters, D; Curtis, J; Cheung, K; Krishnan, P; Mitra, S; Widjaja, K; Shaby, BA; Lotz, GP; Newhouse, Y; Mitchell, EJ; Osmand, A; Gray, M; Thulasiramin, V; Saudou, F; Segal, M; Yang, XW; Masliah, E; Thompson, LM; Muchowski, PJ; Weisgraber, KH; Finkbeiner, S				Miller, Jason; Arrasate, Montserrat; Brooks, Elizabeth; Libeu, Clare Peters; Legleiter, Justin; Hatters, Danny; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Mitra, Siddhartha; Widjaja, Kartika; Shaby, Benjamin A.; Lotz, Gregor P.; Newhouse, Yvonne; Mitchell, Emily J.; Osmand, Alex; Gray, Michelle; Thulasiramin, Vanitha; Saudou, Frederic; Segal, Mark; Yang, X. William; Masliah, Eliezer; Thompson, Leslie M.; Muchowski, Paul J.; Weisgraber, Karl H.; Finkbeiner, Steven			Identifying polyglutamine protein species in situ that best predict neurodegeneration	NATURE CHEMICAL BIOLOGY			English	Article							INCLUSION-BODY FORMATION; MUTANT HUNTINGTIN; MONOCLONAL-ANTIBODIES; TRINUCLEOTIDE REPEAT; NUCLEAR-LOCALIZATION; DISEASE; AGGREGATION; LENGTH; PATHOGENESIS; MECHANISM	Polyglutamine (polyQ) stretches exceeding a threshold length confer a toxic function to proteins that contain them and cause at least nine neurological disorders. The basis for this toxicity threshold is unclear. Although polyQ expansions render proteins prone to aggregate into inclusion bodies, this may be a neuronal coping response to more toxic forms of polyQ. The exact structure of these more toxic forms is unknown. Here we show that the monoclonal antibody 3B5H10 recognizes a species of polyQ protein in situ that strongly predicts neuronal death. The epitope selectively appears among some of the many low-molecular-weight conformational states assumed by expanded polyQ and disappears in higher-molecular-weight aggregated forms, such as inclusion bodies. These results suggest that protein monomers and possibly small oligomers containing expanded polyQ stretches can adopt a conformation that is recognized by 3B5H10 and is toxic or closely related to a toxic species.	[Miller, Jason; Arrasate, Montserrat; Brooks, Elizabeth; Libeu, Clare Peters; Legleiter, Justin; Hatters, Danny; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Mitra, Siddhartha; Widjaja, Kartika; Lotz, Gregor P.; Newhouse, Yvonne; Muchowski, Paul J.; Weisgraber, Karl H.; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Miller, Jason; Arrasate, Montserrat; Brooks, Elizabeth; Libeu, Clare Peters; Legleiter, Justin; Hatters, Danny; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Mitra, Siddhartha; Widjaja, Kartika; Lotz, Gregor P.; Newhouse, Yvonne; Muchowski, Paul J.; Weisgraber, Karl H.; Finkbeiner, Steven] Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA USA; [Miller, Jason; Arrasate, Montserrat; Brooks, Elizabeth; Libeu, Clare Peters; Legleiter, Justin; Hatters, Danny; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Mitra, Siddhartha; Widjaja, Kartika; Lotz, Gregor P.; Newhouse, Yvonne; Muchowski, Paul J.; Weisgraber, Karl H.; Finkbeiner, Steven] Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA USA; [Miller, Jason] Univ Calif San Francisco, Chem & Chem Biol Program, San Francisco, CA 94143 USA; [Miller, Jason; Mitra, Siddhartha] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Arrasate, Montserrat; Brooks, Elizabeth; Curtis, Jessica; Cheung, Kenneth; Krishnan, Preethi; Widjaja, Kartika; Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Neurosci Program, San Francisco, CA 94143 USA; [Libeu, Clare Peters; Hatters, Danny; Newhouse, Yvonne; Weisgraber, Karl H.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Mitra, Siddhartha; Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Shaby, Benjamin A.] Cornell Univ, Dept Stat Sci, Ithaca, NY USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Osmand, Alex] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN USA; [Gray, Michelle; Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Ctr Neurobehav Genet,Semel Inst Neurosci & Human, Los Angeles, CA 90095 USA; [Thulasiramin, Vanitha] Biorad Labs, Fremont, CA USA; [Saudou, Frederic] Inst Curie, F-91405 Orsay, France; [Saudou, Frederic] CNRS, Unite Mixte Rech 3306, F-91405 Orsay, France; [Saudou, Frederic] Univ Paris 11, INSERM, U1005, F-91405 Orsay, France; [Segal, Mark] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Thompson, Leslie M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Cornell University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	sfinkbeiner@gladstone.ucsf.edu	Sontag, Emily/L-5232-2019; Arrasate, Montserrat/ABB-4450-2020; SAUDOU, Frédéric/L-3454-2014	Sontag, Emily/0000-0003-3068-6253; Arrasate, Montserrat/0000-0002-8911-8990; SAUDOU, Frédéric/0000-0001-6107-1046; Legleiter, Justin/0000-0002-5262-1867; Miller, Jason/0000-0002-2784-9560; Shaby, Benjamin Adam/0000-0002-8663-536X; Lotz, Gregor/0000-0002-0231-5503; Hatters, Danny/0000-0002-9965-2847	HDF; US National Institute of Neurological Disease and Stroke; Hillblom Foundation; US National Institutes of Health (NIH)-National Institute of General Medical Sciences University of California San Fransisco; Achievement Rewards for College Scientists Foundation; John Douglas French Alzheimer's Foundation; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049501, R01NS039074] Funding Source: NIH RePORTER	HDF; US National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hillblom Foundation; US National Institutes of Health (NIH)-National Institute of General Medical Sciences University of California San Fransisco(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); John Douglas French Alzheimer's Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kazantzev, D. Housman and the Hereditary Disease Foundation (HDF) for pcDNA3.1-Htt<SUP>ex1</SUP>-(Q<INF>46</INF>, Q<INF>97</INF>)-GFP plasmids. We also thank R. Truant for eGFP-full-length Htt-beta-galactosidase (Q<INF>17</INF>, Q<INF>138</INF>) plasmids, M. Diamond for the HA-AR (Q<INF>25</INF>, Q<INF>65</INF>) plasmids, J. Burke and CHDI, Inc. for the GST-atrophin-1 (Q<INF>19</INF>, Q<INF>81</INF>) plasmids, R. Kopito for Htt<SUP>ex1</SUP>-CFP (Q<INF>25</INF>, Q<INF>97</INF>) and Htt<SUP>ex1</SUP> YFP (Q<INF>25</INF>, Q<INF>97</INF>) plasmids, D. Devys for GST Htt-171 (Q<INF>66</INF>, Q<INF>142</INF>) plasmids, R. Pittman for Myc-ataxin-3 (Q<INF>27</INF> Q<INF>78</INF>) plasmids, O. Onodera for Htt<SUP>ex1</SUP>-mCFP (Q<INF>17</INF>, Q<INF>58</INF>) and Htt<SUP>ex1</SUP>-mYFP (Q<INF>17</INF>, Q<INF>58</INF>) plasmids, P. Bjorkman for the thio-Htt<SUP>ex1</SUP>-Q<INF>39</INF>-His<INF>6</INF> plasmid and P. Daugherty for mammalian codon-optimized CyPet and YPet plasmids. We thank P. Patterson for the monoclonal antibodies MW1, MW7 and MW8 and C. Glabe for the oligomer-specific polyclonal antibody. We thank members of the Finkbeiner lab for useful discussions, S. Ordway and G. Howard for editorial assistance, K. Nelson for administrative assistance and M. Sutherland for her interest and support. Primary support for this work was provided by the Lieberman Award of the HDF and the US National Institute of Neurological Disease and Stroke (S. F.). Additional support was provided by the National Institute of Aging, the High Q Foundation, the Huntington's Disease Society of America, the National Center for Research Resources, the Taube-Koret Center for Huntington's Disease Research, the Hellman Family Foundation Program for Alzheimer's Disease Research and the J. David Gladstone Institutes (S. F.). M. A. and J. M. are supported by the Hillblom Foundation. J. M. and S. M. are supported by the US National Institutes of Health (NIH)-National Institute of General Medical Sciences University of California San Fransisco Medical Scientist Training Program. J. M is supported by a fellowship from the Achievement Rewards for College Scientists Foundation. D. H. is supported by a postdoctoral fellowship from the John Douglas French Alzheimer's Foundation. J. L. and A. O. are supported by the HDF. E. J. M. is supported by a grant from the NIH. The animal care facility was partly supported by an NIH Extramural Research Facilities Improvement Project. The electron microscopy core (E. M.) is supported by a grant from the National Institute of Neurological Disease and Stroke.	Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Brooks Elizabeth, 2004, V277, P103; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fleming TR, 2000, BIOMETRICS, V56, P971, DOI 10.1111/j.0006-341X.2000.0971.x; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gelman A., 2004, BAYESIAN DATA ANAL; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Li PW, 2007, NAT STRUCT MOL BIOL, V14, P381, DOI 10.1038/nsmb1234; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Roodnat JI, 2004, TRANSPLANTATION, V77, P483, DOI 10.1097/01.TP.0000110424.27977.A1; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yu ZX, 2002, HUM MOL GENET, V11, P905, DOI 10.1093/hmg/11.8.905	49	142	145	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					925	934		10.1038/NCHEMBIO.694	http://dx.doi.org/10.1038/NCHEMBIO.694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22037470	Green Submitted, Green Accepted			2022-12-27	WOS:000297166200016
J	Small, BG; McColl, BW; Allmendinger, R; Pahle, J; Lopez-Castejon, G; Rothwell, NJ; Knowles, J; Mendes, P; Brough, D; Kell, DB				Small, Ben G.; McColl, Barry W.; Allmendinger, Richard; Pahle, Juergen; Lopez-Castejon, Gloria; Rothwell, Nancy J.; Knowles, Joshua; Mendes, Pedro; Brough, David; Kell, Douglas B.			Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing	NATURE CHEMICAL BIOLOGY			English	Article							DRUG-COMBINATIONS; CLOSED-LOOP; MULTIOBJECTIVE OPTIMIZATION; SYSTEMS BIOLOGY; INTERLEUKIN-1; RESPONSES; SEARCH	The control of biochemical fluxes is distributed, and to perturb complex intracellular networks effectively it is often necessary to modulate several steps simultaneously. However, the number of possible permutations leads to a combinatorial explosion in the number of experiments that would have to be performed in a complete analysis. We used a multiobjective evolutionary algorithm to optimize reagent combinations from a dynamic chemical library of 33 compounds with established or predicted targets in the regulatory network controlling IL-1 beta expression. The evolutionary algorithm converged on excellent solutions within 11 generations, during which we studied just 550 combinations out of the potential search space of similar to 9 billion. The top five reagents with the greatest contribution to combinatorial effects throughout the evolutionary algorithm were then optimized pairwise. A p38 MAPK inhibitor together with either an inhibitor of IkB kinase or a chelator of poorly liganded iron yielded synergistic inhibition of macrophage IL-1 beta expression. Evolutionary searches provide a powerful and general approach to the discovery of new combinations of pharmacological agents with therapeutic indices potentially greater than those of single drugs.	[Small, Ben G.; Kell, Douglas B.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester Ctr Integrat Syst Biol, Doctoral Training Ctr, Manchester, Lancs, England; [Small, Ben G.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester, Lancs, England; [McColl, Barry W.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [McColl, Barry W.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Allmendinger, Richard; Pahle, Juergen; Knowles, Joshua; Mendes, Pedro] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Lopez-Castejon, Gloria; Rothwell, Nancy J.; Brough, David] Univ Manchester, Fac Life Sci, NeuroSyst Sect, Manchester, Lancs, England; [Mendes, Pedro] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester, Lancs, England	University of Manchester; University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Manchester; University of Manchester; Virginia Polytechnic Institute & State University; University of Manchester	Kell, DB (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester Ctr Integrat Syst Biol, Doctoral Training Ctr, Manchester, Lancs, England.	dbk@manchester.ac.uk	Allmendinger, Richard/AAX-2294-2021; Lopez-Castejon, Gloria/F-6985-2015; Kell, Douglas/E-8318-2011	Allmendinger, Richard/0000-0003-1236-3143; Lopez-Castejon, Gloria/0000-0002-8585-3381; Pahle, Jurgen/0000-0002-7637-7547; Kell, Douglas/0000-0001-5838-7963; Brough, David/0000-0002-2250-2381; Small, Ben/0000-0002-4387-5689; Knowles, Joshua/0000-0001-8112-6112; Mendes, Pedro/0000-0001-6507-9168; McColl, Barry W/0000-0002-0521-9656	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F018398/1]; Engineering and Physical Sciences Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/C008219/1, BB/F018398/1] Funding Source: researchfish; BBSRC [BB/F018398/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank the Biotechnology and Biological Sciences Research Council (BBSRC) for funding this project (BB/F018398/1) and the BBSRC, Engineering and Physical Sciences Research Council and Wellcome Trust for the funding of studentships and fellowships. We thank the Manchester Centre for Integrative Systems Biology for providing access to the Sciclone instrument. B. G. S. would like to thank S. Wasley and D. Stubbs of Caliper Life Sciences for their help and assistance in commissioning and their image of the Sciclone instrument (Fig. 1), respectively. The images of the computer and 96-well plate (Fig. 1) were used under the Creative Commons CC0 Public Domain Dedication and were obtained from Clker.com.	Akella LB, 2010, CURR OPIN CHEM BIOL, V14, P325, DOI 10.1016/j.cbpa.2010.03.017; Allmendinger R., 2009, MLO12009, P1; Allmendinger R, 2010, LECT NOTES COMPUT SC, V6239, P151, DOI 10.1007/978-3-642-15871-1_16; Back Thomas, 1997, HDB EVOLUTIONARY COM, V1st; Bornkamp B, 2007, J BIOPHARM STAT, V17, P965, DOI 10.1080/10543400701643848; Chatterjee MS, 2010, NAT BIOTECHNOL, V28, P727, DOI 10.1038/nbt.1642; Deb K., 2008, MULTIOBJECTIVE PROBL; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; Goldberg, 2002, DESIGN INNOVATION LE; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hammaker D, 2010, ANN RHEUM DIS, V69, P77, DOI 10.1136/ard.2009.119479; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Horackova M, 2000, CARDIOVASC RES, V47, P529, DOI 10.1016/S0008-6363(00)00088-2; Hughes EJ, 2001, LECT NOTES COMPUT SC, V1993, P329; Jeon YJ, 2000, IMMUNOPHARMACOLOGY, V48, P173, DOI 10.1016/S0162-3109(00)00199-5; Jia J., 2009, NAT REV DRUG DISCOV, V8, P516; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Knight CG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn899; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Knowles J, 2009, IEEE COMPUT INTELL M, V4, P77, DOI 10.1109/MCI.2009.933095; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lofdahl CG, 2008, CLIN RESPIR J, V2, P59, DOI 10.1111/j.1752-699X.2008.00085.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; O'Hagan S, 2005, ANAL CHEM, V77, P290, DOI 10.1021/ac049146x; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; Scully P, 2010, AM J GASTROENTEROL, V105, P2235, DOI 10.1038/ajg.2010.159; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Sun CP, 2009, INTEGR BIOL-UK, V1, P123, DOI 10.1039/b815225j; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; Zitzler E, 2004, LECT NOTES COMPUT SC, V3242, P832	51	47	48	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2011	7	12					902	908		10.1038/NCHEMBIO.689	http://dx.doi.org/10.1038/NCHEMBIO.689			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	850AG	22020553	Green Accepted, Green Submitted			2022-12-27	WOS:000297166200013
J	Jung, K				Jung, Kirsten			MICROBIOLOGY Tuning communication fidelity	NATURE CHEMICAL BIOLOGY			English	News Item							VIBRIO-HARVEYI		Univ Munich, Dept Biol 1, CIPSM, Martinsried, Germany	University of Munich	Jung, K (corresponding author), Univ Munich, Dept Biol 1, CIPSM, Martinsried, Germany.	jung@lmu.de						Anetzberger C, 2009, MOL MICROBIOL, V73, P267, DOI 10.1111/j.1365-2958.2009.06768.x; Chatterjee J, 1996, MOL MICROBIOL, V20, P415, DOI 10.1111/j.1365-2958.1996.tb02628.x; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Teng SW, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.30; Teng SW, 2010, BIOPHYS J, V98, P2024, DOI 10.1016/j.bpj.2010.01.031; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Wei YZ, 2011, ACS CHEM BIOL, V6, P356, DOI 10.1021/cb1003652	9	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					502	503		10.1038/nchembio.618	http://dx.doi.org/10.1038/nchembio.618			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21769096				2022-12-27	WOS:000292825400009
J	Gulyani, A; Vitriol, E; Allen, R; Wu, JR; Gremyachinskiy, D; Lewis, S; Dewar, B; Graves, LM; Kay, BK; Kuhlman, B; Elston, T; Hahn, KM				Gulyani, Akash; Vitriol, Eric; Allen, Richard; Wu, Jianrong; Gremyachinskiy, Dmitriy; Lewis, Steven; Dewar, Brian; Graves, Lee M.; Kay, Brian K.; Kuhlman, Brian; Elston, Tim; Hahn, Klaus M.			A biosensor generated via high-throughput screening quantifies cell edge Src dynamics	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN CONFORMATIONAL-CHANGES; GROWTH-FACTOR RECEPTOR; LIVING CELLS; FAMILY KINASES; TYROSINE PHOSPHORYLATION; ACTIN POLYMERIZATION; MEROCYANINE DYES; BINDING-PROTEINS; DORSAL RUFFLES; DISTINCT POOLS	Fluorescent biosensors for living cells currently require laborious optimization and a unique design for each target. They are limited by the availability of naturally occurring ligands with appropriate target specificity. Here we describe a biosensor based on an engineered fibronectin monobody scaffold that can be tailored to bind different targets via high-throughput screening. We made this Src-family kinase (SFK) biosensor by derivatizing a monobody specific for activated SFKs with a bright dye whose fluorescence increases upon target binding. We identified sites for dye attachment and changes to eliminate vesiculation in living cells, providing a generalizable scaffold for biosensor production. This approach minimizes cell perturbation because it senses endogenous, unmodified target, and because sensitivity is enhanced by direct dye excitation. Automated correlation of cell velocities and SFK activity revealed that SFKs are activated specifically during protrusion. Activity correlates with velocity, and peaks 1-2 mm from the leading edge.	[Gulyani, Akash; Vitriol, Eric; Allen, Richard; Wu, Jianrong; Gremyachinskiy, Dmitriy; Dewar, Brian; Graves, Lee M.; Elston, Tim; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Lewis, Steven; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gulyani, A (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.	khahn@med.unc.edu	Graves, Lee/AAG-5470-2021	Hahn, Klaus/0000-0002-1970-7562; Gulyani, Akash/0000-0003-4130-4257; Vitriol, Eric/0000-0003-3398-1450	American Heart Association; US National Institutes of Health [GM GM082288, GM057464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073960, R55GM057464, R01GM082288, R01GM057464] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. MacNevin for assistance with dye synthesis, F. Shen for help with imaging studies, D. Renfrew for assistance with computational modeling, A. Nguyen for technical assistance and B. Clarke for administrative assistance. We gratefully acknowledge funding from the American Heart Association (A.G.) and the US National Institutes of Health (GM GM082288 and GM057464 to K. M. H.).	Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dewar BJ, 2007, MOL PHARMACOL, V72, P1146, DOI 10.1124/mol.107.037549; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gardner OS, 2003, J BIOL CHEM, V278, P46261, DOI 10.1074/jbc.M307827200; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Hodgson L., 2010, CURR PROTOC CELL BIO, V46; Karatan E, 2004, CHEM BIOL, V11, P835, DOI 10.1016/j.chembiol.2004.04.009; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2002, P NATL ACAD SCI USA, V99, P1253, DOI 10.1073/pnas.032665299; Koide A, 2001, BIOCHEMISTRY-US, V40, P10326, DOI 10.1021/bi010916y; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Reis RCM, 1998, EUR J CELL BIOL, V75, P192, DOI 10.1016/S0171-9335(98)80061-7; Renard M, 2002, J MOL BIOL, V318, P429, DOI 10.1016/S0022-2836(02)00023-2; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Toutchkine A, 2003, J AM CHEM SOC, V125, P4132, DOI 10.1021/ja0290882; Toutchkine A, 2007, ORG LETT, V9, P2775, DOI 10.1021/ol070780h; Toutchkine A, 2007, BIOCONJUGATE CHEM, V18, P1344, DOI 10.1021/bc060376n; Veracini L, 2005, BIOCHEM SOC T, V33, P1313, DOI 10.1042/BST0331313; Veracini L, 2006, J CELL SCI, V119, P2921, DOI 10.1242/jcs.03015; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Yang L, 2006, CIRC RES, V98, P394, DOI 10.1161/01.RES.0000201958.59020.1a	50	59	60	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					437	444		10.1038/NCHEMBIO.585	http://dx.doi.org/10.1038/NCHEMBIO.585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21666688	Green Submitted, Green Accepted			2022-12-27	WOS:000292252100011
J	Karplus, M				Karplus, Martin			Behind the folding funnel diagram	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN; DYNAMICS; PATHWAYS; KINETICS	This Commentary clarifies the meaning of the funnel diagram, which has been widely cited in papers on protein folding. To aid in the analysis of the funnel diagram, this Commentary reviews historical approaches to understanding the mechanism of protein folding. The primary role of free energy in protein folding is discussed, and it is pointed out that the increase in the configurational entropy as the native state is approached hinders folding, rather than guiding it. Diagrams are introduced that provide a less ambiguous representation of the factors governing the protein folding reaction than the funnel diagram.	[Karplus, Martin] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Karplus, Martin] Univ Strasbourg, Inst Sci & Ingn Supramol, Lab Chim Biophys, Strasbourg, France	Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	marci@tammy.harvard.edu						BALDWIN RL, 1994, NATURE, V369, P183, DOI 10.1038/369183a0; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; Cavalli A, 2003, PROTEIN SCI, V12, P1801, DOI 10.1110/ps.0366103; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Eaton WA, 1996, STRUCTURE, V4, P1133, DOI 10.1016/S0969-2126(96)00121-9; Ferrara P, 2000, J PHYS CHEM B, V104, P5000, DOI 10.1021/jp994157t; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; HARRISON SC, 1985, P NATL ACAD SCI USA, V82, P4028, DOI 10.1073/pnas.82.12.4028; Karplus M, 2000, J PHYS CHEM B, V104, P11, DOI 10.1021/jp993555t; KARPLUS M, 1976, NATURE, V260, P404, DOI 10.1038/260404a0; Krivov SV, 2008, J PHYS CHEM B, V112, P8701, DOI 10.1021/jp711864r; Kubelka J, 2008, P NATL ACAD SCI USA, V105, P18655, DOI 10.1073/pnas.0808600105; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; MULLERPLATHE F, 2006, SOFT MATTER, V1; Ngo JT, 1994, PROTEIN FOLDING PROB, P435; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Zagrovic B, 2003, J COMPUT CHEM, V24, P1432, DOI 10.1002/jcc.10297; ZWANZIG R, 1992, P NATL ACAD SCI USA, V89, P20, DOI 10.1073/pnas.89.1.20	25	86	88	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2011	7	7					401	404		10.1038/nchembio.565	http://dx.doi.org/10.1038/nchembio.565			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	785TF	21685880				2022-12-27	WOS:000292252100001
J	Kitano, H; Ghosh, S; Matsuoka, Y				Kitano, Hiroaki; Ghosh, Samik; Matsuoka, Yukiko			Social engineering for virtual 'big science' in systems biology	NATURE CHEMICAL BIOLOGY			English	Article							SBML		[Kitano, Hiroaki; Ghosh, Samik; Matsuoka, Yukiko] Syst Biol Inst, Tokyo, Japan; [Kitano, Hiroaki] Sony Comp Sci Labs, Tokyo, Japan; [Kitano, Hiroaki] Okinawa Inst Sci & Technol, Okinawa, Japan; [Matsuoka, Yukiko] Japan Sci & Technol Agcy, Tokyo, Japan	Okinawa Institute of Science & Technology Graduate University; Japan Science & Technology Agency (JST)	Kitano, H (corresponding author), Syst Biol Inst, Tokyo, Japan.		Ghosh, Samik/AAF-6207-2021	Ghosh, Samik/0000-0002-0239-5400				Altshuler JS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001515; Bauer-Mehren A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.47; Callaway E, 2010, NATURE, V468, P358; Caron E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.108; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Donald PR, 2009, NEW ENGL J MED, V360, P2393, DOI 10.1056/NEJMp0903806; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hill CT, 2007, ISSUES SCI TECHNOL, V24, P78; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kitano H, 1997, AI MAG, V18, P73; Kittur A, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P453; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Matsuoka Y, 2010, BIOINFORMATICS, V26, P1381, DOI 10.1093/bioinformatics/btq143; MURPHY R, 2008, SPRINGER HDB ROBOTIC, P1152; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Singh S, 2008, CELL, V133, P201, DOI 10.1016/j.cell.2008.04.003	19	24	24	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					323	326		10.1038/nchembio.574	http://dx.doi.org/10.1038/nchembio.574			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21587248				2022-12-27	WOS:000290677900002
J	Rosenthal, RG; Ebert, MO; Kiefer, P; Peter, DM; Vorholt, JA; Erb, TJ				Rosenthal, Raoul G.; Ebert, Marc-Olivier; Kiefer, Patrick; Peter, Dominik M.; Vorholt, Julia A.; Erb, Tobias J.			Direct evidence for a covalent ene adduct intermediate in NAD(P)H-dependent enzymes	NATURE CHEMICAL BIOLOGY			English	Article							CROTONYL-COA CARBOXYLASE/REDUCTASE; TRANSITION-STATE ANALOG; HYDRIDE TRANSFER; THIOESTER REDUCTASE; MECHANISM; ALCOHOL; DEHYDROGENASE; HYDROGEN; MODEL; NADH	The pyridine nucleotides NADH and NADPH (NAD(P)H) are ubiquitous redox coenzymes that are present in all living cells. Although about 16% of all characterized enzymes use pyridine nucleotides as hydride donors or acceptors during catalysis, a detailed understanding of how the hydride is transferred between NAD(P) H and the corresponding substrate is lacking for many enzymes. Here we present evidence for a new mechanism that operates during enzymatic hydride transfers using crotonyl-CoA carboxylase/reductase (Ccr) as a case study. We observed a covalent ene intermediate between NADPH and the substrate, crotonyl-CoA, using NMR, high-resolution MS and stopped-flow spectroscopy. Preparation of the ene intermediate further allowed direct access to the catalytic cycle of other NADPH-dependent enzymes-including those from type II fatty acid biosynthesis-in an unprecedented way, suggesting that formation of NAD(P) H ene intermediates is a more general principle in catalysis.	[Rosenthal, Raoul G.; Kiefer, Patrick; Peter, Dominik M.; Vorholt, Julia A.; Erb, Tobias J.] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Ebert, Marc-Olivier] ETH, Organ Chem Lab, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rosenthal, RG (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	toerb@ethz.ch	Erb, Tobias/J-5214-2013; Vorholt, Julia/K-3514-2016; Ebert, Marc-Olivier/L-6197-2017	Erb, Tobias/0000-0003-3685-0894; Vorholt, Julia/0000-0002-6011-4910; Ebert, Marc-Olivier/0000-0003-1507-219X	Schweizerische Nationalfonds-Ambizione grant [PZ00P3_136828/1]; ETH fellowship	Schweizerische Nationalfonds-Ambizione grant; ETH fellowship	This work was supported by a Schweizerische Nationalfonds-Ambizione grant (PZ00P3_136828/1) and an ETH fellowship to T. J. E. We thank B. M. Jaun for valuable discussions and critical inspection of NMR data, A. J. Rosenthal for suggestions during the early phase of this work and S. Weidenweber and U. Ermler for discussions about a structural understanding of Ccr. We acknowledge K. Hiltunen, J. Torkko and A. Kastaniotis (University of Oulu, Finland) for providing the etr1p gene, G. Sturm (Albert-Ludwigs-University of Freiburg, Germany) for providing plasmid pGS5, A. Essig, M. Kunzler and M. Aebi (ETH Zurich, Switzerland) for help with the Pichia pastoris expression system, R. Kissner and C. Molina (ETH Zurich, Switzerland) for stopped-flow experiments, S. Weidenweber and C. Vogel for the initial cloning of the Ccr and Etr1p constructs, respectively, and National BioResource Project (NBRP)-E. coli at the National Institute of Genetics (NIG) for providing E. coli strain JW3222.	ABELES RH, 1957, J AM CHEM SOC, V79, P712, DOI 10.1021/ja01560a058; Agarwal PK, 2000, J AM CHEM SOC, V122, P4803, DOI 10.1021/ja994456w; Airenne TT, 2003, J MOL BIOL, V327, P47, DOI 10.1016/S0022-2836(03)00038-X; Alder K, 1943, BER DTSCH CHEM GES, V76, P27, DOI 10.1002/cber.19430760105; Asao M, 2013, J BACTERIOL, V195, P4716, DOI 10.1128/JB.00685-13; BAHNSON BJ, 1993, BIOCHEMISTRY-US, V32, P5503, DOI 10.1021/bi00072a003; Bugg T.D.H., 2012, INTRO ENZYME COENZYM; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Cheng JP, 1998, J ORG CHEM, V63, P6108, DOI 10.1021/jo9715985; CHOOK YM, 1994, J MOL BIOL, V240, P476, DOI 10.1006/jmbi.1994.1462; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DeClue MS, 2005, J AM CHEM SOC, V127, P15002, DOI 10.1021/ja055871t; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Hamilton G., 1971, PROGRESS BIOORGANIC, V1, P83; Harden A, 1906, P R SOC LOND B-CONTA, V77, P405, DOI 10.1098/rspb.1906.0029; Hedlund J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-534; INAGAKI S, 1977, B CHEM SOC JPN, V50, P3360, DOI 10.1246/bcsj.50.3360; JACOBSON BM, 1980, J AM CHEM SOC, V102, P886, DOI 10.1021/ja00522a094; KAPMEYER H, 1976, BIOCHEMISTRY-US, V15, P5024, DOI 10.1021/bi00668a012; Kuntze K, 2011, MOL MICROBIOL, V82, P758, DOI 10.1111/j.1365-2958.2011.07856.x; Lamb AL, 2011, BIOCHEMISTRY-US, V50, P7476, DOI 10.1021/bi2009739; Libby RD, 2012, BIOORG CHEM, V40, P57, DOI 10.1016/j.bioorg.2011.10.002; MACINNES I, 1983, J CHEM SOC PERK T 1, P2777; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; PINDUR U, 1994, CHEM SOC REV, V23, P409, DOI 10.1039/cs9942300409; Porte S, 2011, CELL MOL LIFE SCI, V68, P1065, DOI 10.1007/s00018-010-0508-2; Quade N, 2012, NAT CHEM BIOL, V8, P117, DOI 10.1038/nchembio.734; Roston D, 2010, P NATL ACAD SCI USA, V107, P9572, DOI 10.1073/pnas.1000931107; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P11003, DOI 10.1021/bi980475r; Schneider K, 2012, J BACTERIOL, V194, P225, DOI 10.1128/JB.05959-11; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SULZBACH RA, 1971, ANGEW CHEM INT EDIT, V10, P733, DOI 10.1002/anie.197107331; Todd JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035947; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; WALLACE KK, 1995, EUR J BIOCHEM, V233, P954, DOI 10.1111/j.1432-1033.1995.954_3.x; Westheimer F.H., 1986, PYRIDINE NUCLEOTIDE, V2, P253; WESTHEIMER FH, 1951, J AM CHEM SOC, V73, P2403, DOI 10.1021/ja01149a561; Wilson MC, 2012, NAT PROD REP, V29, P72, DOI 10.1039/c1np00082a; WOLFENDE.R, 1969, NATURE, V223, P704, DOI 10.1038/223704a0; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; WU YD, 1987, J AM CHEM SOC, V109, P2226, DOI 10.1021/ja00241a074; Yoo HG, 2011, BIOSCI BIOTECH BIOCH, V75, P1191, DOI 10.1271/bbb.110003; Youn B, 2006, J BIOL CHEM, V281, P40076, DOI 10.1074/jbc.M605900200	47	45	45	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					50	U85		10.1038/NCHEMBIO.1385	http://dx.doi.org/10.1038/NCHEMBIO.1385			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24240506				2022-12-27	WOS:000328854900010
J	Roth, A; Weinberg, Z; Chen, AGY; Kim, PB; Ames, TD; Breaker, RR				Roth, Adam; Weinberg, Zasha; Chen, Andy G. Y.; Kim, Peter B.; Ames, Tyler D.; Breaker, Ronald R.			A widespread self-cleaving ribozyme class is revealed by bioinformatics	NATURE CHEMICAL BIOLOGY			English	Article							HEPATITIS-DELTA-VIRUS; STRUCTURAL BASIS; SPLICING RNA; CLEAVAGE; SEQUENCE; SPEED; RETROTRANSPOSONS; IDENTIFICATION; MOTIF	Ribozymes are noncoding RNAs that promote chemical transformations with rate enhancements approaching those of protein enzymes. Although ribozymes are likely to have been abundant during the RNA world era, only ten classes are known to exist among contemporary organisms. We report the discovery and analysis of an additional self-cleaving ribozyme class, called twister, which is present in many species of bacteria and eukarya. Nearly 2,700 twister ribozymes were identified that conform to a secondary structure consensus that is small yet complex, with three stems conjoined by internal and terminal loops. Two pseudoknots provide tertiary structure contacts that are critical for catalytic activity. The twister ribozyme motif provides another example of a natural RNA catalyst and calls attention to the potentially varied biological roles of this and other classes of widely distributed self-cleaving RNAs.	[Roth, Adam; Weinberg, Zasha; Chen, Andy G. Y.; Kim, Peter B.; Ames, Tyler D.; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Roth, Adam; Weinberg, Zasha; Ames, Tyler D.; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Roth, A (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Weinberg, Zasha/0000-0002-6681-3624; Breaker, Ronald/0000-0002-2165-536X	US National Institutes of Health (NIH) [RR19895-02, GM022778]; Howard Hughes Medical Institute; Gruber Science Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gruber Science Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Murdock for performing the twister ribozyme ligation assay, P. McCown and other members of the Breaker laboratory for helpful discussions, R. Knight for alerting us to useful metagenome data sets, S.L. Tausta and T. Nelson (Yale University) for providing us with rice seeds, and N. Carriero and R. Bjornson for assistance with the Yale Life Sciences High Performance Computing Center (US National Institutes of Health (NIH) grant RR19895-02). This work was supported by the NIH (GM022778) and by the Howard Hughes Medical Institute. P.B.K. was supported by the Gruber Science Fellowship.	Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Breaker RR, 2003, RNA, V9, P949, DOI 10.1261/rna.5670703; BUZAYAN JM, 1986, NATURE, V323, P349, DOI 10.1038/323349a0; Canny MD, 2004, J AM CHEM SOC, V126, P10848, DOI 10.1021/ja046848v; Cech TR, 2002, BIOCHEM SOC T, V30, P1162, DOI 10.1042/BST0301162; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Collins JA, 2007, GENE DEV, V21, P3356, DOI 10.1101/gad.1605307; de la Pena M, 2010, RNA, V16, P1943, DOI 10.1261/rna.2130310; DEYOUNG MB, 1995, BIOCHEMISTRY-US, V34, P15785, DOI 10.1021/bi00048a024; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Emilsson GM, 2003, RNA, V9, P907, DOI 10.1261/rna.5680603; Ferre-D'Amare AR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003574; Flores R, 2009, VIRUSES-BASEL, V1, P317, DOI 10.3390/v1020317; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hammann Christian, 2009, F1000 Biol Rep, V1, P6, DOI 10.3410/B1-6; Hammann C, 2012, RNA, V18, P871, DOI 10.1261/rna.031401.111; Hofacker IL, 2009, CURR PROTOC BIOINFOR, V12, P2; Jimenez RM, 2011, J BIOL CHEM, V286, P7737, DOI 10.1074/jbc.C110.209288; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; McCarthy TJ, 2005, CHEM BIOL, V12, P1221, DOI 10.1016/j.chembiol.2005.09.006; McCown PJ, 2011, RNA, V17, P728, DOI 10.1261/rna.2590811; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Mondragon A, 2013, ANNU REV BIOPHYS, V42, P537, DOI 10.1146/annurev-biophys-083012-130406; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Perreault J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002031; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roth A, 2006, RNA, V12, P607, DOI 10.1261/rna.2266506; Ruminski DJ, 2011, J BIOL CHEM, V286, P41286, DOI 10.1074/jbc.M111.297283; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Sanchez-Luque FJ, 2011, NUCLEIC ACIDS RES, V39, P8065, DOI 10.1093/nar/gkr478; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Seehafer C, 2011, RNA, V17, P21, DOI 10.1261/rna.2429911; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Webb CHT, 2011, RNA BIOL, V8, P719, DOI 10.4161/rna.8.5.16226; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; WILLIAMS KP, 1995, EMBO J, V14, P4551, DOI 10.1002/j.1460-2075.1995.tb00134.x; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275; Zytnicki M, 2008, CONSTRAINTS, V13, P91, DOI 10.1007/s10601-007-9033-9	55	155	159	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					56	U92		10.1038/NCHEMBIO.1386	http://dx.doi.org/10.1038/NCHEMBIO.1386			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24240507	Green Accepted			2022-12-27	WOS:000328854900011
J	Wolfert, MA; Boons, GJ				Wolfert, Margreet A.; Boons, Geert-Jan			Adaptive immune activation: glycosylation does matter	NATURE CHEMICAL BIOLOGY			English	Review							MHC CLASS-II; T-CELLS; PROTEIN GLYCOSYLATION; DENDRITIC CELLS; DC-SIGN; LECTIN RECEPTORS; O-GLYCOSYLATION; QUALITY-CONTROL; GLYCAN-BINDING; IN-VITRO	Major histocompatibility complex (MHC) class I and II are glycoproteins that can present antigenic peptides at the cell surface for recognition and activation of circulating T lymphocytes. Here, the importance of the modification of protein antigens by glycans on cellular uptake, proteolytic processing, presentation by MHC and subsequent T-cell priming is reviewed. Antigen glycosylation is important for a number of diseases and vaccine design. All of the key proteins involved in antigen recognition and the orchestration of downstream effector functions are glycosylated. The influence of protein glycosylation on immune function and disease is covered.	[Wolfert, Margreet A.; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu	Wolfert, Margreet A/J-1726-2016; Boons, Geert-Jan P H/J-3211-2016	Wolfert, Margreet A/0000-0003-4864-0026; Boons, Geert-Jan P H/0000-0003-3111-5954	National Cancer Institute [R01CA88986]; National Institute of General Medical Sciences of the US National Institutes of Health [R01GM061761, R01GM090269]; NATIONAL CANCER INSTITUTE [R01CA088986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761, R01GM090269] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors receive research support by the National Cancer Institute (R01CA88986) and the National Institute of General Medical Sciences (R01GM061761 and R01GM090269) of the US National Institutes of Health. We thank Z. S. Chinoy for assistance with figure preparation.	Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; Andersson IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017881; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Apostolopoulos V, 2003, P NATL ACAD SCI USA, V100, P15029, DOI 10.1073/pnas.2432220100; Avci FY, 2013, SEMIN IMMUNOL, V25, P146, DOI 10.1016/j.smim.2013.05.005; Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535; Backlund J, 2002, P NATL ACAD SCI USA, V99, P9960, DOI 10.1073/pnas.132254199; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Baum LG, 2009, IMMUNOL REV, V230, P5, DOI 10.1111/j.1600-065X.2009.00800.x; Beatson RE, 2010, IMMUNOTHERAPY-UK, V2, P305, DOI 10.2217/IMT.10.17; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Clark MC, 2012, ANN NY ACAD SCI, V1253, P58, DOI 10.1111/j.1749-6632.2011.06304.x; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Coltart DM, 2002, J AM CHEM SOC, V124, P9833, DOI 10.1021/ja020208f; Costantino P, 2011, EXPERT OPIN DRUG DIS, V6, P1045, DOI 10.1517/17460441.2011.609554; Courtney AH, 2009, P NATL ACAD SCI USA, V106, P2500, DOI 10.1073/pnas.0807207106; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dengjel J, 2006, TRANSFUS MED HEMOTH, V33, P38, DOI 10.1159/000090194; DOE B, 1994, EUR J IMMUNOL, V24, P2369, DOI 10.1002/eji.1830241017; Duong BH, 2010, J EXP MED, V207, P444; Duong BH, 2010, J EXP MED, V207, P173, DOI 10.1084/jem.20091873; Dzhambazov B, 2006, J IMMUNOL, V176, P1525, DOI 10.4049/jimmunol.176.3.1525; Dziadek S, 2006, CHEM-EUR J, V12, P4981, DOI 10.1002/chem.200600144; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; Gaidzik N, 2013, CHEM SOC REV, V42, P4421, DOI 10.1039/c3cs35470a; Garcia-Vallejo JJ, 2013, MOL IMMUNOL, V53, P387, DOI 10.1016/j.molimm.2012.09.012; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Garstka MA, 2013, MOL IMMUNOL, V55, P162, DOI 10.1016/j.molimm.2012.10.022; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Hanisch FG, 2006, CURR PROTEIN PEPT SC, V7, P307, DOI 10.2174/138920306778018034; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Haslam SM, 2008, IMMUNOL CELL BIOL, V86, P564, DOI 10.1038/icb.2008.54; Haurum JS, 1999, J EXP MED, V190, P145, DOI 10.1084/jem.190.1.145; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Jensen T, 1997, J IMMUNOL, V158, P3769; Johnson JL, 2013, TRENDS IMMUNOL, V34, P290, DOI 10.1016/j.it.2013.01.006; Johnson MA, 2013, CHEM SOC REV, V42, P4327, DOI 10.1039/c2cs35382b; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Karsten U, 2004, GLYCOBIOLOGY, V14, P681, DOI 10.1093/glycob/cwh090; Kimura T, 2013, EXPERT OPIN BIOL TH, V13, P35, DOI 10.1517/14712598.2012.725719; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kolarich D, 2012, CURR OPIN CHEM BIOL, V16, P214, DOI 10.1016/j.cbpa.2011.12.006; Lai ZZ, 2009, VACCINE, V27, P3137, DOI 10.1016/j.vaccine.2009.03.064; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Li HL, 2009, J IMMUNOL, V182, P6369, DOI 10.4049/jimmunol.0804287; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nairn A, 2009, HANDBOOK OF GLYCOMICS, P95; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ninkovic T, 2007, J IMMUNOL, V179, P2380, DOI 10.4049/jimmunol.179.4.2380; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Petersen J, 2009, J MOL MED, V87, P1045, DOI 10.1007/s00109-009-0526-4; Pilobello KT, 2007, CURR OPIN CHEM BIOL, V11, P300, DOI 10.1016/j.cbpa.2007.05.002; Plato A, 2013, INT REV IMMUNOL, V32, P134, DOI 10.3109/08830185.2013.777065; Poe JC, 2012, TRENDS IMMUNOL, V33, P413, DOI 10.1016/j.it.2012.04.010; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Purcell AW, 2008, IMMUNOL CELL BIOL, V86, P574, DOI 10.1038/icb.2008.48; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Roulois D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/871936; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Ryan SO, 2012, MICROBES INFECT, V14, P894, DOI 10.1016/j.micinf.2012.04.010; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Smith DF, 2013, MOL CELL PROTEOMICS, V12, P902, DOI 10.1074/mcp.R112.027110; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Stepensky D, 2006, CLIN EXP IMMUNOL, V143, P139, DOI 10.1111/j.1365-2249.2005.02965.x; Svajger U, 2010, CELL SIGNAL, V22, P1397, DOI 10.1016/j.cellsig.2010.03.018; Taniguchi N, 2011, BMB REP, V44, P772, DOI 10.5483/BMBRep.2011.44.12.772; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Taylor ME, 2003, METHOD ENZYMOL, V363, P3; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Kooyk Y, 2013, MOL IMMUNOL, V55, P143, DOI 10.1016/j.molimm.2012.10.031; Vanderschaeghe D, 2010, BIOL CHEM, V391, P149, DOI 10.1515/bc.2010.031; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Tribulatti MV, 2009, J LEUKOCYTE BIOL, V86, P371, DOI 10.1189/jlb.0908529; Vlad AM, 2002, J EXP MED, V196, P1435, DOI 10.1084/jem.20020493; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wang Z, 2013, SCIENCE, V341, P379, DOI 10.1126/science.1236231; Wells L, 2013, MOL CELL PROTEOMICS, V12, P833, DOI 10.1074/mcp.E113.027904; Werdelin O, 2002, P NATL ACAD SCI USA, V99, P9611, DOI 10.1073/pnas.152345899	111	193	200	2	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					776	784		10.1038/NCHEMBIO.1403	http://dx.doi.org/10.1038/NCHEMBIO.1403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24231619	Green Accepted			2022-12-27	WOS:000327130000008
J	Magnaghi, P; D'Alessio, R; Valsasina, B; Avanzi, N; Rizzi, S; Asa, D; Gasparri, F; Cozzi, L; Cucchi, U; Orrenius, C; Polucci, P; Ballinari, D; Perrera, C; Leone, A; Cervi, G; Casale, E; Xiao, Y; Wong, C; Anderson, DJ; Galvani, A; Donati, D; O'Brien, T; Jackson, PK; Isacchi, A				Magnaghi, Paola; D'Alessio, Roberto; Valsasina, Barbara; Avanzi, Nilla; Rizzi, Simona; Asa, Daniela; Gasparri, Fabio; Cozzi, Liviana; Cucchi, Ulisse; Orrenius, Christian; Polucci, Paolo; Ballinari, Dario; Perrera, Claudia; Leone, Antonella; Cervi, Giovanni; Casale, Elena; Xiao, Yang; Wong, Chihunt; Anderson, Daniel J.; Galvani, Arturo; Donati, Daniele; O'Brien, Tom; Jackson, Peter K.; Isacchi, Antonella			Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death	NATURE CHEMICAL BIOLOGY			English	Article							VALOSIN-CONTAINING PROTEIN; INCLUSION-BODY MYOPATHY; INTERPROTOMER MOTION-TRANSMISSION; ENDOPLASMIC-RETICULUM STRESS; P97 AAA ATPASE; FRONTOTEMPORAL DEMENTIA; CONFORMATIONAL-CHANGES; PROSTATE-CANCER; AUTOPHAGY; DEGRADATION	VCP (also known as p97 or Cdc48p in yeast) is an AAA(+) ATPase regulating endoplasmic reticulum-associated degradation. After high-throughput screening, we developed compounds that inhibit VCP via different mechanisms, including covalent modification of an active site cysteine and a new allosteric mechanism. Using photoaffinity labeling, structural analysis and mutagenesis, we mapped the binding site of allosteric inhibitors to a region spanning the D1 and D2 domains of adjacent protomers encompassing elements important for nucleotide-state sensing and ATP hydrolysis. These compounds induced an increased affinity for nucleotides. Interference with nucleotide turnover in individual subunits and distortion of interprotomer communication cooperated to impair VCP enzymatic activity. Chemical expansion of this allosteric class identified NMS-873, the most potent and specific VCP inhibitor described to date, which activated the unfolded protein response, interfered with autophagy and induced cancer cell death. The consistent pattern of cancer cell killing by covalent and allosteric inhibitors provided critical validation of VCP as a cancer target.	[Magnaghi, Paola; D'Alessio, Roberto; Valsasina, Barbara; Avanzi, Nilla; Rizzi, Simona; Asa, Daniela; Gasparri, Fabio; Cozzi, Liviana; Cucchi, Ulisse; Orrenius, Christian; Polucci, Paolo; Ballinari, Dario; Perrera, Claudia; Leone, Antonella; Cervi, Giovanni; Casale, Elena; Galvani, Arturo; Donati, Daniele; Isacchi, Antonella] Nerviano Med Sci, Business Unit Oncol, Nerviano, Italy; [Xiao, Yang; Wong, Chihunt; Anderson, Daniel J.; O'Brien, Tom; Jackson, Peter K.] Genentech Inc, San Francisco, CA 94080 USA	Nerviano Medical Sciences S.r.l; Roche Holding; Genentech	Magnaghi, P (corresponding author), Nerviano Med Sci, Business Unit Oncol, Nerviano, Italy.	paola.magnaghi@nervianoms.com	Gasparri, Fabio/AFN-9316-2022	O'Brien, Thomas/0000-0002-9161-8070; Jackson, Peter/0000-0002-1742-2539; Anderson, Daniel/0000-0002-3249-2439				Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Beria I, 2011, BIOORG MED CHEM LETT, V21, P2969, DOI 10.1016/j.bmcl.2011.03.054; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Bursavich MG, 2010, BIOORG MED CHEM LETT, V20, P1677, DOI 10.1016/j.bmcl.2010.01.058; Chou TF, 2013, CHEMMEDCHEM, V8, P297, DOI 10.1002/cmdc.201200520; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; FROHLICH KU, 1995, BBA-PROTEIN STRUCT M, V1253, P25, DOI 10.1016/0167-4838(95)00136-I; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Huang CD, 2012, P NATL ACAD SCI USA, V109, P9792, DOI 10.1073/pnas.1205853109; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kitami MI, 2006, FEBS LETT, V580, P474, DOI 10.1016/j.febslet.2005.12.044; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li GT, 2012, P NATL ACAD SCI USA, V109, P3737, DOI 10.1073/pnas.1200255109; Lundgren K, 2009, MOL CANCER THER, V8, P921, DOI 10.1158/1535-7163.MCT-08-0758; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Polucci P, 2013, J MED CHEM, V56, P437, DOI 10.1021/jm3013213; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Robinette D, 2006, EXPERT REV PROTEOMIC, V3, P399, DOI 10.1586/14789450.3.4.399; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	48	242	243	5	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					548	U44		10.1038/NCHEMBIO.1313	http://dx.doi.org/10.1038/NCHEMBIO.1313			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23892893				2022-12-27	WOS:000323417500006
J	Tsvetkov, AS; Arrasate, M; Barmada, S; Ando, DM; Sharma, P; Shaby, BA; Finkbeiner, S				Tsvetkov, Andrey S.; Arrasate, Montserrat; Barmada, Sami; Ando, D. Michael; Sharma, Punita; Shaby, Benjamin A.; Finkbeiner, Steven			Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration	NATURE CHEMICAL BIOLOGY			English	Article							HUNTINGTONS-DISEASE; PROTEIN AGGREGATION; IN-VIVO; AUTOPHAGY; CELLS; MODEL; GENE; ABNORMALITIES; ACCUMULATION; PROTEOLYSIS	In polyglutamine (polyQ) diseases, only certain neurons die, despite widespread expression of the offending protein. PolyQ expansion may induce neurodegeneration by impairing proteostasis, but protein aggregation and toxicity tend to confound conventional measurements of protein stability. Here, we used optical pulse labeling to measure effects of polyQ expansions on the mean lifetime of a fragment of huntingtin, the protein that causes Huntington's disease, in living neurons. We show that polyQ expansion reduced the mean lifetime of mutant huntingtin within a given neuron and that the mean lifetime varied among neurons, indicating differences in their capacity to clear the polypeptide. We found that neuronal longevity is predicted by the mean lifetime of huntingtin, as cortical neurons cleared mutant huntingtin faster and lived longer than striatal neurons. Thus, cell type-specific differences in turnover capacity may contribute to cellular susceptibility to toxic proteins, and efforts to bolster proteostasis in Huntington's disease, such as protein clearance, could be neuroprotective.	[Tsvetkov, Andrey S.; Arrasate, Montserrat; Barmada, Sami; Sharma, Punita; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Tsvetkov, Andrey S.; Arrasate, Montserrat; Sharma, Punita; Finkbeiner, Steven] Taube Koret Ctr Neurodegenerat Dis Res, San Francisco, CA USA; [Ando, D. Michael; Finkbeiner, Steven] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Shaby, Benjamin A.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Finkbeiner, Steven] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol & Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	sfinkbeiner@gladstone.ucsf.edu	Arrasate, Montserrat/ABB-4450-2020	Arrasate, Montserrat/0000-0002-8911-8990; Shaby, Benjamin Adam/0000-0002-8663-536X; Barmada, Sami/0000-0002-9604-968X	US National Institute of Neurological Disease and Stroke [R01 3NS039746, 2R01 NS045191]; National Institute on Aging [P01 2AG022074]; Huntington's Disease Society of America; Taube-Koret Center for Neurodegenerative disease; Gladstone Institutes; Hereditary Disease Foundation; Hillblom Foundation; California Institute for Regenerative Medicine; US National Science Foundation [DMS-0914906]; US National Center for Research Resources [RR18928-01]; US National Institutes of Health Extramural Research Facilities Improvement Project [C06 RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039746, K08NS072233, R01NS039074, R01NS083390, R01NS045191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	US National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Huntington's Disease Society of America; Taube-Koret Center for Neurodegenerative disease; Gladstone Institutes(University of California System); Hereditary Disease Foundation; Hillblom Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); US National Science Foundation(National Science Foundation (NSF)); US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health Extramural Research Facilities Improvement Project; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants R01 3NS039746 and 2R01 NS045191 from the US National Institute of Neurological Disease and Stroke; grant P01 2AG022074 from the National Institute on Aging; by the Huntington's Disease Society of America (made possible with a gift from the James E. Bashaw Family); the Taube-Koret Center for Neurodegenerative disease and the Gladstone Institutes (S. F.); the Milton Wexler Award and a fellowship from the Hereditary Disease Foundation (A. S. T.); a fellowship from the Hillblom Foundation (M. A.); a fellowship from California Institute for Regenerative Medicine (P. S.), and in part by DMS-0914906 from the US National Science Foundation (B. A. S.). Gladstone Institutes received support from a US National Center for Research Resources Grant RR18928-01. We thank Y. Dabaghian, I. Kelmanson, A. Gelfand and members of the Finkbeiner laboratory for helpful discussions. The animal care facility was partly supported by a US National Institutes of Health Extramural Research Facilities Improvement Project (C06 RR018928). K. Nelson provided administrative assistance, and G. C. Howard, A. L. Lucido and S. Ordway edited the manuscript.	Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bilimoria P. M., 2008, COLD SPRING HARB PRO; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; DiFiglia M, 1997, AM J PSYCHIAT, V154, P1046; Dyer RB, 2001, NAT GENET, V29, P270, DOI 10.1038/ng745; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Mitra S, 2009, J BIOL CHEM, V284, P4398, DOI 10.1074/jbc.M806269200; Persichetti F, 1996, NEUROBIOL DIS, V3, P183, DOI 10.1006/nbdi.1996.0018; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Takahashi Mikiko, 2003, Methods Mol Biol, V233, P163; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tsakiri EN, 2013, AGING CELL, V12, P802, DOI 10.1111/acel.12111; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; Wu JC, 2012, ACTA PHARMACOL SIN, V33, P743, DOI 10.1038/aps.2012.14; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	36	126	131	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					586	U91		10.1038/NCHEMBIO.1308	http://dx.doi.org/10.1038/NCHEMBIO.1308			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23873212	Green Accepted			2022-12-27	WOS:000323417500011
J	Wilson, R; Kumar, P; Parashar, V; Vilcheze, C; Veyron-Churlet, R; Freundlich, JS; Barnes, SW; Walker, JR; Szymonifka, MJ; Marchiano, E; Shenai, S; Colangeli, R; Jacobs, WR; Neiditch, MB; Kremer, L; Alland, D				Wilson, Regina; Kumar, Pradeep; Parashar, Vijay; Vilcheze, Catherine; Veyron-Churlet, Romain; Freundlich, Joel S.; Barnes, S. Whitney; Walker, John R.; Szymonifka, Michael J.; Marchiano, Emily; Shenai, Shubhada; Colangeli, Roberto; Jacobs, William R., Jr.; Neiditch, Matthew B.; Kremer, Laurent; Alland, David			Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; CELL-WALL; IN-VITRO; BACTERICIDAL ACTIVITY; DERIVATIVES; INHIBITION; ETHAMBUTOL; VIRULENCE; STRAINS; GROWTH	We report a new class of thiophene (TP) compounds that kill Mycobacterium tuberculosis by the previously uncharacterized mechanism of Pks13 inhibition. An F79S mutation near the catalytic Ser55 site in Pks13 conferred TP resistance in M. tuberculosis. Overexpression of wild-type Pks13 resulted in TP resistance, and overexpression of the Pks13(F79S) mutant conferred high resistance. In vitro, TP inhibited fatty acyl-AMP loading onto Pks13. TP inhibited mycolic acid biosynthesis in wild-type M. tuberculosis, but it did so to a much lesser extent in TP-resistant M. tuberculosis. TP treatment was bactericidal and equivalent to treatment with the first-line drug isoniazid, but it was less likely to permit emergent resistance. Combined isoniazid and TP treatment resulted in sterilizing activity. Computational docking identified a possible TP-binding groove within the Pks13 acyl carrier protein domain. This study confirms that M. tuberculosis Pks13 is required for mycolic acid biosynthesis, validates it as a druggable target and demonstrates the therapeutic potential of simultaneously inhibiting multiple targets in the same biosynthetic pathway.	[Wilson, Regina; Kumar, Pradeep; Marchiano, Emily; Shenai, Shubhada; Colangeli, Roberto; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Div Infect Dis, Newark, NJ 07103 USA; [Wilson, Regina; Kumar, Pradeep; Freundlich, Joel S.; Szymonifka, Michael J.; Marchiano, Emily; Shenai, Shubhada; Colangeli, Roberto; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Wilson, Regina; Kumar, Pradeep; Freundlich, Joel S.; Szymonifka, Michael J.; Marchiano, Emily; Shenai, Shubhada; Colangeli, Roberto; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Ruy V Lourenco Ctr Study Emerging & Reemerging Pa, Newark, NJ 07103 USA; [Parashar, Vijay; Neiditch, Matthew B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Vilcheze, Catherine; Jacobs, William R., Jr.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Vilcheze, Catherine; Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA; [Veyron-Churlet, Romain; Kremer, Laurent] Univ Montpellier 2, CNRS, Lab Dynam Interact Membranaires Normales & Pathol, Unite Mixte Rech 5235, Montpellier, France; [Freundlich, Joel S.; Szymonifka, Michael J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pharmacol & Physiol, Newark, NJ 07103 USA; [Barnes, S. Whitney; Walker, John R.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Kremer, Laurent] INSERM, Montpellier, France	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Rutgers State University New Brunswick; Rutgers State University Medical Center; Novartis; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Alland, D (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Div Infect Dis, 185 S Orange Ave, Newark, NJ 07103 USA.	allandda@umdnj.edu	Kremer, Laurent/M-4935-2017; Veyron-Churlet, Romain/J-4254-2019; Kumar, Pradeep/I-7989-2014	Kremer, Laurent/0000-0002-6604-4458; Veyron-Churlet, Romain/0000-0001-6902-5917; Kumar, Pradeep/0000-0003-0042-7525; Jacobs, William/0000-0003-3321-3080; ROBERTO, COLANGELI/0000-0003-3263-7404; Neiditch, Matthew/0000-0002-7039-4469	US National Institutes of Health (NIH) [R01 AI080653]; United Negro College Fund-Merck Postdoctoral Science Research Fellowship; University of Medicine and Dentistry of New Jersey (UMDNJ) foundation; NIH [R01 AI081736, AI26170, AI-95364, AI-15449, NS046593]; NIH Centers for AIDS Research grant at the Albert Einstein College of Medicine [AI-051519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI026170, R01AI026170, P30AI051519, R37AI026170, N01AI095364, R01AI081736, R01AI080653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Negro College Fund-Merck Postdoctoral Science Research Fellowship; University of Medicine and Dentistry of New Jersey (UMDNJ) foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Centers for AIDS Research grant at the Albert Einstein College of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by US National Institutes of Health (NIH) grant R01 AI080653 to D. A., a United Negro College Fund-Merck Postdoctoral Science Research Fellowship to R. W., a grant from the University of Medicine and Dentistry of New Jersey (UMDNJ) foundation to R. C. and NIH grant R01 AI081736 to M.B.N. W.R.J. acknowledges generous support from the NIH Centers for AIDS Research grant AI-051519 at the Albert Einstein College of Medicine and by NIH grant AI26170. The compounds initially screened in this work were supplied as part of NIH grants AI-95364 and AI-15449. We thank R. C. Goldman (formally Department of Health and Human Services, NIH, and Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), currently RCG Consulting) for his support obtaining Molecular Libraries Probe Centers Network (MLPCN) compounds for the piniBAC screen, R. Reynolds (Southern Research Institute) for his advice on the initial analysis of the MLPCN library and C. E. Barry, III and H. I. M. Boshoff (Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, NIAID, NIH) for their kind gift of TDM and TMM standards. The MS data were obtained from an Orbitrap instrument funded in part by NIH grant NS046593 for the support of the UMDNJ Neuroproteomics Core Facility.	Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Alland D, 2000, J BACTERIOL, V182, P1802, DOI 10.1128/JB.182.7.1802-1811.2000; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Boechat N, 2011, J MED CHEM, V54, P5988, DOI 10.1021/jm2003624; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; Falzari K, 2005, ANTIMICROB AGENTS CH, V49, P1447, DOI 10.1128/AAC.49.4.1447-1454.2005; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P2329, DOI 10.1128/AAC.00185-07; Gumbo T, 2007, J INFECT DIS, V195, P194, DOI 10.1086/510247; Jovetic S, 2010, TRENDS BIOTECHNOL, V28, P596, DOI 10.1016/j.tibtech.2010.09.004; Khoo KH, 1996, J BIOL CHEM, V271, P28682, DOI 10.1074/jbc.271.45.28682; Kim P, 2009, J MED CHEM, V52, P1329, DOI 10.1021/jm801374t; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kremer L, 2003, J BIOL CHEM, V278, P20547, DOI 10.1074/jbc.M302435200; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; KROON AM, 1983, PHARM WEEKBLAD, V5, P81, DOI 10.1007/BF01960982; Lee RE, 2003, J COMB CHEM, V5, P172, DOI 10.1021/cc020071p; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; MIDDLEBROOK G, 1952, AM REV TUBERC PULM, V65, P765; Mondal R, 2007, EMERG INFECT DIS, V13, P1429, DOI 10.3201/eid1309.070443; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Onodera Y, 2001, J ANTIMICROB CHEMOTH, V47, P447, DOI 10.1093/jac/47.4.447; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Phetsuksiri B, 1999, ANTIMICROB AGENTS CH, V43, P1042, DOI 10.1128/AAC.43.5.1042; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Reddy VM, 2010, ANTIMICROB AGENTS CH, V54, P2840, DOI 10.1128/AAC.01601-09; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Safi H, 2008, ANTIMICROB AGENTS CH, V52, P2027, DOI 10.1128/AAC.01486-07; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Seeliger JC, 2012, J BIOL CHEM, V287, P7990, DOI 10.1074/jbc.M111.315473; Siddiqi S, 2007, ANTIMICROB AGENTS CH, V51, P2100, DOI 10.1128/AAC.00086-07; SIDDIQI SH, 1981, J CLIN MICROBIOL, V13, P908, DOI 10.1128/JCM.13.5.908-912.1981; Slayden R A, 2001, Methods Mol Med, V54, P229, DOI 10.1385/1-59259-147-7:229; Slayden RA, 1996, ANTIMICROB AGENTS CH, V40, P2813, DOI 10.1128/AAC.40.12.2813; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tahlan K., ANTIMICROB AGENTS CH, V56, P1797; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Wallis RS, 1999, ANTIMICROB AGENTS CH, V43, P2600, DOI 10.1128/AAC.43.11.2600; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108	58	97	102	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2013	9	8					499	U60		10.1038/nchembio.1277	http://dx.doi.org/10.1038/nchembio.1277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185FV	23770708	Green Accepted			2022-12-27	WOS:000321952700009
J	Piggott, MJ; Attwood, PV				Piggott, Matthew J.; Attwood, Paul V.			POST-TRANSLATIONAL MODIFICATIONS Panning for phosphohistidine	NATURE CHEMICAL BIOLOGY			English	News Item							HISTIDINE; PROTEINS; ANALOGS		[Piggott, Matthew J.; Attwood, Paul V.] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia	University of Western Australia	Piggott, MJ (corresponding author), Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia.	matthew.piggott@uwa.edu.au; paul.attwood@uwa.edu.au	Attwood, Paul V/I-8207-2012; Piggott, Matthew J/A-3251-2008; Piggott, Matthew/K-6990-2019	Piggott, Matthew/0000-0002-5857-7051				Attwood PV, 2007, AMINO ACIDS, V32, P145, DOI 10.1007/s00726-006-0443-6; Besant PG, 2010, METHOD ENZYMOL, V471, P403, DOI 10.1016/S0076-6879(10)71021-1; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Kee JM, 2013, NAT CHEM BIOL, V9, P416, DOI [10.1038/NCHEMBIO.1259, 10.1038/nchembio.1259]; Kee JM, 2010, J AM CHEM SOC, V132, P14327, DOI 10.1021/ja104393t; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; McAllister TE, 2012, ORG BIOMOL CHEM, V10, P4043, DOI 10.1039/c2ob25517k; McAllister TE, 2011, CHEM COMMUN, V47, P1297, DOI 10.1039/c0cc04238b; Mukai S, 2012, AMINO ACIDS, V43, P857, DOI 10.1007/s00726-011-1145-2; Pirrung MC, 2000, J ORG CHEM, V65, P8448, DOI 10.1021/jo000771l; Schenkels C, 1999, BIOORG MED CHEM LETT, V9, P1443, DOI 10.1016/S0960-894X(99)00209-7; Tan EL, 2004, CARCINOGENESIS, V25, P2083, DOI 10.1093/carcin/bgh222	12	3	3	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					411	412		10.1038/nchembio.1273	http://dx.doi.org/10.1038/nchembio.1273			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23708075				2022-12-27	WOS:000320449700002
J	Veglia, G				Veglia, Gianluigi			PROTEIN DYNAMICS Catch them if you can	NATURE CHEMICAL BIOLOGY			English	News Item							NMR-SPECTROSCOPY; STATES		[Veglia, Gianluigi] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Veglia, Gianluigi] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Veglia, G (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	vegli001@umn.edu						Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Tzeng SR, 2013, NAT CHEM BIOL, V9, P462, DOI [10.1038/NCHEMBIO.1250, 10.1038/nchembio.1250]	10	2	2	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2013	9	7					410	411		10.1038/nchembio.1258	http://dx.doi.org/10.1038/nchembio.1258			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164YT	23644477				2022-12-27	WOS:000320449700001
J	Eggert, US				Eggert, Ulrike S.			The why and how of phenotypic small-molecule screens	NATURE CHEMICAL BIOLOGY			English	Article							BREFELDIN-A; INHIBITOR; MECHANISM; PROTEINS; TARGET; DRUGS; ER		[Eggert, Ulrike S.] Kings Coll London, Dept Chem, London WC2R 2LS, England; [Eggert, Ulrike S.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Eggert, US (corresponding author), Kings Coll London, Dept Chem, London WC2R 2LS, England.	ulrike.eggert@kcl.ac.uk		Eggert, Ulrike/0000-0003-0932-5525	US National Institutes of Health [R01 GM082834]; Human Frontier Science Program; Marie Curie Career Integration Grant [304137]; European Research Council [306659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082834] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Marie Curie Career Integration Grant; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank C. Shamu (Institute of Chemistry and Cell Biology-Longwood, Harvard Medical School), M. Houslay (King's College London) and members of my laboratory for helpful discussions and comments on the manuscript. Research in my laboratory is funded by US National Institutes of Health grant R01 GM082834, a Human Frontier Science Program Young Investigator Award, Marie Curie Career Integration Grant no. 304137 and European Research Council Starting Grant 306659.	Castoreno AB, 2011, ACS CHEM BIOL, V6, P86, DOI 10.1021/cb1002976; Castoreno AB, 2010, NAT CHEM BIOL, V6, P457, DOI 10.1038/nchembio.363; Chidley C, 2011, CHIMIA, V65, P720, DOI 10.2533/chimia.2011.720; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Eggert US, 2006, MOL BIOSYST, V2, P93, DOI 10.1039/b515335b; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gregori-Puigjane E, 2012, P NATL ACAD SCI USA, V109, P11178, DOI 10.1073/pnas.1204524109; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Owen SC, 2012, ACS CHEM BIOL, V7, P1429, DOI 10.1021/cb300189b; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; TAMURA G, 1968, J ANTIBIOT, V21, P160, DOI 10.7164/antibiotics.21.160; von Kleist L, 2011, CELL, V146, P841, DOI 10.1016/j.cell.2011.08.014; Zhang X, 2012, P NATL ACAD SCI USA, V109, P12485, DOI 10.1073/pnas.1207821109	24	97	103	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					206	209		10.1038/nchembio.1206	http://dx.doi.org/10.1038/nchembio.1206			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23508174				2022-12-27	WOS:000317025800004
J	Kaylor, JJ; Yuan, Q; Cook, J; Sarfare, S; Makshanoff, J; Miu, A; Kim, A; Kim, P; Habib, S; Roybal, CN; Xu, TZ; Nusinowitz, S; Travis, GH				Kaylor, Joanna J.; Yuan, Quan; Cook, Jeremy; Sarfare, Shanta; Makshanoff, Jacob; Miu, Anh; Kim, Anita; Kim, Paul; Habib, Samer; Roybal, C. Nathaniel; Xu, Tongzhou; Nusinowitz, Steven; Travis, Gabriel H.			Identification of DES1 as a vitamin A isomerase in Muller glial cells of the retina	NATURE CHEMICAL BIOLOGY			English	Article							RETINALDEHYDE-BINDING PROTEIN; ALL-TRANS-RETINOL; DIHYDROCERAMIDE DESATURASE; PIGMENT REGENERATION; RPE65; LOCALIZATION; RODS; ISOMEROHYDROLASE; DEHYDROGENASE; SENSITIVITY	Absorption of a light particle by an opsin-pigment causes photoisomerization of its retinaldehyde chromophore. Restoration of light sensitivity to the resulting apo-opsin requires chemical re-isomerization of the photobleached chromophore. This is carried out by a multistep enzyme pathway called the visual cycle. Accumulating evidence suggests the existence of an alternative visual cycle for regenerating opsins in daylight. Here we identified dihydroceramide desaturase-1 (DES1) as a retinol isomerase and an excellent candidate for isomerase-2 in this alternative pathway. DES1 is expressed in retinal Muller cells, where it coimmuno-precipitates with cellular retinaldehyde binding protein (CRALBP). Adenoviral gene therapy with DES1 partially rescued the biochemical and physiological phenotypes in Rpe65(-/-) mice lacking isomerohydrolase (isomerase-1). Knockdown of DES1 expression by RNA interference concordantly reduced isomerase-2 activity in cultured Muller cells. Purified DES1 had very high isomerase-2 activity in the presence of appropriate cofactors, suggesting that DES1 by itself is sufficient for isomerase activity.	[Kaylor, Joanna J.; Yuan, Quan; Cook, Jeremy; Sarfare, Shanta; Makshanoff, Jacob; Miu, Anh; Kim, Anita; Kim, Paul; Habib, Samer; Roybal, C. Nathaniel; Xu, Tongzhou; Nusinowitz, Steven; Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kaylor, JJ (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	travis@jsei.ucla.edu	yuan, quan/GZM-5597-2022; Kaylor, Joanna/Y-5184-2019; Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493	US National Eye Institute [R01-EY11713]; NATIONAL EYE INSTITUTE [R01EY011713, P30EY000331] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank R. Radu for insightful suggestions throughout this project and valuable comments on the manuscript, J. Hu and D. Bok for assistance with immunocytochemistry, M. Redmond (National Eye Institute) for providing Rpe65<SUP>-/-</SUP> mice, and R. Crouch (Medical University of South Carolina) for the gift of 11-cis-RAL. This work was supported by a grant to G.H.T. from the US National Eye Institute (R01-EY11713). G.H.T. is the Charles Kenneth Feldman Professor of Ophthalmology.	BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; Beauchamp E, 2007, BIOCHIMIE, V89, P1553, DOI 10.1016/j.biochi.2007.07.001; Beauchamp E, 2009, BIOCHIMIE, V91, P1411, DOI 10.1016/j.biochi.2009.07.014; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Caruso RC, 2010, INVEST OPHTH VIS SCI, V51, P5304, DOI 10.1167/iovs.10-5559; Causeret C, 2000, LIPIDS, V35, P1117, DOI 10.1007/s11745-000-0627-6; CROUCH R, 1975, P NATL ACAD SCI USA, V72, P1538, DOI 10.1073/pnas.72.4.1538; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; EISENFELD AJ, 1985, EXP EYE RES, V41, P299, DOI 10.1016/S0014-4835(85)80020-8; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Farjo KM, 2009, INVEST OPHTH VIS SCI, V50, P5089, DOI 10.1167/iovs.09-3797; GOLDSTEI.EB, 1970, VISION RES, V10, P1065, DOI 10.1016/0042-6989(70)90082-9; Golovleva I, 2003, J BIOL CHEM, V278, P12397, DOI 10.1074/jbc.M207300200; HOOD DC, 1973, VISION RES, V13, P1943, DOI 10.1016/0042-6989(73)90065-5; HSU SC, 1994, J BIOL CHEM, V269, P17954; HUBBARD R, 1958, J GEN PHYSIOL, V42, P259, DOI 10.1085/jgp.42.2.259; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Mata NL, 2005, BIOCHEMISTRY-US, V44, P11715, DOI 10.1021/bi050942m; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Muniz A, 2009, BIOCHEMISTRY-US, V48, P6854, DOI 10.1021/bi9002937; Nusinowitz S, 2007, EXP EYE RES, V84, P1104, DOI 10.1016/j.exer.2007.02.009; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; RANDO RR, 1992, PHOTOCHEM PHOTOBIOL, V56, P1145, DOI 10.1111/j.1751-1097.1992.tb09739.x; RANDO RR, 1983, J AM CHEM SOC, V105, P2879, DOI 10.1021/ja00347a058; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rioux V, 2011, BBA-MOL CELL BIOL L, V1811, P1, DOI 10.1016/j.bbalip.2010.09.005; Rohrer B, 2003, INVEST OPHTH VIS SCI, V44, P310, DOI 10.1167/iovs.02-0567; SAARI JC, 1987, J BIOL CHEM, V262, P7618; Saari JC, 2009, MOL VIS, V15, P844; Savile CK, 2001, J AM CHEM SOC, V123, P4382, DOI 10.1021/ja010088w; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Trevino SG, 2005, J EXP BIOL, V208, P4151, DOI 10.1242/jeb.01881; Triola G, 2003, J ORG CHEM, V68, P9924, DOI 10.1021/jo030141u; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	48	79	81	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					30	+		10.1038/NCHEMBIO.1114	http://dx.doi.org/10.1038/NCHEMBIO.1114			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23143414	Green Submitted, Green Accepted			2022-12-27	WOS:000312484200009
J	Betz, K; Malyshev, DA; Lavergne, T; Welte, W; Diederichs, K; Dwyer, TJ; Ordoukhanian, P; Romesberg, FE; Marx, A				Betz, Karin; Malyshev, Denis A.; Lavergne, Thomas; Welte, Wolfram; Diederichs, Kay; Dwyer, Tammy J.; Ordoukhanian, Phillip; Romesberg, Floyd E.; Marx, Andreas			KlenTaq polymerase replicates unnatural base pairs by inducing a Watson-Crick geometry	NATURE CHEMICAL BIOLOGY			English	Article							DNA-REPLICATION; GENETIC ALPHABET; HYDROPHOBIC BASE; FIDELITY; OPTIMIZATION; MECHANISM; EXPANSION; RECOGNITION; SELECTION; FRAGMENT	Many candidate unnatural DNA base pairs have been developed, but some of the best-replicated pairs adopt intercalated structures in free DNA that are difficult to reconcile with known mechanisms of polymerase recognition. Here we present crystal structures of KlenTaq DNA polymerase at different stages of replication for one such pair, dNaM-d5SICS, and show that efficient replication results from the polymerase itself, inducing the required natural-like structure.	[Betz, Karin; Marx, Andreas] Univ Konstanz, Dept Chem, Constance, Germany; [Betz, Karin; Welte, Wolfram; Diederichs, Kay; Marx, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Malyshev, Denis A.; Lavergne, Thomas; Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Welte, Wolfram; Diederichs, Kay] Univ Konstanz, Dept Biol, Constance, Germany; [Dwyer, Tammy J.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Ordoukhanian, Phillip] Scripps Res Inst, Ctr Prot & Nucle Acid Res, La Jolla, CA 92037 USA	University of Konstanz; University of Konstanz; Scripps Research Institute; University of Konstanz; University of California System; University of California San Diego; Scripps Research Institute	Marx, A (corresponding author), Univ Konstanz, Dept Chem, Constance, Germany.	floyd@scripps.edu; andreas.marx@uni-konstanz.de	Malyshev, Denis/K-6756-2012; LAVERGNE, Thomas G/N-8896-2013; Romesberg, Floyd/M-2821-2017	Malyshev, Denis/0000-0002-0670-9905; LAVERGNE, Thomas G/0000-0002-0029-0015; Romesberg, Floyd/0000-0001-6317-1315	Konstanz Research School Chemical Biology; US National Institutes of Health [GM060005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060005] Funding Source: NIH RePORTER	Konstanz Research School Chemical Biology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff of the Swiss Light Source at the Paul Scherrer Institute for their assistance during data collection. This work was supported by the Konstanz Research School Chemical Biology (to K.B.) and the US National Institutes of Health (GM060005 to F.E.R.).	Brotschi C, 2001, ANGEW CHEM INT EDIT, V40, P3012, DOI 10.1002/1521-3773(20010817)40:16<3012::AID-ANIE3012>3.0.CO;2-Y; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Hirao I, 2006, NAT METHODS, V3, P729, DOI 10.1038/nmeth915; Hollenstein M, 2009, NUCLEIC ACIDS RES, V37, P1638, DOI 10.1093/nar/gkn1070; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Lavergne T, 2012, CHEM-EUR J, V18, P1231, DOI 10.1002/chem.201102066; Leconte AM, 2008, J AM CHEM SOC, V130, P2336, DOI 10.1021/ja078223d; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Malyshev DA, 2010, CHEM-EUR J, V16, P12650, DOI 10.1002/chem.201000959; Malyshev DA, 2009, J AM CHEM SOC, V131, P14620, DOI 10.1021/ja906186f; Matsuda S, 2007, J AM CHEM SOC, V129, P10466, DOI 10.1021/ja072276d; McMinn DL, 1999, J AM CHEM SOC, V121, P11585, DOI 10.1021/ja9925150; Meyer AS, 2004, J BIOL CHEM, V279, P33043, DOI 10.1074/jbc.C400232200; Moran S, 1997, J AM CHEM SOC, V119, P2056, DOI 10.1021/ja963718g; PICCIRILLI JA, 1990, NATURE, V343, P33, DOI 10.1038/343033a0; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Seo YJ, 2009, J AM CHEM SOC, V131, P3246, DOI 10.1021/ja807853m; Seo YJ, 2009, J AM CHEM SOC, V131, P5046, DOI 10.1021/ja9006996; Wojciechowski F, 2011, CHEM SOC REV, V40, P5669, DOI 10.1039/c1cs15027h; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005	25	105	119	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					612	614		10.1038/NCHEMBIO.966	http://dx.doi.org/10.1038/NCHEMBIO.966			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22660438	Green Accepted, Green Submitted			2022-12-27	WOS:000305471400007
J	Connell, JL; Whiteley, M; Shear, JB				Connell, Jodi L.; Whiteley, Marvin; Shear, Jason B.			Sociomicrobiology in engineered landscapes	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN HYDROGELS; QUORUM; FABRICATION; BIOFILMS		[Connell, Jodi L.; Shear, Jason B.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Connell, Jodi L.; Whiteley, Marvin; Shear, Jason B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Whiteley, Marvin] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Connell, JL (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	mwhiteley@austin.utexas.edu; jshear@mail.utexas.edu			NIAID NIH HHS [5R01AI075068, 5R03AI081216] Funding Source: Medline; NIDCR NIH HHS [R01 DE020100] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI081216, R01AI075068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020100] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/NCHEMBIO.264, 10.1038/nchembio.264]; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Connell JL, 2010, MBIO, V1, DOI 10.1128/mBio.00202-10; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001; Donnenberg MS, 2001, J CLIN INVEST, V107, P539, DOI 10.1172/JCI12404; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hill RT, 2005, J AM CHEM SOC, V127, P10707, DOI 10.1021/ja052211f; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kaehr B, 2004, P NATL ACAD SCI USA, V101, P16104, DOI 10.1073/pnas.0407204101; Kaehr B, 2008, P NATL ACAD SCI USA, V105, P8850, DOI 10.1073/pnas.0709571105; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Khripin CY, 2010, SOFT MATTER, V6, P2842, DOI 10.1039/c001193b; Kuebler S. M., 2001, Journal of Photopolymer Science and Technology, V14, P657, DOI 10.2494/photopolymer.14.657; Liu XH, 2011, P NATL ACAD SCI USA, V108, P2668, DOI 10.1073/pnas.1018391108; Loka Bharathi P.A., 2004, MARINE MICROBIOLOGY, P27; Nielson R, 2009, SMALL, V5, P120, DOI 10.1002/smll.200801084; Pitts JD, 2000, MACROMOLECULES, V33, P1514, DOI 10.1021/ma9910437; Ramsey MM, 2009, P NATL ACAD SCI USA, V106, P1578, DOI 10.1073/pnas.0809533106; RITSCHDORFF ET, 2010, MAT RES SOC S P SERI, V1272; Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115; ten Cate JM, 2006, ODONTOLOGY, V94, P1, DOI 10.1007/s10266-006-0063-3	25	19	20	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					10	13		10.1038/nchembio.749	http://dx.doi.org/10.1038/nchembio.749			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173344				2022-12-27	WOS:000298414100004
J	Ly, M; Leach, FE; Laremore, TN; Toida, T; Amster, IJ; Linhardt, RJ				Ly, Mellisa; Leach, Franklin E., III; Laremore, Tatiana N.; Toida, Toshihiko; Amster, I. Jonathan; Linhardt, Robert J.			The proteoglycan bikunin has a defined sequence	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-TRYPSIN INHIBITOR; CHONDROITIN SULFATE OLIGOSACCHARIDES; ELECTRON DETACHMENT DISSOCIATION; COVALENTLY CROSS-LINKS; HEPARAN-SULFATE; HUMAN PLASMA; GLYCOSAMINOGLYCAN OLIGOSACCHARIDES; STRUCTURAL-ANALYSIS; ANTITHROMBIN-III; MASS-SPECTRA	Proteoglycans are complex glycoconjugates that regulate critical biological pathways in all higher organisms. Bikunin, the simplest proteoglycan, with a single glycosaminoglycan chain, is a serine protease inhibitor used to treat acute pancreatitis. Unlike nucleic acids and proteins, whose synthesis is template driven, Golgi-synthesized glycosaminoglycans are not believed to have predictable or deterministic sequences. Bikunin peptidoglycosaminoglycans were prepared and fractionated to obtain a collection of size-similar and charge-similar chains. Fourier transform mass spectral analysis identified a small number of parent molecular ions corresponding to monocompositional peptidoglycosaminoglycans. Fragmentation using collision-induced dissociation unexpectedly afforded a single sequence for each monocompositional parent ion, unequivocally demonstrating the presence of a defined sequence. The biosynthetic pathway common to all proteoglycans suggests that even more structurally complex proteoglycans, such as heparan sulfate, may have defined sequences, requiring a readjustment in the understanding of information storage in complex glycans.	[Ly, Mellisa; Laremore, Tatiana N.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Leach, Franklin E., III; Amster, I. Jonathan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Toida, Toshihiko] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; University System of Georgia; University of Georgia; Chiba University; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA.	linhar@rpi.edu	Amster, Jon/D-6957-2011	Amster, Jon/0000-0001-7523-5144; Laremore, Tatiana/0000-0002-1036-8963	US National Institutes of Health [GM38060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank D. Zagorevski for his expertise in the proteomics core at Rensselaer Polytechnic Institute and the US National Institutes of Health for support (GM38060).	ATHA DH, 1987, BIOCHEMISTRY-US, V26, P6454, DOI 10.1021/bi00394a024; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Capon C, 2003, BIOCHIMIE, V85, P101, DOI 10.1016/S0300-9084(03)00066-X; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; CONRAD HE, 2001, CURR PROTOC MOL BIOL, V17; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; GU KN, 1993, CARBOHYD RES, V244, P369, DOI 10.1016/0008-6215(83)85014-9; Gunay NS, 2003, ANAL CHEM, V75, P3226, DOI 10.1021/ac034053l; Hitchcock AM, 2008, PROTEOMICS, V8, P1384, DOI 10.1002/pmic.200700787; Josic D, 2006, PROTEOMICS, V6, P2874, DOI 10.1002/pmic.200500563; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Laremore TN, 2011, INT J MASS SPECTROM, V305, P109, DOI 10.1016/j.ijms.2010.09.020; Laremore TN, 2010, BIOCHEM J, V431, P199, DOI 10.1042/BJ20100788; Laremore TN, 2010, ANAL BIOCHEM, V401, P236, DOI 10.1016/j.ab.2010.03.004; Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x; Liu J, 1995, GLYCOBIOLOGY, V5, P765, DOI 10.1093/glycob/5.8.765; LY M, 2011, THESIS RENSSELAER PO; Ly M, 2011, ANAL BIOANAL CHEM, V399, P737, DOI 10.1007/s00216-010-3679-7; Ly M, 2010, OMICS, V14, P389, DOI 10.1089/omi.2009.0123; McClellan JE, 2002, ANAL CHEM, V74, P3760, DOI 10.1021/ac025506+; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; MICHALSKI C, 1994, VOX SANG, V67, P329, DOI 10.1111/j.1423-0410.1994.tb01269.x; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Perez S., 1998, POLYSACCHARIDES STRU, P41; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; TOYODA H, 1993, BIOL PHARM BULL, V16, P945; TURNBULL JE, 1991, BIOCHEM J, V277, P297, DOI 10.1042/bj2770297; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Wolff JJ, 2008, J AM SOC MASS SPECTR, V19, P1449, DOI 10.1016/j.jasms.2008.06.024; Wolff JJ, 2008, J AM SOC MASS SPECTR, V19, P790, DOI 10.1016/j.jasms.2008.03.010; Wolff JJ, 2007, J AM SOC MASS SPECTR, V18, P234, DOI 10.1016/j.jasms.2006.09.020; Wolff JJ, 2010, ANAL CHEM, V82, P3460, DOI 10.1021/ac100554a; YAMADA S, 1995, GLYCOBIOLOGY, V5, P335, DOI 10.1093/glycob/5.3.335; Zaia J, 2003, J AM SOC MASS SPECTR, V14, P1270, DOI 10.1016/S1044-0305(03)00541-5; Zaia J, 2005, J BIOMACROMOL MASS S, V1, P3; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2002, GLYCOCONJUGATE J, V19, P241, DOI 10.1023/A:1025331929373	50	140	141	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					827	833		10.1038/nchembio.673	http://dx.doi.org/10.1038/nchembio.673			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21983600	Green Accepted			2022-12-27	WOS:000296381600013
J	Wang, XX; Kim, Y; Hong, SH; Ma, Q; Brown, BL; Pu, MM; Tarone, AM; Benedik, MJ; Peti, W; Page, R; Wood, TK				Wang, Xiaoxue; Kim, Younghoon; Hong, Seok Hoon; Ma, Qun; Brown, Breann L.; Pu, Mingming; Tarone, Aaron M.; Benedik, Michael J.; Peti, Wolfgang; Page, Rebecca; Wood, Thomas K.			Antitoxin MqsA helps mediate the bacterial general stress response	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI BIOFILMS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; CELL-DEATH; EXPRESSION; SYSTEMS; LOCUS; RPOS; INACTIVATION; TRANSLATION	n Although it is well recognized that bacteria respond to environmental stress through global networks, the mechanism by which stress is relayed to the interior of the cell is poorly understood. Here we show that enigmatic toxin-antitoxin systems are vital in mediating the environmental stress response. Specifically, the antitoxin MqsA represses rpoS, which encodes the master regulator of stress. Repression of rpoS by MqsA reduces the concentration of the internal messenger 3,5-cyclic diguanylic acid, leading to increased motility and decreased biofilm formation. Furthermore, the repression of rpoS by MqsA decreases oxidative stress resistance via catalase activity. Upon oxidative stress, MqsA is rapidly degraded by Lon protease, resulting in induction of rpoS. Hence, we show that external stress alters gene regulation controlled by toxin-antitoxin systems, such that the degradation of antitoxins during stress leads to a switch from the planktonic state (high motility) to the biofilm state (low motility).	[Wang, Xiaoxue; Kim, Younghoon; Hong, Seok Hoon; Ma, Qun; Pu, Mingming; Wood, Thomas K.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Brown, Breann L.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Tarone, Aaron M.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Benedik, Michael J.; Wood, Thomas K.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Texas A&M University System; Texas A&M University College Station; Brown University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Brown University	Wang, XX (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	Thomas.Wood@chemail.tamu.edu	Hong, Seok Hoon/E-1289-2014; Peti, Wolfgang/L-3492-2014; Benedik, Michael J/H-2478-2011; Pu, Mingming/F-6760-2012; Hong, Seok Hoon/AAF-7163-2021; Tarone, Aaron/I-6483-2012; Wood, Thomas/GWZ-2481-2022	Hong, Seok Hoon/0000-0003-2401-6368; Benedik, Michael J/0000-0002-7435-0092; Hong, Seok Hoon/0000-0003-2401-6368; Wood, Thomas/0000-0001-8962-8571; Wood, Thomas/0000-0002-6258-529X; Tarone, Aaron/0000-0003-0965-7634; Wang, Xiaoxue/0000-0002-7257-1916	US National Institutes of Health; F31 fellowship; US National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089999] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F31 fellowship; US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the US National Institutes of Health to T. K. W. and W. P. and an F31 fellowship to B. L. B. and by a US National Science Foundation CAREER award to R. P. We are grateful for the Keio and ASKA strains provided by the Genome Analysis Project in Japan.	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hengge R, 2008, ADV EXP MED BIOL, V631, P40, DOI 10.1007/978-0-387-78885-2_4; Ito A, 2008, BIOTECHNOL BIOENG, V99, P1462, DOI 10.1002/bit.21695; Ito A, 2009, BIOTECHNOL BIOENG, V103, P975, DOI 10.1002/bit.22305; Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Landini P, 2009, RES MICROBIOL, V160, P259, DOI 10.1016/j.resmic.2009.03.001; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Macvanin M, 2010, METHODS MOL BIOL, V642, P95, DOI 10.1007/978-1-60327-279-7_7; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Pecota DC, 1996, J BACTERIOL, V178, P2044, DOI 10.1128/jb.178.7.2044-2050.1996; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SAMMARTANO LJ, 1986, J BACTERIOL, V168, P13, DOI 10.1128/jb.168.1.13-21.1986; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	50	168	182	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2011	7	6					359	366		10.1038/NCHEMBIO.560	http://dx.doi.org/10.1038/NCHEMBIO.560			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	765BH	21516113	Green Accepted			2022-12-27	WOS:000290677900011
J	Mayer, N; Schweiger, M; Romauch, M; Grabner, GF; Eichmann, TO; Fuchs, E; Ivkovic, J; Heier, C; Mrak, I; Lass, A; Hofler, G; Fledelius, C; Zechner, R; Zimmermann, R; Breinbauer, R				Mayer, Nicole; Schweiger, Martina; Romauch, Matthias; Grabner, Gernot F.; Eichmann, Thomas O.; Fuchs, Elisabeth; Ivkovic, Jakov; Heier, Christoph; Mrak, Irina; Lass, Achim; Hoefler, Gerald; Fledelius, Christian; Zechner, Rudolf; Zimmermann, Robert; Breinbauer, Rolf			Development of small-molecule inhibitors targeting adipose triglyceride lipase	NATURE CHEMICAL BIOLOGY			English	Article							HORMONE-SENSITIVE LIPASE; INDUCED INSULIN-RESISTANCE; LIPOTOXICITY; LIPOLYSIS; TRIACYLGLYCEROL; METABOLISM; CATABOLISM; CACHEXIA; OBESITY; TISSUE	Adipose triglyceride lipase (ATGL) is rate limiting in the mobilization of fatty acids from cellular triglyceride stores. This central role in lipolysis marks ATGL as an interesting pharmacological target as deregulated fatty acid metabolism is closely linked to dyslipidemic and metabolic disorders. Here we report on the development and characterization of a small-molecule inhibitor of ATGL. Atglistatin is selective for ATGL and reduces fatty acid mobilization in vitro and in vivo.	[Mayer, Nicole; Fuchs, Elisabeth; Ivkovic, Jakov; Breinbauer, Rolf] Graz Univ Technol, Inst Organ Chem, A-8010 Graz, Austria; [Schweiger, Martina; Romauch, Matthias; Grabner, Gernot F.; Eichmann, Thomas O.; Heier, Christoph; Mrak, Irina; Lass, Achim; Zechner, Rudolf; Zimmermann, Robert] Graz Univ, Inst Mol Biosci, Graz, Austria; [Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Fledelius, Christian] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark	Graz University of Technology; University of Graz; Medical University of Graz; Novo Nordisk	Zimmermann, R (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	robert.zimmermann@uni-graz.at; breinbauer@tugraz.at	Lass, Achim/C-3332-2008; Breinbauer, Rolf/AAK-1750-2020	Lass, Achim/0000-0002-8190-7151; Breinbauer, Rolf/0000-0001-6009-7359; Zimmermann, Robert/0000-0002-7354-870X; Eichmann, Thomas O./0000-0002-8521-2795; Zechner, Rudolf/0000-0001-5483-1182; Grabner, Gernot/0000-0002-7110-9957; Ivkovic, Jakov/0000-0001-8593-5427; Heier, Christoph/0000-0001-6858-408X; Schweiger, Martina/0000-0002-3419-1007	Austrian Science Fund (FWF) [W901-B05, TRP4, Z136]; Forschungsforderungsgesellschaft und Bundesministerium fur Wissenschaft und Forschung (Austrian Genome Project GEN-AU: Genomics of Lipid-Associated Disorders (GOLD)); Platform for Chemical Biology in Austria (PLACEBO); Austrian Science Fund (FWF) [W 901, TRP 4, F 3002, Z 136] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Forschungsforderungsgesellschaft und Bundesministerium fur Wissenschaft und Forschung (Austrian Genome Project GEN-AU: Genomics of Lipid-Associated Disorders (GOLD)); Platform for Chemical Biology in Austria (PLACEBO); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF) projects (W901-B05 DK Molecular Enzymology (R. Zimmermann, R. B.), Translational Program TRP4 (R. Zimmermann), Wittgenstein Award 2007 (grant no. Z136, R. Zechner)) and by the Forschungsforderungsgesellschaft und Bundesministerium fur Wissenschaft und Forschung (Austrian Genome Project GEN-AU: Genomics of Lipid-Associated Disorders (GOLD, R. Zechner, R. Zimmermann) and Platform for Chemical Biology in Austria (PLACEBO, R. B.)). We are grateful to B. Grumm and B. Wolfl for skillful help in the synthesis of Atglistatin. Furthermore, we thank P. Jacobsen and H. Tornqvist from Novo Nordisk for helpful discussions and for the provision of lead compounds.	Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Carobbio S, 2011, CURR OPIN CLIN NUTR, V14, P520, DOI 10.1097/MCO.0b013e32834ad966; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Ebdrup S, 2004, J MED CHEM, V47, P400, DOI 10.1021/jm031004s; Ebdrup S, 2007, J MED CHEM, V50, P5449, DOI 10.1021/jm0607653; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hirano K, 2009, J ATHEROSCLER THROMB, V16, P702, DOI 10.5551/jat.1669; Honors M.A., 2012, CACHEXIA SARCOPENIA, V3, P5; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Kienesberger PC, 2008, J BIOL CHEM, V283, P5908, DOI 10.1074/jbc.M709598200; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Ong KT, 2013, FASEB J, V27, P313, DOI 10.1096/fj.12-213454; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Tisdale MJ, 2010, CURR OPIN GASTROEN, V26, P146, DOI 10.1097/MOG.0b013e3283347e77; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	25	133	137	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					785	+		10.1038/NCHEMBIO.1359	http://dx.doi.org/10.1038/NCHEMBIO.1359			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24096302	Green Accepted			2022-12-27	WOS:000327130000009
J	Tsunematsu, Y; Ishikawa, N; Wakana, D; Goda, Y; Noguchi, H; Moriya, H; Hotta, K; Watanabe, K				Tsunematsu, Yuta; Ishikawa, Noriyasu; Wakana, Daigo; Goda, Yukihiro; Noguchi, Hiroshi; Moriya, Hisao; Hotta, Kinya; Watanabe, Kenji			Distinct mechanisms for spiro-carbon formation reveal biosynthetic pathway crosstalk	NATURE CHEMICAL BIOLOGY			English	Article							MAMMALIAN-CELL CYCLE; DIELS-ALDER CONSTRUCTION; ASPERGILLUS-FUMIGATUS; SACCHAROMYCES-CEREVISIAE; BENZYLISOQUINOLINE ALKALOIDS; COMPLEXITY GENERATION; POLYKETIDE SYNTHASE; REDOX ENZYMES; IN-VITRO; SPIROTRYPROSTATIN	Spirotryprostatins, an indole alkaloid class of nonribosomal peptides isolated from Aspergillus fumigatus, are known for their antimitotic activity in tumor cells. Because spirotryprostatins and many other chemically complex spiro-carbon-bearing natural products exhibit useful biological activities, identifying and understanding the mechanism of spiro-carbon biosynthesis is of great interest. Here we report a detailed study of spiro-ring formation in spirotryprostatins from tryprostatins derived from the fumitremorgin biosynthetic pathway, using reactants and products prepared with engineered yeast and fungal strains. Unexpectedly, FqzB, an FAD-dependent monooxygenase from the unrelated fumiquinazoline biosynthetic pathway, catalyzed spiro-carbon formation in spirotryprostatin A via an epoxidation route. Furthermore, FtmG, a cytochrome P450 from the fumitremorgin biosynthetic pathway, was determined to catalyze the spiro-ring formation in spirotryprostatin B. Our results highlight the versatile role of oxygenating enzymes in the biosynthesis of structurally complex natural products and indicate that cross-talk of different biosynthetic pathways allows product diversification in natural product biosynthesis.	[Tsunematsu, Yuta; Ishikawa, Noriyasu; Noguchi, Hiroshi; Watanabe, Kenji] Univ Shizuoka, Dept Pharmaceut Sci, Shizuoka 4228526, Japan; [Wakana, Daigo; Goda, Yukihiro] Natl Inst Hlth Sci, Tokyo, Japan; [Moriya, Hisao] Okayama Univ, Res Core Interdisciplinary Sci, Okayama 7008530, Japan; [Hotta, Kinya] Univ Nottingham Malaysia Campus, Sch Biosci, Selangor, Malaysia	University of Shizuoka; National Institute of Health Sciences - Japan; Okayama University; University of Nottingham Malaysia	Watanabe, K (corresponding author), Univ Shizuoka, Dept Pharmaceut Sci, Shizuoka 4228526, Japan.	kenji55@u-shizuoka-ken.ac.jp	Moriya, Hisao/B-2424-2011; Watanabe, Kenji/N-2012-2015; Hotta, Kinya/A-2574-2009; Tsunematsu, Yuta/AAI-1139-2020	Moriya, Hisao/0000-0001-7638-3640; Watanabe, Kenji/0000-0002-0463-4831; Hotta, Kinya/0000-0002-9427-0081; 	Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy [LS103]; New Energy and Industrial Technology Development Organization (NEDO) of Japan [09C46001a]; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Hokuto Foundation for Bioscience; Naito Foundation Japan; JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Naito Foundation Japan(Naito Memorial Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We would like to thank J. Shimokawa at the University of Tokyo for providing us with a sample of spirotryprostatin A. We would like to express our appreciation to financial support from Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers', initiated by the Council for Science and Technology Policy (no. LS103) (K. W.) and by the Industrial Technology Research Grant Program in 2009 (no. 09C46001a) from the New Energy and Industrial Technology Development Organization (NEDO) of Japan (K. W.). These works were also supported in part by The Uehara Memorial Foundation (K. W.), by Mochida Memorial Foundation for Medical and Pharmaceutical Research (K. W.), by The Hokuto Foundation for Bioscience (K. W.) and by The Naito Foundation Japan (K. W.). Postdoctoral fellowships to Y. T. from JSPS are gratefully acknowledged.	Allen JD, 2002, MOL CANCER THER, V1, P417; Ames BD, 2011, BIOCHEMISTRY-US, V50, P8756, DOI 10.1021/bi201302w; Ames BD, 2010, BIOCHEMISTRY-US, V49, P8564, DOI 10.1021/bi1012029; Brachmann CB, 1998, YEAST, V14, P115; Cui CB, 1996, J ANTIBIOT, V49, P832, DOI 10.7164/antibiotics.49.832; Cui CB, 1996, TETRAHEDRON, V52, P12651, DOI 10.1016/0040-4020(96)00737-5; Cui CB, 1996, J ANTIBIOT, V49, P527, DOI 10.7164/antibiotics.49.527; Edmondson S, 1999, J AM CHEM SOC, V121, P2147, DOI 10.1021/ja983788i; Edmondson SD, 1998, ANGEW CHEM INT EDIT, V37, P1138, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1138::AID-ANIE1138>3.0.CO;2-N; Gao X, 2011, J AM CHEM SOC, V133, P2729, DOI 10.1021/ja1101085; Garcia-Estrada C, 2011, CHEM BIOL, V18, P1499, DOI 10.1016/j.chembiol.2011.08.012; Grubbs AW, 2007, ANGEW CHEM INT EDIT, V46, P2257, DOI 10.1002/anie.200604377; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Haynes SW, 2011, BIOCHEMISTRY-US, V50, P5668, DOI 10.1021/bi2004922; Ishiuchi K, 2013, J AM CHEM SOC, V135, P7371, DOI 10.1021/ja402828w; Ishiuchi K, 2012, CHEMBIOCHEM, V13, P846, DOI 10.1002/cbic.201100798; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Kato H, 2011, TETRAHEDRON LETT, V52, P6923, DOI 10.1016/j.tetlet.2011.10.065; Kato N, 2013, BIOSCI BIOTECH BIOCH, V77, P1061, DOI 10.1271/bbb.130026; Kato N, 2009, CHEMBIOCHEM, V10, P920, DOI 10.1002/cbic.200800787; Lazos O, 2010, CHEM BIOL, V17, P160, DOI 10.1016/j.chembiol.2010.01.011; Li SY, 2012, J AM CHEM SOC, V134, P788, DOI 10.1021/ja2093212; Li SM, 2011, J ANTIBIOT, V64, P45, DOI 10.1038/ja.2010.128; Lubertozzi D, 2009, BIOTECHNOL ADV, V27, P53, DOI 10.1016/j.biotechadv.2008.09.001; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Ohnishi K, 2005, YEAST, V22, P321, DOI 10.1002/yea.1213; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; SANZCERVERA JF, 1993, TETRAHEDRON, V49, P8471, DOI 10.1016/S0040-4020(01)96255-6; TAKAHASHI C, 1995, J CHEM SOC PERK T 1, P2345, DOI 10.1039/p19950002345; Wang HS, 2000, J ORG CHEM, V65, P4685, DOI 10.1021/jo000306o; Wang P, 2012, CURR OPIN CHEM BIOL, V16, P362, DOI 10.1016/j.cbpa.2012.04.008; Williams RM, 2002, CHEM PHARM BULL, V50, P711, DOI 10.1248/cpb.50.711; Xu W, 2010, J AM CHEM SOC, V132, P13604, DOI 10.1021/ja107084d; Yin WB, 2013, J AM CHEM SOC, V135, P2064, DOI 10.1021/ja311145n; Zhang H, 2008, MOL PHARMACEUT, V5, P212, DOI 10.1021/mp7001329	41	93	94	6	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					818	+		10.1038/NCHEMBIO.1366	http://dx.doi.org/10.1038/NCHEMBIO.1366			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24121553				2022-12-27	WOS:000327130000014
J	Yip, GMS; Chen, ZW; Edge, CJ; Smith, EH; Dickinson, R; Hohenester, E; Townsend, RR; Fuchs, K; Sieghart, W; Evers, AS; Franks, NP				Yip, Grace M. S.; Chen, Zi-Wei; Edge, Christopher J.; Smith, Edward H.; Dickinson, Robert; Hohenester, Erhard; Townsend, R. Reid; Fuchs, Karoline; Sieghart, Werner; Evers, Alex S.; Franks, Nicholas P.			A propofol binding site on mammalian GABA(A) receptors identified by photolabeling	NATURE CHEMICAL BIOLOGY			English	Article							ACID TYPE-A; HUMAN SERUM-ALBUMIN; GENERAL-ANESTHETICS; TRANSMEMBRANE DOMAIN; SUBUNIT; MODULATION; RESIDUE; SENSITIVITY; ANALOG; LOOP	Propofol is the most important intravenous general anesthetic in current clinical use. It acts by potentiating GABA(A) (gamma-aminobutyric acid type A) receptors, but where it binds to this receptor is not known and has been a matter of some debate. We synthesized a new propofol analog photolabeling reagent whose biological activity is very similar to that of propofol. We confirmed that this reagent labeled known propofol binding sites in human serum albumin that have been identified using X-ray crystallography. Using a combination of protiated and deuterated versions of the reagent to label mammalian receptors in intact membranes, we identified a new binding site for propofol in GABA(A) receptors consisting of both beta(3) homopentamers and alpha(1)beta(3) heteropentamers. The binding site is located within the beta subunit at the interface between the transmembrane domains and the extracellular domain and lies close to known determinants of anesthetic sensitivity in the transmembrane segments TM1 and TM2.	[Yip, Grace M. S.; Edge, Christopher J.; Smith, Edward H.; Hohenester, Erhard; Franks, Nicholas P.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Chen, Zi-Wei; Evers, Alex S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Edge, Christopher J.] Royal Berkshire Hosp, Dept Anaesthet, Reading RG1 5AN, Berks, England; [Dickinson, Robert] Imperial Coll Sch Med, Dept Surg & Canc, London, England; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Fuchs, Karoline; Sieghart, Werner] Med Univ Vienna, Dept Biochem & Mol Biol, Ctr Brain Res, Vienna, Austria	Imperial College London; Washington University (WUSTL); Royal Berkshire Hospital; Imperial College London; Washington University (WUSTL); Medical University of Vienna	Yip, GMS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	eversa@wustl.edu; n.franks@imperial.ac.uk	Sieghart, Werner/A-4877-2013	Sieghart, Werner/0000-0002-0443-0302; Franks, Nicholas/0000-0003-4874-4212; Evers, Alex/0000-0002-0342-0575	Medical Research Council (UK) [G0901892]; US National Institutes of Health (NIH) - National Institute of General Medical Sciences [PO1-GM47969, 8 P41 GM103422-35]; Austrian Ministry of Science and Research; European Seventh Framework Program [HEALTH-F4-2008-202088]; MRC [G0901892] Funding Source: UKRI; Medical Research Council [G0901892] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969, P41GM103422] Funding Source: NIH RePORTER	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH) - National Institute of General Medical Sciences; Austrian Ministry of Science and Research; European Seventh Framework Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Medical Research Council (UK) (grant G0901892 to N.P.F.), the US National Institutes of Health (NIH) - National Institute of General Medical Sciences (grant PO1-GM47969 to A. S. E. and grant 8 P41 GM103422-35 to R.R.T.), the Austrian Ministry of Science and Research and the European Seventh Framework Program (grant HEALTH-F4-2008-202088 to W.S.) for support. We also thank R. Yustos for technical assistance and D. Droste, M. Bennett, T. Gent, K. Karu, B. Manion, R. Ruby and J. Malone for help with the experiments.	Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bright DP, 2007, J BIOL CHEM, V282, P12038, DOI 10.1074/jbc.M700479200; Carlson BX, 2000, MOL PHARMACOL, V57, P474, DOI 10.1124/mol.57.3.474; Cestari IN, 2000, J NEUROCHEM, V74, P827, DOI 10.1046/j.1471-4159.2000.740827.x; Chang CSS, 2003, J BIOL CHEM, V278, P42821, DOI 10.1074/jbc.M306978200; Chen ZW, 2012, MOL PHARMACOL, V82, P408, DOI 10.1124/mol.112.078410; Chen ZW, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011445; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Davies PA, 1997, BRIT J PHARMACOL, V120, P899, DOI 10.1038/sj.bjp.0700987; Evers AS, 2010, J PHARMACOL EXP THER, V333, P404, DOI 10.1124/jpet.109.164079; Feng HJ, 2004, MOL PHARMACOL, V66, P1517, DOI 10.1124/mol.104.003426; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; HALES TG, 1991, BRIT J PHARMACOL, V104, P619, DOI 10.1111/j.1476-5381.1991.tb12479.x; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; JAMES R, 1980, J MED CHEM, V23, P1350, DOI 10.1021/jm00186a013; JONES MV, 1995, J PHARMACOL EXP THER, V274, P962; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kang SU, 2008, J PROTEOME RES, V7, P3498, DOI 10.1021/pr800236u; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Krasowski MD, 1997, NEUROPHARMACOLOGY, V36, P941, DOI 10.1016/S0028-3908(97)00074-9; Lam DW, 1998, BRAIN RES, V784, P179, DOI 10.1016/S0006-8993(97)01334-6; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; O'Shea SM, 2009, MOL PHARMACOL, V76, P641, DOI 10.1124/mol.109.055111; Richardson JE, 2007, ANESTHESIOLOGY, V107, P412, DOI 10.1097/01.anes.0000278875.36639.2c; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Siegwart Roberta, 2003, BMC Pharmacol, V3, P13, DOI 10.1186/1471-2210-3-13; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; WAUD DR, 1972, J PHARMACOL EXP THER, V183, P577; Williams CA, 2010, J BIOL CHEM, V285, P7281, DOI 10.1074/jbc.M109.050294; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; Zezula J, 1996, EUR J PHARMACOL, V301, P207, DOI 10.1016/0014-2999(96)00066-0	38	159	159	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2013	9	11					715	+		10.1038/NCHEMBIO.1340	http://dx.doi.org/10.1038/NCHEMBIO.1340			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238GD	24056400	Green Submitted, Green Accepted			2022-12-27	WOS:000325930500011
J	Monk, BC				Monk, Brian C.			TRANSPORTERS A yeast ABC interactome primer	NATURE CHEMICAL BIOLOGY			English	News Item							SACCHAROMYCES-CEREVISIAE; DRUG-RESISTANCE; PROTEINS	Analysis of the yeast ATP-binding cassette transporter interactome provides insight relevant to human health on the regulation and function of a protein family that determines tolerance to physiological conditions and externally imposed stress.	Univ Otago, Sir John Walsh Res Inst, Dunedin, New Zealand	University of Otago	Monk, BC (corresponding author), Univ Otago, Sir John Walsh Res Inst, Dunedin, New Zealand.	brian.monk@otago.ac.nz		Monk, Brian/0000-0003-2264-3480				Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Jensen LJ, 2008, SCIENCE, V322, P56, DOI 10.1126/science.1164801; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Snider J, 2013, NAT CHEM BIOL, V9, P565, DOI [10.1038/NCHEMBIO.1293, 10.1038/nchembio.1293]; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83	10	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2013	9	9					531	533		10.1038/nchembio.1317	http://dx.doi.org/10.1038/nchembio.1317			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	205CD	23959129				2022-12-27	WOS:000323417500002
J	Scheuermann, TH; Li, QM; Ma, HW; Key, J; Zhang, L; Chen, R; Garcia, JA; Naidoo, J; Longgood, J; Frantz, DE; Tambar, UK; Gardner, KH; Bruick, RK				Scheuermann, Thomas H.; Li, Qiming; Ma, He-Wen; Key, Jason; Zhang, Lei; Chen, Rui; Garcia, Joseph A.; Naidoo, Jacinth; Longgood, Jamie; Frantz, Doug E.; Tambar, Uttam K.; Gardner, Kevin H.; Bruick, Richard K.			Allosteric inhibition of hypoxia inducible factor-2 with small molecules	NATURE CHEMICAL BIOLOGY			English	Article							LIGAND-BINDING; STRUCTURAL BASIS; HIF-BINDING; PAS DOMAIN; HIF-2-ALPHA; HIF-1-ALPHA; NEUROBLASTOMA; HYDROXYLATION; RECRUITMENT; HIF1-ALPHA	Hypoxia inducible factors (HIFs) are heterodimeric transcription factors induced in many cancers where they frequently promote the expression of protumorigenic pathways. Though transcription factors are typically considered 'undruggable', the PAS-B domain of the HIF-2 alpha subunit contains a large cavity within its hydrophobic core that offers a unique foothold for small-molecule regulation. Here we identify artificial ligands that bind within this pocket and characterize the resulting structural and functional changes caused by binding. Notably, these ligands antagonize HIF-2 heterodimerization and DNA-binding activity in vitro and in cultured cells, reducing HIF-2 target gene expression. Despite the high sequence identity between HIF-2 alpha and HIF-1 alpha, these ligands are highly selective and do not affect HIF-1 function. These chemical tools establish the molecular basis for selective regulation of HIF-2, providing potential therapeutic opportunities to intervene in HIF-2-driven tumors, such as renal cell carcinomas.	[Scheuermann, Thomas H.; Li, Qiming; Ma, He-Wen; Key, Jason; Zhang, Lei; Naidoo, Jacinth; Longgood, Jamie; Frantz, Doug E.; Tambar, Uttam K.; Gardner, Kevin H.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Scheuermann, Thomas H.; Key, Jason; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Chen, Rui; Garcia, Joseph A.] Vet Affairs North Texas Hlth Care Syst, Dept Med, Dallas, TX USA; [Chen, Rui; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bruick, RK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Kevin.Gardner@utsouthwestern.edu; Richard.Bruick@utsouthwestern.edu	Gardner, Kevin/K-5493-2019; Gardner, Kevin H./K-7802-2012	Gardner, Kevin H./0000-0002-8671-2556; Garcia, Joseph/0000-0002-5621-7538; Key, Jason/0000-0001-6002-2111	US National Institutes of Health [P01 CA095471, P30 CA142543]; Cancer Prevention Research Institute of Texas [RP-100846]; Burroughs Wellcome Fund; Department of Veterans Affairs; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Center for Research Resources, US National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA095471, P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Department of Veterans Affairs(US Department of Veterans Affairs); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank S. Wang and members of the University of Texas Southwestern High-Throughput Screening Core Facility, D. Tomchick, C. Brautigam, J. MacMillan, N. Williams and members of our laboratories for their help. This work was funded by grants from the US National Institutes of Health (P01 CA095471, P30 CA142543) and the Cancer Prevention Research Institute of Texas (RP-100846). R.K.B. is the Michael L. Rosenberg Scholar in Medical Research and was supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; K.H.G. is the Virginia Lazenby O'Hara Chair in Biochemistry and W.W. Caruth Scholar in Biomedical Research; and U.K.T. is a W.W. Caruth Jr. Scholar in Biomedical Research. J.A.G. was supported by funds provided by the Department of Veterans Affairs. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (grant no. C06 RR 15437-01) from the National Center for Research Resources, US National Institutes of Health.	Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Key J, 2009, J AM CHEM SOC, V131, P17647, DOI 10.1021/ja9073062; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Morris MR, 2009, ANTICANCER RES, V29, P4337; Park EJ, 2006, CELL CYCLE, V5, P1847, DOI 10.4161/cc.5.16.3019; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Qing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200	42	193	208	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					271	276		10.1038/NCHEMBIO.1185	http://dx.doi.org/10.1038/NCHEMBIO.1185			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23434853	Green Published, Green Accepted			2022-12-27	WOS:000317025800018
J	Chao, FA; Morelli, A; Haugner, JC; Churchfield, L; Hagmann, LN; Shi, L; Masterson, LR; Sarangi, R; Veglia, G; Seelig, B				Chao, Fa-An; Morelli, Aleardo; Haugner, John C., III; Churchfield, Lewis; Hagmann, Leonardo N.; Shi, Lei; Masterson, Larry R.; Sarangi, Ritimukta; Veglia, Gianluigi; Seelig, Burckhard			Structure and dynamics of a primordial catalytic fold generated by in vitro evolution	NATURE CHEMICAL BIOLOGY			English	Article							PROTEINS; BINDING; SELECTION; ENZYMES; DOMAIN	Engineering functional protein scaffolds capable of carrying out chemical catalysis is a major challenge in enzyme design. Starting from a noncatalytic protein scaffold, we recently generated a new RNA ligase by in vitro directed evolution. This artificial enzyme lost its original fold and adopted an entirely new structure with substantially enhanced conformational dynamics, demonstrating that a primordial fold with suitable flexibility is sufficient to carry out enzymatic function.	[Chao, Fa-An; Morelli, Aleardo; Haugner, John C., III; Churchfield, Lewis; Hagmann, Leonardo N.; Masterson, Larry R.; Veglia, Gianluigi; Seelig, Burckhard] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Morelli, Aleardo; Haugner, John C., III; Churchfield, Lewis; Hagmann, Leonardo N.; Seelig, Burckhard] Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA; [Shi, Lei; Veglia, Gianluigi] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Sarangi, Ritimukta] Stanford Synchrotron Radiat Lightsource, SLAC Natl Accelerator Lab, Menlo Pk, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Seelig, B (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	seelig@umn.edu	Seelig, Burckhard/D-1042-2013	Seelig, Burckhard/0000-0001-8598-0586; Chao, Fa-An/0000-0001-5215-8545	US National Aeronautics and Space Administration (NASA) through the NASA Astrobiology Institute-Ames Research Center [NNX09AH70A]; Minnesota Medical Foundation; US National Institutes of Health (NIH) [T32 GM08347, T32 DE007288, GM100310, P41 RR001209]; US Department of Energy (DOE)-Basic Energy Sciences; NIH-National Center for Research Resources; DOE-Biological Environmental Resarch; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008347, R01GM100310, R01GM081388] Funding Source: NIH RePORTER	US National Aeronautics and Space Administration (NASA) through the NASA Astrobiology Institute-Ames Research Center; Minnesota Medical Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy (DOE)-Basic Energy Sciences(United States Department of Energy (DOE)); NIH-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE-Biological Environmental Resarch; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Golynskiy and A. Pohorille for helpful discussions; Z. Sachs, F.P. Seebeck, J.W. Szostak and F. Hollfelder for comments on the manuscript; and R. Majerle for isothermal titration calorimetry instrument use. This work was supported by the US National Aeronautics and Space Administration (NASA) Agreement no. NNX09AH70A through the NASA Astrobiology Institute-Ames Research Center (to F.-A.C., A.M., L.C. and B.S.); the Minnesota Medical Foundation (to B.S.) and the US National Institutes of Health (NIH) (T32 GM08347 to J.C.H., T32 DE007288 to L.R.M., GM100310 to G.V. and P41 RR001209). Stanford Synchrotron Radiation Lightsource (SSRL) operations are funded by the US Department of Energy (DOE)-Basic Energy Sciences. The SSRL Structural Molecular Biology program is supported by NIH-National Center for Research Resources and DOE-Biological Environmental Resarch.	Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Bryan PN, 2010, CURR OPIN STRUC BIOL, V20, P482, DOI 10.1016/j.sbi.2010.06.002; Cho GS, 2006, CHEM BIOL, V13, P139, DOI 10.1016/j.chembiol.2005.10.015; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cordes MHJ, 1999, SCIENCE, V284, P325, DOI 10.1126/science.284.5412.325; Golynskiy MV, 2010, TRENDS BIOTECHNOL, V28, P340, DOI 10.1016/j.tibtech.2010.04.003; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Holmbeck SMA, 1998, J MOL BIOL, V281, P271, DOI 10.1006/jmbi.1998.1908; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Mansy SS, 2007, J MOL BIOL, V371, P501, DOI 10.1016/j.jmb.2007.05.062; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; OHNO S, 1971, EVOLUTION GENE DUPLI; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Seelig B, 2011, NAT PROTOC, V6, P540, DOI 10.1038/nprot.2011.312; Smith BA, 2011, CURR OPIN CHEM BIOL, V15, P421, DOI 10.1016/j.cbpa.2011.03.006; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; van Tilborg PJA, 2000, BIOCHEMISTRY-US, V39, P8747, DOI 10.1021/bi991550g; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zhao Q, 2000, J MOL BIOL, V296, P509, DOI 10.1006/jmbi.1999.3457	25	44	44	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					81	83		10.1038/NCHEMBIO.1138	http://dx.doi.org/10.1038/NCHEMBIO.1138			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23222886	Green Accepted			2022-12-27	WOS:000314083200005
J	Linster, CL; Van Schaftingen, E; Hanson, AD				Linster, Carole L.; Van Schaftingen, Emile; Hanson, Andrew D.			Metabolite damage and its repair or pre-emption	NATURE CHEMICAL BIOLOGY			English	Review							L-2-HYDROXYGLUTARIC ACIDURIA; ESCHERICHIA-COLI; TRANS-ACONITATE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GENE; IDENTIFICATION; ENZYME; MECHANISM; 5-FORMYLTETRAHYDROFOLATE; MUTATIONS	It is increasingly evident that metabolites suffer various kinds of damage, that such damage happens in all organisms and that cells have dedicated systems for damage repair and containment. First, chemical biology is demonstrating that diverse metabolites are damaged by side reactions of 'promiscuous' enzymes or by spontaneous chemical reactions, that the products are useless or toxic and that the unchecked buildup of these products can be devastating. Second, genetic and genomic evidence from prokaryotes and eukaryotes is implicating a network of new, conserved enzymes that repair damaged metabolites or somehow pre-empt damage. Metabolite (that is, small-molecule) repair is analogous to macromolecule (DNA and protein) repair and seems from comparative genomic evidence to be equally widespread. Comparative genomics also implies that metabolite repair could be the function of many conserved protein families lacking known activities. How-and how well-cells deal with metabolite damage affects fields ranging from medical genetics to metabolic engineering.	[Linster, Carole L.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Van Schaftingen, Emile] Catholic Univ Louvain, Walloon Excellence Lifesci & Biotechnol WELBIO, de Duve Inst, Brussels, Belgium; [Hanson, Andrew D.] Univ Florida, Dept Hort Sci, Gainesville, FL USA	University of Luxembourg; Universite Catholique Louvain; WELBIO; State University System of Florida; University of Florida	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Walloon Excellence Lifesci & Biotechnol WELBIO, de Duve Inst, Brussels, Belgium.	emile.vanschaftingen@uclouvain.be; adha@ufl.edu	Van+Schaftingen, Emile/AAF-5532-2020	Linster, Carole/0000-0001-7143-0719; Van Schaftingen, Emile/0000-0002-6199-7647	US National Science Foundation [MCB-1153413]; Fonds National de la Recherche Scientifique; Walloon Region (WELBIO); European Union [276814]	US National Science Foundation(National Science Foundation (NSF)); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Walloon Region (WELBIO)(WELBIO); European Union(European Commission)	The authors' research on metabolite damage control is supported by the US National Science Foundation (award no. MCB-1153413 to A.D.H.), the Fonds National de la Recherche Scientifique (to E.V.S. and C.L.L.), the Walloon Region (WELBIO to E.V.S.) and the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 276814 (to C.L.L.). We thank M. Stitt, J.R. Roth and T.P. Begley for insightful discussions and V. de Crecy-Lagard, O. Fiehn and C.S. Henry for critically reading this article.	ACHESON SA, 1988, BIOCHEMISTRY-US, V27, P7371, DOI 10.1021/bi00419a030; Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Andralojc PJ, 2012, BIOCHEM J, V442, P733, DOI 10.1042/BJ20111443; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Aon JC, 2008, APPL ENVIRON MICROB, V74, P950, DOI 10.1128/AEM.01790-07; Aravind L, 2000, GENOME RES, V10, P1074, DOI 10.1101/gr.10.8.1074; Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baggott JE, 2000, BIOCHEMISTRY-US, V39, P14647, DOI 10.1021/bi001362m; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bertoldi M, 2001, PROTEIN SCI, V10, P1178, DOI 10.1110/ps.46601; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Burow M, 2006, FEBS J, V273, P2432, DOI 10.1111/j.1742-4658.2006.05252.x; Cai H, 2001, BIOCHEMISTRY-US, V40, P13699, DOI 10.1021/bi011380j; Cai H, 2001, BIOCHEMISTRY-US, V40, P2210, DOI 10.1021/bi0022902; Cai H, 1999, J BIOL CHEM, V274, P13470, DOI 10.1074/jbc.274.19.13470; Choe E, 2005, J FOOD SCI, V70, pR28, DOI 10.1111/j.1365-2621.2005.tb09055.x; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; Copley S.D., 2010, J COSMOL, V10, P3345; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; di Salvo ML, 2003, BBA-PROTEINS PROTEOM, V1647, P76, DOI 10.1016/S1570-9639(03)00060-8; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Fuhrer T, 2007, J BACTERIOL, V189, P8073, DOI 10.1128/JB.01027-07; Fujii T, 2002, BIOSCI BIOTECH BIOCH, V66, P622, DOI 10.1271/bbb.66.622; FUKUI S, 1965, J BIOL CHEM, V240, P1315; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gangolf M, 2010, J BIOL CHEM, V285, P583, DOI 10.1074/jbc.M109.054379; Gerdes S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S2; Golubev A G, 1996, Biokhimiia, V61, P2018; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Goyer A, 2005, J BIOL CHEM, V280, P26137, DOI 10.1074/jbc.M503106200; Goyer A, 2004, J BIOL CHEM, V279, P16947, DOI 10.1074/jbc.M400071200; Grininger M, 2006, J MOL BIOL, V357, P842, DOI 10.1016/j.jmb.2005.12.072; Grininger M, 2009, J BIOL CHEM, V284, P13068, DOI 10.1074/jbc.M808063200; HAGEDORN CH, 1983, ARCH BIOCHEM BIOPHYS, V225, P95, DOI 10.1016/0003-9861(83)90010-3; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Helling RB, 2002, J BACTERIOL, V184, P3699, DOI 10.1128/JB.184.13.3699-3703.2002; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; IZUMI Y, 1973, BIOCHIM BIOPHYS ACTA, V326, P485, DOI 10.1016/0005-2760(73)90156-2; Jeanguenin L, 2010, J BIOL CHEM, V285, P41557, DOI 10.1074/jbc.M110.190504; Jenkins AL, 2008, BIOORG CHEM, V36, P29, DOI 10.1016/j.bioorg.2007.10.005; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kalliri E, 2008, J BACTERIOL, V190, P3793, DOI 10.1128/JB.01977-07; KATO N, 1986, EUR J BIOCHEM, V156, P59, DOI 10.1111/j.1432-1033.1986.tb09548.x; KAUFMAN EE, 1988, J BIOL CHEM, V263, P16872; Keeley JE, 2003, INT J PLANT SCI, V164, pS55, DOI 10.1086/374192; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; KOCHHAR S, 1992, EUR J BIOCHEM, V203, P563, DOI 10.1111/j.1432-1033.1992.tb16584.x; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; Kozmin SG, 2008, MOL MICROBIOL, V68, P51, DOI 10.1111/j.1365-2958.2008.06128.x; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; KRUSCHWITZ HL, 1994, J BIOL CHEM, V269, P28757; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Linster CL, 2011, J BIOL CHEM, V286, P42992, DOI 10.1074/jbc.M111.281527; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Moroz OV, 2005, J MOL BIOL, V347, P243, DOI 10.1016/j.jmb.2005.01.030; Murdanoto AP, 1997, APPL ENVIRON MICROB, V63, P1715, DOI 10.1128/AEM.63.5.1715-1720.1997; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; OPPENHEIMER NJ, 1974, BIOCHEMISTRY-US, V13, P4685, DOI 10.1021/bi00720a002; Peterhansel C, 2011, PLANT PHYSIOL, V155, P49, DOI 10.1104/pp.110.165019; PIERSON DE, 1990, J BACTERIOL, V172, P2194, DOI 10.1128/jb.172.4.2194-2198.1990; RAFTER GW, 1954, J BIOL CHEM, V208, P799; RAYAPATI PJ, 1989, PLANT PHYSIOL, V91, P581, DOI 10.1104/pp.91.2.581; RICHARD JP, 1991, BIOCHEMISTRY-US, V30, P4581, DOI 10.1021/bi00232a031; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Saito N, 2009, J BIOL CHEM, V284, P16442, DOI 10.1074/jbc.M109.002089; Seaver SMD, 2012, J EXP BOT, V63, P2247, DOI 10.1093/jxb/err371; Sikora M, 2009, MICROBIOL-SGM, V155, P1858, DOI 10.1099/mic.0.026609-0; Stefani M, 1997, CELL MOL LIFE SCI, V53, P141, DOI 10.1007/PL00000585; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2010, FEBS LETT, V584, P181, DOI 10.1016/j.febslet.2009.11.055; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Topcu M, 2004, HUM MOL GENET, V13, P2803, DOI 10.1093/hmg/ddh300; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Vinci CR, 2007, J BIOL CHEM, V282, P8604, DOI 10.1074/jbc.M610029200; Vinci CR, 2010, J BIOL CHEM, V285, P20526, DOI 10.1074/jbc.M110.113076; WAITE M, 1962, J BIOL CHEM, V237, P2750; Waller JC, 2010, P NATL ACAD SCI USA, V107, P10412, DOI 10.1073/pnas.0911586107; Wright SK, 2001, J BIOL CHEM, V276, P31151, DOI 10.1074/jbc.M100892200; YOSHIDA A, 1975, ARCH BIOCHEM BIOPHYS, V169, P298, DOI 10.1016/0003-9861(75)90344-6; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	100	209	212	3	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					72	80		10.1038/NCHEMBIO.1141	http://dx.doi.org/10.1038/NCHEMBIO.1141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23334546				2022-12-27	WOS:000314083200004
J	Wang, AM; Miyata, Y; Klinedinst, S; Peng, HM; Chua, JP; Komiyama, T; Li, XK; Morishima, Y; Merry, DE; Pratt, WB; Osawa, Y; Collins, CA; Gestwicki, JE; Lieberman, AP				Wang, Adrienne M.; Miyata, Yoshinari; Klinedinst, Susan; Peng, Hwei-Ming; Chua, Jason P.; Komiyama, Tomoko; Li, Xiaokai; Morishima, Yoshihiro; Merry, Diane E.; Pratt, William B.; Osawa, Yoichi; Collins, Catherine A.; Gestwicki, Jason E.; Lieberman, Andrew P.			Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; BULBAR MUSCULAR-ATROPHY; ANDROGEN RECEPTOR PROTEIN; AMELIORATES PHENOTYPES; CHAPERONE MACHINERY; BINDING; HSP90; CHIP; MUTANT; CELLS	We sought new strategies to reduce amounts of the polyglutamine androgen receptor (polyQ AR) and achieve benefits in models of spinobulbar muscular atrophy, a protein aggregation neurodegenerative disorder. Proteostasis of the polyQ AR is controlled by the heat shock protein 90 (Hsp90)- and Hsp70-based chaperone machinery, but mechanisms regulating the protein's turnover are incompletely understood. We demonstrate that overexpression of Hsp70 interacting protein (Hip), a co-chaperone that enhances binding of Hsp70 to its substrates, promotes client protein ubiquitination and polyQ AR clearance. Furthermore, we identify a small molecule that acts similarly to Hip by allosterically promoting Hsp70 binding to unfolded substrates. Like Hip, this synthetic co-chaperone enhances client protein ubiquitination and polyQ AR degradation. Both genetic and pharmacologic approaches targeting Hsp70 alleviate toxicity in a Drosophila model of spinobulbar muscular atrophy. These findings highlight the therapeutic potential of allosteric regulators of Hsp70 and provide new insights into the role of the chaperone machinery in protein quality control.	[Wang, Adrienne M.; Miyata, Yoshinari; Chua, Jason P.; Komiyama, Tomoko; Li, Xiaokai; Gestwicki, Jason E.; Lieberman, Andrew P.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Wang, Adrienne M.; Chua, Jason P.; Lieberman, Andrew P.] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Miyata, Yoshinari; Komiyama, Tomoko; Li, Xiaokai; Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Klinedinst, Susan; Collins, Catherine A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Peng, Hwei-Ming; Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chua, Jason P.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Merry, Diane E.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Jefferson University	Lieberman, AP (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	gestwick@umich.edu; liebermn@umich.edu	Li, Xiaokai/D-2680-2014; Li, Xiaokai/A-7162-2012	Collins, Catherine/0000-0002-1608-6692	McKnight Foundation; US National Institutes of Health [NS055746, NS055746-04S1, NS059690, GM077430, NS069844, NS32214, NS076189]; Muscular Dystrophy Association [MDA238924]; US National Science Foundation [IOS-0842701]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401, R01NS059690, R01NS032214, R01NS069844, R56NS032214, F31NS076189, R01NS055746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007281] Funding Source: NIH RePORTER	McKnight Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Reddy, J. Diep and T. Washington for technical assistance and K. Takeyama (University of Tokyo) and the Bloomington Stock Center for fly strains. This work was initiated under a grant from the McKnight Foundation (to A.P.L.) and was supported by the US National Institutes of Health (NS055746, NS055746-04S1 to A.P.L.; NS059690 to J.E.G.; GM077430 to Y.O.; NS069844 to C.A.C.; NS32214 to D.E.M.; NS076189 to J.P.C.), the Muscular Dystrophy Association (MDA238924 to A.P.L.) and the US National Science Foundation (IOS-0842701 to C.A.C.).	Adachi H, 2003, J NEUROSCI, V23, P2203; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Burlison JA, 2006, J AM CHEM SOC, V128, P15529, DOI 10.1021/ja065793p; Clapp KM, 2010, J BIOL CHEM, V285, P33642, DOI 10.1074/jbc.M110.159178; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; HOHFELD J, 1995, CELL, V83, P589; Howarth JL, 2009, J NEUROCHEM, V108, P945, DOI [10.1111/j.1471-4159.2008.05847.x, 10.1111/j.0022-3042.2008.05847.x]; Kemp MQ, 2011, HUM MOL GENET, V20, P4475, DOI 10.1093/hmg/ddr380; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Lieberman AP, 2002, HUM MOL GENET, V11, P1967, DOI 10.1093/hmg/11.17.1967; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; Morishima Y, 2011, BIOCHEMISTRY-US, V50, P7146, DOI 10.1021/bi200751t; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Patury S, 2009, CURR TOP MED CHEM, V9, P1337, DOI 10.2174/156802609789895674; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2012, J BIOL CHEM, V287, P1556, DOI 10.1074/jbc.M111.323295; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Tikoo A, 2000, CANCER J, V6, P162; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Wadhwa R, 2000, CANCER RES, V60, P6818; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Yu ZG, 2009, DIS MODEL MECH, V2, P500, DOI 10.1242/dmm.003301; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	42	129	132	0	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					112	118		10.1038/NCHEMBIO.1140	http://dx.doi.org/10.1038/NCHEMBIO.1140			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23222885	Green Accepted, Green Submitted			2022-12-27	WOS:000314083200010
J	Banci, L; Luchinat, C				Banci, Lucia; Luchinat, Claudio			Ivano Bertini 1940-2012 obituary	NATURE CHEMICAL BIOLOGY			English	Biographical-Item									[Banci, Lucia] Univ Florence, CERM CIRMMP, Sesto Fiorentino, Italy; Univ Florence, Dept Chem, Sesto Fiorentino, Italy	University of Florence; University of Florence	Banci, L (corresponding author), Univ Florence, CERM CIRMMP, Sesto Fiorentino, Italy.	luchinat@cerm.unifi.it		BANCI, LUCIA/0000-0003-0562-5774				BERTINI I, PUBLICATION LIST	1	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					807	807		10.1038/nchembio.1072	http://dx.doi.org/10.1038/nchembio.1072			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22986998	Bronze			2022-12-27	WOS:000309056200001
J	Sentelle, RD; Senkal, CE; Jiang, WH; Ponnusamy, S; Gencer, S; Selvam, SP; Ramshesh, VK; Peterson, YK; Lemasters, JJ; Szulc, ZM; Bielawski, J; Ogretmen, B				Sentelle, R. David; Senkal, Can E.; Jiang, Wenhui; Ponnusamy, Suriyan; Gencer, Salih; Selvam, Shanmugam Panneer; Ramshesh, Venkat K.; Peterson, Yuri K.; Lemasters, John J.; Szulc, Zdzislaw M.; Bielawski, Jacek; Ogretmen, Besim			Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy	NATURE CHEMICAL BIOLOGY			English	Article							LONGEVITY ASSURANCE GENE-1; SQUAMOUS-CELL CARCINOMAS; HUMAN HEAD; IN-VITRO; (DIHYDRO)CERAMIDE SYNTHASE; NONVESICULAR TRAFFICKING; PROTEIN-KINASE; ER STRESS; C-ELEGANS; DEATH	Mechanisms by which autophagy promotes cell survival or death are unclear. We provide evidence that C-18-pyridinium ceramide treatment or endogenous C-18-ceramide generation by ceramide synthase 1 (CerS1) expression mediates autophagic cell death, independent of apoptosis in human cancer cells. C-18-ceramide-induced lethal autophagy was regulated via microtubule-associated protein 1 light chain 3 beta-lipidation, forming LC3B-II, and selective targeting of mitochondria by LC3B-II-containing autophagolysosomes (mitophagy) through direct interaction between ceramide and LC3B-II upon Drp1-dependent mitochondrial fission, leading to inhibition of mitochondrial function and oxygen consumption. Accordingly, expression of mutant LC3B with impaired ceramide binding, as predicted by molecular modeling, prevented CerS1-mediated mitochondrial targeting, recovering oxygen consumption. Moreover, knockdown of CerS1 abrogated sodium selenite-induced mitophagy, and stable LC3B knockdown protected against CerS1- and C-18-ceramide-dependent mitophagy and blocked tumor suppression in vivo. Thus, these data suggest a new receptor function of ceramide for anchoring LC3B-II autophagolysosomes to mitochondrial membranes, defining a key mechanism for the induction of lethal mitophagy.	[Sentelle, R. David; Senkal, Can E.; Jiang, Wenhui; Ponnusamy, Suriyan; Gencer, Salih; Selvam, Shanmugam Panneer; Szulc, Zdzislaw M.; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Sentelle, R. David; Senkal, Can E.; Jiang, Wenhui; Ponnusamy, Suriyan; Gencer, Salih; Selvam, Shanmugam Panneer; Ramshesh, Venkat K.; Peterson, Yuri K.; Lemasters, John J.; Szulc, Zdzislaw M.; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Ramshesh, Venkat K.; Peterson, Yuri K.; Lemasters, John J.] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Sentelle, RD (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	ogretmen@musc.edu	jiang, wen/GYI-9662-2022; Gencer, Salih/B-6436-2012; Gencer, Salih/AAL-5502-2020; Panneer Selvam, Shanmugam/K-4759-2016	Panneer Selvam, Shanmugam/0000-0002-3290-8844; Szulc, Zdzislaw M./0000-0003-1756-9028	US National Institutes of Health (NIH) [CA088932, DE016572, CA097165]; NIH [C06 RR015455, 5-P30-DK34987, 1-P50-AA11605, P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA088932, P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011605] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank J.G. Schnellmann for her editorial review. We also thank D.J. Hazen-Martin and her group for TEM preparations. This work was supported by research grants obtained from the US National Institutes of Health (NIH; CA088932, DE016572 and CA097165 to B.O.). The core facilities used for animal studies, lipidomics and imaging were constructed using support from NIH (C06 RR015455, 5-P30-DK34987, 1-P50-AA11605 and P30 CA138313).	Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Kim EH, 2008, AUTOPHAGY, V4, P76, DOI 10.4161/auto.5119; Kim I, 2011, AM J PHYSIOL-CELL PH, V300, pC308, DOI 10.1152/ajpcell.00056.2010; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Masud A, 2007, J BIOL CHEM, V282, P14132, DOI 10.1074/jbc.M700077200; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Saddoughi SA, 2011, CLIN CANCER RES, V17, P6097, DOI 10.1158/1078-0432.CCR-11-0930; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Senkal CE, 2006, J PHARMACOL EXP THER, V317, P1188, DOI 10.1124/jpet.106.101949; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	43	315	322	8	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					831	838		10.1038/NCHEMBIO.1059	http://dx.doi.org/10.1038/NCHEMBIO.1059			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22922758	Green Accepted			2022-12-27	WOS:000309056200008
J	Gloster, TM; Vocadlo, DJ				Gloster, Tracey M.; Vocadlo, David J.			Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology	NATURE CHEMICAL BIOLOGY			English	Review							ACIDIC MAMMALIAN CHITINASE; O-GLCNACASE INHIBITOR; TRANSITION-STATE ANALOGS; PANCREATIC ALPHA-AMYLASE; GAUCHER-DISEASE; N-BUTYLDEOXYNOJIRIMYCIN; ISOFAGOMINE INCREASES; BETA-GLUCOSIDASE; GLYCOSPHINGOLIPID SYNTHESIS; PHARMACOLOGICAL CHAPERONES	Glycoconjugates are ubiquitous biomolecules found in all kingdoms of life. These diverse structures are metabolically responsive and occur in a cell line-and protein-specific manner, conferring tissue type-specific properties. Glycans have essential roles in diverse processes, including, for example, intercellular signaling, inflammation, protein quality control, glucohomeostasis and cellular adhesion as well as cell differentiation and proliferation. Many mysteries remain in the field, however, and uncovering the physiological roles of various glycans remains a key pursuit. Realizing this aim necessitates the ability to subtly and selectively manipulate the series of different glycoconjugates both in cells and in vivo. Selective small-molecule inhibitors of glycan processing enzymes hold great potential for such manipulation as well as for determining the function of 'orphan' carbohydrate-processing enzymes. In this review, we discuss recent advances and existing inhibitors, the prospects for small-molecule inhibitors and the challenges associated with generating high-quality chemical probes for these families of enzymes. The coordinated efforts of chemists, biochemists and biologists will be crucial for creating and characterizing inhibitors that are useful tools both for advancing a basic understanding of glycobiology in mammals as well as for validating new potential therapeutic targets within this burgeoning field.	[Gloster, Tracey M.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Gloster, TM (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Simon Fraser University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Simon Fraser University	T.M.G. is a Wellcome Trust Research Career Development Fellow. D.J.V. is a scholar of the Michael Smith Foundation for Health Research, holds a Canada Research Chair in Chemical Glycobiology and is an E. W. R. Steacie memorial fellow. We thank the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes of Health Research and Simon Fraser University for funding support.	Abad-Zapatero C, 2007, EXPERT OPIN DRUG DIS, V2, P469, DOI 10.1517/17460441.2.4.469; Andersen OA, 2008, CHEM BIOL, V15, P295, DOI 10.1016/j.chembiol.2008.02.015; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Benalla W, 2010, CURR DIABETES REV, V6, P247, DOI 10.2174/157339910791658826; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Brown JR, 2009, J BIOL CHEM, V284, P4952, DOI 10.1074/jbc.M805782200; Brown JR, 2006, CLIN CANCER RES, V12, P2894, DOI 10.1158/1078-0432.CCR-05-2745; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Chiang CH, 2010, J CELL PHYSIOL, V223, P492, DOI 10.1002/jcp.22068; Clarke JTR, 2011, MOL GENET METAB, V102, P6, DOI 10.1016/j.ymgme.2010.09.004; Cole DC, 2010, J MED CHEM, V53, P6122, DOI 10.1021/jm100533p; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Dehennaut V, 2007, J BIOL CHEM, V282, P12527, DOI 10.1074/jbc.M700444200; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Dimitroff CJ, 2003, J CLIN INVEST, V112, P1008, DOI 10.1172/JCI200319220; Dorfmueller HC, 2006, J AM CHEM SOC, V128, P16484, DOI 10.1021/ja066743n; Dorfmueller HC, 2010, CHEM BIOL, V17, P1250, DOI 10.1016/j.chembiol.2010.09.014; Dorfmueller HC, 2010, FEBS LETT, V584, P694, DOI 10.1016/j.febslet.2009.12.020; Dorfmueller HC, 2009, BIOCHEM J, V420, P221, DOI 10.1042/BJ20090110; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; Fitz LJ, 2012, AM J RESP CELL MOL, V46, P71, DOI 10.1165/rcmb.2011-0095OC; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gloster TM, 2007, J AM CHEM SOC, V129, P2345, DOI 10.1021/ja066961g; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gloster TM, 2010, ORG BIOMOL CHEM, V8, P305, DOI 10.1039/b915870g; Gross BJ, 2008, J AM CHEM SOC, V130, P440, DOI 10.1021/ja078125s; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Ho CW, 2010, ACS CHEM BIOL, V5, P489, DOI 10.1021/cb100011u; Hosoguchi K, 2010, J MED CHEM, V53, P5607, DOI 10.1021/jm100612r; Hrmova M, 2005, BIOCHEMISTRY-US, V44, P16529, DOI 10.1021/bi0514818; Kageyama S, 1997, CLIN THER, V19, P720, DOI 10.1016/S0149-2918(97)80096-3; Khanna R, 2010, FEBS J, V277, P1618, DOI 10.1111/j.1742-4658.2010.07588.x; Khanna R, 2010, MOL THER, V18, P23, DOI 10.1038/mt.2009.220; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Laferte S, 2000, EUR J BIOCHEM, V267, P4840, DOI 10.1046/j.1432-1327.2000.01544.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee KY, 2002, J BIOL CHEM, V277, P49341, DOI 10.1074/jbc.M209618200; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lillelund VH, 2002, CHEM REV, V102, P515, DOI 10.1021/cr000433k; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; MADAR Z, 1989, J NUTR, V119, P2023, DOI 10.1093/jn/119.12.2023; Mader MM, 1997, CHEM REV, V97, P1281, DOI 10.1021/cr960435y; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; Masciullo M, 2010, J INHERIT METAB DIS, V33, pS355, DOI 10.1007/s10545-010-9186-3; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Muller B, 1998, ANGEW CHEM INT EDIT, V37, P2893, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2893::AID-ANIE2893>3.0.CO;2-W; Nahoum V, 2000, BIOCHEM J, V346, P201, DOI 10.1042/0264-6021:3460201; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Niewiadomski S, 2010, ORG BIOMOL CHEM, V8, P3488, DOI 10.1039/c004165c; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Patterson MC, 2010, J CHILD NEUROL, V25, P300, DOI 10.1177/0883073809344222; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Platt FM, 1997, SCIENCE, V276, P428, DOI 10.1126/science.276.5311.428; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Qin XH, 2011, J STRUCT BIOL, V174, P196, DOI 10.1016/j.jsb.2010.11.020; RALTON JE, 1993, J BIOL CHEM, V268, P24183; Reichner JS, 1998, GLYCOBIOLOGY, V8, P1173, DOI 10.1093/glycob/8.12.1173; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; Rishton GM, 2003, DRUG DISCOV TODAY, V8, P86, DOI 10.1016/S1359644602025722; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; Shen JS, 2008, BIOCHEM BIOPH RES CO, V369, P1071, DOI 10.1016/j.bbrc.2008.02.125; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Soya N, 2011, GLYCOBIOLOGY, V21, P547, DOI 10.1093/glycob/cwq190; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Sutherland TE, 2009, CLIN EXP ALLERGY, V39, P943, DOI 10.1111/j.1365-2222.2009.03243.x; Tarling CA, 2008, CHEMBIOCHEM, V9, P433, DOI 10.1002/cbic.200700470; Tropak MB, 2007, CHEM BIOL, V14, P153, DOI 10.1016/j.chembiol.2006.12.006; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; VUNNAM RR, 1980, CHEM PHYS LIPIDS, V26, P265; Wang R, 1997, BIOORGAN MED CHEM, V5, P661, DOI 10.1016/S0968-0896(97)00005-9; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	100	142	145	6	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					683	694		10.1038/NCHEMBIO.1029	http://dx.doi.org/10.1038/NCHEMBIO.1029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22810773				2022-12-27	WOS:000306527600006
J	Wacker, SA; Houghtaling, BR; Elemento, O; Kapoor, TM				Wacker, Sarah A.; Houghtaling, Benjamin R.; Elemento, Olivier; Kapoor, Tarun M.			Using transcriptome sequencing to identify mechanisms of drug action and resistance	NATURE CHEMICAL BIOLOGY			English	Article							BORTEZOMIB RESISTANCE; MOLECULAR-BASIS; GENE MUTATION; BCR-ABL; INHIBITOR; PROTEASOME; DISCOVERY; PROTEIN; AURORA; CELLS	Determining mechanisms of drug action in human cells remains a major challenge. Here we describe an approach in which multiple-drug-resistant clones are isolated and transcriptome sequencing is used to find mutations in each clone. Further analysis of mutations common to more than one clone can identify a drug's physiological target and indirect resistance mechanisms, as indicated by our proof-of-concept studies of the cytotoxic anticancer drugs BI 2536 and bortezomib.	[Wacker, Sarah A.; Houghtaling, Benjamin R.; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA; [Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA	Rockefeller University; Cornell University	Wacker, SA (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	ole2001@med.cornell.edu; kapoor@rockefeller.edu			US National Science Foundation [1054964]; US National Institutes of Health [GM98579, GM65933]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098579, R01GM065933] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Genomics Resources Core Facility of Weill Cornell Medical College for conducting the RNA-seq and D. Soong (Weill Cornell Medical College) for providing custom analysis software. This work was supported by the US National Science Foundation CAREER grant 1054964 (O.E.) and US National Institutes of Health GM98579 and GM65933 (T.M.K.).	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Chan JNY, 2010, TRENDS PHARMACOL SCI, V31, P82, DOI 10.1016/j.tips.2009.11.002; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Rickert KW, 2008, ARCH BIOCHEM BIOPHYS, V469, P220, DOI 10.1016/j.abb.2007.10.016; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Teraishi F, 2005, CANCER RES, V65, P6380, DOI 10.1158/0008-5472.CAN-05-0575; WALKER GM, 1982, J GEN MICROBIOL, V128, P61; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754	23	121	123	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					235	237		10.1038/NCHEMBIO.779	http://dx.doi.org/10.1038/NCHEMBIO.779			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22327403	Green Accepted			2022-12-27	WOS:000300600000007
J	Chait, R; Vetsigian, K; Kishony, R				Chait, Remy; Vetsigian, Kalin; Kishony, Roy			What counters antibiotic resistance in nature?	NATURE CHEMICAL BIOLOGY			English	Article							SELECTION; AGENTS; ACID		[Chait, Remy; Vetsigian, Kalin; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Chait, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA.	roy_kishony@hms.harvard.edu		Chait, Remy/0000-0003-0876-3187				Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; BANNISTE.D, 1970, J GEN MICROBIOL, V61, P273, DOI 10.1099/00221287-61-2-273; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chait R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015179; Clardy J, 2009, CURR BIOL, V19, pR437, DOI 10.1016/j.cub.2009.04.001; CRAINE BL, 1982, J BACTERIOL, V151, P487, DOI 10.1128/JB.151.1.487-490.1982; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hopwood DA, 2007, STREPTOMYCES NATURE; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Palmer AC, 2010, NAT CHEM BIOL, V6, P105, DOI [10.1038/NCHEMBIO.289, 10.1038/nchembio.289]; READING C, 1977, ANTIMICROB AGENTS CH, V11, P852, DOI 10.1128/AAC.11.5.852; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Xiao Y, 2011, J BACTERIOL, V193, P4626, DOI 10.1128/JB.05052-11; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755	25	34	38	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					2	5		10.1038/nchembio.745	http://dx.doi.org/10.1038/nchembio.745			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173342				2022-12-27	WOS:000298414100002
J	Muellner, MK; Uras, IZ; Gapp, BV; Kerzendorfer, C; Smida, M; Lechtermann, H; Craig-Mueller, N; Colinge, J; Duernberger, G; Nijman, SMB				Muellner, Markus K.; Uras, Iris Z.; Gapp, Bianca V.; Kerzendorfer, Claudia; Smida, Michal; Lechtermann, Hannelore; Craig-Mueller, Nils; Colinge, Jacques; Duernberger, Gerhard; Nijman, Sebastian M. B.			A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer	NATURE CHEMICAL BIOLOGY			English	Article							DUAL PI3K/MTOR INHIBITOR; BREAST-CANCER; C-MYC; DRUG-RESISTANCE; NOTCH1; NVP-BEZ235; THERAPY; GENOME; TARGET; CELLS	Linking the molecular aberrations of cancer to drug responses could guide treatment choice and identify new therapeutic applications. However, there has been no systematic approach for analyzing gene-drug interactions in human cells. Here we establish a multiplexed assay to study the cellular fitness of a panel of engineered isogenic cancer cells in response to a collection of drugs, enabling the systematic analysis of thousands of gene-drug interactions. Applying this approach to breast cancer revealed various synthetic-lethal interactions and drug-resistance mechanisms, some of which were known, thereby validating the method. NOTCH pathway activation, which occurs frequently in breast cancer, unexpectedly conferred resistance to phosphoinositide 3-kinase (PI3K) inhibitors, which are currently undergoing clinical trials in breast cancer patients. NOTCH1 and downstream induction of c-MYC over-rode the dependency of cells on the PI3K-mTOR pathway for proliferation. These data reveal a new mechanism of resistance to PI3K inhibitors with direct clinical implications.	[Muellner, Markus K.; Uras, Iris Z.; Gapp, Bianca V.; Kerzendorfer, Claudia; Smida, Michal; Lechtermann, Hannelore; Craig-Mueller, Nils; Colinge, Jacques; Duernberger, Gerhard; Nijman, Sebastian M. B.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Nijman, SMB (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	snijman@cemm.oeaw.ac.at	Uras, Iris/AAH-2221-2021; Colinge, Jacques/Z-2613-2019; Smida, Michal/J-5046-2014; Colinge, Jacques/D-1578-2017	Colinge, Jacques/0000-0003-2466-4824; Smida, Michal/0000-0002-7335-3435; Colinge, Jacques/0000-0003-2466-4824; Uras, Iris/0000-0002-2434-2756; Nijman, Sebastian/0000-0003-0464-6661	Austrian Science Fund (FWF) [P21768-B13]; Vienna Science and Technology Fund (WWTF) [LS09-009]; Austrian Science Fund (FWF) [P 21768] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the T. Berg, A. Harutyunyan, U. Rix and G. Hofbauer for technical assistance; F. Ganglberger, B. Eizinger and P. Markt for assisting in data analysis; and H. Pickersgill, M. Creyghton and G. Superti-Furga for critical reading and suggestions. We are grateful to T. Golub and C. Yu for support and discussions in the early phases of the project; and to A. D'Andrea, H. Dolznig, C. Tabin, T. Brummelkamp, R. Bernards, P. Eichhorn, D. Peeper, W. Hahn, R. Conaway, J. Conaway, R. Weinberg, I. Screpanti, J. Zhao, R. Hynes, Y. Xiong, R. Basch, B. Vogelstein, D. Bulavin, P. Yaswen, R. Kopan, M. Parker, J. Bradner and D. Root for providing reagents. We thank Luminex for providing reagents and support. This work was made possible by research grants from the Austrian Science Fund (FWF, P21768-B13) and the Vienna Science and Technology Fund (WWTF, LS09-009).	Bernards R, 2010, CELL, V141, P13, DOI 10.1016/j.cell.2010.03.018; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Iavarone A, 1997, NATURE, V387, P417; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nijman SMB, 2011, FEBS LETT, V585, P1, DOI 10.1016/j.febslet.2010.11.024; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reinhardt HC, 2009, CELL CYCLE, V8, P3112, DOI 10.4161/cc.8.19.9626; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107	43	123	128	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					787	793		10.1038/nchembio.695	http://dx.doi.org/10.1038/nchembio.695			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21946274	Green Accepted			2022-12-27	WOS:000296381600008
J	White, TR; Renzelman, CM; Rand, AC; Rezai, T; McEwen, CM; Gelev, VM; Turner, RA; Linington, RG; Leung, SSF; Kalgutkar, AS; Bauman, JN; Zhang, YZ; Liras, S; Price, DA; Mathiowetz, AM; Jacobson, MP; Lokey, RS				White, Tina R.; Renzelman, Chad M.; Rand, Arthur C.; Rezai, Taha; McEwen, Cayla M.; Gelev, Vladimir M.; Turner, Rushia A.; Linington, Roger G.; Leung, Siegfried S. F.; Kalgutkar, Amit S.; Bauman, Jonathan N.; Zhang, Yizhong; Liras, Spiros; Price, David A.; Mathiowetz, Alan M.; Jacobson, Matthew P.; Lokey, R. Scott			On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds	NATURE CHEMICAL BIOLOGY			English	Article							PASSIVE MEMBRANE-PERMEABILITY; HYDROGEN-BOND; RGD PEPTIDES; CONFORMATION; PREDICTION; PERMEATION; CRYSTAL; CACO-2; SOMATOSTATIN; LIBRARIES	Backbone N-methylation is common among peptide natural products and has a substantial impact on both the physical properties and the conformational states of cyclic peptides. However, the specific impact of N-methylation on passive membrane diffusion in cyclic peptides has not been investigated systematically. Here we report a method for the selective, on-resin N-methylation of cyclic peptides to generate compounds with drug-like membrane permeability and oral bioavailability. The selectivity and degree of N-methylation of the cyclic peptide was dependent on backbone stereochemistry, suggesting that conformation dictates the regiochemistry of the N-methylation reaction. The permeabilities of the N-methyl variants were corroborated by computational studies on a 1,024-member virtual library of N-methyl cyclic peptides. One of the most permeable compounds, a cyclic hexapeptide (molecular mass = 755 Da) with three N-methyl groups, showed an oral bioavailability of 28% in rat.	[White, Tina R.; Renzelman, Chad M.; Rand, Arthur C.; Rezai, Taha; McEwen, Cayla M.; Turner, Rushia A.; Linington, Roger G.; Lokey, R. Scott] Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA; [Gelev, Vladimir M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Leung, Siegfried S. F.; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Kalgutkar, Amit S.; Bauman, Jonathan N.; Zhang, Yizhong] Pfizer Inc, Pharmacokinet & Drug Metab, Groton, CT 06340 USA; [Liras, Spiros; Price, David A.; Mathiowetz, Alan M.] Pfizer Inc, Worldwide Med Chem, Groton, CT 06340 USA	University of California System; University of California Santa Cruz; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California San Francisco; Pfizer; Pfizer	Lokey, RS (corresponding author), Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA.	matt.Jacobson@ucsf.edu; slokey@ucsc.edu	Jacobson, Matthew/Y-5161-2018; Linington, Roger/ABD-5582-2021	Jacobson, Matthew/0000-0001-6262-655X; Linington, Roger/0000-0003-1818-4971	US National Institutes of Health [GM084530-06, R01-GM086602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086602, R01GM084530] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The synthesis and analytical results were supported by US National Institutes of Health grant GM084530-06 (R.S.L.). The computational results were supported by US National Institutes of Health grant R01-GM086602 to M.P.J. M.P.J. is a consultant to Schrodinger LLC. Cell-based assays and in vivo pharmacokinetics were provided by Pfizer.	Ashwood VA, 2001, J MED CHEM, V44, P2276, DOI 10.1021/jm010825z; Bauer RA, 2010, CURR OPIN CHEM BIOL, V14, P308, DOI 10.1016/j.cbpa.2010.02.001; Bermejo M, 2004, EUR J PHARM SCI, V21, P429, DOI 10.1016/j.ejps.2003.10.009; Biron E, 2008, ANGEW CHEM INT EDIT, V47, P2595, DOI 10.1002/anie.200705797; Boguslavsky V, 2003, J PEPT RES, V61, P287, DOI 10.1034/j.1399-3011.2003.00047.x; Chatterjee J, 2008, ACCOUNTS CHEM RES, V41, P1331, DOI 10.1021/ar8000603; Davies JS, 2003, J PEPT SCI, V9, P471, DOI 10.1002/psc.491; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Doedens L, 2010, J AM CHEM SOC, V132, P8115, DOI 10.1021/ja101428m; Dorner B, 1997, ADV AMIN AC MIM PEPT, V1, P109; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Fujikawa M, 2005, BIOORGAN MED CHEM, V13, P4721, DOI 10.1016/j.bmc.2005.04.076; Fukushima K, 2008, BIOL PHARM BULL, V31, P1209, DOI 10.1248/bpb.31.1209; Fukushima K, 2009, BIOMED PHARMACOTHER, V63, P635, DOI 10.1016/j.biopha.2009.01.008; Gudmundsson OS, 1999, J PEPT RES, V53, P383, DOI 10.1034/j.1399-3011.1999.00076.x; GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x; Houghten RA, 1996, MOL DIVERS, V2, P41, DOI 10.1007/BF01718699; Hwang KK, 2003, J PHARM PHARM SCI, V6, P315; In Y, 1999, J PEPT RES, V53, P492, DOI 10.1034/j.1399-3011.1999.00046.x; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jin Mingji, 2005, Drug Metab Pharmacokinet, V20, P324, DOI 10.2133/dmpk.20.324; Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e; Kim YK, 2004, J AM CHEM SOC, V126, P14740, DOI 10.1021/ja048170p; Knipp GT, 1997, PHARMACEUT RES, V14, P1332, DOI 10.1023/A:1012152117703; LOOSLI HR, 1985, HELV CHIM ACTA, V68, P682, DOI 10.1002/hlca.19850680319; Miller SC, 1997, J AM CHEM SOC, V119, P2301, DOI 10.1021/ja9635443; Ovadia O, 2011, MOL PHARMACEUT, V8, P479, DOI 10.1021/mp1003306; Rezai T, 2006, J AM CHEM SOC, V128, P2510, DOI 10.1021/ja0563455; Rezai T, 2006, J AM CHEM SOC, V128, P14073, DOI 10.1021/ja063076p; Steffel LR, 2007, J AM CHEM SOC, V129, P12956, DOI 10.1021/ja076185s; STEINER JR, 1988, INT J PEPT PROT RES, V31, P212; VEBER DF, 1981, NATURE, V292, P55, DOI 10.1038/292055a0	32	259	272	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2011	7	11					810	817		10.1038/nchembio.664	http://dx.doi.org/10.1038/nchembio.664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	839PX	21946276	Green Accepted, Green Submitted			2022-12-27	WOS:000296381600011
J	Chen, T; Ozel, D; Qiao, Y; Harbinski, F; Chen, LM; Denoyelle, S; He, XY; Zvereva, N; Supko, JG; Chorev, M; Halperin, JA; Aktas, BH				Chen, Ting; Ozel, Duygu; Qiao, Yuan; Harbinski, Fred; Chen, Limo; Denoyelle, Severine; He, Xiaoying; Zvereva, Nela; Supko, Jeffrey G.; Chorev, Michael; Halperin, Jose A.; Aktas, Bertal H.			Chemical genetics identify eIF2 alpha kinase heme-regulated inhibitor as an anticancer target	NATURE CHEMICAL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INITIATION-FACTORS; PROTEIN-KINASE; TRANSLATIONAL CONTROL; EXPRESSION; CELLS; PERK; ACTIVATION; DEPLETION; PKR	Translation initiation plays a critical role in cellular homeostasis, proliferation, differentiation and malignant transformation. Consistently, increasing the abundance of the eIF2-GTP-tRNA(i)(Met) translation initiation complex transforms normal cells and contributes to cancer initiation and the severity of some anemias. The chemical modifiers of the eIF2-GTP-tRNA(i)(Met) ternary complex are therefore invaluable tools for studying its role in the pathobiology of human disorders and for determining whether this complex can be pharmacologically targeted for therapeutic purposes. Using a cell-based assay, we identified N,N'-diarylureas as unique inhibitors of ternary complex accumulation. Direct functional-genetic and biochemical evidence demonstrated that the N,N'-diarylureas activate heme-regulated inhibitor kinase, thereby phosphorylating eIF2 alpha and reducing the abundance of the ternary complex. Using tumor cell proliferation in vitro and tumor growth in vivo as paradigms, we demonstrate that N,N'-diarylureas are potent and specific tools for studying the role of eIF2-GTP-tRNA(i)(Met) ternary complex in the pathobiology of human disorders.	[Chen, Ting; Ozel, Duygu; Qiao, Yuan; Harbinski, Fred; Chen, Limo; Denoyelle, Severine; Chorev, Michael; Halperin, Jose A.; Aktas, Bertal H.] Harvard Univ, Sch Med, Lab Translat Res, Boston, MA 02115 USA; [He, Xiaoying; Zvereva, Nela; Supko, Jeffrey G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Chorev, Michael; Halperin, Jose A.; Aktas, Bertal H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Chen, T (corresponding author), Harvard Univ, Sch Med, Lab Translat Res, Boston, MA 02115 USA.	huseyin_aktas@hms.harvard.edu	Chen, Ting/A-2124-2012	Chen, Ting/0000-0003-1725-7956	NIH [NCDDG 5 U19 CA87427]; Susan B. Komen Foundation for Cancer Research [BCTR0707713]; US Department of Defense [W81ZWH-05-1-0096]; US National Institutes of Health [R21AG032546]; NATIONAL CANCER INSTITUTE [U19CA087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan B. Komen Foundation for Cancer Research(Susan G. Komen Breast Cancer Foundation); US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D.C. Tosteson (Harvard Medical School), mentor and role model to authors, for encouragement; J.J. Chen for providing the HRI expression plasmid; and M. Tosteson for critical comments on the manuscript. This work was supported in part by NIH grant NCDDG 5 U19 CA87427 to J.A.H., Susan B. Komen Foundation for Cancer Research grant BCTR0707713, US Department of Defense grant no. W81ZWH-05-1-0096 and US National Institutes of Health grant no. R21AG032546 to B.H.A.	Abraham N, 1998, EXP CELL RES, V244, P394, DOI 10.1006/excr.1998.4201; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Biason-Lauber A, 2002, DIABETES, V51, P2301, DOI 10.2337/diabetes.51.7.2301; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Han AP, 2005, J CLIN INVEST, V115, P1562, DOI 10.1172/JCI24141; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Heaney JD, 2009, HUM MOL GENET, V18, P1395, DOI 10.1093/hmg/ddp045; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; KOROMILAS AE, 1995, J BIOL CHEM, V270, P25426, DOI 10.1074/jbc.270.43.25426; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Marbach I, 2001, J BIOL CHEM, V276, P16944, DOI 10.1074/jbc.M100383200; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Palakurthi SS, 2001, CANCER RES, V61, P6213; PROSTKO CR, 1995, J BIOL CHEM, V270, P6211, DOI 10.1074/jbc.270.11.6211; Ranganathan AC, 2008, CANCER RES, V68, P3260, DOI 10.1158/0008-5472.CAN-07-6215; Rosenwald IB, 2003, CANCER-AM CANCER SOC, V98, P1080, DOI 10.1002/cncr.11619; Rosenwald IB, 2008, HUM PATHOL, V39, P910, DOI 10.1016/j.humpath.2007.10.021; ROSENWALD LB, 2001, CANCER, V92, P2164; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Skalnikova H, 2008, PROTEOMICS, V8, P4547, DOI 10.1002/pmic.200800096; SRIVASTAVA SP, 1995, J BIOL CHEM, V270, P16619, DOI 10.1074/jbc.270.28.16619; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ziegeler G, 2010, J BIOL CHEM, V285, P15408, DOI 10.1074/jbc.M110.113365	42	74	80	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2011	7	9					610	616		10.1038/NCHEMBIO.613	http://dx.doi.org/10.1038/NCHEMBIO.613			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	813QG	21765405	Green Accepted, Green Submitted			2022-12-27	WOS:000294381400011
J	Stelzer, AC; Frank, AT; Kratz, JD; Swanson, MD; Gonzalez-Hernandez, MJ; Lee, J; Andricioaei, I; Markovitz, DM; Al-Hashimi, HM				Stelzer, Andrew C.; Frank, Aaron T.; Kratz, Jeremy D.; Swanson, Michael D.; Gonzalez-Hernandez, Marta J.; Lee, Janghyun; Andricioaei, Ioan; Markovitz, David M.; Al-Hashimi, Hashim M.			Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble	NATURE CHEMICAL BIOLOGY			English	Article							HIV-1 TAR RNA; PROTEIN RECOGNITION; NMR-SPECTROSCOPY; INDUCED FIT; BINDING; CONFORMATION; FLUORESCENCE; DESIGN; LIGANDS; BULGE	Current approaches used to identify protein-binding small molecules are not suited for identifying small molecules that can bind emerging RNA drug targets. By docking small molecules onto an RNA dynamic ensemble constructed by combining NMR spectroscopy and computational molecular dynamics, we virtually screened small molecules that target the entire structure landscape of the transactivation response element (TAR) from HIV type 1 (HIV-1). We quantitatively predict binding energies for small molecules that bind different RNA conformations and report the de novo discovery of six compounds that bind TAR with high affinity and inhibit its interaction with a Tat peptide in vitro (K(i) values of 710 nM-169 mu M). One compound binds HIV-1 TAR with marked selectivity and inhibits Tat-mediated activation of the HIV-1 long terminal repeat by 81% in T-cell lines and HIV replication in an HIV-1 indicator cell line (IC(50) similar to 23.1 mu M).	[Stelzer, Andrew C.; Kratz, Jeremy D.; Lee, Janghyun; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Frank, Aaron T.; Andricioaei, Ioan] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Swanson, Michael D.; Gonzalez-Hernandez, Marta J.; Markovitz, David M.] Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of California System; University of California Irvine; University of Michigan System; University of Michigan	Stelzer, AC (corresponding author), Nymirum, Ann Arbor, MI USA.	hashimi@umich.edu		Frank, Aaron/0000-0002-7782-2200	US National Institutes of Health [R01 AI066975-01, R01 CA144043]; US National Science Foundation [CHE-0918817]; NSF; NATIONAL CANCER INSTITUTE [F31CA150523, R01CA144043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008078] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A.V. Kurochkin for NMR expertise, and we thank the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for support of the purchase of a 600-MHz spectrometer. This work was supported by the US National Institutes of Health (R01 AI066975-01 and R01 CA144043), the US National Science Foundation (NSF Career Award CHE-0918817) and an NSF Graduate Research Fellowship for A.C.S. and A.T.F.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Blount KF, 2005, J AM CHEM SOC, V127, P9818, DOI 10.1021/ja050918w; Blount KF, 2003, NUCLEIC ACIDS RES, V31, P5490, DOI 10.1093/nar/gkg755; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bradrick TD, 2004, RNA, V10, P1459, DOI 10.1261/rna.7620304; Cabrera C, 2002, ANTIVIR RES, V53, P1, DOI 10.1016/S0166-3542(01)00188-7; Chen Y, 2007, BIOPHYS J, V93, P2300, DOI [10.1529/biophysj.107.104174, 10.1529/biophysj.l07.104174]; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Clore GM, 2004, BIOCHEMISTRY-US, V43, P10678, DOI 10.1021/bi049357w; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Davidson A, 2011, NUCLEIC ACIDS RES, V39, P248, DOI 10.1093/nar/gkq713; Davidson A, 2009, P NATL ACAD SCI USA, V106, P11931, DOI 10.1073/pnas.0900629106; DeJong ES, 2003, BIOCHEMISTRY-US, V42, P8035, DOI 10.1021/bi034252z; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Faber C, 2000, J BIOL CHEM, V275, P20660, DOI 10.1074/jbc.M000920200; Filikov AV, 2000, J COMPUT AID MOL DES, V14, P593, DOI 10.1023/A:1008121029716; Frank AT, 2009, NUCLEIC ACIDS RES, V37, P3670, DOI 10.1093/nar/gkp156; Fulle S, 2010, J MOL RECOGNIT, V23, P220, DOI 10.1002/jmr.1000; Guilbert C, 2008, J CHEM INF MODEL, V48, P1257, DOI 10.1021/ci8000327; Hermann T, 2002, BIOCHIMIE, V84, P869, DOI 10.1016/S0300-9084(02)01460-8; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; Kaul M, 2004, J AM CHEM SOC, V126, P3447, DOI 10.1021/ja030568i; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lapidot A, 2004, FEBS LETT, V577, P415, DOI 10.1016/j.febslet.2004.10.038; Lapidot A, 2008, FEBS J, V275, P5236, DOI 10.1111/j.1742-4658.2008.06657.x; Latham MP, 2009, J AM CHEM SOC, V131, P5052, DOI 10.1021/ja900695m; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; Matsumoto C, 2000, BIOORG MED CHEM LETT, V10, P1857, DOI 10.1016/S0960-894X(00)00359-0; Parolin C, 2003, ANTIMICROB AGENTS CH, V47, P889, DOI 10.1128/AAC.47.3.889-896.2003; Parsons J, 2009, NAT CHEM BIOL, V5, P823, DOI 10.1038/nchembio.217; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Stelzer AC, 2010, ANGEW CHEM INT EDIT, V49, P5731, DOI 10.1002/anie.201000814; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Vaiana AC, 2009, J MOL BIOL, V386, P648, DOI 10.1016/j.jmb.2008.12.035; WHITE RJ, 1985, INVEST NEW DRUG, V3, P85; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Yang Ming, 2005, Current Drug Targets - Infectious Disorders, V5, P433, DOI 10.2174/156800505774912901; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488	43	181	186	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2011	7	8					553	559		10.1038/NCHEMBIO.596	http://dx.doi.org/10.1038/NCHEMBIO.596			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	793LW	21706033	Green Accepted			2022-12-27	WOS:000292825400017
